data_1j3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j3g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.27 168.75 18.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 44.18 57.98 3.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.189 1.795 . . . . 1.0 109.711 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.49 156.25 41.68 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.958 2.103 . . . . 1.0 108.91 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -93.28 125.13 37.72 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -83.62 118.7 24.01 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.19 66.72 60.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.67 123.44 11.7 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 N-CA-C 108.339 -1.447 . . . . 1.0 108.339 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 t -54.82 142.71 53.71 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 123.193 0.597 . . . . 1.0 111.581 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.35 -12.01 24.99 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 116.039 1.515 . . . . 1.0 116.039 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -151.74 111.37 3.99 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -79.6 178.76 7.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.11 0.868 . . . . 1.0 110.532 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.0 -173.22 2.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.341 2.656 . . . . 1.0 109.916 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.8 m -165.66 118.13 1.13 Allowed 'General case' 0 CA--C 1.54 0.569 1 C-N-CA 131.705 4.002 . . . . 1.0 104.65 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.26 139.08 28.92 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 120.349 1.431 . . . . 1.0 109.809 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 70.03 6.07 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 124.449 3.433 . . . . 1.0 113.467 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -143.52 154.65 43.84 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.598 1.559 . . . . 1.0 108.68 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -151.19 103.43 3.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.354 0.979 . . . . 1.0 112.127 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' CD ' ' HE ' ' A' ' 105' ' ' ARG . 28.9 tp10 -136.61 147.04 46.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 129.423 3.089 . . . . 1.0 104.68 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -59.66 123.79 72.93 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 119.949 1.25 . . . . 1.0 111.476 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.96 103.85 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.023 2.482 . . . . 1.0 111.847 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -172.24 79.39 0.05 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.703 1.601 . . . . 1.0 107.444 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.8 tp -139.93 133.66 30.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 tp -97.2 123.17 40.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.465 1.029 . . . . 1.0 108.311 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.69 118.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.957 -1.498 . . . . 1.0 106.957 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -116.02 114.79 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.289 -2.115 . . . . 1.0 105.289 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.6 p80 -167.34 152.33 7.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.267 -1.382 . . . . 1.0 107.267 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.67 112.23 24.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -127.51 175.95 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.597 1.959 . . . . 1.0 109.127 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 122.4 3.49 Favored 'General case' 0 N--CA 1.442 -0.869 1 N-CA-C 99.099 -4.408 . . . . 1.0 99.099 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -142.2 -48.4 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 118.174 -0.917 . . . . 1.0 108.979 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 39.0 Cg_endo -91.1 146.51 3.61 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 121.791 1.661 . . . . 1.0 114.465 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.48 44.3 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.508 3.472 . . . . 1.0 113.967 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.17 -65.02 2.0 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.971 -1.08 . . . . 1.0 111.71 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -152.35 122.78 7.26 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.886 -1.894 . . . . 1.0 105.886 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -176.42 175.85 1.72 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.782 2.833 . . . . 1.0 108.547 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.6 27.12 3.98 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.636 2.065 . . . . 1.0 109.634 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.13 118.18 6.1 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 106.037 -2.825 . . . . 1.0 106.037 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.26 -17.45 35.3 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 119.796 1.798 . . . . 1.0 115.13 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -66.14 -43.3 87.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.011 1.278 . . . . 1.0 110.996 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.02 -47.18 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.059 0.943 . . . . 1.0 109.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.9 -35.86 81.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.351 -0.843 . . . . 1.0 112.154 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -33.47 68.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.013 0.925 . . . . 1.0 111.498 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.38 -54.58 43.87 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.511 -0.743 . . . . 1.0 109.893 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -66.77 -45.37 78.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.805 -0.617 . . . . 1.0 111.751 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 t -63.62 -39.39 94.23 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.33 3.26 22.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.412 1.958 . . . . 1.0 114.775 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -88.63 9.01 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.947 1.874 . . . . 1.0 112.627 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 tt -54.58 136.02 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.465 0.575 . . . . 1.0 110.896 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.22 136.6 19.17 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 127.71 2.404 . . . . 1.0 108.689 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.29 60.89 3.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.12 3.214 . . . . 1.0 112.719 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.48 -49.13 3.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 117.795 -1.098 . . . . 1.0 112.793 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.4 0.41 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.505 1.048 . . . . 1.0 112.079 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -163.57 177.83 1.71 Allowed Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -70.43 -43.85 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.458 1.438 . . . . 1.0 114.834 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -51.47 -57.89 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.366 1.439 . . . . 1.0 111.999 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.47 -51.14 71.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.817 0.847 . . . . 1.0 110.182 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.86 -43.93 86.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 1.0 111.17 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -65.18 3.75 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.329 1.442 . . . . 1.0 110.535 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.27 -25.54 30.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-O 115.92 -1.991 . . . . 1.0 113.639 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.75 -43.04 5.82 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.966 1.712 . . . . 1.0 113.209 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -54.98 -38.28 67.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.419 1.488 . . . . 1.0 111.075 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.51 135.29 33.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.096 -1.816 . . . . 1.0 106.096 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 158.92 27.32 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.738 -1.227 . . . . 1.0 108.343 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.44 161.59 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.8 122.91 1.43 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.83 -154.0 0.42 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.969 1.308 . . . . 1.0 107.624 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -131.15 -67.16 0.71 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.67 1.123 . . . . 1.0 111.132 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.58 119.15 16.99 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.344 -2.095 . . . . 1.0 105.344 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tt -113.29 118.08 33.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.116 1.766 . . . . 1.0 107.571 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -100.71 113.98 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.194 -1.78 . . . . 1.0 106.194 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -83.3 153.79 24.45 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 120.041 1.291 . . . . 1.0 108.636 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -17.94 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 128.939 2.896 . . . . 1.0 115.624 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 27.13 2.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.06 1.3 . . . . 1.0 112.668 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.26 42.75 99.87 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.544 1.069 . . . . 1.0 112.592 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.08 149.22 29.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.366 1.083 . . . . 1.0 108.837 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.05 119.08 60.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.606 -1.257 . . . . 1.0 107.606 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.46 147.82 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.402 -2.073 . . . . 1.0 105.402 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.69 122.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.618 -1.252 . . . . 1.0 107.618 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -120.98 113.69 20.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.876 -2.268 . . . . 1.0 104.876 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t 79.84 92.1 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.448 1.476 . . . . 1.0 111.439 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -61.7 -175.76 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.615 1.543 . . . . 1.0 110.877 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -58.34 5.49 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.89 2.476 . . . . 1.0 114.294 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.41 115.25 19.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.168 2.587 . . . . 1.0 108.795 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 85.81 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.67 2.788 . . . . 1.0 112.288 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -32.56 138.05 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.753 3.221 . . . . 1.0 115.642 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.58 -178.12 3.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 129.273 3.029 . . . . 1.0 111.945 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -155.06 118.33 4.44 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.477 1.511 . . . . 1.0 110.628 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 7.4 p80 -158.23 63.13 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.068 -1.645 . . . . 1.0 112.204 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.96 -56.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 118.734 -2.479 . . . . 1.0 114.148 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.03 -79.8 0.29 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 104.017 -3.633 . . . . 1.0 104.017 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.98 146.63 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.063 2.145 . . . . 1.0 108.881 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.6 p -156.18 150.72 25.81 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.533 1.533 . . . . 1.0 110.209 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.2 p -143.65 145.72 32.69 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 119.69 1.132 . . . . 1.0 111.248 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.42 145.29 21.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.83 -1.544 . . . . 1.0 106.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 42.08 53.85 4.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.976 1.71 . . . . 1.0 113.051 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.52 28.43 67.57 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.608 0.623 . . . . 1.0 113.375 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.433 ' HE ' ' CD ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -131.53 116.44 17.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 176.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -103.65 135.31 45.45 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -105.57 118.24 36.07 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.175 -2.528 . . . . 1.0 104.175 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.57 -25.47 66.23 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.745 1.618 . . . . 1.0 111.542 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -154.26 170.4 21.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.611 2.764 . . . . 1.0 107.588 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 6.3 t70 -84.76 76.71 10.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.32 33.65 2.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.243 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -132.9 142.72 49.05 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 124.483 1.113 . . . . 1.0 110.568 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -79.19 56.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 127.09 2.156 . . . . 1.0 110.806 -176.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.5 -136.5 1.7 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.946 -1.097 . . . . 1.0 113.034 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.6 mm -142.57 165.3 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 130.515 3.526 . . . . 1.0 102.985 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -145.82 138.58 25.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 103.7 -2.704 . . . . 1.0 103.7 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.0 149.04 24.34 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.485 -1.384 . . . . 1.0 109.269 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -124.52 139.74 53.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.614 0.721 . . . . 1.0 111.151 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.39 -177.55 30.61 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 127.676 2.56 . . . . 1.0 108.701 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 p -145.96 108.28 4.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.601 -2.37 . . . . 1.0 104.601 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.54 43.54 28.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.24 1.016 . . . . 1.0 112.528 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p 49.57 38.55 15.02 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.67 1.988 . . . . 1.0 113.706 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.66 136.16 56.67 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -25.9 114.03 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.999 2.12 . . . . 1.0 113.431 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.87 -15.31 58.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 116.36 -1.781 . . . . 1.0 113.908 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.351 28.7 p 65.59 77.06 0.31 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.862 1.664 . . . . 1.0 111.668 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -23.22 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.069 1.748 . . . . 1.0 113.993 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.0 -38.91 3.77 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.65 1.98 . . . . 1.0 110.442 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -49.39 -51.9 31.98 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.268 1.427 . . . . 1.0 109.643 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.8 -42.08 96.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.029 0.932 . . . . 1.0 110.207 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -65.66 -51.6 58.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.089 0.955 . . . . 1.0 110.353 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -65.97 -43.62 87.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.669 0.788 . . . . 1.0 110.679 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.4 tp -55.38 -51.53 66.51 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.74 67.78 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.316 0.962 . . . . 1.0 111.488 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.47 56.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.127 0.971 . . . . 1.0 110.787 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.22 -51.27 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.3 m -54.63 -36.7 64.78 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.659 1.583 . . . . 1.0 111.882 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -60.68 -46.67 89.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.884 1.674 . . . . 1.0 109.462 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.79 62.84 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-O 119.412 -0.327 . . . . 1.0 110.871 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.91 -39.09 71.13 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.02 -45.02 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.426 1.012 . . . . 1.0 108.916 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.7 m -65.76 -19.13 65.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.217 0.607 . . . . 1.0 111.182 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -84.16 -63.22 1.38 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.931 1.292 . . . . 1.0 107.858 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -126.06 112.98 24.14 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.57 107.94 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 120.237 1.12 . . . . 1.0 111.724 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.25 -52.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.387 1.875 . . . . 1.0 107.39 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 mt -45.98 -33.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 131.146 3.778 . . . . 1.0 111.061 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.86 -26.03 9.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.673 1.189 . . . . 1.0 112.987 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -136.32 23.67 3.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.359 1.863 . . . . 1.0 109.755 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -138.51 83.6 1.97 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -127.24 120.85 29.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.09 -1.818 . . . . 1.0 106.09 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.2 t -154.53 -170.48 3.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.77 -131.58 1.76 Allowed Glycine 0 CA--C 1.517 0.181 0 N-CA-C 106.818 -2.513 . . . . 1.0 106.818 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 10.8 m170 -113.53 -22.97 10.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.069 1.434 . . . . 1.0 111.576 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.0 t -103.23 -8.55 20.29 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -89.04 28.25 1.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.737 1.215 . . . . 1.0 109.147 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.75 -14.87 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 121.389 -0.82 . . . . 1.0 110.45 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.67 -53.54 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.683 . . . . 1.0 112.582 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.43 108.63 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.91 1.718 . . . . 1.0 111.385 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.02 -14.61 55.5 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.875 -1.141 . . . . 1.0 113.117 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.66 -6.3 36.0 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.156 -1.59 . . . . 1.0 111.601 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -136.93 141.05 42.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.875 -1.898 . . . . 1.0 105.875 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 3.1 m -132.78 -16.78 2.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.862 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.84 -178.87 0.34 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.39 63.27 7.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.304 2.002 . . . . 1.0 109.102 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 141.28 74.57 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.123 1.821 . . . . 1.0 111.653 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.13 -98.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 1.0 110.837 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.4 t 53.84 43.86 30.35 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.801 1.64 . . . . 1.0 112.533 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -106.32 18.45 21.98 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.054 0.942 . . . . 1.0 110.387 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.296 9.3 t0 42.95 82.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.866 2.467 . . . . 1.0 112.355 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -55.4 -34.95 64.83 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.55 -0.75 . . . . 1.0 112.821 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.09 -45.98 79.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.573 -0.727 . . . . 1.0 110.647 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -58.93 -56.78 17.89 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.846 0.748 . . . . 1.0 110.12 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -59.08 -53.24 60.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -61.52 -33.79 74.43 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.403 -0.808 . . . . 1.0 111.906 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.47 86.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.695 0.68 . . . . 1.0 111.818 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.14 -51.92 27.63 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.523 0.729 . . . . 1.0 110.37 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.6 166.41 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.381 1.073 . . . . 1.0 108.335 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 126.281 1.832 . . . . 1.0 109.334 176.071 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--O 1.235 0.304 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.98 170.89 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.632 1.173 . . . . 1.0 110.661 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 40.58 58.38 2.38 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.182 1.793 . . . . 1.0 111.221 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.76 156.34 38.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.644 1.578 . . . . 1.0 110.112 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -78.4 130.05 35.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.12 140.34 45.75 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.183 -0.948 . . . . 1.0 110.265 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -142.74 71.84 19.82 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.479 -1.674 . . . . 1.0 106.479 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.6 123.2 9.91 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 N-CA-C 107.784 -1.66 . . . . 1.0 107.784 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -121.85 132.09 24.3 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.98 52.97 4.53 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.189 1.926 . . . . 1.0 111.177 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -124.13 43.11 3.08 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.24 178.21 5.95 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.076 0.465 . . . . 1.0 110.045 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.73 -178.25 4.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 1.0 108.51 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.5 m -154.95 131.36 10.46 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 128.623 2.769 . . . . 1.0 103.674 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -130.55 140.05 37.5 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.791 1.632 . . . . 1.0 109.628 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.05 40.19 0.85 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.36 3.374 . . . . 1.0 116.84 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.24 149.78 44.73 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.293 2.637 . . . . 1.0 108.834 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -151.61 120.13 6.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.936 1.694 . . . . 1.0 111.682 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 27' ' ' ASN . 10.5 tt0 -136.62 172.74 12.56 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 174.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.415 ' H ' ' HG2' ' A' ' 26' ' ' GLU . 8.0 t30 -64.69 123.82 84.42 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 175.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.58 103.6 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.768 1.645 . . . . 1.0 110.706 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -170.83 77.16 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.711 -1.588 . . . . 1.0 106.711 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.16 124.34 12.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.54 126.08 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.87 134.26 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.76 123.78 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -176.56 150.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.116 1.766 . . . . 1.0 107.884 175.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.5 112.61 24.6 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' CG2' ' H ' ' A' ' 37' ' ' SER . 26.3 mm -127.65 176.78 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 128.024 2.53 . . . . 1.0 105.067 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.426 ' H ' ' CG2' ' A' ' 36' ' ' ILE . 28.8 t -151.09 122.22 7.72 Favored 'General case' 0 C--N 1.313 -0.995 1 N-CA-C 94.003 -6.295 . . . . 1.0 94.003 174.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.318 0.2 OUTLIER -142.66 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 119.827 1.194 . . . . 1.0 110.427 175.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.36 153.47 27.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.041 1.828 . . . . 1.0 112.042 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -82.0 53.61 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.673 2.916 . . . . 1.0 114.232 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.72 -70.81 0.65 Allowed Glycine 0 CA--C 1.535 1.317 0 N-CA-C 108.269 -1.932 . . . . 1.0 108.269 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -155.82 123.09 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.221 2.609 . . . . 1.0 106.549 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -169.73 173.44 6.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.956 2.902 . . . . 1.0 105.913 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.8 31.37 2.48 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.674 1.607 . . . . 1.0 109.298 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 118.9 6.28 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 107.605 -2.198 . . . . 1.0 107.605 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.34 -9.62 26.3 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-N 120.842 2.321 . . . . 1.0 113.339 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -65.52 -47.43 75.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.802 1.183 . . . . 1.0 109.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 mm -59.22 -43.84 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.799 0.84 . . . . 1.0 109.668 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.28 -46.36 90.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.267 0.627 . . . . 1.0 111.462 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.8 67.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.135 1.374 . . . . 1.0 111.677 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.68 -57.07 12.32 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.196 -0.94 . . . . 1.0 109.352 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -42.98 85.86 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 t -66.4 -35.4 80.22 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.475 0.58 . . . . 1.0 110.59 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.46 60.23 1.11 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.373 1.94 . . . . 1.0 112.103 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 p -136.58 8.85 3.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.201 1.8 . . . . 1.0 111.588 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.34 134.78 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.116 0.966 . . . . 1.0 112.508 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 136.64 20.33 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.668 2.787 . . . . 1.0 108.834 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.63 69.74 1.55 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.216 3.278 . . . . 1.0 112.435 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -103.35 -56.64 2.18 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.659 0.784 . . . . 1.0 110.966 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.47 -55.04 36.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.979 0.512 . . . . 1.0 111.321 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -171.08 177.89 0.88 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.149 1.779 . . . . 1.0 107.615 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.55 -43.39 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.866 1.71 . . . . 1.0 114.804 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -50.19 -54.76 18.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.577 1.08 . . . . 1.0 113.475 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.0 -52.93 63.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.964 0.802 . . . . 1.0 111.118 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.51 98.3 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.465 0.706 . . . . 1.0 111.904 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.93 -57.69 17.04 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.283 0.944 . . . . 1.0 110.94 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.79 -27.33 42.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-O 115.964 -1.97 . . . . 1.0 112.99 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.83 -43.26 2.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.153 1.781 . . . . 1.0 114.489 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -57.58 -43.36 84.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.031 1.333 . . . . 1.0 111.116 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.6 127.37 32.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 148.55 51.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.382 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.86 163.19 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.064 2.146 . . . . 1.0 109.843 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 m -172.33 133.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.872 2.469 . . . . 1.0 106.27 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.46 -154.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.137 1.375 . . . . 1.0 107.461 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.48 -59.21 0.92 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.95 1.3 . . . . 1.0 108.999 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 57.4 m -136.88 118.73 15.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.096 -1.446 . . . . 1.0 107.096 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -102.48 113.85 27.54 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.82 122.89 53.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -89.8 156.65 18.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.853 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -22.66 2.58 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 126.967 2.107 . . . . 1.0 113.533 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -91.75 19.75 6.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.915 1.686 . . . . 1.0 113.699 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.16 35.8 91.39 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.614 1.578 . . . . 1.0 112.821 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.43 109.25 22.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.16 113.45 19.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 105.263 -2.125 . . . . 1.0 105.263 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -111.81 147.8 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.295 1.438 . . . . 1.0 107.306 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.2 120.24 29.55 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.386 1.074 . . . . 1.0 109.618 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.44 129.97 53.3 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.255 64.3 t 63.75 91.46 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 121.498 1.953 . . . . 1.0 113.76 175.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.89 -169.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.394 3.396 . . . . 1.0 116.387 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.85 24.15 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.012 2.525 . . . . 1.0 110.487 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -144.57 119.47 9.95 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.469 2.707 . . . . 1.0 107.855 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.471 ' HB2' ' HZ3' ' A' ' 92' ' ' LYS 0.308 3.4 ttmp? 85.96 81.48 0.02 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.877 1.671 . . . . 1.0 111.717 175.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -34.89 145.16 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.973 2.509 . . . . 1.0 111.942 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.12 172.4 8.28 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.258 1.423 . . . . 1.0 110.104 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.548 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 62.4 t90 -141.63 119.19 11.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.897 1.679 . . . . 1.0 109.722 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -159.38 63.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.151 0.977 . . . . 1.0 109.255 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.73 -70.74 0.03 OUTLIER 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.66 -1.9 . . . . 1.0 114.657 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.43 -91.02 0.48 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 105.834 -2.907 . . . . 1.0 105.834 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.2 t -144.44 146.46 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.92 1.86 . . . . 1.0 108.551 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -156.56 166.54 33.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.431 1.492 . . . . 1.0 108.924 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 157' ' ' ILE . 54.6 p -151.65 146.13 25.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -162.62 148.69 12.63 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 49.6 54.57 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.415 1.486 . . . . 1.0 110.83 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.04 29.45 62.37 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.995 1.283 . . . . 1.0 114.471 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.18 113.93 12.55 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.483 -1.302 . . . . 1.0 107.483 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -78.95 146.46 33.45 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.368 -1.345 . . . . 1.0 107.368 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -133.42 118.16 18.08 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.752 -1.944 . . . . 1.0 105.752 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.85 -40.24 96.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.286 0.634 . . . . 1.0 112.52 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 4.0 m120 -149.18 174.94 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.492 2.317 . . . . 1.0 106.979 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -89.85 75.05 7.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.359 1.552 . . . . 1.0 110.501 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 37.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 109.093 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -123.55 157.28 34.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.939 2.896 . . . . 1.0 109.819 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.277 0.1 OUTLIER -104.62 56.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.266 1.426 . . . . 1.0 108.096 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.79 -136.09 0.9 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-O 122.86 1.256 . . . . 1.0 112.163 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.6 mm -150.28 161.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 130.497 3.519 . . . . 1.0 104.236 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.79 128.61 17.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 103.334 -2.839 . . . . 1.0 103.334 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.4 154.34 19.74 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.1 138.66 54.41 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.547 0.739 . . . . 1.0 111.859 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.08 174.09 45.3 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.769 0.649 . . . . 1.0 112.613 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 p -133.92 97.09 3.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.044 2.137 . . . . 1.0 107.157 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.412 ' C ' ' HG1' ' A' ' 122' ' ' THR 0.322 25.0 t0 46.62 56.74 6.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.251 1.82 . . . . 1.0 114.102 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 121' ' ' ASP . 69.2 p 55.39 38.82 30.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.366 1.466 . . . . 1.0 112.563 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.57 133.95 53.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 104.956 -2.238 . . . . 1.0 104.956 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.12 113.45 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.212 2.205 . . . . 1.0 110.839 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -78.85 -11.61 60.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 115.14 -2.362 . . . . 1.0 116.679 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.349 18.2 p 59.57 77.86 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 121.662 2.028 . . . . 1.0 111.156 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -23.06 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.12 2.168 . . . . 1.0 114.593 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.31 -38.48 2.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.499 2.32 . . . . 1.0 109.433 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -53.8 -49.96 67.16 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 125.382 1.473 . . . . 1.0 110.688 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -56.48 -40.46 74.96 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.52 1.055 . . . . 1.0 109.668 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.72 -58.22 6.21 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.244 -0.408 . . . . 1.0 110.097 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -66.45 -37.99 86.37 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -47.06 87.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.84 80.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.036 0.835 . . . . 1.0 110.858 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -53.75 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.072 0.949 . . . . 1.0 111.21 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.8 t -58.04 -41.0 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.1 m -57.09 -46.28 82.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.272 . . . . 1.0 109.647 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.21 -48.19 82.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.53 1.059 . . . . 1.0 110.277 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.94 -48.6 81.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.172 0.589 . . . . 1.0 110.028 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -55.88 -46.86 78.21 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.873 1.269 . . . . 1.0 111.029 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.88 -42.22 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 118.858 0.754 . . . . 1.0 110.346 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.3 m -65.57 -13.91 59.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.178 0.991 . . . . 1.0 111.524 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -106.24 -54.02 2.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.496 1.518 . . . . 1.0 111.016 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -126.24 113.25 23.7 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 104.383 -2.451 . . . . 1.0 104.383 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -99.22 107.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.029 1.403 . . . . 1.0 114.554 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.27 -48.35 0.1 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.679 2.391 . . . . 1.0 107.642 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -46.19 -34.28 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 130.111 3.364 . . . . 1.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.86 -23.19 6.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.054 1.341 . . . . 1.0 114.275 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -137.18 18.42 2.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.719 1.607 . . . . 1.0 110.657 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -139.08 83.65 1.96 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.732 1.213 . . . . 1.0 108.213 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 114.1 21.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.036 -2.579 . . . . 1.0 104.036 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -151.08 -166.35 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.525 -0.734 . . . . 1.0 109.219 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.11 -131.79 1.5 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 108.66 -1.776 . . . . 1.0 108.66 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 11.4 m170 -109.01 -23.59 11.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 117.902 0.851 . . . . 1.0 111.066 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.28 -14.38 15.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.486 -0.769 . . . . 1.0 110.647 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -87.74 40.54 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.777 1.171 . . . . 1.0 109.158 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -66.27 -8.76 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 O-C-N 120.684 -1.26 . . . . 1.0 110.869 175.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.24 -53.79 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 127.953 2.501 . . . . 1.0 111.857 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -91.14 115.42 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.978 3.119 . . . . 1.0 113.618 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.23 -25.58 64.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.765 1.226 . . . . 1.0 113.124 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -63.65 -20.28 65.57 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.88 -1.137 . . . . 1.0 113.324 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -123.12 140.76 52.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.464 -2.05 . . . . 1.0 105.464 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.0 m -136.01 -16.73 1.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.546 -0.862 . . . . 1.0 111.508 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.43 177.95 0.47 Allowed Pre-proline 0 CA--C 1.546 0.805 1 C-N-CA 131.808 4.043 . . . . 1.0 103.53 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.05 86.93 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.517 1.478 . . . . 1.0 109.353 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.32 81.12 1.25 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.863 1.221 . . . . 1.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.72 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.154 2.57 . . . . 1.0 112.187 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 t 55.52 43.93 27.64 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.907 1.283 . . . . 1.0 114.08 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -115.33 17.82 16.36 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 120.203 1.365 . . . . 1.0 113.755 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.6 t0 43.91 69.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 1.0 112.206 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -56.37 -32.87 65.18 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.759 -0.638 . . . . 1.0 112.334 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -60.25 2.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.657 0.783 . . . . 1.0 110.605 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -41.81 96.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-O 118.13 -0.938 . . . . 1.0 110.574 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -59.81 -57.55 12.42 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 123.876 0.735 . . . . 1.0 110.737 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -40.71 75.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.71 0.686 . . . . 1.0 111.222 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.07 77.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.16 0.8 . . . . 1.0 113.16 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.25 -43.55 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.6 1.16 . . . . 1.0 113.036 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.87 166.63 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.186 1.794 . . . . 1.0 110.797 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 70.6 m . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 125.679 1.592 . . . . 1.0 108.263 175.522 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 119.119 -0.467 . . . . 1.0 110.996 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.29 27.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.208 1.003 . . . . 1.0 112.148 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 38.88 58.21 1.78 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.108 2.563 . . . . 1.0 112.057 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.85 136.06 17.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.263 -0.898 . . . . 1.0 109.104 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -73.11 123.46 23.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.364 -1.717 . . . . 1.0 106.364 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -92.92 118.87 31.63 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.536 -0.727 . . . . 1.0 110.855 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.52 72.25 20.79 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.29 1.036 . . . . 1.0 108.554 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.21 123.44 9.21 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.758 1.306 . . . . 1.0 109.904 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -87.32 114.17 57.4 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 106.379 -1.712 . . . . 1.0 106.379 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.52 55.86 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.676 2.251 . . . . 1.0 110.636 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -138.4 43.73 2.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.572 1.949 . . . . 1.0 109.437 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -73.65 178.35 4.8 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.083 1.142 . . . . 1.0 114.083 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.63 179.1 4.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 128.857 2.863 . . . . 1.0 109.805 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -165.28 118.78 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.966 4.506 . . . . 1.0 102.94 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 156.46 77.75 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.27 84.72 1.9 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.312 2.008 . . . . 1.0 111.696 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.1 145.26 16.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.329 1.852 . . . . 1.0 106.685 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -137.51 103.58 5.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.371 -1.344 . . . . 1.0 107.371 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -136.2 152.86 51.22 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.743 1.217 . . . . 1.0 108.677 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -71.98 123.41 89.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 103.271 -2.862 . . . . 1.0 103.271 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.5 106.16 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.416 2.077 . . . . 1.0 112.512 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 t -164.32 76.35 0.33 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.37 123.72 11.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.99 -1.856 . . . . 1.0 105.99 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.54 127.61 39.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.193 0.997 . . . . 1.0 108.474 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.47 140.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.9 t -135.86 113.94 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.847 -2.279 . . . . 1.0 104.847 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.49 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -163.16 129.85 3.41 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 115.944 -1.979 . . . . 1.0 108.194 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.42 HD21 ' N ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -72.69 112.52 8.82 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 117.443 -1.703 . . . . 1.0 106.746 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 HG13 ' CE1' ' A' ' 34' ' ' HIS . 14.4 mm -126.73 176.77 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 131.646 3.979 . . . . 1.0 108.587 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.409 ' H ' ' CG2' ' A' ' 36' ' ' ILE . 41.3 t -160.68 121.84 2.98 Favored 'General case' 0 C--O 1.247 0.973 1 N-CA-C 94.992 -5.929 . . . . 1.0 94.992 174.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.253 1.3 tm? -142.4 -57.37 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 121.032 -1.042 . . . . 1.0 111.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.16 144.26 26.4 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 122.674 2.249 . . . . 1.0 111.075 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.09 44.11 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.335 2.69 . . . . 1.0 114.657 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.18 -71.19 0.57 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -156.13 122.94 5.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.614 1.566 . . . . 1.0 111.234 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.318 18.8 m-85 -177.06 170.94 2.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 131.361 3.864 . . . . 1.0 109.619 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.08 27.28 7.12 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.434 1.016 . . . . 1.0 111.628 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.37 118.56 5.35 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 108.726 -1.75 . . . . 1.0 108.726 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.59 -15.81 48.78 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 120.096 1.948 . . . . 1.0 112.621 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -49.79 -47.85 50.95 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.513 1.125 . . . . 1.0 112.576 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.39 -45.09 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.96 -43.97 94.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.63 69.69 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.09 1.356 . . . . 1.0 111.489 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.89 -55.33 17.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 120.945 -1.097 . . . . 1.0 110.039 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.04 -43.03 79.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.87 -0.585 . . . . 1.0 111.893 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 t -65.84 -33.83 76.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.286 1.434 . . . . 1.0 109.994 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.57 -2.64 30.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.567 1.555 . . . . 1.0 115.163 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -88.81 9.93 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.75 2.275 . . . . 1.0 114.12 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 tt -47.68 129.55 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.274 1.829 . . . . 1.0 112.1 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.74 125.52 42.13 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 130.473 3.509 . . . . 1.0 108.957 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.38 75.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.494 3.462 . . . . 1.0 108.412 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -103.63 -64.23 1.11 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.441 0.297 . . . . 1.0 111.618 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.02 -52.01 65.74 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.98 0.912 . . . . 1.0 112.086 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -161.92 177.9 1.8 Allowed Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.561 1.545 . . . . 1.0 107.805 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.33 -43.43 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.823 1.682 . . . . 1.0 114.342 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -48.46 -43.65 34.81 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.118 0.967 . . . . 1.0 113.586 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.52 -55.6 32.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.839 0.856 . . . . 1.0 110.275 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.751 0.82 . . . . 1.0 110.697 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.65 -62.56 2.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.81 1.672 . . . . 1.0 111.536 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.1 pt -57.69 -35.54 51.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 116.752 -1.594 . . . . 1.0 112.76 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.0 -43.02 3.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.622 1.969 . . . . 1.0 115.735 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.26 -36.24 70.75 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.555 1.142 . . . . 1.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.03 136.76 33.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 102.502 -3.147 . . . . 1.0 102.502 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 155.81 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.622 -1.298 . . . . 1.0 109.14 175.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.47 155.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 123.593 0.757 . . . . 1.0 109.037 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -177.79 114.12 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.836 1.654 . . . . 1.0 110.012 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.96 -175.4 3.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -112.47 -76.85 0.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.977 1.262 . . . . 1.0 110.906 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.4 m -112.57 118.51 35.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp -101.26 113.44 26.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 103.605 -2.739 . . . . 1.0 103.605 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mt -105.98 113.22 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 103.852 -2.647 . . . . 1.0 103.852 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -81.59 153.79 26.53 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.772 0.714 . . . . 1.0 110.57 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.64 -13.5 0.4 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 126.229 1.812 . . . . 1.0 113.941 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -91.65 18.31 7.66 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.37 0.986 . . . . 1.0 111.241 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.34 45.35 96.63 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.115 -1.616 . . . . 1.0 111.601 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -112.97 143.96 43.36 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.91 114.32 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.28 142.74 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.522 -1.659 . . . . 1.0 106.522 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -126.22 114.44 18.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.947 0.899 . . . . 1.0 110.467 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -110.06 147.09 34.24 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 103.25 -2.87 . . . . 1.0 103.25 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.274 42.4 t 63.1 91.78 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 120.304 1.411 . . . . 1.0 114.362 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.21 -174.29 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 121.404 1.402 . . . . 1.0 111.985 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -72.87 49.92 0.25 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.781 1.233 . . . . 1.0 109.941 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -161.13 136.14 7.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.766 2.827 . . . . 1.0 105.33 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 54.78 81.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 129.376 3.07 . . . . 1.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.05 152.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.659 2.384 . . . . 1.0 111.545 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.83 -178.08 3.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.423 2.289 . . . . 1.0 111.055 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -149.88 118.4 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.855 1.262 . . . . 1.0 108.919 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -160.92 62.75 0.29 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.967 1.365 . . . . 1.0 110.209 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -163.95 -69.34 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 119.839 -1.788 . . . . 1.0 113.044 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 -90.89 0.51 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 103.246 -3.941 . . . . 1.0 103.246 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.94 142.15 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.742 1.271 . . . . 1.0 110.065 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -155.93 165.8 35.38 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.667 2.387 . . . . 1.0 108.066 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -159.81 126.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.972 -2.233 . . . . 1.0 104.972 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -151.52 151.13 31.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.718 1.145 . . . . 1.0 107.999 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 42.12 66.72 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.669 1.588 . . . . 1.0 109.75 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.31 29.53 5.2 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.81 1.672 . . . . 1.0 116.681 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -137.98 113.8 9.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.759 1.78 . . . . 1.0 106.835 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -80.91 146.37 30.83 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.574 1.15 . . . . 1.0 108.417 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -129.57 118.13 21.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.94 -24.49 63.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.98 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -152.98 176.26 12.06 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 128.623 2.769 . . . . 1.0 107.369 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.14 76.29 6.92 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.149 -1.426 . . . . 1.0 107.149 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -92.86 33.58 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.862 0.865 . . . . 1.0 112.392 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 m -124.53 156.51 37.22 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 125.508 1.523 . . . . 1.0 111.815 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.85 56.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.221 1.808 . . . . 1.0 107.713 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 -136.79 2.45 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.417 -0.802 . . . . 1.0 111.978 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.3 mm -140.13 165.19 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.191 -2.522 . . . . 1.0 104.191 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 123.95 12.19 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.443 -2.799 . . . . 1.0 103.443 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 128.06 48.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.802 -1.186 . . . . 1.0 109.034 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.35 142.74 33.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.038 0.923 . . . . 1.0 111.929 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.39 178.64 32.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.52 2.01 . . . . 1.0 111.242 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -148.29 101.77 3.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.6 t0 51.4 54.56 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 124.032 1.872 . . . . 1.0 112.389 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 49.69 38.5 15.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.446 1.898 . . . . 1.0 114.269 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.63 145.87 47.01 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 104.932 -2.247 . . . . 1.0 104.932 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -39.32 125.53 1.66 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.327 1.851 . . . . 1.0 111.777 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.4 -10.84 59.89 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 115.285 1.587 . . . . 1.0 115.285 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.381 26.6 p 62.47 77.5 0.33 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 121.592 1.996 . . . . 1.0 111.968 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -23.5 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.158 2.183 . . . . 1.0 114.667 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.96 -40.14 4.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.425 2.29 . . . . 1.0 111.095 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.27 -57.87 4.73 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.788 0.835 . . . . 1.0 109.613 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.68 -39.36 80.46 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.229 0.611 . . . . 1.0 111.593 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -65.82 -59.24 4.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.216 0.322 . . . . 1.0 110.166 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -66.0 -34.27 77.72 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.757 0.708 . . . . 1.0 112.082 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.51 -48.08 80.22 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.46 85.79 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.075 0.852 . . . . 1.0 109.819 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 -53.13 44.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.585 1.154 . . . . 1.0 111.046 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.19 -48.31 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.19 0.596 . . . . 1.0 110.121 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.7 m -53.25 -45.5 68.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.154 1.381 . . . . 1.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.32 -42.38 98.59 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.2 1.0 . . . . 1.0 110.54 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.19 -49.08 78.63 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.064 0.545 . . . . 1.0 110.194 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.94 -44.59 78.55 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.418 -0.801 . . . . 1.0 111.784 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.66 -40.23 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.187 0.903 . . . . 1.0 109.868 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.4 m -63.2 -27.67 69.52 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.885 0.874 . . . . 1.0 111.294 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.42 -60.58 2.03 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.138 0.975 . . . . 1.0 109.435 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -126.54 112.9 22.99 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.866 1.666 . . . . 1.0 106.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.61 107.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 120.912 1.361 . . . . 1.0 111.421 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.07 -45.09 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.99 2.116 . . . . 1.0 108.296 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.8 mt -44.91 -33.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.44 0 C-N-CA 130.666 3.587 . . . . 1.0 110.988 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.67 -26.19 13.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.373 1.069 . . . . 1.0 113.441 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.62 18.36 5.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.849 2.06 . . . . 1.0 110.873 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -138.45 83.3 1.96 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 119.866 -1.771 . . . . 1.0 106.363 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.4 mtt -126.42 118.07 24.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 102.876 -3.009 . . . . 1.0 102.876 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 t -157.66 -165.52 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.21 -131.57 1.25 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 106.798 -2.521 . . . . 1.0 106.798 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.49 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 12.2 m170 -114.34 -23.26 9.49 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.475 1.137 . . . . 1.0 111.964 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 15.9 t -103.02 -4.3 24.81 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.855 1.262 . . . . 1.0 108.448 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -97.91 23.15 8.34 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.156 1.382 . . . . 1.0 108.964 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -15.74 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 121.171 -0.955 . . . . 1.0 110.618 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.19 -66.06 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.882 1.673 . . . . 1.0 109.478 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.63 119.89 4.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 CA-C-N 122.019 1.757 . . . . 1.0 112.473 -175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -70.79 0.63 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.643 0.777 . . . . 1.0 111.808 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -84.44 -25.62 28.85 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 119.556 -1.965 . . . . 1.0 113.442 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -129.29 140.65 51.35 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m -127.43 -16.53 4.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 124.352 1.033 . . . . 1.0 112.881 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.66 -179.14 0.36 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.244 2.218 . . . . 1.0 105.819 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.09 77.42 3.49 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.641 2.228 . . . . 1.0 111.073 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.92 76.59 0.94 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.587 1.565 . . . . 1.0 109.639 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.416 ' HG2' ' H ' ' A' ' 168' ' ' SER . 89.3 Cg_endo -83.79 -72.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.338 2.692 . . . . 1.0 111.636 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 9.2 t 54.0 44.78 28.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.876 2.07 . . . . 1.0 111.343 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -93.65 17.87 11.05 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 43.4 t0 43.44 71.98 0.21 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.155 1.382 . . . . 1.0 110.542 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -58.38 -28.81 65.51 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.231 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -49.91 68.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.713 0.688 . . . . 1.0 110.631 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -64.9 -48.9 72.54 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.727 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.78 -53.31 58.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.237 0.926 . . . . 1.0 112.372 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -37.7 81.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.782 -0.628 . . . . 1.0 110.084 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.54 89.72 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.444 0.535 . . . . 1.0 112.444 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.74 -45.95 84.29 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.202 1.001 . . . . 1.0 111.737 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.79 165.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.911 1.284 . . . . 1.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 127.41 2.284 . . . . 1.0 109.58 176.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.35 9.38 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.581 0.753 . . . . 1.0 112.195 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 44.33 58.07 3.99 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.076 2.151 . . . . 1.0 110.087 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.6 22.05 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.01 0.924 . . . . 1.0 109.269 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -74.61 123.47 24.89 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.751 -1.574 . . . . 1.0 106.751 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 125.7 34.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.183 0.901 . . . . 1.0 108.651 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.95 76.13 59.62 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.67 130.05 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.511 2.141 . . . . 1.0 110.772 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -129.5 124.48 21.97 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 126.497 1.919 . . . . 1.0 106.918 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.83 52.74 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.384 2.723 . . . . 1.0 111.417 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -124.11 48.98 1.82 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -73.8 178.28 4.95 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.332 1.453 . . . . 1.0 112.026 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.92 178.22 4.36 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 128.151 2.58 . . . . 1.0 116.445 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.0 m -156.23 121.49 4.77 Favored 'General case' 0 N--CA 1.446 -0.672 1 C-N-CA 132.938 4.495 . . . . 1.0 103.396 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -135.82 141.18 35.86 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 117.682 -1.151 . . . . 1.0 108.602 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.64 90.22 1.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 124.305 3.336 . . . . 1.0 111.003 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -171.86 154.48 3.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 131.391 3.877 . . . . 1.0 103.97 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -151.43 104.76 3.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 104.641 -2.355 . . . . 1.0 104.641 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.75 159.78 40.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.752 1.621 . . . . 1.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.25 123.54 84.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 118.843 0.747 . . . . 1.0 109.495 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.37 103.6 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.768 1.645 . . . . 1.0 110.842 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -167.55 74.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.994 -1.066 . . . . 1.0 108.844 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.49 135.01 18.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.324 1.849 . . . . 1.0 107.627 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -87.54 133.03 33.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.6 141.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.993 -2.225 . . . . 1.0 104.993 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -136.03 118.89 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.999 -1.482 . . . . 1.0 106.999 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.9 p80 -176.23 144.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.474 1.51 . . . . 1.0 107.525 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.09 112.71 19.39 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 119.542 1.065 . . . . 1.0 110.066 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.29 176.93 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.838 3.255 . . . . 1.0 108.95 175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -159.55 122.77 3.63 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 95.714 -5.661 . . . . 1.0 95.714 174.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.288 1.8 tm? -142.63 -65.31 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 116.67 -1.633 . . . . 1.0 113.722 -175.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -91.35 163.09 3.66 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 124.328 3.352 . . . . 1.0 112.788 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.91 72.75 6.01 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.632 2.888 . . . . 1.0 118.716 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.64 -73.07 0.93 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.758 -2.937 . . . . 1.0 105.758 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -156.82 122.74 4.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.568 1.547 . . . . 1.0 108.16 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -176.7 177.61 1.35 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.577 3.151 . . . . 1.0 107.464 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.72 22.98 10.45 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 109.319 -1.512 . . . . 1.0 109.319 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.81 118.52 5.16 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.205 -1.33 . . . . 1.0 111.179 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.88 -18.33 28.18 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.376 2.051 . . . . 1.0 113.035 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -53.88 -36.37 62.59 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.088 0.858 . . . . 1.0 110.51 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mt -65.44 -44.71 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.456 -0.783 . . . . 1.0 109.614 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.05 -52.21 51.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.183 0.901 . . . . 1.0 110.351 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.34 -34.07 32.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.303 1.441 . . . . 1.0 112.475 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.58 -61.45 2.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.622 1.569 . . . . 1.0 111.188 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -70.92 -39.32 72.78 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.537 -0.744 . . . . 1.0 112.063 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -66.16 -36.63 83.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.271 1.028 . . . . 1.0 109.008 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.92 1.93 39.4 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 117.487 -1.729 . . . . 1.0 115.965 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -88.81 8.52 28.62 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.662 2.231 . . . . 1.0 113.193 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.7 128.58 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.361 1.464 . . . . 1.0 112.168 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.91 136.4 20.63 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 128.174 2.59 . . . . 1.0 109.409 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.56 79.16 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.518 2.812 . . . . 1.0 109.04 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.1 -60.1 1.6 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.189 0.596 . . . . 1.0 110.723 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.44 77.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.429 0.691 . . . . 1.0 109.841 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -171.2 178.09 0.84 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.683 2.393 . . . . 1.0 106.898 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -71.73 -43.45 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.436 2.091 . . . . 1.0 115.53 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -44.18 -50.89 8.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -58.65 6.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.145 1.378 . . . . 1.0 110.615 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.62 -43.41 96.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.892 0.877 . . . . 1.0 111.959 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.13 -61.63 6.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.234 1.397 . . . . 1.0 111.555 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.72 -42.19 91.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.012 -0.994 . . . . 1.0 111.874 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.63 -43.75 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 116.924 2.194 . . . . 1.0 116.924 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.35 -34.33 73.7 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.721 -0.612 . . . . 1.0 109.714 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.57 135.89 34.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 101.183 -3.636 . . . . 1.0 101.183 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.71 144.58 13.81 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.601 -0.687 . . . . 1.0 110.992 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.83 162.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.207 1.803 . . . . 1.0 107.307 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.07 114.24 0.09 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.595 0.758 . . . . 1.0 109.159 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.58 -176.7 3.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -111.53 -76.31 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.986 0.812 . . . . 1.0 112.977 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -118.3 118.34 31.55 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 104.896 -2.261 . . . . 1.0 104.896 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tp -103.12 113.58 27.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.165 -2.161 . . . . 1.0 105.165 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.97 113.56 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -71.3 144.93 49.8 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -13.76 3.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 119.272 0.942 . . . . 1.0 113.151 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.32 26.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.889 2.476 . . . . 1.0 112.483 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.14 71.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.112 1.815 . . . . 1.0 114.535 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.32 156.3 17.32 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.839 . . . . 1.0 110.243 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mt -115.88 115.7 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 100.713 -3.81 . . . . 1.0 100.713 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.91 143.03 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.48 120.97 37.44 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.47 117.62 31.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 128.642 2.777 . . . . 1.0 106.205 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.4 t 68.2 92.06 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 120.847 1.658 . . . . 1.0 113.938 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.91 -178.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 121.575 1.517 . . . . 1.0 110.553 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -59.37 30.42 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 130.159 3.384 . . . . 1.0 116.495 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.15 116.01 6.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.537 2.335 . . . . 1.0 108.722 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.295 27.6 ttmt 83.2 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.631 1.972 . . . . 1.0 111.461 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -35.95 159.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 130.911 3.684 . . . . 1.0 116.599 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.17 -178.63 3.43 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 129.384 3.074 . . . . 1.0 114.139 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -155.07 118.59 4.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.628 1.571 . . . . 1.0 108.642 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -159.55 63.13 0.38 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.067 0.937 . . . . 1.0 110.361 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.34 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 119.11 -2.244 . . . . 1.0 114.561 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.79 -91.27 0.9 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.191 -3.163 . . . . 1.0 105.191 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 t -127.95 133.85 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.662 1.231 . . . . 1.0 109.407 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 p -160.35 159.06 30.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.84 2.056 . . . . 1.0 108.72 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' H ' HG23 ' A' ' 157' ' ' ILE . 33.9 p -152.03 147.07 26.07 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.542 1.137 . . . . 1.0 111.45 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -148.88 144.8 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 38.91 53.99 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.761 2.024 . . . . 1.0 112.354 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.41 67.9 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.293 0.949 . . . . 1.0 114.838 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -128.85 113.52 15.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 103.576 -2.749 . . . . 1.0 103.576 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -82.88 142.0 31.81 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.943 -1.873 . . . . 1.0 105.943 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -102.94 118.53 37.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.04 -2.578 . . . . 1.0 104.04 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.95 -23.65 58.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.615 0.366 . . . . 1.0 110.653 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -146.52 175.15 10.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.533 2.333 . . . . 1.0 106.128 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.7 76.67 3.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.555 1.169 . . . . 1.0 109.313 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -88.54 45.19 1.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.979 1.712 . . . . 1.0 109.431 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -138.81 127.15 22.91 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 120.081 -1.637 . . . . 1.0 113.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.252 0.1 OUTLIER -78.74 56.7 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.732 2.013 . . . . 1.0 108.996 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.18 -136.51 3.74 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.12 163.61 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.209 -2.515 . . . . 1.0 104.209 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.81 117.8 9.43 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.764 -1.939 . . . . 1.0 105.764 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.23 131.07 34.48 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.808 -1.183 . . . . 1.0 110.195 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -104.36 147.03 27.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.641 0.376 . . . . 1.0 111.776 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.43 173.38 33.6 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.978 1.275 . . . . 1.0 110.356 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -148.18 109.2 4.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 44.93 46.32 8.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.928 2.491 . . . . 1.0 112.671 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 50.62 38.19 18.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.621 1.969 . . . . 1.0 113.499 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.8 tp -68.27 146.55 53.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.688 1.995 . . . . 1.0 108.142 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -31.51 114.23 0.13 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 126.39 1.876 . . . . 1.0 111.812 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.42 -8.58 58.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 115.361 -2.257 . . . . 1.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.396 17.4 p 68.9 78.68 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 122.18 2.264 . . . . 1.0 113.374 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -22.8 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.949 2.159 . . . . 1.0 115.08 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.69 -42.91 7.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.628 2.371 . . . . 1.0 110.629 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -52.44 -51.46 59.09 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.154 0.888 . . . . 1.0 110.432 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -60.61 -39.71 89.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.574 -0.727 . . . . 1.0 109.877 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.13 -51.53 57.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.176 0.898 . . . . 1.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.48 -47.63 78.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.469 1.507 . . . . 1.0 110.393 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.2 tp -56.6 -50.53 71.71 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.33 1.052 . . . . 1.0 108.498 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.06 84.14 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.691 0.678 . . . . 1.0 110.284 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.98 48.78 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.186 0.594 . . . . 1.0 110.648 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.28 -41.78 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.896 0.771 . . . . 1.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.1 m -59.25 -56.79 17.67 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.997 1.319 . . . . 1.0 109.466 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.93 -43.65 77.59 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.939 0.896 . . . . 1.0 110.245 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.82 -50.7 63.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.975 0.51 . . . . 1.0 111.076 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.74 -37.44 71.01 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.487 -0.758 . . . . 1.0 111.378 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.04 -39.31 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.946 0.898 . . . . 1.0 110.057 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.5 m -57.96 -35.33 71.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.38 0.991 . . . . 1.0 111.217 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -83.45 -49.23 9.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -125.79 112.85 24.82 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 107.271 -1.381 . . . . 1.0 107.271 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.37 106.85 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.148 -1.52 . . . . 1.0 108.148 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.94 -55.62 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.797 1.639 . . . . 1.0 107.848 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.0 mt -48.86 -33.94 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.056 2.942 . . . . 1.0 110.329 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.88 -23.03 6.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.497 1.519 . . . . 1.0 113.744 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -137.76 20.73 2.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.985 2.514 . . . . 1.0 109.295 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.13 87.74 2.22 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.69 1.596 . . . . 1.0 106.888 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.5 mtt -136.5 117.6 14.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.16 1.784 . . . . 1.0 107.547 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.9 t -153.52 -176.37 5.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.466 1.485 . . . . 1.0 109.544 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.91 -131.62 2.73 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 107.279 -2.329 . . . . 1.0 107.279 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 22.7 m170 -115.72 -24.04 8.41 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.683 1.241 . . . . 1.0 112.415 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.5 t -103.73 -11.47 17.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.819 0.847 . . . . 1.0 109.024 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.81 18.54 2.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.145 1.778 . . . . 1.0 110.31 -175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.433 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.73 -18.99 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.918 0.887 . . . . 1.0 112.456 -175.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.1 -66.13 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.378 1.471 . . . . 1.0 108.54 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.59 111.32 2.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.834 1.691 . . . . 1.0 111.786 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.06 -17.58 27.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.971 1.309 . . . . 1.0 111.915 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.83 -25.64 63.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.458 -1.401 . . . . 1.0 112.388 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -134.17 140.61 46.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 17.0 m -121.71 -16.6 7.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.001 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.08 -178.98 0.63 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 130.717 3.607 . . . . 1.0 104.561 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -78.49 51.27 3.68 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.621 2.214 . . . . 1.0 109.919 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.11 80.89 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.73 2.586 . . . . 1.0 108.485 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.98 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.583 2.189 . . . . 1.0 111.995 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.4 t 53.66 43.03 31.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.329 2.251 . . . . 1.0 112.808 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -122.27 17.94 10.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.259 0.936 . . . . 1.0 112.637 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.263 8.5 t0 41.78 70.56 0.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.583 1.553 . . . . 1.0 111.006 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -52.87 -30.43 33.86 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 121.27 -0.894 . . . . 1.0 111.448 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.57 51.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.461 -0.781 . . . . 1.0 110.162 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -60.46 -50.98 71.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 120.18 1.354 . . . . 1.0 112.008 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.72 -46.87 83.45 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.243 -0.983 . . . . 1.0 111.469 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -64.69 -31.3 72.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.716 0.689 . . . . 1.0 109.932 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -41.19 88.27 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 1.0 111.813 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.17 -55.09 8.88 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.416 1.486 . . . . 1.0 112.166 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.4 t -66.34 152.52 9.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 123.402 0.681 . . . . 1.0 109.845 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 124.722 1.209 . . . . 1.0 111.802 175.647 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tt . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.67 175.72 9.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.162 0.985 . . . . 1.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 39.19 58.4 1.87 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.718 1.207 . . . . 1.0 111.569 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.17 155.91 28.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.094 0.958 . . . . 1.0 108.98 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -78.08 123.35 26.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.41 125.54 33.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.337 -1.356 . . . . 1.0 107.337 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -140.32 79.09 21.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.14 123.69 11.93 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -65.4 145.89 99.02 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.695 -0.854 . . . . 1.0 108.695 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.03 -9.32 11.84 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.921 1.747 . . . . 1.0 116.131 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -144.02 135.92 26.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.386 -2.82 . . . . 1.0 103.386 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.7 178.39 4.57 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.291 1.437 . . . . 1.0 108.769 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.79 178.79 4.86 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.248 1.499 . . . . 1.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.0 m -151.28 118.41 5.92 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.912 -2.255 . . . . 1.0 104.912 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -135.93 138.85 28.82 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 106.205 -1.776 . . . . 1.0 106.205 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.44 83.1 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.626 2.217 . . . . 1.0 109.395 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -163.56 149.05 11.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.047 1.739 . . . . 1.0 108.371 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -146.51 104.14 3.74 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.01 160.58 38.17 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 127.446 2.298 . . . . 1.0 107.339 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.51 123.41 88.39 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 106.478 -1.675 . . . . 1.0 106.478 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.93 103.54 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.436 1.424 . . . . 1.0 109.783 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -172.95 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 tp -148.74 132.18 16.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.15 -2.167 . . . . 1.0 105.15 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -91.43 122.49 34.07 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.27 113.45 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.35 114.22 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 105.675 -1.972 . . . . 1.0 105.675 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -165.92 137.22 3.75 Favored 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.11 112.59 19.95 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 105.67 -1.974 . . . . 1.0 105.67 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.323 6.6 mm -126.39 179.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 128.966 2.907 . . . . 1.0 106.146 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -149.58 121.91 8.43 Favored 'General case' 0 N--CA 1.432 -1.327 1 N-CA-C 99.207 -4.368 . . . . 1.0 99.207 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.31 -62.9 0.02 OUTLIER Pre-proline 0 C--O 1.254 1.325 0 CA-C-O 115.796 -2.05 . . . . 1.0 111.821 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.57 153.09 23.32 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 CA-C-N 123.564 2.308 . . . . 1.0 111.626 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.7 45.52 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.492 3.461 . . . . 1.0 114.69 -175.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.72 -71.8 0.43 Allowed Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.869 -0.962 . . . . 1.0 111.847 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -155.6 122.76 5.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.142 1.377 . . . . 1.0 107.369 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -163.12 166.66 23.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 128.426 2.691 . . . . 1.0 111.514 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.86 -22.65 7.51 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 117.875 -1.514 . . . . 1.0 113.342 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.24 136.77 13.97 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.426 1.613 . . . . 1.0 111.021 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.43 -4.42 14.66 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.42 2.747 . . . . 1.0 116.476 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -49.51 -49.46 45.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 121.653 2.024 . . . . 1.0 112.569 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 23.3 mm -66.23 -43.85 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.156 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.67 -44.55 96.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.51 67.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.715 1.606 . . . . 1.0 111.987 -177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -62.05 2.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.801 1.24 . . . . 1.0 109.091 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -66.61 -53.59 32.63 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.545 1.138 . . . . 1.0 111.555 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -56.01 -33.51 64.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.765 1.226 . . . . 1.0 109.311 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.37 25.37 8.83 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 119.762 1.165 . . . . 1.0 114.356 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -115.09 9.91 16.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.983 1.313 . . . . 1.0 112.009 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.5 tt -51.7 126.18 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.652 1.181 . . . . 1.0 112.437 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -98.8 124.37 46.13 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.259 2.224 . . . . 1.0 107.758 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.3 70.41 3.16 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.895 3.064 . . . . 1.0 110.434 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -103.63 -63.71 1.16 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.487 0.715 . . . . 1.0 112.414 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.83 73.7 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.47 0.708 . . . . 1.0 111.391 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 31.3 p80 -164.31 177.98 1.59 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 107.072 -1.455 . . . . 1.0 107.072 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.92 -43.52 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.329 1.353 . . . . 1.0 112.512 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -45.48 -42.2 10.38 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.243 1.417 . . . . 1.0 113.459 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -57.92 -54.26 48.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.55 1.14 . . . . 1.0 107.943 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.6 85.62 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.018 0.927 . . . . 1.0 110.59 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.94 -61.85 2.18 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 127.892 2.663 . . . . 1.0 111.02 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -59.02 -49.42 83.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-O 116.976 -1.488 . . . . 1.0 110.663 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.63 -43.3 0.4 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.584 2.753 . . . . 1.0 116.529 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -56.01 -41.39 74.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.359 1.076 . . . . 1.0 110.662 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.76 136.95 34.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.892 -2.262 . . . . 1.0 104.892 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 154.64 12.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.768 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.1 162.96 14.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 126.365 1.866 . . . . 1.0 111.681 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.303 2.241 . . . . 1.0 106.722 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.93 -153.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.68 1.592 . . . . 1.0 108.204 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -128.15 -58.9 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.66 1.184 . . . . 1.0 109.84 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.2 m -145.58 126.8 14.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.58 113.73 26.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 104.813 -2.291 . . . . 1.0 104.813 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 mt -94.08 121.34 44.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -75.14 144.6 42.72 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -49.01 -20.58 0.54 Allowed 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.564 1.946 . . . . 1.0 112.949 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -92.07 32.17 1.18 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 130.666 3.586 . . . . 1.0 113.154 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.66 28.41 67.87 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 119.991 -1.693 . . . . 1.0 116.515 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -98.81 145.15 27.25 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 119.194 1.497 . . . . 1.0 108.878 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.36 113.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.171 -1.788 . . . . 1.0 106.171 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.07 143.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -115.76 113.87 24.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -110.67 114.07 27.17 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 105.187 -2.153 . . . . 1.0 105.187 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.5 t 71.39 91.37 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 121.71 2.05 . . . . 1.0 111.954 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.34 -166.93 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.093 1.862 . . . . 1.0 111.052 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -61.4 26.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 130.34 3.456 . . . . 1.0 116.918 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.27 134.86 19.77 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 121.247 1.84 . . . . 1.0 106.741 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 75.69 82.69 0.1 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.626 1.57 . . . . 1.0 111.504 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -43.96 145.28 0.74 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.333 1.853 . . . . 1.0 112.546 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.29 -178.59 3.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.206 2.202 . . . . 1.0 110.26 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -154.39 119.74 5.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.604 0.638 . . . . 1.0 111.051 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -157.21 64.46 0.5 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.058 1.409 . . . . 1.0 111.46 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.01 -57.96 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 117.953 -2.967 . . . . 1.0 111.286 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.91 -69.61 0.44 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.331 -1.908 . . . . 1.0 108.331 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -146.04 144.02 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.464 1.632 . . . . 1.0 109.544 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 p -165.71 162.83 18.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.738 1.215 . . . . 1.0 111.444 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -158.77 145.32 17.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 1.0 108.982 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -166.9 157.15 11.53 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.537 -1.221 . . . . 1.0 108.943 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 39.58 53.91 2.42 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.511 1.924 . . . . 1.0 112.3 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.36 29.82 53.94 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 114.885 -1.052 . . . . 1.0 113.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 tpt85 -131.71 116.72 17.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.081 1.441 . . . . 1.0 108.433 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.51 146.49 34.32 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.474 -1.676 . . . . 1.0 106.474 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -126.01 117.97 24.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.387 -2.079 . . . . 1.0 105.387 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.86 -26.25 61.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.812 -1.085 . . . . 1.0 110.588 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -151.42 173.23 14.79 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.972 1.309 . . . . 1.0 108.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.49 75.64 6.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.205 1.479 . . . . 1.0 107.054 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.18 39.2 1.12 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.475 1.11 . . . . 1.0 109.769 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.9 m -140.02 124.26 17.83 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.471 -1.393 . . . . 1.0 113.205 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -78.46 57.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.545 2.338 . . . . 1.0 111.57 -175.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.26 -119.02 0.45 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.411 -1.475 . . . . 1.0 109.411 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.8 mm -149.01 165.56 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 130.234 3.413 . . . . 1.0 104.105 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -141.16 134.13 29.12 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.846 2.858 . . . . 1.0 104.129 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.4 164.24 11.87 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.355 -0.841 . . . . 1.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.37 150.79 50.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.207 0.603 . . . . 1.0 111.135 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.51 173.88 39.67 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.935 1.255 . . . . 1.0 110.734 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 p -151.01 110.53 4.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.635 -2.357 . . . . 1.0 104.635 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.5 t0 49.55 52.67 14.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 123.789 1.757 . . . . 1.0 112.507 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 47.83 37.98 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.373 2.669 . . . . 1.0 114.031 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.5 145.62 38.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.722 1.209 . . . . 1.0 107.744 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.87 120.72 2.44 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.268 1.027 . . . . 1.0 109.678 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.41 10.38 7.24 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 117.129 -1.415 . . . . 1.0 113.673 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.311 28.6 p 37.4 74.65 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 1 N-CA-C 123.667 4.691 . . . . 1.0 123.667 -174.121 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -17.19 -32.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.998 2.919 . . . . 1.0 114.918 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.34 -41.2 18.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.594 1.557 . . . . 1.0 109.387 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -49.56 -57.29 7.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.51 1.924 . . . . 1.0 109.299 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -56.34 -43.17 78.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.736 -0.65 . . . . 1.0 109.561 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -64.51 -57.06 10.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.652 0.66 . . . . 1.0 111.004 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.77 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.974 -1.704 . . . . 1.0 111.516 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.6 -46.43 89.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.609 1.095 . . . . 1.0 108.761 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.05 76.71 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.247 0.931 . . . . 1.0 109.187 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.33 52.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.856 0.753 . . . . 1.0 110.703 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.06 -46.03 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.092 -0.38 . . . . 1.0 110.044 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.9 m -59.21 -50.08 75.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.373 1.469 . . . . 1.0 109.838 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.15 -42.26 94.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.0 110.341 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.93 88.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.849 0.46 . . . . 1.0 112.054 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.36 -47.12 79.52 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.531 -0.747 . . . . 1.0 109.313 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.05 -37.27 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.166 0.986 . . . . 1.0 110.773 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.4 m -65.63 -14.07 60.42 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.071 0.949 . . . . 1.0 111.953 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -111.07 -50.83 2.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.391 1.45 . . . . 1.0 111.744 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -126.77 113.06 22.44 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -97.33 107.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.049 1.41 . . . . 1.0 110.198 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.95 -51.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.064 1.746 . . . . 1.0 106.405 175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 59.5 mt -46.71 -33.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 129.497 3.119 . . . . 1.0 110.999 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.25 -26.42 17.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.407 1.083 . . . . 1.0 113.621 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -135.69 18.15 3.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.705 2.002 . . . . 1.0 110.043 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -139.78 83.56 1.93 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.926 1.29 . . . . 1.0 108.068 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 64.5 mtt -120.29 126.71 51.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -167.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.546 1.067 . . . . 1.0 108.345 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.28 -130.88 1.32 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 105.508 -3.037 . . . . 1.0 105.508 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.317 13.2 m170 -112.31 -22.99 10.62 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.325 0.861 . . . . 1.0 113.325 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 9.0 t -102.98 -11.13 18.4 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 118.568 -0.729 . . . . 1.0 109.287 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -89.42 43.05 1.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -8.96 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 120.801 -1.187 . . . . 1.0 110.515 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -160.72 -53.92 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.669 2.388 . . . . 1.0 111.246 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.52 111.96 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.097 1.865 . . . . 1.0 113.031 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.95 -25.38 63.46 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.965 -1.084 . . . . 1.0 112.281 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 20.4 ttp85 -71.27 -5.29 31.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.64 -1.287 . . . . 1.0 112.549 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 127.22 22.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 103.888 -2.634 . . . . 1.0 103.888 174.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.3 m -123.73 -16.21 6.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.289 0.95 . . . . 1.0 110.884 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.78 -178.75 0.34 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.216 2.607 . . . . 1.0 105.697 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.79 51.52 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.525 . . . . 1.0 112.96 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.34 76.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.158 1.361 . . . . 1.0 110.202 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.49 -74.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.373 2.049 . . . . 1.0 111.636 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.75 44.02 30.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.431 1.892 . . . . 1.0 111.206 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -99.09 18.38 17.52 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.038 -1.039 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.258 9.4 t0 44.17 70.52 0.32 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.388 1.475 . . . . 1.0 110.46 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -56.7 -29.12 62.07 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 120.669 -1.269 . . . . 1.0 110.311 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.4 -53.61 33.8 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.755 1.161 . . . . 1.0 111.994 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -65.93 -47.88 73.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 118.079 -0.962 . . . . 1.0 109.868 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.11 -55.63 31.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.123 0.874 . . . . 1.0 112.176 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -58.64 -36.6 74.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.795 -1.098 . . . . 1.0 109.8 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -45.1 80.82 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.471 1.107 . . . . 1.0 113.629 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.55 -46.08 84.38 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.087 0.955 . . . . 1.0 112.054 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.69 166.55 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.741 2.016 . . . . 1.0 110.082 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 1.0 109.457 175.5 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--O 1.24 0.577 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.42 154.52 32.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 46.2 58.35 4.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.168 2.187 . . . . 1.0 113.59 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.77 134.73 15.73 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.182 -0.949 . . . . 1.0 111.334 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -71.65 123.18 21.96 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.428 -1.693 . . . . 1.0 106.428 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -92.88 123.93 36.5 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.638 -0.664 . . . . 1.0 110.42 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.45 67.29 75.82 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.333 1.453 . . . . 1.0 107.666 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.52 152.47 59.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.78 1.653 . . . . 1.0 110.071 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -154.1 114.96 2.54 Favored Pre-proline 0 CA--C 1.511 -0.554 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 90.8 Cg_endo -74.75 71.4 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.002 1.801 . . . . 1.0 109.261 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -133.85 43.03 2.89 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.073 2.949 . . . . 1.0 105.064 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 18.9 m-85 -79.28 178.7 7.88 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.425 2.29 . . . . 1.0 113.077 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -122.2 -179.76 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.615 1.966 . . . . 1.0 111.011 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 m -158.26 118.27 3.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 131.395 3.878 . . . . 1.0 101.547 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -120.2 138.72 27.48 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 106.047 -1.835 . . . . 1.0 106.047 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.96 61.27 8.09 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.115 3.21 . . . . 1.0 112.54 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -138.8 151.39 47.01 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 128.675 2.79 . . . . 1.0 105.023 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -150.85 104.36 3.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.802 1.183 . . . . 1.0 109.713 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.14 161.71 34.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 105.97 -1.863 . . . . 1.0 105.97 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -57.69 123.86 65.19 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.97 0.908 . . . . 1.0 108.923 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.34 103.6 1.29 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.366 2.044 . . . . 1.0 108.302 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 t -174.15 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.198 -2.149 . . . . 1.0 105.198 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.07 131.48 9.49 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.376 1.471 . . . . 1.0 107.482 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 tp -92.07 127.51 37.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.342 1.057 . . . . 1.0 109.437 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.67 116.84 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.913 1.285 . . . . 1.0 108.514 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.6 t -110.88 114.94 48.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.0 OUTLIER -168.07 129.39 1.4 Allowed 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 174.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.88 111.84 6.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -127.0 177.58 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.828 2.451 . . . . 1.0 112.12 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -151.28 122.32 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 1 N-CA-C 95.992 -5.559 . . . . 1.0 95.992 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.301 0.6 OUTLIER -142.84 -60.9 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 121.727 2.058 . . . . 1.0 112.426 176.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.14 157.58 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.572 2.181 . . . . 1.0 111.449 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.16 13.47 2.37 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.771 2.981 . . . . 1.0 116.664 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -24.55 -68.59 0.03 OUTLIER Glycine 0 C--N 1.353 1.508 0 CA-C-N 121.402 1.91 . . . . 1.0 111.694 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -148.89 122.97 9.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.776 -1.565 . . . . 1.0 106.776 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -176.47 159.26 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.649 2.78 . . . . 1.0 108.294 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.46 -6.4 10.62 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.721 1.153 . . . . 1.0 110.664 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.09 120.37 7.18 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 108.383 -1.887 . . . . 1.0 108.383 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.82 -24.86 80.05 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.62 2.213 . . . . 1.0 115.191 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -49.36 -45.81 46.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.794 1.179 . . . . 1.0 113.741 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 mm -65.6 -49.31 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 123.567 0.747 . . . . 1.0 110.651 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.34 -36.33 82.62 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 118.861 -1.136 . . . . 1.0 110.744 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.75 -34.2 71.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.717 0.807 . . . . 1.0 110.996 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.94 -54.33 46.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.547 1.139 . . . . 1.0 108.077 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.96 -48.29 69.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.51 -34.77 78.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.275 1.43 . . . . 1.0 110.431 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.09 1.57 29.98 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.195 1.379 . . . . 1.0 115.221 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -88.96 8.69 28.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.232 2.016 . . . . 1.0 113.255 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -57.46 127.92 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.978 1.311 . . . . 1.0 112.219 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.84 135.54 20.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.238 2.215 . . . . 1.0 109.609 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.08 77.34 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.649 2.899 . . . . 1.0 107.261 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.41 -64.58 1.07 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.105 0.562 . . . . 1.0 111.013 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.8 -47.55 76.93 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.042 0.937 . . . . 1.0 110.855 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -170.07 177.9 0.98 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.677 1.591 . . . . 1.0 107.607 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.37 -43.41 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.437 2.091 . . . . 1.0 114.973 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -46.29 -49.76 17.03 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.956 1.095 . . . . 1.0 113.956 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 -55.58 31.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.116 0.966 . . . . 1.0 110.397 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.28 99.17 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.14 0.976 . . . . 1.0 111.39 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.31 23.09 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.907 1.718 . . . . 1.0 112.38 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.7 pt -60.26 -36.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-O 117.221 -1.371 . . . . 1.0 112.38 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.78 -43.15 5.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.58 1.952 . . . . 1.0 115.435 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -60.34 -33.57 72.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.672 -0.643 . . . . 1.0 109.692 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.62 136.65 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 102.924 -2.991 . . . . 1.0 102.924 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 153.89 15.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.694 -1.202 . . . . 1.0 110.456 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.59 159.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -165.84 130.21 2.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.632 -1.248 . . . . 1.0 107.632 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.32 -176.77 3.75 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -123.69 -76.6 0.59 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.549 -2.019 . . . . 1.0 105.549 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -122.51 118.47 28.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.891 -2.263 . . . . 1.0 104.891 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.97 113.33 25.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.407 -2.071 . . . . 1.0 105.407 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.4 mt -88.1 119.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 106.029 -1.841 . . . . 1.0 106.029 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.29 141.9 58.61 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.437 -1.69 . . . . 1.0 106.437 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -53.14 -24.99 11.8 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 124.442 1.097 . . . . 1.0 111.324 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.37 34.57 0.95 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.529 1.132 . . . . 1.0 111.845 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.48 48.2 86.28 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 120.112 -1.617 . . . . 1.0 115.944 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.48 156.26 31.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.08 113.51 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 104.948 -2.241 . . . . 1.0 104.948 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.26 139.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -124.79 113.96 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.87 140.41 43.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.911 2.484 . . . . 1.0 104.384 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t 63.18 90.91 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 120.65 1.568 . . . . 1.0 113.519 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.67 -177.55 0.97 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 120.807 1.005 . . . . 1.0 110.432 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.69 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.682 2.793 . . . . 1.0 115.558 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -149.89 120.36 7.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.523 2.729 . . . . 1.0 107.204 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 84.07 81.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.662 2.785 . . . . 1.0 110.639 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -41.04 152.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.699 3.2 . . . . 1.0 114.603 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.72 -178.77 3.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 1.0 110.219 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -152.34 118.44 5.51 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -162.73 62.5 0.2 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.969 0.89 . . . . 1.0 110.914 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.76 -61.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 117.635 -3.166 . . . . 1.0 113.296 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.96 -73.65 1.14 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.203 -1.332 . . . . 1.0 112.943 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.95 129.4 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.973 1.387 . . . . 1.0 111.633 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 p -165.96 146.73 6.67 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.824 1.65 . . . . 1.0 108.231 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.8 p -144.53 146.39 32.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.762 2.025 . . . . 1.0 108.533 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -150.32 149.65 30.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.943 -2.244 . . . . 1.0 104.943 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 43.49 53.61 5.65 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.745 1.218 . . . . 1.0 114.273 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.8 39.46 67.84 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 121.011 -1.056 . . . . 1.0 113.09 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -146.48 113.57 6.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.579 -2.378 . . . . 1.0 104.579 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -105.98 132.84 51.59 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -102.55 118.26 36.48 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.5 t -61.31 -25.05 66.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 1.0 111.611 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -153.77 161.08 42.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 112' ' ' SER . 32.1 t70 -81.3 76.76 8.23 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.04 40.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.821 2.448 . . . . 1.0 109.74 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 110' ' ' ASP . 1.7 m -123.73 133.79 53.8 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.852 1.261 . . . . 1.0 110.96 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.39 56.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.162 -1.421 . . . . 1.0 107.162 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.02 -137.01 3.79 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 120.909 -1.119 . . . . 1.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.1 mm -143.15 164.77 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.238 -2.875 . . . . 1.0 103.238 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.33 137.18 28.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.329 2.651 . . . . 1.0 103.898 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.91 141.62 33.54 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.589 -1.319 . . . . 1.0 109.407 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -103.92 154.3 19.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.465 -0.198 . . . . 1.0 110.465 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.02 -177.62 46.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 128.49 2.948 . . . . 1.0 109.401 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 p -156.35 116.64 3.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.735 -2.321 . . . . 1.0 104.735 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.4 t0 50.59 40.45 23.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.261 65.4 p 58.8 38.48 24.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.249 2.22 . . . . 1.0 115.163 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.44 146.08 30.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.906 1.682 . . . . 1.0 107.886 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -42.4 113.38 0.44 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -81.02 -5.75 57.97 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 115.855 1.798 . . . . 1.0 115.855 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.8 p 51.62 77.78 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 120.194 1.361 . . . . 1.0 111.505 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.84 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.245 2.618 . . . . 1.0 114.159 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -41.62 -36.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.497 2.319 . . . . 1.0 109.452 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -48.17 -50.07 30.32 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.594 0.757 . . . . 1.0 110.375 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.84 -47.73 83.82 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.321 0.648 . . . . 1.0 109.982 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.02 -51.95 67.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.578 0.704 . . . . 1.0 109.72 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -66.45 -47.9 71.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 1.0 110.837 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.5 tp -55.76 -41.77 74.47 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.81 98.26 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.458 1.481 . . . . 1.0 111.907 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.74 47.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.384 0.674 . . . . 1.0 109.246 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.62 -48.25 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.5 m -55.85 -49.35 73.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.843 1.257 . . . . 1.0 109.893 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.39 -41.08 98.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.488 0.715 . . . . 1.0 110.338 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.74 68.03 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.268 -0.895 . . . . 1.0 110.673 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.12 -41.13 74.83 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.876 -1.059 . . . . 1.0 112.05 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.68 -43.24 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.678 1.126 . . . . 1.0 108.574 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.8 m -65.61 -22.03 66.63 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.386 0.674 . . . . 1.0 111.799 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.62 -56.15 3.48 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 120.478 -1.389 . . . . 1.0 108.098 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.36 112.54 23.44 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -89.97 108.55 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 117.05 -1.5 . . . . 1.0 110.122 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.41 -50.42 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.081 1.752 . . . . 1.0 109.033 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.9 mt -47.33 -33.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.847 3.259 . . . . 1.0 110.765 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.08 -26.3 4.29 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.405 1.082 . . . . 1.0 113.272 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.92 17.92 5.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.676 1.991 . . . . 1.0 111.267 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -139.47 88.02 2.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.34 1.427 . . . . 1.0 109.717 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 46.0 mtt -129.89 113.86 15.16 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -148.6 -165.9 2.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.45 -131.41 1.43 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 106.326 -2.709 . . . . 1.0 106.326 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.0 m170 -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.588 1.194 . . . . 1.0 111.907 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.93 -11.59 17.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.787 0.835 . . . . 1.0 109.573 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.52 39.56 0.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.1 -1.0 . . . . 1.0 110.393 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.458 HG23 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -74.43 -11.69 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 O-C-N 121.251 -0.906 . . . . 1.0 108.68 175.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -159.59 -54.16 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.956 1.702 . . . . 1.0 113.037 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.12 108.86 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 122.71 2.004 . . . . 1.0 111.277 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.23 -13.42 37.6 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.198 -0.938 . . . . 1.0 113.219 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.09 -25.74 63.66 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.544 -1.347 . . . . 1.0 111.957 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -113.91 141.6 47.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -140.37 -15.07 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 118.872 -1.131 . . . . 1.0 111.427 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.71 177.55 0.43 Allowed Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 131.0 3.72 . . . . 1.0 104.092 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.07 77.86 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.33 2.02 . . . . 1.0 109.892 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 127.17 67.27 0.15 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.086 1.803 . . . . 1.0 109.582 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.62 -89.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.08 2.52 . . . . 1.0 109.551 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t 53.4 42.98 31.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.876 2.07 . . . . 1.0 114.095 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -95.13 19.28 10.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 119.862 -1.774 . . . . 1.0 113.982 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.5 t0 45.61 56.2 6.02 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.213 -1.554 . . . . 1.0 113.479 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -45.2 -40.5 7.32 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.096 1.758 . . . . 1.0 113.011 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.63 -60.85 2.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.381 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -64.55 -36.2 83.45 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 117.884 -1.526 . . . . 1.0 111.251 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.55 -57.56 12.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.589 0.556 . . . . 1.0 110.397 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -64.38 -32.72 74.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.761 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.75 96.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.536 0.607 . . . . 1.0 111.715 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.82 -46.48 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.243 1.017 . . . . 1.0 112.262 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.04 166.87 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.371 1.868 . . . . 1.0 111.702 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 125.951 1.7 . . . . 1.0 108.876 175.274 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.12 176.33 5.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.895 0.878 . . . . 1.0 112.037 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 45.79 57.97 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.971 2.108 . . . . 1.0 109.694 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 139.83 13.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.557 -1.339 . . . . 1.0 111.294 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.03 130.11 39.18 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -83.61 133.2 34.85 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.024 0.53 . . . . 1.0 110.319 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.84 73.12 28.24 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.422 -1.696 . . . . 1.0 106.422 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.62 123.27 9.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 N-CA-C 108.08 -1.546 . . . . 1.0 108.08 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -113.91 114.51 46.5 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -79.86 38.93 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.665 2.91 . . . . 1.0 113.989 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.97 44.53 2.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.503 1.121 . . . . 1.0 109.254 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -73.52 178.52 4.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.066 0.946 . . . . 1.0 112.863 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.67 178.6 4.51 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 118.919 2.933 . . . . 1.0 118.919 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.2 m -162.83 118.73 1.84 Allowed 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 135.911 5.684 . . . . 1.0 101.173 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -130.09 154.96 81.39 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.439 -2.06 . . . . 1.0 105.439 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.26 51.97 4.12 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.985 3.124 . . . . 1.0 114.398 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -139.59 151.18 45.83 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.904 1.282 . . . . 1.0 110.205 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -148.43 103.82 3.46 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.791 1.236 . . . . 1.0 108.179 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.44 173.53 11.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.082 0.953 . . . . 1.0 109.01 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -79.46 124.32 84.01 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 119.648 1.113 . . . . 1.0 109.789 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.72 103.95 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.504 2.136 . . . . 1.0 112.436 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -178.13 83.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.067 1.747 . . . . 1.0 108.002 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.67 141.04 17.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.571 1.149 . . . . 1.0 108.183 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -94.25 127.48 40.13 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.475 1.51 . . . . 1.0 108.478 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 140.43 24.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -135.56 113.72 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 104.888 -2.264 . . . . 1.0 104.888 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.6 OUTLIER -170.16 152.16 4.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.796 1.638 . . . . 1.0 107.601 175.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -94.88 112.42 24.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mm -128.05 166.67 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 106.179 -1.785 . . . . 1.0 106.179 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -139.13 122.25 16.87 Favored 'General case' 0 N--CA 1.444 -0.733 1 N-CA-C 94.35 -6.167 . . . . 1.0 94.35 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.366 0.7 OUTLIER -142.96 -66.1 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.462 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -87.85 155.92 7.36 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.096 2.531 . . . . 1.0 114.352 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.19 59.09 5.86 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 125.174 3.916 . . . . 1.0 116.157 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.79 -71.77 0.95 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -156.48 123.46 5.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.463 1.505 . . . . 1.0 110.496 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -168.56 166.4 12.01 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.227 2.611 . . . . 1.0 110.715 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.06 6.49 25.4 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.623 2.059 . . . . 1.0 111.649 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.2 118.74 6.27 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.187 -1.965 . . . . 1.0 108.187 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.23 -7.88 20.25 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.825 2.35 . . . . 1.0 114.457 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -45.95 -49.63 15.62 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.283 1.433 . . . . 1.0 113.293 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -65.12 -46.01 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.619 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.4 -38.31 87.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.163 -0.681 . . . . 1.0 109.163 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.24 74.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.68 1.192 . . . . 1.0 111.897 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -59.66 -51.89 67.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.905 1.282 . . . . 1.0 109.152 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -70.03 -48.66 57.1 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.609 1.163 . . . . 1.0 111.558 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.05 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.046 0.938 . . . . 1.0 109.378 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.53 1.82 24.48 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.006 -1.441 . . . . 1.0 115.319 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -89.07 9.29 25.9 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.301 2.05 . . . . 1.0 113.038 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.4 tt -53.51 145.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.648 1.579 . . . . 1.0 114.431 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.82 136.77 20.56 Favored Pre-proline 0 CA--C 1.546 0.804 1 C-N-CA 131.77 4.028 . . . . 1.0 113.02 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.51 38.1 0.29 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.769 3.646 . . . . 1.0 113.695 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -103.16 -33.36 9.23 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.229 1.832 . . . . 1.0 111.061 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.9 -52.96 36.78 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 106.207 -1.775 . . . . 1.0 106.207 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -171.31 178.38 0.79 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 131.046 3.738 . . . . 1.0 104.181 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.3 -43.54 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.69 1.593 . . . . 1.0 113.658 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -42.28 -47.64 4.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.889 1.676 . . . . 1.0 114.105 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.66 -55.6 30.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.758 1.223 . . . . 1.0 109.136 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.33 99.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.253 1.021 . . . . 1.0 110.745 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.77 -57.49 10.75 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.87 1.7 . . . . 1.0 113.1 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 pt -61.7 -39.88 84.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.121 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.15 -43.26 0.74 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.89 2.476 . . . . 1.0 115.188 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -56.4 -40.05 74.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.008 0.923 . . . . 1.0 108.868 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.56 136.93 32.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 1.0 105.062 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 154.98 5.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.131 -0.98 . . . . 1.0 112.399 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 m -116.73 160.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.349 1.86 . . . . 1.0 108.872 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -174.24 120.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.583 1.553 . . . . 1.0 107.586 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.23 -169.39 1.91 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.243 1.417 . . . . 1.0 108.153 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -120.18 -59.04 1.82 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.854 1.261 . . . . 1.0 109.42 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.72 119.12 10.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 119.709 -1.869 . . . . 1.0 106.684 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp -98.88 113.74 26.02 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 102.579 -3.119 . . . . 1.0 102.579 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.0 mt -95.83 114.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.686 -1.968 . . . . 1.0 105.686 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -67.22 152.57 45.49 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 118.519 0.6 . . . . 1.0 110.165 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -14.0 18.74 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 125.467 1.507 . . . . 1.0 112.784 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -91.88 20.35 5.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.834 1.654 . . . . 1.0 111.755 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.56 47.71 89.79 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.743 2.592 . . . . 1.0 114.118 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -119.36 115.05 23.32 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.383 0.673 . . . . 1.0 110.521 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.92 117.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.55 147.28 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -124.3 117.92 25.6 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.569 1.548 . . . . 1.0 112.321 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.64 123.24 41.44 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 128.391 2.676 . . . . 1.0 105.205 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 t 64.34 91.29 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 122.339 2.336 . . . . 1.0 112.696 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -69.1 -169.13 0.28 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.144 1.896 . . . . 1.0 112.031 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.93 17.58 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.996 2.918 . . . . 1.0 114.994 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -143.68 125.27 14.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.687 2.395 . . . . 1.0 107.249 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? 85.09 81.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.559 3.144 . . . . 1.0 109.678 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.442 ' HB3' HH11 ' A' ' 93' ' ' ARG . 0.1 OUTLIER -38.71 141.44 0.27 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.598 2.759 . . . . 1.0 115.246 -175.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.45 -178.54 3.68 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 129.002 2.921 . . . . 1.0 111.625 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -153.71 118.32 4.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.678 1.591 . . . . 1.0 108.318 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -160.12 63.19 0.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.401 1.572 . . . . 1.0 111.498 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -159.53 -53.97 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.747 -2.471 . . . . 1.0 113.457 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.57 -69.41 0.74 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.5 t -145.86 137.57 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 1.0 108.019 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.9 p -166.46 165.96 16.68 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.092 1.757 . . . . 1.0 108.875 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.433 ' H ' HG22 ' A' ' 157' ' ' ILE . 5.3 p -159.27 146.38 17.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -156.48 152.81 27.85 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.62 -1.252 . . . . 1.0 107.62 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 39.85 53.41 2.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.368 1.467 . . . . 1.0 111.846 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.16 28.47 26.33 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.396 -1.224 . . . . 1.0 114.872 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -129.22 117.36 20.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.83 146.64 30.81 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.424 1.49 . . . . 1.0 111.191 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.15 117.99 24.28 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.406 ' C ' HD21 ' A' ' 109' ' ' ASN . 50.7 t -78.38 -23.87 46.6 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.207 1.003 . . . . 1.0 110.133 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.406 HD21 ' C ' ' A' ' 108' ' ' CYS . 1.0 OUTLIER -141.13 169.98 16.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.912 -1.885 . . . . 1.0 105.912 176.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.43 76.0 4.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 38.42 0.72 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.099 1.759 . . . . 1.0 109.497 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -128.23 143.07 51.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.574 1.55 . . . . 1.0 109.343 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -78.96 56.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.208 2.203 . . . . 1.0 107.451 175.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.07 -136.59 1.57 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 122.227 0.904 . . . . 1.0 112.773 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 28.2 mm -147.26 155.44 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 129.522 3.129 . . . . 1.0 104.104 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.43 129.97 21.35 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.97 161.5 13.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.646 -1.909 . . . . 1.0 110.626 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.68 144.82 48.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 1.0 111.084 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.71 38.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.55 2.024 . . . . 1.0 111.232 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.3 p -149.42 106.51 3.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.026 -1.842 . . . . 1.0 106.026 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.6 t0 45.52 48.81 10.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.59 1.956 . . . . 1.0 112.593 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p 52.32 38.39 24.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.695 1.998 . . . . 1.0 114.881 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.6 142.05 55.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 104.482 -2.414 . . . . 1.0 104.482 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -32.09 113.6 0.13 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.057 1.743 . . . . 1.0 112.039 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -79.59 -14.68 58.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 116.322 -1.799 . . . . 1.0 115.388 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 25.4 p 64.2 78.09 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.747 1.612 . . . . 1.0 111.841 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -24.39 -33.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.819 1.648 . . . . 1.0 113.335 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.59 -34.54 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.911 2.884 . . . . 1.0 110.644 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.59 -57.06 11.2 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.915 1.286 . . . . 1.0 107.998 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.01 -42.6 69.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.153 0.981 . . . . 1.0 109.715 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -66.03 -58.77 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.552 1.141 . . . . 1.0 111.542 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.5 -36.25 82.27 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.667 -1.271 . . . . 1.0 112.368 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tt -61.09 -39.22 89.12 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.897 -1.127 . . . . 1.0 108.146 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.72 95.47 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.963 -1.086 . . . . 1.0 111.337 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -53.53 57.23 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.22 -41.72 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.763 0.825 . . . . 1.0 110.869 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 m -59.59 -44.53 93.33 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.124 -0.985 . . . . 1.0 109.908 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.64 -44.57 90.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.894 0.77 . . . . 1.0 109.748 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.67 -56.22 22.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.941 0.896 . . . . 1.0 110.264 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.07 -44.76 79.25 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 118.241 -0.885 . . . . 1.0 112.325 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.3 -42.13 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.854 0.752 . . . . 1.0 109.786 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.225 0.61 . . . . 1.0 112.193 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -93.1 -51.2 5.15 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.693 1.197 . . . . 1.0 110.304 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.51 112.54 23.06 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -90.74 107.89 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 CA-C-N 121.539 1.585 . . . . 1.0 108.64 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.28 -50.99 0.11 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.603 2.361 . . . . 1.0 108.427 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.26 -33.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 130.367 3.467 . . . . 1.0 110.995 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.84 -26.49 10.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.036 1.125 . . . . 1.0 114.036 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -128.97 18.58 6.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.412 2.285 . . . . 1.0 111.374 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -138.15 83.36 1.97 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.4 mtt -127.61 114.02 16.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.317 -2.475 . . . . 1.0 104.317 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -154.47 -173.43 4.57 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.96 -122.84 1.75 Allowed Glycine 0 C--O 1.234 0.106 0 N-CA-C 106.413 -2.675 . . . . 1.0 106.413 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 97' ' ' ALA 0.255 14.9 m170 -118.3 -23.82 7.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.557 2.343 . . . . 1.0 112.029 176.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.79 -18.39 15.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.466 -0.778 . . . . 1.0 109.991 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -86.55 44.0 1.12 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.33 -23.08 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 120.446 -1.409 . . . . 1.0 107.427 175.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.403 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -151.6 -53.98 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.521 2.728 . . . . 1.0 111.164 175.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 95.1 Cg_endo -80.88 109.23 2.18 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.662 2.241 . . . . 1.0 113.348 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.64 -25.52 68.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.837 -1.164 . . . . 1.0 113.221 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -60.44 -23.18 64.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -135.68 131.95 36.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.2 m -113.69 -16.04 12.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.858 0.361 . . . . 1.0 110.13 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.1 -179.18 0.65 Allowed Pre-proline 0 CA--C 1.55 0.963 1 C-N-CA 132.572 4.349 . . . . 1.0 103.252 175.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.74 77.11 2.3 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 122.415 1.898 . . . . 1.0 111.432 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.36 73.58 0.81 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.1 1.333 . . . . 1.0 110.468 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.09 -57.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.816 0 CA-C-N 119.952 1.876 . . . . 1.0 113.645 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 53.35 43.08 31.89 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.32 1.448 . . . . 1.0 111.971 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.01 19.53 14.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.928 0.331 . . . . 1.0 111.486 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.264 22.6 t0 42.96 67.03 0.68 Allowed 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 126.38 1.872 . . . . 1.0 111.185 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -53.56 -32.96 53.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.209 -0.905 . . . . 1.0 111.904 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.41 -52.69 43.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.96 1.254 . . . . 1.0 110.755 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -65.94 -46.01 79.76 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.264 0.938 . . . . 1.0 111.254 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.33 -51.85 67.11 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.921 1.237 . . . . 1.0 111.58 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.329 -0.857 . . . . 1.0 110.049 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.06 77.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.19 -52.64 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.932 0.787 . . . . 1.0 108.996 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.53 161.6 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 122.115 0.959 . . . . 1.0 110.747 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 127.799 2.44 . . . . 1.0 108.864 175.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 107.442 -1.318 . . . . 1.0 107.442 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.32 135.29 55.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.715 0.634 . . . . 1.0 112.095 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 52.72 58.72 5.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.087 1.755 . . . . 1.0 111.294 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.75 141.6 25.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.774 -1.557 . . . . 1.0 108.378 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 tpt85 -76.38 123.44 25.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 ptt-85 -88.07 119.59 28.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.25 1.02 . . . . 1.0 111.388 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -143.45 73.98 17.28 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.175 0.99 . . . . 1.0 109.833 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.17 149.69 76.51 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 121.421 1.414 . . . . 1.0 109.87 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -137.44 134.1 18.42 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.576 1.15 . . . . 1.0 108.064 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.18 43.9 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.258 2.638 . . . . 1.0 113.251 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -123.47 43.67 2.9 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.351 -0.843 . . . . 1.0 109.381 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -73.52 178.74 4.46 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.676 1.19 . . . . 1.0 110.298 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -121.08 178.35 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.661 1.22 . . . . 1.0 113.003 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.0 m -148.64 118.61 7.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.079 2.952 . . . . 1.0 104.344 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -138.81 139.21 23.24 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 121.292 1.86 . . . . 1.0 108.717 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 75.18 4.76 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.511 2.807 . . . . 1.0 110.69 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -154.35 144.71 22.13 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.186 2.594 . . . . 1.0 106.853 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -149.8 103.44 3.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 127.257 2.223 . . . . 1.0 105.855 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -136.66 165.23 26.39 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.816 1.646 . . . . 1.0 107.613 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.49 123.61 83.45 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.615 -0.707 . . . . 1.0 111.33 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -86.85 103.59 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.506 2.137 . . . . 1.0 111.802 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -176.46 85.04 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 104.596 -2.372 . . . . 1.0 104.596 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -145.96 146.09 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.974 2.509 . . . . 1.0 105.489 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.26 127.84 56.07 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.026 -1.472 . . . . 1.0 107.026 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.18 135.66 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.1 t -135.57 114.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.753 1.621 . . . . 1.0 107.839 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -164.56 161.89 21.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.38 1.472 . . . . 1.0 107.236 175.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.64 112.42 24.3 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -127.99 176.42 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 127.809 2.444 . . . . 1.0 108.21 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -156.92 122.13 4.62 Favored 'General case' 0 N--CA 1.438 -1.039 1 N-CA-C 97.483 -5.006 . . . . 1.0 97.483 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -65.89 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.551 0 CA-C-N 120.298 1.408 . . . . 1.0 108.38 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.09 150.71 66.57 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 121.527 1.581 . . . . 1.0 109.924 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.29 28.49 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.105 3.204 . . . . 1.0 113.846 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -18.21 -71.64 0.01 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 127.686 2.565 . . . . 1.0 110.443 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -155.52 122.75 5.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -176.84 175.95 1.55 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.88 2.872 . . . . 1.0 108.089 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.56 1.54 8.09 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.91 -0.939 . . . . 1.0 113.743 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.35 118.52 5.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.219 1.509 . . . . 1.0 112.584 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.2 -4.29 13.36 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.936 2.424 . . . . 1.0 113.758 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.98 -38.77 76.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.948 -1.095 . . . . 1.0 110.292 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.35 -44.08 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.81 -48.01 82.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.108 0.867 . . . . 1.0 109.274 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.08 62.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 1.0 111.565 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.12 -61.06 2.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.792 0.837 . . . . 1.0 109.835 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -67.23 -49.98 62.43 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 t -57.73 -33.86 68.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 1.0 109.753 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 40.64 3.19 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.916 0.78 . . . . 1.0 111.879 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -131.3 16.28 5.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 117.972 0.886 . . . . 1.0 110.691 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.74 139.39 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.338 1.055 . . . . 1.0 110.445 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -98.42 127.47 36.05 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 127.641 2.376 . . . . 1.0 106.91 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.4 56.94 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.077 3.185 . . . . 1.0 111.819 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.77 -57.92 1.96 Allowed 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 124.961 1.304 . . . . 1.0 112.34 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.58 -60.33 1.58 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.744 1.217 . . . . 1.0 112.292 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -168.51 177.79 1.18 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 1.0 108.548 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.87 -43.45 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.726 1.618 . . . . 1.0 113.684 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -50.54 -60.1 3.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.672 1.189 . . . . 1.0 111.928 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.84 -51.65 68.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.846 0.858 . . . . 1.0 110.395 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.54 77.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.415 1.086 . . . . 1.0 111.508 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.19 -65.36 3.62 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 125.418 1.485 . . . . 1.0 110.603 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.91 -24.24 32.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 116.68 -1.629 . . . . 1.0 113.544 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.01 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.526 1.512 . . . . 1.0 113.659 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -57.41 -34.11 68.56 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.612 0.365 . . . . 1.0 110.956 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.49 136.38 33.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -66.04 149.29 50.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.909 -1.119 . . . . 1.0 109.402 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.3 m -117.09 162.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.068 1.347 . . . . 1.0 109.952 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -166.34 130.57 2.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.256 2.223 . . . . 1.0 105.976 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.11 -157.09 0.56 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -130.21 -61.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.192 0.997 . . . . 1.0 108.821 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.8 m -140.7 118.55 11.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.911 -1.885 . . . . 1.0 105.911 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.22 113.8 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.717 2.007 . . . . 1.0 105.607 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.64 114.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.974 -1.491 . . . . 1.0 106.974 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -70.99 152.84 43.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -14.05 2.58 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.693 0.797 . . . . 1.0 112.952 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -91.5 19.61 6.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 127.477 2.311 . . . . 1.0 112.1 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 28.94 70.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.686 2.565 . . . . 1.0 115.551 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.6 109.09 20.59 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.1 mt -76.54 121.12 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.073 -2.195 . . . . 1.0 105.073 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.33 125.78 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.506 -2.405 . . . . 1.0 104.506 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.36 113.6 27.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.146 0.978 . . . . 1.0 108.519 -175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.9 114.31 20.83 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t 83.75 91.62 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.537 1.971 . . . . 1.0 110.357 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.72 -170.37 0.27 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.755 2.303 . . . . 1.0 110.68 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.3 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.243 2.217 . . . . 1.0 115.26 -176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -143.76 123.0 12.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.485 1.914 . . . . 1.0 109.531 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 86.44 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.22 3.008 . . . . 1.0 111.506 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -34.62 138.58 0.1 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.15 2.58 . . . . 1.0 113.04 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.88 -178.83 3.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.554 2.342 . . . . 1.0 111.353 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -150.28 118.73 6.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.241 1.416 . . . . 1.0 108.003 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -167.46 63.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.483 1.135 . . . . 1.0 110.442 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.08 -69.92 0.1 Allowed 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 118.606 -2.559 . . . . 1.0 111.749 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.36 0.33 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 125.187 1.554 . . . . 1.0 110.0 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 t -144.72 145.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.827 1.651 . . . . 1.0 109.899 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 p -165.82 149.54 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.626 1.171 . . . . 1.0 110.573 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.8 p -143.71 132.21 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.788 -1.93 . . . . 1.0 105.788 175.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -159.59 124.26 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.447 1.022 . . . . 1.0 108.313 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 58.79 71.69 0.57 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.41 1.884 . . . . 1.0 113.571 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.38 28.6 44.24 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.527 2.489 . . . . 1.0 113.312 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -147.02 113.22 5.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.36 141.42 28.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -123.95 117.86 25.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 102.997 -2.964 . . . . 1.0 102.997 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.4 t -66.23 -35.13 79.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -145.01 172.1 13.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.787 2.835 . . . . 1.0 106.006 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -84.84 77.11 10.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.413 1.102 . . . . 1.0 108.829 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.75 35.13 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.406 1.882 . . . . 1.0 111.417 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -123.72 153.05 41.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.879 0.872 . . . . 1.0 112.475 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -88.86 57.11 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.534 1.934 . . . . 1.0 107.029 175.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.95 -136.59 1.2 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.947 -1.095 . . . . 1.0 111.74 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 6.2 mm -142.55 161.47 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 129.329 3.052 . . . . 1.0 103.096 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -134.44 130.13 36.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.309 2.244 . . . . 1.0 105.001 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -101.19 153.03 19.95 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.736 -1.228 . . . . 1.0 108.919 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 158.03 45.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.73 0.776 . . . . 1.0 111.641 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.92 39.53 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.453 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.9 p -146.48 104.0 3.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 103.367 -2.827 . . . . 1.0 103.367 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t0 43.87 49.66 7.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.751 2.02 . . . . 1.0 112.984 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 p 50.31 38.08 16.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.051 2.14 . . . . 1.0 114.191 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.48 136.2 57.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.19 0.04 OUTLIER 'General case' 0 C--N 1.347 0.486 0 C-N-CA 127.373 2.269 . . . . 1.0 110.615 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -78.03 -10.3 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 115.892 -2.004 . . . . 1.0 116.339 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.333 44.8 p 64.74 77.31 0.32 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 121.355 1.889 . . . . 1.0 110.987 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -24.43 -32.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.246 1.818 . . . . 1.0 114.683 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -39.85 -43.67 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.314 1.846 . . . . 1.0 109.231 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -43.71 -50.93 7.45 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.779 1.231 . . . . 1.0 111.668 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.31 -39.81 88.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.458 0.572 . . . . 1.0 111.032 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -61.63 -58.57 7.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.032 0.533 . . . . 1.0 109.667 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -65.92 -47.12 75.81 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.544 -0.741 . . . . 1.0 111.599 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -54.85 -46.55 74.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.048 1.295 . . . . 1.0 109.34 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.44 96.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.535 1.061 . . . . 1.0 111.416 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.1 50.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.001 0.52 . . . . 1.0 109.654 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.0 t -52.2 -64.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.533 1.933 . . . . 1.0 108.61 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -53.96 -53.6 50.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.484 1.914 . . . . 1.0 112.209 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -57.85 -41.93 83.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.763 1.165 . . . . 1.0 109.555 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.86 -44.34 70.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.205 -0.935 . . . . 1.0 111.165 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.97 -36.77 70.71 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.12 -1.612 . . . . 1.0 111.458 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 mt -62.1 -35.57 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.01 -1.107 . . . . 1.0 108.01 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -64.96 -13.61 57.88 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.785 1.234 . . . . 1.0 110.774 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -98.63 -65.89 0.93 Allowed 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.158 -1.589 . . . . 1.0 106.981 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -119.41 112.91 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 106.673 -1.603 . . . . 1.0 106.673 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -92.78 108.19 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.649 1.566 . . . . 1.0 112.288 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.05 -49.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.587 1.955 . . . . 1.0 106.583 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.0 mt -48.41 -33.61 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 128.934 2.894 . . . . 1.0 110.829 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.42 12.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.344 1.057 . . . . 1.0 113.395 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.31 18.58 4.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.085 2.154 . . . . 1.0 110.656 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.83 83.62 1.97 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.67 1.188 . . . . 1.0 107.967 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.3 mtt -118.78 120.19 36.63 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.592 -1.633 . . . . 1.0 106.592 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -155.26 -169.57 3.2 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.27 -0.894 . . . . 1.0 110.339 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.03 -131.19 1.51 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 14.2 m170 -113.39 -23.51 9.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.362 1.081 . . . . 1.0 111.791 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -11.16 18.56 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -91.36 38.92 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.742 1.156 . . . . 1.0 108.489 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.07 -12.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 120.295 -1.503 . . . . 1.0 110.267 175.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.8 -54.39 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.546 1.939 . . . . 1.0 111.088 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.38 117.94 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.293 1.996 . . . . 1.0 113.395 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.85 -24.29 61.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.271 -0.893 . . . . 1.0 111.785 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -57.49 -19.35 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.64 2.376 . . . . 1.0 112.087 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.98 141.44 38.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.748 -1.575 . . . . 1.0 106.748 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -130.91 -16.72 3.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.898 1.226 . . . . 1.0 109.831 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.98 179.88 0.36 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 129.844 3.257 . . . . 1.0 104.772 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.33 79.75 3.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.149 1.899 . . . . 1.0 108.423 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.15 59.26 0.53 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.389 -1.229 . . . . 1.0 115.251 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 -52.3 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.069 2.435 . . . . 1.0 112.357 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.0 t 54.07 43.62 30.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.197 1.399 . . . . 1.0 111.866 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . 0.253 83.5 t80 -107.27 18.34 21.76 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.986 1.847 . . . . 1.0 115.986 -175.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.327 5.8 t70 42.05 75.0 0.1 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.424 1.49 . . . . 1.0 113.625 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -50.18 -35.34 25.84 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.64 79.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.861 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -51.28 68.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.849 1.204 . . . . 1.0 109.651 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.22 -52.82 60.67 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.825 0.306 . . . . 1.0 111.825 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -63.74 -26.65 68.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.265 -0.897 . . . . 1.0 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.11 88.65 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 1.0 109.992 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.29 -61.21 1.85 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.677 1.591 . . . . 1.0 111.7 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.6 t -66.26 165.77 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.3 1.04 . . . . 1.0 110.158 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 54.4 m . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 125.331 1.453 . . . . 1.0 110.717 175.768 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.718 -1.215 . . . . 1.0 107.718 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 156.53 32.69 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.515 0.726 . . . . 1.0 110.24 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 38.7 58.08 1.74 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.133 2.173 . . . . 1.0 111.304 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.95 143.83 23.73 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.424 -0.797 . . . . 1.0 111.341 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -82.34 124.23 29.8 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.027 1.331 . . . . 1.0 108.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.57 119.23 24.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 t -142.18 75.34 20.25 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.011 1.324 . . . . 1.0 108.198 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 123.58 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.516 1.478 . . . . 1.0 112.673 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -49.8 146.08 7.99 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.434 1.894 . . . . 1.0 111.92 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.76 -37.42 6.8 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 N-CA-C 114.734 1.013 . . . . 1.0 114.734 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -151.48 135.67 16.73 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -104.28 -170.88 1.83 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.553 1.141 . . . . 1.0 109.675 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.69 178.95 5.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.283 2.633 . . . . 1.0 111.61 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.1 m -140.92 153.95 45.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 129.522 3.129 . . . . 1.0 104.993 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -131.16 157.03 79.27 Favored Pre-proline 0 N--CA 1.467 0.377 0 O-C-N 120.918 -1.114 . . . . 1.0 109.444 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.31 51.08 2.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.072 2.515 . . . . 1.0 111.883 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -148.6 153.63 38.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 126.305 1.842 . . . . 1.0 109.988 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.72 103.2 3.76 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -137.0 164.65 27.85 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.734 -0.603 . . . . 1.0 109.431 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.87 123.8 78.98 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.438 1.895 . . . . 1.0 108.068 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.27 103.48 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 N-CA-C 108.318 -1.455 . . . . 1.0 108.318 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 t -165.09 67.67 0.13 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.37 129.58 22.22 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -95.13 128.64 42.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.959 -1.867 . . . . 1.0 105.959 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.17 140.11 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.31 114.2 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -169.61 133.6 1.31 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.81 113.57 8.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.105 -1.443 . . . . 1.0 107.105 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' CG2' ' H ' ' A' ' 37' ' ' SER . 32.4 mm -126.41 177.06 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 127.741 2.416 . . . . 1.0 107.623 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.411 ' H ' ' CG2' ' A' ' 36' ' ' ILE . 30.9 t -155.5 121.72 5.17 Favored 'General case' 0 C--N 1.316 -0.871 1 N-CA-C 95.421 -5.77 . . . . 1.0 95.421 173.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.324 0.5 OUTLIER -141.44 -61.45 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 119.119 0.872 . . . . 1.0 111.336 175.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 61.3 Cg_endo -79.77 157.79 24.53 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.676 2.25 . . . . 1.0 112.024 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.15 -0.23 10.57 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-O 114.159 -2.517 . . . . 1.0 115.172 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -11.79 -71.05 0.01 OUTLIER Glycine 0 C--N 1.352 1.44 0 C-N-CA 127.278 2.37 . . . . 1.0 113.36 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -155.02 122.97 5.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.345 1.858 . . . . 1.0 109.05 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -175.77 175.42 2.03 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 130.009 3.324 . . . . 1.0 107.614 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.31 6.96 24.89 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.235 1.398 . . . . 1.0 112.83 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.41 118.5 6.2 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.533 1.666 . . . . 1.0 109.951 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.73 -13.08 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.261 1.974 . . . . 1.0 114.386 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -62.01 -35.94 80.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.399 1.454 . . . . 1.0 110.928 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -64.18 -47.03 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.061 0.944 . . . . 1.0 109.238 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -34.74 78.88 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.482 -0.761 . . . . 1.0 112.126 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.8 -33.78 50.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.132 1.373 . . . . 1.0 111.625 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.69 -55.92 28.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.965 1.306 . . . . 1.0 110.259 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE1' ' HA ' ' A' ' 39' ' ' PRO . 42.0 m-85 -71.31 -40.74 70.64 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 126.649 1.98 . . . . 1.0 112.969 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 t -66.0 -33.32 75.55 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.222 -0.924 . . . . 1.0 109.538 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.56 24.86 10.51 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 118.698 -1.057 . . . . 1.0 113.525 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -121.46 16.63 11.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.185 1.492 . . . . 1.0 111.575 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.7 135.27 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.408 1.083 . . . . 1.0 110.758 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.95 136.59 20.56 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.199 1.8 . . . . 1.0 109.095 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.78 56.87 3.01 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.798 2.999 . . . . 1.0 113.204 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -103.47 -49.65 3.65 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.586 0.958 . . . . 1.0 113.586 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.93 -60.62 2.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.972 0.805 . . . . 1.0 112.674 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -170.53 177.79 0.95 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.558 1.543 . . . . 1.0 107.477 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -72.85 -43.53 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.304 1.336 . . . . 1.0 114.996 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -50.77 -59.11 4.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.954 1.252 . . . . 1.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.12 -49.83 76.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 1.0 110.251 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.68 90.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.818 0.847 . . . . 1.0 111.108 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.14 -63.63 4.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.048 1.785 . . . . 1.0 110.075 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.89 -26.83 41.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 116.408 -1.758 . . . . 1.0 112.947 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -42.98 3.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.105 1.762 . . . . 1.0 114.729 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -52.49 -39.08 60.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.572 1.549 . . . . 1.0 110.871 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.78 136.28 33.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.499 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.06 161.26 22.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.416 -0.802 . . . . 1.0 109.035 175.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.49 164.39 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.896 1.279 . . . . 1.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -169.52 118.05 0.63 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.909 1.284 . . . . 1.0 108.332 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.61 -174.48 3.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.79 1.236 . . . . 1.0 109.052 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -112.17 -73.64 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.242 1.017 . . . . 1.0 111.628 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.02 118.74 27.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 103.66 -2.719 . . . . 1.0 103.66 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tp -104.23 113.34 26.82 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.264 -2.865 . . . . 1.0 103.264 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.03 113.49 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 105.644 -1.984 . . . . 1.0 105.644 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -85.37 149.22 25.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.115 0.87 . . . . 1.0 110.399 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -46.82 -13.85 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 128.418 2.687 . . . . 1.0 115.547 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.89 27.98 1.95 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.929 1.291 . . . . 1.0 112.711 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.3 28.96 70.14 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.584 1.564 . . . . 1.0 114.484 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.48 153.05 20.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.299 1.05 . . . . 1.0 111.502 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.45 114.08 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 104.668 -2.345 . . . . 1.0 104.668 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 145.69 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -124.3 115.49 21.11 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.947 0.899 . . . . 1.0 110.403 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -110.38 129.8 55.69 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 127.828 2.451 . . . . 1.0 105.525 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.6 t 63.4 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 121.985 2.175 . . . . 1.0 115.148 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -64.1 -174.11 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 121.658 1.572 . . . . 1.0 111.423 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -67.18 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.57 1.948 . . . . 1.0 114.372 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -140.84 111.53 6.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.734 2.014 . . . . 1.0 108.482 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 84.05 81.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.421 2.289 . . . . 1.0 109.976 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -37.33 146.28 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.675 3.19 . . . . 1.0 111.469 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.14 -178.35 3.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.859 1.264 . . . . 1.0 111.674 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -141.78 118.6 11.12 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.2 63.16 0.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.852 1.31 . . . . 1.0 107.964 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.24 -69.04 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 119.224 -2.172 . . . . 1.0 114.454 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.96 -85.67 0.4 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 103.203 -3.959 . . . . 1.0 103.203 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.21 146.45 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 119.797 1.799 . . . . 1.0 110.502 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.5 p -155.84 155.77 33.52 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.055 1.742 . . . . 1.0 108.096 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.413 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.9 p -147.99 132.32 17.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.094 -1.817 . . . . 1.0 106.094 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -160.63 156.93 26.35 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.228 0.611 . . . . 1.0 109.565 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 39.13 53.65 2.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.4 1.48 . . . . 1.0 112.251 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.21 28.26 18.36 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.298 2.856 . . . . 1.0 114.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -129.86 121.4 26.63 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 119.619 1.709 . . . . 1.0 107.058 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -92.62 141.96 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -116.35 118.52 32.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.8 -1.556 . . . . 1.0 106.8 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.5 t -55.69 -38.83 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.815 0.846 . . . . 1.0 110.09 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -152.98 164.79 37.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.997 2.919 . . . . 1.0 105.019 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 112' ' ' SER . 32.0 t70 -84.28 76.71 10.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 122.584 1.183 . . . . 1.0 111.154 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.85 43.42 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.894 2.478 . . . . 1.0 108.542 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASP . 2.8 m -123.29 156.79 34.57 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.391 1.876 . . . . 1.0 111.434 -175.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -96.54 57.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.705 2.002 . . . . 1.0 107.92 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.13 -136.96 1.65 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.983 -1.073 . . . . 1.0 112.033 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.8 mt -152.29 164.88 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 131.512 3.925 . . . . 1.0 102.36 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -144.86 143.1 30.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.053 2.141 . . . . 1.0 105.277 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -101.46 155.39 18.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.824 -1.173 . . . . 1.0 110.303 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -131.43 138.87 49.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.33 -172.73 39.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.353 0.978 . . . . 1.0 110.906 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -133.78 92.46 2.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.578 -0.954 . . . . 1.0 108.628 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.4 t0 54.34 56.97 6.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.471 1.508 . . . . 1.0 113.49 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 16.5 p 60.91 38.42 17.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.181 1.792 . . . . 1.0 113.605 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.6 132.02 47.26 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.29 -2.485 . . . . 1.0 104.29 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -30.32 115.03 0.12 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.387 1.875 . . . . 1.0 110.536 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -78.09 -2.45 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 114.943 -2.456 . . . . 1.0 116.975 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.341 42.4 p 67.39 78.05 0.25 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 115.727 -2.083 . . . . 1.0 111.374 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -24.23 -34.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 121.596 1.998 . . . . 1.0 116.157 177.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.75 14.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.163 2.185 . . . . 1.0 110.333 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -49.15 -50.55 37.07 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 125.077 1.351 . . . . 1.0 109.826 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -60.87 -40.63 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.832 -0.604 . . . . 1.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -65.38 -47.88 74.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.354 0.524 . . . . 1.0 111.061 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.89 -54.04 31.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.451 1.1 . . . . 1.0 110.254 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -46.47 73.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.122 1.369 . . . . 1.0 108.805 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.46 87.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.934 1.243 . . . . 1.0 111.664 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.64 54.24 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.7 -53.11 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.623 -0.703 . . . . 1.0 109.365 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.4 m -55.38 -61.31 2.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.403 1.881 . . . . 1.0 111.059 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -53.75 -43.08 68.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.606 0.717 . . . . 1.0 110.878 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.009 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 mt -56.76 -36.93 70.38 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.087 -1.633 . . . . 1.0 111.373 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.04 -31.88 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.655 1.182 . . . . 1.0 109.727 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m -64.26 -16.88 62.96 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.88 0.764 . . . . 1.0 111.006 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -65.15 0.98 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 120.664 -1.272 . . . . 1.0 108.274 175.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -110.29 112.84 56.92 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 108.004 -1.109 . . . . 1.0 108.004 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -104.07 108.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 119.697 0.927 . . . . 1.0 111.372 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.15 -51.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.097 2.559 . . . . 1.0 105.912 174.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -45.2 -33.51 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 1 C-N-CA 131.82 4.048 . . . . 1.0 110.013 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.15 -25.54 0.91 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.59 18.97 4.29 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.582 2.353 . . . . 1.0 111.133 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.75 84.29 2.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.88 1.272 . . . . 1.0 109.687 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 116.58 21.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.03 -1.841 . . . . 1.0 106.03 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 -173.25 4.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.846 0.748 . . . . 1.0 109.852 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.31 -131.06 2.64 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 106.696 -2.562 . . . . 1.0 106.696 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.465 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 19.8 m170 -112.71 -23.87 9.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.59 0.756 . . . . 1.0 111.215 -177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 t -102.89 -17.05 15.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.615 1.166 . . . . 1.0 111.081 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -85.12 40.3 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.338 1.426 . . . . 1.0 109.196 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.413 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -69.71 -9.2 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 O-C-N 120.744 -1.222 . . . . 1.0 109.019 175.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.13 -53.52 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.001 2.52 . . . . 1.0 111.538 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -96.42 121.61 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.852 2.368 . . . . 1.0 114.217 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.51 -17.09 63.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.564 -1.335 . . . . 1.0 112.141 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -24.93 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.115 -0.991 . . . . 1.0 111.48 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -144.31 123.77 13.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.475 -2.046 . . . . 1.0 105.475 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.2 m -114.16 -16.29 12.1 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.402 0.438 . . . . 1.0 112.045 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.24 171.46 1.06 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 128.446 2.698 . . . . 1.0 104.755 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 87.34 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.308 2.006 . . . . 1.0 109.747 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.74 75.42 0.68 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.143 1.83 . . . . 1.0 110.996 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.14 -95.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.736 2.291 . . . . 1.0 110.024 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 54.3 43.64 30.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.188 2.595 . . . . 1.0 111.0 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -97.53 18.58 15.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.348 0.659 . . . . 1.0 111.94 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.4 t0 44.88 67.22 0.74 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.745 1.218 . . . . 1.0 111.803 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.19 -25.51 59.14 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.706 -0.621 . . . . 1.0 112.474 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -55.75 15.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 117.794 -1.098 . . . . 1.0 109.605 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -62.4 -42.84 99.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 117.312 -1.328 . . . . 1.0 110.547 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -61.41 -52.67 63.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.108 1.322 . . . . 1.0 110.881 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.36 77.78 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.16 86.96 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.68 -54.8 14.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.79 1.636 . . . . 1.0 111.007 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.8 160.09 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.133 0.973 . . . . 1.0 109.098 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 126.51 1.924 . . . . 1.0 105.89 175.162 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.33 173.86 8.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.605 0.762 . . . . 1.0 111.042 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 40.04 57.75 2.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.721 2.408 . . . . 1.0 109.993 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.14 153.6 20.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -81.68 130.15 34.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.55 118.64 23.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -138.48 88.74 14.27 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.11 123.82 11.41 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 N-CA-C 109.333 -1.064 . . . . 1.0 109.333 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -63.64 146.53 96.65 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.05 -25.29 19.55 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 N-CA-C 117.393 2.036 . . . . 1.0 117.393 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -150.82 117.89 5.93 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.841 -1.911 . . . . 1.0 105.841 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.92 178.17 7.04 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.084 0.954 . . . . 1.0 112.543 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.38 178.99 4.09 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.931 1.693 . . . . 1.0 111.859 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.3 m -164.94 127.46 2.22 Favored 'General case' 0 CA--C 1.534 0.354 1 C-N-CA 133.356 4.662 . . . . 1.0 103.184 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -131.33 153.78 81.74 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.699 1.136 . . . . 1.0 108.614 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.92 67.67 8.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.104 3.203 . . . . 1.0 110.804 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.48 159.5 42.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.632 1.573 . . . . 1.0 110.734 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -150.91 103.92 3.11 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 27' ' ' ASN . 2.0 tm-20 -137.25 176.48 8.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.41 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 10.9 t30 -84.48 123.0 75.2 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.792 -1.559 . . . . 1.0 106.792 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.26 103.02 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 N-CA-C 108.3 -1.462 . . . . 1.0 108.3 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 t -175.76 69.05 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -147.9 130.45 15.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.99 0.916 . . . . 1.0 108.705 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.7 tp -84.38 124.52 31.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.28 114.04 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.8 t -114.22 113.93 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -163.54 143.58 8.63 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.545 -2.021 . . . . 1.0 105.545 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 8.0 mm -127.59 176.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 130.835 3.654 . . . . 1.0 107.851 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -160.28 121.78 3.12 Favored 'General case' 0 N--CA 1.432 -1.365 1 N-CA-C 97.829 -4.878 . . . . 1.0 97.829 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.557 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 4.8 tt -142.57 -43.9 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.398 -1.763 . . . . 1.0 112.941 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 44.7 Cg_endo -82.99 150.31 13.93 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 121.662 1.629 . . . . 1.0 114.833 -175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 7.38 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.843 3.028 . . . . 1.0 116.777 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -23.49 -71.3 0.01 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 121.059 1.754 . . . . 1.0 112.525 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -156.6 123.21 5.09 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.291 14.1 m-85 -177.76 153.94 0.9 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 129.649 3.18 . . . . 1.0 109.862 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.31 2.09 77.75 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.05 -0.861 . . . . 1.0 112.885 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.85 118.54 5.51 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.01 -4.05 14.45 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.373 2.049 . . . . 1.0 113.213 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' CZ2' ' CD1' ' A' ' 64' ' ' PHE . 32.6 t-105 -64.55 -39.55 93.97 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.598 1.09 . . . . 1.0 110.305 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.86 -46.63 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.568 1.947 . . . . 1.0 109.274 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.63 -46.37 89.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.861 0.755 . . . . 1.0 110.552 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.2 -34.06 63.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.236 1.414 . . . . 1.0 111.39 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.27 -54.79 27.7 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.195 0.452 . . . . 1.0 110.524 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -70.1 -42.5 72.62 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 119.014 -0.517 . . . . 1.0 112.297 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.16 -34.23 77.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.33 1.052 . . . . 1.0 109.049 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.21 -0.47 31.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.367 1.46 . . . . 1.0 115.681 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.3 p -88.99 11.19 18.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.057 1.928 . . . . 1.0 112.934 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.8 tt -51.63 135.9 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.108 1.763 . . . . 1.0 112.793 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -98.62 131.31 26.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 127.446 2.299 . . . . 1.0 109.29 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.2 63.01 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.68 3.587 . . . . 1.0 110.184 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -104.54 -65.93 1.0 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.407 1.883 . . . . 1.0 113.15 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.35 -54.76 15.55 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.69 1.196 . . . . 1.0 110.714 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -171.32 177.82 0.87 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.685 1.994 . . . . 1.0 106.766 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.49 -43.63 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.494 1.462 . . . . 1.0 114.033 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -50.84 -57.6 8.03 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' CZ2' ' A' ' 47' ' ' TRP . 20.8 t80 -59.27 -44.96 92.4 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.205 0.602 . . . . 1.0 111.475 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.67 97.94 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.831 -0.543 . . . . 1.0 111.324 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.68 -60.81 8.23 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.827 1.203 . . . . 1.0 112.026 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.2 pt -51.0 -41.48 22.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.798 1.239 . . . . 1.0 112.96 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.01 -43.53 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 127.901 2.48 . . . . 1.0 115.158 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -60.8 -35.58 76.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.449 0.7 . . . . 1.0 110.423 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.77 135.75 33.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 153.46 32.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.377 -0.929 . . . . 1.0 110.05 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.54 163.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.165 1.386 . . . . 1.0 108.671 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -170.67 128.04 0.78 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.306 -1.739 . . . . 1.0 106.306 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.17 -154.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.461 -1.681 . . . . 1.0 106.461 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -124.63 -58.55 1.5 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.879 1.672 . . . . 1.0 110.0 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -142.65 121.35 12.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.53 113.93 21.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.385 1.474 . . . . 1.0 107.853 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.3 mt -97.55 116.59 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.711 1.204 . . . . 1.0 108.078 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -78.92 153.35 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.345 1.884 . . . . 1.0 109.574 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -46.87 -23.23 0.41 Allowed 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.711 2.004 . . . . 1.0 114.259 176.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . 18.3 t0 -91.42 34.61 0.95 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.225 0.921 . . . . 1.0 110.478 -175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.08 29.56 71.33 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.109 -0.995 . . . . 1.0 113.868 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.53 140.67 32.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.01 114.07 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 103.838 -2.653 . . . . 1.0 103.838 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 t -111.67 139.6 35.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.362 0.665 . . . . 1.0 109.514 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -104.87 118.83 37.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -117.65 113.34 21.76 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 103.239 -2.874 . . . . 1.0 103.239 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t 69.2 91.8 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.31 1.414 . . . . 1.0 112.332 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -66.88 -168.25 0.15 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.471 2.114 . . . . 1.0 111.669 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -60.71 22.76 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 129.378 3.071 . . . . 1.0 116.811 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -159.69 133.49 7.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.972 1.714 . . . . 1.0 107.865 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 tptm 86.29 82.14 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 129.453 3.101 . . . . 1.0 109.665 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.12 147.5 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.991 3.317 . . . . 1.0 115.425 -174.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.07 175.95 5.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.342 3.057 . . . . 1.0 111.076 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -156.12 118.19 4.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.074 1.75 . . . . 1.0 107.343 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.9 63.22 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.287 -1.508 . . . . 1.0 112.318 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.14 -62.79 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.202 -2.186 . . . . 1.0 114.358 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.32 -91.4 0.47 Allowed Glycine 0 CA--C 1.53 1.005 0 N-CA-C 103.608 -3.797 . . . . 1.0 103.608 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.84 146.4 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.807 1.803 . . . . 1.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -154.77 166.51 33.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.479 1.511 . . . . 1.0 110.312 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.422 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -150.9 146.83 26.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.4 1.48 . . . . 1.0 110.745 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.54 133.88 21.81 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.832 -0.543 . . . . 1.0 110.054 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 39.36 65.77 0.65 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.74 2.016 . . . . 1.0 111.367 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 29.26 67.21 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.089 1.196 . . . . 1.0 116.089 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -130.55 136.25 48.73 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.854 -1.906 . . . . 1.0 105.854 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.05 146.83 28.55 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.529 2.332 . . . . 1.0 111.931 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -127.42 118.35 23.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.763 1.225 . . . . 1.0 107.814 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -79.68 -23.42 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.469 0.708 . . . . 1.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -144.97 175.22 10.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.863 2.065 . . . . 1.0 106.547 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -101.2 76.73 1.74 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.55 33.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.011 2.124 . . . . 1.0 113.72 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -129.37 138.98 51.84 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 121.201 -0.937 . . . . 1.0 111.491 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.257 0.1 OUTLIER -78.54 56.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.931 2.092 . . . . 1.0 109.798 -177.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.6 -136.4 1.39 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 122.289 0.939 . . . . 1.0 111.247 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.5 mm -144.02 166.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 130.151 3.38 . . . . 1.0 103.144 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -143.43 136.85 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 103.222 -2.881 . . . . 1.0 103.222 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -98.81 134.28 41.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.166 -0.959 . . . . 1.0 109.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 24.3 tt0 -105.61 138.28 42.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.806 0.812 . . . . 1.0 110.285 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.47 40.11 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.47 1.986 . . . . 1.0 109.41 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -153.28 116.18 4.53 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.32 39.7 30.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.865 1.316 . . . . 1.0 112.194 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p 45.08 37.73 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.293 2.237 . . . . 1.0 112.529 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.04 136.69 58.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.66 113.38 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.695 2.398 . . . . 1.0 112.618 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -78.67 -16.2 57.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 116.554 -1.689 . . . . 1.0 112.876 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.359 10.3 p 66.51 77.54 0.28 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 121.183 1.81 . . . . 1.0 112.118 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.25 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.699 2.045 . . . . 1.0 115.25 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.12 -36.92 3.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 1.0 109.354 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -56.41 -58.49 7.77 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 125.564 1.546 . . . . 1.0 107.559 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -52.79 -44.73 66.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.263 0.938 . . . . 1.0 110.075 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -66.16 -58.15 6.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.549 0.74 . . . . 1.0 111.947 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -66.3 -34.33 77.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.503 1.047 . . . . 1.0 112.09 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 tp -61.14 -44.56 97.13 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 106.962 -1.495 . . . . 1.0 106.962 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.5 80.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.134 -0.936 . . . . 1.0 110.412 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.99 -55.35 35.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.447 1.021 . . . . 1.0 109.972 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.33 -49.18 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 1.0 109.338 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.1 m -58.38 -53.89 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.594 1.158 . . . . 1.0 109.873 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -56.09 -43.67 78.25 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.914 1.285 . . . . 1.0 110.478 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.62 63.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.12 0.568 . . . . 1.0 111.713 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -56.56 -34.57 67.24 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 117.918 -1.039 . . . . 1.0 111.264 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.28 -43.38 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 120.159 1.345 . . . . 1.0 109.144 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.5 m -64.43 -23.1 67.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.854 0.752 . . . . 1.0 111.524 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -83.77 -58.55 2.75 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.788 -1.195 . . . . 1.0 108.438 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.61 113.15 22.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.549 1.54 . . . . 1.0 109.104 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.54 107.78 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 CA-C-N 120.857 1.342 . . . . 1.0 111.867 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.23 -51.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.014 2.125 . . . . 1.0 107.798 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.4 mt -45.16 -33.4 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 131.508 3.923 . . . . 1.0 111.078 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.99 -23.42 5.08 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.222 1.009 . . . . 1.0 113.541 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -140.52 30.75 1.9 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.687 2.395 . . . . 1.0 109.089 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -140.7 83.78 1.91 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.367 1.867 . . . . 1.0 110.311 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.57 116.65 16.15 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 126.661 1.984 . . . . 1.0 105.718 175.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 t -151.69 -173.2 4.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.98 -131.52 2.29 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 105.604 -2.998 . . . . 1.0 105.604 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.306 13.0 m170 -112.98 -22.28 10.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.867 1.267 . . . . 1.0 111.311 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.02 -11.25 17.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.493 0.588 . . . . 1.0 109.807 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -86.57 36.41 0.7 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.632 1.105 . . . . 1.0 108.532 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -67.8 -12.07 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 120.399 -1.438 . . . . 1.0 109.859 175.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.06 -66.01 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.74 2.416 . . . . 1.0 111.16 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -92.65 127.89 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.275 1.983 . . . . 1.0 114.075 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.46 -26.25 65.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.938 1.295 . . . . 1.0 112.615 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -63.13 -21.66 66.34 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.856 1.263 . . . . 1.0 111.774 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 138.92 53.29 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 105.174 -2.158 . . . . 1.0 105.174 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -132.39 -16.63 2.7 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 118.868 -1.133 . . . . 1.0 110.844 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -179.27 0.35 Allowed Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 129.171 2.989 . . . . 1.0 104.292 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.29 52.23 4.2 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 122.543 2.162 . . . . 1.0 112.5 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.72 73.24 0.12 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.005 1.764 . . . . 1.0 112.538 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.15 -63.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.46 2.106 . . . . 1.0 111.955 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.7 t 54.46 43.8 29.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.932 2.093 . . . . 1.0 110.446 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -94.02 18.25 10.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.72 71.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.942 1.297 . . . . 1.0 112.858 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -54.78 -32.28 59.87 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 115.154 -0.93 . . . . 1.0 112.634 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.06 71.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.356 -0.83 . . . . 1.0 110.148 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -61.66 -55.96 24.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.399 0.999 . . . . 1.0 110.74 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.86 -51.28 70.4 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.727 1.751 . . . . 1.0 115.727 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -39.11 84.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.137 0.881 . . . . 1.0 109.279 -175.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.39 78.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.566 0.95 . . . . 1.0 113.566 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.12 -45.33 92.5 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.352 1.461 . . . . 1.0 114.068 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.34 160.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.238 0.469 0 C-N-CA 125.869 1.668 . . . . 1.0 106.554 175.308 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 106.112 -1.811 . . . . 1.0 106.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 165.91 23.3 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.556 0.743 . . . . 1.0 112.239 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 42.28 58.46 2.99 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.815 1.646 . . . . 1.0 109.046 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.49 145.94 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.656 1.183 . . . . 1.0 109.683 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -76.08 123.15 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.45 118.96 30.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.906 0.775 . . . . 1.0 109.027 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.19 73.52 81.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.3 123.92 11.11 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.724 1.616 . . . . 1.0 108.812 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -137.53 113.51 9.38 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 126.566 1.947 . . . . 1.0 106.949 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.25 58.8 7.11 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.275 1.983 . . . . 1.0 110.845 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -123.73 43.53 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.925 1.69 . . . . 1.0 106.709 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -82.82 179.28 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.385 1.474 . . . . 1.0 110.374 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.3 178.57 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.666 1.586 . . . . 1.0 109.031 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.4 m -150.55 131.64 14.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.865 2.466 . . . . 1.0 105.121 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.26 149.28 72.11 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 108.258 -1.015 . . . . 1.0 108.258 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.04 97.38 1.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 N-CA-C 106.601 -2.115 . . . . 1.0 106.601 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -162.6 147.95 12.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -146.73 108.07 4.25 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.979 0.809 . . . . 1.0 109.699 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -136.2 160.24 39.29 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 127.399 2.28 . . . . 1.0 106.952 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -69.36 123.4 88.28 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.59 103.0 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.626 -1.336 . . . . 1.0 108.626 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.41 ' HG ' ' HB3' ' A' ' 146' ' ' ALA . 29.0 t -175.9 70.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.07 127.35 13.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 105.091 -2.188 . . . . 1.0 105.091 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.31 129.37 41.01 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.9 139.53 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 105.976 -1.861 . . . . 1.0 105.976 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.84 122.9 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.473 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -171.07 150.22 3.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.275 1.43 . . . . 1.0 107.357 175.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -95.3 111.9 23.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mm -127.37 176.4 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 128.333 2.653 . . . . 1.0 107.59 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 t -148.89 122.18 8.99 Favored 'General case' 0 C--O 1.247 0.938 1 N-CA-C 94.825 -5.991 . . . . 1.0 94.825 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.338 0.4 OUTLIER -142.57 -65.15 0.02 OUTLIER Pre-proline 0 C--O 1.222 -0.347 0 CA-C-O 117.823 -1.084 . . . . 1.0 113.316 178.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.81 162.25 9.09 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.822 3.015 . . . . 1.0 115.523 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.58 28.83 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.831 3.021 . . . . 1.0 114.973 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -40.87 -71.42 0.31 Allowed Glycine 0 C--N 1.35 1.339 0 CA-C-N 120.78 1.627 . . . . 1.0 109.312 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -156.31 123.48 5.34 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.648 2.379 . . . . 1.0 107.124 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -176.89 176.95 1.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 131.366 3.866 . . . . 1.0 108.098 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.67 4.95 8.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.316 1.436 . . . . 1.0 111.603 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.61 136.56 14.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.368 1.584 . . . . 1.0 110.497 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.32 -16.99 15.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.828 2.352 . . . . 1.0 113.782 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -54.32 -39.9 67.46 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.528 1.058 . . . . 1.0 111.556 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.3 mt -64.99 -48.73 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.352 1.061 . . . . 1.0 109.047 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.55 -49.65 76.69 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.02 -34.68 68.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.942 0.897 . . . . 1.0 111.727 -176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.92 -49.31 68.44 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.151 0.98 . . . . 1.0 110.26 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -70.41 -48.27 56.87 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.257 0.623 . . . . 1.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.14 -37.47 85.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.305 1.842 . . . . 1.0 109.955 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.24 1.65 28.1 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.222 1.391 . . . . 1.0 115.357 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -89.08 9.89 23.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.322 2.061 . . . . 1.0 113.045 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.81 136.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.142 1.777 . . . . 1.0 113.116 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.88 122.7 51.94 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.87 2.468 . . . . 1.0 109.375 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.56 58.77 5.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.032 3.155 . . . . 1.0 111.016 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.09 -54.72 2.56 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 117.752 -1.118 . . . . 1.0 111.914 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.65 -51.15 61.39 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.59 1.087 . . . . 1.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -170.4 178.02 0.93 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.701 2.0 . . . . 1.0 107.032 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -75.95 -43.31 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.36 1.373 . . . . 1.0 114.125 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -42.41 -47.54 4.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.886 1.675 . . . . 1.0 113.758 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.81 -55.45 34.7 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.839 1.256 . . . . 1.0 109.6 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.0 95.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.265 1.426 . . . . 1.0 110.733 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.61 -64.11 1.96 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 127.048 2.261 . . . . 1.0 111.874 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 pt -61.42 -32.66 53.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 117.243 -1.36 . . . . 1.0 112.661 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.0 -43.12 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.004 2.224 . . . . 1.0 117.004 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.55 -33.83 73.25 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.489 -0.757 . . . . 1.0 110.33 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.88 135.37 33.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.528 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.17 162.67 19.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 175.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.48 158.54 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 124.513 1.125 . . . . 1.0 108.691 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 m -175.44 125.28 0.24 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.042 1.337 . . . . 1.0 108.887 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.18 -168.8 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 174.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -113.22 -76.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 m -124.03 118.41 26.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.86 113.69 27.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.081 -2.192 . . . . 1.0 105.081 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.7 mt -99.26 113.4 34.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ttp85 -85.28 153.4 22.61 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.54 -1.282 . . . . 1.0 107.54 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -48.65 -20.24 0.44 Allowed 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.543 1.937 . . . . 1.0 115.266 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.68 28.24 1.82 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.104 0.962 . . . . 1.0 112.442 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.83 30.04 71.89 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.297 1.903 . . . . 1.0 113.766 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.68 113.08 25.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.674 0.79 . . . . 1.0 110.474 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.38 120.97 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 104.822 -2.288 . . . . 1.0 104.822 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.43 149.08 14.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.666 -2.346 . . . . 1.0 104.666 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -126.12 122.1 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.731 0.812 . . . . 1.0 110.818 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -121.21 129.51 53.24 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 128.856 2.862 . . . . 1.0 103.922 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.8 t 64.42 91.72 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 CA-C-N 121.684 2.038 . . . . 1.0 113.753 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -66.44 -170.43 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.515 2.143 . . . . 1.0 113.396 177.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.09 15.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.455 2.702 . . . . 1.0 115.099 -175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -137.87 116.69 12.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.329 2.252 . . . . 1.0 108.021 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 tttt 78.86 81.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 128.288 2.635 . . . . 1.0 107.554 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.28 150.78 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 130.266 3.426 . . . . 1.0 113.67 -175.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.28 -178.24 3.6 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.993 2.117 . . . . 1.0 110.104 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -147.88 118.9 7.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.175 1.352 . . . . 1.0 110.34 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.49 63.06 0.17 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.728 1.251 . . . . 1.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -158.26 -54.89 0.07 Allowed 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 118.76 -2.463 . . . . 1.0 114.354 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.81 -74.83 1.12 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.029 -2.028 . . . . 1.0 108.029 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.8 t -149.26 135.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.605 1.703 . . . . 1.0 110.933 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -166.98 149.24 6.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.202 1.801 . . . . 1.0 109.789 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.592 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.7 p -134.03 146.45 50.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 128.374 2.669 . . . . 1.0 110.785 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -150.17 142.61 24.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 39.13 53.81 2.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.507 1.523 . . . . 1.0 112.802 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.01 29.16 70.14 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.374 -0.681 . . . . 1.0 114.751 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -130.11 113.8 14.95 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.444 -1.688 . . . . 1.0 106.444 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 146.7 23.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.776 1.23 . . . . 1.0 107.721 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.5 mtm-85 -112.29 118.58 35.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.849 1.26 . . . . 1.0 108.076 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.51 -30.11 71.14 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.807 0.692 . . . . 1.0 110.338 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -146.03 170.14 17.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.516 1.126 . . . . 1.0 108.192 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.91 76.89 8.79 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.208 1.004 . . . . 1.0 109.485 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.95 33.8 1.3 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.054 1.341 . . . . 1.0 112.415 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -127.89 156.47 42.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.08 1.352 . . . . 1.0 112.628 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.08 56.83 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.832 2.053 . . . . 1.0 109.089 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.22 -136.78 3.84 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.05 -1.031 . . . . 1.0 112.385 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.3 mm -145.15 165.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.44 2.696 . . . . 1.0 104.549 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.49 138.55 26.2 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.492 -2.41 . . . . 1.0 104.492 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.8 151.38 22.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.897 0.771 . . . . 1.0 110.52 176.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -130.43 138.93 50.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.294 0.568 . . . . 1.0 111.064 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.85 -171.75 37.88 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.002 1.763 . . . . 1.0 110.124 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 p -148.65 115.33 5.97 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 103.346 -2.835 . . . . 1.0 103.346 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t0 42.18 53.15 4.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 129.393 3.077 . . . . 1.0 113.994 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 49.32 38.87 14.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.793 1.637 . . . . 1.0 113.493 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 tp -56.66 143.81 34.71 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 107.127 -1.435 . . . . 1.0 107.127 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -34.84 115.67 0.29 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.625 1.97 . . . . 1.0 109.867 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.67 -7.85 58.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.776 -2.059 . . . . 1.0 114.517 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.397 20.3 p 66.5 78.59 0.26 Allowed 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 121.398 1.908 . . . . 1.0 112.528 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.34 -34.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.007 1.73 . . . . 1.0 114.372 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.42 -41.33 9.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.072 2.149 . . . . 1.0 111.635 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -48.97 -51.18 31.87 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.023 1.329 . . . . 1.0 109.29 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -58.67 -37.35 75.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.536 -0.745 . . . . 1.0 110.541 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -64.61 -55.85 17.64 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.154 0.888 . . . . 1.0 110.861 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.93 -47.32 75.1 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.069 0.948 . . . . 1.0 110.918 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.36 -47.36 79.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.021 1.328 . . . . 1.0 108.43 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.37 99.26 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.493 1.042 . . . . 1.0 110.236 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.72 54.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.027 0.831 . . . . 1.0 110.036 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.88 -47.3 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.657 0.783 . . . . 1.0 109.375 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 72.9 m -57.12 -53.31 59.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.253 1.021 . . . . 1.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -56.04 -45.7 79.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.927 0.891 . . . . 1.0 110.542 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.7 63.93 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.524 -0.735 . . . . 1.0 110.385 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.86 -45.32 82.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.528 1.531 . . . . 1.0 110.763 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.51 -42.96 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.191 0.996 . . . . 1.0 109.582 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -64.73 -24.93 67.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.969 -0.457 . . . . 1.0 110.508 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -84.08 -59.29 2.45 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.263 -1.384 . . . . 1.0 107.263 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -122.2 113.0 31.27 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -102.92 107.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 116.595 -1.803 . . . . 1.0 112.809 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.41 ' HB3' ' HG ' ' A' ' 29' ' ' SER . . . -152.5 -44.08 0.1 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 128.674 2.79 . . . . 1.0 106.809 174.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 42.8 mt -45.2 -33.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 128.546 2.738 . . . . 1.0 110.592 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.43 -21.97 4.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.476 1.51 . . . . 1.0 113.929 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -135.12 18.57 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.091 2.156 . . . . 1.0 109.452 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -138.97 83.69 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.614 1.097 . . . . 1.0 109.595 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 124.56 29.28 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.154 -2.535 . . . . 1.0 104.154 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 t -156.96 -174.42 4.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.265 0.484 . . . . 1.0 109.885 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.59 -131.8 2.54 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.541 -2.224 . . . . 1.0 107.541 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 11.8 m170 -121.2 -23.52 5.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.956 1.378 . . . . 1.0 112.694 -175.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.56 -6.29 22.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -83.58 15.59 3.06 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 128.556 2.743 . . . . 1.0 111.549 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.592 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.53 -15.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.609 0.763 . . . . 1.0 111.815 -175.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.74 -53.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.617 1.967 . . . . 1.0 110.282 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.22 108.74 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.594 1.605 . . . . 1.0 111.367 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.25 -26.16 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.485 -1.384 . . . . 1.0 110.049 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.2 -25.96 66.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.446 1.898 . . . . 1.0 111.946 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -127.22 124.26 38.51 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 105.161 -2.163 . . . . 1.0 105.161 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 23.9 m -119.29 -16.69 8.99 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.913 -0.715 . . . . 1.0 112.43 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.46 179.67 0.39 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.812 2.445 . . . . 1.0 104.679 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.47 88.01 1.2 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.027 2.485 . . . . 1.0 109.862 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 69.7 0.67 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.093 1.33 . . . . 1.0 109.96 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -76.13 -81.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.303 2.052 . . . . 1.0 110.995 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t 53.66 42.9 31.75 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.453 1.501 . . . . 1.0 109.576 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.29 17.53 19.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.27 0.486 . . . . 1.0 112.178 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.3 t0 44.52 68.01 0.61 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.905 1.682 . . . . 1.0 113.008 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -54.88 -33.0 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 119.059 -0.496 . . . . 1.0 111.717 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.29 22.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.853 -1.07 . . . . 1.0 109.912 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -60.12 -47.66 84.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.257 0.935 . . . . 1.0 111.982 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.37 -58.94 6.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.771 0.669 . . . . 1.0 110.942 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -34.03 74.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.922 -0.561 . . . . 1.0 111.687 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.03 93.3 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 117.941 0.337 . . . . 1.0 111.667 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.16 -50.72 30.36 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.796 0.839 . . . . 1.0 111.647 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.95 166.38 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.664 1.986 . . . . 1.0 111.255 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 175.235 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.08 148.34 26.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.619 1.099 . . . . 1.0 110.368 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 47.33 75.05 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.004 1.722 . . . . 1.0 110.799 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.63 155.49 21.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.984 2.514 . . . . 1.0 107.916 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -76.71 123.38 26.09 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 104.728 -2.323 . . . . 1.0 104.728 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -93.19 138.43 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.12 76.69 50.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.711 1.204 . . . . 1.0 107.785 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.66 125.91 13.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.454 2.103 . . . . 1.0 109.416 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -144.5 113.32 5.11 Favored Pre-proline 0 CA--C 1.518 -0.288 0 C-N-CA 124.887 1.275 . . . . 1.0 107.626 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.21 65.39 8.83 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.307 2.005 . . . . 1.0 111.288 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -130.29 43.63 3.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 1.0 107.358 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.76 178.49 7.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.427 1.091 . . . . 1.0 110.337 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.53 178.07 4.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.727 0.775 . . . . 1.0 112.718 -175.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.6 m -165.07 118.48 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 128.329 2.652 . . . . 1.0 108.177 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 158.36 62.95 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.346 -1.724 . . . . 1.0 106.346 175.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.84 88.08 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.468 1.445 . . . . 1.0 109.762 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.68 143.37 29.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.919 -1.882 . . . . 1.0 105.919 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -151.52 103.35 2.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.645 1.111 . . . . 1.0 110.738 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -137.37 162.67 32.97 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -69.63 123.23 88.1 Favored Pre-proline 0 C--O 1.239 0.526 0 N-CA-C 104.928 -2.249 . . . . 1.0 104.928 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.2 103.37 1.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.789 1.318 . . . . 1.0 108.72 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 t -169.3 80.49 0.12 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -152.77 124.1 7.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -99.31 126.45 45.17 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.764 1.626 . . . . 1.0 108.381 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.5 145.03 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.36 123.91 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 104.181 -2.526 . . . . 1.0 104.181 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -175.38 146.93 0.84 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 117.339 -1.315 . . . . 1.0 107.507 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.15 112.32 22.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.414 1.006 . . . . 1.0 110.468 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.25 174.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.8 t -144.06 121.84 11.93 Favored 'General case' 0 C--O 1.247 0.93 1 N-CA-C 97.146 -5.131 . . . . 1.0 97.146 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.324 1.1 tm? -141.67 -65.58 0.02 OUTLIER Pre-proline 0 C--O 1.224 -0.266 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.3 157.66 22.79 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 121.982 1.744 . . . . 1.0 112.066 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.43 12.26 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.102 3.201 . . . . 1.0 116.363 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -28.18 -71.13 0.05 OUTLIER Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.697 -1.613 . . . . 1.0 114.062 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -156.54 123.64 5.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.712 1.605 . . . . 1.0 111.257 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -169.39 150.72 4.31 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.503 1.521 . . . . 1.0 110.795 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.8 -6.53 52.27 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.122 -1.377 . . . . 1.0 112.089 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.25 118.61 5.7 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.566 -1.813 . . . . 1.0 108.566 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.262 88.6 Cg_endo -65.26 -3.06 6.75 Favored 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 126.123 4.549 . . . . 1.0 118.964 -175.143 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -55.63 -46.93 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.922 2.146 . . . . 1.0 113.262 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 mm -61.38 -47.05 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.567 -1.271 . . . . 1.0 107.567 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.89 -48.58 67.07 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 124.841 1.257 . . . . 1.0 109.129 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.79 77.53 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.254 1.022 . . . . 1.0 112.381 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.75 -51.13 61.69 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.784 0.434 . . . . 1.0 109.878 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.28 -39.51 71.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.346 0.499 . . . . 1.0 112.346 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -66.58 -52.63 43.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.645 1.178 . . . . 1.0 110.647 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.94 9.82 2.68 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 118.439 -1.201 . . . . 1.0 115.45 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 p -107.87 9.07 28.88 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.658 2.229 . . . . 1.0 114.86 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.2 134.4 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.76 1.164 . . . . 1.0 111.981 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.15 136.5 25.76 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 129.141 2.976 . . . . 1.0 109.338 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.7 76.33 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 1.0 106.923 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -103.55 -64.14 1.12 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.266 0.626 . . . . 1.0 111.266 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.6 79.15 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.614 0.766 . . . . 1.0 111.07 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 24.3 p80 -170.08 177.96 0.97 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.623 1.969 . . . . 1.0 107.047 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.05 -43.71 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.393 1.395 . . . . 1.0 114.33 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -46.14 -45.78 16.78 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.101 1.148 . . . . 1.0 114.101 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -56.12 -53.92 51.24 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.951 0.901 . . . . 1.0 109.193 -175.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.57 84.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.235 1.014 . . . . 1.0 111.665 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.66 -53.94 15.39 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.639 1.59 . . . . 1.0 111.515 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 pt -61.02 -43.45 96.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 117.303 -1.332 . . . . 1.0 110.908 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.56 -43.05 1.8 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.084 2.154 . . . . 1.0 115.19 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -46.96 -56.64 6.05 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.75 136.98 53.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.149 2.979 . . . . 1.0 106.912 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.65 155.13 16.26 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.475 -1.391 . . . . 1.0 109.211 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.83 158.39 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -173.66 131.73 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.582 1.553 . . . . 1.0 108.645 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.5 -176.64 3.68 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.67 -1.604 . . . . 1.0 106.67 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -120.02 -76.28 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.115 0.966 . . . . 1.0 109.481 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.6 m -117.34 118.37 32.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.3 114.15 20.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.432 1.093 . . . . 1.0 108.318 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 mt -94.4 117.21 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.927 0.891 . . . . 1.0 108.641 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -77.21 149.7 35.5 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.073 1.306 . . . . 1.0 109.171 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -23.74 2.93 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 126.466 1.906 . . . . 1.0 114.917 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.03 35.0 0.99 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.764 1.226 . . . . 1.0 113.798 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.24 40.8 99.09 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.757 1.17 . . . . 1.0 114.661 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -108.4 151.69 25.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.982 0.891 . . . . 1.0 110.676 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.16 113.98 44.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 102.492 -3.151 . . . . 1.0 102.492 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.11 145.45 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 119.29 27.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.779 1.632 . . . . 1.0 106.776 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -120.15 140.99 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.975 -2.231 . . . . 1.0 104.975 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 t 65.23 92.09 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.162 1.541 . . . . 1.0 115.162 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -56.73 169.65 1.71 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 N-CA-C 109.052 -1.172 . . . . 1.0 109.052 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.74 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.944 2.572 . . . . 1.0 117.944 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -134.51 117.05 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.735 2.814 . . . . 1.0 105.807 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.65 81.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.37 2.668 . . . . 1.0 109.539 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -35.02 148.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 131.205 3.802 . . . . 1.0 114.356 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.25 178.55 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.933 2.093 . . . . 1.0 109.657 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -149.49 119.01 6.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.246 1.384 . . . . 1.0 110.568 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.68 62.92 0.47 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.076 1.417 . . . . 1.0 110.185 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -163.27 -63.8 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 119.015 -2.303 . . . . 1.0 113.852 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.96 -68.87 0.21 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 106.274 -2.73 . . . . 1.0 106.274 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -145.53 146.49 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.075 1.35 . . . . 1.0 109.519 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.8 p -160.38 166.31 29.57 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.092 1.757 . . . . 1.0 107.857 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 p -159.28 145.83 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -159.77 154.0 23.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.612 1.096 . . . . 1.0 109.343 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 39.43 54.99 2.33 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.3 1.84 . . . . 1.0 111.153 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.65 84.98 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.933 -0.926 . . . . 1.0 113.117 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.75 119.24 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.842 1.321 . . . . 1.0 108.492 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.91 146.74 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.255 1.422 . . . . 1.0 111.699 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -124.45 118.22 26.17 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -72.02 -31.03 65.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.674 0.79 . . . . 1.0 111.683 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.22 176.24 11.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 128.407 2.683 . . . . 1.0 106.401 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.331 15.3 t70 -87.19 77.07 9.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.104 0.954 . . . . 1.0 111.78 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -90.51 44.54 1.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.616 -1.253 . . . . 1.0 107.616 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -123.26 133.45 54.18 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.272 1.029 . . . . 1.0 110.785 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.1 OUTLIER -91.21 56.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.39 -136.4 3.82 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.488 1.049 . . . . 1.0 111.217 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.65 165.14 22.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 128.156 2.582 . . . . 1.0 104.114 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -146.18 131.34 18.38 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.961 -2.977 . . . . 1.0 102.961 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.71 127.98 48.23 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.055 -1.653 . . . . 1.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -103.36 138.37 40.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.425 0.631 . . . . 1.0 111.224 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.03 40.49 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.945 1.26 . . . . 1.0 111.586 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.7 p -142.32 108.3 5.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.408 1.483 . . . . 1.0 107.923 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t0 49.76 55.67 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.124 2.17 . . . . 1.0 113.83 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 48.96 38.38 12.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.255 1.822 . . . . 1.0 113.973 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.19 142.8 58.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 105.283 -2.118 . . . . 1.0 105.283 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -43.03 114.78 0.65 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.683 1.193 . . . . 1.0 108.771 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -78.52 -2.12 37.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 116.783 -1.579 . . . . 1.0 114.83 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 29.0 p 64.01 76.5 0.35 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.077 1.308 . . . . 1.0 111.013 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.35 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.723 2.009 . . . . 1.0 113.132 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.01 -38.35 4.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.629 2.372 . . . . 1.0 111.837 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -47.6 -43.88 25.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.242 1.417 . . . . 1.0 110.112 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -60.64 -39.6 88.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.284 -0.865 . . . . 1.0 110.811 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.59 -51.56 58.78 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.492 1.042 . . . . 1.0 110.27 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -65.4 -40.18 93.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.488 0.315 . . . . 1.0 111.293 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.9 tp -59.11 -51.94 67.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.249 1.82 . . . . 1.0 108.201 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -40.03 78.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.83 -0.605 . . . . 1.0 110.256 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -53.96 51.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.131 0.878 . . . . 1.0 111.659 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.23 -47.83 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.9 m -58.15 -47.01 84.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.357 1.463 . . . . 1.0 112.029 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -60.19 -38.13 82.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.553 0.741 . . . . 1.0 109.606 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.52 86.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 117.823 -1.084 . . . . 1.0 110.332 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.17 -45.67 79.61 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 120.252 1.387 . . . . 1.0 110.595 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.81 -41.62 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.0 m -62.04 -27.24 68.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.366 0.666 . . . . 1.0 111.269 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -83.9 -61.23 1.88 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.956 -1.09 . . . . 1.0 108.111 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -125.8 112.79 24.8 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.27 -1.381 . . . . 1.0 107.27 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -93.18 107.8 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-O 123.425 1.344 . . . . 1.0 109.731 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.39 -44.8 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.559 1.944 . . . . 1.0 109.412 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.3 mt -49.36 -33.51 6.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 130.731 3.613 . . . . 1.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.01 -26.43 37.0 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.155 0.428 . . . . 1.0 112.155 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.46 25.65 4.11 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.123 2.569 . . . . 1.0 110.184 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -139.09 83.51 1.95 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 50.9 mtt -126.88 118.57 24.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.66 -2.348 . . . . 1.0 104.66 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -148.21 -175.38 4.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.586 1.084 . . . . 1.0 109.237 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.21 -131.77 2.39 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 105.789 -2.924 . . . . 1.0 105.789 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.2 m170 -114.78 -23.47 9.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.675 1.238 . . . . 1.0 110.381 175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.34 -18.67 14.75 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.84 38.31 0.63 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.19 0.905 . . . . 1.0 108.918 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -16.6 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 O-C-N 120.513 -1.367 . . . . 1.0 108.715 175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.49 -54.4 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.783 2.433 . . . . 1.0 111.518 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.57 109.51 2.88 Favored 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 122.146 1.802 . . . . 1.0 113.608 -175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -62.36 -12.29 20.41 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.145 -0.972 . . . . 1.0 110.688 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -22.5 57.37 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.313 -1.492 . . . . 1.0 114.553 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.26 125.75 20.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.559 1.527 . . . . 1.0 107.091 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 167' ' ' PRO . 2.6 m -114.79 -16.7 11.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.19 -178.83 0.3 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 126.3 1.84 . . . . 1.0 106.311 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.22 80.71 2.96 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 N-CA-C 105.633 -2.487 . . . . 1.0 105.633 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 124.22 72.28 0.23 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.513 2.006 . . . . 1.0 109.866 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.454 ' HB3' ' H ' ' A' ' 163' ' ' THR . 68.7 Cg_endo -79.0 -99.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.301 2.667 . . . . 1.0 111.066 176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.7 t 53.82 42.9 31.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.513 1.525 . . . . 1.0 111.538 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -96.81 17.87 15.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.978 -1.076 . . . . 1.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t0 43.79 63.74 1.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.421 -2.049 . . . . 1.0 111.831 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -54.07 -35.17 61.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.344 0.658 . . . . 1.0 111.725 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -54.35 48.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.453 -0.784 . . . . 1.0 110.157 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -60.29 -48.54 81.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.814 -1.089 . . . . 1.0 112.13 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.32 -53.54 56.07 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.883 0.765 . . . . 1.0 109.938 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -48.81 80.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 117.962 -1.018 . . . . 1.0 108.773 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.7 76.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.931 0.893 . . . . 1.0 112.981 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.3 mt -71.28 -44.21 65.66 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.878 0.871 . . . . 1.0 110.62 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.37 157.07 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 122.958 1.361 . . . . 1.0 110.051 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 125.952 1.701 . . . . 1.0 111.607 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 106.912 -1.514 . . . . 1.0 106.912 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.63 175.92 9.95 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.469 0.708 . . . . 1.0 111.408 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 42.33 57.86 3.22 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.286 1.834 . . . . 1.0 109.464 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.29 155.2 30.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.983 1.313 . . . . 1.0 109.1 -176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -81.29 123.46 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.79 124.6 33.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.379 0.99 . . . . 1.0 108.334 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.92 82.53 43.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.99 124.03 7.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.034 1.823 . . . . 1.0 110.299 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -119.74 114.19 34.25 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.87 56.39 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.183 1.922 . . . . 1.0 111.416 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -126.05 44.56 2.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.811 2.045 . . . . 1.0 105.632 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -73.66 177.98 5.05 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.417 0.687 . . . . 1.0 111.142 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.56 178.62 4.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.693 1.597 . . . . 1.0 113.513 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.6 m -154.19 124.67 7.01 Favored 'General case' 0 N--CA 1.448 -0.574 1 C-N-CA 132.028 4.131 . . . . 1.0 103.137 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.64 142.77 45.09 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 117.981 -1.009 . . . . 1.0 108.831 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.57 69.1 7.88 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.598 2.865 . . . . 1.0 113.454 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -151.71 158.54 43.54 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 127.073 2.149 . . . . 1.0 106.799 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -151.17 104.67 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.309 1.444 . . . . 1.0 107.481 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.77 158.67 43.92 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.915 1.686 . . . . 1.0 106.61 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -67.51 123.67 87.3 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 118.679 0.672 . . . . 1.0 109.441 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.16 103.65 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 108.974 -1.202 . . . . 1.0 108.974 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -165.38 65.57 0.12 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.469 -1.394 . . . . 1.0 108.265 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -148.3 137.63 22.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.73 1.612 . . . . 1.0 107.175 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.85 133.4 34.76 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.243 1.417 . . . . 1.0 108.111 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.91 142.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.938 -2.245 . . . . 1.0 104.938 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.16 115.77 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.977 -1.86 . . . . 1.0 105.977 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -176.3 132.82 0.23 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.348 0.976 . . . . 1.0 108.835 175.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -63.39 118.73 8.49 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.925 0.89 . . . . 1.0 110.22 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -145.71 176.43 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.174 2.59 . . . . 1.0 107.153 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -160.93 117.97 2.33 Favored 'General case' 0 C--N 1.322 -0.624 1 N-CA-C 96.695 -5.298 . . . . 1.0 96.695 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -144.78 -61.3 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 116.022 -1.942 . . . . 1.0 112.79 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -87.34 157.3 8.1 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.825 2.35 . . . . 1.0 112.92 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.37 70.45 4.78 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.326 3.35 . . . . 1.0 118.658 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.94 -72.2 1.06 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 105.811 -2.916 . . . . 1.0 105.811 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -157.2 123.42 4.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.324 2.25 . . . . 1.0 109.186 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -176.94 176.42 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 130.706 3.602 . . . . 1.0 107.836 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.41 22.78 10.04 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.91 1.719 . . . . 1.0 109.464 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.38 118.6 5.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.116 -1.38 . . . . 1.0 110.203 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.8 -21.03 38.9 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.415 2.077 . . . . 1.0 112.331 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -53.9 -34.19 58.79 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.853 0.861 . . . . 1.0 111.082 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 mt -66.12 -50.01 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.246 -0.883 . . . . 1.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.94 -46.46 78.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.076 -1.049 . . . . 1.0 110.395 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.78 -33.89 50.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.114 0.966 . . . . 1.0 111.887 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -58.49 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.616 1.566 . . . . 1.0 110.296 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -70.6 -41.32 72.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.4 0.68 . . . . 1.0 112.545 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -65.91 -34.28 77.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.59 1.156 . . . . 1.0 108.455 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.22 54.77 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.308 -1.829 . . . . 1.0 116.153 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -89.15 8.27 30.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.743 2.272 . . . . 1.0 113.615 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.02 132.93 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.629 1.572 . . . . 1.0 111.891 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.02 135.99 20.7 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 128.636 2.774 . . . . 1.0 109.529 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.39 80.68 1.04 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.502 2.801 . . . . 1.0 106.909 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -103.23 -63.43 1.18 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.034 0.534 . . . . 1.0 111.012 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.57 78.85 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.06 0.944 . . . . 1.0 110.646 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -170.35 177.95 0.95 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.403 2.281 . . . . 1.0 106.331 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -74.05 -43.43 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.531 1.488 . . . . 1.0 114.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -43.23 -53.58 5.03 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -58.22 6.89 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.07 1.348 . . . . 1.0 110.513 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.6 89.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.167 0.587 . . . . 1.0 111.521 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.45 -63.54 4.0 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.127 1.346 . . . . 1.0 111.863 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.49 -38.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.24 0.52 . . . . 1.0 112.065 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 -43.53 11.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.262 88.0 m-70 -57.9 -33.54 68.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.721 -0.657 . . . . 1.0 109.779 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.32 136.61 33.83 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.504 -2.776 . . . . 1.0 103.504 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 141.67 40.74 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.227 0.921 . . . . 1.0 111.723 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -116.97 165.49 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.663 2.385 . . . . 1.0 109.59 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -172.52 116.64 0.33 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.955 1.302 . . . . 1.0 108.632 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.44 -176.89 3.77 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -110.68 -76.27 0.61 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.884 1.22 . . . . 1.0 112.478 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -116.97 118.26 31.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.543 -2.021 . . . . 1.0 105.543 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.57 113.55 27.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.761 -2.311 . . . . 1.0 104.761 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -96.14 113.38 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.662 -2.348 . . . . 1.0 104.662 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -68.74 148.13 50.8 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.696 1.134 . . . . 1.0 108.502 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.74 22.09 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 122.824 0.45 . . . . 1.0 111.645 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.27 24.51 2.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.25 2.22 . . . . 1.0 111.896 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.01 76.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.456 1.979 . . . . 1.0 115.623 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.94 156.57 17.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.726 1.763 . . . . 1.0 110.58 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -116.24 116.53 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.71 141.68 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.45 121.57 37.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.411 -1.7 . . . . 1.0 106.411 -176.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.94 123.93 50.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.829 2.452 . . . . 1.0 106.495 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.2 t 67.16 92.1 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.091 1.314 . . . . 1.0 113.664 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -60.8 -179.15 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.192 1.261 . . . . 1.0 109.963 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -59.18 26.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.812 3.245 . . . . 1.0 116.678 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.97 117.48 7.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.905 2.482 . . . . 1.0 108.788 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.268 28.0 ttmt 85.93 81.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.903 2.481 . . . . 1.0 111.844 175.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -36.44 156.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.721 4.009 . . . . 1.0 117.216 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.75 -179.2 3.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.909 3.684 . . . . 1.0 115.857 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 46.7 t90 -156.46 118.52 3.95 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.514 1.926 . . . . 1.0 109.709 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -162.78 62.85 0.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.228 0.922 . . . . 1.0 111.439 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.55 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 118.785 -2.447 . . . . 1.0 114.779 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.84 -90.74 1.1 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 105.248 -3.141 . . . . 1.0 105.248 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.07 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 118.734 1.267 . . . . 1.0 109.456 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 p -165.98 157.32 13.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.119 2.168 . . . . 1.0 108.118 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.401 ' H ' HG23 ' A' ' 157' ' ' ILE . 78.1 p -153.46 147.1 25.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.386 1.074 . . . . 1.0 110.763 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -149.46 148.98 30.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.586 -1.265 . . . . 1.0 107.586 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 38.66 53.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.368 1.867 . . . . 1.0 111.446 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.7 28.44 65.47 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.605 -1.108 . . . . 1.0 115.465 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 113.22 13.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 120.544 2.172 . . . . 1.0 105.245 175.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.83 145.65 32.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -105.22 118.24 36.05 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.38 -23.7 60.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.322 0.389 . . . . 1.0 110.559 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -145.58 170.69 15.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.485 2.314 . . . . 1.0 106.857 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.52 76.66 7.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.358 1.075 . . . . 1.0 108.919 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -89.49 40.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.454 1.502 . . . . 1.0 110.108 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -131.67 130.4 42.0 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 119.977 -1.702 . . . . 1.0 111.882 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 56.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.809 2.044 . . . . 1.0 107.947 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -136.62 5.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.67 164.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.77 116.33 8.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.664 -2.347 . . . . 1.0 104.664 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.3 135.42 34.32 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.298 -1.501 . . . . 1.0 109.604 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -103.67 152.94 21.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.65 173.46 39.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.821 1.677 . . . . 1.0 111.04 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -147.13 107.08 3.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.7 t0 46.08 47.75 12.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.471 2.308 . . . . 1.0 112.282 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.7 p 46.78 38.27 5.73 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.301 1.84 . . . . 1.0 113.417 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.24 146.52 54.84 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.236 1.814 . . . . 1.0 108.542 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -33.0 113.14 0.13 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.079 2.152 . . . . 1.0 110.508 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -78.31 -9.0 59.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.701 -2.095 . . . . 1.0 114.985 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.407 11.7 p 69.26 78.41 0.21 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 121.404 1.911 . . . . 1.0 113.537 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -22.99 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 119.709 -1.869 . . . . 1.0 115.403 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.37 -46.45 13.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.236 2.214 . . . . 1.0 110.472 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -51.26 -49.34 61.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.571 1.078 . . . . 1.0 109.904 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.71 -40.09 90.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.546 -0.74 . . . . 1.0 109.757 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.97 -50.55 63.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.988 0.813 . . . . 1.0 111.424 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -63.1 -48.49 78.35 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.985 1.714 . . . . 1.0 110.255 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.16 -49.98 74.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.217 1.407 . . . . 1.0 108.856 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.57 -39.84 89.47 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 118.722 -0.656 . . . . 1.0 110.155 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -53.58 56.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.829 0.852 . . . . 1.0 110.304 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.01 -46.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.6 m -58.29 -53.6 56.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.983 1.313 . . . . 1.0 109.964 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -56.76 -46.04 81.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.67 1.188 . . . . 1.0 110.12 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.15 77.71 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.792 0.437 . . . . 1.0 111.535 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.8 mt -57.03 -38.24 72.89 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-O 118.436 -0.792 . . . . 1.0 111.029 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.28 -38.75 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.547 0.739 . . . . 1.0 109.752 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 m -57.42 -35.07 69.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.089 0.859 . . . . 1.0 110.55 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -83.67 -52.66 6.25 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.129 -0.982 . . . . 1.0 108.6 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -126.33 112.9 23.49 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.92 107.15 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 121.378 1.528 . . . . 1.0 109.031 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.18 -49.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.094 1.758 . . . . 1.0 107.685 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 65.8 mt -48.35 -34.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 129.018 2.927 . . . . 1.0 109.586 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.12 -25.67 9.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.738 1.615 . . . . 1.0 113.627 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.31 22.01 3.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.037 1.735 . . . . 1.0 109.63 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.06 85.9 2.1 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.016 1.726 . . . . 1.0 107.7 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.2 mtt -131.96 119.13 20.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.893 2.077 . . . . 1.0 106.609 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -152.15 -176.34 5.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.532 1.514 . . . . 1.0 108.992 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.57 -131.4 2.73 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 106.875 -2.49 . . . . 1.0 106.875 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 25.5 m170 -116.35 -23.9 8.15 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.327 1.064 . . . . 1.0 112.12 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.4 t -103.63 -12.55 16.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.368 0.667 . . . . 1.0 109.255 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.41 17.96 2.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.449 1.9 . . . . 1.0 110.478 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.401 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.59 -20.14 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.764 0.825 . . . . 1.0 112.489 -175.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.47 -66.14 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.11 1.364 . . . . 1.0 107.995 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.06 108.85 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.877 1.718 . . . . 1.0 111.202 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.97 -17.46 38.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.391 1.076 . . . . 1.0 112.096 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -60.06 -24.24 64.41 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.239 -1.538 . . . . 1.0 112.687 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -131.22 140.57 49.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 104.1 -2.556 . . . . 1.0 104.1 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 m -123.19 -16.76 6.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.34 177.92 0.95 Allowed Pre-proline 0 C--O 1.244 0.815 0 C-N-CA 131.316 3.846 . . . . 1.0 103.333 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.25 57.91 6.7 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.772 2.314 . . . . 1.0 109.438 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.5 78.81 0.02 OUTLIER Glycine 0 CA--C 1.541 1.671 0 C-N-CA 128.918 3.151 . . . . 1.0 108.054 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.01 -72.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.1 2.534 . . . . 1.0 112.107 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.3 t 53.94 43.79 30.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.514 1.926 . . . . 1.0 113.176 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -122.04 17.56 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.347 0.976 . . . . 1.0 112.731 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 t0 42.6 68.47 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.288 1.435 . . . . 1.0 110.604 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -48.85 -34.95 13.53 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -48.18 73.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.362 -0.828 . . . . 1.0 111.246 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -60.78 -51.14 70.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.51 1.504 . . . . 1.0 110.893 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.51 -46.6 82.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.187 0.903 . . . . 1.0 111.619 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -62.44 -32.78 73.69 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.567 0.621 . . . . 1.0 110.119 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.42 80.72 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.786 -1.197 . . . . 1.0 111.436 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 mt -67.87 -55.27 13.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.601 1.56 . . . . 1.0 112.636 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.43 150.12 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 122.766 0.426 . . . . 1.0 109.92 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 125.49 1.516 . . . . 1.0 110.327 175.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.74 55.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.194 0.198 . . . . 1.0 111.351 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 49.25 58.42 5.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.973 2.109 . . . . 1.0 110.807 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.47 133.25 21.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.382 -1.281 . . . . 1.0 109.475 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -67.87 123.34 20.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.615 -1.994 . . . . 1.0 105.615 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -91.87 128.16 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.185 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -145.82 85.58 7.63 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.092 . . . . 1.0 108.796 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.39 152.08 71.22 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.285 1.323 . . . . 1.0 110.578 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -146.75 132.67 9.43 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 126.056 1.742 . . . . 1.0 107.788 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.49 45.13 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.005 2.47 . . . . 1.0 113.133 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -123.88 43.2 3.04 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.384 -0.823 . . . . 1.0 109.982 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -73.57 -179.83 3.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.088 1.355 . . . . 1.0 109.878 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.39 178.6 4.39 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.754 1.264 . . . . 1.0 112.898 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -152.66 118.5 5.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.066 -2.939 . . . . 1.0 103.066 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -135.71 145.61 53.79 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 120.273 1.397 . . . . 1.0 108.742 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 67.22 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.459 2.773 . . . . 1.0 111.71 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -154.41 143.82 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.661 2.384 . . . . 1.0 107.131 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.92 103.93 3.11 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.898 2.079 . . . . 1.0 106.681 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.44 169.46 17.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.817 2.447 . . . . 1.0 106.972 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.97 123.54 82.27 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 124.912 1.285 . . . . 1.0 110.371 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.69 103.44 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.831 1.687 . . . . 1.0 110.512 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.1 t -177.1 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.51 -2.404 . . . . 1.0 104.51 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -148.34 145.75 28.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.395 3.078 . . . . 1.0 104.181 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.5 tp -114.5 129.76 56.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.89 136.03 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.02 113.95 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -165.15 167.26 18.32 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.273 1.429 . . . . 1.0 107.276 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -96.93 116.67 29.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -142.03 172.2 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.943 2.097 . . . . 1.0 106.926 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 t -155.55 118.04 4.2 Favored 'General case' 0 N--CA 1.443 -0.795 1 N-CA-C 98.981 -4.451 . . . . 1.0 98.981 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 -66.74 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.529 0 CA-C-O 116.007 -1.949 . . . . 1.0 109.285 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.24 136.94 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 CA-C-N 123.943 2.444 . . . . 1.0 107.36 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.25 44.73 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.096 3.198 . . . . 1.0 114.986 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -31.5 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.241 0 C-N-CA 126.125 1.822 . . . . 1.0 110.829 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.29 122.69 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.167 -2.531 . . . . 1.0 104.167 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -176.76 175.54 1.64 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.884 2.874 . . . . 1.0 107.942 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.76 26.58 4.02 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.588 1.566 . . . . 1.0 112.331 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.65 118.24 6.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.26 1.53 . . . . 1.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.13 -5.0 15.41 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.316 2.011 . . . . 1.0 113.148 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -62.02 -38.65 89.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.415 1.086 . . . . 1.0 109.43 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.7 -45.06 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.44 -46.61 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -36.18 63.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 1.0 111.719 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -60.45 3.78 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.694 0.798 . . . . 1.0 109.655 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -68.78 -46.92 67.48 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.574 0.625 . . . . 1.0 112.384 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -60.48 -33.89 73.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.486 1.114 . . . . 1.0 108.732 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.56 35.8 4.25 Favored Glycine 0 C--N 1.342 0.879 0 C-N-CA 124.552 1.072 . . . . 1.0 113.349 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -124.77 18.05 8.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.885 1.342 . . . . 1.0 111.752 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.03 140.0 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.701 0.801 . . . . 1.0 110.427 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -98.37 128.01 34.5 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 127.713 2.405 . . . . 1.0 106.257 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.21 70.51 2.38 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.211 3.274 . . . . 1.0 109.472 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -106.9 -65.28 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.948 1.299 . . . . 1.0 112.843 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.4 -60.46 1.49 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.917 1.687 . . . . 1.0 113.225 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 20.8 p80 -168.48 177.69 1.2 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.562 1.145 . . . . 1.0 108.13 175.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -70.25 -43.62 2.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.733 1.622 . . . . 1.0 113.926 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -50.48 -62.26 1.69 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.805 1.242 . . . . 1.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 5.2 t80 -56.88 -50.35 72.75 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.409 0.684 . . . . 1.0 111.201 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.17 96.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.892 0.477 . . . . 1.0 110.849 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -57.73 17.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 124.791 1.186 . . . . 1.0 110.629 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.49 -24.15 34.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-O 116.589 -1.672 . . . . 1.0 113.734 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.11 -43.52 20.58 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.716 1.598 . . . . 1.0 113.0 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -58.04 -33.85 69.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.095 0.558 . . . . 1.0 110.806 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.39 136.4 33.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -65.28 146.49 54.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.163 -1.415 . . . . 1.0 109.445 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -116.92 162.26 15.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 125.506 1.522 . . . . 1.0 110.507 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 m -174.05 128.1 0.37 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.543 2.337 . . . . 1.0 108.151 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.26 -172.47 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.453 -1.684 . . . . 1.0 106.453 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -110.81 -58.72 2.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.597 1.159 . . . . 1.0 111.767 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -141.04 118.44 11.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.189 -1.782 . . . . 1.0 106.189 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.94 113.42 25.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.825 -2.287 . . . . 1.0 104.825 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -89.16 113.48 25.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.22 150.63 45.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.871 -1.159 . . . . 1.0 107.871 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -13.76 0.96 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.565 1.146 . . . . 1.0 113.917 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -91.7 21.03 5.01 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 128.037 2.535 . . . . 1.0 112.737 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.51 29.32 71.42 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.792 2.139 . . . . 1.0 114.885 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -102.14 108.94 20.5 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.652 1.226 . . . . 1.0 108.239 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.03 113.69 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.767 -2.679 . . . . 1.0 103.767 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.57 123.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 103.084 -2.932 . . . . 1.0 103.084 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.29 113.44 26.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.91 114.35 20.9 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 89.11 91.57 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 122.432 2.378 . . . . 1.0 110.554 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.26 -171.66 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.208 1.938 . . . . 1.0 109.907 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -64.57 21.77 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.498 1.919 . . . . 1.0 115.941 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.44 126.14 17.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.625 1.97 . . . . 1.0 109.127 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 86.56 81.92 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.849 3.26 . . . . 1.0 111.762 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -36.7 135.38 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 128.259 2.624 . . . . 1.0 112.373 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.04 -178.67 3.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.769 2.428 . . . . 1.0 111.058 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.467 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 80.0 t90 -146.23 118.55 8.4 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.418 1.887 . . . . 1.0 107.114 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -164.96 63.29 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.224 1.012 . . . . 1.0 110.601 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.64 -68.72 0.07 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 118.792 -2.443 . . . . 1.0 112.274 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.38 -90.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.421 -1.872 . . . . 1.0 108.421 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.6 t -140.32 146.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.473 1.909 . . . . 1.0 110.758 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -163.47 155.49 17.58 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.059 1.743 . . . . 1.0 109.044 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.502 ' H ' HG23 ' A' ' 157' ' ' ILE . 3.0 p -146.86 133.55 19.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -161.49 124.59 3.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.286 0.948 . . . . 1.0 108.898 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 60.13 71.57 0.57 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.044 1.738 . . . . 1.0 113.622 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.4 30.3 55.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 126.433 1.968 . . . . 1.0 113.922 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.7 ttm105 -150.05 113.63 4.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.441 1.096 . . . . 1.0 108.566 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.05 145.13 30.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.226 -2.139 . . . . 1.0 105.226 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -128.98 118.03 21.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.992 -1.855 . . . . 1.0 105.992 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t -66.11 -36.02 82.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.842 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.467 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 15.8 m120 -146.73 174.12 11.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.91 2.884 . . . . 1.0 106.037 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.48 76.84 9.91 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 106.533 -1.655 . . . . 1.0 106.533 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 39.68 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.482 1.913 . . . . 1.0 109.889 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -124.23 156.72 36.34 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.204 1.802 . . . . 1.0 112.29 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.255 0.0 OUTLIER -99.98 57.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 105.971 -1.862 . . . . 1.0 105.971 175.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.35 -136.53 1.65 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.225 -0.922 . . . . 1.0 111.595 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.5 mm -142.25 163.15 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 128.888 2.875 . . . . 1.0 103.723 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -136.12 129.3 31.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.393 2.277 . . . . 1.0 105.338 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mt -101.24 153.81 19.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 120.258 1.39 . . . . 1.0 109.305 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.34 47.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.83 0.824 . . . . 1.0 111.36 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.31 -173.47 41.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.294 2.378 . . . . 1.0 108.946 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 p -136.44 100.2 4.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 102.692 -3.077 . . . . 1.0 102.692 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 43.01 55.63 4.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.848 2.459 . . . . 1.0 112.472 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.4 p 52.69 38.09 25.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.089 2.155 . . . . 1.0 114.155 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 tp -60.2 136.01 57.9 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.84 113.2 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.29 2.236 . . . . 1.0 110.411 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.02 -8.17 57.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 115.683 -2.103 . . . . 1.0 116.371 -174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.325 37.3 p 63.89 77.96 0.3 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 121.636 2.016 . . . . 1.0 111.383 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.64 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.901 2.081 . . . . 1.0 113.97 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.09 -38.61 1.72 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.435 2.294 . . . . 1.0 109.455 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.67 -48.82 58.3 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.999 1.32 . . . . 1.0 110.575 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -59.16 -38.27 79.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.079 0.854 . . . . 1.0 110.509 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -66.02 -55.03 18.72 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.253 0.621 . . . . 1.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -61.69 -54.06 47.66 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.861 0.865 . . . . 1.0 109.131 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.3 tp -53.22 -49.32 67.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.251 1.021 . . . . 1.0 109.728 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.0 85.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 120.408 1.458 . . . . 1.0 111.682 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.85 51.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.741 0.7 . . . . 1.0 109.294 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.91 -64.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 126.758 2.023 . . . . 1.0 108.417 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 64.0 m -54.35 -52.43 61.63 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.902 2.081 . . . . 1.0 111.456 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -57.22 -42.02 80.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.382 1.447 . . . . 1.0 110.408 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.48 66.65 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.266 -0.896 . . . . 1.0 111.352 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.7 mt -56.91 -34.71 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.58 -1.325 . . . . 1.0 111.598 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.61 -40.08 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.474 -1.306 . . . . 1.0 107.474 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -63.15 -13.44 37.05 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.13 1.372 . . . . 1.0 110.965 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -95.93 -65.39 0.98 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.158 -1.589 . . . . 1.0 107.406 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -120.89 112.99 33.23 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -95.89 107.89 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 CA-C-N 120.182 1.101 . . . . 1.0 111.208 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.91 -49.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.365 1.866 . . . . 1.0 106.636 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.5 mt -45.9 -33.37 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 128.944 2.898 . . . . 1.0 110.815 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.16 -26.53 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 1.0 113.412 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -133.13 18.62 4.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.945 2.098 . . . . 1.0 110.178 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -138.44 83.74 1.98 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.454 -1.404 . . . . 1.0 107.842 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.6 mtt -121.55 114.05 20.66 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -149.18 -168.07 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.93 -130.67 1.64 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 105.017 -3.233 . . . . 1.0 105.017 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.259 14.7 m170 -112.73 -24.43 9.61 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.978 0.911 . . . . 1.0 111.277 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.67 -16.03 16.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.417 0.687 . . . . 1.0 110.359 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -86.59 39.62 0.85 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.893 -1.151 . . . . 1.0 107.893 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.502 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.62 -17.5 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 O-C-N 120.322 -1.486 . . . . 1.0 109.294 175.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -149.54 -64.53 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.553 1.541 . . . . 1.0 109.715 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.51 115.06 3.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.365 2.043 . . . . 1.0 113.23 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -22.48 58.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 1.0 112.273 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.2 tpt85 -58.65 -17.15 19.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.199 2.2 . . . . 1.0 112.686 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -141.66 141.02 33.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -131.84 -16.72 2.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 118.903 -1.119 . . . . 1.0 110.358 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.9 -179.62 0.34 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 130.117 3.367 . . . . 1.0 104.085 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 78.25 3.5 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 121.876 1.717 . . . . 1.0 108.561 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.44 64.08 0.56 Allowed Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.866 -1.519 . . . . 1.0 114.811 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.52 -54.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.429 2.615 . . . . 1.0 111.599 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 t 54.52 44.5 28.66 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.918 1.687 . . . . 1.0 112.468 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -108.73 17.68 21.62 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.369 11.3 t70 43.0 75.69 0.09 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.086 1.754 . . . . 1.0 113.194 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -48.65 -34.16 11.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.838 0.681 . . . . 1.0 112.838 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.63 75.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.942 -1.028 . . . . 1.0 111.707 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.4 -49.45 77.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.773 1.17 . . . . 1.0 109.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -66.2 -52.15 50.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.424 0.898 . . . . 1.0 113.424 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -61.55 -28.26 69.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.592 0.633 . . . . 1.0 111.476 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.45 87.28 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.125 0.875 . . . . 1.0 111.341 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.8 mt -71.04 -61.53 1.73 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.292 1.437 . . . . 1.0 111.065 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.35 166.36 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 124.13 0.972 . . . . 1.0 110.062 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 92.7 m . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 125.297 1.439 . . . . 1.0 109.369 175.431 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.02 36.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 40.67 57.88 2.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.553 2.741 . . . . 1.0 108.6 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.61 150.98 30.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.838 1.255 . . . . 1.0 109.375 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -86.21 123.24 31.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -84.63 129.62 34.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.43 79.33 20.84 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.189 -1.041 . . . . 1.0 108.189 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.27 127.93 12.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.409 2.072 . . . . 1.0 109.104 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -128.18 120.93 21.4 Favored Pre-proline 0 C--O 1.232 0.184 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.3 52.08 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.128 2.552 . . . . 1.0 112.465 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -123.63 43.44 2.97 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -74.26 178.46 5.12 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.723 0.809 . . . . 1.0 109.694 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.65 179.48 5.66 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.94 1.296 . . . . 1.0 110.975 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.5 m -162.67 118.63 1.88 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.756 2.822 . . . . 1.0 105.738 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -131.9 138.47 32.55 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 117.257 -1.354 . . . . 1.0 107.455 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.61 99.66 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.473 2.782 . . . . 1.0 109.389 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -168.03 151.48 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.9 2.48 . . . . 1.0 105.966 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -151.53 106.74 3.31 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.261 1.391 . . . . 1.0 108.288 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -136.36 165.48 25.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.85 2.06 . . . . 1.0 107.28 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -67.43 123.47 86.7 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.173 -1.047 . . . . 1.0 108.173 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.96 103.71 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.548 2.165 . . . . 1.0 110.528 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 t -170.54 73.88 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.57 124.03 11.01 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.666 1.587 . . . . 1.0 106.97 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -88.44 131.64 34.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.119 0.968 . . . . 1.0 109.389 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.3 143.17 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.756 -1.942 . . . . 1.0 105.756 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.14 116.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 105.991 -1.855 . . . . 1.0 105.991 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.4 OUTLIER -172.08 152.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.264 1.425 . . . . 1.0 107.465 175.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 112.4 24.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 mm -128.27 176.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 128.672 2.789 . . . . 1.0 106.545 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -153.28 121.47 6.19 Favored 'General case' 0 C--N 1.31 -1.124 1 N-CA-C 93.728 -6.397 . . . . 1.0 93.728 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.297 0.3 OUTLIER -142.0 -60.33 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 119.459 1.027 . . . . 1.0 110.537 176.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.52 134.31 11.06 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 CA-C-N 121.904 1.716 . . . . 1.0 110.419 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.27 75.81 3.25 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.341 2.694 . . . . 1.0 115.408 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.82 -71.7 0.85 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 106.615 -2.594 . . . . 1.0 106.615 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -156.21 123.63 5.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.888 1.275 . . . . 1.0 110.7 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -174.2 148.22 1.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.778 2.831 . . . . 1.0 108.294 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.51 -35.37 55.89 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.442 0.565 . . . . 1.0 113.406 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.39 118.94 11.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.558 1.075 . . . . 1.0 113.157 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.78 -5.88 17.42 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.636 2.891 . . . . 1.0 115.262 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -48.36 -45.73 35.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.439 1.472 . . . . 1.0 110.905 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.0 mt -65.98 -45.14 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.816 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.16 -39.35 92.34 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.542 -0.463 . . . . 1.0 109.768 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.25 70.68 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.238 0.472 . . . . 1.0 111.686 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.69 -52.4 51.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.573 1.149 . . . . 1.0 109.372 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.28 -41.37 73.49 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 t -66.02 -48.58 70.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.86 2.46 11.35 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.713 1.625 . . . . 1.0 114.503 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -89.08 9.21 26.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.913 1.856 . . . . 1.0 113.008 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 tt -52.21 129.53 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.293 1.437 . . . . 1.0 112.543 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.0 135.52 20.84 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.272 2.229 . . . . 1.0 109.599 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.88 78.1 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.604 2.869 . . . . 1.0 106.951 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -103.2 -65.07 1.02 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.036 0.534 . . . . 1.0 111.055 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.45 79.01 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.226 0.61 . . . . 1.0 111.117 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -171.08 178.08 0.85 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.037 1.735 . . . . 1.0 107.71 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.22 -43.4 4.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.596 2.197 . . . . 1.0 114.972 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -46.14 -50.88 14.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -54.62 42.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.302 1.041 . . . . 1.0 110.025 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.27 99.22 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.434 1.093 . . . . 1.0 111.29 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.99 -58.15 12.55 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 126.106 1.813 . . . . 1.0 112.184 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 pt -57.94 -38.26 65.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 117.954 -1.022 . . . . 1.0 111.879 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.79 -43.1 2.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.304 2.241 . . . . 1.0 115.318 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -61.22 -33.39 73.41 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.599 -0.688 . . . . 1.0 110.377 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.76 135.78 33.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 103.376 -2.824 . . . . 1.0 103.376 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.54 145.7 55.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.583 -0.698 . . . . 1.0 109.152 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.91 161.85 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 127.587 2.355 . . . . 1.0 111.418 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -175.97 139.96 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.412 2.285 . . . . 1.0 106.847 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -160.21 0.78 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.837 1.255 . . . . 1.0 108.074 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -130.41 -58.85 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.437 1.495 . . . . 1.0 108.539 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.97 119.42 17.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.196 -2.52 . . . . 1.0 104.196 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 tp -107.3 113.55 27.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.199 -2.519 . . . . 1.0 104.199 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.16 114.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -76.0 145.39 40.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -20.55 2.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.97 1.471 . . . . 1.0 114.97 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -91.4 29.95 1.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.271 1.828 . . . . 1.0 112.105 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.42 52.28 52.38 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.127 1.822 . . . . 1.0 114.085 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -126.77 117.34 22.47 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.331 -0.842 . . . . 1.0 110.465 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.4 mt -83.02 114.73 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 101.6 -3.481 . . . . 1.0 101.6 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.48 142.27 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 103.34 -2.837 . . . . 1.0 103.34 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -121.14 114.04 20.87 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.074 -1.641 . . . . 1.0 111.264 -175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -108.98 120.17 41.74 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t 64.93 88.6 0.11 Allowed Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.024 1.284 . . . . 1.0 112.869 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.19 178.21 5.7 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 121.528 1.485 . . . . 1.0 109.548 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -43.55 9.26 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.149 1 C-N-CA 133.476 4.71 . . . . 1.0 120.198 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -133.89 111.12 10.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 119.371 -2.081 . . . . 1.0 107.552 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 86.25 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.889 2.076 . . . . 1.0 111.41 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -34.0 156.29 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.302 2.641 . . . . 1.0 114.669 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.59 -178.51 3.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 130.008 3.323 . . . . 1.0 109.998 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -145.93 118.54 8.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.95 1.25 . . . . 1.0 110.246 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -154.79 62.82 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 123.132 1.444 . . . . 1.0 110.747 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -161.76 -55.77 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 118.944 -2.348 . . . . 1.0 112.917 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.92 -74.41 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.177 -1.969 . . . . 1.0 108.177 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.18 128.82 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.244 1.417 . . . . 1.0 109.675 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.6 p -166.19 154.28 10.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.68 1.592 . . . . 1.0 112.14 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 157' ' ' ILE . 60.6 p -153.21 146.63 24.91 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 120.864 -1.147 . . . . 1.0 110.812 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -153.88 154.62 34.21 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.549 0.613 . . . . 1.0 110.504 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 38.91 55.38 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.223 1.809 . . . . 1.0 111.612 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.67 77.1 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.86 -0.967 . . . . 1.0 114.468 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -136.55 119.86 16.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.503 -1.665 . . . . 1.0 106.503 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -100.44 138.7 37.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 36.4 mtm180 -113.31 118.34 34.32 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.1 t -58.07 -41.75 84.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.348 1.059 . . . . 1.0 111.212 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -148.19 177.02 9.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.514 3.126 . . . . 1.0 108.059 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.0 76.91 10.01 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.387 1.089 . . . . 1.0 108.689 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -87.51 33.92 0.7 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.198 0.999 . . . . 1.0 111.185 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.2 m -135.46 137.61 42.35 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.034 -1.666 . . . . 1.0 113.013 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.98 57.0 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.932 2.093 . . . . 1.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.18 -136.79 2.41 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.85 -1.156 . . . . 1.0 111.029 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.1 mm -142.63 162.02 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 129.177 2.991 . . . . 1.0 103.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.94 130.22 29.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.76 -3.052 . . . . 1.0 102.76 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.54 157.53 16.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 107.435 -1.321 . . . . 1.0 107.435 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.08 155.82 46.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.959 0.885 . . . . 1.0 111.12 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.55 179.36 43.35 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.393 -1.276 . . . . 1.0 111.027 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -147.88 116.35 6.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 128.229 2.611 . . . . 1.0 105.434 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.8 t0 54.17 32.48 15.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.858 2.463 . . . . 1.0 115.109 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.0 p 51.25 37.53 18.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.3 1.84 . . . . 1.0 113.212 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.44 146.46 54.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.749 1.62 . . . . 1.0 108.508 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -29.3 113.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.658 1.983 . . . . 1.0 111.206 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -78.36 -9.41 59.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.354 18.3 p 66.84 77.66 0.27 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 116.711 -1.614 . . . . 1.0 111.84 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.45 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 121.148 1.795 . . . . 1.0 113.729 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.12 -43.08 3.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.728 2.011 . . . . 1.0 110.245 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -55.53 -44.65 76.91 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.263 1.025 . . . . 1.0 111.461 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.55 -43.31 97.38 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.755 1.162 . . . . 1.0 109.902 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -63.08 -55.54 24.57 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.01 -43.06 88.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.767 0.827 . . . . 1.0 111.08 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.75 -48.01 80.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.314 1.415 . . . . 1.0 108.902 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.06 89.53 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.292 -0.861 . . . . 1.0 109.438 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.58 -53.89 45.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.991 0.916 . . . . 1.0 110.797 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -55.84 -53.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.0 m -57.88 -57.6 12.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.405 1.482 . . . . 1.0 110.452 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.19 -46.4 79.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.653 1.581 . . . . 1.0 110.738 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.38 72.15 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.968 -0.539 . . . . 1.0 111.379 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.71 -42.69 79.6 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.927 -1.108 . . . . 1.0 109.93 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.8 -41.03 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.673 1.189 . . . . 1.0 109.721 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.7 m -59.25 -13.08 6.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.337 1.055 . . . . 1.0 112.394 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -111.85 -43.61 3.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.275 -1.345 . . . . 1.0 111.39 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.52 112.81 23.03 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -97.97 107.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 121.286 1.495 . . . . 1.0 111.493 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.81 -54.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.71 2.004 . . . . 1.0 108.251 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 60.0 mt -49.77 -32.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 129.5 3.12 . . . . 1.0 110.813 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.36 -21.46 2.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.708 1.203 . . . . 1.0 113.345 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.57 18.39 3.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.881 2.072 . . . . 1.0 110.894 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -143.2 83.96 1.81 Allowed 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.125 -0.984 . . . . 1.0 109.899 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.26 127.9 40.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -158.53 -168.23 2.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.32 -0.992 . . . . 1.0 108.32 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.75 -131.67 1.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 106.7 -2.56 . . . . 1.0 106.7 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 9.2 m170 -113.78 -23.2 9.8 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.111 0.964 . . . . 1.0 111.276 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.3 -15.89 15.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.145 0.978 . . . . 1.0 109.543 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.82 38.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.173 -0.954 . . . . 1.0 109.759 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -68.92 -17.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.914 -1.116 . . . . 1.0 109.446 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.02 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.232 1.813 . . . . 1.0 111.453 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -92.3 110.24 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.795 2.33 . . . . 1.0 112.781 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -58.39 -25.95 62.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.346 1.858 . . . . 1.0 113.924 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -25.31 62.87 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.497 0.719 . . . . 1.0 112.794 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -127.69 139.73 52.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -127.65 -16.43 4.77 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.978 -0.378 . . . . 1.0 109.978 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.18 178.85 0.48 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 131.281 3.832 . . . . 1.0 103.725 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.13 85.63 1.36 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.186 1.924 . . . . 1.0 109.994 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.96 68.32 0.62 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.236 1.398 . . . . 1.0 111.64 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 168' ' ' SER . 71.9 Cg_endo -75.38 -70.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.688 2.259 . . . . 1.0 112.592 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 15.4 t 53.7 42.9 31.72 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.582 2.353 . . . . 1.0 111.408 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -99.56 18.92 16.75 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.11 -1.619 . . . . 1.0 113.9 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.8 t0 43.35 70.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.781 1.233 . . . . 1.0 112.93 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -56.27 -30.09 62.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 1.0 112.66 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.86 -60.07 3.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.037 0.835 . . . . 1.0 109.065 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -64.18 -34.54 78.32 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.371 -0.931 . . . . 1.0 111.967 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.01 -52.7 46.89 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.823 1.192 . . . . 1.0 110.618 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -34.64 74.6 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 119.049 -0.5 . . . . 1.0 109.985 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.06 89.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.868 0.867 . . . . 1.0 112.557 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.54 -58.86 3.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.793 1.237 . . . . 1.0 110.155 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.03 166.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.327 1.051 . . . . 1.0 110.23 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 109.765 176.092 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.86 139.77 41.86 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.964 0.347 . . . . 1.0 110.682 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 57.24 65.99 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 127.062 2.145 . . . . 1.0 112.818 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.41 148.48 37.89 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.262 1.425 . . . . 1.0 107.289 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -72.07 123.38 22.71 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.545 -2.391 . . . . 1.0 104.545 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.91 38.32 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.734 0.814 . . . . 1.0 111.929 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.67 72.92 77.08 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.066 0.946 . . . . 1.0 108.803 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.57 123.26 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 107.513 -1.764 . . . . 1.0 107.513 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -136.02 113.38 10.62 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.3 61.78 4.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.97 2.447 . . . . 1.0 108.926 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -124.01 44.69 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.892 -1.892 . . . . 1.0 105.892 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -82.01 178.38 8.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.819 2.048 . . . . 1.0 113.466 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.87 -179.3 3.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 128.268 2.627 . . . . 1.0 112.912 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 m -157.65 118.59 3.54 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.173 4.589 . . . . 1.0 101.337 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -132.92 138.46 31.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 116.728 -1.606 . . . . 1.0 107.975 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.68 86.95 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.57 2.846 . . . . 1.0 108.675 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HB2' HH12 ' A' ' 93' ' ' ARG . 13.2 m-20 -160.29 150.88 18.58 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.828 2.451 . . . . 1.0 106.226 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -151.49 104.06 3.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.322 1.849 . . . . 1.0 106.134 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.11 170.36 16.23 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.476 1.489 . . . . 1.0 108.138 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -75.43 123.19 88.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 119.905 -1.747 . . . . 1.0 109.033 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.22 103.54 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.967 1.778 . . . . 1.0 110.712 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.3 t -171.08 77.23 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.55 -1.648 . . . . 1.0 106.55 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -145.8 124.72 12.72 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.23 127.26 35.75 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.834 -1.543 . . . . 1.0 106.834 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.09 113.8 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -108.79 114.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 104.916 -2.253 . . . . 1.0 104.916 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.63 149.18 5.54 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 116.731 -1.604 . . . . 1.0 106.868 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -95.54 111.43 23.34 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 117.145 -1.822 . . . . 1.0 110.138 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -127.6 176.78 6.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 129.98 3.312 . . . . 1.0 107.273 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.1 t -149.15 121.04 8.16 Favored 'General case' 0 C--N 1.313 -1.016 1 N-CA-C 94.697 -6.038 . . . . 1.0 94.697 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.295 0.1 OUTLIER -142.36 -61.39 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.26 0.937 . . . . 1.0 109.8 175.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.07 124.67 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.212 1.942 . . . . 1.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.8 68.89 7.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.538 2.825 . . . . 1.0 111.73 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.92 -71.1 0.69 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.855 -1.698 . . . . 1.0 108.855 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -152.33 123.48 7.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.545 1.938 . . . . 1.0 106.121 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -175.71 158.58 2.18 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.42 2.688 . . . . 1.0 107.857 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.84 -0.75 63.87 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.558 -1.134 . . . . 1.0 113.058 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 118.47 4.79 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.67 1.735 . . . . 1.0 110.903 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.35 -12.88 15.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.64 2.227 . . . . 1.0 114.101 -175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -61.81 -33.92 75.0 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.921 1.237 . . . . 1.0 111.017 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.6 mt -64.17 -55.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.314 -1.365 . . . . 1.0 107.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.6 -33.28 75.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.439 0.563 . . . . 1.0 112.271 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.25 -34.25 56.42 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.74 0.816 . . . . 1.0 111.3 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.36 -51.11 60.53 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.14 -0.975 . . . . 1.0 109.559 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -61.23 -50.63 72.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 1.0 110.884 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 -33.91 74.91 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.346 1.458 . . . . 1.0 110.548 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.63 2.75 37.44 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.804 -1.554 . . . . 1.0 115.666 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.5 p -93.04 9.3 36.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.177 1.988 . . . . 1.0 113.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 tt -49.13 137.55 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.344 1.058 . . . . 1.0 112.19 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 136.33 20.75 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 126.415 1.886 . . . . 1.0 107.015 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.49 67.25 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.967 3.112 . . . . 1.0 110.296 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.56 -48.31 4.0 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.486 1.291 . . . . 1.0 114.486 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.46 -64.51 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.065 0.946 . . . . 1.0 112.76 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -171.04 178.01 0.87 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.376 1.47 . . . . 1.0 108.199 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.78 -43.9 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.848 2.365 . . . . 1.0 115.154 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -51.45 -59.04 4.68 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.984 1.266 . . . . 1.0 112.246 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.7 -49.22 69.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.718 0.807 . . . . 1.0 111.094 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.04 95.1 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.32 0.648 . . . . 1.0 111.595 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.43 -63.47 5.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 125.29 1.424 . . . . 1.0 110.751 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.33 -26.12 38.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-O 116.06 -1.924 . . . . 1.0 112.49 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.79 -43.22 3.89 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 121.002 1.728 . . . . 1.0 115.059 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -60.01 -34.5 73.43 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.499 0.72 . . . . 1.0 111.188 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.43 136.18 33.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.946 -2.613 . . . . 1.0 103.946 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 164.29 15.18 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.853 -1.154 . . . . 1.0 109.358 175.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -116.58 166.39 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.346 1.058 . . . . 1.0 109.593 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -170.73 121.56 0.58 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.351 1.46 . . . . 1.0 107.653 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.29 -155.5 0.48 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.382 1.873 . . . . 1.0 107.329 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -136.06 -59.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.327 1.851 . . . . 1.0 108.029 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.1 m -132.63 118.97 19.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -109.01 113.63 26.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -95.37 114.25 31.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.173 -2.158 . . . . 1.0 105.173 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.92 148.91 43.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.394 0.997 . . . . 1.0 108.323 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -13.61 2.51 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.232 1.197 . . . . 1.0 114.232 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -91.82 23.41 3.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.258 1.023 . . . . 1.0 110.986 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.75 41.44 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 127.674 2.559 . . . . 1.0 112.891 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.98 154.63 44.33 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.077 0.951 . . . . 1.0 108.956 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.96 113.77 44.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.53 146.95 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.686 -1.598 . . . . 1.0 106.686 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -124.7 113.78 18.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.278 1.031 . . . . 1.0 108.876 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -114.05 114.8 26.61 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 104.149 -2.538 . . . . 1.0 104.149 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t 81.46 91.95 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.898 1.226 . . . . 1.0 109.254 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -64.83 -167.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.964 1.776 . . . . 1.0 110.289 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -77.29 51.26 0.83 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.377 -1.452 . . . . 1.0 110.976 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -154.99 129.57 9.18 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.545 2.738 . . . . 1.0 105.611 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.6 tttp 62.93 81.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.04 2.136 . . . . 1.0 112.773 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.404 HH12 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -35.45 155.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.138 2.975 . . . . 1.0 112.972 -176.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.272 . . -103.45 178.5 4.54 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.81 2.444 . . . . 1.0 114.42 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -151.79 118.05 5.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.855 2.062 . . . . 1.0 105.497 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -165.33 62.96 0.12 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.135 1.445 . . . . 1.0 109.734 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -168.89 -69.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 O-C-N 119.114 -2.241 . . . . 1.0 114.758 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.04 -78.04 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.6 t -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.166 0.987 . . . . 1.0 108.727 -176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 p -166.32 158.32 13.83 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.636 2.375 . . . . 1.0 106.956 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 p -161.25 145.57 13.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.13 -1.804 . . . . 1.0 106.13 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -166.03 155.05 11.49 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . 0.275 37.6 mm-40 39.16 58.01 1.91 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.46 1.904 . . . . 1.0 113.008 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.16 28.74 50.42 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.344 1.45 . . . . 1.0 114.247 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -128.9 113.26 15.01 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -89.76 135.15 33.79 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.0 mtt85 -125.54 140.71 52.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.384 0.993 . . . . 1.0 109.155 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -86.32 -24.72 25.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.844 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -158.34 170.44 22.22 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.085 2.554 . . . . 1.0 106.238 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.5 76.3 10.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 123.095 1.426 . . . . 1.0 110.507 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.05 44.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.69 2.396 . . . . 1.0 110.297 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 m -123.5 156.56 35.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.439 1.495 . . . . 1.0 112.549 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.262 0.0 OUTLIER -97.65 56.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.705 2.002 . . . . 1.0 108.189 176.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.24 -135.38 3.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 10.7 mm -143.92 161.12 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 128.827 2.851 . . . . 1.0 104.848 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -131.92 113.66 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 101.536 -3.505 . . . . 1.0 101.536 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.51 148.26 28.2 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.291 -1.374 . . . . 1.0 107.291 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.05 155.26 47.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.635 0.731 . . . . 1.0 112.175 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.12 173.4 43.57 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.811 -1.541 . . . . 1.0 111.556 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.4 p -137.89 103.15 4.9 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.484 1.913 . . . . 1.0 106.297 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 t70 57.87 30.46 19.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.041 1.736 . . . . 1.0 113.344 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.255 81.7 p 57.82 38.74 27.3 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.545 1.938 . . . . 1.0 113.444 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.66 145.58 52.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -28.36 113.46 0.07 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 128.059 2.543 . . . . 1.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -79.02 -9.84 59.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 115.163 -2.351 . . . . 1.0 116.043 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 43.6 p 65.08 77.04 0.32 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 121.801 2.091 . . . . 1.0 112.698 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -23.36 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.548 1.539 . . . . 1.0 114.578 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.05 -40.71 6.93 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.301 2.24 . . . . 1.0 111.379 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.73 -54.0 13.5 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.394 1.078 . . . . 1.0 109.378 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -59.13 -38.82 80.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.334 0.654 . . . . 1.0 111.597 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.59 -57.38 8.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.4 0.545 . . . . 1.0 110.888 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -65.08 -37.12 86.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.972 0.805 . . . . 1.0 110.765 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.1 tp -56.52 -47.88 78.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.43 1.014 . . . . 1.0 108.603 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.16 93.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.589 -0.72 . . . . 1.0 110.527 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.82 53.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.071 0.85 . . . . 1.0 110.292 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.8 t -57.1 -48.61 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.909 -0.775 . . . . 1.0 108.909 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.0 m -56.45 -49.52 74.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.976 1.311 . . . . 1.0 110.438 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -59.02 -46.87 87.12 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.89 0.876 . . . . 1.0 109.944 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.3 77.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.864 0.302 . . . . 1.0 110.594 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.0 mt -55.94 -44.21 78.16 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.988 0.915 . . . . 1.0 111.187 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.73 -41.08 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.126 0.875 . . . . 1.0 110.432 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -65.69 -14.26 60.91 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.826 -1.171 . . . . 1.0 112.252 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.68 -59.24 1.78 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.632 1.105 . . . . 1.0 108.191 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -124.82 112.88 27.04 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -101.76 107.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 123.347 1.311 . . . . 1.0 112.465 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.29 -41.26 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.073 2.549 . . . . 1.0 105.85 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.4 mt -47.75 -33.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 128.869 2.868 . . . . 1.0 109.851 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.81 -26.25 13.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.023 0.929 . . . . 1.0 112.89 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -129.9 18.58 5.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.565 1.946 . . . . 1.0 109.992 175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.84 83.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 122.221 1.01 . . . . 1.0 108.332 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.91 113.41 17.82 Favored 'General case' 0 N--CA 1.448 -0.563 1 N-CA-C 99.988 -4.079 . . . . 1.0 99.988 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -152.98 -166.67 2.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -149.41 -131.78 2.0 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.148 -2.381 . . . . 1.0 107.148 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.427 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 16.9 m170 -116.63 -23.76 8.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.467 1.134 . . . . 1.0 110.629 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.5 t -103.86 2.34 32.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 4.1 t-20 -104.08 22.83 13.98 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.356 1.463 . . . . 1.0 111.459 -175.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.59 -15.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.34 0.656 . . . . 1.0 111.949 -175.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.26 -57.48 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.847 1.659 . . . . 1.0 108.934 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.4 117.12 3.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 CA-C-N 122.085 1.78 . . . . 1.0 112.204 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -25.56 64.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.784 0.834 . . . . 1.0 111.926 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -62.32 -19.27 63.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.476 2.31 . . . . 1.0 114.905 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -137.25 141.92 42.0 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 2.5 m -130.94 -17.05 3.17 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 117.158 -1.817 . . . . 1.0 112.422 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.58 -178.34 0.28 Allowed Pre-proline 0 C--O 1.249 1.036 0 C-N-CA 128.894 2.878 . . . . 1.0 105.093 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 80.01 2.31 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 N-CA-C 106.704 -2.076 . . . . 1.0 106.704 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 128.38 79.15 0.25 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.105 1.812 . . . . 1.0 111.035 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.57 -113.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 123.93 3.087 . . . . 1.0 110.237 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 t 56.36 43.51 26.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.284 1.833 . . . . 1.0 112.807 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -95.94 17.68 14.86 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.351 1.46 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.0 t0 44.08 77.27 0.07 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.106 1.362 . . . . 1.0 112.351 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -54.98 -32.87 62.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.392 0.516 . . . . 1.0 112.392 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.38 78.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.723 0.692 . . . . 1.0 111.252 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -59.8 -57.61 12.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.916 0.78 . . . . 1.0 110.07 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.55 -50.29 74.33 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.33 -38.96 81.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 118.481 0.582 . . . . 1.0 110.403 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.67 76.17 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.839 0.681 . . . . 1.0 112.839 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.59 -44.71 66.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.322 1.049 . . . . 1.0 111.862 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.64 162.89 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.17 0.988 . . . . 1.0 109.745 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 124.367 1.067 . . . . 1.0 109.084 175.603 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.46 145.29 44.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.871 1.434 . . . . 1.0 114.871 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 40.25 58.77 2.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 128.085 2.554 . . . . 1.0 108.941 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.66 156.71 46.67 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.467 1.107 . . . . 1.0 110.624 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -88.81 123.76 33.52 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -83.59 132.58 34.9 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -137.1 70.34 56.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.25 135.18 11.91 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.874 2.382 . . . . 1.0 111.787 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 t -159.18 113.2 1.57 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 N-CA-C 104.846 -2.279 . . . . 1.0 104.846 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.11 69.83 7.75 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.57 2.18 . . . . 1.0 110.207 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -123.19 43.57 2.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.876 2.071 . . . . 1.0 107.109 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -106.7 177.78 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.087 1.355 . . . . 1.0 110.005 -176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.25 -175.15 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.055 2.142 . . . . 1.0 112.101 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.87 130.16 14.65 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.712 2.805 . . . . 1.0 104.377 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.29 171.33 6.9 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 119.407 1.003 . . . . 1.0 109.345 -175.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.1 76.64 4.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.103 1.869 . . . . 1.0 112.738 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -149.81 144.0 25.72 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.849 2.46 . . . . 1.0 108.516 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -144.0 104.2 4.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.879 -1.526 . . . . 1.0 106.879 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -136.27 157.58 46.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.349 1.46 . . . . 1.0 109.224 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -70.7 123.56 89.37 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 103.14 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.04 1.407 . . . . 1.0 110.394 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 t -177.9 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.53 -1.655 . . . . 1.0 106.53 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tt -155.51 137.31 14.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.623 -1.991 . . . . 1.0 105.623 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.0 tp -99.21 125.44 44.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.878 0.871 . . . . 1.0 109.594 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.46 113.81 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.13 120.93 59.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 104.902 -2.259 . . . . 1.0 104.902 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -169.82 134.23 1.32 Allowed 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -90.45 112.26 23.82 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.602 -1.259 . . . . 1.0 107.602 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm -127.38 176.62 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 130.627 3.571 . . . . 1.0 107.259 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 t -140.77 122.71 15.5 Favored 'General case' 0 C--O 1.245 0.842 1 N-CA-C 95.789 -5.634 . . . . 1.0 95.789 174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.309 1.0 OUTLIER -141.79 -64.3 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 114.139 1.163 . . . . 1.0 114.139 176.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 159.86 33.91 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.275 1.134 . . . . 1.0 112.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.04 0.76 9.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.044 3.163 . . . . 1.0 116.524 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -19.82 -66.48 0.01 OUTLIER Glycine 0 C--N 1.347 1.181 0 C-N-CA 126.178 1.847 . . . . 1.0 112.607 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -152.68 123.7 7.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.169 1.388 . . . . 1.0 112.021 175.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -176.6 164.79 2.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.412 3.085 . . . . 1.0 108.617 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.97 18.75 16.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.534 2.016 . . . . 1.0 111.2 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.8 118.47 6.16 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 107.69 -2.164 . . . . 1.0 107.69 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.2 -19.4 26.0 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 CA-C-N 121.286 2.543 . . . . 1.0 113.682 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -56.95 -34.61 68.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.651 1.18 . . . . 1.0 112.705 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -66.06 -53.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.27 -33.22 75.26 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.773 -0.58 . . . . 1.0 112.228 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.19 -33.94 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.25 1.02 . . . . 1.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.08 -51.28 64.81 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.363 -0.835 . . . . 1.0 111.335 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -71.01 -39.43 72.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.377 1.071 . . . . 1.0 112.419 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 t -66.35 -40.37 89.77 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.96 16.88 6.58 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 124.939 1.257 . . . . 1.0 115.55 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.5 p -110.84 18.39 19.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.894 1.847 . . . . 1.0 113.805 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.72 132.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.465 1.029 . . . . 1.0 111.509 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.66 136.81 20.62 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 127.558 2.343 . . . . 1.0 108.887 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.65 62.67 1.72 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.31 2.674 . . . . 1.0 113.157 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -103.53 -50.16 3.51 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.042 1.127 . . . . 1.0 114.042 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.49 -63.27 1.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.729 0.695 . . . . 1.0 112.333 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -170.83 178.01 0.89 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.653 1.581 . . . . 1.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -44.2 18.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.067 1.845 . . . . 1.0 114.789 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -51.36 -58.7 5.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.41 1.005 . . . . 1.0 111.855 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -43.73 98.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.716 0.806 . . . . 1.0 110.136 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.8 98.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.404 -0.81 . . . . 1.0 111.817 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.44 -63.02 5.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.147 2.308 . . . . 1.0 112.742 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 pt -57.57 -34.26 46.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.9 -1.048 . . . . 1.0 113.077 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.5 -43.79 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 117.236 2.31 . . . . 1.0 117.236 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -64.88 -33.61 76.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.848 0.459 . . . . 1.0 110.189 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.83 119.6 25.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.137 -1.801 . . . . 1.0 106.137 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.33 132.64 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.621 -0.674 . . . . 1.0 109.841 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.65 162.79 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.366 1.466 . . . . 1.0 111.108 -175.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.2 m -161.7 115.94 1.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.749 0.82 . . . . 1.0 109.363 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.45 -156.98 0.53 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.628 1.171 . . . . 1.0 108.809 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -134.87 -75.98 0.46 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.5 m -124.08 118.28 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 102.207 -3.257 . . . . 1.0 102.207 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.03 113.57 27.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 103.688 -2.708 . . . . 1.0 103.688 176.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.62 122.04 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.174 -1.787 . . . . 1.0 106.174 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.04 150.16 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -57.12 -14.75 4.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.924 -1.512 . . . . 1.0 114.144 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.34 19.33 6.12 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 120.505 1.502 . . . . 1.0 112.267 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.78 51.88 54.33 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.028 1.775 . . . . 1.0 112.58 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.27 111.02 16.85 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.586 -1.635 . . . . 1.0 106.586 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.7 mt -79.74 120.17 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.669 -1.604 . . . . 1.0 106.669 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.66 141.4 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 102.819 -3.03 . . . . 1.0 102.819 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 116.87 21.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -118.38 131.02 56.31 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.966 2.507 . . . . 1.0 105.615 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 t 69.05 91.51 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 120.726 1.603 . . . . 1.0 111.465 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 91' ' ' ASP . 74.0 Cg_endo -66.32 -169.48 0.17 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.827 2.351 . . . . 1.0 112.026 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -69.59 30.41 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.319 1.447 . . . . 1.0 110.668 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 89' ' ' PRO . 3.0 t0 -144.5 115.32 7.78 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 128.57 2.748 . . . . 1.0 108.305 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HZ2' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 79.14 82.19 0.06 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.241 2.616 . . . . 1.0 112.486 174.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -34.38 146.22 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.337 2.655 . . . . 1.0 114.834 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.09 -178.55 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.863 2.065 . . . . 1.0 113.194 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -155.91 118.28 4.12 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.63 2.372 . . . . 1.0 108.472 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -161.01 63.03 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.715 1.245 . . . . 1.0 109.402 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.503 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.83 -70.85 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 119.627 -1.921 . . . . 1.0 113.261 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.93 -74.7 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 106.35 -2.7 . . . . 1.0 106.35 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.19 140.53 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.582 1.191 . . . . 1.0 110.061 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.3 p -166.32 162.45 17.23 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.969 1.307 . . . . 1.0 110.282 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 p -166.23 146.79 6.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.736 1.614 . . . . 1.0 108.928 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -156.39 147.24 21.95 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.333 0.97 . . . . 1.0 110.674 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 38.91 56.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.343 1.857 . . . . 1.0 112.142 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.95 28.89 69.41 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.289 0.947 . . . . 1.0 114.527 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -128.63 113.79 15.86 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.96 146.5 24.33 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -123.17 118.89 28.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.031 0.533 . . . . 1.0 111.108 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.52 -25.8 50.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.976 0.91 . . . . 1.0 110.042 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.67 168.88 18.86 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 127.558 2.343 . . . . 1.0 107.857 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -88.18 75.91 8.54 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.98 33.83 1.84 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.521 1.128 . . . . 1.0 112.276 -175.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -126.94 131.07 51.18 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.938 0.895 . . . . 1.0 109.542 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.289 0.1 OUTLIER -79.01 56.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.214 1.806 . . . . 1.0 110.073 -177.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.44 -133.26 3.42 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 122.578 1.099 . . . . 1.0 111.684 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 20.6 mm -137.03 166.38 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.351 3.46 . . . . 1.0 104.085 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -144.85 135.38 24.42 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 101.839 -3.393 . . . . 1.0 101.839 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.3 165.69 11.14 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.522 -1.361 . . . . 1.0 110.412 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.15 150.35 49.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.771 0.829 . . . . 1.0 110.256 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.1 175.6 45.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.872 1.262 . . . . 1.0 112.383 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.5 p -141.28 110.1 6.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.983 2.113 . . . . 1.0 106.111 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 t0 45.67 48.73 11.43 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 128.301 2.64 . . . . 1.0 111.82 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p 50.7 38.08 18.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.776 2.831 . . . . 1.0 115.404 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.4 145.92 50.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.123 2.169 . . . . 1.0 110.55 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.34 114.68 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 129.405 3.082 . . . . 1.0 110.987 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -84.36 -8.05 59.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 114.123 -2.846 . . . . 1.0 113.155 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.391 26.5 p 64.9 77.92 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 122.568 2.44 . . . . 1.0 115.014 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -23.22 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 121.073 1.76 . . . . 1.0 114.815 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.9 -43.1 13.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.827 2.051 . . . . 1.0 110.733 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -50.15 -50.72 48.0 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 118.299 -0.857 . . . . 1.0 109.738 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -60.56 -36.36 78.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 117.559 -1.21 . . . . 1.0 111.222 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -65.29 -60.04 3.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.512 1.051 . . . . 1.0 109.713 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -62.8 -41.45 99.28 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.483 0.313 . . . . 1.0 111.138 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.01 -52.98 63.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.812 1.645 . . . . 1.0 109.122 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.71 76.23 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 118.289 -0.862 . . . . 1.0 110.273 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.79 52.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.683 0.793 . . . . 1.0 108.929 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.61 -50.29 68.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -58.27 -57.39 13.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.266 1.026 . . . . 1.0 112.13 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -55.79 -43.16 76.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.537 1.062 . . . . 1.0 110.328 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.85 51.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.788 -0.57 . . . . 1.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.53 -34.06 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.144 1.378 . . . . 1.0 112.105 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 mt -63.58 -39.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.405 -1.332 . . . . 1.0 107.405 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.8 m -64.53 -14.35 57.02 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.297 1.039 . . . . 1.0 110.4 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -64.93 1.07 Allowed 'General case' 0 C--N 1.347 0.47 0 O-C-N 120.24 -1.538 . . . . 1.0 106.942 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.85 113.01 24.66 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 106.922 -1.511 . . . . 1.0 106.922 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -88.65 107.25 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.865 1.702 . . . . 1.0 111.288 -175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.27 -51.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.296 1.438 . . . . 1.0 108.723 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 32.0 mt -46.04 -35.11 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 130.823 3.649 . . . . 1.0 111.789 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.06 63.49 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -131.39 18.34 4.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.353 2.261 . . . . 1.0 109.803 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -143.17 83.45 1.79 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 49.4 mtt -121.67 122.02 38.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.666 -2.716 . . . . 1.0 103.666 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 t -158.65 -176.45 5.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.02 -131.33 2.89 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 105.787 -2.925 . . . . 1.0 105.787 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 16.1 m170 -118.15 -23.12 7.47 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.134 0.974 . . . . 1.0 110.63 176.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.4 t -103.36 -18.4 14.86 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -91.78 45.83 1.25 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.925 1.29 . . . . 1.0 107.521 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -14.68 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.319 -1.488 . . . . 1.0 109.933 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -153.65 -65.95 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 127.304 2.241 . . . . 1.0 107.334 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.16 113.29 3.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.932 1.726 . . . . 1.0 113.382 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -18.71 36.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.121 1.368 . . . . 1.0 112.056 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.11 -25.99 64.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.536 1.934 . . . . 1.0 112.759 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -139.6 135.14 33.03 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.499 -2.037 . . . . 1.0 105.499 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 37.4 m -119.96 -16.49 8.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.103 0.408 . . . . 1.0 112.103 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.24 175.35 1.31 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.689 2.795 . . . . 1.0 105.095 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.73 69.3 7.85 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.953 2.435 . . . . 1.0 109.563 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 124.33 69.69 0.21 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.978 2.704 . . . . 1.0 108.54 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.39 -87.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.022 3.148 . . . . 1.0 112.263 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 t 53.49 73.35 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.211 3.005 . . . . 1.0 109.214 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.35 18.97 12.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.411 1.085 . . . . 1.0 113.885 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.13 74.54 0.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.879 -1.763 . . . . 1.0 112.759 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -58.65 -31.57 68.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.866 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.07 77.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.857 -1.068 . . . . 1.0 110.666 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -60.81 -51.66 68.37 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.555 1.07 . . . . 1.0 110.516 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -60.79 -56.48 20.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.213 0.82 . . . . 1.0 113.213 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -64.29 -25.63 68.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.018 -0.991 . . . . 1.0 112.176 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.79 83.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.042 0.837 . . . . 1.0 111.093 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.16 -59.9 2.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.327 1.451 . . . . 1.0 111.019 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.48 166.02 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.546 0.794 0 C-N-CA 124.329 1.051 . . . . 1.0 110.225 179.177 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 103.957 -2.609 . . . . 1.0 103.957 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.91 175.04 7.02 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.19 0.996 . . . . 1.0 112.186 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 43.87 58.17 3.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.229 1.812 . . . . 1.0 109.697 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.0 132.93 7.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.462 1.905 . . . . 1.0 107.322 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -63.83 123.47 19.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 142.36 28.54 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.999 -1.063 . . . . 1.0 109.681 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.34 70.4 72.99 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 105.351 -2.092 . . . . 1.0 105.351 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.21 124.22 9.82 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.639 2.226 . . . . 1.0 111.047 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -160.24 113.46 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.67 71.1 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.866 2.377 . . . . 1.0 110.756 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -123.69 54.2 1.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.783 1.633 . . . . 1.0 107.281 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -95.53 -175.71 3.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.302 2.241 . . . . 1.0 112.352 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.09 -177.08 3.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.959 2.104 . . . . 1.0 108.488 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 m -163.77 122.11 1.91 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 130.135 3.374 . . . . 1.0 103.82 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.8 152.94 52.21 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -80.88 36.6 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.991 2.461 . . . . 1.0 113.344 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.11 143.22 37.15 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.873 2.469 . . . . 1.0 104.497 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -146.69 103.26 3.64 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 9.2 tp10 -137.04 165.36 26.22 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -68.67 124.1 89.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.447 1.099 . . . . 1.0 110.695 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.5 113.94 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.025 2.484 . . . . 1.0 111.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t 178.91 85.29 0.01 OUTLIER 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.616 1.967 . . . . 1.0 105.983 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tp -148.32 143.15 26.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.259 -1.756 . . . . 1.0 106.259 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp -110.68 116.06 30.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.996 -1.853 . . . . 1.0 105.996 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.78 122.73 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.3 t -112.95 120.7 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.8 p80 -167.04 128.56 1.63 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 107.526 -1.287 . . . . 1.0 107.526 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -80.34 112.63 17.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 116.63 -2.028 . . . . 1.0 108.142 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -128.13 176.97 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 C-N-CA 131.993 4.117 . . . . 1.0 106.086 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 t -152.09 121.95 7.03 Favored 'General case' 0 N--CA 1.44 -0.96 1 N-CA-C 95.305 -5.813 . . . . 1.0 95.305 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.82 -66.17 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.511 0 CA-C-N 119.432 1.014 . . . . 1.0 110.86 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.65 136.33 17.06 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.16 2.574 . . . . 1.0 110.838 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.86 77.76 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.73 1.62 . . . . 1.0 111.919 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.08 -72.09 0.72 Allowed Glycine 0 CA--C 1.533 1.194 0 N-CA-C 105.308 -3.117 . . . . 1.0 105.308 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -155.34 122.89 5.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.012 1.725 . . . . 1.0 107.857 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -176.84 167.64 2.55 Favored 'General case' 0 N--CA 1.469 0.523 1 C-N-CA 132.107 4.163 . . . . 1.0 107.157 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.99 16.11 20.75 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.088 1.328 . . . . 1.0 111.691 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.52 118.78 4.89 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 -7.69 21.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.018 2.479 . . . . 1.0 114.143 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -60.78 -38.86 86.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.638 1.108 . . . . 1.0 109.808 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -66.16 -46.58 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.68 -47.76 79.15 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.697 -0.627 . . . . 1.0 110.675 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.5 -33.66 63.91 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.479 1.512 . . . . 1.0 111.794 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.2 -57.45 10.46 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.23 1.012 . . . . 1.0 109.744 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -64.76 -45.24 87.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.834 0.854 . . . . 1.0 112.423 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 t -65.86 -37.12 85.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.07 0.948 . . . . 1.0 109.853 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.11 37.94 3.96 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.36 -1.245 . . . . 1.0 115.648 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 p -130.68 20.61 5.09 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.398 1.599 . . . . 1.0 112.163 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.29 151.32 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.996 1.319 . . . . 1.0 112.26 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -98.68 129.36 30.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 127.271 2.228 . . . . 1.0 107.937 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.82 67.99 3.07 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.33 3.353 . . . . 1.0 109.599 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -104.77 -65.63 1.02 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.026 1.33 . . . . 1.0 112.64 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.68 4.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.177 1.391 . . . . 1.0 112.772 -175.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -170.5 177.86 0.95 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.559 1.544 . . . . 1.0 107.86 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -70.93 -43.44 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.536 1.49 . . . . 1.0 115.34 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -50.62 -58.31 6.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.005 1.275 . . . . 1.0 113.026 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -45.04 91.79 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.0 0.92 . . . . 1.0 111.005 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.77 86.86 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.704 -0.622 . . . . 1.0 111.997 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -60.36 9.05 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 125.797 1.665 . . . . 1.0 111.271 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.2 -32.45 40.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 116.435 -1.745 . . . . 1.0 112.052 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -35.86 -43.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.241 2.216 . . . . 1.0 115.775 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -62.19 -39.84 94.05 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.846 1.258 . . . . 1.0 109.949 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.88 135.25 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.519 -2.401 . . . . 1.0 104.519 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 159.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.057 -1.027 . . . . 1.0 108.595 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.49 164.27 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.911 1.284 . . . . 1.0 107.867 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -164.31 118.2 1.41 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.334 0.654 . . . . 1.0 110.31 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.79 -153.89 0.35 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -129.94 -62.19 0.96 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.3 1.44 . . . . 1.0 108.598 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -130.4 119.05 22.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.86 113.43 25.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.816 -2.661 . . . . 1.0 103.816 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 mt -100.91 124.45 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -83.95 148.0 27.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -16.38 0.77 Allowed 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 115.314 1.598 . . . . 1.0 115.314 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.99 22.45 4.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.12 56.23 23.4 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.425 -1.422 . . . . 1.0 112.808 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -128.7 143.34 50.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mt -116.46 125.6 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.059 1.3 . . . . 1.0 109.973 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.3 t -111.75 153.29 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.572 -2.01 . . . . 1.0 105.572 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -125.73 120.6 31.07 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.106 -0.996 . . . . 1.0 110.27 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -120.56 113.61 20.52 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 103.352 -2.833 . . . . 1.0 103.352 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t 80.17 91.84 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 121.412 1.914 . . . . 1.0 114.461 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.35 -173.52 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.313 2.675 . . . . 1.0 111.816 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -80.65 51.59 1.52 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.873 -1.142 . . . . 1.0 108.989 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -148.86 113.04 5.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 130.287 3.435 . . . . 1.0 105.806 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.358 27.9 tttp 73.64 82.37 0.12 Allowed 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 115.497 1.665 . . . . 1.0 115.497 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 ttm-85 -32.72 138.11 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.855 2.862 . . . . 1.0 111.388 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.96 -178.87 3.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.118 1.767 . . . . 1.0 113.247 -175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -148.01 120.26 8.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.051 1.74 . . . . 1.0 109.976 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -162.08 62.85 0.23 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 106.49 -1.67 . . . . 1.0 106.49 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -157.8 -65.2 0.09 Allowed 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 119.356 -2.09 . . . . 1.0 114.082 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.16 -68.25 0.71 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.99 -0.895 . . . . 1.0 112.873 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.3 t -132.25 136.23 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.071 1.348 . . . . 1.0 109.726 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 p -166.35 137.13 3.44 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.54 1.136 . . . . 1.0 111.136 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 p -154.96 132.42 11.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.48 -2.415 . . . . 1.0 104.48 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -152.96 159.66 42.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.117 0.871 . . . . 1.0 108.907 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 41.66 53.69 3.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.331 1.452 . . . . 1.0 111.11 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.53 32.49 53.2 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.951 -0.916 . . . . 1.0 113.382 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -139.54 114.88 9.8 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 119.084 1.442 . . . . 1.0 107.81 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.36 144.69 35.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -123.51 118.42 27.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.9 t -53.04 -39.15 63.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.663 0.665 . . . . 1.0 111.012 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -143.68 162.41 36.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.753 3.221 . . . . 1.0 104.896 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.298 28.6 t70 -86.95 76.71 9.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 123.283 1.516 . . . . 1.0 109.297 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -75.24 44.19 0.24 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 131.133 3.773 . . . . 1.0 110.255 175.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -123.15 155.43 37.05 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.133 1.373 . . . . 1.0 112.289 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.2 57.08 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.914 2.486 . . . . 1.0 109.005 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.21 -136.9 6.05 Favored Glycine 0 CA--C 1.527 0.834 0 O-C-N 120.174 -1.578 . . . . 1.0 114.055 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.1 mm -142.12 159.55 20.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 129.129 2.972 . . . . 1.0 103.776 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.54 119.05 9.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.094 -2.928 . . . . 1.0 103.094 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.14 133.23 34.47 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.604 -1.31 . . . . 1.0 107.635 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -103.52 138.51 40.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.904 0.882 . . . . 1.0 108.765 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.55 33.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.699 1.142 . . . . 1.0 110.484 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.1 p -150.31 113.57 4.89 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.85 41.42 22.51 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.58 1.552 . . . . 1.0 114.384 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 45.77 38.16 4.04 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.295 1.838 . . . . 1.0 113.014 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -59.89 138.02 57.92 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.894 -1.891 . . . . 1.0 105.894 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.53 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.567 2.347 . . . . 1.0 111.25 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.54 -4.29 47.92 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 116.468 -1.73 . . . . 1.0 115.147 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.315 73.5 p 55.37 78.02 0.2 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.465 -1.731 . . . . 1.0 113.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -23.31 -33.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.176 2.591 . . . . 1.0 113.421 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.04 -35.71 7.14 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.485 1.914 . . . . 1.0 110.148 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.7 -50.14 63.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.342 0.973 . . . . 1.0 109.959 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.403 ' HH ' ' C ' ' A' ' 169' ' ' PHE . 10.8 m-85 -60.41 -39.19 86.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.672 0.789 . . . . 1.0 110.43 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.02 -54.52 28.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.844 1.258 . . . . 1.0 109.839 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -66.52 -47.47 72.83 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 0.68 . . . . 1.0 111.146 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.1 tp -50.7 -49.51 57.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.874 1.27 . . . . 1.0 109.74 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.09 89.36 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 119.172 0.897 . . . . 1.0 110.519 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.33 59.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.424 0.689 . . . . 1.0 110.561 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.72 -46.5 62.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.4 m -59.9 -43.36 94.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.459 1.104 . . . . 1.0 110.576 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -58.82 -47.47 84.7 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.605 1.093 . . . . 1.0 109.564 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.73 -58.19 9.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.227 1.011 . . . . 1.0 109.253 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.3 -38.1 68.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.871 -1.062 . . . . 1.0 113.554 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.7 mt -61.25 -49.38 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 120.041 1.291 . . . . 1.0 108.991 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.5 m -66.36 -20.53 66.1 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.272 -0.268 . . . . 1.0 110.811 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -83.64 -57.1 3.37 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.01 1.724 . . . . 1.0 108.943 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.46 112.97 23.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 106.537 -1.653 . . . . 1.0 106.537 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -95.07 107.87 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 CA-C-N 120.848 1.339 . . . . 1.0 113.459 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.99 -50.64 0.11 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.855 1.662 . . . . 1.0 108.471 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.35 -33.64 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 129.689 3.196 . . . . 1.0 111.282 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.73 -21.98 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.704 1.601 . . . . 1.0 113.994 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -141.43 18.6 2.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.889 1.676 . . . . 1.0 110.398 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -138.44 84.17 2.01 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.707 -1.246 . . . . 1.0 108.046 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.0 mtt -121.5 114.38 21.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.8 t -145.37 -169.37 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.78 -131.51 2.57 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 106.285 -2.726 . . . . 1.0 106.285 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 20.2 m170 -117.49 -23.17 7.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.052 1.341 . . . . 1.0 109.314 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -23.07 13.82 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -84.14 42.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.539 1.063 . . . . 1.0 108.367 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -14.14 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 O-C-N 120.073 -1.642 . . . . 1.0 108.281 175.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -158.02 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 128.634 2.774 . . . . 1.0 111.584 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.61 108.44 2.29 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.199 1.933 . . . . 1.0 113.144 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -62.33 -21.68 65.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.246 1.418 . . . . 1.0 111.813 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -67.59 -24.39 65.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.656 -1.277 . . . . 1.0 113.002 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -132.7 124.29 27.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.177 -2.156 . . . . 1.0 105.177 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -114.18 -17.41 11.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.624 -1.23 . . . . 1.0 111.479 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.69 178.98 0.41 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 131.398 3.879 . . . . 1.0 103.603 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 91.64 0.65 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 121.697 1.642 . . . . 1.0 108.07 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 114.18 76.81 0.73 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.776 1.655 . . . . 1.0 111.263 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.83 -90.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.553 2.836 . . . . 1.0 110.452 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t 53.01 46.85 25.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.695 2.398 . . . . 1.0 113.782 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' C ' ' HH ' ' A' ' 130' ' ' TYR . 27.2 t80 -118.24 16.46 14.0 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.851 -1.156 . . . . 1.0 112.629 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.5 t0 43.84 80.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.068 -1.645 . . . . 1.0 113.756 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -62.73 -33.93 76.13 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.237 -0.915 . . . . 1.0 112.396 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.47 91.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.299 0.954 . . . . 1.0 110.934 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -65.91 -52.52 49.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.115 0.87 . . . . 1.0 110.237 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.86 -51.84 67.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -62.04 -35.42 78.55 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.222 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.62 80.71 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.6 -46.91 62.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.128 0.571 . . . . 1.0 110.046 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.18 166.52 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.618 1.967 . . . . 1.0 111.488 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.547 0.84 0 C-N-CA 127.168 2.187 . . . . 1.0 108.499 175.144 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 C--O 1.237 0.436 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.09 172.45 12.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.542 0.61 . . . . 1.0 110.738 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 37.51 57.85 1.36 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.959 2.904 . . . . 1.0 110.71 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.03 156.73 22.53 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.155 -0.966 . . . . 1.0 110.074 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -88.0 123.06 32.33 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.152 0.433 . . . . 1.0 111.769 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -98.22 130.02 44.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.47 1.108 . . . . 1.0 111.212 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.87 92.43 9.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.987 0.915 . . . . 1.0 108.654 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.4 160.47 44.62 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.54 1.493 . . . . 1.0 112.576 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 t -159.94 113.41 1.45 Allowed Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.4 61.17 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.792 2.328 . . . . 1.0 111.983 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -133.53 43.26 2.91 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.099 1.76 . . . . 1.0 107.068 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -73.84 178.47 4.85 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.994 1.317 . . . . 1.0 109.832 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.07 178.79 4.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 124.117 1.913 . . . . 1.0 113.953 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -138.13 118.44 13.68 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 111.921 -2.4 . . . . 1.0 106.729 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -126.16 167.26 17.52 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 129.045 2.938 . . . . 1.0 106.144 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -179.1 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.619 1.546 . . . . 1.0 109.132 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.85 143.33 45.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.627 -2.361 . . . . 1.0 104.627 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -150.99 167.33 27.96 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 102.727 -3.064 . . . . 1.0 102.727 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.77 163.46 24.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.713 1.605 . . . . 1.0 108.962 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.39 123.59 3.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.307 2.243 . . . . 1.0 110.282 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HB2' ' H ' ' A' ' 113' ' ' ILE . 63.2 Cg_endo -66.11 135.28 39.86 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.495 2.797 . . . . 1.0 111.008 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 t 178.88 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.523 1.929 . . . . 1.0 106.768 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.27 125.15 6.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.1 126.01 39.07 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.77 144.31 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 104.593 -2.373 . . . . 1.0 104.593 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.67 113.88 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.544 -3.132 . . . . 1.0 102.544 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -167.39 143.04 4.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.51 112.51 21.61 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.868 0.73 . . . . 1.0 109.409 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.4 176.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.629 1.972 . . . . 1.0 107.387 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 t -141.47 122.4 14.51 Favored 'General case' 0 N--CA 1.442 -0.834 1 N-CA-C 95.345 -5.798 . . . . 1.0 95.345 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.353 0.7 OUTLIER -142.58 -66.7 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 116.337 -1.792 . . . . 1.0 115.162 -178.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -94.38 157.74 2.03 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.588 2.192 . . . . 1.0 114.783 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.25 51.72 4.02 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 125.215 3.943 . . . . 1.0 117.487 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.15 -71.2 0.83 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 107.373 -2.291 . . . . 1.0 107.373 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -156.32 122.82 5.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.72 2.008 . . . . 1.0 108.251 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -176.74 161.74 2.09 Favored 'General case' 0 C--O 1.235 0.295 1 C-N-CA 132.745 4.418 . . . . 1.0 108.229 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.18 4.0 29.99 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.522 1.058 . . . . 1.0 111.005 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.81 119.09 4.88 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 117.952 -1.471 . . . . 1.0 110.015 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -5.48 14.08 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.78 2.32 . . . . 1.0 114.771 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -60.9 -47.63 85.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.565 1.984 . . . . 1.0 110.926 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 mt -62.27 -51.28 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.35 -46.91 86.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.308 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.48 80.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.04 0.936 . . . . 1.0 111.361 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.2 -49.94 73.76 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.485 0.584 . . . . 1.0 110.143 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -70.85 -46.91 61.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.177 -0.439 . . . . 1.0 110.93 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -65.9 -37.83 87.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.516 1.126 . . . . 1.0 109.63 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 8.09 11.26 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.915 1.721 . . . . 1.0 115.513 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -104.3 19.4 20.29 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.234 2.017 . . . . 1.0 113.34 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -59.41 125.25 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.306 1.442 . . . . 1.0 111.709 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.14 136.65 20.46 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.44 1.896 . . . . 1.0 110.671 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -71.36 70.38 2.5 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.788 2.992 . . . . 1.0 111.225 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -103.3 -62.5 1.28 Allowed 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.659 -0.651 . . . . 1.0 111.808 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.22 76.0 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.949 0.5 . . . . 1.0 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -170.63 177.98 0.91 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.865 1.666 . . . . 1.0 107.396 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.8 -43.33 2.69 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 1.0 114.718 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -46.47 -51.05 16.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -57.48 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.128 0.971 . . . . 1.0 111.243 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.2 96.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.671 0.788 . . . . 1.0 111.05 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.04 -61.47 3.94 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.171 1.843 . . . . 1.0 111.672 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 pt -59.89 -33.98 54.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 116.743 -1.599 . . . . 1.0 112.709 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.38 -43.15 2.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.538 1.935 . . . . 1.0 115.154 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -54.67 -36.51 64.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.912 0.885 . . . . 1.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 136.54 33.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.352 -2.462 . . . . 1.0 104.352 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -60.49 152.06 26.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.088 -1.007 . . . . 1.0 108.55 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.7 158.7 17.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.481 1.112 . . . . 1.0 110.273 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -171.59 128.68 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.875 2.07 . . . . 1.0 108.127 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.13 -172.2 2.61 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -120.77 -59.71 1.72 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -138.97 118.72 13.13 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.433 -1.691 . . . . 1.0 106.433 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.77 113.47 26.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -95.44 118.28 41.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.077 -1.823 . . . . 1.0 106.077 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -72.67 148.3 44.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 117.994 -1.003 . . . . 1.0 108.304 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -45.45 -35.14 3.55 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 113.438 0.903 . . . . 1.0 113.438 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -91.67 36.64 0.95 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.882 0.873 . . . . 1.0 112.068 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.17 52.76 49.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.274 1.416 . . . . 1.0 115.299 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -119.49 111.92 18.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.388 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.6 mt -85.78 113.88 24.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.295 -2.113 . . . . 1.0 105.295 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 140.27 30.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.273 -1.751 . . . . 1.0 106.273 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -121.85 114.87 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.487 1.115 . . . . 1.0 108.321 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -114.11 121.06 42.64 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 103.538 -2.764 . . . . 1.0 103.538 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.4 t 70.8 92.01 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 121.041 1.746 . . . . 1.0 111.344 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.57 -168.4 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.405 2.737 . . . . 1.0 111.891 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -59.61 2.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.965 2.506 . . . . 1.0 115.596 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -125.58 135.08 51.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 128.025 2.53 . . . . 1.0 104.372 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.261 14.4 tptp 77.19 82.15 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.303 1.841 . . . . 1.0 111.882 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -34.11 136.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.521 1.928 . . . . 1.0 113.878 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.64 -178.39 3.65 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.451 2.3 . . . . 1.0 108.989 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -148.2 118.58 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.77 62.89 0.47 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.591 -1.318 . . . . 1.0 111.035 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -168.74 -68.22 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 119.177 -2.202 . . . . 1.0 113.99 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.99 -84.57 0.37 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 106.959 -2.456 . . . . 1.0 106.959 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.85 145.45 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.683 1.242 . . . . 1.0 109.468 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.6 p -165.97 145.47 6.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.8 1.24 . . . . 1.0 111.248 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -133.23 146.55 51.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.43 1.892 . . . . 1.0 109.79 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.72 148.91 28.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 41.53 53.5 3.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.24 1.816 . . . . 1.0 110.224 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.66 28.43 56.58 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.167 1.841 . . . . 1.0 116.277 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -132.82 136.6 46.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.145 1.973 . . . . 1.0 107.08 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 15.0 tp10 -96.2 145.79 25.24 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.65 1.18 . . . . 1.0 109.222 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -112.7 120.28 40.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.413 -2.069 . . . . 1.0 105.413 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.7 t -54.42 -31.2 54.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 1.0 112.826 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -164.27 176.29 9.3 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 129.552 3.141 . . . . 1.0 104.602 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -81.29 76.45 8.23 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 123.038 1.399 . . . . 1.0 109.628 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -80.94 33.52 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.233 1.813 . . . . 1.0 110.62 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 m -129.54 143.26 50.75 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 124.182 0.993 . . . . 1.0 113.124 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.484 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -80.01 57.09 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.56 2.344 . . . . 1.0 107.825 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.41 -136.58 1.35 Allowed Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.526 1.07 . . . . 1.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.19 163.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 103.299 -2.852 . . . . 1.0 103.299 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.71 130.79 23.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.471 -2.788 . . . . 1.0 103.471 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mp -101.13 166.03 11.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.529 0.681 . . . . 1.0 109.387 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.42 158.38 44.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.979 0.895 . . . . 1.0 111.4 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.75 173.04 45.4 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 113.759 -1.564 . . . . 1.0 110.876 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.8 p -141.14 101.94 4.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.796 -1.928 . . . . 1.0 105.796 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t70 49.48 55.74 8.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.584 1.954 . . . . 1.0 111.842 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.321 18.6 p 47.29 38.69 7.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.836 2.854 . . . . 1.0 115.131 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.55 146.19 55.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -38.14 114.13 0.34 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.14 2.176 . . . . 1.0 112.679 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -79.06 0.54 27.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 116.202 -1.856 . . . . 1.0 114.541 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.506 4.8 p 55.43 77.97 0.2 Allowed 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.017 -2.42 . . . . 1.0 117.443 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -23.4 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 122.479 2.399 . . . . 1.0 116.346 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.87 -41.73 16.22 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.722 1.609 . . . . 1.0 109.549 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.97 -50.92 60.31 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.919 0.887 . . . . 1.0 110.549 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -59.99 -43.27 95.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.221 0.918 . . . . 1.0 110.157 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.12 -51.05 61.63 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.864 0.466 . . . . 1.0 110.754 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -62.84 -50.2 71.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.142 1.777 . . . . 1.0 109.713 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 35.7 tp -54.14 -49.08 70.05 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.4 76.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 1.0 111.37 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.42 55.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.7 0.8 . . . . 1.0 109.253 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.52 -47.69 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.8 m -52.75 -48.84 66.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.696 1.598 . . . . 1.0 110.232 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -59.66 -46.93 87.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.795 0.725 . . . . 1.0 111.951 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.17 74.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.271 0.487 . . . . 1.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.34 -41.23 75.74 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.934 0.893 . . . . 1.0 112.583 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.56 -49.47 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.726 1.148 . . . . 1.0 109.605 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.1 m -59.77 -16.65 29.44 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.439 0.695 . . . . 1.0 111.903 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -94.34 -58.87 2.09 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.467 -1.396 . . . . 1.0 109.55 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -125.95 112.9 24.41 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.068 -1.456 . . . . 1.0 107.068 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.77 107.48 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.644 1.266 . . . . 1.0 112.814 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.64 -50.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.919 2.088 . . . . 1.0 107.73 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.5 mt -44.78 -33.77 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.5 0 C-N-CA 129.478 3.111 . . . . 1.0 110.543 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.06 4.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.7 2.0 . . . . 1.0 114.118 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -136.54 18.57 3.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.803 1.641 . . . . 1.0 109.75 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.76 84.62 2.03 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.262 0.937 . . . . 1.0 110.176 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.37 114.07 19.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.9 t -146.73 -171.08 3.67 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.571 -0.706 . . . . 1.0 110.012 -175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.59 2.04 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 107.021 -2.431 . . . . 1.0 107.021 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.409 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 20.9 m170 -113.58 -23.23 9.88 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.688 0.795 . . . . 1.0 111.639 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.59 -12.34 17.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.124 0.57 . . . . 1.0 109.695 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -88.09 40.02 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.153 0.888 . . . . 1.0 110.448 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.8 -26.57 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 120.955 -1.091 . . . . 1.0 108.449 175.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -143.68 -65.48 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.667 1.587 . . . . 1.0 111.767 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.9 110.68 1.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.744 2.296 . . . . 1.0 112.807 -176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.23 -18.76 39.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.303 1.441 . . . . 1.0 113.609 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -57.42 -26.29 60.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.594 1.557 . . . . 1.0 112.154 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -126.22 141.16 52.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.085 -2.191 . . . . 1.0 105.085 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 m -132.15 -16.45 2.81 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.696 -0.628 . . . . 1.0 110.634 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.8 176.23 0.82 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 131.434 3.894 . . . . 1.0 102.805 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.45 70.31 6.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.802 2.335 . . . . 1.0 111.756 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 119.18 78.18 0.57 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.34 -2.304 . . . . 1.0 107.34 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 -62.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.028 2.485 . . . . 1.0 112.155 -175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.53 51.67 14.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.793 2.037 . . . . 1.0 114.027 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -124.22 18.18 9.1 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.203 0.91 . . . . 1.0 113.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.386 19.9 t0 41.01 76.46 0.07 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.245 1.818 . . . . 1.0 113.748 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -51.29 -34.29 32.42 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.43 91.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 117.56 -1.21 . . . . 1.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -66.57 -53.17 37.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.294 1.406 . . . . 1.0 109.221 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.85 -51.24 70.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.369 0.507 . . . . 1.0 112.369 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -66.11 -23.49 66.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.84 0.745 . . . . 1.0 110.321 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.77 -51.9 50.44 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.298 -1.501 . . . . 1.0 109.754 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.79 -57.82 8.75 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.144 1.377 . . . . 1.0 111.339 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.86 166.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 175.474 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.0 158.22 33.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.657 1.354 . . . . 1.0 114.657 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 38.56 57.98 1.7 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.587 2.755 . . . . 1.0 109.759 -175.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.24 51.82 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.593 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.511 ' HB2' HH11 ' A' ' 12' ' ' ARG . 8.5 ttm105 -79.11 123.14 27.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.329 -2.471 . . . . 1.0 104.329 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.9 122.5 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -143.01 79.54 14.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.994 -1.854 . . . . 1.0 105.994 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 132.95 30.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.927 1.751 . . . . 1.0 111.217 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 t -69.34 145.41 95.73 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 124.765 1.226 . . . . 1.0 109.587 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 -23.41 7.19 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 117.025 1.894 . . . . 1.0 117.025 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -150.16 121.46 7.85 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.57 178.98 5.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 178.45 4.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 123.11 1.433 . . . . 1.0 111.612 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 m -154.69 118.5 4.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 131.603 3.961 . . . . 1.0 101.594 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -130.69 155.21 81.62 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 125.853 1.661 . . . . 1.0 108.121 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -88.01 56.41 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.268 2.645 . . . . 1.0 109.794 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -140.25 143.64 36.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.41 103.92 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.56 171.22 14.09 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 105.877 -1.897 . . . . 1.0 105.877 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -71.37 123.3 89.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 119.53 1.059 . . . . 1.0 108.915 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.12 103.61 1.46 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 CA-C-N 120.687 1.281 . . . . 1.0 109.519 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -175.76 78.46 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.165 1.786 . . . . 1.0 107.337 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 tp -143.69 140.79 30.22 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.143 1.777 . . . . 1.0 106.722 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -106.11 126.59 52.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.665 1.121 . . . . 1.0 108.376 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.37 130.15 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.408 -2.071 . . . . 1.0 105.408 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.6 112.98 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -158.52 149.71 20.71 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 176.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -81.54 111.26 17.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.644 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.18 176.79 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.763 2.025 . . . . 1.0 107.451 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t -161.84 122.31 2.61 Favored 'General case' 0 C--N 1.313 -0.986 1 N-CA-C 93.93 -6.322 . . . . 1.0 93.93 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.273 1.2 tm? -142.66 -56.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 O-C-N 121.035 -1.04 . . . . 1.0 109.688 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -71.53 149.29 55.53 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.133 1.889 . . . . 1.0 112.631 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -82.41 39.66 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.56 3.506 . . . . 1.0 114.265 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -53.0 -71.61 0.66 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-O 117.461 -1.744 . . . . 1.0 110.581 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -156.6 122.87 4.98 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.707 1.754 . . . . 1.0 111.996 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -177.8 160.92 1.56 Allowed 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.493 4.317 . . . . 1.0 108.183 175.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.94 6.13 59.97 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.137 0.875 . . . . 1.0 111.846 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.89 118.65 4.73 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.0 1.4 . . . . 1.0 109.651 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 -21.44 44.62 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.364 2.043 . . . . 1.0 114.083 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -52.06 -43.09 63.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.099 0.863 . . . . 1.0 112.08 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.75 -44.3 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.449 1.1 . . . . 1.0 109.665 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.51 -45.64 78.88 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.05 0.841 . . . . 1.0 110.363 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.23 -33.56 58.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.476 1.511 . . . . 1.0 111.356 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -61.28 2.42 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.633 1.573 . . . . 1.0 108.985 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.99 -37.54 75.75 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.13 0.972 . . . . 1.0 113.279 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 t -65.82 -33.84 76.79 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.92 -5.43 53.5 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 125.211 1.386 . . . . 1.0 115.505 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -89.42 8.9 28.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.295 2.048 . . . . 1.0 112.515 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -51.94 134.42 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 125.961 1.705 . . . . 1.0 111.176 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.72 134.18 21.85 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 127.585 2.354 . . . . 1.0 110.225 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 77.52 1.82 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.641 2.894 . . . . 1.0 107.422 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.32 -63.26 1.19 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.364 0.666 . . . . 1.0 110.639 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.0 78.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.755 0.822 . . . . 1.0 110.69 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -171.0 178.0 0.87 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.737 2.015 . . . . 1.0 107.167 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.05 -43.48 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.049 1.832 . . . . 1.0 114.684 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -46.38 -47.61 18.74 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -58.13 8.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.451 1.1 . . . . 1.0 110.066 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.42 92.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.899 0.88 . . . . 1.0 111.37 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.59 -65.78 2.62 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.645 1.593 . . . . 1.0 111.553 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.15 -38.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.476 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.05 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.359 1.864 . . . . 1.0 114.951 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -57.36 -33.55 67.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.71 -0.619 . . . . 1.0 110.323 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.51 134.23 33.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 102.2 -3.259 . . . . 1.0 102.2 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 152.14 19.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.949 0.795 . . . . 1.0 110.967 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.43 161.43 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.772 1.629 . . . . 1.0 110.74 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -172.88 123.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.584 1.554 . . . . 1.0 108.242 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.51 -154.05 0.43 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -128.89 -65.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.487 1.115 . . . . 1.0 110.133 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.8 m -133.99 118.69 18.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.678 -1.264 . . . . 1.0 107.689 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -103.47 113.97 27.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.809 -1.923 . . . . 1.0 105.809 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.56 114.59 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -66.36 148.62 51.59 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.72 1.145 . . . . 1.0 108.532 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -13.62 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.721 1.608 . . . . 1.0 112.306 175.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -91.21 18.96 6.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 131.478 3.911 . . . . 1.0 112.304 -176.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.5 46.97 93.37 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.229 1.395 . . . . 1.0 113.168 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.97 110.25 14.56 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.706 1.253 . . . . 1.0 110.156 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.48 117.45 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 106.729 -1.582 . . . . 1.0 106.729 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.45 147.9 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.216 -1.772 . . . . 1.0 106.216 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -125.75 124.26 40.64 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 1.0 110.141 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.0 117.86 28.36 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 129.463 3.105 . . . . 1.0 103.755 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t 72.06 91.78 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 122.656 2.48 . . . . 1.0 113.205 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.91 -166.61 0.23 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.331 2.021 . . . . 1.0 111.079 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -70.85 46.07 0.09 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.856 2.862 . . . . 1.0 113.703 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.01 127.16 4.5 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 127.215 2.206 . . . . 1.0 106.508 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 tptm 77.35 81.48 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.543 1.137 . . . . 1.0 111.377 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -39.53 154.9 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.462 2.305 . . . . 1.0 113.232 -175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.31 -178.29 3.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.566 2.346 . . . . 1.0 113.008 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -153.12 118.73 5.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.905 1.682 . . . . 1.0 108.956 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -166.32 64.02 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 122.595 1.188 . . . . 1.0 111.167 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.15 -54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 118.103 -2.873 . . . . 1.0 112.602 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.37 -74.73 0.25 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.347 -1.807 . . . . 1.0 109.137 -175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.55 142.2 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.935 1.694 . . . . 1.0 110.018 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -166.33 163.66 17.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.984 2.514 . . . . 1.0 110.643 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.7 p -163.14 146.23 10.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -159.65 157.48 29.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.738 1.154 . . . . 1.0 108.94 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 39.9 53.28 2.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.623 1.569 . . . . 1.0 109.994 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.3 42.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 116.262 1.265 . . . . 1.0 116.262 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -129.0 121.98 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 120.019 1.909 . . . . 1.0 106.861 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.45 141.06 38.55 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -119.51 118.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.5 -42.87 97.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.3 0.852 . . . . 1.0 113.3 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.95 176.52 8.74 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.277 1.831 . . . . 1.0 108.968 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -83.15 76.46 9.86 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.91 38.41 1.23 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.986 1.315 . . . . 1.0 111.758 -175.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -134.14 149.94 51.09 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.094 0.958 . . . . 1.0 113.013 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -82.52 56.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.845 2.058 . . . . 1.0 109.645 177.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.51 -136.86 2.15 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 122.393 0.996 . . . . 1.0 113.359 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.7 mm -140.86 160.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 103.532 -2.766 . . . . 1.0 103.532 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -138.46 126.04 22.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 103.324 -2.843 . . . . 1.0 103.324 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.51 139.56 37.0 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.993 -1.067 . . . . 1.0 109.459 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -104.53 154.09 20.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.471 0.653 . . . . 1.0 110.539 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.42 -179.74 45.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.405 1.955 . . . . 1.0 110.213 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 p -141.87 106.41 4.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.074 -1.824 . . . . 1.0 106.074 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.414 ' C ' ' HG1' ' A' ' 122' ' ' THR 0.266 43.7 t0 38.95 56.63 1.98 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.107 2.563 . . . . 1.0 113.986 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 121' ' ' ASP . 38.3 p 56.16 38.2 29.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.564 1.32 . . . . 1.0 114.564 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -69.17 146.0 52.81 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 105.389 -2.078 . . . . 1.0 105.389 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -37.26 113.55 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.133 1.373 . . . . 1.0 111.062 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.94 -6.62 56.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 115.521 1.674 . . . . 1.0 115.521 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.395 10.9 p 66.7 76.96 0.29 Allowed 'General case' 0 C--N 1.352 0.704 0 CA-C-N 120.872 1.669 . . . . 1.0 112.797 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -25.54 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.734 1.753 . . . . 1.0 115.734 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.75 7.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.669 1.588 . . . . 1.0 109.719 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.47 -48.79 37.48 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.037 1.335 . . . . 1.0 110.64 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.65 -40.52 92.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.13 0.877 . . . . 1.0 110.266 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -65.95 -50.12 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.38 0.536 . . . . 1.0 110.208 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -62.15 -52.66 62.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.689 1.596 . . . . 1.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.2 tp -54.23 -47.99 71.59 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.835 1.654 . . . . 1.0 109.656 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.9 98.05 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.304 0.956 . . . . 1.0 110.54 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.15 49.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.47 -43.29 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.868 0.867 . . . . 1.0 110.766 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.8 m -57.57 -54.0 51.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 1.0 109.492 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -65.69 -33.75 76.61 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.2 -59.25 5.77 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . 0.341 2.9 mm? -56.71 -33.83 66.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.738 -1.125 . . . . 1.0 113.555 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.68 -39.68 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.597 1.544 . . . . 1.0 107.908 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.2 m -60.18 -24.63 64.93 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.726 0.811 . . . . 1.0 110.866 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -84.3 -64.85 1.09 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 106.367 -1.716 . . . . 1.0 106.367 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -126.92 113.38 22.07 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.219 1.008 . . . . 1.0 109.976 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.63 107.36 0.33 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 CA-C-N 120.287 1.138 . . . . 1.0 110.838 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.3 -47.23 0.1 Allowed 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 128.212 2.605 . . . . 1.0 105.855 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.5 mt -48.54 -34.09 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 129.555 3.142 . . . . 1.0 110.644 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.91 7.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.803 0.841 . . . . 1.0 113.076 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -137.27 18.33 2.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.5 2.32 . . . . 1.0 109.926 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -141.99 83.67 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.409 1.004 . . . . 1.0 110.148 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.24 114.83 18.16 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 102.878 -3.008 . . . . 1.0 102.878 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.6 t -153.38 -166.98 2.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.315 0.579 . . . . 1.0 111.688 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.26 -131.93 1.59 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.378 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 13.9 m170 -112.83 -23.26 10.23 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.899 0.88 . . . . 1.0 109.223 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -108.39 -21.98 12.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.104 1.361 . . . . 1.0 108.991 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -83.85 34.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.883 -1.136 . . . . 1.0 109.074 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -22.53 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -149.19 -55.92 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.952 2.501 . . . . 1.0 110.926 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.78 112.01 2.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.27 1.98 . . . . 1.0 112.907 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.42 -26.19 64.96 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.847 -1.158 . . . . 1.0 111.705 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -21.94 66.19 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.857 1.263 . . . . 1.0 112.091 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -137.81 124.7 21.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -113.75 -15.75 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.395 0.543 . . . . 1.0 110.937 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.86 178.08 0.5 Allowed Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 129.645 3.178 . . . . 1.0 105.314 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -78.99 50.02 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.45 2.1 . . . . 1.0 111.185 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.55 65.82 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.36 1.933 . . . . 1.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.88 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.222 2.615 . . . . 1.0 111.51 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.1 t 53.61 50.66 16.7 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.603 1.161 . . . . 1.0 111.036 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -105.33 17.73 23.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.967 1.258 . . . . 1.0 113.175 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.1 t0 43.74 62.56 1.87 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.702 -1.873 . . . . 1.0 110.905 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -52.15 -33.43 40.3 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.748 -0.644 . . . . 1.0 111.279 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.98 -60.45 3.81 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.622 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -60.45 -42.3 95.86 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 117.574 -1.203 . . . . 1.0 111.411 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.94 -62.0 2.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.107 0.867 . . . . 1.0 111.128 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -61.14 -32.4 72.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.702 -0.666 . . . . 1.0 110.858 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.76 76.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.021 0.828 . . . . 1.0 112.233 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.75 -57.23 4.88 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.889 -1.132 . . . . 1.0 108.367 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.67 164.6 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.084 1.754 . . . . 1.0 110.76 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 125.405 1.482 . . . . 1.0 109.019 175.738 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 28.1 tp -74.26 142.44 45.28 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.718 1.145 . . . . 1.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -131.88 136.49 47.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.664 2.386 . . . . 1.0 104.955 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -134.81 124.23 24.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.868 2.067 . . . . 1.0 109.001 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 54.01 35.32 21.77 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.442 2.297 . . . . 1.0 112.05 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.03 3.95 25.65 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.866 0.746 . . . . 1.0 112.794 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -97.48 168.01 10.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.4 123.46 28.05 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.27 168.75 18.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 44.18 57.98 3.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.189 1.795 . . . . 1.0 109.711 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.49 156.25 41.68 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.958 2.103 . . . . 1.0 108.91 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -93.28 125.13 37.72 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -83.62 118.7 24.01 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.19 66.72 60.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.67 123.44 11.7 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 N-CA-C 108.339 -1.447 . . . . 1.0 108.339 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 t -54.82 142.71 53.71 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 123.193 0.597 . . . . 1.0 111.581 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.35 -12.01 24.99 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 116.039 1.515 . . . . 1.0 116.039 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -151.74 111.37 3.99 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -79.6 178.76 7.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.11 0.868 . . . . 1.0 110.532 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.0 -173.22 2.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.341 2.656 . . . . 1.0 109.916 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.8 m -165.66 118.13 1.13 Allowed 'General case' 0 CA--C 1.54 0.569 1 C-N-CA 131.705 4.002 . . . . 1.0 104.65 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.26 139.08 28.92 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 120.349 1.431 . . . . 1.0 109.809 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 70.03 6.07 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 124.449 3.433 . . . . 1.0 113.467 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -143.52 154.65 43.84 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.598 1.559 . . . . 1.0 108.68 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -151.19 103.43 3.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.354 0.979 . . . . 1.0 112.127 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' CD ' ' HE ' ' A' ' 105' ' ' ARG . 28.9 tp10 -136.61 147.04 46.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 129.423 3.089 . . . . 1.0 104.68 175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -59.66 123.79 72.93 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 119.949 1.25 . . . . 1.0 111.476 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.96 103.85 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.023 2.482 . . . . 1.0 111.847 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -172.24 79.39 0.05 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.703 1.601 . . . . 1.0 107.444 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.8 tp -139.93 133.66 30.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 tp -97.2 123.17 40.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.465 1.029 . . . . 1.0 108.311 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.69 118.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.957 -1.498 . . . . 1.0 106.957 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.3 t -116.02 114.79 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.289 -2.115 . . . . 1.0 105.289 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.6 p80 -167.34 152.33 7.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.267 -1.382 . . . . 1.0 107.267 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.67 112.23 24.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -127.51 175.95 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.597 1.959 . . . . 1.0 109.127 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 122.4 3.49 Favored 'General case' 0 N--CA 1.442 -0.869 1 N-CA-C 99.099 -4.408 . . . . 1.0 99.099 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -142.2 -48.4 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 118.174 -0.917 . . . . 1.0 108.979 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 39.0 Cg_endo -91.1 146.51 3.61 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 121.791 1.661 . . . . 1.0 114.465 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.48 44.3 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.508 3.472 . . . . 1.0 113.967 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.17 -65.02 2.0 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.971 -1.08 . . . . 1.0 111.71 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -152.35 122.78 7.26 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.886 -1.894 . . . . 1.0 105.886 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -176.42 175.85 1.72 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.782 2.833 . . . . 1.0 108.547 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.6 27.12 3.98 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.636 2.065 . . . . 1.0 109.634 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.13 118.18 6.1 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 106.037 -2.825 . . . . 1.0 106.037 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.26 -17.45 35.3 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 119.796 1.798 . . . . 1.0 115.13 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -66.14 -43.3 87.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.011 1.278 . . . . 1.0 110.996 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.02 -47.18 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.059 0.943 . . . . 1.0 109.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.9 -35.86 81.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.351 -0.843 . . . . 1.0 112.154 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.94 -33.47 68.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.013 0.925 . . . . 1.0 111.498 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.38 -54.58 43.87 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.511 -0.743 . . . . 1.0 109.893 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -66.77 -45.37 78.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.805 -0.617 . . . . 1.0 111.751 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 t -63.62 -39.39 94.23 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.33 3.26 22.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.412 1.958 . . . . 1.0 114.775 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -88.63 9.01 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.947 1.874 . . . . 1.0 112.627 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 tt -54.58 136.02 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.465 0.575 . . . . 1.0 110.896 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.22 136.6 19.17 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 127.71 2.404 . . . . 1.0 108.689 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.29 60.89 3.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.12 3.214 . . . . 1.0 112.719 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.48 -49.13 3.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 117.795 -1.098 . . . . 1.0 112.793 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.4 0.41 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.505 1.048 . . . . 1.0 112.079 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -163.57 177.83 1.71 Allowed Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -70.43 -43.85 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.458 1.438 . . . . 1.0 114.834 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -51.47 -57.89 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.366 1.439 . . . . 1.0 111.999 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.47 -51.14 71.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.817 0.847 . . . . 1.0 110.182 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.86 -43.93 86.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 1.0 111.17 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -65.18 3.75 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.329 1.442 . . . . 1.0 110.535 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.27 -25.54 30.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-O 115.92 -1.991 . . . . 1.0 113.639 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.75 -43.04 5.82 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.966 1.712 . . . . 1.0 113.209 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -54.98 -38.28 67.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.419 1.488 . . . . 1.0 111.075 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.51 135.29 33.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.096 -1.816 . . . . 1.0 106.096 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 158.92 27.32 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.738 -1.227 . . . . 1.0 108.343 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.44 161.59 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.8 122.91 1.43 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.83 -154.0 0.42 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.969 1.308 . . . . 1.0 107.624 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -131.15 -67.16 0.71 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.67 1.123 . . . . 1.0 111.132 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.58 119.15 16.99 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.344 -2.095 . . . . 1.0 105.344 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tt -113.29 118.08 33.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.116 1.766 . . . . 1.0 107.571 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -100.71 113.98 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.194 -1.78 . . . . 1.0 106.194 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -83.3 153.79 24.45 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 120.041 1.291 . . . . 1.0 108.636 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -17.94 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 128.939 2.896 . . . . 1.0 115.624 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 27.13 2.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.06 1.3 . . . . 1.0 112.668 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.26 42.75 99.87 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.544 1.069 . . . . 1.0 112.592 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.08 149.22 29.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.366 1.083 . . . . 1.0 108.837 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.05 119.08 60.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.606 -1.257 . . . . 1.0 107.606 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.46 147.82 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.402 -2.073 . . . . 1.0 105.402 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.69 122.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.618 -1.252 . . . . 1.0 107.618 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -120.98 113.69 20.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.876 -2.268 . . . . 1.0 104.876 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t 79.84 92.1 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.448 1.476 . . . . 1.0 111.439 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -61.7 -175.76 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.615 1.543 . . . . 1.0 110.877 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -58.34 5.49 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.89 2.476 . . . . 1.0 114.294 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.41 115.25 19.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.168 2.587 . . . . 1.0 108.795 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 85.81 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.67 2.788 . . . . 1.0 112.288 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -32.56 138.05 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.753 3.221 . . . . 1.0 115.642 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.58 -178.12 3.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 129.273 3.029 . . . . 1.0 111.945 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -155.06 118.33 4.44 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.477 1.511 . . . . 1.0 110.628 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.479 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 7.4 p80 -158.23 63.13 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.068 -1.645 . . . . 1.0 112.204 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.96 -56.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 118.734 -2.479 . . . . 1.0 114.148 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.03 -79.8 0.29 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 104.017 -3.633 . . . . 1.0 104.017 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.98 146.63 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.063 2.145 . . . . 1.0 108.881 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.6 p -156.18 150.72 25.81 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.533 1.533 . . . . 1.0 110.209 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.2 p -143.65 145.72 32.69 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 119.69 1.132 . . . . 1.0 111.248 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.42 145.29 21.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.83 -1.544 . . . . 1.0 106.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 42.08 53.85 4.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.976 1.71 . . . . 1.0 113.051 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.52 28.43 67.57 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.608 0.623 . . . . 1.0 113.375 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.433 ' HE ' ' CD ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -131.53 116.44 17.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 176.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -103.65 135.31 45.45 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -105.57 118.24 36.07 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.175 -2.528 . . . . 1.0 104.175 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.57 -25.47 66.23 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.745 1.618 . . . . 1.0 111.542 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -154.26 170.4 21.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.611 2.764 . . . . 1.0 107.588 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 6.3 t70 -84.76 76.71 10.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.32 33.65 2.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.243 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -132.9 142.72 49.05 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 124.483 1.113 . . . . 1.0 110.568 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -79.19 56.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 127.09 2.156 . . . . 1.0 110.806 -176.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.5 -136.5 1.7 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.946 -1.097 . . . . 1.0 113.034 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 3.6 mm -142.57 165.3 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 130.515 3.526 . . . . 1.0 102.985 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -145.82 138.58 25.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 103.7 -2.704 . . . . 1.0 103.7 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.0 149.04 24.34 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.485 -1.384 . . . . 1.0 109.269 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -124.52 139.74 53.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.614 0.721 . . . . 1.0 111.151 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.39 -177.55 30.61 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 127.676 2.56 . . . . 1.0 108.701 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 p -145.96 108.28 4.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.601 -2.37 . . . . 1.0 104.601 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.54 43.54 28.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.24 1.016 . . . . 1.0 112.528 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p 49.57 38.55 15.02 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.67 1.988 . . . . 1.0 113.706 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.66 136.16 56.67 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -25.9 114.03 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.999 2.12 . . . . 1.0 113.431 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.87 -15.31 58.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 116.36 -1.781 . . . . 1.0 113.908 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.351 28.7 p 65.59 77.06 0.31 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.862 1.664 . . . . 1.0 111.668 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -23.22 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.069 1.748 . . . . 1.0 113.993 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.0 -38.91 3.77 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.65 1.98 . . . . 1.0 110.442 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -49.39 -51.9 31.98 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.268 1.427 . . . . 1.0 109.643 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.8 -42.08 96.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.029 0.932 . . . . 1.0 110.207 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -65.66 -51.6 58.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.089 0.955 . . . . 1.0 110.353 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -65.97 -43.62 87.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.669 0.788 . . . . 1.0 110.679 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.4 tp -55.38 -51.53 66.51 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.74 67.78 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.316 0.962 . . . . 1.0 111.488 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.47 56.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.127 0.971 . . . . 1.0 110.787 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.22 -51.27 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.3 m -54.63 -36.7 64.78 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.659 1.583 . . . . 1.0 111.882 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -60.68 -46.67 89.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.884 1.674 . . . . 1.0 109.462 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.79 62.84 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-O 119.412 -0.327 . . . . 1.0 110.871 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.91 -39.09 71.13 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.02 -45.02 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.426 1.012 . . . . 1.0 108.916 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.7 m -65.76 -19.13 65.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.217 0.607 . . . . 1.0 111.182 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -84.16 -63.22 1.38 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.931 1.292 . . . . 1.0 107.858 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -126.06 112.98 24.14 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.57 107.94 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 120.237 1.12 . . . . 1.0 111.724 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.25 -52.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.387 1.875 . . . . 1.0 107.39 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 mt -45.98 -33.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 131.146 3.778 . . . . 1.0 111.061 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.86 -26.03 9.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.673 1.189 . . . . 1.0 112.987 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -136.32 23.67 3.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.359 1.863 . . . . 1.0 109.755 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -138.51 83.6 1.97 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -127.24 120.85 29.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.09 -1.818 . . . . 1.0 106.09 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.2 t -154.53 -170.48 3.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.77 -131.58 1.76 Allowed Glycine 0 CA--C 1.517 0.181 0 N-CA-C 106.818 -2.513 . . . . 1.0 106.818 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 10.8 m170 -113.53 -22.97 10.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.069 1.434 . . . . 1.0 111.576 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.0 t -103.23 -8.55 20.29 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -89.04 28.25 1.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.737 1.215 . . . . 1.0 109.147 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.75 -14.87 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 121.389 -0.82 . . . . 1.0 110.45 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.67 -53.54 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.683 . . . . 1.0 112.582 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.43 108.63 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.91 1.718 . . . . 1.0 111.385 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.02 -14.61 55.5 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.875 -1.141 . . . . 1.0 113.117 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.66 -6.3 36.0 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.156 -1.59 . . . . 1.0 111.601 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -136.93 141.05 42.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.875 -1.898 . . . . 1.0 105.875 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 3.1 m -132.78 -16.78 2.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.862 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.84 -178.87 0.34 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.39 63.27 7.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.304 2.002 . . . . 1.0 109.102 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 141.28 74.57 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.123 1.821 . . . . 1.0 111.653 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.13 -98.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 1.0 110.837 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.4 t 53.84 43.86 30.35 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.801 1.64 . . . . 1.0 112.533 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -106.32 18.45 21.98 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.054 0.942 . . . . 1.0 110.387 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.296 9.3 t0 42.95 82.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.866 2.467 . . . . 1.0 112.355 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -55.4 -34.95 64.83 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.55 -0.75 . . . . 1.0 112.821 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.09 -45.98 79.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.573 -0.727 . . . . 1.0 110.647 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -58.93 -56.78 17.89 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.846 0.748 . . . . 1.0 110.12 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -59.08 -53.24 60.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -61.52 -33.79 74.43 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.403 -0.808 . . . . 1.0 111.906 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.47 86.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.695 0.68 . . . . 1.0 111.818 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.14 -51.92 27.63 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.523 0.729 . . . . 1.0 110.37 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.6 166.41 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.381 1.073 . . . . 1.0 108.335 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 m -42.27 113.25 1.21 Allowed Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.281 1.832 . . . . 1.0 109.334 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -95.26 54.92 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.996 2.464 . . . . 1.0 111.165 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.7 t 51.54 33.35 10.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.717 1.607 . . . . 1.0 111.489 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 177.68 7.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 129.791 3.237 . . . . 1.0 105.405 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 49.11 50.92 17.16 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 123.206 1.479 . . . . 1.0 110.627 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -140.41 168.68 19.23 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.322 2.649 . . . . 1.0 105.91 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.71 177.94 8.34 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.995 2.118 . . . . 1.0 107.567 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.5 tpt 57.54 -95.43 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.757 1.623 . . . . 1.0 109.751 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.247 0.971 0 C-N-CA 129.926 3.29 . . . . 1.0 103.473 175.726 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp -139.36 158.22 44.53 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.202 1.401 . . . . 1.0 108.91 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.62 136.97 53.83 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.049 2.14 . . . . 1.0 106.899 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -127.17 124.42 38.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.552 1.541 . . . . 1.0 107.874 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 45.13 36.96 2.3 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.759 1.623 . . . . 1.0 113.797 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.45 -2.9 80.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.33 -0.857 . . . . 1.0 113.677 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -95.38 168.35 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.733 2.013 . . . . 1.0 107.503 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.34 124.11 34.14 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.98 170.89 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.632 1.173 . . . . 1.0 110.661 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 40.58 58.38 2.38 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.182 1.793 . . . . 1.0 111.221 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.76 156.34 38.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.644 1.578 . . . . 1.0 110.112 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -78.4 130.05 35.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.12 140.34 45.75 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.183 -0.948 . . . . 1.0 110.265 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -142.74 71.84 19.82 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.479 -1.674 . . . . 1.0 106.479 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.6 123.2 9.91 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 N-CA-C 107.784 -1.66 . . . . 1.0 107.784 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -121.85 132.09 24.3 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.98 52.97 4.53 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.189 1.926 . . . . 1.0 111.177 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -124.13 43.11 3.08 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.24 178.21 5.95 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.076 0.465 . . . . 1.0 110.045 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.73 -178.25 4.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 1.0 108.51 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.5 m -154.95 131.36 10.46 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 128.623 2.769 . . . . 1.0 103.674 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -130.55 140.05 37.5 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.791 1.632 . . . . 1.0 109.628 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.05 40.19 0.85 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.36 3.374 . . . . 1.0 116.84 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.24 149.78 44.73 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.293 2.637 . . . . 1.0 108.834 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -151.61 120.13 6.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.936 1.694 . . . . 1.0 111.682 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 27' ' ' ASN . 10.5 tt0 -136.62 172.74 12.56 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 174.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.415 ' H ' ' HG2' ' A' ' 26' ' ' GLU . 8.0 t30 -64.69 123.82 84.42 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 175.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.58 103.6 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.768 1.645 . . . . 1.0 110.706 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -170.83 77.16 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.711 -1.588 . . . . 1.0 106.711 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.16 124.34 12.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.54 126.08 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.87 134.26 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.76 123.78 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -176.56 150.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.116 1.766 . . . . 1.0 107.884 175.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.5 112.61 24.6 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' CG2' ' H ' ' A' ' 37' ' ' SER . 26.3 mm -127.65 176.78 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 128.024 2.53 . . . . 1.0 105.067 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.426 ' H ' ' CG2' ' A' ' 36' ' ' ILE . 28.8 t -151.09 122.22 7.72 Favored 'General case' 0 C--N 1.313 -0.995 1 N-CA-C 94.003 -6.295 . . . . 1.0 94.003 174.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.318 0.2 OUTLIER -142.66 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 119.827 1.194 . . . . 1.0 110.427 175.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.36 153.47 27.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.041 1.828 . . . . 1.0 112.042 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -82.0 53.61 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.673 2.916 . . . . 1.0 114.232 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.72 -70.81 0.65 Allowed Glycine 0 CA--C 1.535 1.317 0 N-CA-C 108.269 -1.932 . . . . 1.0 108.269 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -155.82 123.09 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.221 2.609 . . . . 1.0 106.549 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -169.73 173.44 6.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.956 2.902 . . . . 1.0 105.913 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.8 31.37 2.48 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.674 1.607 . . . . 1.0 109.298 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 118.9 6.28 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 107.605 -2.198 . . . . 1.0 107.605 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.34 -9.62 26.3 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-N 120.842 2.321 . . . . 1.0 113.339 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -65.52 -47.43 75.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.802 1.183 . . . . 1.0 109.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 mm -59.22 -43.84 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.799 0.84 . . . . 1.0 109.668 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.28 -46.36 90.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.267 0.627 . . . . 1.0 111.462 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.15 -33.8 67.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.135 1.374 . . . . 1.0 111.677 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.68 -57.07 12.32 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.196 -0.94 . . . . 1.0 109.352 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -42.98 85.86 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 t -66.4 -35.4 80.22 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.475 0.58 . . . . 1.0 110.59 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.46 60.23 1.11 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.373 1.94 . . . . 1.0 112.103 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 p -136.58 8.85 3.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.201 1.8 . . . . 1.0 111.588 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.34 134.78 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.116 0.966 . . . . 1.0 112.508 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 136.64 20.33 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.668 2.787 . . . . 1.0 108.834 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.63 69.74 1.55 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.216 3.278 . . . . 1.0 112.435 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -103.35 -56.64 2.18 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.659 0.784 . . . . 1.0 110.966 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.47 -55.04 36.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.979 0.512 . . . . 1.0 111.321 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -171.08 177.89 0.88 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.149 1.779 . . . . 1.0 107.615 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.55 -43.39 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.866 1.71 . . . . 1.0 114.804 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -50.19 -54.76 18.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.577 1.08 . . . . 1.0 113.475 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.0 -52.93 63.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.964 0.802 . . . . 1.0 111.118 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.51 98.3 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.465 0.706 . . . . 1.0 111.904 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.93 -57.69 17.04 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.283 0.944 . . . . 1.0 110.94 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.79 -27.33 42.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-O 115.964 -1.97 . . . . 1.0 112.99 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.83 -43.26 2.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.153 1.781 . . . . 1.0 114.489 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -57.58 -43.36 84.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.031 1.333 . . . . 1.0 111.116 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.6 127.37 32.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 148.55 51.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.382 176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.86 163.19 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.064 2.146 . . . . 1.0 109.843 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 m -172.33 133.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.872 2.469 . . . . 1.0 106.27 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.46 -154.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.137 1.375 . . . . 1.0 107.461 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -132.48 -59.21 0.92 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.95 1.3 . . . . 1.0 108.999 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 57.4 m -136.88 118.73 15.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.096 -1.446 . . . . 1.0 107.096 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -102.48 113.85 27.54 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.82 122.89 53.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -89.8 156.65 18.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.853 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -22.66 2.58 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 126.967 2.107 . . . . 1.0 113.533 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -91.75 19.75 6.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.915 1.686 . . . . 1.0 113.699 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.16 35.8 91.39 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.614 1.578 . . . . 1.0 112.821 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.43 109.25 22.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.16 113.45 19.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 105.263 -2.125 . . . . 1.0 105.263 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -111.81 147.8 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.295 1.438 . . . . 1.0 107.306 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.2 120.24 29.55 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.386 1.074 . . . . 1.0 109.618 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.44 129.97 53.3 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.255 64.3 t 63.75 91.46 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 121.498 1.953 . . . . 1.0 113.76 175.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.89 -169.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.394 3.396 . . . . 1.0 116.387 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.85 24.15 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.012 2.525 . . . . 1.0 110.487 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -144.57 119.47 9.95 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.469 2.707 . . . . 1.0 107.855 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.471 ' HB2' ' HZ3' ' A' ' 92' ' ' LYS 0.308 3.4 ttmp? 85.96 81.48 0.02 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.877 1.671 . . . . 1.0 111.717 175.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -34.89 145.16 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.973 2.509 . . . . 1.0 111.942 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.12 172.4 8.28 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.258 1.423 . . . . 1.0 110.104 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.548 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 62.4 t90 -141.63 119.19 11.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.897 1.679 . . . . 1.0 109.722 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -159.38 63.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.151 0.977 . . . . 1.0 109.255 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.73 -70.74 0.03 OUTLIER 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.66 -1.9 . . . . 1.0 114.657 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.43 -91.02 0.48 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 105.834 -2.907 . . . . 1.0 105.834 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.2 t -144.44 146.46 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.92 1.86 . . . . 1.0 108.551 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -156.56 166.54 33.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.431 1.492 . . . . 1.0 108.924 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 157' ' ' ILE . 54.6 p -151.65 146.13 25.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -162.62 148.69 12.63 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 49.6 54.57 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.415 1.486 . . . . 1.0 110.83 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.04 29.45 62.37 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.995 1.283 . . . . 1.0 114.471 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.18 113.93 12.55 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.483 -1.302 . . . . 1.0 107.483 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -78.95 146.46 33.45 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.368 -1.345 . . . . 1.0 107.368 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -133.42 118.16 18.08 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.752 -1.944 . . . . 1.0 105.752 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.85 -40.24 96.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.286 0.634 . . . . 1.0 112.52 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 4.0 m120 -149.18 174.94 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.492 2.317 . . . . 1.0 106.979 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -89.85 75.05 7.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.359 1.552 . . . . 1.0 110.501 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 37.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 109.093 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -123.55 157.28 34.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.939 2.896 . . . . 1.0 109.819 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.277 0.1 OUTLIER -104.62 56.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.266 1.426 . . . . 1.0 108.096 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.79 -136.09 0.9 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-O 122.86 1.256 . . . . 1.0 112.163 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.6 mm -150.28 161.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 130.497 3.519 . . . . 1.0 104.236 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.79 128.61 17.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 103.334 -2.839 . . . . 1.0 103.334 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.4 154.34 19.74 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.1 138.66 54.41 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.547 0.739 . . . . 1.0 111.859 -175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.08 174.09 45.3 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.769 0.649 . . . . 1.0 112.613 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 p -133.92 97.09 3.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.044 2.137 . . . . 1.0 107.157 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.412 ' C ' ' HG1' ' A' ' 122' ' ' THR 0.322 25.0 t0 46.62 56.74 6.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.251 1.82 . . . . 1.0 114.102 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 121' ' ' ASP . 69.2 p 55.39 38.82 30.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.366 1.466 . . . . 1.0 112.563 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.57 133.95 53.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 104.956 -2.238 . . . . 1.0 104.956 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.12 113.45 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.212 2.205 . . . . 1.0 110.839 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -78.85 -11.61 60.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 115.14 -2.362 . . . . 1.0 116.679 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.349 18.2 p 59.57 77.86 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 121.662 2.028 . . . . 1.0 111.156 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -23.06 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.12 2.168 . . . . 1.0 114.593 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.31 -38.48 2.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.499 2.32 . . . . 1.0 109.433 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -53.8 -49.96 67.16 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 125.382 1.473 . . . . 1.0 110.688 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -56.48 -40.46 74.96 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.52 1.055 . . . . 1.0 109.668 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.72 -58.22 6.21 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.244 -0.408 . . . . 1.0 110.097 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -66.45 -37.99 86.37 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.63 -47.06 87.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.84 80.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.036 0.835 . . . . 1.0 110.858 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -53.75 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.072 0.949 . . . . 1.0 111.21 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.8 t -58.04 -41.0 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.1 m -57.09 -46.28 82.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.272 . . . . 1.0 109.647 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.21 -48.19 82.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.53 1.059 . . . . 1.0 110.277 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.94 -48.6 81.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.172 0.589 . . . . 1.0 110.028 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -55.88 -46.86 78.21 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.873 1.269 . . . . 1.0 111.029 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.88 -42.22 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 118.858 0.754 . . . . 1.0 110.346 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.3 m -65.57 -13.91 59.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.178 0.991 . . . . 1.0 111.524 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -106.24 -54.02 2.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.496 1.518 . . . . 1.0 111.016 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -126.24 113.25 23.7 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 104.383 -2.451 . . . . 1.0 104.383 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -99.22 107.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.029 1.403 . . . . 1.0 114.554 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.27 -48.35 0.1 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.679 2.391 . . . . 1.0 107.642 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -46.19 -34.28 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 130.111 3.364 . . . . 1.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.86 -23.19 6.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.054 1.341 . . . . 1.0 114.275 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -137.18 18.42 2.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.719 1.607 . . . . 1.0 110.657 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -139.08 83.65 1.96 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.732 1.213 . . . . 1.0 108.213 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 114.1 21.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.036 -2.579 . . . . 1.0 104.036 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -151.08 -166.35 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.525 -0.734 . . . . 1.0 109.219 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.11 -131.79 1.5 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 108.66 -1.776 . . . . 1.0 108.66 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 11.4 m170 -109.01 -23.59 11.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 117.902 0.851 . . . . 1.0 111.066 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.28 -14.38 15.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.486 -0.769 . . . . 1.0 110.647 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -87.74 40.54 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.777 1.171 . . . . 1.0 109.158 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -66.27 -8.76 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 O-C-N 120.684 -1.26 . . . . 1.0 110.869 175.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.24 -53.79 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 127.953 2.501 . . . . 1.0 111.857 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -91.14 115.42 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.978 3.119 . . . . 1.0 113.618 -175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.23 -25.58 64.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.765 1.226 . . . . 1.0 113.124 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -63.65 -20.28 65.57 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.88 -1.137 . . . . 1.0 113.324 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -123.12 140.76 52.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.464 -2.05 . . . . 1.0 105.464 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.0 m -136.01 -16.73 1.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.546 -0.862 . . . . 1.0 111.508 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.43 177.95 0.47 Allowed Pre-proline 0 CA--C 1.546 0.805 1 C-N-CA 131.808 4.043 . . . . 1.0 103.53 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.05 86.93 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.517 1.478 . . . . 1.0 109.353 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.32 81.12 1.25 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.863 1.221 . . . . 1.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.72 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.154 2.57 . . . . 1.0 112.187 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 t 55.52 43.93 27.64 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.907 1.283 . . . . 1.0 114.08 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -115.33 17.82 16.36 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 120.203 1.365 . . . . 1.0 113.755 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.6 t0 43.91 69.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 1.0 112.206 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -56.37 -32.87 65.18 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.759 -0.638 . . . . 1.0 112.334 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -60.25 2.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.657 0.783 . . . . 1.0 110.605 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -41.81 96.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-O 118.13 -0.938 . . . . 1.0 110.574 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -59.81 -57.55 12.42 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 123.876 0.735 . . . . 1.0 110.737 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -40.71 75.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.71 0.686 . . . . 1.0 111.222 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.07 77.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.16 0.8 . . . . 1.0 113.16 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.25 -43.55 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.6 1.16 . . . . 1.0 113.036 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.87 166.63 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.186 1.794 . . . . 1.0 110.797 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 70.6 m -42.5 131.09 2.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.679 1.592 . . . . 1.0 108.263 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -80.22 40.1 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.788 2.325 . . . . 1.0 114.222 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.3 t 45.57 34.3 1.64 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.905 1.682 . . . . 1.0 111.354 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.3 t -159.56 64.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -164.1 116.03 1.35 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -149.87 134.73 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.749 -1.945 . . . . 1.0 105.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.89 161.12 18.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.5 tpt 58.35 66.38 1.1 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.418 1.487 . . . . 1.0 111.526 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 115.142 -2.361 . . . . 1.0 108.41 -175.896 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 tpp . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 108.236 -1.024 . . . . 1.0 108.236 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp -112.34 167.33 10.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -108.74 131.85 54.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -123.69 125.23 44.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.917 1.287 . . . . 1.0 108.728 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 49.14 33.72 5.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.044 1.337 . . . . 1.0 112.106 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.45 -5.23 69.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.317 1.437 . . . . 1.0 114.058 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -102.92 173.07 6.47 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.716 1.758 . . . . 1.0 107.243 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 134.94 34.44 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.942 -1.099 . . . . 1.0 110.996 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.29 27.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.208 1.003 . . . . 1.0 112.148 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 38.88 58.21 1.78 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.108 2.563 . . . . 1.0 112.057 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.85 136.06 17.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.263 -0.898 . . . . 1.0 109.104 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -73.11 123.46 23.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.364 -1.717 . . . . 1.0 106.364 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -92.92 118.87 31.63 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.536 -0.727 . . . . 1.0 110.855 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.52 72.25 20.79 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.29 1.036 . . . . 1.0 108.554 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.21 123.44 9.21 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.758 1.306 . . . . 1.0 109.904 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -87.32 114.17 57.4 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 106.379 -1.712 . . . . 1.0 106.379 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.52 55.86 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.676 2.251 . . . . 1.0 110.636 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -138.4 43.73 2.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.572 1.949 . . . . 1.0 109.437 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -73.65 178.35 4.8 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.083 1.142 . . . . 1.0 114.083 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.63 179.1 4.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 128.857 2.863 . . . . 1.0 109.805 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -165.28 118.78 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.966 4.506 . . . . 1.0 102.94 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 156.46 77.75 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.27 84.72 1.9 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.312 2.008 . . . . 1.0 111.696 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.1 145.26 16.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.329 1.852 . . . . 1.0 106.685 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -137.51 103.58 5.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.371 -1.344 . . . . 1.0 107.371 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -136.2 152.86 51.22 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.743 1.217 . . . . 1.0 108.677 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -71.98 123.41 89.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 103.271 -2.862 . . . . 1.0 103.271 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.5 106.16 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.416 2.077 . . . . 1.0 112.512 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 t -164.32 76.35 0.33 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.37 123.72 11.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.99 -1.856 . . . . 1.0 105.99 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.54 127.61 39.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.193 0.997 . . . . 1.0 108.474 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.47 140.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.9 t -135.86 113.94 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.847 -2.279 . . . . 1.0 104.847 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.49 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -163.16 129.85 3.41 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 115.944 -1.979 . . . . 1.0 108.194 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.42 HD21 ' N ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -72.69 112.52 8.82 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 117.443 -1.703 . . . . 1.0 106.746 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 HG13 ' CE1' ' A' ' 34' ' ' HIS . 14.4 mm -126.73 176.77 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 131.646 3.979 . . . . 1.0 108.587 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.409 ' H ' ' CG2' ' A' ' 36' ' ' ILE . 41.3 t -160.68 121.84 2.98 Favored 'General case' 0 C--O 1.247 0.973 1 N-CA-C 94.992 -5.929 . . . . 1.0 94.992 174.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.253 1.3 tm? -142.4 -57.37 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 121.032 -1.042 . . . . 1.0 111.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.16 144.26 26.4 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 122.674 2.249 . . . . 1.0 111.075 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.09 44.11 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.335 2.69 . . . . 1.0 114.657 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.18 -71.19 0.57 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -156.13 122.94 5.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.614 1.566 . . . . 1.0 111.234 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.318 18.8 m-85 -177.06 170.94 2.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 131.361 3.864 . . . . 1.0 109.619 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.08 27.28 7.12 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.434 1.016 . . . . 1.0 111.628 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.37 118.56 5.35 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 108.726 -1.75 . . . . 1.0 108.726 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.59 -15.81 48.78 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 120.096 1.948 . . . . 1.0 112.621 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -49.79 -47.85 50.95 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.513 1.125 . . . . 1.0 112.576 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.39 -45.09 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.96 -43.97 94.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.63 69.69 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.09 1.356 . . . . 1.0 111.489 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.89 -55.33 17.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 120.945 -1.097 . . . . 1.0 110.039 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.04 -43.03 79.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.87 -0.585 . . . . 1.0 111.893 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 t -65.84 -33.83 76.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.286 1.434 . . . . 1.0 109.994 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.57 -2.64 30.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.567 1.555 . . . . 1.0 115.163 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -88.81 9.93 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.75 2.275 . . . . 1.0 114.12 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 tt -47.68 129.55 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.274 1.829 . . . . 1.0 112.1 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.74 125.52 42.13 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 130.473 3.509 . . . . 1.0 108.957 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.38 75.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.494 3.462 . . . . 1.0 108.412 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -103.63 -64.23 1.11 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.441 0.297 . . . . 1.0 111.618 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.02 -52.01 65.74 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.98 0.912 . . . . 1.0 112.086 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -161.92 177.9 1.8 Allowed Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.561 1.545 . . . . 1.0 107.805 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.33 -43.43 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.823 1.682 . . . . 1.0 114.342 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -48.46 -43.65 34.81 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.118 0.967 . . . . 1.0 113.586 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.52 -55.6 32.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.839 0.856 . . . . 1.0 110.275 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.751 0.82 . . . . 1.0 110.697 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.65 -62.56 2.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.81 1.672 . . . . 1.0 111.536 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.1 pt -57.69 -35.54 51.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 116.752 -1.594 . . . . 1.0 112.76 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.0 -43.02 3.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.622 1.969 . . . . 1.0 115.735 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.26 -36.24 70.75 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.555 1.142 . . . . 1.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.03 136.76 33.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 102.502 -3.147 . . . . 1.0 102.502 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 155.81 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.622 -1.298 . . . . 1.0 109.14 175.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.47 155.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 123.593 0.757 . . . . 1.0 109.037 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -177.79 114.12 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.836 1.654 . . . . 1.0 110.012 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.96 -175.4 3.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -112.47 -76.85 0.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.977 1.262 . . . . 1.0 110.906 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.4 m -112.57 118.51 35.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp -101.26 113.44 26.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 103.605 -2.739 . . . . 1.0 103.605 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mt -105.98 113.22 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 103.852 -2.647 . . . . 1.0 103.852 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -81.59 153.79 26.53 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.772 0.714 . . . . 1.0 110.57 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.64 -13.5 0.4 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 126.229 1.812 . . . . 1.0 113.941 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -91.65 18.31 7.66 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.37 0.986 . . . . 1.0 111.241 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.34 45.35 96.63 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.115 -1.616 . . . . 1.0 111.601 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -112.97 143.96 43.36 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.91 114.32 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.28 142.74 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.522 -1.659 . . . . 1.0 106.522 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -126.22 114.44 18.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.947 0.899 . . . . 1.0 110.467 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -110.06 147.09 34.24 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 103.25 -2.87 . . . . 1.0 103.25 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.274 42.4 t 63.1 91.78 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 120.304 1.411 . . . . 1.0 114.362 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.21 -174.29 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 121.404 1.402 . . . . 1.0 111.985 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -72.87 49.92 0.25 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.781 1.233 . . . . 1.0 109.941 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -161.13 136.14 7.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.766 2.827 . . . . 1.0 105.33 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 54.78 81.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 129.376 3.07 . . . . 1.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.05 152.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.659 2.384 . . . . 1.0 111.545 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -102.83 -178.08 3.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.423 2.289 . . . . 1.0 111.055 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -149.88 118.4 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.855 1.262 . . . . 1.0 108.919 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -160.92 62.75 0.29 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.967 1.365 . . . . 1.0 110.209 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -163.95 -69.34 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 119.839 -1.788 . . . . 1.0 113.044 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 -90.89 0.51 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 103.246 -3.941 . . . . 1.0 103.246 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.94 142.15 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.742 1.271 . . . . 1.0 110.065 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -155.93 165.8 35.38 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.667 2.387 . . . . 1.0 108.066 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -159.81 126.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.972 -2.233 . . . . 1.0 104.972 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -151.52 151.13 31.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.718 1.145 . . . . 1.0 107.999 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 42.12 66.72 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.669 1.588 . . . . 1.0 109.75 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.31 29.53 5.2 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.81 1.672 . . . . 1.0 116.681 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -137.98 113.8 9.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.759 1.78 . . . . 1.0 106.835 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -80.91 146.37 30.83 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.574 1.15 . . . . 1.0 108.417 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -129.57 118.13 21.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.94 -24.49 63.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.98 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -152.98 176.26 12.06 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 128.623 2.769 . . . . 1.0 107.369 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.14 76.29 6.92 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.149 -1.426 . . . . 1.0 107.149 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -92.86 33.58 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.862 0.865 . . . . 1.0 112.392 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 m -124.53 156.51 37.22 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 125.508 1.523 . . . . 1.0 111.815 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.85 56.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.221 1.808 . . . . 1.0 107.713 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 -136.79 2.45 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.417 -0.802 . . . . 1.0 111.978 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 9.3 mm -140.13 165.19 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.191 -2.522 . . . . 1.0 104.191 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 123.95 12.19 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.443 -2.799 . . . . 1.0 103.443 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 128.06 48.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.802 -1.186 . . . . 1.0 109.034 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.35 142.74 33.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.038 0.923 . . . . 1.0 111.929 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.39 178.64 32.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.52 2.01 . . . . 1.0 111.242 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -148.29 101.77 3.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.6 t0 51.4 54.56 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 124.032 1.872 . . . . 1.0 112.389 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 49.69 38.5 15.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.446 1.898 . . . . 1.0 114.269 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.63 145.87 47.01 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 104.932 -2.247 . . . . 1.0 104.932 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -39.32 125.53 1.66 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.327 1.851 . . . . 1.0 111.777 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.4 -10.84 59.89 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 115.285 1.587 . . . . 1.0 115.285 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.381 26.6 p 62.47 77.5 0.33 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 121.592 1.996 . . . . 1.0 111.968 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -23.5 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.158 2.183 . . . . 1.0 114.667 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.96 -40.14 4.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.425 2.29 . . . . 1.0 111.095 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.27 -57.87 4.73 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.788 0.835 . . . . 1.0 109.613 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.68 -39.36 80.46 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.229 0.611 . . . . 1.0 111.593 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -65.82 -59.24 4.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.216 0.322 . . . . 1.0 110.166 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -66.0 -34.27 77.72 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.757 0.708 . . . . 1.0 112.082 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.8 tp -57.51 -48.08 80.22 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.46 85.79 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.075 0.852 . . . . 1.0 109.819 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 -53.13 44.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.585 1.154 . . . . 1.0 111.046 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.19 -48.31 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.19 0.596 . . . . 1.0 110.121 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.7 m -53.25 -45.5 68.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.154 1.381 . . . . 1.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.32 -42.38 98.59 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.2 1.0 . . . . 1.0 110.54 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.19 -49.08 78.63 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.064 0.545 . . . . 1.0 110.194 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.94 -44.59 78.55 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.418 -0.801 . . . . 1.0 111.784 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.66 -40.23 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.187 0.903 . . . . 1.0 109.868 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.4 m -63.2 -27.67 69.52 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.885 0.874 . . . . 1.0 111.294 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.42 -60.58 2.03 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.138 0.975 . . . . 1.0 109.435 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -126.54 112.9 22.99 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.866 1.666 . . . . 1.0 106.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.61 107.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 120.912 1.361 . . . . 1.0 111.421 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.07 -45.09 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.99 2.116 . . . . 1.0 108.296 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.8 mt -44.91 -33.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.44 0 C-N-CA 130.666 3.587 . . . . 1.0 110.988 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.67 -26.19 13.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.373 1.069 . . . . 1.0 113.441 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.62 18.36 5.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.849 2.06 . . . . 1.0 110.873 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -138.45 83.3 1.96 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 119.866 -1.771 . . . . 1.0 106.363 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.4 mtt -126.42 118.07 24.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 102.876 -3.009 . . . . 1.0 102.876 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 t -157.66 -165.52 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.21 -131.57 1.25 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 106.798 -2.521 . . . . 1.0 106.798 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.49 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 12.2 m170 -114.34 -23.26 9.49 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.475 1.137 . . . . 1.0 111.964 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 15.9 t -103.02 -4.3 24.81 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.855 1.262 . . . . 1.0 108.448 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -97.91 23.15 8.34 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.156 1.382 . . . . 1.0 108.964 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -15.74 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 121.171 -0.955 . . . . 1.0 110.618 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -144.19 -66.06 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.882 1.673 . . . . 1.0 109.478 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.63 119.89 4.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 CA-C-N 122.019 1.757 . . . . 1.0 112.473 -175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -70.79 0.63 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.643 0.777 . . . . 1.0 111.808 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -84.44 -25.62 28.85 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 119.556 -1.965 . . . . 1.0 113.442 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -129.29 140.65 51.35 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m -127.43 -16.53 4.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 124.352 1.033 . . . . 1.0 112.881 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.66 -179.14 0.36 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.244 2.218 . . . . 1.0 105.819 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.09 77.42 3.49 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.641 2.228 . . . . 1.0 111.073 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.92 76.59 0.94 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.587 1.565 . . . . 1.0 109.639 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.416 ' HG2' ' H ' ' A' ' 168' ' ' SER . 89.3 Cg_endo -83.79 -72.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.338 2.692 . . . . 1.0 111.636 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 9.2 t 54.0 44.78 28.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.876 2.07 . . . . 1.0 111.343 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -93.65 17.87 11.05 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 43.4 t0 43.44 71.98 0.21 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.155 1.382 . . . . 1.0 110.542 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -58.38 -28.81 65.51 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.231 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -49.91 68.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.713 0.688 . . . . 1.0 110.631 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -64.9 -48.9 72.54 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.727 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.78 -53.31 58.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.237 0.926 . . . . 1.0 112.372 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -37.7 81.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.782 -0.628 . . . . 1.0 110.084 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.54 89.72 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.444 0.535 . . . . 1.0 112.444 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.74 -45.95 84.29 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.202 1.001 . . . . 1.0 111.737 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.79 165.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.911 1.284 . . . . 1.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 94.0 m -41.54 113.89 1.18 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.41 2.284 . . . . 1.0 109.58 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.63 53.56 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.081 3.187 . . . . 1.0 113.033 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.6 t 44.58 33.66 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.082 2.153 . . . . 1.0 113.192 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.2 t -164.15 -177.97 5.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 130.745 3.618 . . . . 1.0 104.785 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 56.59 60.13 3.24 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.74 1.257 . . . . 1.0 108.692 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -127.17 149.14 50.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 57.09 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.994 2.918 . . . . 1.0 113.36 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.25 87.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.363 1.065 . . . . 1.0 110.244 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . 0.268 20.4 m . . . . . 0 C--O 1.247 0.929 0 C-N-CA 126.929 2.092 . . . . 1.0 109.218 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -82.66 136.97 34.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.96 136.01 43.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 102.991 -2.966 . . . . 1.0 102.991 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.21 123.84 41.14 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 50.98 33.38 8.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.126 0.876 . . . . 1.0 111.661 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.74 -6.28 5.08 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.015 1.293 . . . . 1.0 113.861 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -82.06 157.45 24.13 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 102.889 -3.004 . . . . 1.0 102.889 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.392 -1.442 . . . . 1.0 107.304 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.35 9.38 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.581 0.753 . . . . 1.0 112.195 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 44.33 58.07 3.99 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.076 2.151 . . . . 1.0 110.087 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.6 22.05 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.01 0.924 . . . . 1.0 109.269 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -74.61 123.47 24.89 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.751 -1.574 . . . . 1.0 106.751 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 125.7 34.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.183 0.901 . . . . 1.0 108.651 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.95 76.13 59.62 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.67 130.05 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.511 2.141 . . . . 1.0 110.772 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -129.5 124.48 21.97 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 126.497 1.919 . . . . 1.0 106.918 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.83 52.74 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.384 2.723 . . . . 1.0 111.417 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -124.11 48.98 1.82 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -73.8 178.28 4.95 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.332 1.453 . . . . 1.0 112.026 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.92 178.22 4.36 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 128.151 2.58 . . . . 1.0 116.445 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.0 m -156.23 121.49 4.77 Favored 'General case' 0 N--CA 1.446 -0.672 1 C-N-CA 132.938 4.495 . . . . 1.0 103.396 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -135.82 141.18 35.86 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 117.682 -1.151 . . . . 1.0 108.602 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.64 90.22 1.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 124.305 3.336 . . . . 1.0 111.003 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -171.86 154.48 3.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 131.391 3.877 . . . . 1.0 103.97 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -151.43 104.76 3.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 104.641 -2.355 . . . . 1.0 104.641 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.75 159.78 40.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.752 1.621 . . . . 1.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.25 123.54 84.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 118.843 0.747 . . . . 1.0 109.495 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.37 103.6 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.768 1.645 . . . . 1.0 110.842 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -167.55 74.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.994 -1.066 . . . . 1.0 108.844 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.49 135.01 18.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.324 1.849 . . . . 1.0 107.627 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -87.54 133.03 33.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.6 141.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.993 -2.225 . . . . 1.0 104.993 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -136.03 118.89 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.999 -1.482 . . . . 1.0 106.999 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.9 p80 -176.23 144.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.474 1.51 . . . . 1.0 107.525 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.09 112.71 19.39 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 119.542 1.065 . . . . 1.0 110.066 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 mm -127.29 176.93 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.838 3.255 . . . . 1.0 108.95 175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -159.55 122.77 3.63 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 95.714 -5.661 . . . . 1.0 95.714 174.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.288 1.8 tm? -142.63 -65.31 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 116.67 -1.633 . . . . 1.0 113.722 -175.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -91.35 163.09 3.66 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 124.328 3.352 . . . . 1.0 112.788 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.91 72.75 6.01 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.632 2.888 . . . . 1.0 118.716 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.64 -73.07 0.93 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.758 -2.937 . . . . 1.0 105.758 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -156.82 122.74 4.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.568 1.547 . . . . 1.0 108.16 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -176.7 177.61 1.35 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.577 3.151 . . . . 1.0 107.464 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.72 22.98 10.45 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 109.319 -1.512 . . . . 1.0 109.319 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.81 118.52 5.16 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.205 -1.33 . . . . 1.0 111.179 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.88 -18.33 28.18 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.376 2.051 . . . . 1.0 113.035 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -53.88 -36.37 62.59 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.088 0.858 . . . . 1.0 110.51 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mt -65.44 -44.71 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.456 -0.783 . . . . 1.0 109.614 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.05 -52.21 51.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.183 0.901 . . . . 1.0 110.351 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.34 -34.07 32.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.303 1.441 . . . . 1.0 112.475 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.58 -61.45 2.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.622 1.569 . . . . 1.0 111.188 176.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -70.92 -39.32 72.78 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.537 -0.744 . . . . 1.0 112.063 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -66.16 -36.63 83.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.271 1.028 . . . . 1.0 109.008 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.92 1.93 39.4 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 117.487 -1.729 . . . . 1.0 115.965 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -88.81 8.52 28.62 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.662 2.231 . . . . 1.0 113.193 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.7 128.58 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.361 1.464 . . . . 1.0 112.168 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.91 136.4 20.63 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 128.174 2.59 . . . . 1.0 109.409 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.56 79.16 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.518 2.812 . . . . 1.0 109.04 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.1 -60.1 1.6 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.189 0.596 . . . . 1.0 110.723 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.44 77.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.429 0.691 . . . . 1.0 109.841 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -171.2 178.09 0.84 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.683 2.393 . . . . 1.0 106.898 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -71.73 -43.45 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.436 2.091 . . . . 1.0 115.53 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -44.18 -50.89 8.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -58.65 6.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.145 1.378 . . . . 1.0 110.615 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.62 -43.41 96.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.892 0.877 . . . . 1.0 111.959 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.13 -61.63 6.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.234 1.397 . . . . 1.0 111.555 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.72 -42.19 91.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.012 -0.994 . . . . 1.0 111.874 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.63 -43.75 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 116.924 2.194 . . . . 1.0 116.924 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.35 -34.33 73.7 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.721 -0.612 . . . . 1.0 109.714 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.57 135.89 34.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 101.183 -3.636 . . . . 1.0 101.183 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.71 144.58 13.81 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.601 -0.687 . . . . 1.0 110.992 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.83 162.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.207 1.803 . . . . 1.0 107.307 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.07 114.24 0.09 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.595 0.758 . . . . 1.0 109.159 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.58 -176.7 3.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -111.53 -76.31 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.986 0.812 . . . . 1.0 112.977 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -118.3 118.34 31.55 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 104.896 -2.261 . . . . 1.0 104.896 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tp -103.12 113.58 27.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.165 -2.161 . . . . 1.0 105.165 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.97 113.56 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -71.3 144.93 49.8 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -13.76 3.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 119.272 0.942 . . . . 1.0 113.151 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.32 26.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.889 2.476 . . . . 1.0 112.483 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.14 71.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.112 1.815 . . . . 1.0 114.535 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.32 156.3 17.32 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.839 . . . . 1.0 110.243 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mt -115.88 115.7 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 100.713 -3.81 . . . . 1.0 100.713 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.91 143.03 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.48 120.97 37.44 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.47 117.62 31.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 128.642 2.777 . . . . 1.0 106.205 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.4 t 68.2 92.06 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 120.847 1.658 . . . . 1.0 113.938 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.91 -178.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 121.575 1.517 . . . . 1.0 110.553 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -59.37 30.42 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 130.159 3.384 . . . . 1.0 116.495 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.15 116.01 6.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.537 2.335 . . . . 1.0 108.722 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.295 27.6 ttmt 83.2 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.631 1.972 . . . . 1.0 111.461 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -35.95 159.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 130.911 3.684 . . . . 1.0 116.599 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.17 -178.63 3.43 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 129.384 3.074 . . . . 1.0 114.139 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -155.07 118.59 4.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.628 1.571 . . . . 1.0 108.642 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -159.55 63.13 0.38 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.067 0.937 . . . . 1.0 110.361 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.34 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 119.11 -2.244 . . . . 1.0 114.561 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.79 -91.27 0.9 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.191 -3.163 . . . . 1.0 105.191 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 t -127.95 133.85 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.662 1.231 . . . . 1.0 109.407 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 p -160.35 159.06 30.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.84 2.056 . . . . 1.0 108.72 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' H ' HG23 ' A' ' 157' ' ' ILE . 33.9 p -152.03 147.07 26.07 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.542 1.137 . . . . 1.0 111.45 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -148.88 144.8 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 38.91 53.99 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.761 2.024 . . . . 1.0 112.354 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.41 67.9 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.293 0.949 . . . . 1.0 114.838 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -128.85 113.52 15.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 103.576 -2.749 . . . . 1.0 103.576 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -82.88 142.0 31.81 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.943 -1.873 . . . . 1.0 105.943 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -102.94 118.53 37.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.04 -2.578 . . . . 1.0 104.04 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.95 -23.65 58.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.615 0.366 . . . . 1.0 110.653 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -146.52 175.15 10.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.533 2.333 . . . . 1.0 106.128 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.7 76.67 3.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.555 1.169 . . . . 1.0 109.313 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -88.54 45.19 1.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.979 1.712 . . . . 1.0 109.431 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -138.81 127.15 22.91 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 120.081 -1.637 . . . . 1.0 113.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.252 0.1 OUTLIER -78.74 56.7 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.732 2.013 . . . . 1.0 108.996 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.18 -136.51 3.74 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.12 163.61 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.209 -2.515 . . . . 1.0 104.209 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.81 117.8 9.43 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.764 -1.939 . . . . 1.0 105.764 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.23 131.07 34.48 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.808 -1.183 . . . . 1.0 110.195 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -104.36 147.03 27.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.641 0.376 . . . . 1.0 111.776 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.43 173.38 33.6 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.978 1.275 . . . . 1.0 110.356 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -148.18 109.2 4.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 44.93 46.32 8.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.928 2.491 . . . . 1.0 112.671 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 50.62 38.19 18.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.621 1.969 . . . . 1.0 113.499 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.8 tp -68.27 146.55 53.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.688 1.995 . . . . 1.0 108.142 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -31.51 114.23 0.13 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 126.39 1.876 . . . . 1.0 111.812 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.42 -8.58 58.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 115.361 -2.257 . . . . 1.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.396 17.4 p 68.9 78.68 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 122.18 2.264 . . . . 1.0 113.374 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -22.8 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.949 2.159 . . . . 1.0 115.08 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.69 -42.91 7.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.628 2.371 . . . . 1.0 110.629 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -52.44 -51.46 59.09 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.154 0.888 . . . . 1.0 110.432 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -60.61 -39.71 89.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.574 -0.727 . . . . 1.0 109.877 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.13 -51.53 57.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.176 0.898 . . . . 1.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.48 -47.63 78.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.469 1.507 . . . . 1.0 110.393 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.2 tp -56.6 -50.53 71.71 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.33 1.052 . . . . 1.0 108.498 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.06 84.14 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.691 0.678 . . . . 1.0 110.284 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.98 48.78 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.186 0.594 . . . . 1.0 110.648 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.28 -41.78 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.896 0.771 . . . . 1.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.1 m -59.25 -56.79 17.67 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.997 1.319 . . . . 1.0 109.466 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.93 -43.65 77.59 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.939 0.896 . . . . 1.0 110.245 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.82 -50.7 63.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.975 0.51 . . . . 1.0 111.076 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.74 -37.44 71.01 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.487 -0.758 . . . . 1.0 111.378 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.04 -39.31 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.946 0.898 . . . . 1.0 110.057 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.5 m -57.96 -35.33 71.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.38 0.991 . . . . 1.0 111.217 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -83.45 -49.23 9.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -125.79 112.85 24.82 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 107.271 -1.381 . . . . 1.0 107.271 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.37 106.85 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.148 -1.52 . . . . 1.0 108.148 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.94 -55.62 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.797 1.639 . . . . 1.0 107.848 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.0 mt -48.86 -33.94 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.056 2.942 . . . . 1.0 110.329 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.88 -23.03 6.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.497 1.519 . . . . 1.0 113.744 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -137.76 20.73 2.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.985 2.514 . . . . 1.0 109.295 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.13 87.74 2.22 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.69 1.596 . . . . 1.0 106.888 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.5 mtt -136.5 117.6 14.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.16 1.784 . . . . 1.0 107.547 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.9 t -153.52 -176.37 5.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.466 1.485 . . . . 1.0 109.544 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.91 -131.62 2.73 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 107.279 -2.329 . . . . 1.0 107.279 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 22.7 m170 -115.72 -24.04 8.41 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.683 1.241 . . . . 1.0 112.415 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.5 t -103.73 -11.47 17.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.819 0.847 . . . . 1.0 109.024 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.81 18.54 2.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.145 1.778 . . . . 1.0 110.31 -175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.433 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.73 -18.99 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.918 0.887 . . . . 1.0 112.456 -175.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.1 -66.13 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.378 1.471 . . . . 1.0 108.54 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.59 111.32 2.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.834 1.691 . . . . 1.0 111.786 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.06 -17.58 27.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.971 1.309 . . . . 1.0 111.915 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.83 -25.64 63.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.458 -1.401 . . . . 1.0 112.388 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -134.17 140.61 46.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 17.0 m -121.71 -16.6 7.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.001 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.08 -178.98 0.63 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 130.717 3.607 . . . . 1.0 104.561 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -78.49 51.27 3.68 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.621 2.214 . . . . 1.0 109.919 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.11 80.89 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.73 2.586 . . . . 1.0 108.485 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.98 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.583 2.189 . . . . 1.0 111.995 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.4 t 53.66 43.03 31.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.329 2.251 . . . . 1.0 112.808 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -122.27 17.94 10.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.259 0.936 . . . . 1.0 112.637 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.263 8.5 t0 41.78 70.56 0.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.583 1.553 . . . . 1.0 111.006 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -52.87 -30.43 33.86 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 121.27 -0.894 . . . . 1.0 111.448 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.57 51.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.461 -0.781 . . . . 1.0 110.162 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -60.46 -50.98 71.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 120.18 1.354 . . . . 1.0 112.008 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.72 -46.87 83.45 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.243 -0.983 . . . . 1.0 111.469 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -64.69 -31.3 72.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.716 0.689 . . . . 1.0 109.932 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -41.19 88.27 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 1.0 111.813 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.17 -55.09 8.88 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.416 1.486 . . . . 1.0 112.166 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.4 t -66.34 152.52 9.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 123.402 0.681 . . . . 1.0 109.845 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -49.12 113.76 3.35 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.722 1.209 . . . . 1.0 111.802 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.15 78.34 2.94 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.12 2.546 . . . . 1.0 110.9 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 34.0 40.28 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.9 2.88 . . . . 1.0 115.114 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 t -158.05 -46.35 0.06 Allowed 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.427 -0.796 . . . . 1.0 111.074 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.34 56.81 0.66 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.025 1.73 . . . . 1.0 110.348 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -98.82 124.31 43.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 4.2 pm0 -64.69 -166.75 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 130.988 3.715 . . . . 1.0 113.709 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.02 115.54 4.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.844 1.657 . . . . 1.0 109.816 -175.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.255 1.355 1 C-N-CA 135.388 5.475 . . . . 1.0 106.431 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.646 ' H3 ' ' CD2' ' A' ' 8' ' ' LEU . 5.5 tpp . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 160.05 0.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.682 -1.261 . . . . 1.0 111.367 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.45 123.14 42.42 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.612 0.765 . . . . 1.0 108.957 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -126.85 142.85 51.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 129.037 2.935 . . . . 1.0 108.023 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 45.61 35.02 1.89 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.041 1.736 . . . . 1.0 112.172 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.71 -1.87 56.43 Favored Glycine 0 CA--C 1.521 0.407 0 O-C-N 120.888 -1.133 . . . . 1.0 115.246 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -112.87 176.75 4.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.613 2.365 . . . . 1.0 106.348 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.646 ' CD2' ' H3 ' ' A' ' 1' ' ' MET . 6.5 tt -98.89 123.63 43.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.67 175.72 9.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.162 0.985 . . . . 1.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 39.19 58.4 1.87 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.718 1.207 . . . . 1.0 111.569 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.17 155.91 28.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.094 0.958 . . . . 1.0 108.98 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -78.08 123.35 26.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.41 125.54 33.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.337 -1.356 . . . . 1.0 107.337 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -140.32 79.09 21.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.14 123.69 11.93 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -65.4 145.89 99.02 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.695 -0.854 . . . . 1.0 108.695 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.03 -9.32 11.84 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.921 1.747 . . . . 1.0 116.131 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -144.02 135.92 26.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.386 -2.82 . . . . 1.0 103.386 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -106.7 178.39 4.57 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.291 1.437 . . . . 1.0 108.769 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.79 178.79 4.86 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.248 1.499 . . . . 1.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.0 m -151.28 118.41 5.92 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.912 -2.255 . . . . 1.0 104.912 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -135.93 138.85 28.82 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 106.205 -1.776 . . . . 1.0 106.205 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.44 83.1 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.626 2.217 . . . . 1.0 109.395 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -163.56 149.05 11.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.047 1.739 . . . . 1.0 108.371 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -146.51 104.14 3.74 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.01 160.58 38.17 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 127.446 2.298 . . . . 1.0 107.339 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.51 123.41 88.39 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 106.478 -1.675 . . . . 1.0 106.478 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.93 103.54 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.436 1.424 . . . . 1.0 109.783 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -172.95 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 tp -148.74 132.18 16.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.15 -2.167 . . . . 1.0 105.15 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -91.43 122.49 34.07 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.27 113.45 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.35 114.22 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 105.675 -1.972 . . . . 1.0 105.675 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -165.92 137.22 3.75 Favored 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.11 112.59 19.95 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 105.67 -1.974 . . . . 1.0 105.67 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.323 6.6 mm -126.39 179.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 128.966 2.907 . . . . 1.0 106.146 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -149.58 121.91 8.43 Favored 'General case' 0 N--CA 1.432 -1.327 1 N-CA-C 99.207 -4.368 . . . . 1.0 99.207 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.31 -62.9 0.02 OUTLIER Pre-proline 0 C--O 1.254 1.325 0 CA-C-O 115.796 -2.05 . . . . 1.0 111.821 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.57 153.09 23.32 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 CA-C-N 123.564 2.308 . . . . 1.0 111.626 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.7 45.52 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.492 3.461 . . . . 1.0 114.69 -175.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.72 -71.8 0.43 Allowed Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.869 -0.962 . . . . 1.0 111.847 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -155.6 122.76 5.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.142 1.377 . . . . 1.0 107.369 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -163.12 166.66 23.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 128.426 2.691 . . . . 1.0 111.514 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.86 -22.65 7.51 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 117.875 -1.514 . . . . 1.0 113.342 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.24 136.77 13.97 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.426 1.613 . . . . 1.0 111.021 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.43 -4.42 14.66 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.42 2.747 . . . . 1.0 116.476 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -49.51 -49.46 45.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 121.653 2.024 . . . . 1.0 112.569 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 23.3 mm -66.23 -43.85 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.156 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.67 -44.55 96.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.72 -34.51 67.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.715 1.606 . . . . 1.0 111.987 -177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -62.05 2.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.801 1.24 . . . . 1.0 109.091 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -66.61 -53.59 32.63 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.545 1.138 . . . . 1.0 111.555 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -56.01 -33.51 64.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.765 1.226 . . . . 1.0 109.311 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.37 25.37 8.83 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 119.762 1.165 . . . . 1.0 114.356 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -115.09 9.91 16.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.983 1.313 . . . . 1.0 112.009 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.5 tt -51.7 126.18 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.652 1.181 . . . . 1.0 112.437 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -98.8 124.37 46.13 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.259 2.224 . . . . 1.0 107.758 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.3 70.41 3.16 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.895 3.064 . . . . 1.0 110.434 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -103.63 -63.71 1.16 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.487 0.715 . . . . 1.0 112.414 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.83 73.7 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.47 0.708 . . . . 1.0 111.391 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 31.3 p80 -164.31 177.98 1.59 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 107.072 -1.455 . . . . 1.0 107.072 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.92 -43.52 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.329 1.353 . . . . 1.0 112.512 -176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -45.48 -42.2 10.38 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.243 1.417 . . . . 1.0 113.459 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -57.92 -54.26 48.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.55 1.14 . . . . 1.0 107.943 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.6 85.62 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.018 0.927 . . . . 1.0 110.59 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.94 -61.85 2.18 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 127.892 2.663 . . . . 1.0 111.02 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -59.02 -49.42 83.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-O 116.976 -1.488 . . . . 1.0 110.663 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.63 -43.3 0.4 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.584 2.753 . . . . 1.0 116.529 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -56.01 -41.39 74.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.359 1.076 . . . . 1.0 110.662 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.76 136.95 34.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.892 -2.262 . . . . 1.0 104.892 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 154.64 12.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.768 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.1 162.96 14.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 126.365 1.866 . . . . 1.0 111.681 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.303 2.241 . . . . 1.0 106.722 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.93 -153.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.68 1.592 . . . . 1.0 108.204 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -128.15 -58.9 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.66 1.184 . . . . 1.0 109.84 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 59.2 m -145.58 126.8 14.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.58 113.73 26.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 104.813 -2.291 . . . . 1.0 104.813 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 mt -94.08 121.34 44.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -75.14 144.6 42.72 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -49.01 -20.58 0.54 Allowed 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.564 1.946 . . . . 1.0 112.949 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -92.07 32.17 1.18 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 130.666 3.586 . . . . 1.0 113.154 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.66 28.41 67.87 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 119.991 -1.693 . . . . 1.0 116.515 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -98.81 145.15 27.25 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 119.194 1.497 . . . . 1.0 108.878 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.36 113.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.171 -1.788 . . . . 1.0 106.171 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.07 143.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -115.76 113.87 24.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -110.67 114.07 27.17 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 105.187 -2.153 . . . . 1.0 105.187 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 74.5 t 71.39 91.37 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 121.71 2.05 . . . . 1.0 111.954 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.34 -166.93 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.093 1.862 . . . . 1.0 111.052 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -61.4 26.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 130.34 3.456 . . . . 1.0 116.918 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.27 134.86 19.77 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 121.247 1.84 . . . . 1.0 106.741 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 75.69 82.69 0.1 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.626 1.57 . . . . 1.0 111.504 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -43.96 145.28 0.74 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.333 1.853 . . . . 1.0 112.546 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.29 -178.59 3.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.206 2.202 . . . . 1.0 110.26 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -154.39 119.74 5.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.604 0.638 . . . . 1.0 111.051 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -157.21 64.46 0.5 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.058 1.409 . . . . 1.0 111.46 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.01 -57.96 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 117.953 -2.967 . . . . 1.0 111.286 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.91 -69.61 0.44 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.331 -1.908 . . . . 1.0 108.331 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -146.04 144.02 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.464 1.632 . . . . 1.0 109.544 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 p -165.71 162.83 18.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.738 1.215 . . . . 1.0 111.444 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.0 p -158.77 145.32 17.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 1.0 108.982 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -166.9 157.15 11.53 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.537 -1.221 . . . . 1.0 108.943 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 39.58 53.91 2.42 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.511 1.924 . . . . 1.0 112.3 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.36 29.82 53.94 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 114.885 -1.052 . . . . 1.0 113.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 tpt85 -131.71 116.72 17.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.081 1.441 . . . . 1.0 108.433 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.51 146.49 34.32 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.474 -1.676 . . . . 1.0 106.474 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -126.01 117.97 24.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.387 -2.079 . . . . 1.0 105.387 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.86 -26.25 61.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.812 -1.085 . . . . 1.0 110.588 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -151.42 173.23 14.79 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.972 1.309 . . . . 1.0 108.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.49 75.64 6.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.205 1.479 . . . . 1.0 107.054 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.18 39.2 1.12 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.475 1.11 . . . . 1.0 109.769 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.9 m -140.02 124.26 17.83 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.471 -1.393 . . . . 1.0 113.205 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -78.46 57.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.545 2.338 . . . . 1.0 111.57 -175.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.26 -119.02 0.45 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.411 -1.475 . . . . 1.0 109.411 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.8 mm -149.01 165.56 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 130.234 3.413 . . . . 1.0 104.105 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -141.16 134.13 29.12 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.846 2.858 . . . . 1.0 104.129 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.4 164.24 11.87 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.355 -0.841 . . . . 1.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.37 150.79 50.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.207 0.603 . . . . 1.0 111.135 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.51 173.88 39.67 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.935 1.255 . . . . 1.0 110.734 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 p -151.01 110.53 4.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.635 -2.357 . . . . 1.0 104.635 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.5 t0 49.55 52.67 14.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 123.789 1.757 . . . . 1.0 112.507 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 47.83 37.98 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.373 2.669 . . . . 1.0 114.031 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 tt -58.5 145.62 38.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.722 1.209 . . . . 1.0 107.744 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.87 120.72 2.44 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.268 1.027 . . . . 1.0 109.678 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.41 10.38 7.24 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 117.129 -1.415 . . . . 1.0 113.673 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.311 28.6 p 37.4 74.65 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 1 N-CA-C 123.667 4.691 . . . . 1.0 123.667 -174.121 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -17.19 -32.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.998 2.919 . . . . 1.0 114.918 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.34 -41.2 18.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.594 1.557 . . . . 1.0 109.387 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -49.56 -57.29 7.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.51 1.924 . . . . 1.0 109.299 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -56.34 -43.17 78.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.736 -0.65 . . . . 1.0 109.561 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -64.51 -57.06 10.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.652 0.66 . . . . 1.0 111.004 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -65.77 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.974 -1.704 . . . . 1.0 111.516 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.6 -46.43 89.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.609 1.095 . . . . 1.0 108.761 175.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.05 76.71 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.247 0.931 . . . . 1.0 109.187 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.33 52.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.856 0.753 . . . . 1.0 110.703 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.06 -46.03 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.092 -0.38 . . . . 1.0 110.044 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.9 m -59.21 -50.08 75.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.373 1.469 . . . . 1.0 109.838 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.15 -42.26 94.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.0 110.341 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.93 88.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.849 0.46 . . . . 1.0 112.054 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.36 -47.12 79.52 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.531 -0.747 . . . . 1.0 109.313 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.05 -37.27 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.166 0.986 . . . . 1.0 110.773 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.4 m -65.63 -14.07 60.42 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.071 0.949 . . . . 1.0 111.953 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -111.07 -50.83 2.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.391 1.45 . . . . 1.0 111.744 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -126.77 113.06 22.44 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -97.33 107.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.049 1.41 . . . . 1.0 110.198 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.95 -51.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.064 1.746 . . . . 1.0 106.405 175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 59.5 mt -46.71 -33.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 129.497 3.119 . . . . 1.0 110.999 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.25 -26.42 17.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.407 1.083 . . . . 1.0 113.621 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -135.69 18.15 3.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.705 2.002 . . . . 1.0 110.043 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -139.78 83.56 1.93 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.926 1.29 . . . . 1.0 108.068 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 64.5 mtt -120.29 126.71 51.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -167.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.546 1.067 . . . . 1.0 108.345 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.28 -130.88 1.32 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 105.508 -3.037 . . . . 1.0 105.508 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.317 13.2 m170 -112.31 -22.99 10.62 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.325 0.861 . . . . 1.0 113.325 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 9.0 t -102.98 -11.13 18.4 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 118.568 -0.729 . . . . 1.0 109.287 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -89.42 43.05 1.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -8.96 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 120.801 -1.187 . . . . 1.0 110.515 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -160.72 -53.92 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.669 2.388 . . . . 1.0 111.246 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -91.52 111.96 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.097 1.865 . . . . 1.0 113.031 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.95 -25.38 63.46 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.965 -1.084 . . . . 1.0 112.281 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 20.4 ttp85 -71.27 -5.29 31.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.64 -1.287 . . . . 1.0 112.549 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 127.22 22.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 103.888 -2.634 . . . . 1.0 103.888 174.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.3 m -123.73 -16.21 6.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.289 0.95 . . . . 1.0 110.884 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.78 -178.75 0.34 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.216 2.607 . . . . 1.0 105.697 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.79 51.52 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.525 . . . . 1.0 112.96 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.34 76.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.158 1.361 . . . . 1.0 110.202 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.49 -74.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.373 2.049 . . . . 1.0 111.636 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.75 44.02 30.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.431 1.892 . . . . 1.0 111.206 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -99.09 18.38 17.52 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.038 -1.039 . . . . 1.0 110.926 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.258 9.4 t0 44.17 70.52 0.32 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.388 1.475 . . . . 1.0 110.46 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -56.7 -29.12 62.07 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 120.669 -1.269 . . . . 1.0 110.311 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.4 -53.61 33.8 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.755 1.161 . . . . 1.0 111.994 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -65.93 -47.88 73.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 118.079 -0.962 . . . . 1.0 109.868 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.11 -55.63 31.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.123 0.874 . . . . 1.0 112.176 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -58.64 -36.6 74.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.795 -1.098 . . . . 1.0 109.8 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -45.1 80.82 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.471 1.107 . . . . 1.0 113.629 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.55 -46.08 84.38 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.087 0.955 . . . . 1.0 112.054 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.69 166.55 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.741 2.016 . . . . 1.0 110.082 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.0 m -45.14 128.54 5.68 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 1.0 109.457 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.13 44.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.323 2.682 . . . . 1.0 111.379 -176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.2 t 46.52 41.72 10.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.867 1.667 . . . . 1.0 109.501 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.8 t -155.09 29.2 0.41 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.535 0.734 . . . . 1.0 111.005 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -150.25 67.59 0.97 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.125 0.875 . . . . 1.0 110.516 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -149.07 144.59 26.78 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.246 -2.131 . . . . 1.0 105.246 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -129.16 137.21 51.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.843 -1.91 . . . . 1.0 105.843 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.0 tpt 51.94 100.28 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.901 2.88 . . . . 1.0 114.154 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.258 1.51 0 C-N-CA 128.19 2.596 . . . . 1.0 108.985 -177.137 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ttm . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.428 -0.212 . . . . 1.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 17.2 tp -134.31 176.11 8.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.49 2.316 . . . . 1.0 108.092 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 82.8 mt -124.96 125.27 43.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 103.992 -2.595 . . . . 1.0 103.992 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -126.66 134.23 50.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.508 1.049 . . . . 1.0 109.583 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 51.91 33.61 11.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.055 2.142 . . . . 1.0 111.519 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.91 5.45 79.87 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.304 -1.276 . . . . 1.0 113.492 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -113.87 171.91 7.3 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.168 1.484 . . . . 1.0 108.28 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp -81.62 138.74 35.29 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.863 -0.523 . . . . 1.0 110.183 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.42 154.52 32.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 46.2 58.35 4.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.168 2.187 . . . . 1.0 113.59 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.77 134.73 15.73 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.182 -0.949 . . . . 1.0 111.334 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -71.65 123.18 21.96 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.428 -1.693 . . . . 1.0 106.428 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -92.88 123.93 36.5 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.638 -0.664 . . . . 1.0 110.42 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.45 67.29 75.82 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.333 1.453 . . . . 1.0 107.666 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.52 152.47 59.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.78 1.653 . . . . 1.0 110.071 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -154.1 114.96 2.54 Favored Pre-proline 0 CA--C 1.511 -0.554 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 90.8 Cg_endo -74.75 71.4 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.002 1.801 . . . . 1.0 109.261 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -133.85 43.03 2.89 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.073 2.949 . . . . 1.0 105.064 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 18.9 m-85 -79.28 178.7 7.88 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.425 2.29 . . . . 1.0 113.077 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -122.2 -179.76 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.615 1.966 . . . . 1.0 111.011 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 m -158.26 118.27 3.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 131.395 3.878 . . . . 1.0 101.547 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -120.2 138.72 27.48 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 106.047 -1.835 . . . . 1.0 106.047 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.96 61.27 8.09 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.115 3.21 . . . . 1.0 112.54 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -138.8 151.39 47.01 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 128.675 2.79 . . . . 1.0 105.023 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -150.85 104.36 3.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.802 1.183 . . . . 1.0 109.713 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.14 161.71 34.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 105.97 -1.863 . . . . 1.0 105.97 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -57.69 123.86 65.19 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.97 0.908 . . . . 1.0 108.923 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.34 103.6 1.29 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.366 2.044 . . . . 1.0 108.302 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 t -174.15 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.198 -2.149 . . . . 1.0 105.198 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.07 131.48 9.49 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.376 1.471 . . . . 1.0 107.482 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 tp -92.07 127.51 37.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.342 1.057 . . . . 1.0 109.437 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.67 116.84 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.913 1.285 . . . . 1.0 108.514 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.6 t -110.88 114.94 48.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.0 OUTLIER -168.07 129.39 1.4 Allowed 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 174.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.88 111.84 6.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -127.0 177.58 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.828 2.451 . . . . 1.0 112.12 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -151.28 122.32 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 1 N-CA-C 95.992 -5.559 . . . . 1.0 95.992 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.301 0.6 OUTLIER -142.84 -60.9 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 121.727 2.058 . . . . 1.0 112.426 176.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.14 157.58 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.572 2.181 . . . . 1.0 111.449 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.16 13.47 2.37 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.771 2.981 . . . . 1.0 116.664 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -24.55 -68.59 0.03 OUTLIER Glycine 0 C--N 1.353 1.508 0 CA-C-N 121.402 1.91 . . . . 1.0 111.694 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -148.89 122.97 9.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.776 -1.565 . . . . 1.0 106.776 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -176.47 159.26 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.649 2.78 . . . . 1.0 108.294 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.46 -6.4 10.62 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.721 1.153 . . . . 1.0 110.664 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.09 120.37 7.18 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 108.383 -1.887 . . . . 1.0 108.383 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.82 -24.86 80.05 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.62 2.213 . . . . 1.0 115.191 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -49.36 -45.81 46.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.794 1.179 . . . . 1.0 113.741 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 mm -65.6 -49.31 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 123.567 0.747 . . . . 1.0 110.651 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.34 -36.33 82.62 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 118.861 -1.136 . . . . 1.0 110.744 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.75 -34.2 71.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.717 0.807 . . . . 1.0 110.996 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.94 -54.33 46.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.547 1.139 . . . . 1.0 108.077 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.96 -48.29 69.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.51 -34.77 78.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.275 1.43 . . . . 1.0 110.431 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.09 1.57 29.98 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.195 1.379 . . . . 1.0 115.221 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -88.96 8.69 28.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.232 2.016 . . . . 1.0 113.255 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -57.46 127.92 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.978 1.311 . . . . 1.0 112.219 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.84 135.54 20.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.238 2.215 . . . . 1.0 109.609 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.08 77.34 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.649 2.899 . . . . 1.0 107.261 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.41 -64.58 1.07 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.105 0.562 . . . . 1.0 111.013 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.8 -47.55 76.93 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.042 0.937 . . . . 1.0 110.855 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -170.07 177.9 0.98 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.677 1.591 . . . . 1.0 107.607 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.37 -43.41 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.437 2.091 . . . . 1.0 114.973 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -46.29 -49.76 17.03 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.956 1.095 . . . . 1.0 113.956 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 -55.58 31.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.116 0.966 . . . . 1.0 110.397 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.28 99.17 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.14 0.976 . . . . 1.0 111.39 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.31 23.09 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.907 1.718 . . . . 1.0 112.38 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.7 pt -60.26 -36.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-O 117.221 -1.371 . . . . 1.0 112.38 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.78 -43.15 5.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.58 1.952 . . . . 1.0 115.435 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -60.34 -33.57 72.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.672 -0.643 . . . . 1.0 109.692 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.62 136.65 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 102.924 -2.991 . . . . 1.0 102.924 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 153.89 15.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.694 -1.202 . . . . 1.0 110.456 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.59 159.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -165.84 130.21 2.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.632 -1.248 . . . . 1.0 107.632 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.32 -176.77 3.75 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -123.69 -76.6 0.59 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.549 -2.019 . . . . 1.0 105.549 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -122.51 118.47 28.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.891 -2.263 . . . . 1.0 104.891 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.97 113.33 25.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.407 -2.071 . . . . 1.0 105.407 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.4 mt -88.1 119.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 106.029 -1.841 . . . . 1.0 106.029 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.29 141.9 58.61 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.437 -1.69 . . . . 1.0 106.437 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -53.14 -24.99 11.8 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 124.442 1.097 . . . . 1.0 111.324 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.37 34.57 0.95 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.529 1.132 . . . . 1.0 111.845 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.48 48.2 86.28 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 120.112 -1.617 . . . . 1.0 115.944 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.48 156.26 31.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.08 113.51 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 104.948 -2.241 . . . . 1.0 104.948 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.26 139.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -124.79 113.96 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.87 140.41 43.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.911 2.484 . . . . 1.0 104.384 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t 63.18 90.91 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 120.65 1.568 . . . . 1.0 113.519 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.67 -177.55 0.97 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 120.807 1.005 . . . . 1.0 110.432 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.69 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.682 2.793 . . . . 1.0 115.558 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -149.89 120.36 7.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.523 2.729 . . . . 1.0 107.204 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 84.07 81.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.662 2.785 . . . . 1.0 110.639 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -41.04 152.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.699 3.2 . . . . 1.0 114.603 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.72 -178.77 3.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 1.0 110.219 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -152.34 118.44 5.51 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -162.73 62.5 0.2 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.969 0.89 . . . . 1.0 110.914 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.76 -61.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 117.635 -3.166 . . . . 1.0 113.296 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.96 -73.65 1.14 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.203 -1.332 . . . . 1.0 112.943 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.95 129.4 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.973 1.387 . . . . 1.0 111.633 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 p -165.96 146.73 6.67 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.824 1.65 . . . . 1.0 108.231 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.8 p -144.53 146.39 32.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.762 2.025 . . . . 1.0 108.533 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -150.32 149.65 30.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.943 -2.244 . . . . 1.0 104.943 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 43.49 53.61 5.65 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.745 1.218 . . . . 1.0 114.273 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.8 39.46 67.84 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 121.011 -1.056 . . . . 1.0 113.09 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -146.48 113.57 6.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.579 -2.378 . . . . 1.0 104.579 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -105.98 132.84 51.59 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -102.55 118.26 36.48 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.5 t -61.31 -25.05 66.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 1.0 111.611 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -153.77 161.08 42.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 112' ' ' SER . 32.1 t70 -81.3 76.76 8.23 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.04 40.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.821 2.448 . . . . 1.0 109.74 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 110' ' ' ASP . 1.7 m -123.73 133.79 53.8 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.852 1.261 . . . . 1.0 110.96 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.39 56.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.162 -1.421 . . . . 1.0 107.162 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.02 -137.01 3.79 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 120.909 -1.119 . . . . 1.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.1 mm -143.15 164.77 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.238 -2.875 . . . . 1.0 103.238 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.33 137.18 28.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.329 2.651 . . . . 1.0 103.898 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.91 141.62 33.54 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.589 -1.319 . . . . 1.0 109.407 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -103.92 154.3 19.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.465 -0.198 . . . . 1.0 110.465 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.02 -177.62 46.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 128.49 2.948 . . . . 1.0 109.401 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 p -156.35 116.64 3.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.735 -2.321 . . . . 1.0 104.735 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.4 t0 50.59 40.45 23.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.261 65.4 p 58.8 38.48 24.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.249 2.22 . . . . 1.0 115.163 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.44 146.08 30.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.906 1.682 . . . . 1.0 107.886 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -42.4 113.38 0.44 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -81.02 -5.75 57.97 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 115.855 1.798 . . . . 1.0 115.855 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.8 p 51.62 77.78 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 120.194 1.361 . . . . 1.0 111.505 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.84 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.245 2.618 . . . . 1.0 114.159 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -41.62 -36.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.497 2.319 . . . . 1.0 109.452 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -48.17 -50.07 30.32 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.594 0.757 . . . . 1.0 110.375 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.84 -47.73 83.82 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.321 0.648 . . . . 1.0 109.982 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.02 -51.95 67.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.578 0.704 . . . . 1.0 109.72 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -66.45 -47.9 71.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 1.0 110.837 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.5 tp -55.76 -41.77 74.47 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.81 98.26 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.458 1.481 . . . . 1.0 111.907 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.74 47.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.384 0.674 . . . . 1.0 109.246 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.62 -48.25 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.5 m -55.85 -49.35 73.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.843 1.257 . . . . 1.0 109.893 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.39 -41.08 98.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.488 0.715 . . . . 1.0 110.338 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.74 68.03 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.268 -0.895 . . . . 1.0 110.673 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.12 -41.13 74.83 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.876 -1.059 . . . . 1.0 112.05 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.68 -43.24 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.678 1.126 . . . . 1.0 108.574 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.8 m -65.61 -22.03 66.63 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.386 0.674 . . . . 1.0 111.799 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.62 -56.15 3.48 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 120.478 -1.389 . . . . 1.0 108.098 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.36 112.54 23.44 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -89.97 108.55 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 117.05 -1.5 . . . . 1.0 110.122 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.41 -50.42 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.081 1.752 . . . . 1.0 109.033 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.9 mt -47.33 -33.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.847 3.259 . . . . 1.0 110.765 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.08 -26.3 4.29 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.405 1.082 . . . . 1.0 113.272 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.92 17.92 5.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.676 1.991 . . . . 1.0 111.267 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -139.47 88.02 2.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.34 1.427 . . . . 1.0 109.717 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 46.0 mtt -129.89 113.86 15.16 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -148.6 -165.9 2.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.45 -131.41 1.43 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 106.326 -2.709 . . . . 1.0 106.326 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.0 m170 -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.588 1.194 . . . . 1.0 111.907 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.93 -11.59 17.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.787 0.835 . . . . 1.0 109.573 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.52 39.56 0.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.1 -1.0 . . . . 1.0 110.393 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.458 HG23 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -74.43 -11.69 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 O-C-N 121.251 -0.906 . . . . 1.0 108.68 175.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -159.59 -54.16 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.956 1.702 . . . . 1.0 113.037 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.12 108.86 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 122.71 2.004 . . . . 1.0 111.277 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.23 -13.42 37.6 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.198 -0.938 . . . . 1.0 113.219 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.09 -25.74 63.66 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.544 -1.347 . . . . 1.0 111.957 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -113.91 141.6 47.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -140.37 -15.07 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 118.872 -1.131 . . . . 1.0 111.427 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.71 177.55 0.43 Allowed Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 131.0 3.72 . . . . 1.0 104.092 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.07 77.86 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.33 2.02 . . . . 1.0 109.892 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 127.17 67.27 0.15 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.086 1.803 . . . . 1.0 109.582 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.62 -89.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.08 2.52 . . . . 1.0 109.551 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t 53.4 42.98 31.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.876 2.07 . . . . 1.0 114.095 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -95.13 19.28 10.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 119.862 -1.774 . . . . 1.0 113.982 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.5 t0 45.61 56.2 6.02 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.213 -1.554 . . . . 1.0 113.479 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -45.2 -40.5 7.32 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.096 1.758 . . . . 1.0 113.011 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.63 -60.85 2.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.381 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -64.55 -36.2 83.45 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 117.884 -1.526 . . . . 1.0 111.251 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.55 -57.56 12.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.589 0.556 . . . . 1.0 110.397 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -64.38 -32.72 74.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.761 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.75 96.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.536 0.607 . . . . 1.0 111.715 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.82 -46.48 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.243 1.017 . . . . 1.0 112.262 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.04 166.87 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.371 1.868 . . . . 1.0 111.702 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -38.78 121.6 1.17 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.951 1.7 . . . . 1.0 108.876 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.08 45.2 1.86 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.327 3.351 . . . . 1.0 112.699 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.5 t 53.86 33.96 18.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.765 2.026 . . . . 1.0 110.702 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.7 t -167.49 94.9 0.45 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.476 -1.305 . . . . 1.0 107.476 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -166.97 125.17 1.33 Allowed 'General case' 0 C--O 1.231 0.098 0 O-C-N 121.167 -0.958 . . . . 1.0 109.217 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -149.05 165.35 31.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.14 -172.17 3.87 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.02 2.928 . . . . 1.0 105.824 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.7 tpp 34.06 -85.97 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.585 2.754 . . . . 1.0 116.323 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.249 1.073 0 C-N-CA 128.214 2.606 . . . . 1.0 106.04 176.225 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.0 tp -57.15 129.46 41.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -133.91 135.11 43.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 101.723 -3.436 . . . . 1.0 101.723 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -119.01 124.06 46.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.045 -1.095 . . . . 1.0 108.045 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 52.92 33.97 15.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.99 0.814 . . . . 1.0 112.381 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.38 -2.77 6.82 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.681 -1.066 . . . . 1.0 113.809 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -87.75 161.43 17.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 104.176 -2.527 . . . . 1.0 104.176 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.66 124.34 27.49 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.283 -1.511 . . . . 1.0 107.258 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.12 176.33 5.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.895 0.878 . . . . 1.0 112.037 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 45.79 57.97 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.971 2.108 . . . . 1.0 109.694 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 139.83 13.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.557 -1.339 . . . . 1.0 111.294 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.03 130.11 39.18 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -83.61 133.2 34.85 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.024 0.53 . . . . 1.0 110.319 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.84 73.12 28.24 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.422 -1.696 . . . . 1.0 106.422 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.62 123.27 9.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 N-CA-C 108.08 -1.546 . . . . 1.0 108.08 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -113.91 114.51 46.5 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -79.86 38.93 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.665 2.91 . . . . 1.0 113.989 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.97 44.53 2.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.503 1.121 . . . . 1.0 109.254 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -73.52 178.52 4.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.066 0.946 . . . . 1.0 112.863 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.67 178.6 4.51 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 118.919 2.933 . . . . 1.0 118.919 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.2 m -162.83 118.73 1.84 Allowed 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 135.911 5.684 . . . . 1.0 101.173 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -130.09 154.96 81.39 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.439 -2.06 . . . . 1.0 105.439 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.26 51.97 4.12 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.985 3.124 . . . . 1.0 114.398 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -139.59 151.18 45.83 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.904 1.282 . . . . 1.0 110.205 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -148.43 103.82 3.46 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.791 1.236 . . . . 1.0 108.179 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.44 173.53 11.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.082 0.953 . . . . 1.0 109.01 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -79.46 124.32 84.01 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 119.648 1.113 . . . . 1.0 109.789 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.72 103.95 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.504 2.136 . . . . 1.0 112.436 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -178.13 83.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.067 1.747 . . . . 1.0 108.002 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.67 141.04 17.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.571 1.149 . . . . 1.0 108.183 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -94.25 127.48 40.13 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.475 1.51 . . . . 1.0 108.478 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 140.43 24.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -135.56 113.72 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 104.888 -2.264 . . . . 1.0 104.888 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.6 OUTLIER -170.16 152.16 4.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.796 1.638 . . . . 1.0 107.601 175.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -94.88 112.42 24.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mm -128.05 166.67 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 106.179 -1.785 . . . . 1.0 106.179 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -139.13 122.25 16.87 Favored 'General case' 0 N--CA 1.444 -0.733 1 N-CA-C 94.35 -6.167 . . . . 1.0 94.35 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.366 0.7 OUTLIER -142.96 -66.1 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.462 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -87.85 155.92 7.36 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.096 2.531 . . . . 1.0 114.352 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.19 59.09 5.86 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 125.174 3.916 . . . . 1.0 116.157 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.79 -71.77 0.95 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -156.48 123.46 5.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.463 1.505 . . . . 1.0 110.496 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -168.56 166.4 12.01 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.227 2.611 . . . . 1.0 110.715 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.06 6.49 25.4 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.623 2.059 . . . . 1.0 111.649 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.2 118.74 6.27 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.187 -1.965 . . . . 1.0 108.187 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.23 -7.88 20.25 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.825 2.35 . . . . 1.0 114.457 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -45.95 -49.63 15.62 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.283 1.433 . . . . 1.0 113.293 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -65.12 -46.01 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.619 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.4 -38.31 87.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.163 -0.681 . . . . 1.0 109.163 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.24 74.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.68 1.192 . . . . 1.0 111.897 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -59.66 -51.89 67.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.905 1.282 . . . . 1.0 109.152 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -70.03 -48.66 57.1 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.609 1.163 . . . . 1.0 111.558 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.05 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.046 0.938 . . . . 1.0 109.378 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.53 1.82 24.48 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.006 -1.441 . . . . 1.0 115.319 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -89.07 9.29 25.9 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.301 2.05 . . . . 1.0 113.038 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.4 tt -53.51 145.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.648 1.579 . . . . 1.0 114.431 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.82 136.77 20.56 Favored Pre-proline 0 CA--C 1.546 0.804 1 C-N-CA 131.77 4.028 . . . . 1.0 113.02 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.51 38.1 0.29 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.769 3.646 . . . . 1.0 113.695 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -103.16 -33.36 9.23 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.229 1.832 . . . . 1.0 111.061 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.9 -52.96 36.78 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 106.207 -1.775 . . . . 1.0 106.207 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -171.31 178.38 0.79 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 131.046 3.738 . . . . 1.0 104.181 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.3 -43.54 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.69 1.593 . . . . 1.0 113.658 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -42.28 -47.64 4.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.889 1.676 . . . . 1.0 114.105 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.66 -55.6 30.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.758 1.223 . . . . 1.0 109.136 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.33 99.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.253 1.021 . . . . 1.0 110.745 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.77 -57.49 10.75 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.87 1.7 . . . . 1.0 113.1 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 pt -61.7 -39.88 84.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.121 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.15 -43.26 0.74 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.89 2.476 . . . . 1.0 115.188 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -56.4 -40.05 74.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.008 0.923 . . . . 1.0 108.868 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.56 136.93 32.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 1.0 105.062 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 154.98 5.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.131 -0.98 . . . . 1.0 112.399 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 m -116.73 160.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.349 1.86 . . . . 1.0 108.872 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -174.24 120.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.583 1.553 . . . . 1.0 107.586 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.23 -169.39 1.91 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.243 1.417 . . . . 1.0 108.153 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -120.18 -59.04 1.82 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.854 1.261 . . . . 1.0 109.42 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.72 119.12 10.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 119.709 -1.869 . . . . 1.0 106.684 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp -98.88 113.74 26.02 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 102.579 -3.119 . . . . 1.0 102.579 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.0 mt -95.83 114.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.686 -1.968 . . . . 1.0 105.686 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -67.22 152.57 45.49 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 118.519 0.6 . . . . 1.0 110.165 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.78 -14.0 18.74 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 125.467 1.507 . . . . 1.0 112.784 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -91.88 20.35 5.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.834 1.654 . . . . 1.0 111.755 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.56 47.71 89.79 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.743 2.592 . . . . 1.0 114.118 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -119.36 115.05 23.32 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.383 0.673 . . . . 1.0 110.521 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.92 117.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.55 147.28 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -124.3 117.92 25.6 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.569 1.548 . . . . 1.0 112.321 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.64 123.24 41.44 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 128.391 2.676 . . . . 1.0 105.205 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 t 64.34 91.29 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 122.339 2.336 . . . . 1.0 112.696 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -69.1 -169.13 0.28 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.144 1.896 . . . . 1.0 112.031 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.93 17.58 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.996 2.918 . . . . 1.0 114.994 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -143.68 125.27 14.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.687 2.395 . . . . 1.0 107.249 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? 85.09 81.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.559 3.144 . . . . 1.0 109.678 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.442 ' HB3' HH11 ' A' ' 93' ' ' ARG . 0.1 OUTLIER -38.71 141.44 0.27 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.598 2.759 . . . . 1.0 115.246 -175.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.45 -178.54 3.68 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 129.002 2.921 . . . . 1.0 111.625 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -153.71 118.32 4.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.678 1.591 . . . . 1.0 108.318 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -160.12 63.19 0.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.401 1.572 . . . . 1.0 111.498 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -159.53 -53.97 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.747 -2.471 . . . . 1.0 113.457 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.57 -69.41 0.74 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.5 t -145.86 137.57 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 1.0 108.019 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.9 p -166.46 165.96 16.68 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.092 1.757 . . . . 1.0 108.875 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.433 ' H ' HG22 ' A' ' 157' ' ' ILE . 5.3 p -159.27 146.38 17.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -156.48 152.81 27.85 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.62 -1.252 . . . . 1.0 107.62 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 39.85 53.41 2.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.368 1.467 . . . . 1.0 111.846 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.16 28.47 26.33 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.396 -1.224 . . . . 1.0 114.872 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -129.22 117.36 20.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.83 146.64 30.81 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.424 1.49 . . . . 1.0 111.191 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.15 117.99 24.28 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.406 ' C ' HD21 ' A' ' 109' ' ' ASN . 50.7 t -78.38 -23.87 46.6 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.207 1.003 . . . . 1.0 110.133 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.406 HD21 ' C ' ' A' ' 108' ' ' CYS . 1.0 OUTLIER -141.13 169.98 16.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.912 -1.885 . . . . 1.0 105.912 176.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -93.43 76.0 4.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 38.42 0.72 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.099 1.759 . . . . 1.0 109.497 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -128.23 143.07 51.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.574 1.55 . . . . 1.0 109.343 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -78.96 56.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.208 2.203 . . . . 1.0 107.451 175.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.07 -136.59 1.57 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 122.227 0.904 . . . . 1.0 112.773 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 28.2 mm -147.26 155.44 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 129.522 3.129 . . . . 1.0 104.104 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.43 129.97 21.35 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.97 161.5 13.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.646 -1.909 . . . . 1.0 110.626 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.68 144.82 48.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 1.0 111.084 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.71 38.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.55 2.024 . . . . 1.0 111.232 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.3 p -149.42 106.51 3.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.026 -1.842 . . . . 1.0 106.026 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.6 t0 45.52 48.81 10.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.59 1.956 . . . . 1.0 112.593 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p 52.32 38.39 24.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.695 1.998 . . . . 1.0 114.881 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.6 142.05 55.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 104.482 -2.414 . . . . 1.0 104.482 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -32.09 113.6 0.13 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.057 1.743 . . . . 1.0 112.039 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -79.59 -14.68 58.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 116.322 -1.799 . . . . 1.0 115.388 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 25.4 p 64.2 78.09 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.747 1.612 . . . . 1.0 111.841 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -24.39 -33.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.819 1.648 . . . . 1.0 113.335 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.59 -34.54 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.911 2.884 . . . . 1.0 110.644 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.59 -57.06 11.2 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.915 1.286 . . . . 1.0 107.998 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.01 -42.6 69.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.153 0.981 . . . . 1.0 109.715 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -66.03 -58.77 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.552 1.141 . . . . 1.0 111.542 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.5 -36.25 82.27 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.667 -1.271 . . . . 1.0 112.368 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tt -61.09 -39.22 89.12 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.897 -1.127 . . . . 1.0 108.146 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.72 95.47 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.963 -1.086 . . . . 1.0 111.337 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -53.53 57.23 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -55.22 -41.72 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.763 0.825 . . . . 1.0 110.869 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 m -59.59 -44.53 93.33 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.124 -0.985 . . . . 1.0 109.908 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.64 -44.57 90.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.894 0.77 . . . . 1.0 109.748 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.67 -56.22 22.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.941 0.896 . . . . 1.0 110.264 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.07 -44.76 79.25 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 118.241 -0.885 . . . . 1.0 112.325 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.3 -42.13 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.854 0.752 . . . . 1.0 109.786 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.225 0.61 . . . . 1.0 112.193 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -93.1 -51.2 5.15 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.693 1.197 . . . . 1.0 110.304 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.51 112.54 23.06 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -90.74 107.89 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 CA-C-N 121.539 1.585 . . . . 1.0 108.64 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.28 -50.99 0.11 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.603 2.361 . . . . 1.0 108.427 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.26 -33.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 130.367 3.467 . . . . 1.0 110.995 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.84 -26.49 10.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.036 1.125 . . . . 1.0 114.036 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -128.97 18.58 6.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.412 2.285 . . . . 1.0 111.374 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -138.15 83.36 1.97 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.4 mtt -127.61 114.02 16.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.317 -2.475 . . . . 1.0 104.317 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -154.47 -173.43 4.57 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.96 -122.84 1.75 Allowed Glycine 0 C--O 1.234 0.106 0 N-CA-C 106.413 -2.675 . . . . 1.0 106.413 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 97' ' ' ALA 0.255 14.9 m170 -118.3 -23.82 7.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.557 2.343 . . . . 1.0 112.029 176.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.79 -18.39 15.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.466 -0.778 . . . . 1.0 109.991 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -86.55 44.0 1.12 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.33 -23.08 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 120.446 -1.409 . . . . 1.0 107.427 175.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.403 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -151.6 -53.98 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.521 2.728 . . . . 1.0 111.164 175.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 95.1 Cg_endo -80.88 109.23 2.18 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.662 2.241 . . . . 1.0 113.348 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.64 -25.52 68.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.837 -1.164 . . . . 1.0 113.221 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -60.44 -23.18 64.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -135.68 131.95 36.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.2 m -113.69 -16.04 12.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.858 0.361 . . . . 1.0 110.13 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.1 -179.18 0.65 Allowed Pre-proline 0 CA--C 1.55 0.963 1 C-N-CA 132.572 4.349 . . . . 1.0 103.252 175.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.74 77.11 2.3 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 122.415 1.898 . . . . 1.0 111.432 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.36 73.58 0.81 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.1 1.333 . . . . 1.0 110.468 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.09 -57.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.816 0 CA-C-N 119.952 1.876 . . . . 1.0 113.645 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 53.35 43.08 31.89 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.32 1.448 . . . . 1.0 111.971 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.01 19.53 14.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.928 0.331 . . . . 1.0 111.486 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.264 22.6 t0 42.96 67.03 0.68 Allowed 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 126.38 1.872 . . . . 1.0 111.185 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -53.56 -32.96 53.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.209 -0.905 . . . . 1.0 111.904 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.41 -52.69 43.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.96 1.254 . . . . 1.0 110.755 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -65.94 -46.01 79.76 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.264 0.938 . . . . 1.0 111.254 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.33 -51.85 67.11 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.921 1.237 . . . . 1.0 111.58 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.329 -0.857 . . . . 1.0 110.049 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.06 77.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.19 -52.64 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.932 0.787 . . . . 1.0 108.996 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.53 161.6 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 122.115 0.959 . . . . 1.0 110.747 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.9 m -42.59 131.79 2.9 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.799 2.44 . . . . 1.0 108.864 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.54 39.83 0.65 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.359 3.373 . . . . 1.0 115.755 -175.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 t 46.81 39.74 7.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.665 1.586 . . . . 1.0 109.409 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t -159.85 101.31 1.46 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.898 1.679 . . . . 1.0 106.59 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -176.49 126.95 0.19 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.333 -1.729 . . . . 1.0 106.333 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -71.92 131.75 43.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.865 -1.902 . . . . 1.0 105.865 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -178.34 5.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.867 1.667 . . . . 1.0 109.778 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.7 tpp -142.2 74.02 1.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.946 -1.096 . . . . 1.0 109.111 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . 0.296 46.9 m . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.538 1.535 . . . . 1.0 111.552 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HA ' ' HB2' ' A' ' 139' ' ' ALA . 20.2 ttt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.45 124.19 19.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 155.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.06 123.55 41.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 103.279 -2.86 . . . . 1.0 103.279 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -118.39 148.74 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.299 1.04 . . . . 1.0 108.757 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 53.99 33.06 16.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.709 1.604 . . . . 1.0 109.348 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.25 21.07 56.11 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.135 -0.978 . . . . 1.0 112.618 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -131.19 175.81 8.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.541 1.536 . . . . 1.0 108.086 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.28 124.58 24.22 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.442 -1.318 . . . . 1.0 107.442 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.32 135.29 55.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.715 0.634 . . . . 1.0 112.095 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 52.72 58.72 5.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.087 1.755 . . . . 1.0 111.294 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.75 141.6 25.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.774 -1.557 . . . . 1.0 108.378 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 tpt85 -76.38 123.44 25.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 ptt-85 -88.07 119.59 28.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.25 1.02 . . . . 1.0 111.388 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -143.45 73.98 17.28 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.175 0.99 . . . . 1.0 109.833 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.17 149.69 76.51 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 121.421 1.414 . . . . 1.0 109.87 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -137.44 134.1 18.42 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.576 1.15 . . . . 1.0 108.064 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.18 43.9 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.258 2.638 . . . . 1.0 113.251 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -123.47 43.67 2.9 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.351 -0.843 . . . . 1.0 109.381 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -73.52 178.74 4.46 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.676 1.19 . . . . 1.0 110.298 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -121.08 178.35 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.661 1.22 . . . . 1.0 113.003 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.0 m -148.64 118.61 7.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.079 2.952 . . . . 1.0 104.344 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -138.81 139.21 23.24 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 121.292 1.86 . . . . 1.0 108.717 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 75.18 4.76 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.511 2.807 . . . . 1.0 110.69 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -154.35 144.71 22.13 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.186 2.594 . . . . 1.0 106.853 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -149.8 103.44 3.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 127.257 2.223 . . . . 1.0 105.855 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -136.66 165.23 26.39 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.816 1.646 . . . . 1.0 107.613 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.49 123.61 83.45 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.615 -0.707 . . . . 1.0 111.33 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -86.85 103.59 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.506 2.137 . . . . 1.0 111.802 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -176.46 85.04 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 104.596 -2.372 . . . . 1.0 104.596 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -145.96 146.09 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.974 2.509 . . . . 1.0 105.489 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.26 127.84 56.07 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.026 -1.472 . . . . 1.0 107.026 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.18 135.66 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.1 t -135.57 114.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.753 1.621 . . . . 1.0 107.839 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -164.56 161.89 21.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.38 1.472 . . . . 1.0 107.236 175.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.64 112.42 24.3 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -127.99 176.42 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 127.809 2.444 . . . . 1.0 108.21 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -156.92 122.13 4.62 Favored 'General case' 0 N--CA 1.438 -1.039 1 N-CA-C 97.483 -5.006 . . . . 1.0 97.483 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.51 -65.89 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.551 0 CA-C-N 120.298 1.408 . . . . 1.0 108.38 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.09 150.71 66.57 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 121.527 1.581 . . . . 1.0 109.924 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.29 28.49 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.105 3.204 . . . . 1.0 113.846 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -18.21 -71.64 0.01 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 127.686 2.565 . . . . 1.0 110.443 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -155.52 122.75 5.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -176.84 175.95 1.55 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.88 2.872 . . . . 1.0 108.089 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.56 1.54 8.09 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.91 -0.939 . . . . 1.0 113.743 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.35 118.52 5.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.219 1.509 . . . . 1.0 112.584 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.2 -4.29 13.36 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.936 2.424 . . . . 1.0 113.758 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.98 -38.77 76.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.948 -1.095 . . . . 1.0 110.292 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.1 mt -64.35 -44.08 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.81 -48.01 82.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.108 0.867 . . . . 1.0 109.274 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.36 -35.08 62.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 1.0 111.565 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.12 -61.06 2.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.792 0.837 . . . . 1.0 109.835 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -67.23 -49.98 62.43 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 t -57.73 -33.86 68.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 1.0 109.753 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 40.64 3.19 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.916 0.78 . . . . 1.0 111.879 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -131.3 16.28 5.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 117.972 0.886 . . . . 1.0 110.691 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.74 139.39 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.338 1.055 . . . . 1.0 110.445 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -98.42 127.47 36.05 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 127.641 2.376 . . . . 1.0 106.91 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.4 56.94 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.077 3.185 . . . . 1.0 111.819 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.77 -57.92 1.96 Allowed 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 124.961 1.304 . . . . 1.0 112.34 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.58 -60.33 1.58 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.744 1.217 . . . . 1.0 112.292 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -168.51 177.79 1.18 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 1.0 108.548 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.87 -43.45 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.726 1.618 . . . . 1.0 113.684 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -50.54 -60.1 3.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.672 1.189 . . . . 1.0 111.928 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.84 -51.65 68.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.846 0.858 . . . . 1.0 110.395 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.54 77.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.415 1.086 . . . . 1.0 111.508 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.19 -65.36 3.62 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 125.418 1.485 . . . . 1.0 110.603 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.91 -24.24 32.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 116.68 -1.629 . . . . 1.0 113.544 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.01 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.526 1.512 . . . . 1.0 113.659 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -57.41 -34.11 68.56 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.612 0.365 . . . . 1.0 110.956 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.49 136.38 33.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -66.04 149.29 50.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.909 -1.119 . . . . 1.0 109.402 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.3 m -117.09 162.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.068 1.347 . . . . 1.0 109.952 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -166.34 130.57 2.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.256 2.223 . . . . 1.0 105.976 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.11 -157.09 0.56 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -130.21 -61.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.192 0.997 . . . . 1.0 108.821 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.8 m -140.7 118.55 11.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.911 -1.885 . . . . 1.0 105.911 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.22 113.8 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.717 2.007 . . . . 1.0 105.607 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.64 114.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.974 -1.491 . . . . 1.0 106.974 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -70.99 152.84 43.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -14.05 2.58 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.693 0.797 . . . . 1.0 112.952 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -91.5 19.61 6.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 127.477 2.311 . . . . 1.0 112.1 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 28.94 70.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.686 2.565 . . . . 1.0 115.551 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.6 109.09 20.59 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.1 mt -76.54 121.12 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.073 -2.195 . . . . 1.0 105.073 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.33 125.78 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.506 -2.405 . . . . 1.0 104.506 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.36 113.6 27.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.146 0.978 . . . . 1.0 108.519 -175.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.9 114.31 20.83 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t 83.75 91.62 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.537 1.971 . . . . 1.0 110.357 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.72 -170.37 0.27 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.755 2.303 . . . . 1.0 110.68 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.3 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.243 2.217 . . . . 1.0 115.26 -176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -143.76 123.0 12.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.485 1.914 . . . . 1.0 109.531 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 86.44 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.22 3.008 . . . . 1.0 111.506 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -34.62 138.58 0.1 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.15 2.58 . . . . 1.0 113.04 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.88 -178.83 3.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.554 2.342 . . . . 1.0 111.353 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -150.28 118.73 6.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.241 1.416 . . . . 1.0 108.003 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -167.46 63.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.483 1.135 . . . . 1.0 110.442 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.08 -69.92 0.1 Allowed 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 118.606 -2.559 . . . . 1.0 111.749 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.36 0.33 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 125.187 1.554 . . . . 1.0 110.0 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 t -144.72 145.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.827 1.651 . . . . 1.0 109.899 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 p -165.82 149.54 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.626 1.171 . . . . 1.0 110.573 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.8 p -143.71 132.21 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.788 -1.93 . . . . 1.0 105.788 175.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -159.59 124.26 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.447 1.022 . . . . 1.0 108.313 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 58.79 71.69 0.57 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.41 1.884 . . . . 1.0 113.571 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.38 28.6 44.24 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.527 2.489 . . . . 1.0 113.312 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -147.02 113.22 5.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.36 141.42 28.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -123.95 117.86 25.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 102.997 -2.964 . . . . 1.0 102.997 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.4 t -66.23 -35.13 79.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -145.01 172.1 13.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.787 2.835 . . . . 1.0 106.006 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -84.84 77.11 10.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.413 1.102 . . . . 1.0 108.829 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.75 35.13 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.406 1.882 . . . . 1.0 111.417 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -123.72 153.05 41.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.879 0.872 . . . . 1.0 112.475 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -88.86 57.11 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.534 1.934 . . . . 1.0 107.029 175.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.95 -136.59 1.2 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.947 -1.095 . . . . 1.0 111.74 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 6.2 mm -142.55 161.47 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 129.329 3.052 . . . . 1.0 103.096 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -134.44 130.13 36.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.309 2.244 . . . . 1.0 105.001 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -101.19 153.03 19.95 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.736 -1.228 . . . . 1.0 108.919 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 158.03 45.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.73 0.776 . . . . 1.0 111.641 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.92 39.53 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.453 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.9 p -146.48 104.0 3.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 103.367 -2.827 . . . . 1.0 103.367 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t0 43.87 49.66 7.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.751 2.02 . . . . 1.0 112.984 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 p 50.31 38.08 16.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.051 2.14 . . . . 1.0 114.191 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.48 136.2 57.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.19 0.04 OUTLIER 'General case' 0 C--N 1.347 0.486 0 C-N-CA 127.373 2.269 . . . . 1.0 110.615 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -78.03 -10.3 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 115.892 -2.004 . . . . 1.0 116.339 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.333 44.8 p 64.74 77.31 0.32 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 121.355 1.889 . . . . 1.0 110.987 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -24.43 -32.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.246 1.818 . . . . 1.0 114.683 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -39.85 -43.67 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.314 1.846 . . . . 1.0 109.231 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -43.71 -50.93 7.45 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.779 1.231 . . . . 1.0 111.668 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.31 -39.81 88.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.458 0.572 . . . . 1.0 111.032 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -61.63 -58.57 7.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.032 0.533 . . . . 1.0 109.667 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -65.92 -47.12 75.81 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.544 -0.741 . . . . 1.0 111.599 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -54.85 -46.55 74.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.048 1.295 . . . . 1.0 109.34 177.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.44 96.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.535 1.061 . . . . 1.0 111.416 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.1 50.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.001 0.52 . . . . 1.0 109.654 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.0 t -52.2 -64.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.533 1.933 . . . . 1.0 108.61 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -53.96 -53.6 50.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.484 1.914 . . . . 1.0 112.209 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -57.85 -41.93 83.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.763 1.165 . . . . 1.0 109.555 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -69.86 -44.34 70.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.205 -0.935 . . . . 1.0 111.165 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.97 -36.77 70.71 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.12 -1.612 . . . . 1.0 111.458 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 mt -62.1 -35.57 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.01 -1.107 . . . . 1.0 108.01 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -64.96 -13.61 57.88 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.785 1.234 . . . . 1.0 110.774 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -98.63 -65.89 0.93 Allowed 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.158 -1.589 . . . . 1.0 106.981 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -119.41 112.91 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 106.673 -1.603 . . . . 1.0 106.673 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -92.78 108.19 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.649 1.566 . . . . 1.0 112.288 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.05 -49.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.587 1.955 . . . . 1.0 106.583 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.0 mt -48.41 -33.61 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 128.934 2.894 . . . . 1.0 110.829 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.42 12.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.344 1.057 . . . . 1.0 113.395 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.31 18.58 4.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.085 2.154 . . . . 1.0 110.656 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.83 83.62 1.97 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.67 1.188 . . . . 1.0 107.967 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.3 mtt -118.78 120.19 36.63 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.592 -1.633 . . . . 1.0 106.592 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -155.26 -169.57 3.2 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.27 -0.894 . . . . 1.0 110.339 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.03 -131.19 1.51 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 14.2 m170 -113.39 -23.51 9.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.362 1.081 . . . . 1.0 111.791 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -11.16 18.56 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -91.36 38.92 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.742 1.156 . . . . 1.0 108.489 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.07 -12.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 120.295 -1.503 . . . . 1.0 110.267 175.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.8 -54.39 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.546 1.939 . . . . 1.0 111.088 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.38 117.94 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.293 1.996 . . . . 1.0 113.395 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.85 -24.29 61.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.271 -0.893 . . . . 1.0 111.785 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -57.49 -19.35 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.64 2.376 . . . . 1.0 112.087 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.98 141.44 38.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.748 -1.575 . . . . 1.0 106.748 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -130.91 -16.72 3.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.898 1.226 . . . . 1.0 109.831 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.98 179.88 0.36 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 129.844 3.257 . . . . 1.0 104.772 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.33 79.75 3.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.149 1.899 . . . . 1.0 108.423 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.15 59.26 0.53 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.389 -1.229 . . . . 1.0 115.251 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 -52.3 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.069 2.435 . . . . 1.0 112.357 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.0 t 54.07 43.62 30.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.197 1.399 . . . . 1.0 111.866 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . 0.253 83.5 t80 -107.27 18.34 21.76 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.986 1.847 . . . . 1.0 115.986 -175.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.327 5.8 t70 42.05 75.0 0.1 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.424 1.49 . . . . 1.0 113.625 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -50.18 -35.34 25.84 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.64 79.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.861 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -51.28 68.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.849 1.204 . . . . 1.0 109.651 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -63.22 -52.82 60.67 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.825 0.306 . . . . 1.0 111.825 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -63.74 -26.65 68.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.265 -0.897 . . . . 1.0 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.11 88.65 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 1.0 109.992 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.29 -61.21 1.85 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.677 1.591 . . . . 1.0 111.7 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.6 t -66.26 165.77 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.3 1.04 . . . . 1.0 110.158 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 54.4 m -41.12 113.6 1.07 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.331 1.453 . . . . 1.0 110.717 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.01 54.78 4.03 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.3 2.667 . . . . 1.0 107.822 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 t 50.45 33.99 8.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.565 1.146 . . . . 1.0 113.134 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 t -149.91 -46.47 0.13 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -78.16 81.73 4.52 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -147.01 129.7 16.07 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.341 1.456 . . . . 1.0 107.953 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -66.66 175.33 2.4 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.063 0.392 . . . . 1.0 111.047 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 tpt -66.74 155.55 37.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.215 1.006 . . . . 1.0 112.083 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 114.97 -2.443 . . . . 1.0 108.439 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 104.218 -2.512 . . . . 1.0 104.218 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.23 153.45 15.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.181 0.993 . . . . 1.0 110.615 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.8 131.22 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.129 -2.175 . . . . 1.0 105.129 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.17 137.73 51.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 52.64 32.97 12.73 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.974 1.31 . . . . 1.0 110.601 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.91 1.52 32.93 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.967 1.27 . . . . 1.0 114.37 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -107.41 159.76 16.15 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 103.225 -2.879 . . . . 1.0 103.225 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.01 141.13 58.88 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 119.61 -1.931 . . . . 1.0 107.718 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 156.53 32.69 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.515 0.726 . . . . 1.0 110.24 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 38.7 58.08 1.74 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.133 2.173 . . . . 1.0 111.304 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.95 143.83 23.73 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.424 -0.797 . . . . 1.0 111.341 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -82.34 124.23 29.8 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.027 1.331 . . . . 1.0 108.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.57 119.23 24.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 t -142.18 75.34 20.25 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.011 1.324 . . . . 1.0 108.198 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 123.58 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.516 1.478 . . . . 1.0 112.673 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -49.8 146.08 7.99 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.434 1.894 . . . . 1.0 111.92 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.76 -37.42 6.8 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 N-CA-C 114.734 1.013 . . . . 1.0 114.734 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -151.48 135.67 16.73 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -104.28 -170.88 1.83 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.553 1.141 . . . . 1.0 109.675 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.69 178.95 5.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.283 2.633 . . . . 1.0 111.61 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.1 m -140.92 153.95 45.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 129.522 3.129 . . . . 1.0 104.993 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -131.16 157.03 79.27 Favored Pre-proline 0 N--CA 1.467 0.377 0 O-C-N 120.918 -1.114 . . . . 1.0 109.444 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.31 51.08 2.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.072 2.515 . . . . 1.0 111.883 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -148.6 153.63 38.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 126.305 1.842 . . . . 1.0 109.988 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.72 103.2 3.76 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -137.0 164.65 27.85 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.734 -0.603 . . . . 1.0 109.431 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.87 123.8 78.98 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.438 1.895 . . . . 1.0 108.068 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.27 103.48 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 N-CA-C 108.318 -1.455 . . . . 1.0 108.318 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 t -165.09 67.67 0.13 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.37 129.58 22.22 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -95.13 128.64 42.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.959 -1.867 . . . . 1.0 105.959 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.17 140.11 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.31 114.2 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -169.61 133.6 1.31 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.81 113.57 8.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.105 -1.443 . . . . 1.0 107.105 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' CG2' ' H ' ' A' ' 37' ' ' SER . 32.4 mm -126.41 177.06 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 127.741 2.416 . . . . 1.0 107.623 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.411 ' H ' ' CG2' ' A' ' 36' ' ' ILE . 30.9 t -155.5 121.72 5.17 Favored 'General case' 0 C--N 1.316 -0.871 1 N-CA-C 95.421 -5.77 . . . . 1.0 95.421 173.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.324 0.5 OUTLIER -141.44 -61.45 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 119.119 0.872 . . . . 1.0 111.336 175.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 61.3 Cg_endo -79.77 157.79 24.53 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.676 2.25 . . . . 1.0 112.024 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.15 -0.23 10.57 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-O 114.159 -2.517 . . . . 1.0 115.172 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -11.79 -71.05 0.01 OUTLIER Glycine 0 C--N 1.352 1.44 0 C-N-CA 127.278 2.37 . . . . 1.0 113.36 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -155.02 122.97 5.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.345 1.858 . . . . 1.0 109.05 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -175.77 175.42 2.03 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 130.009 3.324 . . . . 1.0 107.614 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.31 6.96 24.89 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.235 1.398 . . . . 1.0 112.83 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.41 118.5 6.2 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.533 1.666 . . . . 1.0 109.951 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.73 -13.08 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.261 1.974 . . . . 1.0 114.386 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -62.01 -35.94 80.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.399 1.454 . . . . 1.0 110.928 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -64.18 -47.03 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.061 0.944 . . . . 1.0 109.238 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -34.74 78.88 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.482 -0.761 . . . . 1.0 112.126 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.8 -33.78 50.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.132 1.373 . . . . 1.0 111.625 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.69 -55.92 28.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.965 1.306 . . . . 1.0 110.259 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE1' ' HA ' ' A' ' 39' ' ' PRO . 42.0 m-85 -71.31 -40.74 70.64 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 126.649 1.98 . . . . 1.0 112.969 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 t -66.0 -33.32 75.55 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.222 -0.924 . . . . 1.0 109.538 176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.56 24.86 10.51 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 118.698 -1.057 . . . . 1.0 113.525 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -121.46 16.63 11.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.185 1.492 . . . . 1.0 111.575 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.7 135.27 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.408 1.083 . . . . 1.0 110.758 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.95 136.59 20.56 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.199 1.8 . . . . 1.0 109.095 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.78 56.87 3.01 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.798 2.999 . . . . 1.0 113.204 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -103.47 -49.65 3.65 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.586 0.958 . . . . 1.0 113.586 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.93 -60.62 2.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.972 0.805 . . . . 1.0 112.674 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -170.53 177.79 0.95 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.558 1.543 . . . . 1.0 107.477 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -72.85 -43.53 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.304 1.336 . . . . 1.0 114.996 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -50.77 -59.11 4.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.954 1.252 . . . . 1.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.12 -49.83 76.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 1.0 110.251 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.68 90.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.818 0.847 . . . . 1.0 111.108 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.14 -63.63 4.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.048 1.785 . . . . 1.0 110.075 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.89 -26.83 41.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 116.408 -1.758 . . . . 1.0 112.947 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -42.98 3.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.105 1.762 . . . . 1.0 114.729 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -52.49 -39.08 60.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.572 1.549 . . . . 1.0 110.871 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.78 136.28 33.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.499 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.06 161.26 22.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.416 -0.802 . . . . 1.0 109.035 175.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.49 164.39 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.896 1.279 . . . . 1.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -169.52 118.05 0.63 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.909 1.284 . . . . 1.0 108.332 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.61 -174.48 3.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.79 1.236 . . . . 1.0 109.052 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -112.17 -73.64 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.242 1.017 . . . . 1.0 111.628 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.02 118.74 27.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 103.66 -2.719 . . . . 1.0 103.66 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tp -104.23 113.34 26.82 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.264 -2.865 . . . . 1.0 103.264 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.03 113.49 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 105.644 -1.984 . . . . 1.0 105.644 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -85.37 149.22 25.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.115 0.87 . . . . 1.0 110.399 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -46.82 -13.85 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 128.418 2.687 . . . . 1.0 115.547 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.89 27.98 1.95 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.929 1.291 . . . . 1.0 112.711 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.3 28.96 70.14 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.584 1.564 . . . . 1.0 114.484 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.48 153.05 20.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.299 1.05 . . . . 1.0 111.502 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.45 114.08 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 104.668 -2.345 . . . . 1.0 104.668 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 145.69 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -124.3 115.49 21.11 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.947 0.899 . . . . 1.0 110.403 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -110.38 129.8 55.69 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 127.828 2.451 . . . . 1.0 105.525 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.6 t 63.4 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 121.985 2.175 . . . . 1.0 115.148 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -64.1 -174.11 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 121.658 1.572 . . . . 1.0 111.423 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -67.18 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.57 1.948 . . . . 1.0 114.372 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -140.84 111.53 6.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.734 2.014 . . . . 1.0 108.482 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 84.05 81.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.421 2.289 . . . . 1.0 109.976 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -37.33 146.28 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.675 3.19 . . . . 1.0 111.469 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.14 -178.35 3.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.859 1.264 . . . . 1.0 111.674 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -141.78 118.6 11.12 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.2 63.16 0.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.852 1.31 . . . . 1.0 107.964 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.24 -69.04 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 119.224 -2.172 . . . . 1.0 114.454 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.96 -85.67 0.4 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 103.203 -3.959 . . . . 1.0 103.203 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.21 146.45 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 119.797 1.799 . . . . 1.0 110.502 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.5 p -155.84 155.77 33.52 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.055 1.742 . . . . 1.0 108.096 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.413 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.9 p -147.99 132.32 17.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.094 -1.817 . . . . 1.0 106.094 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -160.63 156.93 26.35 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.228 0.611 . . . . 1.0 109.565 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 39.13 53.65 2.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.4 1.48 . . . . 1.0 112.251 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.21 28.26 18.36 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.298 2.856 . . . . 1.0 114.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -129.86 121.4 26.63 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 119.619 1.709 . . . . 1.0 107.058 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -92.62 141.96 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -116.35 118.52 32.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.8 -1.556 . . . . 1.0 106.8 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.5 t -55.69 -38.83 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.815 0.846 . . . . 1.0 110.09 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -152.98 164.79 37.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.997 2.919 . . . . 1.0 105.019 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 112' ' ' SER . 32.0 t70 -84.28 76.71 10.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 122.584 1.183 . . . . 1.0 111.154 178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.85 43.42 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.894 2.478 . . . . 1.0 108.542 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 110' ' ' ASP . 2.8 m -123.29 156.79 34.57 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.391 1.876 . . . . 1.0 111.434 -175.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -96.54 57.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.705 2.002 . . . . 1.0 107.92 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.13 -136.96 1.65 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.983 -1.073 . . . . 1.0 112.033 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.8 mt -152.29 164.88 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 131.512 3.925 . . . . 1.0 102.36 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -144.86 143.1 30.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.053 2.141 . . . . 1.0 105.277 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -101.46 155.39 18.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.824 -1.173 . . . . 1.0 110.303 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -131.43 138.87 49.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.33 -172.73 39.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.353 0.978 . . . . 1.0 110.906 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -133.78 92.46 2.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.578 -0.954 . . . . 1.0 108.628 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.4 t0 54.34 56.97 6.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.471 1.508 . . . . 1.0 113.49 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 16.5 p 60.91 38.42 17.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.181 1.792 . . . . 1.0 113.605 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.6 132.02 47.26 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.29 -2.485 . . . . 1.0 104.29 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -30.32 115.03 0.12 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.387 1.875 . . . . 1.0 110.536 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -78.09 -2.45 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 114.943 -2.456 . . . . 1.0 116.975 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.341 42.4 p 67.39 78.05 0.25 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 115.727 -2.083 . . . . 1.0 111.374 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -24.23 -34.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 121.596 1.998 . . . . 1.0 116.157 177.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.75 14.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.163 2.185 . . . . 1.0 110.333 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -49.15 -50.55 37.07 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 125.077 1.351 . . . . 1.0 109.826 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -60.87 -40.63 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.832 -0.604 . . . . 1.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -65.38 -47.88 74.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.354 0.524 . . . . 1.0 111.061 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.89 -54.04 31.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.451 1.1 . . . . 1.0 110.254 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.5 tp -54.5 -46.47 73.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.122 1.369 . . . . 1.0 108.805 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.46 87.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.934 1.243 . . . . 1.0 111.664 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.64 54.24 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.7 -53.11 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.623 -0.703 . . . . 1.0 109.365 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.4 m -55.38 -61.31 2.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.403 1.881 . . . . 1.0 111.059 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -53.75 -43.08 68.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.606 0.717 . . . . 1.0 110.878 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.009 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 mt -56.76 -36.93 70.38 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.087 -1.633 . . . . 1.0 111.373 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.04 -31.88 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.655 1.182 . . . . 1.0 109.727 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m -64.26 -16.88 62.96 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.88 0.764 . . . . 1.0 111.006 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -65.15 0.98 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 120.664 -1.272 . . . . 1.0 108.274 175.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -110.29 112.84 56.92 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 108.004 -1.109 . . . . 1.0 108.004 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -104.07 108.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 119.697 0.927 . . . . 1.0 111.372 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.15 -51.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.097 2.559 . . . . 1.0 105.912 174.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -45.2 -33.51 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 1 C-N-CA 131.82 4.048 . . . . 1.0 110.013 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.15 -25.54 0.91 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.59 18.97 4.29 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.582 2.353 . . . . 1.0 111.133 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.75 84.29 2.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.88 1.272 . . . . 1.0 109.687 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 116.58 21.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.03 -1.841 . . . . 1.0 106.03 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 -173.25 4.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.846 0.748 . . . . 1.0 109.852 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.31 -131.06 2.64 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 106.696 -2.562 . . . . 1.0 106.696 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.465 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 19.8 m170 -112.71 -23.87 9.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.59 0.756 . . . . 1.0 111.215 -177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 t -102.89 -17.05 15.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.615 1.166 . . . . 1.0 111.081 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -85.12 40.3 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.338 1.426 . . . . 1.0 109.196 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.413 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -69.71 -9.2 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 O-C-N 120.744 -1.222 . . . . 1.0 109.019 175.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.13 -53.52 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.001 2.52 . . . . 1.0 111.538 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -96.42 121.61 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.852 2.368 . . . . 1.0 114.217 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.51 -17.09 63.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.564 -1.335 . . . . 1.0 112.141 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -24.93 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.115 -0.991 . . . . 1.0 111.48 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -144.31 123.77 13.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.475 -2.046 . . . . 1.0 105.475 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.2 m -114.16 -16.29 12.1 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.402 0.438 . . . . 1.0 112.045 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.24 171.46 1.06 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 128.446 2.698 . . . . 1.0 104.755 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 87.34 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.308 2.006 . . . . 1.0 109.747 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.74 75.42 0.68 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.143 1.83 . . . . 1.0 110.996 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.14 -95.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.736 2.291 . . . . 1.0 110.024 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 54.3 43.64 30.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.188 2.595 . . . . 1.0 111.0 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -97.53 18.58 15.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.348 0.659 . . . . 1.0 111.94 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.4 t0 44.88 67.22 0.74 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.745 1.218 . . . . 1.0 111.803 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.19 -25.51 59.14 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.706 -0.621 . . . . 1.0 112.474 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -55.75 15.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 117.794 -1.098 . . . . 1.0 109.605 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -62.4 -42.84 99.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 117.312 -1.328 . . . . 1.0 110.547 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -61.41 -52.67 63.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.108 1.322 . . . . 1.0 110.881 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.36 77.78 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.16 86.96 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.68 -54.8 14.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.79 1.636 . . . . 1.0 111.007 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.8 160.09 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.133 0.973 . . . . 1.0 109.098 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 26.4 m -46.86 115.91 3.62 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.51 1.924 . . . . 1.0 105.89 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.97 49.07 3.02 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.705 2.937 . . . . 1.0 114.28 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.1 t 47.33 35.19 3.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.481 1.61 . . . . 1.0 111.662 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 t -158.92 168.55 26.48 Favored 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 132.313 4.245 . . . . 1.0 102.243 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 55.69 49.03 17.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.95 1.25 . . . . 1.0 107.74 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tmmt? -130.68 167.01 19.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.298 1.039 . . . . 1.0 110.433 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 155.15 50.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.371 2.668 . . . . 1.0 105.956 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 16.4 ttt -171.42 164.72 7.02 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 1.0 107.847 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.249 1.074 0 N-CA-C 102.374 -3.195 . . . . 1.0 102.374 174.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' H1 ' ' HB2' ' A' ' 139' ' ' ALA . 11.6 ttt . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 106.208 -1.775 . . . . 1.0 106.208 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.86 134.41 53.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 161.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.0 mt -122.75 136.3 54.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -116.97 133.44 56.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 45.38 33.3 1.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.829 1.652 . . . . 1.0 115.021 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.71 79.38 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 119.838 -1.789 . . . . 1.0 112.273 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -127.28 164.58 21.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 103.665 -2.717 . . . . 1.0 103.665 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.56 124.23 27.29 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.33 173.86 8.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.605 0.762 . . . . 1.0 111.042 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 40.04 57.75 2.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.721 2.408 . . . . 1.0 109.993 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.14 153.6 20.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -81.68 130.15 34.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.55 118.64 23.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -138.48 88.74 14.27 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.11 123.82 11.41 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 N-CA-C 109.333 -1.064 . . . . 1.0 109.333 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -63.64 146.53 96.65 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.05 -25.29 19.55 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 N-CA-C 117.393 2.036 . . . . 1.0 117.393 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -150.82 117.89 5.93 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.841 -1.911 . . . . 1.0 105.841 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.92 178.17 7.04 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.084 0.954 . . . . 1.0 112.543 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.38 178.99 4.09 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.931 1.693 . . . . 1.0 111.859 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.3 m -164.94 127.46 2.22 Favored 'General case' 0 CA--C 1.534 0.354 1 C-N-CA 133.356 4.662 . . . . 1.0 103.184 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -131.33 153.78 81.74 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.699 1.136 . . . . 1.0 108.614 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.92 67.67 8.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.104 3.203 . . . . 1.0 110.804 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.48 159.5 42.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.632 1.573 . . . . 1.0 110.734 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -150.91 103.92 3.11 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 27' ' ' ASN . 2.0 tm-20 -137.25 176.48 8.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.41 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 10.9 t30 -84.48 123.0 75.2 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.792 -1.559 . . . . 1.0 106.792 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.26 103.02 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 N-CA-C 108.3 -1.462 . . . . 1.0 108.3 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 t -175.76 69.05 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -147.9 130.45 15.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.99 0.916 . . . . 1.0 108.705 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.7 tp -84.38 124.52 31.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.28 114.04 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.8 t -114.22 113.93 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -163.54 143.58 8.63 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.545 -2.021 . . . . 1.0 105.545 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 8.0 mm -127.59 176.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 130.835 3.654 . . . . 1.0 107.851 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -160.28 121.78 3.12 Favored 'General case' 0 N--CA 1.432 -1.365 1 N-CA-C 97.829 -4.878 . . . . 1.0 97.829 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.557 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 4.8 tt -142.57 -43.9 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.398 -1.763 . . . . 1.0 112.941 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 44.7 Cg_endo -82.99 150.31 13.93 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 121.662 1.629 . . . . 1.0 114.833 -175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 7.38 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.843 3.028 . . . . 1.0 116.777 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -23.49 -71.3 0.01 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 121.059 1.754 . . . . 1.0 112.525 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -156.6 123.21 5.09 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.291 14.1 m-85 -177.76 153.94 0.9 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 129.649 3.18 . . . . 1.0 109.862 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.31 2.09 77.75 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.05 -0.861 . . . . 1.0 112.885 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.85 118.54 5.51 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.01 -4.05 14.45 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.373 2.049 . . . . 1.0 113.213 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' CZ2' ' CD1' ' A' ' 64' ' ' PHE . 32.6 t-105 -64.55 -39.55 93.97 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.598 1.09 . . . . 1.0 110.305 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.86 -46.63 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.568 1.947 . . . . 1.0 109.274 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.63 -46.37 89.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.861 0.755 . . . . 1.0 110.552 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.2 -34.06 63.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.236 1.414 . . . . 1.0 111.39 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.27 -54.79 27.7 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.195 0.452 . . . . 1.0 110.524 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -70.1 -42.5 72.62 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 119.014 -0.517 . . . . 1.0 112.297 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.16 -34.23 77.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.33 1.052 . . . . 1.0 109.049 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.21 -0.47 31.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.367 1.46 . . . . 1.0 115.681 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.3 p -88.99 11.19 18.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.057 1.928 . . . . 1.0 112.934 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.8 tt -51.63 135.9 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.108 1.763 . . . . 1.0 112.793 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -98.62 131.31 26.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 127.446 2.299 . . . . 1.0 109.29 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.2 63.01 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.68 3.587 . . . . 1.0 110.184 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -104.54 -65.93 1.0 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.407 1.883 . . . . 1.0 113.15 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.35 -54.76 15.55 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.69 1.196 . . . . 1.0 110.714 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -171.32 177.82 0.87 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.685 1.994 . . . . 1.0 106.766 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.49 -43.63 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.494 1.462 . . . . 1.0 114.033 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -50.84 -57.6 8.03 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' CZ2' ' A' ' 47' ' ' TRP . 20.8 t80 -59.27 -44.96 92.4 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.205 0.602 . . . . 1.0 111.475 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.67 97.94 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.831 -0.543 . . . . 1.0 111.324 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.68 -60.81 8.23 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.827 1.203 . . . . 1.0 112.026 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.2 pt -51.0 -41.48 22.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.798 1.239 . . . . 1.0 112.96 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -38.01 -43.53 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 127.901 2.48 . . . . 1.0 115.158 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -60.8 -35.58 76.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.449 0.7 . . . . 1.0 110.423 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.77 135.75 33.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 153.46 32.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.377 -0.929 . . . . 1.0 110.05 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.54 163.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.165 1.386 . . . . 1.0 108.671 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 m -170.67 128.04 0.78 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.306 -1.739 . . . . 1.0 106.306 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.17 -154.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.461 -1.681 . . . . 1.0 106.461 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -124.63 -58.55 1.5 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.879 1.672 . . . . 1.0 110.0 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -142.65 121.35 12.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.53 113.93 21.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.385 1.474 . . . . 1.0 107.853 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.3 mt -97.55 116.59 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.711 1.204 . . . . 1.0 108.078 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -78.92 153.35 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.345 1.884 . . . . 1.0 109.574 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -46.87 -23.23 0.41 Allowed 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.711 2.004 . . . . 1.0 114.259 176.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . 18.3 t0 -91.42 34.61 0.95 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.225 0.921 . . . . 1.0 110.478 -175.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.08 29.56 71.33 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.109 -0.995 . . . . 1.0 113.868 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.53 140.67 32.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.01 114.07 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 103.838 -2.653 . . . . 1.0 103.838 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 t -111.67 139.6 35.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.362 0.665 . . . . 1.0 109.514 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -104.87 118.83 37.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -117.65 113.34 21.76 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 103.239 -2.874 . . . . 1.0 103.239 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.1 t 69.2 91.8 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.31 1.414 . . . . 1.0 112.332 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -66.88 -168.25 0.15 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.471 2.114 . . . . 1.0 111.669 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -60.71 22.76 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 129.378 3.071 . . . . 1.0 116.811 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -159.69 133.49 7.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.972 1.714 . . . . 1.0 107.865 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 tptm 86.29 82.14 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 129.453 3.101 . . . . 1.0 109.665 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.12 147.5 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.991 3.317 . . . . 1.0 115.425 -174.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.07 175.95 5.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.342 3.057 . . . . 1.0 111.076 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -156.12 118.19 4.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.074 1.75 . . . . 1.0 107.343 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.9 63.22 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.287 -1.508 . . . . 1.0 112.318 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.14 -62.79 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.202 -2.186 . . . . 1.0 114.358 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.32 -91.4 0.47 Allowed Glycine 0 CA--C 1.53 1.005 0 N-CA-C 103.608 -3.797 . . . . 1.0 103.608 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.84 146.4 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.807 1.803 . . . . 1.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -154.77 166.51 33.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.479 1.511 . . . . 1.0 110.312 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.422 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -150.9 146.83 26.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.4 1.48 . . . . 1.0 110.745 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.54 133.88 21.81 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.832 -0.543 . . . . 1.0 110.054 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 39.36 65.77 0.65 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.74 2.016 . . . . 1.0 111.367 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 29.26 67.21 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.089 1.196 . . . . 1.0 116.089 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -130.55 136.25 48.73 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.854 -1.906 . . . . 1.0 105.854 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.05 146.83 28.55 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.529 2.332 . . . . 1.0 111.931 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -127.42 118.35 23.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.763 1.225 . . . . 1.0 107.814 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -79.68 -23.42 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.469 0.708 . . . . 1.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -144.97 175.22 10.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.863 2.065 . . . . 1.0 106.547 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -101.2 76.73 1.74 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.55 33.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.011 2.124 . . . . 1.0 113.72 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -129.37 138.98 51.84 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 121.201 -0.937 . . . . 1.0 111.491 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.257 0.1 OUTLIER -78.54 56.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.931 2.092 . . . . 1.0 109.798 -177.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.6 -136.4 1.39 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 122.289 0.939 . . . . 1.0 111.247 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.5 mm -144.02 166.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 130.151 3.38 . . . . 1.0 103.144 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -143.43 136.85 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 103.222 -2.881 . . . . 1.0 103.222 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -98.81 134.28 41.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.166 -0.959 . . . . 1.0 109.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 24.3 tt0 -105.61 138.28 42.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.806 0.812 . . . . 1.0 110.285 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.47 40.11 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.47 1.986 . . . . 1.0 109.41 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -153.28 116.18 4.53 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.32 39.7 30.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.865 1.316 . . . . 1.0 112.194 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p 45.08 37.73 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.293 2.237 . . . . 1.0 112.529 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.04 136.69 58.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.66 113.38 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.695 2.398 . . . . 1.0 112.618 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -78.67 -16.2 57.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 116.554 -1.689 . . . . 1.0 112.876 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.359 10.3 p 66.51 77.54 0.28 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 121.183 1.81 . . . . 1.0 112.118 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.25 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.699 2.045 . . . . 1.0 115.25 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.12 -36.92 3.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 1.0 109.354 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -56.41 -58.49 7.77 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 125.564 1.546 . . . . 1.0 107.559 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -52.79 -44.73 66.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.263 0.938 . . . . 1.0 110.075 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -66.16 -58.15 6.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.549 0.74 . . . . 1.0 111.947 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -66.3 -34.33 77.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.503 1.047 . . . . 1.0 112.09 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 tp -61.14 -44.56 97.13 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 106.962 -1.495 . . . . 1.0 106.962 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.5 80.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.134 -0.936 . . . . 1.0 110.412 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.99 -55.35 35.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.447 1.021 . . . . 1.0 109.972 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.33 -49.18 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 1.0 109.338 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.1 m -58.38 -53.89 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.594 1.158 . . . . 1.0 109.873 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -56.09 -43.67 78.25 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.914 1.285 . . . . 1.0 110.478 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HB2' ' H1 ' ' A' ' 1' ' ' MET . . . -67.32 -49.62 63.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.12 0.568 . . . . 1.0 111.713 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -56.56 -34.57 67.24 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 117.918 -1.039 . . . . 1.0 111.264 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.28 -43.38 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 120.159 1.345 . . . . 1.0 109.144 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.5 m -64.43 -23.1 67.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.854 0.752 . . . . 1.0 111.524 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -83.77 -58.55 2.75 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.788 -1.195 . . . . 1.0 108.438 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.61 113.15 22.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.549 1.54 . . . . 1.0 109.104 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.54 107.78 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 CA-C-N 120.857 1.342 . . . . 1.0 111.867 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.23 -51.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.014 2.125 . . . . 1.0 107.798 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.4 mt -45.16 -33.4 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 131.508 3.923 . . . . 1.0 111.078 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.99 -23.42 5.08 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.222 1.009 . . . . 1.0 113.541 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -140.52 30.75 1.9 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.687 2.395 . . . . 1.0 109.089 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -140.7 83.78 1.91 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.367 1.867 . . . . 1.0 110.311 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.57 116.65 16.15 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 126.661 1.984 . . . . 1.0 105.718 175.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.6 t -151.69 -173.2 4.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.98 -131.52 2.29 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 105.604 -2.998 . . . . 1.0 105.604 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.306 13.0 m170 -112.98 -22.28 10.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.867 1.267 . . . . 1.0 111.311 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.02 -11.25 17.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.493 0.588 . . . . 1.0 109.807 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -86.57 36.41 0.7 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.632 1.105 . . . . 1.0 108.532 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -67.8 -12.07 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 120.399 -1.438 . . . . 1.0 109.859 175.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.06 -66.01 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.74 2.416 . . . . 1.0 111.16 175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -92.65 127.89 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.275 1.983 . . . . 1.0 114.075 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.46 -26.25 65.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.938 1.295 . . . . 1.0 112.615 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -63.13 -21.66 66.34 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.856 1.263 . . . . 1.0 111.774 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 138.92 53.29 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 105.174 -2.158 . . . . 1.0 105.174 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -132.39 -16.63 2.7 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 118.868 -1.133 . . . . 1.0 110.844 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -179.27 0.35 Allowed Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 129.171 2.989 . . . . 1.0 104.292 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.29 52.23 4.2 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 122.543 2.162 . . . . 1.0 112.5 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.72 73.24 0.12 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.005 1.764 . . . . 1.0 112.538 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.15 -63.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.46 2.106 . . . . 1.0 111.955 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.7 t 54.46 43.8 29.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.932 2.093 . . . . 1.0 110.446 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -94.02 18.25 10.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.72 71.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.942 1.297 . . . . 1.0 112.858 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -54.78 -32.28 59.87 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 115.154 -0.93 . . . . 1.0 112.634 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.06 71.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.356 -0.83 . . . . 1.0 110.148 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -61.66 -55.96 24.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.399 0.999 . . . . 1.0 110.74 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.86 -51.28 70.4 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.727 1.751 . . . . 1.0 115.727 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.453 HH21 ' HA ' ' A' ' 180' ' ' PRO . 0.0 OUTLIER -60.04 -39.11 84.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.137 0.881 . . . . 1.0 109.279 -175.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.39 78.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.566 0.95 . . . . 1.0 113.566 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.12 -45.33 92.5 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.352 1.461 . . . . 1.0 114.068 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.34 160.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -43.66 114.01 1.64 Allowed Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.869 1.668 . . . . 1.0 106.554 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.453 ' HA ' HH21 ' A' ' 175' ' ' ARG . 42.4 Cg_endo -79.28 41.03 1.02 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.145 1.897 . . . . 1.0 114.578 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.6 t 50.3 33.75 7.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.922 2.089 . . . . 1.0 111.087 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.9 t -155.66 34.81 0.36 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.094 1.757 . . . . 1.0 109.131 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -158.15 81.27 0.84 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.992 1.317 . . . . 1.0 107.938 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -156.91 126.38 6.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.54 153.81 17.63 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.195 -1.409 . . . . 1.0 107.195 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.4 tpt -115.4 75.46 0.94 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.79 0.805 . . . . 1.0 110.523 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 C--O 1.251 1.141 0 N-CA-C 103.068 -2.938 . . . . 1.0 103.068 175.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 tpt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.37 123.56 28.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt -136.02 136.35 40.19 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 105.974 -1.862 . . . . 1.0 105.974 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.48 123.43 42.02 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.981 1.712 . . . . 1.0 109.318 -175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 47.23 37.83 6.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.472 1.509 . . . . 1.0 114.711 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.74 16.55 76.2 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.288 -0.882 . . . . 1.0 113.167 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -126.84 173.04 9.88 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.613 2.765 . . . . 1.0 105.301 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.63 130.28 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.112 -1.811 . . . . 1.0 106.112 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 165.91 23.3 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.556 0.743 . . . . 1.0 112.239 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 42.28 58.46 2.99 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.815 1.646 . . . . 1.0 109.046 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.49 145.94 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.656 1.183 . . . . 1.0 109.683 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -76.08 123.15 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.45 118.96 30.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.906 0.775 . . . . 1.0 109.027 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.19 73.52 81.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.3 123.92 11.11 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.724 1.616 . . . . 1.0 108.812 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -137.53 113.51 9.38 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 126.566 1.947 . . . . 1.0 106.949 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.25 58.8 7.11 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.275 1.983 . . . . 1.0 110.845 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -123.73 43.53 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.925 1.69 . . . . 1.0 106.709 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -82.82 179.28 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.385 1.474 . . . . 1.0 110.374 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.3 178.57 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.666 1.586 . . . . 1.0 109.031 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.4 m -150.55 131.64 14.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.865 2.466 . . . . 1.0 105.121 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.26 149.28 72.11 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 108.258 -1.015 . . . . 1.0 108.258 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.04 97.38 1.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 N-CA-C 106.601 -2.115 . . . . 1.0 106.601 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -162.6 147.95 12.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -146.73 108.07 4.25 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.979 0.809 . . . . 1.0 109.699 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -136.2 160.24 39.29 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 127.399 2.28 . . . . 1.0 106.952 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -69.36 123.4 88.28 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.59 103.0 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.626 -1.336 . . . . 1.0 108.626 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.41 ' HG ' ' HB3' ' A' ' 146' ' ' ALA . 29.0 t -175.9 70.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.07 127.35 13.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 105.091 -2.188 . . . . 1.0 105.091 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.31 129.37 41.01 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.9 139.53 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 105.976 -1.861 . . . . 1.0 105.976 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.84 122.9 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.473 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -171.07 150.22 3.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.275 1.43 . . . . 1.0 107.357 175.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -95.3 111.9 23.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mm -127.37 176.4 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 128.333 2.653 . . . . 1.0 107.59 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 t -148.89 122.18 8.99 Favored 'General case' 0 C--O 1.247 0.938 1 N-CA-C 94.825 -5.991 . . . . 1.0 94.825 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.338 0.4 OUTLIER -142.57 -65.15 0.02 OUTLIER Pre-proline 0 C--O 1.222 -0.347 0 CA-C-O 117.823 -1.084 . . . . 1.0 113.316 178.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.81 162.25 9.09 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.822 3.015 . . . . 1.0 115.523 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.58 28.83 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.831 3.021 . . . . 1.0 114.973 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -40.87 -71.42 0.31 Allowed Glycine 0 C--N 1.35 1.339 0 CA-C-N 120.78 1.627 . . . . 1.0 109.312 175.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -156.31 123.48 5.34 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.648 2.379 . . . . 1.0 107.124 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -176.89 176.95 1.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 131.366 3.866 . . . . 1.0 108.098 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.67 4.95 8.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.316 1.436 . . . . 1.0 111.603 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.61 136.56 14.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.368 1.584 . . . . 1.0 110.497 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.32 -16.99 15.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.828 2.352 . . . . 1.0 113.782 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -54.32 -39.9 67.46 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.528 1.058 . . . . 1.0 111.556 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.3 mt -64.99 -48.73 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.352 1.061 . . . . 1.0 109.047 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.55 -49.65 76.69 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.02 -34.68 68.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.942 0.897 . . . . 1.0 111.727 -176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.92 -49.31 68.44 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.151 0.98 . . . . 1.0 110.26 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -70.41 -48.27 56.87 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.257 0.623 . . . . 1.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -66.14 -37.47 85.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.305 1.842 . . . . 1.0 109.955 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.24 1.65 28.1 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.222 1.391 . . . . 1.0 115.357 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -89.08 9.89 23.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.322 2.061 . . . . 1.0 113.045 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.81 136.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.142 1.777 . . . . 1.0 113.116 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.88 122.7 51.94 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.87 2.468 . . . . 1.0 109.375 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.56 58.77 5.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.032 3.155 . . . . 1.0 111.016 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.09 -54.72 2.56 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 117.752 -1.118 . . . . 1.0 111.914 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.65 -51.15 61.39 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.59 1.087 . . . . 1.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -170.4 178.02 0.93 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.701 2.0 . . . . 1.0 107.032 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -75.95 -43.31 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.36 1.373 . . . . 1.0 114.125 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -42.41 -47.54 4.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.886 1.675 . . . . 1.0 113.758 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.81 -55.45 34.7 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.839 1.256 . . . . 1.0 109.6 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.0 95.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.265 1.426 . . . . 1.0 110.733 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.61 -64.11 1.96 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 127.048 2.261 . . . . 1.0 111.874 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 pt -61.42 -32.66 53.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 117.243 -1.36 . . . . 1.0 112.661 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.0 -43.12 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.004 2.224 . . . . 1.0 117.004 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.55 -33.83 73.25 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.489 -0.757 . . . . 1.0 110.33 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.88 135.37 33.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.528 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.17 162.67 19.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 175.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.48 158.54 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 124.513 1.125 . . . . 1.0 108.691 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.4 m -175.44 125.28 0.24 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.042 1.337 . . . . 1.0 108.887 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.18 -168.8 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 174.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -113.22 -76.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.2 m -124.03 118.41 26.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.86 113.69 27.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.081 -2.192 . . . . 1.0 105.081 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.7 mt -99.26 113.4 34.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ttp85 -85.28 153.4 22.61 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.54 -1.282 . . . . 1.0 107.54 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -48.65 -20.24 0.44 Allowed 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.543 1.937 . . . . 1.0 115.266 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.68 28.24 1.82 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.104 0.962 . . . . 1.0 112.442 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.83 30.04 71.89 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.297 1.903 . . . . 1.0 113.766 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.68 113.08 25.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.674 0.79 . . . . 1.0 110.474 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.38 120.97 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 104.822 -2.288 . . . . 1.0 104.822 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.43 149.08 14.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.666 -2.346 . . . . 1.0 104.666 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -126.12 122.1 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.731 0.812 . . . . 1.0 110.818 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -121.21 129.51 53.24 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 128.856 2.862 . . . . 1.0 103.922 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.8 t 64.42 91.72 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 CA-C-N 121.684 2.038 . . . . 1.0 113.753 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -66.44 -170.43 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.515 2.143 . . . . 1.0 113.396 177.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.09 15.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.455 2.702 . . . . 1.0 115.099 -175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -137.87 116.69 12.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.329 2.252 . . . . 1.0 108.021 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 tttt 78.86 81.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 128.288 2.635 . . . . 1.0 107.554 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.28 150.78 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 130.266 3.426 . . . . 1.0 113.67 -175.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.28 -178.24 3.6 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.993 2.117 . . . . 1.0 110.104 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -147.88 118.9 7.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.175 1.352 . . . . 1.0 110.34 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.49 63.06 0.17 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.728 1.251 . . . . 1.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -158.26 -54.89 0.07 Allowed 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 118.76 -2.463 . . . . 1.0 114.354 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.81 -74.83 1.12 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.029 -2.028 . . . . 1.0 108.029 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.8 t -149.26 135.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.605 1.703 . . . . 1.0 110.933 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -166.98 149.24 6.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.202 1.801 . . . . 1.0 109.789 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.592 ' H ' HG23 ' A' ' 157' ' ' ILE . 2.7 p -134.03 146.45 50.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 128.374 2.669 . . . . 1.0 110.785 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -150.17 142.61 24.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 39.13 53.81 2.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.507 1.523 . . . . 1.0 112.802 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.01 29.16 70.14 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.374 -0.681 . . . . 1.0 114.751 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -130.11 113.8 14.95 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.444 -1.688 . . . . 1.0 106.444 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.49 146.7 23.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.776 1.23 . . . . 1.0 107.721 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.5 mtm-85 -112.29 118.58 35.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.849 1.26 . . . . 1.0 108.076 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.51 -30.11 71.14 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.807 0.692 . . . . 1.0 110.338 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -146.03 170.14 17.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.516 1.126 . . . . 1.0 108.192 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.91 76.89 8.79 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.208 1.004 . . . . 1.0 109.485 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.95 33.8 1.3 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.054 1.341 . . . . 1.0 112.415 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -127.89 156.47 42.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.08 1.352 . . . . 1.0 112.628 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.08 56.83 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.832 2.053 . . . . 1.0 109.089 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.22 -136.78 3.84 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.05 -1.031 . . . . 1.0 112.385 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 12.3 mm -145.15 165.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.44 2.696 . . . . 1.0 104.549 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.49 138.55 26.2 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.492 -2.41 . . . . 1.0 104.492 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.8 151.38 22.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.897 0.771 . . . . 1.0 110.52 176.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -130.43 138.93 50.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.294 0.568 . . . . 1.0 111.064 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.85 -171.75 37.88 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.002 1.763 . . . . 1.0 110.124 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 p -148.65 115.33 5.97 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 103.346 -2.835 . . . . 1.0 103.346 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t0 42.18 53.15 4.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 129.393 3.077 . . . . 1.0 113.994 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 49.32 38.87 14.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.793 1.637 . . . . 1.0 113.493 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 tp -56.66 143.81 34.71 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 107.127 -1.435 . . . . 1.0 107.127 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -34.84 115.67 0.29 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.625 1.97 . . . . 1.0 109.867 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.67 -7.85 58.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.776 -2.059 . . . . 1.0 114.517 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.397 20.3 p 66.5 78.59 0.26 Allowed 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 121.398 1.908 . . . . 1.0 112.528 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.34 -34.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.007 1.73 . . . . 1.0 114.372 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.42 -41.33 9.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.072 2.149 . . . . 1.0 111.635 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -48.97 -51.18 31.87 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.023 1.329 . . . . 1.0 109.29 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -58.67 -37.35 75.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.536 -0.745 . . . . 1.0 110.541 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -64.61 -55.85 17.64 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.154 0.888 . . . . 1.0 110.861 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.93 -47.32 75.1 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.069 0.948 . . . . 1.0 110.918 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 56.4 tp -56.36 -47.36 79.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.021 1.328 . . . . 1.0 108.43 175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.37 99.26 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.493 1.042 . . . . 1.0 110.236 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.72 54.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.027 0.831 . . . . 1.0 110.036 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.7 t -55.88 -47.3 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.657 0.783 . . . . 1.0 109.375 176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 72.9 m -57.12 -53.31 59.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.253 1.021 . . . . 1.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -56.04 -45.7 79.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.927 0.891 . . . . 1.0 110.542 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.7 63.93 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.524 -0.735 . . . . 1.0 110.385 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.86 -45.32 82.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.528 1.531 . . . . 1.0 110.763 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.51 -42.96 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.191 0.996 . . . . 1.0 109.582 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -64.73 -24.93 67.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.969 -0.457 . . . . 1.0 110.508 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -84.08 -59.29 2.45 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.263 -1.384 . . . . 1.0 107.263 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -122.2 113.0 31.27 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -102.92 107.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 116.595 -1.803 . . . . 1.0 112.809 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.41 ' HB3' ' HG ' ' A' ' 29' ' ' SER . . . -152.5 -44.08 0.1 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 128.674 2.79 . . . . 1.0 106.809 174.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 42.8 mt -45.2 -33.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 128.546 2.738 . . . . 1.0 110.592 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.43 -21.97 4.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.476 1.51 . . . . 1.0 113.929 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -135.12 18.57 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.091 2.156 . . . . 1.0 109.452 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -138.97 83.69 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.614 1.097 . . . . 1.0 109.595 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 124.56 29.28 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.154 -2.535 . . . . 1.0 104.154 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 t -156.96 -174.42 4.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.265 0.484 . . . . 1.0 109.885 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.59 -131.8 2.54 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.541 -2.224 . . . . 1.0 107.541 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 11.8 m170 -121.2 -23.52 5.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.956 1.378 . . . . 1.0 112.694 -175.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.56 -6.29 22.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -83.58 15.59 3.06 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 128.556 2.743 . . . . 1.0 111.549 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.592 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.53 -15.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.609 0.763 . . . . 1.0 111.815 -175.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.74 -53.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.617 1.967 . . . . 1.0 110.282 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.22 108.74 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.594 1.605 . . . . 1.0 111.367 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.25 -26.16 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.485 -1.384 . . . . 1.0 110.049 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.2 -25.96 66.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.446 1.898 . . . . 1.0 111.946 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -127.22 124.26 38.51 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 105.161 -2.163 . . . . 1.0 105.161 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 23.9 m -119.29 -16.69 8.99 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.913 -0.715 . . . . 1.0 112.43 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.46 179.67 0.39 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.812 2.445 . . . . 1.0 104.679 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.47 88.01 1.2 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.027 2.485 . . . . 1.0 109.862 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 69.7 0.67 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.093 1.33 . . . . 1.0 109.96 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -76.13 -81.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.303 2.052 . . . . 1.0 110.995 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t 53.66 42.9 31.75 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.453 1.501 . . . . 1.0 109.576 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.29 17.53 19.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.27 0.486 . . . . 1.0 112.178 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.3 t0 44.52 68.01 0.61 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.905 1.682 . . . . 1.0 113.008 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -54.88 -33.0 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 119.059 -0.496 . . . . 1.0 111.717 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.29 22.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.853 -1.07 . . . . 1.0 109.912 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -60.12 -47.66 84.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.257 0.935 . . . . 1.0 111.982 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.37 -58.94 6.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.771 0.669 . . . . 1.0 110.942 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -34.03 74.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.922 -0.561 . . . . 1.0 111.687 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.03 93.3 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 117.941 0.337 . . . . 1.0 111.667 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.16 -50.72 30.36 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.796 0.839 . . . . 1.0 111.647 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.95 166.38 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.664 1.986 . . . . 1.0 111.255 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.3 m -48.05 113.45 2.75 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -85.71 40.63 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.875 2.384 . . . . 1.0 112.479 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.7 t 56.48 51.88 10.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.536 1.534 . . . . 1.0 107.969 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t -175.58 179.99 1.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 131.574 3.95 . . . . 1.0 105.599 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 54.99 54.81 8.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.234 1.014 . . . . 1.0 111.888 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -108.85 162.17 14.44 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.74 169.82 17.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.187 1.795 . . . . 1.0 108.448 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.0 tpt 74.91 -107.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 128.65 2.78 . . . . 1.0 111.836 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.42 1.888 . . . . 1.0 106.294 -177.75 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 2.0 tpp . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 105.256 -2.127 . . . . 1.0 105.256 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.7 152.65 0.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 117.356 -3.34 . . . . 1.0 111.682 -162.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.71 126.36 44.29 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 123.109 1.433 . . . . 1.0 112.204 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -136.17 153.99 51.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.781 2.032 . . . . 1.0 109.534 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 43.8 43.08 4.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.888 1.675 . . . . 1.0 113.48 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 8.99 72.6 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.86 -1.522 . . . . 1.0 114.499 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -131.32 170.19 14.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.932 1.866 . . . . 1.0 107.258 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tt -101.29 123.51 45.51 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.08 148.34 26.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.619 1.099 . . . . 1.0 110.368 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 47.33 75.05 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.004 1.722 . . . . 1.0 110.799 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.63 155.49 21.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.984 2.514 . . . . 1.0 107.916 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -76.71 123.38 26.09 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 104.728 -2.323 . . . . 1.0 104.728 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -93.19 138.43 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.12 76.69 50.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.711 1.204 . . . . 1.0 107.785 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.66 125.91 13.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.454 2.103 . . . . 1.0 109.416 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -144.5 113.32 5.11 Favored Pre-proline 0 CA--C 1.518 -0.288 0 C-N-CA 124.887 1.275 . . . . 1.0 107.626 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.21 65.39 8.83 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.307 2.005 . . . . 1.0 111.288 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -130.29 43.63 3.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 1.0 107.358 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.76 178.49 7.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.427 1.091 . . . . 1.0 110.337 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.53 178.07 4.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.727 0.775 . . . . 1.0 112.718 -175.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.6 m -165.07 118.48 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 128.329 2.652 . . . . 1.0 108.177 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 158.36 62.95 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.346 -1.724 . . . . 1.0 106.346 175.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.84 88.08 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.468 1.445 . . . . 1.0 109.762 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.68 143.37 29.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.919 -1.882 . . . . 1.0 105.919 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -151.52 103.35 2.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.645 1.111 . . . . 1.0 110.738 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -137.37 162.67 32.97 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -69.63 123.23 88.1 Favored Pre-proline 0 C--O 1.239 0.526 0 N-CA-C 104.928 -2.249 . . . . 1.0 104.928 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.2 103.37 1.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.789 1.318 . . . . 1.0 108.72 -175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 t -169.3 80.49 0.12 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -152.77 124.1 7.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -99.31 126.45 45.17 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.764 1.626 . . . . 1.0 108.381 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.5 145.03 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.36 123.91 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 104.181 -2.526 . . . . 1.0 104.181 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -175.38 146.93 0.84 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 117.339 -1.315 . . . . 1.0 107.507 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.15 112.32 22.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.414 1.006 . . . . 1.0 110.468 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.25 174.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.8 t -144.06 121.84 11.93 Favored 'General case' 0 C--O 1.247 0.93 1 N-CA-C 97.146 -5.131 . . . . 1.0 97.146 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.324 1.1 tm? -141.67 -65.58 0.02 OUTLIER Pre-proline 0 C--O 1.224 -0.266 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.3 157.66 22.79 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 121.982 1.744 . . . . 1.0 112.066 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.43 12.26 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.102 3.201 . . . . 1.0 116.363 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -28.18 -71.13 0.05 OUTLIER Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.697 -1.613 . . . . 1.0 114.062 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -156.54 123.64 5.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.712 1.605 . . . . 1.0 111.257 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -169.39 150.72 4.31 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.503 1.521 . . . . 1.0 110.795 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.8 -6.53 52.27 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.122 -1.377 . . . . 1.0 112.089 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.25 118.61 5.7 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.566 -1.813 . . . . 1.0 108.566 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.262 88.6 Cg_endo -65.26 -3.06 6.75 Favored 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 126.123 4.549 . . . . 1.0 118.964 -175.143 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -55.63 -46.93 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.922 2.146 . . . . 1.0 113.262 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 mm -61.38 -47.05 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.567 -1.271 . . . . 1.0 107.567 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.89 -48.58 67.07 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 124.841 1.257 . . . . 1.0 109.129 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.23 -38.79 77.53 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.254 1.022 . . . . 1.0 112.381 -176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.75 -51.13 61.69 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.784 0.434 . . . . 1.0 109.878 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.28 -39.51 71.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.346 0.499 . . . . 1.0 112.346 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -66.58 -52.63 43.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.645 1.178 . . . . 1.0 110.647 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.94 9.82 2.68 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 118.439 -1.201 . . . . 1.0 115.45 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 p -107.87 9.07 28.88 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.658 2.229 . . . . 1.0 114.86 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.2 134.4 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.76 1.164 . . . . 1.0 111.981 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.15 136.5 25.76 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 129.141 2.976 . . . . 1.0 109.338 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.7 76.33 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 1.0 106.923 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -103.55 -64.14 1.12 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.266 0.626 . . . . 1.0 111.266 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.6 79.15 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.614 0.766 . . . . 1.0 111.07 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 24.3 p80 -170.08 177.96 0.97 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.623 1.969 . . . . 1.0 107.047 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.05 -43.71 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.393 1.395 . . . . 1.0 114.33 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -46.14 -45.78 16.78 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.101 1.148 . . . . 1.0 114.101 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -56.12 -53.92 51.24 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.951 0.901 . . . . 1.0 109.193 -175.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.57 84.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.235 1.014 . . . . 1.0 111.665 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.66 -53.94 15.39 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.639 1.59 . . . . 1.0 111.515 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 pt -61.02 -43.45 96.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 117.303 -1.332 . . . . 1.0 110.908 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.56 -43.05 1.8 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.084 2.154 . . . . 1.0 115.19 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -46.96 -56.64 6.05 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.75 136.98 53.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.149 2.979 . . . . 1.0 106.912 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.65 155.13 16.26 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.475 -1.391 . . . . 1.0 109.211 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.83 158.39 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -173.66 131.73 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.582 1.553 . . . . 1.0 108.645 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.5 -176.64 3.68 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.67 -1.604 . . . . 1.0 106.67 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -120.02 -76.28 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.115 0.966 . . . . 1.0 109.481 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.6 m -117.34 118.37 32.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.3 114.15 20.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.432 1.093 . . . . 1.0 108.318 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 mt -94.4 117.21 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.927 0.891 . . . . 1.0 108.641 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -77.21 149.7 35.5 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.073 1.306 . . . . 1.0 109.171 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -23.74 2.93 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 126.466 1.906 . . . . 1.0 114.917 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.03 35.0 0.99 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.764 1.226 . . . . 1.0 113.798 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.24 40.8 99.09 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.757 1.17 . . . . 1.0 114.661 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -108.4 151.69 25.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.982 0.891 . . . . 1.0 110.676 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.16 113.98 44.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 102.492 -3.151 . . . . 1.0 102.492 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.11 145.45 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 119.29 27.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.779 1.632 . . . . 1.0 106.776 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -120.15 140.99 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.975 -2.231 . . . . 1.0 104.975 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 t 65.23 92.09 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.162 1.541 . . . . 1.0 115.162 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -56.73 169.65 1.71 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 N-CA-C 109.052 -1.172 . . . . 1.0 109.052 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.74 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.944 2.572 . . . . 1.0 117.944 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -134.51 117.05 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.735 2.814 . . . . 1.0 105.807 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.65 81.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.37 2.668 . . . . 1.0 109.539 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -35.02 148.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 131.205 3.802 . . . . 1.0 114.356 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.25 178.55 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.933 2.093 . . . . 1.0 109.657 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -149.49 119.01 6.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.246 1.384 . . . . 1.0 110.568 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.68 62.92 0.47 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.076 1.417 . . . . 1.0 110.185 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -163.27 -63.8 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 119.015 -2.303 . . . . 1.0 113.852 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.96 -68.87 0.21 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 106.274 -2.73 . . . . 1.0 106.274 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -145.53 146.49 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.075 1.35 . . . . 1.0 109.519 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.8 p -160.38 166.31 29.57 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.092 1.757 . . . . 1.0 107.857 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 p -159.28 145.83 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -159.77 154.0 23.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.612 1.096 . . . . 1.0 109.343 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 39.43 54.99 2.33 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.3 1.84 . . . . 1.0 111.153 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.65 84.98 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.933 -0.926 . . . . 1.0 113.117 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.75 119.24 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.842 1.321 . . . . 1.0 108.492 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.91 146.74 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.255 1.422 . . . . 1.0 111.699 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -124.45 118.22 26.17 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -72.02 -31.03 65.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.674 0.79 . . . . 1.0 111.683 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.22 176.24 11.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 128.407 2.683 . . . . 1.0 106.401 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.331 15.3 t70 -87.19 77.07 9.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.104 0.954 . . . . 1.0 111.78 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -90.51 44.54 1.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.616 -1.253 . . . . 1.0 107.616 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -123.26 133.45 54.18 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.272 1.029 . . . . 1.0 110.785 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.1 OUTLIER -91.21 56.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.39 -136.4 3.82 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.488 1.049 . . . . 1.0 111.217 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.65 165.14 22.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 128.156 2.582 . . . . 1.0 104.114 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -146.18 131.34 18.38 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.961 -2.977 . . . . 1.0 102.961 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.71 127.98 48.23 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.055 -1.653 . . . . 1.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -103.36 138.37 40.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.425 0.631 . . . . 1.0 111.224 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.03 40.49 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.945 1.26 . . . . 1.0 111.586 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.7 p -142.32 108.3 5.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.408 1.483 . . . . 1.0 107.923 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t0 49.76 55.67 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.124 2.17 . . . . 1.0 113.83 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 48.96 38.38 12.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.255 1.822 . . . . 1.0 113.973 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.19 142.8 58.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 105.283 -2.118 . . . . 1.0 105.283 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -43.03 114.78 0.65 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.683 1.193 . . . . 1.0 108.771 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -78.52 -2.12 37.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 116.783 -1.579 . . . . 1.0 114.83 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 29.0 p 64.01 76.5 0.35 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.077 1.308 . . . . 1.0 111.013 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.35 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.723 2.009 . . . . 1.0 113.132 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.01 -38.35 4.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.629 2.372 . . . . 1.0 111.837 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -47.6 -43.88 25.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.242 1.417 . . . . 1.0 110.112 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -60.64 -39.6 88.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.284 -0.865 . . . . 1.0 110.811 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.59 -51.56 58.78 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.492 1.042 . . . . 1.0 110.27 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -65.4 -40.18 93.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.488 0.315 . . . . 1.0 111.293 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.9 tp -59.11 -51.94 67.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.249 1.82 . . . . 1.0 108.201 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -40.03 78.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.83 -0.605 . . . . 1.0 110.256 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -53.96 51.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.131 0.878 . . . . 1.0 111.659 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.23 -47.83 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.9 m -58.15 -47.01 84.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.357 1.463 . . . . 1.0 112.029 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -60.19 -38.13 82.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.553 0.741 . . . . 1.0 109.606 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.52 86.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 117.823 -1.084 . . . . 1.0 110.332 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.17 -45.67 79.61 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 120.252 1.387 . . . . 1.0 110.595 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.81 -41.62 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.0 m -62.04 -27.24 68.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.366 0.666 . . . . 1.0 111.269 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -83.9 -61.23 1.88 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.956 -1.09 . . . . 1.0 108.111 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -125.8 112.79 24.8 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.27 -1.381 . . . . 1.0 107.27 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -93.18 107.8 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-O 123.425 1.344 . . . . 1.0 109.731 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.39 -44.8 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.559 1.944 . . . . 1.0 109.412 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.3 mt -49.36 -33.51 6.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 130.731 3.613 . . . . 1.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.01 -26.43 37.0 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.155 0.428 . . . . 1.0 112.155 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.46 25.65 4.11 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.123 2.569 . . . . 1.0 110.184 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -139.09 83.51 1.95 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 50.9 mtt -126.88 118.57 24.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.66 -2.348 . . . . 1.0 104.66 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -148.21 -175.38 4.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.586 1.084 . . . . 1.0 109.237 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.21 -131.77 2.39 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 105.789 -2.924 . . . . 1.0 105.789 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.2 m170 -114.78 -23.47 9.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.675 1.238 . . . . 1.0 110.381 175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.34 -18.67 14.75 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.84 38.31 0.63 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.19 0.905 . . . . 1.0 108.918 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -16.6 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 O-C-N 120.513 -1.367 . . . . 1.0 108.715 175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.49 -54.4 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.783 2.433 . . . . 1.0 111.518 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.57 109.51 2.88 Favored 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 122.146 1.802 . . . . 1.0 113.608 -175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -62.36 -12.29 20.41 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.145 -0.972 . . . . 1.0 110.688 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -22.5 57.37 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.313 -1.492 . . . . 1.0 114.553 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.26 125.75 20.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.559 1.527 . . . . 1.0 107.091 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 167' ' ' PRO . 2.6 m -114.79 -16.7 11.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.19 -178.83 0.3 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 126.3 1.84 . . . . 1.0 106.311 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.22 80.71 2.96 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 N-CA-C 105.633 -2.487 . . . . 1.0 105.633 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 124.22 72.28 0.23 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.513 2.006 . . . . 1.0 109.866 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.454 ' HB3' ' H ' ' A' ' 163' ' ' THR . 68.7 Cg_endo -79.0 -99.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.301 2.667 . . . . 1.0 111.066 176.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.7 t 53.82 42.9 31.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.513 1.525 . . . . 1.0 111.538 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -96.81 17.87 15.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.978 -1.076 . . . . 1.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t0 43.79 63.74 1.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.421 -2.049 . . . . 1.0 111.831 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -54.07 -35.17 61.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.344 0.658 . . . . 1.0 111.725 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -54.35 48.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.453 -0.784 . . . . 1.0 110.157 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -60.29 -48.54 81.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.814 -1.089 . . . . 1.0 112.13 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.32 -53.54 56.07 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.883 0.765 . . . . 1.0 109.938 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -48.81 80.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 117.962 -1.018 . . . . 1.0 108.773 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.7 76.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.931 0.893 . . . . 1.0 112.981 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.3 mt -71.28 -44.21 65.66 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.878 0.871 . . . . 1.0 110.62 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.37 157.07 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 122.958 1.361 . . . . 1.0 110.051 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m -55.15 139.05 65.42 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.952 1.701 . . . . 1.0 111.607 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -80.23 42.22 1.28 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.718 2.945 . . . . 1.0 110.947 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.6 t 53.07 33.64 15.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.44 2.696 . . . . 1.0 111.754 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.7 t -163.63 106.3 0.97 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.728 1.611 . . . . 1.0 107.41 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -160.06 125.56 4.05 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.52 142.42 58.43 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.44 124.13 20.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -153.62 107.04 2.96 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.352 -0.842 . . . . 1.0 110.022 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 C-N-CA 126.48 1.912 . . . . 1.0 109.723 176.614 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.8 tp -81.57 138.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.24 136.13 45.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 102.837 -3.023 . . . . 1.0 102.837 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.55 123.53 39.29 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 49.82 33.59 6.6 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.062 0.846 . . . . 1.0 111.967 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.55 -6.68 5.77 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.64 1.591 . . . . 1.0 113.89 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -81.65 161.55 23.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 103.857 -2.646 . . . . 1.0 103.857 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -79.65 124.11 28.26 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.912 -1.514 . . . . 1.0 106.912 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.63 175.92 9.95 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.469 0.708 . . . . 1.0 111.408 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 42.33 57.86 3.22 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.286 1.834 . . . . 1.0 109.464 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.29 155.2 30.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.983 1.313 . . . . 1.0 109.1 -176.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -81.29 123.46 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.79 124.6 33.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.379 0.99 . . . . 1.0 108.334 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.92 82.53 43.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.99 124.03 7.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.034 1.823 . . . . 1.0 110.299 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -119.74 114.19 34.25 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.87 56.39 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.183 1.922 . . . . 1.0 111.416 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -126.05 44.56 2.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.811 2.045 . . . . 1.0 105.632 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -73.66 177.98 5.05 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.417 0.687 . . . . 1.0 111.142 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.56 178.62 4.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.693 1.597 . . . . 1.0 113.513 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.6 m -154.19 124.67 7.01 Favored 'General case' 0 N--CA 1.448 -0.574 1 C-N-CA 132.028 4.131 . . . . 1.0 103.137 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.64 142.77 45.09 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 117.981 -1.009 . . . . 1.0 108.831 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.57 69.1 7.88 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.598 2.865 . . . . 1.0 113.454 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -151.71 158.54 43.54 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 127.073 2.149 . . . . 1.0 106.799 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -151.17 104.67 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.309 1.444 . . . . 1.0 107.481 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.77 158.67 43.92 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.915 1.686 . . . . 1.0 106.61 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -67.51 123.67 87.3 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 118.679 0.672 . . . . 1.0 109.441 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.16 103.65 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 108.974 -1.202 . . . . 1.0 108.974 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -165.38 65.57 0.12 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.469 -1.394 . . . . 1.0 108.265 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -148.3 137.63 22.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.73 1.612 . . . . 1.0 107.175 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.85 133.4 34.76 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.243 1.417 . . . . 1.0 108.111 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.91 142.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.938 -2.245 . . . . 1.0 104.938 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.5 t -136.16 115.77 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.977 -1.86 . . . . 1.0 105.977 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -176.3 132.82 0.23 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.348 0.976 . . . . 1.0 108.835 175.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -63.39 118.73 8.49 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.925 0.89 . . . . 1.0 110.22 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -145.71 176.43 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.174 2.59 . . . . 1.0 107.153 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -160.93 117.97 2.33 Favored 'General case' 0 C--N 1.322 -0.624 1 N-CA-C 96.695 -5.298 . . . . 1.0 96.695 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -144.78 -61.3 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 116.022 -1.942 . . . . 1.0 112.79 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -87.34 157.3 8.1 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.825 2.35 . . . . 1.0 112.92 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.37 70.45 4.78 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.326 3.35 . . . . 1.0 118.658 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.94 -72.2 1.06 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 105.811 -2.916 . . . . 1.0 105.811 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -157.2 123.42 4.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.324 2.25 . . . . 1.0 109.186 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -176.94 176.42 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 130.706 3.602 . . . . 1.0 107.836 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.41 22.78 10.04 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.91 1.719 . . . . 1.0 109.464 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.38 118.6 5.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.116 -1.38 . . . . 1.0 110.203 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.8 -21.03 38.9 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.415 2.077 . . . . 1.0 112.331 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -53.9 -34.19 58.79 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.853 0.861 . . . . 1.0 111.082 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 mt -66.12 -50.01 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.246 -0.883 . . . . 1.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.94 -46.46 78.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.076 -1.049 . . . . 1.0 110.395 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.78 -33.89 50.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.114 0.966 . . . . 1.0 111.887 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -58.49 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.616 1.566 . . . . 1.0 110.296 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -70.6 -41.32 72.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.4 0.68 . . . . 1.0 112.545 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 t -65.91 -34.28 77.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.59 1.156 . . . . 1.0 108.455 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.22 54.77 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.308 -1.829 . . . . 1.0 116.153 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -89.15 8.27 30.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.743 2.272 . . . . 1.0 113.615 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.4 tt -60.02 132.93 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.629 1.572 . . . . 1.0 111.891 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.02 135.99 20.7 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 128.636 2.774 . . . . 1.0 109.529 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.39 80.68 1.04 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.502 2.801 . . . . 1.0 106.909 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -103.23 -63.43 1.18 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.034 0.534 . . . . 1.0 111.012 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.57 78.85 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.06 0.944 . . . . 1.0 110.646 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -170.35 177.95 0.95 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.403 2.281 . . . . 1.0 106.331 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -74.05 -43.43 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.531 1.488 . . . . 1.0 114.796 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -43.23 -53.58 5.03 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -58.22 6.89 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.07 1.348 . . . . 1.0 110.513 -175.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.6 89.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.167 0.587 . . . . 1.0 111.521 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.45 -63.54 4.0 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.127 1.346 . . . . 1.0 111.863 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.49 -38.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.24 0.52 . . . . 1.0 112.065 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.52 -43.53 11.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.262 88.0 m-70 -57.9 -33.54 68.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.721 -0.657 . . . . 1.0 109.779 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.32 136.61 33.83 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.504 -2.776 . . . . 1.0 103.504 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 141.67 40.74 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.227 0.921 . . . . 1.0 111.723 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -116.97 165.49 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.663 2.385 . . . . 1.0 109.59 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -172.52 116.64 0.33 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.955 1.302 . . . . 1.0 108.632 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.44 -176.89 3.77 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -110.68 -76.27 0.61 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.884 1.22 . . . . 1.0 112.478 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -116.97 118.26 31.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.543 -2.021 . . . . 1.0 105.543 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.57 113.55 27.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.761 -2.311 . . . . 1.0 104.761 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -96.14 113.38 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.662 -2.348 . . . . 1.0 104.662 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -68.74 148.13 50.8 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.696 1.134 . . . . 1.0 108.502 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.74 22.09 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 122.824 0.45 . . . . 1.0 111.645 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.27 24.51 2.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.25 2.22 . . . . 1.0 111.896 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.01 76.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.456 1.979 . . . . 1.0 115.623 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.94 156.57 17.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.726 1.763 . . . . 1.0 110.58 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -116.24 116.53 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.71 141.68 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.45 121.57 37.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.411 -1.7 . . . . 1.0 106.411 -176.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.94 123.93 50.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.829 2.452 . . . . 1.0 106.495 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.2 t 67.16 92.1 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.091 1.314 . . . . 1.0 113.664 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -60.8 -179.15 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.192 1.261 . . . . 1.0 109.963 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -59.18 26.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.812 3.245 . . . . 1.0 116.678 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.97 117.48 7.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.905 2.482 . . . . 1.0 108.788 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.268 28.0 ttmt 85.93 81.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.903 2.481 . . . . 1.0 111.844 175.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -36.44 156.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.721 4.009 . . . . 1.0 117.216 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.75 -179.2 3.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.909 3.684 . . . . 1.0 115.857 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 46.7 t90 -156.46 118.52 3.95 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.514 1.926 . . . . 1.0 109.709 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -162.78 62.85 0.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.228 0.922 . . . . 1.0 111.439 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.55 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 118.785 -2.447 . . . . 1.0 114.779 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.84 -90.74 1.1 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 105.248 -3.141 . . . . 1.0 105.248 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.07 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 118.734 1.267 . . . . 1.0 109.456 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 p -165.98 157.32 13.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.119 2.168 . . . . 1.0 108.118 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.401 ' H ' HG23 ' A' ' 157' ' ' ILE . 78.1 p -153.46 147.1 25.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.386 1.074 . . . . 1.0 110.763 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -149.46 148.98 30.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.586 -1.265 . . . . 1.0 107.586 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 38.66 53.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.368 1.867 . . . . 1.0 111.446 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.7 28.44 65.47 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.605 -1.108 . . . . 1.0 115.465 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 113.22 13.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 120.544 2.172 . . . . 1.0 105.245 175.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.83 145.65 32.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -105.22 118.24 36.05 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.38 -23.7 60.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.322 0.389 . . . . 1.0 110.559 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -145.58 170.69 15.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.485 2.314 . . . . 1.0 106.857 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.52 76.66 7.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.358 1.075 . . . . 1.0 108.919 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -89.49 40.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.454 1.502 . . . . 1.0 110.108 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -131.67 130.4 42.0 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 119.977 -1.702 . . . . 1.0 111.882 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 56.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.809 2.044 . . . . 1.0 107.947 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -136.62 5.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.67 164.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.77 116.33 8.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.664 -2.347 . . . . 1.0 104.664 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.3 135.42 34.32 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.298 -1.501 . . . . 1.0 109.604 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -103.67 152.94 21.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.65 173.46 39.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.821 1.677 . . . . 1.0 111.04 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -147.13 107.08 3.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.7 t0 46.08 47.75 12.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.471 2.308 . . . . 1.0 112.282 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.7 p 46.78 38.27 5.73 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.301 1.84 . . . . 1.0 113.417 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.24 146.52 54.84 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.236 1.814 . . . . 1.0 108.542 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -33.0 113.14 0.13 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.079 2.152 . . . . 1.0 110.508 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -78.31 -9.0 59.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.701 -2.095 . . . . 1.0 114.985 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.407 11.7 p 69.26 78.41 0.21 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 121.404 1.911 . . . . 1.0 113.537 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -22.99 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 119.709 -1.869 . . . . 1.0 115.403 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.37 -46.45 13.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.236 2.214 . . . . 1.0 110.472 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -51.26 -49.34 61.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.571 1.078 . . . . 1.0 109.904 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.71 -40.09 90.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.546 -0.74 . . . . 1.0 109.757 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.97 -50.55 63.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.988 0.813 . . . . 1.0 111.424 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -63.1 -48.49 78.35 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.985 1.714 . . . . 1.0 110.255 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.16 -49.98 74.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.217 1.407 . . . . 1.0 108.856 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.57 -39.84 89.47 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 118.722 -0.656 . . . . 1.0 110.155 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -53.58 56.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.829 0.852 . . . . 1.0 110.304 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.01 -46.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.6 m -58.29 -53.6 56.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.983 1.313 . . . . 1.0 109.964 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -56.76 -46.04 81.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.67 1.188 . . . . 1.0 110.12 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.15 77.71 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.792 0.437 . . . . 1.0 111.535 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.8 mt -57.03 -38.24 72.89 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-O 118.436 -0.792 . . . . 1.0 111.029 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.28 -38.75 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.547 0.739 . . . . 1.0 109.752 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 m -57.42 -35.07 69.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.089 0.859 . . . . 1.0 110.55 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -83.67 -52.66 6.25 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.129 -0.982 . . . . 1.0 108.6 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -126.33 112.9 23.49 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.92 107.15 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 121.378 1.528 . . . . 1.0 109.031 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.18 -49.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.094 1.758 . . . . 1.0 107.685 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 65.8 mt -48.35 -34.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 129.018 2.927 . . . . 1.0 109.586 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.12 -25.67 9.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.738 1.615 . . . . 1.0 113.627 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.31 22.01 3.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.037 1.735 . . . . 1.0 109.63 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.06 85.9 2.1 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.016 1.726 . . . . 1.0 107.7 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.2 mtt -131.96 119.13 20.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.893 2.077 . . . . 1.0 106.609 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -152.15 -176.34 5.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.532 1.514 . . . . 1.0 108.992 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.57 -131.4 2.73 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 106.875 -2.49 . . . . 1.0 106.875 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 25.5 m170 -116.35 -23.9 8.15 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.327 1.064 . . . . 1.0 112.12 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.4 t -103.63 -12.55 16.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.368 0.667 . . . . 1.0 109.255 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.41 17.96 2.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.449 1.9 . . . . 1.0 110.478 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.401 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.59 -20.14 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.764 0.825 . . . . 1.0 112.489 -175.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -147.47 -66.14 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.11 1.364 . . . . 1.0 107.995 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.06 108.85 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.877 1.718 . . . . 1.0 111.202 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.97 -17.46 38.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.391 1.076 . . . . 1.0 112.096 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -60.06 -24.24 64.41 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.239 -1.538 . . . . 1.0 112.687 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -131.22 140.57 49.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 104.1 -2.556 . . . . 1.0 104.1 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 m -123.19 -16.76 6.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.34 177.92 0.95 Allowed Pre-proline 0 C--O 1.244 0.815 0 C-N-CA 131.316 3.846 . . . . 1.0 103.333 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.25 57.91 6.7 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.772 2.314 . . . . 1.0 109.438 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.5 78.81 0.02 OUTLIER Glycine 0 CA--C 1.541 1.671 0 C-N-CA 128.918 3.151 . . . . 1.0 108.054 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.01 -72.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.1 2.534 . . . . 1.0 112.107 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.3 t 53.94 43.79 30.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.514 1.926 . . . . 1.0 113.176 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -122.04 17.56 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.347 0.976 . . . . 1.0 112.731 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 t0 42.6 68.47 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.288 1.435 . . . . 1.0 110.604 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -48.85 -34.95 13.53 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -48.18 73.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.362 -0.828 . . . . 1.0 111.246 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -60.78 -51.14 70.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.51 1.504 . . . . 1.0 110.893 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.51 -46.6 82.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.187 0.903 . . . . 1.0 111.619 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -62.44 -32.78 73.69 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.567 0.621 . . . . 1.0 110.119 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.42 80.72 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.786 -1.197 . . . . 1.0 111.436 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 mt -67.87 -55.27 13.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.601 1.56 . . . . 1.0 112.636 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.43 150.12 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 122.766 0.426 . . . . 1.0 109.92 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -47.33 113.74 2.65 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.49 1.516 . . . . 1.0 110.327 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 74.07 5.2 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.673 2.249 . . . . 1.0 111.402 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 t 35.54 41.39 0.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.932 2.493 . . . . 1.0 113.966 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.2 t -159.79 -44.96 0.05 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.637 0.775 . . . . 1.0 110.587 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -73.8 45.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 1.0 110.752 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -84.75 124.14 31.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.849 -1.157 . . . . 1.0 108.218 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 5.4 pm0 -64.16 -164.47 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.742 3.617 . . . . 1.0 112.676 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -150.27 119.13 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.39 1.476 . . . . 1.0 107.932 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.253 1.254 1 C-N-CA 135.313 5.445 . . . . 1.0 106.152 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HA ' ' CB ' ' A' ' 139' ' ' ALA . 19.0 ttt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.79 124.51 18.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 153.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -119.55 124.02 45.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.656 -2.72 . . . . 1.0 103.656 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.67 148.53 47.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.09 33.53 15.23 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.359 1.463 . . . . 1.0 110.325 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.66 18.61 52.77 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.625 1.107 . . . . 1.0 113.074 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -131.45 176.26 8.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.113 -1.81 . . . . 1.0 106.113 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.04 130.77 44.19 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.784 -1.197 . . . . 1.0 108.35 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.74 55.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.194 0.198 . . . . 1.0 111.351 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 49.25 58.42 5.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.973 2.109 . . . . 1.0 110.807 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.47 133.25 21.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.382 -1.281 . . . . 1.0 109.475 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -67.87 123.34 20.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.615 -1.994 . . . . 1.0 105.615 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -91.87 128.16 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.185 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -145.82 85.58 7.63 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.092 . . . . 1.0 108.796 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.39 152.08 71.22 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.285 1.323 . . . . 1.0 110.578 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -146.75 132.67 9.43 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 126.056 1.742 . . . . 1.0 107.788 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.49 45.13 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.005 2.47 . . . . 1.0 113.133 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -123.88 43.2 3.04 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.384 -0.823 . . . . 1.0 109.982 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -73.57 -179.83 3.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.088 1.355 . . . . 1.0 109.878 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.39 178.6 4.39 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.754 1.264 . . . . 1.0 112.898 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -152.66 118.5 5.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.066 -2.939 . . . . 1.0 103.066 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -135.71 145.61 53.79 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 120.273 1.397 . . . . 1.0 108.742 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 67.22 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.459 2.773 . . . . 1.0 111.71 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -154.41 143.82 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.661 2.384 . . . . 1.0 107.131 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.92 103.93 3.11 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.898 2.079 . . . . 1.0 106.681 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.44 169.46 17.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.817 2.447 . . . . 1.0 106.972 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.97 123.54 82.27 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 124.912 1.285 . . . . 1.0 110.371 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.69 103.44 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.831 1.687 . . . . 1.0 110.512 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.1 t -177.1 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.51 -2.404 . . . . 1.0 104.51 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -148.34 145.75 28.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.395 3.078 . . . . 1.0 104.181 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.5 tp -114.5 129.76 56.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.89 136.03 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.0 t -135.02 113.95 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -165.15 167.26 18.32 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.273 1.429 . . . . 1.0 107.276 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -96.93 116.67 29.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -142.03 172.2 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.943 2.097 . . . . 1.0 106.926 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 t -155.55 118.04 4.2 Favored 'General case' 0 N--CA 1.443 -0.795 1 N-CA-C 98.981 -4.451 . . . . 1.0 98.981 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 -66.74 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.529 0 CA-C-O 116.007 -1.949 . . . . 1.0 109.285 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.24 136.94 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 CA-C-N 123.943 2.444 . . . . 1.0 107.36 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.25 44.73 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.096 3.198 . . . . 1.0 114.986 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -31.5 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.241 0 C-N-CA 126.125 1.822 . . . . 1.0 110.829 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.29 122.69 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.167 -2.531 . . . . 1.0 104.167 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -176.76 175.54 1.64 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.884 2.874 . . . . 1.0 107.942 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.76 26.58 4.02 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.588 1.566 . . . . 1.0 112.331 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.65 118.24 6.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.26 1.53 . . . . 1.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.13 -5.0 15.41 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.316 2.011 . . . . 1.0 113.148 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -62.02 -38.65 89.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.415 1.086 . . . . 1.0 109.43 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.7 -45.06 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.44 -46.61 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.53 -36.18 63.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 1.0 111.719 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -60.45 3.78 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.694 0.798 . . . . 1.0 109.655 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -68.78 -46.92 67.48 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.574 0.625 . . . . 1.0 112.384 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -60.48 -33.89 73.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.486 1.114 . . . . 1.0 108.732 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.56 35.8 4.25 Favored Glycine 0 C--N 1.342 0.879 0 C-N-CA 124.552 1.072 . . . . 1.0 113.349 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -124.77 18.05 8.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.885 1.342 . . . . 1.0 111.752 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.03 140.0 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.701 0.801 . . . . 1.0 110.427 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -98.37 128.01 34.5 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 127.713 2.405 . . . . 1.0 106.257 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.21 70.51 2.38 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.211 3.274 . . . . 1.0 109.472 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -106.9 -65.28 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.948 1.299 . . . . 1.0 112.843 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.4 -60.46 1.49 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.917 1.687 . . . . 1.0 113.225 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 20.8 p80 -168.48 177.69 1.2 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.562 1.145 . . . . 1.0 108.13 175.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -70.25 -43.62 2.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.733 1.622 . . . . 1.0 113.926 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -50.48 -62.26 1.69 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.805 1.242 . . . . 1.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 5.2 t80 -56.88 -50.35 72.75 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.409 0.684 . . . . 1.0 111.201 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.17 96.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.892 0.477 . . . . 1.0 110.849 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -57.73 17.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 124.791 1.186 . . . . 1.0 110.629 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.49 -24.15 34.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-O 116.589 -1.672 . . . . 1.0 113.734 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.11 -43.52 20.58 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.716 1.598 . . . . 1.0 113.0 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -58.04 -33.85 69.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.095 0.558 . . . . 1.0 110.806 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.39 136.4 33.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -65.28 146.49 54.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.163 -1.415 . . . . 1.0 109.445 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -116.92 162.26 15.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 125.506 1.522 . . . . 1.0 110.507 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 m -174.05 128.1 0.37 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.543 2.337 . . . . 1.0 108.151 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.26 -172.47 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.453 -1.684 . . . . 1.0 106.453 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -110.81 -58.72 2.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.597 1.159 . . . . 1.0 111.767 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -141.04 118.44 11.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.189 -1.782 . . . . 1.0 106.189 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.94 113.42 25.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.825 -2.287 . . . . 1.0 104.825 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -89.16 113.48 25.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.22 150.63 45.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.871 -1.159 . . . . 1.0 107.871 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -13.76 0.96 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.565 1.146 . . . . 1.0 113.917 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -91.7 21.03 5.01 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 128.037 2.535 . . . . 1.0 112.737 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.51 29.32 71.42 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.792 2.139 . . . . 1.0 114.885 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -102.14 108.94 20.5 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.652 1.226 . . . . 1.0 108.239 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.03 113.69 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.767 -2.679 . . . . 1.0 103.767 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.57 123.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 103.084 -2.932 . . . . 1.0 103.084 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.29 113.44 26.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.91 114.35 20.9 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 89.11 91.57 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 122.432 2.378 . . . . 1.0 110.554 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.26 -171.66 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.208 1.938 . . . . 1.0 109.907 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -64.57 21.77 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.498 1.919 . . . . 1.0 115.941 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.44 126.14 17.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.625 1.97 . . . . 1.0 109.127 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 86.56 81.92 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.849 3.26 . . . . 1.0 111.762 175.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -36.7 135.38 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 128.259 2.624 . . . . 1.0 112.373 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.04 -178.67 3.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.769 2.428 . . . . 1.0 111.058 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.467 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 80.0 t90 -146.23 118.55 8.4 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.418 1.887 . . . . 1.0 107.114 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -164.96 63.29 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.224 1.012 . . . . 1.0 110.601 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.64 -68.72 0.07 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 118.792 -2.443 . . . . 1.0 112.274 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.38 -90.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.421 -1.872 . . . . 1.0 108.421 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.6 t -140.32 146.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.473 1.909 . . . . 1.0 110.758 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -163.47 155.49 17.58 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.059 1.743 . . . . 1.0 109.044 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.502 ' H ' HG23 ' A' ' 157' ' ' ILE . 3.0 p -146.86 133.55 19.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -161.49 124.59 3.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.286 0.948 . . . . 1.0 108.898 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 60.13 71.57 0.57 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.044 1.738 . . . . 1.0 113.622 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.4 30.3 55.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 126.433 1.968 . . . . 1.0 113.922 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.7 ttm105 -150.05 113.63 4.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.441 1.096 . . . . 1.0 108.566 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.05 145.13 30.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.226 -2.139 . . . . 1.0 105.226 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -128.98 118.03 21.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.992 -1.855 . . . . 1.0 105.992 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t -66.11 -36.02 82.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.842 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.467 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 15.8 m120 -146.73 174.12 11.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.91 2.884 . . . . 1.0 106.037 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.48 76.84 9.91 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 106.533 -1.655 . . . . 1.0 106.533 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 39.68 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.482 1.913 . . . . 1.0 109.889 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -124.23 156.72 36.34 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.204 1.802 . . . . 1.0 112.29 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.255 0.0 OUTLIER -99.98 57.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 105.971 -1.862 . . . . 1.0 105.971 175.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.35 -136.53 1.65 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.225 -0.922 . . . . 1.0 111.595 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 7.5 mm -142.25 163.15 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 128.888 2.875 . . . . 1.0 103.723 176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -136.12 129.3 31.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.393 2.277 . . . . 1.0 105.338 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mt -101.24 153.81 19.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 120.258 1.39 . . . . 1.0 109.305 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.34 47.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.83 0.824 . . . . 1.0 111.36 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.31 -173.47 41.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.294 2.378 . . . . 1.0 108.946 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 p -136.44 100.2 4.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 102.692 -3.077 . . . . 1.0 102.692 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 43.01 55.63 4.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.848 2.459 . . . . 1.0 112.472 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.4 p 52.69 38.09 25.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.089 2.155 . . . . 1.0 114.155 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 tp -60.2 136.01 57.9 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.84 113.2 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.29 2.236 . . . . 1.0 110.411 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.02 -8.17 57.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 115.683 -2.103 . . . . 1.0 116.371 -174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.325 37.3 p 63.89 77.96 0.3 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 121.636 2.016 . . . . 1.0 111.383 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.64 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.901 2.081 . . . . 1.0 113.97 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.09 -38.61 1.72 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.435 2.294 . . . . 1.0 109.455 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.67 -48.82 58.3 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.999 1.32 . . . . 1.0 110.575 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -59.16 -38.27 79.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.079 0.854 . . . . 1.0 110.509 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -66.02 -55.03 18.72 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.253 0.621 . . . . 1.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -61.69 -54.06 47.66 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.861 0.865 . . . . 1.0 109.131 -177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.3 tp -53.22 -49.32 67.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.251 1.021 . . . . 1.0 109.728 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.0 85.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 120.408 1.458 . . . . 1.0 111.682 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.85 51.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.741 0.7 . . . . 1.0 109.294 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.91 -64.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 126.758 2.023 . . . . 1.0 108.417 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 64.0 m -54.35 -52.43 61.63 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.902 2.081 . . . . 1.0 111.456 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -57.22 -42.02 80.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.382 1.447 . . . . 1.0 110.408 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 1' ' ' MET . . . -68.58 -47.48 66.65 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.266 -0.896 . . . . 1.0 111.352 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.7 mt -56.91 -34.71 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.58 -1.325 . . . . 1.0 111.598 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.61 -40.08 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.474 -1.306 . . . . 1.0 107.474 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -63.15 -13.44 37.05 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.13 1.372 . . . . 1.0 110.965 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -95.93 -65.39 0.98 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.158 -1.589 . . . . 1.0 107.406 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -120.89 112.99 33.23 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.441 ' HB2' ' HE2' ' A' ' 184' ' ' LYS . 71.5 Cg_endo -95.89 107.89 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 CA-C-N 120.182 1.101 . . . . 1.0 111.208 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.91 -49.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.365 1.866 . . . . 1.0 106.636 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.5 mt -45.9 -33.37 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 128.944 2.898 . . . . 1.0 110.815 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.16 -26.53 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 1.0 113.412 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -133.13 18.62 4.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.945 2.098 . . . . 1.0 110.178 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -138.44 83.74 1.98 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.454 -1.404 . . . . 1.0 107.842 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.6 mtt -121.55 114.05 20.66 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -149.18 -168.07 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.93 -130.67 1.64 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 105.017 -3.233 . . . . 1.0 105.017 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.259 14.7 m170 -112.73 -24.43 9.61 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.978 0.911 . . . . 1.0 111.277 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.67 -16.03 16.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.417 0.687 . . . . 1.0 110.359 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -86.59 39.62 0.85 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.893 -1.151 . . . . 1.0 107.893 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.502 HG23 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.62 -17.5 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 O-C-N 120.322 -1.486 . . . . 1.0 109.294 175.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -149.54 -64.53 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.553 1.541 . . . . 1.0 109.715 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.51 115.06 3.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.365 2.043 . . . . 1.0 113.23 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -22.48 58.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 1.0 112.273 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.2 tpt85 -58.65 -17.15 19.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.199 2.2 . . . . 1.0 112.686 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -141.66 141.02 33.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -131.84 -16.72 2.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 118.903 -1.119 . . . . 1.0 110.358 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.9 -179.62 0.34 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 130.117 3.367 . . . . 1.0 104.085 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 78.25 3.5 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 121.876 1.717 . . . . 1.0 108.561 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.44 64.08 0.56 Allowed Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.866 -1.519 . . . . 1.0 114.811 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.52 -54.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.429 2.615 . . . . 1.0 111.599 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 t 54.52 44.5 28.66 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.918 1.687 . . . . 1.0 112.468 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -108.73 17.68 21.62 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.369 11.3 t70 43.0 75.69 0.09 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.086 1.754 . . . . 1.0 113.194 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -48.65 -34.16 11.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.838 0.681 . . . . 1.0 112.838 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.63 75.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.942 -1.028 . . . . 1.0 111.707 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.4 -49.45 77.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.773 1.17 . . . . 1.0 109.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -66.2 -52.15 50.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.424 0.898 . . . . 1.0 113.424 -176.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -61.55 -28.26 69.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.592 0.633 . . . . 1.0 111.476 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.45 87.28 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.125 0.875 . . . . 1.0 111.341 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.8 mt -71.04 -61.53 1.73 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.292 1.437 . . . . 1.0 111.065 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 90.4 t -66.35 166.36 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 124.13 0.972 . . . . 1.0 110.062 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 92.7 m -43.18 113.8 1.47 Allowed Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.297 1.439 . . . . 1.0 109.369 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -86.21 53.85 3.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.368 2.712 . . . . 1.0 107.019 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.4 t 54.32 34.01 19.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.732 0.813 . . . . 1.0 111.473 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -153.35 -46.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -74.27 78.76 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.693 1.197 . . . . 1.0 107.977 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 145' ' ' PRO . 33.1 tttm -139.05 153.24 48.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.677 1.991 . . . . 1.0 107.69 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.77 -176.32 4.01 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.9 tpt -65.16 164.76 12.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.129 0.971 . . . . 1.0 112.075 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.4 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 127.46 2.304 . . . . 1.0 111.366 177.406 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HA ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -64.91 123.76 20.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.649 -1.612 . . . . 1.0 106.649 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.89 123.61 29.35 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.881 -2.266 . . . . 1.0 104.881 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.86 145.2 45.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 51.97 33.05 11.03 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.486 -0.759 . . . . 1.0 112.64 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.94 17.58 51.6 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.364 0.983 . . . . 1.0 113.492 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -129.07 170.26 13.72 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.345 -2.094 . . . . 1.0 105.345 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.09 131.66 46.27 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.432 -1.418 . . . . 1.0 108.837 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.02 36.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 40.67 57.88 2.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.553 2.741 . . . . 1.0 108.6 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.61 150.98 30.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.838 1.255 . . . . 1.0 109.375 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -86.21 123.24 31.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -84.63 129.62 34.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.43 79.33 20.84 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.189 -1.041 . . . . 1.0 108.189 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.27 127.93 12.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.409 2.072 . . . . 1.0 109.104 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -128.18 120.93 21.4 Favored Pre-proline 0 C--O 1.232 0.184 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.3 52.08 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.128 2.552 . . . . 1.0 112.465 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -123.63 43.44 2.97 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -74.26 178.46 5.12 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.723 0.809 . . . . 1.0 109.694 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.65 179.48 5.66 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.94 1.296 . . . . 1.0 110.975 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.5 m -162.67 118.63 1.88 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.756 2.822 . . . . 1.0 105.738 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -131.9 138.47 32.55 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 117.257 -1.354 . . . . 1.0 107.455 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.61 99.66 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.473 2.782 . . . . 1.0 109.389 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -168.03 151.48 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.9 2.48 . . . . 1.0 105.966 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -151.53 106.74 3.31 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.261 1.391 . . . . 1.0 108.288 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -136.36 165.48 25.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.85 2.06 . . . . 1.0 107.28 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -67.43 123.47 86.7 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.173 -1.047 . . . . 1.0 108.173 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.96 103.71 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.548 2.165 . . . . 1.0 110.528 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 t -170.54 73.88 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.57 124.03 11.01 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.666 1.587 . . . . 1.0 106.97 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -88.44 131.64 34.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.119 0.968 . . . . 1.0 109.389 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.3 143.17 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.756 -1.942 . . . . 1.0 105.756 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.14 116.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 105.991 -1.855 . . . . 1.0 105.991 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.4 OUTLIER -172.08 152.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.264 1.425 . . . . 1.0 107.465 175.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 112.4 24.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.8 mm -128.27 176.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 128.672 2.789 . . . . 1.0 106.545 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -153.28 121.47 6.19 Favored 'General case' 0 C--N 1.31 -1.124 1 N-CA-C 93.728 -6.397 . . . . 1.0 93.728 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.297 0.3 OUTLIER -142.0 -60.33 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 119.459 1.027 . . . . 1.0 110.537 176.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.52 134.31 11.06 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 CA-C-N 121.904 1.716 . . . . 1.0 110.419 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.27 75.81 3.25 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.341 2.694 . . . . 1.0 115.408 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.82 -71.7 0.85 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 106.615 -2.594 . . . . 1.0 106.615 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -156.21 123.63 5.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.888 1.275 . . . . 1.0 110.7 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -174.2 148.22 1.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.778 2.831 . . . . 1.0 108.294 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.51 -35.37 55.89 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.442 0.565 . . . . 1.0 113.406 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.39 118.94 11.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.558 1.075 . . . . 1.0 113.157 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.78 -5.88 17.42 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.636 2.891 . . . . 1.0 115.262 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -48.36 -45.73 35.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.439 1.472 . . . . 1.0 110.905 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.0 mt -65.98 -45.14 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.816 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.16 -39.35 92.34 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.542 -0.463 . . . . 1.0 109.768 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.25 70.68 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.238 0.472 . . . . 1.0 111.686 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.69 -52.4 51.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.573 1.149 . . . . 1.0 109.372 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.28 -41.37 73.49 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 t -66.02 -48.58 70.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.86 2.46 11.35 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.713 1.625 . . . . 1.0 114.503 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -89.08 9.21 26.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.913 1.856 . . . . 1.0 113.008 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 tt -52.21 129.53 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.293 1.437 . . . . 1.0 112.543 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.0 135.52 20.84 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.272 2.229 . . . . 1.0 109.599 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.88 78.1 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.604 2.869 . . . . 1.0 106.951 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -103.2 -65.07 1.02 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.036 0.534 . . . . 1.0 111.055 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.45 79.01 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.226 0.61 . . . . 1.0 111.117 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -171.08 178.08 0.85 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.037 1.735 . . . . 1.0 107.71 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.22 -43.4 4.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.596 2.197 . . . . 1.0 114.972 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -46.14 -50.88 14.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -54.62 42.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.302 1.041 . . . . 1.0 110.025 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.27 99.22 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.434 1.093 . . . . 1.0 111.29 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.99 -58.15 12.55 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 126.106 1.813 . . . . 1.0 112.184 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 pt -57.94 -38.26 65.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 117.954 -1.022 . . . . 1.0 111.879 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.79 -43.1 2.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.304 2.241 . . . . 1.0 115.318 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -61.22 -33.39 73.41 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.599 -0.688 . . . . 1.0 110.377 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.76 135.78 33.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 103.376 -2.824 . . . . 1.0 103.376 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.54 145.7 55.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.583 -0.698 . . . . 1.0 109.152 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.91 161.85 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 127.587 2.355 . . . . 1.0 111.418 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -175.97 139.96 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.412 2.285 . . . . 1.0 106.847 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -160.21 0.78 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.837 1.255 . . . . 1.0 108.074 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -130.41 -58.85 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.437 1.495 . . . . 1.0 108.539 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.97 119.42 17.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.196 -2.52 . . . . 1.0 104.196 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 tp -107.3 113.55 27.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.199 -2.519 . . . . 1.0 104.199 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.16 114.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -76.0 145.39 40.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -20.55 2.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.97 1.471 . . . . 1.0 114.97 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -91.4 29.95 1.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.271 1.828 . . . . 1.0 112.105 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.42 52.28 52.38 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.127 1.822 . . . . 1.0 114.085 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -126.77 117.34 22.47 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.331 -0.842 . . . . 1.0 110.465 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.4 mt -83.02 114.73 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 101.6 -3.481 . . . . 1.0 101.6 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.48 142.27 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 103.34 -2.837 . . . . 1.0 103.34 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -121.14 114.04 20.87 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.074 -1.641 . . . . 1.0 111.264 -175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -108.98 120.17 41.74 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 72.8 t 64.93 88.6 0.11 Allowed Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.024 1.284 . . . . 1.0 112.869 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.19 178.21 5.7 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 121.528 1.485 . . . . 1.0 109.548 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -43.55 9.26 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.149 1 C-N-CA 133.476 4.71 . . . . 1.0 120.198 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -133.89 111.12 10.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 119.371 -2.081 . . . . 1.0 107.552 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 86.25 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.889 2.076 . . . . 1.0 111.41 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -34.0 156.29 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.302 2.641 . . . . 1.0 114.669 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.59 -178.51 3.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 130.008 3.323 . . . . 1.0 109.998 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -145.93 118.54 8.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.95 1.25 . . . . 1.0 110.246 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -154.79 62.82 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 123.132 1.444 . . . . 1.0 110.747 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -161.76 -55.77 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 118.944 -2.348 . . . . 1.0 112.917 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.92 -74.41 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.177 -1.969 . . . . 1.0 108.177 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.18 128.82 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.244 1.417 . . . . 1.0 109.675 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.6 p -166.19 154.28 10.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.68 1.592 . . . . 1.0 112.14 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' H ' HG22 ' A' ' 157' ' ' ILE . 60.6 p -153.21 146.63 24.91 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 120.864 -1.147 . . . . 1.0 110.812 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -153.88 154.62 34.21 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.549 0.613 . . . . 1.0 110.504 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 38.91 55.38 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.223 1.809 . . . . 1.0 111.612 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.67 77.1 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.86 -0.967 . . . . 1.0 114.468 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -136.55 119.86 16.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.503 -1.665 . . . . 1.0 106.503 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -100.44 138.7 37.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 36.4 mtm180 -113.31 118.34 34.32 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.1 t -58.07 -41.75 84.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.348 1.059 . . . . 1.0 111.212 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -148.19 177.02 9.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.514 3.126 . . . . 1.0 108.059 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.0 76.91 10.01 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.387 1.089 . . . . 1.0 108.689 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -87.51 33.92 0.7 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.198 0.999 . . . . 1.0 111.185 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.2 m -135.46 137.61 42.35 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.034 -1.666 . . . . 1.0 113.013 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.98 57.0 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.932 2.093 . . . . 1.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.18 -136.79 2.41 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.85 -1.156 . . . . 1.0 111.029 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.1 mm -142.63 162.02 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 129.177 2.991 . . . . 1.0 103.329 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.94 130.22 29.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.76 -3.052 . . . . 1.0 102.76 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.54 157.53 16.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 107.435 -1.321 . . . . 1.0 107.435 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.08 155.82 46.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.959 0.885 . . . . 1.0 111.12 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.55 179.36 43.35 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.393 -1.276 . . . . 1.0 111.027 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -147.88 116.35 6.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 128.229 2.611 . . . . 1.0 105.434 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.8 t0 54.17 32.48 15.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.858 2.463 . . . . 1.0 115.109 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.0 p 51.25 37.53 18.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.3 1.84 . . . . 1.0 113.212 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.44 146.46 54.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.749 1.62 . . . . 1.0 108.508 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -29.3 113.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.658 1.983 . . . . 1.0 111.206 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -78.36 -9.41 59.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.354 18.3 p 66.84 77.66 0.27 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 116.711 -1.614 . . . . 1.0 111.84 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.45 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 121.148 1.795 . . . . 1.0 113.729 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.12 -43.08 3.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.728 2.011 . . . . 1.0 110.245 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -55.53 -44.65 76.91 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.263 1.025 . . . . 1.0 111.461 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.55 -43.31 97.38 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.755 1.162 . . . . 1.0 109.902 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -63.08 -55.54 24.57 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.01 -43.06 88.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.767 0.827 . . . . 1.0 111.08 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.75 -48.01 80.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.314 1.415 . . . . 1.0 108.902 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.06 89.53 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.292 -0.861 . . . . 1.0 109.438 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.58 -53.89 45.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.991 0.916 . . . . 1.0 110.797 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.6 t -55.84 -53.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.0 m -57.88 -57.6 12.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.405 1.482 . . . . 1.0 110.452 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.19 -46.4 79.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.653 1.581 . . . . 1.0 110.738 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 1' ' ' MET . . . -70.67 -41.38 72.15 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.968 -0.539 . . . . 1.0 111.379 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.71 -42.69 79.6 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.927 -1.108 . . . . 1.0 109.93 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.8 -41.03 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.673 1.189 . . . . 1.0 109.721 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.7 m -59.25 -13.08 6.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.337 1.055 . . . . 1.0 112.394 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -111.85 -43.61 3.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.275 -1.345 . . . . 1.0 111.39 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.52 112.81 23.03 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -97.97 107.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 121.286 1.495 . . . . 1.0 111.493 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.81 -54.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.71 2.004 . . . . 1.0 108.251 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 60.0 mt -49.77 -32.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 129.5 3.12 . . . . 1.0 110.813 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.36 -21.46 2.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.708 1.203 . . . . 1.0 113.345 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.57 18.39 3.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.881 2.072 . . . . 1.0 110.894 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -143.2 83.96 1.81 Allowed 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.125 -0.984 . . . . 1.0 109.899 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.26 127.9 40.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -158.53 -168.23 2.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.32 -0.992 . . . . 1.0 108.32 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.75 -131.67 1.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 106.7 -2.56 . . . . 1.0 106.7 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 9.2 m170 -113.78 -23.2 9.8 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.111 0.964 . . . . 1.0 111.276 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.3 -15.89 15.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.145 0.978 . . . . 1.0 109.543 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.82 38.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.173 -0.954 . . . . 1.0 109.759 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -68.92 -17.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.914 -1.116 . . . . 1.0 109.446 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -155.02 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.232 1.813 . . . . 1.0 111.453 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -92.3 110.24 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.795 2.33 . . . . 1.0 112.781 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -58.39 -25.95 62.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.346 1.858 . . . . 1.0 113.924 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -25.31 62.87 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.497 0.719 . . . . 1.0 112.794 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -127.69 139.73 52.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -127.65 -16.43 4.77 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.978 -0.378 . . . . 1.0 109.978 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.18 178.85 0.48 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 131.281 3.832 . . . . 1.0 103.725 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.13 85.63 1.36 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.186 1.924 . . . . 1.0 109.994 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.96 68.32 0.62 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.236 1.398 . . . . 1.0 111.64 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 168' ' ' SER . 71.9 Cg_endo -75.38 -70.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.688 2.259 . . . . 1.0 112.592 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 15.4 t 53.7 42.9 31.72 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.582 2.353 . . . . 1.0 111.408 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -99.56 18.92 16.75 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.11 -1.619 . . . . 1.0 113.9 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.8 t0 43.35 70.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.781 1.233 . . . . 1.0 112.93 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -56.27 -30.09 62.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 1.0 112.66 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.86 -60.07 3.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.037 0.835 . . . . 1.0 109.065 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -64.18 -34.54 78.32 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.371 -0.931 . . . . 1.0 111.967 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.01 -52.7 46.89 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.823 1.192 . . . . 1.0 110.618 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -34.64 74.6 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 119.049 -0.5 . . . . 1.0 109.985 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.06 89.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.868 0.867 . . . . 1.0 112.557 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.54 -58.86 3.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.793 1.237 . . . . 1.0 110.155 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.03 166.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.327 1.051 . . . . 1.0 110.23 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 86.3 m -40.26 114.68 1.07 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 109.765 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -80.95 46.38 2.25 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 124.142 3.228 . . . . 1.0 114.623 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.8 t 49.18 34.56 6.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.495 1.918 . . . . 1.0 113.507 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -162.43 89.99 0.71 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -166.2 100.54 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.04 -1.037 . . . . 1.0 108.495 -175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -69.39 123.64 21.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 118.617 -1.233 . . . . 1.0 108.29 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -162.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.275 2.63 . . . . 1.0 108.861 175.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -152.41 114.77 4.49 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.463 -1.68 . . . . 1.0 106.463 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.895 1.678 . . . . 1.0 109.762 -176.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttm . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 11.7 tp -141.5 170.75 15.14 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.282 1.833 . . . . 1.0 106.923 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 85.7 mt -108.76 123.35 48.88 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 101.558 -3.497 . . . . 1.0 101.558 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -114.34 123.11 48.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 47.09 36.44 4.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.073 0.949 . . . . 1.0 111.435 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.43 2.03 39.79 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.551 1.072 . . . . 1.0 114.615 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.04 167.71 10.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.148 -2.167 . . . . 1.0 105.148 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tt -80.2 124.04 28.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.811 -1.181 . . . . 1.0 108.382 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.86 139.77 41.86 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.964 0.347 . . . . 1.0 110.682 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 57.24 65.99 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 127.062 2.145 . . . . 1.0 112.818 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.41 148.48 37.89 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.262 1.425 . . . . 1.0 107.289 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -72.07 123.38 22.71 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.545 -2.391 . . . . 1.0 104.545 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.91 38.32 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.734 0.814 . . . . 1.0 111.929 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.67 72.92 77.08 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.066 0.946 . . . . 1.0 108.803 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.57 123.26 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 107.513 -1.764 . . . . 1.0 107.513 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -136.02 113.38 10.62 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.3 61.78 4.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.97 2.447 . . . . 1.0 108.926 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -124.01 44.69 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.892 -1.892 . . . . 1.0 105.892 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -82.01 178.38 8.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.819 2.048 . . . . 1.0 113.466 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.87 -179.3 3.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 128.268 2.627 . . . . 1.0 112.912 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 m -157.65 118.59 3.54 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.173 4.589 . . . . 1.0 101.337 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -132.92 138.46 31.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 116.728 -1.606 . . . . 1.0 107.975 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.68 86.95 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.57 2.846 . . . . 1.0 108.675 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HB2' HH12 ' A' ' 93' ' ' ARG . 13.2 m-20 -160.29 150.88 18.58 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.828 2.451 . . . . 1.0 106.226 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -151.49 104.06 3.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.322 1.849 . . . . 1.0 106.134 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.11 170.36 16.23 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.476 1.489 . . . . 1.0 108.138 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -75.43 123.19 88.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 119.905 -1.747 . . . . 1.0 109.033 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.22 103.54 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.967 1.778 . . . . 1.0 110.712 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.3 t -171.08 77.23 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.55 -1.648 . . . . 1.0 106.55 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -145.8 124.72 12.72 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.23 127.26 35.75 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.834 -1.543 . . . . 1.0 106.834 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.09 113.8 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -108.79 114.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 104.916 -2.253 . . . . 1.0 104.916 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.63 149.18 5.54 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 116.731 -1.604 . . . . 1.0 106.868 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -95.54 111.43 23.34 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 117.145 -1.822 . . . . 1.0 110.138 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -127.6 176.78 6.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 129.98 3.312 . . . . 1.0 107.273 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.1 t -149.15 121.04 8.16 Favored 'General case' 0 C--N 1.313 -1.016 1 N-CA-C 94.697 -6.038 . . . . 1.0 94.697 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.295 0.1 OUTLIER -142.36 -61.39 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.26 0.937 . . . . 1.0 109.8 175.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.07 124.67 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.212 1.942 . . . . 1.0 110.013 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.8 68.89 7.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.538 2.825 . . . . 1.0 111.73 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.92 -71.1 0.69 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.855 -1.698 . . . . 1.0 108.855 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -152.33 123.48 7.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.545 1.938 . . . . 1.0 106.121 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -175.71 158.58 2.18 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.42 2.688 . . . . 1.0 107.857 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.84 -0.75 63.87 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.558 -1.134 . . . . 1.0 113.058 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 118.47 4.79 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.67 1.735 . . . . 1.0 110.903 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.35 -12.88 15.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.64 2.227 . . . . 1.0 114.101 -175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -61.81 -33.92 75.0 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.921 1.237 . . . . 1.0 111.017 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.6 mt -64.17 -55.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.314 -1.365 . . . . 1.0 107.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.6 -33.28 75.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.439 0.563 . . . . 1.0 112.271 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.25 -34.25 56.42 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.74 0.816 . . . . 1.0 111.3 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.36 -51.11 60.53 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.14 -0.975 . . . . 1.0 109.559 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -61.23 -50.63 72.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 1.0 110.884 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 t -61.76 -33.91 74.91 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.346 1.458 . . . . 1.0 110.548 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.63 2.75 37.44 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.804 -1.554 . . . . 1.0 115.666 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.5 p -93.04 9.3 36.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.177 1.988 . . . . 1.0 113.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 tt -49.13 137.55 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.344 1.058 . . . . 1.0 112.19 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 136.33 20.75 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 126.415 1.886 . . . . 1.0 107.015 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.49 67.25 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.967 3.112 . . . . 1.0 110.296 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.56 -48.31 4.0 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.486 1.291 . . . . 1.0 114.486 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.46 -64.51 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.065 0.946 . . . . 1.0 112.76 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -171.04 178.01 0.87 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.376 1.47 . . . . 1.0 108.199 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.78 -43.9 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.848 2.365 . . . . 1.0 115.154 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -51.45 -59.04 4.68 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.984 1.266 . . . . 1.0 112.246 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.7 -49.22 69.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.718 0.807 . . . . 1.0 111.094 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.04 95.1 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.32 0.648 . . . . 1.0 111.595 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.43 -63.47 5.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 125.29 1.424 . . . . 1.0 110.751 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.33 -26.12 38.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-O 116.06 -1.924 . . . . 1.0 112.49 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.79 -43.22 3.89 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 121.002 1.728 . . . . 1.0 115.059 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -60.01 -34.5 73.43 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.499 0.72 . . . . 1.0 111.188 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.43 136.18 33.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.946 -2.613 . . . . 1.0 103.946 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 164.29 15.18 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.853 -1.154 . . . . 1.0 109.358 175.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -116.58 166.39 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.346 1.058 . . . . 1.0 109.593 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -170.73 121.56 0.58 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.351 1.46 . . . . 1.0 107.653 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.29 -155.5 0.48 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.382 1.873 . . . . 1.0 107.329 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -136.06 -59.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.327 1.851 . . . . 1.0 108.029 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.1 m -132.63 118.97 19.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -109.01 113.63 26.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -95.37 114.25 31.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.173 -2.158 . . . . 1.0 105.173 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.92 148.91 43.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.394 0.997 . . . . 1.0 108.323 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -13.61 2.51 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.232 1.197 . . . . 1.0 114.232 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -91.82 23.41 3.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.258 1.023 . . . . 1.0 110.986 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.75 41.44 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 127.674 2.559 . . . . 1.0 112.891 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.98 154.63 44.33 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.077 0.951 . . . . 1.0 108.956 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.96 113.77 44.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.53 146.95 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.686 -1.598 . . . . 1.0 106.686 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -124.7 113.78 18.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.278 1.031 . . . . 1.0 108.876 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -114.05 114.8 26.61 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 104.149 -2.538 . . . . 1.0 104.149 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t 81.46 91.95 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.898 1.226 . . . . 1.0 109.254 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -64.83 -167.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.964 1.776 . . . . 1.0 110.289 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -77.29 51.26 0.83 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.377 -1.452 . . . . 1.0 110.976 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -154.99 129.57 9.18 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.545 2.738 . . . . 1.0 105.611 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.6 tttp 62.93 81.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.04 2.136 . . . . 1.0 112.773 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.404 HH12 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -35.45 155.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.138 2.975 . . . . 1.0 112.972 -176.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.272 . . -103.45 178.5 4.54 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.81 2.444 . . . . 1.0 114.42 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -151.79 118.05 5.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.855 2.062 . . . . 1.0 105.497 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -165.33 62.96 0.12 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.135 1.445 . . . . 1.0 109.734 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -168.89 -69.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 O-C-N 119.114 -2.241 . . . . 1.0 114.758 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.04 -78.04 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.6 t -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.166 0.987 . . . . 1.0 108.727 -176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 p -166.32 158.32 13.83 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.636 2.375 . . . . 1.0 106.956 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.9 p -161.25 145.57 13.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.13 -1.804 . . . . 1.0 106.13 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -166.03 155.05 11.49 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . 0.275 37.6 mm-40 39.16 58.01 1.91 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.46 1.904 . . . . 1.0 113.008 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.16 28.74 50.42 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.344 1.45 . . . . 1.0 114.247 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -128.9 113.26 15.01 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -89.76 135.15 33.79 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 -175.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.0 mtt85 -125.54 140.71 52.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.384 0.993 . . . . 1.0 109.155 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -86.32 -24.72 25.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.844 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -158.34 170.44 22.22 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.085 2.554 . . . . 1.0 106.238 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.5 76.3 10.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 123.095 1.426 . . . . 1.0 110.507 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.05 44.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.69 2.396 . . . . 1.0 110.297 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 m -123.5 156.56 35.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.439 1.495 . . . . 1.0 112.549 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.262 0.0 OUTLIER -97.65 56.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.705 2.002 . . . . 1.0 108.189 176.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.24 -135.38 3.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 10.7 mm -143.92 161.12 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 128.827 2.851 . . . . 1.0 104.848 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -131.92 113.66 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 101.536 -3.505 . . . . 1.0 101.536 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.51 148.26 28.2 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.291 -1.374 . . . . 1.0 107.291 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.05 155.26 47.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.635 0.731 . . . . 1.0 112.175 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.12 173.4 43.57 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.811 -1.541 . . . . 1.0 111.556 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.4 p -137.89 103.15 4.9 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.484 1.913 . . . . 1.0 106.297 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 t70 57.87 30.46 19.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.041 1.736 . . . . 1.0 113.344 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.255 81.7 p 57.82 38.74 27.3 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.545 1.938 . . . . 1.0 113.444 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.66 145.58 52.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -28.36 113.46 0.07 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 128.059 2.543 . . . . 1.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -79.02 -9.84 59.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 115.163 -2.351 . . . . 1.0 116.043 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 43.6 p 65.08 77.04 0.32 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 121.801 2.091 . . . . 1.0 112.698 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -23.36 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.548 1.539 . . . . 1.0 114.578 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.05 -40.71 6.93 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.301 2.24 . . . . 1.0 111.379 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.73 -54.0 13.5 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.394 1.078 . . . . 1.0 109.378 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -59.13 -38.82 80.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.334 0.654 . . . . 1.0 111.597 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.59 -57.38 8.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.4 0.545 . . . . 1.0 110.888 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -65.08 -37.12 86.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.972 0.805 . . . . 1.0 110.765 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.1 tp -56.52 -47.88 78.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.43 1.014 . . . . 1.0 108.603 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.16 93.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.589 -0.72 . . . . 1.0 110.527 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.82 53.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.071 0.85 . . . . 1.0 110.292 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.8 t -57.1 -48.61 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.909 -0.775 . . . . 1.0 108.909 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.0 m -56.45 -49.52 74.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.976 1.311 . . . . 1.0 110.438 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -59.02 -46.87 87.12 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.89 0.876 . . . . 1.0 109.944 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.3 77.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.864 0.302 . . . . 1.0 110.594 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.0 mt -55.94 -44.21 78.16 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.988 0.915 . . . . 1.0 111.187 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.73 -41.08 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.126 0.875 . . . . 1.0 110.432 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -65.69 -14.26 60.91 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.826 -1.171 . . . . 1.0 112.252 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.68 -59.24 1.78 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.632 1.105 . . . . 1.0 108.191 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -124.82 112.88 27.04 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -101.76 107.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 123.347 1.311 . . . . 1.0 112.465 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.29 -41.26 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.073 2.549 . . . . 1.0 105.85 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.4 mt -47.75 -33.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 128.869 2.868 . . . . 1.0 109.851 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.81 -26.25 13.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.023 0.929 . . . . 1.0 112.89 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -129.9 18.58 5.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.565 1.946 . . . . 1.0 109.992 175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.84 83.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 122.221 1.01 . . . . 1.0 108.332 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.91 113.41 17.82 Favored 'General case' 0 N--CA 1.448 -0.563 1 N-CA-C 99.988 -4.079 . . . . 1.0 99.988 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -152.98 -166.67 2.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -149.41 -131.78 2.0 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.148 -2.381 . . . . 1.0 107.148 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.427 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 16.9 m170 -116.63 -23.76 8.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.467 1.134 . . . . 1.0 110.629 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.5 t -103.86 2.34 32.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.41 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 4.1 t-20 -104.08 22.83 13.98 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.356 1.463 . . . . 1.0 111.459 -175.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.59 -15.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.34 0.656 . . . . 1.0 111.949 -175.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -152.26 -57.48 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.847 1.659 . . . . 1.0 108.934 175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.4 117.12 3.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 CA-C-N 122.085 1.78 . . . . 1.0 112.204 -175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.31 -25.56 64.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.784 0.834 . . . . 1.0 111.926 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -62.32 -19.27 63.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.476 2.31 . . . . 1.0 114.905 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -137.25 141.92 42.0 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 2.5 m -130.94 -17.05 3.17 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 117.158 -1.817 . . . . 1.0 112.422 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.58 -178.34 0.28 Allowed Pre-proline 0 C--O 1.249 1.036 0 C-N-CA 128.894 2.878 . . . . 1.0 105.093 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 80.01 2.31 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 N-CA-C 106.704 -2.076 . . . . 1.0 106.704 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 128.38 79.15 0.25 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.105 1.812 . . . . 1.0 111.035 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.57 -113.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 123.93 3.087 . . . . 1.0 110.237 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 t 56.36 43.51 26.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.284 1.833 . . . . 1.0 112.807 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -95.94 17.68 14.86 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.351 1.46 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.0 t0 44.08 77.27 0.07 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.106 1.362 . . . . 1.0 112.351 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -54.98 -32.87 62.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.392 0.516 . . . . 1.0 112.392 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.38 78.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.723 0.692 . . . . 1.0 111.252 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -59.8 -57.61 12.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.916 0.78 . . . . 1.0 110.07 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.55 -50.29 74.33 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.33 -38.96 81.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 118.481 0.582 . . . . 1.0 110.403 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.67 76.17 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.839 0.681 . . . . 1.0 112.839 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.59 -44.71 66.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.322 1.049 . . . . 1.0 111.862 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.64 162.89 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.17 0.988 . . . . 1.0 109.745 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -59.49 118.01 27.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.367 1.067 . . . . 1.0 109.084 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.87 50.34 3.54 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.918 3.079 . . . . 1.0 113.244 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.5 t 47.14 33.81 2.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.989 1.716 . . . . 1.0 113.543 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.2 t -158.4 153.93 26.11 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.636 -2.727 . . . . 1.0 103.636 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 52.87 79.75 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.399 1.079 . . . . 1.0 112.472 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.411 ' HE2' ' OE2' ' A' ' 185' ' ' GLU . 16.2 tttt -66.14 149.67 49.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 175.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.411 ' OE2' ' HE2' ' A' ' 184' ' ' LYS . 0.3 OUTLIER -67.6 179.25 1.39 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.214 1.007 . . . . 1.0 112.15 176.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.5 tpt -162.06 158.21 24.56 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.707 2.803 . . . . 1.0 105.727 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 114.693 -2.575 . . . . 1.0 110.079 -178.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ttt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.1 tp -50.92 123.45 9.21 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 152.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.0 mt -136.3 135.21 38.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 103.407 -2.812 . . . . 1.0 103.407 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -135.54 153.15 51.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.491 0.716 . . . . 1.0 109.71 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 51.46 33.36 10.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.109 1.764 . . . . 1.0 110.494 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.42 20.01 49.54 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.634 -1.291 . . . . 1.0 112.208 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -131.59 176.87 7.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.318 3.047 . . . . 1.0 106.366 -175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 129.87 43.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.46 145.29 44.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.871 1.434 . . . . 1.0 114.871 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 40.25 58.77 2.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 128.085 2.554 . . . . 1.0 108.941 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.66 156.71 46.67 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.467 1.107 . . . . 1.0 110.624 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -88.81 123.76 33.52 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -83.59 132.58 34.9 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -137.1 70.34 56.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.25 135.18 11.91 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.874 2.382 . . . . 1.0 111.787 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 t -159.18 113.2 1.57 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 N-CA-C 104.846 -2.279 . . . . 1.0 104.846 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.11 69.83 7.75 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.57 2.18 . . . . 1.0 110.207 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -123.19 43.57 2.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.876 2.071 . . . . 1.0 107.109 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -106.7 177.78 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.087 1.355 . . . . 1.0 110.005 -176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.25 -175.15 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.055 2.142 . . . . 1.0 112.101 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.87 130.16 14.65 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.712 2.805 . . . . 1.0 104.377 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.29 171.33 6.9 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 119.407 1.003 . . . . 1.0 109.345 -175.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.1 76.64 4.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.103 1.869 . . . . 1.0 112.738 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -149.81 144.0 25.72 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.849 2.46 . . . . 1.0 108.516 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -144.0 104.2 4.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.879 -1.526 . . . . 1.0 106.879 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -136.27 157.58 46.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.349 1.46 . . . . 1.0 109.224 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -70.7 123.56 89.37 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 103.14 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.04 1.407 . . . . 1.0 110.394 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 t -177.9 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.53 -1.655 . . . . 1.0 106.53 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tt -155.51 137.31 14.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.623 -1.991 . . . . 1.0 105.623 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.0 tp -99.21 125.44 44.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.878 0.871 . . . . 1.0 109.594 -175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.46 113.81 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.13 120.93 59.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 104.902 -2.259 . . . . 1.0 104.902 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -169.82 134.23 1.32 Allowed 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -90.45 112.26 23.82 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.602 -1.259 . . . . 1.0 107.602 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm -127.38 176.62 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 130.627 3.571 . . . . 1.0 107.259 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 t -140.77 122.71 15.5 Favored 'General case' 0 C--O 1.245 0.842 1 N-CA-C 95.789 -5.634 . . . . 1.0 95.789 174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.309 1.0 OUTLIER -141.79 -64.3 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 114.139 1.163 . . . . 1.0 114.139 176.201 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 159.86 33.91 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.275 1.134 . . . . 1.0 112.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.04 0.76 9.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.044 3.163 . . . . 1.0 116.524 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -19.82 -66.48 0.01 OUTLIER Glycine 0 C--N 1.347 1.181 0 C-N-CA 126.178 1.847 . . . . 1.0 112.607 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -152.68 123.7 7.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.169 1.388 . . . . 1.0 112.021 175.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -176.6 164.79 2.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.412 3.085 . . . . 1.0 108.617 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.97 18.75 16.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.534 2.016 . . . . 1.0 111.2 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.8 118.47 6.16 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 107.69 -2.164 . . . . 1.0 107.69 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.2 -19.4 26.0 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 CA-C-N 121.286 2.543 . . . . 1.0 113.682 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -56.95 -34.61 68.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.651 1.18 . . . . 1.0 112.705 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -66.06 -53.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.27 -33.22 75.26 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.773 -0.58 . . . . 1.0 112.228 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.19 -33.94 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.25 1.02 . . . . 1.0 111.017 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.08 -51.28 64.81 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.363 -0.835 . . . . 1.0 111.335 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -71.01 -39.43 72.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.377 1.071 . . . . 1.0 112.419 -175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 t -66.35 -40.37 89.77 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.96 16.88 6.58 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 124.939 1.257 . . . . 1.0 115.55 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.5 p -110.84 18.39 19.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.894 1.847 . . . . 1.0 113.805 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.72 132.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.465 1.029 . . . . 1.0 111.509 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.66 136.81 20.62 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 127.558 2.343 . . . . 1.0 108.887 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.65 62.67 1.72 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.31 2.674 . . . . 1.0 113.157 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -103.53 -50.16 3.51 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.042 1.127 . . . . 1.0 114.042 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.49 -63.27 1.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.729 0.695 . . . . 1.0 112.333 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -170.83 178.01 0.89 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.653 1.581 . . . . 1.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -44.2 18.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.067 1.845 . . . . 1.0 114.789 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -51.36 -58.7 5.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.41 1.005 . . . . 1.0 111.855 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -43.73 98.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.716 0.806 . . . . 1.0 110.136 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.8 98.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.404 -0.81 . . . . 1.0 111.817 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.44 -63.02 5.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.147 2.308 . . . . 1.0 112.742 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 pt -57.57 -34.26 46.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.9 -1.048 . . . . 1.0 113.077 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.5 -43.79 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 117.236 2.31 . . . . 1.0 117.236 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -64.88 -33.61 76.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.848 0.459 . . . . 1.0 110.189 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.83 119.6 25.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.137 -1.801 . . . . 1.0 106.137 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.33 132.64 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.621 -0.674 . . . . 1.0 109.841 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.65 162.79 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.366 1.466 . . . . 1.0 111.108 -175.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.2 m -161.7 115.94 1.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.749 0.82 . . . . 1.0 109.363 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.45 -156.98 0.53 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.628 1.171 . . . . 1.0 108.809 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -134.87 -75.98 0.46 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 55.5 m -124.08 118.28 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 102.207 -3.257 . . . . 1.0 102.207 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.03 113.57 27.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 103.688 -2.708 . . . . 1.0 103.688 176.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.62 122.04 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.174 -1.787 . . . . 1.0 106.174 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.04 150.16 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -57.12 -14.75 4.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.924 -1.512 . . . . 1.0 114.144 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.34 19.33 6.12 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 120.505 1.502 . . . . 1.0 112.267 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.78 51.88 54.33 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.028 1.775 . . . . 1.0 112.58 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.27 111.02 16.85 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.586 -1.635 . . . . 1.0 106.586 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.7 mt -79.74 120.17 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.669 -1.604 . . . . 1.0 106.669 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.66 141.4 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 102.819 -3.03 . . . . 1.0 102.819 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 116.87 21.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -118.38 131.02 56.31 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.966 2.507 . . . . 1.0 105.615 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 t 69.05 91.51 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 120.726 1.603 . . . . 1.0 111.465 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 91' ' ' ASP . 74.0 Cg_endo -66.32 -169.48 0.17 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.827 2.351 . . . . 1.0 112.026 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -69.59 30.41 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.319 1.447 . . . . 1.0 110.668 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 89' ' ' PRO . 3.0 t0 -144.5 115.32 7.78 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 128.57 2.748 . . . . 1.0 108.305 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HZ2' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER 79.14 82.19 0.06 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.241 2.616 . . . . 1.0 112.486 174.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -34.38 146.22 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.337 2.655 . . . . 1.0 114.834 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.09 -178.55 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.863 2.065 . . . . 1.0 113.194 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -155.91 118.28 4.12 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.63 2.372 . . . . 1.0 108.472 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -161.01 63.03 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.715 1.245 . . . . 1.0 109.402 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.503 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.83 -70.85 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 119.627 -1.921 . . . . 1.0 113.261 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.93 -74.7 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 106.35 -2.7 . . . . 1.0 106.35 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.19 140.53 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.582 1.191 . . . . 1.0 110.061 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.3 p -166.32 162.45 17.23 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.969 1.307 . . . . 1.0 110.282 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 p -166.23 146.79 6.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.736 1.614 . . . . 1.0 108.928 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -156.39 147.24 21.95 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.333 0.97 . . . . 1.0 110.674 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 38.91 56.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.343 1.857 . . . . 1.0 112.142 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.95 28.89 69.41 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.289 0.947 . . . . 1.0 114.527 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -128.63 113.79 15.86 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.96 146.5 24.33 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -123.17 118.89 28.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.031 0.533 . . . . 1.0 111.108 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.52 -25.8 50.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.976 0.91 . . . . 1.0 110.042 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.67 168.88 18.86 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 127.558 2.343 . . . . 1.0 107.857 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -88.18 75.91 8.54 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.98 33.83 1.84 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.521 1.128 . . . . 1.0 112.276 -175.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -126.94 131.07 51.18 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.938 0.895 . . . . 1.0 109.542 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.289 0.1 OUTLIER -79.01 56.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.214 1.806 . . . . 1.0 110.073 -177.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.44 -133.26 3.42 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 122.578 1.099 . . . . 1.0 111.684 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 20.6 mm -137.03 166.38 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.351 3.46 . . . . 1.0 104.085 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -144.85 135.38 24.42 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 101.839 -3.393 . . . . 1.0 101.839 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.3 165.69 11.14 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.522 -1.361 . . . . 1.0 110.412 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.15 150.35 49.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.771 0.829 . . . . 1.0 110.256 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.1 175.6 45.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.872 1.262 . . . . 1.0 112.383 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.5 p -141.28 110.1 6.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.983 2.113 . . . . 1.0 106.111 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 t0 45.67 48.73 11.43 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 128.301 2.64 . . . . 1.0 111.82 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p 50.7 38.08 18.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.776 2.831 . . . . 1.0 115.404 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.4 145.92 50.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.123 2.169 . . . . 1.0 110.55 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.34 114.68 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 129.405 3.082 . . . . 1.0 110.987 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -84.36 -8.05 59.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 114.123 -2.846 . . . . 1.0 113.155 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.391 26.5 p 64.9 77.92 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 122.568 2.44 . . . . 1.0 115.014 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -23.22 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 121.073 1.76 . . . . 1.0 114.815 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.9 -43.1 13.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.827 2.051 . . . . 1.0 110.733 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -50.15 -50.72 48.0 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 118.299 -0.857 . . . . 1.0 109.738 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -60.56 -36.36 78.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 117.559 -1.21 . . . . 1.0 111.222 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -65.29 -60.04 3.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.512 1.051 . . . . 1.0 109.713 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -62.8 -41.45 99.28 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.483 0.313 . . . . 1.0 111.138 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.01 -52.98 63.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.812 1.645 . . . . 1.0 109.122 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.71 76.23 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 118.289 -0.862 . . . . 1.0 110.273 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.79 52.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.683 0.793 . . . . 1.0 108.929 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.61 -50.29 68.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 176.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -58.27 -57.39 13.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.266 1.026 . . . . 1.0 112.13 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -55.79 -43.16 76.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.537 1.062 . . . . 1.0 110.328 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.85 51.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.788 -0.57 . . . . 1.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.53 -34.06 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.144 1.378 . . . . 1.0 112.105 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 mt -63.58 -39.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.405 -1.332 . . . . 1.0 107.405 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.8 m -64.53 -14.35 57.02 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.297 1.039 . . . . 1.0 110.4 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -64.93 1.07 Allowed 'General case' 0 C--N 1.347 0.47 0 O-C-N 120.24 -1.538 . . . . 1.0 106.942 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.85 113.01 24.66 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 106.922 -1.511 . . . . 1.0 106.922 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -88.65 107.25 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.865 1.702 . . . . 1.0 111.288 -175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.27 -51.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.296 1.438 . . . . 1.0 108.723 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 32.0 mt -46.04 -35.11 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 130.823 3.649 . . . . 1.0 111.789 -175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.06 63.49 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -131.39 18.34 4.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.353 2.261 . . . . 1.0 109.803 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -143.17 83.45 1.79 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 49.4 mtt -121.67 122.02 38.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.666 -2.716 . . . . 1.0 103.666 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.2 t -158.65 -176.45 5.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.02 -131.33 2.89 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 105.787 -2.925 . . . . 1.0 105.787 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 16.1 m170 -118.15 -23.12 7.47 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.134 0.974 . . . . 1.0 110.63 176.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.4 t -103.36 -18.4 14.86 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -91.78 45.83 1.25 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.925 1.29 . . . . 1.0 107.521 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -14.68 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.319 -1.488 . . . . 1.0 109.933 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -153.65 -65.95 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 127.304 2.241 . . . . 1.0 107.334 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.16 113.29 3.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.932 1.726 . . . . 1.0 113.382 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -18.71 36.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.121 1.368 . . . . 1.0 112.056 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.11 -25.99 64.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.536 1.934 . . . . 1.0 112.759 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -139.6 135.14 33.03 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.499 -2.037 . . . . 1.0 105.499 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 37.4 m -119.96 -16.49 8.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.103 0.408 . . . . 1.0 112.103 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.24 175.35 1.31 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.689 2.795 . . . . 1.0 105.095 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.73 69.3 7.85 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.953 2.435 . . . . 1.0 109.563 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 124.33 69.69 0.21 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.978 2.704 . . . . 1.0 108.54 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -82.39 -87.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.022 3.148 . . . . 1.0 112.263 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 t 53.49 73.35 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.211 3.005 . . . . 1.0 109.214 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.35 18.97 12.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.411 1.085 . . . . 1.0 113.885 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.13 74.54 0.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.879 -1.763 . . . . 1.0 112.759 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -58.65 -31.57 68.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.866 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.07 77.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.857 -1.068 . . . . 1.0 110.666 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -60.81 -51.66 68.37 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.555 1.07 . . . . 1.0 110.516 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -60.79 -56.48 20.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.213 0.82 . . . . 1.0 113.213 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -64.29 -25.63 68.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.018 -0.991 . . . . 1.0 112.176 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.79 83.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.042 0.837 . . . . 1.0 111.093 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.16 -59.9 2.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.327 1.451 . . . . 1.0 111.019 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.48 166.02 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 m -45.1 113.72 1.92 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.329 1.051 . . . . 1.0 110.225 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.7 34.75 0.55 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.691 2.26 . . . . 1.0 111.323 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 50.26 50.34 18.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.472 2.709 . . . . 1.0 109.598 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -166.16 -36.63 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.882 2.073 . . . . 1.0 108.819 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 58.9 t60 62.9 44.56 6.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.869 2.067 . . . . 1.0 113.532 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -75.6 -176.52 3.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -72.46 169.12 17.08 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.167 -0.958 . . . . 1.0 109.426 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.8 tpt -171.25 -150.72 0.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 104.577 -2.379 . . . . 1.0 104.577 175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.247 0.937 0 N-CA-C 102.547 -3.131 . . . . 1.0 102.547 175.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -142.02 152.41 43.36 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 155.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.51 127.87 36.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 103.719 -2.697 . . . . 1.0 103.719 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -136.19 129.1 31.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.756 -1.202 . . . . 1.0 107.756 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 44.22 48.52 7.78 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.54 1.936 . . . . 1.0 113.732 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.11 27.01 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.64 1.114 . . . . 1.0 113.377 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -96.78 165.62 12.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.394 1.478 . . . . 1.0 107.126 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tt -89.86 122.86 33.31 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 103.957 -2.609 . . . . 1.0 103.957 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.91 175.04 7.02 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.19 0.996 . . . . 1.0 112.186 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 43.87 58.17 3.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.229 1.812 . . . . 1.0 109.697 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.0 132.93 7.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.462 1.905 . . . . 1.0 107.322 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -63.83 123.47 19.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 142.36 28.54 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.999 -1.063 . . . . 1.0 109.681 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.34 70.4 72.99 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 105.351 -2.092 . . . . 1.0 105.351 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.21 124.22 9.82 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.639 2.226 . . . . 1.0 111.047 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -160.24 113.46 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.67 71.1 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.866 2.377 . . . . 1.0 110.756 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -123.69 54.2 1.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.783 1.633 . . . . 1.0 107.281 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -95.53 -175.71 3.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.302 2.241 . . . . 1.0 112.352 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.09 -177.08 3.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.959 2.104 . . . . 1.0 108.488 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 m -163.77 122.11 1.91 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 130.135 3.374 . . . . 1.0 103.82 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.8 152.94 52.21 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -80.88 36.6 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.991 2.461 . . . . 1.0 113.344 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.11 143.22 37.15 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.873 2.469 . . . . 1.0 104.497 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -146.69 103.26 3.64 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 9.2 tp10 -137.04 165.36 26.22 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -68.67 124.1 89.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.447 1.099 . . . . 1.0 110.695 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.5 113.94 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.025 2.484 . . . . 1.0 111.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t 178.91 85.29 0.01 OUTLIER 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.616 1.967 . . . . 1.0 105.983 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tp -148.32 143.15 26.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.259 -1.756 . . . . 1.0 106.259 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp -110.68 116.06 30.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.996 -1.853 . . . . 1.0 105.996 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.78 122.73 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.3 t -112.95 120.7 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.8 p80 -167.04 128.56 1.63 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 107.526 -1.287 . . . . 1.0 107.526 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -80.34 112.63 17.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 116.63 -2.028 . . . . 1.0 108.142 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -128.13 176.97 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 C-N-CA 131.993 4.117 . . . . 1.0 106.086 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 t -152.09 121.95 7.03 Favored 'General case' 0 N--CA 1.44 -0.96 1 N-CA-C 95.305 -5.813 . . . . 1.0 95.305 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.82 -66.17 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.511 0 CA-C-N 119.432 1.014 . . . . 1.0 110.86 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.65 136.33 17.06 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.16 2.574 . . . . 1.0 110.838 -175.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.86 77.76 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.73 1.62 . . . . 1.0 111.919 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.08 -72.09 0.72 Allowed Glycine 0 CA--C 1.533 1.194 0 N-CA-C 105.308 -3.117 . . . . 1.0 105.308 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -155.34 122.89 5.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.012 1.725 . . . . 1.0 107.857 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -176.84 167.64 2.55 Favored 'General case' 0 N--CA 1.469 0.523 1 C-N-CA 132.107 4.163 . . . . 1.0 107.157 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.99 16.11 20.75 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.088 1.328 . . . . 1.0 111.691 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.52 118.78 4.89 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 -7.69 21.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.018 2.479 . . . . 1.0 114.143 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -60.78 -38.86 86.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.638 1.108 . . . . 1.0 109.808 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.7 mt -66.16 -46.58 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.68 -47.76 79.15 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.697 -0.627 . . . . 1.0 110.675 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.5 -33.66 63.91 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.479 1.512 . . . . 1.0 111.794 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.2 -57.45 10.46 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.23 1.012 . . . . 1.0 109.744 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -64.76 -45.24 87.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.834 0.854 . . . . 1.0 112.423 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.2 t -65.86 -37.12 85.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.07 0.948 . . . . 1.0 109.853 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.11 37.94 3.96 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.36 -1.245 . . . . 1.0 115.648 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 p -130.68 20.61 5.09 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.398 1.599 . . . . 1.0 112.163 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.29 151.32 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.996 1.319 . . . . 1.0 112.26 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -98.68 129.36 30.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 127.271 2.228 . . . . 1.0 107.937 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.82 67.99 3.07 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.33 3.353 . . . . 1.0 109.599 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -104.77 -65.63 1.02 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.026 1.33 . . . . 1.0 112.64 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.68 4.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.177 1.391 . . . . 1.0 112.772 -175.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -170.5 177.86 0.95 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.559 1.544 . . . . 1.0 107.86 175.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -70.93 -43.44 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.536 1.49 . . . . 1.0 115.34 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -50.62 -58.31 6.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.005 1.275 . . . . 1.0 113.026 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -45.04 91.79 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.0 0.92 . . . . 1.0 111.005 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.77 86.86 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.704 -0.622 . . . . 1.0 111.997 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -60.36 9.05 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 125.797 1.665 . . . . 1.0 111.271 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.2 -32.45 40.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 116.435 -1.745 . . . . 1.0 112.052 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -35.86 -43.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.241 2.216 . . . . 1.0 115.775 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -62.19 -39.84 94.05 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.846 1.258 . . . . 1.0 109.949 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.88 135.25 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.519 -2.401 . . . . 1.0 104.519 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 159.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.057 -1.027 . . . . 1.0 108.595 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.49 164.27 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.911 1.284 . . . . 1.0 107.867 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.5 m -164.31 118.2 1.41 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.334 0.654 . . . . 1.0 110.31 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.79 -153.89 0.35 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -129.94 -62.19 0.96 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.3 1.44 . . . . 1.0 108.598 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -130.4 119.05 22.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.86 113.43 25.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.816 -2.661 . . . . 1.0 103.816 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 mt -100.91 124.45 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -83.95 148.0 27.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -16.38 0.77 Allowed 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 115.314 1.598 . . . . 1.0 115.314 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.99 22.45 4.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.12 56.23 23.4 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.425 -1.422 . . . . 1.0 112.808 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -128.7 143.34 50.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mt -116.46 125.6 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.059 1.3 . . . . 1.0 109.973 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.3 t -111.75 153.29 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.572 -2.01 . . . . 1.0 105.572 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -125.73 120.6 31.07 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.106 -0.996 . . . . 1.0 110.27 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -120.56 113.61 20.52 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 103.352 -2.833 . . . . 1.0 103.352 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 t 80.17 91.84 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 121.412 1.914 . . . . 1.0 114.461 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.35 -173.52 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.313 2.675 . . . . 1.0 111.816 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -80.65 51.59 1.52 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.873 -1.142 . . . . 1.0 108.989 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -148.86 113.04 5.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 130.287 3.435 . . . . 1.0 105.806 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.358 27.9 tttp 73.64 82.37 0.12 Allowed 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 115.497 1.665 . . . . 1.0 115.497 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 ttm-85 -32.72 138.11 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.855 2.862 . . . . 1.0 111.388 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.96 -178.87 3.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.118 1.767 . . . . 1.0 113.247 -175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -148.01 120.26 8.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.051 1.74 . . . . 1.0 109.976 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -162.08 62.85 0.23 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 106.49 -1.67 . . . . 1.0 106.49 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -157.8 -65.2 0.09 Allowed 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 119.356 -2.09 . . . . 1.0 114.082 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.16 -68.25 0.71 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.99 -0.895 . . . . 1.0 112.873 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.3 t -132.25 136.23 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.071 1.348 . . . . 1.0 109.726 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 p -166.35 137.13 3.44 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.54 1.136 . . . . 1.0 111.136 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 p -154.96 132.42 11.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.48 -2.415 . . . . 1.0 104.48 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -152.96 159.66 42.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.117 0.871 . . . . 1.0 108.907 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 41.66 53.69 3.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.331 1.452 . . . . 1.0 111.11 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.53 32.49 53.2 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.951 -0.916 . . . . 1.0 113.382 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -139.54 114.88 9.8 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 119.084 1.442 . . . . 1.0 107.81 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.36 144.69 35.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -123.51 118.42 27.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.9 t -53.04 -39.15 63.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.663 0.665 . . . . 1.0 111.012 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -143.68 162.41 36.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.753 3.221 . . . . 1.0 104.896 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.298 28.6 t70 -86.95 76.71 9.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 123.283 1.516 . . . . 1.0 109.297 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -75.24 44.19 0.24 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 131.133 3.773 . . . . 1.0 110.255 175.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -123.15 155.43 37.05 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.133 1.373 . . . . 1.0 112.289 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.2 57.08 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.914 2.486 . . . . 1.0 109.005 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.21 -136.9 6.05 Favored Glycine 0 CA--C 1.527 0.834 0 O-C-N 120.174 -1.578 . . . . 1.0 114.055 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.1 mm -142.12 159.55 20.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 129.129 2.972 . . . . 1.0 103.776 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.54 119.05 9.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.094 -2.928 . . . . 1.0 103.094 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.14 133.23 34.47 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.604 -1.31 . . . . 1.0 107.635 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -103.52 138.51 40.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.904 0.882 . . . . 1.0 108.765 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.55 33.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.699 1.142 . . . . 1.0 110.484 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.1 p -150.31 113.57 4.89 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.85 41.42 22.51 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.58 1.552 . . . . 1.0 114.384 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 45.77 38.16 4.04 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.295 1.838 . . . . 1.0 113.014 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -59.89 138.02 57.92 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.894 -1.891 . . . . 1.0 105.894 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.53 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.567 2.347 . . . . 1.0 111.25 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.54 -4.29 47.92 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 116.468 -1.73 . . . . 1.0 115.147 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.315 73.5 p 55.37 78.02 0.2 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.465 -1.731 . . . . 1.0 113.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -23.31 -33.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.176 2.591 . . . . 1.0 113.421 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.04 -35.71 7.14 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.485 1.914 . . . . 1.0 110.148 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.7 -50.14 63.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.342 0.973 . . . . 1.0 109.959 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.403 ' HH ' ' C ' ' A' ' 169' ' ' PHE . 10.8 m-85 -60.41 -39.19 86.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.672 0.789 . . . . 1.0 110.43 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.02 -54.52 28.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.844 1.258 . . . . 1.0 109.839 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -66.52 -47.47 72.83 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 0.68 . . . . 1.0 111.146 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.1 tp -50.7 -49.51 57.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.874 1.27 . . . . 1.0 109.74 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.09 89.36 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 119.172 0.897 . . . . 1.0 110.519 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.33 59.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.424 0.689 . . . . 1.0 110.561 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.72 -46.5 62.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.4 m -59.9 -43.36 94.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.459 1.104 . . . . 1.0 110.576 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -58.82 -47.47 84.7 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.605 1.093 . . . . 1.0 109.564 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.73 -58.19 9.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.227 1.011 . . . . 1.0 109.253 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.3 -38.1 68.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.871 -1.062 . . . . 1.0 113.554 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.7 mt -61.25 -49.38 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 120.041 1.291 . . . . 1.0 108.991 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.5 m -66.36 -20.53 66.1 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.272 -0.268 . . . . 1.0 110.811 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -83.64 -57.1 3.37 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.01 1.724 . . . . 1.0 108.943 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.46 112.97 23.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 106.537 -1.653 . . . . 1.0 106.537 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -95.07 107.87 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 CA-C-N 120.848 1.339 . . . . 1.0 113.459 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.99 -50.64 0.11 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.855 1.662 . . . . 1.0 108.471 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.35 -33.64 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 129.689 3.196 . . . . 1.0 111.282 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.73 -21.98 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.704 1.601 . . . . 1.0 113.994 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -141.43 18.6 2.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.889 1.676 . . . . 1.0 110.398 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -138.44 84.17 2.01 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.707 -1.246 . . . . 1.0 108.046 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.0 mtt -121.5 114.38 21.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.8 t -145.37 -169.37 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.78 -131.51 2.57 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 106.285 -2.726 . . . . 1.0 106.285 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 20.2 m170 -117.49 -23.17 7.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.052 1.341 . . . . 1.0 109.314 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -23.07 13.82 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -84.14 42.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.539 1.063 . . . . 1.0 108.367 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.6 -14.14 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 O-C-N 120.073 -1.642 . . . . 1.0 108.281 175.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -158.02 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 128.634 2.774 . . . . 1.0 111.584 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.61 108.44 2.29 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.199 1.933 . . . . 1.0 113.144 -175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -62.33 -21.68 65.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.246 1.418 . . . . 1.0 111.813 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -67.59 -24.39 65.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.656 -1.277 . . . . 1.0 113.002 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -132.7 124.29 27.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.177 -2.156 . . . . 1.0 105.177 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -114.18 -17.41 11.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.624 -1.23 . . . . 1.0 111.479 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.69 178.98 0.41 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 131.398 3.879 . . . . 1.0 103.603 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 91.64 0.65 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 121.697 1.642 . . . . 1.0 108.07 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 114.18 76.81 0.73 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.776 1.655 . . . . 1.0 111.263 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.83 -90.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.553 2.836 . . . . 1.0 110.452 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t 53.01 46.85 25.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.695 2.398 . . . . 1.0 113.782 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' C ' ' HH ' ' A' ' 130' ' ' TYR . 27.2 t80 -118.24 16.46 14.0 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.851 -1.156 . . . . 1.0 112.629 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.5 t0 43.84 80.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.068 -1.645 . . . . 1.0 113.756 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -62.73 -33.93 76.13 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.237 -0.915 . . . . 1.0 112.396 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.47 91.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.299 0.954 . . . . 1.0 110.934 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -65.91 -52.52 49.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.115 0.87 . . . . 1.0 110.237 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.86 -51.84 67.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -62.04 -35.42 78.55 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.222 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.62 80.71 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.6 -46.91 62.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.128 0.571 . . . . 1.0 110.046 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.18 166.52 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.618 1.967 . . . . 1.0 111.488 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 m -41.09 118.88 1.69 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.168 2.187 . . . . 1.0 108.499 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -76.66 55.2 4.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.464 3.443 . . . . 1.0 113.924 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 t 54.68 35.83 24.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.127 0.971 . . . . 1.0 110.101 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.6 t -164.59 103.12 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.686 1.194 . . . . 1.0 109.792 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -173.3 115.94 0.26 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.777 1.631 . . . . 1.0 107.164 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -65.98 156.32 33.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.49 1.495 . . . . 1.0 107.612 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -93.96 178.7 5.57 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.664 1.986 . . . . 1.0 110.609 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.401 ' C ' ' HG1' ' A' ' 187' ' ' THR . 5.4 tpt 85.46 33.29 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.23 2.612 . . . . 1.0 116.322 175.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 186' ' ' MET . 72.3 m . . . . . 0 C--O 1.249 1.051 0 O-C-N 119.718 -1.864 . . . . 1.0 110.266 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.5 tpp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 8.2 tp -142.06 176.24 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 1.0 109.201 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.567 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 22.7 mt -109.92 123.57 49.85 Favored 'General case' 0 C--N 1.327 -0.407 1 N-CA-C 98.897 -4.482 . . . . 1.0 98.897 174.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.96 126.46 39.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.965 -1.494 . . . . 1.0 106.965 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 55.31 33.33 20.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.635 1.574 . . . . 1.0 109.598 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.56 38.34 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.511 -1.368 . . . . 1.0 113.767 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -107.71 170.8 7.76 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 103.309 -2.848 . . . . 1.0 103.309 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.73 139.88 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.354 -1.466 . . . . 1.0 108.475 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.09 172.45 12.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.542 0.61 . . . . 1.0 110.738 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 37.51 57.85 1.36 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.959 2.904 . . . . 1.0 110.71 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.03 156.73 22.53 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.155 -0.966 . . . . 1.0 110.074 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -88.0 123.06 32.33 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.152 0.433 . . . . 1.0 111.769 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -98.22 130.02 44.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.47 1.108 . . . . 1.0 111.212 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.87 92.43 9.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.987 0.915 . . . . 1.0 108.654 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.4 160.47 44.62 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.54 1.493 . . . . 1.0 112.576 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 t -159.94 113.41 1.45 Allowed Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.4 61.17 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.792 2.328 . . . . 1.0 111.983 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -133.53 43.26 2.91 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.099 1.76 . . . . 1.0 107.068 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -73.84 178.47 4.85 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.994 1.317 . . . . 1.0 109.832 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.07 178.79 4.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 124.117 1.913 . . . . 1.0 113.953 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -138.13 118.44 13.68 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 111.921 -2.4 . . . . 1.0 106.729 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -126.16 167.26 17.52 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 129.045 2.938 . . . . 1.0 106.144 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -179.1 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.619 1.546 . . . . 1.0 109.132 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.85 143.33 45.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.627 -2.361 . . . . 1.0 104.627 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -150.99 167.33 27.96 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 102.727 -3.064 . . . . 1.0 102.727 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.77 163.46 24.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.713 1.605 . . . . 1.0 108.962 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.39 123.59 3.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.307 2.243 . . . . 1.0 110.282 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HB2' ' H ' ' A' ' 113' ' ' ILE . 63.2 Cg_endo -66.11 135.28 39.86 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.495 2.797 . . . . 1.0 111.008 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 t 178.88 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.523 1.929 . . . . 1.0 106.768 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.27 125.15 6.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.1 126.01 39.07 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.77 144.31 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 104.593 -2.373 . . . . 1.0 104.593 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.67 113.88 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.544 -3.132 . . . . 1.0 102.544 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -167.39 143.04 4.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.51 112.51 21.61 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.868 0.73 . . . . 1.0 109.409 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.4 176.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.629 1.972 . . . . 1.0 107.387 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 t -141.47 122.4 14.51 Favored 'General case' 0 N--CA 1.442 -0.834 1 N-CA-C 95.345 -5.798 . . . . 1.0 95.345 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.353 0.7 OUTLIER -142.58 -66.7 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 116.337 -1.792 . . . . 1.0 115.162 -178.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -94.38 157.74 2.03 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.588 2.192 . . . . 1.0 114.783 -175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.25 51.72 4.02 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 125.215 3.943 . . . . 1.0 117.487 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.15 -71.2 0.83 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 107.373 -2.291 . . . . 1.0 107.373 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -156.32 122.82 5.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.72 2.008 . . . . 1.0 108.251 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -176.74 161.74 2.09 Favored 'General case' 0 C--O 1.235 0.295 1 C-N-CA 132.745 4.418 . . . . 1.0 108.229 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.18 4.0 29.99 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.522 1.058 . . . . 1.0 111.005 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.81 119.09 4.88 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 117.952 -1.471 . . . . 1.0 110.015 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -5.48 14.08 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.78 2.32 . . . . 1.0 114.771 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -60.9 -47.63 85.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.565 1.984 . . . . 1.0 110.926 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 mt -62.27 -51.28 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.35 -46.91 86.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.308 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.1 -37.48 80.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.04 0.936 . . . . 1.0 111.361 -177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.2 -49.94 73.76 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.485 0.584 . . . . 1.0 110.143 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -70.85 -46.91 61.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.177 -0.439 . . . . 1.0 110.93 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -65.9 -37.83 87.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.516 1.126 . . . . 1.0 109.63 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 8.09 11.26 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.915 1.721 . . . . 1.0 115.513 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -104.3 19.4 20.29 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.234 2.017 . . . . 1.0 113.34 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -59.41 125.25 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.306 1.442 . . . . 1.0 111.709 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.14 136.65 20.46 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.44 1.896 . . . . 1.0 110.671 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -71.36 70.38 2.5 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.788 2.992 . . . . 1.0 111.225 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -103.3 -62.5 1.28 Allowed 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.659 -0.651 . . . . 1.0 111.808 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.22 76.0 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.949 0.5 . . . . 1.0 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -170.63 177.98 0.91 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.865 1.666 . . . . 1.0 107.396 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -69.8 -43.33 2.69 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 1.0 114.718 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -46.47 -51.05 16.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -57.48 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.128 0.971 . . . . 1.0 111.243 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.2 96.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.671 0.788 . . . . 1.0 111.05 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.04 -61.47 3.94 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.171 1.843 . . . . 1.0 111.672 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 pt -59.89 -33.98 54.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 116.743 -1.599 . . . . 1.0 112.709 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.38 -43.15 2.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.538 1.935 . . . . 1.0 115.154 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -54.67 -36.51 64.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.912 0.885 . . . . 1.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 136.54 33.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.352 -2.462 . . . . 1.0 104.352 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -60.49 152.06 26.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.088 -1.007 . . . . 1.0 108.55 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.7 158.7 17.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.481 1.112 . . . . 1.0 110.273 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -171.59 128.68 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.875 2.07 . . . . 1.0 108.127 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.13 -172.2 2.61 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -120.77 -59.71 1.72 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -138.97 118.72 13.13 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.433 -1.691 . . . . 1.0 106.433 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.77 113.47 26.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -95.44 118.28 41.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.077 -1.823 . . . . 1.0 106.077 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -72.67 148.3 44.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 117.994 -1.003 . . . . 1.0 108.304 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -45.45 -35.14 3.55 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 113.438 0.903 . . . . 1.0 113.438 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -91.67 36.64 0.95 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.882 0.873 . . . . 1.0 112.068 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.17 52.76 49.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.274 1.416 . . . . 1.0 115.299 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -119.49 111.92 18.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.388 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.6 mt -85.78 113.88 24.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.295 -2.113 . . . . 1.0 105.295 175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 140.27 30.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.273 -1.751 . . . . 1.0 106.273 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -121.85 114.87 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.487 1.115 . . . . 1.0 108.321 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -114.11 121.06 42.64 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 103.538 -2.764 . . . . 1.0 103.538 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 88.4 t 70.8 92.01 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 121.041 1.746 . . . . 1.0 111.344 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.57 -168.4 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.405 2.737 . . . . 1.0 111.891 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -59.61 2.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.965 2.506 . . . . 1.0 115.596 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -125.58 135.08 51.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 128.025 2.53 . . . . 1.0 104.372 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.261 14.4 tptp 77.19 82.15 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.303 1.841 . . . . 1.0 111.882 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -34.11 136.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.521 1.928 . . . . 1.0 113.878 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.64 -178.39 3.65 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.451 2.3 . . . . 1.0 108.989 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -148.2 118.58 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.77 62.89 0.47 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.591 -1.318 . . . . 1.0 111.035 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.409 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -168.74 -68.22 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 119.177 -2.202 . . . . 1.0 113.99 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.99 -84.57 0.37 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 106.959 -2.456 . . . . 1.0 106.959 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.85 145.45 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.683 1.242 . . . . 1.0 109.468 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.6 p -165.97 145.47 6.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.8 1.24 . . . . 1.0 111.248 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -133.23 146.55 51.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.43 1.892 . . . . 1.0 109.79 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.72 148.91 28.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 41.53 53.5 3.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.24 1.816 . . . . 1.0 110.224 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.66 28.43 56.58 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.167 1.841 . . . . 1.0 116.277 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -132.82 136.6 46.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.145 1.973 . . . . 1.0 107.08 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 15.0 tp10 -96.2 145.79 25.24 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.65 1.18 . . . . 1.0 109.222 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -112.7 120.28 40.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.413 -2.069 . . . . 1.0 105.413 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.7 t -54.42 -31.2 54.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 1.0 112.826 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -164.27 176.29 9.3 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 129.552 3.141 . . . . 1.0 104.602 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -81.29 76.45 8.23 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 123.038 1.399 . . . . 1.0 109.628 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -80.94 33.52 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.233 1.813 . . . . 1.0 110.62 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 m -129.54 143.26 50.75 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 124.182 0.993 . . . . 1.0 113.124 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.484 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -80.01 57.09 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.56 2.344 . . . . 1.0 107.825 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.41 -136.58 1.35 Allowed Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.526 1.07 . . . . 1.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.19 163.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 103.299 -2.852 . . . . 1.0 103.299 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.71 130.79 23.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.471 -2.788 . . . . 1.0 103.471 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mp -101.13 166.03 11.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.529 0.681 . . . . 1.0 109.387 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.42 158.38 44.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.979 0.895 . . . . 1.0 111.4 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.75 173.04 45.4 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 113.759 -1.564 . . . . 1.0 110.876 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.8 p -141.14 101.94 4.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.796 -1.928 . . . . 1.0 105.796 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t70 49.48 55.74 8.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.584 1.954 . . . . 1.0 111.842 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.321 18.6 p 47.29 38.69 7.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.836 2.854 . . . . 1.0 115.131 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.55 146.19 55.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -38.14 114.13 0.34 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.14 2.176 . . . . 1.0 112.679 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -79.06 0.54 27.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 116.202 -1.856 . . . . 1.0 114.541 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.506 4.8 p 55.43 77.97 0.2 Allowed 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.017 -2.42 . . . . 1.0 117.443 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -23.4 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 122.479 2.399 . . . . 1.0 116.346 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.87 -41.73 16.22 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.722 1.609 . . . . 1.0 109.549 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.97 -50.92 60.31 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.919 0.887 . . . . 1.0 110.549 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -59.99 -43.27 95.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.221 0.918 . . . . 1.0 110.157 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.12 -51.05 61.63 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.864 0.466 . . . . 1.0 110.754 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -62.84 -50.2 71.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.142 1.777 . . . . 1.0 109.713 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 35.7 tp -54.14 -49.08 70.05 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.4 76.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 1.0 111.37 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.42 55.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.7 0.8 . . . . 1.0 109.253 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.52 -47.69 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.8 m -52.75 -48.84 66.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.696 1.598 . . . . 1.0 110.232 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -59.66 -46.93 87.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.795 0.725 . . . . 1.0 111.951 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.17 74.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.271 0.487 . . . . 1.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.34 -41.23 75.74 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.934 0.893 . . . . 1.0 112.583 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.56 -49.47 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.726 1.148 . . . . 1.0 109.605 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.1 m -59.77 -16.65 29.44 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.439 0.695 . . . . 1.0 111.903 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -94.34 -58.87 2.09 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.467 -1.396 . . . . 1.0 109.55 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -125.95 112.9 24.41 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.068 -1.456 . . . . 1.0 107.068 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.77 107.48 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.644 1.266 . . . . 1.0 112.814 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.64 -50.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.919 2.088 . . . . 1.0 107.73 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.5 mt -44.78 -33.77 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.5 0 C-N-CA 129.478 3.111 . . . . 1.0 110.543 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.06 4.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.7 2.0 . . . . 1.0 114.118 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -136.54 18.57 3.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.803 1.641 . . . . 1.0 109.75 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.76 84.62 2.03 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.262 0.937 . . . . 1.0 110.176 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.37 114.07 19.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.9 t -146.73 -171.08 3.67 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.571 -0.706 . . . . 1.0 110.012 -175.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.59 2.04 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 107.021 -2.431 . . . . 1.0 107.021 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.409 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 20.9 m170 -113.58 -23.23 9.88 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.688 0.795 . . . . 1.0 111.639 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.59 -12.34 17.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.124 0.57 . . . . 1.0 109.695 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -88.09 40.02 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.153 0.888 . . . . 1.0 110.448 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.8 -26.57 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 120.955 -1.091 . . . . 1.0 108.449 175.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -143.68 -65.48 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.667 1.587 . . . . 1.0 111.767 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.9 110.68 1.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.744 2.296 . . . . 1.0 112.807 -176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.23 -18.76 39.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.303 1.441 . . . . 1.0 113.609 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -57.42 -26.29 60.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.594 1.557 . . . . 1.0 112.154 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -126.22 141.16 52.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.085 -2.191 . . . . 1.0 105.085 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 m -132.15 -16.45 2.81 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.696 -0.628 . . . . 1.0 110.634 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.8 176.23 0.82 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 131.434 3.894 . . . . 1.0 102.805 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.45 70.31 6.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.802 2.335 . . . . 1.0 111.756 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 119.18 78.18 0.57 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.34 -2.304 . . . . 1.0 107.34 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 -62.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.028 2.485 . . . . 1.0 112.155 -175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.53 51.67 14.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.793 2.037 . . . . 1.0 114.027 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -124.22 18.18 9.1 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.203 0.91 . . . . 1.0 113.232 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.386 19.9 t0 41.01 76.46 0.07 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.245 1.818 . . . . 1.0 113.748 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -51.29 -34.29 32.42 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.43 91.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 117.56 -1.21 . . . . 1.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -66.57 -53.17 37.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.294 1.406 . . . . 1.0 109.221 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.85 -51.24 70.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.369 0.507 . . . . 1.0 112.369 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -66.11 -23.49 66.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.84 0.745 . . . . 1.0 110.321 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.77 -51.9 50.44 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.298 -1.501 . . . . 1.0 109.754 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.79 -57.82 8.75 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.144 1.377 . . . . 1.0 111.339 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.86 166.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -49.81 122.36 13.68 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -83.5 53.24 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.44 2.76 . . . . 1.0 110.038 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 51.14 37.7 18.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.065 1.746 . . . . 1.0 111.204 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.7 t -154.4 23.22 0.48 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.423 1.089 . . . . 1.0 112.425 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -158.7 90.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.15 1.341 . . . . 1.0 113.753 -175.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -155.76 131.96 10.1 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.44 177.99 3.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.315 1.046 . . . . 1.0 110.915 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.448 ' CE ' ' H ' ' A' ' 187' ' ' THR . 7.9 tpt -69.65 171.57 8.8 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.448 ' H ' ' CE ' ' A' ' 186' ' ' MET . 2.7 m . . . . . 0 C--O 1.251 1.156 0 C-N-CA 126.715 2.006 . . . . 1.0 106.177 -175.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 tpt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 123.45 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 168.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.89 135.93 48.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 102.32 -3.215 . . . . 1.0 102.32 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.87 135.39 49.96 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 118.962 -0.542 . . . . 1.0 109.734 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.0 33.91 7.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.159 1.384 . . . . 1.0 110.918 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.39 1.43 21.64 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.429 1.49 . . . . 1.0 113.77 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -100.97 174.29 6.09 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 104.76 -2.311 . . . . 1.0 104.76 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.69 127.44 32.68 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.0 158.22 33.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.657 1.354 . . . . 1.0 114.657 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 38.56 57.98 1.7 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.587 2.755 . . . . 1.0 109.759 -175.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.24 51.82 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.593 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.511 ' HB2' HH11 ' A' ' 12' ' ' ARG . 8.5 ttm105 -79.11 123.14 27.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.329 -2.471 . . . . 1.0 104.329 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.9 122.5 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -143.01 79.54 14.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.994 -1.854 . . . . 1.0 105.994 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 132.95 30.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.927 1.751 . . . . 1.0 111.217 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 t -69.34 145.41 95.73 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 124.765 1.226 . . . . 1.0 109.587 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 -23.41 7.19 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 117.025 1.894 . . . . 1.0 117.025 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -150.16 121.46 7.85 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -96.57 178.98 5.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 178.45 4.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 123.11 1.433 . . . . 1.0 111.612 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 m -154.69 118.5 4.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 131.603 3.961 . . . . 1.0 101.594 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -130.69 155.21 81.62 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 125.853 1.661 . . . . 1.0 108.121 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -88.01 56.41 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.268 2.645 . . . . 1.0 109.794 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -140.25 143.64 36.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.41 103.92 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.56 171.22 14.09 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 105.877 -1.897 . . . . 1.0 105.877 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -71.37 123.3 89.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 119.53 1.059 . . . . 1.0 108.915 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.12 103.61 1.46 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 CA-C-N 120.687 1.281 . . . . 1.0 109.519 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -175.76 78.46 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.165 1.786 . . . . 1.0 107.337 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 tp -143.69 140.79 30.22 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.143 1.777 . . . . 1.0 106.722 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -106.11 126.59 52.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.665 1.121 . . . . 1.0 108.376 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.37 130.15 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.408 -2.071 . . . . 1.0 105.408 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.6 112.98 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -158.52 149.71 20.71 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 176.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -81.54 111.26 17.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.644 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mm -127.18 176.79 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.763 2.025 . . . . 1.0 107.451 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t -161.84 122.31 2.61 Favored 'General case' 0 C--N 1.313 -0.986 1 N-CA-C 93.93 -6.322 . . . . 1.0 93.93 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.273 1.2 tm? -142.66 -56.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 O-C-N 121.035 -1.04 . . . . 1.0 109.688 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -71.53 149.29 55.53 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.133 1.889 . . . . 1.0 112.631 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -82.41 39.66 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.56 3.506 . . . . 1.0 114.265 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -53.0 -71.61 0.66 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-O 117.461 -1.744 . . . . 1.0 110.581 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -156.6 122.87 4.98 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.707 1.754 . . . . 1.0 111.996 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -177.8 160.92 1.56 Allowed 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.493 4.317 . . . . 1.0 108.183 175.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.94 6.13 59.97 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.137 0.875 . . . . 1.0 111.846 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.89 118.65 4.73 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.0 1.4 . . . . 1.0 109.651 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 -21.44 44.62 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.364 2.043 . . . . 1.0 114.083 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -52.06 -43.09 63.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.099 0.863 . . . . 1.0 112.08 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.75 -44.3 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.449 1.1 . . . . 1.0 109.665 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.51 -45.64 78.88 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.05 0.841 . . . . 1.0 110.363 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.23 -33.56 58.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.476 1.511 . . . . 1.0 111.356 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.06 -61.28 2.42 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.633 1.573 . . . . 1.0 108.985 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.99 -37.54 75.75 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.13 0.972 . . . . 1.0 113.279 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.5 t -65.82 -33.84 76.79 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.92 -5.43 53.5 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 125.211 1.386 . . . . 1.0 115.505 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -89.42 8.9 28.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.295 2.048 . . . . 1.0 112.515 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -51.94 134.42 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 125.961 1.705 . . . . 1.0 111.176 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.72 134.18 21.85 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 127.585 2.354 . . . . 1.0 110.225 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 77.52 1.82 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.641 2.894 . . . . 1.0 107.422 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.32 -63.26 1.19 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.364 0.666 . . . . 1.0 110.639 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.0 78.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.755 0.822 . . . . 1.0 110.69 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -171.0 178.0 0.87 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.737 2.015 . . . . 1.0 107.167 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -73.05 -43.48 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.049 1.832 . . . . 1.0 114.684 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -46.38 -47.61 18.74 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.4 -58.13 8.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.451 1.1 . . . . 1.0 110.066 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.42 92.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.899 0.88 . . . . 1.0 111.37 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.59 -65.78 2.62 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.645 1.593 . . . . 1.0 111.553 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.15 -38.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.476 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.05 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.359 1.864 . . . . 1.0 114.951 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -57.36 -33.55 67.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.71 -0.619 . . . . 1.0 110.323 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.51 134.23 33.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 102.2 -3.259 . . . . 1.0 102.2 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 152.14 19.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.949 0.795 . . . . 1.0 110.967 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.43 161.43 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.772 1.629 . . . . 1.0 110.74 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -172.88 123.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.584 1.554 . . . . 1.0 108.242 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.51 -154.05 0.43 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -128.89 -65.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.487 1.115 . . . . 1.0 110.133 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 18.8 m -133.99 118.69 18.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.678 -1.264 . . . . 1.0 107.689 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -103.47 113.97 27.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.809 -1.923 . . . . 1.0 105.809 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.56 114.59 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -66.36 148.62 51.59 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.72 1.145 . . . . 1.0 108.532 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -13.62 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.721 1.608 . . . . 1.0 112.306 175.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -91.21 18.96 6.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 131.478 3.911 . . . . 1.0 112.304 -176.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.5 46.97 93.37 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.229 1.395 . . . . 1.0 113.168 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.97 110.25 14.56 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.706 1.253 . . . . 1.0 110.156 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.48 117.45 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 106.729 -1.582 . . . . 1.0 106.729 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.45 147.9 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.216 -1.772 . . . . 1.0 106.216 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -125.75 124.26 40.64 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 1.0 110.141 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.0 117.86 28.36 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 129.463 3.105 . . . . 1.0 103.755 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t 72.06 91.78 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 122.656 2.48 . . . . 1.0 113.205 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.91 -166.61 0.23 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.331 2.021 . . . . 1.0 111.079 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -70.85 46.07 0.09 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.856 2.862 . . . . 1.0 113.703 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.01 127.16 4.5 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 127.215 2.206 . . . . 1.0 106.508 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 tptm 77.35 81.48 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.543 1.137 . . . . 1.0 111.377 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -39.53 154.9 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.462 2.305 . . . . 1.0 113.232 -175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.31 -178.29 3.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.566 2.346 . . . . 1.0 113.008 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -153.12 118.73 5.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.905 1.682 . . . . 1.0 108.956 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -166.32 64.02 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 122.595 1.188 . . . . 1.0 111.167 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.15 -54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 118.103 -2.873 . . . . 1.0 112.602 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.37 -74.73 0.25 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.347 -1.807 . . . . 1.0 109.137 -175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.55 142.2 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.935 1.694 . . . . 1.0 110.018 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -166.33 163.66 17.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.984 2.514 . . . . 1.0 110.643 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.7 p -163.14 146.23 10.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -159.65 157.48 29.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.738 1.154 . . . . 1.0 108.94 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 39.9 53.28 2.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.623 1.569 . . . . 1.0 109.994 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.3 42.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 116.262 1.265 . . . . 1.0 116.262 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -129.0 121.98 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 120.019 1.909 . . . . 1.0 106.861 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.45 141.06 38.55 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -119.51 118.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.5 -42.87 97.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.3 0.852 . . . . 1.0 113.3 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.95 176.52 8.74 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.277 1.831 . . . . 1.0 108.968 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -83.15 76.46 9.86 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.91 38.41 1.23 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.986 1.315 . . . . 1.0 111.758 -175.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -134.14 149.94 51.09 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.094 0.958 . . . . 1.0 113.013 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -82.52 56.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.845 2.058 . . . . 1.0 109.645 177.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.51 -136.86 2.15 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 122.393 0.996 . . . . 1.0 113.359 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 14.7 mm -140.86 160.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 103.532 -2.766 . . . . 1.0 103.532 178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -138.46 126.04 22.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 103.324 -2.843 . . . . 1.0 103.324 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.51 139.56 37.0 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.993 -1.067 . . . . 1.0 109.459 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -104.53 154.09 20.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.471 0.653 . . . . 1.0 110.539 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.42 -179.74 45.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.405 1.955 . . . . 1.0 110.213 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 p -141.87 106.41 4.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.074 -1.824 . . . . 1.0 106.074 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.414 ' C ' ' HG1' ' A' ' 122' ' ' THR 0.266 43.7 t0 38.95 56.63 1.98 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.107 2.563 . . . . 1.0 113.986 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 121' ' ' ASP . 38.3 p 56.16 38.2 29.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.564 1.32 . . . . 1.0 114.564 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -69.17 146.0 52.81 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 105.389 -2.078 . . . . 1.0 105.389 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -37.26 113.55 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.133 1.373 . . . . 1.0 111.062 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.94 -6.62 56.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 115.521 1.674 . . . . 1.0 115.521 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.395 10.9 p 66.7 76.96 0.29 Allowed 'General case' 0 C--N 1.352 0.704 0 CA-C-N 120.872 1.669 . . . . 1.0 112.797 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -25.54 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.734 1.753 . . . . 1.0 115.734 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.75 7.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.669 1.588 . . . . 1.0 109.719 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.47 -48.79 37.48 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.037 1.335 . . . . 1.0 110.64 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.65 -40.52 92.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.13 0.877 . . . . 1.0 110.266 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -65.95 -50.12 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.38 0.536 . . . . 1.0 110.208 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -62.15 -52.66 62.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.689 1.596 . . . . 1.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.2 tp -54.23 -47.99 71.59 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.835 1.654 . . . . 1.0 109.656 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.9 98.05 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.304 0.956 . . . . 1.0 110.54 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.15 49.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.47 -43.29 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.868 0.867 . . . . 1.0 110.766 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.8 m -57.57 -54.0 51.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 1.0 109.492 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -65.69 -33.75 76.61 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.2 -59.25 5.77 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . 0.341 2.9 mm? -56.71 -33.83 66.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.738 -1.125 . . . . 1.0 113.555 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.68 -39.68 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.597 1.544 . . . . 1.0 107.908 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.2 m -60.18 -24.63 64.93 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.726 0.811 . . . . 1.0 110.866 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -84.3 -64.85 1.09 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 106.367 -1.716 . . . . 1.0 106.367 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -126.92 113.38 22.07 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.219 1.008 . . . . 1.0 109.976 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.63 107.36 0.33 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 CA-C-N 120.287 1.138 . . . . 1.0 110.838 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.3 -47.23 0.1 Allowed 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 128.212 2.605 . . . . 1.0 105.855 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.5 mt -48.54 -34.09 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 129.555 3.142 . . . . 1.0 110.644 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.91 7.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.803 0.841 . . . . 1.0 113.076 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -137.27 18.33 2.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.5 2.32 . . . . 1.0 109.926 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -141.99 83.67 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.409 1.004 . . . . 1.0 110.148 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.24 114.83 18.16 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 102.878 -3.008 . . . . 1.0 102.878 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.6 t -153.38 -166.98 2.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.315 0.579 . . . . 1.0 111.688 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.26 -131.93 1.59 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.378 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 13.9 m170 -112.83 -23.26 10.23 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.899 0.88 . . . . 1.0 109.223 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -108.39 -21.98 12.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.104 1.361 . . . . 1.0 108.991 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -83.85 34.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.883 -1.136 . . . . 1.0 109.074 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -22.53 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -149.19 -55.92 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.952 2.501 . . . . 1.0 110.926 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.78 112.01 2.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.27 1.98 . . . . 1.0 112.907 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.42 -26.19 64.96 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.847 -1.158 . . . . 1.0 111.705 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -21.94 66.19 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.857 1.263 . . . . 1.0 112.091 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -137.81 124.7 21.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -113.75 -15.75 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.395 0.543 . . . . 1.0 110.937 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.86 178.08 0.5 Allowed Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 129.645 3.178 . . . . 1.0 105.314 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -78.99 50.02 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.45 2.1 . . . . 1.0 111.185 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.55 65.82 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.36 1.933 . . . . 1.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.88 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.222 2.615 . . . . 1.0 111.51 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.1 t 53.61 50.66 16.7 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.603 1.161 . . . . 1.0 111.036 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -105.33 17.73 23.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.967 1.258 . . . . 1.0 113.175 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.1 t0 43.74 62.56 1.87 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.702 -1.873 . . . . 1.0 110.905 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -52.15 -33.43 40.3 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.748 -0.644 . . . . 1.0 111.279 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.98 -60.45 3.81 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.622 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -60.45 -42.3 95.86 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 117.574 -1.203 . . . . 1.0 111.411 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.94 -62.0 2.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.107 0.867 . . . . 1.0 111.128 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -61.14 -32.4 72.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.702 -0.666 . . . . 1.0 110.858 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.76 76.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.021 0.828 . . . . 1.0 112.233 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.75 -57.23 4.88 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.889 -1.132 . . . . 1.0 108.367 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.67 164.6 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.084 1.754 . . . . 1.0 110.76 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 m -55.65 121.07 36.71 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.405 1.482 . . . . 1.0 109.019 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.37 43.24 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.774 2.983 . . . . 1.0 109.511 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 t 46.34 53.2 9.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.795 2.438 . . . . 1.0 108.931 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -158.17 -45.47 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.729 1.611 . . . . 1.0 109.418 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -73.73 34.26 0.08 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.904 2.082 . . . . 1.0 111.001 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -67.02 161.82 23.51 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.69 -172.87 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.17 1.788 . . . . 1.0 114.085 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -115.53 -4.55 12.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.567 1.547 . . . . 1.0 112.895 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.4 m . . . . . 0 C--O 1.247 0.957 0 O-C-N 119.497 -2.002 . . . . 1.0 106.913 175.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.27 168.75 18.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 44.18 57.98 3.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.189 1.795 . . . . 1.0 109.711 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.49 156.25 41.68 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.958 2.103 . . . . 1.0 108.91 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -93.28 125.13 37.72 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -83.62 118.7 24.01 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.19 66.72 60.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.67 123.44 11.7 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 N-CA-C 108.339 -1.447 . . . . 1.0 108.339 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 t -54.82 142.71 53.71 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 123.193 0.597 . . . . 1.0 111.581 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.35 -12.01 24.99 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 116.039 1.515 . . . . 1.0 116.039 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -151.74 111.37 3.99 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CE1' HG22 ' A' ' 88' ' ' VAL . 9.6 m-30 -79.6 178.76 7.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.11 0.868 . . . . 1.0 110.532 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.0 -173.22 2.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.341 2.656 . . . . 1.0 109.916 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.8 m -165.66 118.13 1.13 Allowed 'General case' 0 CA--C 1.54 0.569 1 C-N-CA 131.705 4.002 . . . . 1.0 104.65 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.26 139.08 28.92 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 120.349 1.431 . . . . 1.0 109.809 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 70.03 6.07 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 124.449 3.433 . . . . 1.0 113.467 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -143.52 154.65 43.84 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.598 1.559 . . . . 1.0 108.68 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -151.19 103.43 3.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.354 0.979 . . . . 1.0 112.127 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -136.61 147.04 46.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 129.423 3.089 . . . . 1.0 104.68 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -59.66 123.79 72.93 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 119.949 1.25 . . . . 1.0 111.476 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.96 103.85 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.023 2.482 . . . . 1.0 111.847 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -172.24 79.39 0.05 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.703 1.601 . . . . 1.0 107.444 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.8 tp -139.93 133.66 30.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 tp -97.2 123.17 40.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.465 1.029 . . . . 1.0 108.311 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.69 118.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.957 -1.498 . . . . 1.0 106.957 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' THR . 69.3 t -116.02 114.79 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.289 -2.115 . . . . 1.0 105.289 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -167.34 152.33 7.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.267 -1.382 . . . . 1.0 107.267 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.67 112.23 24.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -127.51 175.95 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.597 1.959 . . . . 1.0 109.127 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 122.4 3.49 Favored 'General case' 0 N--CA 1.442 -0.869 1 N-CA-C 99.099 -4.408 . . . . 1.0 99.099 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.612 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -142.2 -48.4 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 118.174 -0.917 . . . . 1.0 108.979 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.612 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 39.0 Cg_endo -91.1 146.51 3.61 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 121.791 1.661 . . . . 1.0 114.465 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.48 44.3 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.508 3.472 . . . . 1.0 113.967 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.17 -65.02 2.0 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.971 -1.08 . . . . 1.0 111.71 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -152.35 122.78 7.26 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.886 -1.894 . . . . 1.0 105.886 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -176.42 175.85 1.72 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.782 2.833 . . . . 1.0 108.547 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.6 27.12 3.98 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.636 2.065 . . . . 1.0 109.634 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.13 118.18 6.1 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 106.037 -2.825 . . . . 1.0 106.037 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.26 -17.45 35.3 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 119.796 1.798 . . . . 1.0 115.13 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -66.14 -43.3 87.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.011 1.278 . . . . 1.0 110.996 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.02 -47.18 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.059 0.943 . . . . 1.0 109.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.9 -35.86 81.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.351 -0.843 . . . . 1.0 112.154 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.94 -33.47 68.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.013 0.925 . . . . 1.0 111.498 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.38 -54.58 43.87 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.511 -0.743 . . . . 1.0 109.893 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -66.77 -45.37 78.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.805 -0.617 . . . . 1.0 111.751 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -63.62 -39.39 94.23 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.33 3.26 22.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.412 1.958 . . . . 1.0 114.775 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -88.63 9.01 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.947 1.874 . . . . 1.0 112.627 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 tt -54.58 136.02 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.465 0.575 . . . . 1.0 110.896 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.22 136.6 19.17 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 127.71 2.404 . . . . 1.0 108.689 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.29 60.89 3.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.12 3.214 . . . . 1.0 112.719 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.48 -49.13 3.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 117.795 -1.098 . . . . 1.0 112.793 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.4 0.41 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.505 1.048 . . . . 1.0 112.079 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 24.6 p80 -163.57 177.83 1.71 Allowed Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 12.1 Cg_endo -70.43 -43.85 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.458 1.438 . . . . 1.0 114.834 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -51.47 -57.89 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.366 1.439 . . . . 1.0 111.999 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.47 -51.14 71.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.817 0.847 . . . . 1.0 110.182 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.86 -43.93 86.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 1.0 111.17 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -65.18 3.75 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.329 1.442 . . . . 1.0 110.535 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.27 -25.54 30.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-O 115.92 -1.991 . . . . 1.0 113.639 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.75 -43.04 5.82 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.966 1.712 . . . . 1.0 113.209 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -54.98 -38.28 67.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.419 1.488 . . . . 1.0 111.075 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.51 135.29 33.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.096 -1.816 . . . . 1.0 106.096 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 158.92 27.32 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.738 -1.227 . . . . 1.0 108.343 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.44 161.59 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB3' HG21 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -165.8 122.91 1.43 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 175.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.83 -154.0 0.42 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.969 1.308 . . . . 1.0 107.624 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.8 m80 -131.15 -67.16 0.71 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.67 1.123 . . . . 1.0 111.132 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HB2' HD13 ' A' ' 115' ' ' ILE . 61.2 m -135.58 119.15 16.99 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.344 -2.095 . . . . 1.0 105.344 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tt -113.29 118.08 33.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.116 1.766 . . . . 1.0 107.571 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -100.71 113.98 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.194 -1.78 . . . . 1.0 106.194 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -83.3 153.79 24.45 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 120.041 1.291 . . . . 1.0 108.636 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -17.94 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 128.939 2.896 . . . . 1.0 115.624 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 27.13 2.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.06 1.3 . . . . 1.0 112.668 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.26 42.75 99.87 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.544 1.069 . . . . 1.0 112.592 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.08 149.22 29.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.366 1.083 . . . . 1.0 108.837 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.05 119.08 60.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.606 -1.257 . . . . 1.0 107.606 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.46 147.82 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.402 -2.073 . . . . 1.0 105.402 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.69 122.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.618 -1.252 . . . . 1.0 107.618 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -120.98 113.69 20.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.876 -2.268 . . . . 1.0 104.876 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 19' ' ' TYR . 4.1 t 79.84 92.1 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.448 1.476 . . . . 1.0 111.439 176.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -61.7 -175.76 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.615 1.543 . . . . 1.0 110.877 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -58.34 5.49 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.89 2.476 . . . . 1.0 114.294 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.41 115.25 19.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.168 2.587 . . . . 1.0 108.795 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 85.81 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.67 2.788 . . . . 1.0 112.288 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.459 HH11 ' HB2' ' A' ' 111' ' ' PHE . 7.3 ttm180 -32.56 138.05 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.753 3.221 . . . . 1.0 115.642 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.58 -178.12 3.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 129.273 3.029 . . . . 1.0 111.945 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -155.06 118.33 4.44 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.477 1.511 . . . . 1.0 110.628 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 7.4 p80 -158.23 63.13 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.068 -1.645 . . . . 1.0 112.204 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 154' ' ' HIS . . . -164.96 -56.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 118.734 -2.479 . . . . 1.0 114.148 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.03 -79.8 0.29 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 104.017 -3.633 . . . . 1.0 104.017 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.98 146.63 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.063 2.145 . . . . 1.0 108.881 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.6 p -156.18 150.72 25.81 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.533 1.533 . . . . 1.0 110.209 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.469 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.2 p -143.65 145.72 32.69 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 119.69 1.132 . . . . 1.0 111.248 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.42 145.29 21.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.83 -1.544 . . . . 1.0 106.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 42.08 53.85 4.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.976 1.71 . . . . 1.0 113.051 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.52 28.43 67.57 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.608 0.623 . . . . 1.0 113.375 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 116.44 17.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 176.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 5.8 tt0 -103.65 135.31 45.45 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 8.9 mtt85 -105.57 118.24 36.07 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.175 -2.528 . . . . 1.0 104.175 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.57 -25.47 66.23 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.745 1.618 . . . . 1.0 111.542 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -154.26 170.4 21.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.611 2.764 . . . . 1.0 107.588 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 6.3 t70 -84.76 76.71 10.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.459 ' HB2' HH11 ' A' ' 93' ' ' ARG . 0.2 OUTLIER -100.32 33.65 2.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.243 -175.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -132.9 142.72 49.05 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 124.483 1.113 . . . . 1.0 110.568 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -79.19 56.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 127.09 2.156 . . . . 1.0 110.806 -176.224 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.5 -136.5 1.7 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.946 -1.097 . . . . 1.0 113.034 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG21 HD13 ' A' ' 133' ' ' LEU . 3.6 mm -142.57 165.3 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 130.515 3.526 . . . . 1.0 102.985 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -145.82 138.58 25.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 103.7 -2.704 . . . . 1.0 103.7 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.0 149.04 24.34 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.485 -1.384 . . . . 1.0 109.269 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -124.52 139.74 53.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.614 0.721 . . . . 1.0 111.151 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.39 -177.55 30.61 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 127.676 2.56 . . . . 1.0 108.701 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 p -145.96 108.28 4.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.601 -2.37 . . . . 1.0 104.601 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.54 43.54 28.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.24 1.016 . . . . 1.0 112.528 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p 49.57 38.55 15.02 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.67 1.988 . . . . 1.0 113.706 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.66 136.16 56.67 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -25.9 114.03 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.999 2.12 . . . . 1.0 113.431 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.87 -15.31 58.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 116.36 -1.781 . . . . 1.0 113.908 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.351 28.7 p 65.59 77.06 0.31 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.862 1.664 . . . . 1.0 111.668 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -23.22 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.069 1.748 . . . . 1.0 113.993 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.0 -38.91 3.77 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.65 1.98 . . . . 1.0 110.442 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -49.39 -51.9 31.98 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.268 1.427 . . . . 1.0 109.643 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.8 -42.08 96.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.029 0.932 . . . . 1.0 110.207 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -65.66 -51.6 58.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.089 0.955 . . . . 1.0 110.353 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -65.97 -43.62 87.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.669 0.788 . . . . 1.0 110.679 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 115' ' ' ILE . 10.4 tp -55.38 -51.53 66.51 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.74 67.78 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.316 0.962 . . . . 1.0 111.488 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.47 56.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.127 0.971 . . . . 1.0 110.787 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.22 -51.27 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.3 m -54.63 -36.7 64.78 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.659 1.583 . . . . 1.0 111.882 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -60.68 -46.67 89.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.884 1.674 . . . . 1.0 109.462 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.79 62.84 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-O 119.412 -0.327 . . . . 1.0 110.871 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.91 -39.09 71.13 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.02 -45.02 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.426 1.012 . . . . 1.0 108.916 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.7 m -65.76 -19.13 65.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.217 0.607 . . . . 1.0 111.182 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -84.16 -63.22 1.38 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.931 1.292 . . . . 1.0 107.858 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -126.06 112.98 24.14 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.57 107.94 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 120.237 1.12 . . . . 1.0 111.724 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.25 -52.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.387 1.875 . . . . 1.0 107.39 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 mt -45.98 -33.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 131.146 3.778 . . . . 1.0 111.061 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.86 -26.03 9.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.673 1.189 . . . . 1.0 112.987 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -136.32 23.67 3.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.359 1.863 . . . . 1.0 109.755 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -138.51 83.6 1.97 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -127.24 120.85 29.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.09 -1.818 . . . . 1.0 106.09 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.2 t -154.53 -170.48 3.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.77 -131.58 1.76 Allowed Glycine 0 CA--C 1.517 0.181 0 N-CA-C 106.818 -2.513 . . . . 1.0 106.818 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.425 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 8.0 m-70 -113.53 -22.97 10.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.069 1.434 . . . . 1.0 111.576 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.0 t -103.23 -8.55 20.29 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -89.04 28.25 1.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.737 1.215 . . . . 1.0 109.147 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.469 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.75 -14.87 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 121.389 -0.82 . . . . 1.0 110.45 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.67 -53.54 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.683 . . . . 1.0 112.582 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.43 108.63 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.91 1.718 . . . . 1.0 111.385 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.02 -14.61 55.5 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.875 -1.141 . . . . 1.0 113.117 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.66 -6.3 36.0 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.156 -1.59 . . . . 1.0 111.601 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -136.93 141.05 42.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.875 -1.898 . . . . 1.0 105.875 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 3.1 m -132.78 -16.78 2.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.862 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.84 -178.87 0.34 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.39 63.27 7.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.304 2.002 . . . . 1.0 109.102 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 141.28 74.57 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.123 1.821 . . . . 1.0 111.653 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.13 -98.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 1.0 110.837 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.4 t 53.84 43.86 30.35 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.801 1.64 . . . . 1.0 112.533 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -106.32 18.45 21.98 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.054 0.942 . . . . 1.0 110.387 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.296 9.3 t0 42.95 82.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.866 2.467 . . . . 1.0 112.355 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -55.4 -34.95 64.83 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.55 -0.75 . . . . 1.0 112.821 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.09 -45.98 79.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.573 -0.727 . . . . 1.0 110.647 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -58.93 -56.78 17.89 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.846 0.748 . . . . 1.0 110.12 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -59.08 -53.24 60.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -61.52 -33.79 74.43 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.403 -0.808 . . . . 1.0 111.906 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.47 86.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.695 0.68 . . . . 1.0 111.818 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.14 -51.92 27.63 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.523 0.729 . . . . 1.0 110.37 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.6 166.41 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.381 1.073 . . . . 1.0 108.335 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 126.281 1.832 . . . . 1.0 109.334 176.071 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--O 1.235 0.304 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.98 170.89 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.632 1.173 . . . . 1.0 110.661 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 40.58 58.38 2.38 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.182 1.793 . . . . 1.0 111.221 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.76 156.34 38.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.644 1.578 . . . . 1.0 110.112 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -78.4 130.05 35.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.12 140.34 45.75 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.183 -0.948 . . . . 1.0 110.265 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -142.74 71.84 19.82 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.479 -1.674 . . . . 1.0 106.479 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.6 123.2 9.91 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 N-CA-C 107.784 -1.66 . . . . 1.0 107.784 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -121.85 132.09 24.3 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.98 52.97 4.53 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.189 1.926 . . . . 1.0 111.177 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -124.13 43.11 3.08 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE2' HG22 ' A' ' 88' ' ' VAL . 95.7 m-85 -75.24 178.21 5.95 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.076 0.465 . . . . 1.0 110.045 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.73 -178.25 4.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 1.0 108.51 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.5 m -154.95 131.36 10.46 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 128.623 2.769 . . . . 1.0 103.674 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -130.55 140.05 37.5 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.791 1.632 . . . . 1.0 109.628 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.05 40.19 0.85 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.36 3.374 . . . . 1.0 116.84 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.24 149.78 44.73 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.293 2.637 . . . . 1.0 108.834 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -151.61 120.13 6.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.936 1.694 . . . . 1.0 111.682 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.62 172.74 12.56 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -64.69 123.82 84.42 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.58 103.6 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.768 1.645 . . . . 1.0 110.706 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -170.83 77.16 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.711 -1.588 . . . . 1.0 106.711 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.16 124.34 12.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.54 126.08 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.87 134.26 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.3 t -131.76 123.78 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.56 150.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.116 1.766 . . . . 1.0 107.884 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.5 112.61 24.6 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 26.3 mm -127.65 176.78 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 128.024 2.53 . . . . 1.0 105.067 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -151.09 122.22 7.72 Favored 'General case' 0 C--N 1.313 -0.995 1 N-CA-C 94.003 -6.295 . . . . 1.0 94.003 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.318 0.2 OUTLIER -142.66 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 119.827 1.194 . . . . 1.0 110.427 175.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.36 153.47 27.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.041 1.828 . . . . 1.0 112.042 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -82.0 53.61 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.673 2.916 . . . . 1.0 114.232 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.72 -70.81 0.65 Allowed Glycine 0 CA--C 1.535 1.317 0 N-CA-C 108.269 -1.932 . . . . 1.0 108.269 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -155.82 123.09 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.221 2.609 . . . . 1.0 106.549 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -169.73 173.44 6.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.956 2.902 . . . . 1.0 105.913 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.8 31.37 2.48 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.674 1.607 . . . . 1.0 109.298 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 118.9 6.28 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 107.605 -2.198 . . . . 1.0 107.605 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.34 -9.62 26.3 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-N 120.842 2.321 . . . . 1.0 113.339 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -65.52 -47.43 75.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.802 1.183 . . . . 1.0 109.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 mm -59.22 -43.84 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.799 0.84 . . . . 1.0 109.668 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.28 -46.36 90.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.267 0.627 . . . . 1.0 111.462 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.15 -33.8 67.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.135 1.374 . . . . 1.0 111.677 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.68 -57.07 12.32 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.196 -0.94 . . . . 1.0 109.352 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -42.98 85.86 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.528 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -66.4 -35.4 80.22 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.475 0.58 . . . . 1.0 110.59 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.46 60.23 1.11 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.373 1.94 . . . . 1.0 112.103 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 p -136.58 8.85 3.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.201 1.8 . . . . 1.0 111.588 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.34 134.78 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.116 0.966 . . . . 1.0 112.508 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 136.64 20.33 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.668 2.787 . . . . 1.0 108.834 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.63 69.74 1.55 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.216 3.278 . . . . 1.0 112.435 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -103.35 -56.64 2.18 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.659 0.784 . . . . 1.0 110.966 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.47 -55.04 36.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.979 0.512 . . . . 1.0 111.321 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.4 p80 -171.08 177.89 0.88 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.149 1.779 . . . . 1.0 107.615 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -70.55 -43.39 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.866 1.71 . . . . 1.0 114.804 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -50.19 -54.76 18.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.577 1.08 . . . . 1.0 113.475 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.0 -52.93 63.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.964 0.802 . . . . 1.0 111.118 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.51 98.3 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.465 0.706 . . . . 1.0 111.904 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.93 -57.69 17.04 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.283 0.944 . . . . 1.0 110.94 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.79 -27.33 42.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-O 115.964 -1.97 . . . . 1.0 112.99 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.83 -43.26 2.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.153 1.781 . . . . 1.0 114.489 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -57.58 -43.36 84.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.031 1.333 . . . . 1.0 111.116 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.6 127.37 32.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.53 148.55 51.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.382 176.118 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.86 163.19 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.064 2.146 . . . . 1.0 109.843 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.508 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -172.33 133.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.872 2.469 . . . . 1.0 106.27 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.46 -154.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.137 1.375 . . . . 1.0 107.461 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -132.48 -59.21 0.92 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.95 1.3 . . . . 1.0 108.999 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.773 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.4 m -136.88 118.73 15.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.096 -1.446 . . . . 1.0 107.096 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -102.48 113.85 27.54 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.82 122.89 53.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -89.8 156.65 18.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.853 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -22.66 2.58 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 126.967 2.107 . . . . 1.0 113.533 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -91.75 19.75 6.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.915 1.686 . . . . 1.0 113.699 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.16 35.8 91.39 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.614 1.578 . . . . 1.0 112.821 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.43 109.25 22.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.16 113.45 19.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 105.263 -2.125 . . . . 1.0 105.263 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -111.81 147.8 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.295 1.438 . . . . 1.0 107.306 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.2 120.24 29.55 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.386 1.074 . . . . 1.0 109.618 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.44 129.97 53.3 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.255 64.3 t 63.75 91.46 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 121.498 1.953 . . . . 1.0 113.76 175.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.7 Cg_exo -58.89 -169.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.394 3.396 . . . . 1.0 116.387 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.85 24.15 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.012 2.525 . . . . 1.0 110.487 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 89' ' ' PRO . 2.7 t70 -144.57 119.47 9.95 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.469 2.707 . . . . 1.0 107.855 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.308 3.4 ttmp? 85.96 81.48 0.02 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.877 1.671 . . . . 1.0 111.717 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -34.89 145.16 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.973 2.509 . . . . 1.0 111.942 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -122.12 172.4 8.28 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.258 1.423 . . . . 1.0 110.104 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -141.63 119.19 11.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.897 1.679 . . . . 1.0 109.722 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -159.38 63.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.151 0.977 . . . . 1.0 109.255 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -165.73 -70.74 0.03 OUTLIER 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.66 -1.9 . . . . 1.0 114.657 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.43 -91.02 0.48 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 105.834 -2.907 . . . . 1.0 105.834 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.2 t -144.44 146.46 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.92 1.86 . . . . 1.0 108.551 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -156.56 166.54 33.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.431 1.492 . . . . 1.0 108.924 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 157' ' ' ILE . 54.6 p -151.65 146.13 25.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -162.62 148.69 12.63 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 49.6 54.57 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.415 1.486 . . . . 1.0 110.83 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.04 29.45 62.37 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.995 1.283 . . . . 1.0 114.471 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.18 113.93 12.55 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.483 -1.302 . . . . 1.0 107.483 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -78.95 146.46 33.45 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.368 -1.345 . . . . 1.0 107.368 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -133.42 118.16 18.08 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.752 -1.944 . . . . 1.0 105.752 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.85 -40.24 96.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.286 0.634 . . . . 1.0 112.52 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -149.18 174.94 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.492 2.317 . . . . 1.0 106.979 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -89.85 75.05 7.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.359 1.552 . . . . 1.0 110.501 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 37.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 109.093 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -123.55 157.28 34.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.939 2.896 . . . . 1.0 109.819 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.277 0.1 OUTLIER -104.62 56.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.266 1.426 . . . . 1.0 108.096 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.79 -136.09 0.9 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-O 122.86 1.256 . . . . 1.0 112.163 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 76' ' ' CYS . 8.6 mm -150.28 161.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 130.497 3.519 . . . . 1.0 104.236 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.79 128.61 17.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 103.334 -2.839 . . . . 1.0 103.334 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.4 154.34 19.74 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -124.1 138.66 54.41 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.547 0.739 . . . . 1.0 111.859 -175.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.08 174.09 45.3 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.769 0.649 . . . . 1.0 112.613 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 p -133.92 97.09 3.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.044 2.137 . . . . 1.0 107.157 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.322 25.0 t0 46.62 56.74 6.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.251 1.82 . . . . 1.0 114.102 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.2 p 55.39 38.82 30.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.366 1.466 . . . . 1.0 112.563 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.57 133.95 53.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 104.956 -2.238 . . . . 1.0 104.956 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.12 113.45 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.212 2.205 . . . . 1.0 110.839 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -78.85 -11.61 60.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 115.14 -2.362 . . . . 1.0 116.679 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.349 18.2 p 59.57 77.86 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 121.662 2.028 . . . . 1.0 111.156 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -23.06 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.12 2.168 . . . . 1.0 114.593 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.31 -38.48 2.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.499 2.32 . . . . 1.0 109.433 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -53.8 -49.96 67.16 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 125.382 1.473 . . . . 1.0 110.688 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -56.48 -40.46 74.96 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.52 1.055 . . . . 1.0 109.668 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.72 -58.22 6.21 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.244 -0.408 . . . . 1.0 110.097 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -66.45 -37.99 86.37 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -60.63 -47.06 87.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.84 80.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.036 0.835 . . . . 1.0 110.858 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -53.75 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.072 0.949 . . . . 1.0 111.21 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 115' ' ' ILE . 64.8 t -58.04 -41.0 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.1 m -57.09 -46.28 82.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.272 . . . . 1.0 109.647 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.21 -48.19 82.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.53 1.059 . . . . 1.0 110.277 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.94 -48.6 81.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.172 0.589 . . . . 1.0 110.028 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -55.88 -46.86 78.21 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.873 1.269 . . . . 1.0 111.029 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.88 -42.22 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 118.858 0.754 . . . . 1.0 110.346 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.3 m -65.57 -13.91 59.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.178 0.991 . . . . 1.0 111.524 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -106.24 -54.02 2.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.496 1.518 . . . . 1.0 111.016 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -126.24 113.25 23.7 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 104.383 -2.451 . . . . 1.0 104.383 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -99.22 107.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.029 1.403 . . . . 1.0 114.554 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.27 -48.35 0.1 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.679 2.391 . . . . 1.0 107.642 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -46.19 -34.28 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 130.111 3.364 . . . . 1.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.86 -23.19 6.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.054 1.341 . . . . 1.0 114.275 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -137.18 18.42 2.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.719 1.607 . . . . 1.0 110.657 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -139.08 83.65 1.96 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.732 1.213 . . . . 1.0 108.213 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 114.1 21.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.036 -2.579 . . . . 1.0 104.036 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -151.08 -166.35 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.525 -0.734 . . . . 1.0 109.219 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.11 -131.79 1.5 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 108.66 -1.776 . . . . 1.0 108.66 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.01 -23.59 11.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 117.902 0.851 . . . . 1.0 111.066 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.28 -14.38 15.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.486 -0.769 . . . . 1.0 110.647 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -87.74 40.54 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.777 1.171 . . . . 1.0 109.158 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -66.27 -8.76 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 O-C-N 120.684 -1.26 . . . . 1.0 110.869 175.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -164.24 -53.79 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 127.953 2.501 . . . . 1.0 111.857 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 57.0 Cg_endo -91.14 115.42 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.978 3.119 . . . . 1.0 113.618 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.23 -25.58 64.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.765 1.226 . . . . 1.0 113.124 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -63.65 -20.28 65.57 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.88 -1.137 . . . . 1.0 113.324 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -123.12 140.76 52.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.464 -2.05 . . . . 1.0 105.464 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.0 m -136.01 -16.73 1.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.546 -0.862 . . . . 1.0 111.508 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.43 177.95 0.47 Allowed Pre-proline 0 CA--C 1.546 0.805 1 C-N-CA 131.808 4.043 . . . . 1.0 103.53 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.05 86.93 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.517 1.478 . . . . 1.0 109.353 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.32 81.12 1.25 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.863 1.221 . . . . 1.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.72 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.154 2.57 . . . . 1.0 112.187 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 t 55.52 43.93 27.64 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.907 1.283 . . . . 1.0 114.08 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' A' ' 33' ' ' VAL . 87.9 t80 -115.33 17.82 16.36 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 120.203 1.365 . . . . 1.0 113.755 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.6 t0 43.91 69.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 1.0 112.206 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -56.37 -32.87 65.18 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.759 -0.638 . . . . 1.0 112.334 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -60.25 2.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.657 0.783 . . . . 1.0 110.605 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -41.81 96.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-O 118.13 -0.938 . . . . 1.0 110.574 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -59.81 -57.55 12.42 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 123.876 0.735 . . . . 1.0 110.737 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -40.71 75.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.71 0.686 . . . . 1.0 111.222 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.07 77.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.16 0.8 . . . . 1.0 113.16 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.25 -43.55 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.6 1.16 . . . . 1.0 113.036 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.87 166.63 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.186 1.794 . . . . 1.0 110.797 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 70.6 m . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 125.679 1.592 . . . . 1.0 108.263 175.522 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 119.119 -0.467 . . . . 1.0 110.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.29 27.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.208 1.003 . . . . 1.0 112.148 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 38.88 58.21 1.78 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.108 2.563 . . . . 1.0 112.057 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.85 136.06 17.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.263 -0.898 . . . . 1.0 109.104 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -73.11 123.46 23.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.364 -1.717 . . . . 1.0 106.364 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -92.92 118.87 31.63 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.536 -0.727 . . . . 1.0 110.855 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.52 72.25 20.79 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.29 1.036 . . . . 1.0 108.554 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.21 123.44 9.21 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.758 1.306 . . . . 1.0 109.904 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -87.32 114.17 57.4 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 106.379 -1.712 . . . . 1.0 106.379 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.52 55.86 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.676 2.251 . . . . 1.0 110.636 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -138.4 43.73 2.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.572 1.949 . . . . 1.0 109.437 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -73.65 178.35 4.8 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.083 1.142 . . . . 1.0 114.083 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.63 179.1 4.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 128.857 2.863 . . . . 1.0 109.805 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -165.28 118.78 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.966 4.506 . . . . 1.0 102.94 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 156.46 77.75 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.27 84.72 1.9 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.312 2.008 . . . . 1.0 111.696 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.1 145.26 16.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.329 1.852 . . . . 1.0 106.685 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -137.51 103.58 5.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.371 -1.344 . . . . 1.0 107.371 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -136.2 152.86 51.22 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.743 1.217 . . . . 1.0 108.677 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -71.98 123.41 89.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 103.271 -2.862 . . . . 1.0 103.271 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.5 106.16 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.416 2.077 . . . . 1.0 112.512 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 t -164.32 76.35 0.33 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.37 123.72 11.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.99 -1.856 . . . . 1.0 105.99 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.54 127.61 39.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.193 0.997 . . . . 1.0 108.474 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.47 140.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.9 t -135.86 113.94 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.847 -2.279 . . . . 1.0 104.847 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -163.16 129.85 3.41 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 115.944 -1.979 . . . . 1.0 108.194 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.69 112.52 8.82 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 117.443 -1.703 . . . . 1.0 106.746 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mm -126.73 176.77 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 131.646 3.979 . . . . 1.0 108.587 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.3 t -160.68 121.84 2.98 Favored 'General case' 0 C--O 1.247 0.973 1 N-CA-C 94.992 -5.929 . . . . 1.0 94.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.253 1.3 tm? -142.4 -57.37 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 121.032 -1.042 . . . . 1.0 111.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 77' ' ' LEU . 2.9 Cg_exo -76.16 144.26 26.4 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 122.674 2.249 . . . . 1.0 111.075 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.09 44.11 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.335 2.69 . . . . 1.0 114.657 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.18 -71.19 0.57 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -156.13 122.94 5.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.614 1.566 . . . . 1.0 111.234 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.318 18.8 m-85 -177.06 170.94 2.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 131.361 3.864 . . . . 1.0 109.619 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.08 27.28 7.12 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.434 1.016 . . . . 1.0 111.628 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.37 118.56 5.35 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 108.726 -1.75 . . . . 1.0 108.726 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.59 -15.81 48.78 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 120.096 1.948 . . . . 1.0 112.621 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -49.79 -47.85 50.95 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.513 1.125 . . . . 1.0 112.576 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.39 -45.09 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.96 -43.97 94.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.12 -35.63 69.69 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.09 1.356 . . . . 1.0 111.489 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.89 -55.33 17.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 120.945 -1.097 . . . . 1.0 110.039 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.04 -43.03 79.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.87 -0.585 . . . . 1.0 111.893 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -65.84 -33.83 76.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.286 1.434 . . . . 1.0 109.994 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.57 -2.64 30.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.567 1.555 . . . . 1.0 115.163 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -88.81 9.93 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.75 2.275 . . . . 1.0 114.12 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 tt -47.68 129.55 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.274 1.829 . . . . 1.0 112.1 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.74 125.52 42.13 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 130.473 3.509 . . . . 1.0 108.957 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.38 75.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.494 3.462 . . . . 1.0 108.412 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -103.63 -64.23 1.11 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.441 0.297 . . . . 1.0 111.618 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.02 -52.01 65.74 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.98 0.912 . . . . 1.0 112.086 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 25.8 p80 -161.92 177.9 1.8 Allowed Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.561 1.545 . . . . 1.0 107.805 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 29.2 Cg_endo -74.33 -43.43 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.823 1.682 . . . . 1.0 114.342 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -48.46 -43.65 34.81 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.118 0.967 . . . . 1.0 113.586 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -57.52 -55.6 32.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.839 0.856 . . . . 1.0 110.275 -175.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.751 0.82 . . . . 1.0 110.697 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.65 -62.56 2.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.81 1.672 . . . . 1.0 111.536 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.1 pt -57.69 -35.54 51.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 116.752 -1.594 . . . . 1.0 112.76 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.0 -43.02 3.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.622 1.969 . . . . 1.0 115.735 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.26 -36.24 70.75 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.555 1.142 . . . . 1.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.03 136.76 33.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 102.502 -3.147 . . . . 1.0 102.502 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 155.81 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.622 -1.298 . . . . 1.0 109.14 175.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.47 155.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 123.593 0.757 . . . . 1.0 109.037 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 4.3 m -177.79 114.12 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.836 1.654 . . . . 1.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.96 -175.4 3.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -112.47 -76.85 0.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.977 1.262 . . . . 1.0 110.906 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.4 m -112.57 118.51 35.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 39' ' ' PRO . 13.6 tp -101.26 113.44 26.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 103.605 -2.739 . . . . 1.0 103.605 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mt -105.98 113.22 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 103.852 -2.647 . . . . 1.0 103.852 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -81.59 153.79 26.53 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.772 0.714 . . . . 1.0 110.57 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.64 -13.5 0.4 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 126.229 1.812 . . . . 1.0 113.941 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -91.65 18.31 7.66 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.37 0.986 . . . . 1.0 111.241 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.34 45.35 96.63 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.115 -1.616 . . . . 1.0 111.601 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -112.97 143.96 43.36 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.91 114.32 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.28 142.74 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.522 -1.659 . . . . 1.0 106.522 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -126.22 114.44 18.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.947 0.899 . . . . 1.0 110.467 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -110.06 147.09 34.24 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 103.25 -2.87 . . . . 1.0 103.25 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.274 42.4 t 63.1 91.78 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 120.304 1.411 . . . . 1.0 114.362 175.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.21 -174.29 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 121.404 1.402 . . . . 1.0 111.985 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -72.87 49.92 0.25 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.781 1.233 . . . . 1.0 109.941 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -161.13 136.14 7.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.766 2.827 . . . . 1.0 105.33 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 54.78 81.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 129.376 3.07 . . . . 1.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.05 152.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.659 2.384 . . . . 1.0 111.545 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -102.83 -178.08 3.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.423 2.289 . . . . 1.0 111.055 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -149.88 118.4 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.855 1.262 . . . . 1.0 108.919 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -160.92 62.75 0.29 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.967 1.365 . . . . 1.0 110.209 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.95 -69.34 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 119.839 -1.788 . . . . 1.0 113.044 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 -90.89 0.51 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 103.246 -3.941 . . . . 1.0 103.246 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.94 142.15 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.742 1.271 . . . . 1.0 110.065 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -155.93 165.8 35.38 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.667 2.387 . . . . 1.0 108.066 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -159.81 126.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.972 -2.233 . . . . 1.0 104.972 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -151.52 151.13 31.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.718 1.145 . . . . 1.0 107.999 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 42.12 66.72 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.669 1.588 . . . . 1.0 109.75 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.31 29.53 5.2 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.81 1.672 . . . . 1.0 116.681 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -137.98 113.8 9.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.759 1.78 . . . . 1.0 106.835 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -80.91 146.37 30.83 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.574 1.15 . . . . 1.0 108.417 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -129.57 118.13 21.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.94 -24.49 63.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.98 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -152.98 176.26 12.06 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 128.623 2.769 . . . . 1.0 107.369 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.14 76.29 6.92 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.149 -1.426 . . . . 1.0 107.149 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -92.86 33.58 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.862 0.865 . . . . 1.0 112.392 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 m -124.53 156.51 37.22 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 125.508 1.523 . . . . 1.0 111.815 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.85 56.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.221 1.808 . . . . 1.0 107.713 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 -136.79 2.45 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.417 -0.802 . . . . 1.0 111.978 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 133' ' ' LEU . 9.3 mm -140.13 165.19 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.191 -2.522 . . . . 1.0 104.191 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 123.95 12.19 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.443 -2.799 . . . . 1.0 103.443 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 128.06 48.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.802 -1.186 . . . . 1.0 109.034 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.35 142.74 33.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.038 0.923 . . . . 1.0 111.929 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.39 178.64 32.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.52 2.01 . . . . 1.0 111.242 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -148.29 101.77 3.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.6 t0 51.4 54.56 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 124.032 1.872 . . . . 1.0 112.389 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 49.69 38.5 15.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.446 1.898 . . . . 1.0 114.269 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 124' ' ' ALA . 4.2 tt -72.63 145.87 47.01 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 104.932 -2.247 . . . . 1.0 104.932 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.49 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -39.32 125.53 1.66 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.327 1.851 . . . . 1.0 111.777 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.4 -10.84 59.89 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 115.285 1.587 . . . . 1.0 115.285 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.381 26.6 p 62.47 77.5 0.33 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 121.592 1.996 . . . . 1.0 111.968 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -23.5 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.158 2.183 . . . . 1.0 114.667 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.96 -40.14 4.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.425 2.29 . . . . 1.0 111.095 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -47.27 -57.87 4.73 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.788 0.835 . . . . 1.0 109.613 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.68 -39.36 80.46 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.229 0.611 . . . . 1.0 111.593 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -65.82 -59.24 4.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.216 0.322 . . . . 1.0 110.166 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -66.0 -34.27 77.72 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.757 0.708 . . . . 1.0 112.082 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 36.8 tp -57.51 -48.08 80.22 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.46 85.79 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.075 0.852 . . . . 1.0 109.819 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 -53.13 44.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.585 1.154 . . . . 1.0 111.046 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.19 -48.31 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.19 0.596 . . . . 1.0 110.121 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.7 m -53.25 -45.5 68.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.154 1.381 . . . . 1.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.32 -42.38 98.59 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.2 1.0 . . . . 1.0 110.54 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.19 -49.08 78.63 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.064 0.545 . . . . 1.0 110.194 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.94 -44.59 78.55 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.418 -0.801 . . . . 1.0 111.784 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.66 -40.23 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.187 0.903 . . . . 1.0 109.868 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.4 m -63.2 -27.67 69.52 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.885 0.874 . . . . 1.0 111.294 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.42 -60.58 2.03 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.138 0.975 . . . . 1.0 109.435 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -126.54 112.9 22.99 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.866 1.666 . . . . 1.0 106.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.61 107.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 120.912 1.361 . . . . 1.0 111.421 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.07 -45.09 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.99 2.116 . . . . 1.0 108.296 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.8 mt -44.91 -33.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.44 0 C-N-CA 130.666 3.587 . . . . 1.0 110.988 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.67 -26.19 13.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.373 1.069 . . . . 1.0 113.441 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.62 18.36 5.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.849 2.06 . . . . 1.0 110.873 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -138.45 83.3 1.96 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 119.866 -1.771 . . . . 1.0 106.363 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.4 mtt -126.42 118.07 24.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 102.876 -3.009 . . . . 1.0 102.876 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 t -157.66 -165.52 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.21 -131.57 1.25 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 106.798 -2.521 . . . . 1.0 106.798 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -114.34 -23.26 9.49 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.475 1.137 . . . . 1.0 111.964 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 15.9 t -103.02 -4.3 24.81 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.855 1.262 . . . . 1.0 108.448 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -97.91 23.15 8.34 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.156 1.382 . . . . 1.0 108.964 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.61 -15.74 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 121.171 -0.955 . . . . 1.0 110.618 -175.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -144.19 -66.06 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.882 1.673 . . . . 1.0 109.478 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 94.5 Cg_endo -77.63 119.89 4.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 CA-C-N 122.019 1.757 . . . . 1.0 112.473 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -70.79 0.63 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.643 0.777 . . . . 1.0 111.808 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -84.44 -25.62 28.85 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 119.556 -1.965 . . . . 1.0 113.442 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -129.29 140.65 51.35 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m -127.43 -16.53 4.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 124.352 1.033 . . . . 1.0 112.881 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.66 -179.14 0.36 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.244 2.218 . . . . 1.0 105.819 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.09 77.42 3.49 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.641 2.228 . . . . 1.0 111.073 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.92 76.59 0.94 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.587 1.565 . . . . 1.0 109.639 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.79 -72.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.338 2.692 . . . . 1.0 111.636 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.2 t 54.0 44.78 28.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.876 2.07 . . . . 1.0 111.343 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -93.65 17.87 11.05 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 43.4 t0 43.44 71.98 0.21 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.155 1.382 . . . . 1.0 110.542 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -58.38 -28.81 65.51 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.231 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -49.91 68.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.713 0.688 . . . . 1.0 110.631 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -64.9 -48.9 72.54 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.727 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.78 -53.31 58.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.237 0.926 . . . . 1.0 112.372 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -37.7 81.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.782 -0.628 . . . . 1.0 110.084 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.54 89.72 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.444 0.535 . . . . 1.0 112.444 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.74 -45.95 84.29 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.202 1.001 . . . . 1.0 111.737 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.79 165.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.911 1.284 . . . . 1.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 127.41 2.284 . . . . 1.0 109.58 176.17 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.35 9.38 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.581 0.753 . . . . 1.0 112.195 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 44.33 58.07 3.99 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.076 2.151 . . . . 1.0 110.087 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.6 22.05 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.01 0.924 . . . . 1.0 109.269 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -74.61 123.47 24.89 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.751 -1.574 . . . . 1.0 106.751 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 125.7 34.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.183 0.901 . . . . 1.0 108.651 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.95 76.13 59.62 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.67 130.05 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.511 2.141 . . . . 1.0 110.772 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -129.5 124.48 21.97 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 126.497 1.919 . . . . 1.0 106.918 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.83 52.74 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.384 2.723 . . . . 1.0 111.417 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -124.11 48.98 1.82 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.7 m-85 -73.8 178.28 4.95 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.332 1.453 . . . . 1.0 112.026 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.92 178.22 4.36 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 128.151 2.58 . . . . 1.0 116.445 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.0 m -156.23 121.49 4.77 Favored 'General case' 0 N--CA 1.446 -0.672 1 C-N-CA 132.938 4.495 . . . . 1.0 103.396 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -135.82 141.18 35.86 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 117.682 -1.151 . . . . 1.0 108.602 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.64 90.22 1.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 124.305 3.336 . . . . 1.0 111.003 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -171.86 154.48 3.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 131.391 3.877 . . . . 1.0 103.97 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -151.43 104.76 3.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 104.641 -2.355 . . . . 1.0 104.641 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.75 159.78 40.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.752 1.621 . . . . 1.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.25 123.54 84.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 118.843 0.747 . . . . 1.0 109.495 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.37 103.6 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.768 1.645 . . . . 1.0 110.842 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -167.55 74.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.994 -1.066 . . . . 1.0 108.844 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.49 135.01 18.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.324 1.849 . . . . 1.0 107.627 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -87.54 133.03 33.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.6 141.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.993 -2.225 . . . . 1.0 104.993 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -136.03 118.89 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.999 -1.482 . . . . 1.0 106.999 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -176.23 144.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.474 1.51 . . . . 1.0 107.525 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.09 112.71 19.39 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 119.542 1.065 . . . . 1.0 110.066 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 10.3 mm -127.29 176.93 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.838 3.255 . . . . 1.0 108.95 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -159.55 122.77 3.63 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 95.714 -5.661 . . . . 1.0 95.714 174.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.288 1.8 tm? -142.63 -65.31 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 116.67 -1.633 . . . . 1.0 113.722 -175.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 15.0 Cg_endo -91.35 163.09 3.66 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 124.328 3.352 . . . . 1.0 112.788 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.91 72.75 6.01 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.632 2.888 . . . . 1.0 118.716 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.64 -73.07 0.93 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.758 -2.937 . . . . 1.0 105.758 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -156.82 122.74 4.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.568 1.547 . . . . 1.0 108.16 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -176.7 177.61 1.35 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.577 3.151 . . . . 1.0 107.464 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.72 22.98 10.45 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 109.319 -1.512 . . . . 1.0 109.319 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.81 118.52 5.16 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.205 -1.33 . . . . 1.0 111.179 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.88 -18.33 28.18 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.376 2.051 . . . . 1.0 113.035 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -53.88 -36.37 62.59 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.088 0.858 . . . . 1.0 110.51 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mt -65.44 -44.71 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.456 -0.783 . . . . 1.0 109.614 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.05 -52.21 51.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.183 0.901 . . . . 1.0 110.351 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -51.34 -34.07 32.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.303 1.441 . . . . 1.0 112.475 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -62.58 -61.45 2.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.622 1.569 . . . . 1.0 111.188 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -70.92 -39.32 72.78 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.537 -0.744 . . . . 1.0 112.063 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.16 -36.63 83.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.271 1.028 . . . . 1.0 109.008 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.92 1.93 39.4 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 117.487 -1.729 . . . . 1.0 115.965 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -88.81 8.52 28.62 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.662 2.231 . . . . 1.0 113.193 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.7 128.58 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.361 1.464 . . . . 1.0 112.168 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.91 136.4 20.63 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 128.174 2.59 . . . . 1.0 109.409 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.56 79.16 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.518 2.812 . . . . 1.0 109.04 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.1 -60.1 1.6 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.189 0.596 . . . . 1.0 110.723 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.44 77.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.429 0.691 . . . . 1.0 109.841 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.0 p80 -171.2 178.09 0.84 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.683 2.393 . . . . 1.0 106.898 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.6 Cg_endo -71.73 -43.45 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.436 2.091 . . . . 1.0 115.53 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -44.18 -50.89 8.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -58.65 6.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.145 1.378 . . . . 1.0 110.615 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.62 -43.41 96.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.892 0.877 . . . . 1.0 111.959 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.13 -61.63 6.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.234 1.397 . . . . 1.0 111.555 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.72 -42.19 91.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.012 -0.994 . . . . 1.0 111.874 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -39.63 -43.75 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 116.924 2.194 . . . . 1.0 116.924 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.35 -34.33 73.7 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.721 -0.612 . . . . 1.0 109.714 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.57 135.89 34.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 101.183 -3.636 . . . . 1.0 101.183 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -52.71 144.58 13.81 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.601 -0.687 . . . . 1.0 110.992 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.83 162.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.207 1.803 . . . . 1.0 107.307 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.07 114.24 0.09 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.595 0.758 . . . . 1.0 109.159 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.58 -176.7 3.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.4 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.6 m80 -111.53 -76.31 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.986 0.812 . . . . 1.0 112.977 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -118.3 118.34 31.55 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 104.896 -2.261 . . . . 1.0 104.896 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tp -103.12 113.58 27.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.165 -2.161 . . . . 1.0 105.165 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.97 113.56 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -71.3 144.93 49.8 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -13.76 3.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 119.272 0.942 . . . . 1.0 113.151 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.32 26.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.889 2.476 . . . . 1.0 112.483 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.14 71.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.112 1.815 . . . . 1.0 114.535 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.32 156.3 17.32 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.839 . . . . 1.0 110.243 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mt -115.88 115.7 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 100.713 -3.81 . . . . 1.0 100.713 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.91 143.03 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.48 120.97 37.44 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.47 117.62 31.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 128.642 2.777 . . . . 1.0 106.205 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' A' ' 19' ' ' TYR . 44.4 t 68.2 92.06 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 120.847 1.658 . . . . 1.0 113.938 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.91 -178.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 121.575 1.517 . . . . 1.0 110.553 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -59.37 30.42 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 130.159 3.384 . . . . 1.0 116.495 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.15 116.01 6.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.537 2.335 . . . . 1.0 108.722 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.295 27.6 ttmt 83.2 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.631 1.972 . . . . 1.0 111.461 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -35.95 159.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 130.911 3.684 . . . . 1.0 116.599 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -113.17 -178.63 3.43 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 129.384 3.074 . . . . 1.0 114.139 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -155.07 118.59 4.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.628 1.571 . . . . 1.0 108.642 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -159.55 63.13 0.38 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.067 0.937 . . . . 1.0 110.361 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.34 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 119.11 -2.244 . . . . 1.0 114.561 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.79 -91.27 0.9 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.191 -3.163 . . . . 1.0 105.191 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 t -127.95 133.85 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.662 1.231 . . . . 1.0 109.407 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 p -160.35 159.06 30.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.84 2.056 . . . . 1.0 108.72 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 157' ' ' ILE . 33.9 p -152.03 147.07 26.07 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.542 1.137 . . . . 1.0 111.45 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -148.88 144.8 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 38.91 53.99 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.761 2.024 . . . . 1.0 112.354 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.41 67.9 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.293 0.949 . . . . 1.0 114.838 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -128.85 113.52 15.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 103.576 -2.749 . . . . 1.0 103.576 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 11.8 tt0 -82.88 142.0 31.81 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.943 -1.873 . . . . 1.0 105.943 175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -102.94 118.53 37.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.04 -2.578 . . . . 1.0 104.04 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.95 -23.65 58.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.615 0.366 . . . . 1.0 110.653 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -146.52 175.15 10.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.533 2.333 . . . . 1.0 106.128 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.7 76.67 3.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.555 1.169 . . . . 1.0 109.313 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -88.54 45.19 1.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.979 1.712 . . . . 1.0 109.431 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -138.81 127.15 22.91 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 120.081 -1.637 . . . . 1.0 113.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.252 0.1 OUTLIER -78.74 56.7 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.732 2.013 . . . . 1.0 108.996 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.18 -136.51 3.74 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.12 163.61 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.209 -2.515 . . . . 1.0 104.209 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.81 117.8 9.43 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.764 -1.939 . . . . 1.0 105.764 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.23 131.07 34.48 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.808 -1.183 . . . . 1.0 110.195 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.0 tt0 -104.36 147.03 27.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.641 0.376 . . . . 1.0 111.776 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.43 173.38 33.6 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.978 1.275 . . . . 1.0 110.356 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -148.18 109.2 4.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 44.93 46.32 8.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.928 2.491 . . . . 1.0 112.671 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 50.62 38.19 18.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.621 1.969 . . . . 1.0 113.499 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.8 tp -68.27 146.55 53.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.688 1.995 . . . . 1.0 108.142 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -31.51 114.23 0.13 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 126.39 1.876 . . . . 1.0 111.812 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.42 -8.58 58.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 115.361 -2.257 . . . . 1.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.396 17.4 p 68.9 78.68 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 122.18 2.264 . . . . 1.0 113.374 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -22.8 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.949 2.159 . . . . 1.0 115.08 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.69 -42.91 7.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.628 2.371 . . . . 1.0 110.629 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -52.44 -51.46 59.09 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.154 0.888 . . . . 1.0 110.432 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -60.61 -39.71 89.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.574 -0.727 . . . . 1.0 109.877 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.13 -51.53 57.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.176 0.898 . . . . 1.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.48 -47.63 78.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.469 1.507 . . . . 1.0 110.393 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.2 tp -56.6 -50.53 71.71 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.33 1.052 . . . . 1.0 108.498 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.06 84.14 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.691 0.678 . . . . 1.0 110.284 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.98 48.78 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.186 0.594 . . . . 1.0 110.648 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.28 -41.78 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.896 0.771 . . . . 1.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.1 m -59.25 -56.79 17.67 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.997 1.319 . . . . 1.0 109.466 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.93 -43.65 77.59 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.939 0.896 . . . . 1.0 110.245 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.82 -50.7 63.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.975 0.51 . . . . 1.0 111.076 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.74 -37.44 71.01 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.487 -0.758 . . . . 1.0 111.378 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.04 -39.31 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.946 0.898 . . . . 1.0 110.057 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.5 m -57.96 -35.33 71.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.38 0.991 . . . . 1.0 111.217 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -83.45 -49.23 9.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -125.79 112.85 24.82 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 107.271 -1.381 . . . . 1.0 107.271 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.37 106.85 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.148 -1.52 . . . . 1.0 108.148 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.94 -55.62 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.797 1.639 . . . . 1.0 107.848 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.0 mt -48.86 -33.94 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.056 2.942 . . . . 1.0 110.329 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.88 -23.03 6.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.497 1.519 . . . . 1.0 113.744 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -137.76 20.73 2.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.985 2.514 . . . . 1.0 109.295 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.13 87.74 2.22 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.69 1.596 . . . . 1.0 106.888 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.5 mtt -136.5 117.6 14.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.16 1.784 . . . . 1.0 107.547 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.9 t -153.52 -176.37 5.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.466 1.485 . . . . 1.0 109.544 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.91 -131.62 2.73 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 107.279 -2.329 . . . . 1.0 107.279 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -115.72 -24.04 8.41 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.683 1.241 . . . . 1.0 112.415 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.5 t -103.73 -11.47 17.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.819 0.847 . . . . 1.0 109.024 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.9 OUTLIER -85.81 18.54 2.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.145 1.778 . . . . 1.0 110.31 -175.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.73 -18.99 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.918 0.887 . . . . 1.0 112.456 -175.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.1 -66.13 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.378 1.471 . . . . 1.0 108.54 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 83.2 Cg_endo -81.59 111.32 2.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.834 1.691 . . . . 1.0 111.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.06 -17.58 27.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.971 1.309 . . . . 1.0 111.915 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.83 -25.64 63.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.458 -1.401 . . . . 1.0 112.388 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -134.17 140.61 46.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.522 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 17.0 m -121.71 -16.6 7.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.001 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.08 -178.98 0.63 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 130.717 3.607 . . . . 1.0 104.561 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -78.49 51.27 3.68 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.621 2.214 . . . . 1.0 109.919 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.11 80.89 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.73 2.586 . . . . 1.0 108.485 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.98 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.583 2.189 . . . . 1.0 111.995 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.4 t 53.66 43.03 31.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.329 2.251 . . . . 1.0 112.808 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -122.27 17.94 10.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.259 0.936 . . . . 1.0 112.637 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.263 8.5 t0 41.78 70.56 0.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.583 1.553 . . . . 1.0 111.006 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -52.87 -30.43 33.86 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 121.27 -0.894 . . . . 1.0 111.448 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.57 51.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.461 -0.781 . . . . 1.0 110.162 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -60.46 -50.98 71.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 120.18 1.354 . . . . 1.0 112.008 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.72 -46.87 83.45 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.243 -0.983 . . . . 1.0 111.469 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -64.69 -31.3 72.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.716 0.689 . . . . 1.0 109.932 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -41.19 88.27 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 1.0 111.813 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.17 -55.09 8.88 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.416 1.486 . . . . 1.0 112.166 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.4 t -66.34 152.52 9.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 123.402 0.681 . . . . 1.0 109.845 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 124.722 1.209 . . . . 1.0 111.802 175.647 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 9' ' ' ALA . 6.5 tt . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -84.67 175.72 9.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.162 0.985 . . . . 1.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 39.19 58.4 1.87 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.718 1.207 . . . . 1.0 111.569 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.17 155.91 28.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.094 0.958 . . . . 1.0 108.98 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -78.08 123.35 26.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.41 125.54 33.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.337 -1.356 . . . . 1.0 107.337 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -140.32 79.09 21.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.14 123.69 11.93 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -65.4 145.89 99.02 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.695 -0.854 . . . . 1.0 108.695 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.03 -9.32 11.84 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.921 1.747 . . . . 1.0 116.131 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -144.02 135.92 26.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.386 -2.82 . . . . 1.0 103.386 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.546 ' CE2' HG22 ' A' ' 88' ' ' VAL . 7.2 m-85 -106.7 178.39 4.57 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.291 1.437 . . . . 1.0 108.769 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.79 178.79 4.86 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.248 1.499 . . . . 1.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.0 m -151.28 118.41 5.92 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.912 -2.255 . . . . 1.0 104.912 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -135.93 138.85 28.82 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 106.205 -1.776 . . . . 1.0 106.205 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.44 83.1 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.626 2.217 . . . . 1.0 109.395 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -163.56 149.05 11.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.047 1.739 . . . . 1.0 108.371 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -146.51 104.14 3.74 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.01 160.58 38.17 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 127.446 2.298 . . . . 1.0 107.339 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.51 123.41 88.39 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 106.478 -1.675 . . . . 1.0 106.478 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.93 103.54 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.436 1.424 . . . . 1.0 109.783 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -172.95 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 150' ' ' ASN . 4.5 tp -148.74 132.18 16.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.15 -2.167 . . . . 1.0 105.15 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -91.43 122.49 34.07 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.27 113.45 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 169' ' ' PHE . 15.3 t -110.35 114.22 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 105.675 -1.972 . . . . 1.0 105.675 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -165.92 137.22 3.75 Favored 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.11 112.59 19.95 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 105.67 -1.974 . . . . 1.0 105.67 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.323 6.6 mm -126.39 179.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 128.966 2.907 . . . . 1.0 106.146 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -149.58 121.91 8.43 Favored 'General case' 0 N--CA 1.432 -1.327 1 N-CA-C 99.207 -4.368 . . . . 1.0 99.207 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -143.31 -62.9 0.02 OUTLIER Pre-proline 0 C--O 1.254 1.325 0 CA-C-O 115.796 -2.05 . . . . 1.0 111.821 176.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.57 153.09 23.32 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 CA-C-N 123.564 2.308 . . . . 1.0 111.626 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.7 45.52 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.492 3.461 . . . . 1.0 114.69 -175.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.72 -71.8 0.43 Allowed Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.869 -0.962 . . . . 1.0 111.847 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -155.6 122.76 5.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.142 1.377 . . . . 1.0 107.369 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -163.12 166.66 23.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 128.426 2.691 . . . . 1.0 111.514 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.86 -22.65 7.51 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 117.875 -1.514 . . . . 1.0 113.342 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.24 136.77 13.97 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.426 1.613 . . . . 1.0 111.021 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.43 -4.42 14.66 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.42 2.747 . . . . 1.0 116.476 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -49.51 -49.46 45.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 121.653 2.024 . . . . 1.0 112.569 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 23.3 mm -66.23 -43.85 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.156 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.67 -44.55 96.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -56.72 -34.51 67.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.715 1.606 . . . . 1.0 111.987 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -62.05 2.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.801 1.24 . . . . 1.0 109.091 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -66.61 -53.59 32.63 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.545 1.138 . . . . 1.0 111.555 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -56.01 -33.51 64.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.765 1.226 . . . . 1.0 109.311 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.37 25.37 8.83 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 119.762 1.165 . . . . 1.0 114.356 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -115.09 9.91 16.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.983 1.313 . . . . 1.0 112.009 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.5 tt -51.7 126.18 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.652 1.181 . . . . 1.0 112.437 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -98.8 124.37 46.13 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.259 2.224 . . . . 1.0 107.758 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.3 70.41 3.16 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.895 3.064 . . . . 1.0 110.434 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -103.63 -63.71 1.16 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.487 0.715 . . . . 1.0 112.414 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.83 73.7 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.47 0.708 . . . . 1.0 111.391 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 31.3 p80 -164.31 177.98 1.59 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 107.072 -1.455 . . . . 1.0 107.072 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 69.5 Cg_endo -81.92 -43.52 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.329 1.353 . . . . 1.0 112.512 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -45.48 -42.2 10.38 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.243 1.417 . . . . 1.0 113.459 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -57.92 -54.26 48.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.55 1.14 . . . . 1.0 107.943 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.6 85.62 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.018 0.927 . . . . 1.0 110.59 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.94 -61.85 2.18 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 127.892 2.663 . . . . 1.0 111.02 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -59.02 -49.42 83.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-O 116.976 -1.488 . . . . 1.0 110.663 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.63 -43.3 0.4 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.584 2.753 . . . . 1.0 116.529 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -56.01 -41.39 74.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.359 1.076 . . . . 1.0 110.662 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.76 136.95 34.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.892 -2.262 . . . . 1.0 104.892 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 154.64 12.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.768 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.1 162.96 14.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 126.365 1.866 . . . . 1.0 111.681 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.303 2.241 . . . . 1.0 106.722 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.93 -153.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.68 1.592 . . . . 1.0 108.204 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -128.15 -58.9 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.66 1.184 . . . . 1.0 109.84 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.695 ' HB2' HD13 ' A' ' 115' ' ' ILE . 59.2 m -145.58 126.8 14.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.58 113.73 26.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 104.813 -2.291 . . . . 1.0 104.813 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 mt -94.08 121.34 44.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -75.14 144.6 42.72 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 123' ' ' LEU . 36.2 ptt-85 -49.01 -20.58 0.54 Allowed 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.564 1.946 . . . . 1.0 112.949 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -92.07 32.17 1.18 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 130.666 3.586 . . . . 1.0 113.154 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.66 28.41 67.87 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 119.991 -1.693 . . . . 1.0 116.515 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -98.81 145.15 27.25 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 119.194 1.497 . . . . 1.0 108.878 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.36 113.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.171 -1.788 . . . . 1.0 106.171 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.07 143.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -115.76 113.87 24.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -110.67 114.07 27.17 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 105.187 -2.153 . . . . 1.0 105.187 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 19' ' ' TYR . 74.5 t 71.39 91.37 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 121.71 2.05 . . . . 1.0 111.954 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.34 -166.93 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.093 1.862 . . . . 1.0 111.052 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -61.4 26.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 130.34 3.456 . . . . 1.0 116.918 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.27 134.86 19.77 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 121.247 1.84 . . . . 1.0 106.741 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 75.69 82.69 0.1 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.626 1.57 . . . . 1.0 111.504 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -43.96 145.28 0.74 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.333 1.853 . . . . 1.0 112.546 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -109.29 -178.59 3.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.206 2.202 . . . . 1.0 110.26 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -154.39 119.74 5.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.604 0.638 . . . . 1.0 111.051 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -157.21 64.46 0.5 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.058 1.409 . . . . 1.0 111.46 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.01 -57.96 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 117.953 -2.967 . . . . 1.0 111.286 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.91 -69.61 0.44 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.331 -1.908 . . . . 1.0 108.331 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -146.04 144.02 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.464 1.632 . . . . 1.0 109.544 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 p -165.71 162.83 18.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.738 1.215 . . . . 1.0 111.444 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 3.0 p -158.77 145.32 17.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 1.0 108.982 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -166.9 157.15 11.53 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.537 -1.221 . . . . 1.0 108.943 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 39.58 53.91 2.42 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.511 1.924 . . . . 1.0 112.3 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.36 29.82 53.94 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 114.885 -1.052 . . . . 1.0 113.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 tpt85 -131.71 116.72 17.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.081 1.441 . . . . 1.0 108.433 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 2.1 tt0 -78.51 146.49 34.32 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.474 -1.676 . . . . 1.0 106.474 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -126.01 117.97 24.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.387 -2.079 . . . . 1.0 105.387 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.86 -26.25 61.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.812 -1.085 . . . . 1.0 110.588 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -151.42 173.23 14.79 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.972 1.309 . . . . 1.0 108.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.49 75.64 6.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.205 1.479 . . . . 1.0 107.054 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.18 39.2 1.12 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.475 1.11 . . . . 1.0 109.769 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.9 m -140.02 124.26 17.83 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.471 -1.393 . . . . 1.0 113.205 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -78.46 57.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.545 2.338 . . . . 1.0 111.57 -175.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.26 -119.02 0.45 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.411 -1.475 . . . . 1.0 109.411 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.696 HD11 HG11 ' A' ' 136' ' ' VAL . 15.8 mm -149.01 165.56 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 130.234 3.413 . . . . 1.0 104.105 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -141.16 134.13 29.12 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.846 2.858 . . . . 1.0 104.129 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.4 164.24 11.87 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.355 -0.841 . . . . 1.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.37 150.79 50.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.207 0.603 . . . . 1.0 111.135 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.51 173.88 39.67 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.935 1.255 . . . . 1.0 110.734 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 p -151.01 110.53 4.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.635 -2.357 . . . . 1.0 104.635 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.5 t0 49.55 52.67 14.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 123.789 1.757 . . . . 1.0 112.507 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 47.83 37.98 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.373 2.669 . . . . 1.0 114.031 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 80' ' ' ARG . 7.7 tt -58.5 145.62 38.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.722 1.209 . . . . 1.0 107.744 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.434 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -44.87 120.72 2.44 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.268 1.027 . . . . 1.0 109.678 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.41 10.38 7.24 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 117.129 -1.415 . . . . 1.0 113.673 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.311 28.6 p 37.4 74.65 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 1 N-CA-C 123.667 4.691 . . . . 1.0 123.667 -174.121 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -17.19 -32.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.998 2.919 . . . . 1.0 114.918 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.34 -41.2 18.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.594 1.557 . . . . 1.0 109.387 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -49.56 -57.29 7.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.51 1.924 . . . . 1.0 109.299 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -56.34 -43.17 78.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.736 -0.65 . . . . 1.0 109.561 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -64.51 -57.06 10.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.652 0.66 . . . . 1.0 111.004 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 136' ' ' VAL . 43.3 mt-30 -65.77 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.974 -1.704 . . . . 1.0 111.516 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.662 HD13 HG21 ' A' ' 115' ' ' ILE . 7.3 tp -61.6 -46.43 89.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.609 1.095 . . . . 1.0 108.761 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.05 76.71 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.247 0.931 . . . . 1.0 109.187 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.33 52.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.856 0.753 . . . . 1.0 110.703 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.696 HG11 HD11 ' A' ' 115' ' ' ILE . 4.1 t -56.06 -46.03 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.092 -0.38 . . . . 1.0 110.044 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.9 m -59.21 -50.08 75.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.373 1.469 . . . . 1.0 109.838 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -60.15 -42.26 94.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.0 110.341 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.93 88.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.849 0.46 . . . . 1.0 112.054 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.36 -47.12 79.52 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.531 -0.747 . . . . 1.0 109.313 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.05 -37.27 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.166 0.986 . . . . 1.0 110.773 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.4 m -65.63 -14.07 60.42 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.071 0.949 . . . . 1.0 111.953 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -111.07 -50.83 2.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.391 1.45 . . . . 1.0 111.744 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -126.77 113.06 22.44 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -97.33 107.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.049 1.41 . . . . 1.0 110.198 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.95 -51.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.064 1.746 . . . . 1.0 106.405 175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 59.5 mt -46.71 -33.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 129.497 3.119 . . . . 1.0 110.999 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.25 -26.42 17.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.407 1.083 . . . . 1.0 113.621 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -135.69 18.15 3.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.705 2.002 . . . . 1.0 110.043 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.434 ' HB3' HD12 ' A' ' 30' ' ' LEU . 11.5 m120 -139.78 83.56 1.93 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.926 1.29 . . . . 1.0 108.068 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 64.5 mtt -120.29 126.71 51.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -167.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.546 1.067 . . . . 1.0 108.345 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.28 -130.88 1.32 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 105.508 -3.037 . . . . 1.0 105.508 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.317 19.3 m-70 -112.31 -22.99 10.62 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.325 0.861 . . . . 1.0 113.325 -175.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 9.0 t -102.98 -11.13 18.4 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 118.568 -0.729 . . . . 1.0 109.287 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -89.42 43.05 1.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -71.63 -8.96 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 120.801 -1.187 . . . . 1.0 110.515 175.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -160.72 -53.92 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.669 2.388 . . . . 1.0 111.246 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 64.5 Cg_endo -91.52 111.96 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.097 1.865 . . . . 1.0 113.031 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.95 -25.38 63.46 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.965 -1.084 . . . . 1.0 112.281 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 20.4 ttp85 -71.27 -5.29 31.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.64 -1.287 . . . . 1.0 112.549 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 127.22 22.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 103.888 -2.634 . . . . 1.0 103.888 174.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.3 m -123.73 -16.21 6.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.289 0.95 . . . . 1.0 110.884 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.78 -178.75 0.34 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.216 2.607 . . . . 1.0 105.697 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.79 51.52 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.525 . . . . 1.0 112.96 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.34 76.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.158 1.361 . . . . 1.0 110.202 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.49 -74.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.373 2.049 . . . . 1.0 111.636 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.75 44.02 30.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.431 1.892 . . . . 1.0 111.206 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 33' ' ' VAL . 51.6 t80 -99.09 18.38 17.52 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.038 -1.039 . . . . 1.0 110.926 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.258 9.4 t0 44.17 70.52 0.32 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.388 1.475 . . . . 1.0 110.46 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -56.7 -29.12 62.07 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 120.669 -1.269 . . . . 1.0 110.311 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.4 -53.61 33.8 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.755 1.161 . . . . 1.0 111.994 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -65.93 -47.88 73.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 118.079 -0.962 . . . . 1.0 109.868 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.11 -55.63 31.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.123 0.874 . . . . 1.0 112.176 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -58.64 -36.6 74.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.795 -1.098 . . . . 1.0 109.8 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -45.1 80.82 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.471 1.107 . . . . 1.0 113.629 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.55 -46.08 84.38 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.087 0.955 . . . . 1.0 112.054 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.69 166.55 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.741 2.016 . . . . 1.0 110.082 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 1.0 109.457 175.5 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--O 1.24 0.577 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.42 154.52 32.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 46.2 58.35 4.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.168 2.187 . . . . 1.0 113.59 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.77 134.73 15.73 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.182 -0.949 . . . . 1.0 111.334 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -71.65 123.18 21.96 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.428 -1.693 . . . . 1.0 106.428 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -92.88 123.93 36.5 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.638 -0.664 . . . . 1.0 110.42 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.45 67.29 75.82 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.333 1.453 . . . . 1.0 107.666 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.52 152.47 59.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.78 1.653 . . . . 1.0 110.071 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -154.1 114.96 2.54 Favored Pre-proline 0 CA--C 1.511 -0.554 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 90.8 Cg_endo -74.75 71.4 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.002 1.801 . . . . 1.0 109.261 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -133.85 43.03 2.89 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.073 2.949 . . . . 1.0 105.064 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 18.9 m-85 -79.28 178.7 7.88 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.425 2.29 . . . . 1.0 113.077 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -122.2 -179.76 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.615 1.966 . . . . 1.0 111.011 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 m -158.26 118.27 3.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 131.395 3.878 . . . . 1.0 101.547 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -120.2 138.72 27.48 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 106.047 -1.835 . . . . 1.0 106.047 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.96 61.27 8.09 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.115 3.21 . . . . 1.0 112.54 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -138.8 151.39 47.01 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 128.675 2.79 . . . . 1.0 105.023 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -150.85 104.36 3.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.802 1.183 . . . . 1.0 109.713 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.14 161.71 34.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 105.97 -1.863 . . . . 1.0 105.97 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -57.69 123.86 65.19 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.97 0.908 . . . . 1.0 108.923 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.34 103.6 1.29 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.366 2.044 . . . . 1.0 108.302 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 t -174.15 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.198 -2.149 . . . . 1.0 105.198 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.07 131.48 9.49 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.376 1.471 . . . . 1.0 107.482 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 tp -92.07 127.51 37.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.342 1.057 . . . . 1.0 109.437 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.67 116.84 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.913 1.285 . . . . 1.0 108.514 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 169' ' ' PHE . 93.6 t -110.88 114.94 48.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -168.07 129.39 1.4 Allowed 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.88 111.84 6.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 5.9 mm -127.0 177.58 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.828 2.451 . . . . 1.0 112.12 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -151.28 122.32 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 1 N-CA-C 95.992 -5.559 . . . . 1.0 95.992 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.301 0.6 OUTLIER -142.84 -60.9 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 121.727 2.058 . . . . 1.0 112.426 176.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.14 157.58 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.572 2.181 . . . . 1.0 111.449 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.16 13.47 2.37 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.771 2.981 . . . . 1.0 116.664 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -24.55 -68.59 0.03 OUTLIER Glycine 0 C--N 1.353 1.508 0 CA-C-N 121.402 1.91 . . . . 1.0 111.694 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -148.89 122.97 9.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.776 -1.565 . . . . 1.0 106.776 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -176.47 159.26 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.649 2.78 . . . . 1.0 108.294 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.46 -6.4 10.62 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.721 1.153 . . . . 1.0 110.664 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.09 120.37 7.18 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 108.383 -1.887 . . . . 1.0 108.383 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.82 -24.86 80.05 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.62 2.213 . . . . 1.0 115.191 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -49.36 -45.81 46.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.794 1.179 . . . . 1.0 113.741 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 mm -65.6 -49.31 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 123.567 0.747 . . . . 1.0 110.651 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.34 -36.33 82.62 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 118.861 -1.136 . . . . 1.0 110.744 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.75 -34.2 71.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.717 0.807 . . . . 1.0 110.996 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.1 tm? -60.94 -54.33 46.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.547 1.139 . . . . 1.0 108.077 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.96 -48.29 69.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.51 -34.77 78.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.275 1.43 . . . . 1.0 110.431 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.09 1.57 29.98 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.195 1.379 . . . . 1.0 115.221 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -88.96 8.69 28.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.232 2.016 . . . . 1.0 113.255 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -57.46 127.92 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.978 1.311 . . . . 1.0 112.219 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.84 135.54 20.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.238 2.215 . . . . 1.0 109.609 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.08 77.34 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.649 2.899 . . . . 1.0 107.261 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.41 -64.58 1.07 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.105 0.562 . . . . 1.0 111.013 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.8 -47.55 76.93 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.042 0.937 . . . . 1.0 110.855 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 17.8 p80 -170.07 177.9 0.98 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.677 1.591 . . . . 1.0 107.607 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -71.37 -43.41 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.437 2.091 . . . . 1.0 114.973 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -46.29 -49.76 17.03 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.956 1.095 . . . . 1.0 113.956 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 -55.58 31.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.116 0.966 . . . . 1.0 110.397 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.28 99.17 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.14 0.976 . . . . 1.0 111.39 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.31 23.09 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.907 1.718 . . . . 1.0 112.38 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.7 pt -60.26 -36.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-O 117.221 -1.371 . . . . 1.0 112.38 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -43.78 -43.15 5.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.58 1.952 . . . . 1.0 115.435 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -60.34 -33.57 72.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.672 -0.643 . . . . 1.0 109.692 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.62 136.65 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 102.924 -2.991 . . . . 1.0 102.924 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 153.89 15.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.694 -1.202 . . . . 1.0 110.456 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.59 159.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -165.84 130.21 2.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.632 -1.248 . . . . 1.0 107.632 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.32 -176.77 3.75 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -123.69 -76.6 0.59 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.549 -2.019 . . . . 1.0 105.549 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' CB ' HD13 ' A' ' 115' ' ' ILE . 3.8 m -122.51 118.47 28.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.891 -2.263 . . . . 1.0 104.891 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.97 113.33 25.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.407 -2.071 . . . . 1.0 105.407 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.4 mt -88.1 119.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 106.029 -1.841 . . . . 1.0 106.029 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.29 141.9 58.61 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.437 -1.69 . . . . 1.0 106.437 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -53.14 -24.99 11.8 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 124.442 1.097 . . . . 1.0 111.324 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.37 34.57 0.95 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.529 1.132 . . . . 1.0 111.845 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.48 48.2 86.28 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 120.112 -1.617 . . . . 1.0 115.944 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.48 156.26 31.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.08 113.51 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 104.948 -2.241 . . . . 1.0 104.948 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.26 139.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -124.79 113.96 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.87 140.41 43.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.911 2.484 . . . . 1.0 104.384 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t 63.18 90.91 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 120.65 1.568 . . . . 1.0 113.519 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.67 -177.55 0.97 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 120.807 1.005 . . . . 1.0 110.432 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.69 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.682 2.793 . . . . 1.0 115.558 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -149.89 120.36 7.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.523 2.729 . . . . 1.0 107.204 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 84.07 81.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.662 2.785 . . . . 1.0 110.639 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -41.04 152.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.699 3.2 . . . . 1.0 114.603 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.72 -178.77 3.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 1.0 110.219 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -152.34 118.44 5.51 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -162.73 62.5 0.2 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.969 0.89 . . . . 1.0 110.914 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -165.76 -61.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 117.635 -3.166 . . . . 1.0 113.296 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.96 -73.65 1.14 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.203 -1.332 . . . . 1.0 112.943 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.95 129.4 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.973 1.387 . . . . 1.0 111.633 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 p -165.96 146.73 6.67 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.824 1.65 . . . . 1.0 108.231 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.563 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -144.53 146.39 32.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.762 2.025 . . . . 1.0 108.533 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -150.32 149.65 30.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.943 -2.244 . . . . 1.0 104.943 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 43.49 53.61 5.65 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.745 1.218 . . . . 1.0 114.273 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.8 39.46 67.84 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 121.011 -1.056 . . . . 1.0 113.09 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -146.48 113.57 6.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.579 -2.378 . . . . 1.0 104.579 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -105.98 132.84 51.59 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -102.55 118.26 36.48 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.5 t -61.31 -25.05 66.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 1.0 111.611 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -153.77 161.08 42.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.3 76.76 8.23 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.04 40.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.821 2.448 . . . . 1.0 109.74 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -123.73 133.79 53.8 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.852 1.261 . . . . 1.0 110.96 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.39 56.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.162 -1.421 . . . . 1.0 107.162 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.02 -137.01 3.79 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 120.909 -1.119 . . . . 1.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 1.1 mm -143.15 164.77 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.238 -2.875 . . . . 1.0 103.238 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.33 137.18 28.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.329 2.651 . . . . 1.0 103.898 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.91 141.62 33.54 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.589 -1.319 . . . . 1.0 109.407 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 6.0 tm-20 -103.92 154.3 19.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.465 -0.198 . . . . 1.0 110.465 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.02 -177.62 46.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 128.49 2.948 . . . . 1.0 109.401 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 p -156.35 116.64 3.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.735 -2.321 . . . . 1.0 104.735 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.4 t0 50.59 40.45 23.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.261 65.4 p 58.8 38.48 24.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.249 2.22 . . . . 1.0 115.163 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.44 146.08 30.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.906 1.682 . . . . 1.0 107.886 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -42.4 113.38 0.44 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -81.02 -5.75 57.97 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 115.855 1.798 . . . . 1.0 115.855 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.8 p 51.62 77.78 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 120.194 1.361 . . . . 1.0 111.505 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.84 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.245 2.618 . . . . 1.0 114.159 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -41.62 -36.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.497 2.319 . . . . 1.0 109.452 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -48.17 -50.07 30.32 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.594 0.757 . . . . 1.0 110.375 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.84 -47.73 83.82 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.321 0.648 . . . . 1.0 109.982 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.02 -51.95 67.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.578 0.704 . . . . 1.0 109.72 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -66.45 -47.9 71.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 1.0 110.837 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 115' ' ' ILE . 21.5 tp -55.76 -41.77 74.47 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.81 98.26 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.458 1.481 . . . . 1.0 111.907 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.74 47.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.384 0.674 . . . . 1.0 109.246 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 115' ' ' ILE . 22.0 t -60.62 -48.25 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.5 m -55.85 -49.35 73.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.843 1.257 . . . . 1.0 109.893 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.39 -41.08 98.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.488 0.715 . . . . 1.0 110.338 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.74 68.03 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.268 -0.895 . . . . 1.0 110.673 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.12 -41.13 74.83 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.876 -1.059 . . . . 1.0 112.05 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.68 -43.24 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.678 1.126 . . . . 1.0 108.574 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.8 m -65.61 -22.03 66.63 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.386 0.674 . . . . 1.0 111.799 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.62 -56.15 3.48 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 120.478 -1.389 . . . . 1.0 108.098 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.36 112.54 23.44 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -89.97 108.55 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 117.05 -1.5 . . . . 1.0 110.122 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.41 -50.42 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.081 1.752 . . . . 1.0 109.033 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.9 mt -47.33 -33.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.847 3.259 . . . . 1.0 110.765 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.08 -26.3 4.29 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.405 1.082 . . . . 1.0 113.272 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.92 17.92 5.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.676 1.991 . . . . 1.0 111.267 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -139.47 88.02 2.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.34 1.427 . . . . 1.0 109.717 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 46.0 mtt -129.89 113.86 15.16 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -148.6 -165.9 2.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.45 -131.41 1.43 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 106.326 -2.709 . . . . 1.0 106.326 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.588 1.194 . . . . 1.0 111.907 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.93 -11.59 17.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.787 0.835 . . . . 1.0 109.573 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.52 39.56 0.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.1 -1.0 . . . . 1.0 110.393 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -74.43 -11.69 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 O-C-N 121.251 -0.906 . . . . 1.0 108.68 175.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -159.59 -54.16 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.956 1.702 . . . . 1.0 113.037 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.12 108.86 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 122.71 2.004 . . . . 1.0 111.277 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.23 -13.42 37.6 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.198 -0.938 . . . . 1.0 113.219 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.09 -25.74 63.66 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.544 -1.347 . . . . 1.0 111.957 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -113.91 141.6 47.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -140.37 -15.07 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 118.872 -1.131 . . . . 1.0 111.427 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.71 177.55 0.43 Allowed Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 131.0 3.72 . . . . 1.0 104.092 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.07 77.86 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.33 2.02 . . . . 1.0 109.892 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 127.17 67.27 0.15 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.086 1.803 . . . . 1.0 109.582 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 88.0 Cg_endo -74.62 -89.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.08 2.52 . . . . 1.0 109.551 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t 53.4 42.98 31.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.876 2.07 . . . . 1.0 114.095 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 33' ' ' VAL . 65.8 t80 -95.13 19.28 10.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 119.862 -1.774 . . . . 1.0 113.982 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.5 t0 45.61 56.2 6.02 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.213 -1.554 . . . . 1.0 113.479 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -45.2 -40.5 7.32 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.096 1.758 . . . . 1.0 113.011 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.63 -60.85 2.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.381 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -64.55 -36.2 83.45 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 117.884 -1.526 . . . . 1.0 111.251 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.55 -57.56 12.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.589 0.556 . . . . 1.0 110.397 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -64.38 -32.72 74.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.761 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.75 96.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.536 0.607 . . . . 1.0 111.715 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.82 -46.48 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.243 1.017 . . . . 1.0 112.262 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.04 166.87 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.371 1.868 . . . . 1.0 111.702 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 125.951 1.7 . . . . 1.0 108.876 175.274 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.493 ' N ' HE22 ' A' ' 86' ' ' GLN . 4.6 tt . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.12 176.33 5.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.895 0.878 . . . . 1.0 112.037 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 45.79 57.97 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.971 2.108 . . . . 1.0 109.694 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 139.83 13.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.557 -1.339 . . . . 1.0 111.294 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.03 130.11 39.18 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -83.61 133.2 34.85 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.024 0.53 . . . . 1.0 110.319 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.84 73.12 28.24 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.422 -1.696 . . . . 1.0 106.422 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.62 123.27 9.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 N-CA-C 108.08 -1.546 . . . . 1.0 108.08 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -113.91 114.51 46.5 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 29.1 Cg_endo -79.86 38.93 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.665 2.91 . . . . 1.0 113.989 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.97 44.53 2.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.503 1.121 . . . . 1.0 109.254 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 21.9 m-85 -73.52 178.52 4.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.066 0.946 . . . . 1.0 112.863 -175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.67 178.6 4.51 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 118.919 2.933 . . . . 1.0 118.919 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.2 m -162.83 118.73 1.84 Allowed 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 135.911 5.684 . . . . 1.0 101.173 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -130.09 154.96 81.39 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.439 -2.06 . . . . 1.0 105.439 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.26 51.97 4.12 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.985 3.124 . . . . 1.0 114.398 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -139.59 151.18 45.83 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.904 1.282 . . . . 1.0 110.205 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -148.43 103.82 3.46 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.791 1.236 . . . . 1.0 108.179 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.44 173.53 11.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.082 0.953 . . . . 1.0 109.01 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -79.46 124.32 84.01 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 119.648 1.113 . . . . 1.0 109.789 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.72 103.95 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.504 2.136 . . . . 1.0 112.436 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -178.13 83.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.067 1.747 . . . . 1.0 108.002 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.67 141.04 17.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.571 1.149 . . . . 1.0 108.183 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -94.25 127.48 40.13 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.475 1.51 . . . . 1.0 108.478 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 140.43 24.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -135.56 113.72 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 104.888 -2.264 . . . . 1.0 104.888 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -170.16 152.16 4.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.796 1.638 . . . . 1.0 107.601 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -94.88 112.42 24.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 36' ' ' ILE . 5.2 mm -128.05 166.67 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 106.179 -1.785 . . . . 1.0 106.179 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -139.13 122.25 16.87 Favored 'General case' 0 N--CA 1.444 -0.733 1 N-CA-C 94.35 -6.167 . . . . 1.0 94.35 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.366 0.7 OUTLIER -142.96 -66.1 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.462 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 179.4 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 27.4 Cg_endo -87.85 155.92 7.36 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.096 2.531 . . . . 1.0 114.352 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.19 59.09 5.86 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 125.174 3.916 . . . . 1.0 116.157 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.79 -71.77 0.95 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -156.48 123.46 5.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.463 1.505 . . . . 1.0 110.496 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -168.56 166.4 12.01 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.227 2.611 . . . . 1.0 110.715 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.06 6.49 25.4 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.623 2.059 . . . . 1.0 111.649 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.2 118.74 6.27 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.187 -1.965 . . . . 1.0 108.187 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.23 -7.88 20.25 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.825 2.35 . . . . 1.0 114.457 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 13.6 m95 -45.95 -49.63 15.62 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.283 1.433 . . . . 1.0 113.293 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -65.12 -46.01 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.619 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.4 -38.31 87.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.163 -0.681 . . . . 1.0 109.163 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -61.16 -34.24 74.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.68 1.192 . . . . 1.0 111.897 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.4 tm? -59.66 -51.89 67.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.905 1.282 . . . . 1.0 109.152 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -70.03 -48.66 57.1 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.609 1.163 . . . . 1.0 111.558 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.05 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.046 0.938 . . . . 1.0 109.378 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.53 1.82 24.48 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.006 -1.441 . . . . 1.0 115.319 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -89.07 9.29 25.9 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.301 2.05 . . . . 1.0 113.038 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.4 tt -53.51 145.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.648 1.579 . . . . 1.0 114.431 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.82 136.77 20.56 Favored Pre-proline 0 CA--C 1.546 0.804 1 C-N-CA 131.77 4.028 . . . . 1.0 113.02 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.51 38.1 0.29 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.769 3.646 . . . . 1.0 113.695 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -103.16 -33.36 9.23 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.229 1.832 . . . . 1.0 111.061 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -50.9 -52.96 36.78 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 106.207 -1.775 . . . . 1.0 106.207 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 12.9 p80 -171.31 178.38 0.79 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 131.046 3.738 . . . . 1.0 104.181 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.3 -43.54 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.69 1.593 . . . . 1.0 113.658 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -42.28 -47.64 4.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.889 1.676 . . . . 1.0 114.105 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -55.66 -55.6 30.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.758 1.223 . . . . 1.0 109.136 -175.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.33 99.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.253 1.021 . . . . 1.0 110.745 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.77 -57.49 10.75 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.87 1.7 . . . . 1.0 113.1 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 pt -61.7 -39.88 84.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.121 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -38.15 -43.26 0.74 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.89 2.476 . . . . 1.0 115.188 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -56.4 -40.05 74.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.008 0.923 . . . . 1.0 108.868 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.56 136.93 32.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 1.0 105.062 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 154.98 5.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.131 -0.98 . . . . 1.0 112.399 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 m -116.73 160.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.349 1.86 . . . . 1.0 108.872 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -174.24 120.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.583 1.553 . . . . 1.0 107.586 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.23 -169.39 1.91 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.243 1.417 . . . . 1.0 108.153 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -120.18 -59.04 1.82 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.854 1.261 . . . . 1.0 109.42 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.72 119.12 10.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 119.709 -1.869 . . . . 1.0 106.684 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp -98.88 113.74 26.02 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 102.579 -3.119 . . . . 1.0 102.579 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.0 mt -95.83 114.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.686 -1.968 . . . . 1.0 105.686 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -67.22 152.57 45.49 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 118.519 0.6 . . . . 1.0 110.165 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -60.78 -14.0 18.74 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 125.467 1.507 . . . . 1.0 112.784 175.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -91.88 20.35 5.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.834 1.654 . . . . 1.0 111.755 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.56 47.71 89.79 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.743 2.592 . . . . 1.0 114.118 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -119.36 115.05 23.32 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.383 0.673 . . . . 1.0 110.521 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.92 117.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.55 147.28 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.493 HE22 ' N ' ' A' ' 8' ' ' LEU . 43.1 tt0 -124.3 117.92 25.6 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.569 1.548 . . . . 1.0 112.321 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.64 123.24 41.44 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 128.391 2.676 . . . . 1.0 105.205 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 t 64.34 91.29 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 122.339 2.336 . . . . 1.0 112.696 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -69.1 -169.13 0.28 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.144 1.896 . . . . 1.0 112.031 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.93 17.58 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.996 2.918 . . . . 1.0 114.994 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -143.68 125.27 14.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.687 2.395 . . . . 1.0 107.249 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? 85.09 81.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.559 3.144 . . . . 1.0 109.678 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB3' HH11 ' A' ' 93' ' ' ARG . 0.1 OUTLIER -38.71 141.44 0.27 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.598 2.759 . . . . 1.0 115.246 -175.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.45 -178.54 3.68 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 129.002 2.921 . . . . 1.0 111.625 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -153.71 118.32 4.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.678 1.591 . . . . 1.0 108.318 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -160.12 63.19 0.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.401 1.572 . . . . 1.0 111.498 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 110' ' ' ASP . . . -159.53 -53.97 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.747 -2.471 . . . . 1.0 113.457 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.57 -69.41 0.74 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.5 t -145.86 137.57 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 1.0 108.019 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.9 p -166.46 165.96 16.68 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.092 1.757 . . . . 1.0 108.875 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 157' ' ' ILE . 5.3 p -159.27 146.38 17.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -156.48 152.81 27.85 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.62 -1.252 . . . . 1.0 107.62 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 39.85 53.41 2.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.368 1.467 . . . . 1.0 111.846 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.16 28.47 26.33 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.396 -1.224 . . . . 1.0 114.872 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -129.22 117.36 20.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.83 146.64 30.81 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.424 1.49 . . . . 1.0 111.191 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.15 117.99 24.28 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 50.7 t -78.38 -23.87 46.6 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.207 1.003 . . . . 1.0 110.133 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.13 169.98 16.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.912 -1.885 . . . . 1.0 105.912 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 6.1 t70 -93.43 76.0 4.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 38.42 0.72 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.099 1.759 . . . . 1.0 109.497 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -128.23 143.07 51.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.574 1.55 . . . . 1.0 109.343 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -78.96 56.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.208 2.203 . . . . 1.0 107.451 175.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.07 -136.59 1.57 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 122.227 0.904 . . . . 1.0 112.773 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 136' ' ' VAL . 28.2 mm -147.26 155.44 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 129.522 3.129 . . . . 1.0 104.104 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.43 129.97 21.35 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.97 161.5 13.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.646 -1.909 . . . . 1.0 110.626 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.68 144.82 48.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 1.0 111.084 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.71 38.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.55 2.024 . . . . 1.0 111.232 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.3 p -149.42 106.51 3.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.026 -1.842 . . . . 1.0 106.026 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.6 t0 45.52 48.81 10.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.59 1.956 . . . . 1.0 112.593 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p 52.32 38.39 24.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.695 1.998 . . . . 1.0 114.881 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.605 HD22 ' HD2' ' A' ' 80' ' ' ARG . 5.9 tt -60.6 142.05 55.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 104.482 -2.414 . . . . 1.0 104.482 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -32.09 113.6 0.13 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.057 1.743 . . . . 1.0 112.039 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -79.59 -14.68 58.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 116.322 -1.799 . . . . 1.0 115.388 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 25.4 p 64.2 78.09 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.747 1.612 . . . . 1.0 111.841 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -24.39 -33.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.819 1.648 . . . . 1.0 113.335 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.59 -34.54 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.911 2.884 . . . . 1.0 110.644 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.59 -57.06 11.2 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.915 1.286 . . . . 1.0 107.998 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.01 -42.6 69.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.153 0.981 . . . . 1.0 109.715 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -66.03 -58.77 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.552 1.141 . . . . 1.0 111.542 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.5 -36.25 82.27 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.667 -1.271 . . . . 1.0 112.368 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tt -61.09 -39.22 89.12 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.897 -1.127 . . . . 1.0 108.146 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.72 95.47 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.963 -1.086 . . . . 1.0 111.337 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -53.53 57.23 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 115' ' ' ILE . 55.6 t -55.22 -41.72 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.763 0.825 . . . . 1.0 110.869 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 m -59.59 -44.53 93.33 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.124 -0.985 . . . . 1.0 109.908 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.64 -44.57 90.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.894 0.77 . . . . 1.0 109.748 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.67 -56.22 22.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.941 0.896 . . . . 1.0 110.264 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.07 -44.76 79.25 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 118.241 -0.885 . . . . 1.0 112.325 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.3 -42.13 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.854 0.752 . . . . 1.0 109.786 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.225 0.61 . . . . 1.0 112.193 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -93.1 -51.2 5.15 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.693 1.197 . . . . 1.0 110.304 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.51 112.54 23.06 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -90.74 107.89 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 CA-C-N 121.539 1.585 . . . . 1.0 108.64 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.28 -50.99 0.11 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.603 2.361 . . . . 1.0 108.427 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.26 -33.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 130.367 3.467 . . . . 1.0 110.995 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.84 -26.49 10.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.036 1.125 . . . . 1.0 114.036 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -128.97 18.58 6.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.412 2.285 . . . . 1.0 111.374 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -138.15 83.36 1.97 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.4 mtt -127.61 114.02 16.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.317 -2.475 . . . . 1.0 104.317 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -154.47 -173.43 4.57 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.96 -122.84 1.75 Allowed Glycine 0 C--O 1.234 0.106 0 N-CA-C 106.413 -2.675 . . . . 1.0 106.413 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.255 13.1 m-70 -118.3 -23.82 7.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.557 2.343 . . . . 1.0 112.029 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.79 -18.39 15.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.466 -0.778 . . . . 1.0 109.991 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -86.55 44.0 1.12 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.33 -23.08 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 120.446 -1.409 . . . . 1.0 107.427 175.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.522 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -151.6 -53.98 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.521 2.728 . . . . 1.0 111.164 175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 95.1 Cg_endo -80.88 109.23 2.18 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.662 2.241 . . . . 1.0 113.348 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.64 -25.52 68.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.837 -1.164 . . . . 1.0 113.221 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -60.44 -23.18 64.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -135.68 131.95 36.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.2 m -113.69 -16.04 12.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.858 0.361 . . . . 1.0 110.13 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.1 -179.18 0.65 Allowed Pre-proline 0 CA--C 1.55 0.963 1 C-N-CA 132.572 4.349 . . . . 1.0 103.252 175.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.74 77.11 2.3 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 122.415 1.898 . . . . 1.0 111.432 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.36 73.58 0.81 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.1 1.333 . . . . 1.0 110.468 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.09 -57.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.816 0 CA-C-N 119.952 1.876 . . . . 1.0 113.645 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 53.35 43.08 31.89 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.32 1.448 . . . . 1.0 111.971 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.01 19.53 14.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.928 0.331 . . . . 1.0 111.486 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.264 22.6 t0 42.96 67.03 0.68 Allowed 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 126.38 1.872 . . . . 1.0 111.185 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -53.56 -32.96 53.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.209 -0.905 . . . . 1.0 111.904 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.41 -52.69 43.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.96 1.254 . . . . 1.0 110.755 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -65.94 -46.01 79.76 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.264 0.938 . . . . 1.0 111.254 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.33 -51.85 67.11 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.921 1.237 . . . . 1.0 111.58 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.329 -0.857 . . . . 1.0 110.049 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.06 77.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.19 -52.64 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.932 0.787 . . . . 1.0 108.996 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.53 161.6 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 122.115 0.959 . . . . 1.0 110.747 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 127.799 2.44 . . . . 1.0 108.864 175.875 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 107.442 -1.318 . . . . 1.0 107.442 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.32 135.29 55.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.715 0.634 . . . . 1.0 112.095 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 52.72 58.72 5.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.087 1.755 . . . . 1.0 111.294 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.75 141.6 25.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.774 -1.557 . . . . 1.0 108.378 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 tpt85 -76.38 123.44 25.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 ptt-85 -88.07 119.59 28.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.25 1.02 . . . . 1.0 111.388 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -143.45 73.98 17.28 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.175 0.99 . . . . 1.0 109.833 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.17 149.69 76.51 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 121.421 1.414 . . . . 1.0 109.87 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -137.44 134.1 18.42 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.576 1.15 . . . . 1.0 108.064 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.18 43.9 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.258 2.638 . . . . 1.0 113.251 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -123.47 43.67 2.9 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.351 -0.843 . . . . 1.0 109.381 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -73.52 178.74 4.46 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.676 1.19 . . . . 1.0 110.298 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -121.08 178.35 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.661 1.22 . . . . 1.0 113.003 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.0 m -148.64 118.61 7.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.079 2.952 . . . . 1.0 104.344 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -138.81 139.21 23.24 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 121.292 1.86 . . . . 1.0 108.717 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 75.18 4.76 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.511 2.807 . . . . 1.0 110.69 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -154.35 144.71 22.13 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.186 2.594 . . . . 1.0 106.853 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -149.8 103.44 3.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 127.257 2.223 . . . . 1.0 105.855 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -136.66 165.23 26.39 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.816 1.646 . . . . 1.0 107.613 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.49 123.61 83.45 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.615 -0.707 . . . . 1.0 111.33 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -86.85 103.59 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.506 2.137 . . . . 1.0 111.802 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -176.46 85.04 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 104.596 -2.372 . . . . 1.0 104.596 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -145.96 146.09 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.974 2.509 . . . . 1.0 105.489 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.26 127.84 56.07 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.026 -1.472 . . . . 1.0 107.026 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.18 135.66 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 169' ' ' PHE . 70.1 t -135.57 114.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.753 1.621 . . . . 1.0 107.839 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.56 161.89 21.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.38 1.472 . . . . 1.0 107.236 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.64 112.42 24.3 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -127.99 176.42 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 127.809 2.444 . . . . 1.0 108.21 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -156.92 122.13 4.62 Favored 'General case' 0 N--CA 1.438 -1.039 1 N-CA-C 97.483 -5.006 . . . . 1.0 97.483 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.51 -65.89 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.551 0 CA-C-N 120.298 1.408 . . . . 1.0 108.38 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.09 150.71 66.57 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 121.527 1.581 . . . . 1.0 109.924 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.29 28.49 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.105 3.204 . . . . 1.0 113.846 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -18.21 -71.64 0.01 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 127.686 2.565 . . . . 1.0 110.443 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -155.52 122.75 5.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -176.84 175.95 1.55 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.88 2.872 . . . . 1.0 108.089 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.56 1.54 8.09 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.91 -0.939 . . . . 1.0 113.743 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.35 118.52 5.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.219 1.509 . . . . 1.0 112.584 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.2 -4.29 13.36 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.936 2.424 . . . . 1.0 113.758 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.98 -38.77 76.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.948 -1.095 . . . . 1.0 110.292 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 38' ' ' LEU . 84.1 mt -64.35 -44.08 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.81 -48.01 82.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.108 0.867 . . . . 1.0 109.274 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.36 -35.08 62.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 1.0 111.565 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.12 -61.06 2.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.792 0.837 . . . . 1.0 109.835 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -67.23 -49.98 62.43 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -57.73 -33.86 68.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 1.0 109.753 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 40.64 3.19 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.916 0.78 . . . . 1.0 111.879 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -131.3 16.28 5.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 117.972 0.886 . . . . 1.0 110.691 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.74 139.39 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.338 1.055 . . . . 1.0 110.445 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -98.42 127.47 36.05 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 127.641 2.376 . . . . 1.0 106.91 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.4 56.94 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.077 3.185 . . . . 1.0 111.819 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.77 -57.92 1.96 Allowed 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 124.961 1.304 . . . . 1.0 112.34 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.58 -60.33 1.58 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.744 1.217 . . . . 1.0 112.292 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.443 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 23.0 p80 -168.51 177.79 1.18 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 1.0 108.548 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 20.2 Cg_endo -72.87 -43.45 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.726 1.618 . . . . 1.0 113.684 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -50.54 -60.1 3.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.672 1.189 . . . . 1.0 111.928 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.84 -51.65 68.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.846 0.858 . . . . 1.0 110.395 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.54 77.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.415 1.086 . . . . 1.0 111.508 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.19 -65.36 3.62 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 125.418 1.485 . . . . 1.0 110.603 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.91 -24.24 32.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 116.68 -1.629 . . . . 1.0 113.544 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.01 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.526 1.512 . . . . 1.0 113.659 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -57.41 -34.11 68.56 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.612 0.365 . . . . 1.0 110.956 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.49 136.38 33.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -66.04 149.29 50.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.909 -1.119 . . . . 1.0 109.402 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.3 m -117.09 162.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.068 1.347 . . . . 1.0 109.952 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.5 m -166.34 130.57 2.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.256 2.223 . . . . 1.0 105.976 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.11 -157.09 0.56 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -130.21 -61.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.192 0.997 . . . . 1.0 108.821 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' HD13 ' A' ' 115' ' ' ILE . 45.8 m -140.7 118.55 11.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.911 -1.885 . . . . 1.0 105.911 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.22 113.8 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.717 2.007 . . . . 1.0 105.607 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.64 114.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.974 -1.491 . . . . 1.0 106.974 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -70.99 152.84 43.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -14.05 2.58 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.693 0.797 . . . . 1.0 112.952 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -91.5 19.61 6.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 127.477 2.311 . . . . 1.0 112.1 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 28.94 70.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.686 2.565 . . . . 1.0 115.551 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.6 109.09 20.59 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 132' ' ' GLN . 34.1 mt -76.54 121.12 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.073 -2.195 . . . . 1.0 105.073 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.33 125.78 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.506 -2.405 . . . . 1.0 104.506 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.36 113.6 27.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.146 0.978 . . . . 1.0 108.519 -175.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.9 114.31 20.83 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t 83.75 91.62 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.537 1.971 . . . . 1.0 110.357 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.72 -170.37 0.27 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.755 2.303 . . . . 1.0 110.68 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.3 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.243 2.217 . . . . 1.0 115.26 -176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -143.76 123.0 12.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.485 1.914 . . . . 1.0 109.531 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER 86.44 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.22 3.008 . . . . 1.0 111.506 177.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -34.62 138.58 0.1 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.15 2.58 . . . . 1.0 113.04 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.88 -178.83 3.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.554 2.342 . . . . 1.0 111.353 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -150.28 118.73 6.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.241 1.416 . . . . 1.0 108.003 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -167.46 63.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.483 1.135 . . . . 1.0 110.442 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.08 -69.92 0.1 Allowed 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 118.606 -2.559 . . . . 1.0 111.749 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.36 0.33 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 125.187 1.554 . . . . 1.0 110.0 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 t -144.72 145.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.827 1.651 . . . . 1.0 109.899 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 p -165.82 149.54 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.626 1.171 . . . . 1.0 110.573 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.606 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -143.71 132.21 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.788 -1.93 . . . . 1.0 105.788 175.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -159.59 124.26 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.447 1.022 . . . . 1.0 108.313 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 58.79 71.69 0.57 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.41 1.884 . . . . 1.0 113.571 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.38 28.6 44.24 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.527 2.489 . . . . 1.0 113.312 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -147.02 113.22 5.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.36 141.42 28.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -123.95 117.86 25.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 102.997 -2.964 . . . . 1.0 102.997 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.4 t -66.23 -35.13 79.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -145.01 172.1 13.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.787 2.835 . . . . 1.0 106.006 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -84.84 77.11 10.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.413 1.102 . . . . 1.0 108.829 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.75 35.13 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.406 1.882 . . . . 1.0 111.417 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -123.72 153.05 41.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.879 0.872 . . . . 1.0 112.475 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -88.86 57.11 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.534 1.934 . . . . 1.0 107.029 175.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.95 -136.59 1.2 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.947 -1.095 . . . . 1.0 111.74 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.713 HD11 HG11 ' A' ' 136' ' ' VAL . 6.2 mm -142.55 161.47 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 129.329 3.052 . . . . 1.0 103.096 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -134.44 130.13 36.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.309 2.244 . . . . 1.0 105.001 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -101.19 153.03 19.95 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.736 -1.228 . . . . 1.0 108.919 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 158.03 45.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.73 0.776 . . . . 1.0 111.641 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.92 39.53 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.453 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.9 p -146.48 104.0 3.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 103.367 -2.827 . . . . 1.0 103.367 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t0 43.87 49.66 7.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.751 2.02 . . . . 1.0 112.984 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 p 50.31 38.08 16.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.051 2.14 . . . . 1.0 114.191 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.48 136.2 57.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.19 0.04 OUTLIER 'General case' 0 C--N 1.347 0.486 0 C-N-CA 127.373 2.269 . . . . 1.0 110.615 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -78.03 -10.3 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 115.892 -2.004 . . . . 1.0 116.339 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.333 44.8 p 64.74 77.31 0.32 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 121.355 1.889 . . . . 1.0 110.987 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -24.43 -32.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.246 1.818 . . . . 1.0 114.683 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -39.85 -43.67 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.314 1.846 . . . . 1.0 109.231 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -43.71 -50.93 7.45 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.779 1.231 . . . . 1.0 111.668 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.31 -39.81 88.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.458 0.572 . . . . 1.0 111.032 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -61.63 -58.57 7.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.032 0.533 . . . . 1.0 109.667 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.1 mp0 -65.92 -47.12 75.81 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.544 -0.741 . . . . 1.0 111.599 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 115' ' ' ILE . 53.4 tp -54.85 -46.55 74.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.048 1.295 . . . . 1.0 109.34 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.44 96.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.535 1.061 . . . . 1.0 111.416 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.1 50.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.001 0.52 . . . . 1.0 109.654 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 115' ' ' ILE . 98.0 t -52.2 -64.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.533 1.933 . . . . 1.0 108.61 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -53.96 -53.6 50.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.484 1.914 . . . . 1.0 112.209 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -57.85 -41.93 83.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.763 1.165 . . . . 1.0 109.555 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.86 -44.34 70.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.205 -0.935 . . . . 1.0 111.165 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.97 -36.77 70.71 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.12 -1.612 . . . . 1.0 111.458 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 mt -62.1 -35.57 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.01 -1.107 . . . . 1.0 108.01 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -64.96 -13.61 57.88 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.785 1.234 . . . . 1.0 110.774 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -98.63 -65.89 0.93 Allowed 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.158 -1.589 . . . . 1.0 106.981 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -119.41 112.91 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 106.673 -1.603 . . . . 1.0 106.673 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -92.78 108.19 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.649 1.566 . . . . 1.0 112.288 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.05 -49.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.587 1.955 . . . . 1.0 106.583 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.0 mt -48.41 -33.61 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 128.934 2.894 . . . . 1.0 110.829 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.42 12.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.344 1.057 . . . . 1.0 113.395 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.31 18.58 4.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.085 2.154 . . . . 1.0 110.656 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.83 83.62 1.97 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.67 1.188 . . . . 1.0 107.967 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.3 mtt -118.78 120.19 36.63 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.592 -1.633 . . . . 1.0 106.592 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -155.26 -169.57 3.2 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.27 -0.894 . . . . 1.0 110.339 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.03 -131.19 1.51 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -113.39 -23.51 9.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.362 1.081 . . . . 1.0 111.791 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -11.16 18.56 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -91.36 38.92 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.742 1.156 . . . . 1.0 108.489 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.07 -12.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 120.295 -1.503 . . . . 1.0 110.267 175.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -157.8 -54.39 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.546 1.939 . . . . 1.0 111.088 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 62.7 Cg_endo -87.38 117.94 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.293 1.996 . . . . 1.0 113.395 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.85 -24.29 61.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.271 -0.893 . . . . 1.0 111.785 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -57.49 -19.35 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.64 2.376 . . . . 1.0 112.087 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.98 141.44 38.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.748 -1.575 . . . . 1.0 106.748 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -130.91 -16.72 3.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.898 1.226 . . . . 1.0 109.831 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.98 179.88 0.36 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 129.844 3.257 . . . . 1.0 104.772 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.33 79.75 3.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.149 1.899 . . . . 1.0 108.423 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.15 59.26 0.53 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.389 -1.229 . . . . 1.0 115.251 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 -52.3 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.069 2.435 . . . . 1.0 112.357 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.0 t 54.07 43.62 30.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.197 1.399 . . . . 1.0 111.866 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CD2' HG11 ' A' ' 33' ' ' VAL 0.253 83.5 t80 -107.27 18.34 21.76 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.986 1.847 . . . . 1.0 115.986 -175.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.327 5.8 t70 42.05 75.0 0.1 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.424 1.49 . . . . 1.0 113.625 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -50.18 -35.34 25.84 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.64 79.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.861 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -51.28 68.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.849 1.204 . . . . 1.0 109.651 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 66.5 t80 -63.22 -52.82 60.67 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.825 0.306 . . . . 1.0 111.825 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -63.74 -26.65 68.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.265 -0.897 . . . . 1.0 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.11 88.65 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 1.0 109.992 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.29 -61.21 1.85 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.677 1.591 . . . . 1.0 111.7 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 94.6 t -66.26 165.77 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.3 1.04 . . . . 1.0 110.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 54.4 m . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 125.331 1.453 . . . . 1.0 110.717 175.768 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.718 -1.215 . . . . 1.0 107.718 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 156.53 32.69 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.515 0.726 . . . . 1.0 110.24 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 38.7 58.08 1.74 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.133 2.173 . . . . 1.0 111.304 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.95 143.83 23.73 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.424 -0.797 . . . . 1.0 111.341 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -82.34 124.23 29.8 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.027 1.331 . . . . 1.0 108.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.57 119.23 24.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 t -142.18 75.34 20.25 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.011 1.324 . . . . 1.0 108.198 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 123.58 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.516 1.478 . . . . 1.0 112.673 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -49.8 146.08 7.99 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.434 1.894 . . . . 1.0 111.92 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.76 -37.42 6.8 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 N-CA-C 114.734 1.013 . . . . 1.0 114.734 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -151.48 135.67 16.73 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -104.28 -170.88 1.83 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.553 1.141 . . . . 1.0 109.675 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.69 178.95 5.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.283 2.633 . . . . 1.0 111.61 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.1 m -140.92 153.95 45.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 129.522 3.129 . . . . 1.0 104.993 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -131.16 157.03 79.27 Favored Pre-proline 0 N--CA 1.467 0.377 0 O-C-N 120.918 -1.114 . . . . 1.0 109.444 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.31 51.08 2.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.072 2.515 . . . . 1.0 111.883 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -148.6 153.63 38.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 126.305 1.842 . . . . 1.0 109.988 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.72 103.2 3.76 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -137.0 164.65 27.85 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.734 -0.603 . . . . 1.0 109.431 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.87 123.8 78.98 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.438 1.895 . . . . 1.0 108.068 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.27 103.48 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 N-CA-C 108.318 -1.455 . . . . 1.0 108.318 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 t -165.09 67.67 0.13 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.37 129.58 22.22 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -95.13 128.64 42.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.959 -1.867 . . . . 1.0 105.959 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.17 140.11 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.31 114.2 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -169.61 133.6 1.31 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.81 113.57 8.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.105 -1.443 . . . . 1.0 107.105 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.4 mm -126.41 177.06 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 127.741 2.416 . . . . 1.0 107.623 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -155.5 121.72 5.17 Favored 'General case' 0 C--N 1.316 -0.871 1 N-CA-C 95.421 -5.77 . . . . 1.0 95.421 173.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HD2' ' A' ' 39' ' ' PRO 0.324 0.5 OUTLIER -141.44 -61.45 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 119.119 0.872 . . . . 1.0 111.336 175.848 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 61.3 Cg_endo -79.77 157.79 24.53 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.676 2.25 . . . . 1.0 112.024 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.15 -0.23 10.57 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-O 114.159 -2.517 . . . . 1.0 115.172 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -11.79 -71.05 0.01 OUTLIER Glycine 0 C--N 1.352 1.44 0 C-N-CA 127.278 2.37 . . . . 1.0 113.36 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -155.02 122.97 5.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.345 1.858 . . . . 1.0 109.05 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -175.77 175.42 2.03 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 130.009 3.324 . . . . 1.0 107.614 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.31 6.96 24.89 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.235 1.398 . . . . 1.0 112.83 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.41 118.5 6.2 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.533 1.666 . . . . 1.0 109.951 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.73 -13.08 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.261 1.974 . . . . 1.0 114.386 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -62.01 -35.94 80.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.399 1.454 . . . . 1.0 110.928 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -64.18 -47.03 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.061 0.944 . . . . 1.0 109.238 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -34.74 78.88 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.482 -0.761 . . . . 1.0 112.126 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.8 -33.78 50.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.132 1.373 . . . . 1.0 111.625 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.69 -55.92 28.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.965 1.306 . . . . 1.0 110.259 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 39' ' ' PRO . 42.0 m-85 -71.31 -40.74 70.64 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 126.649 1.98 . . . . 1.0 112.969 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.0 -33.32 75.55 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.222 -0.924 . . . . 1.0 109.538 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.56 24.86 10.51 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 118.698 -1.057 . . . . 1.0 113.525 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -121.46 16.63 11.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.185 1.492 . . . . 1.0 111.575 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.7 135.27 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.408 1.083 . . . . 1.0 110.758 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.95 136.59 20.56 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.199 1.8 . . . . 1.0 109.095 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.78 56.87 3.01 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.798 2.999 . . . . 1.0 113.204 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -103.47 -49.65 3.65 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.586 0.958 . . . . 1.0 113.586 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.93 -60.62 2.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.972 0.805 . . . . 1.0 112.674 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 22.7 p80 -170.53 177.79 0.95 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.558 1.543 . . . . 1.0 107.477 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 16.8 Cg_endo -72.85 -43.53 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.304 1.336 . . . . 1.0 114.996 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -50.77 -59.11 4.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.954 1.252 . . . . 1.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 1.6 t80 -60.12 -49.83 76.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 1.0 110.251 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.68 90.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.818 0.847 . . . . 1.0 111.108 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.14 -63.63 4.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.048 1.785 . . . . 1.0 110.075 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.89 -26.83 41.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 116.408 -1.758 . . . . 1.0 112.947 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -42.98 3.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.105 1.762 . . . . 1.0 114.729 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -52.49 -39.08 60.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.572 1.549 . . . . 1.0 110.871 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.78 136.28 33.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' CD ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.06 161.26 22.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.416 -0.802 . . . . 1.0 109.035 175.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.49 164.39 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.896 1.279 . . . . 1.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.7 m -169.52 118.05 0.63 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.909 1.284 . . . . 1.0 108.332 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.61 -174.48 3.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.79 1.236 . . . . 1.0 109.052 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -112.17 -73.64 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.242 1.017 . . . . 1.0 111.628 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.02 118.74 27.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 103.66 -2.719 . . . . 1.0 103.66 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tp -104.23 113.34 26.82 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.264 -2.865 . . . . 1.0 103.264 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.03 113.49 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 105.644 -1.984 . . . . 1.0 105.644 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -85.37 149.22 25.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.115 0.87 . . . . 1.0 110.399 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -46.82 -13.85 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 128.418 2.687 . . . . 1.0 115.547 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.89 27.98 1.95 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.929 1.291 . . . . 1.0 112.711 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.3 28.96 70.14 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.584 1.564 . . . . 1.0 114.484 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.48 153.05 20.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.299 1.05 . . . . 1.0 111.502 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.45 114.08 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 104.668 -2.345 . . . . 1.0 104.668 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 145.69 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -124.3 115.49 21.11 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.947 0.899 . . . . 1.0 110.403 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -110.38 129.8 55.69 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 127.828 2.451 . . . . 1.0 105.525 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' A' ' 19' ' ' TYR . 16.6 t 63.4 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 121.985 2.175 . . . . 1.0 115.148 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -64.1 -174.11 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 121.658 1.572 . . . . 1.0 111.423 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -67.18 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.57 1.948 . . . . 1.0 114.372 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -140.84 111.53 6.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.734 2.014 . . . . 1.0 108.482 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 84.05 81.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.421 2.289 . . . . 1.0 109.976 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -37.33 146.28 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.675 3.19 . . . . 1.0 111.469 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -104.14 -178.35 3.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.859 1.264 . . . . 1.0 111.674 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -141.78 118.6 11.12 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.2 63.16 0.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.852 1.31 . . . . 1.0 107.964 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.24 -69.04 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 119.224 -2.172 . . . . 1.0 114.454 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.96 -85.67 0.4 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 103.203 -3.959 . . . . 1.0 103.203 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.21 146.45 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 119.797 1.799 . . . . 1.0 110.502 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.5 p -155.84 155.77 33.52 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.055 1.742 . . . . 1.0 108.096 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.484 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -147.99 132.32 17.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.094 -1.817 . . . . 1.0 106.094 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -160.63 156.93 26.35 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.228 0.611 . . . . 1.0 109.565 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 39.13 53.65 2.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.4 1.48 . . . . 1.0 112.251 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.21 28.26 18.36 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.298 2.856 . . . . 1.0 114.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -129.86 121.4 26.63 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 119.619 1.709 . . . . 1.0 107.058 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -92.62 141.96 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -116.35 118.52 32.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.8 -1.556 . . . . 1.0 106.8 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.5 t -55.69 -38.83 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.815 0.846 . . . . 1.0 110.09 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -152.98 164.79 37.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.997 2.919 . . . . 1.0 105.019 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.28 76.71 10.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 122.584 1.183 . . . . 1.0 111.154 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.85 43.42 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.894 2.478 . . . . 1.0 108.542 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 m -123.29 156.79 34.57 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.391 1.876 . . . . 1.0 111.434 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -96.54 57.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.705 2.002 . . . . 1.0 107.92 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.13 -136.96 1.65 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.983 -1.073 . . . . 1.0 112.033 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 133' ' ' LEU . 4.8 mt -152.29 164.88 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 131.512 3.925 . . . . 1.0 102.36 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -144.86 143.1 30.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.053 2.141 . . . . 1.0 105.277 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -101.46 155.39 18.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.824 -1.173 . . . . 1.0 110.303 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -131.43 138.87 49.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.33 -172.73 39.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.353 0.978 . . . . 1.0 110.906 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -133.78 92.46 2.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.578 -0.954 . . . . 1.0 108.628 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.4 t0 54.34 56.97 6.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.471 1.508 . . . . 1.0 113.49 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 16.5 p 60.91 38.42 17.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.181 1.792 . . . . 1.0 113.605 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.6 132.02 47.26 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.29 -2.485 . . . . 1.0 104.29 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -30.32 115.03 0.12 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.387 1.875 . . . . 1.0 110.536 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -78.09 -2.45 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 114.943 -2.456 . . . . 1.0 116.975 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.341 42.4 p 67.39 78.05 0.25 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 115.727 -2.083 . . . . 1.0 111.374 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -24.23 -34.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 121.596 1.998 . . . . 1.0 116.157 177.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.75 14.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.163 2.185 . . . . 1.0 110.333 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -49.15 -50.55 37.07 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 125.077 1.351 . . . . 1.0 109.826 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -60.87 -40.63 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.832 -0.604 . . . . 1.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -65.38 -47.88 74.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.354 0.524 . . . . 1.0 111.061 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.89 -54.04 31.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.451 1.1 . . . . 1.0 110.254 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 115' ' ' ILE . 14.5 tp -54.5 -46.47 73.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.122 1.369 . . . . 1.0 108.805 175.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.46 87.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.934 1.243 . . . . 1.0 111.664 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.64 54.24 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.7 -53.11 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.623 -0.703 . . . . 1.0 109.365 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.4 m -55.38 -61.31 2.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.403 1.881 . . . . 1.0 111.059 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -53.75 -43.08 68.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.606 0.717 . . . . 1.0 110.878 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.009 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 mt -56.76 -36.93 70.38 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.087 -1.633 . . . . 1.0 111.373 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.04 -31.88 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.655 1.182 . . . . 1.0 109.727 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m -64.26 -16.88 62.96 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.88 0.764 . . . . 1.0 111.006 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -65.15 0.98 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 120.664 -1.272 . . . . 1.0 108.274 175.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -110.29 112.84 56.92 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 108.004 -1.109 . . . . 1.0 108.004 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -104.07 108.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 119.697 0.927 . . . . 1.0 111.372 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.15 -51.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.097 2.559 . . . . 1.0 105.912 174.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -45.2 -33.51 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 1 C-N-CA 131.82 4.048 . . . . 1.0 110.013 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.15 -25.54 0.91 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.59 18.97 4.29 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.582 2.353 . . . . 1.0 111.133 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.75 84.29 2.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.88 1.272 . . . . 1.0 109.687 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 116.58 21.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.03 -1.841 . . . . 1.0 106.03 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 -173.25 4.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.846 0.748 . . . . 1.0 109.852 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.31 -131.06 2.64 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 106.696 -2.562 . . . . 1.0 106.696 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -112.71 -23.87 9.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.59 0.756 . . . . 1.0 111.215 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 t -102.89 -17.05 15.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.615 1.166 . . . . 1.0 111.081 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -85.12 40.3 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.338 1.426 . . . . 1.0 109.196 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -69.71 -9.2 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 O-C-N 120.744 -1.222 . . . . 1.0 109.019 175.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.13 -53.52 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.001 2.52 . . . . 1.0 111.538 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -96.42 121.61 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.852 2.368 . . . . 1.0 114.217 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.51 -17.09 63.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.564 -1.335 . . . . 1.0 112.141 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -24.93 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.115 -0.991 . . . . 1.0 111.48 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -144.31 123.77 13.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.475 -2.046 . . . . 1.0 105.475 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.2 m -114.16 -16.29 12.1 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.402 0.438 . . . . 1.0 112.045 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.24 171.46 1.06 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 128.446 2.698 . . . . 1.0 104.755 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 87.34 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.308 2.006 . . . . 1.0 109.747 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.74 75.42 0.68 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.143 1.83 . . . . 1.0 110.996 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.14 -95.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.736 2.291 . . . . 1.0 110.024 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 54.3 43.64 30.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.188 2.595 . . . . 1.0 111.0 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -97.53 18.58 15.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.348 0.659 . . . . 1.0 111.94 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.4 t0 44.88 67.22 0.74 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.745 1.218 . . . . 1.0 111.803 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.19 -25.51 59.14 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.706 -0.621 . . . . 1.0 112.474 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -55.75 15.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 117.794 -1.098 . . . . 1.0 109.605 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -62.4 -42.84 99.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 117.312 -1.328 . . . . 1.0 110.547 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -61.41 -52.67 63.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.108 1.322 . . . . 1.0 110.881 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.36 77.78 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.16 86.96 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.68 -54.8 14.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.79 1.636 . . . . 1.0 111.007 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.8 160.09 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.133 0.973 . . . . 1.0 109.098 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 126.51 1.924 . . . . 1.0 105.89 175.162 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.33 173.86 8.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.605 0.762 . . . . 1.0 111.042 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 40.04 57.75 2.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.721 2.408 . . . . 1.0 109.993 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.14 153.6 20.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -81.68 130.15 34.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -83.55 118.64 23.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -138.48 88.74 14.27 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.11 123.82 11.41 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 N-CA-C 109.333 -1.064 . . . . 1.0 109.333 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -63.64 146.53 96.65 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.05 -25.29 19.55 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 N-CA-C 117.393 2.036 . . . . 1.0 117.393 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -150.82 117.89 5.93 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.841 -1.911 . . . . 1.0 105.841 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' VAL . 3.3 m-85 -86.92 178.17 7.04 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.084 0.954 . . . . 1.0 112.543 -175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.38 178.99 4.09 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.931 1.693 . . . . 1.0 111.859 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.3 m -164.94 127.46 2.22 Favored 'General case' 0 CA--C 1.534 0.354 1 C-N-CA 133.356 4.662 . . . . 1.0 103.184 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -131.33 153.78 81.74 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.699 1.136 . . . . 1.0 108.614 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.92 67.67 8.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.104 3.203 . . . . 1.0 110.804 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.48 159.5 42.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.632 1.573 . . . . 1.0 110.734 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -150.91 103.92 3.11 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -137.25 176.48 8.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -84.48 123.0 75.2 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.792 -1.559 . . . . 1.0 106.792 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.26 103.02 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 N-CA-C 108.3 -1.462 . . . . 1.0 108.3 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 t -175.76 69.05 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 150' ' ' ASN . 26.6 tp -147.9 130.45 15.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.99 0.916 . . . . 1.0 108.705 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.476 HD11 HD11 ' A' ' 133' ' ' LEU . 15.7 tp -84.38 124.52 31.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.28 114.04 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 169' ' ' PHE . 87.8 t -114.22 113.93 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -163.54 143.58 8.63 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.545 -2.021 . . . . 1.0 105.545 175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 8.0 mm -127.59 176.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 130.835 3.654 . . . . 1.0 107.851 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -160.28 121.78 3.12 Favored 'General case' 0 N--CA 1.432 -1.365 1 N-CA-C 97.829 -4.878 . . . . 1.0 97.829 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.652 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 4.8 tt -142.57 -43.9 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.398 -1.763 . . . . 1.0 112.941 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 44.7 Cg_endo -82.99 150.31 13.93 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 121.662 1.629 . . . . 1.0 114.833 -175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 7.38 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.843 3.028 . . . . 1.0 116.777 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -23.49 -71.3 0.01 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 121.059 1.754 . . . . 1.0 112.525 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -156.6 123.21 5.09 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.291 14.1 m-85 -177.76 153.94 0.9 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 129.649 3.18 . . . . 1.0 109.862 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.31 2.09 77.75 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.05 -0.861 . . . . 1.0 112.885 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.85 118.54 5.51 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.01 -4.05 14.45 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.373 2.049 . . . . 1.0 113.213 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' CZ2' ' CD1' ' A' ' 64' ' ' PHE . 32.6 t-105 -64.55 -39.55 93.97 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.598 1.09 . . . . 1.0 110.305 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 38' ' ' LEU . 5.8 mt -65.86 -46.63 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.568 1.947 . . . . 1.0 109.274 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.63 -46.37 89.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.861 0.755 . . . . 1.0 110.552 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.2 -34.06 63.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.236 1.414 . . . . 1.0 111.39 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.27 -54.79 27.7 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.195 0.452 . . . . 1.0 110.524 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -70.1 -42.5 72.62 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 119.014 -0.517 . . . . 1.0 112.297 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.16 -34.23 77.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.33 1.052 . . . . 1.0 109.049 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.21 -0.47 31.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.367 1.46 . . . . 1.0 115.681 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.3 p -88.99 11.19 18.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.057 1.928 . . . . 1.0 112.934 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.566 HG21 ' CB ' ' A' ' 68' ' ' ALA . 10.8 tt -51.63 135.9 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.108 1.763 . . . . 1.0 112.793 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -98.62 131.31 26.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 127.446 2.299 . . . . 1.0 109.29 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.2 63.01 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.68 3.587 . . . . 1.0 110.184 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -104.54 -65.93 1.0 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.407 1.883 . . . . 1.0 113.15 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.35 -54.76 15.55 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.69 1.196 . . . . 1.0 110.714 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.2 p80 -171.32 177.82 0.87 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.685 1.994 . . . . 1.0 106.766 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.4 Cg_endo -72.49 -43.63 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.494 1.462 . . . . 1.0 114.033 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -50.84 -57.6 8.03 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HD1' HD11 ' A' ' 56' ' ' ILE . 20.8 t80 -59.27 -44.96 92.4 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.205 0.602 . . . . 1.0 111.475 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.67 97.94 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.831 -0.543 . . . . 1.0 111.324 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.68 -60.81 8.23 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.827 1.203 . . . . 1.0 112.026 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.2 pt -51.0 -41.48 22.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.798 1.239 . . . . 1.0 112.96 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' A' ' 56' ' ' ILE . . . -38.01 -43.53 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 127.901 2.48 . . . . 1.0 115.158 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -60.8 -35.58 76.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.449 0.7 . . . . 1.0 110.423 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.77 135.75 33.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 153.46 32.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.377 -0.929 . . . . 1.0 110.05 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.54 163.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.165 1.386 . . . . 1.0 108.671 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 88' ' ' VAL . 2.4 m -170.67 128.04 0.78 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.306 -1.739 . . . . 1.0 106.306 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.17 -154.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.461 -1.681 . . . . 1.0 106.461 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -124.63 -58.55 1.5 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.879 1.672 . . . . 1.0 110.0 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HB2' HD13 ' A' ' 115' ' ' ILE . 68.0 m -142.65 121.35 12.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.53 113.93 21.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.385 1.474 . . . . 1.0 107.853 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.3 mt -97.55 116.59 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.711 1.204 . . . . 1.0 108.078 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -78.92 153.35 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.345 1.884 . . . . 1.0 109.574 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.621 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -46.87 -23.23 0.41 Allowed 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.711 2.004 . . . . 1.0 114.259 176.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.621 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . 18.3 t0 -91.42 34.61 0.95 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.225 0.921 . . . . 1.0 110.478 -175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.08 29.56 71.33 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.109 -0.995 . . . . 1.0 113.868 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.53 140.67 32.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.01 114.07 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 103.838 -2.653 . . . . 1.0 103.838 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 t -111.67 139.6 35.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.362 0.665 . . . . 1.0 109.514 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -104.87 118.83 37.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -117.65 113.34 21.76 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 103.239 -2.874 . . . . 1.0 103.239 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 19' ' ' TYR . 48.1 t 69.2 91.8 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.31 1.414 . . . . 1.0 112.332 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -66.88 -168.25 0.15 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.471 2.114 . . . . 1.0 111.669 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -60.71 22.76 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 129.378 3.071 . . . . 1.0 116.811 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -159.69 133.49 7.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.972 1.714 . . . . 1.0 107.865 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 tptm 86.29 82.14 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 129.453 3.101 . . . . 1.0 109.665 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.12 147.5 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.991 3.317 . . . . 1.0 115.425 -174.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.07 175.95 5.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.342 3.057 . . . . 1.0 111.076 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -156.12 118.19 4.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.074 1.75 . . . . 1.0 107.343 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.9 63.22 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.287 -1.508 . . . . 1.0 112.318 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.14 -62.79 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.202 -2.186 . . . . 1.0 114.358 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.32 -91.4 0.47 Allowed Glycine 0 CA--C 1.53 1.005 0 N-CA-C 103.608 -3.797 . . . . 1.0 103.608 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.84 146.4 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.807 1.803 . . . . 1.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -154.77 166.51 33.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.479 1.511 . . . . 1.0 110.312 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.43 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -150.9 146.83 26.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.4 1.48 . . . . 1.0 110.745 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.54 133.88 21.81 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.832 -0.543 . . . . 1.0 110.054 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 39.36 65.77 0.65 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.74 2.016 . . . . 1.0 111.367 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 29.26 67.21 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.089 1.196 . . . . 1.0 116.089 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -130.55 136.25 48.73 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.854 -1.906 . . . . 1.0 105.854 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.05 146.83 28.55 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.529 2.332 . . . . 1.0 111.931 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -127.42 118.35 23.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.763 1.225 . . . . 1.0 107.814 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -79.68 -23.42 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.469 0.708 . . . . 1.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -144.97 175.22 10.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.863 2.065 . . . . 1.0 106.547 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -101.2 76.73 1.74 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.55 33.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.011 2.124 . . . . 1.0 113.72 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -129.37 138.98 51.84 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 121.201 -0.937 . . . . 1.0 111.491 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.257 0.1 OUTLIER -78.54 56.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.931 2.092 . . . . 1.0 109.798 -177.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.6 -136.4 1.39 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 122.289 0.939 . . . . 1.0 111.247 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 136' ' ' VAL . 8.5 mm -144.02 166.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 130.151 3.38 . . . . 1.0 103.144 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -143.43 136.85 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 103.222 -2.881 . . . . 1.0 103.222 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -98.81 134.28 41.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.166 -0.959 . . . . 1.0 109.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 24.3 tt0 -105.61 138.28 42.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.806 0.812 . . . . 1.0 110.285 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.47 40.11 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.47 1.986 . . . . 1.0 109.41 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -153.28 116.18 4.53 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.32 39.7 30.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.865 1.316 . . . . 1.0 112.194 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p 45.08 37.73 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.293 2.237 . . . . 1.0 112.529 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.04 136.69 58.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.66 113.38 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.695 2.398 . . . . 1.0 112.618 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -78.67 -16.2 57.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 116.554 -1.689 . . . . 1.0 112.876 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.359 10.3 p 66.51 77.54 0.28 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 121.183 1.81 . . . . 1.0 112.118 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.25 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.699 2.045 . . . . 1.0 115.25 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.12 -36.92 3.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 1.0 109.354 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -56.41 -58.49 7.77 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 125.564 1.546 . . . . 1.0 107.559 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -52.79 -44.73 66.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.263 0.938 . . . . 1.0 110.075 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -66.16 -58.15 6.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.549 0.74 . . . . 1.0 111.947 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -66.3 -34.33 77.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.503 1.047 . . . . 1.0 112.09 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 115' ' ' ILE . 9.2 tp -61.14 -44.56 97.13 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 106.962 -1.495 . . . . 1.0 106.962 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.5 80.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.134 -0.936 . . . . 1.0 110.412 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.99 -55.35 35.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.447 1.021 . . . . 1.0 109.972 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 115' ' ' ILE . 57.6 t -54.33 -49.18 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 1.0 109.338 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.1 m -58.38 -53.89 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.594 1.158 . . . . 1.0 109.873 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -56.09 -43.67 78.25 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.914 1.285 . . . . 1.0 110.478 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.62 63.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.12 0.568 . . . . 1.0 111.713 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -56.56 -34.57 67.24 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 117.918 -1.039 . . . . 1.0 111.264 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.28 -43.38 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 120.159 1.345 . . . . 1.0 109.144 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.5 m -64.43 -23.1 67.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.854 0.752 . . . . 1.0 111.524 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -83.77 -58.55 2.75 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.788 -1.195 . . . . 1.0 108.438 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.61 113.15 22.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.549 1.54 . . . . 1.0 109.104 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.54 107.78 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 CA-C-N 120.857 1.342 . . . . 1.0 111.867 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.23 -51.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.014 2.125 . . . . 1.0 107.798 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.4 mt -45.16 -33.4 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 131.508 3.923 . . . . 1.0 111.078 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.99 -23.42 5.08 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.222 1.009 . . . . 1.0 113.541 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -140.52 30.75 1.9 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.687 2.395 . . . . 1.0 109.089 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.549 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.7 m120 -140.7 83.78 1.91 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.367 1.867 . . . . 1.0 110.311 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.57 116.65 16.15 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 126.661 1.984 . . . . 1.0 105.718 175.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 HD11 ' A' ' 30' ' ' LEU . 10.6 t -151.69 -173.2 4.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.98 -131.52 2.29 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 105.604 -2.998 . . . . 1.0 105.604 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.306 9.5 m-70 -112.98 -22.28 10.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.867 1.267 . . . . 1.0 111.311 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.02 -11.25 17.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.493 0.588 . . . . 1.0 109.807 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -86.57 36.41 0.7 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.632 1.105 . . . . 1.0 108.532 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -67.8 -12.07 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 120.399 -1.438 . . . . 1.0 109.859 175.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.06 -66.01 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.74 2.416 . . . . 1.0 111.16 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 95.3 Cg_endo -92.65 127.89 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.275 1.983 . . . . 1.0 114.075 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.46 -26.25 65.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.938 1.295 . . . . 1.0 112.615 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -63.13 -21.66 66.34 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.856 1.263 . . . . 1.0 111.774 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 138.92 53.29 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 105.174 -2.158 . . . . 1.0 105.174 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -132.39 -16.63 2.7 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 118.868 -1.133 . . . . 1.0 110.844 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -179.27 0.35 Allowed Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 129.171 2.989 . . . . 1.0 104.292 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.29 52.23 4.2 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 122.543 2.162 . . . . 1.0 112.5 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.72 73.24 0.12 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.005 1.764 . . . . 1.0 112.538 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.15 -63.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.46 2.106 . . . . 1.0 111.955 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.7 t 54.46 43.8 29.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.932 2.093 . . . . 1.0 110.446 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 33' ' ' VAL . 58.2 t80 -94.02 18.25 10.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -175.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.72 71.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.942 1.297 . . . . 1.0 112.858 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -54.78 -32.28 59.87 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 115.154 -0.93 . . . . 1.0 112.634 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.06 71.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.356 -0.83 . . . . 1.0 110.148 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -61.66 -55.96 24.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.399 0.999 . . . . 1.0 110.74 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.86 -51.28 70.4 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.727 1.751 . . . . 1.0 115.727 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -39.11 84.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.137 0.881 . . . . 1.0 109.279 -175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.39 78.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.566 0.95 . . . . 1.0 113.566 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.12 -45.33 92.5 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.352 1.461 . . . . 1.0 114.068 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.34 160.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.238 0.469 0 C-N-CA 125.869 1.668 . . . . 1.0 106.554 175.308 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' N ' HE22 ' A' ' 86' ' ' GLN . 4.1 tt . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 106.112 -1.811 . . . . 1.0 106.112 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 165.91 23.3 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.556 0.743 . . . . 1.0 112.239 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 42.28 58.46 2.99 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.815 1.646 . . . . 1.0 109.046 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.49 145.94 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.656 1.183 . . . . 1.0 109.683 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -76.08 123.15 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.45 118.96 30.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.906 0.775 . . . . 1.0 109.027 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.19 73.52 81.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.3 123.92 11.11 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.724 1.616 . . . . 1.0 108.812 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -137.53 113.51 9.38 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 126.566 1.947 . . . . 1.0 106.949 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.25 58.8 7.11 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.275 1.983 . . . . 1.0 110.845 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -123.73 43.53 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.925 1.69 . . . . 1.0 106.709 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.487 ' CD1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -82.82 179.28 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.385 1.474 . . . . 1.0 110.374 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.3 178.57 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.666 1.586 . . . . 1.0 109.031 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.4 m -150.55 131.64 14.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.865 2.466 . . . . 1.0 105.121 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.26 149.28 72.11 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 108.258 -1.015 . . . . 1.0 108.258 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.04 97.38 1.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 N-CA-C 106.601 -2.115 . . . . 1.0 106.601 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -162.6 147.95 12.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -146.73 108.07 4.25 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.979 0.809 . . . . 1.0 109.699 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -136.2 160.24 39.29 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 127.399 2.28 . . . . 1.0 106.952 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -69.36 123.4 88.28 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.59 103.0 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.626 -1.336 . . . . 1.0 108.626 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -175.9 70.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.07 127.35 13.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 105.091 -2.188 . . . . 1.0 105.091 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.31 129.37 41.01 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.9 139.53 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 105.976 -1.861 . . . . 1.0 105.976 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.84 122.9 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -171.07 150.22 3.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.275 1.43 . . . . 1.0 107.357 175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -95.3 111.9 23.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mm -127.37 176.4 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 128.333 2.653 . . . . 1.0 107.59 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 t -148.89 122.18 8.99 Favored 'General case' 0 C--O 1.247 0.938 1 N-CA-C 94.825 -5.991 . . . . 1.0 94.825 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.338 0.4 OUTLIER -142.57 -65.15 0.02 OUTLIER Pre-proline 0 C--O 1.222 -0.347 0 CA-C-O 117.823 -1.084 . . . . 1.0 113.316 178.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.81 162.25 9.09 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.822 3.015 . . . . 1.0 115.523 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.58 28.83 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.831 3.021 . . . . 1.0 114.973 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -40.87 -71.42 0.31 Allowed Glycine 0 C--N 1.35 1.339 0 CA-C-N 120.78 1.627 . . . . 1.0 109.312 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 23.4 mt-10 -156.31 123.48 5.34 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.648 2.379 . . . . 1.0 107.124 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -176.89 176.95 1.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 131.366 3.866 . . . . 1.0 108.098 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.67 4.95 8.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.316 1.436 . . . . 1.0 111.603 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.61 136.56 14.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.368 1.584 . . . . 1.0 110.497 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.32 -16.99 15.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.828 2.352 . . . . 1.0 113.782 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -54.32 -39.9 67.46 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.528 1.058 . . . . 1.0 111.556 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.3 mt -64.99 -48.73 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.352 1.061 . . . . 1.0 109.047 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.55 -49.65 76.69 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.02 -34.68 68.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.942 0.897 . . . . 1.0 111.727 -176.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.92 -49.31 68.44 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.151 0.98 . . . . 1.0 110.26 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -70.41 -48.27 56.87 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.257 0.623 . . . . 1.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.14 -37.47 85.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.305 1.842 . . . . 1.0 109.955 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.24 1.65 28.1 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.222 1.391 . . . . 1.0 115.357 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -89.08 9.89 23.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.322 2.061 . . . . 1.0 113.045 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.81 136.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.142 1.777 . . . . 1.0 113.116 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.88 122.7 51.94 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.87 2.468 . . . . 1.0 109.375 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.56 58.77 5.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.032 3.155 . . . . 1.0 111.016 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.09 -54.72 2.56 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 117.752 -1.118 . . . . 1.0 111.914 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.65 -51.15 61.39 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.59 1.087 . . . . 1.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 20.8 p80 -170.4 178.02 0.93 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.701 2.0 . . . . 1.0 107.032 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 25.4 Cg_endo -75.95 -43.31 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.36 1.373 . . . . 1.0 114.125 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -42.41 -47.54 4.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.886 1.675 . . . . 1.0 113.758 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.81 -55.45 34.7 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.839 1.256 . . . . 1.0 109.6 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.0 95.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.265 1.426 . . . . 1.0 110.733 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.61 -64.11 1.96 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 127.048 2.261 . . . . 1.0 111.874 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 pt -61.42 -32.66 53.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 117.243 -1.36 . . . . 1.0 112.661 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.0 -43.12 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.004 2.224 . . . . 1.0 117.004 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.55 -33.83 73.25 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.489 -0.757 . . . . 1.0 110.33 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.88 135.37 33.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' NE ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.17 162.67 19.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 175.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.48 158.54 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 124.513 1.125 . . . . 1.0 108.691 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.4 m -175.44 125.28 0.24 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.042 1.337 . . . . 1.0 108.887 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.18 -168.8 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 174.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -113.22 -76.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.643 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.2 m -124.03 118.41 26.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.86 113.69 27.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.081 -2.192 . . . . 1.0 105.081 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.7 mt -99.26 113.4 34.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ttp85 -85.28 153.4 22.61 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.54 -1.282 . . . . 1.0 107.54 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -48.65 -20.24 0.44 Allowed 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.543 1.937 . . . . 1.0 115.266 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.68 28.24 1.82 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.104 0.962 . . . . 1.0 112.442 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.83 30.04 71.89 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.297 1.903 . . . . 1.0 113.766 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.68 113.08 25.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.674 0.79 . . . . 1.0 110.474 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.38 120.97 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 104.822 -2.288 . . . . 1.0 104.822 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.43 149.08 14.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.666 -2.346 . . . . 1.0 104.666 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.414 HE22 ' N ' ' A' ' 8' ' ' LEU . 8.9 tt0 -126.12 122.1 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.731 0.812 . . . . 1.0 110.818 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -121.21 129.51 53.24 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 128.856 2.862 . . . . 1.0 103.922 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 73' ' ' SER . 3.8 t 64.42 91.72 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 CA-C-N 121.684 2.038 . . . . 1.0 113.753 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -66.44 -170.43 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.515 2.143 . . . . 1.0 113.396 177.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.09 15.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.455 2.702 . . . . 1.0 115.099 -175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -137.87 116.69 12.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.329 2.252 . . . . 1.0 108.021 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 tttt 78.86 81.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 128.288 2.635 . . . . 1.0 107.554 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.28 150.78 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 130.266 3.426 . . . . 1.0 113.67 -175.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.28 -178.24 3.6 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.993 2.117 . . . . 1.0 110.104 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -147.88 118.9 7.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.175 1.352 . . . . 1.0 110.34 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.49 63.06 0.17 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.728 1.251 . . . . 1.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.26 -54.89 0.07 Allowed 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 118.76 -2.463 . . . . 1.0 114.354 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.81 -74.83 1.12 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.029 -2.028 . . . . 1.0 108.029 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.8 t -149.26 135.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.605 1.703 . . . . 1.0 110.933 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -166.98 149.24 6.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.202 1.801 . . . . 1.0 109.789 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.69 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -134.03 146.45 50.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 128.374 2.669 . . . . 1.0 110.785 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -150.17 142.61 24.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 39.13 53.81 2.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.507 1.523 . . . . 1.0 112.802 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.01 29.16 70.14 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.374 -0.681 . . . . 1.0 114.751 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -130.11 113.8 14.95 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.444 -1.688 . . . . 1.0 106.444 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -93.49 146.7 23.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.776 1.23 . . . . 1.0 107.721 175.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.5 mtm-85 -112.29 118.58 35.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.849 1.26 . . . . 1.0 108.076 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.51 -30.11 71.14 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.807 0.692 . . . . 1.0 110.338 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -146.03 170.14 17.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.516 1.126 . . . . 1.0 108.192 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.91 76.89 8.79 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.208 1.004 . . . . 1.0 109.485 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.95 33.8 1.3 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.054 1.341 . . . . 1.0 112.415 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -127.89 156.47 42.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.08 1.352 . . . . 1.0 112.628 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.08 56.83 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.832 2.053 . . . . 1.0 109.089 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.22 -136.78 3.84 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.05 -1.031 . . . . 1.0 112.385 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 76' ' ' CYS . 12.3 mm -145.15 165.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.44 2.696 . . . . 1.0 104.549 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.49 138.55 26.2 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.492 -2.41 . . . . 1.0 104.492 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.8 151.38 22.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.897 0.771 . . . . 1.0 110.52 176.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -130.43 138.93 50.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.294 0.568 . . . . 1.0 111.064 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.85 -171.75 37.88 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.002 1.763 . . . . 1.0 110.124 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 p -148.65 115.33 5.97 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 103.346 -2.835 . . . . 1.0 103.346 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t0 42.18 53.15 4.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 129.393 3.077 . . . . 1.0 113.994 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 49.32 38.87 14.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.793 1.637 . . . . 1.0 113.493 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 tp -56.66 143.81 34.71 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 107.127 -1.435 . . . . 1.0 107.127 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -34.84 115.67 0.29 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.625 1.97 . . . . 1.0 109.867 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.67 -7.85 58.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.776 -2.059 . . . . 1.0 114.517 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.397 20.3 p 66.5 78.59 0.26 Allowed 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 121.398 1.908 . . . . 1.0 112.528 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.34 -34.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.007 1.73 . . . . 1.0 114.372 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.42 -41.33 9.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.072 2.149 . . . . 1.0 111.635 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -48.97 -51.18 31.87 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.023 1.329 . . . . 1.0 109.29 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -58.67 -37.35 75.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.536 -0.745 . . . . 1.0 110.541 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -64.61 -55.85 17.64 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.154 0.888 . . . . 1.0 110.861 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.93 -47.32 75.1 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.069 0.948 . . . . 1.0 110.918 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 115' ' ' ILE . 56.4 tp -56.36 -47.36 79.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.021 1.328 . . . . 1.0 108.43 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.37 99.26 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.493 1.042 . . . . 1.0 110.236 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.72 54.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.027 0.831 . . . . 1.0 110.036 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 115' ' ' ILE . 89.7 t -55.88 -47.3 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.657 0.783 . . . . 1.0 109.375 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 72.9 m -57.12 -53.31 59.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.253 1.021 . . . . 1.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -56.04 -45.7 79.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.927 0.891 . . . . 1.0 110.542 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.7 63.93 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.524 -0.735 . . . . 1.0 110.385 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.86 -45.32 82.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.528 1.531 . . . . 1.0 110.763 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.51 -42.96 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.191 0.996 . . . . 1.0 109.582 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -64.73 -24.93 67.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.969 -0.457 . . . . 1.0 110.508 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -84.08 -59.29 2.45 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.263 -1.384 . . . . 1.0 107.263 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -122.2 113.0 31.27 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -102.92 107.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 116.595 -1.803 . . . . 1.0 112.809 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.5 -44.08 0.1 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 128.674 2.79 . . . . 1.0 106.809 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 42.8 mt -45.2 -33.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 128.546 2.738 . . . . 1.0 110.592 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.43 -21.97 4.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.476 1.51 . . . . 1.0 113.929 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -135.12 18.57 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.091 2.156 . . . . 1.0 109.452 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -138.97 83.69 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.614 1.097 . . . . 1.0 109.595 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 124.56 29.28 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.154 -2.535 . . . . 1.0 104.154 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 t -156.96 -174.42 4.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.265 0.484 . . . . 1.0 109.885 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -143.59 -131.8 2.54 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.541 -2.224 . . . . 1.0 107.541 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -121.2 -23.52 5.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.956 1.378 . . . . 1.0 112.694 -175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.56 -6.29 22.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 19.6 t-20 -83.58 15.59 3.06 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 128.556 2.743 . . . . 1.0 111.549 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.69 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.53 -15.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.609 0.763 . . . . 1.0 111.815 -175.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.74 -53.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.617 1.967 . . . . 1.0 110.282 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.22 108.74 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.594 1.605 . . . . 1.0 111.367 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.25 -26.16 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.485 -1.384 . . . . 1.0 110.049 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.2 -25.96 66.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.446 1.898 . . . . 1.0 111.946 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -127.22 124.26 38.51 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 105.161 -2.163 . . . . 1.0 105.161 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 23.9 m -119.29 -16.69 8.99 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.913 -0.715 . . . . 1.0 112.43 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.46 179.67 0.39 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.812 2.445 . . . . 1.0 104.679 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.47 88.01 1.2 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.027 2.485 . . . . 1.0 109.862 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 69.7 0.67 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.093 1.33 . . . . 1.0 109.96 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -76.13 -81.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.303 2.052 . . . . 1.0 110.995 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t 53.66 42.9 31.75 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.453 1.501 . . . . 1.0 109.576 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.29 17.53 19.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.27 0.486 . . . . 1.0 112.178 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.3 t0 44.52 68.01 0.61 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.905 1.682 . . . . 1.0 113.008 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -54.88 -33.0 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 119.059 -0.496 . . . . 1.0 111.717 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.29 22.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.853 -1.07 . . . . 1.0 109.912 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -60.12 -47.66 84.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.257 0.935 . . . . 1.0 111.982 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.37 -58.94 6.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.771 0.669 . . . . 1.0 110.942 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -34.03 74.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.922 -0.561 . . . . 1.0 111.687 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.03 93.3 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 117.941 0.337 . . . . 1.0 111.667 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.16 -50.72 30.36 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.796 0.839 . . . . 1.0 111.647 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.95 166.38 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.664 1.986 . . . . 1.0 111.255 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 175.235 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 11' ' ' ALA . 5.8 tt . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.08 148.34 26.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.619 1.099 . . . . 1.0 110.368 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 47.33 75.05 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.004 1.722 . . . . 1.0 110.799 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' HD22 ' A' ' 8' ' ' LEU . . . -161.63 155.49 21.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.984 2.514 . . . . 1.0 107.916 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -76.71 123.38 26.09 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 104.728 -2.323 . . . . 1.0 104.728 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -93.19 138.43 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.12 76.69 50.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.711 1.204 . . . . 1.0 107.785 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.66 125.91 13.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.454 2.103 . . . . 1.0 109.416 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -144.5 113.32 5.11 Favored Pre-proline 0 CA--C 1.518 -0.288 0 C-N-CA 124.887 1.275 . . . . 1.0 107.626 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.21 65.39 8.83 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.307 2.005 . . . . 1.0 111.288 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -130.29 43.63 3.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 1.0 107.358 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.76 178.49 7.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.427 1.091 . . . . 1.0 110.337 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.53 178.07 4.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.727 0.775 . . . . 1.0 112.718 -175.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.6 m -165.07 118.48 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 128.329 2.652 . . . . 1.0 108.177 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 158.36 62.95 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.346 -1.724 . . . . 1.0 106.346 175.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.84 88.08 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.468 1.445 . . . . 1.0 109.762 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.68 143.37 29.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.919 -1.882 . . . . 1.0 105.919 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -151.52 103.35 2.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.645 1.111 . . . . 1.0 110.738 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -137.37 162.67 32.97 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -69.63 123.23 88.1 Favored Pre-proline 0 C--O 1.239 0.526 0 N-CA-C 104.928 -2.249 . . . . 1.0 104.928 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HB2' HG22 ' A' ' 113' ' ' ILE . 91.4 Cg_endo -78.2 103.37 1.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.789 1.318 . . . . 1.0 108.72 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 t -169.3 80.49 0.12 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -152.77 124.1 7.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -99.31 126.45 45.17 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.764 1.626 . . . . 1.0 108.381 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.5 145.03 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' A' ' 169' ' ' PHE . 21.4 t -136.36 123.91 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 104.181 -2.526 . . . . 1.0 104.181 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -175.38 146.93 0.84 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 117.339 -1.315 . . . . 1.0 107.507 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.15 112.32 22.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.414 1.006 . . . . 1.0 110.468 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.25 174.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.8 t -144.06 121.84 11.93 Favored 'General case' 0 C--O 1.247 0.93 1 N-CA-C 97.146 -5.131 . . . . 1.0 97.146 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' ILE 0.324 1.1 tm? -141.67 -65.58 0.02 OUTLIER Pre-proline 0 C--O 1.224 -0.266 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.3 157.66 22.79 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 121.982 1.744 . . . . 1.0 112.066 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.43 12.26 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.102 3.201 . . . . 1.0 116.363 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -28.18 -71.13 0.05 OUTLIER Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.697 -1.613 . . . . 1.0 114.062 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -156.54 123.64 5.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.712 1.605 . . . . 1.0 111.257 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -169.39 150.72 4.31 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.503 1.521 . . . . 1.0 110.795 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.8 -6.53 52.27 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.122 -1.377 . . . . 1.0 112.089 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.25 118.61 5.7 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.566 -1.813 . . . . 1.0 108.566 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.262 88.6 Cg_endo -65.26 -3.06 6.75 Favored 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 126.123 4.549 . . . . 1.0 118.964 -175.143 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -55.63 -46.93 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.922 2.146 . . . . 1.0 113.262 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' LEU . 9.4 mm -61.38 -47.05 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.567 -1.271 . . . . 1.0 107.567 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.89 -48.58 67.07 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 124.841 1.257 . . . . 1.0 109.129 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.23 -38.79 77.53 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.254 1.022 . . . . 1.0 112.381 -176.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.75 -51.13 61.69 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.784 0.434 . . . . 1.0 109.878 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.28 -39.51 71.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.346 0.499 . . . . 1.0 112.346 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.58 -52.63 43.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.645 1.178 . . . . 1.0 110.647 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.94 9.82 2.68 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 118.439 -1.201 . . . . 1.0 115.45 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 p -107.87 9.07 28.88 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.658 2.229 . . . . 1.0 114.86 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.2 134.4 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.76 1.164 . . . . 1.0 111.981 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.15 136.5 25.76 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 129.141 2.976 . . . . 1.0 109.338 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.7 76.33 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 1.0 106.923 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -103.55 -64.14 1.12 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.266 0.626 . . . . 1.0 111.266 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.6 79.15 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.614 0.766 . . . . 1.0 111.07 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 24.3 p80 -170.08 177.96 0.97 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.623 1.969 . . . . 1.0 107.047 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.05 -43.71 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.393 1.395 . . . . 1.0 114.33 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -46.14 -45.78 16.78 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.101 1.148 . . . . 1.0 114.101 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -56.12 -53.92 51.24 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.951 0.901 . . . . 1.0 109.193 -175.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.57 84.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.235 1.014 . . . . 1.0 111.665 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.66 -53.94 15.39 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.639 1.59 . . . . 1.0 111.515 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 pt -61.02 -43.45 96.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 117.303 -1.332 . . . . 1.0 110.908 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.56 -43.05 1.8 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.084 2.154 . . . . 1.0 115.19 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -46.96 -56.64 6.05 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.75 136.98 53.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.149 2.979 . . . . 1.0 106.912 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.65 155.13 16.26 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.475 -1.391 . . . . 1.0 109.211 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.83 158.39 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.543 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 m -173.66 131.73 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.582 1.553 . . . . 1.0 108.645 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.5 -176.64 3.68 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.67 -1.604 . . . . 1.0 106.67 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -120.02 -76.28 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.115 0.966 . . . . 1.0 109.481 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.745 ' HB2' HD13 ' A' ' 115' ' ' ILE . 85.6 m -117.34 118.37 32.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.3 114.15 20.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.432 1.093 . . . . 1.0 108.318 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 mt -94.4 117.21 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.927 0.891 . . . . 1.0 108.641 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -77.21 149.7 35.5 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.073 1.306 . . . . 1.0 109.171 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -23.74 2.93 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 126.466 1.906 . . . . 1.0 114.917 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.03 35.0 0.99 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.764 1.226 . . . . 1.0 113.798 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.24 40.8 99.09 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.757 1.17 . . . . 1.0 114.661 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -108.4 151.69 25.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.982 0.891 . . . . 1.0 110.676 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.16 113.98 44.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 102.492 -3.151 . . . . 1.0 102.492 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.11 145.45 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 119.29 27.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.779 1.632 . . . . 1.0 106.776 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -120.15 140.99 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.975 -2.231 . . . . 1.0 104.975 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 73' ' ' SER . 15.9 t 65.23 92.09 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.162 1.541 . . . . 1.0 115.162 175.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -56.73 169.65 1.71 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 N-CA-C 109.052 -1.172 . . . . 1.0 109.052 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.74 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.944 2.572 . . . . 1.0 117.944 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -134.51 117.05 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.735 2.814 . . . . 1.0 105.807 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.65 81.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.37 2.668 . . . . 1.0 109.539 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -35.02 148.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 131.205 3.802 . . . . 1.0 114.356 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.25 178.55 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.933 2.093 . . . . 1.0 109.657 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -149.49 119.01 6.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.246 1.384 . . . . 1.0 110.568 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.68 62.92 0.47 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.076 1.417 . . . . 1.0 110.185 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.27 -63.8 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 119.015 -2.303 . . . . 1.0 113.852 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.96 -68.87 0.21 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 106.274 -2.73 . . . . 1.0 106.274 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -145.53 146.49 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.075 1.35 . . . . 1.0 109.519 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.8 p -160.38 166.31 29.57 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.092 1.757 . . . . 1.0 107.857 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 p -159.28 145.83 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -159.77 154.0 23.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.612 1.096 . . . . 1.0 109.343 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 39.43 54.99 2.33 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.3 1.84 . . . . 1.0 111.153 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.65 84.98 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.933 -0.926 . . . . 1.0 113.117 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.75 119.24 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.842 1.321 . . . . 1.0 108.492 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.91 146.74 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.255 1.422 . . . . 1.0 111.699 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -124.45 118.22 26.17 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -72.02 -31.03 65.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.674 0.79 . . . . 1.0 111.683 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.22 176.24 11.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 128.407 2.683 . . . . 1.0 106.401 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.331 15.3 t70 -87.19 77.07 9.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.104 0.954 . . . . 1.0 111.78 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -90.51 44.54 1.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.616 -1.253 . . . . 1.0 107.616 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -123.26 133.45 54.18 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.272 1.029 . . . . 1.0 110.785 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 28' ' ' PRO 0.256 0.1 OUTLIER -91.21 56.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 175.57 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.39 -136.4 3.82 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.488 1.049 . . . . 1.0 111.217 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 76' ' ' CYS . 7.9 mm -139.65 165.14 22.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 128.156 2.582 . . . . 1.0 104.114 176.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -146.18 131.34 18.38 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.961 -2.977 . . . . 1.0 102.961 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.71 127.98 48.23 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.055 -1.653 . . . . 1.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -103.36 138.37 40.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.425 0.631 . . . . 1.0 111.224 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.03 40.49 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.945 1.26 . . . . 1.0 111.586 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.7 p -142.32 108.3 5.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.408 1.483 . . . . 1.0 107.923 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t0 49.76 55.67 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.124 2.17 . . . . 1.0 113.83 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 48.96 38.38 12.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.255 1.822 . . . . 1.0 113.973 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.19 142.8 58.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 105.283 -2.118 . . . . 1.0 105.283 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -43.03 114.78 0.65 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.683 1.193 . . . . 1.0 108.771 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -78.52 -2.12 37.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 116.783 -1.579 . . . . 1.0 114.83 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 29.0 p 64.01 76.5 0.35 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.077 1.308 . . . . 1.0 111.013 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.35 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.723 2.009 . . . . 1.0 113.132 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.01 -38.35 4.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.629 2.372 . . . . 1.0 111.837 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -47.6 -43.88 25.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.242 1.417 . . . . 1.0 110.112 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -60.64 -39.6 88.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.284 -0.865 . . . . 1.0 110.811 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.59 -51.56 58.78 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.492 1.042 . . . . 1.0 110.27 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -65.4 -40.18 93.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.488 0.315 . . . . 1.0 111.293 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.9 tp -59.11 -51.94 67.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.249 1.82 . . . . 1.0 108.201 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -40.03 78.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.83 -0.605 . . . . 1.0 110.256 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -53.96 51.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.131 0.878 . . . . 1.0 111.659 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.23 -47.83 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.9 m -58.15 -47.01 84.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.357 1.463 . . . . 1.0 112.029 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -60.19 -38.13 82.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.553 0.741 . . . . 1.0 109.606 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.52 86.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 117.823 -1.084 . . . . 1.0 110.332 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.17 -45.67 79.61 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 120.252 1.387 . . . . 1.0 110.595 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.81 -41.62 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.0 m -62.04 -27.24 68.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.366 0.666 . . . . 1.0 111.269 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -83.9 -61.23 1.88 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.956 -1.09 . . . . 1.0 108.111 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -125.8 112.79 24.8 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.27 -1.381 . . . . 1.0 107.27 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -93.18 107.8 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-O 123.425 1.344 . . . . 1.0 109.731 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.39 -44.8 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.559 1.944 . . . . 1.0 109.412 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.3 mt -49.36 -33.51 6.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 130.731 3.613 . . . . 1.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.01 -26.43 37.0 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.155 0.428 . . . . 1.0 112.155 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.46 25.65 4.11 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.123 2.569 . . . . 1.0 110.184 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -139.09 83.51 1.95 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 50.9 mtt -126.88 118.57 24.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.66 -2.348 . . . . 1.0 104.66 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -148.21 -175.38 4.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.586 1.084 . . . . 1.0 109.237 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.21 -131.77 2.39 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 105.789 -2.924 . . . . 1.0 105.789 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -114.78 -23.47 9.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.675 1.238 . . . . 1.0 110.381 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.34 -18.67 14.75 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.84 38.31 0.63 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.19 0.905 . . . . 1.0 108.918 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -16.6 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 O-C-N 120.513 -1.367 . . . . 1.0 108.715 175.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.465 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -155.49 -54.4 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.783 2.433 . . . . 1.0 111.518 175.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 98.2 Cg_endo -76.57 109.51 2.88 Favored 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 122.146 1.802 . . . . 1.0 113.608 -175.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -62.36 -12.29 20.41 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.145 -0.972 . . . . 1.0 110.688 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -22.5 57.37 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.313 -1.492 . . . . 1.0 114.553 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.26 125.75 20.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.559 1.527 . . . . 1.0 107.091 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 167' ' ' PRO . 2.6 m -114.79 -16.7 11.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.19 -178.83 0.3 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 126.3 1.84 . . . . 1.0 106.311 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.22 80.71 2.96 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 N-CA-C 105.633 -2.487 . . . . 1.0 105.633 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.404 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.22 72.28 0.23 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.513 2.006 . . . . 1.0 109.866 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.492 ' HB3' ' H ' ' A' ' 163' ' ' THR . 68.7 Cg_endo -79.0 -99.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.301 2.667 . . . . 1.0 111.066 176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.7 t 53.82 42.9 31.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.513 1.525 . . . . 1.0 111.538 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.41 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -96.81 17.87 15.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.978 -1.076 . . . . 1.0 113.453 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t0 43.79 63.74 1.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.421 -2.049 . . . . 1.0 111.831 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -54.07 -35.17 61.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.344 0.658 . . . . 1.0 111.725 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -54.35 48.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.453 -0.784 . . . . 1.0 110.157 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -60.29 -48.54 81.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.814 -1.089 . . . . 1.0 112.13 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.32 -53.54 56.07 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.883 0.765 . . . . 1.0 109.938 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -48.81 80.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 117.962 -1.018 . . . . 1.0 108.773 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.7 76.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.931 0.893 . . . . 1.0 112.981 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.3 mt -71.28 -44.21 65.66 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.878 0.871 . . . . 1.0 110.62 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.37 157.07 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 122.958 1.361 . . . . 1.0 110.051 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 125.952 1.701 . . . . 1.0 111.607 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.6 tm? . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 106.912 -1.514 . . . . 1.0 106.912 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.63 175.92 9.95 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.469 0.708 . . . . 1.0 111.408 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 42.33 57.86 3.22 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.286 1.834 . . . . 1.0 109.464 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.29 155.2 30.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.983 1.313 . . . . 1.0 109.1 -176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -81.29 123.46 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.79 124.6 33.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.379 0.99 . . . . 1.0 108.334 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.92 82.53 43.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.99 124.03 7.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.034 1.823 . . . . 1.0 110.299 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -119.74 114.19 34.25 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.87 56.39 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.183 1.922 . . . . 1.0 111.416 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -126.05 44.56 2.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.811 2.045 . . . . 1.0 105.632 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.465 ' CE2' HG13 ' A' ' 88' ' ' VAL . 1.8 m-30 -73.66 177.98 5.05 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.417 0.687 . . . . 1.0 111.142 -174.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.56 178.62 4.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.693 1.597 . . . . 1.0 113.513 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.6 m -154.19 124.67 7.01 Favored 'General case' 0 N--CA 1.448 -0.574 1 C-N-CA 132.028 4.131 . . . . 1.0 103.137 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.64 142.77 45.09 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 117.981 -1.009 . . . . 1.0 108.831 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.57 69.1 7.88 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.598 2.865 . . . . 1.0 113.454 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -151.71 158.54 43.54 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 127.073 2.149 . . . . 1.0 106.799 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -151.17 104.67 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.309 1.444 . . . . 1.0 107.481 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.77 158.67 43.92 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.915 1.686 . . . . 1.0 106.61 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -67.51 123.67 87.3 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 118.679 0.672 . . . . 1.0 109.441 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.16 103.65 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 108.974 -1.202 . . . . 1.0 108.974 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -165.38 65.57 0.12 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.469 -1.394 . . . . 1.0 108.265 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -148.3 137.63 22.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.73 1.612 . . . . 1.0 107.175 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.85 133.4 34.76 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.243 1.417 . . . . 1.0 108.111 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.91 142.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.938 -2.245 . . . . 1.0 104.938 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 98.5 t -136.16 115.77 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.977 -1.86 . . . . 1.0 105.977 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -176.3 132.82 0.23 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.348 0.976 . . . . 1.0 108.835 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -63.39 118.73 8.49 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.925 0.89 . . . . 1.0 110.22 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 7.5 mm -145.71 176.43 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.174 2.59 . . . . 1.0 107.153 176.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -160.93 117.97 2.33 Favored 'General case' 0 C--N 1.322 -0.624 1 N-CA-C 96.695 -5.298 . . . . 1.0 96.695 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 1.3 tm? -144.78 -61.3 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 116.022 -1.942 . . . . 1.0 112.79 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 23.8 Cg_endo -87.34 157.3 8.1 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.825 2.35 . . . . 1.0 112.92 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.37 70.45 4.78 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.326 3.35 . . . . 1.0 118.658 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.94 -72.2 1.06 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 105.811 -2.916 . . . . 1.0 105.811 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -157.2 123.42 4.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.324 2.25 . . . . 1.0 109.186 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -176.94 176.42 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 130.706 3.602 . . . . 1.0 107.836 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.41 22.78 10.04 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.91 1.719 . . . . 1.0 109.464 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.38 118.6 5.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.116 -1.38 . . . . 1.0 110.203 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.8 -21.03 38.9 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.415 2.077 . . . . 1.0 112.331 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -53.9 -34.19 58.79 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.853 0.861 . . . . 1.0 111.082 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 mt -66.12 -50.01 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.246 -0.883 . . . . 1.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.94 -46.46 78.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.076 -1.049 . . . . 1.0 110.395 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.78 -33.89 50.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.114 0.966 . . . . 1.0 111.887 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -63.83 -58.49 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.616 1.566 . . . . 1.0 110.296 176.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -70.6 -41.32 72.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.4 0.68 . . . . 1.0 112.545 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -65.91 -34.28 77.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.59 1.156 . . . . 1.0 108.455 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.22 54.77 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.308 -1.829 . . . . 1.0 116.153 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -89.15 8.27 30.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.743 2.272 . . . . 1.0 113.615 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 68' ' ' ALA . 13.4 tt -60.02 132.93 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.629 1.572 . . . . 1.0 111.891 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.02 135.99 20.7 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 128.636 2.774 . . . . 1.0 109.529 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.39 80.68 1.04 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.502 2.801 . . . . 1.0 106.909 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -103.23 -63.43 1.18 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.034 0.534 . . . . 1.0 111.012 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.57 78.85 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.06 0.944 . . . . 1.0 110.646 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 17.4 p80 -170.35 177.95 0.95 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.403 2.281 . . . . 1.0 106.331 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.7 Cg_endo -74.05 -43.43 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.531 1.488 . . . . 1.0 114.796 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -43.23 -53.58 5.03 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -51.51 -58.22 6.89 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.07 1.348 . . . . 1.0 110.513 -175.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.6 89.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.167 0.587 . . . . 1.0 111.521 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.45 -63.54 4.0 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.127 1.346 . . . . 1.0 111.863 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.49 -38.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.24 0.52 . . . . 1.0 112.065 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.52 -43.53 11.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.262 88.0 m-70 -57.9 -33.54 68.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.721 -0.657 . . . . 1.0 109.779 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.32 136.61 33.83 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.504 -2.776 . . . . 1.0 103.504 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 141.67 40.74 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.227 0.921 . . . . 1.0 111.723 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -116.97 165.49 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.663 2.385 . . . . 1.0 109.59 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -172.52 116.64 0.33 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.955 1.302 . . . . 1.0 108.632 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.44 -176.89 3.77 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -110.68 -76.27 0.61 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.884 1.22 . . . . 1.0 112.478 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -116.97 118.26 31.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.543 -2.021 . . . . 1.0 105.543 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.57 113.55 27.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.761 -2.311 . . . . 1.0 104.761 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -96.14 113.38 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.662 -2.348 . . . . 1.0 104.662 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -68.74 148.13 50.8 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.696 1.134 . . . . 1.0 108.502 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.74 22.09 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 122.824 0.45 . . . . 1.0 111.645 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.27 24.51 2.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.25 2.22 . . . . 1.0 111.896 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.01 76.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.456 1.979 . . . . 1.0 115.623 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.94 156.57 17.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.726 1.763 . . . . 1.0 110.58 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -116.24 116.53 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.71 141.68 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.45 121.57 37.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.411 -1.7 . . . . 1.0 106.411 -176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.94 123.93 50.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.829 2.452 . . . . 1.0 106.495 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 19' ' ' TYR . 36.2 t 67.16 92.1 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.091 1.314 . . . . 1.0 113.664 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -60.8 -179.15 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.192 1.261 . . . . 1.0 109.963 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -59.18 26.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.812 3.245 . . . . 1.0 116.678 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.97 117.48 7.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.905 2.482 . . . . 1.0 108.788 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.268 28.0 ttmt 85.93 81.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.903 2.481 . . . . 1.0 111.844 175.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -36.44 156.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.721 4.009 . . . . 1.0 117.216 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.75 -179.2 3.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.909 3.684 . . . . 1.0 115.857 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 46.7 t90 -156.46 118.52 3.95 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.514 1.926 . . . . 1.0 109.709 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -162.78 62.85 0.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.228 0.922 . . . . 1.0 111.439 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.55 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 118.785 -2.447 . . . . 1.0 114.779 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.84 -90.74 1.1 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 105.248 -3.141 . . . . 1.0 105.248 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.07 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 118.734 1.267 . . . . 1.0 109.456 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 p -165.98 157.32 13.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.119 2.168 . . . . 1.0 108.118 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' HG22 ' A' ' 157' ' ' ILE . 78.1 p -153.46 147.1 25.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.386 1.074 . . . . 1.0 110.763 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -149.46 148.98 30.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.586 -1.265 . . . . 1.0 107.586 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 38.66 53.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.368 1.867 . . . . 1.0 111.446 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.7 28.44 65.47 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.605 -1.108 . . . . 1.0 115.465 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 113.22 13.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 120.544 2.172 . . . . 1.0 105.245 175.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 12.8 tt0 -79.83 145.65 32.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -105.22 118.24 36.05 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.38 -23.7 60.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.322 0.389 . . . . 1.0 110.559 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -145.58 170.69 15.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.485 2.314 . . . . 1.0 106.857 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.52 76.66 7.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.358 1.075 . . . . 1.0 108.919 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -89.49 40.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.454 1.502 . . . . 1.0 110.108 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -131.67 130.4 42.0 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 119.977 -1.702 . . . . 1.0 111.882 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 56.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.809 2.044 . . . . 1.0 107.947 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -136.62 5.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.67 164.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.77 116.33 8.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.664 -2.347 . . . . 1.0 104.664 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.3 135.42 34.32 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.298 -1.501 . . . . 1.0 109.604 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.1 tt0 -103.67 152.94 21.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.65 173.46 39.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.821 1.677 . . . . 1.0 111.04 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -147.13 107.08 3.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.7 t0 46.08 47.75 12.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.471 2.308 . . . . 1.0 112.282 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.7 p 46.78 38.27 5.73 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.301 1.84 . . . . 1.0 113.417 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.24 146.52 54.84 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.236 1.814 . . . . 1.0 108.542 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -33.0 113.14 0.13 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.079 2.152 . . . . 1.0 110.508 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -78.31 -9.0 59.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.701 -2.095 . . . . 1.0 114.985 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.407 11.7 p 69.26 78.41 0.21 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 121.404 1.911 . . . . 1.0 113.537 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -22.99 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 119.709 -1.869 . . . . 1.0 115.403 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.37 -46.45 13.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.236 2.214 . . . . 1.0 110.472 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -51.26 -49.34 61.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.571 1.078 . . . . 1.0 109.904 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.71 -40.09 90.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.546 -0.74 . . . . 1.0 109.757 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.97 -50.55 63.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.988 0.813 . . . . 1.0 111.424 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -63.1 -48.49 78.35 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.985 1.714 . . . . 1.0 110.255 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.16 -49.98 74.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.217 1.407 . . . . 1.0 108.856 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.57 -39.84 89.47 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 118.722 -0.656 . . . . 1.0 110.155 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -53.58 56.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.829 0.852 . . . . 1.0 110.304 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.01 -46.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.6 m -58.29 -53.6 56.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.983 1.313 . . . . 1.0 109.964 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -56.76 -46.04 81.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.67 1.188 . . . . 1.0 110.12 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.15 77.71 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.792 0.437 . . . . 1.0 111.535 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.8 mt -57.03 -38.24 72.89 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-O 118.436 -0.792 . . . . 1.0 111.029 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.28 -38.75 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.547 0.739 . . . . 1.0 109.752 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 m -57.42 -35.07 69.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.089 0.859 . . . . 1.0 110.55 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -83.67 -52.66 6.25 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.129 -0.982 . . . . 1.0 108.6 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -126.33 112.9 23.49 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.92 107.15 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 121.378 1.528 . . . . 1.0 109.031 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.18 -49.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.094 1.758 . . . . 1.0 107.685 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 65.8 mt -48.35 -34.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 129.018 2.927 . . . . 1.0 109.586 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.12 -25.67 9.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.738 1.615 . . . . 1.0 113.627 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.31 22.01 3.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.037 1.735 . . . . 1.0 109.63 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.06 85.9 2.1 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.016 1.726 . . . . 1.0 107.7 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.2 mtt -131.96 119.13 20.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.893 2.077 . . . . 1.0 106.609 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -152.15 -176.34 5.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.532 1.514 . . . . 1.0 108.992 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.57 -131.4 2.73 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 106.875 -2.49 . . . . 1.0 106.875 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -116.35 -23.9 8.15 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.327 1.064 . . . . 1.0 112.12 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.4 t -103.63 -12.55 16.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.368 0.667 . . . . 1.0 109.255 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.7 OUTLIER -85.41 17.96 2.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.449 1.9 . . . . 1.0 110.478 -175.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.59 -20.14 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.764 0.825 . . . . 1.0 112.489 -175.26 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -147.47 -66.14 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.11 1.364 . . . . 1.0 107.995 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 86.0 Cg_endo -80.06 108.85 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.877 1.718 . . . . 1.0 111.202 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.97 -17.46 38.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.391 1.076 . . . . 1.0 112.096 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -60.06 -24.24 64.41 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.239 -1.538 . . . . 1.0 112.687 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -131.22 140.57 49.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 104.1 -2.556 . . . . 1.0 104.1 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 20.2 m -123.19 -16.76 6.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.34 177.92 0.95 Allowed Pre-proline 0 C--O 1.244 0.815 0 C-N-CA 131.316 3.846 . . . . 1.0 103.333 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.25 57.91 6.7 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.772 2.314 . . . . 1.0 109.438 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.5 78.81 0.02 OUTLIER Glycine 0 CA--C 1.541 1.671 0 C-N-CA 128.918 3.151 . . . . 1.0 108.054 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.01 -72.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.1 2.534 . . . . 1.0 112.107 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.3 t 53.94 43.79 30.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.514 1.926 . . . . 1.0 113.176 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -122.04 17.56 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.347 0.976 . . . . 1.0 112.731 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 t0 42.6 68.47 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.288 1.435 . . . . 1.0 110.604 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -48.85 -34.95 13.53 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -48.18 73.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.362 -0.828 . . . . 1.0 111.246 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -60.78 -51.14 70.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.51 1.504 . . . . 1.0 110.893 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.51 -46.6 82.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.187 0.903 . . . . 1.0 111.619 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -62.44 -32.78 73.69 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.567 0.621 . . . . 1.0 110.119 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.42 80.72 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.786 -1.197 . . . . 1.0 111.436 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 mt -67.87 -55.27 13.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.601 1.56 . . . . 1.0 112.636 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.43 150.12 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 122.766 0.426 . . . . 1.0 109.92 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 125.49 1.516 . . . . 1.0 110.327 175.925 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.74 55.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.194 0.198 . . . . 1.0 111.351 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 49.25 58.42 5.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.973 2.109 . . . . 1.0 110.807 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.47 133.25 21.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.382 -1.281 . . . . 1.0 109.475 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -67.87 123.34 20.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.615 -1.994 . . . . 1.0 105.615 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -91.87 128.16 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.185 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -145.82 85.58 7.63 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.092 . . . . 1.0 108.796 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.39 152.08 71.22 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.285 1.323 . . . . 1.0 110.578 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -146.75 132.67 9.43 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 126.056 1.742 . . . . 1.0 107.788 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.49 45.13 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.005 2.47 . . . . 1.0 113.133 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -123.88 43.2 3.04 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.384 -0.823 . . . . 1.0 109.982 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CB ' ' HG2' ' A' ' 92' ' ' LYS . 36.6 m-85 -73.57 -179.83 3.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.088 1.355 . . . . 1.0 109.878 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.39 178.6 4.39 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.754 1.264 . . . . 1.0 112.898 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -152.66 118.5 5.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.066 -2.939 . . . . 1.0 103.066 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -135.71 145.61 53.79 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 120.273 1.397 . . . . 1.0 108.742 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 67.22 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.459 2.773 . . . . 1.0 111.71 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -154.41 143.82 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.661 2.384 . . . . 1.0 107.131 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.92 103.93 3.11 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.898 2.079 . . . . 1.0 106.681 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.44 169.46 17.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.817 2.447 . . . . 1.0 106.972 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.97 123.54 82.27 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 124.912 1.285 . . . . 1.0 110.371 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.69 103.44 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.831 1.687 . . . . 1.0 110.512 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.1 t -177.1 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.51 -2.404 . . . . 1.0 104.51 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -148.34 145.75 28.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.395 3.078 . . . . 1.0 104.181 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.5 tp -114.5 129.76 56.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -105.89 136.03 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 169' ' ' PHE . 74.0 t -135.02 113.95 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CD2' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -165.15 167.26 18.32 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.273 1.429 . . . . 1.0 107.276 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -96.93 116.67 29.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -142.03 172.2 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.943 2.097 . . . . 1.0 106.926 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 t -155.55 118.04 4.2 Favored 'General case' 0 N--CA 1.443 -0.795 1 N-CA-C 98.981 -4.451 . . . . 1.0 98.981 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 -66.74 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.529 0 CA-C-O 116.007 -1.949 . . . . 1.0 109.285 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.24 136.94 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 CA-C-N 123.943 2.444 . . . . 1.0 107.36 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.25 44.73 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.096 3.198 . . . . 1.0 114.986 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -31.5 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.241 0 C-N-CA 126.125 1.822 . . . . 1.0 110.829 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.29 122.69 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.167 -2.531 . . . . 1.0 104.167 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -176.76 175.54 1.64 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.884 2.874 . . . . 1.0 107.942 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.76 26.58 4.02 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.588 1.566 . . . . 1.0 112.331 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.65 118.24 6.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.26 1.53 . . . . 1.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.13 -5.0 15.41 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.316 2.011 . . . . 1.0 113.148 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -62.02 -38.65 89.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.415 1.086 . . . . 1.0 109.43 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.7 -45.06 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.44 -46.61 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.53 -36.18 63.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 1.0 111.719 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -60.45 3.78 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.694 0.798 . . . . 1.0 109.655 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -68.78 -46.92 67.48 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.574 0.625 . . . . 1.0 112.384 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -60.48 -33.89 73.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.486 1.114 . . . . 1.0 108.732 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.56 35.8 4.25 Favored Glycine 0 C--N 1.342 0.879 0 C-N-CA 124.552 1.072 . . . . 1.0 113.349 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -124.77 18.05 8.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.885 1.342 . . . . 1.0 111.752 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.03 140.0 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.701 0.801 . . . . 1.0 110.427 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -98.37 128.01 34.5 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 127.713 2.405 . . . . 1.0 106.257 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.21 70.51 2.38 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.211 3.274 . . . . 1.0 109.472 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -106.9 -65.28 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.948 1.299 . . . . 1.0 112.843 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.4 -60.46 1.49 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.917 1.687 . . . . 1.0 113.225 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 20.8 p80 -168.48 177.69 1.2 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.562 1.145 . . . . 1.0 108.13 175.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.9 Cg_endo -70.25 -43.62 2.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.733 1.622 . . . . 1.0 113.926 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -50.48 -62.26 1.69 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.805 1.242 . . . . 1.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 5.2 t80 -56.88 -50.35 72.75 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.409 0.684 . . . . 1.0 111.201 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.17 96.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.892 0.477 . . . . 1.0 110.849 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -57.73 17.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 124.791 1.186 . . . . 1.0 110.629 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.49 -24.15 34.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-O 116.589 -1.672 . . . . 1.0 113.734 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.11 -43.52 20.58 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.716 1.598 . . . . 1.0 113.0 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -58.04 -33.85 69.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.095 0.558 . . . . 1.0 110.806 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.39 136.4 33.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -65.28 146.49 54.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.163 -1.415 . . . . 1.0 109.445 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -116.92 162.26 15.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 125.506 1.522 . . . . 1.0 110.507 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.612 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -174.05 128.1 0.37 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.543 2.337 . . . . 1.0 108.151 175.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.26 -172.47 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.453 -1.684 . . . . 1.0 106.453 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -110.81 -58.72 2.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.597 1.159 . . . . 1.0 111.767 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.507 ' HB2' HD13 ' A' ' 115' ' ' ILE . 19.9 m -141.04 118.44 11.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.189 -1.782 . . . . 1.0 106.189 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.94 113.42 25.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.825 -2.287 . . . . 1.0 104.825 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -89.16 113.48 25.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.22 150.63 45.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.871 -1.159 . . . . 1.0 107.871 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -13.76 0.96 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.565 1.146 . . . . 1.0 113.917 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -91.7 21.03 5.01 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 128.037 2.535 . . . . 1.0 112.737 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.51 29.32 71.42 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.792 2.139 . . . . 1.0 114.885 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -102.14 108.94 20.5 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.652 1.226 . . . . 1.0 108.239 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.03 113.69 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.767 -2.679 . . . . 1.0 103.767 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.57 123.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 103.084 -2.932 . . . . 1.0 103.084 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.29 113.44 26.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.91 114.35 20.9 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 89.11 91.57 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 122.432 2.378 . . . . 1.0 110.554 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.26 -171.66 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.208 1.938 . . . . 1.0 109.907 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -64.57 21.77 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.498 1.919 . . . . 1.0 115.941 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.44 126.14 17.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.625 1.97 . . . . 1.0 109.127 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HG2' ' CB ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER 86.56 81.92 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.849 3.26 . . . . 1.0 111.762 175.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -36.7 135.38 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 128.259 2.624 . . . . 1.0 112.373 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -104.04 -178.67 3.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.769 2.428 . . . . 1.0 111.058 -175.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -146.23 118.55 8.4 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.418 1.887 . . . . 1.0 107.114 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -164.96 63.29 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.224 1.012 . . . . 1.0 110.601 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 154' ' ' HIS . . . -160.64 -68.72 0.07 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 118.792 -2.443 . . . . 1.0 112.274 -175.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.38 -90.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.421 -1.872 . . . . 1.0 108.421 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.6 t -140.32 146.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.473 1.909 . . . . 1.0 110.758 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -163.47 155.49 17.58 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.059 1.743 . . . . 1.0 109.044 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.662 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.0 p -146.86 133.55 19.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -161.49 124.59 3.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.286 0.948 . . . . 1.0 108.898 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 60.13 71.57 0.57 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.044 1.738 . . . . 1.0 113.622 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.4 30.3 55.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 126.433 1.968 . . . . 1.0 113.922 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.7 ttm105 -150.05 113.63 4.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.441 1.096 . . . . 1.0 108.566 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.05 145.13 30.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.226 -2.139 . . . . 1.0 105.226 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -128.98 118.03 21.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.992 -1.855 . . . . 1.0 105.992 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t -66.11 -36.02 82.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.842 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.73 174.12 11.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.91 2.884 . . . . 1.0 106.037 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.48 76.84 9.91 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 106.533 -1.655 . . . . 1.0 106.533 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 39.68 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.482 1.913 . . . . 1.0 109.889 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -124.23 156.72 36.34 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.204 1.802 . . . . 1.0 112.29 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.255 0.0 OUTLIER -99.98 57.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 105.971 -1.862 . . . . 1.0 105.971 175.317 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.35 -136.53 1.65 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.225 -0.922 . . . . 1.0 111.595 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 136' ' ' VAL . 7.5 mm -142.25 163.15 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 128.888 2.875 . . . . 1.0 103.723 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -136.12 129.3 31.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.393 2.277 . . . . 1.0 105.338 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mt -101.24 153.81 19.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 120.258 1.39 . . . . 1.0 109.305 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.34 47.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.83 0.824 . . . . 1.0 111.36 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.31 -173.47 41.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.294 2.378 . . . . 1.0 108.946 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 p -136.44 100.2 4.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 102.692 -3.077 . . . . 1.0 102.692 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 43.01 55.63 4.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.848 2.459 . . . . 1.0 112.472 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.4 p 52.69 38.09 25.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.089 2.155 . . . . 1.0 114.155 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 tp -60.2 136.01 57.9 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.84 113.2 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.29 2.236 . . . . 1.0 110.411 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.02 -8.17 57.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 115.683 -2.103 . . . . 1.0 116.371 -174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.325 37.3 p 63.89 77.96 0.3 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 121.636 2.016 . . . . 1.0 111.383 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.64 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.901 2.081 . . . . 1.0 113.97 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.09 -38.61 1.72 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.435 2.294 . . . . 1.0 109.455 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.67 -48.82 58.3 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.999 1.32 . . . . 1.0 110.575 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -59.16 -38.27 79.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.079 0.854 . . . . 1.0 110.509 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -66.02 -55.03 18.72 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.253 0.621 . . . . 1.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 12.1 mt-30 -61.69 -54.06 47.66 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.861 0.865 . . . . 1.0 109.131 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 115' ' ' ILE . 55.3 tp -53.22 -49.32 67.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.251 1.021 . . . . 1.0 109.728 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.0 85.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 120.408 1.458 . . . . 1.0 111.682 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.85 51.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.741 0.7 . . . . 1.0 109.294 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 115' ' ' ILE . 95.7 t -52.91 -64.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 126.758 2.023 . . . . 1.0 108.417 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 64.0 m -54.35 -52.43 61.63 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.902 2.081 . . . . 1.0 111.456 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -57.22 -42.02 80.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.382 1.447 . . . . 1.0 110.408 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.48 66.65 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.266 -0.896 . . . . 1.0 111.352 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.7 mt -56.91 -34.71 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.58 -1.325 . . . . 1.0 111.598 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.61 -40.08 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.474 -1.306 . . . . 1.0 107.474 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -63.15 -13.44 37.05 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.13 1.372 . . . . 1.0 110.965 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -95.93 -65.39 0.98 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.158 -1.589 . . . . 1.0 107.406 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -120.89 112.99 33.23 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -95.89 107.89 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 CA-C-N 120.182 1.101 . . . . 1.0 111.208 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.91 -49.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.365 1.866 . . . . 1.0 106.636 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.5 mt -45.9 -33.37 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 128.944 2.898 . . . . 1.0 110.815 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.16 -26.53 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 1.0 113.412 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -133.13 18.62 4.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.945 2.098 . . . . 1.0 110.178 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -138.44 83.74 1.98 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.454 -1.404 . . . . 1.0 107.842 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.6 mtt -121.55 114.05 20.66 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -149.18 -168.07 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.93 -130.67 1.64 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 105.017 -3.233 . . . . 1.0 105.017 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.473 ' CE1' ' HB1' ' A' ' 97' ' ' ALA 0.259 12.2 m-70 -112.73 -24.43 9.61 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.978 0.911 . . . . 1.0 111.277 -176.337 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.67 -16.03 16.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.417 0.687 . . . . 1.0 110.359 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -86.59 39.62 0.85 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.893 -1.151 . . . . 1.0 107.893 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.62 -17.5 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 O-C-N 120.322 -1.486 . . . . 1.0 109.294 175.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -149.54 -64.53 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.553 1.541 . . . . 1.0 109.715 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 98.4 Cg_endo -78.51 115.06 3.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.365 2.043 . . . . 1.0 113.23 -175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -22.48 58.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 1.0 112.273 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.2 tpt85 -58.65 -17.15 19.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.199 2.2 . . . . 1.0 112.686 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -141.66 141.02 33.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -131.84 -16.72 2.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 118.903 -1.119 . . . . 1.0 110.358 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.9 -179.62 0.34 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 130.117 3.367 . . . . 1.0 104.085 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 78.25 3.5 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 121.876 1.717 . . . . 1.0 108.561 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.44 64.08 0.56 Allowed Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.866 -1.519 . . . . 1.0 114.811 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.52 -54.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.429 2.615 . . . . 1.0 111.599 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 t 54.52 44.5 28.66 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.918 1.687 . . . . 1.0 112.468 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' CD2' HG11 ' A' ' 33' ' ' VAL . 81.4 t80 -108.73 17.68 21.62 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -175.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.369 11.3 t70 43.0 75.69 0.09 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.086 1.754 . . . . 1.0 113.194 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -48.65 -34.16 11.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.838 0.681 . . . . 1.0 112.838 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.63 75.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.942 -1.028 . . . . 1.0 111.707 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.4 -49.45 77.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.773 1.17 . . . . 1.0 109.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 34.3 t80 -66.2 -52.15 50.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.424 0.898 . . . . 1.0 113.424 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -61.55 -28.26 69.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.592 0.633 . . . . 1.0 111.476 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.45 87.28 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.125 0.875 . . . . 1.0 111.341 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.8 mt -71.04 -61.53 1.73 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.292 1.437 . . . . 1.0 111.065 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 90.4 t -66.35 166.36 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 124.13 0.972 . . . . 1.0 110.062 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 92.7 m . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 125.297 1.439 . . . . 1.0 109.369 175.431 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.02 36.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 40.67 57.88 2.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.553 2.741 . . . . 1.0 108.6 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.61 150.98 30.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.838 1.255 . . . . 1.0 109.375 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB3' HG13 ' A' ' 85' ' ' VAL . 25.6 tpt85 -86.21 123.24 31.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -84.63 129.62 34.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.43 79.33 20.84 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.189 -1.041 . . . . 1.0 108.189 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.27 127.93 12.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.409 2.072 . . . . 1.0 109.104 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -128.18 120.93 21.4 Favored Pre-proline 0 C--O 1.232 0.184 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.3 52.08 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.128 2.552 . . . . 1.0 112.465 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -123.63 43.44 2.97 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 88' ' ' VAL . 22.9 m-85 -74.26 178.46 5.12 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.723 0.809 . . . . 1.0 109.694 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.65 179.48 5.66 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.94 1.296 . . . . 1.0 110.975 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.5 m -162.67 118.63 1.88 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.756 2.822 . . . . 1.0 105.738 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -131.9 138.47 32.55 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 117.257 -1.354 . . . . 1.0 107.455 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.61 99.66 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.473 2.782 . . . . 1.0 109.389 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -168.03 151.48 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.9 2.48 . . . . 1.0 105.966 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -151.53 106.74 3.31 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.261 1.391 . . . . 1.0 108.288 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -136.36 165.48 25.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.85 2.06 . . . . 1.0 107.28 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -67.43 123.47 86.7 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.173 -1.047 . . . . 1.0 108.173 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.96 103.71 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.548 2.165 . . . . 1.0 110.528 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 t -170.54 73.88 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.57 124.03 11.01 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.666 1.587 . . . . 1.0 106.97 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -88.44 131.64 34.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.119 0.968 . . . . 1.0 109.389 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.3 143.17 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.756 -1.942 . . . . 1.0 105.756 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.14 116.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 105.991 -1.855 . . . . 1.0 105.991 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -172.08 152.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.264 1.425 . . . . 1.0 107.465 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 112.4 24.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 6.8 mm -128.27 176.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 128.672 2.789 . . . . 1.0 106.545 175.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -153.28 121.47 6.19 Favored 'General case' 0 C--N 1.31 -1.124 1 N-CA-C 93.728 -6.397 . . . . 1.0 93.728 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 48' ' ' ILE 0.297 0.3 OUTLIER -142.0 -60.33 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 119.459 1.027 . . . . 1.0 110.537 176.488 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.52 134.31 11.06 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 CA-C-N 121.904 1.716 . . . . 1.0 110.419 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.27 75.81 3.25 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.341 2.694 . . . . 1.0 115.408 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.82 -71.7 0.85 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 106.615 -2.594 . . . . 1.0 106.615 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -156.21 123.63 5.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.888 1.275 . . . . 1.0 110.7 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -174.2 148.22 1.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.778 2.831 . . . . 1.0 108.294 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.51 -35.37 55.89 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.442 0.565 . . . . 1.0 113.406 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.39 118.94 11.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.558 1.075 . . . . 1.0 113.157 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.78 -5.88 17.42 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.636 2.891 . . . . 1.0 115.262 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -48.36 -45.73 35.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.439 1.472 . . . . 1.0 110.905 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 38' ' ' LEU . 7.0 mt -65.98 -45.14 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.816 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.16 -39.35 92.34 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.542 -0.463 . . . . 1.0 109.768 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.48 -34.25 70.68 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.238 0.472 . . . . 1.0 111.686 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.69 -52.4 51.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.573 1.149 . . . . 1.0 109.372 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.28 -41.37 73.49 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.02 -48.58 70.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.86 2.46 11.35 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.713 1.625 . . . . 1.0 114.503 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -89.08 9.21 26.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.913 1.856 . . . . 1.0 113.008 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 tt -52.21 129.53 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.293 1.437 . . . . 1.0 112.543 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.0 135.52 20.84 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.272 2.229 . . . . 1.0 109.599 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.88 78.1 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.604 2.869 . . . . 1.0 106.951 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -103.2 -65.07 1.02 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.036 0.534 . . . . 1.0 111.055 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.45 79.01 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.226 0.61 . . . . 1.0 111.117 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -171.08 178.08 0.85 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.037 1.735 . . . . 1.0 107.71 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.22 -43.4 4.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.596 2.197 . . . . 1.0 114.972 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -46.14 -50.88 14.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -54.62 42.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.302 1.041 . . . . 1.0 110.025 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.27 99.22 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.434 1.093 . . . . 1.0 111.29 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.99 -58.15 12.55 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 126.106 1.813 . . . . 1.0 112.184 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 pt -57.94 -38.26 65.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 117.954 -1.022 . . . . 1.0 111.879 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.79 -43.1 2.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.304 2.241 . . . . 1.0 115.318 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -61.22 -33.39 73.41 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.599 -0.688 . . . . 1.0 110.377 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.76 135.78 33.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 103.376 -2.824 . . . . 1.0 103.376 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.54 145.7 55.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.583 -0.698 . . . . 1.0 109.152 176.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.91 161.85 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 127.587 2.355 . . . . 1.0 111.418 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -175.97 139.96 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.412 2.285 . . . . 1.0 106.847 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -160.21 0.78 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.837 1.255 . . . . 1.0 108.074 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -130.41 -58.85 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.437 1.495 . . . . 1.0 108.539 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.97 119.42 17.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.196 -2.52 . . . . 1.0 104.196 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 tp -107.3 113.55 27.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.199 -2.519 . . . . 1.0 104.199 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.16 114.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -76.0 145.39 40.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -20.55 2.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.97 1.471 . . . . 1.0 114.97 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -91.4 29.95 1.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.271 1.828 . . . . 1.0 112.105 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.42 52.28 52.38 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.127 1.822 . . . . 1.0 114.085 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -126.77 117.34 22.47 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.331 -0.842 . . . . 1.0 110.465 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 132' ' ' GLN . 83.4 mt -83.02 114.73 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 101.6 -3.481 . . . . 1.0 101.6 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.3 t -110.48 142.27 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 103.34 -2.837 . . . . 1.0 103.34 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -121.14 114.04 20.87 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.074 -1.641 . . . . 1.0 111.264 -175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -108.98 120.17 41.74 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 19' ' ' TYR . 72.8 t 64.93 88.6 0.11 Allowed Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.024 1.284 . . . . 1.0 112.869 175.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.19 178.21 5.7 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 121.528 1.485 . . . . 1.0 109.548 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -43.55 9.26 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.149 1 C-N-CA 133.476 4.71 . . . . 1.0 120.198 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -133.89 111.12 10.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 119.371 -2.081 . . . . 1.0 107.552 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 86.25 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.889 2.076 . . . . 1.0 111.41 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -34.0 156.29 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.302 2.641 . . . . 1.0 114.669 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.59 -178.51 3.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 130.008 3.323 . . . . 1.0 109.998 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -145.93 118.54 8.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.95 1.25 . . . . 1.0 110.246 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -154.79 62.82 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 123.132 1.444 . . . . 1.0 110.747 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.76 -55.77 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 118.944 -2.348 . . . . 1.0 112.917 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.92 -74.41 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.177 -1.969 . . . . 1.0 108.177 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.18 128.82 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.244 1.417 . . . . 1.0 109.675 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.6 p -166.19 154.28 10.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.68 1.592 . . . . 1.0 112.14 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 157' ' ' ILE . 60.6 p -153.21 146.63 24.91 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 120.864 -1.147 . . . . 1.0 110.812 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -153.88 154.62 34.21 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.549 0.613 . . . . 1.0 110.504 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 38.91 55.38 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.223 1.809 . . . . 1.0 111.612 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.67 77.1 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.86 -0.967 . . . . 1.0 114.468 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -136.55 119.86 16.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.503 -1.665 . . . . 1.0 106.503 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 1.2 tt0 -100.44 138.7 37.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 36.4 mtm180 -113.31 118.34 34.32 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.1 t -58.07 -41.75 84.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.348 1.059 . . . . 1.0 111.212 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -148.19 177.02 9.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.514 3.126 . . . . 1.0 108.059 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.0 76.91 10.01 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.387 1.089 . . . . 1.0 108.689 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -87.51 33.92 0.7 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.198 0.999 . . . . 1.0 111.185 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.2 m -135.46 137.61 42.35 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.034 -1.666 . . . . 1.0 113.013 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.98 57.0 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.932 2.093 . . . . 1.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.18 -136.79 2.41 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.85 -1.156 . . . . 1.0 111.029 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 136' ' ' VAL . 1.1 mm -142.63 162.02 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 129.177 2.991 . . . . 1.0 103.329 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.94 130.22 29.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.76 -3.052 . . . . 1.0 102.76 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.54 157.53 16.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 107.435 -1.321 . . . . 1.0 107.435 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -131.08 155.82 46.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.959 0.885 . . . . 1.0 111.12 -178.574 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.55 179.36 43.35 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.393 -1.276 . . . . 1.0 111.027 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -147.88 116.35 6.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 128.229 2.611 . . . . 1.0 105.434 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.8 t0 54.17 32.48 15.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.858 2.463 . . . . 1.0 115.109 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.0 p 51.25 37.53 18.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.3 1.84 . . . . 1.0 113.212 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.44 146.46 54.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.749 1.62 . . . . 1.0 108.508 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -29.3 113.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.658 1.983 . . . . 1.0 111.206 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -78.36 -9.41 59.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.354 18.3 p 66.84 77.66 0.27 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 116.711 -1.614 . . . . 1.0 111.84 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.45 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 121.148 1.795 . . . . 1.0 113.729 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.12 -43.08 3.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.728 2.011 . . . . 1.0 110.245 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -55.53 -44.65 76.91 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.263 1.025 . . . . 1.0 111.461 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.55 -43.31 97.38 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.755 1.162 . . . . 1.0 109.902 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -63.08 -55.54 24.57 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' ILE . 82.3 mt-30 -66.01 -43.06 88.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.767 0.827 . . . . 1.0 111.08 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.75 -48.01 80.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.314 1.415 . . . . 1.0 108.902 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.06 89.53 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.292 -0.861 . . . . 1.0 109.438 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.58 -53.89 45.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.991 0.916 . . . . 1.0 110.797 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 115' ' ' ILE . 61.6 t -55.84 -53.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.0 m -57.88 -57.6 12.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.405 1.482 . . . . 1.0 110.452 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -56.19 -46.4 79.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.653 1.581 . . . . 1.0 110.738 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.38 72.15 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.968 -0.539 . . . . 1.0 111.379 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.71 -42.69 79.6 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.927 -1.108 . . . . 1.0 109.93 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.8 -41.03 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.673 1.189 . . . . 1.0 109.721 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.7 m -59.25 -13.08 6.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.337 1.055 . . . . 1.0 112.394 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -111.85 -43.61 3.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.275 -1.345 . . . . 1.0 111.39 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.52 112.81 23.03 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -97.97 107.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 121.286 1.495 . . . . 1.0 111.493 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.81 -54.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.71 2.004 . . . . 1.0 108.251 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 60.0 mt -49.77 -32.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 129.5 3.12 . . . . 1.0 110.813 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.36 -21.46 2.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.708 1.203 . . . . 1.0 113.345 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.57 18.39 3.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.881 2.072 . . . . 1.0 110.894 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -143.2 83.96 1.81 Allowed 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.125 -0.984 . . . . 1.0 109.899 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.26 127.9 40.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -158.53 -168.23 2.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.32 -0.992 . . . . 1.0 108.32 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.75 -131.67 1.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 106.7 -2.56 . . . . 1.0 106.7 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -113.78 -23.2 9.8 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.111 0.964 . . . . 1.0 111.276 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.3 -15.89 15.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.145 0.978 . . . . 1.0 109.543 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.82 38.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.173 -0.954 . . . . 1.0 109.759 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -68.92 -17.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.914 -1.116 . . . . 1.0 109.446 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -155.02 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.232 1.813 . . . . 1.0 111.453 175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 60.0 Cg_endo -92.3 110.24 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.795 2.33 . . . . 1.0 112.781 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -58.39 -25.95 62.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.346 1.858 . . . . 1.0 113.924 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -25.31 62.87 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.497 0.719 . . . . 1.0 112.794 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -127.69 139.73 52.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -127.65 -16.43 4.77 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.978 -0.378 . . . . 1.0 109.978 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.18 178.85 0.48 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 131.281 3.832 . . . . 1.0 103.725 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.13 85.63 1.36 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.186 1.924 . . . . 1.0 109.994 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.96 68.32 0.62 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.236 1.398 . . . . 1.0 111.64 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 168' ' ' SER . 71.9 Cg_endo -75.38 -70.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.688 2.259 . . . . 1.0 112.592 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.403 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 15.4 t 53.7 42.9 31.72 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.582 2.353 . . . . 1.0 111.408 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -99.56 18.92 16.75 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.11 -1.619 . . . . 1.0 113.9 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.8 t0 43.35 70.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.781 1.233 . . . . 1.0 112.93 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -56.27 -30.09 62.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 1.0 112.66 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.86 -60.07 3.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.037 0.835 . . . . 1.0 109.065 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -64.18 -34.54 78.32 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.371 -0.931 . . . . 1.0 111.967 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 85.6 t80 -66.01 -52.7 46.89 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.823 1.192 . . . . 1.0 110.618 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -34.64 74.6 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 119.049 -0.5 . . . . 1.0 109.985 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.06 89.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.868 0.867 . . . . 1.0 112.557 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.54 -58.86 3.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.793 1.237 . . . . 1.0 110.155 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 53.5 t -66.03 166.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.327 1.051 . . . . 1.0 110.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 109.765 176.092 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.86 139.77 41.86 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.964 0.347 . . . . 1.0 110.682 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 57.24 65.99 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 127.062 2.145 . . . . 1.0 112.818 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.41 148.48 37.89 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.262 1.425 . . . . 1.0 107.289 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -72.07 123.38 22.71 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.545 -2.391 . . . . 1.0 104.545 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.91 38.32 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.734 0.814 . . . . 1.0 111.929 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.67 72.92 77.08 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.066 0.946 . . . . 1.0 108.803 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.57 123.26 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 107.513 -1.764 . . . . 1.0 107.513 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -136.02 113.38 10.62 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.3 61.78 4.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.97 2.447 . . . . 1.0 108.926 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -124.01 44.69 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.892 -1.892 . . . . 1.0 105.892 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.495 ' HE1' HG22 ' A' ' 88' ' ' VAL . 14.4 m-85 -82.01 178.38 8.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.819 2.048 . . . . 1.0 113.466 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.87 -179.3 3.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 128.268 2.627 . . . . 1.0 112.912 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 m -157.65 118.59 3.54 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.173 4.589 . . . . 1.0 101.337 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -132.92 138.46 31.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 116.728 -1.606 . . . . 1.0 107.975 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.68 86.95 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.57 2.846 . . . . 1.0 108.675 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB2' HH12 ' A' ' 93' ' ' ARG . 13.2 m-20 -160.29 150.88 18.58 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.828 2.451 . . . . 1.0 106.226 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -151.49 104.06 3.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.322 1.849 . . . . 1.0 106.134 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.11 170.36 16.23 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.476 1.489 . . . . 1.0 108.138 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -75.43 123.19 88.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 119.905 -1.747 . . . . 1.0 109.033 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.22 103.54 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.967 1.778 . . . . 1.0 110.712 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 146' ' ' ALA . 11.3 t -171.08 77.23 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.55 -1.648 . . . . 1.0 106.55 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' A' ' 150' ' ' ASN . 5.0 tp -145.8 124.72 12.72 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.23 127.26 35.75 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.834 -1.543 . . . . 1.0 106.834 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.09 113.8 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 163' ' ' THR . 48.4 t -108.79 114.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 104.916 -2.253 . . . . 1.0 104.916 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -167.63 149.18 5.54 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 116.731 -1.604 . . . . 1.0 106.868 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -95.54 111.43 23.34 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 117.145 -1.822 . . . . 1.0 110.138 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -127.6 176.78 6.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 129.98 3.312 . . . . 1.0 107.273 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.1 t -149.15 121.04 8.16 Favored 'General case' 0 C--N 1.313 -1.016 1 N-CA-C 94.697 -6.038 . . . . 1.0 94.697 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 72' ' ' VAL 0.295 0.1 OUTLIER -142.36 -61.39 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.26 0.937 . . . . 1.0 109.8 175.603 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 11.8 Cg_exo -73.07 124.67 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.212 1.942 . . . . 1.0 110.013 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.8 68.89 7.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.538 2.825 . . . . 1.0 111.73 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.92 -71.1 0.69 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.855 -1.698 . . . . 1.0 108.855 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -152.33 123.48 7.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.545 1.938 . . . . 1.0 106.121 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -175.71 158.58 2.18 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.42 2.688 . . . . 1.0 107.857 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.84 -0.75 63.87 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.558 -1.134 . . . . 1.0 113.058 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 118.47 4.79 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.67 1.735 . . . . 1.0 110.903 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.35 -12.88 15.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.64 2.227 . . . . 1.0 114.101 -175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -61.81 -33.92 75.0 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.921 1.237 . . . . 1.0 111.017 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.6 mt -64.17 -55.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.314 -1.365 . . . . 1.0 107.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.6 -33.28 75.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.439 0.563 . . . . 1.0 112.271 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -53.25 -34.25 56.42 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.74 0.816 . . . . 1.0 111.3 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.36 -51.11 60.53 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.14 -0.975 . . . . 1.0 109.559 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -61.23 -50.63 72.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 1.0 110.884 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 50' ' ' ALA . 4.7 t -61.76 -33.91 74.91 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.346 1.458 . . . . 1.0 110.548 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.63 2.75 37.44 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.804 -1.554 . . . . 1.0 115.666 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.5 p -93.04 9.3 36.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.177 1.988 . . . . 1.0 113.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 tt -49.13 137.55 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.344 1.058 . . . . 1.0 112.19 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 136.33 20.75 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 126.415 1.886 . . . . 1.0 107.015 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.49 67.25 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.967 3.112 . . . . 1.0 110.296 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.56 -48.31 4.0 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.486 1.291 . . . . 1.0 114.486 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.46 -64.51 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.065 0.946 . . . . 1.0 112.76 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -171.04 178.01 0.87 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.376 1.47 . . . . 1.0 108.199 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.78 -43.9 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.848 2.365 . . . . 1.0 115.154 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -51.45 -59.04 4.68 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.984 1.266 . . . . 1.0 112.246 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.7 -49.22 69.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.718 0.807 . . . . 1.0 111.094 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.04 95.1 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.32 0.648 . . . . 1.0 111.595 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.43 -63.47 5.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 125.29 1.424 . . . . 1.0 110.751 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.33 -26.12 38.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-O 116.06 -1.924 . . . . 1.0 112.49 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.79 -43.22 3.89 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 121.002 1.728 . . . . 1.0 115.059 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -60.01 -34.5 73.43 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.499 0.72 . . . . 1.0 111.188 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.43 136.18 33.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.946 -2.613 . . . . 1.0 103.946 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 164.29 15.18 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.853 -1.154 . . . . 1.0 109.358 175.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 38' ' ' LEU . 29.1 m -116.58 166.39 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.346 1.058 . . . . 1.0 109.593 175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.5 m -170.73 121.56 0.58 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.351 1.46 . . . . 1.0 107.653 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.29 -155.5 0.48 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.382 1.873 . . . . 1.0 107.329 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -136.06 -59.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.327 1.851 . . . . 1.0 108.029 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HB2' HD13 ' A' ' 115' ' ' ILE . 78.1 m -132.63 118.97 19.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -109.01 113.63 26.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -95.37 114.25 31.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.173 -2.158 . . . . 1.0 105.173 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.92 148.91 43.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.394 0.997 . . . . 1.0 108.323 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -13.61 2.51 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.232 1.197 . . . . 1.0 114.232 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -91.82 23.41 3.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.258 1.023 . . . . 1.0 110.986 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.75 41.44 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 127.674 2.559 . . . . 1.0 112.891 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.98 154.63 44.33 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.077 0.951 . . . . 1.0 108.956 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.96 113.77 44.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.53 146.95 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.686 -1.598 . . . . 1.0 106.686 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -124.7 113.78 18.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.278 1.031 . . . . 1.0 108.876 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -114.05 114.8 26.61 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 104.149 -2.538 . . . . 1.0 104.149 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 19' ' ' TYR . 5.6 t 81.46 91.95 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.898 1.226 . . . . 1.0 109.254 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -64.83 -167.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.964 1.776 . . . . 1.0 110.289 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -77.29 51.26 0.83 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.377 -1.452 . . . . 1.0 110.976 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -154.99 129.57 9.18 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.545 2.738 . . . . 1.0 105.611 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.6 tttp 62.93 81.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.04 2.136 . . . . 1.0 112.773 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.434 HH12 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -35.45 155.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.138 2.975 . . . . 1.0 112.972 -176.208 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.272 . . -103.45 178.5 4.54 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.81 2.444 . . . . 1.0 114.42 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -151.79 118.05 5.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.855 2.062 . . . . 1.0 105.497 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -165.33 62.96 0.12 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.135 1.445 . . . . 1.0 109.734 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.89 -69.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 O-C-N 119.114 -2.241 . . . . 1.0 114.758 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.04 -78.04 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.6 t -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.166 0.987 . . . . 1.0 108.727 -176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 p -166.32 158.32 13.83 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.636 2.375 . . . . 1.0 106.956 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.448 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -161.25 145.57 13.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.13 -1.804 . . . . 1.0 106.13 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -166.03 155.05 11.49 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . 0.275 37.6 mm-40 39.16 58.01 1.91 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.46 1.904 . . . . 1.0 113.008 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.16 28.74 50.42 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.344 1.45 . . . . 1.0 114.247 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -128.9 113.26 15.01 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 26.5 tp10 -89.76 135.15 33.79 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.0 mtt85 -125.54 140.71 52.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.384 0.993 . . . . 1.0 109.155 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -86.32 -24.72 25.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.844 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -158.34 170.44 22.22 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.085 2.554 . . . . 1.0 106.238 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.5 76.3 10.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 123.095 1.426 . . . . 1.0 110.507 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.05 44.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.69 2.396 . . . . 1.0 110.297 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 m -123.5 156.56 35.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.439 1.495 . . . . 1.0 112.549 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.262 0.0 OUTLIER -97.65 56.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.705 2.002 . . . . 1.0 108.189 176.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.24 -135.38 3.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 136' ' ' VAL . 10.7 mm -143.92 161.12 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 128.827 2.851 . . . . 1.0 104.848 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -131.92 113.66 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 101.536 -3.505 . . . . 1.0 101.536 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.51 148.26 28.2 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.291 -1.374 . . . . 1.0 107.291 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.05 155.26 47.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.635 0.731 . . . . 1.0 112.175 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.12 173.4 43.57 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.811 -1.541 . . . . 1.0 111.556 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.4 p -137.89 103.15 4.9 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.484 1.913 . . . . 1.0 106.297 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 t70 57.87 30.46 19.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.041 1.736 . . . . 1.0 113.344 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.255 81.7 p 57.82 38.74 27.3 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.545 1.938 . . . . 1.0 113.444 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.66 145.58 52.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -28.36 113.46 0.07 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 128.059 2.543 . . . . 1.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -79.02 -9.84 59.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 115.163 -2.351 . . . . 1.0 116.043 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 43.6 p 65.08 77.04 0.32 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 121.801 2.091 . . . . 1.0 112.698 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -23.36 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.548 1.539 . . . . 1.0 114.578 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.05 -40.71 6.93 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.301 2.24 . . . . 1.0 111.379 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -47.73 -54.0 13.5 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.394 1.078 . . . . 1.0 109.378 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -59.13 -38.82 80.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.334 0.654 . . . . 1.0 111.597 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.59 -57.38 8.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.4 0.545 . . . . 1.0 110.888 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -65.08 -37.12 86.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.972 0.805 . . . . 1.0 110.765 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.1 tp -56.52 -47.88 78.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.43 1.014 . . . . 1.0 108.603 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.16 93.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.589 -0.72 . . . . 1.0 110.527 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.82 53.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.071 0.85 . . . . 1.0 110.292 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 115' ' ' ILE . 25.8 t -57.1 -48.61 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.909 -0.775 . . . . 1.0 108.909 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.0 m -56.45 -49.52 74.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.976 1.311 . . . . 1.0 110.438 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -59.02 -46.87 87.12 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.89 0.876 . . . . 1.0 109.944 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.3 77.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.864 0.302 . . . . 1.0 110.594 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.0 mt -55.94 -44.21 78.16 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.988 0.915 . . . . 1.0 111.187 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.73 -41.08 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.126 0.875 . . . . 1.0 110.432 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -65.69 -14.26 60.91 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.826 -1.171 . . . . 1.0 112.252 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.68 -59.24 1.78 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.632 1.105 . . . . 1.0 108.191 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -124.82 112.88 27.04 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -101.76 107.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 123.347 1.311 . . . . 1.0 112.465 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' SER . . . -152.29 -41.26 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.073 2.549 . . . . 1.0 105.85 174.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.4 mt -47.75 -33.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 128.869 2.868 . . . . 1.0 109.851 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.81 -26.25 13.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.023 0.929 . . . . 1.0 112.89 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -129.9 18.58 5.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.565 1.946 . . . . 1.0 109.992 175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.502 ' HB3' HD12 ' A' ' 30' ' ' LEU . 15.6 m-80 -138.84 83.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 122.221 1.01 . . . . 1.0 108.332 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.91 113.41 17.82 Favored 'General case' 0 N--CA 1.448 -0.563 1 N-CA-C 99.988 -4.079 . . . . 1.0 99.988 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -152.98 -166.67 2.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -149.41 -131.78 2.0 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.148 -2.381 . . . . 1.0 107.148 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -116.63 -23.76 8.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.467 1.134 . . . . 1.0 110.629 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.5 t -103.86 2.34 32.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 4.1 t-20 -104.08 22.83 13.98 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.356 1.463 . . . . 1.0 111.459 -175.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.59 -15.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.34 0.656 . . . . 1.0 111.949 -175.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.49 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -152.26 -57.48 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.847 1.659 . . . . 1.0 108.934 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.49 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 84.6 Cg_endo -79.4 117.12 3.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 CA-C-N 122.085 1.78 . . . . 1.0 112.204 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 156' ' ' ASN . 0.7 OUTLIER -59.31 -25.56 64.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.784 0.834 . . . . 1.0 111.926 175.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -62.32 -19.27 63.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.476 2.31 . . . . 1.0 114.905 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -137.25 141.92 42.0 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 2.5 m -130.94 -17.05 3.17 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 117.158 -1.817 . . . . 1.0 112.422 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.58 -178.34 0.28 Allowed Pre-proline 0 C--O 1.249 1.036 0 C-N-CA 128.894 2.878 . . . . 1.0 105.093 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 80.01 2.31 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 N-CA-C 106.704 -2.076 . . . . 1.0 106.704 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 128.38 79.15 0.25 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.105 1.812 . . . . 1.0 111.035 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.57 -113.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 123.93 3.087 . . . . 1.0 110.237 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 t 56.36 43.51 26.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.284 1.833 . . . . 1.0 112.807 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -95.94 17.68 14.86 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.351 1.46 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.0 t0 44.08 77.27 0.07 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.106 1.362 . . . . 1.0 112.351 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -54.98 -32.87 62.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.392 0.516 . . . . 1.0 112.392 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.38 78.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.723 0.692 . . . . 1.0 111.252 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -59.8 -57.61 12.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.916 0.78 . . . . 1.0 110.07 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.55 -50.29 74.33 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.33 -38.96 81.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 118.481 0.582 . . . . 1.0 110.403 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.67 76.17 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.839 0.681 . . . . 1.0 112.839 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.59 -44.71 66.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.322 1.049 . . . . 1.0 111.862 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.64 162.89 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.17 0.988 . . . . 1.0 109.745 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 124.367 1.067 . . . . 1.0 109.084 175.603 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.46 145.29 44.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.871 1.434 . . . . 1.0 114.871 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 40.25 58.77 2.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 128.085 2.554 . . . . 1.0 108.941 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.66 156.71 46.67 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.467 1.107 . . . . 1.0 110.624 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -88.81 123.76 33.52 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -83.59 132.58 34.9 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -137.1 70.34 56.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.25 135.18 11.91 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.874 2.382 . . . . 1.0 111.787 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 t -159.18 113.2 1.57 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 N-CA-C 104.846 -2.279 . . . . 1.0 104.846 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.11 69.83 7.75 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.57 2.18 . . . . 1.0 110.207 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -123.19 43.57 2.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.876 2.071 . . . . 1.0 107.109 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 88' ' ' VAL . 3.5 m-85 -106.7 177.78 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.087 1.355 . . . . 1.0 110.005 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.25 -175.15 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.055 2.142 . . . . 1.0 112.101 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.87 130.16 14.65 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.712 2.805 . . . . 1.0 104.377 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.29 171.33 6.9 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 119.407 1.003 . . . . 1.0 109.345 -175.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.1 76.64 4.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.103 1.869 . . . . 1.0 112.738 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -149.81 144.0 25.72 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.849 2.46 . . . . 1.0 108.516 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -144.0 104.2 4.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.879 -1.526 . . . . 1.0 106.879 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -136.27 157.58 46.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.349 1.46 . . . . 1.0 109.224 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -70.7 123.56 89.37 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 103.14 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.04 1.407 . . . . 1.0 110.394 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 t -177.9 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.53 -1.655 . . . . 1.0 106.53 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.512 HD21 ' CG2' ' A' ' 152' ' ' THR . 7.7 tt -155.51 137.31 14.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.623 -1.991 . . . . 1.0 105.623 175.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 147' ' ' ILE . 19.0 tp -99.21 125.44 44.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.878 0.871 . . . . 1.0 109.594 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.46 113.81 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.8 t -107.13 120.93 59.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 104.902 -2.259 . . . . 1.0 104.902 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -169.82 134.23 1.32 Allowed 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -90.45 112.26 23.82 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.602 -1.259 . . . . 1.0 107.602 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm -127.38 176.62 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 130.627 3.571 . . . . 1.0 107.259 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 t -140.77 122.71 15.5 Favored 'General case' 0 C--O 1.245 0.842 1 N-CA-C 95.789 -5.634 . . . . 1.0 95.789 174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.309 1.0 OUTLIER -141.79 -64.3 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 114.139 1.163 . . . . 1.0 114.139 176.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 159.86 33.91 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.275 1.134 . . . . 1.0 112.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HD3' ' CE1' ' A' ' 52' ' ' PHE . 92.1 Cg_endo -82.04 0.76 9.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.044 3.163 . . . . 1.0 116.524 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -19.82 -66.48 0.01 OUTLIER Glycine 0 C--N 1.347 1.181 0 C-N-CA 126.178 1.847 . . . . 1.0 112.607 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -152.68 123.7 7.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.169 1.388 . . . . 1.0 112.021 175.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -176.6 164.79 2.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.412 3.085 . . . . 1.0 108.617 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.97 18.75 16.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.534 2.016 . . . . 1.0 111.2 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.8 118.47 6.16 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 107.69 -2.164 . . . . 1.0 107.69 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.2 -19.4 26.0 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 CA-C-N 121.286 2.543 . . . . 1.0 113.682 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -56.95 -34.61 68.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.651 1.18 . . . . 1.0 112.705 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -66.06 -53.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.27 -33.22 75.26 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.773 -0.58 . . . . 1.0 112.228 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -47.19 -33.94 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.25 1.02 . . . . 1.0 111.017 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.08 -51.28 64.81 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.363 -0.835 . . . . 1.0 111.335 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 40' ' ' PRO . 70.1 m-85 -71.01 -39.43 72.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.377 1.071 . . . . 1.0 112.419 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 50' ' ' ALA . 3.1 t -66.35 -40.37 89.77 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 175.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.96 16.88 6.58 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 124.939 1.257 . . . . 1.0 115.55 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.5 p -110.84 18.39 19.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.894 1.847 . . . . 1.0 113.805 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.72 132.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.465 1.029 . . . . 1.0 111.509 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.66 136.81 20.62 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 127.558 2.343 . . . . 1.0 108.887 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.65 62.67 1.72 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.31 2.674 . . . . 1.0 113.157 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -103.53 -50.16 3.51 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.042 1.127 . . . . 1.0 114.042 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.49 -63.27 1.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.729 0.695 . . . . 1.0 112.333 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 7.0 p80 -170.83 178.01 0.89 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.653 1.581 . . . . 1.0 107.639 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 9.8 Cg_endo -62.67 -44.2 18.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.067 1.845 . . . . 1.0 114.789 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -51.36 -58.7 5.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.41 1.005 . . . . 1.0 111.855 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -43.73 98.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.716 0.806 . . . . 1.0 110.136 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.8 98.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.404 -0.81 . . . . 1.0 111.817 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.44 -63.02 5.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.147 2.308 . . . . 1.0 112.742 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 pt -57.57 -34.26 46.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.9 -1.048 . . . . 1.0 113.077 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.5 -43.79 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 117.236 2.31 . . . . 1.0 117.236 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -64.88 -33.61 76.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.848 0.459 . . . . 1.0 110.189 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.83 119.6 25.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.137 -1.801 . . . . 1.0 106.137 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.33 132.64 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.621 -0.674 . . . . 1.0 109.841 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.65 162.79 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.366 1.466 . . . . 1.0 111.108 -175.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.633 ' HB3' HG21 ' A' ' 88' ' ' VAL . 71.2 m -161.7 115.94 1.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.749 0.82 . . . . 1.0 109.363 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.45 -156.98 0.53 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.628 1.171 . . . . 1.0 108.809 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -134.87 -75.98 0.46 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.645 ' HB2' HD13 ' A' ' 115' ' ' ILE . 55.5 m -124.08 118.28 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 102.207 -3.257 . . . . 1.0 102.207 175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.03 113.57 27.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 103.688 -2.708 . . . . 1.0 103.688 176.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.62 122.04 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.174 -1.787 . . . . 1.0 106.174 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.04 150.16 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -57.12 -14.75 4.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.924 -1.512 . . . . 1.0 114.144 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.34 19.33 6.12 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 120.505 1.502 . . . . 1.0 112.267 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.78 51.88 54.33 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.028 1.775 . . . . 1.0 112.58 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.27 111.02 16.85 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.586 -1.635 . . . . 1.0 106.586 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.7 mt -79.74 120.17 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.669 -1.604 . . . . 1.0 106.669 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.66 141.4 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 102.819 -3.03 . . . . 1.0 102.819 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 116.87 21.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -118.38 131.02 56.31 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.966 2.507 . . . . 1.0 105.615 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.807 HG22 ' CE1' ' A' ' 19' ' ' TYR . 3.0 t 69.05 91.51 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 120.726 1.603 . . . . 1.0 111.465 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' ASP . 74.0 Cg_endo -66.32 -169.48 0.17 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.827 2.351 . . . . 1.0 112.026 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -69.59 30.41 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.319 1.447 . . . . 1.0 110.668 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 89' ' ' PRO . 3.0 t0 -144.5 115.32 7.78 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 128.57 2.748 . . . . 1.0 108.305 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.14 82.19 0.06 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.241 2.616 . . . . 1.0 112.486 174.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -34.38 146.22 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.337 2.655 . . . . 1.0 114.834 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.09 -178.55 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.863 2.065 . . . . 1.0 113.194 -175.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -155.91 118.28 4.12 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.63 2.372 . . . . 1.0 108.472 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -161.01 63.03 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.715 1.245 . . . . 1.0 109.402 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.83 -70.85 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 119.627 -1.921 . . . . 1.0 113.261 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.93 -74.7 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 106.35 -2.7 . . . . 1.0 106.35 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.19 140.53 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.582 1.191 . . . . 1.0 110.061 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.3 p -166.32 162.45 17.23 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.969 1.307 . . . . 1.0 110.282 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 11.0 p -166.23 146.79 6.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.736 1.614 . . . . 1.0 108.928 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -156.39 147.24 21.95 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.333 0.97 . . . . 1.0 110.674 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 38.91 56.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.343 1.857 . . . . 1.0 112.142 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.95 28.89 69.41 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.289 0.947 . . . . 1.0 114.527 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -128.63 113.79 15.86 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -89.96 146.5 24.33 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -123.17 118.89 28.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.031 0.533 . . . . 1.0 111.108 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.52 -25.8 50.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.976 0.91 . . . . 1.0 110.042 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.67 168.88 18.86 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 127.558 2.343 . . . . 1.0 107.857 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -88.18 75.91 8.54 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.98 33.83 1.84 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.521 1.128 . . . . 1.0 112.276 -175.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -126.94 131.07 51.18 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.938 0.895 . . . . 1.0 109.542 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.289 0.1 OUTLIER -79.01 56.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.214 1.806 . . . . 1.0 110.073 -177.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.44 -133.26 3.42 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 122.578 1.099 . . . . 1.0 111.684 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 76' ' ' CYS . 20.6 mm -137.03 166.38 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.351 3.46 . . . . 1.0 104.085 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -144.85 135.38 24.42 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 101.839 -3.393 . . . . 1.0 101.839 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.3 165.69 11.14 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.522 -1.361 . . . . 1.0 110.412 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.15 150.35 49.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.771 0.829 . . . . 1.0 110.256 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.1 175.6 45.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.872 1.262 . . . . 1.0 112.383 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.5 p -141.28 110.1 6.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.983 2.113 . . . . 1.0 106.111 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 t0 45.67 48.73 11.43 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 128.301 2.64 . . . . 1.0 111.82 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p 50.7 38.08 18.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.776 2.831 . . . . 1.0 115.404 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.4 145.92 50.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.123 2.169 . . . . 1.0 110.55 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.34 114.68 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 129.405 3.082 . . . . 1.0 110.987 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -84.36 -8.05 59.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 114.123 -2.846 . . . . 1.0 113.155 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.391 26.5 p 64.9 77.92 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 122.568 2.44 . . . . 1.0 115.014 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -23.22 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 121.073 1.76 . . . . 1.0 114.815 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.9 -43.1 13.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.827 2.051 . . . . 1.0 110.733 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -50.15 -50.72 48.0 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 118.299 -0.857 . . . . 1.0 109.738 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -60.56 -36.36 78.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 117.559 -1.21 . . . . 1.0 111.222 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -65.29 -60.04 3.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.512 1.051 . . . . 1.0 109.713 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -62.8 -41.45 99.28 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.483 0.313 . . . . 1.0 111.138 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.01 -52.98 63.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.812 1.645 . . . . 1.0 109.122 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.71 76.23 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 118.289 -0.862 . . . . 1.0 110.273 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.79 52.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.683 0.793 . . . . 1.0 108.929 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.633 HG11 HD11 ' A' ' 115' ' ' ILE . 47.4 t -55.61 -50.29 68.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -58.27 -57.39 13.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.266 1.026 . . . . 1.0 112.13 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -55.79 -43.16 76.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.537 1.062 . . . . 1.0 110.328 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.85 51.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.788 -0.57 . . . . 1.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.53 -34.06 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.144 1.378 . . . . 1.0 112.105 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 mt -63.58 -39.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.405 -1.332 . . . . 1.0 107.405 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.8 m -64.53 -14.35 57.02 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.297 1.039 . . . . 1.0 110.4 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -64.93 1.07 Allowed 'General case' 0 C--N 1.347 0.47 0 O-C-N 120.24 -1.538 . . . . 1.0 106.942 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.85 113.01 24.66 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 106.922 -1.511 . . . . 1.0 106.922 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -88.65 107.25 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.865 1.702 . . . . 1.0 111.288 -175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.27 -51.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.296 1.438 . . . . 1.0 108.723 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.0 mt -46.04 -35.11 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 130.823 3.649 . . . . 1.0 111.789 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.06 63.49 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -131.39 18.34 4.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.353 2.261 . . . . 1.0 109.803 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -143.17 83.45 1.79 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 49.4 mtt -121.67 122.02 38.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.666 -2.716 . . . . 1.0 103.666 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 30' ' ' LEU . 5.2 t -158.65 -176.45 5.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.02 -131.33 2.89 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 105.787 -2.925 . . . . 1.0 105.787 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -118.15 -23.12 7.47 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.134 0.974 . . . . 1.0 110.63 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.4 t -103.36 -18.4 14.86 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -91.78 45.83 1.25 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.925 1.29 . . . . 1.0 107.521 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -71.45 -14.68 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.319 -1.488 . . . . 1.0 109.933 175.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -153.65 -65.95 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 127.304 2.241 . . . . 1.0 107.334 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 89.7 Cg_endo -76.16 113.29 3.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.932 1.726 . . . . 1.0 113.382 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -18.71 36.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.121 1.368 . . . . 1.0 112.056 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.11 -25.99 64.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.536 1.934 . . . . 1.0 112.759 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -139.6 135.14 33.03 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.499 -2.037 . . . . 1.0 105.499 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 37.4 m -119.96 -16.49 8.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.103 0.408 . . . . 1.0 112.103 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.24 175.35 1.31 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.689 2.795 . . . . 1.0 105.095 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.73 69.3 7.85 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.953 2.435 . . . . 1.0 109.563 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.33 69.69 0.21 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.978 2.704 . . . . 1.0 108.54 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 87.4 Cg_endo -82.39 -87.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.022 3.148 . . . . 1.0 112.263 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 t 53.49 73.35 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.211 3.005 . . . . 1.0 109.214 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 56.8 t80 -119.35 18.97 12.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.411 1.085 . . . . 1.0 113.885 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.13 74.54 0.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.879 -1.763 . . . . 1.0 112.759 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -58.65 -31.57 68.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.866 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.07 77.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.857 -1.068 . . . . 1.0 110.666 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -60.81 -51.66 68.37 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.555 1.07 . . . . 1.0 110.516 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -60.79 -56.48 20.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.213 0.82 . . . . 1.0 113.213 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -64.29 -25.63 68.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.018 -0.991 . . . . 1.0 112.176 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.79 83.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.042 0.837 . . . . 1.0 111.093 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.16 -59.9 2.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.327 1.451 . . . . 1.0 111.019 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.48 166.02 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.546 0.794 0 C-N-CA 124.329 1.051 . . . . 1.0 110.225 179.177 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 103.957 -2.609 . . . . 1.0 103.957 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.91 175.04 7.02 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.19 0.996 . . . . 1.0 112.186 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 43.87 58.17 3.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.229 1.812 . . . . 1.0 109.697 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.0 132.93 7.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.462 1.905 . . . . 1.0 107.322 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -63.83 123.47 19.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 142.36 28.54 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.999 -1.063 . . . . 1.0 109.681 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.34 70.4 72.99 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 105.351 -2.092 . . . . 1.0 105.351 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.21 124.22 9.82 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.639 2.226 . . . . 1.0 111.047 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -160.24 113.46 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.67 71.1 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.866 2.377 . . . . 1.0 110.756 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -123.69 54.2 1.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.783 1.633 . . . . 1.0 107.281 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.8 m-30 -95.53 -175.71 3.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.302 2.241 . . . . 1.0 112.352 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.09 -177.08 3.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.959 2.104 . . . . 1.0 108.488 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 m -163.77 122.11 1.91 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 130.135 3.374 . . . . 1.0 103.82 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.8 152.94 52.21 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -80.88 36.6 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.991 2.461 . . . . 1.0 113.344 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.11 143.22 37.15 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.873 2.469 . . . . 1.0 104.497 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -146.69 103.26 3.64 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 9.2 tp10 -137.04 165.36 26.22 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -68.67 124.1 89.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.447 1.099 . . . . 1.0 110.695 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.5 113.94 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.025 2.484 . . . . 1.0 111.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t 178.91 85.29 0.01 OUTLIER 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.616 1.967 . . . . 1.0 105.983 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tp -148.32 143.15 26.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.259 -1.756 . . . . 1.0 106.259 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp -110.68 116.06 30.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.996 -1.853 . . . . 1.0 105.996 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.78 122.73 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.3 t -112.95 120.7 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -167.04 128.56 1.63 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 107.526 -1.287 . . . . 1.0 107.526 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -80.34 112.63 17.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 116.63 -2.028 . . . . 1.0 108.142 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -128.13 176.97 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 C-N-CA 131.993 4.117 . . . . 1.0 106.086 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 t -152.09 121.95 7.03 Favored 'General case' 0 N--CA 1.44 -0.96 1 N-CA-C 95.305 -5.813 . . . . 1.0 95.305 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.82 -66.17 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.511 0 CA-C-N 119.432 1.014 . . . . 1.0 110.86 175.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 4.0 Cg_exo -76.65 136.33 17.06 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.16 2.574 . . . . 1.0 110.838 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.86 77.76 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.73 1.62 . . . . 1.0 111.919 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.08 -72.09 0.72 Allowed Glycine 0 CA--C 1.533 1.194 0 N-CA-C 105.308 -3.117 . . . . 1.0 105.308 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -155.34 122.89 5.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.012 1.725 . . . . 1.0 107.857 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -176.84 167.64 2.55 Favored 'General case' 0 N--CA 1.469 0.523 1 C-N-CA 132.107 4.163 . . . . 1.0 107.157 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.99 16.11 20.75 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.088 1.328 . . . . 1.0 111.691 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.52 118.78 4.89 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 -7.69 21.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.018 2.479 . . . . 1.0 114.143 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -60.78 -38.86 86.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.638 1.108 . . . . 1.0 109.808 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 38' ' ' LEU . 58.7 mt -66.16 -46.58 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.68 -47.76 79.15 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.697 -0.627 . . . . 1.0 110.675 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.5 -33.66 63.91 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.479 1.512 . . . . 1.0 111.794 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.2 -57.45 10.46 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.23 1.012 . . . . 1.0 109.744 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -64.76 -45.24 87.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.834 0.854 . . . . 1.0 112.423 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 50' ' ' ALA . 5.2 t -65.86 -37.12 85.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.07 0.948 . . . . 1.0 109.853 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.11 37.94 3.96 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.36 -1.245 . . . . 1.0 115.648 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 p -130.68 20.61 5.09 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.398 1.599 . . . . 1.0 112.163 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.29 151.32 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.996 1.319 . . . . 1.0 112.26 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -98.68 129.36 30.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 127.271 2.228 . . . . 1.0 107.937 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.82 67.99 3.07 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.33 3.353 . . . . 1.0 109.599 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -104.77 -65.63 1.02 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.026 1.33 . . . . 1.0 112.64 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.68 4.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.177 1.391 . . . . 1.0 112.772 -175.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 21.4 p80 -170.5 177.86 0.95 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.559 1.544 . . . . 1.0 107.86 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.2 Cg_endo -70.93 -43.44 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.536 1.49 . . . . 1.0 115.34 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -50.62 -58.31 6.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.005 1.275 . . . . 1.0 113.026 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -45.04 91.79 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.0 0.92 . . . . 1.0 111.005 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.77 86.86 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.704 -0.622 . . . . 1.0 111.997 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -60.36 9.05 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 125.797 1.665 . . . . 1.0 111.271 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.2 -32.45 40.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 116.435 -1.745 . . . . 1.0 112.052 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -35.86 -43.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.241 2.216 . . . . 1.0 115.775 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -62.19 -39.84 94.05 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.846 1.258 . . . . 1.0 109.949 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.88 135.25 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.519 -2.401 . . . . 1.0 104.519 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 159.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.057 -1.027 . . . . 1.0 108.595 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.49 164.27 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.911 1.284 . . . . 1.0 107.867 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.5 m -164.31 118.2 1.41 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.334 0.654 . . . . 1.0 110.31 175.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.79 -153.89 0.35 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -129.94 -62.19 0.96 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.3 1.44 . . . . 1.0 108.598 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -130.4 119.05 22.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.86 113.43 25.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.816 -2.661 . . . . 1.0 103.816 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 mt -100.91 124.45 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -83.95 148.0 27.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -16.38 0.77 Allowed 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 115.314 1.598 . . . . 1.0 115.314 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.99 22.45 4.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.12 56.23 23.4 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.425 -1.422 . . . . 1.0 112.808 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -128.7 143.34 50.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mt -116.46 125.6 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.059 1.3 . . . . 1.0 109.973 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.3 t -111.75 153.29 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.572 -2.01 . . . . 1.0 105.572 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -125.73 120.6 31.07 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.106 -0.996 . . . . 1.0 110.27 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -120.56 113.61 20.52 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 103.352 -2.833 . . . . 1.0 103.352 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.671 HG22 ' CE1' ' A' ' 19' ' ' TYR . 9.1 t 80.17 91.84 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 121.412 1.914 . . . . 1.0 114.461 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.35 -173.52 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.313 2.675 . . . . 1.0 111.816 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -80.65 51.59 1.52 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.873 -1.142 . . . . 1.0 108.989 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -148.86 113.04 5.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 130.287 3.435 . . . . 1.0 105.806 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.358 27.9 tttp 73.64 82.37 0.12 Allowed 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 115.497 1.665 . . . . 1.0 115.497 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 ttm-85 -32.72 138.11 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.855 2.862 . . . . 1.0 111.388 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.96 -178.87 3.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.118 1.767 . . . . 1.0 113.247 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -148.01 120.26 8.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.051 1.74 . . . . 1.0 109.976 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -162.08 62.85 0.23 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 106.49 -1.67 . . . . 1.0 106.49 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.8 -65.2 0.09 Allowed 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 119.356 -2.09 . . . . 1.0 114.082 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.16 -68.25 0.71 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.99 -0.895 . . . . 1.0 112.873 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.3 t -132.25 136.23 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.071 1.348 . . . . 1.0 109.726 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 p -166.35 137.13 3.44 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.54 1.136 . . . . 1.0 111.136 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.417 ' H ' HG22 ' A' ' 157' ' ' ILE . 16.1 p -154.96 132.42 11.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.48 -2.415 . . . . 1.0 104.48 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -152.96 159.66 42.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.117 0.871 . . . . 1.0 108.907 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 41.66 53.69 3.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.331 1.452 . . . . 1.0 111.11 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.53 32.49 53.2 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.951 -0.916 . . . . 1.0 113.382 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -139.54 114.88 9.8 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 119.084 1.442 . . . . 1.0 107.81 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.36 144.69 35.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -123.51 118.42 27.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.9 t -53.04 -39.15 63.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.663 0.665 . . . . 1.0 111.012 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -143.68 162.41 36.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.753 3.221 . . . . 1.0 104.896 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.298 28.6 t70 -86.95 76.71 9.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 123.283 1.516 . . . . 1.0 109.297 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -75.24 44.19 0.24 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 131.133 3.773 . . . . 1.0 110.255 175.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -123.15 155.43 37.05 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.133 1.373 . . . . 1.0 112.289 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.2 57.08 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.914 2.486 . . . . 1.0 109.005 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.21 -136.9 6.05 Favored Glycine 0 CA--C 1.527 0.834 0 O-C-N 120.174 -1.578 . . . . 1.0 114.055 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 133' ' ' LEU . 8.1 mm -142.12 159.55 20.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 129.129 2.972 . . . . 1.0 103.776 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.54 119.05 9.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.094 -2.928 . . . . 1.0 103.094 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.14 133.23 34.47 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.604 -1.31 . . . . 1.0 107.635 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -103.52 138.51 40.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.904 0.882 . . . . 1.0 108.765 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.55 33.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.699 1.142 . . . . 1.0 110.484 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.1 p -150.31 113.57 4.89 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.85 41.42 22.51 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.58 1.552 . . . . 1.0 114.384 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 45.77 38.16 4.04 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.295 1.838 . . . . 1.0 113.014 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -59.89 138.02 57.92 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.894 -1.891 . . . . 1.0 105.894 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.53 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.567 2.347 . . . . 1.0 111.25 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.54 -4.29 47.92 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 116.468 -1.73 . . . . 1.0 115.147 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.315 73.5 p 55.37 78.02 0.2 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.465 -1.731 . . . . 1.0 113.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -23.31 -33.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.176 2.591 . . . . 1.0 113.421 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.04 -35.71 7.14 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.485 1.914 . . . . 1.0 110.148 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.7 -50.14 63.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.342 0.973 . . . . 1.0 109.959 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.41 -39.19 86.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.672 0.789 . . . . 1.0 110.43 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.02 -54.52 28.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.844 1.258 . . . . 1.0 109.839 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -66.52 -47.47 72.83 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 0.68 . . . . 1.0 111.146 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 115' ' ' ILE . 25.1 tp -50.7 -49.51 57.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.874 1.27 . . . . 1.0 109.74 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.09 89.36 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 119.172 0.897 . . . . 1.0 110.519 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.33 59.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.424 0.689 . . . . 1.0 110.561 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.72 -46.5 62.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.4 m -59.9 -43.36 94.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.459 1.104 . . . . 1.0 110.576 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -58.82 -47.47 84.7 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.605 1.093 . . . . 1.0 109.564 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.73 -58.19 9.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.227 1.011 . . . . 1.0 109.253 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.3 -38.1 68.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.871 -1.062 . . . . 1.0 113.554 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.7 mt -61.25 -49.38 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 120.041 1.291 . . . . 1.0 108.991 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.5 m -66.36 -20.53 66.1 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.272 -0.268 . . . . 1.0 110.811 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -83.64 -57.1 3.37 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.01 1.724 . . . . 1.0 108.943 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.46 112.97 23.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 106.537 -1.653 . . . . 1.0 106.537 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -95.07 107.87 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 CA-C-N 120.848 1.339 . . . . 1.0 113.459 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.99 -50.64 0.11 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.855 1.662 . . . . 1.0 108.471 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.35 -33.64 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 129.689 3.196 . . . . 1.0 111.282 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.73 -21.98 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.704 1.601 . . . . 1.0 113.994 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -141.43 18.6 2.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.889 1.676 . . . . 1.0 110.398 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -138.44 84.17 2.01 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.707 -1.246 . . . . 1.0 108.046 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.0 mtt -121.5 114.38 21.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.8 t -145.37 -169.37 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.78 -131.51 2.57 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 106.285 -2.726 . . . . 1.0 106.285 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -117.49 -23.17 7.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.052 1.341 . . . . 1.0 109.314 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -23.07 13.82 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -84.14 42.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.539 1.063 . . . . 1.0 108.367 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.6 -14.14 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 O-C-N 120.073 -1.642 . . . . 1.0 108.281 175.285 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.506 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -158.02 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 128.634 2.774 . . . . 1.0 111.584 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 91.7 Cg_endo -79.61 108.44 2.29 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.199 1.933 . . . . 1.0 113.144 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -62.33 -21.68 65.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.246 1.418 . . . . 1.0 111.813 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -67.59 -24.39 65.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.656 -1.277 . . . . 1.0 113.002 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -132.7 124.29 27.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.177 -2.156 . . . . 1.0 105.177 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -114.18 -17.41 11.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.624 -1.23 . . . . 1.0 111.479 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.69 178.98 0.41 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 131.398 3.879 . . . . 1.0 103.603 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 91.64 0.65 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 121.697 1.642 . . . . 1.0 108.07 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 114.18 76.81 0.73 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.776 1.655 . . . . 1.0 111.263 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.83 -90.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.553 2.836 . . . . 1.0 110.452 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t 53.01 46.85 25.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.695 2.398 . . . . 1.0 113.782 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -118.24 16.46 14.0 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.851 -1.156 . . . . 1.0 112.629 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.5 t0 43.84 80.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.068 -1.645 . . . . 1.0 113.756 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -62.73 -33.93 76.13 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.237 -0.915 . . . . 1.0 112.396 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.47 91.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.299 0.954 . . . . 1.0 110.934 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -65.91 -52.52 49.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.115 0.87 . . . . 1.0 110.237 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.86 -51.84 67.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -62.04 -35.42 78.55 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.222 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.62 80.71 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.6 -46.91 62.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.128 0.571 . . . . 1.0 110.046 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.18 166.52 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.618 1.967 . . . . 1.0 111.488 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.547 0.84 0 C-N-CA 127.168 2.187 . . . . 1.0 108.499 175.144 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 C--O 1.237 0.436 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.09 172.45 12.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.542 0.61 . . . . 1.0 110.738 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 37.51 57.85 1.36 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.959 2.904 . . . . 1.0 110.71 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.03 156.73 22.53 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.155 -0.966 . . . . 1.0 110.074 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -88.0 123.06 32.33 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.152 0.433 . . . . 1.0 111.769 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -98.22 130.02 44.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.47 1.108 . . . . 1.0 111.212 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.87 92.43 9.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.987 0.915 . . . . 1.0 108.654 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.4 160.47 44.62 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.54 1.493 . . . . 1.0 112.576 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 t -159.94 113.41 1.45 Allowed Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.4 61.17 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.792 2.328 . . . . 1.0 111.983 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -133.53 43.26 2.91 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.099 1.76 . . . . 1.0 107.068 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.6 m-85 -73.84 178.47 4.85 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.994 1.317 . . . . 1.0 109.832 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.07 178.79 4.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 124.117 1.913 . . . . 1.0 113.953 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -138.13 118.44 13.68 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 111.921 -2.4 . . . . 1.0 106.729 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -126.16 167.26 17.52 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 129.045 2.938 . . . . 1.0 106.144 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -179.1 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.619 1.546 . . . . 1.0 109.132 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.85 143.33 45.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.627 -2.361 . . . . 1.0 104.627 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -150.99 167.33 27.96 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 102.727 -3.064 . . . . 1.0 102.727 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.77 163.46 24.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.713 1.605 . . . . 1.0 108.962 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.39 123.59 3.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.307 2.243 . . . . 1.0 110.282 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HB2' ' H ' ' A' ' 113' ' ' ILE . 63.2 Cg_endo -66.11 135.28 39.86 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.495 2.797 . . . . 1.0 111.008 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 t 178.88 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.523 1.929 . . . . 1.0 106.768 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.27 125.15 6.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.1 126.01 39.07 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.77 144.31 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 104.593 -2.373 . . . . 1.0 104.593 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 169' ' ' PHE . 47.2 t -135.67 113.88 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.544 -3.132 . . . . 1.0 102.544 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -167.39 143.04 4.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.51 112.51 21.61 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.868 0.73 . . . . 1.0 109.409 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.4 176.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.629 1.972 . . . . 1.0 107.387 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 t -141.47 122.4 14.51 Favored 'General case' 0 N--CA 1.442 -0.834 1 N-CA-C 95.345 -5.798 . . . . 1.0 95.345 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.353 0.7 OUTLIER -142.58 -66.7 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 116.337 -1.792 . . . . 1.0 115.162 -178.656 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 32.2 Cg_endo -94.38 157.74 2.03 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.588 2.192 . . . . 1.0 114.783 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.25 51.72 4.02 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 125.215 3.943 . . . . 1.0 117.487 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.15 -71.2 0.83 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 107.373 -2.291 . . . . 1.0 107.373 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -156.32 122.82 5.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.72 2.008 . . . . 1.0 108.251 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -176.74 161.74 2.09 Favored 'General case' 0 C--O 1.235 0.295 1 C-N-CA 132.745 4.418 . . . . 1.0 108.229 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.18 4.0 29.99 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.522 1.058 . . . . 1.0 111.005 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.81 119.09 4.88 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 117.952 -1.471 . . . . 1.0 110.015 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -5.48 14.08 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.78 2.32 . . . . 1.0 114.771 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -60.9 -47.63 85.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.565 1.984 . . . . 1.0 110.926 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 mt -62.27 -51.28 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.35 -46.91 86.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.308 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -60.1 -37.48 80.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.04 0.936 . . . . 1.0 111.361 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.2 -49.94 73.76 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.485 0.584 . . . . 1.0 110.143 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -70.85 -46.91 61.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.177 -0.439 . . . . 1.0 110.93 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -65.9 -37.83 87.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.516 1.126 . . . . 1.0 109.63 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 8.09 11.26 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.915 1.721 . . . . 1.0 115.513 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -104.3 19.4 20.29 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.234 2.017 . . . . 1.0 113.34 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -59.41 125.25 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.306 1.442 . . . . 1.0 111.709 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.14 136.65 20.46 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.44 1.896 . . . . 1.0 110.671 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -71.36 70.38 2.5 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.788 2.992 . . . . 1.0 111.225 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -103.3 -62.5 1.28 Allowed 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.659 -0.651 . . . . 1.0 111.808 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.22 76.0 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.949 0.5 . . . . 1.0 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.3 p80 -170.63 177.98 0.91 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.865 1.666 . . . . 1.0 107.396 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.8 Cg_endo -69.8 -43.33 2.69 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 1.0 114.718 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -46.47 -51.05 16.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -57.48 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.128 0.971 . . . . 1.0 111.243 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.2 96.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.671 0.788 . . . . 1.0 111.05 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.04 -61.47 3.94 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.171 1.843 . . . . 1.0 111.672 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 pt -59.89 -33.98 54.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 116.743 -1.599 . . . . 1.0 112.709 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.38 -43.15 2.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.538 1.935 . . . . 1.0 115.154 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -54.67 -36.51 64.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.912 0.885 . . . . 1.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 136.54 33.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.352 -2.462 . . . . 1.0 104.352 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -60.49 152.06 26.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.088 -1.007 . . . . 1.0 108.55 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.7 158.7 17.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.481 1.112 . . . . 1.0 110.273 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -171.59 128.68 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.875 2.07 . . . . 1.0 108.127 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.13 -172.2 2.61 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -120.77 -59.71 1.72 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -138.97 118.72 13.13 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.433 -1.691 . . . . 1.0 106.433 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.77 113.47 26.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -95.44 118.28 41.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.077 -1.823 . . . . 1.0 106.077 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -72.67 148.3 44.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 117.994 -1.003 . . . . 1.0 108.304 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -45.45 -35.14 3.55 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 113.438 0.903 . . . . 1.0 113.438 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -91.67 36.64 0.95 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.882 0.873 . . . . 1.0 112.068 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.17 52.76 49.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.274 1.416 . . . . 1.0 115.299 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -119.49 111.92 18.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.388 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 132' ' ' GLN . 86.6 mt -85.78 113.88 24.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.295 -2.113 . . . . 1.0 105.295 175.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 140.27 30.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.273 -1.751 . . . . 1.0 106.273 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -121.85 114.87 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.487 1.115 . . . . 1.0 108.321 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -114.11 121.06 42.64 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 103.538 -2.764 . . . . 1.0 103.538 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 19' ' ' TYR . 88.4 t 70.8 92.01 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 121.041 1.746 . . . . 1.0 111.344 -177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.57 -168.4 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.405 2.737 . . . . 1.0 111.891 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -59.61 2.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.965 2.506 . . . . 1.0 115.596 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -125.58 135.08 51.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 128.025 2.53 . . . . 1.0 104.372 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.261 14.4 tptp 77.19 82.15 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.303 1.841 . . . . 1.0 111.882 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -34.11 136.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.521 1.928 . . . . 1.0 113.878 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.64 -178.39 3.65 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.451 2.3 . . . . 1.0 108.989 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -148.2 118.58 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.77 62.89 0.47 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.591 -1.318 . . . . 1.0 111.035 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' A' ' 154' ' ' HIS . . . -168.74 -68.22 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 119.177 -2.202 . . . . 1.0 113.99 -175.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.99 -84.57 0.37 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 106.959 -2.456 . . . . 1.0 106.959 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.85 145.45 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.683 1.242 . . . . 1.0 109.468 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.6 p -165.97 145.47 6.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.8 1.24 . . . . 1.0 111.248 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.504 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -133.23 146.55 51.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.43 1.892 . . . . 1.0 109.79 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.72 148.91 28.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 41.53 53.5 3.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.24 1.816 . . . . 1.0 110.224 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.66 28.43 56.58 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.167 1.841 . . . . 1.0 116.277 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -132.82 136.6 46.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.145 1.973 . . . . 1.0 107.08 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 15.0 tp10 -96.2 145.79 25.24 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.65 1.18 . . . . 1.0 109.222 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -112.7 120.28 40.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.413 -2.069 . . . . 1.0 105.413 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.7 t -54.42 -31.2 54.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 1.0 112.826 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -164.27 176.29 9.3 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 129.552 3.141 . . . . 1.0 104.602 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -81.29 76.45 8.23 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 123.038 1.399 . . . . 1.0 109.628 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -80.94 33.52 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.233 1.813 . . . . 1.0 110.62 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 m -129.54 143.26 50.75 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 124.182 0.993 . . . . 1.0 113.124 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.524 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -80.01 57.09 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.56 2.344 . . . . 1.0 107.825 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.41 -136.58 1.35 Allowed Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.526 1.07 . . . . 1.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 133' ' ' LEU . 8.2 mm -143.19 163.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 103.299 -2.852 . . . . 1.0 103.299 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.71 130.79 23.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.471 -2.788 . . . . 1.0 103.471 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mp -101.13 166.03 11.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.529 0.681 . . . . 1.0 109.387 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.42 158.38 44.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.979 0.895 . . . . 1.0 111.4 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.75 173.04 45.4 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 113.759 -1.564 . . . . 1.0 110.876 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.8 p -141.14 101.94 4.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.796 -1.928 . . . . 1.0 105.796 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t70 49.48 55.74 8.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.584 1.954 . . . . 1.0 111.842 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.321 18.6 p 47.29 38.69 7.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.836 2.854 . . . . 1.0 115.131 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.55 146.19 55.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -38.14 114.13 0.34 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.14 2.176 . . . . 1.0 112.679 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -79.06 0.54 27.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 116.202 -1.856 . . . . 1.0 114.541 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.506 4.8 p 55.43 77.97 0.2 Allowed 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.017 -2.42 . . . . 1.0 117.443 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -23.4 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 122.479 2.399 . . . . 1.0 116.346 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.87 -41.73 16.22 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.722 1.609 . . . . 1.0 109.549 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.97 -50.92 60.31 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.919 0.887 . . . . 1.0 110.549 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -59.99 -43.27 95.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.221 0.918 . . . . 1.0 110.157 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.12 -51.05 61.63 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.864 0.466 . . . . 1.0 110.754 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.481 ' HB3' HD11 ' A' ' 84' ' ' ILE . 38.2 mm-40 -62.84 -50.2 71.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.142 1.777 . . . . 1.0 109.713 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 115' ' ' ILE . 35.7 tp -54.14 -49.08 70.05 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.4 76.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 1.0 111.37 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.42 55.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.7 0.8 . . . . 1.0 109.253 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.52 -47.69 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.8 m -52.75 -48.84 66.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.696 1.598 . . . . 1.0 110.232 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -59.66 -46.93 87.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.795 0.725 . . . . 1.0 111.951 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.17 74.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.271 0.487 . . . . 1.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.34 -41.23 75.74 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.934 0.893 . . . . 1.0 112.583 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.56 -49.47 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.726 1.148 . . . . 1.0 109.605 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.1 m -59.77 -16.65 29.44 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.439 0.695 . . . . 1.0 111.903 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -94.34 -58.87 2.09 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.467 -1.396 . . . . 1.0 109.55 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -125.95 112.9 24.41 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.068 -1.456 . . . . 1.0 107.068 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.77 107.48 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.644 1.266 . . . . 1.0 112.814 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.64 -50.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.919 2.088 . . . . 1.0 107.73 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.5 mt -44.78 -33.77 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.5 0 C-N-CA 129.478 3.111 . . . . 1.0 110.543 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.06 4.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.7 2.0 . . . . 1.0 114.118 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -136.54 18.57 3.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.803 1.641 . . . . 1.0 109.75 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.76 84.62 2.03 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.262 0.937 . . . . 1.0 110.176 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.37 114.07 19.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.9 t -146.73 -171.08 3.67 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.571 -0.706 . . . . 1.0 110.012 -175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.59 2.04 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 107.021 -2.431 . . . . 1.0 107.021 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.403 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.0 m-70 -113.58 -23.23 9.88 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.688 0.795 . . . . 1.0 111.639 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.59 -12.34 17.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.124 0.57 . . . . 1.0 109.695 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -88.09 40.02 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.153 0.888 . . . . 1.0 110.448 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.8 -26.57 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 120.955 -1.091 . . . . 1.0 108.449 175.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -143.68 -65.48 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.667 1.587 . . . . 1.0 111.767 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 96.2 Cg_endo -82.9 110.68 1.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.744 2.296 . . . . 1.0 112.807 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.23 -18.76 39.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.303 1.441 . . . . 1.0 113.609 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -57.42 -26.29 60.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.594 1.557 . . . . 1.0 112.154 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -126.22 141.16 52.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.085 -2.191 . . . . 1.0 105.085 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 m -132.15 -16.45 2.81 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.696 -0.628 . . . . 1.0 110.634 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.8 176.23 0.82 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 131.434 3.894 . . . . 1.0 102.805 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.45 70.31 6.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.802 2.335 . . . . 1.0 111.756 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 119.18 78.18 0.57 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.34 -2.304 . . . . 1.0 107.34 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 -62.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.028 2.485 . . . . 1.0 112.155 -175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.53 51.67 14.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.793 2.037 . . . . 1.0 114.027 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 33' ' ' VAL . 33.6 t80 -124.22 18.18 9.1 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.203 0.91 . . . . 1.0 113.232 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.386 19.9 t0 41.01 76.46 0.07 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.245 1.818 . . . . 1.0 113.748 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -51.29 -34.29 32.42 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.43 91.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 117.56 -1.21 . . . . 1.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -66.57 -53.17 37.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.294 1.406 . . . . 1.0 109.221 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.85 -51.24 70.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.369 0.507 . . . . 1.0 112.369 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -66.11 -23.49 66.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.84 0.745 . . . . 1.0 110.321 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.77 -51.9 50.44 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.298 -1.501 . . . . 1.0 109.754 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.79 -57.82 8.75 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.144 1.377 . . . . 1.0 111.339 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.86 166.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 175.474 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.7 tm? . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.0 158.22 33.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.657 1.354 . . . . 1.0 114.657 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 38.56 57.98 1.7 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.587 2.755 . . . . 1.0 109.759 -175.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.24 51.82 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.593 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.551 ' HB2' HH11 ' A' ' 12' ' ' ARG . 8.5 ttm105 -79.11 123.14 27.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.329 -2.471 . . . . 1.0 104.329 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.9 122.5 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -143.01 79.54 14.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.994 -1.854 . . . . 1.0 105.994 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 132.95 30.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.927 1.751 . . . . 1.0 111.217 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 t -69.34 145.41 95.73 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 124.765 1.226 . . . . 1.0 109.587 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 -23.41 7.19 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 117.025 1.894 . . . . 1.0 117.025 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -150.16 121.46 7.85 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CE2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -96.57 178.98 5.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 178.45 4.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 123.11 1.433 . . . . 1.0 111.612 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 m -154.69 118.5 4.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 131.603 3.961 . . . . 1.0 101.594 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -130.69 155.21 81.62 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 125.853 1.661 . . . . 1.0 108.121 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -88.01 56.41 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.268 2.645 . . . . 1.0 109.794 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -140.25 143.64 36.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.41 103.92 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.56 171.22 14.09 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 105.877 -1.897 . . . . 1.0 105.877 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -71.37 123.3 89.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 119.53 1.059 . . . . 1.0 108.915 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.12 103.61 1.46 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 CA-C-N 120.687 1.281 . . . . 1.0 109.519 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -175.76 78.46 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.165 1.786 . . . . 1.0 107.337 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 150' ' ' ASN . 4.9 tp -143.69 140.79 30.22 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.143 1.777 . . . . 1.0 106.722 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -106.11 126.59 52.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.665 1.121 . . . . 1.0 108.376 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.37 130.15 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.408 -2.071 . . . . 1.0 105.408 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HD13 ' A' ' 117' ' ' LEU . 59.4 t -134.6 112.98 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.52 149.71 20.71 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.54 111.26 17.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.644 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.3 mm -127.18 176.79 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.763 2.025 . . . . 1.0 107.451 174.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t -161.84 122.31 2.61 Favored 'General case' 0 C--N 1.313 -0.986 1 N-CA-C 93.93 -6.322 . . . . 1.0 93.93 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.273 1.2 tm? -142.66 -56.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 O-C-N 121.035 -1.04 . . . . 1.0 109.688 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -71.53 149.29 55.53 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.133 1.889 . . . . 1.0 112.631 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -82.41 39.66 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.56 3.506 . . . . 1.0 114.265 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -53.0 -71.61 0.66 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-O 117.461 -1.744 . . . . 1.0 110.581 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -156.6 122.87 4.98 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.707 1.754 . . . . 1.0 111.996 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -177.8 160.92 1.56 Allowed 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.493 4.317 . . . . 1.0 108.183 175.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.94 6.13 59.97 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.137 0.875 . . . . 1.0 111.846 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.89 118.65 4.73 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.0 1.4 . . . . 1.0 109.651 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 -21.44 44.62 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.364 2.043 . . . . 1.0 114.083 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -52.06 -43.09 63.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.099 0.863 . . . . 1.0 112.08 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.75 -44.3 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.449 1.1 . . . . 1.0 109.665 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.51 -45.64 78.88 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.05 0.841 . . . . 1.0 110.363 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.23 -33.56 58.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.476 1.511 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -55.06 -61.28 2.42 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.633 1.573 . . . . 1.0 108.985 175.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.99 -37.54 75.75 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.13 0.972 . . . . 1.0 113.279 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.5 t -65.82 -33.84 76.79 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.92 -5.43 53.5 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 125.211 1.386 . . . . 1.0 115.505 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -89.42 8.9 28.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.295 2.048 . . . . 1.0 112.515 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -51.94 134.42 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 125.961 1.705 . . . . 1.0 111.176 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.72 134.18 21.85 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 127.585 2.354 . . . . 1.0 110.225 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 77.52 1.82 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.641 2.894 . . . . 1.0 107.422 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.32 -63.26 1.19 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.364 0.666 . . . . 1.0 110.639 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.0 78.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.755 0.822 . . . . 1.0 110.69 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 19.5 p80 -171.0 178.0 0.87 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.737 2.015 . . . . 1.0 107.167 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 26.1 Cg_endo -73.05 -43.48 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.049 1.832 . . . . 1.0 114.684 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -46.38 -47.61 18.74 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -55.4 -58.13 8.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.451 1.1 . . . . 1.0 110.066 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.42 92.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.899 0.88 . . . . 1.0 111.37 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.59 -65.78 2.62 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.645 1.593 . . . . 1.0 111.553 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.15 -38.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.476 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.18 -43.41 10.05 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.359 1.864 . . . . 1.0 114.951 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -57.36 -33.55 67.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.71 -0.619 . . . . 1.0 110.323 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.51 134.23 33.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 102.2 -3.259 . . . . 1.0 102.2 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 152.14 19.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.949 0.795 . . . . 1.0 110.967 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.43 161.43 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.772 1.629 . . . . 1.0 110.74 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.0 m -172.88 123.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.584 1.554 . . . . 1.0 108.242 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.51 -154.05 0.43 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -128.89 -65.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.487 1.115 . . . . 1.0 110.133 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.8 m -133.99 118.69 18.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.678 -1.264 . . . . 1.0 107.689 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -103.47 113.97 27.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.809 -1.923 . . . . 1.0 105.809 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.56 114.59 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -66.36 148.62 51.59 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.72 1.145 . . . . 1.0 108.532 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -13.62 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.721 1.608 . . . . 1.0 112.306 175.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -91.21 18.96 6.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 131.478 3.911 . . . . 1.0 112.304 -176.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.5 46.97 93.37 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.229 1.395 . . . . 1.0 113.168 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.97 110.25 14.56 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.706 1.253 . . . . 1.0 110.156 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' A' ' 132' ' ' GLN . 52.0 mt -81.48 117.45 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 106.729 -1.582 . . . . 1.0 106.729 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.45 147.9 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.216 -1.772 . . . . 1.0 106.216 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -125.75 124.26 40.64 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 1.0 110.141 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.0 117.86 28.36 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 129.463 3.105 . . . . 1.0 103.755 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 19' ' ' TYR . 39.5 t 72.06 91.78 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 122.656 2.48 . . . . 1.0 113.205 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.91 -166.61 0.23 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.331 2.021 . . . . 1.0 111.079 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -70.85 46.07 0.09 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.856 2.862 . . . . 1.0 113.703 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.01 127.16 4.5 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 127.215 2.206 . . . . 1.0 106.508 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 tptm 77.35 81.48 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.543 1.137 . . . . 1.0 111.377 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -39.53 154.9 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.462 2.305 . . . . 1.0 113.232 -175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.31 -178.29 3.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.566 2.346 . . . . 1.0 113.008 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -153.12 118.73 5.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.905 1.682 . . . . 1.0 108.956 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -166.32 64.02 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 122.595 1.188 . . . . 1.0 111.167 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' HB1' ' CE1' ' A' ' 154' ' ' HIS . . . -155.15 -54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 118.103 -2.873 . . . . 1.0 112.602 175.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.37 -74.73 0.25 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.347 -1.807 . . . . 1.0 109.137 -175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.55 142.2 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.935 1.694 . . . . 1.0 110.018 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -166.33 163.66 17.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.984 2.514 . . . . 1.0 110.643 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.7 p -163.14 146.23 10.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -159.65 157.48 29.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.738 1.154 . . . . 1.0 108.94 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 39.9 53.28 2.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.623 1.569 . . . . 1.0 109.994 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.3 42.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 116.262 1.265 . . . . 1.0 116.262 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -129.0 121.98 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 120.019 1.909 . . . . 1.0 106.861 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.45 141.06 38.55 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -119.51 118.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.5 -42.87 97.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.3 0.852 . . . . 1.0 113.3 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.95 176.52 8.74 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.277 1.831 . . . . 1.0 108.968 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -83.15 76.46 9.86 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.91 38.41 1.23 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.986 1.315 . . . . 1.0 111.758 -175.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -134.14 149.94 51.09 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.094 0.958 . . . . 1.0 113.013 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -82.52 56.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.845 2.058 . . . . 1.0 109.645 177.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.51 -136.86 2.15 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 122.393 0.996 . . . . 1.0 113.359 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 136' ' ' VAL . 14.7 mm -140.86 160.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 103.532 -2.766 . . . . 1.0 103.532 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -138.46 126.04 22.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 103.324 -2.843 . . . . 1.0 103.324 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.443 HD13 HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -101.51 139.56 37.0 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.993 -1.067 . . . . 1.0 109.459 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 5.4 tm-20 -104.53 154.09 20.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.471 0.653 . . . . 1.0 110.539 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.42 -179.74 45.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.405 1.955 . . . . 1.0 110.213 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 p -141.87 106.41 4.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.074 -1.824 . . . . 1.0 106.074 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.266 43.7 t0 38.95 56.63 1.98 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.107 2.563 . . . . 1.0 113.986 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p 56.16 38.2 29.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.564 1.32 . . . . 1.0 114.564 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -69.17 146.0 52.81 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 105.389 -2.078 . . . . 1.0 105.389 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -37.26 113.55 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.133 1.373 . . . . 1.0 111.062 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.94 -6.62 56.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 115.521 1.674 . . . . 1.0 115.521 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.395 10.9 p 66.7 76.96 0.29 Allowed 'General case' 0 C--N 1.352 0.704 0 CA-C-N 120.872 1.669 . . . . 1.0 112.797 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -25.54 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.734 1.753 . . . . 1.0 115.734 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.75 7.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.669 1.588 . . . . 1.0 109.719 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.47 -48.79 37.48 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.037 1.335 . . . . 1.0 110.64 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.65 -40.52 92.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.13 0.877 . . . . 1.0 110.266 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -65.95 -50.12 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.38 0.536 . . . . 1.0 110.208 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HB3' HD11 ' A' ' 84' ' ' ILE . 90.8 mt-30 -62.15 -52.66 62.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.689 1.596 . . . . 1.0 110.274 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.2 tp -54.23 -47.99 71.59 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.835 1.654 . . . . 1.0 109.656 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.9 98.05 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.304 0.956 . . . . 1.0 110.54 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.15 49.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 115' ' ' ILE . 97.1 t -59.47 -43.29 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.868 0.867 . . . . 1.0 110.766 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.8 m -57.57 -54.0 51.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 1.0 109.492 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -65.69 -33.75 76.61 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.2 -59.25 5.77 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . 0.341 2.9 mm? -56.71 -33.83 66.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.738 -1.125 . . . . 1.0 113.555 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.68 -39.68 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.597 1.544 . . . . 1.0 107.908 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.2 m -60.18 -24.63 64.93 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.726 0.811 . . . . 1.0 110.866 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -84.3 -64.85 1.09 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 106.367 -1.716 . . . . 1.0 106.367 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -126.92 113.38 22.07 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.219 1.008 . . . . 1.0 109.976 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.63 107.36 0.33 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 CA-C-N 120.287 1.138 . . . . 1.0 110.838 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.3 -47.23 0.1 Allowed 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 128.212 2.605 . . . . 1.0 105.855 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.5 mt -48.54 -34.09 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 129.555 3.142 . . . . 1.0 110.644 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.91 7.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.803 0.841 . . . . 1.0 113.076 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -137.27 18.33 2.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.5 2.32 . . . . 1.0 109.926 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HB3' HD12 ' A' ' 30' ' ' LEU . 3.4 m-80 -141.99 83.67 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.409 1.004 . . . . 1.0 110.148 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.24 114.83 18.16 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 102.878 -3.008 . . . . 1.0 102.878 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.6 t -153.38 -166.98 2.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.315 0.579 . . . . 1.0 111.688 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.26 -131.93 1.59 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.378 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.495 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 6.0 m-70 -112.83 -23.26 10.23 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.899 0.88 . . . . 1.0 109.223 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -108.39 -21.98 12.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.104 1.361 . . . . 1.0 108.991 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -83.85 34.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.883 -1.136 . . . . 1.0 109.074 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -22.53 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.434 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -149.19 -55.92 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.952 2.501 . . . . 1.0 110.926 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 83.8 Cg_endo -81.78 112.01 2.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.27 1.98 . . . . 1.0 112.907 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.42 -26.19 64.96 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.847 -1.158 . . . . 1.0 111.705 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -21.94 66.19 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.857 1.263 . . . . 1.0 112.091 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -137.81 124.7 21.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -113.75 -15.75 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.395 0.543 . . . . 1.0 110.937 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.86 178.08 0.5 Allowed Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 129.645 3.178 . . . . 1.0 105.314 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -78.99 50.02 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.45 2.1 . . . . 1.0 111.185 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.55 65.82 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.36 1.933 . . . . 1.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.88 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.222 2.615 . . . . 1.0 111.51 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.1 t 53.61 50.66 16.7 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.603 1.161 . . . . 1.0 111.036 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.439 ' CD2' HG11 ' A' ' 33' ' ' VAL . 27.7 t80 -105.33 17.73 23.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.967 1.258 . . . . 1.0 113.175 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.1 t0 43.74 62.56 1.87 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.702 -1.873 . . . . 1.0 110.905 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -52.15 -33.43 40.3 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.748 -0.644 . . . . 1.0 111.279 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.98 -60.45 3.81 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.622 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -60.45 -42.3 95.86 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 117.574 -1.203 . . . . 1.0 111.411 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.94 -62.0 2.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.107 0.867 . . . . 1.0 111.128 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -61.14 -32.4 72.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.702 -0.666 . . . . 1.0 110.858 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.76 76.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.021 0.828 . . . . 1.0 112.233 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.75 -57.23 4.88 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.889 -1.132 . . . . 1.0 108.367 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.67 164.6 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.084 1.754 . . . . 1.0 110.76 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 125.405 1.482 . . . . 1.0 109.019 175.738 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 28.1 tp -74.26 142.44 45.28 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.718 1.145 . . . . 1.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -131.88 136.49 47.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.664 2.386 . . . . 1.0 104.955 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -134.81 124.23 24.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.868 2.067 . . . . 1.0 109.001 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 54.01 35.32 21.77 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.442 2.297 . . . . 1.0 112.05 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.03 3.95 25.65 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.866 0.746 . . . . 1.0 112.794 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -97.48 168.01 10.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.4 123.46 28.05 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.27 168.75 18.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 44.18 57.98 3.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.189 1.795 . . . . 1.0 109.711 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.49 156.25 41.68 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.958 2.103 . . . . 1.0 108.91 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -93.28 125.13 37.72 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -83.62 118.7 24.01 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.19 66.72 60.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.67 123.44 11.7 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 N-CA-C 108.339 -1.447 . . . . 1.0 108.339 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 t -54.82 142.71 53.71 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 123.193 0.597 . . . . 1.0 111.581 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.35 -12.01 24.99 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 116.039 1.515 . . . . 1.0 116.039 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -151.74 111.37 3.99 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CE1' HG22 ' A' ' 88' ' ' VAL . 9.6 m-30 -79.6 178.76 7.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.11 0.868 . . . . 1.0 110.532 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.0 -173.22 2.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.341 2.656 . . . . 1.0 109.916 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.8 m -165.66 118.13 1.13 Allowed 'General case' 0 CA--C 1.54 0.569 1 C-N-CA 131.705 4.002 . . . . 1.0 104.65 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.26 139.08 28.92 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 120.349 1.431 . . . . 1.0 109.809 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 70.03 6.07 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 124.449 3.433 . . . . 1.0 113.467 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -143.52 154.65 43.84 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.598 1.559 . . . . 1.0 108.68 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -151.19 103.43 3.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.354 0.979 . . . . 1.0 112.127 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -136.61 147.04 46.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 129.423 3.089 . . . . 1.0 104.68 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -59.66 123.79 72.93 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 119.949 1.25 . . . . 1.0 111.476 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.96 103.85 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.023 2.482 . . . . 1.0 111.847 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -172.24 79.39 0.05 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.703 1.601 . . . . 1.0 107.444 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.8 tp -139.93 133.66 30.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 tp -97.2 123.17 40.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.465 1.029 . . . . 1.0 108.311 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.69 118.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.957 -1.498 . . . . 1.0 106.957 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' THR . 69.3 t -116.02 114.79 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.289 -2.115 . . . . 1.0 105.289 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.6 p80 -167.34 152.33 7.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.267 -1.382 . . . . 1.0 107.267 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.67 112.23 24.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -127.51 175.95 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.597 1.959 . . . . 1.0 109.127 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 122.4 3.49 Favored 'General case' 0 N--CA 1.442 -0.869 1 N-CA-C 99.099 -4.408 . . . . 1.0 99.099 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.612 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -142.2 -48.4 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 118.174 -0.917 . . . . 1.0 108.979 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.612 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 39.0 Cg_endo -91.1 146.51 3.61 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 121.791 1.661 . . . . 1.0 114.465 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.48 44.3 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.508 3.472 . . . . 1.0 113.967 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.17 -65.02 2.0 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.971 -1.08 . . . . 1.0 111.71 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -152.35 122.78 7.26 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.886 -1.894 . . . . 1.0 105.886 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -176.42 175.85 1.72 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.782 2.833 . . . . 1.0 108.547 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.6 27.12 3.98 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.636 2.065 . . . . 1.0 109.634 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.13 118.18 6.1 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 106.037 -2.825 . . . . 1.0 106.037 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.26 -17.45 35.3 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 119.796 1.798 . . . . 1.0 115.13 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -66.14 -43.3 87.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.011 1.278 . . . . 1.0 110.996 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.02 -47.18 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.059 0.943 . . . . 1.0 109.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.9 -35.86 81.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.351 -0.843 . . . . 1.0 112.154 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.94 -33.47 68.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.013 0.925 . . . . 1.0 111.498 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.38 -54.58 43.87 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.511 -0.743 . . . . 1.0 109.893 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -66.77 -45.37 78.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.805 -0.617 . . . . 1.0 111.751 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -63.62 -39.39 94.23 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.33 3.26 22.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.412 1.958 . . . . 1.0 114.775 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -88.63 9.01 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.947 1.874 . . . . 1.0 112.627 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 tt -54.58 136.02 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.465 0.575 . . . . 1.0 110.896 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.22 136.6 19.17 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 127.71 2.404 . . . . 1.0 108.689 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.29 60.89 3.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.12 3.214 . . . . 1.0 112.719 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.48 -49.13 3.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 117.795 -1.098 . . . . 1.0 112.793 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.4 0.41 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.505 1.048 . . . . 1.0 112.079 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 24.6 p80 -163.57 177.83 1.71 Allowed Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 12.1 Cg_endo -70.43 -43.85 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.458 1.438 . . . . 1.0 114.834 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -51.47 -57.89 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.366 1.439 . . . . 1.0 111.999 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.47 -51.14 71.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.817 0.847 . . . . 1.0 110.182 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.86 -43.93 86.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 1.0 111.17 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -65.18 3.75 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.329 1.442 . . . . 1.0 110.535 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.27 -25.54 30.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-O 115.92 -1.991 . . . . 1.0 113.639 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.75 -43.04 5.82 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.966 1.712 . . . . 1.0 113.209 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -54.98 -38.28 67.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.419 1.488 . . . . 1.0 111.075 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.51 135.29 33.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.096 -1.816 . . . . 1.0 106.096 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 158.92 27.32 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.738 -1.227 . . . . 1.0 108.343 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.44 161.59 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB3' HG21 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -165.8 122.91 1.43 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 175.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.83 -154.0 0.42 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.969 1.308 . . . . 1.0 107.624 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.8 m80 -131.15 -67.16 0.71 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.67 1.123 . . . . 1.0 111.132 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HB2' HD13 ' A' ' 115' ' ' ILE . 61.2 m -135.58 119.15 16.99 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.344 -2.095 . . . . 1.0 105.344 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tt -113.29 118.08 33.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.116 1.766 . . . . 1.0 107.571 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -100.71 113.98 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.194 -1.78 . . . . 1.0 106.194 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -83.3 153.79 24.45 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 120.041 1.291 . . . . 1.0 108.636 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -17.94 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 128.939 2.896 . . . . 1.0 115.624 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 27.13 2.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.06 1.3 . . . . 1.0 112.668 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.26 42.75 99.87 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.544 1.069 . . . . 1.0 112.592 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.08 149.22 29.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.366 1.083 . . . . 1.0 108.837 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.05 119.08 60.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.606 -1.257 . . . . 1.0 107.606 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.46 147.82 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.402 -2.073 . . . . 1.0 105.402 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.69 122.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.618 -1.252 . . . . 1.0 107.618 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -120.98 113.69 20.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.876 -2.268 . . . . 1.0 104.876 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 19' ' ' TYR . 4.1 t 79.84 92.1 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.448 1.476 . . . . 1.0 111.439 176.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -61.7 -175.76 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.615 1.543 . . . . 1.0 110.877 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -58.34 5.49 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.89 2.476 . . . . 1.0 114.294 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.41 115.25 19.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.168 2.587 . . . . 1.0 108.795 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 85.81 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.67 2.788 . . . . 1.0 112.288 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.459 HH11 ' HB2' ' A' ' 111' ' ' PHE . 7.3 ttm180 -32.56 138.05 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.753 3.221 . . . . 1.0 115.642 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.58 -178.12 3.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 129.273 3.029 . . . . 1.0 111.945 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -155.06 118.33 4.44 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.477 1.511 . . . . 1.0 110.628 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 7.4 p80 -158.23 63.13 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.068 -1.645 . . . . 1.0 112.204 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.96 -56.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 118.734 -2.479 . . . . 1.0 114.148 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.03 -79.8 0.29 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 104.017 -3.633 . . . . 1.0 104.017 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.98 146.63 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.063 2.145 . . . . 1.0 108.881 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.6 p -156.18 150.72 25.81 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.533 1.533 . . . . 1.0 110.209 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.469 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.2 p -143.65 145.72 32.69 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 119.69 1.132 . . . . 1.0 111.248 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.42 145.29 21.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.83 -1.544 . . . . 1.0 106.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 42.08 53.85 4.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.976 1.71 . . . . 1.0 113.051 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.52 28.43 67.57 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.608 0.623 . . . . 1.0 113.375 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 116.44 17.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 176.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 5.8 tt0 -103.65 135.31 45.45 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 8.9 mtt85 -105.57 118.24 36.07 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.175 -2.528 . . . . 1.0 104.175 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.57 -25.47 66.23 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.745 1.618 . . . . 1.0 111.542 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -154.26 170.4 21.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.611 2.764 . . . . 1.0 107.588 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 6.3 t70 -84.76 76.71 10.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.459 ' HB2' HH11 ' A' ' 93' ' ' ARG . 0.2 OUTLIER -100.32 33.65 2.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.243 -175.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -132.9 142.72 49.05 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 124.483 1.113 . . . . 1.0 110.568 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -79.19 56.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 127.09 2.156 . . . . 1.0 110.806 -176.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.5 -136.5 1.7 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.946 -1.097 . . . . 1.0 113.034 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG21 HD13 ' A' ' 133' ' ' LEU . 3.6 mm -142.57 165.3 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 130.515 3.526 . . . . 1.0 102.985 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -145.82 138.58 25.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 103.7 -2.704 . . . . 1.0 103.7 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.0 149.04 24.34 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.485 -1.384 . . . . 1.0 109.269 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -124.52 139.74 53.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.614 0.721 . . . . 1.0 111.151 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.39 -177.55 30.61 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 127.676 2.56 . . . . 1.0 108.701 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 p -145.96 108.28 4.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.601 -2.37 . . . . 1.0 104.601 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.54 43.54 28.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.24 1.016 . . . . 1.0 112.528 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p 49.57 38.55 15.02 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.67 1.988 . . . . 1.0 113.706 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.66 136.16 56.67 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -25.9 114.03 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.999 2.12 . . . . 1.0 113.431 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.87 -15.31 58.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 116.36 -1.781 . . . . 1.0 113.908 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.351 28.7 p 65.59 77.06 0.31 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.862 1.664 . . . . 1.0 111.668 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -23.22 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.069 1.748 . . . . 1.0 113.993 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.0 -38.91 3.77 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.65 1.98 . . . . 1.0 110.442 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -49.39 -51.9 31.98 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.268 1.427 . . . . 1.0 109.643 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.8 -42.08 96.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.029 0.932 . . . . 1.0 110.207 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -65.66 -51.6 58.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.089 0.955 . . . . 1.0 110.353 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -65.97 -43.62 87.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.669 0.788 . . . . 1.0 110.679 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 115' ' ' ILE . 10.4 tp -55.38 -51.53 66.51 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.74 67.78 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.316 0.962 . . . . 1.0 111.488 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.47 56.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.127 0.971 . . . . 1.0 110.787 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.22 -51.27 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.3 m -54.63 -36.7 64.78 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.659 1.583 . . . . 1.0 111.882 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -60.68 -46.67 89.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.884 1.674 . . . . 1.0 109.462 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.79 62.84 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-O 119.412 -0.327 . . . . 1.0 110.871 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.91 -39.09 71.13 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.02 -45.02 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.426 1.012 . . . . 1.0 108.916 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.7 m -65.76 -19.13 65.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.217 0.607 . . . . 1.0 111.182 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -84.16 -63.22 1.38 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.931 1.292 . . . . 1.0 107.858 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -126.06 112.98 24.14 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.57 107.94 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 120.237 1.12 . . . . 1.0 111.724 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.25 -52.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.387 1.875 . . . . 1.0 107.39 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 mt -45.98 -33.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 131.146 3.778 . . . . 1.0 111.061 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.86 -26.03 9.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.673 1.189 . . . . 1.0 112.987 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -136.32 23.67 3.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.359 1.863 . . . . 1.0 109.755 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -138.51 83.6 1.97 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -127.24 120.85 29.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.09 -1.818 . . . . 1.0 106.09 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.2 t -154.53 -170.48 3.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.77 -131.58 1.76 Allowed Glycine 0 CA--C 1.517 0.181 0 N-CA-C 106.818 -2.513 . . . . 1.0 106.818 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 10.8 m170 -113.53 -22.97 10.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.069 1.434 . . . . 1.0 111.576 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.0 t -103.23 -8.55 20.29 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -89.04 28.25 1.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.737 1.215 . . . . 1.0 109.147 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.469 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.75 -14.87 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 121.389 -0.82 . . . . 1.0 110.45 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.67 -53.54 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.683 . . . . 1.0 112.582 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.43 108.63 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.91 1.718 . . . . 1.0 111.385 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.02 -14.61 55.5 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.875 -1.141 . . . . 1.0 113.117 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.66 -6.3 36.0 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.156 -1.59 . . . . 1.0 111.601 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -136.93 141.05 42.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.875 -1.898 . . . . 1.0 105.875 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 3.1 m -132.78 -16.78 2.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.862 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.84 -178.87 0.34 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.39 63.27 7.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.304 2.002 . . . . 1.0 109.102 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 141.28 74.57 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.123 1.821 . . . . 1.0 111.653 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.13 -98.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 1.0 110.837 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.4 t 53.84 43.86 30.35 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.801 1.64 . . . . 1.0 112.533 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -106.32 18.45 21.98 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.054 0.942 . . . . 1.0 110.387 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.296 9.3 t0 42.95 82.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.866 2.467 . . . . 1.0 112.355 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -55.4 -34.95 64.83 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.55 -0.75 . . . . 1.0 112.821 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.09 -45.98 79.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.573 -0.727 . . . . 1.0 110.647 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -58.93 -56.78 17.89 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.846 0.748 . . . . 1.0 110.12 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -59.08 -53.24 60.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -61.52 -33.79 74.43 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.403 -0.808 . . . . 1.0 111.906 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.47 86.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.695 0.68 . . . . 1.0 111.818 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.14 -51.92 27.63 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.523 0.729 . . . . 1.0 110.37 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.6 166.41 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.381 1.073 . . . . 1.0 108.335 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 m -42.27 113.25 1.21 Allowed Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.281 1.832 . . . . 1.0 109.334 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -95.26 54.92 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.996 2.464 . . . . 1.0 111.165 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.7 t 51.54 33.35 10.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.717 1.607 . . . . 1.0 111.489 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 177.68 7.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 129.791 3.237 . . . . 1.0 105.405 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 49.11 50.92 17.16 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 123.206 1.479 . . . . 1.0 110.627 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -140.41 168.68 19.23 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.322 2.649 . . . . 1.0 105.91 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.71 177.94 8.34 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.995 2.118 . . . . 1.0 107.567 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.5 tpt 57.54 -95.43 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.757 1.623 . . . . 1.0 109.751 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.247 0.971 0 C-N-CA 129.926 3.29 . . . . 1.0 103.473 175.726 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HG2' HG22 ' A' ' 136' ' ' VAL . 44.1 tpp . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp -139.36 158.22 44.53 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.202 1.401 . . . . 1.0 108.91 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.62 136.97 53.83 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.049 2.14 . . . . 1.0 106.899 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -127.17 124.42 38.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.552 1.541 . . . . 1.0 107.874 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 45.13 36.96 2.3 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.759 1.623 . . . . 1.0 113.797 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.45 -2.9 80.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.33 -0.857 . . . . 1.0 113.677 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -95.38 168.35 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.733 2.013 . . . . 1.0 107.503 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.34 124.11 34.14 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.98 170.89 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.632 1.173 . . . . 1.0 110.661 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 40.58 58.38 2.38 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.182 1.793 . . . . 1.0 111.221 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.76 156.34 38.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.644 1.578 . . . . 1.0 110.112 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -78.4 130.05 35.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.12 140.34 45.75 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.183 -0.948 . . . . 1.0 110.265 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -142.74 71.84 19.82 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.479 -1.674 . . . . 1.0 106.479 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.6 123.2 9.91 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 N-CA-C 107.784 -1.66 . . . . 1.0 107.784 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -121.85 132.09 24.3 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.98 52.97 4.53 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.189 1.926 . . . . 1.0 111.177 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -124.13 43.11 3.08 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE2' HG22 ' A' ' 88' ' ' VAL . 95.7 m-85 -75.24 178.21 5.95 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.076 0.465 . . . . 1.0 110.045 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.73 -178.25 4.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 1.0 108.51 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.5 m -154.95 131.36 10.46 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 128.623 2.769 . . . . 1.0 103.674 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -130.55 140.05 37.5 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.791 1.632 . . . . 1.0 109.628 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.05 40.19 0.85 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.36 3.374 . . . . 1.0 116.84 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.24 149.78 44.73 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.293 2.637 . . . . 1.0 108.834 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -151.61 120.13 6.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.936 1.694 . . . . 1.0 111.682 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.62 172.74 12.56 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -64.69 123.82 84.42 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.58 103.6 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.768 1.645 . . . . 1.0 110.706 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -170.83 77.16 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.711 -1.588 . . . . 1.0 106.711 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.16 124.34 12.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.54 126.08 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.87 134.26 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.3 t -131.76 123.78 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -176.56 150.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.116 1.766 . . . . 1.0 107.884 175.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.5 112.61 24.6 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 26.3 mm -127.65 176.78 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 128.024 2.53 . . . . 1.0 105.067 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -151.09 122.22 7.72 Favored 'General case' 0 C--N 1.313 -0.995 1 N-CA-C 94.003 -6.295 . . . . 1.0 94.003 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.318 0.2 OUTLIER -142.66 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 119.827 1.194 . . . . 1.0 110.427 175.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.36 153.47 27.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.041 1.828 . . . . 1.0 112.042 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -82.0 53.61 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.673 2.916 . . . . 1.0 114.232 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.72 -70.81 0.65 Allowed Glycine 0 CA--C 1.535 1.317 0 N-CA-C 108.269 -1.932 . . . . 1.0 108.269 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -155.82 123.09 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.221 2.609 . . . . 1.0 106.549 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -169.73 173.44 6.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.956 2.902 . . . . 1.0 105.913 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.8 31.37 2.48 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.674 1.607 . . . . 1.0 109.298 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 118.9 6.28 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 107.605 -2.198 . . . . 1.0 107.605 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.34 -9.62 26.3 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-N 120.842 2.321 . . . . 1.0 113.339 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -65.52 -47.43 75.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.802 1.183 . . . . 1.0 109.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 mm -59.22 -43.84 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.799 0.84 . . . . 1.0 109.668 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.28 -46.36 90.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.267 0.627 . . . . 1.0 111.462 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.15 -33.8 67.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.135 1.374 . . . . 1.0 111.677 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.68 -57.07 12.32 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.196 -0.94 . . . . 1.0 109.352 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -42.98 85.86 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.528 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -66.4 -35.4 80.22 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.475 0.58 . . . . 1.0 110.59 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.46 60.23 1.11 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.373 1.94 . . . . 1.0 112.103 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 p -136.58 8.85 3.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.201 1.8 . . . . 1.0 111.588 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.34 134.78 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.116 0.966 . . . . 1.0 112.508 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 136.64 20.33 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.668 2.787 . . . . 1.0 108.834 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.63 69.74 1.55 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.216 3.278 . . . . 1.0 112.435 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -103.35 -56.64 2.18 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.659 0.784 . . . . 1.0 110.966 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.47 -55.04 36.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.979 0.512 . . . . 1.0 111.321 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.4 p80 -171.08 177.89 0.88 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.149 1.779 . . . . 1.0 107.615 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -70.55 -43.39 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.866 1.71 . . . . 1.0 114.804 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -50.19 -54.76 18.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.577 1.08 . . . . 1.0 113.475 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.0 -52.93 63.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.964 0.802 . . . . 1.0 111.118 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.51 98.3 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.465 0.706 . . . . 1.0 111.904 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.93 -57.69 17.04 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.283 0.944 . . . . 1.0 110.94 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.79 -27.33 42.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-O 115.964 -1.97 . . . . 1.0 112.99 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.83 -43.26 2.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.153 1.781 . . . . 1.0 114.489 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -57.58 -43.36 84.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.031 1.333 . . . . 1.0 111.116 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.6 127.37 32.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.53 148.55 51.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.382 176.118 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.86 163.19 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.064 2.146 . . . . 1.0 109.843 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.508 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -172.33 133.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.872 2.469 . . . . 1.0 106.27 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.46 -154.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.137 1.375 . . . . 1.0 107.461 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -132.48 -59.21 0.92 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.95 1.3 . . . . 1.0 108.999 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.773 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.4 m -136.88 118.73 15.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.096 -1.446 . . . . 1.0 107.096 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -102.48 113.85 27.54 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.82 122.89 53.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -89.8 156.65 18.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.853 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -22.66 2.58 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 126.967 2.107 . . . . 1.0 113.533 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -91.75 19.75 6.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.915 1.686 . . . . 1.0 113.699 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.16 35.8 91.39 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.614 1.578 . . . . 1.0 112.821 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.43 109.25 22.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.16 113.45 19.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 105.263 -2.125 . . . . 1.0 105.263 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -111.81 147.8 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.295 1.438 . . . . 1.0 107.306 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.2 120.24 29.55 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.386 1.074 . . . . 1.0 109.618 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.44 129.97 53.3 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.255 64.3 t 63.75 91.46 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 121.498 1.953 . . . . 1.0 113.76 175.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.7 Cg_exo -58.89 -169.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.394 3.396 . . . . 1.0 116.387 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.85 24.15 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.012 2.525 . . . . 1.0 110.487 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 89' ' ' PRO . 2.7 t70 -144.57 119.47 9.95 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.469 2.707 . . . . 1.0 107.855 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.308 3.4 ttmp? 85.96 81.48 0.02 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.877 1.671 . . . . 1.0 111.717 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -34.89 145.16 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.973 2.509 . . . . 1.0 111.942 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -122.12 172.4 8.28 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.258 1.423 . . . . 1.0 110.104 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -141.63 119.19 11.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.897 1.679 . . . . 1.0 109.722 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -159.38 63.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.151 0.977 . . . . 1.0 109.255 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.73 -70.74 0.03 OUTLIER 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.66 -1.9 . . . . 1.0 114.657 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.43 -91.02 0.48 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 105.834 -2.907 . . . . 1.0 105.834 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.2 t -144.44 146.46 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.92 1.86 . . . . 1.0 108.551 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -156.56 166.54 33.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.431 1.492 . . . . 1.0 108.924 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 157' ' ' ILE . 54.6 p -151.65 146.13 25.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -162.62 148.69 12.63 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 49.6 54.57 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.415 1.486 . . . . 1.0 110.83 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.04 29.45 62.37 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.995 1.283 . . . . 1.0 114.471 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.18 113.93 12.55 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.483 -1.302 . . . . 1.0 107.483 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -78.95 146.46 33.45 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.368 -1.345 . . . . 1.0 107.368 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -133.42 118.16 18.08 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.752 -1.944 . . . . 1.0 105.752 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.85 -40.24 96.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.286 0.634 . . . . 1.0 112.52 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -149.18 174.94 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.492 2.317 . . . . 1.0 106.979 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -89.85 75.05 7.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.359 1.552 . . . . 1.0 110.501 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 37.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 109.093 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -123.55 157.28 34.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.939 2.896 . . . . 1.0 109.819 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.277 0.1 OUTLIER -104.62 56.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.266 1.426 . . . . 1.0 108.096 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.79 -136.09 0.9 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-O 122.86 1.256 . . . . 1.0 112.163 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 76' ' ' CYS . 8.6 mm -150.28 161.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 130.497 3.519 . . . . 1.0 104.236 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.79 128.61 17.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 103.334 -2.839 . . . . 1.0 103.334 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.4 154.34 19.74 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -124.1 138.66 54.41 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.547 0.739 . . . . 1.0 111.859 -175.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.08 174.09 45.3 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.769 0.649 . . . . 1.0 112.613 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 p -133.92 97.09 3.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.044 2.137 . . . . 1.0 107.157 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.322 25.0 t0 46.62 56.74 6.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.251 1.82 . . . . 1.0 114.102 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.2 p 55.39 38.82 30.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.366 1.466 . . . . 1.0 112.563 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.57 133.95 53.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 104.956 -2.238 . . . . 1.0 104.956 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.12 113.45 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.212 2.205 . . . . 1.0 110.839 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -78.85 -11.61 60.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 115.14 -2.362 . . . . 1.0 116.679 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.349 18.2 p 59.57 77.86 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 121.662 2.028 . . . . 1.0 111.156 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -23.06 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.12 2.168 . . . . 1.0 114.593 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.31 -38.48 2.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.499 2.32 . . . . 1.0 109.433 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -53.8 -49.96 67.16 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 125.382 1.473 . . . . 1.0 110.688 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -56.48 -40.46 74.96 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.52 1.055 . . . . 1.0 109.668 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.72 -58.22 6.21 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.244 -0.408 . . . . 1.0 110.097 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -66.45 -37.99 86.37 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -60.63 -47.06 87.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.84 80.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.036 0.835 . . . . 1.0 110.858 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -53.75 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.072 0.949 . . . . 1.0 111.21 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 115' ' ' ILE . 64.8 t -58.04 -41.0 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.1 m -57.09 -46.28 82.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.272 . . . . 1.0 109.647 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.21 -48.19 82.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.53 1.059 . . . . 1.0 110.277 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.94 -48.6 81.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.172 0.589 . . . . 1.0 110.028 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -55.88 -46.86 78.21 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.873 1.269 . . . . 1.0 111.029 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.88 -42.22 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 118.858 0.754 . . . . 1.0 110.346 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.3 m -65.57 -13.91 59.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.178 0.991 . . . . 1.0 111.524 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -106.24 -54.02 2.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.496 1.518 . . . . 1.0 111.016 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -126.24 113.25 23.7 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 104.383 -2.451 . . . . 1.0 104.383 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -99.22 107.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.029 1.403 . . . . 1.0 114.554 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.27 -48.35 0.1 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.679 2.391 . . . . 1.0 107.642 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -46.19 -34.28 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 130.111 3.364 . . . . 1.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.86 -23.19 6.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.054 1.341 . . . . 1.0 114.275 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -137.18 18.42 2.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.719 1.607 . . . . 1.0 110.657 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -139.08 83.65 1.96 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.732 1.213 . . . . 1.0 108.213 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 114.1 21.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.036 -2.579 . . . . 1.0 104.036 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -151.08 -166.35 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.525 -0.734 . . . . 1.0 109.219 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.11 -131.79 1.5 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 108.66 -1.776 . . . . 1.0 108.66 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 11.4 m170 -109.01 -23.59 11.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 117.902 0.851 . . . . 1.0 111.066 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.28 -14.38 15.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.486 -0.769 . . . . 1.0 110.647 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -87.74 40.54 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.777 1.171 . . . . 1.0 109.158 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -66.27 -8.76 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 O-C-N 120.684 -1.26 . . . . 1.0 110.869 175.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -164.24 -53.79 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 127.953 2.501 . . . . 1.0 111.857 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 57.0 Cg_endo -91.14 115.42 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.978 3.119 . . . . 1.0 113.618 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.23 -25.58 64.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.765 1.226 . . . . 1.0 113.124 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -63.65 -20.28 65.57 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.88 -1.137 . . . . 1.0 113.324 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -123.12 140.76 52.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.464 -2.05 . . . . 1.0 105.464 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.0 m -136.01 -16.73 1.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.546 -0.862 . . . . 1.0 111.508 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.43 177.95 0.47 Allowed Pre-proline 0 CA--C 1.546 0.805 1 C-N-CA 131.808 4.043 . . . . 1.0 103.53 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.05 86.93 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.517 1.478 . . . . 1.0 109.353 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.32 81.12 1.25 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.863 1.221 . . . . 1.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.72 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.154 2.57 . . . . 1.0 112.187 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 t 55.52 43.93 27.64 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.907 1.283 . . . . 1.0 114.08 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' A' ' 33' ' ' VAL . 87.9 t80 -115.33 17.82 16.36 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 120.203 1.365 . . . . 1.0 113.755 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.6 t0 43.91 69.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 1.0 112.206 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -56.37 -32.87 65.18 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.759 -0.638 . . . . 1.0 112.334 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -60.25 2.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.657 0.783 . . . . 1.0 110.605 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -41.81 96.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-O 118.13 -0.938 . . . . 1.0 110.574 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -59.81 -57.55 12.42 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 123.876 0.735 . . . . 1.0 110.737 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -40.71 75.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.71 0.686 . . . . 1.0 111.222 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.07 77.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.16 0.8 . . . . 1.0 113.16 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.25 -43.55 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.6 1.16 . . . . 1.0 113.036 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.87 166.63 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.186 1.794 . . . . 1.0 110.797 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 70.6 m -42.5 131.09 2.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.679 1.592 . . . . 1.0 108.263 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -80.22 40.1 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.788 2.325 . . . . 1.0 114.222 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.3 t 45.57 34.3 1.64 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.905 1.682 . . . . 1.0 111.354 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.3 t -159.56 64.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -164.1 116.03 1.35 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -149.87 134.73 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.749 -1.945 . . . . 1.0 105.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.89 161.12 18.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.5 tpt 58.35 66.38 1.1 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.418 1.487 . . . . 1.0 111.526 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 115.142 -2.361 . . . . 1.0 108.41 -175.896 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 tpp . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 108.236 -1.024 . . . . 1.0 108.236 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp -112.34 167.33 10.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -108.74 131.85 54.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -123.69 125.23 44.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.917 1.287 . . . . 1.0 108.728 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 49.14 33.72 5.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.044 1.337 . . . . 1.0 112.106 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.45 -5.23 69.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.317 1.437 . . . . 1.0 114.058 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -102.92 173.07 6.47 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.716 1.758 . . . . 1.0 107.243 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 134.94 34.44 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.942 -1.099 . . . . 1.0 110.996 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.29 27.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.208 1.003 . . . . 1.0 112.148 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 38.88 58.21 1.78 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.108 2.563 . . . . 1.0 112.057 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.85 136.06 17.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.263 -0.898 . . . . 1.0 109.104 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -73.11 123.46 23.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.364 -1.717 . . . . 1.0 106.364 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -92.92 118.87 31.63 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.536 -0.727 . . . . 1.0 110.855 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.52 72.25 20.79 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.29 1.036 . . . . 1.0 108.554 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.21 123.44 9.21 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.758 1.306 . . . . 1.0 109.904 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -87.32 114.17 57.4 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 106.379 -1.712 . . . . 1.0 106.379 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.52 55.86 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.676 2.251 . . . . 1.0 110.636 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -138.4 43.73 2.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.572 1.949 . . . . 1.0 109.437 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -73.65 178.35 4.8 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.083 1.142 . . . . 1.0 114.083 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.63 179.1 4.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 128.857 2.863 . . . . 1.0 109.805 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -165.28 118.78 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.966 4.506 . . . . 1.0 102.94 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 156.46 77.75 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.27 84.72 1.9 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.312 2.008 . . . . 1.0 111.696 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.1 145.26 16.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.329 1.852 . . . . 1.0 106.685 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -137.51 103.58 5.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.371 -1.344 . . . . 1.0 107.371 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -136.2 152.86 51.22 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.743 1.217 . . . . 1.0 108.677 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -71.98 123.41 89.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 103.271 -2.862 . . . . 1.0 103.271 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.5 106.16 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.416 2.077 . . . . 1.0 112.512 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 t -164.32 76.35 0.33 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.37 123.72 11.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.99 -1.856 . . . . 1.0 105.99 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.54 127.61 39.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.193 0.997 . . . . 1.0 108.474 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.47 140.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.9 t -135.86 113.94 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.847 -2.279 . . . . 1.0 104.847 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -163.16 129.85 3.41 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 115.944 -1.979 . . . . 1.0 108.194 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -72.69 112.52 8.82 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 117.443 -1.703 . . . . 1.0 106.746 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.484 HG13 ' CE1' ' A' ' 34' ' ' HIS . 14.4 mm -126.73 176.77 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 131.646 3.979 . . . . 1.0 108.587 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.3 t -160.68 121.84 2.98 Favored 'General case' 0 C--O 1.247 0.973 1 N-CA-C 94.992 -5.929 . . . . 1.0 94.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.253 1.3 tm? -142.4 -57.37 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 121.032 -1.042 . . . . 1.0 111.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 77' ' ' LEU . 2.9 Cg_exo -76.16 144.26 26.4 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 122.674 2.249 . . . . 1.0 111.075 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.09 44.11 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.335 2.69 . . . . 1.0 114.657 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.18 -71.19 0.57 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -156.13 122.94 5.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.614 1.566 . . . . 1.0 111.234 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.318 18.8 m-85 -177.06 170.94 2.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 131.361 3.864 . . . . 1.0 109.619 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.08 27.28 7.12 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.434 1.016 . . . . 1.0 111.628 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.37 118.56 5.35 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 108.726 -1.75 . . . . 1.0 108.726 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.59 -15.81 48.78 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 120.096 1.948 . . . . 1.0 112.621 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -49.79 -47.85 50.95 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.513 1.125 . . . . 1.0 112.576 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.39 -45.09 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.96 -43.97 94.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.12 -35.63 69.69 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.09 1.356 . . . . 1.0 111.489 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.89 -55.33 17.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 120.945 -1.097 . . . . 1.0 110.039 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.04 -43.03 79.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.87 -0.585 . . . . 1.0 111.893 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -65.84 -33.83 76.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.286 1.434 . . . . 1.0 109.994 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.57 -2.64 30.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.567 1.555 . . . . 1.0 115.163 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -88.81 9.93 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.75 2.275 . . . . 1.0 114.12 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 tt -47.68 129.55 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.274 1.829 . . . . 1.0 112.1 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.74 125.52 42.13 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 130.473 3.509 . . . . 1.0 108.957 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.38 75.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.494 3.462 . . . . 1.0 108.412 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -103.63 -64.23 1.11 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.441 0.297 . . . . 1.0 111.618 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.02 -52.01 65.74 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.98 0.912 . . . . 1.0 112.086 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 25.8 p80 -161.92 177.9 1.8 Allowed Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.561 1.545 . . . . 1.0 107.805 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 29.2 Cg_endo -74.33 -43.43 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.823 1.682 . . . . 1.0 114.342 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -48.46 -43.65 34.81 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.118 0.967 . . . . 1.0 113.586 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -57.52 -55.6 32.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.839 0.856 . . . . 1.0 110.275 -175.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.751 0.82 . . . . 1.0 110.697 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.65 -62.56 2.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.81 1.672 . . . . 1.0 111.536 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.1 pt -57.69 -35.54 51.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 116.752 -1.594 . . . . 1.0 112.76 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.0 -43.02 3.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.622 1.969 . . . . 1.0 115.735 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.26 -36.24 70.75 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.555 1.142 . . . . 1.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.03 136.76 33.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 102.502 -3.147 . . . . 1.0 102.502 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 155.81 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.622 -1.298 . . . . 1.0 109.14 175.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.47 155.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 123.593 0.757 . . . . 1.0 109.037 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 4.3 m -177.79 114.12 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.836 1.654 . . . . 1.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.96 -175.4 3.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -112.47 -76.85 0.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.977 1.262 . . . . 1.0 110.906 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.4 m -112.57 118.51 35.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 39' ' ' PRO . 13.6 tp -101.26 113.44 26.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 103.605 -2.739 . . . . 1.0 103.605 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mt -105.98 113.22 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 103.852 -2.647 . . . . 1.0 103.852 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -81.59 153.79 26.53 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.772 0.714 . . . . 1.0 110.57 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.64 -13.5 0.4 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 126.229 1.812 . . . . 1.0 113.941 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -91.65 18.31 7.66 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.37 0.986 . . . . 1.0 111.241 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.34 45.35 96.63 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.115 -1.616 . . . . 1.0 111.601 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -112.97 143.96 43.36 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.91 114.32 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.28 142.74 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.522 -1.659 . . . . 1.0 106.522 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -126.22 114.44 18.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.947 0.899 . . . . 1.0 110.467 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -110.06 147.09 34.24 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 103.25 -2.87 . . . . 1.0 103.25 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.274 42.4 t 63.1 91.78 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 120.304 1.411 . . . . 1.0 114.362 175.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.21 -174.29 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 121.404 1.402 . . . . 1.0 111.985 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -72.87 49.92 0.25 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.781 1.233 . . . . 1.0 109.941 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -161.13 136.14 7.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.766 2.827 . . . . 1.0 105.33 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 54.78 81.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 129.376 3.07 . . . . 1.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.05 152.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.659 2.384 . . . . 1.0 111.545 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -102.83 -178.08 3.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.423 2.289 . . . . 1.0 111.055 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -149.88 118.4 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.855 1.262 . . . . 1.0 108.919 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -160.92 62.75 0.29 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.967 1.365 . . . . 1.0 110.209 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.95 -69.34 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 119.839 -1.788 . . . . 1.0 113.044 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 -90.89 0.51 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 103.246 -3.941 . . . . 1.0 103.246 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.94 142.15 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.742 1.271 . . . . 1.0 110.065 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -155.93 165.8 35.38 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.667 2.387 . . . . 1.0 108.066 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -159.81 126.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.972 -2.233 . . . . 1.0 104.972 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -151.52 151.13 31.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.718 1.145 . . . . 1.0 107.999 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 42.12 66.72 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.669 1.588 . . . . 1.0 109.75 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.31 29.53 5.2 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.81 1.672 . . . . 1.0 116.681 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -137.98 113.8 9.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.759 1.78 . . . . 1.0 106.835 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -80.91 146.37 30.83 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.574 1.15 . . . . 1.0 108.417 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -129.57 118.13 21.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.94 -24.49 63.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.98 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -152.98 176.26 12.06 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 128.623 2.769 . . . . 1.0 107.369 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.14 76.29 6.92 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.149 -1.426 . . . . 1.0 107.149 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -92.86 33.58 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.862 0.865 . . . . 1.0 112.392 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 m -124.53 156.51 37.22 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 125.508 1.523 . . . . 1.0 111.815 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.85 56.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.221 1.808 . . . . 1.0 107.713 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 -136.79 2.45 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.417 -0.802 . . . . 1.0 111.978 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 133' ' ' LEU . 9.3 mm -140.13 165.19 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.191 -2.522 . . . . 1.0 104.191 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 123.95 12.19 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.443 -2.799 . . . . 1.0 103.443 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 128.06 48.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.802 -1.186 . . . . 1.0 109.034 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.35 142.74 33.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.038 0.923 . . . . 1.0 111.929 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.39 178.64 32.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.52 2.01 . . . . 1.0 111.242 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -148.29 101.77 3.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.6 t0 51.4 54.56 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 124.032 1.872 . . . . 1.0 112.389 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 49.69 38.5 15.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.446 1.898 . . . . 1.0 114.269 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 124' ' ' ALA . 4.2 tt -72.63 145.87 47.01 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 104.932 -2.247 . . . . 1.0 104.932 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.49 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -39.32 125.53 1.66 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.327 1.851 . . . . 1.0 111.777 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.4 -10.84 59.89 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 115.285 1.587 . . . . 1.0 115.285 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.381 26.6 p 62.47 77.5 0.33 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 121.592 1.996 . . . . 1.0 111.968 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -23.5 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.158 2.183 . . . . 1.0 114.667 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.96 -40.14 4.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.425 2.29 . . . . 1.0 111.095 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -47.27 -57.87 4.73 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.788 0.835 . . . . 1.0 109.613 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.68 -39.36 80.46 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.229 0.611 . . . . 1.0 111.593 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -65.82 -59.24 4.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.216 0.322 . . . . 1.0 110.166 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -66.0 -34.27 77.72 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.757 0.708 . . . . 1.0 112.082 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 36.8 tp -57.51 -48.08 80.22 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.46 85.79 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.075 0.852 . . . . 1.0 109.819 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 -53.13 44.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.585 1.154 . . . . 1.0 111.046 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.19 -48.31 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.19 0.596 . . . . 1.0 110.121 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.7 m -53.25 -45.5 68.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.154 1.381 . . . . 1.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.32 -42.38 98.59 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.2 1.0 . . . . 1.0 110.54 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.19 -49.08 78.63 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.064 0.545 . . . . 1.0 110.194 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.94 -44.59 78.55 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.418 -0.801 . . . . 1.0 111.784 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.66 -40.23 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.187 0.903 . . . . 1.0 109.868 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.4 m -63.2 -27.67 69.52 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.885 0.874 . . . . 1.0 111.294 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.42 -60.58 2.03 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.138 0.975 . . . . 1.0 109.435 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -126.54 112.9 22.99 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.866 1.666 . . . . 1.0 106.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.61 107.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 120.912 1.361 . . . . 1.0 111.421 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.07 -45.09 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.99 2.116 . . . . 1.0 108.296 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.8 mt -44.91 -33.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.44 0 C-N-CA 130.666 3.587 . . . . 1.0 110.988 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.67 -26.19 13.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.373 1.069 . . . . 1.0 113.441 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.62 18.36 5.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.849 2.06 . . . . 1.0 110.873 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -138.45 83.3 1.96 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 119.866 -1.771 . . . . 1.0 106.363 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.4 mtt -126.42 118.07 24.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 102.876 -3.009 . . . . 1.0 102.876 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 t -157.66 -165.52 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.21 -131.57 1.25 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 106.798 -2.521 . . . . 1.0 106.798 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.528 ' HE1' ' CE1' ' A' ' 34' ' ' HIS . 12.2 m170 -114.34 -23.26 9.49 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.475 1.137 . . . . 1.0 111.964 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 15.9 t -103.02 -4.3 24.81 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.855 1.262 . . . . 1.0 108.448 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -97.91 23.15 8.34 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.156 1.382 . . . . 1.0 108.964 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.61 -15.74 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 121.171 -0.955 . . . . 1.0 110.618 -175.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -144.19 -66.06 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.882 1.673 . . . . 1.0 109.478 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 94.5 Cg_endo -77.63 119.89 4.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 CA-C-N 122.019 1.757 . . . . 1.0 112.473 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -70.79 0.63 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.643 0.777 . . . . 1.0 111.808 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -84.44 -25.62 28.85 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 119.556 -1.965 . . . . 1.0 113.442 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -129.29 140.65 51.35 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m -127.43 -16.53 4.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 124.352 1.033 . . . . 1.0 112.881 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.66 -179.14 0.36 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.244 2.218 . . . . 1.0 105.819 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.09 77.42 3.49 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.641 2.228 . . . . 1.0 111.073 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.92 76.59 0.94 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.587 1.565 . . . . 1.0 109.639 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.79 -72.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.338 2.692 . . . . 1.0 111.636 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.2 t 54.0 44.78 28.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.876 2.07 . . . . 1.0 111.343 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -93.65 17.87 11.05 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 43.4 t0 43.44 71.98 0.21 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.155 1.382 . . . . 1.0 110.542 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -58.38 -28.81 65.51 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.231 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -49.91 68.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.713 0.688 . . . . 1.0 110.631 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -64.9 -48.9 72.54 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.727 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.78 -53.31 58.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.237 0.926 . . . . 1.0 112.372 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -37.7 81.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.782 -0.628 . . . . 1.0 110.084 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.54 89.72 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.444 0.535 . . . . 1.0 112.444 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.74 -45.95 84.29 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.202 1.001 . . . . 1.0 111.737 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.79 165.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.911 1.284 . . . . 1.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 94.0 m -41.54 113.89 1.18 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.41 2.284 . . . . 1.0 109.58 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.63 53.56 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.081 3.187 . . . . 1.0 113.033 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.6 t 44.58 33.66 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.082 2.153 . . . . 1.0 113.192 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.2 t -164.15 -177.97 5.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 130.745 3.618 . . . . 1.0 104.785 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 56.59 60.13 3.24 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.74 1.257 . . . . 1.0 108.692 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -127.17 149.14 50.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 57.09 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.994 2.918 . . . . 1.0 113.36 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.25 87.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.363 1.065 . . . . 1.0 110.244 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . 0.268 20.4 m . . . . . 0 C--O 1.247 0.929 0 C-N-CA 126.929 2.092 . . . . 1.0 109.218 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -82.66 136.97 34.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.96 136.01 43.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 102.991 -2.966 . . . . 1.0 102.991 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.21 123.84 41.14 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 50.98 33.38 8.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.126 0.876 . . . . 1.0 111.661 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.74 -6.28 5.08 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.015 1.293 . . . . 1.0 113.861 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -82.06 157.45 24.13 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 102.889 -3.004 . . . . 1.0 102.889 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.392 -1.442 . . . . 1.0 107.304 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.35 9.38 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.581 0.753 . . . . 1.0 112.195 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 44.33 58.07 3.99 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.076 2.151 . . . . 1.0 110.087 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.6 22.05 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.01 0.924 . . . . 1.0 109.269 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -74.61 123.47 24.89 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.751 -1.574 . . . . 1.0 106.751 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 125.7 34.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.183 0.901 . . . . 1.0 108.651 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.95 76.13 59.62 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.67 130.05 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.511 2.141 . . . . 1.0 110.772 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -129.5 124.48 21.97 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 126.497 1.919 . . . . 1.0 106.918 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.83 52.74 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.384 2.723 . . . . 1.0 111.417 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -124.11 48.98 1.82 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.7 m-85 -73.8 178.28 4.95 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.332 1.453 . . . . 1.0 112.026 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.92 178.22 4.36 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 128.151 2.58 . . . . 1.0 116.445 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.0 m -156.23 121.49 4.77 Favored 'General case' 0 N--CA 1.446 -0.672 1 C-N-CA 132.938 4.495 . . . . 1.0 103.396 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -135.82 141.18 35.86 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 117.682 -1.151 . . . . 1.0 108.602 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.64 90.22 1.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 124.305 3.336 . . . . 1.0 111.003 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -171.86 154.48 3.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 131.391 3.877 . . . . 1.0 103.97 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -151.43 104.76 3.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 104.641 -2.355 . . . . 1.0 104.641 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.75 159.78 40.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.752 1.621 . . . . 1.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.25 123.54 84.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 118.843 0.747 . . . . 1.0 109.495 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.37 103.6 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.768 1.645 . . . . 1.0 110.842 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -167.55 74.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.994 -1.066 . . . . 1.0 108.844 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.49 135.01 18.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.324 1.849 . . . . 1.0 107.627 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -87.54 133.03 33.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.6 141.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.993 -2.225 . . . . 1.0 104.993 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -136.03 118.89 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.999 -1.482 . . . . 1.0 106.999 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.9 p80 -176.23 144.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.474 1.51 . . . . 1.0 107.525 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.09 112.71 19.39 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 119.542 1.065 . . . . 1.0 110.066 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 10.3 mm -127.29 176.93 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.838 3.255 . . . . 1.0 108.95 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -159.55 122.77 3.63 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 95.714 -5.661 . . . . 1.0 95.714 174.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.288 1.8 tm? -142.63 -65.31 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 116.67 -1.633 . . . . 1.0 113.722 -175.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 15.0 Cg_endo -91.35 163.09 3.66 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 124.328 3.352 . . . . 1.0 112.788 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.91 72.75 6.01 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.632 2.888 . . . . 1.0 118.716 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.64 -73.07 0.93 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.758 -2.937 . . . . 1.0 105.758 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -156.82 122.74 4.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.568 1.547 . . . . 1.0 108.16 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -176.7 177.61 1.35 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.577 3.151 . . . . 1.0 107.464 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.72 22.98 10.45 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 109.319 -1.512 . . . . 1.0 109.319 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.81 118.52 5.16 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.205 -1.33 . . . . 1.0 111.179 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.88 -18.33 28.18 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.376 2.051 . . . . 1.0 113.035 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -53.88 -36.37 62.59 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.088 0.858 . . . . 1.0 110.51 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mt -65.44 -44.71 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.456 -0.783 . . . . 1.0 109.614 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.05 -52.21 51.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.183 0.901 . . . . 1.0 110.351 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -51.34 -34.07 32.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.303 1.441 . . . . 1.0 112.475 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -62.58 -61.45 2.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.622 1.569 . . . . 1.0 111.188 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -70.92 -39.32 72.78 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.537 -0.744 . . . . 1.0 112.063 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.16 -36.63 83.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.271 1.028 . . . . 1.0 109.008 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.92 1.93 39.4 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 117.487 -1.729 . . . . 1.0 115.965 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -88.81 8.52 28.62 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.662 2.231 . . . . 1.0 113.193 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.7 128.58 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.361 1.464 . . . . 1.0 112.168 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.91 136.4 20.63 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 128.174 2.59 . . . . 1.0 109.409 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.56 79.16 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.518 2.812 . . . . 1.0 109.04 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.1 -60.1 1.6 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.189 0.596 . . . . 1.0 110.723 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.44 77.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.429 0.691 . . . . 1.0 109.841 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.0 p80 -171.2 178.09 0.84 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.683 2.393 . . . . 1.0 106.898 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.6 Cg_endo -71.73 -43.45 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.436 2.091 . . . . 1.0 115.53 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -44.18 -50.89 8.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -58.65 6.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.145 1.378 . . . . 1.0 110.615 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.62 -43.41 96.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.892 0.877 . . . . 1.0 111.959 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.13 -61.63 6.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.234 1.397 . . . . 1.0 111.555 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.72 -42.19 91.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.012 -0.994 . . . . 1.0 111.874 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -39.63 -43.75 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 116.924 2.194 . . . . 1.0 116.924 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.35 -34.33 73.7 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.721 -0.612 . . . . 1.0 109.714 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.57 135.89 34.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 101.183 -3.636 . . . . 1.0 101.183 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -52.71 144.58 13.81 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.601 -0.687 . . . . 1.0 110.992 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.83 162.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.207 1.803 . . . . 1.0 107.307 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.07 114.24 0.09 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.595 0.758 . . . . 1.0 109.159 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.58 -176.7 3.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.4 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.6 m80 -111.53 -76.31 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.986 0.812 . . . . 1.0 112.977 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -118.3 118.34 31.55 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 104.896 -2.261 . . . . 1.0 104.896 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tp -103.12 113.58 27.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.165 -2.161 . . . . 1.0 105.165 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.97 113.56 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -71.3 144.93 49.8 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -13.76 3.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 119.272 0.942 . . . . 1.0 113.151 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.32 26.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.889 2.476 . . . . 1.0 112.483 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.14 71.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.112 1.815 . . . . 1.0 114.535 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.32 156.3 17.32 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.839 . . . . 1.0 110.243 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mt -115.88 115.7 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 100.713 -3.81 . . . . 1.0 100.713 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.91 143.03 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.48 120.97 37.44 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.47 117.62 31.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 128.642 2.777 . . . . 1.0 106.205 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' A' ' 19' ' ' TYR . 44.4 t 68.2 92.06 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 120.847 1.658 . . . . 1.0 113.938 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.91 -178.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 121.575 1.517 . . . . 1.0 110.553 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -59.37 30.42 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 130.159 3.384 . . . . 1.0 116.495 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.15 116.01 6.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.537 2.335 . . . . 1.0 108.722 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.295 27.6 ttmt 83.2 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.631 1.972 . . . . 1.0 111.461 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -35.95 159.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 130.911 3.684 . . . . 1.0 116.599 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -113.17 -178.63 3.43 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 129.384 3.074 . . . . 1.0 114.139 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -155.07 118.59 4.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.628 1.571 . . . . 1.0 108.642 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -159.55 63.13 0.38 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.067 0.937 . . . . 1.0 110.361 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.34 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 119.11 -2.244 . . . . 1.0 114.561 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.79 -91.27 0.9 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.191 -3.163 . . . . 1.0 105.191 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 t -127.95 133.85 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.662 1.231 . . . . 1.0 109.407 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 p -160.35 159.06 30.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.84 2.056 . . . . 1.0 108.72 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 157' ' ' ILE . 33.9 p -152.03 147.07 26.07 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.542 1.137 . . . . 1.0 111.45 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -148.88 144.8 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 38.91 53.99 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.761 2.024 . . . . 1.0 112.354 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.41 67.9 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.293 0.949 . . . . 1.0 114.838 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -128.85 113.52 15.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 103.576 -2.749 . . . . 1.0 103.576 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 11.8 tt0 -82.88 142.0 31.81 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.943 -1.873 . . . . 1.0 105.943 175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -102.94 118.53 37.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.04 -2.578 . . . . 1.0 104.04 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.95 -23.65 58.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.615 0.366 . . . . 1.0 110.653 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -146.52 175.15 10.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.533 2.333 . . . . 1.0 106.128 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.7 76.67 3.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.555 1.169 . . . . 1.0 109.313 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -88.54 45.19 1.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.979 1.712 . . . . 1.0 109.431 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -138.81 127.15 22.91 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 120.081 -1.637 . . . . 1.0 113.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.252 0.1 OUTLIER -78.74 56.7 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.732 2.013 . . . . 1.0 108.996 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.18 -136.51 3.74 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.12 163.61 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.209 -2.515 . . . . 1.0 104.209 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.81 117.8 9.43 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.764 -1.939 . . . . 1.0 105.764 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.23 131.07 34.48 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.808 -1.183 . . . . 1.0 110.195 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.0 tt0 -104.36 147.03 27.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.641 0.376 . . . . 1.0 111.776 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.43 173.38 33.6 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.978 1.275 . . . . 1.0 110.356 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -148.18 109.2 4.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 44.93 46.32 8.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.928 2.491 . . . . 1.0 112.671 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 50.62 38.19 18.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.621 1.969 . . . . 1.0 113.499 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.8 tp -68.27 146.55 53.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.688 1.995 . . . . 1.0 108.142 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -31.51 114.23 0.13 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 126.39 1.876 . . . . 1.0 111.812 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.42 -8.58 58.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 115.361 -2.257 . . . . 1.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.396 17.4 p 68.9 78.68 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 122.18 2.264 . . . . 1.0 113.374 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -22.8 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.949 2.159 . . . . 1.0 115.08 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.69 -42.91 7.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.628 2.371 . . . . 1.0 110.629 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -52.44 -51.46 59.09 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.154 0.888 . . . . 1.0 110.432 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -60.61 -39.71 89.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.574 -0.727 . . . . 1.0 109.877 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.13 -51.53 57.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.176 0.898 . . . . 1.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.48 -47.63 78.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.469 1.507 . . . . 1.0 110.393 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.2 tp -56.6 -50.53 71.71 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.33 1.052 . . . . 1.0 108.498 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.06 84.14 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.691 0.678 . . . . 1.0 110.284 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.98 48.78 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.186 0.594 . . . . 1.0 110.648 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.28 -41.78 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.896 0.771 . . . . 1.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.1 m -59.25 -56.79 17.67 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.997 1.319 . . . . 1.0 109.466 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.93 -43.65 77.59 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.939 0.896 . . . . 1.0 110.245 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.82 -50.7 63.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.975 0.51 . . . . 1.0 111.076 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.74 -37.44 71.01 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.487 -0.758 . . . . 1.0 111.378 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.04 -39.31 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.946 0.898 . . . . 1.0 110.057 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.5 m -57.96 -35.33 71.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.38 0.991 . . . . 1.0 111.217 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -83.45 -49.23 9.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -125.79 112.85 24.82 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 107.271 -1.381 . . . . 1.0 107.271 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.37 106.85 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.148 -1.52 . . . . 1.0 108.148 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.94 -55.62 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.797 1.639 . . . . 1.0 107.848 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.0 mt -48.86 -33.94 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.056 2.942 . . . . 1.0 110.329 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.88 -23.03 6.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.497 1.519 . . . . 1.0 113.744 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -137.76 20.73 2.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.985 2.514 . . . . 1.0 109.295 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.13 87.74 2.22 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.69 1.596 . . . . 1.0 106.888 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.5 mtt -136.5 117.6 14.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.16 1.784 . . . . 1.0 107.547 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.9 t -153.52 -176.37 5.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.466 1.485 . . . . 1.0 109.544 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.91 -131.62 2.73 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 107.279 -2.329 . . . . 1.0 107.279 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 22.7 m170 -115.72 -24.04 8.41 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.683 1.241 . . . . 1.0 112.415 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.5 t -103.73 -11.47 17.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.819 0.847 . . . . 1.0 109.024 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.9 OUTLIER -85.81 18.54 2.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.145 1.778 . . . . 1.0 110.31 -175.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.73 -18.99 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.918 0.887 . . . . 1.0 112.456 -175.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.1 -66.13 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.378 1.471 . . . . 1.0 108.54 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 83.2 Cg_endo -81.59 111.32 2.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.834 1.691 . . . . 1.0 111.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.06 -17.58 27.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.971 1.309 . . . . 1.0 111.915 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.83 -25.64 63.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.458 -1.401 . . . . 1.0 112.388 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -134.17 140.61 46.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.522 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 17.0 m -121.71 -16.6 7.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.001 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.08 -178.98 0.63 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 130.717 3.607 . . . . 1.0 104.561 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -78.49 51.27 3.68 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.621 2.214 . . . . 1.0 109.919 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.11 80.89 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.73 2.586 . . . . 1.0 108.485 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.98 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.583 2.189 . . . . 1.0 111.995 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.4 t 53.66 43.03 31.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.329 2.251 . . . . 1.0 112.808 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -122.27 17.94 10.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.259 0.936 . . . . 1.0 112.637 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.263 8.5 t0 41.78 70.56 0.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.583 1.553 . . . . 1.0 111.006 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -52.87 -30.43 33.86 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 121.27 -0.894 . . . . 1.0 111.448 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.57 51.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.461 -0.781 . . . . 1.0 110.162 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -60.46 -50.98 71.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 120.18 1.354 . . . . 1.0 112.008 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.72 -46.87 83.45 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.243 -0.983 . . . . 1.0 111.469 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -64.69 -31.3 72.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.716 0.689 . . . . 1.0 109.932 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -41.19 88.27 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 1.0 111.813 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.17 -55.09 8.88 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.416 1.486 . . . . 1.0 112.166 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.4 t -66.34 152.52 9.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 123.402 0.681 . . . . 1.0 109.845 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -49.12 113.76 3.35 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.722 1.209 . . . . 1.0 111.802 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.15 78.34 2.94 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.12 2.546 . . . . 1.0 110.9 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 34.0 40.28 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.9 2.88 . . . . 1.0 115.114 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 t -158.05 -46.35 0.06 Allowed 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.427 -0.796 . . . . 1.0 111.074 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.34 56.81 0.66 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.025 1.73 . . . . 1.0 110.348 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -98.82 124.31 43.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 185' ' ' GLU . 4.2 pm0 -64.69 -166.75 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 130.988 3.715 . . . . 1.0 113.709 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.02 115.54 4.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.844 1.657 . . . . 1.0 109.816 -175.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.255 1.355 1 C-N-CA 135.388 5.475 . . . . 1.0 106.431 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.753 ' N ' HD21 ' A' ' 8' ' ' LEU . 5.5 tpp . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 160.05 0.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.682 -1.261 . . . . 1.0 111.367 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.45 123.14 42.42 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.612 0.765 . . . . 1.0 108.957 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -126.85 142.85 51.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 129.037 2.935 . . . . 1.0 108.023 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 45.61 35.02 1.89 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.041 1.736 . . . . 1.0 112.172 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.71 -1.87 56.43 Favored Glycine 0 CA--C 1.521 0.407 0 O-C-N 120.888 -1.133 . . . . 1.0 115.246 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -112.87 176.75 4.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.613 2.365 . . . . 1.0 106.348 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.753 HD21 ' N ' ' A' ' 1' ' ' MET . 6.5 tt -98.89 123.63 43.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -84.67 175.72 9.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.162 0.985 . . . . 1.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 39.19 58.4 1.87 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.718 1.207 . . . . 1.0 111.569 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.17 155.91 28.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.094 0.958 . . . . 1.0 108.98 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -78.08 123.35 26.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.41 125.54 33.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.337 -1.356 . . . . 1.0 107.337 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -140.32 79.09 21.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.14 123.69 11.93 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -65.4 145.89 99.02 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.695 -0.854 . . . . 1.0 108.695 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.03 -9.32 11.84 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.921 1.747 . . . . 1.0 116.131 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -144.02 135.92 26.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.386 -2.82 . . . . 1.0 103.386 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.546 ' CE2' HG22 ' A' ' 88' ' ' VAL . 7.2 m-85 -106.7 178.39 4.57 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.291 1.437 . . . . 1.0 108.769 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.79 178.79 4.86 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.248 1.499 . . . . 1.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.0 m -151.28 118.41 5.92 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.912 -2.255 . . . . 1.0 104.912 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -135.93 138.85 28.82 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 106.205 -1.776 . . . . 1.0 106.205 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.44 83.1 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.626 2.217 . . . . 1.0 109.395 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -163.56 149.05 11.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.047 1.739 . . . . 1.0 108.371 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -146.51 104.14 3.74 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.01 160.58 38.17 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 127.446 2.298 . . . . 1.0 107.339 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.51 123.41 88.39 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 106.478 -1.675 . . . . 1.0 106.478 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.93 103.54 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.436 1.424 . . . . 1.0 109.783 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -172.95 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 150' ' ' ASN . 4.5 tp -148.74 132.18 16.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.15 -2.167 . . . . 1.0 105.15 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -91.43 122.49 34.07 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.27 113.45 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 169' ' ' PHE . 15.3 t -110.35 114.22 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 105.675 -1.972 . . . . 1.0 105.675 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 2.8 p80 -165.92 137.22 3.75 Favored 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.11 112.59 19.95 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 105.67 -1.974 . . . . 1.0 105.67 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.323 6.6 mm -126.39 179.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 128.966 2.907 . . . . 1.0 106.146 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -149.58 121.91 8.43 Favored 'General case' 0 N--CA 1.432 -1.327 1 N-CA-C 99.207 -4.368 . . . . 1.0 99.207 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -143.31 -62.9 0.02 OUTLIER Pre-proline 0 C--O 1.254 1.325 0 CA-C-O 115.796 -2.05 . . . . 1.0 111.821 176.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.57 153.09 23.32 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 CA-C-N 123.564 2.308 . . . . 1.0 111.626 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.7 45.52 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.492 3.461 . . . . 1.0 114.69 -175.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.72 -71.8 0.43 Allowed Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.869 -0.962 . . . . 1.0 111.847 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -155.6 122.76 5.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.142 1.377 . . . . 1.0 107.369 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -163.12 166.66 23.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 128.426 2.691 . . . . 1.0 111.514 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.86 -22.65 7.51 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 117.875 -1.514 . . . . 1.0 113.342 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.24 136.77 13.97 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.426 1.613 . . . . 1.0 111.021 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.43 -4.42 14.66 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.42 2.747 . . . . 1.0 116.476 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -49.51 -49.46 45.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 121.653 2.024 . . . . 1.0 112.569 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 23.3 mm -66.23 -43.85 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.156 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.67 -44.55 96.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -56.72 -34.51 67.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.715 1.606 . . . . 1.0 111.987 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -62.05 2.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.801 1.24 . . . . 1.0 109.091 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -66.61 -53.59 32.63 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.545 1.138 . . . . 1.0 111.555 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -56.01 -33.51 64.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.765 1.226 . . . . 1.0 109.311 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.37 25.37 8.83 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 119.762 1.165 . . . . 1.0 114.356 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -115.09 9.91 16.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.983 1.313 . . . . 1.0 112.009 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.5 tt -51.7 126.18 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.652 1.181 . . . . 1.0 112.437 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -98.8 124.37 46.13 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.259 2.224 . . . . 1.0 107.758 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.3 70.41 3.16 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.895 3.064 . . . . 1.0 110.434 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -103.63 -63.71 1.16 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.487 0.715 . . . . 1.0 112.414 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.83 73.7 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.47 0.708 . . . . 1.0 111.391 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 31.3 p80 -164.31 177.98 1.59 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 107.072 -1.455 . . . . 1.0 107.072 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 69.5 Cg_endo -81.92 -43.52 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.329 1.353 . . . . 1.0 112.512 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -45.48 -42.2 10.38 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.243 1.417 . . . . 1.0 113.459 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -57.92 -54.26 48.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.55 1.14 . . . . 1.0 107.943 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.6 85.62 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.018 0.927 . . . . 1.0 110.59 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.94 -61.85 2.18 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 127.892 2.663 . . . . 1.0 111.02 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -59.02 -49.42 83.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-O 116.976 -1.488 . . . . 1.0 110.663 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.63 -43.3 0.4 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.584 2.753 . . . . 1.0 116.529 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -56.01 -41.39 74.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.359 1.076 . . . . 1.0 110.662 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.76 136.95 34.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.892 -2.262 . . . . 1.0 104.892 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 154.64 12.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.768 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.1 162.96 14.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 126.365 1.866 . . . . 1.0 111.681 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.303 2.241 . . . . 1.0 106.722 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.93 -153.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.68 1.592 . . . . 1.0 108.204 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -128.15 -58.9 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.66 1.184 . . . . 1.0 109.84 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.695 ' HB2' HD13 ' A' ' 115' ' ' ILE . 59.2 m -145.58 126.8 14.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.58 113.73 26.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 104.813 -2.291 . . . . 1.0 104.813 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 mt -94.08 121.34 44.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -75.14 144.6 42.72 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 123' ' ' LEU . 36.2 ptt-85 -49.01 -20.58 0.54 Allowed 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.564 1.946 . . . . 1.0 112.949 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -92.07 32.17 1.18 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 130.666 3.586 . . . . 1.0 113.154 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.66 28.41 67.87 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 119.991 -1.693 . . . . 1.0 116.515 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -98.81 145.15 27.25 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 119.194 1.497 . . . . 1.0 108.878 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.36 113.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.171 -1.788 . . . . 1.0 106.171 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.07 143.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -115.76 113.87 24.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -110.67 114.07 27.17 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 105.187 -2.153 . . . . 1.0 105.187 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 19' ' ' TYR . 74.5 t 71.39 91.37 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 121.71 2.05 . . . . 1.0 111.954 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.34 -166.93 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.093 1.862 . . . . 1.0 111.052 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -61.4 26.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 130.34 3.456 . . . . 1.0 116.918 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.27 134.86 19.77 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 121.247 1.84 . . . . 1.0 106.741 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 75.69 82.69 0.1 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.626 1.57 . . . . 1.0 111.504 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -43.96 145.28 0.74 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.333 1.853 . . . . 1.0 112.546 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -109.29 -178.59 3.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.206 2.202 . . . . 1.0 110.26 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -154.39 119.74 5.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.604 0.638 . . . . 1.0 111.051 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -157.21 64.46 0.5 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.058 1.409 . . . . 1.0 111.46 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.01 -57.96 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 117.953 -2.967 . . . . 1.0 111.286 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.91 -69.61 0.44 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.331 -1.908 . . . . 1.0 108.331 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -146.04 144.02 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.464 1.632 . . . . 1.0 109.544 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 p -165.71 162.83 18.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.738 1.215 . . . . 1.0 111.444 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 3.0 p -158.77 145.32 17.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 1.0 108.982 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -166.9 157.15 11.53 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.537 -1.221 . . . . 1.0 108.943 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 39.58 53.91 2.42 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.511 1.924 . . . . 1.0 112.3 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.36 29.82 53.94 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 114.885 -1.052 . . . . 1.0 113.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 tpt85 -131.71 116.72 17.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.081 1.441 . . . . 1.0 108.433 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 2.1 tt0 -78.51 146.49 34.32 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.474 -1.676 . . . . 1.0 106.474 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -126.01 117.97 24.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.387 -2.079 . . . . 1.0 105.387 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.86 -26.25 61.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.812 -1.085 . . . . 1.0 110.588 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -151.42 173.23 14.79 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.972 1.309 . . . . 1.0 108.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.49 75.64 6.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.205 1.479 . . . . 1.0 107.054 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.18 39.2 1.12 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.475 1.11 . . . . 1.0 109.769 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.9 m -140.02 124.26 17.83 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.471 -1.393 . . . . 1.0 113.205 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -78.46 57.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.545 2.338 . . . . 1.0 111.57 -175.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.26 -119.02 0.45 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.411 -1.475 . . . . 1.0 109.411 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.696 HD11 HG11 ' A' ' 136' ' ' VAL . 15.8 mm -149.01 165.56 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 130.234 3.413 . . . . 1.0 104.105 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -141.16 134.13 29.12 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.846 2.858 . . . . 1.0 104.129 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.4 164.24 11.87 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.355 -0.841 . . . . 1.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.37 150.79 50.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.207 0.603 . . . . 1.0 111.135 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.51 173.88 39.67 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.935 1.255 . . . . 1.0 110.734 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 p -151.01 110.53 4.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.635 -2.357 . . . . 1.0 104.635 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.5 t0 49.55 52.67 14.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 123.789 1.757 . . . . 1.0 112.507 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 47.83 37.98 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.373 2.669 . . . . 1.0 114.031 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 80' ' ' ARG . 7.7 tt -58.5 145.62 38.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.722 1.209 . . . . 1.0 107.744 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -44.87 120.72 2.44 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.268 1.027 . . . . 1.0 109.678 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.41 10.38 7.24 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 117.129 -1.415 . . . . 1.0 113.673 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.311 28.6 p 37.4 74.65 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 1 N-CA-C 123.667 4.691 . . . . 1.0 123.667 -174.121 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -17.19 -32.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.998 2.919 . . . . 1.0 114.918 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.34 -41.2 18.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.594 1.557 . . . . 1.0 109.387 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -49.56 -57.29 7.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.51 1.924 . . . . 1.0 109.299 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -56.34 -43.17 78.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.736 -0.65 . . . . 1.0 109.561 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -64.51 -57.06 10.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.652 0.66 . . . . 1.0 111.004 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 136' ' ' VAL . 43.3 mt-30 -65.77 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.974 -1.704 . . . . 1.0 111.516 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.662 HD13 HG21 ' A' ' 115' ' ' ILE . 7.3 tp -61.6 -46.43 89.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.609 1.095 . . . . 1.0 108.761 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.05 76.71 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.247 0.931 . . . . 1.0 109.187 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.33 52.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.856 0.753 . . . . 1.0 110.703 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.696 HG11 HD11 ' A' ' 115' ' ' ILE . 4.1 t -56.06 -46.03 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.092 -0.38 . . . . 1.0 110.044 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.9 m -59.21 -50.08 75.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.373 1.469 . . . . 1.0 109.838 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -60.15 -42.26 94.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.0 110.341 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.93 88.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.849 0.46 . . . . 1.0 112.054 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.36 -47.12 79.52 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.531 -0.747 . . . . 1.0 109.313 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.05 -37.27 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.166 0.986 . . . . 1.0 110.773 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.4 m -65.63 -14.07 60.42 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.071 0.949 . . . . 1.0 111.953 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -111.07 -50.83 2.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.391 1.45 . . . . 1.0 111.744 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -126.77 113.06 22.44 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -97.33 107.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.049 1.41 . . . . 1.0 110.198 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.95 -51.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.064 1.746 . . . . 1.0 106.405 175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 59.5 mt -46.71 -33.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 129.497 3.119 . . . . 1.0 110.999 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.25 -26.42 17.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.407 1.083 . . . . 1.0 113.621 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -135.69 18.15 3.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.705 2.002 . . . . 1.0 110.043 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.434 ' HB3' HD12 ' A' ' 30' ' ' LEU . 11.5 m120 -139.78 83.56 1.93 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.926 1.29 . . . . 1.0 108.068 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 64.5 mtt -120.29 126.71 51.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -167.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.546 1.067 . . . . 1.0 108.345 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.28 -130.88 1.32 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 105.508 -3.037 . . . . 1.0 105.508 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.406 ' HE1' ' CE1' ' A' ' 34' ' ' HIS 0.317 13.2 m170 -112.31 -22.99 10.62 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.325 0.861 . . . . 1.0 113.325 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 9.0 t -102.98 -11.13 18.4 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 118.568 -0.729 . . . . 1.0 109.287 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -89.42 43.05 1.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -71.63 -8.96 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 120.801 -1.187 . . . . 1.0 110.515 175.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -160.72 -53.92 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.669 2.388 . . . . 1.0 111.246 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 64.5 Cg_endo -91.52 111.96 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.097 1.865 . . . . 1.0 113.031 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.95 -25.38 63.46 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.965 -1.084 . . . . 1.0 112.281 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 20.4 ttp85 -71.27 -5.29 31.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.64 -1.287 . . . . 1.0 112.549 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 127.22 22.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 103.888 -2.634 . . . . 1.0 103.888 174.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.3 m -123.73 -16.21 6.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.289 0.95 . . . . 1.0 110.884 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.78 -178.75 0.34 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.216 2.607 . . . . 1.0 105.697 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.79 51.52 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.525 . . . . 1.0 112.96 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.34 76.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.158 1.361 . . . . 1.0 110.202 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.49 -74.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.373 2.049 . . . . 1.0 111.636 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.75 44.02 30.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.431 1.892 . . . . 1.0 111.206 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 33' ' ' VAL . 51.6 t80 -99.09 18.38 17.52 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.038 -1.039 . . . . 1.0 110.926 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.258 9.4 t0 44.17 70.52 0.32 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.388 1.475 . . . . 1.0 110.46 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -56.7 -29.12 62.07 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 120.669 -1.269 . . . . 1.0 110.311 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.4 -53.61 33.8 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.755 1.161 . . . . 1.0 111.994 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -65.93 -47.88 73.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 118.079 -0.962 . . . . 1.0 109.868 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.11 -55.63 31.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.123 0.874 . . . . 1.0 112.176 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -58.64 -36.6 74.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.795 -1.098 . . . . 1.0 109.8 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -45.1 80.82 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.471 1.107 . . . . 1.0 113.629 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.55 -46.08 84.38 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.087 0.955 . . . . 1.0 112.054 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.69 166.55 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.741 2.016 . . . . 1.0 110.082 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 183' ' ' HIS . 6.0 m -45.14 128.54 5.68 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 1.0 109.457 175.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.13 44.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.323 2.682 . . . . 1.0 111.379 -176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.2 t 46.52 41.72 10.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.867 1.667 . . . . 1.0 109.501 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.8 t -155.09 29.2 0.41 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.535 0.734 . . . . 1.0 111.005 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.44 ' HB3' HG23 ' A' ' 179' ' ' THR . 4.6 t-160 -150.25 67.59 0.97 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.125 0.875 . . . . 1.0 110.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -149.07 144.59 26.78 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.246 -2.131 . . . . 1.0 105.246 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -129.16 137.21 51.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.843 -1.91 . . . . 1.0 105.843 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.0 tpt 51.94 100.28 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.901 2.88 . . . . 1.0 114.154 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.258 1.51 0 C-N-CA 128.19 2.596 . . . . 1.0 108.985 -177.137 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ttm . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.428 -0.212 . . . . 1.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 17.2 tp -134.31 176.11 8.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.49 2.316 . . . . 1.0 108.092 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 82.8 mt -124.96 125.27 43.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 103.992 -2.595 . . . . 1.0 103.992 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -126.66 134.23 50.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.508 1.049 . . . . 1.0 109.583 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 51.91 33.61 11.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.055 2.142 . . . . 1.0 111.519 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.91 5.45 79.87 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.304 -1.276 . . . . 1.0 113.492 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -113.87 171.91 7.3 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.168 1.484 . . . . 1.0 108.28 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp -81.62 138.74 35.29 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.863 -0.523 . . . . 1.0 110.183 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.42 154.52 32.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 46.2 58.35 4.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.168 2.187 . . . . 1.0 113.59 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.77 134.73 15.73 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.182 -0.949 . . . . 1.0 111.334 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -71.65 123.18 21.96 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.428 -1.693 . . . . 1.0 106.428 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -92.88 123.93 36.5 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.638 -0.664 . . . . 1.0 110.42 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.45 67.29 75.82 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.333 1.453 . . . . 1.0 107.666 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.52 152.47 59.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.78 1.653 . . . . 1.0 110.071 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -154.1 114.96 2.54 Favored Pre-proline 0 CA--C 1.511 -0.554 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 90.8 Cg_endo -74.75 71.4 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.002 1.801 . . . . 1.0 109.261 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -133.85 43.03 2.89 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.073 2.949 . . . . 1.0 105.064 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 18.9 m-85 -79.28 178.7 7.88 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.425 2.29 . . . . 1.0 113.077 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -122.2 -179.76 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.615 1.966 . . . . 1.0 111.011 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 m -158.26 118.27 3.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 131.395 3.878 . . . . 1.0 101.547 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -120.2 138.72 27.48 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 106.047 -1.835 . . . . 1.0 106.047 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.96 61.27 8.09 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.115 3.21 . . . . 1.0 112.54 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -138.8 151.39 47.01 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 128.675 2.79 . . . . 1.0 105.023 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -150.85 104.36 3.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.802 1.183 . . . . 1.0 109.713 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.14 161.71 34.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 105.97 -1.863 . . . . 1.0 105.97 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -57.69 123.86 65.19 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.97 0.908 . . . . 1.0 108.923 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.34 103.6 1.29 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.366 2.044 . . . . 1.0 108.302 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 t -174.15 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.198 -2.149 . . . . 1.0 105.198 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.07 131.48 9.49 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.376 1.471 . . . . 1.0 107.482 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 tp -92.07 127.51 37.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.342 1.057 . . . . 1.0 109.437 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.67 116.84 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.913 1.285 . . . . 1.0 108.514 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 169' ' ' PHE . 93.6 t -110.88 114.94 48.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -168.07 129.39 1.4 Allowed 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.88 111.84 6.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 5.9 mm -127.0 177.58 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.828 2.451 . . . . 1.0 112.12 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -151.28 122.32 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 1 N-CA-C 95.992 -5.559 . . . . 1.0 95.992 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.301 0.6 OUTLIER -142.84 -60.9 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 121.727 2.058 . . . . 1.0 112.426 176.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.14 157.58 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.572 2.181 . . . . 1.0 111.449 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.16 13.47 2.37 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.771 2.981 . . . . 1.0 116.664 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -24.55 -68.59 0.03 OUTLIER Glycine 0 C--N 1.353 1.508 0 CA-C-N 121.402 1.91 . . . . 1.0 111.694 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -148.89 122.97 9.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.776 -1.565 . . . . 1.0 106.776 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -176.47 159.26 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.649 2.78 . . . . 1.0 108.294 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.46 -6.4 10.62 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.721 1.153 . . . . 1.0 110.664 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.09 120.37 7.18 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 108.383 -1.887 . . . . 1.0 108.383 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.82 -24.86 80.05 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.62 2.213 . . . . 1.0 115.191 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -49.36 -45.81 46.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.794 1.179 . . . . 1.0 113.741 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 mm -65.6 -49.31 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 123.567 0.747 . . . . 1.0 110.651 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.34 -36.33 82.62 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 118.861 -1.136 . . . . 1.0 110.744 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.75 -34.2 71.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.717 0.807 . . . . 1.0 110.996 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.1 tm? -60.94 -54.33 46.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.547 1.139 . . . . 1.0 108.077 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.96 -48.29 69.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.51 -34.77 78.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.275 1.43 . . . . 1.0 110.431 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.09 1.57 29.98 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.195 1.379 . . . . 1.0 115.221 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -88.96 8.69 28.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.232 2.016 . . . . 1.0 113.255 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -57.46 127.92 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.978 1.311 . . . . 1.0 112.219 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.84 135.54 20.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.238 2.215 . . . . 1.0 109.609 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.08 77.34 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.649 2.899 . . . . 1.0 107.261 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.41 -64.58 1.07 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.105 0.562 . . . . 1.0 111.013 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.8 -47.55 76.93 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.042 0.937 . . . . 1.0 110.855 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 17.8 p80 -170.07 177.9 0.98 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.677 1.591 . . . . 1.0 107.607 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -71.37 -43.41 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.437 2.091 . . . . 1.0 114.973 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -46.29 -49.76 17.03 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.956 1.095 . . . . 1.0 113.956 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 -55.58 31.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.116 0.966 . . . . 1.0 110.397 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.28 99.17 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.14 0.976 . . . . 1.0 111.39 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.31 23.09 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.907 1.718 . . . . 1.0 112.38 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.7 pt -60.26 -36.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-O 117.221 -1.371 . . . . 1.0 112.38 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -43.78 -43.15 5.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.58 1.952 . . . . 1.0 115.435 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -60.34 -33.57 72.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.672 -0.643 . . . . 1.0 109.692 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.62 136.65 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 102.924 -2.991 . . . . 1.0 102.924 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 153.89 15.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.694 -1.202 . . . . 1.0 110.456 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.59 159.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -165.84 130.21 2.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.632 -1.248 . . . . 1.0 107.632 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.32 -176.77 3.75 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -123.69 -76.6 0.59 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.549 -2.019 . . . . 1.0 105.549 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' CB ' HD13 ' A' ' 115' ' ' ILE . 3.8 m -122.51 118.47 28.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.891 -2.263 . . . . 1.0 104.891 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.97 113.33 25.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.407 -2.071 . . . . 1.0 105.407 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.4 mt -88.1 119.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 106.029 -1.841 . . . . 1.0 106.029 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.29 141.9 58.61 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.437 -1.69 . . . . 1.0 106.437 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -53.14 -24.99 11.8 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 124.442 1.097 . . . . 1.0 111.324 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.37 34.57 0.95 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.529 1.132 . . . . 1.0 111.845 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.48 48.2 86.28 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 120.112 -1.617 . . . . 1.0 115.944 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.48 156.26 31.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.08 113.51 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 104.948 -2.241 . . . . 1.0 104.948 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.26 139.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -124.79 113.96 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.87 140.41 43.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.911 2.484 . . . . 1.0 104.384 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t 63.18 90.91 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 120.65 1.568 . . . . 1.0 113.519 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.67 -177.55 0.97 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 120.807 1.005 . . . . 1.0 110.432 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.69 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.682 2.793 . . . . 1.0 115.558 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -149.89 120.36 7.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.523 2.729 . . . . 1.0 107.204 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 84.07 81.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.662 2.785 . . . . 1.0 110.639 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -41.04 152.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.699 3.2 . . . . 1.0 114.603 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.72 -178.77 3.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 1.0 110.219 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -152.34 118.44 5.51 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -162.73 62.5 0.2 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.969 0.89 . . . . 1.0 110.914 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.76 -61.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 117.635 -3.166 . . . . 1.0 113.296 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.96 -73.65 1.14 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.203 -1.332 . . . . 1.0 112.943 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.95 129.4 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.973 1.387 . . . . 1.0 111.633 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 p -165.96 146.73 6.67 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.824 1.65 . . . . 1.0 108.231 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.563 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -144.53 146.39 32.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.762 2.025 . . . . 1.0 108.533 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -150.32 149.65 30.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.943 -2.244 . . . . 1.0 104.943 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 43.49 53.61 5.65 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.745 1.218 . . . . 1.0 114.273 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.8 39.46 67.84 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 121.011 -1.056 . . . . 1.0 113.09 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -146.48 113.57 6.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.579 -2.378 . . . . 1.0 104.579 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -105.98 132.84 51.59 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -102.55 118.26 36.48 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.5 t -61.31 -25.05 66.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 1.0 111.611 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -153.77 161.08 42.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.3 76.76 8.23 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.04 40.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.821 2.448 . . . . 1.0 109.74 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -123.73 133.79 53.8 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.852 1.261 . . . . 1.0 110.96 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.39 56.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.162 -1.421 . . . . 1.0 107.162 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.02 -137.01 3.79 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 120.909 -1.119 . . . . 1.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 1.1 mm -143.15 164.77 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.238 -2.875 . . . . 1.0 103.238 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.33 137.18 28.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.329 2.651 . . . . 1.0 103.898 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.91 141.62 33.54 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.589 -1.319 . . . . 1.0 109.407 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 6.0 tm-20 -103.92 154.3 19.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.465 -0.198 . . . . 1.0 110.465 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.02 -177.62 46.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 128.49 2.948 . . . . 1.0 109.401 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 p -156.35 116.64 3.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.735 -2.321 . . . . 1.0 104.735 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.4 t0 50.59 40.45 23.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.261 65.4 p 58.8 38.48 24.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.249 2.22 . . . . 1.0 115.163 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.44 146.08 30.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.906 1.682 . . . . 1.0 107.886 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -42.4 113.38 0.44 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -81.02 -5.75 57.97 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 115.855 1.798 . . . . 1.0 115.855 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.8 p 51.62 77.78 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 120.194 1.361 . . . . 1.0 111.505 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.84 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.245 2.618 . . . . 1.0 114.159 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -41.62 -36.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.497 2.319 . . . . 1.0 109.452 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -48.17 -50.07 30.32 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.594 0.757 . . . . 1.0 110.375 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.84 -47.73 83.82 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.321 0.648 . . . . 1.0 109.982 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.02 -51.95 67.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.578 0.704 . . . . 1.0 109.72 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -66.45 -47.9 71.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 1.0 110.837 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 115' ' ' ILE . 21.5 tp -55.76 -41.77 74.47 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.81 98.26 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.458 1.481 . . . . 1.0 111.907 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.74 47.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.384 0.674 . . . . 1.0 109.246 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 115' ' ' ILE . 22.0 t -60.62 -48.25 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.5 m -55.85 -49.35 73.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.843 1.257 . . . . 1.0 109.893 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.39 -41.08 98.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.488 0.715 . . . . 1.0 110.338 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.74 68.03 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.268 -0.895 . . . . 1.0 110.673 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.12 -41.13 74.83 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.876 -1.059 . . . . 1.0 112.05 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.68 -43.24 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.678 1.126 . . . . 1.0 108.574 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.8 m -65.61 -22.03 66.63 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.386 0.674 . . . . 1.0 111.799 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.62 -56.15 3.48 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 120.478 -1.389 . . . . 1.0 108.098 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.36 112.54 23.44 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -89.97 108.55 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 117.05 -1.5 . . . . 1.0 110.122 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.41 -50.42 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.081 1.752 . . . . 1.0 109.033 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.9 mt -47.33 -33.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.847 3.259 . . . . 1.0 110.765 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.08 -26.3 4.29 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.405 1.082 . . . . 1.0 113.272 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.92 17.92 5.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.676 1.991 . . . . 1.0 111.267 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -139.47 88.02 2.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.34 1.427 . . . . 1.0 109.717 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 46.0 mtt -129.89 113.86 15.16 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -148.6 -165.9 2.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.45 -131.41 1.43 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 106.326 -2.709 . . . . 1.0 106.326 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 16.0 m170 -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.588 1.194 . . . . 1.0 111.907 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.93 -11.59 17.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.787 0.835 . . . . 1.0 109.573 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.52 39.56 0.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.1 -1.0 . . . . 1.0 110.393 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -74.43 -11.69 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 O-C-N 121.251 -0.906 . . . . 1.0 108.68 175.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -159.59 -54.16 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.956 1.702 . . . . 1.0 113.037 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.12 108.86 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 122.71 2.004 . . . . 1.0 111.277 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.23 -13.42 37.6 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.198 -0.938 . . . . 1.0 113.219 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.09 -25.74 63.66 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.544 -1.347 . . . . 1.0 111.957 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -113.91 141.6 47.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -140.37 -15.07 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 118.872 -1.131 . . . . 1.0 111.427 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.71 177.55 0.43 Allowed Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 131.0 3.72 . . . . 1.0 104.092 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.07 77.86 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.33 2.02 . . . . 1.0 109.892 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 127.17 67.27 0.15 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.086 1.803 . . . . 1.0 109.582 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 88.0 Cg_endo -74.62 -89.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.08 2.52 . . . . 1.0 109.551 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t 53.4 42.98 31.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.876 2.07 . . . . 1.0 114.095 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 33' ' ' VAL . 65.8 t80 -95.13 19.28 10.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 119.862 -1.774 . . . . 1.0 113.982 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.5 t0 45.61 56.2 6.02 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.213 -1.554 . . . . 1.0 113.479 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -45.2 -40.5 7.32 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.096 1.758 . . . . 1.0 113.011 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.63 -60.85 2.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.381 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -64.55 -36.2 83.45 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 117.884 -1.526 . . . . 1.0 111.251 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.55 -57.56 12.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.589 0.556 . . . . 1.0 110.397 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -64.38 -32.72 74.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.761 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.75 96.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.536 0.607 . . . . 1.0 111.715 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.82 -46.48 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.243 1.017 . . . . 1.0 112.262 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.04 166.87 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.371 1.868 . . . . 1.0 111.702 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -38.78 121.6 1.17 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.951 1.7 . . . . 1.0 108.876 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.08 45.2 1.86 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.327 3.351 . . . . 1.0 112.699 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.5 t 53.86 33.96 18.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.765 2.026 . . . . 1.0 110.702 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.7 t -167.49 94.9 0.45 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.476 -1.305 . . . . 1.0 107.476 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -166.97 125.17 1.33 Allowed 'General case' 0 C--O 1.231 0.098 0 O-C-N 121.167 -0.958 . . . . 1.0 109.217 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -149.05 165.35 31.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.14 -172.17 3.87 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.02 2.928 . . . . 1.0 105.824 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.7 tpp 34.06 -85.97 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.585 2.754 . . . . 1.0 116.323 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.249 1.073 0 C-N-CA 128.214 2.606 . . . . 1.0 106.04 176.225 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.0 tp -57.15 129.46 41.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -133.91 135.11 43.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 101.723 -3.436 . . . . 1.0 101.723 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -119.01 124.06 46.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.045 -1.095 . . . . 1.0 108.045 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 52.92 33.97 15.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.99 0.814 . . . . 1.0 112.381 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.38 -2.77 6.82 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.681 -1.066 . . . . 1.0 113.809 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -87.75 161.43 17.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 104.176 -2.527 . . . . 1.0 104.176 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.66 124.34 27.49 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.283 -1.511 . . . . 1.0 107.258 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.12 176.33 5.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.895 0.878 . . . . 1.0 112.037 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 45.79 57.97 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.971 2.108 . . . . 1.0 109.694 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 139.83 13.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.557 -1.339 . . . . 1.0 111.294 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.03 130.11 39.18 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -83.61 133.2 34.85 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.024 0.53 . . . . 1.0 110.319 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.84 73.12 28.24 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.422 -1.696 . . . . 1.0 106.422 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.62 123.27 9.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 N-CA-C 108.08 -1.546 . . . . 1.0 108.08 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -113.91 114.51 46.5 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 29.1 Cg_endo -79.86 38.93 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.665 2.91 . . . . 1.0 113.989 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.97 44.53 2.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.503 1.121 . . . . 1.0 109.254 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 21.9 m-85 -73.52 178.52 4.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.066 0.946 . . . . 1.0 112.863 -175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.67 178.6 4.51 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 118.919 2.933 . . . . 1.0 118.919 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.2 m -162.83 118.73 1.84 Allowed 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 135.911 5.684 . . . . 1.0 101.173 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -130.09 154.96 81.39 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.439 -2.06 . . . . 1.0 105.439 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.26 51.97 4.12 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.985 3.124 . . . . 1.0 114.398 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -139.59 151.18 45.83 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.904 1.282 . . . . 1.0 110.205 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -148.43 103.82 3.46 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.791 1.236 . . . . 1.0 108.179 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.44 173.53 11.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.082 0.953 . . . . 1.0 109.01 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -79.46 124.32 84.01 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 119.648 1.113 . . . . 1.0 109.789 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.72 103.95 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.504 2.136 . . . . 1.0 112.436 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -178.13 83.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.067 1.747 . . . . 1.0 108.002 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.67 141.04 17.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.571 1.149 . . . . 1.0 108.183 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -94.25 127.48 40.13 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.475 1.51 . . . . 1.0 108.478 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 140.43 24.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -135.56 113.72 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 104.888 -2.264 . . . . 1.0 104.888 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -170.16 152.16 4.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.796 1.638 . . . . 1.0 107.601 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -94.88 112.42 24.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 36' ' ' ILE . 5.2 mm -128.05 166.67 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 106.179 -1.785 . . . . 1.0 106.179 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -139.13 122.25 16.87 Favored 'General case' 0 N--CA 1.444 -0.733 1 N-CA-C 94.35 -6.167 . . . . 1.0 94.35 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.366 0.7 OUTLIER -142.96 -66.1 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.462 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 179.4 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 27.4 Cg_endo -87.85 155.92 7.36 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.096 2.531 . . . . 1.0 114.352 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.19 59.09 5.86 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 125.174 3.916 . . . . 1.0 116.157 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.79 -71.77 0.95 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -156.48 123.46 5.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.463 1.505 . . . . 1.0 110.496 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -168.56 166.4 12.01 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.227 2.611 . . . . 1.0 110.715 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.06 6.49 25.4 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.623 2.059 . . . . 1.0 111.649 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.2 118.74 6.27 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.187 -1.965 . . . . 1.0 108.187 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.23 -7.88 20.25 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.825 2.35 . . . . 1.0 114.457 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 13.6 m95 -45.95 -49.63 15.62 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.283 1.433 . . . . 1.0 113.293 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -65.12 -46.01 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.619 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.4 -38.31 87.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.163 -0.681 . . . . 1.0 109.163 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -61.16 -34.24 74.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.68 1.192 . . . . 1.0 111.897 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.4 tm? -59.66 -51.89 67.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.905 1.282 . . . . 1.0 109.152 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -70.03 -48.66 57.1 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.609 1.163 . . . . 1.0 111.558 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.05 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.046 0.938 . . . . 1.0 109.378 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.53 1.82 24.48 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.006 -1.441 . . . . 1.0 115.319 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -89.07 9.29 25.9 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.301 2.05 . . . . 1.0 113.038 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.4 tt -53.51 145.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.648 1.579 . . . . 1.0 114.431 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.82 136.77 20.56 Favored Pre-proline 0 CA--C 1.546 0.804 1 C-N-CA 131.77 4.028 . . . . 1.0 113.02 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.51 38.1 0.29 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.769 3.646 . . . . 1.0 113.695 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -103.16 -33.36 9.23 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.229 1.832 . . . . 1.0 111.061 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -50.9 -52.96 36.78 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 106.207 -1.775 . . . . 1.0 106.207 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 12.9 p80 -171.31 178.38 0.79 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 131.046 3.738 . . . . 1.0 104.181 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.3 -43.54 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.69 1.593 . . . . 1.0 113.658 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -42.28 -47.64 4.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.889 1.676 . . . . 1.0 114.105 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -55.66 -55.6 30.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.758 1.223 . . . . 1.0 109.136 -175.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.33 99.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.253 1.021 . . . . 1.0 110.745 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.77 -57.49 10.75 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.87 1.7 . . . . 1.0 113.1 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 pt -61.7 -39.88 84.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.121 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -38.15 -43.26 0.74 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.89 2.476 . . . . 1.0 115.188 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -56.4 -40.05 74.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.008 0.923 . . . . 1.0 108.868 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.56 136.93 32.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 1.0 105.062 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 154.98 5.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.131 -0.98 . . . . 1.0 112.399 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 m -116.73 160.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.349 1.86 . . . . 1.0 108.872 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -174.24 120.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.583 1.553 . . . . 1.0 107.586 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.23 -169.39 1.91 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.243 1.417 . . . . 1.0 108.153 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -120.18 -59.04 1.82 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.854 1.261 . . . . 1.0 109.42 175.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.72 119.12 10.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 119.709 -1.869 . . . . 1.0 106.684 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp -98.88 113.74 26.02 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 102.579 -3.119 . . . . 1.0 102.579 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.0 mt -95.83 114.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.686 -1.968 . . . . 1.0 105.686 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -67.22 152.57 45.49 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 118.519 0.6 . . . . 1.0 110.165 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -60.78 -14.0 18.74 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 125.467 1.507 . . . . 1.0 112.784 175.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -91.88 20.35 5.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.834 1.654 . . . . 1.0 111.755 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.56 47.71 89.79 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.743 2.592 . . . . 1.0 114.118 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -119.36 115.05 23.32 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.383 0.673 . . . . 1.0 110.521 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.92 117.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.55 147.28 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -124.3 117.92 25.6 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.569 1.548 . . . . 1.0 112.321 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.64 123.24 41.44 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 128.391 2.676 . . . . 1.0 105.205 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 t 64.34 91.29 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 122.339 2.336 . . . . 1.0 112.696 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -69.1 -169.13 0.28 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.144 1.896 . . . . 1.0 112.031 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.93 17.58 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.996 2.918 . . . . 1.0 114.994 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -143.68 125.27 14.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.687 2.395 . . . . 1.0 107.249 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? 85.09 81.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.559 3.144 . . . . 1.0 109.678 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB3' HH11 ' A' ' 93' ' ' ARG . 0.1 OUTLIER -38.71 141.44 0.27 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.598 2.759 . . . . 1.0 115.246 -175.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.45 -178.54 3.68 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 129.002 2.921 . . . . 1.0 111.625 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -153.71 118.32 4.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.678 1.591 . . . . 1.0 108.318 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -160.12 63.19 0.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.401 1.572 . . . . 1.0 111.498 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -159.53 -53.97 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.747 -2.471 . . . . 1.0 113.457 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.57 -69.41 0.74 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.5 t -145.86 137.57 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 1.0 108.019 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.9 p -166.46 165.96 16.68 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.092 1.757 . . . . 1.0 108.875 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 157' ' ' ILE . 5.3 p -159.27 146.38 17.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -156.48 152.81 27.85 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.62 -1.252 . . . . 1.0 107.62 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 39.85 53.41 2.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.368 1.467 . . . . 1.0 111.846 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.16 28.47 26.33 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.396 -1.224 . . . . 1.0 114.872 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -129.22 117.36 20.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.83 146.64 30.81 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.424 1.49 . . . . 1.0 111.191 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.15 117.99 24.28 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 50.7 t -78.38 -23.87 46.6 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.207 1.003 . . . . 1.0 110.133 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.13 169.98 16.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.912 -1.885 . . . . 1.0 105.912 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 6.1 t70 -93.43 76.0 4.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 38.42 0.72 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.099 1.759 . . . . 1.0 109.497 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -128.23 143.07 51.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.574 1.55 . . . . 1.0 109.343 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -78.96 56.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.208 2.203 . . . . 1.0 107.451 175.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.07 -136.59 1.57 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 122.227 0.904 . . . . 1.0 112.773 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 136' ' ' VAL . 28.2 mm -147.26 155.44 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 129.522 3.129 . . . . 1.0 104.104 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.43 129.97 21.35 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.97 161.5 13.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.646 -1.909 . . . . 1.0 110.626 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.68 144.82 48.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 1.0 111.084 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.71 38.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.55 2.024 . . . . 1.0 111.232 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.3 p -149.42 106.51 3.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.026 -1.842 . . . . 1.0 106.026 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.6 t0 45.52 48.81 10.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.59 1.956 . . . . 1.0 112.593 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p 52.32 38.39 24.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.695 1.998 . . . . 1.0 114.881 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.605 HD22 ' HD2' ' A' ' 80' ' ' ARG . 5.9 tt -60.6 142.05 55.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 104.482 -2.414 . . . . 1.0 104.482 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -32.09 113.6 0.13 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.057 1.743 . . . . 1.0 112.039 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -79.59 -14.68 58.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 116.322 -1.799 . . . . 1.0 115.388 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 25.4 p 64.2 78.09 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.747 1.612 . . . . 1.0 111.841 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -24.39 -33.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.819 1.648 . . . . 1.0 113.335 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.59 -34.54 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.911 2.884 . . . . 1.0 110.644 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.59 -57.06 11.2 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.915 1.286 . . . . 1.0 107.998 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.01 -42.6 69.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.153 0.981 . . . . 1.0 109.715 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -66.03 -58.77 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.552 1.141 . . . . 1.0 111.542 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.5 -36.25 82.27 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.667 -1.271 . . . . 1.0 112.368 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tt -61.09 -39.22 89.12 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.897 -1.127 . . . . 1.0 108.146 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.72 95.47 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.963 -1.086 . . . . 1.0 111.337 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -53.53 57.23 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 115' ' ' ILE . 55.6 t -55.22 -41.72 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.763 0.825 . . . . 1.0 110.869 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 m -59.59 -44.53 93.33 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.124 -0.985 . . . . 1.0 109.908 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.64 -44.57 90.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.894 0.77 . . . . 1.0 109.748 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.67 -56.22 22.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.941 0.896 . . . . 1.0 110.264 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.07 -44.76 79.25 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 118.241 -0.885 . . . . 1.0 112.325 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.3 -42.13 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.854 0.752 . . . . 1.0 109.786 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.225 0.61 . . . . 1.0 112.193 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -93.1 -51.2 5.15 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.693 1.197 . . . . 1.0 110.304 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.51 112.54 23.06 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -90.74 107.89 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 CA-C-N 121.539 1.585 . . . . 1.0 108.64 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.28 -50.99 0.11 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.603 2.361 . . . . 1.0 108.427 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.26 -33.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 130.367 3.467 . . . . 1.0 110.995 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.84 -26.49 10.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.036 1.125 . . . . 1.0 114.036 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -128.97 18.58 6.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.412 2.285 . . . . 1.0 111.374 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -138.15 83.36 1.97 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.4 mtt -127.61 114.02 16.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.317 -2.475 . . . . 1.0 104.317 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -154.47 -173.43 4.57 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.96 -122.84 1.75 Allowed Glycine 0 C--O 1.234 0.106 0 N-CA-C 106.413 -2.675 . . . . 1.0 106.413 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 97' ' ' ALA 0.255 14.9 m170 -118.3 -23.82 7.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.557 2.343 . . . . 1.0 112.029 176.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.79 -18.39 15.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.466 -0.778 . . . . 1.0 109.991 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -86.55 44.0 1.12 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.33 -23.08 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 120.446 -1.409 . . . . 1.0 107.427 175.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.522 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -151.6 -53.98 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.521 2.728 . . . . 1.0 111.164 175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 95.1 Cg_endo -80.88 109.23 2.18 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.662 2.241 . . . . 1.0 113.348 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.64 -25.52 68.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.837 -1.164 . . . . 1.0 113.221 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -60.44 -23.18 64.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -135.68 131.95 36.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.2 m -113.69 -16.04 12.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.858 0.361 . . . . 1.0 110.13 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.1 -179.18 0.65 Allowed Pre-proline 0 CA--C 1.55 0.963 1 C-N-CA 132.572 4.349 . . . . 1.0 103.252 175.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.74 77.11 2.3 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 122.415 1.898 . . . . 1.0 111.432 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.36 73.58 0.81 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.1 1.333 . . . . 1.0 110.468 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.09 -57.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.816 0 CA-C-N 119.952 1.876 . . . . 1.0 113.645 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 53.35 43.08 31.89 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.32 1.448 . . . . 1.0 111.971 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.01 19.53 14.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.928 0.331 . . . . 1.0 111.486 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.264 22.6 t0 42.96 67.03 0.68 Allowed 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 126.38 1.872 . . . . 1.0 111.185 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -53.56 -32.96 53.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.209 -0.905 . . . . 1.0 111.904 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.41 -52.69 43.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.96 1.254 . . . . 1.0 110.755 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -65.94 -46.01 79.76 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.264 0.938 . . . . 1.0 111.254 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.33 -51.85 67.11 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.921 1.237 . . . . 1.0 111.58 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.329 -0.857 . . . . 1.0 110.049 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.06 77.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.19 -52.64 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.932 0.787 . . . . 1.0 108.996 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.53 161.6 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 122.115 0.959 . . . . 1.0 110.747 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.9 m -42.59 131.79 2.9 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.799 2.44 . . . . 1.0 108.864 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.54 39.83 0.65 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.359 3.373 . . . . 1.0 115.755 -175.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 t 46.81 39.74 7.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.665 1.586 . . . . 1.0 109.409 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t -159.85 101.31 1.46 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.898 1.679 . . . . 1.0 106.59 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -176.49 126.95 0.19 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.333 -1.729 . . . . 1.0 106.333 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -71.92 131.75 43.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.865 -1.902 . . . . 1.0 105.865 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -178.34 5.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.867 1.667 . . . . 1.0 109.778 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.7 tpp -142.2 74.02 1.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.946 -1.096 . . . . 1.0 109.111 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . 0.296 46.9 m . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.538 1.535 . . . . 1.0 111.552 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.714 ' HA ' ' HB1' ' A' ' 139' ' ' ALA . 20.2 ttt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.45 124.19 19.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 155.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.06 123.55 41.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 103.279 -2.86 . . . . 1.0 103.279 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -118.39 148.74 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.299 1.04 . . . . 1.0 108.757 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 53.99 33.06 16.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.709 1.604 . . . . 1.0 109.348 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.25 21.07 56.11 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.135 -0.978 . . . . 1.0 112.618 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -131.19 175.81 8.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.541 1.536 . . . . 1.0 108.086 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.28 124.58 24.22 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.442 -1.318 . . . . 1.0 107.442 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.32 135.29 55.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.715 0.634 . . . . 1.0 112.095 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 52.72 58.72 5.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.087 1.755 . . . . 1.0 111.294 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.75 141.6 25.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.774 -1.557 . . . . 1.0 108.378 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 tpt85 -76.38 123.44 25.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 ptt-85 -88.07 119.59 28.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.25 1.02 . . . . 1.0 111.388 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -143.45 73.98 17.28 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.175 0.99 . . . . 1.0 109.833 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.17 149.69 76.51 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 121.421 1.414 . . . . 1.0 109.87 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -137.44 134.1 18.42 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.576 1.15 . . . . 1.0 108.064 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.18 43.9 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.258 2.638 . . . . 1.0 113.251 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -123.47 43.67 2.9 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.351 -0.843 . . . . 1.0 109.381 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -73.52 178.74 4.46 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.676 1.19 . . . . 1.0 110.298 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -121.08 178.35 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.661 1.22 . . . . 1.0 113.003 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.0 m -148.64 118.61 7.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.079 2.952 . . . . 1.0 104.344 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -138.81 139.21 23.24 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 121.292 1.86 . . . . 1.0 108.717 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 75.18 4.76 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.511 2.807 . . . . 1.0 110.69 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -154.35 144.71 22.13 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.186 2.594 . . . . 1.0 106.853 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -149.8 103.44 3.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 127.257 2.223 . . . . 1.0 105.855 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -136.66 165.23 26.39 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.816 1.646 . . . . 1.0 107.613 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.49 123.61 83.45 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.615 -0.707 . . . . 1.0 111.33 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -86.85 103.59 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.506 2.137 . . . . 1.0 111.802 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -176.46 85.04 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 104.596 -2.372 . . . . 1.0 104.596 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -145.96 146.09 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.974 2.509 . . . . 1.0 105.489 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.26 127.84 56.07 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.026 -1.472 . . . . 1.0 107.026 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.18 135.66 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 169' ' ' PHE . 70.1 t -135.57 114.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.753 1.621 . . . . 1.0 107.839 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -164.56 161.89 21.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.38 1.472 . . . . 1.0 107.236 175.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.64 112.42 24.3 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -127.99 176.42 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 127.809 2.444 . . . . 1.0 108.21 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -156.92 122.13 4.62 Favored 'General case' 0 N--CA 1.438 -1.039 1 N-CA-C 97.483 -5.006 . . . . 1.0 97.483 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.51 -65.89 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.551 0 CA-C-N 120.298 1.408 . . . . 1.0 108.38 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.09 150.71 66.57 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 121.527 1.581 . . . . 1.0 109.924 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.29 28.49 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.105 3.204 . . . . 1.0 113.846 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -18.21 -71.64 0.01 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 127.686 2.565 . . . . 1.0 110.443 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -155.52 122.75 5.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -176.84 175.95 1.55 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.88 2.872 . . . . 1.0 108.089 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.56 1.54 8.09 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.91 -0.939 . . . . 1.0 113.743 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.35 118.52 5.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.219 1.509 . . . . 1.0 112.584 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.2 -4.29 13.36 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.936 2.424 . . . . 1.0 113.758 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.98 -38.77 76.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.948 -1.095 . . . . 1.0 110.292 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 38' ' ' LEU . 84.1 mt -64.35 -44.08 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.81 -48.01 82.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.108 0.867 . . . . 1.0 109.274 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.36 -35.08 62.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 1.0 111.565 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.12 -61.06 2.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.792 0.837 . . . . 1.0 109.835 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -67.23 -49.98 62.43 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -57.73 -33.86 68.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 1.0 109.753 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 40.64 3.19 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.916 0.78 . . . . 1.0 111.879 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -131.3 16.28 5.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 117.972 0.886 . . . . 1.0 110.691 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.74 139.39 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.338 1.055 . . . . 1.0 110.445 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -98.42 127.47 36.05 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 127.641 2.376 . . . . 1.0 106.91 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.4 56.94 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.077 3.185 . . . . 1.0 111.819 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.77 -57.92 1.96 Allowed 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 124.961 1.304 . . . . 1.0 112.34 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.58 -60.33 1.58 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.744 1.217 . . . . 1.0 112.292 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.443 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 23.0 p80 -168.51 177.79 1.18 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 1.0 108.548 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 20.2 Cg_endo -72.87 -43.45 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.726 1.618 . . . . 1.0 113.684 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -50.54 -60.1 3.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.672 1.189 . . . . 1.0 111.928 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.84 -51.65 68.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.846 0.858 . . . . 1.0 110.395 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.54 77.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.415 1.086 . . . . 1.0 111.508 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.19 -65.36 3.62 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 125.418 1.485 . . . . 1.0 110.603 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.91 -24.24 32.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 116.68 -1.629 . . . . 1.0 113.544 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.01 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.526 1.512 . . . . 1.0 113.659 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -57.41 -34.11 68.56 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.612 0.365 . . . . 1.0 110.956 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.49 136.38 33.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -66.04 149.29 50.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.909 -1.119 . . . . 1.0 109.402 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.3 m -117.09 162.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.068 1.347 . . . . 1.0 109.952 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.5 m -166.34 130.57 2.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.256 2.223 . . . . 1.0 105.976 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.11 -157.09 0.56 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -130.21 -61.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.192 0.997 . . . . 1.0 108.821 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' HD13 ' A' ' 115' ' ' ILE . 45.8 m -140.7 118.55 11.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.911 -1.885 . . . . 1.0 105.911 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.22 113.8 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.717 2.007 . . . . 1.0 105.607 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.64 114.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.974 -1.491 . . . . 1.0 106.974 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -70.99 152.84 43.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -14.05 2.58 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.693 0.797 . . . . 1.0 112.952 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -91.5 19.61 6.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 127.477 2.311 . . . . 1.0 112.1 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 28.94 70.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.686 2.565 . . . . 1.0 115.551 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.6 109.09 20.59 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 132' ' ' GLN . 34.1 mt -76.54 121.12 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.073 -2.195 . . . . 1.0 105.073 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.33 125.78 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.506 -2.405 . . . . 1.0 104.506 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.36 113.6 27.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.146 0.978 . . . . 1.0 108.519 -175.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.9 114.31 20.83 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t 83.75 91.62 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.537 1.971 . . . . 1.0 110.357 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.72 -170.37 0.27 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.755 2.303 . . . . 1.0 110.68 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.3 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.243 2.217 . . . . 1.0 115.26 -176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -143.76 123.0 12.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.485 1.914 . . . . 1.0 109.531 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER 86.44 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.22 3.008 . . . . 1.0 111.506 177.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -34.62 138.58 0.1 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.15 2.58 . . . . 1.0 113.04 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.88 -178.83 3.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.554 2.342 . . . . 1.0 111.353 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -150.28 118.73 6.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.241 1.416 . . . . 1.0 108.003 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -167.46 63.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.483 1.135 . . . . 1.0 110.442 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.08 -69.92 0.1 Allowed 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 118.606 -2.559 . . . . 1.0 111.749 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.36 0.33 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 125.187 1.554 . . . . 1.0 110.0 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 t -144.72 145.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.827 1.651 . . . . 1.0 109.899 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 p -165.82 149.54 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.626 1.171 . . . . 1.0 110.573 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.606 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -143.71 132.21 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.788 -1.93 . . . . 1.0 105.788 175.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -159.59 124.26 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.447 1.022 . . . . 1.0 108.313 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 58.79 71.69 0.57 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.41 1.884 . . . . 1.0 113.571 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.38 28.6 44.24 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.527 2.489 . . . . 1.0 113.312 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -147.02 113.22 5.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.36 141.42 28.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -123.95 117.86 25.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 102.997 -2.964 . . . . 1.0 102.997 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.4 t -66.23 -35.13 79.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -145.01 172.1 13.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.787 2.835 . . . . 1.0 106.006 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -84.84 77.11 10.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.413 1.102 . . . . 1.0 108.829 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.75 35.13 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.406 1.882 . . . . 1.0 111.417 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -123.72 153.05 41.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.879 0.872 . . . . 1.0 112.475 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -88.86 57.11 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.534 1.934 . . . . 1.0 107.029 175.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.95 -136.59 1.2 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.947 -1.095 . . . . 1.0 111.74 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.713 HD11 HG11 ' A' ' 136' ' ' VAL . 6.2 mm -142.55 161.47 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 129.329 3.052 . . . . 1.0 103.096 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -134.44 130.13 36.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.309 2.244 . . . . 1.0 105.001 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -101.19 153.03 19.95 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.736 -1.228 . . . . 1.0 108.919 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 158.03 45.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.73 0.776 . . . . 1.0 111.641 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.92 39.53 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.453 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.9 p -146.48 104.0 3.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 103.367 -2.827 . . . . 1.0 103.367 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t0 43.87 49.66 7.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.751 2.02 . . . . 1.0 112.984 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 p 50.31 38.08 16.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.051 2.14 . . . . 1.0 114.191 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.48 136.2 57.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.19 0.04 OUTLIER 'General case' 0 C--N 1.347 0.486 0 C-N-CA 127.373 2.269 . . . . 1.0 110.615 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -78.03 -10.3 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 115.892 -2.004 . . . . 1.0 116.339 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.333 44.8 p 64.74 77.31 0.32 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 121.355 1.889 . . . . 1.0 110.987 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -24.43 -32.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.246 1.818 . . . . 1.0 114.683 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -39.85 -43.67 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.314 1.846 . . . . 1.0 109.231 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -43.71 -50.93 7.45 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.779 1.231 . . . . 1.0 111.668 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.31 -39.81 88.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.458 0.572 . . . . 1.0 111.032 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -61.63 -58.57 7.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.032 0.533 . . . . 1.0 109.667 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.1 mp0 -65.92 -47.12 75.81 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.544 -0.741 . . . . 1.0 111.599 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 115' ' ' ILE . 53.4 tp -54.85 -46.55 74.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.048 1.295 . . . . 1.0 109.34 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.44 96.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.535 1.061 . . . . 1.0 111.416 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.1 50.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.001 0.52 . . . . 1.0 109.654 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 115' ' ' ILE . 98.0 t -52.2 -64.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.533 1.933 . . . . 1.0 108.61 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -53.96 -53.6 50.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.484 1.914 . . . . 1.0 112.209 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -57.85 -41.93 83.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.763 1.165 . . . . 1.0 109.555 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -69.86 -44.34 70.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.205 -0.935 . . . . 1.0 111.165 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.97 -36.77 70.71 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.12 -1.612 . . . . 1.0 111.458 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 mt -62.1 -35.57 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.01 -1.107 . . . . 1.0 108.01 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -64.96 -13.61 57.88 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.785 1.234 . . . . 1.0 110.774 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -98.63 -65.89 0.93 Allowed 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.158 -1.589 . . . . 1.0 106.981 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -119.41 112.91 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 106.673 -1.603 . . . . 1.0 106.673 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -92.78 108.19 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.649 1.566 . . . . 1.0 112.288 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.05 -49.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.587 1.955 . . . . 1.0 106.583 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.0 mt -48.41 -33.61 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 128.934 2.894 . . . . 1.0 110.829 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.42 12.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.344 1.057 . . . . 1.0 113.395 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.31 18.58 4.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.085 2.154 . . . . 1.0 110.656 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.83 83.62 1.97 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.67 1.188 . . . . 1.0 107.967 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.3 mtt -118.78 120.19 36.63 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.592 -1.633 . . . . 1.0 106.592 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -155.26 -169.57 3.2 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.27 -0.894 . . . . 1.0 110.339 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.03 -131.19 1.51 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 14.2 m170 -113.39 -23.51 9.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.362 1.081 . . . . 1.0 111.791 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -11.16 18.56 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -91.36 38.92 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.742 1.156 . . . . 1.0 108.489 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.07 -12.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 120.295 -1.503 . . . . 1.0 110.267 175.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -157.8 -54.39 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.546 1.939 . . . . 1.0 111.088 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 62.7 Cg_endo -87.38 117.94 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.293 1.996 . . . . 1.0 113.395 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.85 -24.29 61.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.271 -0.893 . . . . 1.0 111.785 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -57.49 -19.35 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.64 2.376 . . . . 1.0 112.087 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.98 141.44 38.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.748 -1.575 . . . . 1.0 106.748 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -130.91 -16.72 3.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.898 1.226 . . . . 1.0 109.831 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.98 179.88 0.36 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 129.844 3.257 . . . . 1.0 104.772 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.33 79.75 3.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.149 1.899 . . . . 1.0 108.423 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.15 59.26 0.53 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.389 -1.229 . . . . 1.0 115.251 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 -52.3 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.069 2.435 . . . . 1.0 112.357 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.0 t 54.07 43.62 30.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.197 1.399 . . . . 1.0 111.866 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CD2' HG11 ' A' ' 33' ' ' VAL 0.253 83.5 t80 -107.27 18.34 21.76 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.986 1.847 . . . . 1.0 115.986 -175.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.327 5.8 t70 42.05 75.0 0.1 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.424 1.49 . . . . 1.0 113.625 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -50.18 -35.34 25.84 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.64 79.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.861 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -51.28 68.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.849 1.204 . . . . 1.0 109.651 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 66.5 t80 -63.22 -52.82 60.67 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.825 0.306 . . . . 1.0 111.825 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -63.74 -26.65 68.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.265 -0.897 . . . . 1.0 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.11 88.65 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 1.0 109.992 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.29 -61.21 1.85 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.677 1.591 . . . . 1.0 111.7 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 94.6 t -66.26 165.77 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.3 1.04 . . . . 1.0 110.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 54.4 m -41.12 113.6 1.07 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.331 1.453 . . . . 1.0 110.717 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.01 54.78 4.03 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.3 2.667 . . . . 1.0 107.822 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 t 50.45 33.99 8.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.565 1.146 . . . . 1.0 113.134 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 t -149.91 -46.47 0.13 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -78.16 81.73 4.52 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -147.01 129.7 16.07 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.341 1.456 . . . . 1.0 107.953 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -66.66 175.33 2.4 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.063 0.392 . . . . 1.0 111.047 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 tpt -66.74 155.55 37.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.215 1.006 . . . . 1.0 112.083 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 114.97 -2.443 . . . . 1.0 108.439 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 104.218 -2.512 . . . . 1.0 104.218 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.23 153.45 15.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.181 0.993 . . . . 1.0 110.615 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.8 131.22 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.129 -2.175 . . . . 1.0 105.129 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.17 137.73 51.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 52.64 32.97 12.73 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.974 1.31 . . . . 1.0 110.601 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.91 1.52 32.93 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.967 1.27 . . . . 1.0 114.37 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -107.41 159.76 16.15 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 103.225 -2.879 . . . . 1.0 103.225 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.01 141.13 58.88 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 119.61 -1.931 . . . . 1.0 107.718 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 156.53 32.69 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.515 0.726 . . . . 1.0 110.24 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 38.7 58.08 1.74 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.133 2.173 . . . . 1.0 111.304 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.95 143.83 23.73 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.424 -0.797 . . . . 1.0 111.341 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -82.34 124.23 29.8 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.027 1.331 . . . . 1.0 108.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.57 119.23 24.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 t -142.18 75.34 20.25 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.011 1.324 . . . . 1.0 108.198 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 123.58 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.516 1.478 . . . . 1.0 112.673 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -49.8 146.08 7.99 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.434 1.894 . . . . 1.0 111.92 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.76 -37.42 6.8 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 N-CA-C 114.734 1.013 . . . . 1.0 114.734 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -151.48 135.67 16.73 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -104.28 -170.88 1.83 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.553 1.141 . . . . 1.0 109.675 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.69 178.95 5.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.283 2.633 . . . . 1.0 111.61 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.1 m -140.92 153.95 45.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 129.522 3.129 . . . . 1.0 104.993 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -131.16 157.03 79.27 Favored Pre-proline 0 N--CA 1.467 0.377 0 O-C-N 120.918 -1.114 . . . . 1.0 109.444 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.31 51.08 2.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.072 2.515 . . . . 1.0 111.883 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -148.6 153.63 38.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 126.305 1.842 . . . . 1.0 109.988 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.72 103.2 3.76 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -137.0 164.65 27.85 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.734 -0.603 . . . . 1.0 109.431 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.87 123.8 78.98 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.438 1.895 . . . . 1.0 108.068 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.27 103.48 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 N-CA-C 108.318 -1.455 . . . . 1.0 108.318 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 t -165.09 67.67 0.13 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.37 129.58 22.22 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -95.13 128.64 42.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.959 -1.867 . . . . 1.0 105.959 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -106.17 140.11 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.31 114.2 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -169.61 133.6 1.31 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.81 113.57 8.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.105 -1.443 . . . . 1.0 107.105 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.4 mm -126.41 177.06 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 127.741 2.416 . . . . 1.0 107.623 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -155.5 121.72 5.17 Favored 'General case' 0 C--N 1.316 -0.871 1 N-CA-C 95.421 -5.77 . . . . 1.0 95.421 173.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HD2' ' A' ' 39' ' ' PRO 0.324 0.5 OUTLIER -141.44 -61.45 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 119.119 0.872 . . . . 1.0 111.336 175.848 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 61.3 Cg_endo -79.77 157.79 24.53 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.676 2.25 . . . . 1.0 112.024 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.15 -0.23 10.57 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-O 114.159 -2.517 . . . . 1.0 115.172 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -11.79 -71.05 0.01 OUTLIER Glycine 0 C--N 1.352 1.44 0 C-N-CA 127.278 2.37 . . . . 1.0 113.36 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -155.02 122.97 5.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.345 1.858 . . . . 1.0 109.05 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -175.77 175.42 2.03 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 130.009 3.324 . . . . 1.0 107.614 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.31 6.96 24.89 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.235 1.398 . . . . 1.0 112.83 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.41 118.5 6.2 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.533 1.666 . . . . 1.0 109.951 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.73 -13.08 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.261 1.974 . . . . 1.0 114.386 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -62.01 -35.94 80.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.399 1.454 . . . . 1.0 110.928 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -64.18 -47.03 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.061 0.944 . . . . 1.0 109.238 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -34.74 78.88 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.482 -0.761 . . . . 1.0 112.126 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.8 -33.78 50.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.132 1.373 . . . . 1.0 111.625 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.69 -55.92 28.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.965 1.306 . . . . 1.0 110.259 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 39' ' ' PRO . 42.0 m-85 -71.31 -40.74 70.64 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 126.649 1.98 . . . . 1.0 112.969 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.0 -33.32 75.55 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.222 -0.924 . . . . 1.0 109.538 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.56 24.86 10.51 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 118.698 -1.057 . . . . 1.0 113.525 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -121.46 16.63 11.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.185 1.492 . . . . 1.0 111.575 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.7 135.27 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.408 1.083 . . . . 1.0 110.758 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.95 136.59 20.56 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.199 1.8 . . . . 1.0 109.095 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.78 56.87 3.01 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.798 2.999 . . . . 1.0 113.204 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -103.47 -49.65 3.65 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.586 0.958 . . . . 1.0 113.586 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.93 -60.62 2.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.972 0.805 . . . . 1.0 112.674 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 22.7 p80 -170.53 177.79 0.95 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.558 1.543 . . . . 1.0 107.477 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 16.8 Cg_endo -72.85 -43.53 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.304 1.336 . . . . 1.0 114.996 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -50.77 -59.11 4.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.954 1.252 . . . . 1.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 1.6 t80 -60.12 -49.83 76.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 1.0 110.251 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.68 90.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.818 0.847 . . . . 1.0 111.108 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.14 -63.63 4.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.048 1.785 . . . . 1.0 110.075 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.89 -26.83 41.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 116.408 -1.758 . . . . 1.0 112.947 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -42.98 3.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.105 1.762 . . . . 1.0 114.729 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -52.49 -39.08 60.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.572 1.549 . . . . 1.0 110.871 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.78 136.28 33.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' CD ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.06 161.26 22.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.416 -0.802 . . . . 1.0 109.035 175.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.49 164.39 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.896 1.279 . . . . 1.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.7 m -169.52 118.05 0.63 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.909 1.284 . . . . 1.0 108.332 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.61 -174.48 3.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.79 1.236 . . . . 1.0 109.052 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -112.17 -73.64 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.242 1.017 . . . . 1.0 111.628 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.02 118.74 27.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 103.66 -2.719 . . . . 1.0 103.66 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tp -104.23 113.34 26.82 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.264 -2.865 . . . . 1.0 103.264 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.03 113.49 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 105.644 -1.984 . . . . 1.0 105.644 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -85.37 149.22 25.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.115 0.87 . . . . 1.0 110.399 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -46.82 -13.85 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 128.418 2.687 . . . . 1.0 115.547 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.89 27.98 1.95 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.929 1.291 . . . . 1.0 112.711 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.3 28.96 70.14 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.584 1.564 . . . . 1.0 114.484 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.48 153.05 20.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.299 1.05 . . . . 1.0 111.502 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.45 114.08 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 104.668 -2.345 . . . . 1.0 104.668 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 145.69 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -124.3 115.49 21.11 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.947 0.899 . . . . 1.0 110.403 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -110.38 129.8 55.69 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 127.828 2.451 . . . . 1.0 105.525 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' A' ' 19' ' ' TYR . 16.6 t 63.4 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 121.985 2.175 . . . . 1.0 115.148 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -64.1 -174.11 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 121.658 1.572 . . . . 1.0 111.423 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -67.18 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.57 1.948 . . . . 1.0 114.372 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -140.84 111.53 6.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.734 2.014 . . . . 1.0 108.482 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 84.05 81.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.421 2.289 . . . . 1.0 109.976 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -37.33 146.28 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.675 3.19 . . . . 1.0 111.469 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -104.14 -178.35 3.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.859 1.264 . . . . 1.0 111.674 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -141.78 118.6 11.12 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.2 63.16 0.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.852 1.31 . . . . 1.0 107.964 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.24 -69.04 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 119.224 -2.172 . . . . 1.0 114.454 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.96 -85.67 0.4 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 103.203 -3.959 . . . . 1.0 103.203 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.21 146.45 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 119.797 1.799 . . . . 1.0 110.502 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.5 p -155.84 155.77 33.52 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.055 1.742 . . . . 1.0 108.096 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.484 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -147.99 132.32 17.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.094 -1.817 . . . . 1.0 106.094 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -160.63 156.93 26.35 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.228 0.611 . . . . 1.0 109.565 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 39.13 53.65 2.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.4 1.48 . . . . 1.0 112.251 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.21 28.26 18.36 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.298 2.856 . . . . 1.0 114.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -129.86 121.4 26.63 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 119.619 1.709 . . . . 1.0 107.058 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -92.62 141.96 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -116.35 118.52 32.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.8 -1.556 . . . . 1.0 106.8 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.5 t -55.69 -38.83 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.815 0.846 . . . . 1.0 110.09 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -152.98 164.79 37.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.997 2.919 . . . . 1.0 105.019 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.28 76.71 10.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 122.584 1.183 . . . . 1.0 111.154 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.85 43.42 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.894 2.478 . . . . 1.0 108.542 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 m -123.29 156.79 34.57 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.391 1.876 . . . . 1.0 111.434 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -96.54 57.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.705 2.002 . . . . 1.0 107.92 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.13 -136.96 1.65 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.983 -1.073 . . . . 1.0 112.033 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 133' ' ' LEU . 4.8 mt -152.29 164.88 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 131.512 3.925 . . . . 1.0 102.36 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -144.86 143.1 30.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.053 2.141 . . . . 1.0 105.277 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -101.46 155.39 18.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.824 -1.173 . . . . 1.0 110.303 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -131.43 138.87 49.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.33 -172.73 39.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.353 0.978 . . . . 1.0 110.906 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -133.78 92.46 2.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.578 -0.954 . . . . 1.0 108.628 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.4 t0 54.34 56.97 6.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.471 1.508 . . . . 1.0 113.49 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 16.5 p 60.91 38.42 17.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.181 1.792 . . . . 1.0 113.605 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.6 132.02 47.26 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.29 -2.485 . . . . 1.0 104.29 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -30.32 115.03 0.12 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.387 1.875 . . . . 1.0 110.536 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -78.09 -2.45 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 114.943 -2.456 . . . . 1.0 116.975 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.341 42.4 p 67.39 78.05 0.25 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 115.727 -2.083 . . . . 1.0 111.374 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -24.23 -34.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 121.596 1.998 . . . . 1.0 116.157 177.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.75 14.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.163 2.185 . . . . 1.0 110.333 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -49.15 -50.55 37.07 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 125.077 1.351 . . . . 1.0 109.826 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -60.87 -40.63 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.832 -0.604 . . . . 1.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -65.38 -47.88 74.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.354 0.524 . . . . 1.0 111.061 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.89 -54.04 31.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.451 1.1 . . . . 1.0 110.254 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 115' ' ' ILE . 14.5 tp -54.5 -46.47 73.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.122 1.369 . . . . 1.0 108.805 175.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.46 87.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.934 1.243 . . . . 1.0 111.664 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.64 54.24 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.7 -53.11 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.623 -0.703 . . . . 1.0 109.365 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.4 m -55.38 -61.31 2.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.403 1.881 . . . . 1.0 111.059 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -53.75 -43.08 68.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.606 0.717 . . . . 1.0 110.878 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.009 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 mt -56.76 -36.93 70.38 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.087 -1.633 . . . . 1.0 111.373 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.04 -31.88 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.655 1.182 . . . . 1.0 109.727 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m -64.26 -16.88 62.96 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.88 0.764 . . . . 1.0 111.006 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -65.15 0.98 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 120.664 -1.272 . . . . 1.0 108.274 175.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -110.29 112.84 56.92 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 108.004 -1.109 . . . . 1.0 108.004 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -104.07 108.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 119.697 0.927 . . . . 1.0 111.372 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.15 -51.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.097 2.559 . . . . 1.0 105.912 174.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -45.2 -33.51 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 1 C-N-CA 131.82 4.048 . . . . 1.0 110.013 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.15 -25.54 0.91 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.59 18.97 4.29 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.582 2.353 . . . . 1.0 111.133 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.75 84.29 2.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.88 1.272 . . . . 1.0 109.687 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 116.58 21.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.03 -1.841 . . . . 1.0 106.03 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 -173.25 4.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.846 0.748 . . . . 1.0 109.852 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.31 -131.06 2.64 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 106.696 -2.562 . . . . 1.0 106.696 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 19.8 m170 -112.71 -23.87 9.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.59 0.756 . . . . 1.0 111.215 -177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 t -102.89 -17.05 15.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.615 1.166 . . . . 1.0 111.081 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -85.12 40.3 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.338 1.426 . . . . 1.0 109.196 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -69.71 -9.2 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 O-C-N 120.744 -1.222 . . . . 1.0 109.019 175.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.13 -53.52 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.001 2.52 . . . . 1.0 111.538 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -96.42 121.61 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.852 2.368 . . . . 1.0 114.217 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.51 -17.09 63.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.564 -1.335 . . . . 1.0 112.141 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -24.93 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.115 -0.991 . . . . 1.0 111.48 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -144.31 123.77 13.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.475 -2.046 . . . . 1.0 105.475 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.2 m -114.16 -16.29 12.1 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.402 0.438 . . . . 1.0 112.045 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.24 171.46 1.06 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 128.446 2.698 . . . . 1.0 104.755 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 87.34 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.308 2.006 . . . . 1.0 109.747 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.74 75.42 0.68 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.143 1.83 . . . . 1.0 110.996 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.14 -95.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.736 2.291 . . . . 1.0 110.024 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 54.3 43.64 30.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.188 2.595 . . . . 1.0 111.0 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -97.53 18.58 15.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.348 0.659 . . . . 1.0 111.94 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.4 t0 44.88 67.22 0.74 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.745 1.218 . . . . 1.0 111.803 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.19 -25.51 59.14 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.706 -0.621 . . . . 1.0 112.474 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -55.75 15.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 117.794 -1.098 . . . . 1.0 109.605 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -62.4 -42.84 99.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 117.312 -1.328 . . . . 1.0 110.547 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -61.41 -52.67 63.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.108 1.322 . . . . 1.0 110.881 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.36 77.78 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.16 86.96 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.68 -54.8 14.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.79 1.636 . . . . 1.0 111.007 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.8 160.09 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.133 0.973 . . . . 1.0 109.098 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 26.4 m -46.86 115.91 3.62 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.51 1.924 . . . . 1.0 105.89 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.97 49.07 3.02 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.705 2.937 . . . . 1.0 114.28 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.1 t 47.33 35.19 3.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.481 1.61 . . . . 1.0 111.662 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 t -158.92 168.55 26.48 Favored 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 132.313 4.245 . . . . 1.0 102.243 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 55.69 49.03 17.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.95 1.25 . . . . 1.0 107.74 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tmmt? -130.68 167.01 19.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.298 1.039 . . . . 1.0 110.433 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 155.15 50.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.371 2.668 . . . . 1.0 105.956 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 16.4 ttt -171.42 164.72 7.02 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 1.0 107.847 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.249 1.074 0 N-CA-C 102.374 -3.195 . . . . 1.0 102.374 174.846 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 106.208 -1.775 . . . . 1.0 106.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.86 134.41 53.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 161.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.0 mt -122.75 136.3 54.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -116.97 133.44 56.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 45.38 33.3 1.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.829 1.652 . . . . 1.0 115.021 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.71 79.38 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 119.838 -1.789 . . . . 1.0 112.273 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -127.28 164.58 21.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 103.665 -2.717 . . . . 1.0 103.665 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.56 124.23 27.29 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.33 173.86 8.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.605 0.762 . . . . 1.0 111.042 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 40.04 57.75 2.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.721 2.408 . . . . 1.0 109.993 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.14 153.6 20.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -81.68 130.15 34.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -83.55 118.64 23.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -138.48 88.74 14.27 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.11 123.82 11.41 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 N-CA-C 109.333 -1.064 . . . . 1.0 109.333 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -63.64 146.53 96.65 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.05 -25.29 19.55 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 N-CA-C 117.393 2.036 . . . . 1.0 117.393 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -150.82 117.89 5.93 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.841 -1.911 . . . . 1.0 105.841 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' VAL . 3.3 m-85 -86.92 178.17 7.04 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.084 0.954 . . . . 1.0 112.543 -175.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.38 178.99 4.09 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.931 1.693 . . . . 1.0 111.859 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.3 m -164.94 127.46 2.22 Favored 'General case' 0 CA--C 1.534 0.354 1 C-N-CA 133.356 4.662 . . . . 1.0 103.184 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -131.33 153.78 81.74 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.699 1.136 . . . . 1.0 108.614 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.92 67.67 8.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.104 3.203 . . . . 1.0 110.804 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.48 159.5 42.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.632 1.573 . . . . 1.0 110.734 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -150.91 103.92 3.11 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -137.25 176.48 8.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -84.48 123.0 75.2 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.792 -1.559 . . . . 1.0 106.792 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.26 103.02 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 N-CA-C 108.3 -1.462 . . . . 1.0 108.3 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 t -175.76 69.05 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 150' ' ' ASN . 26.6 tp -147.9 130.45 15.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.99 0.916 . . . . 1.0 108.705 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.476 HD11 HD11 ' A' ' 133' ' ' LEU . 15.7 tp -84.38 124.52 31.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.28 114.04 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 169' ' ' PHE . 87.8 t -114.22 113.93 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.429 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 1.3 p80 -163.54 143.58 8.63 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.545 -2.021 . . . . 1.0 105.545 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 8.0 mm -127.59 176.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 130.835 3.654 . . . . 1.0 107.851 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -160.28 121.78 3.12 Favored 'General case' 0 N--CA 1.432 -1.365 1 N-CA-C 97.829 -4.878 . . . . 1.0 97.829 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.652 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 4.8 tt -142.57 -43.9 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.398 -1.763 . . . . 1.0 112.941 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 44.7 Cg_endo -82.99 150.31 13.93 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 121.662 1.629 . . . . 1.0 114.833 -175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 7.38 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.843 3.028 . . . . 1.0 116.777 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -23.49 -71.3 0.01 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 121.059 1.754 . . . . 1.0 112.525 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -156.6 123.21 5.09 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.291 14.1 m-85 -177.76 153.94 0.9 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 129.649 3.18 . . . . 1.0 109.862 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.31 2.09 77.75 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.05 -0.861 . . . . 1.0 112.885 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.85 118.54 5.51 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.01 -4.05 14.45 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.373 2.049 . . . . 1.0 113.213 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' CZ2' ' CD1' ' A' ' 64' ' ' PHE . 32.6 t-105 -64.55 -39.55 93.97 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.598 1.09 . . . . 1.0 110.305 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 38' ' ' LEU . 5.8 mt -65.86 -46.63 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.568 1.947 . . . . 1.0 109.274 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.63 -46.37 89.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.861 0.755 . . . . 1.0 110.552 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.2 -34.06 63.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.236 1.414 . . . . 1.0 111.39 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.27 -54.79 27.7 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.195 0.452 . . . . 1.0 110.524 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -70.1 -42.5 72.62 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 119.014 -0.517 . . . . 1.0 112.297 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.16 -34.23 77.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.33 1.052 . . . . 1.0 109.049 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.21 -0.47 31.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.367 1.46 . . . . 1.0 115.681 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.3 p -88.99 11.19 18.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.057 1.928 . . . . 1.0 112.934 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.566 HG21 ' CB ' ' A' ' 68' ' ' ALA . 10.8 tt -51.63 135.9 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.108 1.763 . . . . 1.0 112.793 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -98.62 131.31 26.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 127.446 2.299 . . . . 1.0 109.29 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.2 63.01 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.68 3.587 . . . . 1.0 110.184 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -104.54 -65.93 1.0 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.407 1.883 . . . . 1.0 113.15 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.35 -54.76 15.55 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.69 1.196 . . . . 1.0 110.714 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.2 p80 -171.32 177.82 0.87 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.685 1.994 . . . . 1.0 106.766 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.4 Cg_endo -72.49 -43.63 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.494 1.462 . . . . 1.0 114.033 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -50.84 -57.6 8.03 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HD1' HD11 ' A' ' 56' ' ' ILE . 20.8 t80 -59.27 -44.96 92.4 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.205 0.602 . . . . 1.0 111.475 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.67 97.94 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.831 -0.543 . . . . 1.0 111.324 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.68 -60.81 8.23 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.827 1.203 . . . . 1.0 112.026 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.2 pt -51.0 -41.48 22.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.798 1.239 . . . . 1.0 112.96 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' A' ' 56' ' ' ILE . . . -38.01 -43.53 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 127.901 2.48 . . . . 1.0 115.158 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -60.8 -35.58 76.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.449 0.7 . . . . 1.0 110.423 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.77 135.75 33.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 153.46 32.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.377 -0.929 . . . . 1.0 110.05 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.54 163.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.165 1.386 . . . . 1.0 108.671 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 88' ' ' VAL . 2.4 m -170.67 128.04 0.78 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.306 -1.739 . . . . 1.0 106.306 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.17 -154.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.461 -1.681 . . . . 1.0 106.461 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -124.63 -58.55 1.5 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.879 1.672 . . . . 1.0 110.0 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HB2' HD13 ' A' ' 115' ' ' ILE . 68.0 m -142.65 121.35 12.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.53 113.93 21.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.385 1.474 . . . . 1.0 107.853 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.3 mt -97.55 116.59 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.711 1.204 . . . . 1.0 108.078 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -78.92 153.35 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.345 1.884 . . . . 1.0 109.574 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.621 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -46.87 -23.23 0.41 Allowed 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.711 2.004 . . . . 1.0 114.259 176.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.621 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . 18.3 t0 -91.42 34.61 0.95 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.225 0.921 . . . . 1.0 110.478 -175.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.08 29.56 71.33 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.109 -0.995 . . . . 1.0 113.868 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.53 140.67 32.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.01 114.07 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 103.838 -2.653 . . . . 1.0 103.838 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 t -111.67 139.6 35.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.362 0.665 . . . . 1.0 109.514 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -104.87 118.83 37.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -117.65 113.34 21.76 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 103.239 -2.874 . . . . 1.0 103.239 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 19' ' ' TYR . 48.1 t 69.2 91.8 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.31 1.414 . . . . 1.0 112.332 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -66.88 -168.25 0.15 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.471 2.114 . . . . 1.0 111.669 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -60.71 22.76 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 129.378 3.071 . . . . 1.0 116.811 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -159.69 133.49 7.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.972 1.714 . . . . 1.0 107.865 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 tptm 86.29 82.14 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 129.453 3.101 . . . . 1.0 109.665 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.12 147.5 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.991 3.317 . . . . 1.0 115.425 -174.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.07 175.95 5.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.342 3.057 . . . . 1.0 111.076 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -156.12 118.19 4.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.074 1.75 . . . . 1.0 107.343 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.9 63.22 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.287 -1.508 . . . . 1.0 112.318 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.14 -62.79 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.202 -2.186 . . . . 1.0 114.358 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.32 -91.4 0.47 Allowed Glycine 0 CA--C 1.53 1.005 0 N-CA-C 103.608 -3.797 . . . . 1.0 103.608 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.84 146.4 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.807 1.803 . . . . 1.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -154.77 166.51 33.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.479 1.511 . . . . 1.0 110.312 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.43 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -150.9 146.83 26.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.4 1.48 . . . . 1.0 110.745 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.54 133.88 21.81 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.832 -0.543 . . . . 1.0 110.054 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 39.36 65.77 0.65 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.74 2.016 . . . . 1.0 111.367 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 29.26 67.21 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.089 1.196 . . . . 1.0 116.089 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -130.55 136.25 48.73 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.854 -1.906 . . . . 1.0 105.854 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.05 146.83 28.55 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.529 2.332 . . . . 1.0 111.931 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -127.42 118.35 23.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.763 1.225 . . . . 1.0 107.814 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -79.68 -23.42 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.469 0.708 . . . . 1.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -144.97 175.22 10.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.863 2.065 . . . . 1.0 106.547 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -101.2 76.73 1.74 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.55 33.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.011 2.124 . . . . 1.0 113.72 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -129.37 138.98 51.84 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 121.201 -0.937 . . . . 1.0 111.491 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.257 0.1 OUTLIER -78.54 56.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.931 2.092 . . . . 1.0 109.798 -177.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.6 -136.4 1.39 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 122.289 0.939 . . . . 1.0 111.247 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 136' ' ' VAL . 8.5 mm -144.02 166.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 130.151 3.38 . . . . 1.0 103.144 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -143.43 136.85 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 103.222 -2.881 . . . . 1.0 103.222 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -98.81 134.28 41.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.166 -0.959 . . . . 1.0 109.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 24.3 tt0 -105.61 138.28 42.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.806 0.812 . . . . 1.0 110.285 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.47 40.11 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.47 1.986 . . . . 1.0 109.41 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -153.28 116.18 4.53 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.32 39.7 30.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.865 1.316 . . . . 1.0 112.194 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p 45.08 37.73 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.293 2.237 . . . . 1.0 112.529 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.04 136.69 58.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.66 113.38 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.695 2.398 . . . . 1.0 112.618 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -78.67 -16.2 57.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 116.554 -1.689 . . . . 1.0 112.876 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.359 10.3 p 66.51 77.54 0.28 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 121.183 1.81 . . . . 1.0 112.118 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.25 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.699 2.045 . . . . 1.0 115.25 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.12 -36.92 3.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 1.0 109.354 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -56.41 -58.49 7.77 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 125.564 1.546 . . . . 1.0 107.559 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -52.79 -44.73 66.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.263 0.938 . . . . 1.0 110.075 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -66.16 -58.15 6.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.549 0.74 . . . . 1.0 111.947 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -66.3 -34.33 77.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.503 1.047 . . . . 1.0 112.09 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 115' ' ' ILE . 9.2 tp -61.14 -44.56 97.13 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 106.962 -1.495 . . . . 1.0 106.962 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.5 80.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.134 -0.936 . . . . 1.0 110.412 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.99 -55.35 35.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.447 1.021 . . . . 1.0 109.972 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 115' ' ' ILE . 57.6 t -54.33 -49.18 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 1.0 109.338 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.1 m -58.38 -53.89 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.594 1.158 . . . . 1.0 109.873 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -56.09 -43.67 78.25 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.914 1.285 . . . . 1.0 110.478 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.62 63.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.12 0.568 . . . . 1.0 111.713 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -56.56 -34.57 67.24 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 117.918 -1.039 . . . . 1.0 111.264 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.28 -43.38 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 120.159 1.345 . . . . 1.0 109.144 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.5 m -64.43 -23.1 67.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.854 0.752 . . . . 1.0 111.524 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -83.77 -58.55 2.75 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.788 -1.195 . . . . 1.0 108.438 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.61 113.15 22.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.549 1.54 . . . . 1.0 109.104 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.54 107.78 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 CA-C-N 120.857 1.342 . . . . 1.0 111.867 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.23 -51.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.014 2.125 . . . . 1.0 107.798 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.4 mt -45.16 -33.4 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 131.508 3.923 . . . . 1.0 111.078 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.99 -23.42 5.08 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.222 1.009 . . . . 1.0 113.541 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -140.52 30.75 1.9 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.687 2.395 . . . . 1.0 109.089 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.549 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.7 m120 -140.7 83.78 1.91 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.367 1.867 . . . . 1.0 110.311 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.57 116.65 16.15 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 126.661 1.984 . . . . 1.0 105.718 175.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 HD11 ' A' ' 30' ' ' LEU . 10.6 t -151.69 -173.2 4.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.98 -131.52 2.29 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 105.604 -2.998 . . . . 1.0 105.604 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.429 ' HE1' ' CE1' ' A' ' 34' ' ' HIS 0.306 13.0 m170 -112.98 -22.28 10.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.867 1.267 . . . . 1.0 111.311 -176.048 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.02 -11.25 17.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.493 0.588 . . . . 1.0 109.807 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -86.57 36.41 0.7 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.632 1.105 . . . . 1.0 108.532 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -67.8 -12.07 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 120.399 -1.438 . . . . 1.0 109.859 175.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.06 -66.01 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.74 2.416 . . . . 1.0 111.16 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 95.3 Cg_endo -92.65 127.89 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.275 1.983 . . . . 1.0 114.075 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.46 -26.25 65.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.938 1.295 . . . . 1.0 112.615 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -63.13 -21.66 66.34 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.856 1.263 . . . . 1.0 111.774 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 138.92 53.29 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 105.174 -2.158 . . . . 1.0 105.174 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -132.39 -16.63 2.7 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 118.868 -1.133 . . . . 1.0 110.844 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -179.27 0.35 Allowed Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 129.171 2.989 . . . . 1.0 104.292 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.29 52.23 4.2 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 122.543 2.162 . . . . 1.0 112.5 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.72 73.24 0.12 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.005 1.764 . . . . 1.0 112.538 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.15 -63.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.46 2.106 . . . . 1.0 111.955 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.7 t 54.46 43.8 29.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.932 2.093 . . . . 1.0 110.446 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 33' ' ' VAL . 58.2 t80 -94.02 18.25 10.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -175.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.72 71.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.942 1.297 . . . . 1.0 112.858 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -54.78 -32.28 59.87 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 115.154 -0.93 . . . . 1.0 112.634 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.06 71.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.356 -0.83 . . . . 1.0 110.148 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -61.66 -55.96 24.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.399 0.999 . . . . 1.0 110.74 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.86 -51.28 70.4 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.727 1.751 . . . . 1.0 115.727 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.492 HH21 ' HA ' ' A' ' 180' ' ' PRO . 0.0 OUTLIER -60.04 -39.11 84.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.137 0.881 . . . . 1.0 109.279 -175.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.39 78.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.566 0.95 . . . . 1.0 113.566 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.12 -45.33 92.5 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.352 1.461 . . . . 1.0 114.068 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.34 160.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -43.66 114.01 1.64 Allowed Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.869 1.668 . . . . 1.0 106.554 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.492 ' HA ' HH21 ' A' ' 175' ' ' ARG . 42.4 Cg_endo -79.28 41.03 1.02 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.145 1.897 . . . . 1.0 114.578 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.6 t 50.3 33.75 7.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.922 2.089 . . . . 1.0 111.087 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.9 t -155.66 34.81 0.36 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.094 1.757 . . . . 1.0 109.131 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -158.15 81.27 0.84 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.992 1.317 . . . . 1.0 107.938 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -156.91 126.38 6.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.54 153.81 17.63 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.195 -1.409 . . . . 1.0 107.195 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.4 tpt -115.4 75.46 0.94 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.79 0.805 . . . . 1.0 110.523 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 C--O 1.251 1.141 0 N-CA-C 103.068 -2.938 . . . . 1.0 103.068 175.581 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 tpt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.37 123.56 28.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt -136.02 136.35 40.19 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 105.974 -1.862 . . . . 1.0 105.974 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.48 123.43 42.02 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.981 1.712 . . . . 1.0 109.318 -175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 47.23 37.83 6.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.472 1.509 . . . . 1.0 114.711 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.74 16.55 76.2 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.288 -0.882 . . . . 1.0 113.167 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -126.84 173.04 9.88 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.613 2.765 . . . . 1.0 105.301 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.63 130.28 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.112 -1.811 . . . . 1.0 106.112 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 165.91 23.3 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.556 0.743 . . . . 1.0 112.239 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 42.28 58.46 2.99 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.815 1.646 . . . . 1.0 109.046 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.49 145.94 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.656 1.183 . . . . 1.0 109.683 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -76.08 123.15 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.45 118.96 30.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.906 0.775 . . . . 1.0 109.027 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.19 73.52 81.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.3 123.92 11.11 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.724 1.616 . . . . 1.0 108.812 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -137.53 113.51 9.38 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 126.566 1.947 . . . . 1.0 106.949 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.25 58.8 7.11 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.275 1.983 . . . . 1.0 110.845 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -123.73 43.53 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.925 1.69 . . . . 1.0 106.709 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.487 ' CD1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -82.82 179.28 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.385 1.474 . . . . 1.0 110.374 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.3 178.57 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.666 1.586 . . . . 1.0 109.031 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.4 m -150.55 131.64 14.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.865 2.466 . . . . 1.0 105.121 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.26 149.28 72.11 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 108.258 -1.015 . . . . 1.0 108.258 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.04 97.38 1.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 N-CA-C 106.601 -2.115 . . . . 1.0 106.601 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -162.6 147.95 12.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -146.73 108.07 4.25 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.979 0.809 . . . . 1.0 109.699 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -136.2 160.24 39.29 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 127.399 2.28 . . . . 1.0 106.952 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -69.36 123.4 88.28 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.59 103.0 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.626 -1.336 . . . . 1.0 108.626 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -175.9 70.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.07 127.35 13.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 105.091 -2.188 . . . . 1.0 105.091 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.31 129.37 41.01 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.9 139.53 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 105.976 -1.861 . . . . 1.0 105.976 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.84 122.9 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -171.07 150.22 3.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.275 1.43 . . . . 1.0 107.357 175.331 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -95.3 111.9 23.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mm -127.37 176.4 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 128.333 2.653 . . . . 1.0 107.59 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 t -148.89 122.18 8.99 Favored 'General case' 0 C--O 1.247 0.938 1 N-CA-C 94.825 -5.991 . . . . 1.0 94.825 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.338 0.4 OUTLIER -142.57 -65.15 0.02 OUTLIER Pre-proline 0 C--O 1.222 -0.347 0 CA-C-O 117.823 -1.084 . . . . 1.0 113.316 178.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.81 162.25 9.09 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.822 3.015 . . . . 1.0 115.523 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.58 28.83 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.831 3.021 . . . . 1.0 114.973 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -40.87 -71.42 0.31 Allowed Glycine 0 C--N 1.35 1.339 0 CA-C-N 120.78 1.627 . . . . 1.0 109.312 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 23.4 mt-10 -156.31 123.48 5.34 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.648 2.379 . . . . 1.0 107.124 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -176.89 176.95 1.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 131.366 3.866 . . . . 1.0 108.098 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.67 4.95 8.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.316 1.436 . . . . 1.0 111.603 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.61 136.56 14.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.368 1.584 . . . . 1.0 110.497 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.32 -16.99 15.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.828 2.352 . . . . 1.0 113.782 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -54.32 -39.9 67.46 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.528 1.058 . . . . 1.0 111.556 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.3 mt -64.99 -48.73 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.352 1.061 . . . . 1.0 109.047 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.55 -49.65 76.69 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.02 -34.68 68.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.942 0.897 . . . . 1.0 111.727 -176.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.92 -49.31 68.44 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.151 0.98 . . . . 1.0 110.26 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -70.41 -48.27 56.87 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.257 0.623 . . . . 1.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.14 -37.47 85.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.305 1.842 . . . . 1.0 109.955 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.24 1.65 28.1 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.222 1.391 . . . . 1.0 115.357 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -89.08 9.89 23.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.322 2.061 . . . . 1.0 113.045 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.81 136.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.142 1.777 . . . . 1.0 113.116 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.88 122.7 51.94 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.87 2.468 . . . . 1.0 109.375 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.56 58.77 5.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.032 3.155 . . . . 1.0 111.016 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.09 -54.72 2.56 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 117.752 -1.118 . . . . 1.0 111.914 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.65 -51.15 61.39 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.59 1.087 . . . . 1.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 20.8 p80 -170.4 178.02 0.93 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.701 2.0 . . . . 1.0 107.032 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 25.4 Cg_endo -75.95 -43.31 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.36 1.373 . . . . 1.0 114.125 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -42.41 -47.54 4.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.886 1.675 . . . . 1.0 113.758 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.81 -55.45 34.7 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.839 1.256 . . . . 1.0 109.6 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.0 95.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.265 1.426 . . . . 1.0 110.733 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.61 -64.11 1.96 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 127.048 2.261 . . . . 1.0 111.874 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 pt -61.42 -32.66 53.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 117.243 -1.36 . . . . 1.0 112.661 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.0 -43.12 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.004 2.224 . . . . 1.0 117.004 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.55 -33.83 73.25 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.489 -0.757 . . . . 1.0 110.33 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.88 135.37 33.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' NE ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.17 162.67 19.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 175.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.48 158.54 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 124.513 1.125 . . . . 1.0 108.691 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.4 m -175.44 125.28 0.24 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.042 1.337 . . . . 1.0 108.887 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.18 -168.8 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 174.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -113.22 -76.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.643 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.2 m -124.03 118.41 26.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.86 113.69 27.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.081 -2.192 . . . . 1.0 105.081 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.7 mt -99.26 113.4 34.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ttp85 -85.28 153.4 22.61 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.54 -1.282 . . . . 1.0 107.54 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -48.65 -20.24 0.44 Allowed 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.543 1.937 . . . . 1.0 115.266 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.68 28.24 1.82 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.104 0.962 . . . . 1.0 112.442 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.83 30.04 71.89 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.297 1.903 . . . . 1.0 113.766 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.68 113.08 25.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.674 0.79 . . . . 1.0 110.474 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.38 120.97 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 104.822 -2.288 . . . . 1.0 104.822 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.43 149.08 14.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.666 -2.346 . . . . 1.0 104.666 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -126.12 122.1 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.731 0.812 . . . . 1.0 110.818 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -121.21 129.51 53.24 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 128.856 2.862 . . . . 1.0 103.922 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 73' ' ' SER . 3.8 t 64.42 91.72 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 CA-C-N 121.684 2.038 . . . . 1.0 113.753 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -66.44 -170.43 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.515 2.143 . . . . 1.0 113.396 177.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.09 15.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.455 2.702 . . . . 1.0 115.099 -175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -137.87 116.69 12.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.329 2.252 . . . . 1.0 108.021 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 tttt 78.86 81.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 128.288 2.635 . . . . 1.0 107.554 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.28 150.78 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 130.266 3.426 . . . . 1.0 113.67 -175.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.28 -178.24 3.6 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.993 2.117 . . . . 1.0 110.104 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -147.88 118.9 7.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.175 1.352 . . . . 1.0 110.34 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.49 63.06 0.17 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.728 1.251 . . . . 1.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -158.26 -54.89 0.07 Allowed 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 118.76 -2.463 . . . . 1.0 114.354 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.81 -74.83 1.12 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.029 -2.028 . . . . 1.0 108.029 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.8 t -149.26 135.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.605 1.703 . . . . 1.0 110.933 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -166.98 149.24 6.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.202 1.801 . . . . 1.0 109.789 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.69 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -134.03 146.45 50.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 128.374 2.669 . . . . 1.0 110.785 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -150.17 142.61 24.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 39.13 53.81 2.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.507 1.523 . . . . 1.0 112.802 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.01 29.16 70.14 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.374 -0.681 . . . . 1.0 114.751 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -130.11 113.8 14.95 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.444 -1.688 . . . . 1.0 106.444 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -93.49 146.7 23.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.776 1.23 . . . . 1.0 107.721 175.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.5 mtm-85 -112.29 118.58 35.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.849 1.26 . . . . 1.0 108.076 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.51 -30.11 71.14 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.807 0.692 . . . . 1.0 110.338 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -146.03 170.14 17.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.516 1.126 . . . . 1.0 108.192 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.91 76.89 8.79 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.208 1.004 . . . . 1.0 109.485 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.95 33.8 1.3 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.054 1.341 . . . . 1.0 112.415 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -127.89 156.47 42.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.08 1.352 . . . . 1.0 112.628 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.08 56.83 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.832 2.053 . . . . 1.0 109.089 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.22 -136.78 3.84 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.05 -1.031 . . . . 1.0 112.385 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 76' ' ' CYS . 12.3 mm -145.15 165.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.44 2.696 . . . . 1.0 104.549 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.49 138.55 26.2 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.492 -2.41 . . . . 1.0 104.492 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.8 151.38 22.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.897 0.771 . . . . 1.0 110.52 176.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -130.43 138.93 50.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.294 0.568 . . . . 1.0 111.064 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.85 -171.75 37.88 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.002 1.763 . . . . 1.0 110.124 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 p -148.65 115.33 5.97 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 103.346 -2.835 . . . . 1.0 103.346 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t0 42.18 53.15 4.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 129.393 3.077 . . . . 1.0 113.994 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 49.32 38.87 14.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.793 1.637 . . . . 1.0 113.493 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 tp -56.66 143.81 34.71 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 107.127 -1.435 . . . . 1.0 107.127 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -34.84 115.67 0.29 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.625 1.97 . . . . 1.0 109.867 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.67 -7.85 58.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.776 -2.059 . . . . 1.0 114.517 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.397 20.3 p 66.5 78.59 0.26 Allowed 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 121.398 1.908 . . . . 1.0 112.528 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.34 -34.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.007 1.73 . . . . 1.0 114.372 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.42 -41.33 9.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.072 2.149 . . . . 1.0 111.635 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -48.97 -51.18 31.87 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.023 1.329 . . . . 1.0 109.29 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -58.67 -37.35 75.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.536 -0.745 . . . . 1.0 110.541 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -64.61 -55.85 17.64 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.154 0.888 . . . . 1.0 110.861 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.93 -47.32 75.1 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.069 0.948 . . . . 1.0 110.918 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 115' ' ' ILE . 56.4 tp -56.36 -47.36 79.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.021 1.328 . . . . 1.0 108.43 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.37 99.26 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.493 1.042 . . . . 1.0 110.236 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.72 54.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.027 0.831 . . . . 1.0 110.036 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 115' ' ' ILE . 89.7 t -55.88 -47.3 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.657 0.783 . . . . 1.0 109.375 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 72.9 m -57.12 -53.31 59.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.253 1.021 . . . . 1.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -56.04 -45.7 79.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.927 0.891 . . . . 1.0 110.542 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.7 63.93 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.524 -0.735 . . . . 1.0 110.385 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.86 -45.32 82.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.528 1.531 . . . . 1.0 110.763 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.51 -42.96 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.191 0.996 . . . . 1.0 109.582 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -64.73 -24.93 67.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.969 -0.457 . . . . 1.0 110.508 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -84.08 -59.29 2.45 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.263 -1.384 . . . . 1.0 107.263 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -122.2 113.0 31.27 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -102.92 107.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 116.595 -1.803 . . . . 1.0 112.809 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.5 -44.08 0.1 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 128.674 2.79 . . . . 1.0 106.809 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 42.8 mt -45.2 -33.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 128.546 2.738 . . . . 1.0 110.592 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.43 -21.97 4.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.476 1.51 . . . . 1.0 113.929 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -135.12 18.57 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.091 2.156 . . . . 1.0 109.452 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -138.97 83.69 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.614 1.097 . . . . 1.0 109.595 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 124.56 29.28 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.154 -2.535 . . . . 1.0 104.154 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 t -156.96 -174.42 4.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.265 0.484 . . . . 1.0 109.885 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -143.59 -131.8 2.54 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.541 -2.224 . . . . 1.0 107.541 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.496 ' HE1' ' CE1' ' A' ' 34' ' ' HIS . 11.8 m170 -121.2 -23.52 5.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.956 1.378 . . . . 1.0 112.694 -175.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.56 -6.29 22.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 19.6 t-20 -83.58 15.59 3.06 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 128.556 2.743 . . . . 1.0 111.549 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.69 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.53 -15.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.609 0.763 . . . . 1.0 111.815 -175.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.74 -53.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.617 1.967 . . . . 1.0 110.282 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.22 108.74 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.594 1.605 . . . . 1.0 111.367 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.25 -26.16 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.485 -1.384 . . . . 1.0 110.049 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.2 -25.96 66.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.446 1.898 . . . . 1.0 111.946 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -127.22 124.26 38.51 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 105.161 -2.163 . . . . 1.0 105.161 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 23.9 m -119.29 -16.69 8.99 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.913 -0.715 . . . . 1.0 112.43 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.46 179.67 0.39 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.812 2.445 . . . . 1.0 104.679 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.47 88.01 1.2 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.027 2.485 . . . . 1.0 109.862 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 69.7 0.67 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.093 1.33 . . . . 1.0 109.96 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -76.13 -81.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.303 2.052 . . . . 1.0 110.995 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t 53.66 42.9 31.75 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.453 1.501 . . . . 1.0 109.576 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.29 17.53 19.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.27 0.486 . . . . 1.0 112.178 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.3 t0 44.52 68.01 0.61 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.905 1.682 . . . . 1.0 113.008 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -54.88 -33.0 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 119.059 -0.496 . . . . 1.0 111.717 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.29 22.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.853 -1.07 . . . . 1.0 109.912 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -60.12 -47.66 84.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.257 0.935 . . . . 1.0 111.982 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.37 -58.94 6.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.771 0.669 . . . . 1.0 110.942 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -34.03 74.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.922 -0.561 . . . . 1.0 111.687 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.03 93.3 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 117.941 0.337 . . . . 1.0 111.667 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.16 -50.72 30.36 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.796 0.839 . . . . 1.0 111.647 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.95 166.38 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.664 1.986 . . . . 1.0 111.255 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.3 m -48.05 113.45 2.75 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -85.71 40.63 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.875 2.384 . . . . 1.0 112.479 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.7 t 56.48 51.88 10.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.536 1.534 . . . . 1.0 107.969 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t -175.58 179.99 1.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 131.574 3.95 . . . . 1.0 105.599 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 54.99 54.81 8.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.234 1.014 . . . . 1.0 111.888 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -108.85 162.17 14.44 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.74 169.82 17.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.187 1.795 . . . . 1.0 108.448 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.0 tpt 74.91 -107.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 128.65 2.78 . . . . 1.0 111.836 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.42 1.888 . . . . 1.0 106.294 -177.75 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 2.0 tpp . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 105.256 -2.127 . . . . 1.0 105.256 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.7 152.65 0.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 117.356 -3.34 . . . . 1.0 111.682 -162.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.71 126.36 44.29 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 123.109 1.433 . . . . 1.0 112.204 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -136.17 153.99 51.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.781 2.032 . . . . 1.0 109.534 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 43.8 43.08 4.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.888 1.675 . . . . 1.0 113.48 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 8.99 72.6 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.86 -1.522 . . . . 1.0 114.499 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -131.32 170.19 14.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.932 1.866 . . . . 1.0 107.258 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 11' ' ' ALA . 5.8 tt -101.29 123.51 45.51 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.08 148.34 26.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.619 1.099 . . . . 1.0 110.368 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 47.33 75.05 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.004 1.722 . . . . 1.0 110.799 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' HD22 ' A' ' 8' ' ' LEU . . . -161.63 155.49 21.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.984 2.514 . . . . 1.0 107.916 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -76.71 123.38 26.09 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 104.728 -2.323 . . . . 1.0 104.728 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -93.19 138.43 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.12 76.69 50.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.711 1.204 . . . . 1.0 107.785 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.66 125.91 13.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.454 2.103 . . . . 1.0 109.416 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -144.5 113.32 5.11 Favored Pre-proline 0 CA--C 1.518 -0.288 0 C-N-CA 124.887 1.275 . . . . 1.0 107.626 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.21 65.39 8.83 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.307 2.005 . . . . 1.0 111.288 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -130.29 43.63 3.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 1.0 107.358 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.76 178.49 7.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.427 1.091 . . . . 1.0 110.337 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.53 178.07 4.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.727 0.775 . . . . 1.0 112.718 -175.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.6 m -165.07 118.48 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 128.329 2.652 . . . . 1.0 108.177 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 158.36 62.95 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.346 -1.724 . . . . 1.0 106.346 175.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.84 88.08 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.468 1.445 . . . . 1.0 109.762 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.68 143.37 29.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.919 -1.882 . . . . 1.0 105.919 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -151.52 103.35 2.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.645 1.111 . . . . 1.0 110.738 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -137.37 162.67 32.97 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -69.63 123.23 88.1 Favored Pre-proline 0 C--O 1.239 0.526 0 N-CA-C 104.928 -2.249 . . . . 1.0 104.928 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HB2' HG22 ' A' ' 113' ' ' ILE . 91.4 Cg_endo -78.2 103.37 1.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.789 1.318 . . . . 1.0 108.72 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 t -169.3 80.49 0.12 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -152.77 124.1 7.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -99.31 126.45 45.17 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.764 1.626 . . . . 1.0 108.381 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.5 145.03 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' A' ' 169' ' ' PHE . 21.4 t -136.36 123.91 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 104.181 -2.526 . . . . 1.0 104.181 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -175.38 146.93 0.84 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 117.339 -1.315 . . . . 1.0 107.507 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.15 112.32 22.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.414 1.006 . . . . 1.0 110.468 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.25 174.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.8 t -144.06 121.84 11.93 Favored 'General case' 0 C--O 1.247 0.93 1 N-CA-C 97.146 -5.131 . . . . 1.0 97.146 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' ILE 0.324 1.1 tm? -141.67 -65.58 0.02 OUTLIER Pre-proline 0 C--O 1.224 -0.266 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.3 157.66 22.79 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 121.982 1.744 . . . . 1.0 112.066 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.43 12.26 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.102 3.201 . . . . 1.0 116.363 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -28.18 -71.13 0.05 OUTLIER Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.697 -1.613 . . . . 1.0 114.062 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -156.54 123.64 5.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.712 1.605 . . . . 1.0 111.257 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -169.39 150.72 4.31 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.503 1.521 . . . . 1.0 110.795 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.8 -6.53 52.27 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.122 -1.377 . . . . 1.0 112.089 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.25 118.61 5.7 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.566 -1.813 . . . . 1.0 108.566 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.262 88.6 Cg_endo -65.26 -3.06 6.75 Favored 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 126.123 4.549 . . . . 1.0 118.964 -175.143 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -55.63 -46.93 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.922 2.146 . . . . 1.0 113.262 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' LEU . 9.4 mm -61.38 -47.05 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.567 -1.271 . . . . 1.0 107.567 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.89 -48.58 67.07 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 124.841 1.257 . . . . 1.0 109.129 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.23 -38.79 77.53 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.254 1.022 . . . . 1.0 112.381 -176.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.75 -51.13 61.69 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.784 0.434 . . . . 1.0 109.878 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.28 -39.51 71.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.346 0.499 . . . . 1.0 112.346 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.58 -52.63 43.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.645 1.178 . . . . 1.0 110.647 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.94 9.82 2.68 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 118.439 -1.201 . . . . 1.0 115.45 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 p -107.87 9.07 28.88 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.658 2.229 . . . . 1.0 114.86 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.2 134.4 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.76 1.164 . . . . 1.0 111.981 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.15 136.5 25.76 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 129.141 2.976 . . . . 1.0 109.338 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.7 76.33 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 1.0 106.923 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -103.55 -64.14 1.12 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.266 0.626 . . . . 1.0 111.266 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.6 79.15 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.614 0.766 . . . . 1.0 111.07 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 24.3 p80 -170.08 177.96 0.97 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.623 1.969 . . . . 1.0 107.047 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.05 -43.71 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.393 1.395 . . . . 1.0 114.33 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -46.14 -45.78 16.78 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.101 1.148 . . . . 1.0 114.101 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -56.12 -53.92 51.24 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.951 0.901 . . . . 1.0 109.193 -175.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.57 84.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.235 1.014 . . . . 1.0 111.665 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.66 -53.94 15.39 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.639 1.59 . . . . 1.0 111.515 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 pt -61.02 -43.45 96.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 117.303 -1.332 . . . . 1.0 110.908 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.56 -43.05 1.8 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.084 2.154 . . . . 1.0 115.19 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -46.96 -56.64 6.05 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.75 136.98 53.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.149 2.979 . . . . 1.0 106.912 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.65 155.13 16.26 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.475 -1.391 . . . . 1.0 109.211 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.83 158.39 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.543 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 m -173.66 131.73 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.582 1.553 . . . . 1.0 108.645 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.5 -176.64 3.68 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.67 -1.604 . . . . 1.0 106.67 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -120.02 -76.28 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.115 0.966 . . . . 1.0 109.481 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.745 ' HB2' HD13 ' A' ' 115' ' ' ILE . 85.6 m -117.34 118.37 32.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.3 114.15 20.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.432 1.093 . . . . 1.0 108.318 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 mt -94.4 117.21 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.927 0.891 . . . . 1.0 108.641 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -77.21 149.7 35.5 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.073 1.306 . . . . 1.0 109.171 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -23.74 2.93 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 126.466 1.906 . . . . 1.0 114.917 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.03 35.0 0.99 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.764 1.226 . . . . 1.0 113.798 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.24 40.8 99.09 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.757 1.17 . . . . 1.0 114.661 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -108.4 151.69 25.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.982 0.891 . . . . 1.0 110.676 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.16 113.98 44.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 102.492 -3.151 . . . . 1.0 102.492 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.11 145.45 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 119.29 27.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.779 1.632 . . . . 1.0 106.776 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -120.15 140.99 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.975 -2.231 . . . . 1.0 104.975 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 73' ' ' SER . 15.9 t 65.23 92.09 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.162 1.541 . . . . 1.0 115.162 175.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -56.73 169.65 1.71 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 N-CA-C 109.052 -1.172 . . . . 1.0 109.052 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.74 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.944 2.572 . . . . 1.0 117.944 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -134.51 117.05 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.735 2.814 . . . . 1.0 105.807 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.65 81.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.37 2.668 . . . . 1.0 109.539 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -35.02 148.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 131.205 3.802 . . . . 1.0 114.356 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.25 178.55 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.933 2.093 . . . . 1.0 109.657 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -149.49 119.01 6.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.246 1.384 . . . . 1.0 110.568 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.68 62.92 0.47 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.076 1.417 . . . . 1.0 110.185 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.27 -63.8 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 119.015 -2.303 . . . . 1.0 113.852 176.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.96 -68.87 0.21 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 106.274 -2.73 . . . . 1.0 106.274 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -145.53 146.49 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.075 1.35 . . . . 1.0 109.519 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.8 p -160.38 166.31 29.57 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.092 1.757 . . . . 1.0 107.857 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 p -159.28 145.83 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -159.77 154.0 23.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.612 1.096 . . . . 1.0 109.343 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 39.43 54.99 2.33 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.3 1.84 . . . . 1.0 111.153 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.65 84.98 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.933 -0.926 . . . . 1.0 113.117 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.75 119.24 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.842 1.321 . . . . 1.0 108.492 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.91 146.74 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.255 1.422 . . . . 1.0 111.699 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -124.45 118.22 26.17 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -72.02 -31.03 65.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.674 0.79 . . . . 1.0 111.683 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.22 176.24 11.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 128.407 2.683 . . . . 1.0 106.401 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.331 15.3 t70 -87.19 77.07 9.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.104 0.954 . . . . 1.0 111.78 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -90.51 44.54 1.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.616 -1.253 . . . . 1.0 107.616 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -123.26 133.45 54.18 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.272 1.029 . . . . 1.0 110.785 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 28' ' ' PRO 0.256 0.1 OUTLIER -91.21 56.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 175.57 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.39 -136.4 3.82 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.488 1.049 . . . . 1.0 111.217 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 76' ' ' CYS . 7.9 mm -139.65 165.14 22.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 128.156 2.582 . . . . 1.0 104.114 176.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -146.18 131.34 18.38 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.961 -2.977 . . . . 1.0 102.961 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.71 127.98 48.23 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.055 -1.653 . . . . 1.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -103.36 138.37 40.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.425 0.631 . . . . 1.0 111.224 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.03 40.49 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.945 1.26 . . . . 1.0 111.586 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.7 p -142.32 108.3 5.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.408 1.483 . . . . 1.0 107.923 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t0 49.76 55.67 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.124 2.17 . . . . 1.0 113.83 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 48.96 38.38 12.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.255 1.822 . . . . 1.0 113.973 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.19 142.8 58.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 105.283 -2.118 . . . . 1.0 105.283 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -43.03 114.78 0.65 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.683 1.193 . . . . 1.0 108.771 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -78.52 -2.12 37.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 116.783 -1.579 . . . . 1.0 114.83 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 29.0 p 64.01 76.5 0.35 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.077 1.308 . . . . 1.0 111.013 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.35 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.723 2.009 . . . . 1.0 113.132 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.01 -38.35 4.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.629 2.372 . . . . 1.0 111.837 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -47.6 -43.88 25.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.242 1.417 . . . . 1.0 110.112 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -60.64 -39.6 88.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.284 -0.865 . . . . 1.0 110.811 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.59 -51.56 58.78 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.492 1.042 . . . . 1.0 110.27 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -65.4 -40.18 93.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.488 0.315 . . . . 1.0 111.293 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.9 tp -59.11 -51.94 67.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.249 1.82 . . . . 1.0 108.201 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -40.03 78.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.83 -0.605 . . . . 1.0 110.256 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -53.96 51.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.131 0.878 . . . . 1.0 111.659 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.23 -47.83 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.9 m -58.15 -47.01 84.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.357 1.463 . . . . 1.0 112.029 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -60.19 -38.13 82.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.553 0.741 . . . . 1.0 109.606 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.52 86.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 117.823 -1.084 . . . . 1.0 110.332 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.17 -45.67 79.61 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 120.252 1.387 . . . . 1.0 110.595 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.81 -41.62 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.0 m -62.04 -27.24 68.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.366 0.666 . . . . 1.0 111.269 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -83.9 -61.23 1.88 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.956 -1.09 . . . . 1.0 108.111 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -125.8 112.79 24.8 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.27 -1.381 . . . . 1.0 107.27 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -93.18 107.8 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-O 123.425 1.344 . . . . 1.0 109.731 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.39 -44.8 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.559 1.944 . . . . 1.0 109.412 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.3 mt -49.36 -33.51 6.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 130.731 3.613 . . . . 1.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.01 -26.43 37.0 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.155 0.428 . . . . 1.0 112.155 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.46 25.65 4.11 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.123 2.569 . . . . 1.0 110.184 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -139.09 83.51 1.95 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 50.9 mtt -126.88 118.57 24.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.66 -2.348 . . . . 1.0 104.66 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -148.21 -175.38 4.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.586 1.084 . . . . 1.0 109.237 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.21 -131.77 2.39 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 105.789 -2.924 . . . . 1.0 105.789 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -114.78 -23.47 9.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.675 1.238 . . . . 1.0 110.381 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.34 -18.67 14.75 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.84 38.31 0.63 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.19 0.905 . . . . 1.0 108.918 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -16.6 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 O-C-N 120.513 -1.367 . . . . 1.0 108.715 175.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.465 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -155.49 -54.4 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.783 2.433 . . . . 1.0 111.518 175.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 98.2 Cg_endo -76.57 109.51 2.88 Favored 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 122.146 1.802 . . . . 1.0 113.608 -175.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -62.36 -12.29 20.41 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.145 -0.972 . . . . 1.0 110.688 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -22.5 57.37 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.313 -1.492 . . . . 1.0 114.553 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.26 125.75 20.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.559 1.527 . . . . 1.0 107.091 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 167' ' ' PRO . 2.6 m -114.79 -16.7 11.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.19 -178.83 0.3 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 126.3 1.84 . . . . 1.0 106.311 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.22 80.71 2.96 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 N-CA-C 105.633 -2.487 . . . . 1.0 105.633 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.404 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.22 72.28 0.23 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.513 2.006 . . . . 1.0 109.866 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.492 ' HB3' ' H ' ' A' ' 163' ' ' THR . 68.7 Cg_endo -79.0 -99.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.301 2.667 . . . . 1.0 111.066 176.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.7 t 53.82 42.9 31.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.513 1.525 . . . . 1.0 111.538 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.41 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -96.81 17.87 15.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.978 -1.076 . . . . 1.0 113.453 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t0 43.79 63.74 1.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.421 -2.049 . . . . 1.0 111.831 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -54.07 -35.17 61.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.344 0.658 . . . . 1.0 111.725 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -54.35 48.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.453 -0.784 . . . . 1.0 110.157 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -60.29 -48.54 81.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.814 -1.089 . . . . 1.0 112.13 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.32 -53.54 56.07 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.883 0.765 . . . . 1.0 109.938 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -48.81 80.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 117.962 -1.018 . . . . 1.0 108.773 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.7 76.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.931 0.893 . . . . 1.0 112.981 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.3 mt -71.28 -44.21 65.66 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.878 0.871 . . . . 1.0 110.62 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.37 157.07 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 122.958 1.361 . . . . 1.0 110.051 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 183' ' ' HIS . 7.3 m -55.15 139.05 65.42 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.952 1.701 . . . . 1.0 111.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -80.23 42.22 1.28 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.718 2.945 . . . . 1.0 110.947 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.6 t 53.07 33.64 15.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.44 2.696 . . . . 1.0 111.754 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.7 t -163.63 106.3 0.97 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.728 1.611 . . . . 1.0 107.41 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.425 ' HB2' HG23 ' A' ' 179' ' ' THR . 32.8 t60 -160.06 125.56 4.05 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.52 142.42 58.43 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.44 124.13 20.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -153.62 107.04 2.96 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.352 -0.842 . . . . 1.0 110.022 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 C-N-CA 126.48 1.912 . . . . 1.0 109.723 176.614 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.8 tp -81.57 138.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.24 136.13 45.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 102.837 -3.023 . . . . 1.0 102.837 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.55 123.53 39.29 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 49.82 33.59 6.6 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.062 0.846 . . . . 1.0 111.967 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.55 -6.68 5.77 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.64 1.591 . . . . 1.0 113.89 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -81.65 161.55 23.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 103.857 -2.646 . . . . 1.0 103.857 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.6 tm? -79.65 124.11 28.26 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.912 -1.514 . . . . 1.0 106.912 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.63 175.92 9.95 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.469 0.708 . . . . 1.0 111.408 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 42.33 57.86 3.22 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.286 1.834 . . . . 1.0 109.464 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.29 155.2 30.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.983 1.313 . . . . 1.0 109.1 -176.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -81.29 123.46 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.79 124.6 33.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.379 0.99 . . . . 1.0 108.334 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.92 82.53 43.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.99 124.03 7.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.034 1.823 . . . . 1.0 110.299 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -119.74 114.19 34.25 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.87 56.39 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.183 1.922 . . . . 1.0 111.416 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -126.05 44.56 2.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.811 2.045 . . . . 1.0 105.632 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.465 ' CE2' HG13 ' A' ' 88' ' ' VAL . 1.8 m-30 -73.66 177.98 5.05 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.417 0.687 . . . . 1.0 111.142 -174.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.56 178.62 4.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.693 1.597 . . . . 1.0 113.513 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.6 m -154.19 124.67 7.01 Favored 'General case' 0 N--CA 1.448 -0.574 1 C-N-CA 132.028 4.131 . . . . 1.0 103.137 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.64 142.77 45.09 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 117.981 -1.009 . . . . 1.0 108.831 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.57 69.1 7.88 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.598 2.865 . . . . 1.0 113.454 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -151.71 158.54 43.54 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 127.073 2.149 . . . . 1.0 106.799 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -151.17 104.67 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.309 1.444 . . . . 1.0 107.481 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.77 158.67 43.92 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.915 1.686 . . . . 1.0 106.61 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -67.51 123.67 87.3 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 118.679 0.672 . . . . 1.0 109.441 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.16 103.65 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 108.974 -1.202 . . . . 1.0 108.974 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -165.38 65.57 0.12 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.469 -1.394 . . . . 1.0 108.265 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -148.3 137.63 22.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.73 1.612 . . . . 1.0 107.175 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.85 133.4 34.76 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.243 1.417 . . . . 1.0 108.111 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.91 142.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.938 -2.245 . . . . 1.0 104.938 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 98.5 t -136.16 115.77 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.977 -1.86 . . . . 1.0 105.977 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -176.3 132.82 0.23 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.348 0.976 . . . . 1.0 108.835 175.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -63.39 118.73 8.49 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.925 0.89 . . . . 1.0 110.22 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 7.5 mm -145.71 176.43 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.174 2.59 . . . . 1.0 107.153 176.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -160.93 117.97 2.33 Favored 'General case' 0 C--N 1.322 -0.624 1 N-CA-C 96.695 -5.298 . . . . 1.0 96.695 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 1.3 tm? -144.78 -61.3 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 116.022 -1.942 . . . . 1.0 112.79 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 23.8 Cg_endo -87.34 157.3 8.1 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.825 2.35 . . . . 1.0 112.92 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.37 70.45 4.78 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.326 3.35 . . . . 1.0 118.658 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.94 -72.2 1.06 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 105.811 -2.916 . . . . 1.0 105.811 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -157.2 123.42 4.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.324 2.25 . . . . 1.0 109.186 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -176.94 176.42 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 130.706 3.602 . . . . 1.0 107.836 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.41 22.78 10.04 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.91 1.719 . . . . 1.0 109.464 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.38 118.6 5.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.116 -1.38 . . . . 1.0 110.203 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.8 -21.03 38.9 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.415 2.077 . . . . 1.0 112.331 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -53.9 -34.19 58.79 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.853 0.861 . . . . 1.0 111.082 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 mt -66.12 -50.01 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.246 -0.883 . . . . 1.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.94 -46.46 78.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.076 -1.049 . . . . 1.0 110.395 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.78 -33.89 50.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.114 0.966 . . . . 1.0 111.887 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -63.83 -58.49 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.616 1.566 . . . . 1.0 110.296 176.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -70.6 -41.32 72.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.4 0.68 . . . . 1.0 112.545 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -65.91 -34.28 77.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.59 1.156 . . . . 1.0 108.455 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.22 54.77 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.308 -1.829 . . . . 1.0 116.153 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -89.15 8.27 30.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.743 2.272 . . . . 1.0 113.615 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 68' ' ' ALA . 13.4 tt -60.02 132.93 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.629 1.572 . . . . 1.0 111.891 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.02 135.99 20.7 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 128.636 2.774 . . . . 1.0 109.529 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.39 80.68 1.04 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.502 2.801 . . . . 1.0 106.909 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -103.23 -63.43 1.18 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.034 0.534 . . . . 1.0 111.012 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.57 78.85 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.06 0.944 . . . . 1.0 110.646 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 17.4 p80 -170.35 177.95 0.95 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.403 2.281 . . . . 1.0 106.331 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.7 Cg_endo -74.05 -43.43 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.531 1.488 . . . . 1.0 114.796 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -43.23 -53.58 5.03 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -51.51 -58.22 6.89 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.07 1.348 . . . . 1.0 110.513 -175.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.6 89.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.167 0.587 . . . . 1.0 111.521 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.45 -63.54 4.0 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.127 1.346 . . . . 1.0 111.863 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.49 -38.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.24 0.52 . . . . 1.0 112.065 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.52 -43.53 11.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.262 88.0 m-70 -57.9 -33.54 68.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.721 -0.657 . . . . 1.0 109.779 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.32 136.61 33.83 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.504 -2.776 . . . . 1.0 103.504 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 141.67 40.74 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.227 0.921 . . . . 1.0 111.723 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -116.97 165.49 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.663 2.385 . . . . 1.0 109.59 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -172.52 116.64 0.33 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.955 1.302 . . . . 1.0 108.632 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.44 -176.89 3.77 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -110.68 -76.27 0.61 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.884 1.22 . . . . 1.0 112.478 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -116.97 118.26 31.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.543 -2.021 . . . . 1.0 105.543 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.57 113.55 27.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.761 -2.311 . . . . 1.0 104.761 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -96.14 113.38 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.662 -2.348 . . . . 1.0 104.662 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -68.74 148.13 50.8 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.696 1.134 . . . . 1.0 108.502 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.74 22.09 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 122.824 0.45 . . . . 1.0 111.645 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.27 24.51 2.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.25 2.22 . . . . 1.0 111.896 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.01 76.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.456 1.979 . . . . 1.0 115.623 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.94 156.57 17.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.726 1.763 . . . . 1.0 110.58 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -116.24 116.53 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.71 141.68 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.45 121.57 37.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.411 -1.7 . . . . 1.0 106.411 -176.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.94 123.93 50.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.829 2.452 . . . . 1.0 106.495 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 19' ' ' TYR . 36.2 t 67.16 92.1 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.091 1.314 . . . . 1.0 113.664 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -60.8 -179.15 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.192 1.261 . . . . 1.0 109.963 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -59.18 26.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.812 3.245 . . . . 1.0 116.678 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.97 117.48 7.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.905 2.482 . . . . 1.0 108.788 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.268 28.0 ttmt 85.93 81.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.903 2.481 . . . . 1.0 111.844 175.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -36.44 156.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.721 4.009 . . . . 1.0 117.216 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.75 -179.2 3.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.909 3.684 . . . . 1.0 115.857 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 46.7 t90 -156.46 118.52 3.95 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.514 1.926 . . . . 1.0 109.709 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -162.78 62.85 0.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.228 0.922 . . . . 1.0 111.439 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.55 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 118.785 -2.447 . . . . 1.0 114.779 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.84 -90.74 1.1 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 105.248 -3.141 . . . . 1.0 105.248 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.07 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 118.734 1.267 . . . . 1.0 109.456 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 p -165.98 157.32 13.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.119 2.168 . . . . 1.0 108.118 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' HG22 ' A' ' 157' ' ' ILE . 78.1 p -153.46 147.1 25.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.386 1.074 . . . . 1.0 110.763 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -149.46 148.98 30.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.586 -1.265 . . . . 1.0 107.586 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 38.66 53.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.368 1.867 . . . . 1.0 111.446 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.7 28.44 65.47 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.605 -1.108 . . . . 1.0 115.465 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 113.22 13.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 120.544 2.172 . . . . 1.0 105.245 175.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 12.8 tt0 -79.83 145.65 32.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -105.22 118.24 36.05 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.38 -23.7 60.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.322 0.389 . . . . 1.0 110.559 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -145.58 170.69 15.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.485 2.314 . . . . 1.0 106.857 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.52 76.66 7.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.358 1.075 . . . . 1.0 108.919 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -89.49 40.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.454 1.502 . . . . 1.0 110.108 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -131.67 130.4 42.0 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 119.977 -1.702 . . . . 1.0 111.882 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 56.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.809 2.044 . . . . 1.0 107.947 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -136.62 5.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.67 164.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.77 116.33 8.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.664 -2.347 . . . . 1.0 104.664 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.3 135.42 34.32 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.298 -1.501 . . . . 1.0 109.604 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.1 tt0 -103.67 152.94 21.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.65 173.46 39.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.821 1.677 . . . . 1.0 111.04 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -147.13 107.08 3.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.7 t0 46.08 47.75 12.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.471 2.308 . . . . 1.0 112.282 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.7 p 46.78 38.27 5.73 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.301 1.84 . . . . 1.0 113.417 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.24 146.52 54.84 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.236 1.814 . . . . 1.0 108.542 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -33.0 113.14 0.13 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.079 2.152 . . . . 1.0 110.508 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -78.31 -9.0 59.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.701 -2.095 . . . . 1.0 114.985 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.407 11.7 p 69.26 78.41 0.21 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 121.404 1.911 . . . . 1.0 113.537 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -22.99 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 119.709 -1.869 . . . . 1.0 115.403 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.37 -46.45 13.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.236 2.214 . . . . 1.0 110.472 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -51.26 -49.34 61.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.571 1.078 . . . . 1.0 109.904 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.71 -40.09 90.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.546 -0.74 . . . . 1.0 109.757 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.97 -50.55 63.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.988 0.813 . . . . 1.0 111.424 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -63.1 -48.49 78.35 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.985 1.714 . . . . 1.0 110.255 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.16 -49.98 74.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.217 1.407 . . . . 1.0 108.856 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.57 -39.84 89.47 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 118.722 -0.656 . . . . 1.0 110.155 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -53.58 56.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.829 0.852 . . . . 1.0 110.304 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.01 -46.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.6 m -58.29 -53.6 56.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.983 1.313 . . . . 1.0 109.964 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -56.76 -46.04 81.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.67 1.188 . . . . 1.0 110.12 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.15 77.71 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.792 0.437 . . . . 1.0 111.535 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.8 mt -57.03 -38.24 72.89 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-O 118.436 -0.792 . . . . 1.0 111.029 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.28 -38.75 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.547 0.739 . . . . 1.0 109.752 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 m -57.42 -35.07 69.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.089 0.859 . . . . 1.0 110.55 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -83.67 -52.66 6.25 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.129 -0.982 . . . . 1.0 108.6 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -126.33 112.9 23.49 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.92 107.15 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 121.378 1.528 . . . . 1.0 109.031 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.18 -49.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.094 1.758 . . . . 1.0 107.685 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 65.8 mt -48.35 -34.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 129.018 2.927 . . . . 1.0 109.586 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.12 -25.67 9.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.738 1.615 . . . . 1.0 113.627 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.31 22.01 3.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.037 1.735 . . . . 1.0 109.63 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.06 85.9 2.1 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.016 1.726 . . . . 1.0 107.7 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.2 mtt -131.96 119.13 20.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.893 2.077 . . . . 1.0 106.609 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -152.15 -176.34 5.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.532 1.514 . . . . 1.0 108.992 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.57 -131.4 2.73 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 106.875 -2.49 . . . . 1.0 106.875 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -116.35 -23.9 8.15 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.327 1.064 . . . . 1.0 112.12 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.4 t -103.63 -12.55 16.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.368 0.667 . . . . 1.0 109.255 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.7 OUTLIER -85.41 17.96 2.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.449 1.9 . . . . 1.0 110.478 -175.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.59 -20.14 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.764 0.825 . . . . 1.0 112.489 -175.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -147.47 -66.14 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.11 1.364 . . . . 1.0 107.995 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 86.0 Cg_endo -80.06 108.85 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.877 1.718 . . . . 1.0 111.202 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.97 -17.46 38.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.391 1.076 . . . . 1.0 112.096 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -60.06 -24.24 64.41 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.239 -1.538 . . . . 1.0 112.687 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -131.22 140.57 49.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 104.1 -2.556 . . . . 1.0 104.1 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 20.2 m -123.19 -16.76 6.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.34 177.92 0.95 Allowed Pre-proline 0 C--O 1.244 0.815 0 C-N-CA 131.316 3.846 . . . . 1.0 103.333 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.25 57.91 6.7 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.772 2.314 . . . . 1.0 109.438 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.5 78.81 0.02 OUTLIER Glycine 0 CA--C 1.541 1.671 0 C-N-CA 128.918 3.151 . . . . 1.0 108.054 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.01 -72.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.1 2.534 . . . . 1.0 112.107 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.3 t 53.94 43.79 30.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.514 1.926 . . . . 1.0 113.176 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -122.04 17.56 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.347 0.976 . . . . 1.0 112.731 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 t0 42.6 68.47 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.288 1.435 . . . . 1.0 110.604 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -48.85 -34.95 13.53 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -48.18 73.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.362 -0.828 . . . . 1.0 111.246 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -60.78 -51.14 70.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.51 1.504 . . . . 1.0 110.893 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.51 -46.6 82.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.187 0.903 . . . . 1.0 111.619 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -62.44 -32.78 73.69 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.567 0.621 . . . . 1.0 110.119 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.42 80.72 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.786 -1.197 . . . . 1.0 111.436 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 mt -67.87 -55.27 13.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.601 1.56 . . . . 1.0 112.636 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.43 150.12 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 122.766 0.426 . . . . 1.0 109.92 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -47.33 113.74 2.65 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.49 1.516 . . . . 1.0 110.327 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 74.07 5.2 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.673 2.249 . . . . 1.0 111.402 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 t 35.54 41.39 0.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.932 2.493 . . . . 1.0 113.966 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.2 t -159.79 -44.96 0.05 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.637 0.775 . . . . 1.0 110.587 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -73.8 45.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 1.0 110.752 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -84.75 124.14 31.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.849 -1.157 . . . . 1.0 108.218 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 185' ' ' GLU . 5.4 pm0 -64.16 -164.47 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.742 3.617 . . . . 1.0 112.676 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -150.27 119.13 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.39 1.476 . . . . 1.0 107.932 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.253 1.254 1 C-N-CA 135.313 5.445 . . . . 1.0 106.152 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.675 ' HA ' ' HB1' ' A' ' 139' ' ' ALA . 19.0 ttt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.79 124.51 18.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 153.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -119.55 124.02 45.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.656 -2.72 . . . . 1.0 103.656 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.67 148.53 47.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.09 33.53 15.23 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.359 1.463 . . . . 1.0 110.325 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.66 18.61 52.77 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.625 1.107 . . . . 1.0 113.074 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -131.45 176.26 8.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.113 -1.81 . . . . 1.0 106.113 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.04 130.77 44.19 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.784 -1.197 . . . . 1.0 108.35 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.74 55.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.194 0.198 . . . . 1.0 111.351 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 49.25 58.42 5.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.973 2.109 . . . . 1.0 110.807 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.47 133.25 21.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.382 -1.281 . . . . 1.0 109.475 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -67.87 123.34 20.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.615 -1.994 . . . . 1.0 105.615 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -91.87 128.16 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.185 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -145.82 85.58 7.63 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.092 . . . . 1.0 108.796 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.39 152.08 71.22 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.285 1.323 . . . . 1.0 110.578 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -146.75 132.67 9.43 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 126.056 1.742 . . . . 1.0 107.788 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.49 45.13 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.005 2.47 . . . . 1.0 113.133 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -123.88 43.2 3.04 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.384 -0.823 . . . . 1.0 109.982 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CB ' ' HG2' ' A' ' 92' ' ' LYS . 36.6 m-85 -73.57 -179.83 3.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.088 1.355 . . . . 1.0 109.878 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.39 178.6 4.39 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.754 1.264 . . . . 1.0 112.898 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -152.66 118.5 5.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.066 -2.939 . . . . 1.0 103.066 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -135.71 145.61 53.79 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 120.273 1.397 . . . . 1.0 108.742 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 67.22 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.459 2.773 . . . . 1.0 111.71 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -154.41 143.82 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.661 2.384 . . . . 1.0 107.131 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.92 103.93 3.11 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.898 2.079 . . . . 1.0 106.681 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.44 169.46 17.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.817 2.447 . . . . 1.0 106.972 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.97 123.54 82.27 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 124.912 1.285 . . . . 1.0 110.371 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.69 103.44 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.831 1.687 . . . . 1.0 110.512 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.1 t -177.1 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.51 -2.404 . . . . 1.0 104.51 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -148.34 145.75 28.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.395 3.078 . . . . 1.0 104.181 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.5 tp -114.5 129.76 56.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -105.89 136.03 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 169' ' ' PHE . 74.0 t -135.02 113.95 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CD2' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -165.15 167.26 18.32 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.273 1.429 . . . . 1.0 107.276 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -96.93 116.67 29.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -142.03 172.2 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.943 2.097 . . . . 1.0 106.926 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 t -155.55 118.04 4.2 Favored 'General case' 0 N--CA 1.443 -0.795 1 N-CA-C 98.981 -4.451 . . . . 1.0 98.981 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 -66.74 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.529 0 CA-C-O 116.007 -1.949 . . . . 1.0 109.285 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.24 136.94 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 CA-C-N 123.943 2.444 . . . . 1.0 107.36 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.25 44.73 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.096 3.198 . . . . 1.0 114.986 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -31.5 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.241 0 C-N-CA 126.125 1.822 . . . . 1.0 110.829 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.29 122.69 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.167 -2.531 . . . . 1.0 104.167 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -176.76 175.54 1.64 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.884 2.874 . . . . 1.0 107.942 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.76 26.58 4.02 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.588 1.566 . . . . 1.0 112.331 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.65 118.24 6.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.26 1.53 . . . . 1.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.13 -5.0 15.41 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.316 2.011 . . . . 1.0 113.148 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -62.02 -38.65 89.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.415 1.086 . . . . 1.0 109.43 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.7 -45.06 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.44 -46.61 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.53 -36.18 63.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 1.0 111.719 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -60.45 3.78 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.694 0.798 . . . . 1.0 109.655 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -68.78 -46.92 67.48 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.574 0.625 . . . . 1.0 112.384 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -60.48 -33.89 73.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.486 1.114 . . . . 1.0 108.732 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.56 35.8 4.25 Favored Glycine 0 C--N 1.342 0.879 0 C-N-CA 124.552 1.072 . . . . 1.0 113.349 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -124.77 18.05 8.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.885 1.342 . . . . 1.0 111.752 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.03 140.0 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.701 0.801 . . . . 1.0 110.427 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -98.37 128.01 34.5 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 127.713 2.405 . . . . 1.0 106.257 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.21 70.51 2.38 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.211 3.274 . . . . 1.0 109.472 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -106.9 -65.28 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.948 1.299 . . . . 1.0 112.843 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.4 -60.46 1.49 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.917 1.687 . . . . 1.0 113.225 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 20.8 p80 -168.48 177.69 1.2 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.562 1.145 . . . . 1.0 108.13 175.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.9 Cg_endo -70.25 -43.62 2.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.733 1.622 . . . . 1.0 113.926 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -50.48 -62.26 1.69 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.805 1.242 . . . . 1.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 5.2 t80 -56.88 -50.35 72.75 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.409 0.684 . . . . 1.0 111.201 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.17 96.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.892 0.477 . . . . 1.0 110.849 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -57.73 17.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 124.791 1.186 . . . . 1.0 110.629 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.49 -24.15 34.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-O 116.589 -1.672 . . . . 1.0 113.734 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.11 -43.52 20.58 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.716 1.598 . . . . 1.0 113.0 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -58.04 -33.85 69.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.095 0.558 . . . . 1.0 110.806 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.39 136.4 33.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -65.28 146.49 54.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.163 -1.415 . . . . 1.0 109.445 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -116.92 162.26 15.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 125.506 1.522 . . . . 1.0 110.507 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.612 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -174.05 128.1 0.37 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.543 2.337 . . . . 1.0 108.151 175.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.26 -172.47 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.453 -1.684 . . . . 1.0 106.453 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -110.81 -58.72 2.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.597 1.159 . . . . 1.0 111.767 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.507 ' HB2' HD13 ' A' ' 115' ' ' ILE . 19.9 m -141.04 118.44 11.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.189 -1.782 . . . . 1.0 106.189 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.94 113.42 25.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.825 -2.287 . . . . 1.0 104.825 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -89.16 113.48 25.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.22 150.63 45.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.871 -1.159 . . . . 1.0 107.871 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -13.76 0.96 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.565 1.146 . . . . 1.0 113.917 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -91.7 21.03 5.01 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 128.037 2.535 . . . . 1.0 112.737 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.51 29.32 71.42 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.792 2.139 . . . . 1.0 114.885 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -102.14 108.94 20.5 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.652 1.226 . . . . 1.0 108.239 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.03 113.69 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.767 -2.679 . . . . 1.0 103.767 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.57 123.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 103.084 -2.932 . . . . 1.0 103.084 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.29 113.44 26.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.91 114.35 20.9 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 89.11 91.57 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 122.432 2.378 . . . . 1.0 110.554 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.26 -171.66 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.208 1.938 . . . . 1.0 109.907 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -64.57 21.77 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.498 1.919 . . . . 1.0 115.941 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.44 126.14 17.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.625 1.97 . . . . 1.0 109.127 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HG2' ' CB ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER 86.56 81.92 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.849 3.26 . . . . 1.0 111.762 175.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -36.7 135.38 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 128.259 2.624 . . . . 1.0 112.373 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -104.04 -178.67 3.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.769 2.428 . . . . 1.0 111.058 -175.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 80.0 t90 -146.23 118.55 8.4 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.418 1.887 . . . . 1.0 107.114 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -164.96 63.29 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.224 1.012 . . . . 1.0 110.601 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.64 -68.72 0.07 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 118.792 -2.443 . . . . 1.0 112.274 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.38 -90.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.421 -1.872 . . . . 1.0 108.421 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.6 t -140.32 146.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.473 1.909 . . . . 1.0 110.758 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -163.47 155.49 17.58 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.059 1.743 . . . . 1.0 109.044 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.662 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.0 p -146.86 133.55 19.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -161.49 124.59 3.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.286 0.948 . . . . 1.0 108.898 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 60.13 71.57 0.57 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.044 1.738 . . . . 1.0 113.622 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.4 30.3 55.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 126.433 1.968 . . . . 1.0 113.922 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.7 ttm105 -150.05 113.63 4.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.441 1.096 . . . . 1.0 108.566 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.05 145.13 30.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.226 -2.139 . . . . 1.0 105.226 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -128.98 118.03 21.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.992 -1.855 . . . . 1.0 105.992 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t -66.11 -36.02 82.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.842 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -146.73 174.12 11.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.91 2.884 . . . . 1.0 106.037 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.48 76.84 9.91 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 106.533 -1.655 . . . . 1.0 106.533 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 39.68 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.482 1.913 . . . . 1.0 109.889 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -124.23 156.72 36.34 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.204 1.802 . . . . 1.0 112.29 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.255 0.0 OUTLIER -99.98 57.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 105.971 -1.862 . . . . 1.0 105.971 175.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.35 -136.53 1.65 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.225 -0.922 . . . . 1.0 111.595 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 136' ' ' VAL . 7.5 mm -142.25 163.15 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 128.888 2.875 . . . . 1.0 103.723 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -136.12 129.3 31.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.393 2.277 . . . . 1.0 105.338 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mt -101.24 153.81 19.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 120.258 1.39 . . . . 1.0 109.305 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.34 47.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.83 0.824 . . . . 1.0 111.36 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.31 -173.47 41.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.294 2.378 . . . . 1.0 108.946 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 p -136.44 100.2 4.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 102.692 -3.077 . . . . 1.0 102.692 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 43.01 55.63 4.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.848 2.459 . . . . 1.0 112.472 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.4 p 52.69 38.09 25.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.089 2.155 . . . . 1.0 114.155 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 tp -60.2 136.01 57.9 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.84 113.2 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.29 2.236 . . . . 1.0 110.411 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.02 -8.17 57.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 115.683 -2.103 . . . . 1.0 116.371 -174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.325 37.3 p 63.89 77.96 0.3 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 121.636 2.016 . . . . 1.0 111.383 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.64 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.901 2.081 . . . . 1.0 113.97 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.09 -38.61 1.72 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.435 2.294 . . . . 1.0 109.455 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.67 -48.82 58.3 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.999 1.32 . . . . 1.0 110.575 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -59.16 -38.27 79.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.079 0.854 . . . . 1.0 110.509 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -66.02 -55.03 18.72 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.253 0.621 . . . . 1.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 12.1 mt-30 -61.69 -54.06 47.66 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.861 0.865 . . . . 1.0 109.131 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 115' ' ' ILE . 55.3 tp -53.22 -49.32 67.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.251 1.021 . . . . 1.0 109.728 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.0 85.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 120.408 1.458 . . . . 1.0 111.682 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.85 51.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.741 0.7 . . . . 1.0 109.294 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 115' ' ' ILE . 95.7 t -52.91 -64.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 126.758 2.023 . . . . 1.0 108.417 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 64.0 m -54.35 -52.43 61.63 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.902 2.081 . . . . 1.0 111.456 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -57.22 -42.02 80.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.382 1.447 . . . . 1.0 110.408 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -68.58 -47.48 66.65 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.266 -0.896 . . . . 1.0 111.352 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.7 mt -56.91 -34.71 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.58 -1.325 . . . . 1.0 111.598 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.61 -40.08 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.474 -1.306 . . . . 1.0 107.474 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -63.15 -13.44 37.05 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.13 1.372 . . . . 1.0 110.965 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -95.93 -65.39 0.98 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.158 -1.589 . . . . 1.0 107.406 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -120.89 112.99 33.23 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HB2' ' HE2' ' A' ' 184' ' ' LYS . 71.5 Cg_endo -95.89 107.89 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 CA-C-N 120.182 1.101 . . . . 1.0 111.208 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.91 -49.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.365 1.866 . . . . 1.0 106.636 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.5 mt -45.9 -33.37 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 128.944 2.898 . . . . 1.0 110.815 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.16 -26.53 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 1.0 113.412 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -133.13 18.62 4.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.945 2.098 . . . . 1.0 110.178 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -138.44 83.74 1.98 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.454 -1.404 . . . . 1.0 107.842 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.6 mtt -121.55 114.05 20.66 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -149.18 -168.07 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.93 -130.67 1.64 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 105.017 -3.233 . . . . 1.0 105.017 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.259 14.7 m170 -112.73 -24.43 9.61 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.978 0.911 . . . . 1.0 111.277 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.67 -16.03 16.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.417 0.687 . . . . 1.0 110.359 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -86.59 39.62 0.85 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.893 -1.151 . . . . 1.0 107.893 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.62 -17.5 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 O-C-N 120.322 -1.486 . . . . 1.0 109.294 175.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -149.54 -64.53 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.553 1.541 . . . . 1.0 109.715 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 98.4 Cg_endo -78.51 115.06 3.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.365 2.043 . . . . 1.0 113.23 -175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -22.48 58.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 1.0 112.273 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.2 tpt85 -58.65 -17.15 19.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.199 2.2 . . . . 1.0 112.686 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -141.66 141.02 33.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -131.84 -16.72 2.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 118.903 -1.119 . . . . 1.0 110.358 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.9 -179.62 0.34 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 130.117 3.367 . . . . 1.0 104.085 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 78.25 3.5 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 121.876 1.717 . . . . 1.0 108.561 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.44 64.08 0.56 Allowed Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.866 -1.519 . . . . 1.0 114.811 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.52 -54.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.429 2.615 . . . . 1.0 111.599 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 t 54.52 44.5 28.66 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.918 1.687 . . . . 1.0 112.468 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' CD2' HG11 ' A' ' 33' ' ' VAL . 81.4 t80 -108.73 17.68 21.62 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -175.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.369 11.3 t70 43.0 75.69 0.09 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.086 1.754 . . . . 1.0 113.194 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -48.65 -34.16 11.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.838 0.681 . . . . 1.0 112.838 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.63 75.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.942 -1.028 . . . . 1.0 111.707 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.4 -49.45 77.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.773 1.17 . . . . 1.0 109.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 34.3 t80 -66.2 -52.15 50.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.424 0.898 . . . . 1.0 113.424 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -61.55 -28.26 69.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.592 0.633 . . . . 1.0 111.476 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.45 87.28 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.125 0.875 . . . . 1.0 111.341 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.8 mt -71.04 -61.53 1.73 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.292 1.437 . . . . 1.0 111.065 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 90.4 t -66.35 166.36 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 124.13 0.972 . . . . 1.0 110.062 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 92.7 m -43.18 113.8 1.47 Allowed Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.297 1.439 . . . . 1.0 109.369 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -86.21 53.85 3.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.368 2.712 . . . . 1.0 107.019 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.4 t 54.32 34.01 19.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.732 0.813 . . . . 1.0 111.473 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -153.35 -46.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -74.27 78.76 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.693 1.197 . . . . 1.0 107.977 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 145' ' ' PRO . 33.1 tttm -139.05 153.24 48.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.677 1.991 . . . . 1.0 107.69 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.77 -176.32 4.01 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.9 tpt -65.16 164.76 12.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.129 0.971 . . . . 1.0 112.075 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.4 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 127.46 2.304 . . . . 1.0 111.366 177.406 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HA ' ' HB1' ' A' ' 139' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -64.91 123.76 20.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.649 -1.612 . . . . 1.0 106.649 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.89 123.61 29.35 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.881 -2.266 . . . . 1.0 104.881 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.86 145.2 45.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 51.97 33.05 11.03 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.486 -0.759 . . . . 1.0 112.64 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.94 17.58 51.6 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.364 0.983 . . . . 1.0 113.492 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -129.07 170.26 13.72 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.345 -2.094 . . . . 1.0 105.345 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.09 131.66 46.27 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.432 -1.418 . . . . 1.0 108.837 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.02 36.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 40.67 57.88 2.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.553 2.741 . . . . 1.0 108.6 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.61 150.98 30.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.838 1.255 . . . . 1.0 109.375 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB3' HG13 ' A' ' 85' ' ' VAL . 25.6 tpt85 -86.21 123.24 31.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -84.63 129.62 34.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.43 79.33 20.84 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.189 -1.041 . . . . 1.0 108.189 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.27 127.93 12.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.409 2.072 . . . . 1.0 109.104 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -128.18 120.93 21.4 Favored Pre-proline 0 C--O 1.232 0.184 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.3 52.08 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.128 2.552 . . . . 1.0 112.465 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -123.63 43.44 2.97 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 88' ' ' VAL . 22.9 m-85 -74.26 178.46 5.12 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.723 0.809 . . . . 1.0 109.694 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.65 179.48 5.66 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.94 1.296 . . . . 1.0 110.975 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.5 m -162.67 118.63 1.88 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.756 2.822 . . . . 1.0 105.738 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -131.9 138.47 32.55 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 117.257 -1.354 . . . . 1.0 107.455 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.61 99.66 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.473 2.782 . . . . 1.0 109.389 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -168.03 151.48 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.9 2.48 . . . . 1.0 105.966 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -151.53 106.74 3.31 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.261 1.391 . . . . 1.0 108.288 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -136.36 165.48 25.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.85 2.06 . . . . 1.0 107.28 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -67.43 123.47 86.7 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.173 -1.047 . . . . 1.0 108.173 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.96 103.71 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.548 2.165 . . . . 1.0 110.528 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 t -170.54 73.88 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.57 124.03 11.01 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.666 1.587 . . . . 1.0 106.97 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -88.44 131.64 34.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.119 0.968 . . . . 1.0 109.389 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.3 143.17 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.756 -1.942 . . . . 1.0 105.756 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.14 116.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 105.991 -1.855 . . . . 1.0 105.991 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -172.08 152.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.264 1.425 . . . . 1.0 107.465 175.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 112.4 24.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 6.8 mm -128.27 176.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 128.672 2.789 . . . . 1.0 106.545 175.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -153.28 121.47 6.19 Favored 'General case' 0 C--N 1.31 -1.124 1 N-CA-C 93.728 -6.397 . . . . 1.0 93.728 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 48' ' ' ILE 0.297 0.3 OUTLIER -142.0 -60.33 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 119.459 1.027 . . . . 1.0 110.537 176.488 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.52 134.31 11.06 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 CA-C-N 121.904 1.716 . . . . 1.0 110.419 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.27 75.81 3.25 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.341 2.694 . . . . 1.0 115.408 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.82 -71.7 0.85 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 106.615 -2.594 . . . . 1.0 106.615 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -156.21 123.63 5.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.888 1.275 . . . . 1.0 110.7 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -174.2 148.22 1.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.778 2.831 . . . . 1.0 108.294 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.51 -35.37 55.89 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.442 0.565 . . . . 1.0 113.406 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.39 118.94 11.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.558 1.075 . . . . 1.0 113.157 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.78 -5.88 17.42 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.636 2.891 . . . . 1.0 115.262 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -48.36 -45.73 35.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.439 1.472 . . . . 1.0 110.905 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 38' ' ' LEU . 7.0 mt -65.98 -45.14 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.816 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.16 -39.35 92.34 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.542 -0.463 . . . . 1.0 109.768 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.48 -34.25 70.68 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.238 0.472 . . . . 1.0 111.686 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.69 -52.4 51.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.573 1.149 . . . . 1.0 109.372 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.28 -41.37 73.49 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.02 -48.58 70.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.86 2.46 11.35 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.713 1.625 . . . . 1.0 114.503 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -89.08 9.21 26.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.913 1.856 . . . . 1.0 113.008 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 tt -52.21 129.53 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.293 1.437 . . . . 1.0 112.543 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.0 135.52 20.84 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.272 2.229 . . . . 1.0 109.599 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.88 78.1 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.604 2.869 . . . . 1.0 106.951 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -103.2 -65.07 1.02 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.036 0.534 . . . . 1.0 111.055 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.45 79.01 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.226 0.61 . . . . 1.0 111.117 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -171.08 178.08 0.85 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.037 1.735 . . . . 1.0 107.71 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.22 -43.4 4.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.596 2.197 . . . . 1.0 114.972 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -46.14 -50.88 14.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -54.62 42.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.302 1.041 . . . . 1.0 110.025 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.27 99.22 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.434 1.093 . . . . 1.0 111.29 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.99 -58.15 12.55 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 126.106 1.813 . . . . 1.0 112.184 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 pt -57.94 -38.26 65.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 117.954 -1.022 . . . . 1.0 111.879 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.79 -43.1 2.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.304 2.241 . . . . 1.0 115.318 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -61.22 -33.39 73.41 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.599 -0.688 . . . . 1.0 110.377 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.76 135.78 33.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 103.376 -2.824 . . . . 1.0 103.376 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.54 145.7 55.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.583 -0.698 . . . . 1.0 109.152 176.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.91 161.85 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 127.587 2.355 . . . . 1.0 111.418 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -175.97 139.96 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.412 2.285 . . . . 1.0 106.847 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -160.21 0.78 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.837 1.255 . . . . 1.0 108.074 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -130.41 -58.85 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.437 1.495 . . . . 1.0 108.539 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.97 119.42 17.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.196 -2.52 . . . . 1.0 104.196 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 tp -107.3 113.55 27.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.199 -2.519 . . . . 1.0 104.199 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.16 114.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -76.0 145.39 40.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -20.55 2.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.97 1.471 . . . . 1.0 114.97 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -91.4 29.95 1.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.271 1.828 . . . . 1.0 112.105 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.42 52.28 52.38 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.127 1.822 . . . . 1.0 114.085 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -126.77 117.34 22.47 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.331 -0.842 . . . . 1.0 110.465 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 132' ' ' GLN . 83.4 mt -83.02 114.73 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 101.6 -3.481 . . . . 1.0 101.6 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.3 t -110.48 142.27 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 103.34 -2.837 . . . . 1.0 103.34 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -121.14 114.04 20.87 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.074 -1.641 . . . . 1.0 111.264 -175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -108.98 120.17 41.74 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 19' ' ' TYR . 72.8 t 64.93 88.6 0.11 Allowed Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.024 1.284 . . . . 1.0 112.869 175.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.19 178.21 5.7 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 121.528 1.485 . . . . 1.0 109.548 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -43.55 9.26 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.149 1 C-N-CA 133.476 4.71 . . . . 1.0 120.198 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -133.89 111.12 10.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 119.371 -2.081 . . . . 1.0 107.552 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 86.25 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.889 2.076 . . . . 1.0 111.41 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -34.0 156.29 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.302 2.641 . . . . 1.0 114.669 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.59 -178.51 3.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 130.008 3.323 . . . . 1.0 109.998 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -145.93 118.54 8.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.95 1.25 . . . . 1.0 110.246 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -154.79 62.82 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 123.132 1.444 . . . . 1.0 110.747 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -161.76 -55.77 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 118.944 -2.348 . . . . 1.0 112.917 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.92 -74.41 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.177 -1.969 . . . . 1.0 108.177 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.18 128.82 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.244 1.417 . . . . 1.0 109.675 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.6 p -166.19 154.28 10.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.68 1.592 . . . . 1.0 112.14 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 157' ' ' ILE . 60.6 p -153.21 146.63 24.91 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 120.864 -1.147 . . . . 1.0 110.812 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -153.88 154.62 34.21 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.549 0.613 . . . . 1.0 110.504 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 38.91 55.38 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.223 1.809 . . . . 1.0 111.612 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.67 77.1 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.86 -0.967 . . . . 1.0 114.468 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -136.55 119.86 16.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.503 -1.665 . . . . 1.0 106.503 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 1.2 tt0 -100.44 138.7 37.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 36.4 mtm180 -113.31 118.34 34.32 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.1 t -58.07 -41.75 84.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.348 1.059 . . . . 1.0 111.212 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -148.19 177.02 9.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.514 3.126 . . . . 1.0 108.059 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.0 76.91 10.01 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.387 1.089 . . . . 1.0 108.689 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -87.51 33.92 0.7 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.198 0.999 . . . . 1.0 111.185 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.2 m -135.46 137.61 42.35 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.034 -1.666 . . . . 1.0 113.013 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.98 57.0 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.932 2.093 . . . . 1.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.18 -136.79 2.41 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.85 -1.156 . . . . 1.0 111.029 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 136' ' ' VAL . 1.1 mm -142.63 162.02 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 129.177 2.991 . . . . 1.0 103.329 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.94 130.22 29.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.76 -3.052 . . . . 1.0 102.76 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.54 157.53 16.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 107.435 -1.321 . . . . 1.0 107.435 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -131.08 155.82 46.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.959 0.885 . . . . 1.0 111.12 -178.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.55 179.36 43.35 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.393 -1.276 . . . . 1.0 111.027 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -147.88 116.35 6.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 128.229 2.611 . . . . 1.0 105.434 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.8 t0 54.17 32.48 15.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.858 2.463 . . . . 1.0 115.109 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.0 p 51.25 37.53 18.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.3 1.84 . . . . 1.0 113.212 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.44 146.46 54.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.749 1.62 . . . . 1.0 108.508 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -29.3 113.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.658 1.983 . . . . 1.0 111.206 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -78.36 -9.41 59.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.354 18.3 p 66.84 77.66 0.27 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 116.711 -1.614 . . . . 1.0 111.84 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.45 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 121.148 1.795 . . . . 1.0 113.729 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.12 -43.08 3.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.728 2.011 . . . . 1.0 110.245 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -55.53 -44.65 76.91 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.263 1.025 . . . . 1.0 111.461 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.55 -43.31 97.38 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.755 1.162 . . . . 1.0 109.902 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -63.08 -55.54 24.57 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' ILE . 82.3 mt-30 -66.01 -43.06 88.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.767 0.827 . . . . 1.0 111.08 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.75 -48.01 80.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.314 1.415 . . . . 1.0 108.902 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.06 89.53 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.292 -0.861 . . . . 1.0 109.438 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.58 -53.89 45.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.991 0.916 . . . . 1.0 110.797 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 115' ' ' ILE . 61.6 t -55.84 -53.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.0 m -57.88 -57.6 12.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.405 1.482 . . . . 1.0 110.452 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -56.19 -46.4 79.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.653 1.581 . . . . 1.0 110.738 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.558 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -70.67 -41.38 72.15 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.968 -0.539 . . . . 1.0 111.379 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.71 -42.69 79.6 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.927 -1.108 . . . . 1.0 109.93 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.8 -41.03 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.673 1.189 . . . . 1.0 109.721 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.7 m -59.25 -13.08 6.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.337 1.055 . . . . 1.0 112.394 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -111.85 -43.61 3.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.275 -1.345 . . . . 1.0 111.39 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.52 112.81 23.03 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -97.97 107.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 121.286 1.495 . . . . 1.0 111.493 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.81 -54.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.71 2.004 . . . . 1.0 108.251 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 60.0 mt -49.77 -32.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 129.5 3.12 . . . . 1.0 110.813 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.36 -21.46 2.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.708 1.203 . . . . 1.0 113.345 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.57 18.39 3.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.881 2.072 . . . . 1.0 110.894 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -143.2 83.96 1.81 Allowed 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.125 -0.984 . . . . 1.0 109.899 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.26 127.9 40.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -158.53 -168.23 2.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.32 -0.992 . . . . 1.0 108.32 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.75 -131.67 1.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 106.7 -2.56 . . . . 1.0 106.7 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 9.2 m170 -113.78 -23.2 9.8 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.111 0.964 . . . . 1.0 111.276 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.3 -15.89 15.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.145 0.978 . . . . 1.0 109.543 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.82 38.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.173 -0.954 . . . . 1.0 109.759 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -68.92 -17.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.914 -1.116 . . . . 1.0 109.446 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -155.02 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.232 1.813 . . . . 1.0 111.453 175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 60.0 Cg_endo -92.3 110.24 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.795 2.33 . . . . 1.0 112.781 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -58.39 -25.95 62.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.346 1.858 . . . . 1.0 113.924 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -25.31 62.87 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.497 0.719 . . . . 1.0 112.794 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -127.69 139.73 52.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -127.65 -16.43 4.77 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.978 -0.378 . . . . 1.0 109.978 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.18 178.85 0.48 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 131.281 3.832 . . . . 1.0 103.725 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.13 85.63 1.36 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.186 1.924 . . . . 1.0 109.994 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.96 68.32 0.62 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.236 1.398 . . . . 1.0 111.64 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 168' ' ' SER . 71.9 Cg_endo -75.38 -70.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.688 2.259 . . . . 1.0 112.592 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.403 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 15.4 t 53.7 42.9 31.72 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.582 2.353 . . . . 1.0 111.408 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -99.56 18.92 16.75 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.11 -1.619 . . . . 1.0 113.9 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.8 t0 43.35 70.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.781 1.233 . . . . 1.0 112.93 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -56.27 -30.09 62.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 1.0 112.66 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.86 -60.07 3.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.037 0.835 . . . . 1.0 109.065 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -64.18 -34.54 78.32 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.371 -0.931 . . . . 1.0 111.967 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 85.6 t80 -66.01 -52.7 46.89 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.823 1.192 . . . . 1.0 110.618 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -34.64 74.6 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 119.049 -0.5 . . . . 1.0 109.985 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.06 89.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.868 0.867 . . . . 1.0 112.557 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.54 -58.86 3.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.793 1.237 . . . . 1.0 110.155 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 53.5 t -66.03 166.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.327 1.051 . . . . 1.0 110.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 86.3 m -40.26 114.68 1.07 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 109.765 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -80.95 46.38 2.25 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 124.142 3.228 . . . . 1.0 114.623 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.8 t 49.18 34.56 6.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.495 1.918 . . . . 1.0 113.507 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -162.43 89.99 0.71 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -166.2 100.54 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.04 -1.037 . . . . 1.0 108.495 -175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -69.39 123.64 21.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 118.617 -1.233 . . . . 1.0 108.29 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -86.03 -162.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.275 2.63 . . . . 1.0 108.861 175.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -152.41 114.77 4.49 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.463 -1.68 . . . . 1.0 106.463 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.895 1.678 . . . . 1.0 109.762 -176.695 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' HG22 ' A' ' 136' ' ' VAL . 52.9 ttm . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.7 tp -141.5 170.75 15.14 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.282 1.833 . . . . 1.0 106.923 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.7 mt -108.76 123.35 48.88 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 101.558 -3.497 . . . . 1.0 101.558 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -114.34 123.11 48.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 47.09 36.44 4.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.073 0.949 . . . . 1.0 111.435 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.43 2.03 39.79 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.551 1.072 . . . . 1.0 114.615 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.04 167.71 10.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.148 -2.167 . . . . 1.0 105.148 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tt -80.2 124.04 28.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.811 -1.181 . . . . 1.0 108.382 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.86 139.77 41.86 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.964 0.347 . . . . 1.0 110.682 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 57.24 65.99 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 127.062 2.145 . . . . 1.0 112.818 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.41 148.48 37.89 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.262 1.425 . . . . 1.0 107.289 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -72.07 123.38 22.71 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.545 -2.391 . . . . 1.0 104.545 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.91 38.32 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.734 0.814 . . . . 1.0 111.929 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.67 72.92 77.08 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.066 0.946 . . . . 1.0 108.803 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.57 123.26 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 107.513 -1.764 . . . . 1.0 107.513 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -136.02 113.38 10.62 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.3 61.78 4.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.97 2.447 . . . . 1.0 108.926 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -124.01 44.69 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.892 -1.892 . . . . 1.0 105.892 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.495 ' HE1' HG22 ' A' ' 88' ' ' VAL . 14.4 m-85 -82.01 178.38 8.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.819 2.048 . . . . 1.0 113.466 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.87 -179.3 3.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 128.268 2.627 . . . . 1.0 112.912 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 m -157.65 118.59 3.54 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.173 4.589 . . . . 1.0 101.337 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -132.92 138.46 31.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 116.728 -1.606 . . . . 1.0 107.975 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.68 86.95 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.57 2.846 . . . . 1.0 108.675 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB2' HH12 ' A' ' 93' ' ' ARG . 13.2 m-20 -160.29 150.88 18.58 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.828 2.451 . . . . 1.0 106.226 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -151.49 104.06 3.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.322 1.849 . . . . 1.0 106.134 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.11 170.36 16.23 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.476 1.489 . . . . 1.0 108.138 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -75.43 123.19 88.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 119.905 -1.747 . . . . 1.0 109.033 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.22 103.54 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.967 1.778 . . . . 1.0 110.712 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 146' ' ' ALA . 11.3 t -171.08 77.23 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.55 -1.648 . . . . 1.0 106.55 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' A' ' 150' ' ' ASN . 5.0 tp -145.8 124.72 12.72 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.23 127.26 35.75 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.834 -1.543 . . . . 1.0 106.834 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.09 113.8 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 163' ' ' THR . 48.4 t -108.79 114.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 104.916 -2.253 . . . . 1.0 104.916 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -167.63 149.18 5.54 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 116.731 -1.604 . . . . 1.0 106.868 175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -95.54 111.43 23.34 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 117.145 -1.822 . . . . 1.0 110.138 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -127.6 176.78 6.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 129.98 3.312 . . . . 1.0 107.273 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.1 t -149.15 121.04 8.16 Favored 'General case' 0 C--N 1.313 -1.016 1 N-CA-C 94.697 -6.038 . . . . 1.0 94.697 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 72' ' ' VAL 0.295 0.1 OUTLIER -142.36 -61.39 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.26 0.937 . . . . 1.0 109.8 175.603 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 11.8 Cg_exo -73.07 124.67 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.212 1.942 . . . . 1.0 110.013 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.8 68.89 7.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.538 2.825 . . . . 1.0 111.73 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.92 -71.1 0.69 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.855 -1.698 . . . . 1.0 108.855 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -152.33 123.48 7.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.545 1.938 . . . . 1.0 106.121 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -175.71 158.58 2.18 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.42 2.688 . . . . 1.0 107.857 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.84 -0.75 63.87 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.558 -1.134 . . . . 1.0 113.058 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 118.47 4.79 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.67 1.735 . . . . 1.0 110.903 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.35 -12.88 15.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.64 2.227 . . . . 1.0 114.101 -175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -61.81 -33.92 75.0 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.921 1.237 . . . . 1.0 111.017 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.6 mt -64.17 -55.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.314 -1.365 . . . . 1.0 107.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.6 -33.28 75.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.439 0.563 . . . . 1.0 112.271 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -53.25 -34.25 56.42 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.74 0.816 . . . . 1.0 111.3 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.36 -51.11 60.53 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.14 -0.975 . . . . 1.0 109.559 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -61.23 -50.63 72.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 1.0 110.884 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 50' ' ' ALA . 4.7 t -61.76 -33.91 74.91 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.346 1.458 . . . . 1.0 110.548 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.63 2.75 37.44 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.804 -1.554 . . . . 1.0 115.666 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.5 p -93.04 9.3 36.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.177 1.988 . . . . 1.0 113.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 tt -49.13 137.55 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.344 1.058 . . . . 1.0 112.19 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 136.33 20.75 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 126.415 1.886 . . . . 1.0 107.015 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.49 67.25 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.967 3.112 . . . . 1.0 110.296 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.56 -48.31 4.0 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.486 1.291 . . . . 1.0 114.486 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.46 -64.51 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.065 0.946 . . . . 1.0 112.76 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -171.04 178.01 0.87 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.376 1.47 . . . . 1.0 108.199 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.78 -43.9 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.848 2.365 . . . . 1.0 115.154 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -51.45 -59.04 4.68 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.984 1.266 . . . . 1.0 112.246 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.7 -49.22 69.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.718 0.807 . . . . 1.0 111.094 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.04 95.1 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.32 0.648 . . . . 1.0 111.595 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.43 -63.47 5.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 125.29 1.424 . . . . 1.0 110.751 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.33 -26.12 38.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-O 116.06 -1.924 . . . . 1.0 112.49 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.79 -43.22 3.89 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 121.002 1.728 . . . . 1.0 115.059 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -60.01 -34.5 73.43 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.499 0.72 . . . . 1.0 111.188 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.43 136.18 33.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.946 -2.613 . . . . 1.0 103.946 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 164.29 15.18 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.853 -1.154 . . . . 1.0 109.358 175.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 38' ' ' LEU . 29.1 m -116.58 166.39 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.346 1.058 . . . . 1.0 109.593 175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.5 m -170.73 121.56 0.58 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.351 1.46 . . . . 1.0 107.653 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.29 -155.5 0.48 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.382 1.873 . . . . 1.0 107.329 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -136.06 -59.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.327 1.851 . . . . 1.0 108.029 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HB2' HD13 ' A' ' 115' ' ' ILE . 78.1 m -132.63 118.97 19.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -109.01 113.63 26.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -95.37 114.25 31.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.173 -2.158 . . . . 1.0 105.173 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.92 148.91 43.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.394 0.997 . . . . 1.0 108.323 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -13.61 2.51 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.232 1.197 . . . . 1.0 114.232 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -91.82 23.41 3.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.258 1.023 . . . . 1.0 110.986 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.75 41.44 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 127.674 2.559 . . . . 1.0 112.891 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.98 154.63 44.33 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.077 0.951 . . . . 1.0 108.956 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.96 113.77 44.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.53 146.95 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.686 -1.598 . . . . 1.0 106.686 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -124.7 113.78 18.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.278 1.031 . . . . 1.0 108.876 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -114.05 114.8 26.61 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 104.149 -2.538 . . . . 1.0 104.149 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 19' ' ' TYR . 5.6 t 81.46 91.95 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.898 1.226 . . . . 1.0 109.254 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -64.83 -167.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.964 1.776 . . . . 1.0 110.289 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -77.29 51.26 0.83 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.377 -1.452 . . . . 1.0 110.976 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -154.99 129.57 9.18 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.545 2.738 . . . . 1.0 105.611 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.6 tttp 62.93 81.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.04 2.136 . . . . 1.0 112.773 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.434 HH12 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -35.45 155.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.138 2.975 . . . . 1.0 112.972 -176.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.272 . . -103.45 178.5 4.54 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.81 2.444 . . . . 1.0 114.42 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -151.79 118.05 5.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.855 2.062 . . . . 1.0 105.497 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -165.33 62.96 0.12 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.135 1.445 . . . . 1.0 109.734 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.89 -69.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 O-C-N 119.114 -2.241 . . . . 1.0 114.758 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.04 -78.04 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.6 t -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.166 0.987 . . . . 1.0 108.727 -176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 p -166.32 158.32 13.83 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.636 2.375 . . . . 1.0 106.956 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.448 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -161.25 145.57 13.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.13 -1.804 . . . . 1.0 106.13 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -166.03 155.05 11.49 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . 0.275 37.6 mm-40 39.16 58.01 1.91 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.46 1.904 . . . . 1.0 113.008 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.16 28.74 50.42 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.344 1.45 . . . . 1.0 114.247 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -128.9 113.26 15.01 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 26.5 tp10 -89.76 135.15 33.79 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.0 mtt85 -125.54 140.71 52.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.384 0.993 . . . . 1.0 109.155 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -86.32 -24.72 25.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.844 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -158.34 170.44 22.22 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.085 2.554 . . . . 1.0 106.238 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.5 76.3 10.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 123.095 1.426 . . . . 1.0 110.507 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.05 44.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.69 2.396 . . . . 1.0 110.297 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 m -123.5 156.56 35.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.439 1.495 . . . . 1.0 112.549 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.262 0.0 OUTLIER -97.65 56.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.705 2.002 . . . . 1.0 108.189 176.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.24 -135.38 3.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 136' ' ' VAL . 10.7 mm -143.92 161.12 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 128.827 2.851 . . . . 1.0 104.848 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -131.92 113.66 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 101.536 -3.505 . . . . 1.0 101.536 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.51 148.26 28.2 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.291 -1.374 . . . . 1.0 107.291 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.05 155.26 47.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.635 0.731 . . . . 1.0 112.175 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.12 173.4 43.57 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.811 -1.541 . . . . 1.0 111.556 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.4 p -137.89 103.15 4.9 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.484 1.913 . . . . 1.0 106.297 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 t70 57.87 30.46 19.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.041 1.736 . . . . 1.0 113.344 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.255 81.7 p 57.82 38.74 27.3 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.545 1.938 . . . . 1.0 113.444 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.66 145.58 52.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -28.36 113.46 0.07 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 128.059 2.543 . . . . 1.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -79.02 -9.84 59.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 115.163 -2.351 . . . . 1.0 116.043 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 43.6 p 65.08 77.04 0.32 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 121.801 2.091 . . . . 1.0 112.698 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -23.36 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.548 1.539 . . . . 1.0 114.578 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.05 -40.71 6.93 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.301 2.24 . . . . 1.0 111.379 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -47.73 -54.0 13.5 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.394 1.078 . . . . 1.0 109.378 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -59.13 -38.82 80.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.334 0.654 . . . . 1.0 111.597 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.59 -57.38 8.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.4 0.545 . . . . 1.0 110.888 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -65.08 -37.12 86.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.972 0.805 . . . . 1.0 110.765 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.1 tp -56.52 -47.88 78.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.43 1.014 . . . . 1.0 108.603 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.16 93.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.589 -0.72 . . . . 1.0 110.527 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.82 53.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.071 0.85 . . . . 1.0 110.292 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 115' ' ' ILE . 25.8 t -57.1 -48.61 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.909 -0.775 . . . . 1.0 108.909 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.0 m -56.45 -49.52 74.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.976 1.311 . . . . 1.0 110.438 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -59.02 -46.87 87.12 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.89 0.876 . . . . 1.0 109.944 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.3 77.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.864 0.302 . . . . 1.0 110.594 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.0 mt -55.94 -44.21 78.16 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.988 0.915 . . . . 1.0 111.187 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.73 -41.08 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.126 0.875 . . . . 1.0 110.432 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -65.69 -14.26 60.91 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.826 -1.171 . . . . 1.0 112.252 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.68 -59.24 1.78 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.632 1.105 . . . . 1.0 108.191 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -124.82 112.88 27.04 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -101.76 107.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 123.347 1.311 . . . . 1.0 112.465 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' SER . . . -152.29 -41.26 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.073 2.549 . . . . 1.0 105.85 174.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.4 mt -47.75 -33.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 128.869 2.868 . . . . 1.0 109.851 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.81 -26.25 13.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.023 0.929 . . . . 1.0 112.89 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -129.9 18.58 5.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.565 1.946 . . . . 1.0 109.992 175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.502 ' HB3' HD12 ' A' ' 30' ' ' LEU . 15.6 m-80 -138.84 83.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 122.221 1.01 . . . . 1.0 108.332 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.91 113.41 17.82 Favored 'General case' 0 N--CA 1.448 -0.563 1 N-CA-C 99.988 -4.079 . . . . 1.0 99.988 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -152.98 -166.67 2.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -149.41 -131.78 2.0 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.148 -2.381 . . . . 1.0 107.148 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -116.63 -23.76 8.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.467 1.134 . . . . 1.0 110.629 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.5 t -103.86 2.34 32.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 4.1 t-20 -104.08 22.83 13.98 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.356 1.463 . . . . 1.0 111.459 -175.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.513 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.59 -15.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.34 0.656 . . . . 1.0 111.949 -175.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.49 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -152.26 -57.48 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.847 1.659 . . . . 1.0 108.934 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.49 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 84.6 Cg_endo -79.4 117.12 3.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 CA-C-N 122.085 1.78 . . . . 1.0 112.204 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 156' ' ' ASN . 0.7 OUTLIER -59.31 -25.56 64.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.784 0.834 . . . . 1.0 111.926 175.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -62.32 -19.27 63.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.476 2.31 . . . . 1.0 114.905 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -137.25 141.92 42.0 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 2.5 m -130.94 -17.05 3.17 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 117.158 -1.817 . . . . 1.0 112.422 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.58 -178.34 0.28 Allowed Pre-proline 0 C--O 1.249 1.036 0 C-N-CA 128.894 2.878 . . . . 1.0 105.093 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 80.01 2.31 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 N-CA-C 106.704 -2.076 . . . . 1.0 106.704 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 128.38 79.15 0.25 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.105 1.812 . . . . 1.0 111.035 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.57 -113.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 123.93 3.087 . . . . 1.0 110.237 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 t 56.36 43.51 26.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.284 1.833 . . . . 1.0 112.807 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -95.94 17.68 14.86 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.351 1.46 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.0 t0 44.08 77.27 0.07 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.106 1.362 . . . . 1.0 112.351 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -54.98 -32.87 62.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.392 0.516 . . . . 1.0 112.392 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.38 78.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.723 0.692 . . . . 1.0 111.252 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -59.8 -57.61 12.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.916 0.78 . . . . 1.0 110.07 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.55 -50.29 74.33 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.33 -38.96 81.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 118.481 0.582 . . . . 1.0 110.403 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.67 76.17 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.839 0.681 . . . . 1.0 112.839 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.59 -44.71 66.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.322 1.049 . . . . 1.0 111.862 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.64 162.89 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.17 0.988 . . . . 1.0 109.745 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -59.49 118.01 27.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.367 1.067 . . . . 1.0 109.084 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.87 50.34 3.54 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.918 3.079 . . . . 1.0 113.244 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.5 t 47.14 33.81 2.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.989 1.716 . . . . 1.0 113.543 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.2 t -158.4 153.93 26.11 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.636 -2.727 . . . . 1.0 103.636 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 52.87 79.75 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.399 1.079 . . . . 1.0 112.472 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.402 ' HE2' ' OE2' ' A' ' 185' ' ' GLU . 16.2 tttt -66.14 149.67 49.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 175.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.402 ' OE2' ' HE2' ' A' ' 184' ' ' LYS . 0.3 OUTLIER -67.6 179.25 1.39 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.214 1.007 . . . . 1.0 112.15 176.151 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.5 tpt -162.06 158.21 24.56 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.707 2.803 . . . . 1.0 105.727 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 114.693 -2.575 . . . . 1.0 110.079 -178.917 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ttt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.1 tp -50.92 123.45 9.21 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 152.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.0 mt -136.3 135.21 38.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 103.407 -2.812 . . . . 1.0 103.407 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -135.54 153.15 51.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.491 0.716 . . . . 1.0 109.71 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 51.46 33.36 10.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.109 1.764 . . . . 1.0 110.494 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.42 20.01 49.54 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.634 -1.291 . . . . 1.0 112.208 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -131.59 176.87 7.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.318 3.047 . . . . 1.0 106.366 -175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 129.87 43.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.46 145.29 44.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.871 1.434 . . . . 1.0 114.871 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 40.25 58.77 2.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 128.085 2.554 . . . . 1.0 108.941 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.66 156.71 46.67 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.467 1.107 . . . . 1.0 110.624 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -88.81 123.76 33.52 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -83.59 132.58 34.9 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -137.1 70.34 56.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.25 135.18 11.91 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.874 2.382 . . . . 1.0 111.787 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 t -159.18 113.2 1.57 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 N-CA-C 104.846 -2.279 . . . . 1.0 104.846 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.11 69.83 7.75 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.57 2.18 . . . . 1.0 110.207 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -123.19 43.57 2.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.876 2.071 . . . . 1.0 107.109 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 88' ' ' VAL . 3.5 m-85 -106.7 177.78 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.087 1.355 . . . . 1.0 110.005 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.25 -175.15 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.055 2.142 . . . . 1.0 112.101 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.87 130.16 14.65 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.712 2.805 . . . . 1.0 104.377 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.29 171.33 6.9 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 119.407 1.003 . . . . 1.0 109.345 -175.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.1 76.64 4.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.103 1.869 . . . . 1.0 112.738 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -149.81 144.0 25.72 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.849 2.46 . . . . 1.0 108.516 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -144.0 104.2 4.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.879 -1.526 . . . . 1.0 106.879 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -136.27 157.58 46.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.349 1.46 . . . . 1.0 109.224 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -70.7 123.56 89.37 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 103.14 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.04 1.407 . . . . 1.0 110.394 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 t -177.9 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.53 -1.655 . . . . 1.0 106.53 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.512 HD21 ' CG2' ' A' ' 152' ' ' THR . 7.7 tt -155.51 137.31 14.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.623 -1.991 . . . . 1.0 105.623 175.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 147' ' ' ILE . 19.0 tp -99.21 125.44 44.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.878 0.871 . . . . 1.0 109.594 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.46 113.81 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.8 t -107.13 120.93 59.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 104.902 -2.259 . . . . 1.0 104.902 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -169.82 134.23 1.32 Allowed 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -90.45 112.26 23.82 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.602 -1.259 . . . . 1.0 107.602 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm -127.38 176.62 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 130.627 3.571 . . . . 1.0 107.259 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 t -140.77 122.71 15.5 Favored 'General case' 0 C--O 1.245 0.842 1 N-CA-C 95.789 -5.634 . . . . 1.0 95.789 174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.309 1.0 OUTLIER -141.79 -64.3 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 114.139 1.163 . . . . 1.0 114.139 176.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 159.86 33.91 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.275 1.134 . . . . 1.0 112.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HD3' ' CE1' ' A' ' 52' ' ' PHE . 92.1 Cg_endo -82.04 0.76 9.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.044 3.163 . . . . 1.0 116.524 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -19.82 -66.48 0.01 OUTLIER Glycine 0 C--N 1.347 1.181 0 C-N-CA 126.178 1.847 . . . . 1.0 112.607 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -152.68 123.7 7.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.169 1.388 . . . . 1.0 112.021 175.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -176.6 164.79 2.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.412 3.085 . . . . 1.0 108.617 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.97 18.75 16.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.534 2.016 . . . . 1.0 111.2 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.8 118.47 6.16 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 107.69 -2.164 . . . . 1.0 107.69 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.2 -19.4 26.0 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 CA-C-N 121.286 2.543 . . . . 1.0 113.682 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -56.95 -34.61 68.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.651 1.18 . . . . 1.0 112.705 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -66.06 -53.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.27 -33.22 75.26 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.773 -0.58 . . . . 1.0 112.228 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -47.19 -33.94 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.25 1.02 . . . . 1.0 111.017 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.08 -51.28 64.81 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.363 -0.835 . . . . 1.0 111.335 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 40' ' ' PRO . 70.1 m-85 -71.01 -39.43 72.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.377 1.071 . . . . 1.0 112.419 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 50' ' ' ALA . 3.1 t -66.35 -40.37 89.77 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 175.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.96 16.88 6.58 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 124.939 1.257 . . . . 1.0 115.55 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.5 p -110.84 18.39 19.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.894 1.847 . . . . 1.0 113.805 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.72 132.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.465 1.029 . . . . 1.0 111.509 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.66 136.81 20.62 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 127.558 2.343 . . . . 1.0 108.887 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.65 62.67 1.72 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.31 2.674 . . . . 1.0 113.157 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -103.53 -50.16 3.51 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.042 1.127 . . . . 1.0 114.042 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.49 -63.27 1.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.729 0.695 . . . . 1.0 112.333 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 7.0 p80 -170.83 178.01 0.89 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.653 1.581 . . . . 1.0 107.639 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 9.8 Cg_endo -62.67 -44.2 18.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.067 1.845 . . . . 1.0 114.789 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -51.36 -58.7 5.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.41 1.005 . . . . 1.0 111.855 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -43.73 98.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.716 0.806 . . . . 1.0 110.136 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.8 98.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.404 -0.81 . . . . 1.0 111.817 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.44 -63.02 5.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.147 2.308 . . . . 1.0 112.742 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 pt -57.57 -34.26 46.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.9 -1.048 . . . . 1.0 113.077 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.5 -43.79 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 117.236 2.31 . . . . 1.0 117.236 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -64.88 -33.61 76.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.848 0.459 . . . . 1.0 110.189 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.83 119.6 25.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.137 -1.801 . . . . 1.0 106.137 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.33 132.64 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.621 -0.674 . . . . 1.0 109.841 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.65 162.79 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.366 1.466 . . . . 1.0 111.108 -175.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.633 ' HB3' HG21 ' A' ' 88' ' ' VAL . 71.2 m -161.7 115.94 1.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.749 0.82 . . . . 1.0 109.363 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.45 -156.98 0.53 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.628 1.171 . . . . 1.0 108.809 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -134.87 -75.98 0.46 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.645 ' HB2' HD13 ' A' ' 115' ' ' ILE . 55.5 m -124.08 118.28 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 102.207 -3.257 . . . . 1.0 102.207 175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.03 113.57 27.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 103.688 -2.708 . . . . 1.0 103.688 176.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.62 122.04 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.174 -1.787 . . . . 1.0 106.174 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.04 150.16 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -57.12 -14.75 4.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.924 -1.512 . . . . 1.0 114.144 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.34 19.33 6.12 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 120.505 1.502 . . . . 1.0 112.267 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.78 51.88 54.33 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.028 1.775 . . . . 1.0 112.58 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.27 111.02 16.85 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.586 -1.635 . . . . 1.0 106.586 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.7 mt -79.74 120.17 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.669 -1.604 . . . . 1.0 106.669 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.66 141.4 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 102.819 -3.03 . . . . 1.0 102.819 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 116.87 21.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -118.38 131.02 56.31 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.966 2.507 . . . . 1.0 105.615 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.807 HG22 ' CE1' ' A' ' 19' ' ' TYR . 3.0 t 69.05 91.51 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 120.726 1.603 . . . . 1.0 111.465 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' ASP . 74.0 Cg_endo -66.32 -169.48 0.17 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.827 2.351 . . . . 1.0 112.026 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -69.59 30.41 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.319 1.447 . . . . 1.0 110.668 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 89' ' ' PRO . 3.0 t0 -144.5 115.32 7.78 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 128.57 2.748 . . . . 1.0 108.305 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.14 82.19 0.06 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.241 2.616 . . . . 1.0 112.486 174.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -34.38 146.22 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.337 2.655 . . . . 1.0 114.834 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.09 -178.55 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.863 2.065 . . . . 1.0 113.194 -175.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -155.91 118.28 4.12 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.63 2.372 . . . . 1.0 108.472 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -161.01 63.03 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.715 1.245 . . . . 1.0 109.402 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.83 -70.85 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 119.627 -1.921 . . . . 1.0 113.261 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.93 -74.7 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 106.35 -2.7 . . . . 1.0 106.35 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.19 140.53 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.582 1.191 . . . . 1.0 110.061 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.3 p -166.32 162.45 17.23 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.969 1.307 . . . . 1.0 110.282 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 11.0 p -166.23 146.79 6.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.736 1.614 . . . . 1.0 108.928 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -156.39 147.24 21.95 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.333 0.97 . . . . 1.0 110.674 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 38.91 56.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.343 1.857 . . . . 1.0 112.142 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.95 28.89 69.41 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.289 0.947 . . . . 1.0 114.527 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -128.63 113.79 15.86 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -89.96 146.5 24.33 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -123.17 118.89 28.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.031 0.533 . . . . 1.0 111.108 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.52 -25.8 50.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.976 0.91 . . . . 1.0 110.042 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.67 168.88 18.86 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 127.558 2.343 . . . . 1.0 107.857 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -88.18 75.91 8.54 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.98 33.83 1.84 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.521 1.128 . . . . 1.0 112.276 -175.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -126.94 131.07 51.18 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.938 0.895 . . . . 1.0 109.542 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.289 0.1 OUTLIER -79.01 56.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.214 1.806 . . . . 1.0 110.073 -177.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.44 -133.26 3.42 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 122.578 1.099 . . . . 1.0 111.684 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 76' ' ' CYS . 20.6 mm -137.03 166.38 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.351 3.46 . . . . 1.0 104.085 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -144.85 135.38 24.42 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 101.839 -3.393 . . . . 1.0 101.839 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.3 165.69 11.14 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.522 -1.361 . . . . 1.0 110.412 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.15 150.35 49.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.771 0.829 . . . . 1.0 110.256 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.1 175.6 45.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.872 1.262 . . . . 1.0 112.383 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.5 p -141.28 110.1 6.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.983 2.113 . . . . 1.0 106.111 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 t0 45.67 48.73 11.43 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 128.301 2.64 . . . . 1.0 111.82 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p 50.7 38.08 18.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.776 2.831 . . . . 1.0 115.404 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.4 145.92 50.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.123 2.169 . . . . 1.0 110.55 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.34 114.68 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 129.405 3.082 . . . . 1.0 110.987 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -84.36 -8.05 59.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 114.123 -2.846 . . . . 1.0 113.155 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.391 26.5 p 64.9 77.92 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 122.568 2.44 . . . . 1.0 115.014 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -23.22 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 121.073 1.76 . . . . 1.0 114.815 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.9 -43.1 13.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.827 2.051 . . . . 1.0 110.733 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -50.15 -50.72 48.0 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 118.299 -0.857 . . . . 1.0 109.738 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -60.56 -36.36 78.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 117.559 -1.21 . . . . 1.0 111.222 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -65.29 -60.04 3.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.512 1.051 . . . . 1.0 109.713 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -62.8 -41.45 99.28 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.483 0.313 . . . . 1.0 111.138 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.01 -52.98 63.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.812 1.645 . . . . 1.0 109.122 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.71 76.23 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 118.289 -0.862 . . . . 1.0 110.273 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.79 52.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.683 0.793 . . . . 1.0 108.929 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.633 HG11 HD11 ' A' ' 115' ' ' ILE . 47.4 t -55.61 -50.29 68.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -58.27 -57.39 13.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.266 1.026 . . . . 1.0 112.13 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -55.79 -43.16 76.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.537 1.062 . . . . 1.0 110.328 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.85 51.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.788 -0.57 . . . . 1.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.53 -34.06 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.144 1.378 . . . . 1.0 112.105 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 mt -63.58 -39.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.405 -1.332 . . . . 1.0 107.405 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.8 m -64.53 -14.35 57.02 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.297 1.039 . . . . 1.0 110.4 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -64.93 1.07 Allowed 'General case' 0 C--N 1.347 0.47 0 O-C-N 120.24 -1.538 . . . . 1.0 106.942 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.85 113.01 24.66 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 106.922 -1.511 . . . . 1.0 106.922 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -88.65 107.25 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.865 1.702 . . . . 1.0 111.288 -175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.27 -51.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.296 1.438 . . . . 1.0 108.723 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.0 mt -46.04 -35.11 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 130.823 3.649 . . . . 1.0 111.789 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.06 63.49 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -131.39 18.34 4.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.353 2.261 . . . . 1.0 109.803 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -143.17 83.45 1.79 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 49.4 mtt -121.67 122.02 38.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.666 -2.716 . . . . 1.0 103.666 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 30' ' ' LEU . 5.2 t -158.65 -176.45 5.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.02 -131.33 2.89 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 105.787 -2.925 . . . . 1.0 105.787 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.1 m170 -118.15 -23.12 7.47 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.134 0.974 . . . . 1.0 110.63 176.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.4 t -103.36 -18.4 14.86 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -91.78 45.83 1.25 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.925 1.29 . . . . 1.0 107.521 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.1 OUTLIER -71.45 -14.68 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.319 -1.488 . . . . 1.0 109.933 175.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -153.65 -65.95 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 127.304 2.241 . . . . 1.0 107.334 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 89.7 Cg_endo -76.16 113.29 3.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.932 1.726 . . . . 1.0 113.382 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -18.71 36.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.121 1.368 . . . . 1.0 112.056 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.11 -25.99 64.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.536 1.934 . . . . 1.0 112.759 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -139.6 135.14 33.03 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.499 -2.037 . . . . 1.0 105.499 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 37.4 m -119.96 -16.49 8.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.103 0.408 . . . . 1.0 112.103 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.24 175.35 1.31 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.689 2.795 . . . . 1.0 105.095 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.73 69.3 7.85 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.953 2.435 . . . . 1.0 109.563 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.33 69.69 0.21 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.978 2.704 . . . . 1.0 108.54 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 87.4 Cg_endo -82.39 -87.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.022 3.148 . . . . 1.0 112.263 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 t 53.49 73.35 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.211 3.005 . . . . 1.0 109.214 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 56.8 t80 -119.35 18.97 12.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.411 1.085 . . . . 1.0 113.885 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.13 74.54 0.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.879 -1.763 . . . . 1.0 112.759 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -58.65 -31.57 68.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.866 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.07 77.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.857 -1.068 . . . . 1.0 110.666 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -60.81 -51.66 68.37 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.555 1.07 . . . . 1.0 110.516 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -60.79 -56.48 20.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.213 0.82 . . . . 1.0 113.213 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -64.29 -25.63 68.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.018 -0.991 . . . . 1.0 112.176 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.79 83.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.042 0.837 . . . . 1.0 111.093 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.16 -59.9 2.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.327 1.451 . . . . 1.0 111.019 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.48 166.02 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 m -45.1 113.72 1.92 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.329 1.051 . . . . 1.0 110.225 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.7 34.75 0.55 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.691 2.26 . . . . 1.0 111.323 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 50.26 50.34 18.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.472 2.709 . . . . 1.0 109.598 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -166.16 -36.63 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.882 2.073 . . . . 1.0 108.819 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 58.9 t60 62.9 44.56 6.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.869 2.067 . . . . 1.0 113.532 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -75.6 -176.52 3.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -72.46 169.12 17.08 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.167 -0.958 . . . . 1.0 109.426 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.495 ' HG3' ' H ' ' A' ' 187' ' ' THR . 9.8 tpt -171.25 -150.72 0.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 104.577 -2.379 . . . . 1.0 104.577 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.495 ' H ' ' HG3' ' A' ' 186' ' ' MET . 25.4 m . . . . . 0 C--O 1.247 0.937 0 N-CA-C 102.547 -3.131 . . . . 1.0 102.547 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -142.02 152.41 43.36 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 155.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.51 127.87 36.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 103.719 -2.697 . . . . 1.0 103.719 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -136.19 129.1 31.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.756 -1.202 . . . . 1.0 107.756 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 44.22 48.52 7.78 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.54 1.936 . . . . 1.0 113.732 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.11 27.01 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.64 1.114 . . . . 1.0 113.377 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -96.78 165.62 12.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.394 1.478 . . . . 1.0 107.126 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tt -89.86 122.86 33.31 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 103.957 -2.609 . . . . 1.0 103.957 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.91 175.04 7.02 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.19 0.996 . . . . 1.0 112.186 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 43.87 58.17 3.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.229 1.812 . . . . 1.0 109.697 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.0 132.93 7.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.462 1.905 . . . . 1.0 107.322 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -63.83 123.47 19.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 142.36 28.54 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.999 -1.063 . . . . 1.0 109.681 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.34 70.4 72.99 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 105.351 -2.092 . . . . 1.0 105.351 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.21 124.22 9.82 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.639 2.226 . . . . 1.0 111.047 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -160.24 113.46 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.67 71.1 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.866 2.377 . . . . 1.0 110.756 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -123.69 54.2 1.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.783 1.633 . . . . 1.0 107.281 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.8 m-30 -95.53 -175.71 3.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.302 2.241 . . . . 1.0 112.352 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.09 -177.08 3.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.959 2.104 . . . . 1.0 108.488 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 m -163.77 122.11 1.91 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 130.135 3.374 . . . . 1.0 103.82 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.8 152.94 52.21 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -80.88 36.6 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.991 2.461 . . . . 1.0 113.344 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.11 143.22 37.15 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.873 2.469 . . . . 1.0 104.497 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -146.69 103.26 3.64 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 9.2 tp10 -137.04 165.36 26.22 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -68.67 124.1 89.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.447 1.099 . . . . 1.0 110.695 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.5 113.94 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.025 2.484 . . . . 1.0 111.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t 178.91 85.29 0.01 OUTLIER 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.616 1.967 . . . . 1.0 105.983 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tp -148.32 143.15 26.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.259 -1.756 . . . . 1.0 106.259 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp -110.68 116.06 30.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.996 -1.853 . . . . 1.0 105.996 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.78 122.73 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.3 t -112.95 120.7 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -167.04 128.56 1.63 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 107.526 -1.287 . . . . 1.0 107.526 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -80.34 112.63 17.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 116.63 -2.028 . . . . 1.0 108.142 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -128.13 176.97 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 C-N-CA 131.993 4.117 . . . . 1.0 106.086 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 t -152.09 121.95 7.03 Favored 'General case' 0 N--CA 1.44 -0.96 1 N-CA-C 95.305 -5.813 . . . . 1.0 95.305 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.82 -66.17 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.511 0 CA-C-N 119.432 1.014 . . . . 1.0 110.86 175.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 4.0 Cg_exo -76.65 136.33 17.06 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.16 2.574 . . . . 1.0 110.838 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.86 77.76 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.73 1.62 . . . . 1.0 111.919 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.08 -72.09 0.72 Allowed Glycine 0 CA--C 1.533 1.194 0 N-CA-C 105.308 -3.117 . . . . 1.0 105.308 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -155.34 122.89 5.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.012 1.725 . . . . 1.0 107.857 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -176.84 167.64 2.55 Favored 'General case' 0 N--CA 1.469 0.523 1 C-N-CA 132.107 4.163 . . . . 1.0 107.157 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.99 16.11 20.75 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.088 1.328 . . . . 1.0 111.691 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.52 118.78 4.89 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 -7.69 21.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.018 2.479 . . . . 1.0 114.143 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -60.78 -38.86 86.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.638 1.108 . . . . 1.0 109.808 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 38' ' ' LEU . 58.7 mt -66.16 -46.58 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.68 -47.76 79.15 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.697 -0.627 . . . . 1.0 110.675 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.5 -33.66 63.91 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.479 1.512 . . . . 1.0 111.794 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.2 -57.45 10.46 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.23 1.012 . . . . 1.0 109.744 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -64.76 -45.24 87.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.834 0.854 . . . . 1.0 112.423 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 50' ' ' ALA . 5.2 t -65.86 -37.12 85.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.07 0.948 . . . . 1.0 109.853 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.11 37.94 3.96 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.36 -1.245 . . . . 1.0 115.648 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 p -130.68 20.61 5.09 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.398 1.599 . . . . 1.0 112.163 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.29 151.32 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.996 1.319 . . . . 1.0 112.26 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -98.68 129.36 30.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 127.271 2.228 . . . . 1.0 107.937 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.82 67.99 3.07 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.33 3.353 . . . . 1.0 109.599 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -104.77 -65.63 1.02 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.026 1.33 . . . . 1.0 112.64 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.68 4.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.177 1.391 . . . . 1.0 112.772 -175.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 21.4 p80 -170.5 177.86 0.95 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.559 1.544 . . . . 1.0 107.86 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.2 Cg_endo -70.93 -43.44 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.536 1.49 . . . . 1.0 115.34 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -50.62 -58.31 6.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.005 1.275 . . . . 1.0 113.026 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -45.04 91.79 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.0 0.92 . . . . 1.0 111.005 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.77 86.86 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.704 -0.622 . . . . 1.0 111.997 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -60.36 9.05 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 125.797 1.665 . . . . 1.0 111.271 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.2 -32.45 40.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 116.435 -1.745 . . . . 1.0 112.052 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -35.86 -43.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.241 2.216 . . . . 1.0 115.775 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -62.19 -39.84 94.05 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.846 1.258 . . . . 1.0 109.949 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.88 135.25 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.519 -2.401 . . . . 1.0 104.519 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 159.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.057 -1.027 . . . . 1.0 108.595 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.49 164.27 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.911 1.284 . . . . 1.0 107.867 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.5 m -164.31 118.2 1.41 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.334 0.654 . . . . 1.0 110.31 175.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.79 -153.89 0.35 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -129.94 -62.19 0.96 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.3 1.44 . . . . 1.0 108.598 175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -130.4 119.05 22.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.86 113.43 25.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.816 -2.661 . . . . 1.0 103.816 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 mt -100.91 124.45 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -83.95 148.0 27.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -16.38 0.77 Allowed 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 115.314 1.598 . . . . 1.0 115.314 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.99 22.45 4.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.12 56.23 23.4 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.425 -1.422 . . . . 1.0 112.808 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -128.7 143.34 50.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mt -116.46 125.6 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.059 1.3 . . . . 1.0 109.973 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.3 t -111.75 153.29 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.572 -2.01 . . . . 1.0 105.572 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -125.73 120.6 31.07 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.106 -0.996 . . . . 1.0 110.27 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -120.56 113.61 20.52 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 103.352 -2.833 . . . . 1.0 103.352 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.671 HG22 ' CE1' ' A' ' 19' ' ' TYR . 9.1 t 80.17 91.84 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 121.412 1.914 . . . . 1.0 114.461 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.35 -173.52 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.313 2.675 . . . . 1.0 111.816 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -80.65 51.59 1.52 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.873 -1.142 . . . . 1.0 108.989 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -148.86 113.04 5.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 130.287 3.435 . . . . 1.0 105.806 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.358 27.9 tttp 73.64 82.37 0.12 Allowed 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 115.497 1.665 . . . . 1.0 115.497 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 ttm-85 -32.72 138.11 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.855 2.862 . . . . 1.0 111.388 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.96 -178.87 3.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.118 1.767 . . . . 1.0 113.247 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -148.01 120.26 8.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.051 1.74 . . . . 1.0 109.976 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -162.08 62.85 0.23 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 106.49 -1.67 . . . . 1.0 106.49 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -157.8 -65.2 0.09 Allowed 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 119.356 -2.09 . . . . 1.0 114.082 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.16 -68.25 0.71 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.99 -0.895 . . . . 1.0 112.873 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.3 t -132.25 136.23 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.071 1.348 . . . . 1.0 109.726 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 p -166.35 137.13 3.44 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.54 1.136 . . . . 1.0 111.136 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.417 ' H ' HG22 ' A' ' 157' ' ' ILE . 16.1 p -154.96 132.42 11.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.48 -2.415 . . . . 1.0 104.48 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -152.96 159.66 42.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.117 0.871 . . . . 1.0 108.907 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 41.66 53.69 3.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.331 1.452 . . . . 1.0 111.11 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.53 32.49 53.2 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.951 -0.916 . . . . 1.0 113.382 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -139.54 114.88 9.8 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 119.084 1.442 . . . . 1.0 107.81 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.36 144.69 35.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -123.51 118.42 27.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.9 t -53.04 -39.15 63.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.663 0.665 . . . . 1.0 111.012 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -143.68 162.41 36.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.753 3.221 . . . . 1.0 104.896 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.298 28.6 t70 -86.95 76.71 9.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 123.283 1.516 . . . . 1.0 109.297 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -75.24 44.19 0.24 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 131.133 3.773 . . . . 1.0 110.255 175.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -123.15 155.43 37.05 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.133 1.373 . . . . 1.0 112.289 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.2 57.08 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.914 2.486 . . . . 1.0 109.005 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.21 -136.9 6.05 Favored Glycine 0 CA--C 1.527 0.834 0 O-C-N 120.174 -1.578 . . . . 1.0 114.055 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 133' ' ' LEU . 8.1 mm -142.12 159.55 20.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 129.129 2.972 . . . . 1.0 103.776 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.54 119.05 9.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.094 -2.928 . . . . 1.0 103.094 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.14 133.23 34.47 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.604 -1.31 . . . . 1.0 107.635 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -103.52 138.51 40.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.904 0.882 . . . . 1.0 108.765 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.55 33.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.699 1.142 . . . . 1.0 110.484 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.1 p -150.31 113.57 4.89 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.85 41.42 22.51 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.58 1.552 . . . . 1.0 114.384 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 45.77 38.16 4.04 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.295 1.838 . . . . 1.0 113.014 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -59.89 138.02 57.92 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.894 -1.891 . . . . 1.0 105.894 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.53 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.567 2.347 . . . . 1.0 111.25 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.54 -4.29 47.92 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 116.468 -1.73 . . . . 1.0 115.147 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.315 73.5 p 55.37 78.02 0.2 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.465 -1.731 . . . . 1.0 113.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -23.31 -33.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.176 2.591 . . . . 1.0 113.421 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.04 -35.71 7.14 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.485 1.914 . . . . 1.0 110.148 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.7 -50.14 63.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.342 0.973 . . . . 1.0 109.959 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.41 -39.19 86.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.672 0.789 . . . . 1.0 110.43 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.02 -54.52 28.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.844 1.258 . . . . 1.0 109.839 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -66.52 -47.47 72.83 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 0.68 . . . . 1.0 111.146 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 115' ' ' ILE . 25.1 tp -50.7 -49.51 57.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.874 1.27 . . . . 1.0 109.74 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.09 89.36 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 119.172 0.897 . . . . 1.0 110.519 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.33 59.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.424 0.689 . . . . 1.0 110.561 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.72 -46.5 62.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.4 m -59.9 -43.36 94.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.459 1.104 . . . . 1.0 110.576 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -58.82 -47.47 84.7 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.605 1.093 . . . . 1.0 109.564 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.73 -58.19 9.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.227 1.011 . . . . 1.0 109.253 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.3 -38.1 68.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.871 -1.062 . . . . 1.0 113.554 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.7 mt -61.25 -49.38 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 120.041 1.291 . . . . 1.0 108.991 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.5 m -66.36 -20.53 66.1 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.272 -0.268 . . . . 1.0 110.811 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -83.64 -57.1 3.37 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.01 1.724 . . . . 1.0 108.943 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.46 112.97 23.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 106.537 -1.653 . . . . 1.0 106.537 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -95.07 107.87 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 CA-C-N 120.848 1.339 . . . . 1.0 113.459 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.99 -50.64 0.11 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.855 1.662 . . . . 1.0 108.471 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.35 -33.64 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 129.689 3.196 . . . . 1.0 111.282 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.73 -21.98 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.704 1.601 . . . . 1.0 113.994 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -141.43 18.6 2.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.889 1.676 . . . . 1.0 110.398 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -138.44 84.17 2.01 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.707 -1.246 . . . . 1.0 108.046 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.0 mtt -121.5 114.38 21.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.8 t -145.37 -169.37 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.78 -131.51 2.57 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 106.285 -2.726 . . . . 1.0 106.285 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.405 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 20.2 m170 -117.49 -23.17 7.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.052 1.341 . . . . 1.0 109.314 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -23.07 13.82 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -84.14 42.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.539 1.063 . . . . 1.0 108.367 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.6 -14.14 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 O-C-N 120.073 -1.642 . . . . 1.0 108.281 175.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.506 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -158.02 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 128.634 2.774 . . . . 1.0 111.584 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 91.7 Cg_endo -79.61 108.44 2.29 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.199 1.933 . . . . 1.0 113.144 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -62.33 -21.68 65.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.246 1.418 . . . . 1.0 111.813 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -67.59 -24.39 65.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.656 -1.277 . . . . 1.0 113.002 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -132.7 124.29 27.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.177 -2.156 . . . . 1.0 105.177 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -114.18 -17.41 11.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.624 -1.23 . . . . 1.0 111.479 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.69 178.98 0.41 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 131.398 3.879 . . . . 1.0 103.603 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 91.64 0.65 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 121.697 1.642 . . . . 1.0 108.07 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 114.18 76.81 0.73 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.776 1.655 . . . . 1.0 111.263 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.83 -90.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.553 2.836 . . . . 1.0 110.452 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t 53.01 46.85 25.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.695 2.398 . . . . 1.0 113.782 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -118.24 16.46 14.0 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.851 -1.156 . . . . 1.0 112.629 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.5 t0 43.84 80.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.068 -1.645 . . . . 1.0 113.756 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -62.73 -33.93 76.13 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.237 -0.915 . . . . 1.0 112.396 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.47 91.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.299 0.954 . . . . 1.0 110.934 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -65.91 -52.52 49.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.115 0.87 . . . . 1.0 110.237 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.86 -51.84 67.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -62.04 -35.42 78.55 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.222 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.62 80.71 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.6 -46.91 62.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.128 0.571 . . . . 1.0 110.046 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.18 166.52 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.618 1.967 . . . . 1.0 111.488 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 183' ' ' HIS . 2.8 m -41.09 118.88 1.69 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.168 2.187 . . . . 1.0 108.499 175.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -76.66 55.2 4.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.464 3.443 . . . . 1.0 113.924 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 t 54.68 35.83 24.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.127 0.971 . . . . 1.0 110.101 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.6 t -164.59 103.12 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.686 1.194 . . . . 1.0 109.792 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.499 ' HB2' HG23 ' A' ' 179' ' ' THR . 4.7 t60 -173.3 115.94 0.26 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.777 1.631 . . . . 1.0 107.164 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -65.98 156.32 33.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.49 1.495 . . . . 1.0 107.612 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -93.96 178.7 5.57 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.664 1.986 . . . . 1.0 110.609 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.4 tpt 85.46 33.29 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.23 2.612 . . . . 1.0 116.322 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.249 1.051 0 O-C-N 119.718 -1.864 . . . . 1.0 110.266 175.367 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.5 tpp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 8.2 tp -142.06 176.24 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 1.0 109.201 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 22.7 mt -109.92 123.57 49.85 Favored 'General case' 0 C--N 1.327 -0.407 1 N-CA-C 98.897 -4.482 . . . . 1.0 98.897 174.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.96 126.46 39.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.965 -1.494 . . . . 1.0 106.965 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 55.31 33.33 20.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.635 1.574 . . . . 1.0 109.598 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.56 38.34 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.511 -1.368 . . . . 1.0 113.767 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -107.71 170.8 7.76 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 103.309 -2.848 . . . . 1.0 103.309 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.73 139.88 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.354 -1.466 . . . . 1.0 108.475 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.09 172.45 12.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.542 0.61 . . . . 1.0 110.738 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 37.51 57.85 1.36 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.959 2.904 . . . . 1.0 110.71 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.03 156.73 22.53 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.155 -0.966 . . . . 1.0 110.074 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -88.0 123.06 32.33 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.152 0.433 . . . . 1.0 111.769 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -98.22 130.02 44.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.47 1.108 . . . . 1.0 111.212 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.87 92.43 9.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.987 0.915 . . . . 1.0 108.654 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.4 160.47 44.62 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.54 1.493 . . . . 1.0 112.576 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 t -159.94 113.41 1.45 Allowed Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.4 61.17 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.792 2.328 . . . . 1.0 111.983 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -133.53 43.26 2.91 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.099 1.76 . . . . 1.0 107.068 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.6 m-85 -73.84 178.47 4.85 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.994 1.317 . . . . 1.0 109.832 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.07 178.79 4.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 124.117 1.913 . . . . 1.0 113.953 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -138.13 118.44 13.68 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 111.921 -2.4 . . . . 1.0 106.729 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -126.16 167.26 17.52 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 129.045 2.938 . . . . 1.0 106.144 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -179.1 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.619 1.546 . . . . 1.0 109.132 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.85 143.33 45.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.627 -2.361 . . . . 1.0 104.627 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -150.99 167.33 27.96 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 102.727 -3.064 . . . . 1.0 102.727 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.77 163.46 24.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.713 1.605 . . . . 1.0 108.962 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.39 123.59 3.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.307 2.243 . . . . 1.0 110.282 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HB2' ' H ' ' A' ' 113' ' ' ILE . 63.2 Cg_endo -66.11 135.28 39.86 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.495 2.797 . . . . 1.0 111.008 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 t 178.88 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.523 1.929 . . . . 1.0 106.768 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.27 125.15 6.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.1 126.01 39.07 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.77 144.31 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 104.593 -2.373 . . . . 1.0 104.593 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 169' ' ' PHE . 47.2 t -135.67 113.88 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.544 -3.132 . . . . 1.0 102.544 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -167.39 143.04 4.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.51 112.51 21.61 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.868 0.73 . . . . 1.0 109.409 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.4 176.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.629 1.972 . . . . 1.0 107.387 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 t -141.47 122.4 14.51 Favored 'General case' 0 N--CA 1.442 -0.834 1 N-CA-C 95.345 -5.798 . . . . 1.0 95.345 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.353 0.7 OUTLIER -142.58 -66.7 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 116.337 -1.792 . . . . 1.0 115.162 -178.656 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 32.2 Cg_endo -94.38 157.74 2.03 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.588 2.192 . . . . 1.0 114.783 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.25 51.72 4.02 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 125.215 3.943 . . . . 1.0 117.487 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.15 -71.2 0.83 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 107.373 -2.291 . . . . 1.0 107.373 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -156.32 122.82 5.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.72 2.008 . . . . 1.0 108.251 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -176.74 161.74 2.09 Favored 'General case' 0 C--O 1.235 0.295 1 C-N-CA 132.745 4.418 . . . . 1.0 108.229 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.18 4.0 29.99 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.522 1.058 . . . . 1.0 111.005 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.81 119.09 4.88 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 117.952 -1.471 . . . . 1.0 110.015 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -5.48 14.08 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.78 2.32 . . . . 1.0 114.771 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -60.9 -47.63 85.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.565 1.984 . . . . 1.0 110.926 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 mt -62.27 -51.28 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.35 -46.91 86.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.308 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -60.1 -37.48 80.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.04 0.936 . . . . 1.0 111.361 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.2 -49.94 73.76 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.485 0.584 . . . . 1.0 110.143 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -70.85 -46.91 61.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.177 -0.439 . . . . 1.0 110.93 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -65.9 -37.83 87.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.516 1.126 . . . . 1.0 109.63 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 8.09 11.26 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.915 1.721 . . . . 1.0 115.513 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -104.3 19.4 20.29 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.234 2.017 . . . . 1.0 113.34 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -59.41 125.25 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.306 1.442 . . . . 1.0 111.709 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.14 136.65 20.46 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.44 1.896 . . . . 1.0 110.671 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -71.36 70.38 2.5 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.788 2.992 . . . . 1.0 111.225 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -103.3 -62.5 1.28 Allowed 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.659 -0.651 . . . . 1.0 111.808 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.22 76.0 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.949 0.5 . . . . 1.0 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.3 p80 -170.63 177.98 0.91 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.865 1.666 . . . . 1.0 107.396 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.8 Cg_endo -69.8 -43.33 2.69 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 1.0 114.718 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -46.47 -51.05 16.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -57.48 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.128 0.971 . . . . 1.0 111.243 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.2 96.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.671 0.788 . . . . 1.0 111.05 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.04 -61.47 3.94 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.171 1.843 . . . . 1.0 111.672 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 pt -59.89 -33.98 54.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 116.743 -1.599 . . . . 1.0 112.709 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.38 -43.15 2.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.538 1.935 . . . . 1.0 115.154 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -54.67 -36.51 64.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.912 0.885 . . . . 1.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 136.54 33.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.352 -2.462 . . . . 1.0 104.352 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -60.49 152.06 26.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.088 -1.007 . . . . 1.0 108.55 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.7 158.7 17.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.481 1.112 . . . . 1.0 110.273 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -171.59 128.68 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.875 2.07 . . . . 1.0 108.127 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.13 -172.2 2.61 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -120.77 -59.71 1.72 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -138.97 118.72 13.13 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.433 -1.691 . . . . 1.0 106.433 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.77 113.47 26.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -95.44 118.28 41.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.077 -1.823 . . . . 1.0 106.077 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -72.67 148.3 44.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 117.994 -1.003 . . . . 1.0 108.304 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -45.45 -35.14 3.55 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 113.438 0.903 . . . . 1.0 113.438 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -91.67 36.64 0.95 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.882 0.873 . . . . 1.0 112.068 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.17 52.76 49.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.274 1.416 . . . . 1.0 115.299 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -119.49 111.92 18.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.388 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 132' ' ' GLN . 86.6 mt -85.78 113.88 24.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.295 -2.113 . . . . 1.0 105.295 175.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 140.27 30.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.273 -1.751 . . . . 1.0 106.273 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -121.85 114.87 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.487 1.115 . . . . 1.0 108.321 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -114.11 121.06 42.64 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 103.538 -2.764 . . . . 1.0 103.538 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 19' ' ' TYR . 88.4 t 70.8 92.01 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 121.041 1.746 . . . . 1.0 111.344 -177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.57 -168.4 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.405 2.737 . . . . 1.0 111.891 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -59.61 2.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.965 2.506 . . . . 1.0 115.596 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -125.58 135.08 51.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 128.025 2.53 . . . . 1.0 104.372 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.261 14.4 tptp 77.19 82.15 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.303 1.841 . . . . 1.0 111.882 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -34.11 136.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.521 1.928 . . . . 1.0 113.878 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.64 -178.39 3.65 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.451 2.3 . . . . 1.0 108.989 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -148.2 118.58 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.77 62.89 0.47 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.591 -1.318 . . . . 1.0 111.035 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.74 -68.22 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 119.177 -2.202 . . . . 1.0 113.99 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.99 -84.57 0.37 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 106.959 -2.456 . . . . 1.0 106.959 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.85 145.45 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.683 1.242 . . . . 1.0 109.468 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.6 p -165.97 145.47 6.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.8 1.24 . . . . 1.0 111.248 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.504 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -133.23 146.55 51.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.43 1.892 . . . . 1.0 109.79 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.72 148.91 28.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 41.53 53.5 3.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.24 1.816 . . . . 1.0 110.224 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.66 28.43 56.58 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.167 1.841 . . . . 1.0 116.277 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -132.82 136.6 46.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.145 1.973 . . . . 1.0 107.08 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 15.0 tp10 -96.2 145.79 25.24 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.65 1.18 . . . . 1.0 109.222 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -112.7 120.28 40.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.413 -2.069 . . . . 1.0 105.413 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.7 t -54.42 -31.2 54.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 1.0 112.826 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -164.27 176.29 9.3 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 129.552 3.141 . . . . 1.0 104.602 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -81.29 76.45 8.23 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 123.038 1.399 . . . . 1.0 109.628 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -80.94 33.52 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.233 1.813 . . . . 1.0 110.62 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 m -129.54 143.26 50.75 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 124.182 0.993 . . . . 1.0 113.124 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.524 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -80.01 57.09 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.56 2.344 . . . . 1.0 107.825 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.41 -136.58 1.35 Allowed Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.526 1.07 . . . . 1.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 133' ' ' LEU . 8.2 mm -143.19 163.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 103.299 -2.852 . . . . 1.0 103.299 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.71 130.79 23.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.471 -2.788 . . . . 1.0 103.471 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mp -101.13 166.03 11.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.529 0.681 . . . . 1.0 109.387 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.42 158.38 44.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.979 0.895 . . . . 1.0 111.4 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.75 173.04 45.4 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 113.759 -1.564 . . . . 1.0 110.876 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.8 p -141.14 101.94 4.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.796 -1.928 . . . . 1.0 105.796 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t70 49.48 55.74 8.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.584 1.954 . . . . 1.0 111.842 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.321 18.6 p 47.29 38.69 7.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.836 2.854 . . . . 1.0 115.131 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.55 146.19 55.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -38.14 114.13 0.34 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.14 2.176 . . . . 1.0 112.679 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -79.06 0.54 27.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 116.202 -1.856 . . . . 1.0 114.541 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.506 4.8 p 55.43 77.97 0.2 Allowed 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.017 -2.42 . . . . 1.0 117.443 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -23.4 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 122.479 2.399 . . . . 1.0 116.346 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.87 -41.73 16.22 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.722 1.609 . . . . 1.0 109.549 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.97 -50.92 60.31 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.919 0.887 . . . . 1.0 110.549 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -59.99 -43.27 95.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.221 0.918 . . . . 1.0 110.157 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.12 -51.05 61.63 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.864 0.466 . . . . 1.0 110.754 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.481 ' HB3' HD11 ' A' ' 84' ' ' ILE . 38.2 mm-40 -62.84 -50.2 71.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.142 1.777 . . . . 1.0 109.713 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 115' ' ' ILE . 35.7 tp -54.14 -49.08 70.05 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.4 76.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 1.0 111.37 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.42 55.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.7 0.8 . . . . 1.0 109.253 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.52 -47.69 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.8 m -52.75 -48.84 66.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.696 1.598 . . . . 1.0 110.232 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -59.66 -46.93 87.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.795 0.725 . . . . 1.0 111.951 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.17 74.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.271 0.487 . . . . 1.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.34 -41.23 75.74 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.934 0.893 . . . . 1.0 112.583 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.56 -49.47 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.726 1.148 . . . . 1.0 109.605 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.1 m -59.77 -16.65 29.44 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.439 0.695 . . . . 1.0 111.903 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -94.34 -58.87 2.09 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.467 -1.396 . . . . 1.0 109.55 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -125.95 112.9 24.41 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.068 -1.456 . . . . 1.0 107.068 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.77 107.48 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.644 1.266 . . . . 1.0 112.814 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.64 -50.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.919 2.088 . . . . 1.0 107.73 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.5 mt -44.78 -33.77 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.5 0 C-N-CA 129.478 3.111 . . . . 1.0 110.543 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.06 4.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.7 2.0 . . . . 1.0 114.118 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -136.54 18.57 3.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.803 1.641 . . . . 1.0 109.75 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.76 84.62 2.03 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.262 0.937 . . . . 1.0 110.176 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.37 114.07 19.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.9 t -146.73 -171.08 3.67 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.571 -0.706 . . . . 1.0 110.012 -175.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.59 2.04 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 107.021 -2.431 . . . . 1.0 107.021 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -113.58 -23.23 9.88 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.688 0.795 . . . . 1.0 111.639 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.59 -12.34 17.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.124 0.57 . . . . 1.0 109.695 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -88.09 40.02 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.153 0.888 . . . . 1.0 110.448 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.8 -26.57 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 120.955 -1.091 . . . . 1.0 108.449 175.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -143.68 -65.48 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.667 1.587 . . . . 1.0 111.767 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 96.2 Cg_endo -82.9 110.68 1.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.744 2.296 . . . . 1.0 112.807 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.23 -18.76 39.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.303 1.441 . . . . 1.0 113.609 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -57.42 -26.29 60.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.594 1.557 . . . . 1.0 112.154 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -126.22 141.16 52.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.085 -2.191 . . . . 1.0 105.085 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 m -132.15 -16.45 2.81 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.696 -0.628 . . . . 1.0 110.634 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.8 176.23 0.82 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 131.434 3.894 . . . . 1.0 102.805 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.45 70.31 6.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.802 2.335 . . . . 1.0 111.756 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 119.18 78.18 0.57 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.34 -2.304 . . . . 1.0 107.34 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 -62.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.028 2.485 . . . . 1.0 112.155 -175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.53 51.67 14.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.793 2.037 . . . . 1.0 114.027 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 33' ' ' VAL . 33.6 t80 -124.22 18.18 9.1 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.203 0.91 . . . . 1.0 113.232 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.386 19.9 t0 41.01 76.46 0.07 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.245 1.818 . . . . 1.0 113.748 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -51.29 -34.29 32.42 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.43 91.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 117.56 -1.21 . . . . 1.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -66.57 -53.17 37.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.294 1.406 . . . . 1.0 109.221 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.85 -51.24 70.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.369 0.507 . . . . 1.0 112.369 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -66.11 -23.49 66.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.84 0.745 . . . . 1.0 110.321 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.77 -51.9 50.44 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.298 -1.501 . . . . 1.0 109.754 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.79 -57.82 8.75 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.144 1.377 . . . . 1.0 111.339 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.86 166.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -49.81 122.36 13.68 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -83.5 53.24 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.44 2.76 . . . . 1.0 110.038 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 51.14 37.7 18.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.065 1.746 . . . . 1.0 111.204 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.7 t -154.4 23.22 0.48 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.423 1.089 . . . . 1.0 112.425 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -158.7 90.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.15 1.341 . . . . 1.0 113.753 -175.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -155.76 131.96 10.1 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.44 177.99 3.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.315 1.046 . . . . 1.0 110.915 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.401 ' CE ' ' H ' ' A' ' 187' ' ' THR . 7.9 tpt -69.65 171.57 8.8 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.401 ' H ' ' CE ' ' A' ' 186' ' ' MET . 2.7 m . . . . . 0 C--O 1.251 1.156 0 C-N-CA 126.715 2.006 . . . . 1.0 106.177 -175.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 tpt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 123.45 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 168.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.89 135.93 48.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 102.32 -3.215 . . . . 1.0 102.32 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.87 135.39 49.96 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 118.962 -0.542 . . . . 1.0 109.734 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.0 33.91 7.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.159 1.384 . . . . 1.0 110.918 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.39 1.43 21.64 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.429 1.49 . . . . 1.0 113.77 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -100.97 174.29 6.09 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 104.76 -2.311 . . . . 1.0 104.76 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.7 tm? -70.69 127.44 32.68 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.0 158.22 33.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.657 1.354 . . . . 1.0 114.657 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 38.56 57.98 1.7 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.587 2.755 . . . . 1.0 109.759 -175.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.24 51.82 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.593 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.551 ' HB2' HH11 ' A' ' 12' ' ' ARG . 8.5 ttm105 -79.11 123.14 27.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.329 -2.471 . . . . 1.0 104.329 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.9 122.5 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -143.01 79.54 14.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.994 -1.854 . . . . 1.0 105.994 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 132.95 30.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.927 1.751 . . . . 1.0 111.217 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 t -69.34 145.41 95.73 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 124.765 1.226 . . . . 1.0 109.587 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 -23.41 7.19 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 117.025 1.894 . . . . 1.0 117.025 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -150.16 121.46 7.85 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CE2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -96.57 178.98 5.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 178.45 4.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 123.11 1.433 . . . . 1.0 111.612 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 m -154.69 118.5 4.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 131.603 3.961 . . . . 1.0 101.594 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -130.69 155.21 81.62 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 125.853 1.661 . . . . 1.0 108.121 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -88.01 56.41 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.268 2.645 . . . . 1.0 109.794 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -140.25 143.64 36.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.41 103.92 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.56 171.22 14.09 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 105.877 -1.897 . . . . 1.0 105.877 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -71.37 123.3 89.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 119.53 1.059 . . . . 1.0 108.915 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.12 103.61 1.46 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 CA-C-N 120.687 1.281 . . . . 1.0 109.519 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -175.76 78.46 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.165 1.786 . . . . 1.0 107.337 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.411 HD12 ' HB3' ' A' ' 150' ' ' ASN . 4.9 tp -143.69 140.79 30.22 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.143 1.777 . . . . 1.0 106.722 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -106.11 126.59 52.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.665 1.121 . . . . 1.0 108.376 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.37 130.15 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.408 -2.071 . . . . 1.0 105.408 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HD13 ' A' ' 117' ' ' LEU . 59.4 t -134.6 112.98 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -158.52 149.71 20.71 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 176.393 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -81.54 111.26 17.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.644 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.3 mm -127.18 176.79 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.763 2.025 . . . . 1.0 107.451 174.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t -161.84 122.31 2.61 Favored 'General case' 0 C--N 1.313 -0.986 1 N-CA-C 93.93 -6.322 . . . . 1.0 93.93 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.273 1.2 tm? -142.66 -56.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 O-C-N 121.035 -1.04 . . . . 1.0 109.688 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -71.53 149.29 55.53 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.133 1.889 . . . . 1.0 112.631 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -82.41 39.66 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.56 3.506 . . . . 1.0 114.265 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -53.0 -71.61 0.66 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-O 117.461 -1.744 . . . . 1.0 110.581 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -156.6 122.87 4.98 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.707 1.754 . . . . 1.0 111.996 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -177.8 160.92 1.56 Allowed 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.493 4.317 . . . . 1.0 108.183 175.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.94 6.13 59.97 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.137 0.875 . . . . 1.0 111.846 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.89 118.65 4.73 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.0 1.4 . . . . 1.0 109.651 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 -21.44 44.62 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.364 2.043 . . . . 1.0 114.083 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -52.06 -43.09 63.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.099 0.863 . . . . 1.0 112.08 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.75 -44.3 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.449 1.1 . . . . 1.0 109.665 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.51 -45.64 78.88 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.05 0.841 . . . . 1.0 110.363 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.23 -33.56 58.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.476 1.511 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -55.06 -61.28 2.42 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.633 1.573 . . . . 1.0 108.985 175.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.99 -37.54 75.75 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.13 0.972 . . . . 1.0 113.279 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.5 t -65.82 -33.84 76.79 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.92 -5.43 53.5 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 125.211 1.386 . . . . 1.0 115.505 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -89.42 8.9 28.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.295 2.048 . . . . 1.0 112.515 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -51.94 134.42 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 125.961 1.705 . . . . 1.0 111.176 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.72 134.18 21.85 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 127.585 2.354 . . . . 1.0 110.225 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 77.52 1.82 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.641 2.894 . . . . 1.0 107.422 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.32 -63.26 1.19 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.364 0.666 . . . . 1.0 110.639 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.0 78.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.755 0.822 . . . . 1.0 110.69 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 19.5 p80 -171.0 178.0 0.87 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.737 2.015 . . . . 1.0 107.167 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 26.1 Cg_endo -73.05 -43.48 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.049 1.832 . . . . 1.0 114.684 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -46.38 -47.61 18.74 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -55.4 -58.13 8.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.451 1.1 . . . . 1.0 110.066 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.42 92.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.899 0.88 . . . . 1.0 111.37 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.59 -65.78 2.62 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.645 1.593 . . . . 1.0 111.553 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.15 -38.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.476 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.18 -43.41 10.05 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.359 1.864 . . . . 1.0 114.951 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -57.36 -33.55 67.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.71 -0.619 . . . . 1.0 110.323 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.51 134.23 33.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 102.2 -3.259 . . . . 1.0 102.2 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 152.14 19.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.949 0.795 . . . . 1.0 110.967 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.43 161.43 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.772 1.629 . . . . 1.0 110.74 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.0 m -172.88 123.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.584 1.554 . . . . 1.0 108.242 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.51 -154.05 0.43 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -128.89 -65.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.487 1.115 . . . . 1.0 110.133 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.8 m -133.99 118.69 18.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.678 -1.264 . . . . 1.0 107.689 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -103.47 113.97 27.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.809 -1.923 . . . . 1.0 105.809 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.56 114.59 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -66.36 148.62 51.59 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.72 1.145 . . . . 1.0 108.532 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -13.62 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.721 1.608 . . . . 1.0 112.306 175.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -91.21 18.96 6.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 131.478 3.911 . . . . 1.0 112.304 -176.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.5 46.97 93.37 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.229 1.395 . . . . 1.0 113.168 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.97 110.25 14.56 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.706 1.253 . . . . 1.0 110.156 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' A' ' 132' ' ' GLN . 52.0 mt -81.48 117.45 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 106.729 -1.582 . . . . 1.0 106.729 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.45 147.9 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.216 -1.772 . . . . 1.0 106.216 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -125.75 124.26 40.64 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 1.0 110.141 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.0 117.86 28.36 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 129.463 3.105 . . . . 1.0 103.755 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 19' ' ' TYR . 39.5 t 72.06 91.78 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 122.656 2.48 . . . . 1.0 113.205 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.91 -166.61 0.23 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.331 2.021 . . . . 1.0 111.079 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -70.85 46.07 0.09 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.856 2.862 . . . . 1.0 113.703 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.01 127.16 4.5 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 127.215 2.206 . . . . 1.0 106.508 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 tptm 77.35 81.48 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.543 1.137 . . . . 1.0 111.377 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -39.53 154.9 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.462 2.305 . . . . 1.0 113.232 -175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.31 -178.29 3.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.566 2.346 . . . . 1.0 113.008 -175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -153.12 118.73 5.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.905 1.682 . . . . 1.0 108.956 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -166.32 64.02 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 122.595 1.188 . . . . 1.0 111.167 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.15 -54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 118.103 -2.873 . . . . 1.0 112.602 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.37 -74.73 0.25 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.347 -1.807 . . . . 1.0 109.137 -175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.55 142.2 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.935 1.694 . . . . 1.0 110.018 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -166.33 163.66 17.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.984 2.514 . . . . 1.0 110.643 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.7 p -163.14 146.23 10.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -159.65 157.48 29.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.738 1.154 . . . . 1.0 108.94 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 39.9 53.28 2.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.623 1.569 . . . . 1.0 109.994 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.3 42.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 116.262 1.265 . . . . 1.0 116.262 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -129.0 121.98 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 120.019 1.909 . . . . 1.0 106.861 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.45 141.06 38.55 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -119.51 118.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.5 -42.87 97.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.3 0.852 . . . . 1.0 113.3 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.95 176.52 8.74 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.277 1.831 . . . . 1.0 108.968 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -83.15 76.46 9.86 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.91 38.41 1.23 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.986 1.315 . . . . 1.0 111.758 -175.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -134.14 149.94 51.09 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.094 0.958 . . . . 1.0 113.013 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -82.52 56.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.845 2.058 . . . . 1.0 109.645 177.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.51 -136.86 2.15 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 122.393 0.996 . . . . 1.0 113.359 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 136' ' ' VAL . 14.7 mm -140.86 160.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 103.532 -2.766 . . . . 1.0 103.532 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -138.46 126.04 22.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 103.324 -2.843 . . . . 1.0 103.324 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.443 HD13 HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -101.51 139.56 37.0 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.993 -1.067 . . . . 1.0 109.459 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 5.4 tm-20 -104.53 154.09 20.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.471 0.653 . . . . 1.0 110.539 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.42 -179.74 45.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.405 1.955 . . . . 1.0 110.213 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 p -141.87 106.41 4.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.074 -1.824 . . . . 1.0 106.074 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.266 43.7 t0 38.95 56.63 1.98 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.107 2.563 . . . . 1.0 113.986 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p 56.16 38.2 29.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.564 1.32 . . . . 1.0 114.564 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -69.17 146.0 52.81 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 105.389 -2.078 . . . . 1.0 105.389 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -37.26 113.55 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.133 1.373 . . . . 1.0 111.062 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.94 -6.62 56.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 115.521 1.674 . . . . 1.0 115.521 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.395 10.9 p 66.7 76.96 0.29 Allowed 'General case' 0 C--N 1.352 0.704 0 CA-C-N 120.872 1.669 . . . . 1.0 112.797 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -25.54 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.734 1.753 . . . . 1.0 115.734 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.75 7.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.669 1.588 . . . . 1.0 109.719 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.47 -48.79 37.48 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.037 1.335 . . . . 1.0 110.64 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.65 -40.52 92.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.13 0.877 . . . . 1.0 110.266 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -65.95 -50.12 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.38 0.536 . . . . 1.0 110.208 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HB3' HD11 ' A' ' 84' ' ' ILE . 90.8 mt-30 -62.15 -52.66 62.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.689 1.596 . . . . 1.0 110.274 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.2 tp -54.23 -47.99 71.59 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.835 1.654 . . . . 1.0 109.656 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.9 98.05 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.304 0.956 . . . . 1.0 110.54 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.15 49.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 115' ' ' ILE . 97.1 t -59.47 -43.29 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.868 0.867 . . . . 1.0 110.766 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.8 m -57.57 -54.0 51.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 1.0 109.492 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -65.69 -33.75 76.61 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.2 -59.25 5.77 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . 0.341 2.9 mm? -56.71 -33.83 66.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.738 -1.125 . . . . 1.0 113.555 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.68 -39.68 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.597 1.544 . . . . 1.0 107.908 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.2 m -60.18 -24.63 64.93 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.726 0.811 . . . . 1.0 110.866 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -84.3 -64.85 1.09 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 106.367 -1.716 . . . . 1.0 106.367 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -126.92 113.38 22.07 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.219 1.008 . . . . 1.0 109.976 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.63 107.36 0.33 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 CA-C-N 120.287 1.138 . . . . 1.0 110.838 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.3 -47.23 0.1 Allowed 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 128.212 2.605 . . . . 1.0 105.855 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.5 mt -48.54 -34.09 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 129.555 3.142 . . . . 1.0 110.644 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.91 7.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.803 0.841 . . . . 1.0 113.076 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -137.27 18.33 2.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.5 2.32 . . . . 1.0 109.926 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.411 ' HB3' HD12 ' A' ' 30' ' ' LEU . 3.4 m-80 -141.99 83.67 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.409 1.004 . . . . 1.0 110.148 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.24 114.83 18.16 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 102.878 -3.008 . . . . 1.0 102.878 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.6 t -153.38 -166.98 2.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.315 0.579 . . . . 1.0 111.688 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.26 -131.93 1.59 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.378 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 13.9 m170 -112.83 -23.26 10.23 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.899 0.88 . . . . 1.0 109.223 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -108.39 -21.98 12.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.104 1.361 . . . . 1.0 108.991 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -83.85 34.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.883 -1.136 . . . . 1.0 109.074 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -22.53 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.434 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -149.19 -55.92 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.952 2.501 . . . . 1.0 110.926 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 83.8 Cg_endo -81.78 112.01 2.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.27 1.98 . . . . 1.0 112.907 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.42 -26.19 64.96 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.847 -1.158 . . . . 1.0 111.705 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -21.94 66.19 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.857 1.263 . . . . 1.0 112.091 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -137.81 124.7 21.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -113.75 -15.75 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.395 0.543 . . . . 1.0 110.937 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.86 178.08 0.5 Allowed Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 129.645 3.178 . . . . 1.0 105.314 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -78.99 50.02 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.45 2.1 . . . . 1.0 111.185 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.55 65.82 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.36 1.933 . . . . 1.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.88 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.222 2.615 . . . . 1.0 111.51 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.1 t 53.61 50.66 16.7 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.603 1.161 . . . . 1.0 111.036 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.439 ' CD2' HG11 ' A' ' 33' ' ' VAL . 27.7 t80 -105.33 17.73 23.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.967 1.258 . . . . 1.0 113.175 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.1 t0 43.74 62.56 1.87 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.702 -1.873 . . . . 1.0 110.905 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -52.15 -33.43 40.3 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.748 -0.644 . . . . 1.0 111.279 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.98 -60.45 3.81 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.622 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -60.45 -42.3 95.86 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 117.574 -1.203 . . . . 1.0 111.411 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.94 -62.0 2.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.107 0.867 . . . . 1.0 111.128 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -61.14 -32.4 72.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.702 -0.666 . . . . 1.0 110.858 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.76 76.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.021 0.828 . . . . 1.0 112.233 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.75 -57.23 4.88 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.889 -1.132 . . . . 1.0 108.367 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.67 164.6 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.084 1.754 . . . . 1.0 110.76 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 m -55.65 121.07 36.71 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.405 1.482 . . . . 1.0 109.019 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.37 43.24 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.774 2.983 . . . . 1.0 109.511 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 t 46.34 53.2 9.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.795 2.438 . . . . 1.0 108.931 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -158.17 -45.47 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.729 1.611 . . . . 1.0 109.418 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -73.73 34.26 0.08 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.904 2.082 . . . . 1.0 111.001 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -67.02 161.82 23.51 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.69 -172.87 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.17 1.788 . . . . 1.0 114.085 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -115.53 -4.55 12.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.567 1.547 . . . . 1.0 112.895 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.4 m . . . . . 0 C--O 1.247 0.957 0 O-C-N 119.497 -2.002 . . . . 1.0 106.913 175.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.27 168.75 18.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 44.18 57.98 3.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.189 1.795 . . . . 1.0 109.711 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.49 156.25 41.68 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.958 2.103 . . . . 1.0 108.91 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -93.28 125.13 37.72 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -83.62 118.7 24.01 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.19 66.72 60.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.67 123.44 11.7 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 N-CA-C 108.339 -1.447 . . . . 1.0 108.339 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 t -54.82 142.71 53.71 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 123.193 0.597 . . . . 1.0 111.581 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.35 -12.01 24.99 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 116.039 1.515 . . . . 1.0 116.039 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -151.74 111.37 3.99 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CE1' HG22 ' A' ' 88' ' ' VAL . 9.6 m-30 -79.6 178.76 7.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.11 0.868 . . . . 1.0 110.532 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.0 -173.22 2.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.341 2.656 . . . . 1.0 109.916 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.8 m -165.66 118.13 1.13 Allowed 'General case' 0 CA--C 1.54 0.569 1 C-N-CA 131.705 4.002 . . . . 1.0 104.65 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.26 139.08 28.92 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 120.349 1.431 . . . . 1.0 109.809 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 70.03 6.07 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 124.449 3.433 . . . . 1.0 113.467 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -143.52 154.65 43.84 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.598 1.559 . . . . 1.0 108.68 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -151.19 103.43 3.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.354 0.979 . . . . 1.0 112.127 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -136.61 147.04 46.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 129.423 3.089 . . . . 1.0 104.68 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -59.66 123.79 72.93 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 119.949 1.25 . . . . 1.0 111.476 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.96 103.85 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.023 2.482 . . . . 1.0 111.847 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -172.24 79.39 0.05 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.703 1.601 . . . . 1.0 107.444 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.8 tp -139.93 133.66 30.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 tp -97.2 123.17 40.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.465 1.029 . . . . 1.0 108.311 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.69 118.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.957 -1.498 . . . . 1.0 106.957 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' THR . 69.3 t -116.02 114.79 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.289 -2.115 . . . . 1.0 105.289 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.6 p80 -167.34 152.33 7.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.267 -1.382 . . . . 1.0 107.267 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.67 112.23 24.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -127.51 175.95 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.597 1.959 . . . . 1.0 109.127 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 122.4 3.49 Favored 'General case' 0 N--CA 1.442 -0.869 1 N-CA-C 99.099 -4.408 . . . . 1.0 99.099 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.612 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -142.2 -48.4 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 118.174 -0.917 . . . . 1.0 108.979 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.612 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 39.0 Cg_endo -91.1 146.51 3.61 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 121.791 1.661 . . . . 1.0 114.465 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.48 44.3 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.508 3.472 . . . . 1.0 113.967 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.17 -65.02 2.0 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.971 -1.08 . . . . 1.0 111.71 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -152.35 122.78 7.26 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.886 -1.894 . . . . 1.0 105.886 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -176.42 175.85 1.72 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.782 2.833 . . . . 1.0 108.547 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.6 27.12 3.98 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.636 2.065 . . . . 1.0 109.634 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.13 118.18 6.1 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 106.037 -2.825 . . . . 1.0 106.037 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.26 -17.45 35.3 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 119.796 1.798 . . . . 1.0 115.13 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -66.14 -43.3 87.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.011 1.278 . . . . 1.0 110.996 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.02 -47.18 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.059 0.943 . . . . 1.0 109.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.9 -35.86 81.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.351 -0.843 . . . . 1.0 112.154 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.94 -33.47 68.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.013 0.925 . . . . 1.0 111.498 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.38 -54.58 43.87 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.511 -0.743 . . . . 1.0 109.893 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -66.77 -45.37 78.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.805 -0.617 . . . . 1.0 111.751 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -63.62 -39.39 94.23 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.33 3.26 22.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.412 1.958 . . . . 1.0 114.775 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -88.63 9.01 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.947 1.874 . . . . 1.0 112.627 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 tt -54.58 136.02 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.465 0.575 . . . . 1.0 110.896 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.22 136.6 19.17 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 127.71 2.404 . . . . 1.0 108.689 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.29 60.89 3.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.12 3.214 . . . . 1.0 112.719 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.48 -49.13 3.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 117.795 -1.098 . . . . 1.0 112.793 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.4 0.41 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.505 1.048 . . . . 1.0 112.079 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 24.6 p80 -163.57 177.83 1.71 Allowed Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 12.1 Cg_endo -70.43 -43.85 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.458 1.438 . . . . 1.0 114.834 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -51.47 -57.89 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.366 1.439 . . . . 1.0 111.999 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.47 -51.14 71.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.817 0.847 . . . . 1.0 110.182 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.86 -43.93 86.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 1.0 111.17 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -65.18 3.75 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.329 1.442 . . . . 1.0 110.535 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.27 -25.54 30.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-O 115.92 -1.991 . . . . 1.0 113.639 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.75 -43.04 5.82 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.966 1.712 . . . . 1.0 113.209 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -54.98 -38.28 67.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.419 1.488 . . . . 1.0 111.075 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.51 135.29 33.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.096 -1.816 . . . . 1.0 106.096 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 158.92 27.32 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.738 -1.227 . . . . 1.0 108.343 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.44 161.59 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB3' HG21 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -165.8 122.91 1.43 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 175.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.83 -154.0 0.42 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.969 1.308 . . . . 1.0 107.624 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.8 m80 -131.15 -67.16 0.71 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.67 1.123 . . . . 1.0 111.132 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HB2' HD13 ' A' ' 115' ' ' ILE . 61.2 m -135.58 119.15 16.99 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.344 -2.095 . . . . 1.0 105.344 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tt -113.29 118.08 33.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.116 1.766 . . . . 1.0 107.571 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -100.71 113.98 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.194 -1.78 . . . . 1.0 106.194 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -83.3 153.79 24.45 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 120.041 1.291 . . . . 1.0 108.636 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -17.94 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 128.939 2.896 . . . . 1.0 115.624 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 27.13 2.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.06 1.3 . . . . 1.0 112.668 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.26 42.75 99.87 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.544 1.069 . . . . 1.0 112.592 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.08 149.22 29.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.366 1.083 . . . . 1.0 108.837 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.05 119.08 60.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.606 -1.257 . . . . 1.0 107.606 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.46 147.82 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.402 -2.073 . . . . 1.0 105.402 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.69 122.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.618 -1.252 . . . . 1.0 107.618 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -120.98 113.69 20.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.876 -2.268 . . . . 1.0 104.876 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 19' ' ' TYR . 4.1 t 79.84 92.1 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.448 1.476 . . . . 1.0 111.439 176.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -61.7 -175.76 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.615 1.543 . . . . 1.0 110.877 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -58.34 5.49 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.89 2.476 . . . . 1.0 114.294 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.41 115.25 19.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.168 2.587 . . . . 1.0 108.795 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 85.81 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.67 2.788 . . . . 1.0 112.288 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.459 HH11 ' HB2' ' A' ' 111' ' ' PHE . 7.3 ttm180 -32.56 138.05 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.753 3.221 . . . . 1.0 115.642 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.58 -178.12 3.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 129.273 3.029 . . . . 1.0 111.945 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -155.06 118.33 4.44 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.477 1.511 . . . . 1.0 110.628 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 7.4 p80 -158.23 63.13 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.068 -1.645 . . . . 1.0 112.204 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.96 -56.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 118.734 -2.479 . . . . 1.0 114.148 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.03 -79.8 0.29 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 104.017 -3.633 . . . . 1.0 104.017 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.98 146.63 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.063 2.145 . . . . 1.0 108.881 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.6 p -156.18 150.72 25.81 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.533 1.533 . . . . 1.0 110.209 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.469 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.2 p -143.65 145.72 32.69 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 119.69 1.132 . . . . 1.0 111.248 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.42 145.29 21.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.83 -1.544 . . . . 1.0 106.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 42.08 53.85 4.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.976 1.71 . . . . 1.0 113.051 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.52 28.43 67.57 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.608 0.623 . . . . 1.0 113.375 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 116.44 17.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 176.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 5.8 tt0 -103.65 135.31 45.45 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 8.9 mtt85 -105.57 118.24 36.07 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.175 -2.528 . . . . 1.0 104.175 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.57 -25.47 66.23 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.745 1.618 . . . . 1.0 111.542 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -154.26 170.4 21.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.611 2.764 . . . . 1.0 107.588 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 6.3 t70 -84.76 76.71 10.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.459 ' HB2' HH11 ' A' ' 93' ' ' ARG . 0.2 OUTLIER -100.32 33.65 2.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.243 -175.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -132.9 142.72 49.05 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 124.483 1.113 . . . . 1.0 110.568 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -79.19 56.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 127.09 2.156 . . . . 1.0 110.806 -176.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.5 -136.5 1.7 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.946 -1.097 . . . . 1.0 113.034 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG21 HD13 ' A' ' 133' ' ' LEU . 3.6 mm -142.57 165.3 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 130.515 3.526 . . . . 1.0 102.985 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -145.82 138.58 25.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 103.7 -2.704 . . . . 1.0 103.7 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.0 149.04 24.34 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.485 -1.384 . . . . 1.0 109.269 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -124.52 139.74 53.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.614 0.721 . . . . 1.0 111.151 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.39 -177.55 30.61 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 127.676 2.56 . . . . 1.0 108.701 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 p -145.96 108.28 4.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.601 -2.37 . . . . 1.0 104.601 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.54 43.54 28.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.24 1.016 . . . . 1.0 112.528 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p 49.57 38.55 15.02 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.67 1.988 . . . . 1.0 113.706 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.66 136.16 56.67 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -25.9 114.03 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.999 2.12 . . . . 1.0 113.431 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.87 -15.31 58.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 116.36 -1.781 . . . . 1.0 113.908 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.351 28.7 p 65.59 77.06 0.31 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.862 1.664 . . . . 1.0 111.668 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -23.22 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.069 1.748 . . . . 1.0 113.993 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.0 -38.91 3.77 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.65 1.98 . . . . 1.0 110.442 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -49.39 -51.9 31.98 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.268 1.427 . . . . 1.0 109.643 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.8 -42.08 96.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.029 0.932 . . . . 1.0 110.207 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -65.66 -51.6 58.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.089 0.955 . . . . 1.0 110.353 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -65.97 -43.62 87.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.669 0.788 . . . . 1.0 110.679 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 115' ' ' ILE . 10.4 tp -55.38 -51.53 66.51 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.74 67.78 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.316 0.962 . . . . 1.0 111.488 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.47 56.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.127 0.971 . . . . 1.0 110.787 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.22 -51.27 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.3 m -54.63 -36.7 64.78 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.659 1.583 . . . . 1.0 111.882 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -60.68 -46.67 89.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.884 1.674 . . . . 1.0 109.462 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.79 62.84 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-O 119.412 -0.327 . . . . 1.0 110.871 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.91 -39.09 71.13 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.02 -45.02 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.426 1.012 . . . . 1.0 108.916 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.7 m -65.76 -19.13 65.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.217 0.607 . . . . 1.0 111.182 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -84.16 -63.22 1.38 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.931 1.292 . . . . 1.0 107.858 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -126.06 112.98 24.14 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.57 107.94 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 120.237 1.12 . . . . 1.0 111.724 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.25 -52.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.387 1.875 . . . . 1.0 107.39 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 mt -45.98 -33.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 131.146 3.778 . . . . 1.0 111.061 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.86 -26.03 9.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.673 1.189 . . . . 1.0 112.987 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -136.32 23.67 3.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.359 1.863 . . . . 1.0 109.755 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -138.51 83.6 1.97 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -127.24 120.85 29.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.09 -1.818 . . . . 1.0 106.09 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.2 t -154.53 -170.48 3.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.77 -131.58 1.76 Allowed Glycine 0 CA--C 1.517 0.181 0 N-CA-C 106.818 -2.513 . . . . 1.0 106.818 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 10.8 m170 -113.53 -22.97 10.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.069 1.434 . . . . 1.0 111.576 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.0 t -103.23 -8.55 20.29 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -89.04 28.25 1.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.737 1.215 . . . . 1.0 109.147 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.469 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.75 -14.87 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 121.389 -0.82 . . . . 1.0 110.45 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.67 -53.54 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.683 . . . . 1.0 112.582 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.43 108.63 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.91 1.718 . . . . 1.0 111.385 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.02 -14.61 55.5 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.875 -1.141 . . . . 1.0 113.117 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.66 -6.3 36.0 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.156 -1.59 . . . . 1.0 111.601 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -136.93 141.05 42.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.875 -1.898 . . . . 1.0 105.875 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 3.1 m -132.78 -16.78 2.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.862 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.84 -178.87 0.34 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.39 63.27 7.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.304 2.002 . . . . 1.0 109.102 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 141.28 74.57 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.123 1.821 . . . . 1.0 111.653 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.13 -98.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 1.0 110.837 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.4 t 53.84 43.86 30.35 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.801 1.64 . . . . 1.0 112.533 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -106.32 18.45 21.98 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.054 0.942 . . . . 1.0 110.387 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.296 9.3 t0 42.95 82.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.866 2.467 . . . . 1.0 112.355 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -55.4 -34.95 64.83 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.55 -0.75 . . . . 1.0 112.821 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.09 -45.98 79.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.573 -0.727 . . . . 1.0 110.647 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -58.93 -56.78 17.89 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.846 0.748 . . . . 1.0 110.12 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -59.08 -53.24 60.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -61.52 -33.79 74.43 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.403 -0.808 . . . . 1.0 111.906 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.47 86.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.695 0.68 . . . . 1.0 111.818 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.14 -51.92 27.63 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.523 0.729 . . . . 1.0 110.37 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.6 166.41 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.381 1.073 . . . . 1.0 108.335 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 m . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 126.281 1.832 . . . . 1.0 109.334 176.071 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--O 1.235 0.304 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.98 170.89 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.632 1.173 . . . . 1.0 110.661 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 40.58 58.38 2.38 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.182 1.793 . . . . 1.0 111.221 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.76 156.34 38.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.644 1.578 . . . . 1.0 110.112 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -78.4 130.05 35.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.12 140.34 45.75 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.183 -0.948 . . . . 1.0 110.265 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -142.74 71.84 19.82 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.479 -1.674 . . . . 1.0 106.479 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.6 123.2 9.91 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 N-CA-C 107.784 -1.66 . . . . 1.0 107.784 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -121.85 132.09 24.3 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.98 52.97 4.53 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.189 1.926 . . . . 1.0 111.177 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -124.13 43.11 3.08 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE2' HG22 ' A' ' 88' ' ' VAL . 95.7 m-85 -75.24 178.21 5.95 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.076 0.465 . . . . 1.0 110.045 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.73 -178.25 4.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 1.0 108.51 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.5 m -154.95 131.36 10.46 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 128.623 2.769 . . . . 1.0 103.674 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -130.55 140.05 37.5 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.791 1.632 . . . . 1.0 109.628 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.05 40.19 0.85 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.36 3.374 . . . . 1.0 116.84 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.24 149.78 44.73 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.293 2.637 . . . . 1.0 108.834 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -151.61 120.13 6.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.936 1.694 . . . . 1.0 111.682 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.62 172.74 12.56 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -64.69 123.82 84.42 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.58 103.6 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.768 1.645 . . . . 1.0 110.706 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -170.83 77.16 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.711 -1.588 . . . . 1.0 106.711 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.16 124.34 12.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.54 126.08 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.87 134.26 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.3 t -131.76 123.78 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -176.56 150.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.116 1.766 . . . . 1.0 107.884 175.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.5 112.61 24.6 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 26.3 mm -127.65 176.78 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 128.024 2.53 . . . . 1.0 105.067 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -151.09 122.22 7.72 Favored 'General case' 0 C--N 1.313 -0.995 1 N-CA-C 94.003 -6.295 . . . . 1.0 94.003 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.318 0.2 OUTLIER -142.66 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 119.827 1.194 . . . . 1.0 110.427 175.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.36 153.47 27.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.041 1.828 . . . . 1.0 112.042 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -82.0 53.61 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.673 2.916 . . . . 1.0 114.232 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.72 -70.81 0.65 Allowed Glycine 0 CA--C 1.535 1.317 0 N-CA-C 108.269 -1.932 . . . . 1.0 108.269 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -155.82 123.09 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.221 2.609 . . . . 1.0 106.549 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -169.73 173.44 6.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.956 2.902 . . . . 1.0 105.913 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.8 31.37 2.48 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.674 1.607 . . . . 1.0 109.298 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 118.9 6.28 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 107.605 -2.198 . . . . 1.0 107.605 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.34 -9.62 26.3 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-N 120.842 2.321 . . . . 1.0 113.339 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -65.52 -47.43 75.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.802 1.183 . . . . 1.0 109.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 mm -59.22 -43.84 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.799 0.84 . . . . 1.0 109.668 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.28 -46.36 90.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.267 0.627 . . . . 1.0 111.462 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.15 -33.8 67.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.135 1.374 . . . . 1.0 111.677 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.68 -57.07 12.32 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.196 -0.94 . . . . 1.0 109.352 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -42.98 85.86 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.528 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -66.4 -35.4 80.22 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.475 0.58 . . . . 1.0 110.59 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.46 60.23 1.11 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.373 1.94 . . . . 1.0 112.103 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 p -136.58 8.85 3.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.201 1.8 . . . . 1.0 111.588 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.34 134.78 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.116 0.966 . . . . 1.0 112.508 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 136.64 20.33 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.668 2.787 . . . . 1.0 108.834 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.63 69.74 1.55 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.216 3.278 . . . . 1.0 112.435 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -103.35 -56.64 2.18 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.659 0.784 . . . . 1.0 110.966 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.47 -55.04 36.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.979 0.512 . . . . 1.0 111.321 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.4 p80 -171.08 177.89 0.88 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.149 1.779 . . . . 1.0 107.615 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -70.55 -43.39 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.866 1.71 . . . . 1.0 114.804 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -50.19 -54.76 18.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.577 1.08 . . . . 1.0 113.475 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.0 -52.93 63.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.964 0.802 . . . . 1.0 111.118 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.51 98.3 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.465 0.706 . . . . 1.0 111.904 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.93 -57.69 17.04 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.283 0.944 . . . . 1.0 110.94 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.79 -27.33 42.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-O 115.964 -1.97 . . . . 1.0 112.99 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.83 -43.26 2.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.153 1.781 . . . . 1.0 114.489 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -57.58 -43.36 84.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.031 1.333 . . . . 1.0 111.116 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.6 127.37 32.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' H ' ' HD3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.53 148.55 51.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.382 176.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.86 163.19 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.064 2.146 . . . . 1.0 109.843 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.508 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -172.33 133.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.872 2.469 . . . . 1.0 106.27 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.46 -154.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.137 1.375 . . . . 1.0 107.461 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 55.8 m80 -132.48 -59.21 0.92 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.95 1.3 . . . . 1.0 108.999 175.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.773 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.4 m -136.88 118.73 15.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.096 -1.446 . . . . 1.0 107.096 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -102.48 113.85 27.54 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.82 122.89 53.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -89.8 156.65 18.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.853 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -22.66 2.58 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 126.967 2.107 . . . . 1.0 113.533 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -91.75 19.75 6.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.915 1.686 . . . . 1.0 113.699 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.16 35.8 91.39 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.614 1.578 . . . . 1.0 112.821 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.43 109.25 22.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.16 113.45 19.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 105.263 -2.125 . . . . 1.0 105.263 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -111.81 147.8 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.295 1.438 . . . . 1.0 107.306 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.2 120.24 29.55 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.386 1.074 . . . . 1.0 109.618 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.44 129.97 53.3 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.255 64.3 t 63.75 91.46 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 121.498 1.953 . . . . 1.0 113.76 175.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.7 Cg_exo -58.89 -169.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.394 3.396 . . . . 1.0 116.387 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.85 24.15 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.012 2.525 . . . . 1.0 110.487 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 89' ' ' PRO . 2.7 t70 -144.57 119.47 9.95 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.469 2.707 . . . . 1.0 107.855 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.308 3.4 ttmp? 85.96 81.48 0.02 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.877 1.671 . . . . 1.0 111.717 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -34.89 145.16 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.973 2.509 . . . . 1.0 111.942 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -122.12 172.4 8.28 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.258 1.423 . . . . 1.0 110.104 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.523 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 62.4 t90 -141.63 119.19 11.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.897 1.679 . . . . 1.0 109.722 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -159.38 63.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.151 0.977 . . . . 1.0 109.255 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.73 -70.74 0.03 OUTLIER 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.66 -1.9 . . . . 1.0 114.657 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.43 -91.02 0.48 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 105.834 -2.907 . . . . 1.0 105.834 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.2 t -144.44 146.46 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.92 1.86 . . . . 1.0 108.551 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -156.56 166.54 33.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.431 1.492 . . . . 1.0 108.924 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 157' ' ' ILE . 54.6 p -151.65 146.13 25.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -162.62 148.69 12.63 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 49.6 54.57 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.415 1.486 . . . . 1.0 110.83 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.04 29.45 62.37 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.995 1.283 . . . . 1.0 114.471 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.18 113.93 12.55 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.483 -1.302 . . . . 1.0 107.483 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -78.95 146.46 33.45 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.368 -1.345 . . . . 1.0 107.368 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -133.42 118.16 18.08 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.752 -1.944 . . . . 1.0 105.752 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.85 -40.24 96.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.286 0.634 . . . . 1.0 112.52 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.523 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 4.0 m120 -149.18 174.94 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.492 2.317 . . . . 1.0 106.979 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -89.85 75.05 7.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.359 1.552 . . . . 1.0 110.501 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 37.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 109.093 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -123.55 157.28 34.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.939 2.896 . . . . 1.0 109.819 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.277 0.1 OUTLIER -104.62 56.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.266 1.426 . . . . 1.0 108.096 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.79 -136.09 0.9 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-O 122.86 1.256 . . . . 1.0 112.163 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 76' ' ' CYS . 8.6 mm -150.28 161.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 130.497 3.519 . . . . 1.0 104.236 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.79 128.61 17.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 103.334 -2.839 . . . . 1.0 103.334 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.4 154.34 19.74 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -124.1 138.66 54.41 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.547 0.739 . . . . 1.0 111.859 -175.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.08 174.09 45.3 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.769 0.649 . . . . 1.0 112.613 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 p -133.92 97.09 3.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.044 2.137 . . . . 1.0 107.157 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.322 25.0 t0 46.62 56.74 6.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.251 1.82 . . . . 1.0 114.102 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.2 p 55.39 38.82 30.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.366 1.466 . . . . 1.0 112.563 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.57 133.95 53.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 104.956 -2.238 . . . . 1.0 104.956 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.12 113.45 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.212 2.205 . . . . 1.0 110.839 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -78.85 -11.61 60.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 115.14 -2.362 . . . . 1.0 116.679 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.349 18.2 p 59.57 77.86 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 121.662 2.028 . . . . 1.0 111.156 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -23.06 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.12 2.168 . . . . 1.0 114.593 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.31 -38.48 2.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.499 2.32 . . . . 1.0 109.433 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -53.8 -49.96 67.16 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 125.382 1.473 . . . . 1.0 110.688 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -56.48 -40.46 74.96 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.52 1.055 . . . . 1.0 109.668 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.72 -58.22 6.21 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.244 -0.408 . . . . 1.0 110.097 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -66.45 -37.99 86.37 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -60.63 -47.06 87.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.84 80.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.036 0.835 . . . . 1.0 110.858 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -53.75 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.072 0.949 . . . . 1.0 111.21 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 115' ' ' ILE . 64.8 t -58.04 -41.0 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.1 m -57.09 -46.28 82.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.272 . . . . 1.0 109.647 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.21 -48.19 82.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.53 1.059 . . . . 1.0 110.277 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.94 -48.6 81.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.172 0.589 . . . . 1.0 110.028 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -55.88 -46.86 78.21 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.873 1.269 . . . . 1.0 111.029 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.88 -42.22 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 118.858 0.754 . . . . 1.0 110.346 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.3 m -65.57 -13.91 59.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.178 0.991 . . . . 1.0 111.524 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -106.24 -54.02 2.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.496 1.518 . . . . 1.0 111.016 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -126.24 113.25 23.7 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 104.383 -2.451 . . . . 1.0 104.383 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -99.22 107.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.029 1.403 . . . . 1.0 114.554 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.27 -48.35 0.1 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.679 2.391 . . . . 1.0 107.642 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -46.19 -34.28 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 130.111 3.364 . . . . 1.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.86 -23.19 6.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.054 1.341 . . . . 1.0 114.275 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -137.18 18.42 2.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.719 1.607 . . . . 1.0 110.657 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -139.08 83.65 1.96 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.732 1.213 . . . . 1.0 108.213 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 114.1 21.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.036 -2.579 . . . . 1.0 104.036 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -151.08 -166.35 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.525 -0.734 . . . . 1.0 109.219 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.11 -131.79 1.5 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 108.66 -1.776 . . . . 1.0 108.66 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 11.4 m170 -109.01 -23.59 11.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 117.902 0.851 . . . . 1.0 111.066 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.28 -14.38 15.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.486 -0.769 . . . . 1.0 110.647 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -87.74 40.54 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.777 1.171 . . . . 1.0 109.158 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -66.27 -8.76 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 O-C-N 120.684 -1.26 . . . . 1.0 110.869 175.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -164.24 -53.79 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 127.953 2.501 . . . . 1.0 111.857 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 57.0 Cg_endo -91.14 115.42 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.978 3.119 . . . . 1.0 113.618 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.23 -25.58 64.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.765 1.226 . . . . 1.0 113.124 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -63.65 -20.28 65.57 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.88 -1.137 . . . . 1.0 113.324 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -123.12 140.76 52.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.464 -2.05 . . . . 1.0 105.464 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.0 m -136.01 -16.73 1.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.546 -0.862 . . . . 1.0 111.508 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.43 177.95 0.47 Allowed Pre-proline 0 CA--C 1.546 0.805 1 C-N-CA 131.808 4.043 . . . . 1.0 103.53 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.05 86.93 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.517 1.478 . . . . 1.0 109.353 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.32 81.12 1.25 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.863 1.221 . . . . 1.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.72 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.154 2.57 . . . . 1.0 112.187 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 t 55.52 43.93 27.64 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.907 1.283 . . . . 1.0 114.08 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' A' ' 33' ' ' VAL . 87.9 t80 -115.33 17.82 16.36 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 120.203 1.365 . . . . 1.0 113.755 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.6 t0 43.91 69.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 1.0 112.206 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -56.37 -32.87 65.18 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.759 -0.638 . . . . 1.0 112.334 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -60.25 2.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.657 0.783 . . . . 1.0 110.605 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -41.81 96.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-O 118.13 -0.938 . . . . 1.0 110.574 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -59.81 -57.55 12.42 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 123.876 0.735 . . . . 1.0 110.737 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -40.71 75.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.71 0.686 . . . . 1.0 111.222 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.07 77.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.16 0.8 . . . . 1.0 113.16 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.25 -43.55 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.6 1.16 . . . . 1.0 113.036 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.87 166.63 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.186 1.794 . . . . 1.0 110.797 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 70.6 m . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 125.679 1.592 . . . . 1.0 108.263 175.522 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 119.119 -0.467 . . . . 1.0 110.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.29 27.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.208 1.003 . . . . 1.0 112.148 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 38.88 58.21 1.78 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.108 2.563 . . . . 1.0 112.057 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.85 136.06 17.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.263 -0.898 . . . . 1.0 109.104 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -73.11 123.46 23.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.364 -1.717 . . . . 1.0 106.364 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -92.92 118.87 31.63 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.536 -0.727 . . . . 1.0 110.855 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.52 72.25 20.79 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.29 1.036 . . . . 1.0 108.554 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.21 123.44 9.21 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.758 1.306 . . . . 1.0 109.904 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -87.32 114.17 57.4 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 106.379 -1.712 . . . . 1.0 106.379 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.52 55.86 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.676 2.251 . . . . 1.0 110.636 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -138.4 43.73 2.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.572 1.949 . . . . 1.0 109.437 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -73.65 178.35 4.8 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.083 1.142 . . . . 1.0 114.083 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.63 179.1 4.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 128.857 2.863 . . . . 1.0 109.805 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -165.28 118.78 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.966 4.506 . . . . 1.0 102.94 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 156.46 77.75 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.27 84.72 1.9 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.312 2.008 . . . . 1.0 111.696 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.1 145.26 16.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.329 1.852 . . . . 1.0 106.685 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -137.51 103.58 5.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.371 -1.344 . . . . 1.0 107.371 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -136.2 152.86 51.22 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.743 1.217 . . . . 1.0 108.677 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -71.98 123.41 89.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 103.271 -2.862 . . . . 1.0 103.271 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.5 106.16 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.416 2.077 . . . . 1.0 112.512 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 t -164.32 76.35 0.33 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.37 123.72 11.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.99 -1.856 . . . . 1.0 105.99 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.54 127.61 39.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.193 0.997 . . . . 1.0 108.474 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.47 140.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.9 t -135.86 113.94 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.847 -2.279 . . . . 1.0 104.847 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -163.16 129.85 3.41 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 115.944 -1.979 . . . . 1.0 108.194 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -72.69 112.52 8.82 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 117.443 -1.703 . . . . 1.0 106.746 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.484 HG13 ' CE1' ' A' ' 34' ' ' HIS . 14.4 mm -126.73 176.77 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 131.646 3.979 . . . . 1.0 108.587 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.3 t -160.68 121.84 2.98 Favored 'General case' 0 C--O 1.247 0.973 1 N-CA-C 94.992 -5.929 . . . . 1.0 94.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.253 1.3 tm? -142.4 -57.37 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 121.032 -1.042 . . . . 1.0 111.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 77' ' ' LEU . 2.9 Cg_exo -76.16 144.26 26.4 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 122.674 2.249 . . . . 1.0 111.075 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.09 44.11 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.335 2.69 . . . . 1.0 114.657 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.18 -71.19 0.57 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -156.13 122.94 5.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.614 1.566 . . . . 1.0 111.234 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.318 18.8 m-85 -177.06 170.94 2.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 131.361 3.864 . . . . 1.0 109.619 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.08 27.28 7.12 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.434 1.016 . . . . 1.0 111.628 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.37 118.56 5.35 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 108.726 -1.75 . . . . 1.0 108.726 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.59 -15.81 48.78 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 120.096 1.948 . . . . 1.0 112.621 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -49.79 -47.85 50.95 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.513 1.125 . . . . 1.0 112.576 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.39 -45.09 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.96 -43.97 94.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.12 -35.63 69.69 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.09 1.356 . . . . 1.0 111.489 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.89 -55.33 17.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 120.945 -1.097 . . . . 1.0 110.039 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.04 -43.03 79.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.87 -0.585 . . . . 1.0 111.893 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -65.84 -33.83 76.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.286 1.434 . . . . 1.0 109.994 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.57 -2.64 30.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.567 1.555 . . . . 1.0 115.163 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -88.81 9.93 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.75 2.275 . . . . 1.0 114.12 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 tt -47.68 129.55 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.274 1.829 . . . . 1.0 112.1 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.74 125.52 42.13 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 130.473 3.509 . . . . 1.0 108.957 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.38 75.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.494 3.462 . . . . 1.0 108.412 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -103.63 -64.23 1.11 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.441 0.297 . . . . 1.0 111.618 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.02 -52.01 65.74 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.98 0.912 . . . . 1.0 112.086 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 25.8 p80 -161.92 177.9 1.8 Allowed Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.561 1.545 . . . . 1.0 107.805 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 29.2 Cg_endo -74.33 -43.43 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.823 1.682 . . . . 1.0 114.342 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -48.46 -43.65 34.81 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.118 0.967 . . . . 1.0 113.586 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -57.52 -55.6 32.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.839 0.856 . . . . 1.0 110.275 -175.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.751 0.82 . . . . 1.0 110.697 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.65 -62.56 2.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.81 1.672 . . . . 1.0 111.536 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.1 pt -57.69 -35.54 51.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 116.752 -1.594 . . . . 1.0 112.76 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.0 -43.02 3.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.622 1.969 . . . . 1.0 115.735 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.26 -36.24 70.75 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.555 1.142 . . . . 1.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.03 136.76 33.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 102.502 -3.147 . . . . 1.0 102.502 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 155.81 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.622 -1.298 . . . . 1.0 109.14 175.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.47 155.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 123.593 0.757 . . . . 1.0 109.037 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 4.3 m -177.79 114.12 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.836 1.654 . . . . 1.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.96 -175.4 3.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.473 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 21.1 m80 -112.47 -76.85 0.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.977 1.262 . . . . 1.0 110.906 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.4 m -112.57 118.51 35.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 39' ' ' PRO . 13.6 tp -101.26 113.44 26.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 103.605 -2.739 . . . . 1.0 103.605 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mt -105.98 113.22 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 103.852 -2.647 . . . . 1.0 103.852 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -81.59 153.79 26.53 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.772 0.714 . . . . 1.0 110.57 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.64 -13.5 0.4 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 126.229 1.812 . . . . 1.0 113.941 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -91.65 18.31 7.66 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.37 0.986 . . . . 1.0 111.241 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.34 45.35 96.63 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.115 -1.616 . . . . 1.0 111.601 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -112.97 143.96 43.36 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.91 114.32 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.28 142.74 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.522 -1.659 . . . . 1.0 106.522 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -126.22 114.44 18.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.947 0.899 . . . . 1.0 110.467 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -110.06 147.09 34.24 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 103.25 -2.87 . . . . 1.0 103.25 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.274 42.4 t 63.1 91.78 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 120.304 1.411 . . . . 1.0 114.362 175.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.21 -174.29 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 121.404 1.402 . . . . 1.0 111.985 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -72.87 49.92 0.25 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.781 1.233 . . . . 1.0 109.941 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -161.13 136.14 7.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.766 2.827 . . . . 1.0 105.33 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 54.78 81.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 129.376 3.07 . . . . 1.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.05 152.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.659 2.384 . . . . 1.0 111.545 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -102.83 -178.08 3.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.423 2.289 . . . . 1.0 111.055 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -149.88 118.4 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.855 1.262 . . . . 1.0 108.919 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -160.92 62.75 0.29 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.967 1.365 . . . . 1.0 110.209 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.95 -69.34 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 119.839 -1.788 . . . . 1.0 113.044 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 -90.89 0.51 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 103.246 -3.941 . . . . 1.0 103.246 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.94 142.15 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.742 1.271 . . . . 1.0 110.065 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -155.93 165.8 35.38 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.667 2.387 . . . . 1.0 108.066 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -159.81 126.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.972 -2.233 . . . . 1.0 104.972 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -151.52 151.13 31.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.718 1.145 . . . . 1.0 107.999 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 42.12 66.72 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.669 1.588 . . . . 1.0 109.75 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.31 29.53 5.2 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.81 1.672 . . . . 1.0 116.681 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -137.98 113.8 9.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.759 1.78 . . . . 1.0 106.835 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -80.91 146.37 30.83 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.574 1.15 . . . . 1.0 108.417 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -129.57 118.13 21.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.94 -24.49 63.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.98 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -152.98 176.26 12.06 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 128.623 2.769 . . . . 1.0 107.369 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.14 76.29 6.92 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.149 -1.426 . . . . 1.0 107.149 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -92.86 33.58 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.862 0.865 . . . . 1.0 112.392 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 m -124.53 156.51 37.22 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 125.508 1.523 . . . . 1.0 111.815 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.85 56.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.221 1.808 . . . . 1.0 107.713 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 -136.79 2.45 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.417 -0.802 . . . . 1.0 111.978 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 133' ' ' LEU . 9.3 mm -140.13 165.19 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.191 -2.522 . . . . 1.0 104.191 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 123.95 12.19 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.443 -2.799 . . . . 1.0 103.443 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 128.06 48.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.802 -1.186 . . . . 1.0 109.034 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.35 142.74 33.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.038 0.923 . . . . 1.0 111.929 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.39 178.64 32.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.52 2.01 . . . . 1.0 111.242 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -148.29 101.77 3.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.6 t0 51.4 54.56 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 124.032 1.872 . . . . 1.0 112.389 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 49.69 38.5 15.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.446 1.898 . . . . 1.0 114.269 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 124' ' ' ALA . 4.2 tt -72.63 145.87 47.01 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 104.932 -2.247 . . . . 1.0 104.932 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.49 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -39.32 125.53 1.66 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.327 1.851 . . . . 1.0 111.777 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.4 -10.84 59.89 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 115.285 1.587 . . . . 1.0 115.285 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.381 26.6 p 62.47 77.5 0.33 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 121.592 1.996 . . . . 1.0 111.968 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -23.5 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.158 2.183 . . . . 1.0 114.667 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.96 -40.14 4.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.425 2.29 . . . . 1.0 111.095 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.27 -57.87 4.73 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.788 0.835 . . . . 1.0 109.613 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.68 -39.36 80.46 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.229 0.611 . . . . 1.0 111.593 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -65.82 -59.24 4.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.216 0.322 . . . . 1.0 110.166 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -66.0 -34.27 77.72 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.757 0.708 . . . . 1.0 112.082 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 36.8 tp -57.51 -48.08 80.22 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.46 85.79 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.075 0.852 . . . . 1.0 109.819 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 -53.13 44.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.585 1.154 . . . . 1.0 111.046 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.19 -48.31 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.19 0.596 . . . . 1.0 110.121 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.7 m -53.25 -45.5 68.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.154 1.381 . . . . 1.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.32 -42.38 98.59 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.2 1.0 . . . . 1.0 110.54 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.19 -49.08 78.63 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.064 0.545 . . . . 1.0 110.194 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.94 -44.59 78.55 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.418 -0.801 . . . . 1.0 111.784 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.66 -40.23 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.187 0.903 . . . . 1.0 109.868 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.4 m -63.2 -27.67 69.52 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.885 0.874 . . . . 1.0 111.294 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.42 -60.58 2.03 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.138 0.975 . . . . 1.0 109.435 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -126.54 112.9 22.99 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.866 1.666 . . . . 1.0 106.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.61 107.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 120.912 1.361 . . . . 1.0 111.421 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.07 -45.09 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.99 2.116 . . . . 1.0 108.296 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.8 mt -44.91 -33.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.44 0 C-N-CA 130.666 3.587 . . . . 1.0 110.988 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.67 -26.19 13.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.373 1.069 . . . . 1.0 113.441 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.62 18.36 5.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.849 2.06 . . . . 1.0 110.873 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -138.45 83.3 1.96 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 119.866 -1.771 . . . . 1.0 106.363 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.4 mtt -126.42 118.07 24.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 102.876 -3.009 . . . . 1.0 102.876 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 t -157.66 -165.52 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.21 -131.57 1.25 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 106.798 -2.521 . . . . 1.0 106.798 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.528 ' HE1' ' CE1' ' A' ' 34' ' ' HIS . 12.2 m170 -114.34 -23.26 9.49 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.475 1.137 . . . . 1.0 111.964 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 15.9 t -103.02 -4.3 24.81 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.855 1.262 . . . . 1.0 108.448 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -97.91 23.15 8.34 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.156 1.382 . . . . 1.0 108.964 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.61 -15.74 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 121.171 -0.955 . . . . 1.0 110.618 -175.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -144.19 -66.06 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.882 1.673 . . . . 1.0 109.478 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 94.5 Cg_endo -77.63 119.89 4.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 CA-C-N 122.019 1.757 . . . . 1.0 112.473 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -70.79 0.63 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.643 0.777 . . . . 1.0 111.808 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -84.44 -25.62 28.85 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 119.556 -1.965 . . . . 1.0 113.442 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -129.29 140.65 51.35 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m -127.43 -16.53 4.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 124.352 1.033 . . . . 1.0 112.881 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.66 -179.14 0.36 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.244 2.218 . . . . 1.0 105.819 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.09 77.42 3.49 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.641 2.228 . . . . 1.0 111.073 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.92 76.59 0.94 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.587 1.565 . . . . 1.0 109.639 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.79 -72.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.338 2.692 . . . . 1.0 111.636 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.2 t 54.0 44.78 28.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.876 2.07 . . . . 1.0 111.343 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -93.65 17.87 11.05 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 43.4 t0 43.44 71.98 0.21 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.155 1.382 . . . . 1.0 110.542 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -58.38 -28.81 65.51 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.231 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -49.91 68.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.713 0.688 . . . . 1.0 110.631 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -64.9 -48.9 72.54 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.727 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.78 -53.31 58.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.237 0.926 . . . . 1.0 112.372 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -37.7 81.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.782 -0.628 . . . . 1.0 110.084 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.54 89.72 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.444 0.535 . . . . 1.0 112.444 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.74 -45.95 84.29 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.202 1.001 . . . . 1.0 111.737 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.79 165.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.911 1.284 . . . . 1.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 127.41 2.284 . . . . 1.0 109.58 176.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.35 9.38 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.581 0.753 . . . . 1.0 112.195 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 44.33 58.07 3.99 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.076 2.151 . . . . 1.0 110.087 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.6 22.05 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.01 0.924 . . . . 1.0 109.269 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -74.61 123.47 24.89 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.751 -1.574 . . . . 1.0 106.751 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 125.7 34.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.183 0.901 . . . . 1.0 108.651 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.95 76.13 59.62 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.67 130.05 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.511 2.141 . . . . 1.0 110.772 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -129.5 124.48 21.97 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 126.497 1.919 . . . . 1.0 106.918 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.83 52.74 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.384 2.723 . . . . 1.0 111.417 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -124.11 48.98 1.82 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.7 m-85 -73.8 178.28 4.95 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.332 1.453 . . . . 1.0 112.026 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.92 178.22 4.36 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 128.151 2.58 . . . . 1.0 116.445 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.0 m -156.23 121.49 4.77 Favored 'General case' 0 N--CA 1.446 -0.672 1 C-N-CA 132.938 4.495 . . . . 1.0 103.396 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -135.82 141.18 35.86 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 117.682 -1.151 . . . . 1.0 108.602 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.64 90.22 1.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 124.305 3.336 . . . . 1.0 111.003 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -171.86 154.48 3.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 131.391 3.877 . . . . 1.0 103.97 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -151.43 104.76 3.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 104.641 -2.355 . . . . 1.0 104.641 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.75 159.78 40.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.752 1.621 . . . . 1.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.25 123.54 84.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 118.843 0.747 . . . . 1.0 109.495 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.37 103.6 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.768 1.645 . . . . 1.0 110.842 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -167.55 74.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.994 -1.066 . . . . 1.0 108.844 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.49 135.01 18.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.324 1.849 . . . . 1.0 107.627 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -87.54 133.03 33.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.6 141.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.993 -2.225 . . . . 1.0 104.993 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -136.03 118.89 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.999 -1.482 . . . . 1.0 106.999 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.9 p80 -176.23 144.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.474 1.51 . . . . 1.0 107.525 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.09 112.71 19.39 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 119.542 1.065 . . . . 1.0 110.066 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 10.3 mm -127.29 176.93 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.838 3.255 . . . . 1.0 108.95 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -159.55 122.77 3.63 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 95.714 -5.661 . . . . 1.0 95.714 174.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.288 1.8 tm? -142.63 -65.31 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 116.67 -1.633 . . . . 1.0 113.722 -175.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 15.0 Cg_endo -91.35 163.09 3.66 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 124.328 3.352 . . . . 1.0 112.788 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.91 72.75 6.01 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.632 2.888 . . . . 1.0 118.716 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.64 -73.07 0.93 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.758 -2.937 . . . . 1.0 105.758 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -156.82 122.74 4.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.568 1.547 . . . . 1.0 108.16 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -176.7 177.61 1.35 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.577 3.151 . . . . 1.0 107.464 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.72 22.98 10.45 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 109.319 -1.512 . . . . 1.0 109.319 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.81 118.52 5.16 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.205 -1.33 . . . . 1.0 111.179 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.88 -18.33 28.18 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.376 2.051 . . . . 1.0 113.035 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -53.88 -36.37 62.59 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.088 0.858 . . . . 1.0 110.51 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mt -65.44 -44.71 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.456 -0.783 . . . . 1.0 109.614 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.05 -52.21 51.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.183 0.901 . . . . 1.0 110.351 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -51.34 -34.07 32.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.303 1.441 . . . . 1.0 112.475 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -62.58 -61.45 2.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.622 1.569 . . . . 1.0 111.188 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -70.92 -39.32 72.78 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.537 -0.744 . . . . 1.0 112.063 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.16 -36.63 83.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.271 1.028 . . . . 1.0 109.008 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.92 1.93 39.4 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 117.487 -1.729 . . . . 1.0 115.965 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -88.81 8.52 28.62 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.662 2.231 . . . . 1.0 113.193 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.7 128.58 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.361 1.464 . . . . 1.0 112.168 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.91 136.4 20.63 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 128.174 2.59 . . . . 1.0 109.409 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.56 79.16 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.518 2.812 . . . . 1.0 109.04 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.1 -60.1 1.6 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.189 0.596 . . . . 1.0 110.723 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.44 77.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.429 0.691 . . . . 1.0 109.841 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.0 p80 -171.2 178.09 0.84 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.683 2.393 . . . . 1.0 106.898 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.6 Cg_endo -71.73 -43.45 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.436 2.091 . . . . 1.0 115.53 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -44.18 -50.89 8.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -58.65 6.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.145 1.378 . . . . 1.0 110.615 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.62 -43.41 96.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.892 0.877 . . . . 1.0 111.959 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.13 -61.63 6.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.234 1.397 . . . . 1.0 111.555 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.72 -42.19 91.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.012 -0.994 . . . . 1.0 111.874 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -39.63 -43.75 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 116.924 2.194 . . . . 1.0 116.924 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.35 -34.33 73.7 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.721 -0.612 . . . . 1.0 109.714 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.57 135.89 34.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 101.183 -3.636 . . . . 1.0 101.183 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -52.71 144.58 13.81 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.601 -0.687 . . . . 1.0 110.992 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.83 162.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.207 1.803 . . . . 1.0 107.307 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.07 114.24 0.09 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.595 0.758 . . . . 1.0 109.159 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.58 -176.7 3.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.4 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.6 m80 -111.53 -76.31 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.986 0.812 . . . . 1.0 112.977 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -118.3 118.34 31.55 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 104.896 -2.261 . . . . 1.0 104.896 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tp -103.12 113.58 27.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.165 -2.161 . . . . 1.0 105.165 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.97 113.56 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -71.3 144.93 49.8 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -13.76 3.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 119.272 0.942 . . . . 1.0 113.151 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.32 26.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.889 2.476 . . . . 1.0 112.483 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.14 71.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.112 1.815 . . . . 1.0 114.535 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.32 156.3 17.32 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.839 . . . . 1.0 110.243 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mt -115.88 115.7 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 100.713 -3.81 . . . . 1.0 100.713 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.91 143.03 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.48 120.97 37.44 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.47 117.62 31.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 128.642 2.777 . . . . 1.0 106.205 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' A' ' 19' ' ' TYR . 44.4 t 68.2 92.06 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 120.847 1.658 . . . . 1.0 113.938 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.91 -178.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 121.575 1.517 . . . . 1.0 110.553 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -59.37 30.42 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 130.159 3.384 . . . . 1.0 116.495 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.15 116.01 6.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.537 2.335 . . . . 1.0 108.722 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.295 27.6 ttmt 83.2 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.631 1.972 . . . . 1.0 111.461 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -35.95 159.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 130.911 3.684 . . . . 1.0 116.599 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -113.17 -178.63 3.43 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 129.384 3.074 . . . . 1.0 114.139 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -155.07 118.59 4.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.628 1.571 . . . . 1.0 108.642 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -159.55 63.13 0.38 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.067 0.937 . . . . 1.0 110.361 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.34 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 119.11 -2.244 . . . . 1.0 114.561 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.79 -91.27 0.9 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.191 -3.163 . . . . 1.0 105.191 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 t -127.95 133.85 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.662 1.231 . . . . 1.0 109.407 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 p -160.35 159.06 30.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.84 2.056 . . . . 1.0 108.72 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 157' ' ' ILE . 33.9 p -152.03 147.07 26.07 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.542 1.137 . . . . 1.0 111.45 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -148.88 144.8 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 38.91 53.99 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.761 2.024 . . . . 1.0 112.354 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.41 67.9 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.293 0.949 . . . . 1.0 114.838 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -128.85 113.52 15.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 103.576 -2.749 . . . . 1.0 103.576 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 11.8 tt0 -82.88 142.0 31.81 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.943 -1.873 . . . . 1.0 105.943 175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -102.94 118.53 37.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.04 -2.578 . . . . 1.0 104.04 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.95 -23.65 58.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.615 0.366 . . . . 1.0 110.653 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -146.52 175.15 10.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.533 2.333 . . . . 1.0 106.128 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.7 76.67 3.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.555 1.169 . . . . 1.0 109.313 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -88.54 45.19 1.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.979 1.712 . . . . 1.0 109.431 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -138.81 127.15 22.91 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 120.081 -1.637 . . . . 1.0 113.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.252 0.1 OUTLIER -78.74 56.7 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.732 2.013 . . . . 1.0 108.996 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.18 -136.51 3.74 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.12 163.61 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.209 -2.515 . . . . 1.0 104.209 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.81 117.8 9.43 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.764 -1.939 . . . . 1.0 105.764 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.23 131.07 34.48 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.808 -1.183 . . . . 1.0 110.195 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.0 tt0 -104.36 147.03 27.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.641 0.376 . . . . 1.0 111.776 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.43 173.38 33.6 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.978 1.275 . . . . 1.0 110.356 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -148.18 109.2 4.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 44.93 46.32 8.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.928 2.491 . . . . 1.0 112.671 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 50.62 38.19 18.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.621 1.969 . . . . 1.0 113.499 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.8 tp -68.27 146.55 53.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.688 1.995 . . . . 1.0 108.142 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -31.51 114.23 0.13 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 126.39 1.876 . . . . 1.0 111.812 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.42 -8.58 58.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 115.361 -2.257 . . . . 1.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.396 17.4 p 68.9 78.68 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 122.18 2.264 . . . . 1.0 113.374 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -22.8 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.949 2.159 . . . . 1.0 115.08 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.69 -42.91 7.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.628 2.371 . . . . 1.0 110.629 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -52.44 -51.46 59.09 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.154 0.888 . . . . 1.0 110.432 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -60.61 -39.71 89.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.574 -0.727 . . . . 1.0 109.877 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.13 -51.53 57.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.176 0.898 . . . . 1.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.48 -47.63 78.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.469 1.507 . . . . 1.0 110.393 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.2 tp -56.6 -50.53 71.71 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.33 1.052 . . . . 1.0 108.498 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.06 84.14 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.691 0.678 . . . . 1.0 110.284 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.98 48.78 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.186 0.594 . . . . 1.0 110.648 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.28 -41.78 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.896 0.771 . . . . 1.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.1 m -59.25 -56.79 17.67 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.997 1.319 . . . . 1.0 109.466 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.93 -43.65 77.59 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.939 0.896 . . . . 1.0 110.245 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.82 -50.7 63.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.975 0.51 . . . . 1.0 111.076 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.74 -37.44 71.01 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.487 -0.758 . . . . 1.0 111.378 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.04 -39.31 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.946 0.898 . . . . 1.0 110.057 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.5 m -57.96 -35.33 71.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.38 0.991 . . . . 1.0 111.217 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -83.45 -49.23 9.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -125.79 112.85 24.82 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 107.271 -1.381 . . . . 1.0 107.271 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.37 106.85 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.148 -1.52 . . . . 1.0 108.148 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.94 -55.62 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.797 1.639 . . . . 1.0 107.848 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.0 mt -48.86 -33.94 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.056 2.942 . . . . 1.0 110.329 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.88 -23.03 6.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.497 1.519 . . . . 1.0 113.744 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -137.76 20.73 2.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.985 2.514 . . . . 1.0 109.295 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.13 87.74 2.22 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.69 1.596 . . . . 1.0 106.888 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.5 mtt -136.5 117.6 14.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.16 1.784 . . . . 1.0 107.547 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.9 t -153.52 -176.37 5.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.466 1.485 . . . . 1.0 109.544 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.91 -131.62 2.73 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 107.279 -2.329 . . . . 1.0 107.279 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 22.7 m170 -115.72 -24.04 8.41 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.683 1.241 . . . . 1.0 112.415 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.5 t -103.73 -11.47 17.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.819 0.847 . . . . 1.0 109.024 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.9 OUTLIER -85.81 18.54 2.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.145 1.778 . . . . 1.0 110.31 -175.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.73 -18.99 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.918 0.887 . . . . 1.0 112.456 -175.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.1 -66.13 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.378 1.471 . . . . 1.0 108.54 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 83.2 Cg_endo -81.59 111.32 2.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.834 1.691 . . . . 1.0 111.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.06 -17.58 27.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.971 1.309 . . . . 1.0 111.915 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.83 -25.64 63.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.458 -1.401 . . . . 1.0 112.388 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -134.17 140.61 46.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.522 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 17.0 m -121.71 -16.6 7.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.001 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.08 -178.98 0.63 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 130.717 3.607 . . . . 1.0 104.561 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -78.49 51.27 3.68 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.621 2.214 . . . . 1.0 109.919 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.11 80.89 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.73 2.586 . . . . 1.0 108.485 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.98 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.583 2.189 . . . . 1.0 111.995 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.4 t 53.66 43.03 31.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.329 2.251 . . . . 1.0 112.808 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -122.27 17.94 10.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.259 0.936 . . . . 1.0 112.637 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.263 8.5 t0 41.78 70.56 0.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.583 1.553 . . . . 1.0 111.006 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -52.87 -30.43 33.86 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 121.27 -0.894 . . . . 1.0 111.448 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.57 51.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.461 -0.781 . . . . 1.0 110.162 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -60.46 -50.98 71.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 120.18 1.354 . . . . 1.0 112.008 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.72 -46.87 83.45 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.243 -0.983 . . . . 1.0 111.469 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -64.69 -31.3 72.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.716 0.689 . . . . 1.0 109.932 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -41.19 88.27 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 1.0 111.813 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.17 -55.09 8.88 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.416 1.486 . . . . 1.0 112.166 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.4 t -66.34 152.52 9.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 123.402 0.681 . . . . 1.0 109.845 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 124.722 1.209 . . . . 1.0 111.802 175.647 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 9' ' ' ALA . 6.5 tt . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -84.67 175.72 9.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.162 0.985 . . . . 1.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 39.19 58.4 1.87 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.718 1.207 . . . . 1.0 111.569 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.17 155.91 28.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.094 0.958 . . . . 1.0 108.98 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -78.08 123.35 26.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.41 125.54 33.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.337 -1.356 . . . . 1.0 107.337 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -140.32 79.09 21.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.14 123.69 11.93 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -65.4 145.89 99.02 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.695 -0.854 . . . . 1.0 108.695 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.03 -9.32 11.84 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.921 1.747 . . . . 1.0 116.131 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -144.02 135.92 26.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.386 -2.82 . . . . 1.0 103.386 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.546 ' CE2' HG22 ' A' ' 88' ' ' VAL . 7.2 m-85 -106.7 178.39 4.57 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.291 1.437 . . . . 1.0 108.769 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.79 178.79 4.86 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.248 1.499 . . . . 1.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.0 m -151.28 118.41 5.92 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.912 -2.255 . . . . 1.0 104.912 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -135.93 138.85 28.82 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 106.205 -1.776 . . . . 1.0 106.205 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.44 83.1 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.626 2.217 . . . . 1.0 109.395 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -163.56 149.05 11.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.047 1.739 . . . . 1.0 108.371 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -146.51 104.14 3.74 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.01 160.58 38.17 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 127.446 2.298 . . . . 1.0 107.339 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.51 123.41 88.39 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 106.478 -1.675 . . . . 1.0 106.478 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.93 103.54 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.436 1.424 . . . . 1.0 109.783 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -172.95 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 150' ' ' ASN . 4.5 tp -148.74 132.18 16.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.15 -2.167 . . . . 1.0 105.15 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -91.43 122.49 34.07 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.27 113.45 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 169' ' ' PHE . 15.3 t -110.35 114.22 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 105.675 -1.972 . . . . 1.0 105.675 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 2.8 p80 -165.92 137.22 3.75 Favored 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.11 112.59 19.95 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 105.67 -1.974 . . . . 1.0 105.67 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.323 6.6 mm -126.39 179.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 128.966 2.907 . . . . 1.0 106.146 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -149.58 121.91 8.43 Favored 'General case' 0 N--CA 1.432 -1.327 1 N-CA-C 99.207 -4.368 . . . . 1.0 99.207 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -143.31 -62.9 0.02 OUTLIER Pre-proline 0 C--O 1.254 1.325 0 CA-C-O 115.796 -2.05 . . . . 1.0 111.821 176.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.57 153.09 23.32 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 CA-C-N 123.564 2.308 . . . . 1.0 111.626 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.7 45.52 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.492 3.461 . . . . 1.0 114.69 -175.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.72 -71.8 0.43 Allowed Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.869 -0.962 . . . . 1.0 111.847 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -155.6 122.76 5.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.142 1.377 . . . . 1.0 107.369 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -163.12 166.66 23.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 128.426 2.691 . . . . 1.0 111.514 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.86 -22.65 7.51 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 117.875 -1.514 . . . . 1.0 113.342 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.24 136.77 13.97 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.426 1.613 . . . . 1.0 111.021 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.43 -4.42 14.66 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.42 2.747 . . . . 1.0 116.476 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -49.51 -49.46 45.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 121.653 2.024 . . . . 1.0 112.569 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 23.3 mm -66.23 -43.85 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.156 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.67 -44.55 96.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -56.72 -34.51 67.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.715 1.606 . . . . 1.0 111.987 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -62.05 2.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.801 1.24 . . . . 1.0 109.091 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -66.61 -53.59 32.63 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.545 1.138 . . . . 1.0 111.555 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -56.01 -33.51 64.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.765 1.226 . . . . 1.0 109.311 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.37 25.37 8.83 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 119.762 1.165 . . . . 1.0 114.356 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -115.09 9.91 16.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.983 1.313 . . . . 1.0 112.009 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.5 tt -51.7 126.18 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.652 1.181 . . . . 1.0 112.437 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -98.8 124.37 46.13 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.259 2.224 . . . . 1.0 107.758 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.3 70.41 3.16 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.895 3.064 . . . . 1.0 110.434 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -103.63 -63.71 1.16 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.487 0.715 . . . . 1.0 112.414 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.83 73.7 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.47 0.708 . . . . 1.0 111.391 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 31.3 p80 -164.31 177.98 1.59 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 107.072 -1.455 . . . . 1.0 107.072 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 69.5 Cg_endo -81.92 -43.52 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.329 1.353 . . . . 1.0 112.512 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -45.48 -42.2 10.38 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.243 1.417 . . . . 1.0 113.459 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -57.92 -54.26 48.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.55 1.14 . . . . 1.0 107.943 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.6 85.62 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.018 0.927 . . . . 1.0 110.59 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.94 -61.85 2.18 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 127.892 2.663 . . . . 1.0 111.02 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -59.02 -49.42 83.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-O 116.976 -1.488 . . . . 1.0 110.663 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.63 -43.3 0.4 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.584 2.753 . . . . 1.0 116.529 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -56.01 -41.39 74.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.359 1.076 . . . . 1.0 110.662 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.76 136.95 34.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.892 -2.262 . . . . 1.0 104.892 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 154.64 12.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.768 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.1 162.96 14.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 126.365 1.866 . . . . 1.0 111.681 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.303 2.241 . . . . 1.0 106.722 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.93 -153.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.68 1.592 . . . . 1.0 108.204 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -128.15 -58.9 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.66 1.184 . . . . 1.0 109.84 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.695 ' HB2' HD13 ' A' ' 115' ' ' ILE . 59.2 m -145.58 126.8 14.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.58 113.73 26.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 104.813 -2.291 . . . . 1.0 104.813 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 mt -94.08 121.34 44.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -75.14 144.6 42.72 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 123' ' ' LEU . 36.2 ptt-85 -49.01 -20.58 0.54 Allowed 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.564 1.946 . . . . 1.0 112.949 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -92.07 32.17 1.18 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 130.666 3.586 . . . . 1.0 113.154 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.66 28.41 67.87 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 119.991 -1.693 . . . . 1.0 116.515 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -98.81 145.15 27.25 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 119.194 1.497 . . . . 1.0 108.878 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.36 113.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.171 -1.788 . . . . 1.0 106.171 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.07 143.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -115.76 113.87 24.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -110.67 114.07 27.17 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 105.187 -2.153 . . . . 1.0 105.187 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 19' ' ' TYR . 74.5 t 71.39 91.37 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 121.71 2.05 . . . . 1.0 111.954 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.34 -166.93 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.093 1.862 . . . . 1.0 111.052 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -61.4 26.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 130.34 3.456 . . . . 1.0 116.918 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.27 134.86 19.77 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 121.247 1.84 . . . . 1.0 106.741 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 75.69 82.69 0.1 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.626 1.57 . . . . 1.0 111.504 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -43.96 145.28 0.74 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.333 1.853 . . . . 1.0 112.546 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -109.29 -178.59 3.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.206 2.202 . . . . 1.0 110.26 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -154.39 119.74 5.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.604 0.638 . . . . 1.0 111.051 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -157.21 64.46 0.5 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.058 1.409 . . . . 1.0 111.46 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.01 -57.96 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 117.953 -2.967 . . . . 1.0 111.286 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.91 -69.61 0.44 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.331 -1.908 . . . . 1.0 108.331 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -146.04 144.02 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.464 1.632 . . . . 1.0 109.544 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 p -165.71 162.83 18.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.738 1.215 . . . . 1.0 111.444 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 3.0 p -158.77 145.32 17.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 1.0 108.982 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -166.9 157.15 11.53 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.537 -1.221 . . . . 1.0 108.943 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 39.58 53.91 2.42 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.511 1.924 . . . . 1.0 112.3 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.36 29.82 53.94 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 114.885 -1.052 . . . . 1.0 113.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 tpt85 -131.71 116.72 17.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.081 1.441 . . . . 1.0 108.433 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 2.1 tt0 -78.51 146.49 34.32 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.474 -1.676 . . . . 1.0 106.474 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -126.01 117.97 24.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.387 -2.079 . . . . 1.0 105.387 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.86 -26.25 61.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.812 -1.085 . . . . 1.0 110.588 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -151.42 173.23 14.79 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.972 1.309 . . . . 1.0 108.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.49 75.64 6.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.205 1.479 . . . . 1.0 107.054 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.18 39.2 1.12 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.475 1.11 . . . . 1.0 109.769 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.9 m -140.02 124.26 17.83 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.471 -1.393 . . . . 1.0 113.205 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -78.46 57.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.545 2.338 . . . . 1.0 111.57 -175.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.26 -119.02 0.45 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.411 -1.475 . . . . 1.0 109.411 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.696 HD11 HG11 ' A' ' 136' ' ' VAL . 15.8 mm -149.01 165.56 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 130.234 3.413 . . . . 1.0 104.105 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -141.16 134.13 29.12 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.846 2.858 . . . . 1.0 104.129 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.4 164.24 11.87 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.355 -0.841 . . . . 1.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.37 150.79 50.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.207 0.603 . . . . 1.0 111.135 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.51 173.88 39.67 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.935 1.255 . . . . 1.0 110.734 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 p -151.01 110.53 4.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.635 -2.357 . . . . 1.0 104.635 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.5 t0 49.55 52.67 14.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 123.789 1.757 . . . . 1.0 112.507 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 47.83 37.98 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.373 2.669 . . . . 1.0 114.031 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 80' ' ' ARG . 7.7 tt -58.5 145.62 38.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.722 1.209 . . . . 1.0 107.744 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.434 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -44.87 120.72 2.44 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.268 1.027 . . . . 1.0 109.678 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.41 10.38 7.24 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 117.129 -1.415 . . . . 1.0 113.673 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.311 28.6 p 37.4 74.65 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 1 N-CA-C 123.667 4.691 . . . . 1.0 123.667 -174.121 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -17.19 -32.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.998 2.919 . . . . 1.0 114.918 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.34 -41.2 18.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.594 1.557 . . . . 1.0 109.387 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -49.56 -57.29 7.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.51 1.924 . . . . 1.0 109.299 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -56.34 -43.17 78.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.736 -0.65 . . . . 1.0 109.561 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -64.51 -57.06 10.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.652 0.66 . . . . 1.0 111.004 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 136' ' ' VAL . 43.3 mt-30 -65.77 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.974 -1.704 . . . . 1.0 111.516 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.662 HD13 HG21 ' A' ' 115' ' ' ILE . 7.3 tp -61.6 -46.43 89.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.609 1.095 . . . . 1.0 108.761 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.05 76.71 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.247 0.931 . . . . 1.0 109.187 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.33 52.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.856 0.753 . . . . 1.0 110.703 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.696 HG11 HD11 ' A' ' 115' ' ' ILE . 4.1 t -56.06 -46.03 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.092 -0.38 . . . . 1.0 110.044 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.9 m -59.21 -50.08 75.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.373 1.469 . . . . 1.0 109.838 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.15 -42.26 94.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.0 110.341 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.93 88.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.849 0.46 . . . . 1.0 112.054 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.36 -47.12 79.52 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.531 -0.747 . . . . 1.0 109.313 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.05 -37.27 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.166 0.986 . . . . 1.0 110.773 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.4 m -65.63 -14.07 60.42 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.071 0.949 . . . . 1.0 111.953 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -111.07 -50.83 2.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.391 1.45 . . . . 1.0 111.744 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -126.77 113.06 22.44 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -97.33 107.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.049 1.41 . . . . 1.0 110.198 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.95 -51.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.064 1.746 . . . . 1.0 106.405 175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 59.5 mt -46.71 -33.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 129.497 3.119 . . . . 1.0 110.999 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.25 -26.42 17.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.407 1.083 . . . . 1.0 113.621 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -135.69 18.15 3.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.705 2.002 . . . . 1.0 110.043 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.434 ' HB3' HD12 ' A' ' 30' ' ' LEU . 11.5 m120 -139.78 83.56 1.93 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.926 1.29 . . . . 1.0 108.068 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 64.5 mtt -120.29 126.71 51.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -167.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.546 1.067 . . . . 1.0 108.345 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.28 -130.88 1.32 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 105.508 -3.037 . . . . 1.0 105.508 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.406 ' HE1' ' CE1' ' A' ' 34' ' ' HIS 0.317 13.2 m170 -112.31 -22.99 10.62 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.325 0.861 . . . . 1.0 113.325 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 9.0 t -102.98 -11.13 18.4 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 118.568 -0.729 . . . . 1.0 109.287 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -89.42 43.05 1.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -71.63 -8.96 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 120.801 -1.187 . . . . 1.0 110.515 175.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -160.72 -53.92 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.669 2.388 . . . . 1.0 111.246 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 64.5 Cg_endo -91.52 111.96 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.097 1.865 . . . . 1.0 113.031 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.95 -25.38 63.46 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.965 -1.084 . . . . 1.0 112.281 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 20.4 ttp85 -71.27 -5.29 31.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.64 -1.287 . . . . 1.0 112.549 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 127.22 22.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 103.888 -2.634 . . . . 1.0 103.888 174.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.3 m -123.73 -16.21 6.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.289 0.95 . . . . 1.0 110.884 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.78 -178.75 0.34 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.216 2.607 . . . . 1.0 105.697 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.79 51.52 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.525 . . . . 1.0 112.96 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.34 76.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.158 1.361 . . . . 1.0 110.202 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.49 -74.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.373 2.049 . . . . 1.0 111.636 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.75 44.02 30.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.431 1.892 . . . . 1.0 111.206 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 33' ' ' VAL . 51.6 t80 -99.09 18.38 17.52 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.038 -1.039 . . . . 1.0 110.926 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.258 9.4 t0 44.17 70.52 0.32 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.388 1.475 . . . . 1.0 110.46 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -56.7 -29.12 62.07 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 120.669 -1.269 . . . . 1.0 110.311 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.4 -53.61 33.8 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.755 1.161 . . . . 1.0 111.994 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -65.93 -47.88 73.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 118.079 -0.962 . . . . 1.0 109.868 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.11 -55.63 31.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.123 0.874 . . . . 1.0 112.176 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -58.64 -36.6 74.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.795 -1.098 . . . . 1.0 109.8 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -45.1 80.82 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.471 1.107 . . . . 1.0 113.629 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.55 -46.08 84.38 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.087 0.955 . . . . 1.0 112.054 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.69 166.55 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.741 2.016 . . . . 1.0 110.082 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 1.0 109.457 175.5 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--O 1.24 0.577 0 N-CA-C 110.183 -0.303 . . . . 1.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.42 154.52 32.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 46.2 58.35 4.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.168 2.187 . . . . 1.0 113.59 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.77 134.73 15.73 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.182 -0.949 . . . . 1.0 111.334 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -71.65 123.18 21.96 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.428 -1.693 . . . . 1.0 106.428 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -92.88 123.93 36.5 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.638 -0.664 . . . . 1.0 110.42 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.45 67.29 75.82 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.333 1.453 . . . . 1.0 107.666 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.52 152.47 59.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.78 1.653 . . . . 1.0 110.071 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -154.1 114.96 2.54 Favored Pre-proline 0 CA--C 1.511 -0.554 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 90.8 Cg_endo -74.75 71.4 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.002 1.801 . . . . 1.0 109.261 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -133.85 43.03 2.89 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.073 2.949 . . . . 1.0 105.064 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 18.9 m-85 -79.28 178.7 7.88 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.425 2.29 . . . . 1.0 113.077 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -122.2 -179.76 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.615 1.966 . . . . 1.0 111.011 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 m -158.26 118.27 3.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 131.395 3.878 . . . . 1.0 101.547 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -120.2 138.72 27.48 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 106.047 -1.835 . . . . 1.0 106.047 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.96 61.27 8.09 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.115 3.21 . . . . 1.0 112.54 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -138.8 151.39 47.01 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 128.675 2.79 . . . . 1.0 105.023 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -150.85 104.36 3.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.802 1.183 . . . . 1.0 109.713 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.14 161.71 34.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 105.97 -1.863 . . . . 1.0 105.97 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -57.69 123.86 65.19 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.97 0.908 . . . . 1.0 108.923 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.34 103.6 1.29 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.366 2.044 . . . . 1.0 108.302 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 t -174.15 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.198 -2.149 . . . . 1.0 105.198 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.07 131.48 9.49 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.376 1.471 . . . . 1.0 107.482 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 tp -92.07 127.51 37.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.342 1.057 . . . . 1.0 109.437 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.67 116.84 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.913 1.285 . . . . 1.0 108.514 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 169' ' ' PHE . 93.6 t -110.88 114.94 48.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.0 OUTLIER -168.07 129.39 1.4 Allowed 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 174.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.88 111.84 6.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 5.9 mm -127.0 177.58 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.828 2.451 . . . . 1.0 112.12 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -151.28 122.32 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 1 N-CA-C 95.992 -5.559 . . . . 1.0 95.992 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.301 0.6 OUTLIER -142.84 -60.9 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 121.727 2.058 . . . . 1.0 112.426 176.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.14 157.58 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.572 2.181 . . . . 1.0 111.449 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.16 13.47 2.37 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.771 2.981 . . . . 1.0 116.664 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -24.55 -68.59 0.03 OUTLIER Glycine 0 C--N 1.353 1.508 0 CA-C-N 121.402 1.91 . . . . 1.0 111.694 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -148.89 122.97 9.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.776 -1.565 . . . . 1.0 106.776 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -176.47 159.26 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.649 2.78 . . . . 1.0 108.294 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.46 -6.4 10.62 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.721 1.153 . . . . 1.0 110.664 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.09 120.37 7.18 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 108.383 -1.887 . . . . 1.0 108.383 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.82 -24.86 80.05 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.62 2.213 . . . . 1.0 115.191 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -49.36 -45.81 46.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.794 1.179 . . . . 1.0 113.741 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 mm -65.6 -49.31 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 123.567 0.747 . . . . 1.0 110.651 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.34 -36.33 82.62 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 118.861 -1.136 . . . . 1.0 110.744 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.75 -34.2 71.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.717 0.807 . . . . 1.0 110.996 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.1 tm? -60.94 -54.33 46.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.547 1.139 . . . . 1.0 108.077 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.96 -48.29 69.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.51 -34.77 78.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.275 1.43 . . . . 1.0 110.431 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.09 1.57 29.98 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.195 1.379 . . . . 1.0 115.221 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -88.96 8.69 28.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.232 2.016 . . . . 1.0 113.255 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -57.46 127.92 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.978 1.311 . . . . 1.0 112.219 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.84 135.54 20.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.238 2.215 . . . . 1.0 109.609 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.08 77.34 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.649 2.899 . . . . 1.0 107.261 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.41 -64.58 1.07 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.105 0.562 . . . . 1.0 111.013 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.8 -47.55 76.93 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.042 0.937 . . . . 1.0 110.855 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 17.8 p80 -170.07 177.9 0.98 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.677 1.591 . . . . 1.0 107.607 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -71.37 -43.41 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.437 2.091 . . . . 1.0 114.973 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -46.29 -49.76 17.03 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.956 1.095 . . . . 1.0 113.956 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 -55.58 31.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.116 0.966 . . . . 1.0 110.397 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.28 99.17 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.14 0.976 . . . . 1.0 111.39 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.31 23.09 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.907 1.718 . . . . 1.0 112.38 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.7 pt -60.26 -36.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-O 117.221 -1.371 . . . . 1.0 112.38 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -43.78 -43.15 5.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.58 1.952 . . . . 1.0 115.435 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -60.34 -33.57 72.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.672 -0.643 . . . . 1.0 109.692 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.62 136.65 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 102.924 -2.991 . . . . 1.0 102.924 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 153.89 15.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.694 -1.202 . . . . 1.0 110.456 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.59 159.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -165.84 130.21 2.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.632 -1.248 . . . . 1.0 107.632 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.32 -176.77 3.75 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -123.69 -76.6 0.59 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.549 -2.019 . . . . 1.0 105.549 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' CB ' HD13 ' A' ' 115' ' ' ILE . 3.8 m -122.51 118.47 28.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.891 -2.263 . . . . 1.0 104.891 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.97 113.33 25.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.407 -2.071 . . . . 1.0 105.407 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.4 mt -88.1 119.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 106.029 -1.841 . . . . 1.0 106.029 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.29 141.9 58.61 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.437 -1.69 . . . . 1.0 106.437 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -53.14 -24.99 11.8 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 124.442 1.097 . . . . 1.0 111.324 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.37 34.57 0.95 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.529 1.132 . . . . 1.0 111.845 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.48 48.2 86.28 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 120.112 -1.617 . . . . 1.0 115.944 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.48 156.26 31.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.08 113.51 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 104.948 -2.241 . . . . 1.0 104.948 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.26 139.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -124.79 113.96 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.87 140.41 43.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.911 2.484 . . . . 1.0 104.384 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t 63.18 90.91 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 120.65 1.568 . . . . 1.0 113.519 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.67 -177.55 0.97 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 120.807 1.005 . . . . 1.0 110.432 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.69 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.682 2.793 . . . . 1.0 115.558 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -149.89 120.36 7.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.523 2.729 . . . . 1.0 107.204 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 84.07 81.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.662 2.785 . . . . 1.0 110.639 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -41.04 152.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.699 3.2 . . . . 1.0 114.603 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.72 -178.77 3.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 1.0 110.219 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -152.34 118.44 5.51 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -162.73 62.5 0.2 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.969 0.89 . . . . 1.0 110.914 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.76 -61.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 117.635 -3.166 . . . . 1.0 113.296 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.96 -73.65 1.14 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.203 -1.332 . . . . 1.0 112.943 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.95 129.4 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.973 1.387 . . . . 1.0 111.633 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 p -165.96 146.73 6.67 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.824 1.65 . . . . 1.0 108.231 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.563 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -144.53 146.39 32.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.762 2.025 . . . . 1.0 108.533 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -150.32 149.65 30.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.943 -2.244 . . . . 1.0 104.943 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 43.49 53.61 5.65 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.745 1.218 . . . . 1.0 114.273 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.8 39.46 67.84 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 121.011 -1.056 . . . . 1.0 113.09 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -146.48 113.57 6.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.579 -2.378 . . . . 1.0 104.579 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -105.98 132.84 51.59 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -102.55 118.26 36.48 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.5 t -61.31 -25.05 66.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 1.0 111.611 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -153.77 161.08 42.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.3 76.76 8.23 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.04 40.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.821 2.448 . . . . 1.0 109.74 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -123.73 133.79 53.8 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.852 1.261 . . . . 1.0 110.96 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.39 56.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.162 -1.421 . . . . 1.0 107.162 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.02 -137.01 3.79 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 120.909 -1.119 . . . . 1.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 1.1 mm -143.15 164.77 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.238 -2.875 . . . . 1.0 103.238 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.33 137.18 28.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.329 2.651 . . . . 1.0 103.898 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.91 141.62 33.54 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.589 -1.319 . . . . 1.0 109.407 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 6.0 tm-20 -103.92 154.3 19.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.465 -0.198 . . . . 1.0 110.465 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.02 -177.62 46.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 128.49 2.948 . . . . 1.0 109.401 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 p -156.35 116.64 3.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.735 -2.321 . . . . 1.0 104.735 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.4 t0 50.59 40.45 23.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.261 65.4 p 58.8 38.48 24.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.249 2.22 . . . . 1.0 115.163 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.44 146.08 30.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.906 1.682 . . . . 1.0 107.886 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -42.4 113.38 0.44 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -81.02 -5.75 57.97 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 115.855 1.798 . . . . 1.0 115.855 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.8 p 51.62 77.78 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 120.194 1.361 . . . . 1.0 111.505 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.84 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.245 2.618 . . . . 1.0 114.159 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -41.62 -36.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.497 2.319 . . . . 1.0 109.452 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -48.17 -50.07 30.32 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.594 0.757 . . . . 1.0 110.375 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.84 -47.73 83.82 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.321 0.648 . . . . 1.0 109.982 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.02 -51.95 67.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.578 0.704 . . . . 1.0 109.72 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -66.45 -47.9 71.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 1.0 110.837 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 115' ' ' ILE . 21.5 tp -55.76 -41.77 74.47 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.81 98.26 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.458 1.481 . . . . 1.0 111.907 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.74 47.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.384 0.674 . . . . 1.0 109.246 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 115' ' ' ILE . 22.0 t -60.62 -48.25 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.5 m -55.85 -49.35 73.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.843 1.257 . . . . 1.0 109.893 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.39 -41.08 98.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.488 0.715 . . . . 1.0 110.338 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.74 68.03 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.268 -0.895 . . . . 1.0 110.673 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.12 -41.13 74.83 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.876 -1.059 . . . . 1.0 112.05 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.68 -43.24 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.678 1.126 . . . . 1.0 108.574 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.8 m -65.61 -22.03 66.63 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.386 0.674 . . . . 1.0 111.799 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.62 -56.15 3.48 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 120.478 -1.389 . . . . 1.0 108.098 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.36 112.54 23.44 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -89.97 108.55 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 117.05 -1.5 . . . . 1.0 110.122 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.41 -50.42 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.081 1.752 . . . . 1.0 109.033 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.9 mt -47.33 -33.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.847 3.259 . . . . 1.0 110.765 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.08 -26.3 4.29 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.405 1.082 . . . . 1.0 113.272 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.92 17.92 5.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.676 1.991 . . . . 1.0 111.267 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -139.47 88.02 2.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.34 1.427 . . . . 1.0 109.717 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 46.0 mtt -129.89 113.86 15.16 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -148.6 -165.9 2.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.45 -131.41 1.43 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 106.326 -2.709 . . . . 1.0 106.326 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.0 m170 -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.588 1.194 . . . . 1.0 111.907 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.93 -11.59 17.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.787 0.835 . . . . 1.0 109.573 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.52 39.56 0.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.1 -1.0 . . . . 1.0 110.393 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -74.43 -11.69 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 O-C-N 121.251 -0.906 . . . . 1.0 108.68 175.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -159.59 -54.16 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.956 1.702 . . . . 1.0 113.037 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.12 108.86 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 122.71 2.004 . . . . 1.0 111.277 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.23 -13.42 37.6 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.198 -0.938 . . . . 1.0 113.219 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.09 -25.74 63.66 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.544 -1.347 . . . . 1.0 111.957 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -113.91 141.6 47.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -140.37 -15.07 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 118.872 -1.131 . . . . 1.0 111.427 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.71 177.55 0.43 Allowed Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 131.0 3.72 . . . . 1.0 104.092 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.07 77.86 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.33 2.02 . . . . 1.0 109.892 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 127.17 67.27 0.15 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.086 1.803 . . . . 1.0 109.582 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 88.0 Cg_endo -74.62 -89.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.08 2.52 . . . . 1.0 109.551 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t 53.4 42.98 31.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.876 2.07 . . . . 1.0 114.095 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 33' ' ' VAL . 65.8 t80 -95.13 19.28 10.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 119.862 -1.774 . . . . 1.0 113.982 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.5 t0 45.61 56.2 6.02 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.213 -1.554 . . . . 1.0 113.479 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -45.2 -40.5 7.32 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.096 1.758 . . . . 1.0 113.011 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.63 -60.85 2.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.381 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -64.55 -36.2 83.45 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 117.884 -1.526 . . . . 1.0 111.251 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.55 -57.56 12.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.589 0.556 . . . . 1.0 110.397 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -64.38 -32.72 74.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.761 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.75 96.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.536 0.607 . . . . 1.0 111.715 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.82 -46.48 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.243 1.017 . . . . 1.0 112.262 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.04 166.87 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.371 1.868 . . . . 1.0 111.702 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 125.951 1.7 . . . . 1.0 108.876 175.274 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.12 176.33 5.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.895 0.878 . . . . 1.0 112.037 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 45.79 57.97 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.971 2.108 . . . . 1.0 109.694 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 139.83 13.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.557 -1.339 . . . . 1.0 111.294 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.03 130.11 39.18 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -83.61 133.2 34.85 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.024 0.53 . . . . 1.0 110.319 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.84 73.12 28.24 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.422 -1.696 . . . . 1.0 106.422 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.62 123.27 9.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 N-CA-C 108.08 -1.546 . . . . 1.0 108.08 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -113.91 114.51 46.5 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 29.1 Cg_endo -79.86 38.93 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.665 2.91 . . . . 1.0 113.989 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.97 44.53 2.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.503 1.121 . . . . 1.0 109.254 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 21.9 m-85 -73.52 178.52 4.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.066 0.946 . . . . 1.0 112.863 -175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.67 178.6 4.51 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 118.919 2.933 . . . . 1.0 118.919 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.2 m -162.83 118.73 1.84 Allowed 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 135.911 5.684 . . . . 1.0 101.173 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -130.09 154.96 81.39 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.439 -2.06 . . . . 1.0 105.439 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.26 51.97 4.12 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.985 3.124 . . . . 1.0 114.398 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -139.59 151.18 45.83 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.904 1.282 . . . . 1.0 110.205 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -148.43 103.82 3.46 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.791 1.236 . . . . 1.0 108.179 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.44 173.53 11.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.082 0.953 . . . . 1.0 109.01 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -79.46 124.32 84.01 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 119.648 1.113 . . . . 1.0 109.789 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.72 103.95 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.504 2.136 . . . . 1.0 112.436 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -178.13 83.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.067 1.747 . . . . 1.0 108.002 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.67 141.04 17.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.571 1.149 . . . . 1.0 108.183 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -94.25 127.48 40.13 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.475 1.51 . . . . 1.0 108.478 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 140.43 24.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -135.56 113.72 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 104.888 -2.264 . . . . 1.0 104.888 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.6 OUTLIER -170.16 152.16 4.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.796 1.638 . . . . 1.0 107.601 175.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -94.88 112.42 24.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 36' ' ' ILE . 5.2 mm -128.05 166.67 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 106.179 -1.785 . . . . 1.0 106.179 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -139.13 122.25 16.87 Favored 'General case' 0 N--CA 1.444 -0.733 1 N-CA-C 94.35 -6.167 . . . . 1.0 94.35 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.366 0.7 OUTLIER -142.96 -66.1 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.462 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 179.4 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 27.4 Cg_endo -87.85 155.92 7.36 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.096 2.531 . . . . 1.0 114.352 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.19 59.09 5.86 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 125.174 3.916 . . . . 1.0 116.157 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.79 -71.77 0.95 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -156.48 123.46 5.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.463 1.505 . . . . 1.0 110.496 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -168.56 166.4 12.01 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.227 2.611 . . . . 1.0 110.715 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.06 6.49 25.4 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.623 2.059 . . . . 1.0 111.649 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.2 118.74 6.27 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.187 -1.965 . . . . 1.0 108.187 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.23 -7.88 20.25 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.825 2.35 . . . . 1.0 114.457 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 13.6 m95 -45.95 -49.63 15.62 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.283 1.433 . . . . 1.0 113.293 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -65.12 -46.01 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.619 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.4 -38.31 87.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.163 -0.681 . . . . 1.0 109.163 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -61.16 -34.24 74.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.68 1.192 . . . . 1.0 111.897 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.4 tm? -59.66 -51.89 67.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.905 1.282 . . . . 1.0 109.152 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -70.03 -48.66 57.1 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.609 1.163 . . . . 1.0 111.558 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.05 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.046 0.938 . . . . 1.0 109.378 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.53 1.82 24.48 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.006 -1.441 . . . . 1.0 115.319 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -89.07 9.29 25.9 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.301 2.05 . . . . 1.0 113.038 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.4 tt -53.51 145.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.648 1.579 . . . . 1.0 114.431 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.82 136.77 20.56 Favored Pre-proline 0 CA--C 1.546 0.804 1 C-N-CA 131.77 4.028 . . . . 1.0 113.02 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.51 38.1 0.29 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.769 3.646 . . . . 1.0 113.695 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -103.16 -33.36 9.23 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.229 1.832 . . . . 1.0 111.061 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -50.9 -52.96 36.78 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 106.207 -1.775 . . . . 1.0 106.207 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 12.9 p80 -171.31 178.38 0.79 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 131.046 3.738 . . . . 1.0 104.181 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.3 -43.54 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.69 1.593 . . . . 1.0 113.658 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -42.28 -47.64 4.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.889 1.676 . . . . 1.0 114.105 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -55.66 -55.6 30.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.758 1.223 . . . . 1.0 109.136 -175.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.33 99.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.253 1.021 . . . . 1.0 110.745 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.77 -57.49 10.75 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.87 1.7 . . . . 1.0 113.1 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 pt -61.7 -39.88 84.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.121 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -38.15 -43.26 0.74 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.89 2.476 . . . . 1.0 115.188 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -56.4 -40.05 74.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.008 0.923 . . . . 1.0 108.868 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.56 136.93 32.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 1.0 105.062 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 154.98 5.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.131 -0.98 . . . . 1.0 112.399 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 m -116.73 160.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.349 1.86 . . . . 1.0 108.872 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -174.24 120.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.583 1.553 . . . . 1.0 107.586 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.23 -169.39 1.91 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.243 1.417 . . . . 1.0 108.153 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 24.7 m80 -120.18 -59.04 1.82 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.854 1.261 . . . . 1.0 109.42 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.72 119.12 10.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 119.709 -1.869 . . . . 1.0 106.684 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp -98.88 113.74 26.02 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 102.579 -3.119 . . . . 1.0 102.579 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.0 mt -95.83 114.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.686 -1.968 . . . . 1.0 105.686 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -67.22 152.57 45.49 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 118.519 0.6 . . . . 1.0 110.165 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -60.78 -14.0 18.74 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 125.467 1.507 . . . . 1.0 112.784 175.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -91.88 20.35 5.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.834 1.654 . . . . 1.0 111.755 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.56 47.71 89.79 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.743 2.592 . . . . 1.0 114.118 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -119.36 115.05 23.32 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.383 0.673 . . . . 1.0 110.521 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.92 117.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.55 147.28 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -124.3 117.92 25.6 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.569 1.548 . . . . 1.0 112.321 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.64 123.24 41.44 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 128.391 2.676 . . . . 1.0 105.205 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 t 64.34 91.29 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 122.339 2.336 . . . . 1.0 112.696 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -69.1 -169.13 0.28 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.144 1.896 . . . . 1.0 112.031 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.93 17.58 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.996 2.918 . . . . 1.0 114.994 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -143.68 125.27 14.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.687 2.395 . . . . 1.0 107.249 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? 85.09 81.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.559 3.144 . . . . 1.0 109.678 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB3' HH11 ' A' ' 93' ' ' ARG . 0.1 OUTLIER -38.71 141.44 0.27 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.598 2.759 . . . . 1.0 115.246 -175.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -105.45 -178.54 3.68 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 129.002 2.921 . . . . 1.0 111.625 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -153.71 118.32 4.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.678 1.591 . . . . 1.0 108.318 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -160.12 63.19 0.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.401 1.572 . . . . 1.0 111.498 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -159.53 -53.97 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.747 -2.471 . . . . 1.0 113.457 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.57 -69.41 0.74 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.5 t -145.86 137.57 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 1.0 108.019 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.9 p -166.46 165.96 16.68 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.092 1.757 . . . . 1.0 108.875 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 157' ' ' ILE . 5.3 p -159.27 146.38 17.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -156.48 152.81 27.85 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.62 -1.252 . . . . 1.0 107.62 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 39.85 53.41 2.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.368 1.467 . . . . 1.0 111.846 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.16 28.47 26.33 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.396 -1.224 . . . . 1.0 114.872 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -129.22 117.36 20.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.83 146.64 30.81 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.424 1.49 . . . . 1.0 111.191 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.15 117.99 24.28 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 50.7 t -78.38 -23.87 46.6 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.207 1.003 . . . . 1.0 110.133 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.13 169.98 16.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.912 -1.885 . . . . 1.0 105.912 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 6.1 t70 -93.43 76.0 4.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 38.42 0.72 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.099 1.759 . . . . 1.0 109.497 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -128.23 143.07 51.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.574 1.55 . . . . 1.0 109.343 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -78.96 56.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.208 2.203 . . . . 1.0 107.451 175.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.07 -136.59 1.57 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 122.227 0.904 . . . . 1.0 112.773 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 136' ' ' VAL . 28.2 mm -147.26 155.44 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 129.522 3.129 . . . . 1.0 104.104 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.43 129.97 21.35 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.97 161.5 13.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.646 -1.909 . . . . 1.0 110.626 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.68 144.82 48.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 1.0 111.084 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.71 38.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.55 2.024 . . . . 1.0 111.232 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.3 p -149.42 106.51 3.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.026 -1.842 . . . . 1.0 106.026 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.6 t0 45.52 48.81 10.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.59 1.956 . . . . 1.0 112.593 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p 52.32 38.39 24.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.695 1.998 . . . . 1.0 114.881 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.605 HD22 ' HD2' ' A' ' 80' ' ' ARG . 5.9 tt -60.6 142.05 55.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 104.482 -2.414 . . . . 1.0 104.482 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -32.09 113.6 0.13 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.057 1.743 . . . . 1.0 112.039 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -79.59 -14.68 58.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 116.322 -1.799 . . . . 1.0 115.388 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 25.4 p 64.2 78.09 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.747 1.612 . . . . 1.0 111.841 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -24.39 -33.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.819 1.648 . . . . 1.0 113.335 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.59 -34.54 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.911 2.884 . . . . 1.0 110.644 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.59 -57.06 11.2 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.915 1.286 . . . . 1.0 107.998 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.01 -42.6 69.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.153 0.981 . . . . 1.0 109.715 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -66.03 -58.77 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.552 1.141 . . . . 1.0 111.542 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.5 -36.25 82.27 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.667 -1.271 . . . . 1.0 112.368 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tt -61.09 -39.22 89.12 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.897 -1.127 . . . . 1.0 108.146 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.72 95.47 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.963 -1.086 . . . . 1.0 111.337 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -53.53 57.23 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 115' ' ' ILE . 55.6 t -55.22 -41.72 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.763 0.825 . . . . 1.0 110.869 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 m -59.59 -44.53 93.33 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.124 -0.985 . . . . 1.0 109.908 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.64 -44.57 90.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.894 0.77 . . . . 1.0 109.748 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.67 -56.22 22.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.941 0.896 . . . . 1.0 110.264 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.07 -44.76 79.25 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 118.241 -0.885 . . . . 1.0 112.325 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.3 -42.13 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.854 0.752 . . . . 1.0 109.786 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.225 0.61 . . . . 1.0 112.193 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -93.1 -51.2 5.15 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.693 1.197 . . . . 1.0 110.304 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.51 112.54 23.06 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -90.74 107.89 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 CA-C-N 121.539 1.585 . . . . 1.0 108.64 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.28 -50.99 0.11 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.603 2.361 . . . . 1.0 108.427 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.26 -33.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 130.367 3.467 . . . . 1.0 110.995 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.84 -26.49 10.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.036 1.125 . . . . 1.0 114.036 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -128.97 18.58 6.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.412 2.285 . . . . 1.0 111.374 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -138.15 83.36 1.97 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.4 mtt -127.61 114.02 16.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.317 -2.475 . . . . 1.0 104.317 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -154.47 -173.43 4.57 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.96 -122.84 1.75 Allowed Glycine 0 C--O 1.234 0.106 0 N-CA-C 106.413 -2.675 . . . . 1.0 106.413 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.483 ' CE1' ' CE1' ' A' ' 34' ' ' HIS 0.255 14.9 m170 -118.3 -23.82 7.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.557 2.343 . . . . 1.0 112.029 176.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.79 -18.39 15.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.466 -0.778 . . . . 1.0 109.991 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -86.55 44.0 1.12 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.33 -23.08 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 120.446 -1.409 . . . . 1.0 107.427 175.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.522 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -151.6 -53.98 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.521 2.728 . . . . 1.0 111.164 175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 95.1 Cg_endo -80.88 109.23 2.18 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.662 2.241 . . . . 1.0 113.348 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.64 -25.52 68.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.837 -1.164 . . . . 1.0 113.221 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -60.44 -23.18 64.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -135.68 131.95 36.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.2 m -113.69 -16.04 12.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.858 0.361 . . . . 1.0 110.13 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.1 -179.18 0.65 Allowed Pre-proline 0 CA--C 1.55 0.963 1 C-N-CA 132.572 4.349 . . . . 1.0 103.252 175.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.74 77.11 2.3 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 122.415 1.898 . . . . 1.0 111.432 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.36 73.58 0.81 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.1 1.333 . . . . 1.0 110.468 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.09 -57.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.816 0 CA-C-N 119.952 1.876 . . . . 1.0 113.645 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 53.35 43.08 31.89 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.32 1.448 . . . . 1.0 111.971 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.01 19.53 14.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.928 0.331 . . . . 1.0 111.486 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.264 22.6 t0 42.96 67.03 0.68 Allowed 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 126.38 1.872 . . . . 1.0 111.185 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -53.56 -32.96 53.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.209 -0.905 . . . . 1.0 111.904 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.41 -52.69 43.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.96 1.254 . . . . 1.0 110.755 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -65.94 -46.01 79.76 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.264 0.938 . . . . 1.0 111.254 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.33 -51.85 67.11 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.921 1.237 . . . . 1.0 111.58 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.329 -0.857 . . . . 1.0 110.049 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.06 77.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.19 -52.64 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.932 0.787 . . . . 1.0 108.996 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.53 161.6 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 122.115 0.959 . . . . 1.0 110.747 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 127.799 2.44 . . . . 1.0 108.864 175.875 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 107.442 -1.318 . . . . 1.0 107.442 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.32 135.29 55.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.715 0.634 . . . . 1.0 112.095 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 52.72 58.72 5.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.087 1.755 . . . . 1.0 111.294 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.75 141.6 25.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.774 -1.557 . . . . 1.0 108.378 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 tpt85 -76.38 123.44 25.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 ptt-85 -88.07 119.59 28.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.25 1.02 . . . . 1.0 111.388 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -143.45 73.98 17.28 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.175 0.99 . . . . 1.0 109.833 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.17 149.69 76.51 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 121.421 1.414 . . . . 1.0 109.87 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -137.44 134.1 18.42 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.576 1.15 . . . . 1.0 108.064 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.18 43.9 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.258 2.638 . . . . 1.0 113.251 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -123.47 43.67 2.9 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.351 -0.843 . . . . 1.0 109.381 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -73.52 178.74 4.46 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.676 1.19 . . . . 1.0 110.298 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -121.08 178.35 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.661 1.22 . . . . 1.0 113.003 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.0 m -148.64 118.61 7.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.079 2.952 . . . . 1.0 104.344 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -138.81 139.21 23.24 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 121.292 1.86 . . . . 1.0 108.717 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 75.18 4.76 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.511 2.807 . . . . 1.0 110.69 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -154.35 144.71 22.13 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.186 2.594 . . . . 1.0 106.853 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -149.8 103.44 3.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 127.257 2.223 . . . . 1.0 105.855 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -136.66 165.23 26.39 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.816 1.646 . . . . 1.0 107.613 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.49 123.61 83.45 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.615 -0.707 . . . . 1.0 111.33 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -86.85 103.59 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.506 2.137 . . . . 1.0 111.802 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -176.46 85.04 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 104.596 -2.372 . . . . 1.0 104.596 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -145.96 146.09 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.974 2.509 . . . . 1.0 105.489 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.26 127.84 56.07 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.026 -1.472 . . . . 1.0 107.026 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.18 135.66 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 169' ' ' PHE . 70.1 t -135.57 114.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.753 1.621 . . . . 1.0 107.839 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -164.56 161.89 21.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.38 1.472 . . . . 1.0 107.236 175.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.64 112.42 24.3 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -127.99 176.42 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 127.809 2.444 . . . . 1.0 108.21 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -156.92 122.13 4.62 Favored 'General case' 0 N--CA 1.438 -1.039 1 N-CA-C 97.483 -5.006 . . . . 1.0 97.483 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.51 -65.89 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.551 0 CA-C-N 120.298 1.408 . . . . 1.0 108.38 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.09 150.71 66.57 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 121.527 1.581 . . . . 1.0 109.924 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.29 28.49 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.105 3.204 . . . . 1.0 113.846 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -18.21 -71.64 0.01 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 127.686 2.565 . . . . 1.0 110.443 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -155.52 122.75 5.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -176.84 175.95 1.55 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.88 2.872 . . . . 1.0 108.089 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.56 1.54 8.09 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.91 -0.939 . . . . 1.0 113.743 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.35 118.52 5.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.219 1.509 . . . . 1.0 112.584 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.2 -4.29 13.36 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.936 2.424 . . . . 1.0 113.758 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.98 -38.77 76.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.948 -1.095 . . . . 1.0 110.292 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 38' ' ' LEU . 84.1 mt -64.35 -44.08 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.81 -48.01 82.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.108 0.867 . . . . 1.0 109.274 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.36 -35.08 62.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 1.0 111.565 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.12 -61.06 2.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.792 0.837 . . . . 1.0 109.835 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -67.23 -49.98 62.43 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -57.73 -33.86 68.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 1.0 109.753 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 40.64 3.19 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.916 0.78 . . . . 1.0 111.879 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -131.3 16.28 5.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 117.972 0.886 . . . . 1.0 110.691 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.74 139.39 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.338 1.055 . . . . 1.0 110.445 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -98.42 127.47 36.05 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 127.641 2.376 . . . . 1.0 106.91 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.4 56.94 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.077 3.185 . . . . 1.0 111.819 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.77 -57.92 1.96 Allowed 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 124.961 1.304 . . . . 1.0 112.34 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.58 -60.33 1.58 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.744 1.217 . . . . 1.0 112.292 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.443 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 23.0 p80 -168.51 177.79 1.18 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 1.0 108.548 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 20.2 Cg_endo -72.87 -43.45 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.726 1.618 . . . . 1.0 113.684 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -50.54 -60.1 3.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.672 1.189 . . . . 1.0 111.928 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.84 -51.65 68.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.846 0.858 . . . . 1.0 110.395 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.54 77.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.415 1.086 . . . . 1.0 111.508 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.19 -65.36 3.62 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 125.418 1.485 . . . . 1.0 110.603 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.91 -24.24 32.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 116.68 -1.629 . . . . 1.0 113.544 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.01 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.526 1.512 . . . . 1.0 113.659 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -57.41 -34.11 68.56 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.612 0.365 . . . . 1.0 110.956 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.49 136.38 33.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -66.04 149.29 50.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.909 -1.119 . . . . 1.0 109.402 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.3 m -117.09 162.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.068 1.347 . . . . 1.0 109.952 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.5 m -166.34 130.57 2.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.256 2.223 . . . . 1.0 105.976 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.11 -157.09 0.56 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -130.21 -61.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.192 0.997 . . . . 1.0 108.821 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' HD13 ' A' ' 115' ' ' ILE . 45.8 m -140.7 118.55 11.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.911 -1.885 . . . . 1.0 105.911 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.22 113.8 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.717 2.007 . . . . 1.0 105.607 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.64 114.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.974 -1.491 . . . . 1.0 106.974 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -70.99 152.84 43.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -14.05 2.58 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.693 0.797 . . . . 1.0 112.952 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -91.5 19.61 6.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 127.477 2.311 . . . . 1.0 112.1 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 28.94 70.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.686 2.565 . . . . 1.0 115.551 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.6 109.09 20.59 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 132' ' ' GLN . 34.1 mt -76.54 121.12 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.073 -2.195 . . . . 1.0 105.073 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.33 125.78 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.506 -2.405 . . . . 1.0 104.506 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.36 113.6 27.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.146 0.978 . . . . 1.0 108.519 -175.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.9 114.31 20.83 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t 83.75 91.62 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.537 1.971 . . . . 1.0 110.357 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.72 -170.37 0.27 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.755 2.303 . . . . 1.0 110.68 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.3 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.243 2.217 . . . . 1.0 115.26 -176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -143.76 123.0 12.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.485 1.914 . . . . 1.0 109.531 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 0.4 OUTLIER 86.44 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.22 3.008 . . . . 1.0 111.506 177.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -34.62 138.58 0.1 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.15 2.58 . . . . 1.0 113.04 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.88 -178.83 3.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.554 2.342 . . . . 1.0 111.353 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -150.28 118.73 6.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.241 1.416 . . . . 1.0 108.003 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -167.46 63.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.483 1.135 . . . . 1.0 110.442 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.08 -69.92 0.1 Allowed 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 118.606 -2.559 . . . . 1.0 111.749 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.36 0.33 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 125.187 1.554 . . . . 1.0 110.0 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 t -144.72 145.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.827 1.651 . . . . 1.0 109.899 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 p -165.82 149.54 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.626 1.171 . . . . 1.0 110.573 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.606 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -143.71 132.21 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.788 -1.93 . . . . 1.0 105.788 175.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -159.59 124.26 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.447 1.022 . . . . 1.0 108.313 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 58.79 71.69 0.57 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.41 1.884 . . . . 1.0 113.571 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.38 28.6 44.24 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.527 2.489 . . . . 1.0 113.312 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -147.02 113.22 5.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.36 141.42 28.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -123.95 117.86 25.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 102.997 -2.964 . . . . 1.0 102.997 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.4 t -66.23 -35.13 79.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -145.01 172.1 13.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.787 2.835 . . . . 1.0 106.006 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -84.84 77.11 10.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.413 1.102 . . . . 1.0 108.829 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.75 35.13 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.406 1.882 . . . . 1.0 111.417 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -123.72 153.05 41.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.879 0.872 . . . . 1.0 112.475 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -88.86 57.11 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.534 1.934 . . . . 1.0 107.029 175.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.95 -136.59 1.2 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.947 -1.095 . . . . 1.0 111.74 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.713 HD11 HG11 ' A' ' 136' ' ' VAL . 6.2 mm -142.55 161.47 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 129.329 3.052 . . . . 1.0 103.096 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -134.44 130.13 36.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.309 2.244 . . . . 1.0 105.001 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -101.19 153.03 19.95 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.736 -1.228 . . . . 1.0 108.919 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 158.03 45.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.73 0.776 . . . . 1.0 111.641 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.92 39.53 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.453 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.9 p -146.48 104.0 3.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 103.367 -2.827 . . . . 1.0 103.367 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t0 43.87 49.66 7.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.751 2.02 . . . . 1.0 112.984 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 p 50.31 38.08 16.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.051 2.14 . . . . 1.0 114.191 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.48 136.2 57.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.19 0.04 OUTLIER 'General case' 0 C--N 1.347 0.486 0 C-N-CA 127.373 2.269 . . . . 1.0 110.615 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -78.03 -10.3 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 115.892 -2.004 . . . . 1.0 116.339 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.333 44.8 p 64.74 77.31 0.32 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 121.355 1.889 . . . . 1.0 110.987 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -24.43 -32.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.246 1.818 . . . . 1.0 114.683 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -39.85 -43.67 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.314 1.846 . . . . 1.0 109.231 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -43.71 -50.93 7.45 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.779 1.231 . . . . 1.0 111.668 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.31 -39.81 88.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.458 0.572 . . . . 1.0 111.032 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -61.63 -58.57 7.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.032 0.533 . . . . 1.0 109.667 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.1 mp0 -65.92 -47.12 75.81 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.544 -0.741 . . . . 1.0 111.599 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 115' ' ' ILE . 53.4 tp -54.85 -46.55 74.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.048 1.295 . . . . 1.0 109.34 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.44 96.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.535 1.061 . . . . 1.0 111.416 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.1 50.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.001 0.52 . . . . 1.0 109.654 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 115' ' ' ILE . 98.0 t -52.2 -64.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.533 1.933 . . . . 1.0 108.61 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -53.96 -53.6 50.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.484 1.914 . . . . 1.0 112.209 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -57.85 -41.93 83.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.763 1.165 . . . . 1.0 109.555 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.86 -44.34 70.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.205 -0.935 . . . . 1.0 111.165 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.97 -36.77 70.71 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.12 -1.612 . . . . 1.0 111.458 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 mt -62.1 -35.57 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.01 -1.107 . . . . 1.0 108.01 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -64.96 -13.61 57.88 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.785 1.234 . . . . 1.0 110.774 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -98.63 -65.89 0.93 Allowed 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.158 -1.589 . . . . 1.0 106.981 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -119.41 112.91 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 106.673 -1.603 . . . . 1.0 106.673 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -92.78 108.19 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.649 1.566 . . . . 1.0 112.288 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.05 -49.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.587 1.955 . . . . 1.0 106.583 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.0 mt -48.41 -33.61 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 128.934 2.894 . . . . 1.0 110.829 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.42 12.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.344 1.057 . . . . 1.0 113.395 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.31 18.58 4.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.085 2.154 . . . . 1.0 110.656 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.83 83.62 1.97 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.67 1.188 . . . . 1.0 107.967 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.3 mtt -118.78 120.19 36.63 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.592 -1.633 . . . . 1.0 106.592 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -155.26 -169.57 3.2 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.27 -0.894 . . . . 1.0 110.339 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.03 -131.19 1.51 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 14.2 m170 -113.39 -23.51 9.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.362 1.081 . . . . 1.0 111.791 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -11.16 18.56 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -91.36 38.92 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.742 1.156 . . . . 1.0 108.489 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.07 -12.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 120.295 -1.503 . . . . 1.0 110.267 175.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -157.8 -54.39 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.546 1.939 . . . . 1.0 111.088 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 62.7 Cg_endo -87.38 117.94 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.293 1.996 . . . . 1.0 113.395 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.85 -24.29 61.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.271 -0.893 . . . . 1.0 111.785 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -57.49 -19.35 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.64 2.376 . . . . 1.0 112.087 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.98 141.44 38.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.748 -1.575 . . . . 1.0 106.748 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -130.91 -16.72 3.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.898 1.226 . . . . 1.0 109.831 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.98 179.88 0.36 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 129.844 3.257 . . . . 1.0 104.772 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.33 79.75 3.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.149 1.899 . . . . 1.0 108.423 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.15 59.26 0.53 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.389 -1.229 . . . . 1.0 115.251 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 -52.3 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.069 2.435 . . . . 1.0 112.357 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.0 t 54.07 43.62 30.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.197 1.399 . . . . 1.0 111.866 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CD2' HG11 ' A' ' 33' ' ' VAL 0.253 83.5 t80 -107.27 18.34 21.76 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.986 1.847 . . . . 1.0 115.986 -175.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.327 5.8 t70 42.05 75.0 0.1 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.424 1.49 . . . . 1.0 113.625 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -50.18 -35.34 25.84 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.64 79.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.861 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -51.28 68.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.849 1.204 . . . . 1.0 109.651 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 66.5 t80 -63.22 -52.82 60.67 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.825 0.306 . . . . 1.0 111.825 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -63.74 -26.65 68.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.265 -0.897 . . . . 1.0 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.11 88.65 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 1.0 109.992 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.29 -61.21 1.85 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.677 1.591 . . . . 1.0 111.7 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 94.6 t -66.26 165.77 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.3 1.04 . . . . 1.0 110.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 54.4 m . . . . . 0 CA--C 1.54 0.593 0 C-N-CA 125.331 1.453 . . . . 1.0 110.717 175.768 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.718 -1.215 . . . . 1.0 107.718 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 156.53 32.69 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.515 0.726 . . . . 1.0 110.24 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 38.7 58.08 1.74 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.133 2.173 . . . . 1.0 111.304 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.95 143.83 23.73 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.424 -0.797 . . . . 1.0 111.341 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -82.34 124.23 29.8 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.027 1.331 . . . . 1.0 108.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.57 119.23 24.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 t -142.18 75.34 20.25 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.011 1.324 . . . . 1.0 108.198 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 123.58 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.516 1.478 . . . . 1.0 112.673 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -49.8 146.08 7.99 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.434 1.894 . . . . 1.0 111.92 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.76 -37.42 6.8 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 N-CA-C 114.734 1.013 . . . . 1.0 114.734 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -151.48 135.67 16.73 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -104.28 -170.88 1.83 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.553 1.141 . . . . 1.0 109.675 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.69 178.95 5.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.283 2.633 . . . . 1.0 111.61 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.1 m -140.92 153.95 45.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 129.522 3.129 . . . . 1.0 104.993 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -131.16 157.03 79.27 Favored Pre-proline 0 N--CA 1.467 0.377 0 O-C-N 120.918 -1.114 . . . . 1.0 109.444 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.31 51.08 2.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.072 2.515 . . . . 1.0 111.883 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -148.6 153.63 38.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 126.305 1.842 . . . . 1.0 109.988 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.72 103.2 3.76 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -137.0 164.65 27.85 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.734 -0.603 . . . . 1.0 109.431 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.87 123.8 78.98 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.438 1.895 . . . . 1.0 108.068 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.27 103.48 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 N-CA-C 108.318 -1.455 . . . . 1.0 108.318 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 t -165.09 67.67 0.13 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.37 129.58 22.22 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -95.13 128.64 42.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.959 -1.867 . . . . 1.0 105.959 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -106.17 140.11 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.31 114.2 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -169.61 133.6 1.31 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.81 113.57 8.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.105 -1.443 . . . . 1.0 107.105 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.4 mm -126.41 177.06 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 127.741 2.416 . . . . 1.0 107.623 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -155.5 121.72 5.17 Favored 'General case' 0 C--N 1.316 -0.871 1 N-CA-C 95.421 -5.77 . . . . 1.0 95.421 173.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HD2' ' A' ' 39' ' ' PRO 0.324 0.5 OUTLIER -141.44 -61.45 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 119.119 0.872 . . . . 1.0 111.336 175.848 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 61.3 Cg_endo -79.77 157.79 24.53 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.676 2.25 . . . . 1.0 112.024 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.15 -0.23 10.57 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-O 114.159 -2.517 . . . . 1.0 115.172 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -11.79 -71.05 0.01 OUTLIER Glycine 0 C--N 1.352 1.44 0 C-N-CA 127.278 2.37 . . . . 1.0 113.36 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -155.02 122.97 5.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.345 1.858 . . . . 1.0 109.05 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -175.77 175.42 2.03 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 130.009 3.324 . . . . 1.0 107.614 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.31 6.96 24.89 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.235 1.398 . . . . 1.0 112.83 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.41 118.5 6.2 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.533 1.666 . . . . 1.0 109.951 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.73 -13.08 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.261 1.974 . . . . 1.0 114.386 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -62.01 -35.94 80.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.399 1.454 . . . . 1.0 110.928 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -64.18 -47.03 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.061 0.944 . . . . 1.0 109.238 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -34.74 78.88 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.482 -0.761 . . . . 1.0 112.126 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.8 -33.78 50.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.132 1.373 . . . . 1.0 111.625 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.69 -55.92 28.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.965 1.306 . . . . 1.0 110.259 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 39' ' ' PRO . 42.0 m-85 -71.31 -40.74 70.64 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 126.649 1.98 . . . . 1.0 112.969 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.0 -33.32 75.55 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.222 -0.924 . . . . 1.0 109.538 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.56 24.86 10.51 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 118.698 -1.057 . . . . 1.0 113.525 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -121.46 16.63 11.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.185 1.492 . . . . 1.0 111.575 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.7 135.27 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.408 1.083 . . . . 1.0 110.758 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.95 136.59 20.56 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.199 1.8 . . . . 1.0 109.095 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.78 56.87 3.01 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.798 2.999 . . . . 1.0 113.204 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -103.47 -49.65 3.65 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.586 0.958 . . . . 1.0 113.586 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.93 -60.62 2.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.972 0.805 . . . . 1.0 112.674 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 22.7 p80 -170.53 177.79 0.95 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.558 1.543 . . . . 1.0 107.477 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 16.8 Cg_endo -72.85 -43.53 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.304 1.336 . . . . 1.0 114.996 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -50.77 -59.11 4.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.954 1.252 . . . . 1.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 1.6 t80 -60.12 -49.83 76.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 1.0 110.251 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.68 90.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.818 0.847 . . . . 1.0 111.108 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.14 -63.63 4.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.048 1.785 . . . . 1.0 110.075 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.89 -26.83 41.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 116.408 -1.758 . . . . 1.0 112.947 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -42.98 3.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.105 1.762 . . . . 1.0 114.729 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -52.49 -39.08 60.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.572 1.549 . . . . 1.0 110.871 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.78 136.28 33.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' H ' ' CD ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.06 161.26 22.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.416 -0.802 . . . . 1.0 109.035 175.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.49 164.39 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.896 1.279 . . . . 1.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.7 m -169.52 118.05 0.63 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.909 1.284 . . . . 1.0 108.332 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.61 -174.48 3.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.79 1.236 . . . . 1.0 109.052 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 28.3 m80 -112.17 -73.64 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.242 1.017 . . . . 1.0 111.628 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.02 118.74 27.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 103.66 -2.719 . . . . 1.0 103.66 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tp -104.23 113.34 26.82 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.264 -2.865 . . . . 1.0 103.264 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.03 113.49 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 105.644 -1.984 . . . . 1.0 105.644 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -85.37 149.22 25.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.115 0.87 . . . . 1.0 110.399 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -46.82 -13.85 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 128.418 2.687 . . . . 1.0 115.547 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.89 27.98 1.95 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.929 1.291 . . . . 1.0 112.711 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.3 28.96 70.14 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.584 1.564 . . . . 1.0 114.484 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.48 153.05 20.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.299 1.05 . . . . 1.0 111.502 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.45 114.08 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 104.668 -2.345 . . . . 1.0 104.668 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 145.69 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -124.3 115.49 21.11 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.947 0.899 . . . . 1.0 110.403 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -110.38 129.8 55.69 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 127.828 2.451 . . . . 1.0 105.525 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' A' ' 19' ' ' TYR . 16.6 t 63.4 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 121.985 2.175 . . . . 1.0 115.148 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -64.1 -174.11 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 121.658 1.572 . . . . 1.0 111.423 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -67.18 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.57 1.948 . . . . 1.0 114.372 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -140.84 111.53 6.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.734 2.014 . . . . 1.0 108.482 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 84.05 81.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.421 2.289 . . . . 1.0 109.976 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -37.33 146.28 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.675 3.19 . . . . 1.0 111.469 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -104.14 -178.35 3.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.859 1.264 . . . . 1.0 111.674 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -141.78 118.6 11.12 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.2 63.16 0.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.852 1.31 . . . . 1.0 107.964 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.24 -69.04 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 119.224 -2.172 . . . . 1.0 114.454 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.96 -85.67 0.4 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 103.203 -3.959 . . . . 1.0 103.203 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.21 146.45 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 119.797 1.799 . . . . 1.0 110.502 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.5 p -155.84 155.77 33.52 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.055 1.742 . . . . 1.0 108.096 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.484 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -147.99 132.32 17.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.094 -1.817 . . . . 1.0 106.094 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -160.63 156.93 26.35 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.228 0.611 . . . . 1.0 109.565 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 39.13 53.65 2.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.4 1.48 . . . . 1.0 112.251 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.21 28.26 18.36 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.298 2.856 . . . . 1.0 114.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -129.86 121.4 26.63 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 119.619 1.709 . . . . 1.0 107.058 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -92.62 141.96 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -116.35 118.52 32.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.8 -1.556 . . . . 1.0 106.8 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.5 t -55.69 -38.83 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.815 0.846 . . . . 1.0 110.09 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -152.98 164.79 37.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.997 2.919 . . . . 1.0 105.019 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.28 76.71 10.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 122.584 1.183 . . . . 1.0 111.154 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.85 43.42 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.894 2.478 . . . . 1.0 108.542 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 m -123.29 156.79 34.57 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.391 1.876 . . . . 1.0 111.434 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -96.54 57.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.705 2.002 . . . . 1.0 107.92 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.13 -136.96 1.65 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.983 -1.073 . . . . 1.0 112.033 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 133' ' ' LEU . 4.8 mt -152.29 164.88 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 131.512 3.925 . . . . 1.0 102.36 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -144.86 143.1 30.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.053 2.141 . . . . 1.0 105.277 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -101.46 155.39 18.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.824 -1.173 . . . . 1.0 110.303 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -131.43 138.87 49.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.33 -172.73 39.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.353 0.978 . . . . 1.0 110.906 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -133.78 92.46 2.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.578 -0.954 . . . . 1.0 108.628 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.4 t0 54.34 56.97 6.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.471 1.508 . . . . 1.0 113.49 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 16.5 p 60.91 38.42 17.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.181 1.792 . . . . 1.0 113.605 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.6 132.02 47.26 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.29 -2.485 . . . . 1.0 104.29 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -30.32 115.03 0.12 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.387 1.875 . . . . 1.0 110.536 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -78.09 -2.45 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 114.943 -2.456 . . . . 1.0 116.975 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.341 42.4 p 67.39 78.05 0.25 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 115.727 -2.083 . . . . 1.0 111.374 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -24.23 -34.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 121.596 1.998 . . . . 1.0 116.157 177.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.75 14.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.163 2.185 . . . . 1.0 110.333 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -49.15 -50.55 37.07 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 125.077 1.351 . . . . 1.0 109.826 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -60.87 -40.63 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.832 -0.604 . . . . 1.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -65.38 -47.88 74.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.354 0.524 . . . . 1.0 111.061 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.89 -54.04 31.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.451 1.1 . . . . 1.0 110.254 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 115' ' ' ILE . 14.5 tp -54.5 -46.47 73.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.122 1.369 . . . . 1.0 108.805 175.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.46 87.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.934 1.243 . . . . 1.0 111.664 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.64 54.24 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.7 -53.11 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.623 -0.703 . . . . 1.0 109.365 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.4 m -55.38 -61.31 2.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.403 1.881 . . . . 1.0 111.059 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -53.75 -43.08 68.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.606 0.717 . . . . 1.0 110.878 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.009 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 mt -56.76 -36.93 70.38 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.087 -1.633 . . . . 1.0 111.373 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.04 -31.88 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.655 1.182 . . . . 1.0 109.727 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m -64.26 -16.88 62.96 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.88 0.764 . . . . 1.0 111.006 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -65.15 0.98 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 120.664 -1.272 . . . . 1.0 108.274 175.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -110.29 112.84 56.92 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 108.004 -1.109 . . . . 1.0 108.004 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -104.07 108.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 119.697 0.927 . . . . 1.0 111.372 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.15 -51.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.097 2.559 . . . . 1.0 105.912 174.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -45.2 -33.51 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 1 C-N-CA 131.82 4.048 . . . . 1.0 110.013 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.15 -25.54 0.91 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.59 18.97 4.29 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.582 2.353 . . . . 1.0 111.133 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.75 84.29 2.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.88 1.272 . . . . 1.0 109.687 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 116.58 21.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.03 -1.841 . . . . 1.0 106.03 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 -173.25 4.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.846 0.748 . . . . 1.0 109.852 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.31 -131.06 2.64 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 106.696 -2.562 . . . . 1.0 106.696 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 19.8 m170 -112.71 -23.87 9.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.59 0.756 . . . . 1.0 111.215 -177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 t -102.89 -17.05 15.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.615 1.166 . . . . 1.0 111.081 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -85.12 40.3 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.338 1.426 . . . . 1.0 109.196 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -69.71 -9.2 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 O-C-N 120.744 -1.222 . . . . 1.0 109.019 175.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.13 -53.52 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.001 2.52 . . . . 1.0 111.538 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -96.42 121.61 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.852 2.368 . . . . 1.0 114.217 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.51 -17.09 63.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.564 -1.335 . . . . 1.0 112.141 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -24.93 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.115 -0.991 . . . . 1.0 111.48 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -144.31 123.77 13.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.475 -2.046 . . . . 1.0 105.475 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.2 m -114.16 -16.29 12.1 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.402 0.438 . . . . 1.0 112.045 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.24 171.46 1.06 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 128.446 2.698 . . . . 1.0 104.755 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 87.34 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.308 2.006 . . . . 1.0 109.747 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.74 75.42 0.68 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.143 1.83 . . . . 1.0 110.996 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.14 -95.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.736 2.291 . . . . 1.0 110.024 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 54.3 43.64 30.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.188 2.595 . . . . 1.0 111.0 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -97.53 18.58 15.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.348 0.659 . . . . 1.0 111.94 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.4 t0 44.88 67.22 0.74 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.745 1.218 . . . . 1.0 111.803 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.19 -25.51 59.14 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.706 -0.621 . . . . 1.0 112.474 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -55.75 15.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 117.794 -1.098 . . . . 1.0 109.605 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -62.4 -42.84 99.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 117.312 -1.328 . . . . 1.0 110.547 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -61.41 -52.67 63.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.108 1.322 . . . . 1.0 110.881 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.36 77.78 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.16 86.96 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.68 -54.8 14.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.79 1.636 . . . . 1.0 111.007 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.8 160.09 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.133 0.973 . . . . 1.0 109.098 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 126.51 1.924 . . . . 1.0 105.89 175.162 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.33 173.86 8.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.605 0.762 . . . . 1.0 111.042 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 40.04 57.75 2.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.721 2.408 . . . . 1.0 109.993 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.14 153.6 20.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -81.68 130.15 34.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -83.55 118.64 23.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -138.48 88.74 14.27 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.11 123.82 11.41 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 N-CA-C 109.333 -1.064 . . . . 1.0 109.333 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -63.64 146.53 96.65 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.05 -25.29 19.55 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 N-CA-C 117.393 2.036 . . . . 1.0 117.393 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -150.82 117.89 5.93 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.841 -1.911 . . . . 1.0 105.841 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' VAL . 3.3 m-85 -86.92 178.17 7.04 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.084 0.954 . . . . 1.0 112.543 -175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.38 178.99 4.09 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.931 1.693 . . . . 1.0 111.859 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.3 m -164.94 127.46 2.22 Favored 'General case' 0 CA--C 1.534 0.354 1 C-N-CA 133.356 4.662 . . . . 1.0 103.184 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -131.33 153.78 81.74 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.699 1.136 . . . . 1.0 108.614 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.92 67.67 8.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.104 3.203 . . . . 1.0 110.804 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.48 159.5 42.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.632 1.573 . . . . 1.0 110.734 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -150.91 103.92 3.11 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -137.25 176.48 8.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -84.48 123.0 75.2 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.792 -1.559 . . . . 1.0 106.792 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.26 103.02 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 N-CA-C 108.3 -1.462 . . . . 1.0 108.3 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 t -175.76 69.05 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 150' ' ' ASN . 26.6 tp -147.9 130.45 15.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.99 0.916 . . . . 1.0 108.705 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.476 HD11 HD11 ' A' ' 133' ' ' LEU . 15.7 tp -84.38 124.52 31.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.28 114.04 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 169' ' ' PHE . 87.8 t -114.22 113.93 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.429 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 1.3 p80 -163.54 143.58 8.63 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.545 -2.021 . . . . 1.0 105.545 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 8.0 mm -127.59 176.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 130.835 3.654 . . . . 1.0 107.851 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -160.28 121.78 3.12 Favored 'General case' 0 N--CA 1.432 -1.365 1 N-CA-C 97.829 -4.878 . . . . 1.0 97.829 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.652 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 4.8 tt -142.57 -43.9 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.398 -1.763 . . . . 1.0 112.941 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 44.7 Cg_endo -82.99 150.31 13.93 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 121.662 1.629 . . . . 1.0 114.833 -175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 7.38 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.843 3.028 . . . . 1.0 116.777 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -23.49 -71.3 0.01 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 121.059 1.754 . . . . 1.0 112.525 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -156.6 123.21 5.09 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.291 14.1 m-85 -177.76 153.94 0.9 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 129.649 3.18 . . . . 1.0 109.862 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.31 2.09 77.75 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.05 -0.861 . . . . 1.0 112.885 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.85 118.54 5.51 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.01 -4.05 14.45 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.373 2.049 . . . . 1.0 113.213 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' CZ2' ' CD1' ' A' ' 64' ' ' PHE . 32.6 t-105 -64.55 -39.55 93.97 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.598 1.09 . . . . 1.0 110.305 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 38' ' ' LEU . 5.8 mt -65.86 -46.63 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.568 1.947 . . . . 1.0 109.274 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.63 -46.37 89.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.861 0.755 . . . . 1.0 110.552 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.2 -34.06 63.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.236 1.414 . . . . 1.0 111.39 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.27 -54.79 27.7 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.195 0.452 . . . . 1.0 110.524 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -70.1 -42.5 72.62 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 119.014 -0.517 . . . . 1.0 112.297 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.16 -34.23 77.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.33 1.052 . . . . 1.0 109.049 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.21 -0.47 31.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.367 1.46 . . . . 1.0 115.681 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.3 p -88.99 11.19 18.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.057 1.928 . . . . 1.0 112.934 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.566 HG21 ' CB ' ' A' ' 68' ' ' ALA . 10.8 tt -51.63 135.9 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.108 1.763 . . . . 1.0 112.793 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -98.62 131.31 26.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 127.446 2.299 . . . . 1.0 109.29 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.2 63.01 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.68 3.587 . . . . 1.0 110.184 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -104.54 -65.93 1.0 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.407 1.883 . . . . 1.0 113.15 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.35 -54.76 15.55 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.69 1.196 . . . . 1.0 110.714 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.2 p80 -171.32 177.82 0.87 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.685 1.994 . . . . 1.0 106.766 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.4 Cg_endo -72.49 -43.63 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.494 1.462 . . . . 1.0 114.033 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -50.84 -57.6 8.03 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HD1' HD11 ' A' ' 56' ' ' ILE . 20.8 t80 -59.27 -44.96 92.4 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.205 0.602 . . . . 1.0 111.475 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.67 97.94 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.831 -0.543 . . . . 1.0 111.324 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.68 -60.81 8.23 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.827 1.203 . . . . 1.0 112.026 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.2 pt -51.0 -41.48 22.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.798 1.239 . . . . 1.0 112.96 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' A' ' 56' ' ' ILE . . . -38.01 -43.53 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 127.901 2.48 . . . . 1.0 115.158 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -60.8 -35.58 76.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.449 0.7 . . . . 1.0 110.423 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.77 135.75 33.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 153.46 32.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.377 -0.929 . . . . 1.0 110.05 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.54 163.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.165 1.386 . . . . 1.0 108.671 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 88' ' ' VAL . 2.4 m -170.67 128.04 0.78 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.306 -1.739 . . . . 1.0 106.306 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.17 -154.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.461 -1.681 . . . . 1.0 106.461 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -124.63 -58.55 1.5 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.879 1.672 . . . . 1.0 110.0 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HB2' HD13 ' A' ' 115' ' ' ILE . 68.0 m -142.65 121.35 12.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.53 113.93 21.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.385 1.474 . . . . 1.0 107.853 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 HE21 ' A' ' 129' ' ' GLN . 62.3 mt -97.55 116.59 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.711 1.204 . . . . 1.0 108.078 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -78.92 153.35 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.345 1.884 . . . . 1.0 109.574 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.621 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -46.87 -23.23 0.41 Allowed 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.711 2.004 . . . . 1.0 114.259 176.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.621 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . 18.3 t0 -91.42 34.61 0.95 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.225 0.921 . . . . 1.0 110.478 -175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.08 29.56 71.33 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.109 -0.995 . . . . 1.0 113.868 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.53 140.67 32.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.01 114.07 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 103.838 -2.653 . . . . 1.0 103.838 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 t -111.67 139.6 35.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.362 0.665 . . . . 1.0 109.514 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -104.87 118.83 37.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -117.65 113.34 21.76 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 103.239 -2.874 . . . . 1.0 103.239 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 19' ' ' TYR . 48.1 t 69.2 91.8 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.31 1.414 . . . . 1.0 112.332 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -66.88 -168.25 0.15 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.471 2.114 . . . . 1.0 111.669 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -60.71 22.76 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 129.378 3.071 . . . . 1.0 116.811 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -159.69 133.49 7.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.972 1.714 . . . . 1.0 107.865 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 tptm 86.29 82.14 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 129.453 3.101 . . . . 1.0 109.665 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.12 147.5 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.991 3.317 . . . . 1.0 115.425 -174.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.07 175.95 5.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.342 3.057 . . . . 1.0 111.076 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -156.12 118.19 4.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.074 1.75 . . . . 1.0 107.343 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.9 63.22 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.287 -1.508 . . . . 1.0 112.318 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.14 -62.79 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.202 -2.186 . . . . 1.0 114.358 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.32 -91.4 0.47 Allowed Glycine 0 CA--C 1.53 1.005 0 N-CA-C 103.608 -3.797 . . . . 1.0 103.608 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.84 146.4 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.807 1.803 . . . . 1.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -154.77 166.51 33.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.479 1.511 . . . . 1.0 110.312 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.43 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -150.9 146.83 26.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.4 1.48 . . . . 1.0 110.745 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.54 133.88 21.81 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.832 -0.543 . . . . 1.0 110.054 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 39.36 65.77 0.65 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.74 2.016 . . . . 1.0 111.367 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 29.26 67.21 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.089 1.196 . . . . 1.0 116.089 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -130.55 136.25 48.73 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.854 -1.906 . . . . 1.0 105.854 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.05 146.83 28.55 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.529 2.332 . . . . 1.0 111.931 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -127.42 118.35 23.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.763 1.225 . . . . 1.0 107.814 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -79.68 -23.42 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.469 0.708 . . . . 1.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -144.97 175.22 10.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.863 2.065 . . . . 1.0 106.547 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -101.2 76.73 1.74 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.55 33.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.011 2.124 . . . . 1.0 113.72 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -129.37 138.98 51.84 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 121.201 -0.937 . . . . 1.0 111.491 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.257 0.1 OUTLIER -78.54 56.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.931 2.092 . . . . 1.0 109.798 -177.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.6 -136.4 1.39 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 122.289 0.939 . . . . 1.0 111.247 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 136' ' ' VAL . 8.5 mm -144.02 166.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 130.151 3.38 . . . . 1.0 103.144 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -143.43 136.85 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 103.222 -2.881 . . . . 1.0 103.222 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -98.81 134.28 41.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.166 -0.959 . . . . 1.0 109.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 24.3 tt0 -105.61 138.28 42.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.806 0.812 . . . . 1.0 110.285 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.47 40.11 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.47 1.986 . . . . 1.0 109.41 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -153.28 116.18 4.53 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.32 39.7 30.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.865 1.316 . . . . 1.0 112.194 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p 45.08 37.73 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.293 2.237 . . . . 1.0 112.529 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.04 136.69 58.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.66 113.38 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.695 2.398 . . . . 1.0 112.618 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -78.67 -16.2 57.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 116.554 -1.689 . . . . 1.0 112.876 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.359 10.3 p 66.51 77.54 0.28 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 121.183 1.81 . . . . 1.0 112.118 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.25 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.699 2.045 . . . . 1.0 115.25 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.12 -36.92 3.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 1.0 109.354 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.429 HE21 HG22 ' A' ' 78' ' ' ILE . 37.3 mt-30 -56.41 -58.49 7.77 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 125.564 1.546 . . . . 1.0 107.559 175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -52.79 -44.73 66.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.263 0.938 . . . . 1.0 110.075 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -66.16 -58.15 6.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.549 0.74 . . . . 1.0 111.947 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -66.3 -34.33 77.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.503 1.047 . . . . 1.0 112.09 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 115' ' ' ILE . 9.2 tp -61.14 -44.56 97.13 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 106.962 -1.495 . . . . 1.0 106.962 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.5 80.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.134 -0.936 . . . . 1.0 110.412 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.99 -55.35 35.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.447 1.021 . . . . 1.0 109.972 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 115' ' ' ILE . 57.6 t -54.33 -49.18 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 1.0 109.338 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.1 m -58.38 -53.89 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.594 1.158 . . . . 1.0 109.873 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -56.09 -43.67 78.25 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.914 1.285 . . . . 1.0 110.478 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.62 63.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.12 0.568 . . . . 1.0 111.713 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -56.56 -34.57 67.24 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 117.918 -1.039 . . . . 1.0 111.264 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.28 -43.38 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 120.159 1.345 . . . . 1.0 109.144 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.5 m -64.43 -23.1 67.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.854 0.752 . . . . 1.0 111.524 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -83.77 -58.55 2.75 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.788 -1.195 . . . . 1.0 108.438 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.61 113.15 22.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.549 1.54 . . . . 1.0 109.104 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.54 107.78 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 CA-C-N 120.857 1.342 . . . . 1.0 111.867 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.23 -51.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.014 2.125 . . . . 1.0 107.798 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.4 mt -45.16 -33.4 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 131.508 3.923 . . . . 1.0 111.078 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.99 -23.42 5.08 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.222 1.009 . . . . 1.0 113.541 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -140.52 30.75 1.9 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.687 2.395 . . . . 1.0 109.089 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.549 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.7 m120 -140.7 83.78 1.91 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.367 1.867 . . . . 1.0 110.311 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.57 116.65 16.15 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 126.661 1.984 . . . . 1.0 105.718 175.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 HD11 ' A' ' 30' ' ' LEU . 10.6 t -151.69 -173.2 4.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.98 -131.52 2.29 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 105.604 -2.998 . . . . 1.0 105.604 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.429 ' HE1' ' CE1' ' A' ' 34' ' ' HIS 0.306 13.0 m170 -112.98 -22.28 10.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.867 1.267 . . . . 1.0 111.311 -176.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.02 -11.25 17.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.493 0.588 . . . . 1.0 109.807 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -86.57 36.41 0.7 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.632 1.105 . . . . 1.0 108.532 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -67.8 -12.07 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 120.399 -1.438 . . . . 1.0 109.859 175.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.06 -66.01 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.74 2.416 . . . . 1.0 111.16 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 95.3 Cg_endo -92.65 127.89 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.275 1.983 . . . . 1.0 114.075 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.46 -26.25 65.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.938 1.295 . . . . 1.0 112.615 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -63.13 -21.66 66.34 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.856 1.263 . . . . 1.0 111.774 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 138.92 53.29 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 105.174 -2.158 . . . . 1.0 105.174 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -132.39 -16.63 2.7 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 118.868 -1.133 . . . . 1.0 110.844 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -179.27 0.35 Allowed Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 129.171 2.989 . . . . 1.0 104.292 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.29 52.23 4.2 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 122.543 2.162 . . . . 1.0 112.5 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.72 73.24 0.12 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.005 1.764 . . . . 1.0 112.538 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.15 -63.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.46 2.106 . . . . 1.0 111.955 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.7 t 54.46 43.8 29.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.932 2.093 . . . . 1.0 110.446 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 33' ' ' VAL . 58.2 t80 -94.02 18.25 10.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -175.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.72 71.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.942 1.297 . . . . 1.0 112.858 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -54.78 -32.28 59.87 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 115.154 -0.93 . . . . 1.0 112.634 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.06 71.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.356 -0.83 . . . . 1.0 110.148 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -61.66 -55.96 24.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.399 0.999 . . . . 1.0 110.74 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.86 -51.28 70.4 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.727 1.751 . . . . 1.0 115.727 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -39.11 84.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.137 0.881 . . . . 1.0 109.279 -175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.39 78.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.566 0.95 . . . . 1.0 113.566 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.12 -45.33 92.5 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.352 1.461 . . . . 1.0 114.068 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.34 160.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.238 0.469 0 C-N-CA 125.869 1.668 . . . . 1.0 106.554 175.308 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 106.112 -1.811 . . . . 1.0 106.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 165.91 23.3 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.556 0.743 . . . . 1.0 112.239 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 42.28 58.46 2.99 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.815 1.646 . . . . 1.0 109.046 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.49 145.94 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.656 1.183 . . . . 1.0 109.683 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -76.08 123.15 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.45 118.96 30.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.906 0.775 . . . . 1.0 109.027 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.19 73.52 81.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.3 123.92 11.11 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.724 1.616 . . . . 1.0 108.812 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -137.53 113.51 9.38 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 126.566 1.947 . . . . 1.0 106.949 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.25 58.8 7.11 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.275 1.983 . . . . 1.0 110.845 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -123.73 43.53 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.925 1.69 . . . . 1.0 106.709 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.487 ' CD1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -82.82 179.28 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.385 1.474 . . . . 1.0 110.374 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.3 178.57 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.666 1.586 . . . . 1.0 109.031 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.4 m -150.55 131.64 14.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.865 2.466 . . . . 1.0 105.121 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.26 149.28 72.11 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 108.258 -1.015 . . . . 1.0 108.258 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.04 97.38 1.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 N-CA-C 106.601 -2.115 . . . . 1.0 106.601 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -162.6 147.95 12.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -146.73 108.07 4.25 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.979 0.809 . . . . 1.0 109.699 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -136.2 160.24 39.29 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 127.399 2.28 . . . . 1.0 106.952 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -69.36 123.4 88.28 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.59 103.0 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.626 -1.336 . . . . 1.0 108.626 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -175.9 70.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.07 127.35 13.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 105.091 -2.188 . . . . 1.0 105.091 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.31 129.37 41.01 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.9 139.53 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 105.976 -1.861 . . . . 1.0 105.976 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.84 122.9 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -171.07 150.22 3.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.275 1.43 . . . . 1.0 107.357 175.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -95.3 111.9 23.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mm -127.37 176.4 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 128.333 2.653 . . . . 1.0 107.59 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 t -148.89 122.18 8.99 Favored 'General case' 0 C--O 1.247 0.938 1 N-CA-C 94.825 -5.991 . . . . 1.0 94.825 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.338 0.4 OUTLIER -142.57 -65.15 0.02 OUTLIER Pre-proline 0 C--O 1.222 -0.347 0 CA-C-O 117.823 -1.084 . . . . 1.0 113.316 178.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.81 162.25 9.09 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.822 3.015 . . . . 1.0 115.523 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.58 28.83 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.831 3.021 . . . . 1.0 114.973 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -40.87 -71.42 0.31 Allowed Glycine 0 C--N 1.35 1.339 0 CA-C-N 120.78 1.627 . . . . 1.0 109.312 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 23.4 mt-10 -156.31 123.48 5.34 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.648 2.379 . . . . 1.0 107.124 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -176.89 176.95 1.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 131.366 3.866 . . . . 1.0 108.098 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.67 4.95 8.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.316 1.436 . . . . 1.0 111.603 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.61 136.56 14.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.368 1.584 . . . . 1.0 110.497 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.32 -16.99 15.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.828 2.352 . . . . 1.0 113.782 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -54.32 -39.9 67.46 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.528 1.058 . . . . 1.0 111.556 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.3 mt -64.99 -48.73 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.352 1.061 . . . . 1.0 109.047 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.55 -49.65 76.69 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.02 -34.68 68.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.942 0.897 . . . . 1.0 111.727 -176.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.92 -49.31 68.44 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.151 0.98 . . . . 1.0 110.26 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -70.41 -48.27 56.87 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.257 0.623 . . . . 1.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.14 -37.47 85.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.305 1.842 . . . . 1.0 109.955 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.24 1.65 28.1 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.222 1.391 . . . . 1.0 115.357 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -89.08 9.89 23.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.322 2.061 . . . . 1.0 113.045 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.81 136.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.142 1.777 . . . . 1.0 113.116 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.88 122.7 51.94 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.87 2.468 . . . . 1.0 109.375 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.56 58.77 5.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.032 3.155 . . . . 1.0 111.016 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.09 -54.72 2.56 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 117.752 -1.118 . . . . 1.0 111.914 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.65 -51.15 61.39 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.59 1.087 . . . . 1.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 20.8 p80 -170.4 178.02 0.93 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.701 2.0 . . . . 1.0 107.032 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 25.4 Cg_endo -75.95 -43.31 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.36 1.373 . . . . 1.0 114.125 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -42.41 -47.54 4.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.886 1.675 . . . . 1.0 113.758 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.81 -55.45 34.7 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.839 1.256 . . . . 1.0 109.6 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.0 95.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.265 1.426 . . . . 1.0 110.733 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.61 -64.11 1.96 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 127.048 2.261 . . . . 1.0 111.874 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 pt -61.42 -32.66 53.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 117.243 -1.36 . . . . 1.0 112.661 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.0 -43.12 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.004 2.224 . . . . 1.0 117.004 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.55 -33.83 73.25 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.489 -0.757 . . . . 1.0 110.33 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.88 135.37 33.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.17 162.67 19.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 175.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.48 158.54 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 124.513 1.125 . . . . 1.0 108.691 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.4 m -175.44 125.28 0.24 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.042 1.337 . . . . 1.0 108.887 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.18 -168.8 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 174.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -113.22 -76.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.643 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.2 m -124.03 118.41 26.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.86 113.69 27.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.081 -2.192 . . . . 1.0 105.081 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.7 mt -99.26 113.4 34.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ttp85 -85.28 153.4 22.61 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.54 -1.282 . . . . 1.0 107.54 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -48.65 -20.24 0.44 Allowed 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.543 1.937 . . . . 1.0 115.266 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.68 28.24 1.82 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.104 0.962 . . . . 1.0 112.442 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.83 30.04 71.89 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.297 1.903 . . . . 1.0 113.766 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.68 113.08 25.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.674 0.79 . . . . 1.0 110.474 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.38 120.97 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 104.822 -2.288 . . . . 1.0 104.822 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.43 149.08 14.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.666 -2.346 . . . . 1.0 104.666 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -126.12 122.1 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.731 0.812 . . . . 1.0 110.818 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -121.21 129.51 53.24 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 128.856 2.862 . . . . 1.0 103.922 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 73' ' ' SER . 3.8 t 64.42 91.72 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 CA-C-N 121.684 2.038 . . . . 1.0 113.753 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -66.44 -170.43 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.515 2.143 . . . . 1.0 113.396 177.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.09 15.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.455 2.702 . . . . 1.0 115.099 -175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -137.87 116.69 12.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.329 2.252 . . . . 1.0 108.021 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 tttt 78.86 81.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 128.288 2.635 . . . . 1.0 107.554 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.28 150.78 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 130.266 3.426 . . . . 1.0 113.67 -175.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.28 -178.24 3.6 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.993 2.117 . . . . 1.0 110.104 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -147.88 118.9 7.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.175 1.352 . . . . 1.0 110.34 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.49 63.06 0.17 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.728 1.251 . . . . 1.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -158.26 -54.89 0.07 Allowed 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 118.76 -2.463 . . . . 1.0 114.354 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.81 -74.83 1.12 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.029 -2.028 . . . . 1.0 108.029 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.8 t -149.26 135.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.605 1.703 . . . . 1.0 110.933 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -166.98 149.24 6.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.202 1.801 . . . . 1.0 109.789 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.69 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -134.03 146.45 50.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 128.374 2.669 . . . . 1.0 110.785 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -150.17 142.61 24.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 39.13 53.81 2.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.507 1.523 . . . . 1.0 112.802 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.01 29.16 70.14 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.374 -0.681 . . . . 1.0 114.751 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -130.11 113.8 14.95 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.444 -1.688 . . . . 1.0 106.444 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -93.49 146.7 23.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.776 1.23 . . . . 1.0 107.721 175.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.5 mtm-85 -112.29 118.58 35.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.849 1.26 . . . . 1.0 108.076 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.51 -30.11 71.14 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.807 0.692 . . . . 1.0 110.338 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -146.03 170.14 17.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.516 1.126 . . . . 1.0 108.192 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.91 76.89 8.79 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.208 1.004 . . . . 1.0 109.485 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.95 33.8 1.3 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.054 1.341 . . . . 1.0 112.415 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -127.89 156.47 42.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.08 1.352 . . . . 1.0 112.628 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.08 56.83 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.832 2.053 . . . . 1.0 109.089 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.22 -136.78 3.84 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.05 -1.031 . . . . 1.0 112.385 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 76' ' ' CYS . 12.3 mm -145.15 165.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.44 2.696 . . . . 1.0 104.549 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.49 138.55 26.2 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.492 -2.41 . . . . 1.0 104.492 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.8 151.38 22.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.897 0.771 . . . . 1.0 110.52 176.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -130.43 138.93 50.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.294 0.568 . . . . 1.0 111.064 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.85 -171.75 37.88 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.002 1.763 . . . . 1.0 110.124 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 p -148.65 115.33 5.97 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 103.346 -2.835 . . . . 1.0 103.346 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t0 42.18 53.15 4.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 129.393 3.077 . . . . 1.0 113.994 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 49.32 38.87 14.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.793 1.637 . . . . 1.0 113.493 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 tp -56.66 143.81 34.71 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 107.127 -1.435 . . . . 1.0 107.127 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -34.84 115.67 0.29 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.625 1.97 . . . . 1.0 109.867 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.67 -7.85 58.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.776 -2.059 . . . . 1.0 114.517 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.397 20.3 p 66.5 78.59 0.26 Allowed 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 121.398 1.908 . . . . 1.0 112.528 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.34 -34.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.007 1.73 . . . . 1.0 114.372 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.42 -41.33 9.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.072 2.149 . . . . 1.0 111.635 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -48.97 -51.18 31.87 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.023 1.329 . . . . 1.0 109.29 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -58.67 -37.35 75.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.536 -0.745 . . . . 1.0 110.541 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -64.61 -55.85 17.64 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.154 0.888 . . . . 1.0 110.861 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.93 -47.32 75.1 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.069 0.948 . . . . 1.0 110.918 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 115' ' ' ILE . 56.4 tp -56.36 -47.36 79.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.021 1.328 . . . . 1.0 108.43 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.37 99.26 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.493 1.042 . . . . 1.0 110.236 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.72 54.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.027 0.831 . . . . 1.0 110.036 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 115' ' ' ILE . 89.7 t -55.88 -47.3 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.657 0.783 . . . . 1.0 109.375 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 72.9 m -57.12 -53.31 59.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.253 1.021 . . . . 1.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -56.04 -45.7 79.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.927 0.891 . . . . 1.0 110.542 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.7 63.93 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.524 -0.735 . . . . 1.0 110.385 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.86 -45.32 82.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.528 1.531 . . . . 1.0 110.763 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.51 -42.96 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.191 0.996 . . . . 1.0 109.582 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -64.73 -24.93 67.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.969 -0.457 . . . . 1.0 110.508 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -84.08 -59.29 2.45 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.263 -1.384 . . . . 1.0 107.263 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -122.2 113.0 31.27 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -102.92 107.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 116.595 -1.803 . . . . 1.0 112.809 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.5 -44.08 0.1 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 128.674 2.79 . . . . 1.0 106.809 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 42.8 mt -45.2 -33.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 128.546 2.738 . . . . 1.0 110.592 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.43 -21.97 4.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.476 1.51 . . . . 1.0 113.929 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -135.12 18.57 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.091 2.156 . . . . 1.0 109.452 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -138.97 83.69 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.614 1.097 . . . . 1.0 109.595 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 124.56 29.28 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.154 -2.535 . . . . 1.0 104.154 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 t -156.96 -174.42 4.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.265 0.484 . . . . 1.0 109.885 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -143.59 -131.8 2.54 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.541 -2.224 . . . . 1.0 107.541 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.496 ' HE1' ' CE1' ' A' ' 34' ' ' HIS . 11.8 m170 -121.2 -23.52 5.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.956 1.378 . . . . 1.0 112.694 -175.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.56 -6.29 22.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 19.6 t-20 -83.58 15.59 3.06 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 128.556 2.743 . . . . 1.0 111.549 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.69 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.53 -15.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.609 0.763 . . . . 1.0 111.815 -175.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.74 -53.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.617 1.967 . . . . 1.0 110.282 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.22 108.74 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.594 1.605 . . . . 1.0 111.367 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.25 -26.16 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.485 -1.384 . . . . 1.0 110.049 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.2 -25.96 66.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.446 1.898 . . . . 1.0 111.946 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -127.22 124.26 38.51 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 105.161 -2.163 . . . . 1.0 105.161 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 23.9 m -119.29 -16.69 8.99 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.913 -0.715 . . . . 1.0 112.43 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.46 179.67 0.39 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.812 2.445 . . . . 1.0 104.679 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.47 88.01 1.2 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.027 2.485 . . . . 1.0 109.862 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 69.7 0.67 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.093 1.33 . . . . 1.0 109.96 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -76.13 -81.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.303 2.052 . . . . 1.0 110.995 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t 53.66 42.9 31.75 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.453 1.501 . . . . 1.0 109.576 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.29 17.53 19.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.27 0.486 . . . . 1.0 112.178 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.3 t0 44.52 68.01 0.61 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.905 1.682 . . . . 1.0 113.008 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -54.88 -33.0 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 119.059 -0.496 . . . . 1.0 111.717 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.29 22.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.853 -1.07 . . . . 1.0 109.912 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -60.12 -47.66 84.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.257 0.935 . . . . 1.0 111.982 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.37 -58.94 6.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.771 0.669 . . . . 1.0 110.942 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -34.03 74.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.922 -0.561 . . . . 1.0 111.687 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.03 93.3 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 117.941 0.337 . . . . 1.0 111.667 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.16 -50.72 30.36 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.796 0.839 . . . . 1.0 111.647 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.95 166.38 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.664 1.986 . . . . 1.0 111.255 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 CA--C 1.548 0.867 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 175.235 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 11' ' ' ALA . 5.8 tt . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.08 148.34 26.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.619 1.099 . . . . 1.0 110.368 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 47.33 75.05 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.004 1.722 . . . . 1.0 110.799 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' HD22 ' A' ' 8' ' ' LEU . . . -161.63 155.49 21.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.984 2.514 . . . . 1.0 107.916 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -76.71 123.38 26.09 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 104.728 -2.323 . . . . 1.0 104.728 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -93.19 138.43 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.12 76.69 50.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.711 1.204 . . . . 1.0 107.785 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.66 125.91 13.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.454 2.103 . . . . 1.0 109.416 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -144.5 113.32 5.11 Favored Pre-proline 0 CA--C 1.518 -0.288 0 C-N-CA 124.887 1.275 . . . . 1.0 107.626 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.21 65.39 8.83 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.307 2.005 . . . . 1.0 111.288 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -130.29 43.63 3.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 1.0 107.358 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.76 178.49 7.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.427 1.091 . . . . 1.0 110.337 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.53 178.07 4.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.727 0.775 . . . . 1.0 112.718 -175.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.6 m -165.07 118.48 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 128.329 2.652 . . . . 1.0 108.177 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 158.36 62.95 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.346 -1.724 . . . . 1.0 106.346 175.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.84 88.08 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.468 1.445 . . . . 1.0 109.762 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.68 143.37 29.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.919 -1.882 . . . . 1.0 105.919 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -151.52 103.35 2.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.645 1.111 . . . . 1.0 110.738 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -137.37 162.67 32.97 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -69.63 123.23 88.1 Favored Pre-proline 0 C--O 1.239 0.526 0 N-CA-C 104.928 -2.249 . . . . 1.0 104.928 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HB2' HG22 ' A' ' 113' ' ' ILE . 91.4 Cg_endo -78.2 103.37 1.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.789 1.318 . . . . 1.0 108.72 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 t -169.3 80.49 0.12 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -152.77 124.1 7.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -99.31 126.45 45.17 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.764 1.626 . . . . 1.0 108.381 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.5 145.03 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' A' ' 169' ' ' PHE . 21.4 t -136.36 123.91 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 104.181 -2.526 . . . . 1.0 104.181 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -175.38 146.93 0.84 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 117.339 -1.315 . . . . 1.0 107.507 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.15 112.32 22.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.414 1.006 . . . . 1.0 110.468 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.25 174.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.8 t -144.06 121.84 11.93 Favored 'General case' 0 C--O 1.247 0.93 1 N-CA-C 97.146 -5.131 . . . . 1.0 97.146 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' ILE 0.324 1.1 tm? -141.67 -65.58 0.02 OUTLIER Pre-proline 0 C--O 1.224 -0.266 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.3 157.66 22.79 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 121.982 1.744 . . . . 1.0 112.066 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.43 12.26 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.102 3.201 . . . . 1.0 116.363 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -28.18 -71.13 0.05 OUTLIER Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.697 -1.613 . . . . 1.0 114.062 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -156.54 123.64 5.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.712 1.605 . . . . 1.0 111.257 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -169.39 150.72 4.31 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.503 1.521 . . . . 1.0 110.795 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.8 -6.53 52.27 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.122 -1.377 . . . . 1.0 112.089 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.25 118.61 5.7 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.566 -1.813 . . . . 1.0 108.566 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.262 88.6 Cg_endo -65.26 -3.06 6.75 Favored 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 126.123 4.549 . . . . 1.0 118.964 -175.143 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -55.63 -46.93 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.922 2.146 . . . . 1.0 113.262 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' LEU . 9.4 mm -61.38 -47.05 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.567 -1.271 . . . . 1.0 107.567 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.89 -48.58 67.07 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 124.841 1.257 . . . . 1.0 109.129 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.23 -38.79 77.53 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.254 1.022 . . . . 1.0 112.381 -176.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.75 -51.13 61.69 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.784 0.434 . . . . 1.0 109.878 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.28 -39.51 71.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.346 0.499 . . . . 1.0 112.346 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.58 -52.63 43.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.645 1.178 . . . . 1.0 110.647 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.94 9.82 2.68 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 118.439 -1.201 . . . . 1.0 115.45 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 p -107.87 9.07 28.88 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.658 2.229 . . . . 1.0 114.86 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.2 134.4 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.76 1.164 . . . . 1.0 111.981 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.15 136.5 25.76 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 129.141 2.976 . . . . 1.0 109.338 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.7 76.33 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 1.0 106.923 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -103.55 -64.14 1.12 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.266 0.626 . . . . 1.0 111.266 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.6 79.15 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.614 0.766 . . . . 1.0 111.07 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 24.3 p80 -170.08 177.96 0.97 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.623 1.969 . . . . 1.0 107.047 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.05 -43.71 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.393 1.395 . . . . 1.0 114.33 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -46.14 -45.78 16.78 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.101 1.148 . . . . 1.0 114.101 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -56.12 -53.92 51.24 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.951 0.901 . . . . 1.0 109.193 -175.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.57 84.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.235 1.014 . . . . 1.0 111.665 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.66 -53.94 15.39 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.639 1.59 . . . . 1.0 111.515 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 pt -61.02 -43.45 96.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 117.303 -1.332 . . . . 1.0 110.908 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.56 -43.05 1.8 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.084 2.154 . . . . 1.0 115.19 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -46.96 -56.64 6.05 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.75 136.98 53.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.149 2.979 . . . . 1.0 106.912 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.65 155.13 16.26 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.475 -1.391 . . . . 1.0 109.211 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.83 158.39 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.543 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 m -173.66 131.73 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.582 1.553 . . . . 1.0 108.645 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.5 -176.64 3.68 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.67 -1.604 . . . . 1.0 106.67 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -120.02 -76.28 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.115 0.966 . . . . 1.0 109.481 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.745 ' HB2' HD13 ' A' ' 115' ' ' ILE . 85.6 m -117.34 118.37 32.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.3 114.15 20.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.432 1.093 . . . . 1.0 108.318 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 mt -94.4 117.21 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.927 0.891 . . . . 1.0 108.641 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -77.21 149.7 35.5 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.073 1.306 . . . . 1.0 109.171 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -23.74 2.93 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 126.466 1.906 . . . . 1.0 114.917 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.03 35.0 0.99 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.764 1.226 . . . . 1.0 113.798 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.24 40.8 99.09 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.757 1.17 . . . . 1.0 114.661 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -108.4 151.69 25.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.982 0.891 . . . . 1.0 110.676 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.16 113.98 44.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 102.492 -3.151 . . . . 1.0 102.492 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.11 145.45 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 119.29 27.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.779 1.632 . . . . 1.0 106.776 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -120.15 140.99 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.975 -2.231 . . . . 1.0 104.975 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 73' ' ' SER . 15.9 t 65.23 92.09 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.162 1.541 . . . . 1.0 115.162 175.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -56.73 169.65 1.71 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 N-CA-C 109.052 -1.172 . . . . 1.0 109.052 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.74 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.944 2.572 . . . . 1.0 117.944 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -134.51 117.05 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.735 2.814 . . . . 1.0 105.807 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.65 81.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.37 2.668 . . . . 1.0 109.539 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -35.02 148.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 131.205 3.802 . . . . 1.0 114.356 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.25 178.55 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.933 2.093 . . . . 1.0 109.657 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -149.49 119.01 6.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.246 1.384 . . . . 1.0 110.568 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.68 62.92 0.47 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.076 1.417 . . . . 1.0 110.185 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -163.27 -63.8 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 119.015 -2.303 . . . . 1.0 113.852 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.96 -68.87 0.21 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 106.274 -2.73 . . . . 1.0 106.274 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -145.53 146.49 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.075 1.35 . . . . 1.0 109.519 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.8 p -160.38 166.31 29.57 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.092 1.757 . . . . 1.0 107.857 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 p -159.28 145.83 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -159.77 154.0 23.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.612 1.096 . . . . 1.0 109.343 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 39.43 54.99 2.33 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.3 1.84 . . . . 1.0 111.153 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.65 84.98 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.933 -0.926 . . . . 1.0 113.117 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.75 119.24 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.842 1.321 . . . . 1.0 108.492 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.91 146.74 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.255 1.422 . . . . 1.0 111.699 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -124.45 118.22 26.17 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -72.02 -31.03 65.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.674 0.79 . . . . 1.0 111.683 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.22 176.24 11.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 128.407 2.683 . . . . 1.0 106.401 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.331 15.3 t70 -87.19 77.07 9.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.104 0.954 . . . . 1.0 111.78 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -90.51 44.54 1.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.616 -1.253 . . . . 1.0 107.616 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -123.26 133.45 54.18 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.272 1.029 . . . . 1.0 110.785 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 28' ' ' PRO 0.256 0.1 OUTLIER -91.21 56.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 175.57 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.39 -136.4 3.82 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.488 1.049 . . . . 1.0 111.217 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 76' ' ' CYS . 7.9 mm -139.65 165.14 22.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 128.156 2.582 . . . . 1.0 104.114 176.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -146.18 131.34 18.38 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.961 -2.977 . . . . 1.0 102.961 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.71 127.98 48.23 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.055 -1.653 . . . . 1.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -103.36 138.37 40.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.425 0.631 . . . . 1.0 111.224 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.03 40.49 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.945 1.26 . . . . 1.0 111.586 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.7 p -142.32 108.3 5.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.408 1.483 . . . . 1.0 107.923 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t0 49.76 55.67 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.124 2.17 . . . . 1.0 113.83 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 48.96 38.38 12.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.255 1.822 . . . . 1.0 113.973 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.19 142.8 58.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 105.283 -2.118 . . . . 1.0 105.283 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -43.03 114.78 0.65 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.683 1.193 . . . . 1.0 108.771 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -78.52 -2.12 37.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 116.783 -1.579 . . . . 1.0 114.83 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 29.0 p 64.01 76.5 0.35 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.077 1.308 . . . . 1.0 111.013 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.35 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.723 2.009 . . . . 1.0 113.132 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.01 -38.35 4.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.629 2.372 . . . . 1.0 111.837 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -47.6 -43.88 25.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.242 1.417 . . . . 1.0 110.112 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -60.64 -39.6 88.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.284 -0.865 . . . . 1.0 110.811 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.59 -51.56 58.78 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.492 1.042 . . . . 1.0 110.27 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -65.4 -40.18 93.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.488 0.315 . . . . 1.0 111.293 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.9 tp -59.11 -51.94 67.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.249 1.82 . . . . 1.0 108.201 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -40.03 78.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.83 -0.605 . . . . 1.0 110.256 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -53.96 51.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.131 0.878 . . . . 1.0 111.659 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.23 -47.83 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.9 m -58.15 -47.01 84.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.357 1.463 . . . . 1.0 112.029 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -60.19 -38.13 82.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.553 0.741 . . . . 1.0 109.606 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.52 86.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 117.823 -1.084 . . . . 1.0 110.332 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.17 -45.67 79.61 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 120.252 1.387 . . . . 1.0 110.595 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.81 -41.62 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.0 m -62.04 -27.24 68.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.366 0.666 . . . . 1.0 111.269 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -83.9 -61.23 1.88 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.956 -1.09 . . . . 1.0 108.111 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -125.8 112.79 24.8 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.27 -1.381 . . . . 1.0 107.27 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -93.18 107.8 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-O 123.425 1.344 . . . . 1.0 109.731 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.39 -44.8 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.559 1.944 . . . . 1.0 109.412 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.3 mt -49.36 -33.51 6.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 130.731 3.613 . . . . 1.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.01 -26.43 37.0 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.155 0.428 . . . . 1.0 112.155 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.46 25.65 4.11 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.123 2.569 . . . . 1.0 110.184 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -139.09 83.51 1.95 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 50.9 mtt -126.88 118.57 24.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.66 -2.348 . . . . 1.0 104.66 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -148.21 -175.38 4.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.586 1.084 . . . . 1.0 109.237 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.21 -131.77 2.39 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 105.789 -2.924 . . . . 1.0 105.789 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.2 m170 -114.78 -23.47 9.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.675 1.238 . . . . 1.0 110.381 175.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.34 -18.67 14.75 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.84 38.31 0.63 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.19 0.905 . . . . 1.0 108.918 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -16.6 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 O-C-N 120.513 -1.367 . . . . 1.0 108.715 175.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.465 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -155.49 -54.4 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.783 2.433 . . . . 1.0 111.518 175.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 98.2 Cg_endo -76.57 109.51 2.88 Favored 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 122.146 1.802 . . . . 1.0 113.608 -175.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -62.36 -12.29 20.41 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.145 -0.972 . . . . 1.0 110.688 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -22.5 57.37 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.313 -1.492 . . . . 1.0 114.553 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.26 125.75 20.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.559 1.527 . . . . 1.0 107.091 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 167' ' ' PRO . 2.6 m -114.79 -16.7 11.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.19 -178.83 0.3 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 126.3 1.84 . . . . 1.0 106.311 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.22 80.71 2.96 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 N-CA-C 105.633 -2.487 . . . . 1.0 105.633 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.404 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.22 72.28 0.23 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.513 2.006 . . . . 1.0 109.866 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.492 ' HB3' ' H ' ' A' ' 163' ' ' THR . 68.7 Cg_endo -79.0 -99.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.301 2.667 . . . . 1.0 111.066 176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.7 t 53.82 42.9 31.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.513 1.525 . . . . 1.0 111.538 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.41 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -96.81 17.87 15.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.978 -1.076 . . . . 1.0 113.453 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t0 43.79 63.74 1.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.421 -2.049 . . . . 1.0 111.831 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -54.07 -35.17 61.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.344 0.658 . . . . 1.0 111.725 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -54.35 48.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.453 -0.784 . . . . 1.0 110.157 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -60.29 -48.54 81.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.814 -1.089 . . . . 1.0 112.13 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.32 -53.54 56.07 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.883 0.765 . . . . 1.0 109.938 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -48.81 80.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 117.962 -1.018 . . . . 1.0 108.773 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.7 76.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.931 0.893 . . . . 1.0 112.981 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.3 mt -71.28 -44.21 65.66 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.878 0.871 . . . . 1.0 110.62 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.37 157.07 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 122.958 1.361 . . . . 1.0 110.051 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 125.952 1.701 . . . . 1.0 111.607 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.6 tm? . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 106.912 -1.514 . . . . 1.0 106.912 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.63 175.92 9.95 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.469 0.708 . . . . 1.0 111.408 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 42.33 57.86 3.22 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.286 1.834 . . . . 1.0 109.464 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.29 155.2 30.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.983 1.313 . . . . 1.0 109.1 -176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -81.29 123.46 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.79 124.6 33.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.379 0.99 . . . . 1.0 108.334 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.92 82.53 43.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.99 124.03 7.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.034 1.823 . . . . 1.0 110.299 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -119.74 114.19 34.25 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.87 56.39 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.183 1.922 . . . . 1.0 111.416 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -126.05 44.56 2.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.811 2.045 . . . . 1.0 105.632 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.465 ' CE2' HG13 ' A' ' 88' ' ' VAL . 1.8 m-30 -73.66 177.98 5.05 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.417 0.687 . . . . 1.0 111.142 -174.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.56 178.62 4.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.693 1.597 . . . . 1.0 113.513 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.6 m -154.19 124.67 7.01 Favored 'General case' 0 N--CA 1.448 -0.574 1 C-N-CA 132.028 4.131 . . . . 1.0 103.137 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.64 142.77 45.09 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 117.981 -1.009 . . . . 1.0 108.831 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.57 69.1 7.88 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.598 2.865 . . . . 1.0 113.454 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -151.71 158.54 43.54 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 127.073 2.149 . . . . 1.0 106.799 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -151.17 104.67 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.309 1.444 . . . . 1.0 107.481 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.77 158.67 43.92 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.915 1.686 . . . . 1.0 106.61 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -67.51 123.67 87.3 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 118.679 0.672 . . . . 1.0 109.441 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.16 103.65 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 108.974 -1.202 . . . . 1.0 108.974 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -165.38 65.57 0.12 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.469 -1.394 . . . . 1.0 108.265 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -148.3 137.63 22.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.73 1.612 . . . . 1.0 107.175 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.85 133.4 34.76 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.243 1.417 . . . . 1.0 108.111 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.91 142.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.938 -2.245 . . . . 1.0 104.938 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 98.5 t -136.16 115.77 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.977 -1.86 . . . . 1.0 105.977 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -176.3 132.82 0.23 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.348 0.976 . . . . 1.0 108.835 175.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -63.39 118.73 8.49 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.925 0.89 . . . . 1.0 110.22 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 7.5 mm -145.71 176.43 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.174 2.59 . . . . 1.0 107.153 176.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -160.93 117.97 2.33 Favored 'General case' 0 C--N 1.322 -0.624 1 N-CA-C 96.695 -5.298 . . . . 1.0 96.695 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 1.3 tm? -144.78 -61.3 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 116.022 -1.942 . . . . 1.0 112.79 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 23.8 Cg_endo -87.34 157.3 8.1 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.825 2.35 . . . . 1.0 112.92 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.37 70.45 4.78 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.326 3.35 . . . . 1.0 118.658 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.94 -72.2 1.06 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 105.811 -2.916 . . . . 1.0 105.811 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -157.2 123.42 4.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.324 2.25 . . . . 1.0 109.186 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -176.94 176.42 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 130.706 3.602 . . . . 1.0 107.836 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.41 22.78 10.04 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.91 1.719 . . . . 1.0 109.464 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.38 118.6 5.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.116 -1.38 . . . . 1.0 110.203 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.8 -21.03 38.9 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.415 2.077 . . . . 1.0 112.331 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -53.9 -34.19 58.79 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.853 0.861 . . . . 1.0 111.082 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 mt -66.12 -50.01 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.246 -0.883 . . . . 1.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.94 -46.46 78.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.076 -1.049 . . . . 1.0 110.395 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.78 -33.89 50.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.114 0.966 . . . . 1.0 111.887 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -63.83 -58.49 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.616 1.566 . . . . 1.0 110.296 176.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -70.6 -41.32 72.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.4 0.68 . . . . 1.0 112.545 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -65.91 -34.28 77.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.59 1.156 . . . . 1.0 108.455 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.22 54.77 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.308 -1.829 . . . . 1.0 116.153 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -89.15 8.27 30.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.743 2.272 . . . . 1.0 113.615 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 68' ' ' ALA . 13.4 tt -60.02 132.93 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.629 1.572 . . . . 1.0 111.891 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.02 135.99 20.7 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 128.636 2.774 . . . . 1.0 109.529 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.39 80.68 1.04 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.502 2.801 . . . . 1.0 106.909 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -103.23 -63.43 1.18 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.034 0.534 . . . . 1.0 111.012 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.57 78.85 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.06 0.944 . . . . 1.0 110.646 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 17.4 p80 -170.35 177.95 0.95 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.403 2.281 . . . . 1.0 106.331 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.7 Cg_endo -74.05 -43.43 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.531 1.488 . . . . 1.0 114.796 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -43.23 -53.58 5.03 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -51.51 -58.22 6.89 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.07 1.348 . . . . 1.0 110.513 -175.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.6 89.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.167 0.587 . . . . 1.0 111.521 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.45 -63.54 4.0 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.127 1.346 . . . . 1.0 111.863 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.49 -38.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.24 0.52 . . . . 1.0 112.065 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.52 -43.53 11.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.262 88.0 m-70 -57.9 -33.54 68.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.721 -0.657 . . . . 1.0 109.779 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.32 136.61 33.83 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.504 -2.776 . . . . 1.0 103.504 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 141.67 40.74 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.227 0.921 . . . . 1.0 111.723 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -116.97 165.49 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.663 2.385 . . . . 1.0 109.59 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -172.52 116.64 0.33 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.955 1.302 . . . . 1.0 108.632 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.44 -176.89 3.77 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -110.68 -76.27 0.61 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.884 1.22 . . . . 1.0 112.478 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -116.97 118.26 31.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.543 -2.021 . . . . 1.0 105.543 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.57 113.55 27.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.761 -2.311 . . . . 1.0 104.761 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -96.14 113.38 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.662 -2.348 . . . . 1.0 104.662 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -68.74 148.13 50.8 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.696 1.134 . . . . 1.0 108.502 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.74 22.09 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 122.824 0.45 . . . . 1.0 111.645 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.27 24.51 2.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.25 2.22 . . . . 1.0 111.896 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.01 76.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.456 1.979 . . . . 1.0 115.623 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.94 156.57 17.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.726 1.763 . . . . 1.0 110.58 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -116.24 116.53 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.71 141.68 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.45 121.57 37.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.411 -1.7 . . . . 1.0 106.411 -176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.94 123.93 50.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.829 2.452 . . . . 1.0 106.495 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 19' ' ' TYR . 36.2 t 67.16 92.1 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.091 1.314 . . . . 1.0 113.664 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -60.8 -179.15 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.192 1.261 . . . . 1.0 109.963 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -59.18 26.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.812 3.245 . . . . 1.0 116.678 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.97 117.48 7.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.905 2.482 . . . . 1.0 108.788 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.268 28.0 ttmt 85.93 81.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.903 2.481 . . . . 1.0 111.844 175.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -36.44 156.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.721 4.009 . . . . 1.0 117.216 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.75 -179.2 3.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.909 3.684 . . . . 1.0 115.857 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 46.7 t90 -156.46 118.52 3.95 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.514 1.926 . . . . 1.0 109.709 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -162.78 62.85 0.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.228 0.922 . . . . 1.0 111.439 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.55 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 118.785 -2.447 . . . . 1.0 114.779 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.84 -90.74 1.1 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 105.248 -3.141 . . . . 1.0 105.248 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.07 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 118.734 1.267 . . . . 1.0 109.456 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 p -165.98 157.32 13.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.119 2.168 . . . . 1.0 108.118 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' HG22 ' A' ' 157' ' ' ILE . 78.1 p -153.46 147.1 25.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.386 1.074 . . . . 1.0 110.763 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -149.46 148.98 30.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.586 -1.265 . . . . 1.0 107.586 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 38.66 53.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.368 1.867 . . . . 1.0 111.446 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.7 28.44 65.47 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.605 -1.108 . . . . 1.0 115.465 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 113.22 13.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 120.544 2.172 . . . . 1.0 105.245 175.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 12.8 tt0 -79.83 145.65 32.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -105.22 118.24 36.05 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.38 -23.7 60.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.322 0.389 . . . . 1.0 110.559 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -145.58 170.69 15.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.485 2.314 . . . . 1.0 106.857 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.52 76.66 7.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.358 1.075 . . . . 1.0 108.919 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -89.49 40.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.454 1.502 . . . . 1.0 110.108 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -131.67 130.4 42.0 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 119.977 -1.702 . . . . 1.0 111.882 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 56.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.809 2.044 . . . . 1.0 107.947 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -136.62 5.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.67 164.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.77 116.33 8.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.664 -2.347 . . . . 1.0 104.664 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.3 135.42 34.32 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.298 -1.501 . . . . 1.0 109.604 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.1 tt0 -103.67 152.94 21.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.65 173.46 39.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.821 1.677 . . . . 1.0 111.04 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -147.13 107.08 3.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.7 t0 46.08 47.75 12.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.471 2.308 . . . . 1.0 112.282 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.7 p 46.78 38.27 5.73 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.301 1.84 . . . . 1.0 113.417 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.24 146.52 54.84 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.236 1.814 . . . . 1.0 108.542 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -33.0 113.14 0.13 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.079 2.152 . . . . 1.0 110.508 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -78.31 -9.0 59.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.701 -2.095 . . . . 1.0 114.985 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.407 11.7 p 69.26 78.41 0.21 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 121.404 1.911 . . . . 1.0 113.537 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -22.99 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 119.709 -1.869 . . . . 1.0 115.403 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.37 -46.45 13.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.236 2.214 . . . . 1.0 110.472 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -51.26 -49.34 61.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.571 1.078 . . . . 1.0 109.904 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.71 -40.09 90.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.546 -0.74 . . . . 1.0 109.757 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.97 -50.55 63.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.988 0.813 . . . . 1.0 111.424 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -63.1 -48.49 78.35 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.985 1.714 . . . . 1.0 110.255 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.16 -49.98 74.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.217 1.407 . . . . 1.0 108.856 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.57 -39.84 89.47 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 118.722 -0.656 . . . . 1.0 110.155 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -53.58 56.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.829 0.852 . . . . 1.0 110.304 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.01 -46.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.6 m -58.29 -53.6 56.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.983 1.313 . . . . 1.0 109.964 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -56.76 -46.04 81.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.67 1.188 . . . . 1.0 110.12 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.15 77.71 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.792 0.437 . . . . 1.0 111.535 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.8 mt -57.03 -38.24 72.89 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-O 118.436 -0.792 . . . . 1.0 111.029 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.28 -38.75 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.547 0.739 . . . . 1.0 109.752 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 m -57.42 -35.07 69.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.089 0.859 . . . . 1.0 110.55 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -83.67 -52.66 6.25 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.129 -0.982 . . . . 1.0 108.6 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -126.33 112.9 23.49 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.92 107.15 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 121.378 1.528 . . . . 1.0 109.031 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.18 -49.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.094 1.758 . . . . 1.0 107.685 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 65.8 mt -48.35 -34.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 129.018 2.927 . . . . 1.0 109.586 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.12 -25.67 9.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.738 1.615 . . . . 1.0 113.627 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.31 22.01 3.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.037 1.735 . . . . 1.0 109.63 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.06 85.9 2.1 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.016 1.726 . . . . 1.0 107.7 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.2 mtt -131.96 119.13 20.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.893 2.077 . . . . 1.0 106.609 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -152.15 -176.34 5.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.532 1.514 . . . . 1.0 108.992 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.57 -131.4 2.73 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 106.875 -2.49 . . . . 1.0 106.875 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 25.5 m170 -116.35 -23.9 8.15 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.327 1.064 . . . . 1.0 112.12 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.4 t -103.63 -12.55 16.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.368 0.667 . . . . 1.0 109.255 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.7 OUTLIER -85.41 17.96 2.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.449 1.9 . . . . 1.0 110.478 -175.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.59 -20.14 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.764 0.825 . . . . 1.0 112.489 -175.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -147.47 -66.14 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.11 1.364 . . . . 1.0 107.995 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 86.0 Cg_endo -80.06 108.85 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.877 1.718 . . . . 1.0 111.202 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.97 -17.46 38.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.391 1.076 . . . . 1.0 112.096 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -60.06 -24.24 64.41 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.239 -1.538 . . . . 1.0 112.687 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -131.22 140.57 49.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 104.1 -2.556 . . . . 1.0 104.1 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 20.2 m -123.19 -16.76 6.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.34 177.92 0.95 Allowed Pre-proline 0 C--O 1.244 0.815 0 C-N-CA 131.316 3.846 . . . . 1.0 103.333 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.25 57.91 6.7 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.772 2.314 . . . . 1.0 109.438 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.5 78.81 0.02 OUTLIER Glycine 0 CA--C 1.541 1.671 0 C-N-CA 128.918 3.151 . . . . 1.0 108.054 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.01 -72.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.1 2.534 . . . . 1.0 112.107 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.3 t 53.94 43.79 30.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.514 1.926 . . . . 1.0 113.176 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -122.04 17.56 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.347 0.976 . . . . 1.0 112.731 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 t0 42.6 68.47 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.288 1.435 . . . . 1.0 110.604 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -48.85 -34.95 13.53 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -48.18 73.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.362 -0.828 . . . . 1.0 111.246 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -60.78 -51.14 70.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.51 1.504 . . . . 1.0 110.893 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.51 -46.6 82.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.187 0.903 . . . . 1.0 111.619 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -62.44 -32.78 73.69 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.567 0.621 . . . . 1.0 110.119 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.42 80.72 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.786 -1.197 . . . . 1.0 111.436 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 mt -67.87 -55.27 13.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.601 1.56 . . . . 1.0 112.636 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.43 150.12 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 122.766 0.426 . . . . 1.0 109.92 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 125.49 1.516 . . . . 1.0 110.327 175.925 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.35 -0.982 . . . . 1.0 108.35 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.74 55.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.194 0.198 . . . . 1.0 111.351 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 49.25 58.42 5.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.973 2.109 . . . . 1.0 110.807 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.47 133.25 21.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.382 -1.281 . . . . 1.0 109.475 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -67.87 123.34 20.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.615 -1.994 . . . . 1.0 105.615 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -91.87 128.16 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.185 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -145.82 85.58 7.63 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.092 . . . . 1.0 108.796 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.39 152.08 71.22 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.285 1.323 . . . . 1.0 110.578 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -146.75 132.67 9.43 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 126.056 1.742 . . . . 1.0 107.788 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.49 45.13 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.005 2.47 . . . . 1.0 113.133 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -123.88 43.2 3.04 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.384 -0.823 . . . . 1.0 109.982 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CB ' ' HG2' ' A' ' 92' ' ' LYS . 36.6 m-85 -73.57 -179.83 3.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.088 1.355 . . . . 1.0 109.878 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.39 178.6 4.39 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.754 1.264 . . . . 1.0 112.898 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -152.66 118.5 5.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.066 -2.939 . . . . 1.0 103.066 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -135.71 145.61 53.79 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 120.273 1.397 . . . . 1.0 108.742 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 67.22 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.459 2.773 . . . . 1.0 111.71 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -154.41 143.82 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.661 2.384 . . . . 1.0 107.131 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.92 103.93 3.11 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.898 2.079 . . . . 1.0 106.681 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.44 169.46 17.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.817 2.447 . . . . 1.0 106.972 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.97 123.54 82.27 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 124.912 1.285 . . . . 1.0 110.371 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.69 103.44 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.831 1.687 . . . . 1.0 110.512 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.1 t -177.1 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.51 -2.404 . . . . 1.0 104.51 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -148.34 145.75 28.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.395 3.078 . . . . 1.0 104.181 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.5 tp -114.5 129.76 56.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -105.89 136.03 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 169' ' ' PHE . 74.0 t -135.02 113.95 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CD2' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -165.15 167.26 18.32 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.273 1.429 . . . . 1.0 107.276 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -96.93 116.67 29.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -142.03 172.2 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.943 2.097 . . . . 1.0 106.926 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 t -155.55 118.04 4.2 Favored 'General case' 0 N--CA 1.443 -0.795 1 N-CA-C 98.981 -4.451 . . . . 1.0 98.981 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 -66.74 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.529 0 CA-C-O 116.007 -1.949 . . . . 1.0 109.285 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.24 136.94 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 CA-C-N 123.943 2.444 . . . . 1.0 107.36 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.25 44.73 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.096 3.198 . . . . 1.0 114.986 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -31.5 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.241 0 C-N-CA 126.125 1.822 . . . . 1.0 110.829 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.29 122.69 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.167 -2.531 . . . . 1.0 104.167 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -176.76 175.54 1.64 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.884 2.874 . . . . 1.0 107.942 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.76 26.58 4.02 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.588 1.566 . . . . 1.0 112.331 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.65 118.24 6.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.26 1.53 . . . . 1.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.13 -5.0 15.41 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.316 2.011 . . . . 1.0 113.148 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -62.02 -38.65 89.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.415 1.086 . . . . 1.0 109.43 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.7 -45.06 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.44 -46.61 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.53 -36.18 63.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 1.0 111.719 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -60.45 3.78 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.694 0.798 . . . . 1.0 109.655 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -68.78 -46.92 67.48 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.574 0.625 . . . . 1.0 112.384 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -60.48 -33.89 73.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.486 1.114 . . . . 1.0 108.732 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.56 35.8 4.25 Favored Glycine 0 C--N 1.342 0.879 0 C-N-CA 124.552 1.072 . . . . 1.0 113.349 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -124.77 18.05 8.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.885 1.342 . . . . 1.0 111.752 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.03 140.0 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.701 0.801 . . . . 1.0 110.427 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -98.37 128.01 34.5 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 127.713 2.405 . . . . 1.0 106.257 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.21 70.51 2.38 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.211 3.274 . . . . 1.0 109.472 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -106.9 -65.28 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.948 1.299 . . . . 1.0 112.843 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.4 -60.46 1.49 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.917 1.687 . . . . 1.0 113.225 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 20.8 p80 -168.48 177.69 1.2 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.562 1.145 . . . . 1.0 108.13 175.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.9 Cg_endo -70.25 -43.62 2.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.733 1.622 . . . . 1.0 113.926 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -50.48 -62.26 1.69 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.805 1.242 . . . . 1.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 5.2 t80 -56.88 -50.35 72.75 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.409 0.684 . . . . 1.0 111.201 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.17 96.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.892 0.477 . . . . 1.0 110.849 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -57.73 17.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 124.791 1.186 . . . . 1.0 110.629 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.49 -24.15 34.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-O 116.589 -1.672 . . . . 1.0 113.734 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.11 -43.52 20.58 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.716 1.598 . . . . 1.0 113.0 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -58.04 -33.85 69.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.095 0.558 . . . . 1.0 110.806 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.39 136.4 33.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -65.28 146.49 54.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.163 -1.415 . . . . 1.0 109.445 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -116.92 162.26 15.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 125.506 1.522 . . . . 1.0 110.507 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.612 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -174.05 128.1 0.37 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.543 2.337 . . . . 1.0 108.151 175.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.26 -172.47 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.453 -1.684 . . . . 1.0 106.453 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -110.81 -58.72 2.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.597 1.159 . . . . 1.0 111.767 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.507 ' HB2' HD13 ' A' ' 115' ' ' ILE . 19.9 m -141.04 118.44 11.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.189 -1.782 . . . . 1.0 106.189 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.94 113.42 25.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.825 -2.287 . . . . 1.0 104.825 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -89.16 113.48 25.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.22 150.63 45.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.871 -1.159 . . . . 1.0 107.871 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -13.76 0.96 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.565 1.146 . . . . 1.0 113.917 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -91.7 21.03 5.01 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 128.037 2.535 . . . . 1.0 112.737 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.51 29.32 71.42 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.792 2.139 . . . . 1.0 114.885 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -102.14 108.94 20.5 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.652 1.226 . . . . 1.0 108.239 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.03 113.69 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.767 -2.679 . . . . 1.0 103.767 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.57 123.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 103.084 -2.932 . . . . 1.0 103.084 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.29 113.44 26.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.91 114.35 20.9 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 89.11 91.57 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 122.432 2.378 . . . . 1.0 110.554 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.26 -171.66 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.208 1.938 . . . . 1.0 109.907 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -64.57 21.77 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.498 1.919 . . . . 1.0 115.941 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.44 126.14 17.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.625 1.97 . . . . 1.0 109.127 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HG2' ' CB ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER 86.56 81.92 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.849 3.26 . . . . 1.0 111.762 175.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -36.7 135.38 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 128.259 2.624 . . . . 1.0 112.373 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -104.04 -178.67 3.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.769 2.428 . . . . 1.0 111.058 -175.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 80.0 t90 -146.23 118.55 8.4 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.418 1.887 . . . . 1.0 107.114 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -164.96 63.29 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.224 1.012 . . . . 1.0 110.601 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.64 -68.72 0.07 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 118.792 -2.443 . . . . 1.0 112.274 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.38 -90.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.421 -1.872 . . . . 1.0 108.421 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.6 t -140.32 146.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.473 1.909 . . . . 1.0 110.758 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -163.47 155.49 17.58 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.059 1.743 . . . . 1.0 109.044 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.662 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.0 p -146.86 133.55 19.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -161.49 124.59 3.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.286 0.948 . . . . 1.0 108.898 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 60.13 71.57 0.57 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.044 1.738 . . . . 1.0 113.622 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.4 30.3 55.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 126.433 1.968 . . . . 1.0 113.922 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.7 ttm105 -150.05 113.63 4.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.441 1.096 . . . . 1.0 108.566 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.05 145.13 30.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.226 -2.139 . . . . 1.0 105.226 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -128.98 118.03 21.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.992 -1.855 . . . . 1.0 105.992 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t -66.11 -36.02 82.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.842 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.46 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 15.8 m120 -146.73 174.12 11.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.91 2.884 . . . . 1.0 106.037 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.48 76.84 9.91 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 106.533 -1.655 . . . . 1.0 106.533 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 39.68 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.482 1.913 . . . . 1.0 109.889 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -124.23 156.72 36.34 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.204 1.802 . . . . 1.0 112.29 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.255 0.0 OUTLIER -99.98 57.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 105.971 -1.862 . . . . 1.0 105.971 175.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.35 -136.53 1.65 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.225 -0.922 . . . . 1.0 111.595 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 136' ' ' VAL . 7.5 mm -142.25 163.15 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 128.888 2.875 . . . . 1.0 103.723 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -136.12 129.3 31.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.393 2.277 . . . . 1.0 105.338 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mt -101.24 153.81 19.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 120.258 1.39 . . . . 1.0 109.305 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.34 47.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.83 0.824 . . . . 1.0 111.36 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.31 -173.47 41.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.294 2.378 . . . . 1.0 108.946 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 p -136.44 100.2 4.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 102.692 -3.077 . . . . 1.0 102.692 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 43.01 55.63 4.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.848 2.459 . . . . 1.0 112.472 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.4 p 52.69 38.09 25.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.089 2.155 . . . . 1.0 114.155 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 tp -60.2 136.01 57.9 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.84 113.2 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.29 2.236 . . . . 1.0 110.411 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.02 -8.17 57.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 115.683 -2.103 . . . . 1.0 116.371 -174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.325 37.3 p 63.89 77.96 0.3 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 121.636 2.016 . . . . 1.0 111.383 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.64 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.901 2.081 . . . . 1.0 113.97 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.09 -38.61 1.72 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.435 2.294 . . . . 1.0 109.455 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.67 -48.82 58.3 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.999 1.32 . . . . 1.0 110.575 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -59.16 -38.27 79.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.079 0.854 . . . . 1.0 110.509 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -66.02 -55.03 18.72 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.253 0.621 . . . . 1.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 12.1 mt-30 -61.69 -54.06 47.66 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.861 0.865 . . . . 1.0 109.131 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 115' ' ' ILE . 55.3 tp -53.22 -49.32 67.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.251 1.021 . . . . 1.0 109.728 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.0 85.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 120.408 1.458 . . . . 1.0 111.682 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.85 51.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.741 0.7 . . . . 1.0 109.294 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 115' ' ' ILE . 95.7 t -52.91 -64.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 126.758 2.023 . . . . 1.0 108.417 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 64.0 m -54.35 -52.43 61.63 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.902 2.081 . . . . 1.0 111.456 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -57.22 -42.02 80.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.382 1.447 . . . . 1.0 110.408 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.58 -47.48 66.65 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.266 -0.896 . . . . 1.0 111.352 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.7 mt -56.91 -34.71 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.58 -1.325 . . . . 1.0 111.598 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.61 -40.08 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.474 -1.306 . . . . 1.0 107.474 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -63.15 -13.44 37.05 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.13 1.372 . . . . 1.0 110.965 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -95.93 -65.39 0.98 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.158 -1.589 . . . . 1.0 107.406 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -120.89 112.99 33.23 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -95.89 107.89 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 CA-C-N 120.182 1.101 . . . . 1.0 111.208 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.91 -49.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.365 1.866 . . . . 1.0 106.636 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.5 mt -45.9 -33.37 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 128.944 2.898 . . . . 1.0 110.815 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.16 -26.53 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 1.0 113.412 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -133.13 18.62 4.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.945 2.098 . . . . 1.0 110.178 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -138.44 83.74 1.98 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.454 -1.404 . . . . 1.0 107.842 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.6 mtt -121.55 114.05 20.66 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -149.18 -168.07 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.93 -130.67 1.64 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 105.017 -3.233 . . . . 1.0 105.017 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.259 14.7 m170 -112.73 -24.43 9.61 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.978 0.911 . . . . 1.0 111.277 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.67 -16.03 16.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.417 0.687 . . . . 1.0 110.359 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -86.59 39.62 0.85 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.893 -1.151 . . . . 1.0 107.893 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.62 -17.5 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 O-C-N 120.322 -1.486 . . . . 1.0 109.294 175.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -149.54 -64.53 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.553 1.541 . . . . 1.0 109.715 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 98.4 Cg_endo -78.51 115.06 3.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.365 2.043 . . . . 1.0 113.23 -175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -22.48 58.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 1.0 112.273 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.2 tpt85 -58.65 -17.15 19.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.199 2.2 . . . . 1.0 112.686 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -141.66 141.02 33.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -131.84 -16.72 2.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 118.903 -1.119 . . . . 1.0 110.358 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.9 -179.62 0.34 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 130.117 3.367 . . . . 1.0 104.085 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 78.25 3.5 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 121.876 1.717 . . . . 1.0 108.561 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.44 64.08 0.56 Allowed Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.866 -1.519 . . . . 1.0 114.811 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.52 -54.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.429 2.615 . . . . 1.0 111.599 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 t 54.52 44.5 28.66 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.918 1.687 . . . . 1.0 112.468 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' CD2' HG11 ' A' ' 33' ' ' VAL . 81.4 t80 -108.73 17.68 21.62 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -175.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.369 11.3 t70 43.0 75.69 0.09 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.086 1.754 . . . . 1.0 113.194 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -48.65 -34.16 11.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.838 0.681 . . . . 1.0 112.838 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.63 75.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.942 -1.028 . . . . 1.0 111.707 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.4 -49.45 77.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.773 1.17 . . . . 1.0 109.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 34.3 t80 -66.2 -52.15 50.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.424 0.898 . . . . 1.0 113.424 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -61.55 -28.26 69.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.592 0.633 . . . . 1.0 111.476 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.45 87.28 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.125 0.875 . . . . 1.0 111.341 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.8 mt -71.04 -61.53 1.73 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.292 1.437 . . . . 1.0 111.065 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 90.4 t -66.35 166.36 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 124.13 0.972 . . . . 1.0 110.062 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 92.7 m . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 125.297 1.439 . . . . 1.0 109.369 175.431 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 108.837 -0.801 . . . . 1.0 108.837 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.02 36.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 40.67 57.88 2.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.553 2.741 . . . . 1.0 108.6 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.61 150.98 30.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.838 1.255 . . . . 1.0 109.375 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB3' HG13 ' A' ' 85' ' ' VAL . 25.6 tpt85 -86.21 123.24 31.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -84.63 129.62 34.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.43 79.33 20.84 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.189 -1.041 . . . . 1.0 108.189 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.27 127.93 12.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.409 2.072 . . . . 1.0 109.104 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -128.18 120.93 21.4 Favored Pre-proline 0 C--O 1.232 0.184 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.3 52.08 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.128 2.552 . . . . 1.0 112.465 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -123.63 43.44 2.97 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 88' ' ' VAL . 22.9 m-85 -74.26 178.46 5.12 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.723 0.809 . . . . 1.0 109.694 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.65 179.48 5.66 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.94 1.296 . . . . 1.0 110.975 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.5 m -162.67 118.63 1.88 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.756 2.822 . . . . 1.0 105.738 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -131.9 138.47 32.55 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 117.257 -1.354 . . . . 1.0 107.455 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.61 99.66 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.473 2.782 . . . . 1.0 109.389 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -168.03 151.48 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.9 2.48 . . . . 1.0 105.966 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -151.53 106.74 3.31 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.261 1.391 . . . . 1.0 108.288 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -136.36 165.48 25.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.85 2.06 . . . . 1.0 107.28 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -67.43 123.47 86.7 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.173 -1.047 . . . . 1.0 108.173 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.96 103.71 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.548 2.165 . . . . 1.0 110.528 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 t -170.54 73.88 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.57 124.03 11.01 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.666 1.587 . . . . 1.0 106.97 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -88.44 131.64 34.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.119 0.968 . . . . 1.0 109.389 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.3 143.17 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.756 -1.942 . . . . 1.0 105.756 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.14 116.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 105.991 -1.855 . . . . 1.0 105.991 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.4 OUTLIER -172.08 152.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.264 1.425 . . . . 1.0 107.465 175.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 112.4 24.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 6.8 mm -128.27 176.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 128.672 2.789 . . . . 1.0 106.545 175.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -153.28 121.47 6.19 Favored 'General case' 0 C--N 1.31 -1.124 1 N-CA-C 93.728 -6.397 . . . . 1.0 93.728 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 48' ' ' ILE 0.297 0.3 OUTLIER -142.0 -60.33 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 119.459 1.027 . . . . 1.0 110.537 176.488 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.52 134.31 11.06 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 CA-C-N 121.904 1.716 . . . . 1.0 110.419 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.27 75.81 3.25 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.341 2.694 . . . . 1.0 115.408 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.82 -71.7 0.85 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 106.615 -2.594 . . . . 1.0 106.615 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -156.21 123.63 5.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.888 1.275 . . . . 1.0 110.7 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -174.2 148.22 1.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.778 2.831 . . . . 1.0 108.294 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.51 -35.37 55.89 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.442 0.565 . . . . 1.0 113.406 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.39 118.94 11.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.558 1.075 . . . . 1.0 113.157 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.78 -5.88 17.42 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.636 2.891 . . . . 1.0 115.262 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -48.36 -45.73 35.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.439 1.472 . . . . 1.0 110.905 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 38' ' ' LEU . 7.0 mt -65.98 -45.14 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.816 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.16 -39.35 92.34 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.542 -0.463 . . . . 1.0 109.768 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.48 -34.25 70.68 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.238 0.472 . . . . 1.0 111.686 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.69 -52.4 51.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.573 1.149 . . . . 1.0 109.372 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.28 -41.37 73.49 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.02 -48.58 70.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.86 2.46 11.35 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.713 1.625 . . . . 1.0 114.503 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -89.08 9.21 26.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.913 1.856 . . . . 1.0 113.008 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 tt -52.21 129.53 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.293 1.437 . . . . 1.0 112.543 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.0 135.52 20.84 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.272 2.229 . . . . 1.0 109.599 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.88 78.1 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.604 2.869 . . . . 1.0 106.951 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -103.2 -65.07 1.02 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.036 0.534 . . . . 1.0 111.055 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.45 79.01 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.226 0.61 . . . . 1.0 111.117 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -171.08 178.08 0.85 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.037 1.735 . . . . 1.0 107.71 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.22 -43.4 4.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.596 2.197 . . . . 1.0 114.972 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -46.14 -50.88 14.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -54.62 42.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.302 1.041 . . . . 1.0 110.025 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.27 99.22 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.434 1.093 . . . . 1.0 111.29 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.99 -58.15 12.55 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 126.106 1.813 . . . . 1.0 112.184 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 pt -57.94 -38.26 65.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 117.954 -1.022 . . . . 1.0 111.879 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.79 -43.1 2.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.304 2.241 . . . . 1.0 115.318 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -61.22 -33.39 73.41 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.599 -0.688 . . . . 1.0 110.377 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.76 135.78 33.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 103.376 -2.824 . . . . 1.0 103.376 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.54 145.7 55.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.583 -0.698 . . . . 1.0 109.152 176.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.91 161.85 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 127.587 2.355 . . . . 1.0 111.418 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -175.97 139.96 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.412 2.285 . . . . 1.0 106.847 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -160.21 0.78 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.837 1.255 . . . . 1.0 108.074 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -130.41 -58.85 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.437 1.495 . . . . 1.0 108.539 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.97 119.42 17.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.196 -2.52 . . . . 1.0 104.196 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 tp -107.3 113.55 27.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.199 -2.519 . . . . 1.0 104.199 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.16 114.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -76.0 145.39 40.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -20.55 2.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.97 1.471 . . . . 1.0 114.97 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -91.4 29.95 1.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.271 1.828 . . . . 1.0 112.105 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.42 52.28 52.38 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.127 1.822 . . . . 1.0 114.085 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -126.77 117.34 22.47 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.331 -0.842 . . . . 1.0 110.465 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 132' ' ' GLN . 83.4 mt -83.02 114.73 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 101.6 -3.481 . . . . 1.0 101.6 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.3 t -110.48 142.27 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 103.34 -2.837 . . . . 1.0 103.34 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -121.14 114.04 20.87 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.074 -1.641 . . . . 1.0 111.264 -175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -108.98 120.17 41.74 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 19' ' ' TYR . 72.8 t 64.93 88.6 0.11 Allowed Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.024 1.284 . . . . 1.0 112.869 175.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.19 178.21 5.7 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 121.528 1.485 . . . . 1.0 109.548 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -43.55 9.26 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.149 1 C-N-CA 133.476 4.71 . . . . 1.0 120.198 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -133.89 111.12 10.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 119.371 -2.081 . . . . 1.0 107.552 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 86.25 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.889 2.076 . . . . 1.0 111.41 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -34.0 156.29 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.302 2.641 . . . . 1.0 114.669 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.59 -178.51 3.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 130.008 3.323 . . . . 1.0 109.998 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -145.93 118.54 8.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.95 1.25 . . . . 1.0 110.246 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -154.79 62.82 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 123.132 1.444 . . . . 1.0 110.747 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -161.76 -55.77 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 118.944 -2.348 . . . . 1.0 112.917 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.92 -74.41 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.177 -1.969 . . . . 1.0 108.177 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.18 128.82 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.244 1.417 . . . . 1.0 109.675 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.6 p -166.19 154.28 10.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.68 1.592 . . . . 1.0 112.14 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 157' ' ' ILE . 60.6 p -153.21 146.63 24.91 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 120.864 -1.147 . . . . 1.0 110.812 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -153.88 154.62 34.21 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.549 0.613 . . . . 1.0 110.504 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 38.91 55.38 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.223 1.809 . . . . 1.0 111.612 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.67 77.1 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.86 -0.967 . . . . 1.0 114.468 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -136.55 119.86 16.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.503 -1.665 . . . . 1.0 106.503 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 1.2 tt0 -100.44 138.7 37.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 36.4 mtm180 -113.31 118.34 34.32 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.1 t -58.07 -41.75 84.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.348 1.059 . . . . 1.0 111.212 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -148.19 177.02 9.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.514 3.126 . . . . 1.0 108.059 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.0 76.91 10.01 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.387 1.089 . . . . 1.0 108.689 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -87.51 33.92 0.7 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.198 0.999 . . . . 1.0 111.185 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.2 m -135.46 137.61 42.35 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.034 -1.666 . . . . 1.0 113.013 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.98 57.0 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.932 2.093 . . . . 1.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.18 -136.79 2.41 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.85 -1.156 . . . . 1.0 111.029 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 136' ' ' VAL . 1.1 mm -142.63 162.02 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 129.177 2.991 . . . . 1.0 103.329 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.94 130.22 29.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.76 -3.052 . . . . 1.0 102.76 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.54 157.53 16.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 107.435 -1.321 . . . . 1.0 107.435 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -131.08 155.82 46.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.959 0.885 . . . . 1.0 111.12 -178.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.55 179.36 43.35 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.393 -1.276 . . . . 1.0 111.027 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -147.88 116.35 6.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 128.229 2.611 . . . . 1.0 105.434 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.8 t0 54.17 32.48 15.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.858 2.463 . . . . 1.0 115.109 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.0 p 51.25 37.53 18.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.3 1.84 . . . . 1.0 113.212 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.44 146.46 54.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.749 1.62 . . . . 1.0 108.508 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -29.3 113.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.658 1.983 . . . . 1.0 111.206 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -78.36 -9.41 59.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.354 18.3 p 66.84 77.66 0.27 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 116.711 -1.614 . . . . 1.0 111.84 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.45 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 121.148 1.795 . . . . 1.0 113.729 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.12 -43.08 3.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.728 2.011 . . . . 1.0 110.245 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -55.53 -44.65 76.91 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.263 1.025 . . . . 1.0 111.461 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.55 -43.31 97.38 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.755 1.162 . . . . 1.0 109.902 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -63.08 -55.54 24.57 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' ILE . 82.3 mt-30 -66.01 -43.06 88.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.767 0.827 . . . . 1.0 111.08 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.75 -48.01 80.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.314 1.415 . . . . 1.0 108.902 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.06 89.53 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.292 -0.861 . . . . 1.0 109.438 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.58 -53.89 45.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.991 0.916 . . . . 1.0 110.797 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 115' ' ' ILE . 61.6 t -55.84 -53.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.0 m -57.88 -57.6 12.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.405 1.482 . . . . 1.0 110.452 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.19 -46.4 79.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.653 1.581 . . . . 1.0 110.738 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.67 -41.38 72.15 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.968 -0.539 . . . . 1.0 111.379 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.71 -42.69 79.6 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.927 -1.108 . . . . 1.0 109.93 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.8 -41.03 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.673 1.189 . . . . 1.0 109.721 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.7 m -59.25 -13.08 6.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.337 1.055 . . . . 1.0 112.394 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -111.85 -43.61 3.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.275 -1.345 . . . . 1.0 111.39 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.52 112.81 23.03 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -97.97 107.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 121.286 1.495 . . . . 1.0 111.493 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.81 -54.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.71 2.004 . . . . 1.0 108.251 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 60.0 mt -49.77 -32.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 129.5 3.12 . . . . 1.0 110.813 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.36 -21.46 2.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.708 1.203 . . . . 1.0 113.345 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.57 18.39 3.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.881 2.072 . . . . 1.0 110.894 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -143.2 83.96 1.81 Allowed 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.125 -0.984 . . . . 1.0 109.899 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.26 127.9 40.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -158.53 -168.23 2.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.32 -0.992 . . . . 1.0 108.32 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.75 -131.67 1.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 106.7 -2.56 . . . . 1.0 106.7 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 9.2 m170 -113.78 -23.2 9.8 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.111 0.964 . . . . 1.0 111.276 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.3 -15.89 15.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.145 0.978 . . . . 1.0 109.543 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.82 38.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.173 -0.954 . . . . 1.0 109.759 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -68.92 -17.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.914 -1.116 . . . . 1.0 109.446 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -155.02 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.232 1.813 . . . . 1.0 111.453 175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 60.0 Cg_endo -92.3 110.24 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.795 2.33 . . . . 1.0 112.781 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -58.39 -25.95 62.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.346 1.858 . . . . 1.0 113.924 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -25.31 62.87 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.497 0.719 . . . . 1.0 112.794 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -127.69 139.73 52.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -127.65 -16.43 4.77 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.978 -0.378 . . . . 1.0 109.978 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.18 178.85 0.48 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 131.281 3.832 . . . . 1.0 103.725 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.13 85.63 1.36 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.186 1.924 . . . . 1.0 109.994 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.96 68.32 0.62 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.236 1.398 . . . . 1.0 111.64 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 168' ' ' SER . 71.9 Cg_endo -75.38 -70.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.688 2.259 . . . . 1.0 112.592 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.403 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 15.4 t 53.7 42.9 31.72 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.582 2.353 . . . . 1.0 111.408 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -99.56 18.92 16.75 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.11 -1.619 . . . . 1.0 113.9 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.8 t0 43.35 70.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.781 1.233 . . . . 1.0 112.93 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -56.27 -30.09 62.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 1.0 112.66 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.86 -60.07 3.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.037 0.835 . . . . 1.0 109.065 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -64.18 -34.54 78.32 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.371 -0.931 . . . . 1.0 111.967 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 85.6 t80 -66.01 -52.7 46.89 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.823 1.192 . . . . 1.0 110.618 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -34.64 74.6 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 119.049 -0.5 . . . . 1.0 109.985 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.06 89.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.868 0.867 . . . . 1.0 112.557 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.54 -58.86 3.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.793 1.237 . . . . 1.0 110.155 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 53.5 t -66.03 166.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.327 1.051 . . . . 1.0 110.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 109.765 176.092 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tt . . . . . 0 C--O 1.235 0.331 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.86 139.77 41.86 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.964 0.347 . . . . 1.0 110.682 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 57.24 65.99 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 127.062 2.145 . . . . 1.0 112.818 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.41 148.48 37.89 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.262 1.425 . . . . 1.0 107.289 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -72.07 123.38 22.71 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.545 -2.391 . . . . 1.0 104.545 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.91 38.32 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.734 0.814 . . . . 1.0 111.929 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.67 72.92 77.08 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.066 0.946 . . . . 1.0 108.803 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.57 123.26 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 107.513 -1.764 . . . . 1.0 107.513 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -136.02 113.38 10.62 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.3 61.78 4.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.97 2.447 . . . . 1.0 108.926 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -124.01 44.69 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.892 -1.892 . . . . 1.0 105.892 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.495 ' HE1' HG22 ' A' ' 88' ' ' VAL . 14.4 m-85 -82.01 178.38 8.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.819 2.048 . . . . 1.0 113.466 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.87 -179.3 3.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 128.268 2.627 . . . . 1.0 112.912 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 m -157.65 118.59 3.54 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.173 4.589 . . . . 1.0 101.337 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -132.92 138.46 31.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 116.728 -1.606 . . . . 1.0 107.975 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.68 86.95 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.57 2.846 . . . . 1.0 108.675 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB2' HH12 ' A' ' 93' ' ' ARG . 13.2 m-20 -160.29 150.88 18.58 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.828 2.451 . . . . 1.0 106.226 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -151.49 104.06 3.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.322 1.849 . . . . 1.0 106.134 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.11 170.36 16.23 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.476 1.489 . . . . 1.0 108.138 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -75.43 123.19 88.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 119.905 -1.747 . . . . 1.0 109.033 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.22 103.54 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.967 1.778 . . . . 1.0 110.712 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 146' ' ' ALA . 11.3 t -171.08 77.23 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.55 -1.648 . . . . 1.0 106.55 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' A' ' 150' ' ' ASN . 5.0 tp -145.8 124.72 12.72 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.23 127.26 35.75 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.834 -1.543 . . . . 1.0 106.834 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.09 113.8 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 163' ' ' THR . 48.4 t -108.79 114.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 104.916 -2.253 . . . . 1.0 104.916 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.63 149.18 5.54 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 116.731 -1.604 . . . . 1.0 106.868 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -95.54 111.43 23.34 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 117.145 -1.822 . . . . 1.0 110.138 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -127.6 176.78 6.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 129.98 3.312 . . . . 1.0 107.273 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.1 t -149.15 121.04 8.16 Favored 'General case' 0 C--N 1.313 -1.016 1 N-CA-C 94.697 -6.038 . . . . 1.0 94.697 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 72' ' ' VAL 0.295 0.1 OUTLIER -142.36 -61.39 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.26 0.937 . . . . 1.0 109.8 175.603 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 11.8 Cg_exo -73.07 124.67 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.212 1.942 . . . . 1.0 110.013 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.8 68.89 7.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.538 2.825 . . . . 1.0 111.73 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.92 -71.1 0.69 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.855 -1.698 . . . . 1.0 108.855 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -152.33 123.48 7.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.545 1.938 . . . . 1.0 106.121 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -175.71 158.58 2.18 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.42 2.688 . . . . 1.0 107.857 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.84 -0.75 63.87 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.558 -1.134 . . . . 1.0 113.058 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 118.47 4.79 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.67 1.735 . . . . 1.0 110.903 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.35 -12.88 15.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.64 2.227 . . . . 1.0 114.101 -175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -61.81 -33.92 75.0 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.921 1.237 . . . . 1.0 111.017 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.6 mt -64.17 -55.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.314 -1.365 . . . . 1.0 107.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.6 -33.28 75.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.439 0.563 . . . . 1.0 112.271 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -53.25 -34.25 56.42 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.74 0.816 . . . . 1.0 111.3 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.36 -51.11 60.53 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.14 -0.975 . . . . 1.0 109.559 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -61.23 -50.63 72.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 1.0 110.884 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 50' ' ' ALA . 4.7 t -61.76 -33.91 74.91 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.346 1.458 . . . . 1.0 110.548 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.63 2.75 37.44 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.804 -1.554 . . . . 1.0 115.666 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.5 p -93.04 9.3 36.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.177 1.988 . . . . 1.0 113.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 tt -49.13 137.55 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.344 1.058 . . . . 1.0 112.19 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 136.33 20.75 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 126.415 1.886 . . . . 1.0 107.015 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.49 67.25 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.967 3.112 . . . . 1.0 110.296 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.56 -48.31 4.0 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.486 1.291 . . . . 1.0 114.486 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.46 -64.51 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.065 0.946 . . . . 1.0 112.76 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -171.04 178.01 0.87 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.376 1.47 . . . . 1.0 108.199 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.78 -43.9 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.848 2.365 . . . . 1.0 115.154 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -51.45 -59.04 4.68 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.984 1.266 . . . . 1.0 112.246 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.7 -49.22 69.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.718 0.807 . . . . 1.0 111.094 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.04 95.1 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.32 0.648 . . . . 1.0 111.595 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.43 -63.47 5.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 125.29 1.424 . . . . 1.0 110.751 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.33 -26.12 38.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-O 116.06 -1.924 . . . . 1.0 112.49 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.79 -43.22 3.89 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 121.002 1.728 . . . . 1.0 115.059 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -60.01 -34.5 73.43 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.499 0.72 . . . . 1.0 111.188 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.43 136.18 33.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.946 -2.613 . . . . 1.0 103.946 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 164.29 15.18 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.853 -1.154 . . . . 1.0 109.358 175.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 38' ' ' LEU . 29.1 m -116.58 166.39 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.346 1.058 . . . . 1.0 109.593 175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.5 m -170.73 121.56 0.58 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.351 1.46 . . . . 1.0 107.653 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.29 -155.5 0.48 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.382 1.873 . . . . 1.0 107.329 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -136.06 -59.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.327 1.851 . . . . 1.0 108.029 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HB2' HD13 ' A' ' 115' ' ' ILE . 78.1 m -132.63 118.97 19.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -109.01 113.63 26.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -95.37 114.25 31.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.173 -2.158 . . . . 1.0 105.173 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.92 148.91 43.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.394 0.997 . . . . 1.0 108.323 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -13.61 2.51 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.232 1.197 . . . . 1.0 114.232 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -91.82 23.41 3.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.258 1.023 . . . . 1.0 110.986 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.75 41.44 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 127.674 2.559 . . . . 1.0 112.891 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.98 154.63 44.33 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.077 0.951 . . . . 1.0 108.956 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.96 113.77 44.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.53 146.95 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.686 -1.598 . . . . 1.0 106.686 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -124.7 113.78 18.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.278 1.031 . . . . 1.0 108.876 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -114.05 114.8 26.61 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 104.149 -2.538 . . . . 1.0 104.149 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 19' ' ' TYR . 5.6 t 81.46 91.95 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.898 1.226 . . . . 1.0 109.254 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -64.83 -167.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.964 1.776 . . . . 1.0 110.289 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -77.29 51.26 0.83 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.377 -1.452 . . . . 1.0 110.976 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -154.99 129.57 9.18 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.545 2.738 . . . . 1.0 105.611 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.6 tttp 62.93 81.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.04 2.136 . . . . 1.0 112.773 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.434 HH12 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -35.45 155.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.138 2.975 . . . . 1.0 112.972 -176.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.272 . . -103.45 178.5 4.54 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.81 2.444 . . . . 1.0 114.42 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -151.79 118.05 5.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.855 2.062 . . . . 1.0 105.497 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -165.33 62.96 0.12 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.135 1.445 . . . . 1.0 109.734 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.89 -69.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 O-C-N 119.114 -2.241 . . . . 1.0 114.758 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.04 -78.04 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.6 t -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.166 0.987 . . . . 1.0 108.727 -176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 p -166.32 158.32 13.83 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.636 2.375 . . . . 1.0 106.956 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.448 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -161.25 145.57 13.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.13 -1.804 . . . . 1.0 106.13 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -166.03 155.05 11.49 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . 0.275 37.6 mm-40 39.16 58.01 1.91 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.46 1.904 . . . . 1.0 113.008 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.16 28.74 50.42 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.344 1.45 . . . . 1.0 114.247 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -128.9 113.26 15.01 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 26.5 tp10 -89.76 135.15 33.79 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.0 mtt85 -125.54 140.71 52.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.384 0.993 . . . . 1.0 109.155 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -86.32 -24.72 25.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.844 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -158.34 170.44 22.22 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.085 2.554 . . . . 1.0 106.238 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.5 76.3 10.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 123.095 1.426 . . . . 1.0 110.507 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.05 44.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.69 2.396 . . . . 1.0 110.297 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 m -123.5 156.56 35.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.439 1.495 . . . . 1.0 112.549 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.262 0.0 OUTLIER -97.65 56.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.705 2.002 . . . . 1.0 108.189 176.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.24 -135.38 3.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 136' ' ' VAL . 10.7 mm -143.92 161.12 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 128.827 2.851 . . . . 1.0 104.848 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -131.92 113.66 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 101.536 -3.505 . . . . 1.0 101.536 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.51 148.26 28.2 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.291 -1.374 . . . . 1.0 107.291 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.05 155.26 47.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.635 0.731 . . . . 1.0 112.175 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.12 173.4 43.57 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.811 -1.541 . . . . 1.0 111.556 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.4 p -137.89 103.15 4.9 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.484 1.913 . . . . 1.0 106.297 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 t70 57.87 30.46 19.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.041 1.736 . . . . 1.0 113.344 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.255 81.7 p 57.82 38.74 27.3 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.545 1.938 . . . . 1.0 113.444 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.66 145.58 52.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -28.36 113.46 0.07 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 128.059 2.543 . . . . 1.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -79.02 -9.84 59.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 115.163 -2.351 . . . . 1.0 116.043 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 43.6 p 65.08 77.04 0.32 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 121.801 2.091 . . . . 1.0 112.698 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -23.36 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.548 1.539 . . . . 1.0 114.578 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.05 -40.71 6.93 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.301 2.24 . . . . 1.0 111.379 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.73 -54.0 13.5 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.394 1.078 . . . . 1.0 109.378 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -59.13 -38.82 80.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.334 0.654 . . . . 1.0 111.597 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.59 -57.38 8.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.4 0.545 . . . . 1.0 110.888 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -65.08 -37.12 86.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.972 0.805 . . . . 1.0 110.765 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.1 tp -56.52 -47.88 78.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.43 1.014 . . . . 1.0 108.603 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.16 93.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.589 -0.72 . . . . 1.0 110.527 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.82 53.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.071 0.85 . . . . 1.0 110.292 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 115' ' ' ILE . 25.8 t -57.1 -48.61 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.909 -0.775 . . . . 1.0 108.909 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.0 m -56.45 -49.52 74.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.976 1.311 . . . . 1.0 110.438 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -59.02 -46.87 87.12 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.89 0.876 . . . . 1.0 109.944 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.3 77.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.864 0.302 . . . . 1.0 110.594 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.0 mt -55.94 -44.21 78.16 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.988 0.915 . . . . 1.0 111.187 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.73 -41.08 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.126 0.875 . . . . 1.0 110.432 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -65.69 -14.26 60.91 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.826 -1.171 . . . . 1.0 112.252 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.68 -59.24 1.78 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.632 1.105 . . . . 1.0 108.191 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -124.82 112.88 27.04 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -101.76 107.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 123.347 1.311 . . . . 1.0 112.465 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' SER . . . -152.29 -41.26 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.073 2.549 . . . . 1.0 105.85 174.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.4 mt -47.75 -33.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 128.869 2.868 . . . . 1.0 109.851 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.81 -26.25 13.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.023 0.929 . . . . 1.0 112.89 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -129.9 18.58 5.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.565 1.946 . . . . 1.0 109.992 175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.502 ' HB3' HD12 ' A' ' 30' ' ' LEU . 9.4 m120 -138.84 83.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 122.221 1.01 . . . . 1.0 108.332 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.91 113.41 17.82 Favored 'General case' 0 N--CA 1.448 -0.563 1 N-CA-C 99.988 -4.079 . . . . 1.0 99.988 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -152.98 -166.67 2.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -149.41 -131.78 2.0 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.148 -2.381 . . . . 1.0 107.148 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -116.63 -23.76 8.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.467 1.134 . . . . 1.0 110.629 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.5 t -103.86 2.34 32.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 4.1 t-20 -104.08 22.83 13.98 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.356 1.463 . . . . 1.0 111.459 -175.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.59 -15.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.34 0.656 . . . . 1.0 111.949 -175.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.49 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -152.26 -57.48 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.847 1.659 . . . . 1.0 108.934 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.49 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 84.6 Cg_endo -79.4 117.12 3.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 CA-C-N 122.085 1.78 . . . . 1.0 112.204 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 156' ' ' ASN . 0.7 OUTLIER -59.31 -25.56 64.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.784 0.834 . . . . 1.0 111.926 175.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -62.32 -19.27 63.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.476 2.31 . . . . 1.0 114.905 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -137.25 141.92 42.0 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 2.5 m -130.94 -17.05 3.17 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 117.158 -1.817 . . . . 1.0 112.422 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.58 -178.34 0.28 Allowed Pre-proline 0 C--O 1.249 1.036 0 C-N-CA 128.894 2.878 . . . . 1.0 105.093 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 80.01 2.31 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 N-CA-C 106.704 -2.076 . . . . 1.0 106.704 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 128.38 79.15 0.25 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.105 1.812 . . . . 1.0 111.035 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.57 -113.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 123.93 3.087 . . . . 1.0 110.237 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 t 56.36 43.51 26.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.284 1.833 . . . . 1.0 112.807 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -95.94 17.68 14.86 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.351 1.46 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.0 t0 44.08 77.27 0.07 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.106 1.362 . . . . 1.0 112.351 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -54.98 -32.87 62.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.392 0.516 . . . . 1.0 112.392 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.38 78.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.723 0.692 . . . . 1.0 111.252 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -59.8 -57.61 12.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.916 0.78 . . . . 1.0 110.07 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.55 -50.29 74.33 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.33 -38.96 81.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 118.481 0.582 . . . . 1.0 110.403 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.67 76.17 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.839 0.681 . . . . 1.0 112.839 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.59 -44.71 66.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.322 1.049 . . . . 1.0 111.862 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.64 162.89 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.17 0.988 . . . . 1.0 109.745 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 124.367 1.067 . . . . 1.0 109.084 175.603 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.46 145.29 44.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.871 1.434 . . . . 1.0 114.871 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 40.25 58.77 2.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 128.085 2.554 . . . . 1.0 108.941 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.66 156.71 46.67 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.467 1.107 . . . . 1.0 110.624 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -88.81 123.76 33.52 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -83.59 132.58 34.9 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -137.1 70.34 56.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.25 135.18 11.91 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.874 2.382 . . . . 1.0 111.787 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 t -159.18 113.2 1.57 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 N-CA-C 104.846 -2.279 . . . . 1.0 104.846 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.11 69.83 7.75 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.57 2.18 . . . . 1.0 110.207 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -123.19 43.57 2.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.876 2.071 . . . . 1.0 107.109 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 88' ' ' VAL . 3.5 m-85 -106.7 177.78 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.087 1.355 . . . . 1.0 110.005 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.25 -175.15 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.055 2.142 . . . . 1.0 112.101 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.87 130.16 14.65 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.712 2.805 . . . . 1.0 104.377 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.29 171.33 6.9 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 119.407 1.003 . . . . 1.0 109.345 -175.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.1 76.64 4.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.103 1.869 . . . . 1.0 112.738 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -149.81 144.0 25.72 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.849 2.46 . . . . 1.0 108.516 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -144.0 104.2 4.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.879 -1.526 . . . . 1.0 106.879 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -136.27 157.58 46.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.349 1.46 . . . . 1.0 109.224 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -70.7 123.56 89.37 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 103.14 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.04 1.407 . . . . 1.0 110.394 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 t -177.9 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.53 -1.655 . . . . 1.0 106.53 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.512 HD21 ' CG2' ' A' ' 152' ' ' THR . 7.7 tt -155.51 137.31 14.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.623 -1.991 . . . . 1.0 105.623 175.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 147' ' ' ILE . 19.0 tp -99.21 125.44 44.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.878 0.871 . . . . 1.0 109.594 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.46 113.81 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.8 t -107.13 120.93 59.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 104.902 -2.259 . . . . 1.0 104.902 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -169.82 134.23 1.32 Allowed 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -90.45 112.26 23.82 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.602 -1.259 . . . . 1.0 107.602 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm -127.38 176.62 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 130.627 3.571 . . . . 1.0 107.259 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 t -140.77 122.71 15.5 Favored 'General case' 0 C--O 1.245 0.842 1 N-CA-C 95.789 -5.634 . . . . 1.0 95.789 174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.309 1.0 OUTLIER -141.79 -64.3 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 114.139 1.163 . . . . 1.0 114.139 176.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 159.86 33.91 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.275 1.134 . . . . 1.0 112.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HD3' ' CE1' ' A' ' 52' ' ' PHE . 92.1 Cg_endo -82.04 0.76 9.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.044 3.163 . . . . 1.0 116.524 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -19.82 -66.48 0.01 OUTLIER Glycine 0 C--N 1.347 1.181 0 C-N-CA 126.178 1.847 . . . . 1.0 112.607 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -152.68 123.7 7.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.169 1.388 . . . . 1.0 112.021 175.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -176.6 164.79 2.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.412 3.085 . . . . 1.0 108.617 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.97 18.75 16.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.534 2.016 . . . . 1.0 111.2 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.8 118.47 6.16 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 107.69 -2.164 . . . . 1.0 107.69 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.2 -19.4 26.0 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 CA-C-N 121.286 2.543 . . . . 1.0 113.682 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -56.95 -34.61 68.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.651 1.18 . . . . 1.0 112.705 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -66.06 -53.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.27 -33.22 75.26 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.773 -0.58 . . . . 1.0 112.228 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -47.19 -33.94 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.25 1.02 . . . . 1.0 111.017 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.08 -51.28 64.81 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.363 -0.835 . . . . 1.0 111.335 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 40' ' ' PRO . 70.1 m-85 -71.01 -39.43 72.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.377 1.071 . . . . 1.0 112.419 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 50' ' ' ALA . 3.1 t -66.35 -40.37 89.77 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 175.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.96 16.88 6.58 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 124.939 1.257 . . . . 1.0 115.55 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.5 p -110.84 18.39 19.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.894 1.847 . . . . 1.0 113.805 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.72 132.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.465 1.029 . . . . 1.0 111.509 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.66 136.81 20.62 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 127.558 2.343 . . . . 1.0 108.887 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.65 62.67 1.72 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.31 2.674 . . . . 1.0 113.157 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -103.53 -50.16 3.51 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.042 1.127 . . . . 1.0 114.042 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.49 -63.27 1.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.729 0.695 . . . . 1.0 112.333 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 7.0 p80 -170.83 178.01 0.89 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.653 1.581 . . . . 1.0 107.639 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 9.8 Cg_endo -62.67 -44.2 18.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.067 1.845 . . . . 1.0 114.789 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -51.36 -58.7 5.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.41 1.005 . . . . 1.0 111.855 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -43.73 98.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.716 0.806 . . . . 1.0 110.136 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.8 98.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.404 -0.81 . . . . 1.0 111.817 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.44 -63.02 5.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.147 2.308 . . . . 1.0 112.742 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 pt -57.57 -34.26 46.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.9 -1.048 . . . . 1.0 113.077 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.5 -43.79 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 117.236 2.31 . . . . 1.0 117.236 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -64.88 -33.61 76.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.848 0.459 . . . . 1.0 110.189 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.83 119.6 25.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.137 -1.801 . . . . 1.0 106.137 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.33 132.64 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.621 -0.674 . . . . 1.0 109.841 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.65 162.79 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.366 1.466 . . . . 1.0 111.108 -175.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.633 ' HB3' HG21 ' A' ' 88' ' ' VAL . 71.2 m -161.7 115.94 1.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.749 0.82 . . . . 1.0 109.363 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.45 -156.98 0.53 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.628 1.171 . . . . 1.0 108.809 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.48 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 17.8 m80 -134.87 -75.98 0.46 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.645 ' HB2' HD13 ' A' ' 115' ' ' ILE . 55.5 m -124.08 118.28 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 102.207 -3.257 . . . . 1.0 102.207 175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.03 113.57 27.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 103.688 -2.708 . . . . 1.0 103.688 176.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.62 122.04 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.174 -1.787 . . . . 1.0 106.174 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.04 150.16 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -57.12 -14.75 4.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.924 -1.512 . . . . 1.0 114.144 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.34 19.33 6.12 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 120.505 1.502 . . . . 1.0 112.267 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.78 51.88 54.33 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.028 1.775 . . . . 1.0 112.58 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.27 111.02 16.85 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.586 -1.635 . . . . 1.0 106.586 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.7 mt -79.74 120.17 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.669 -1.604 . . . . 1.0 106.669 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.66 141.4 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 102.819 -3.03 . . . . 1.0 102.819 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 116.87 21.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -118.38 131.02 56.31 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.966 2.507 . . . . 1.0 105.615 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.807 HG22 ' CE1' ' A' ' 19' ' ' TYR . 3.0 t 69.05 91.51 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 120.726 1.603 . . . . 1.0 111.465 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' ASP . 74.0 Cg_endo -66.32 -169.48 0.17 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.827 2.351 . . . . 1.0 112.026 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -69.59 30.41 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.319 1.447 . . . . 1.0 110.668 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 89' ' ' PRO . 3.0 t0 -144.5 115.32 7.78 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 128.57 2.748 . . . . 1.0 108.305 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.14 82.19 0.06 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.241 2.616 . . . . 1.0 112.486 174.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -34.38 146.22 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.337 2.655 . . . . 1.0 114.834 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.09 -178.55 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.863 2.065 . . . . 1.0 113.194 -175.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -155.91 118.28 4.12 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.63 2.372 . . . . 1.0 108.472 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -161.01 63.03 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.715 1.245 . . . . 1.0 109.402 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.83 -70.85 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 119.627 -1.921 . . . . 1.0 113.261 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.93 -74.7 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 106.35 -2.7 . . . . 1.0 106.35 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.19 140.53 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.582 1.191 . . . . 1.0 110.061 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.3 p -166.32 162.45 17.23 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.969 1.307 . . . . 1.0 110.282 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 11.0 p -166.23 146.79 6.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.736 1.614 . . . . 1.0 108.928 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -156.39 147.24 21.95 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.333 0.97 . . . . 1.0 110.674 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 38.91 56.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.343 1.857 . . . . 1.0 112.142 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.95 28.89 69.41 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.289 0.947 . . . . 1.0 114.527 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -128.63 113.79 15.86 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -89.96 146.5 24.33 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -123.17 118.89 28.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.031 0.533 . . . . 1.0 111.108 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.52 -25.8 50.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.976 0.91 . . . . 1.0 110.042 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.67 168.88 18.86 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 127.558 2.343 . . . . 1.0 107.857 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -88.18 75.91 8.54 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.98 33.83 1.84 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.521 1.128 . . . . 1.0 112.276 -175.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -126.94 131.07 51.18 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.938 0.895 . . . . 1.0 109.542 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.289 0.1 OUTLIER -79.01 56.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.214 1.806 . . . . 1.0 110.073 -177.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.44 -133.26 3.42 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 122.578 1.099 . . . . 1.0 111.684 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 76' ' ' CYS . 20.6 mm -137.03 166.38 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.351 3.46 . . . . 1.0 104.085 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -144.85 135.38 24.42 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 101.839 -3.393 . . . . 1.0 101.839 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.3 165.69 11.14 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.522 -1.361 . . . . 1.0 110.412 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.15 150.35 49.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.771 0.829 . . . . 1.0 110.256 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.1 175.6 45.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.872 1.262 . . . . 1.0 112.383 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.5 p -141.28 110.1 6.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.983 2.113 . . . . 1.0 106.111 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 t0 45.67 48.73 11.43 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 128.301 2.64 . . . . 1.0 111.82 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p 50.7 38.08 18.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.776 2.831 . . . . 1.0 115.404 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.4 145.92 50.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.123 2.169 . . . . 1.0 110.55 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.34 114.68 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 129.405 3.082 . . . . 1.0 110.987 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -84.36 -8.05 59.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 114.123 -2.846 . . . . 1.0 113.155 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.391 26.5 p 64.9 77.92 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 122.568 2.44 . . . . 1.0 115.014 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -23.22 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 121.073 1.76 . . . . 1.0 114.815 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.9 -43.1 13.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.827 2.051 . . . . 1.0 110.733 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -50.15 -50.72 48.0 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 118.299 -0.857 . . . . 1.0 109.738 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -60.56 -36.36 78.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 117.559 -1.21 . . . . 1.0 111.222 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -65.29 -60.04 3.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.512 1.051 . . . . 1.0 109.713 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -62.8 -41.45 99.28 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.483 0.313 . . . . 1.0 111.138 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.01 -52.98 63.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.812 1.645 . . . . 1.0 109.122 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.71 76.23 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 118.289 -0.862 . . . . 1.0 110.273 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.79 52.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.683 0.793 . . . . 1.0 108.929 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.633 HG11 HD11 ' A' ' 115' ' ' ILE . 47.4 t -55.61 -50.29 68.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -58.27 -57.39 13.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.266 1.026 . . . . 1.0 112.13 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -55.79 -43.16 76.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.537 1.062 . . . . 1.0 110.328 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.85 51.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.788 -0.57 . . . . 1.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.53 -34.06 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.144 1.378 . . . . 1.0 112.105 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 mt -63.58 -39.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.405 -1.332 . . . . 1.0 107.405 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.8 m -64.53 -14.35 57.02 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.297 1.039 . . . . 1.0 110.4 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -64.93 1.07 Allowed 'General case' 0 C--N 1.347 0.47 0 O-C-N 120.24 -1.538 . . . . 1.0 106.942 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.85 113.01 24.66 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 106.922 -1.511 . . . . 1.0 106.922 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -88.65 107.25 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.865 1.702 . . . . 1.0 111.288 -175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.27 -51.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.296 1.438 . . . . 1.0 108.723 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.0 mt -46.04 -35.11 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 130.823 3.649 . . . . 1.0 111.789 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.06 63.49 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -131.39 18.34 4.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.353 2.261 . . . . 1.0 109.803 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -143.17 83.45 1.79 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 49.4 mtt -121.67 122.02 38.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.666 -2.716 . . . . 1.0 103.666 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 30' ' ' LEU . 5.2 t -158.65 -176.45 5.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.02 -131.33 2.89 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 105.787 -2.925 . . . . 1.0 105.787 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.1 m170 -118.15 -23.12 7.47 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.134 0.974 . . . . 1.0 110.63 176.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.4 t -103.36 -18.4 14.86 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -91.78 45.83 1.25 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.925 1.29 . . . . 1.0 107.521 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -71.45 -14.68 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.319 -1.488 . . . . 1.0 109.933 175.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -153.65 -65.95 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 127.304 2.241 . . . . 1.0 107.334 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 89.7 Cg_endo -76.16 113.29 3.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.932 1.726 . . . . 1.0 113.382 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -18.71 36.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.121 1.368 . . . . 1.0 112.056 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.11 -25.99 64.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.536 1.934 . . . . 1.0 112.759 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -139.6 135.14 33.03 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.499 -2.037 . . . . 1.0 105.499 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 37.4 m -119.96 -16.49 8.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.103 0.408 . . . . 1.0 112.103 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.24 175.35 1.31 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.689 2.795 . . . . 1.0 105.095 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.73 69.3 7.85 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.953 2.435 . . . . 1.0 109.563 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.33 69.69 0.21 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.978 2.704 . . . . 1.0 108.54 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 87.4 Cg_endo -82.39 -87.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.022 3.148 . . . . 1.0 112.263 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 t 53.49 73.35 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.211 3.005 . . . . 1.0 109.214 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 56.8 t80 -119.35 18.97 12.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.411 1.085 . . . . 1.0 113.885 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.13 74.54 0.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.879 -1.763 . . . . 1.0 112.759 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -58.65 -31.57 68.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.866 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.07 77.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.857 -1.068 . . . . 1.0 110.666 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -60.81 -51.66 68.37 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.555 1.07 . . . . 1.0 110.516 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -60.79 -56.48 20.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.213 0.82 . . . . 1.0 113.213 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -64.29 -25.63 68.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.018 -0.991 . . . . 1.0 112.176 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.79 83.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.042 0.837 . . . . 1.0 111.093 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.16 -59.9 2.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.327 1.451 . . . . 1.0 111.019 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.48 166.02 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.546 0.794 0 C-N-CA 124.329 1.051 . . . . 1.0 110.225 179.177 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 103.957 -2.609 . . . . 1.0 103.957 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.91 175.04 7.02 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.19 0.996 . . . . 1.0 112.186 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 43.87 58.17 3.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.229 1.812 . . . . 1.0 109.697 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.0 132.93 7.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.462 1.905 . . . . 1.0 107.322 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -63.83 123.47 19.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 142.36 28.54 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.999 -1.063 . . . . 1.0 109.681 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.34 70.4 72.99 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 105.351 -2.092 . . . . 1.0 105.351 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.21 124.22 9.82 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.639 2.226 . . . . 1.0 111.047 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -160.24 113.46 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.67 71.1 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.866 2.377 . . . . 1.0 110.756 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -123.69 54.2 1.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.783 1.633 . . . . 1.0 107.281 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.8 m-30 -95.53 -175.71 3.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.302 2.241 . . . . 1.0 112.352 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.09 -177.08 3.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.959 2.104 . . . . 1.0 108.488 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 m -163.77 122.11 1.91 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 130.135 3.374 . . . . 1.0 103.82 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.8 152.94 52.21 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -80.88 36.6 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.991 2.461 . . . . 1.0 113.344 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.11 143.22 37.15 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.873 2.469 . . . . 1.0 104.497 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -146.69 103.26 3.64 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 9.2 tp10 -137.04 165.36 26.22 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -68.67 124.1 89.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.447 1.099 . . . . 1.0 110.695 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.5 113.94 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.025 2.484 . . . . 1.0 111.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t 178.91 85.29 0.01 OUTLIER 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.616 1.967 . . . . 1.0 105.983 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tp -148.32 143.15 26.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.259 -1.756 . . . . 1.0 106.259 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp -110.68 116.06 30.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.996 -1.853 . . . . 1.0 105.996 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.78 122.73 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.3 t -112.95 120.7 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.8 p80 -167.04 128.56 1.63 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 107.526 -1.287 . . . . 1.0 107.526 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -80.34 112.63 17.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 116.63 -2.028 . . . . 1.0 108.142 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -128.13 176.97 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 C-N-CA 131.993 4.117 . . . . 1.0 106.086 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 t -152.09 121.95 7.03 Favored 'General case' 0 N--CA 1.44 -0.96 1 N-CA-C 95.305 -5.813 . . . . 1.0 95.305 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.82 -66.17 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.511 0 CA-C-N 119.432 1.014 . . . . 1.0 110.86 175.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 4.0 Cg_exo -76.65 136.33 17.06 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.16 2.574 . . . . 1.0 110.838 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.86 77.76 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.73 1.62 . . . . 1.0 111.919 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.08 -72.09 0.72 Allowed Glycine 0 CA--C 1.533 1.194 0 N-CA-C 105.308 -3.117 . . . . 1.0 105.308 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -155.34 122.89 5.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.012 1.725 . . . . 1.0 107.857 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -176.84 167.64 2.55 Favored 'General case' 0 N--CA 1.469 0.523 1 C-N-CA 132.107 4.163 . . . . 1.0 107.157 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.99 16.11 20.75 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.088 1.328 . . . . 1.0 111.691 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.52 118.78 4.89 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 -7.69 21.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.018 2.479 . . . . 1.0 114.143 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -60.78 -38.86 86.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.638 1.108 . . . . 1.0 109.808 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 38' ' ' LEU . 58.7 mt -66.16 -46.58 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.68 -47.76 79.15 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.697 -0.627 . . . . 1.0 110.675 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.5 -33.66 63.91 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.479 1.512 . . . . 1.0 111.794 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.2 -57.45 10.46 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.23 1.012 . . . . 1.0 109.744 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -64.76 -45.24 87.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.834 0.854 . . . . 1.0 112.423 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 50' ' ' ALA . 5.2 t -65.86 -37.12 85.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.07 0.948 . . . . 1.0 109.853 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.11 37.94 3.96 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.36 -1.245 . . . . 1.0 115.648 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 p -130.68 20.61 5.09 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.398 1.599 . . . . 1.0 112.163 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.29 151.32 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.996 1.319 . . . . 1.0 112.26 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -98.68 129.36 30.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 127.271 2.228 . . . . 1.0 107.937 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.82 67.99 3.07 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.33 3.353 . . . . 1.0 109.599 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -104.77 -65.63 1.02 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.026 1.33 . . . . 1.0 112.64 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.68 4.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.177 1.391 . . . . 1.0 112.772 -175.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 21.4 p80 -170.5 177.86 0.95 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.559 1.544 . . . . 1.0 107.86 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.2 Cg_endo -70.93 -43.44 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.536 1.49 . . . . 1.0 115.34 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -50.62 -58.31 6.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.005 1.275 . . . . 1.0 113.026 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -45.04 91.79 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.0 0.92 . . . . 1.0 111.005 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.77 86.86 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.704 -0.622 . . . . 1.0 111.997 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -60.36 9.05 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 125.797 1.665 . . . . 1.0 111.271 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.2 -32.45 40.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 116.435 -1.745 . . . . 1.0 112.052 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -35.86 -43.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.241 2.216 . . . . 1.0 115.775 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -62.19 -39.84 94.05 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.846 1.258 . . . . 1.0 109.949 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.88 135.25 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.519 -2.401 . . . . 1.0 104.519 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 159.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.057 -1.027 . . . . 1.0 108.595 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.49 164.27 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.911 1.284 . . . . 1.0 107.867 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.5 m -164.31 118.2 1.41 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.334 0.654 . . . . 1.0 110.31 175.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.79 -153.89 0.35 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.606 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 41.7 m80 -129.94 -62.19 0.96 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.3 1.44 . . . . 1.0 108.598 175.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -130.4 119.05 22.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.86 113.43 25.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.816 -2.661 . . . . 1.0 103.816 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 mt -100.91 124.45 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -83.95 148.0 27.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -16.38 0.77 Allowed 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 115.314 1.598 . . . . 1.0 115.314 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.99 22.45 4.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.12 56.23 23.4 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.425 -1.422 . . . . 1.0 112.808 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -128.7 143.34 50.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mt -116.46 125.6 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.059 1.3 . . . . 1.0 109.973 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.3 t -111.75 153.29 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.572 -2.01 . . . . 1.0 105.572 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -125.73 120.6 31.07 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.106 -0.996 . . . . 1.0 110.27 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -120.56 113.61 20.52 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 103.352 -2.833 . . . . 1.0 103.352 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.671 HG22 ' CE1' ' A' ' 19' ' ' TYR . 9.1 t 80.17 91.84 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 121.412 1.914 . . . . 1.0 114.461 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.35 -173.52 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.313 2.675 . . . . 1.0 111.816 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -80.65 51.59 1.52 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.873 -1.142 . . . . 1.0 108.989 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -148.86 113.04 5.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 130.287 3.435 . . . . 1.0 105.806 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.358 27.9 tttp 73.64 82.37 0.12 Allowed 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 115.497 1.665 . . . . 1.0 115.497 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 ttm-85 -32.72 138.11 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.855 2.862 . . . . 1.0 111.388 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.606 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.96 -178.87 3.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.118 1.767 . . . . 1.0 113.247 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -148.01 120.26 8.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.051 1.74 . . . . 1.0 109.976 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -162.08 62.85 0.23 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 106.49 -1.67 . . . . 1.0 106.49 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -157.8 -65.2 0.09 Allowed 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 119.356 -2.09 . . . . 1.0 114.082 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.16 -68.25 0.71 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.99 -0.895 . . . . 1.0 112.873 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.3 t -132.25 136.23 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.071 1.348 . . . . 1.0 109.726 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 p -166.35 137.13 3.44 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.54 1.136 . . . . 1.0 111.136 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.417 ' H ' HG22 ' A' ' 157' ' ' ILE . 16.1 p -154.96 132.42 11.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.48 -2.415 . . . . 1.0 104.48 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -152.96 159.66 42.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.117 0.871 . . . . 1.0 108.907 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 41.66 53.69 3.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.331 1.452 . . . . 1.0 111.11 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.53 32.49 53.2 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.951 -0.916 . . . . 1.0 113.382 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -139.54 114.88 9.8 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 119.084 1.442 . . . . 1.0 107.81 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.36 144.69 35.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -123.51 118.42 27.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.9 t -53.04 -39.15 63.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.663 0.665 . . . . 1.0 111.012 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -143.68 162.41 36.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.753 3.221 . . . . 1.0 104.896 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.298 28.6 t70 -86.95 76.71 9.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 123.283 1.516 . . . . 1.0 109.297 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -75.24 44.19 0.24 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 131.133 3.773 . . . . 1.0 110.255 175.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -123.15 155.43 37.05 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.133 1.373 . . . . 1.0 112.289 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.2 57.08 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.914 2.486 . . . . 1.0 109.005 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.21 -136.9 6.05 Favored Glycine 0 CA--C 1.527 0.834 0 O-C-N 120.174 -1.578 . . . . 1.0 114.055 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 133' ' ' LEU . 8.1 mm -142.12 159.55 20.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 129.129 2.972 . . . . 1.0 103.776 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.54 119.05 9.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.094 -2.928 . . . . 1.0 103.094 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.14 133.23 34.47 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.604 -1.31 . . . . 1.0 107.635 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -103.52 138.51 40.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.904 0.882 . . . . 1.0 108.765 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.55 33.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.699 1.142 . . . . 1.0 110.484 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.1 p -150.31 113.57 4.89 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.85 41.42 22.51 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.58 1.552 . . . . 1.0 114.384 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 45.77 38.16 4.04 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.295 1.838 . . . . 1.0 113.014 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -59.89 138.02 57.92 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.894 -1.891 . . . . 1.0 105.894 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.53 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.567 2.347 . . . . 1.0 111.25 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.54 -4.29 47.92 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 116.468 -1.73 . . . . 1.0 115.147 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.315 73.5 p 55.37 78.02 0.2 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.465 -1.731 . . . . 1.0 113.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -23.31 -33.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.176 2.591 . . . . 1.0 113.421 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.04 -35.71 7.14 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.485 1.914 . . . . 1.0 110.148 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.7 -50.14 63.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.342 0.973 . . . . 1.0 109.959 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.41 -39.19 86.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.672 0.789 . . . . 1.0 110.43 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.02 -54.52 28.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.844 1.258 . . . . 1.0 109.839 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -66.52 -47.47 72.83 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 0.68 . . . . 1.0 111.146 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 115' ' ' ILE . 25.1 tp -50.7 -49.51 57.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.874 1.27 . . . . 1.0 109.74 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.09 89.36 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 119.172 0.897 . . . . 1.0 110.519 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.33 59.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.424 0.689 . . . . 1.0 110.561 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.72 -46.5 62.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.4 m -59.9 -43.36 94.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.459 1.104 . . . . 1.0 110.576 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -58.82 -47.47 84.7 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.605 1.093 . . . . 1.0 109.564 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.73 -58.19 9.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.227 1.011 . . . . 1.0 109.253 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.3 -38.1 68.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.871 -1.062 . . . . 1.0 113.554 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.7 mt -61.25 -49.38 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 120.041 1.291 . . . . 1.0 108.991 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.5 m -66.36 -20.53 66.1 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.272 -0.268 . . . . 1.0 110.811 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -83.64 -57.1 3.37 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.01 1.724 . . . . 1.0 108.943 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.46 112.97 23.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 106.537 -1.653 . . . . 1.0 106.537 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -95.07 107.87 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 CA-C-N 120.848 1.339 . . . . 1.0 113.459 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.99 -50.64 0.11 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.855 1.662 . . . . 1.0 108.471 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.35 -33.64 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 129.689 3.196 . . . . 1.0 111.282 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.73 -21.98 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.704 1.601 . . . . 1.0 113.994 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -141.43 18.6 2.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.889 1.676 . . . . 1.0 110.398 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -138.44 84.17 2.01 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.707 -1.246 . . . . 1.0 108.046 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.0 mtt -121.5 114.38 21.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.8 t -145.37 -169.37 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.78 -131.51 2.57 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 106.285 -2.726 . . . . 1.0 106.285 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 20.2 m170 -117.49 -23.17 7.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.052 1.341 . . . . 1.0 109.314 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -23.07 13.82 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -84.14 42.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.539 1.063 . . . . 1.0 108.367 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.6 -14.14 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 O-C-N 120.073 -1.642 . . . . 1.0 108.281 175.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.506 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -158.02 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 128.634 2.774 . . . . 1.0 111.584 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 91.7 Cg_endo -79.61 108.44 2.29 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.199 1.933 . . . . 1.0 113.144 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -62.33 -21.68 65.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.246 1.418 . . . . 1.0 111.813 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -67.59 -24.39 65.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.656 -1.277 . . . . 1.0 113.002 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -132.7 124.29 27.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.177 -2.156 . . . . 1.0 105.177 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -114.18 -17.41 11.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.624 -1.23 . . . . 1.0 111.479 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.69 178.98 0.41 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 131.398 3.879 . . . . 1.0 103.603 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 91.64 0.65 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 121.697 1.642 . . . . 1.0 108.07 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 114.18 76.81 0.73 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.776 1.655 . . . . 1.0 111.263 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.83 -90.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.553 2.836 . . . . 1.0 110.452 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t 53.01 46.85 25.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.695 2.398 . . . . 1.0 113.782 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -118.24 16.46 14.0 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.851 -1.156 . . . . 1.0 112.629 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.5 t0 43.84 80.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.068 -1.645 . . . . 1.0 113.756 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -62.73 -33.93 76.13 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.237 -0.915 . . . . 1.0 112.396 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.47 91.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.299 0.954 . . . . 1.0 110.934 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -65.91 -52.52 49.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.115 0.87 . . . . 1.0 110.237 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.86 -51.84 67.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -62.04 -35.42 78.55 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.222 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.62 80.71 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.6 -46.91 62.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.128 0.571 . . . . 1.0 110.046 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.18 166.52 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.618 1.967 . . . . 1.0 111.488 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.547 0.84 0 C-N-CA 127.168 2.187 . . . . 1.0 108.499 175.144 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 C--O 1.237 0.436 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.09 172.45 12.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.542 0.61 . . . . 1.0 110.738 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 37.51 57.85 1.36 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.959 2.904 . . . . 1.0 110.71 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.03 156.73 22.53 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.155 -0.966 . . . . 1.0 110.074 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -88.0 123.06 32.33 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.152 0.433 . . . . 1.0 111.769 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -98.22 130.02 44.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.47 1.108 . . . . 1.0 111.212 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.87 92.43 9.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.987 0.915 . . . . 1.0 108.654 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.4 160.47 44.62 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.54 1.493 . . . . 1.0 112.576 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 t -159.94 113.41 1.45 Allowed Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.4 61.17 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.792 2.328 . . . . 1.0 111.983 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -133.53 43.26 2.91 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.099 1.76 . . . . 1.0 107.068 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.6 m-85 -73.84 178.47 4.85 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.994 1.317 . . . . 1.0 109.832 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.07 178.79 4.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 124.117 1.913 . . . . 1.0 113.953 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -138.13 118.44 13.68 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 111.921 -2.4 . . . . 1.0 106.729 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -126.16 167.26 17.52 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 129.045 2.938 . . . . 1.0 106.144 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -179.1 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.619 1.546 . . . . 1.0 109.132 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.85 143.33 45.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.627 -2.361 . . . . 1.0 104.627 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -150.99 167.33 27.96 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 102.727 -3.064 . . . . 1.0 102.727 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.77 163.46 24.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.713 1.605 . . . . 1.0 108.962 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.39 123.59 3.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.307 2.243 . . . . 1.0 110.282 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HB2' ' H ' ' A' ' 113' ' ' ILE . 63.2 Cg_endo -66.11 135.28 39.86 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.495 2.797 . . . . 1.0 111.008 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 t 178.88 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.523 1.929 . . . . 1.0 106.768 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.27 125.15 6.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.1 126.01 39.07 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.77 144.31 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 104.593 -2.373 . . . . 1.0 104.593 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 169' ' ' PHE . 47.2 t -135.67 113.88 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.544 -3.132 . . . . 1.0 102.544 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -167.39 143.04 4.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.51 112.51 21.61 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.868 0.73 . . . . 1.0 109.409 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.4 176.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.629 1.972 . . . . 1.0 107.387 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 t -141.47 122.4 14.51 Favored 'General case' 0 N--CA 1.442 -0.834 1 N-CA-C 95.345 -5.798 . . . . 1.0 95.345 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.353 0.7 OUTLIER -142.58 -66.7 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 116.337 -1.792 . . . . 1.0 115.162 -178.656 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 32.2 Cg_endo -94.38 157.74 2.03 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.588 2.192 . . . . 1.0 114.783 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.25 51.72 4.02 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 125.215 3.943 . . . . 1.0 117.487 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.15 -71.2 0.83 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 107.373 -2.291 . . . . 1.0 107.373 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -156.32 122.82 5.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.72 2.008 . . . . 1.0 108.251 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -176.74 161.74 2.09 Favored 'General case' 0 C--O 1.235 0.295 1 C-N-CA 132.745 4.418 . . . . 1.0 108.229 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.18 4.0 29.99 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.522 1.058 . . . . 1.0 111.005 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.81 119.09 4.88 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 117.952 -1.471 . . . . 1.0 110.015 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -5.48 14.08 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.78 2.32 . . . . 1.0 114.771 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -60.9 -47.63 85.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.565 1.984 . . . . 1.0 110.926 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 mt -62.27 -51.28 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.35 -46.91 86.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.308 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -60.1 -37.48 80.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.04 0.936 . . . . 1.0 111.361 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.2 -49.94 73.76 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.485 0.584 . . . . 1.0 110.143 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -70.85 -46.91 61.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.177 -0.439 . . . . 1.0 110.93 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -65.9 -37.83 87.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.516 1.126 . . . . 1.0 109.63 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 8.09 11.26 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.915 1.721 . . . . 1.0 115.513 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -104.3 19.4 20.29 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.234 2.017 . . . . 1.0 113.34 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -59.41 125.25 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.306 1.442 . . . . 1.0 111.709 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.14 136.65 20.46 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.44 1.896 . . . . 1.0 110.671 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -71.36 70.38 2.5 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.788 2.992 . . . . 1.0 111.225 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -103.3 -62.5 1.28 Allowed 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.659 -0.651 . . . . 1.0 111.808 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.22 76.0 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.949 0.5 . . . . 1.0 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.3 p80 -170.63 177.98 0.91 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.865 1.666 . . . . 1.0 107.396 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.8 Cg_endo -69.8 -43.33 2.69 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 1.0 114.718 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -46.47 -51.05 16.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -57.48 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.128 0.971 . . . . 1.0 111.243 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.2 96.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.671 0.788 . . . . 1.0 111.05 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.04 -61.47 3.94 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.171 1.843 . . . . 1.0 111.672 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 pt -59.89 -33.98 54.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 116.743 -1.599 . . . . 1.0 112.709 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.38 -43.15 2.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.538 1.935 . . . . 1.0 115.154 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -54.67 -36.51 64.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.912 0.885 . . . . 1.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 136.54 33.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.352 -2.462 . . . . 1.0 104.352 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -60.49 152.06 26.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.088 -1.007 . . . . 1.0 108.55 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.7 158.7 17.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.481 1.112 . . . . 1.0 110.273 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -171.59 128.68 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.875 2.07 . . . . 1.0 108.127 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.13 -172.2 2.61 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -120.77 -59.71 1.72 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -138.97 118.72 13.13 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.433 -1.691 . . . . 1.0 106.433 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.77 113.47 26.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -95.44 118.28 41.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.077 -1.823 . . . . 1.0 106.077 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -72.67 148.3 44.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 117.994 -1.003 . . . . 1.0 108.304 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -45.45 -35.14 3.55 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 113.438 0.903 . . . . 1.0 113.438 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -91.67 36.64 0.95 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.882 0.873 . . . . 1.0 112.068 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.17 52.76 49.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.274 1.416 . . . . 1.0 115.299 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -119.49 111.92 18.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.388 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 132' ' ' GLN . 86.6 mt -85.78 113.88 24.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.295 -2.113 . . . . 1.0 105.295 175.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 140.27 30.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.273 -1.751 . . . . 1.0 106.273 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -121.85 114.87 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.487 1.115 . . . . 1.0 108.321 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -114.11 121.06 42.64 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 103.538 -2.764 . . . . 1.0 103.538 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 19' ' ' TYR . 88.4 t 70.8 92.01 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 121.041 1.746 . . . . 1.0 111.344 -177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.57 -168.4 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.405 2.737 . . . . 1.0 111.891 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -59.61 2.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.965 2.506 . . . . 1.0 115.596 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -125.58 135.08 51.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 128.025 2.53 . . . . 1.0 104.372 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.261 14.4 tptp 77.19 82.15 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.303 1.841 . . . . 1.0 111.882 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -34.11 136.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.521 1.928 . . . . 1.0 113.878 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.64 -178.39 3.65 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.451 2.3 . . . . 1.0 108.989 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -148.2 118.58 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.77 62.89 0.47 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.591 -1.318 . . . . 1.0 111.035 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.74 -68.22 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 119.177 -2.202 . . . . 1.0 113.99 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.99 -84.57 0.37 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 106.959 -2.456 . . . . 1.0 106.959 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.85 145.45 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.683 1.242 . . . . 1.0 109.468 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.6 p -165.97 145.47 6.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.8 1.24 . . . . 1.0 111.248 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.504 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -133.23 146.55 51.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.43 1.892 . . . . 1.0 109.79 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.72 148.91 28.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 41.53 53.5 3.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.24 1.816 . . . . 1.0 110.224 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.66 28.43 56.58 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.167 1.841 . . . . 1.0 116.277 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -132.82 136.6 46.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.145 1.973 . . . . 1.0 107.08 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 15.0 tp10 -96.2 145.79 25.24 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.65 1.18 . . . . 1.0 109.222 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -112.7 120.28 40.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.413 -2.069 . . . . 1.0 105.413 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.7 t -54.42 -31.2 54.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 1.0 112.826 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -164.27 176.29 9.3 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 129.552 3.141 . . . . 1.0 104.602 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -81.29 76.45 8.23 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 123.038 1.399 . . . . 1.0 109.628 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -80.94 33.52 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.233 1.813 . . . . 1.0 110.62 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 m -129.54 143.26 50.75 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 124.182 0.993 . . . . 1.0 113.124 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.524 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -80.01 57.09 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.56 2.344 . . . . 1.0 107.825 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.41 -136.58 1.35 Allowed Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.526 1.07 . . . . 1.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 133' ' ' LEU . 8.2 mm -143.19 163.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 103.299 -2.852 . . . . 1.0 103.299 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.71 130.79 23.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.471 -2.788 . . . . 1.0 103.471 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mp -101.13 166.03 11.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.529 0.681 . . . . 1.0 109.387 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.42 158.38 44.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.979 0.895 . . . . 1.0 111.4 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.75 173.04 45.4 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 113.759 -1.564 . . . . 1.0 110.876 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.8 p -141.14 101.94 4.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.796 -1.928 . . . . 1.0 105.796 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t70 49.48 55.74 8.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.584 1.954 . . . . 1.0 111.842 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.321 18.6 p 47.29 38.69 7.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.836 2.854 . . . . 1.0 115.131 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.55 146.19 55.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -38.14 114.13 0.34 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.14 2.176 . . . . 1.0 112.679 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -79.06 0.54 27.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 116.202 -1.856 . . . . 1.0 114.541 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.506 4.8 p 55.43 77.97 0.2 Allowed 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.017 -2.42 . . . . 1.0 117.443 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -23.4 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 122.479 2.399 . . . . 1.0 116.346 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.87 -41.73 16.22 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.722 1.609 . . . . 1.0 109.549 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.97 -50.92 60.31 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.919 0.887 . . . . 1.0 110.549 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -59.99 -43.27 95.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.221 0.918 . . . . 1.0 110.157 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.12 -51.05 61.63 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.864 0.466 . . . . 1.0 110.754 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.481 ' HB3' HD11 ' A' ' 84' ' ' ILE . 38.2 mm-40 -62.84 -50.2 71.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.142 1.777 . . . . 1.0 109.713 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 115' ' ' ILE . 35.7 tp -54.14 -49.08 70.05 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.4 76.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 1.0 111.37 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.42 55.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.7 0.8 . . . . 1.0 109.253 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.52 -47.69 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.8 m -52.75 -48.84 66.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.696 1.598 . . . . 1.0 110.232 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -59.66 -46.93 87.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.795 0.725 . . . . 1.0 111.951 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.17 74.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.271 0.487 . . . . 1.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.34 -41.23 75.74 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.934 0.893 . . . . 1.0 112.583 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.56 -49.47 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.726 1.148 . . . . 1.0 109.605 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.1 m -59.77 -16.65 29.44 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.439 0.695 . . . . 1.0 111.903 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -94.34 -58.87 2.09 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.467 -1.396 . . . . 1.0 109.55 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -125.95 112.9 24.41 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.068 -1.456 . . . . 1.0 107.068 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.77 107.48 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.644 1.266 . . . . 1.0 112.814 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.64 -50.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.919 2.088 . . . . 1.0 107.73 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.5 mt -44.78 -33.77 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.5 0 C-N-CA 129.478 3.111 . . . . 1.0 110.543 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.06 4.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.7 2.0 . . . . 1.0 114.118 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -136.54 18.57 3.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.803 1.641 . . . . 1.0 109.75 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.76 84.62 2.03 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.262 0.937 . . . . 1.0 110.176 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.37 114.07 19.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.9 t -146.73 -171.08 3.67 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.571 -0.706 . . . . 1.0 110.012 -175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.59 2.04 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 107.021 -2.431 . . . . 1.0 107.021 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -113.58 -23.23 9.88 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.688 0.795 . . . . 1.0 111.639 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.59 -12.34 17.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.124 0.57 . . . . 1.0 109.695 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -88.09 40.02 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.153 0.888 . . . . 1.0 110.448 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.8 -26.57 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 120.955 -1.091 . . . . 1.0 108.449 175.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -143.68 -65.48 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.667 1.587 . . . . 1.0 111.767 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 96.2 Cg_endo -82.9 110.68 1.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.744 2.296 . . . . 1.0 112.807 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.23 -18.76 39.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.303 1.441 . . . . 1.0 113.609 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -57.42 -26.29 60.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.594 1.557 . . . . 1.0 112.154 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -126.22 141.16 52.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.085 -2.191 . . . . 1.0 105.085 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 m -132.15 -16.45 2.81 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.696 -0.628 . . . . 1.0 110.634 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.8 176.23 0.82 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 131.434 3.894 . . . . 1.0 102.805 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.45 70.31 6.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.802 2.335 . . . . 1.0 111.756 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 119.18 78.18 0.57 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.34 -2.304 . . . . 1.0 107.34 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 -62.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.028 2.485 . . . . 1.0 112.155 -175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.53 51.67 14.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.793 2.037 . . . . 1.0 114.027 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 33' ' ' VAL . 33.6 t80 -124.22 18.18 9.1 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.203 0.91 . . . . 1.0 113.232 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.386 19.9 t0 41.01 76.46 0.07 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.245 1.818 . . . . 1.0 113.748 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -51.29 -34.29 32.42 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.43 91.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 117.56 -1.21 . . . . 1.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -66.57 -53.17 37.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.294 1.406 . . . . 1.0 109.221 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.85 -51.24 70.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.369 0.507 . . . . 1.0 112.369 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -66.11 -23.49 66.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.84 0.745 . . . . 1.0 110.321 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.77 -51.9 50.44 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.298 -1.501 . . . . 1.0 109.754 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.79 -57.82 8.75 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.144 1.377 . . . . 1.0 111.339 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.86 166.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 175.474 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.7 tm? . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.0 158.22 33.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.657 1.354 . . . . 1.0 114.657 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 38.56 57.98 1.7 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.587 2.755 . . . . 1.0 109.759 -175.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.24 51.82 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.593 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.551 HH11 ' HB2' ' A' ' 12' ' ' ARG . 8.5 ttm105 -79.11 123.14 27.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.329 -2.471 . . . . 1.0 104.329 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.9 122.5 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -143.01 79.54 14.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.994 -1.854 . . . . 1.0 105.994 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 132.95 30.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.927 1.751 . . . . 1.0 111.217 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 t -69.34 145.41 95.73 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 124.765 1.226 . . . . 1.0 109.587 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 -23.41 7.19 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 117.025 1.894 . . . . 1.0 117.025 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -150.16 121.46 7.85 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CE2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -96.57 178.98 5.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 178.45 4.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 123.11 1.433 . . . . 1.0 111.612 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 m -154.69 118.5 4.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 131.603 3.961 . . . . 1.0 101.594 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -130.69 155.21 81.62 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 125.853 1.661 . . . . 1.0 108.121 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -88.01 56.41 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.268 2.645 . . . . 1.0 109.794 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -140.25 143.64 36.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.41 103.92 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.56 171.22 14.09 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 105.877 -1.897 . . . . 1.0 105.877 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -71.37 123.3 89.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 119.53 1.059 . . . . 1.0 108.915 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.12 103.61 1.46 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 CA-C-N 120.687 1.281 . . . . 1.0 109.519 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -175.76 78.46 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.165 1.786 . . . . 1.0 107.337 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.415 HD12 HD22 ' A' ' 150' ' ' ASN . 4.9 tp -143.69 140.79 30.22 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.143 1.777 . . . . 1.0 106.722 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -106.11 126.59 52.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.665 1.121 . . . . 1.0 108.376 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.37 130.15 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.408 -2.071 . . . . 1.0 105.408 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HD13 ' A' ' 117' ' ' LEU . 59.4 t -134.6 112.98 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -158.52 149.71 20.71 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 176.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 119' ' ' GLY . 2.6 t-20 -81.54 111.26 17.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.644 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.3 mm -127.18 176.79 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.763 2.025 . . . . 1.0 107.451 174.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t -161.84 122.31 2.61 Favored 'General case' 0 C--N 1.313 -0.986 1 N-CA-C 93.93 -6.322 . . . . 1.0 93.93 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.273 1.2 tm? -142.66 -56.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 O-C-N 121.035 -1.04 . . . . 1.0 109.688 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -71.53 149.29 55.53 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.133 1.889 . . . . 1.0 112.631 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -82.41 39.66 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.56 3.506 . . . . 1.0 114.265 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -53.0 -71.61 0.66 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-O 117.461 -1.744 . . . . 1.0 110.581 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -156.6 122.87 4.98 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.707 1.754 . . . . 1.0 111.996 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -177.8 160.92 1.56 Allowed 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.493 4.317 . . . . 1.0 108.183 175.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.94 6.13 59.97 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.137 0.875 . . . . 1.0 111.846 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.89 118.65 4.73 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.0 1.4 . . . . 1.0 109.651 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 -21.44 44.62 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.364 2.043 . . . . 1.0 114.083 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -52.06 -43.09 63.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.099 0.863 . . . . 1.0 112.08 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.75 -44.3 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.449 1.1 . . . . 1.0 109.665 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.51 -45.64 78.88 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.05 0.841 . . . . 1.0 110.363 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.23 -33.56 58.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.476 1.511 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -55.06 -61.28 2.42 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.633 1.573 . . . . 1.0 108.985 175.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.99 -37.54 75.75 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.13 0.972 . . . . 1.0 113.279 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.5 t -65.82 -33.84 76.79 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.92 -5.43 53.5 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 125.211 1.386 . . . . 1.0 115.505 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -89.42 8.9 28.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.295 2.048 . . . . 1.0 112.515 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -51.94 134.42 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 125.961 1.705 . . . . 1.0 111.176 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.72 134.18 21.85 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 127.585 2.354 . . . . 1.0 110.225 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 77.52 1.82 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.641 2.894 . . . . 1.0 107.422 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.32 -63.26 1.19 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.364 0.666 . . . . 1.0 110.639 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.0 78.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.755 0.822 . . . . 1.0 110.69 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 19.5 p80 -171.0 178.0 0.87 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.737 2.015 . . . . 1.0 107.167 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 26.1 Cg_endo -73.05 -43.48 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.049 1.832 . . . . 1.0 114.684 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -46.38 -47.61 18.74 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -55.4 -58.13 8.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.451 1.1 . . . . 1.0 110.066 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.42 92.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.899 0.88 . . . . 1.0 111.37 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.59 -65.78 2.62 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.645 1.593 . . . . 1.0 111.553 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.15 -38.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.476 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.18 -43.41 10.05 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.359 1.864 . . . . 1.0 114.951 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -57.36 -33.55 67.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.71 -0.619 . . . . 1.0 110.323 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.51 134.23 33.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 102.2 -3.259 . . . . 1.0 102.2 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 152.14 19.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.949 0.795 . . . . 1.0 110.967 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.43 161.43 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.772 1.629 . . . . 1.0 110.74 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.0 m -172.88 123.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.584 1.554 . . . . 1.0 108.242 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.51 -154.05 0.43 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 28.1 m80 -128.89 -65.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.487 1.115 . . . . 1.0 110.133 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.8 m -133.99 118.69 18.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.678 -1.264 . . . . 1.0 107.689 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -103.47 113.97 27.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.809 -1.923 . . . . 1.0 105.809 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.56 114.59 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -66.36 148.62 51.59 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.72 1.145 . . . . 1.0 108.532 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -13.62 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.721 1.608 . . . . 1.0 112.306 175.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -91.21 18.96 6.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 131.478 3.911 . . . . 1.0 112.304 -176.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.5 46.97 93.37 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.229 1.395 . . . . 1.0 113.168 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.97 110.25 14.56 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.706 1.253 . . . . 1.0 110.156 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' A' ' 132' ' ' GLN . 52.0 mt -81.48 117.45 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 106.729 -1.582 . . . . 1.0 106.729 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.45 147.9 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.216 -1.772 . . . . 1.0 106.216 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -125.75 124.26 40.64 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 1.0 110.141 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.0 117.86 28.36 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 129.463 3.105 . . . . 1.0 103.755 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 19' ' ' TYR . 39.5 t 72.06 91.78 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 122.656 2.48 . . . . 1.0 113.205 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.91 -166.61 0.23 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.331 2.021 . . . . 1.0 111.079 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -70.85 46.07 0.09 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.856 2.862 . . . . 1.0 113.703 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.01 127.16 4.5 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 127.215 2.206 . . . . 1.0 106.508 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 tptm 77.35 81.48 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.543 1.137 . . . . 1.0 111.377 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -39.53 154.9 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.462 2.305 . . . . 1.0 113.232 -175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -108.31 -178.29 3.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.566 2.346 . . . . 1.0 113.008 -175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -153.12 118.73 5.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.905 1.682 . . . . 1.0 108.956 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -166.32 64.02 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 122.595 1.188 . . . . 1.0 111.167 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.15 -54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 118.103 -2.873 . . . . 1.0 112.602 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.37 -74.73 0.25 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.347 -1.807 . . . . 1.0 109.137 -175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.55 142.2 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.935 1.694 . . . . 1.0 110.018 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -166.33 163.66 17.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.984 2.514 . . . . 1.0 110.643 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.7 p -163.14 146.23 10.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -159.65 157.48 29.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.738 1.154 . . . . 1.0 108.94 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 39.9 53.28 2.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.623 1.569 . . . . 1.0 109.994 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.3 42.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 116.262 1.265 . . . . 1.0 116.262 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -129.0 121.98 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 120.019 1.909 . . . . 1.0 106.861 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.45 141.06 38.55 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -119.51 118.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.5 -42.87 97.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.3 0.852 . . . . 1.0 113.3 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.95 176.52 8.74 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.277 1.831 . . . . 1.0 108.968 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -83.15 76.46 9.86 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.91 38.41 1.23 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.986 1.315 . . . . 1.0 111.758 -175.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -134.14 149.94 51.09 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.094 0.958 . . . . 1.0 113.013 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -82.52 56.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.845 2.058 . . . . 1.0 109.645 177.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.51 -136.86 2.15 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 122.393 0.996 . . . . 1.0 113.359 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 136' ' ' VAL . 14.7 mm -140.86 160.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 103.532 -2.766 . . . . 1.0 103.532 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -138.46 126.04 22.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 103.324 -2.843 . . . . 1.0 103.324 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.443 HD13 HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -101.51 139.56 37.0 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.993 -1.067 . . . . 1.0 109.459 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 5.4 tm-20 -104.53 154.09 20.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.471 0.653 . . . . 1.0 110.539 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.451 ' C ' HD21 ' A' ' 35' ' ' ASN . . . -174.42 -179.74 45.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.405 1.955 . . . . 1.0 110.213 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 p -141.87 106.41 4.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.074 -1.824 . . . . 1.0 106.074 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.266 43.7 t0 38.95 56.63 1.98 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.107 2.563 . . . . 1.0 113.986 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p 56.16 38.2 29.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.564 1.32 . . . . 1.0 114.564 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -69.17 146.0 52.81 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 105.389 -2.078 . . . . 1.0 105.389 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -37.26 113.55 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.133 1.373 . . . . 1.0 111.062 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.94 -6.62 56.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 115.521 1.674 . . . . 1.0 115.521 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.395 10.9 p 66.7 76.96 0.29 Allowed 'General case' 0 C--N 1.352 0.704 0 CA-C-N 120.872 1.669 . . . . 1.0 112.797 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -25.54 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.734 1.753 . . . . 1.0 115.734 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.75 7.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.669 1.588 . . . . 1.0 109.719 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.47 -48.79 37.48 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.037 1.335 . . . . 1.0 110.64 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.65 -40.52 92.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.13 0.877 . . . . 1.0 110.266 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -65.95 -50.12 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.38 0.536 . . . . 1.0 110.208 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HB3' HD11 ' A' ' 84' ' ' ILE . 90.8 mt-30 -62.15 -52.66 62.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.689 1.596 . . . . 1.0 110.274 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.2 tp -54.23 -47.99 71.59 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.835 1.654 . . . . 1.0 109.656 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.9 98.05 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.304 0.956 . . . . 1.0 110.54 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.15 49.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 115' ' ' ILE . 97.1 t -59.47 -43.29 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.868 0.867 . . . . 1.0 110.766 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.8 m -57.57 -54.0 51.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 1.0 109.492 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -65.69 -33.75 76.61 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.2 -59.25 5.77 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . 0.341 2.9 mm? -56.71 -33.83 66.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.738 -1.125 . . . . 1.0 113.555 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.68 -39.68 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.597 1.544 . . . . 1.0 107.908 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.2 m -60.18 -24.63 64.93 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.726 0.811 . . . . 1.0 110.866 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -84.3 -64.85 1.09 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 106.367 -1.716 . . . . 1.0 106.367 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -126.92 113.38 22.07 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.219 1.008 . . . . 1.0 109.976 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.63 107.36 0.33 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 CA-C-N 120.287 1.138 . . . . 1.0 110.838 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.3 -47.23 0.1 Allowed 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 128.212 2.605 . . . . 1.0 105.855 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.5 mt -48.54 -34.09 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 129.555 3.142 . . . . 1.0 110.644 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.91 7.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.803 0.841 . . . . 1.0 113.076 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -137.27 18.33 2.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.5 2.32 . . . . 1.0 109.926 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.415 HD22 HD12 ' A' ' 30' ' ' LEU . 5.5 m120 -141.99 83.67 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.409 1.004 . . . . 1.0 110.148 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.24 114.83 18.16 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 102.878 -3.008 . . . . 1.0 102.878 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.6 t -153.38 -166.98 2.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.315 0.579 . . . . 1.0 111.688 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.26 -131.93 1.59 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.378 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 13.9 m170 -112.83 -23.26 10.23 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.899 0.88 . . . . 1.0 109.223 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -108.39 -21.98 12.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.104 1.361 . . . . 1.0 108.991 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -83.85 34.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.883 -1.136 . . . . 1.0 109.074 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -22.53 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.434 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -149.19 -55.92 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.952 2.501 . . . . 1.0 110.926 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 83.8 Cg_endo -81.78 112.01 2.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.27 1.98 . . . . 1.0 112.907 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.42 -26.19 64.96 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.847 -1.158 . . . . 1.0 111.705 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -21.94 66.19 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.857 1.263 . . . . 1.0 112.091 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -137.81 124.7 21.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -113.75 -15.75 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.395 0.543 . . . . 1.0 110.937 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.86 178.08 0.5 Allowed Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 129.645 3.178 . . . . 1.0 105.314 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -78.99 50.02 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.45 2.1 . . . . 1.0 111.185 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.55 65.82 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.36 1.933 . . . . 1.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.88 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.222 2.615 . . . . 1.0 111.51 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.1 t 53.61 50.66 16.7 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.603 1.161 . . . . 1.0 111.036 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.439 ' CD2' HG11 ' A' ' 33' ' ' VAL . 27.7 t80 -105.33 17.73 23.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.967 1.258 . . . . 1.0 113.175 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.1 t0 43.74 62.56 1.87 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.702 -1.873 . . . . 1.0 110.905 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -52.15 -33.43 40.3 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.748 -0.644 . . . . 1.0 111.279 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.98 -60.45 3.81 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.622 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -60.45 -42.3 95.86 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 117.574 -1.203 . . . . 1.0 111.411 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.94 -62.0 2.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.107 0.867 . . . . 1.0 111.128 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -61.14 -32.4 72.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.702 -0.666 . . . . 1.0 110.858 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.76 76.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.021 0.828 . . . . 1.0 112.233 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.75 -57.23 4.88 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.889 -1.132 . . . . 1.0 108.367 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.67 164.6 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.084 1.754 . . . . 1.0 110.76 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 125.405 1.482 . . . . 1.0 109.019 175.738 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 28.1 tp -74.26 142.44 45.28 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.718 1.145 . . . . 1.0 109.819 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.1 mt -131.88 136.49 47.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.664 2.386 . . . . 1.0 104.955 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -134.81 124.23 24.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.868 2.067 . . . . 1.0 109.001 -175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 54.01 35.32 21.77 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.442 2.297 . . . . 1.0 112.05 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.03 3.95 25.65 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.866 0.746 . . . . 1.0 112.794 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -97.48 168.01 10.64 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.428 -2.064 . . . . 1.0 105.428 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.4 123.46 28.05 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.27 168.75 18.66 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 44.18 57.98 3.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.189 1.795 . . . . 1.0 109.711 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.49 156.25 41.68 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.958 2.103 . . . . 1.0 108.91 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -93.28 125.13 37.72 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -83.62 118.7 24.01 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.19 66.72 60.67 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.67 123.44 11.7 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 N-CA-C 108.339 -1.447 . . . . 1.0 108.339 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 t -54.82 142.71 53.71 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 123.193 0.597 . . . . 1.0 111.581 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.35 -12.01 24.99 Favored 'Trans proline' 0 N--CA 1.441 -1.569 0 N-CA-C 116.039 1.515 . . . . 1.0 116.039 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -151.74 111.37 3.99 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CE1' HG22 ' A' ' 88' ' ' VAL . 9.6 m-30 -79.6 178.76 7.91 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.11 0.868 . . . . 1.0 110.532 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.0 -173.22 2.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 128.341 2.656 . . . . 1.0 109.916 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.8 m -165.66 118.13 1.13 Allowed 'General case' 0 CA--C 1.54 0.569 1 C-N-CA 131.705 4.002 . . . . 1.0 104.65 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.26 139.08 28.92 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 120.349 1.431 . . . . 1.0 109.809 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -84.24 70.03 6.07 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 124.449 3.433 . . . . 1.0 113.467 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -143.52 154.65 43.84 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 125.598 1.559 . . . . 1.0 108.68 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -151.19 103.43 3.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.354 0.979 . . . . 1.0 112.127 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -136.61 147.04 46.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 129.423 3.089 . . . . 1.0 104.68 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -59.66 123.79 72.93 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 119.949 1.25 . . . . 1.0 111.476 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.96 103.85 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.023 2.482 . . . . 1.0 111.847 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 t -172.24 79.39 0.05 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.703 1.601 . . . . 1.0 107.444 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.8 tp -139.93 133.66 30.49 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 tp -97.2 123.17 40.9 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.465 1.029 . . . . 1.0 108.311 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.69 118.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.957 -1.498 . . . . 1.0 106.957 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 163' ' ' THR . 69.3 t -116.02 114.79 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.289 -2.115 . . . . 1.0 105.289 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.6 p80 -167.34 152.33 7.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.267 -1.382 . . . . 1.0 107.267 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -96.67 112.23 24.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -127.51 175.95 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.597 1.959 . . . . 1.0 109.127 175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 122.4 3.49 Favored 'General case' 0 N--CA 1.442 -0.869 1 N-CA-C 99.099 -4.408 . . . . 1.0 99.099 174.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.612 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -142.2 -48.4 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-O 118.174 -0.917 . . . . 1.0 108.979 178.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.612 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 39.0 Cg_endo -91.1 146.51 3.61 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 121.791 1.661 . . . . 1.0 114.465 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -84.48 44.3 1.48 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.508 3.472 . . . . 1.0 113.967 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.17 -65.02 2.0 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.971 -1.08 . . . . 1.0 111.71 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -152.35 122.78 7.26 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 105.886 -1.894 . . . . 1.0 105.886 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -176.42 175.85 1.72 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.782 2.833 . . . . 1.0 108.547 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.6 27.12 3.98 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.636 2.065 . . . . 1.0 109.634 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.13 118.18 6.1 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 106.037 -2.825 . . . . 1.0 106.037 175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.26 -17.45 35.3 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 119.796 1.798 . . . . 1.0 115.13 -175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.3 t-105 -66.14 -43.3 87.45 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.011 1.278 . . . . 1.0 110.996 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.02 -47.18 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.059 0.943 . . . . 1.0 109.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.9 -35.86 81.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.351 -0.843 . . . . 1.0 112.154 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.94 -33.47 68.85 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.013 0.925 . . . . 1.0 111.498 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.38 -54.58 43.87 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 121.511 -0.743 . . . . 1.0 109.893 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -66.77 -45.37 78.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 118.805 -0.617 . . . . 1.0 111.751 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -63.62 -39.39 94.23 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.33 3.26 22.77 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.412 1.958 . . . . 1.0 114.775 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.1 p -88.63 9.01 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.947 1.874 . . . . 1.0 112.627 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 tt -54.58 136.02 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 118.465 0.575 . . . . 1.0 110.896 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -105.22 136.6 19.17 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 127.71 2.404 . . . . 1.0 108.689 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -72.29 60.89 3.31 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 124.12 3.214 . . . . 1.0 112.719 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.48 -49.13 3.78 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 117.795 -1.098 . . . . 1.0 112.793 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.63 -66.4 0.41 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.505 1.048 . . . . 1.0 112.079 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.425 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 24.6 p80 -163.57 177.83 1.71 Allowed Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 12.1 Cg_endo -70.43 -43.85 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.458 1.438 . . . . 1.0 114.834 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -51.47 -57.89 7.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.366 1.439 . . . . 1.0 111.999 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.47 -51.14 71.15 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.817 0.847 . . . . 1.0 110.182 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.86 -43.93 86.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.651 0.78 . . . . 1.0 111.17 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -65.18 3.75 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.329 1.442 . . . . 1.0 110.535 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.27 -25.54 30.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-O 115.92 -1.991 . . . . 1.0 113.639 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -43.75 -43.04 5.82 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.966 1.712 . . . . 1.0 113.209 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -54.98 -38.28 67.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.419 1.488 . . . . 1.0 111.075 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.51 135.29 33.51 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.096 -1.816 . . . . 1.0 106.096 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.11 158.92 27.32 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.738 -1.227 . . . . 1.0 108.343 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.44 161.59 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.697 -0.853 . . . . 1.0 108.697 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB3' HG21 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -165.8 122.91 1.43 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.908 -1.886 . . . . 1.0 105.908 175.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.83 -154.0 0.42 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.969 1.308 . . . . 1.0 107.624 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.8 m80 -131.15 -67.16 0.71 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.67 1.123 . . . . 1.0 111.132 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' HB2' HD13 ' A' ' 115' ' ' ILE . 61.2 m -135.58 119.15 16.99 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.344 -2.095 . . . . 1.0 105.344 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tt -113.29 118.08 33.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.116 1.766 . . . . 1.0 107.571 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.3 mt -100.71 113.98 38.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.194 -1.78 . . . . 1.0 106.194 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -83.3 153.79 24.45 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 120.041 1.291 . . . . 1.0 108.636 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -17.94 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 128.939 2.896 . . . . 1.0 115.624 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.79 27.13 2.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.06 1.3 . . . . 1.0 112.668 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.26 42.75 99.87 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.544 1.069 . . . . 1.0 112.592 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.08 149.22 29.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.366 1.083 . . . . 1.0 108.837 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.7 mt -116.05 119.08 60.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.606 -1.257 . . . . 1.0 107.606 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.46 147.82 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.402 -2.073 . . . . 1.0 105.402 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -125.69 122.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.618 -1.252 . . . . 1.0 107.618 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -120.98 113.69 20.45 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.876 -2.268 . . . . 1.0 104.876 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 19' ' ' TYR . 4.1 t 79.84 92.1 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.448 1.476 . . . . 1.0 111.439 176.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -61.7 -175.76 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 121.615 1.543 . . . . 1.0 110.877 175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -58.34 5.49 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.89 2.476 . . . . 1.0 114.294 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.41 115.25 19.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.168 2.587 . . . . 1.0 108.795 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 42.7 tptt 85.81 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 128.67 2.788 . . . . 1.0 112.288 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.459 HH11 ' HB2' ' A' ' 111' ' ' PHE . 7.3 ttm180 -32.56 138.05 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 129.753 3.221 . . . . 1.0 115.642 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.58 -178.12 3.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 129.273 3.029 . . . . 1.0 111.945 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -155.06 118.33 4.44 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.477 1.511 . . . . 1.0 110.628 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.492 ' H ' ' HB3' ' A' ' 110' ' ' ASP . 7.4 p80 -158.23 63.13 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.068 -1.645 . . . . 1.0 112.204 -175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.96 -56.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 O-C-N 118.734 -2.479 . . . . 1.0 114.148 176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.03 -79.8 0.29 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 104.017 -3.633 . . . . 1.0 104.017 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.5 t -149.98 146.63 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.063 2.145 . . . . 1.0 108.881 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.6 p -156.18 150.72 25.81 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.533 1.533 . . . . 1.0 110.209 175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.469 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.2 p -143.65 145.72 32.69 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 119.69 1.132 . . . . 1.0 111.248 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -155.42 145.29 21.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.83 -1.544 . . . . 1.0 106.83 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 42.08 53.85 4.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.976 1.71 . . . . 1.0 113.051 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.52 28.43 67.57 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.608 0.623 . . . . 1.0 113.375 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 116.44 17.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 176.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 5.8 tt0 -103.65 135.31 45.45 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 8.9 mtt85 -105.57 118.24 36.07 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.175 -2.528 . . . . 1.0 104.175 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 17.3 t -60.57 -25.47 66.23 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.745 1.618 . . . . 1.0 111.542 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -154.26 170.4 21.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.611 2.764 . . . . 1.0 107.588 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.492 ' HB3' ' H ' ' A' ' 96' ' ' HIS . 6.3 t70 -84.76 76.71 10.19 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.459 ' HB2' HH11 ' A' ' 93' ' ' ARG . 0.2 OUTLIER -100.32 33.65 2.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.477 -1.238 . . . . 1.0 111.243 -175.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -132.9 142.72 49.05 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 124.483 1.113 . . . . 1.0 110.568 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -79.19 56.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 127.09 2.156 . . . . 1.0 110.806 -176.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.5 -136.5 1.7 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.946 -1.097 . . . . 1.0 113.034 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG21 HD13 ' A' ' 133' ' ' LEU . 3.6 mm -142.57 165.3 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 130.515 3.526 . . . . 1.0 102.985 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -145.82 138.58 25.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 103.7 -2.704 . . . . 1.0 103.7 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.0 149.04 24.34 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.485 -1.384 . . . . 1.0 109.269 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -124.52 139.74 53.59 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.614 0.721 . . . . 1.0 111.151 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -157.39 -177.55 30.61 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 127.676 2.56 . . . . 1.0 108.701 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 p -145.96 108.28 4.43 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 104.601 -2.37 . . . . 1.0 104.601 -175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.5 t70 55.54 43.54 28.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.24 1.016 . . . . 1.0 112.528 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p 49.57 38.55 15.02 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.67 1.988 . . . . 1.0 113.706 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.7 tp -64.66 136.16 56.67 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -25.9 114.03 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.999 2.12 . . . . 1.0 113.431 -175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -78.87 -15.31 58.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 116.36 -1.781 . . . . 1.0 113.908 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.351 28.7 p 65.59 77.06 0.31 Allowed 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.862 1.664 . . . . 1.0 111.668 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -23.22 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.069 1.748 . . . . 1.0 113.993 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.0 -38.91 3.77 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.65 1.98 . . . . 1.0 110.442 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -49.39 -51.9 31.98 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.268 1.427 . . . . 1.0 109.643 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -60.8 -42.08 96.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.029 0.932 . . . . 1.0 110.207 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -65.66 -51.6 58.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.089 0.955 . . . . 1.0 110.353 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -65.97 -43.62 87.36 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.669 0.788 . . . . 1.0 110.679 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 115' ' ' ILE . 10.4 tp -55.38 -51.53 66.51 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 175.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.74 67.78 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.316 0.962 . . . . 1.0 111.488 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.47 56.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.127 0.971 . . . . 1.0 110.787 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.22 -51.27 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.3 m -54.63 -36.7 64.78 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.659 1.583 . . . . 1.0 111.882 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -60.68 -46.67 89.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.884 1.674 . . . . 1.0 109.462 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.69 -52.79 62.84 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-O 119.412 -0.327 . . . . 1.0 110.871 176.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -55.91 -39.09 71.13 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 112.978 0.733 . . . . 1.0 112.978 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.02 -45.02 95.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.426 1.012 . . . . 1.0 108.916 175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.7 m -65.76 -19.13 65.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.217 0.607 . . . . 1.0 111.182 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -84.16 -63.22 1.38 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.931 1.292 . . . . 1.0 107.858 175.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -126.06 112.98 24.14 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -90.57 107.94 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 CA-C-N 120.237 1.12 . . . . 1.0 111.724 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.25 -52.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.387 1.875 . . . . 1.0 107.39 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 mt -45.98 -33.84 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 C-N-CA 131.146 3.778 . . . . 1.0 111.061 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.86 -26.03 9.16 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.673 1.189 . . . . 1.0 112.987 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -136.32 23.67 3.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.359 1.863 . . . . 1.0 109.755 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -138.51 83.6 1.97 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -127.24 120.85 29.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.09 -1.818 . . . . 1.0 106.09 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.2 t -154.53 -170.48 3.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.77 -131.58 1.76 Allowed Glycine 0 CA--C 1.517 0.181 0 N-CA-C 106.818 -2.513 . . . . 1.0 106.818 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.438 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 10.8 m170 -113.53 -22.97 10.05 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.069 1.434 . . . . 1.0 111.576 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.0 t -103.23 -8.55 20.29 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.1 OUTLIER -89.04 28.25 1.22 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.737 1.215 . . . . 1.0 109.147 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.469 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.75 -14.87 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 121.389 -0.82 . . . . 1.0 110.45 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.67 -53.54 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.906 1.683 . . . . 1.0 112.582 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -89.43 108.63 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 CA-C-N 121.91 1.718 . . . . 1.0 111.385 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.02 -14.61 55.5 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.875 -1.141 . . . . 1.0 113.117 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.66 -6.3 36.0 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.156 -1.59 . . . . 1.0 111.601 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -136.93 141.05 42.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.875 -1.898 . . . . 1.0 105.875 175.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 3.1 m -132.78 -16.78 2.55 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.947 -0.701 . . . . 1.0 111.862 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.84 -178.87 0.34 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -76.39 63.27 7.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.304 2.002 . . . . 1.0 109.102 175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 141.28 74.57 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.123 1.821 . . . . 1.0 111.653 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.13 -98.31 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 123.707 2.938 . . . . 1.0 110.837 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 12.4 t 53.84 43.86 30.35 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.801 1.64 . . . . 1.0 112.533 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -106.32 18.45 21.98 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.054 0.942 . . . . 1.0 110.387 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.296 9.3 t0 42.95 82.08 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.866 2.467 . . . . 1.0 112.355 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -55.4 -34.95 64.83 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.55 -0.75 . . . . 1.0 112.821 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.09 -45.98 79.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 118.573 -0.727 . . . . 1.0 110.647 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -58.93 -56.78 17.89 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.846 0.748 . . . . 1.0 110.12 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -59.08 -53.24 60.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -61.52 -33.79 74.43 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.403 -0.808 . . . . 1.0 111.906 -175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.76 -42.47 86.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.695 0.68 . . . . 1.0 111.818 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.14 -51.92 27.63 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.523 0.729 . . . . 1.0 110.37 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.6 166.41 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.381 1.073 . . . . 1.0 108.335 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.2 m -42.27 113.25 1.21 Allowed Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.281 1.832 . . . . 1.0 109.334 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -95.26 54.92 0.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.996 2.464 . . . . 1.0 111.165 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.7 t 51.54 33.35 10.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.717 1.607 . . . . 1.0 111.489 -175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.5 t -165.11 177.68 7.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 129.791 3.237 . . . . 1.0 105.405 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 49.11 50.92 17.16 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 123.206 1.479 . . . . 1.0 110.627 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -140.41 168.68 19.23 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.322 2.649 . . . . 1.0 105.91 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.71 177.94 8.34 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.995 2.118 . . . . 1.0 107.567 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.5 tpt 57.54 -95.43 0.05 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.757 1.623 . . . . 1.0 109.751 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.247 0.971 0 C-N-CA 129.926 3.29 . . . . 1.0 103.473 175.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HG2' HG22 ' A' ' 136' ' ' VAL . 44.1 tpp . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 108.957 -0.757 . . . . 1.0 108.957 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp -139.36 158.22 44.53 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.202 1.401 . . . . 1.0 108.91 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.62 136.97 53.83 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.049 2.14 . . . . 1.0 106.899 177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -127.17 124.42 38.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.552 1.541 . . . . 1.0 107.874 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 45.13 36.96 2.3 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.759 1.623 . . . . 1.0 113.797 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.45 -2.9 80.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.33 -0.857 . . . . 1.0 113.677 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -95.38 168.35 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.733 2.013 . . . . 1.0 107.503 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.34 124.11 34.14 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.98 170.89 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.632 1.173 . . . . 1.0 110.661 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 40.58 58.38 2.38 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.182 1.793 . . . . 1.0 111.221 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.76 156.34 38.92 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.644 1.578 . . . . 1.0 110.112 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -78.4 130.05 35.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.12 140.34 45.75 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.183 -0.948 . . . . 1.0 110.265 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.2 t -142.74 71.84 19.82 Favored Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 106.479 -1.674 . . . . 1.0 106.479 175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.6 123.2 9.91 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 N-CA-C 107.784 -1.66 . . . . 1.0 107.784 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -121.85 132.09 24.3 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 108.305 -0.998 . . . . 1.0 108.305 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.98 52.97 4.53 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.189 1.926 . . . . 1.0 111.177 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -124.13 43.11 3.08 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 106.535 -1.654 . . . . 1.0 106.535 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' CE2' HG22 ' A' ' 88' ' ' VAL . 95.7 m-85 -75.24 178.21 5.95 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.076 0.465 . . . . 1.0 110.045 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.73 -178.25 4.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.848 1.659 . . . . 1.0 108.51 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.5 m -154.95 131.36 10.46 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 128.623 2.769 . . . . 1.0 103.674 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -130.55 140.05 37.5 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 120.791 1.632 . . . . 1.0 109.628 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.05 40.19 0.85 Allowed 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 124.36 3.374 . . . . 1.0 116.84 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.24 149.78 44.73 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.293 2.637 . . . . 1.0 108.834 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -151.61 120.13 6.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.936 1.694 . . . . 1.0 111.682 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -136.62 172.74 12.56 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -64.69 123.82 84.42 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.58 103.6 1.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.768 1.645 . . . . 1.0 110.706 -175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -170.83 77.16 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.711 -1.588 . . . . 1.0 106.711 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -145.16 124.34 12.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 105.582 -2.007 . . . . 1.0 105.582 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.54 126.08 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.87 134.26 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.3 t -131.76 123.78 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.677 -1.601 . . . . 1.0 106.677 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -176.56 150.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.116 1.766 . . . . 1.0 107.884 175.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.5 112.61 24.6 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.211 -2.144 . . . . 1.0 105.211 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 26.3 mm -127.65 176.78 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 128.024 2.53 . . . . 1.0 105.067 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -151.09 122.22 7.72 Favored 'General case' 0 C--N 1.313 -0.995 1 N-CA-C 94.003 -6.295 . . . . 1.0 94.003 174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.318 0.2 OUTLIER -142.66 -66.09 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 119.827 1.194 . . . . 1.0 110.427 175.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.36 153.47 27.57 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.041 1.828 . . . . 1.0 112.042 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -82.0 53.61 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.673 2.916 . . . . 1.0 114.232 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.72 -70.81 0.65 Allowed Glycine 0 CA--C 1.535 1.317 0 N-CA-C 108.269 -1.932 . . . . 1.0 108.269 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -155.82 123.09 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 128.221 2.609 . . . . 1.0 106.549 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -169.73 173.44 6.25 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.956 2.902 . . . . 1.0 105.913 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.8 31.37 2.48 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 125.674 1.607 . . . . 1.0 109.298 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 118.9 6.28 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 107.605 -2.198 . . . . 1.0 107.605 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.34 -9.62 26.3 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 CA-C-N 120.842 2.321 . . . . 1.0 113.339 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -65.52 -47.43 75.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.802 1.183 . . . . 1.0 109.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.6 mm -59.22 -43.84 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.799 0.84 . . . . 1.0 109.668 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -61.28 -46.36 90.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.267 0.627 . . . . 1.0 111.462 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.15 -33.8 67.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.135 1.374 . . . . 1.0 111.677 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.68 -57.07 12.32 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.196 -0.94 . . . . 1.0 109.352 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -66.64 -42.98 85.86 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.528 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -66.4 -35.4 80.22 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 118.475 0.58 . . . . 1.0 110.59 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.46 60.23 1.11 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.373 1.94 . . . . 1.0 112.103 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.4 p -136.58 8.85 3.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.201 1.8 . . . . 1.0 111.588 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.34 134.78 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.116 0.966 . . . . 1.0 112.508 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.45 136.64 20.33 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.668 2.787 . . . . 1.0 108.834 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.63 69.74 1.55 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.216 3.278 . . . . 1.0 112.435 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -103.35 -56.64 2.18 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 123.659 0.784 . . . . 1.0 110.966 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.47 -55.04 36.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.979 0.512 . . . . 1.0 111.321 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.4 p80 -171.08 177.89 0.88 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.149 1.779 . . . . 1.0 107.615 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -70.55 -43.39 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.866 1.71 . . . . 1.0 114.804 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -50.19 -54.76 18.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.577 1.08 . . . . 1.0 113.475 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.0 -52.93 63.65 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.964 0.802 . . . . 1.0 111.118 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.51 98.3 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.465 0.706 . . . . 1.0 111.904 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.93 -57.69 17.04 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.283 0.944 . . . . 1.0 110.94 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.79 -27.33 42.66 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-O 115.964 -1.97 . . . . 1.0 112.99 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.83 -43.26 2.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.153 1.781 . . . . 1.0 114.489 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -57.58 -43.36 84.51 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.031 1.333 . . . . 1.0 111.116 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -77.6 127.37 32.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.323 -2.473 . . . . 1.0 104.323 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.53 148.55 51.54 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.382 176.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.86 163.19 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.064 2.146 . . . . 1.0 109.843 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.508 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -172.33 133.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.872 2.469 . . . . 1.0 106.27 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.46 -154.69 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.137 1.375 . . . . 1.0 107.461 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 55.8 m80 -132.48 -59.21 0.92 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.95 1.3 . . . . 1.0 108.999 175.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.773 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.4 m -136.88 118.73 15.16 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.096 -1.446 . . . . 1.0 107.096 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -102.48 113.85 27.54 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.895 -1.891 . . . . 1.0 105.895 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.82 122.89 53.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -89.8 156.65 18.36 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.853 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -22.66 2.58 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 126.967 2.107 . . . . 1.0 113.533 175.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -91.75 19.75 6.19 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.915 1.686 . . . . 1.0 113.699 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.16 35.8 91.39 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.614 1.578 . . . . 1.0 112.821 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.43 109.25 22.04 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.16 113.45 19.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 105.263 -2.125 . . . . 1.0 105.263 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.1 t -111.81 147.8 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.295 1.438 . . . . 1.0 107.306 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -126.2 120.24 29.55 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.386 1.074 . . . . 1.0 109.618 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.44 129.97 53.3 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 105.136 -2.172 . . . . 1.0 105.136 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.255 64.3 t 63.75 91.46 0.08 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 121.498 1.953 . . . . 1.0 113.76 175.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.7 Cg_exo -58.89 -169.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.394 3.396 . . . . 1.0 116.387 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.85 24.15 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 128.012 2.525 . . . . 1.0 110.487 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 89' ' ' PRO . 2.7 t70 -144.57 119.47 9.95 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.469 2.707 . . . . 1.0 107.855 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.308 3.4 ttmp? 85.96 81.48 0.02 OUTLIER 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.877 1.671 . . . . 1.0 111.717 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -34.89 145.16 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.973 2.509 . . . . 1.0 111.942 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -122.12 172.4 8.28 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.258 1.423 . . . . 1.0 110.104 -175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.523 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 62.4 t90 -141.63 119.19 11.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.897 1.679 . . . . 1.0 109.722 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -159.38 63.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.151 0.977 . . . . 1.0 109.255 -176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.73 -70.74 0.03 OUTLIER 'General case' 0 C--N 1.34 0.163 0 O-C-N 119.66 -1.9 . . . . 1.0 114.657 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.43 -91.02 0.48 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 105.834 -2.907 . . . . 1.0 105.834 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.2 t -144.44 146.46 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.92 1.86 . . . . 1.0 108.551 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -156.56 166.54 33.1 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.431 1.492 . . . . 1.0 108.924 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.487 ' H ' HG22 ' A' ' 157' ' ' ILE . 54.6 p -151.65 146.13 25.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -162.62 148.69 12.63 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 49.6 54.57 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.415 1.486 . . . . 1.0 110.83 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.04 29.45 62.37 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.995 1.283 . . . . 1.0 114.471 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.18 113.93 12.55 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.483 -1.302 . . . . 1.0 107.483 -176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -78.95 146.46 33.45 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.368 -1.345 . . . . 1.0 107.368 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -133.42 118.16 18.08 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.752 -1.944 . . . . 1.0 105.752 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.1 t -62.85 -40.24 96.84 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.286 0.634 . . . . 1.0 112.52 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.523 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 4.0 m120 -149.18 174.94 11.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.492 2.317 . . . . 1.0 106.979 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -89.85 75.05 7.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 123.359 1.552 . . . . 1.0 110.501 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 37.98 0.48 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.777 1.631 . . . . 1.0 109.093 175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -123.55 157.28 34.0 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.939 2.896 . . . . 1.0 109.819 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.277 0.1 OUTLIER -104.62 56.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.266 1.426 . . . . 1.0 108.096 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.79 -136.09 0.9 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-O 122.86 1.256 . . . . 1.0 112.163 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 76' ' ' CYS . 8.6 mm -150.28 161.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 130.497 3.519 . . . . 1.0 104.236 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -144.79 128.61 17.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 103.334 -2.839 . . . . 1.0 103.334 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mp -90.4 154.34 19.74 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.021 -0.733 . . . . 1.0 109.021 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -124.1 138.66 54.41 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.547 0.739 . . . . 1.0 111.859 -175.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.08 174.09 45.3 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.769 0.649 . . . . 1.0 112.613 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.4 p -133.92 97.09 3.79 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.044 2.137 . . . . 1.0 107.157 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.322 25.0 t0 46.62 56.74 6.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.251 1.82 . . . . 1.0 114.102 -177.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.2 p 55.39 38.82 30.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.366 1.466 . . . . 1.0 112.563 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.57 133.95 53.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 104.956 -2.238 . . . . 1.0 104.956 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.12 113.45 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.212 2.205 . . . . 1.0 110.839 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -78.85 -11.61 60.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 115.14 -2.362 . . . . 1.0 116.679 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.349 18.2 p 59.57 77.86 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 121.662 2.028 . . . . 1.0 111.156 -177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -23.06 -33.14 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 127.12 2.168 . . . . 1.0 114.593 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.31 -38.48 2.66 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.499 2.32 . . . . 1.0 109.433 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -53.8 -49.96 67.16 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 125.382 1.473 . . . . 1.0 110.688 175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -56.48 -40.46 74.96 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.52 1.055 . . . . 1.0 109.668 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -65.72 -58.22 6.21 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.244 -0.408 . . . . 1.0 110.097 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -66.45 -37.99 86.37 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 113.023 0.749 . . . . 1.0 113.023 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 115' ' ' ILE . 0.8 OUTLIER -60.63 -47.06 87.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 175.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.84 80.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.036 0.835 . . . . 1.0 110.858 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.24 -53.75 52.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.072 0.949 . . . . 1.0 111.21 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 115' ' ' ILE . 64.8 t -58.04 -41.0 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 89.1 m -57.09 -46.28 82.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.272 . . . . 1.0 109.647 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -59.21 -48.19 82.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.53 1.059 . . . . 1.0 110.277 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.94 -48.6 81.08 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.172 0.589 . . . . 1.0 110.028 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.3 mt -55.88 -46.86 78.21 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.873 1.269 . . . . 1.0 111.029 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.88 -42.22 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 118.858 0.754 . . . . 1.0 110.346 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.3 m -65.57 -13.91 59.99 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.178 0.991 . . . . 1.0 111.524 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -106.24 -54.02 2.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.496 1.518 . . . . 1.0 111.016 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -126.24 113.25 23.7 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 104.383 -2.451 . . . . 1.0 104.383 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -99.22 107.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.029 1.403 . . . . 1.0 114.554 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.27 -48.35 0.1 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.679 2.391 . . . . 1.0 107.642 174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -46.19 -34.28 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 130.111 3.364 . . . . 1.0 110.091 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.86 -23.19 6.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.054 1.341 . . . . 1.0 114.275 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -137.18 18.42 2.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.719 1.607 . . . . 1.0 110.657 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -139.08 83.65 1.96 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.732 1.213 . . . . 1.0 108.213 -176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 114.1 21.16 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 104.036 -2.579 . . . . 1.0 104.036 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.3 t -151.08 -166.35 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.525 -0.734 . . . . 1.0 109.219 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.11 -131.79 1.5 Allowed Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 108.66 -1.776 . . . . 1.0 108.66 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.493 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 11.4 m170 -109.01 -23.59 11.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 117.902 0.851 . . . . 1.0 111.066 -175.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 7.6 t -105.28 -14.38 15.37 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.486 -0.769 . . . . 1.0 110.647 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -87.74 40.54 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.777 1.171 . . . . 1.0 109.158 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -66.27 -8.76 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 O-C-N 120.684 -1.26 . . . . 1.0 110.869 175.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -164.24 -53.79 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 127.953 2.501 . . . . 1.0 111.857 175.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 57.0 Cg_endo -91.14 115.42 0.44 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 123.978 3.119 . . . . 1.0 113.618 -175.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.23 -25.58 64.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.765 1.226 . . . . 1.0 113.124 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -63.65 -20.28 65.57 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 120.88 -1.137 . . . . 1.0 113.324 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -123.12 140.76 52.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.464 -2.05 . . . . 1.0 105.464 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.0 m -136.01 -16.73 1.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 119.546 -0.862 . . . . 1.0 111.508 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.43 177.95 0.47 Allowed Pre-proline 0 CA--C 1.546 0.805 1 C-N-CA 131.808 4.043 . . . . 1.0 103.53 176.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.05 86.93 1.06 Allowed 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.517 1.478 . . . . 1.0 109.353 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.32 81.12 1.25 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.863 1.221 . . . . 1.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.72 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.154 2.57 . . . . 1.0 112.187 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 25.4 t 55.52 43.93 27.64 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.907 1.283 . . . . 1.0 114.08 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.521 ' CD2' HG11 ' A' ' 33' ' ' VAL . 87.9 t80 -115.33 17.82 16.36 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 120.203 1.365 . . . . 1.0 113.755 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.6 t0 43.91 69.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.292 1.437 . . . . 1.0 112.206 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -56.37 -32.87 65.18 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 118.759 -0.638 . . . . 1.0 112.334 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -60.25 2.9 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.657 0.783 . . . . 1.0 110.605 175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.76 -41.81 96.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-O 118.13 -0.938 . . . . 1.0 110.574 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -59.81 -57.55 12.42 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 123.876 0.735 . . . . 1.0 110.737 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -40.71 75.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.71 0.686 . . . . 1.0 111.222 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.07 77.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.16 0.8 . . . . 1.0 113.16 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.25 -43.55 67.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.6 1.16 . . . . 1.0 113.036 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.6 t -63.87 166.63 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.186 1.794 . . . . 1.0 110.797 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 70.6 m -42.5 131.09 2.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.679 1.592 . . . . 1.0 108.263 175.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -80.22 40.1 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.788 2.325 . . . . 1.0 114.222 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.3 t 45.57 34.3 1.64 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.905 1.682 . . . . 1.0 111.354 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.3 t -159.56 64.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 106.934 -1.506 . . . . 1.0 106.934 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -164.1 116.03 1.35 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -149.87 134.73 17.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.749 -1.945 . . . . 1.0 105.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -114.89 161.12 18.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.012 -1.107 . . . . 1.0 108.012 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.5 tpt 58.35 66.38 1.1 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.418 1.487 . . . . 1.0 111.526 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 115.142 -2.361 . . . . 1.0 108.41 -175.896 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.2 tpp . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 108.236 -1.024 . . . . 1.0 108.236 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp -112.34 167.33 10.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 -173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -108.74 131.85 54.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -123.69 125.23 44.41 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.917 1.287 . . . . 1.0 108.728 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 49.14 33.72 5.19 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.044 1.337 . . . . 1.0 112.106 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.45 -5.23 69.18 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.317 1.437 . . . . 1.0 114.058 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -102.92 173.07 6.47 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.716 1.758 . . . . 1.0 107.243 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.3 134.94 34.44 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.942 -1.099 . . . . 1.0 110.996 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.29 27.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.208 1.003 . . . . 1.0 112.148 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 38.88 58.21 1.78 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 128.108 2.563 . . . . 1.0 112.057 -175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.85 136.06 17.67 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.263 -0.898 . . . . 1.0 109.104 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -73.11 123.46 23.64 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.364 -1.717 . . . . 1.0 106.364 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -92.92 118.87 31.63 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.536 -0.727 . . . . 1.0 110.855 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.52 72.25 20.79 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.29 1.036 . . . . 1.0 108.554 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.21 123.44 9.21 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.758 1.306 . . . . 1.0 109.904 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -87.32 114.17 57.4 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 106.379 -1.712 . . . . 1.0 106.379 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.52 55.86 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.676 2.251 . . . . 1.0 110.636 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 38.1 t60 -138.4 43.73 2.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.572 1.949 . . . . 1.0 109.437 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -73.65 178.35 4.8 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 114.083 1.142 . . . . 1.0 114.083 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -123.63 179.1 4.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 128.857 2.863 . . . . 1.0 109.805 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -165.28 118.78 1.21 Allowed 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.966 4.506 . . . . 1.0 102.94 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 156.46 77.75 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.27 84.72 1.9 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.312 2.008 . . . . 1.0 111.696 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.1 145.26 16.61 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.329 1.852 . . . . 1.0 106.685 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -137.51 103.58 5.1 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 107.371 -1.344 . . . . 1.0 107.371 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -136.2 152.86 51.22 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.743 1.217 . . . . 1.0 108.677 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -71.98 123.41 89.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 103.271 -2.862 . . . . 1.0 103.271 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.5 106.16 2.22 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.416 2.077 . . . . 1.0 112.512 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.9 t -164.32 76.35 0.33 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.582 -1.266 . . . . 1.0 107.582 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.37 123.72 11.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 105.99 -1.856 . . . . 1.0 105.99 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.9 tp -93.54 127.61 39.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.193 0.997 . . . . 1.0 108.474 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.47 140.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 97.9 t -135.86 113.94 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.847 -2.279 . . . . 1.0 104.847 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 0.7 OUTLIER -163.16 129.85 3.41 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 115.944 -1.979 . . . . 1.0 108.194 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.467 HD22 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -72.69 112.52 8.82 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 117.443 -1.703 . . . . 1.0 106.746 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.484 HG13 ' CE1' ' A' ' 34' ' ' HIS . 14.4 mm -126.73 176.77 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 131.646 3.979 . . . . 1.0 108.587 174.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.3 t -160.68 121.84 2.98 Favored 'General case' 0 C--O 1.247 0.973 1 N-CA-C 94.992 -5.929 . . . . 1.0 94.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.253 1.3 tm? -142.4 -57.37 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.498 0 O-C-N 121.032 -1.042 . . . . 1.0 111.446 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 77' ' ' LEU . 2.9 Cg_exo -76.16 144.26 26.4 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 122.674 2.249 . . . . 1.0 111.075 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.09 44.11 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.335 2.69 . . . . 1.0 114.657 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.18 -71.19 0.57 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 109.401 -1.48 . . . . 1.0 109.401 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -156.13 122.94 5.24 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.614 1.566 . . . . 1.0 111.234 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.318 18.8 m-85 -177.06 170.94 2.17 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 131.361 3.864 . . . . 1.0 109.619 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.08 27.28 7.12 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.434 1.016 . . . . 1.0 111.628 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.37 118.56 5.35 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 108.726 -1.75 . . . . 1.0 108.726 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.59 -15.81 48.78 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 120.096 1.948 . . . . 1.0 112.621 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -49.79 -47.85 50.95 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.513 1.125 . . . . 1.0 112.576 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.3 mm -66.39 -45.09 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 -175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.96 -43.97 94.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.12 -35.63 69.69 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.09 1.356 . . . . 1.0 111.489 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 tp -65.89 -55.33 17.49 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 120.945 -1.097 . . . . 1.0 110.039 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -68.04 -43.03 79.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.87 -0.585 . . . . 1.0 111.893 -175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.8 t -65.84 -33.83 76.74 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.286 1.434 . . . . 1.0 109.994 175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.57 -2.64 30.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.567 1.555 . . . . 1.0 115.163 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -88.81 9.93 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.75 2.275 . . . . 1.0 114.12 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 tt -47.68 129.55 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.274 1.829 . . . . 1.0 112.1 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -98.74 125.52 42.13 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 130.473 3.509 . . . . 1.0 108.957 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.38 75.86 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.494 3.462 . . . . 1.0 108.412 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -103.63 -64.23 1.11 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.441 0.297 . . . . 1.0 111.618 -174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.02 -52.01 65.74 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.98 0.912 . . . . 1.0 112.086 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 25.8 p80 -161.92 177.9 1.8 Allowed Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.561 1.545 . . . . 1.0 107.805 175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 29.2 Cg_endo -74.33 -43.43 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.823 1.682 . . . . 1.0 114.342 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -48.46 -43.65 34.81 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.118 0.967 . . . . 1.0 113.586 -175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -57.52 -55.6 32.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.839 0.856 . . . . 1.0 110.275 -175.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.751 0.82 . . . . 1.0 110.697 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.65 -62.56 2.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 125.81 1.672 . . . . 1.0 111.536 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.1 pt -57.69 -35.54 51.16 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-O 116.752 -1.594 . . . . 1.0 112.76 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.0 -43.02 3.02 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.622 1.969 . . . . 1.0 115.735 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -57.26 -36.24 70.75 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.555 1.142 . . . . 1.0 110.469 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.03 136.76 33.12 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 102.502 -3.147 . . . . 1.0 102.502 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 155.81 6.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.622 -1.298 . . . . 1.0 109.14 175.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -116.47 155.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 123.593 0.757 . . . . 1.0 109.037 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 4.3 m -177.79 114.12 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.836 1.654 . . . . 1.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.96 -175.4 3.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.473 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 21.1 m80 -112.47 -76.85 0.59 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.977 1.262 . . . . 1.0 110.906 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 13.4 m -112.57 118.51 35.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.781 -2.303 . . . . 1.0 104.781 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD13 ' HD2' ' A' ' 39' ' ' PRO . 13.6 tp -101.26 113.44 26.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 103.605 -2.739 . . . . 1.0 103.605 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.6 mt -105.98 113.22 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 103.852 -2.647 . . . . 1.0 103.852 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -81.59 153.79 26.53 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 118.772 0.714 . . . . 1.0 110.57 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.64 -13.5 0.4 Allowed 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 126.229 1.812 . . . . 1.0 113.941 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -91.65 18.31 7.66 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 119.37 0.986 . . . . 1.0 111.241 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.34 45.35 96.63 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.115 -1.616 . . . . 1.0 111.601 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -112.97 143.96 43.36 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -115.91 114.32 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.28 142.74 22.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.522 -1.659 . . . . 1.0 106.522 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -126.22 114.44 18.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.947 0.899 . . . . 1.0 110.467 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -110.06 147.09 34.24 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 103.25 -2.87 . . . . 1.0 103.25 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 94' ' ' ALA 0.274 42.4 t 63.1 91.78 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.788 0 CA-C-N 120.304 1.411 . . . . 1.0 114.362 175.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.21 -174.29 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 121.404 1.402 . . . . 1.0 111.985 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -72.87 49.92 0.25 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.781 1.233 . . . . 1.0 109.941 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -161.13 136.14 7.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.766 2.827 . . . . 1.0 105.33 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 54.78 81.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 129.376 3.07 . . . . 1.0 109.785 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.05 152.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.659 2.384 . . . . 1.0 111.545 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.473 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -102.83 -178.08 3.57 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.423 2.289 . . . . 1.0 111.055 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 82.1 t90 -149.88 118.4 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.855 1.262 . . . . 1.0 108.919 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -160.92 62.75 0.29 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.967 1.365 . . . . 1.0 110.209 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.95 -69.34 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 119.839 -1.788 . . . . 1.0 113.044 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 -90.89 0.51 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 103.246 -3.941 . . . . 1.0 103.246 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.8 t -133.94 142.15 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.742 1.271 . . . . 1.0 110.065 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -155.93 165.8 35.38 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.667 2.387 . . . . 1.0 108.066 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -159.81 126.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 104.972 -2.233 . . . . 1.0 104.972 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -151.52 151.13 31.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.718 1.145 . . . . 1.0 107.999 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 42.12 66.72 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.669 1.588 . . . . 1.0 109.75 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 47.31 29.53 5.2 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.81 1.672 . . . . 1.0 116.681 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -137.98 113.8 9.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.759 1.78 . . . . 1.0 106.835 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -80.91 146.37 30.83 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.574 1.15 . . . . 1.0 108.417 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -129.57 118.13 21.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.42 -0.956 . . . . 1.0 108.42 -175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.94 -24.49 63.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.159 -0.928 . . . . 1.0 110.98 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -152.98 176.26 12.06 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 128.623 2.769 . . . . 1.0 107.369 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.14 76.29 6.92 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 107.149 -1.426 . . . . 1.0 107.149 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -92.86 33.58 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.862 0.865 . . . . 1.0 112.392 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 m -124.53 156.51 37.22 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 125.508 1.523 . . . . 1.0 111.815 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -96.85 56.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.221 1.808 . . . . 1.0 107.713 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.27 -136.79 2.45 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 121.417 -0.802 . . . . 1.0 111.978 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 133' ' ' LEU . 9.3 mm -140.13 165.19 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 104.191 -2.522 . . . . 1.0 104.191 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.79 123.95 12.19 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.443 -2.799 . . . . 1.0 103.443 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 128.06 48.08 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.802 -1.186 . . . . 1.0 109.034 -176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -103.35 142.74 33.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.038 0.923 . . . . 1.0 111.929 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -156.39 178.64 32.77 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 126.52 2.01 . . . . 1.0 111.242 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -148.29 101.77 3.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 45.6 t0 51.4 54.56 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 124.032 1.872 . . . . 1.0 112.389 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 49.69 38.5 15.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.446 1.898 . . . . 1.0 114.269 176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 124' ' ' ALA . 4.2 tt -72.63 145.87 47.01 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 104.932 -2.247 . . . . 1.0 104.932 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.49 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -39.32 125.53 1.66 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.327 1.851 . . . . 1.0 111.777 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -79.4 -10.84 59.89 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 115.285 1.587 . . . . 1.0 115.285 -175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.381 26.6 p 62.47 77.5 0.33 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 121.592 1.996 . . . . 1.0 111.968 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -23.5 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.158 2.183 . . . . 1.0 114.667 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.96 -40.14 4.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.425 2.29 . . . . 1.0 111.095 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.27 -57.87 4.73 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 123.788 0.835 . . . . 1.0 109.613 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.68 -39.36 80.46 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.229 0.611 . . . . 1.0 111.593 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -65.82 -59.24 4.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.216 0.322 . . . . 1.0 110.166 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -66.0 -34.27 77.72 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.757 0.708 . . . . 1.0 112.082 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 36.8 tp -57.51 -48.08 80.22 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.46 85.79 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.075 0.852 . . . . 1.0 109.819 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 -53.13 44.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.585 1.154 . . . . 1.0 111.046 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.19 -48.31 88.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 123.19 0.596 . . . . 1.0 110.121 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.7 m -53.25 -45.5 68.8 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.154 1.381 . . . . 1.0 110.328 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -61.32 -42.38 98.59 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.2 1.0 . . . . 1.0 110.54 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.19 -49.08 78.63 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.064 0.545 . . . . 1.0 110.194 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.94 -44.59 78.55 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 118.418 -0.801 . . . . 1.0 111.784 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.66 -40.23 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 119.187 0.903 . . . . 1.0 109.868 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 26.4 m -63.2 -27.67 69.52 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.885 0.874 . . . . 1.0 111.294 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -84.42 -60.58 2.03 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.138 0.975 . . . . 1.0 109.435 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -126.54 112.9 22.99 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.866 1.666 . . . . 1.0 106.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -96.61 107.32 0.1 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 120.912 1.361 . . . . 1.0 111.421 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.07 -45.09 0.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.99 2.116 . . . . 1.0 108.296 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.8 mt -44.91 -33.76 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.44 0 C-N-CA 130.666 3.587 . . . . 1.0 110.988 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.67 -26.19 13.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.373 1.069 . . . . 1.0 113.441 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -130.62 18.36 5.23 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.849 2.06 . . . . 1.0 110.873 176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -138.45 83.3 1.96 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 119.866 -1.771 . . . . 1.0 106.363 -175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.4 mtt -126.42 118.07 24.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 102.876 -3.009 . . . . 1.0 102.876 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.9 t -157.66 -165.52 1.79 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.21 -131.57 1.25 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 106.798 -2.521 . . . . 1.0 106.798 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.528 ' HE1' ' CE1' ' A' ' 34' ' ' HIS . 12.2 m170 -114.34 -23.26 9.49 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.475 1.137 . . . . 1.0 111.964 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 15.9 t -103.02 -4.3 24.81 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.855 1.262 . . . . 1.0 108.448 175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -97.91 23.15 8.34 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.156 1.382 . . . . 1.0 108.964 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.453 HD13 ' H ' ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.61 -15.74 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 121.171 -0.955 . . . . 1.0 110.618 -175.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -144.19 -66.06 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.882 1.673 . . . . 1.0 109.478 175.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 94.5 Cg_endo -77.63 119.89 4.99 Favored 'Trans proline' 0 C--N 1.346 0.446 0 CA-C-N 122.019 1.757 . . . . 1.0 112.473 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -70.79 0.63 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.643 0.777 . . . . 1.0 111.808 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -84.44 -25.62 28.85 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 119.556 -1.965 . . . . 1.0 113.442 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -129.29 140.65 51.35 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 105.268 -2.123 . . . . 1.0 105.268 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 4.2 m -127.43 -16.53 4.86 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 124.352 1.033 . . . . 1.0 112.881 -175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.66 -179.14 0.36 Allowed Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 127.244 2.218 . . . . 1.0 105.819 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.09 77.42 3.49 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.641 2.228 . . . . 1.0 111.073 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.92 76.59 0.94 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.587 1.565 . . . . 1.0 109.639 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.79 -72.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.338 2.692 . . . . 1.0 111.636 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 9.2 t 54.0 44.78 28.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.876 2.07 . . . . 1.0 111.343 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -93.65 17.87 11.05 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.568 0.951 . . . . 1.0 113.568 -175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 43.4 t0 43.44 71.98 0.21 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.155 1.382 . . . . 1.0 110.542 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -58.38 -28.81 65.51 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.231 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.89 -49.91 68.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.713 0.688 . . . . 1.0 110.631 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -64.9 -48.9 72.54 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.727 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.78 -53.31 58.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.237 0.926 . . . . 1.0 112.372 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -37.7 81.35 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-O 118.782 -0.628 . . . . 1.0 110.084 -176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.54 89.72 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.444 0.535 . . . . 1.0 112.444 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.74 -45.95 84.29 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.202 1.001 . . . . 1.0 111.737 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.79 165.94 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.911 1.284 . . . . 1.0 110.58 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 94.0 m -41.54 113.89 1.18 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.41 2.284 . . . . 1.0 109.58 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.63 53.56 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.081 3.187 . . . . 1.0 113.033 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.6 t 44.58 33.66 0.97 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.082 2.153 . . . . 1.0 113.192 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.2 t -164.15 -177.97 5.29 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 130.745 3.618 . . . . 1.0 104.785 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 56.59 60.13 3.24 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.74 1.257 . . . . 1.0 108.692 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -127.17 149.14 50.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 57.09 173.67 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.994 2.918 . . . . 1.0 113.36 -175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.25 87.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.363 1.065 . . . . 1.0 110.244 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . 0.268 20.4 m . . . . . 0 C--O 1.247 0.929 0 C-N-CA 126.929 2.092 . . . . 1.0 109.218 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpt . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -82.66 136.97 34.62 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.96 136.01 43.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 102.991 -2.966 . . . . 1.0 102.991 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.21 123.84 41.14 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 50.98 33.38 8.81 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.126 0.876 . . . . 1.0 111.661 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.74 -6.28 5.08 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.015 1.293 . . . . 1.0 113.861 -177.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -82.06 157.45 24.13 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 102.889 -3.004 . . . . 1.0 102.889 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.09 124.39 27.99 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.392 -1.442 . . . . 1.0 107.304 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 176.35 9.38 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.581 0.753 . . . . 1.0 112.195 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 44.33 58.07 3.99 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.076 2.151 . . . . 1.0 110.087 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.6 22.05 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.01 0.924 . . . . 1.0 109.269 -176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -74.61 123.47 24.89 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 106.751 -1.574 . . . . 1.0 106.751 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.71 125.7 34.55 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.183 0.901 . . . . 1.0 108.651 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.8 t -134.95 76.13 59.62 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.67 130.05 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.511 2.141 . . . . 1.0 110.772 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -129.5 124.48 21.97 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 126.497 1.919 . . . . 1.0 106.918 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.83 52.74 3.84 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.384 2.723 . . . . 1.0 111.417 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -124.11 48.98 1.82 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.479 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.7 m-85 -73.8 178.28 4.95 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.332 1.453 . . . . 1.0 112.026 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.92 178.22 4.36 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 128.151 2.58 . . . . 1.0 116.445 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 65.0 m -156.23 121.49 4.77 Favored 'General case' 0 N--CA 1.446 -0.672 1 C-N-CA 132.938 4.495 . . . . 1.0 103.396 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -135.82 141.18 35.86 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 117.682 -1.151 . . . . 1.0 108.602 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.64 90.22 1.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 124.305 3.336 . . . . 1.0 111.003 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -171.86 154.48 3.58 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 131.391 3.877 . . . . 1.0 103.97 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -151.43 104.76 3.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 104.641 -2.355 . . . . 1.0 104.641 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -136.75 159.78 40.82 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.752 1.621 . . . . 1.0 107.279 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.25 123.54 84.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 118.843 0.747 . . . . 1.0 109.495 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.37 103.6 1.54 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.768 1.645 . . . . 1.0 110.842 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -167.55 74.09 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.994 -1.066 . . . . 1.0 108.844 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.49 135.01 18.47 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.324 1.849 . . . . 1.0 107.627 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -87.54 133.03 33.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.6 141.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 104.993 -2.225 . . . . 1.0 104.993 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.5 t -136.03 118.89 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.999 -1.482 . . . . 1.0 106.999 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.9 p80 -176.23 144.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.474 1.51 . . . . 1.0 107.525 174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -82.09 112.71 19.39 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 119.542 1.065 . . . . 1.0 110.066 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 10.3 mm -127.29 176.93 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 129.838 3.255 . . . . 1.0 108.95 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 t -159.55 122.77 3.63 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 95.714 -5.661 . . . . 1.0 95.714 174.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.288 1.8 tm? -142.63 -65.31 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 116.67 -1.633 . . . . 1.0 113.722 -175.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 15.0 Cg_endo -91.35 163.09 3.66 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 124.328 3.352 . . . . 1.0 112.788 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.91 72.75 6.01 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.632 2.888 . . . . 1.0 118.716 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.64 -73.07 0.93 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 105.758 -2.937 . . . . 1.0 105.758 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -156.82 122.74 4.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.568 1.547 . . . . 1.0 108.16 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -176.7 177.61 1.35 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.577 3.151 . . . . 1.0 107.464 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.72 22.98 10.45 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 109.319 -1.512 . . . . 1.0 109.319 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.81 118.52 5.16 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.205 -1.33 . . . . 1.0 111.179 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.88 -18.33 28.18 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.376 2.051 . . . . 1.0 113.035 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -53.88 -36.37 62.59 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.088 0.858 . . . . 1.0 110.51 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.7 mt -65.44 -44.71 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 118.456 -0.783 . . . . 1.0 109.614 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.05 -52.21 51.09 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.183 0.901 . . . . 1.0 110.351 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -51.34 -34.07 32.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.303 1.441 . . . . 1.0 112.475 -175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -62.58 -61.45 2.42 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.622 1.569 . . . . 1.0 111.188 176.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -70.92 -39.32 72.78 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.537 -0.744 . . . . 1.0 112.063 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.16 -36.63 83.62 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.271 1.028 . . . . 1.0 109.008 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.92 1.93 39.4 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 117.487 -1.729 . . . . 1.0 115.965 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.8 p -88.81 8.52 28.62 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.662 2.231 . . . . 1.0 113.193 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 tt -61.7 128.58 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.361 1.464 . . . . 1.0 112.168 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.91 136.4 20.63 Favored Pre-proline 0 C--O 1.239 0.5 0 C-N-CA 128.174 2.59 . . . . 1.0 109.409 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.56 79.16 0.9 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.518 2.812 . . . . 1.0 109.04 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.1 -60.1 1.6 Allowed 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.189 0.596 . . . . 1.0 110.723 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.44 77.75 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.429 0.691 . . . . 1.0 109.841 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.0 p80 -171.2 178.09 0.84 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.683 2.393 . . . . 1.0 106.898 175.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.6 Cg_endo -71.73 -43.45 1.3 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.436 2.091 . . . . 1.0 115.53 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -44.18 -50.89 8.54 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.72 -58.65 6.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.145 1.378 . . . . 1.0 110.615 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.62 -43.41 96.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.892 0.877 . . . . 1.0 111.959 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.13 -61.63 6.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.234 1.397 . . . . 1.0 111.555 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.72 -42.19 91.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.012 -0.994 . . . . 1.0 111.874 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -39.63 -43.75 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 116.924 2.194 . . . . 1.0 116.924 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -60.35 -34.33 73.7 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.721 -0.612 . . . . 1.0 109.714 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.57 135.89 34.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 101.183 -3.636 . . . . 1.0 101.183 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -52.71 144.58 13.81 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.601 -0.687 . . . . 1.0 110.992 178.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.5 m -116.83 162.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.207 1.803 . . . . 1.0 107.307 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.07 114.24 0.09 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.595 0.758 . . . . 1.0 109.159 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.58 -176.7 3.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.4 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 16.6 m80 -111.53 -76.31 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.986 0.812 . . . . 1.0 112.977 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -118.3 118.34 31.55 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 104.896 -2.261 . . . . 1.0 104.896 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tp -103.12 113.58 27.18 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.165 -2.161 . . . . 1.0 105.165 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mm -93.97 113.56 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -71.3 144.93 49.8 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.12 -13.76 3.28 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 119.272 0.942 . . . . 1.0 113.151 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -90.32 26.91 1.8 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.889 2.476 . . . . 1.0 112.483 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.14 71.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.112 1.815 . . . . 1.0 114.535 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -100.32 156.3 17.32 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.839 . . . . 1.0 110.243 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mt -115.88 115.7 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 100.713 -3.81 . . . . 1.0 100.713 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -110.91 143.03 21.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.48 120.97 37.44 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -114.47 117.62 31.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 128.642 2.777 . . . . 1.0 106.205 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG13 ' CE2' ' A' ' 19' ' ' TYR . 44.4 t 68.2 92.06 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 120.847 1.658 . . . . 1.0 113.938 175.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -61.91 -178.14 0.3 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 121.575 1.517 . . . . 1.0 110.553 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -59.37 30.42 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 130.159 3.384 . . . . 1.0 116.495 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -147.15 116.01 6.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 127.537 2.335 . . . . 1.0 108.722 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.295 27.6 ttmt 83.2 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.631 1.972 . . . . 1.0 111.461 175.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -35.95 159.24 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 130.911 3.684 . . . . 1.0 116.599 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -113.17 -178.63 3.43 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 129.384 3.074 . . . . 1.0 114.139 -175.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.1 t90 -155.07 118.59 4.5 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.628 1.571 . . . . 1.0 108.642 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -159.55 63.13 0.38 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.067 0.937 . . . . 1.0 110.361 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.34 -58.53 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 119.11 -2.244 . . . . 1.0 114.561 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.79 -91.27 0.9 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.191 -3.163 . . . . 1.0 105.191 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 t -127.95 133.85 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 118.662 1.231 . . . . 1.0 109.407 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.0 p -160.35 159.06 30.72 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.84 2.056 . . . . 1.0 108.72 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.471 ' H ' HG22 ' A' ' 157' ' ' ILE . 33.9 p -152.03 147.07 26.07 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.542 1.137 . . . . 1.0 111.45 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -148.88 144.8 27.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 38.91 53.99 2.03 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.761 2.024 . . . . 1.0 112.354 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.67 28.41 67.9 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.293 0.949 . . . . 1.0 114.838 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -128.85 113.52 15.38 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 103.576 -2.749 . . . . 1.0 103.576 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 11.8 tt0 -82.88 142.0 31.81 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.943 -1.873 . . . . 1.0 105.943 175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -102.94 118.53 37.03 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.04 -2.578 . . . . 1.0 104.04 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.95 -23.65 58.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.615 0.366 . . . . 1.0 110.653 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -146.52 175.15 10.78 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.533 2.333 . . . . 1.0 106.128 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.7 76.67 3.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.555 1.169 . . . . 1.0 109.313 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -88.54 45.19 1.26 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.979 1.712 . . . . 1.0 109.431 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.9 m -138.81 127.15 22.91 Favored 'General case' 0 C--O 1.225 -0.205 0 O-C-N 120.081 -1.637 . . . . 1.0 113.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.252 0.1 OUTLIER -78.74 56.7 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.732 2.013 . . . . 1.0 108.996 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.18 -136.51 3.74 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.12 163.61 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.209 -2.515 . . . . 1.0 104.209 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.81 117.8 9.43 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 105.764 -1.939 . . . . 1.0 105.764 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.23 131.07 34.48 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 120.808 -1.183 . . . . 1.0 110.195 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.0 tt0 -104.36 147.03 27.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.641 0.376 . . . . 1.0 111.776 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.43 173.38 33.6 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.978 1.275 . . . . 1.0 110.356 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.8 p -148.18 109.2 4.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.507 -2.034 . . . . 1.0 105.507 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 44.93 46.32 8.99 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.928 2.491 . . . . 1.0 112.671 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 50.62 38.19 18.31 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.621 1.969 . . . . 1.0 113.499 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.8 tp -68.27 146.55 53.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.688 1.995 . . . . 1.0 108.142 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -31.51 114.23 0.13 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 126.39 1.876 . . . . 1.0 111.812 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.42 -8.58 58.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 115.361 -2.257 . . . . 1.0 112.951 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.396 17.4 p 68.9 78.68 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 122.18 2.264 . . . . 1.0 113.374 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -22.8 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 121.949 2.159 . . . . 1.0 115.08 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.69 -42.91 7.98 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 127.628 2.371 . . . . 1.0 110.629 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -52.44 -51.46 59.09 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 119.154 0.888 . . . . 1.0 110.432 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -60.61 -39.71 89.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.574 -0.727 . . . . 1.0 109.877 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -66.13 -51.53 57.04 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.176 0.898 . . . . 1.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -64.48 -47.63 78.24 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.469 1.507 . . . . 1.0 110.393 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.2 tp -56.6 -50.53 71.71 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.33 1.052 . . . . 1.0 108.498 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.06 84.14 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 118.691 0.678 . . . . 1.0 110.284 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -53.98 48.78 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.186 0.594 . . . . 1.0 110.648 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.28 -41.78 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 118.896 0.771 . . . . 1.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.1 m -59.25 -56.79 17.67 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.997 1.319 . . . . 1.0 109.466 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -55.93 -43.65 77.59 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.939 0.896 . . . . 1.0 110.245 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.82 -50.7 63.71 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.975 0.51 . . . . 1.0 111.076 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -56.74 -37.44 71.01 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.487 -0.758 . . . . 1.0 111.378 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.5 mt -60.04 -39.31 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.946 0.898 . . . . 1.0 110.057 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.5 m -57.96 -35.33 71.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.38 0.991 . . . . 1.0 111.217 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -83.45 -49.23 9.5 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -125.79 112.85 24.82 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 107.271 -1.381 . . . . 1.0 107.271 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -89.37 106.85 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.19 0 N-CA-C 108.148 -1.52 . . . . 1.0 108.148 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.94 -55.62 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.797 1.639 . . . . 1.0 107.848 175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 43.0 mt -48.86 -33.94 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 129.056 2.942 . . . . 1.0 110.329 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.88 -23.03 6.24 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.497 1.519 . . . . 1.0 113.744 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -137.76 20.73 2.87 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.985 2.514 . . . . 1.0 109.295 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -139.13 87.74 2.22 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.69 1.596 . . . . 1.0 106.888 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 4.5 mtt -136.5 117.6 14.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.16 1.784 . . . . 1.0 107.547 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.9 t -153.52 -176.37 5.78 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.466 1.485 . . . . 1.0 109.544 175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.91 -131.62 2.73 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 107.279 -2.329 . . . . 1.0 107.279 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 22.7 m170 -115.72 -24.04 8.41 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 118.683 1.241 . . . . 1.0 112.415 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 6.5 t -103.73 -11.47 17.59 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.819 0.847 . . . . 1.0 109.024 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.9 OUTLIER -85.81 18.54 2.87 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.145 1.778 . . . . 1.0 110.31 -175.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.73 -18.99 23.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.918 0.887 . . . . 1.0 112.456 -175.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.1 -66.13 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.378 1.471 . . . . 1.0 108.54 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 83.2 Cg_endo -81.59 111.32 2.29 Favored 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 121.834 1.691 . . . . 1.0 111.786 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.06 -17.58 27.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.971 1.309 . . . . 1.0 111.915 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -58.83 -25.64 63.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 120.458 -1.401 . . . . 1.0 112.388 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -134.17 140.61 46.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.522 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 17.0 m -121.71 -16.6 7.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.001 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.08 -178.98 0.63 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 130.717 3.607 . . . . 1.0 104.561 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -78.49 51.27 3.68 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.621 2.214 . . . . 1.0 109.919 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.11 80.89 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.73 2.586 . . . . 1.0 108.485 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.98 -69.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.583 2.189 . . . . 1.0 111.995 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.4 t 53.66 43.03 31.69 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.329 2.251 . . . . 1.0 112.808 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -122.27 17.94 10.67 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.259 0.936 . . . . 1.0 112.637 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.263 8.5 t0 41.78 70.56 0.27 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.583 1.553 . . . . 1.0 111.006 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -52.87 -30.43 33.86 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 121.27 -0.894 . . . . 1.0 111.448 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.57 51.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.461 -0.781 . . . . 1.0 110.162 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.8 mmt-85 -60.46 -50.98 71.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 120.18 1.354 . . . . 1.0 112.008 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -63.72 -46.87 83.45 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 119.243 -0.983 . . . . 1.0 111.469 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -64.69 -31.3 72.47 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.716 0.689 . . . . 1.0 109.932 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -41.19 88.27 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.713 1.142 . . . . 1.0 111.813 175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.17 -55.09 8.88 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.416 1.486 . . . . 1.0 112.166 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 97.4 t -66.34 152.52 9.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 123.402 0.681 . . . . 1.0 109.845 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -49.12 113.76 3.35 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.722 1.209 . . . . 1.0 111.802 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.15 78.34 2.94 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.12 2.546 . . . . 1.0 110.9 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 34.0 40.28 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.9 2.88 . . . . 1.0 115.114 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.6 t -158.05 -46.35 0.06 Allowed 'General case' 0 N--CA 1.462 0.163 0 O-C-N 121.427 -0.796 . . . . 1.0 111.074 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -74.34 56.81 0.66 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.025 1.73 . . . . 1.0 110.348 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -98.82 124.31 43.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 4.2 pm0 -64.69 -166.75 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 130.988 3.715 . . . . 1.0 113.709 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.02 115.54 4.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.844 1.657 . . . . 1.0 109.816 -175.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.4 m . . . . . 0 C--O 1.255 1.355 1 C-N-CA 135.388 5.475 . . . . 1.0 106.431 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.753 ' N ' HD21 ' A' ' 8' ' ' LEU . 5.5 tpp . . . . . 0 N--CA 1.463 0.222 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 160.05 0.2 Allowed 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.682 -1.261 . . . . 1.0 111.367 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.45 123.14 42.42 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.612 0.765 . . . . 1.0 108.957 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -126.85 142.85 51.43 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 129.037 2.935 . . . . 1.0 108.023 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 45.61 35.02 1.89 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.041 1.736 . . . . 1.0 112.172 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.71 -1.87 56.43 Favored Glycine 0 CA--C 1.521 0.407 0 O-C-N 120.888 -1.133 . . . . 1.0 115.246 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -112.87 176.75 4.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.613 2.365 . . . . 1.0 106.348 176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.753 HD21 ' N ' ' A' ' 1' ' ' MET . 6.5 tt -98.89 123.63 43.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.832 -1.544 . . . . 1.0 106.832 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -84.67 175.72 9.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.162 0.985 . . . . 1.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 39.19 58.4 1.87 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.718 1.207 . . . . 1.0 111.569 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.17 155.91 28.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.094 0.958 . . . . 1.0 108.98 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -78.08 123.35 26.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.41 125.54 33.08 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.337 -1.356 . . . . 1.0 107.337 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.0 t -140.32 79.09 21.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.14 123.69 11.93 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 109.641 -0.946 . . . . 1.0 109.641 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -65.4 145.89 99.02 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.695 -0.854 . . . . 1.0 108.695 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -82.03 -9.32 11.84 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.921 1.747 . . . . 1.0 116.131 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -144.02 135.92 26.29 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.386 -2.82 . . . . 1.0 103.386 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.546 ' CE2' HG22 ' A' ' 88' ' ' VAL . 7.2 m-85 -106.7 178.39 4.57 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.291 1.437 . . . . 1.0 108.769 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.79 178.79 4.86 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.248 1.499 . . . . 1.0 111.804 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.0 m -151.28 118.41 5.92 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.912 -2.255 . . . . 1.0 104.912 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -135.93 138.85 28.82 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 106.205 -1.776 . . . . 1.0 106.205 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.44 83.1 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.626 2.217 . . . . 1.0 109.395 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -163.56 149.05 11.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.047 1.739 . . . . 1.0 108.371 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -146.51 104.14 3.74 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.816 -1.179 . . . . 1.0 107.816 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.01 160.58 38.17 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 127.446 2.298 . . . . 1.0 107.339 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -69.51 123.41 88.39 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 106.478 -1.675 . . . . 1.0 106.478 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.93 103.54 1.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.436 1.424 . . . . 1.0 109.783 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -172.95 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 150' ' ' ASN . 4.5 tp -148.74 132.18 16.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 105.15 -2.167 . . . . 1.0 105.15 175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -91.43 122.49 34.07 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.27 113.45 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 105.721 -1.955 . . . . 1.0 105.721 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 169' ' ' PHE . 15.3 t -110.35 114.22 46.43 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 105.675 -1.972 . . . . 1.0 105.675 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 2.8 p80 -165.92 137.22 3.75 Favored 'General case' 0 C--O 1.201 -1.49 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.11 112.59 19.95 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 105.67 -1.974 . . . . 1.0 105.67 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.323 6.6 mm -126.39 179.65 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 128.966 2.907 . . . . 1.0 106.146 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -149.58 121.91 8.43 Favored 'General case' 0 N--CA 1.432 -1.327 1 N-CA-C 99.207 -4.368 . . . . 1.0 99.207 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -143.31 -62.9 0.02 OUTLIER Pre-proline 0 C--O 1.254 1.325 0 CA-C-O 115.796 -2.05 . . . . 1.0 111.821 176.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.57 153.09 23.32 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 CA-C-N 123.564 2.308 . . . . 1.0 111.626 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -80.7 45.52 2.01 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.492 3.461 . . . . 1.0 114.69 -175.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.72 -71.8 0.43 Allowed Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.869 -0.962 . . . . 1.0 111.847 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -155.6 122.76 5.44 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.142 1.377 . . . . 1.0 107.369 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -163.12 166.66 23.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 128.426 2.691 . . . . 1.0 111.514 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.86 -22.65 7.51 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 117.875 -1.514 . . . . 1.0 113.342 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.24 136.77 13.97 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 119.426 1.613 . . . . 1.0 111.021 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.43 -4.42 14.66 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.42 2.747 . . . . 1.0 116.476 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -49.51 -49.46 45.8 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 121.653 2.024 . . . . 1.0 112.569 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.281 23.3 mm -66.23 -43.85 91.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 113.567 -1.651 . . . . 1.0 109.156 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.67 -44.55 96.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -56.72 -34.51 67.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.715 1.606 . . . . 1.0 111.987 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.2 -62.05 2.18 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.801 1.24 . . . . 1.0 109.091 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -66.61 -53.59 32.63 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.545 1.138 . . . . 1.0 111.555 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -56.01 -33.51 64.97 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.765 1.226 . . . . 1.0 109.311 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.37 25.37 8.83 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 119.762 1.165 . . . . 1.0 114.356 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -115.09 9.91 16.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.983 1.313 . . . . 1.0 112.009 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.5 tt -51.7 126.18 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.652 1.181 . . . . 1.0 112.437 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -98.8 124.37 46.13 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.259 2.224 . . . . 1.0 107.758 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.3 70.41 3.16 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.895 3.064 . . . . 1.0 110.434 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -103.63 -63.71 1.16 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.487 0.715 . . . . 1.0 112.414 -175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.83 73.7 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.47 0.708 . . . . 1.0 111.391 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 31.3 p80 -164.31 177.98 1.59 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 107.072 -1.455 . . . . 1.0 107.072 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 69.5 Cg_endo -81.92 -43.52 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 121.329 1.353 . . . . 1.0 112.512 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -45.48 -42.2 10.38 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.243 1.417 . . . . 1.0 113.459 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -57.92 -54.26 48.98 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.55 1.14 . . . . 1.0 107.943 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.6 85.62 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.018 0.927 . . . . 1.0 110.59 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -41.94 -61.85 2.18 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 127.892 2.663 . . . . 1.0 111.02 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 pt -59.02 -49.42 83.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-O 116.976 -1.488 . . . . 1.0 110.663 178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.63 -43.3 0.4 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.584 2.753 . . . . 1.0 116.529 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -56.01 -41.39 74.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.359 1.076 . . . . 1.0 110.662 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -82.76 136.95 34.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 104.892 -2.262 . . . . 1.0 104.892 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.08 154.64 12.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 119.628 -0.829 . . . . 1.0 110.768 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.7 m -117.1 162.96 14.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 C-N-CA 126.365 1.866 . . . . 1.0 111.681 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.04 127.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.303 2.241 . . . . 1.0 106.722 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.93 -153.94 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.68 1.592 . . . . 1.0 108.204 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -128.15 -58.9 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.66 1.184 . . . . 1.0 109.84 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.695 ' HB2' HD13 ' A' ' 115' ' ' ILE . 59.2 m -145.58 126.8 14.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.594 -2.002 . . . . 1.0 105.594 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.58 113.73 26.33 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 104.813 -2.291 . . . . 1.0 104.813 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 mt -94.08 121.34 44.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -75.14 144.6 42.72 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 123' ' ' LEU . 36.2 ptt-85 -49.01 -20.58 0.54 Allowed 'General case' 0 C--O 1.217 -0.626 0 C-N-CA 126.564 1.946 . . . . 1.0 112.949 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -92.07 32.17 1.18 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 130.666 3.586 . . . . 1.0 113.154 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.66 28.41 67.87 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 119.991 -1.693 . . . . 1.0 116.515 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -98.81 145.15 27.25 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 119.194 1.497 . . . . 1.0 108.878 176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.36 113.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.171 -1.788 . . . . 1.0 106.171 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.07 143.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.898 -1.519 . . . . 1.0 106.898 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -115.76 113.87 24.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -110.67 114.07 27.17 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 105.187 -2.153 . . . . 1.0 105.187 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' A' ' 19' ' ' TYR . 74.5 t 71.39 91.37 0.07 OUTLIER Pre-proline 0 N--CA 1.476 0.867 0 CA-C-N 121.71 2.05 . . . . 1.0 111.954 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.34 -166.93 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.093 1.862 . . . . 1.0 111.052 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -61.4 26.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 130.34 3.456 . . . . 1.0 116.918 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -148.27 134.86 19.77 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 121.247 1.84 . . . . 1.0 106.741 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 75.69 82.69 0.1 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.626 1.57 . . . . 1.0 111.504 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -43.96 145.28 0.74 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.333 1.853 . . . . 1.0 112.546 -174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB2' HG11 ' A' ' 88' ' ' VAL . . . -109.29 -178.59 3.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.206 2.202 . . . . 1.0 110.26 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -154.39 119.74 5.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.604 0.638 . . . . 1.0 111.051 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -157.21 64.46 0.5 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.058 1.409 . . . . 1.0 111.46 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.01 -57.96 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 117.953 -2.967 . . . . 1.0 111.286 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.91 -69.61 0.44 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 108.331 -1.908 . . . . 1.0 108.331 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.1 t -146.04 144.02 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.464 1.632 . . . . 1.0 109.544 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 p -165.71 162.83 18.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.738 1.215 . . . . 1.0 111.444 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 3.0 p -158.77 145.32 17.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 1.0 108.982 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -166.9 157.15 11.53 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.537 -1.221 . . . . 1.0 108.943 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 39.58 53.91 2.42 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.511 1.924 . . . . 1.0 112.3 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.36 29.82 53.94 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 114.885 -1.052 . . . . 1.0 113.846 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.6 tpt85 -131.71 116.72 17.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.081 1.441 . . . . 1.0 108.433 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 2.1 tt0 -78.51 146.49 34.32 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.474 -1.676 . . . . 1.0 106.474 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -126.01 117.97 24.35 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.387 -2.079 . . . . 1.0 105.387 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.7 t -72.86 -26.25 61.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.812 -1.085 . . . . 1.0 110.588 -176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -151.42 173.23 14.79 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.972 1.309 . . . . 1.0 108.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -90.49 75.64 6.72 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 123.205 1.479 . . . . 1.0 107.054 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.18 39.2 1.12 Allowed 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.475 1.11 . . . . 1.0 109.769 -175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 44.9 m -140.02 124.26 17.83 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 120.471 -1.393 . . . . 1.0 113.205 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.286 0.1 OUTLIER -78.46 57.25 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.545 2.338 . . . . 1.0 111.57 -175.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.26 -119.02 0.45 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.411 -1.475 . . . . 1.0 109.411 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.696 HD11 HG11 ' A' ' 136' ' ' VAL . 15.8 mm -149.01 165.56 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 130.234 3.413 . . . . 1.0 104.105 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -141.16 134.13 29.12 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.846 2.858 . . . . 1.0 104.129 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.4 164.24 11.87 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.355 -0.841 . . . . 1.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.37 150.79 50.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.207 0.603 . . . . 1.0 111.135 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.51 173.88 39.67 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.935 1.255 . . . . 1.0 110.734 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.2 p -151.01 110.53 4.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.635 -2.357 . . . . 1.0 104.635 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.5 t0 49.55 52.67 14.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 123.789 1.757 . . . . 1.0 112.507 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 47.83 37.98 8.14 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.373 2.669 . . . . 1.0 114.031 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 80' ' ' ARG . 7.7 tt -58.5 145.62 38.3 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.722 1.209 . . . . 1.0 107.744 175.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -44.87 120.72 2.44 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.268 1.027 . . . . 1.0 109.678 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -82.41 10.38 7.24 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 117.129 -1.415 . . . . 1.0 113.673 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.311 28.6 p 37.4 74.65 0.08 Allowed 'General case' 0 C--N 1.315 -0.922 1 N-CA-C 123.667 4.691 . . . . 1.0 123.667 -174.121 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -17.19 -32.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.998 2.919 . . . . 1.0 114.918 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.34 -41.2 18.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.594 1.557 . . . . 1.0 109.387 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -49.56 -57.29 7.38 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 126.51 1.924 . . . . 1.0 109.299 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -56.34 -43.17 78.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.736 -0.65 . . . . 1.0 109.561 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -64.51 -57.06 10.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.652 0.66 . . . . 1.0 111.004 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 136' ' ' VAL . 43.3 mt-30 -65.77 -33.78 76.67 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.974 -1.704 . . . . 1.0 111.516 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.662 HD13 HG21 ' A' ' 115' ' ' ILE . 7.3 tp -61.6 -46.43 89.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.609 1.095 . . . . 1.0 108.761 175.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.05 76.71 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.247 0.931 . . . . 1.0 109.187 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -53.33 52.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.856 0.753 . . . . 1.0 110.703 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.696 HG11 HD11 ' A' ' 115' ' ' ILE . 4.1 t -56.06 -46.03 80.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 122.092 -0.38 . . . . 1.0 110.044 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 60.9 m -59.21 -50.08 75.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.373 1.469 . . . . 1.0 109.838 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.15 -42.26 94.49 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.0 110.341 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.93 88.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.849 0.46 . . . . 1.0 112.054 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 53.9 mt -56.36 -47.12 79.52 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 118.531 -0.747 . . . . 1.0 109.313 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.05 -37.27 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.166 0.986 . . . . 1.0 110.773 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.4 m -65.63 -14.07 60.42 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.071 0.949 . . . . 1.0 111.953 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 mmm-85 -111.07 -50.83 2.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.391 1.45 . . . . 1.0 111.744 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -126.77 113.06 22.44 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 106.771 -1.566 . . . . 1.0 106.771 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -97.33 107.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.049 1.41 . . . . 1.0 110.198 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.95 -51.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.064 1.746 . . . . 1.0 106.405 175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 59.5 mt -46.71 -33.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 129.497 3.119 . . . . 1.0 110.999 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.25 -26.42 17.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.407 1.083 . . . . 1.0 113.621 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -135.69 18.15 3.31 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.705 2.002 . . . . 1.0 110.043 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.434 ' HB3' HD12 ' A' ' 30' ' ' LEU . 11.5 m120 -139.78 83.56 1.93 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.926 1.29 . . . . 1.0 108.068 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 64.5 mtt -120.29 126.71 51.24 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -160.56 -167.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 119.546 1.067 . . . . 1.0 108.345 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.28 -130.88 1.32 Allowed Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 105.508 -3.037 . . . . 1.0 105.508 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.406 ' HE1' ' CE1' ' A' ' 34' ' ' HIS 0.317 13.2 m170 -112.31 -22.99 10.62 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 113.325 0.861 . . . . 1.0 113.325 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 9.0 t -102.98 -11.13 18.4 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 118.568 -0.729 . . . . 1.0 109.287 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -89.42 43.05 1.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.175 -1.046 . . . . 1.0 108.175 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -71.63 -8.96 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 120.801 -1.187 . . . . 1.0 110.515 175.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -160.72 -53.92 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.669 2.388 . . . . 1.0 111.246 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 64.5 Cg_endo -91.52 111.96 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.097 1.865 . . . . 1.0 113.031 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.95 -25.38 63.46 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.965 -1.084 . . . . 1.0 112.281 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 20.4 ttp85 -71.27 -5.29 31.07 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.64 -1.287 . . . . 1.0 112.549 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 127.22 22.31 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 103.888 -2.634 . . . . 1.0 103.888 174.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.3 m -123.73 -16.21 6.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.289 0.95 . . . . 1.0 110.884 -175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.78 -178.75 0.34 Allowed Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 128.216 2.607 . . . . 1.0 105.697 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.79 51.52 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.525 . . . . 1.0 112.96 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.34 76.46 0.09 OUTLIER Glycine 0 CA--C 1.525 0.674 0 C-N-CA 125.158 1.361 . . . . 1.0 110.202 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.49 -74.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.373 2.049 . . . . 1.0 111.636 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.75 44.02 30.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.431 1.892 . . . . 1.0 111.206 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 33' ' ' VAL . 51.6 t80 -99.09 18.38 17.52 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.038 -1.039 . . . . 1.0 110.926 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.258 9.4 t0 44.17 70.52 0.32 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.388 1.475 . . . . 1.0 110.46 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -56.7 -29.12 62.07 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 120.669 -1.269 . . . . 1.0 110.311 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.4 -53.61 33.8 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.755 1.161 . . . . 1.0 111.994 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -65.93 -47.88 73.26 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 118.079 -0.962 . . . . 1.0 109.868 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -60.11 -55.63 31.58 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.123 0.874 . . . . 1.0 112.176 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -58.64 -36.6 74.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.795 -1.098 . . . . 1.0 109.8 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.47 -45.1 80.82 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.471 1.107 . . . . 1.0 113.629 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.55 -46.08 84.38 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.087 0.955 . . . . 1.0 112.054 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.69 166.55 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.741 2.016 . . . . 1.0 110.082 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 183' ' ' HIS . 6.0 m -45.14 128.54 5.68 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 124.438 1.095 . . . . 1.0 109.457 175.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.13 44.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.323 2.682 . . . . 1.0 111.379 -176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.2 t 46.52 41.72 10.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.867 1.667 . . . . 1.0 109.501 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.8 t -155.09 29.2 0.41 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.535 0.734 . . . . 1.0 111.005 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.44 ' HB3' HG23 ' A' ' 179' ' ' THR . 4.6 t-160 -150.25 67.59 0.97 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.125 0.875 . . . . 1.0 110.516 -175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -149.07 144.59 26.78 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 105.246 -2.131 . . . . 1.0 105.246 175.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -129.16 137.21 51.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.843 -1.91 . . . . 1.0 105.843 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.0 tpt 51.94 100.28 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.901 2.88 . . . . 1.0 114.154 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.258 1.51 0 C-N-CA 128.19 2.596 . . . . 1.0 108.985 -177.137 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ttm . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 110.428 -0.212 . . . . 1.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 17.2 tp -134.31 176.11 8.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.49 2.316 . . . . 1.0 108.092 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.446 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 82.8 mt -124.96 125.27 43.65 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 103.992 -2.595 . . . . 1.0 103.992 175.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -126.66 134.23 50.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.508 1.049 . . . . 1.0 109.583 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 51.91 33.61 11.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.055 2.142 . . . . 1.0 111.519 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.91 5.45 79.87 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.304 -1.276 . . . . 1.0 113.492 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -113.87 171.91 7.3 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.168 1.484 . . . . 1.0 108.28 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tp -81.62 138.74 35.29 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.863 -0.523 . . . . 1.0 110.183 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.42 154.52 32.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 46.2 58.35 4.56 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.168 2.187 . . . . 1.0 113.59 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.77 134.73 15.73 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.182 -0.949 . . . . 1.0 111.334 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -71.65 123.18 21.96 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.428 -1.693 . . . . 1.0 106.428 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -92.88 123.93 36.5 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.638 -0.664 . . . . 1.0 110.42 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.45 67.29 75.82 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.333 1.453 . . . . 1.0 107.666 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.52 152.47 59.98 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.78 1.653 . . . . 1.0 110.071 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.8 t -154.1 114.96 2.54 Favored Pre-proline 0 CA--C 1.511 -0.554 0 N-CA-C 105.765 -1.939 . . . . 1.0 105.765 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 90.8 Cg_endo -74.75 71.4 4.82 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.002 1.801 . . . . 1.0 109.261 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -133.85 43.03 2.89 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.073 2.949 . . . . 1.0 105.064 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 18.9 m-85 -79.28 178.7 7.88 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.425 2.29 . . . . 1.0 113.077 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -122.2 -179.76 4.28 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.615 1.966 . . . . 1.0 111.011 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 m -158.26 118.27 3.27 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 131.395 3.878 . . . . 1.0 101.547 175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -120.2 138.72 27.48 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 106.047 -1.835 . . . . 1.0 106.047 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.96 61.27 8.09 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.115 3.21 . . . . 1.0 112.54 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -138.8 151.39 47.01 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 128.675 2.79 . . . . 1.0 105.023 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -150.85 104.36 3.16 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.802 1.183 . . . . 1.0 109.713 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -136.14 161.71 34.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 105.97 -1.863 . . . . 1.0 105.97 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -57.69 123.86 65.19 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 123.97 0.908 . . . . 1.0 108.923 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.34 103.6 1.29 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.366 2.044 . . . . 1.0 108.302 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 t -174.15 82.84 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.198 -2.149 . . . . 1.0 105.198 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tt -156.07 131.48 9.49 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.376 1.471 . . . . 1.0 107.482 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.4 tp -92.07 127.51 37.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.342 1.057 . . . . 1.0 109.437 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.67 116.84 51.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.913 1.285 . . . . 1.0 108.514 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 169' ' ' PHE . 93.6 t -110.88 114.94 48.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.0 OUTLIER -168.07 129.39 1.4 Allowed 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 174.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -70.88 111.84 6.6 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 5.9 mm -127.0 177.58 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.828 2.451 . . . . 1.0 112.12 175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.7 t -151.28 122.32 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 1 N-CA-C 95.992 -5.559 . . . . 1.0 95.992 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.301 0.6 OUTLIER -142.84 -60.9 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 121.727 2.058 . . . . 1.0 112.426 176.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -81.14 157.58 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.572 2.181 . . . . 1.0 111.449 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -81.16 13.47 2.37 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.771 2.981 . . . . 1.0 116.664 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -24.55 -68.59 0.03 OUTLIER Glycine 0 C--N 1.353 1.508 0 CA-C-N 121.402 1.91 . . . . 1.0 111.694 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -148.89 122.97 9.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.776 -1.565 . . . . 1.0 106.776 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -176.47 159.26 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 128.649 2.78 . . . . 1.0 108.294 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.46 -6.4 10.62 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.721 1.153 . . . . 1.0 110.664 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.09 120.37 7.18 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 108.383 -1.887 . . . . 1.0 108.383 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -60.82 -24.86 80.05 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.62 2.213 . . . . 1.0 115.191 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -49.36 -45.81 46.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.794 1.179 . . . . 1.0 113.741 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 mm -65.6 -49.31 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 123.567 0.747 . . . . 1.0 110.651 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.34 -36.33 82.62 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 118.861 -1.136 . . . . 1.0 110.744 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.75 -34.2 71.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.717 0.807 . . . . 1.0 110.996 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.1 tm? -60.94 -54.33 46.32 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.547 1.139 . . . . 1.0 108.077 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.96 -48.29 69.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 113.766 1.024 . . . . 1.0 113.766 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.51 -34.77 78.66 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.275 1.43 . . . . 1.0 110.431 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.09 1.57 29.98 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.195 1.379 . . . . 1.0 115.221 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.4 p -88.96 8.69 28.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.232 2.016 . . . . 1.0 113.255 -176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -57.46 127.92 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.978 1.311 . . . . 1.0 112.219 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.84 135.54 20.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 127.238 2.215 . . . . 1.0 109.609 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.08 77.34 1.99 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.649 2.899 . . . . 1.0 107.261 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.41 -64.58 1.07 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.105 0.562 . . . . 1.0 111.013 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.8 -47.55 76.93 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.042 0.937 . . . . 1.0 110.855 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 17.8 p80 -170.07 177.9 0.98 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.677 1.591 . . . . 1.0 107.607 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 19.1 Cg_endo -71.37 -43.41 1.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.437 2.091 . . . . 1.0 114.973 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -46.29 -49.76 17.03 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.956 1.095 . . . . 1.0 113.956 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.43 -55.58 31.81 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.116 0.966 . . . . 1.0 110.397 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.28 99.17 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.14 0.976 . . . . 1.0 111.39 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.47 -55.31 23.09 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.907 1.718 . . . . 1.0 112.38 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.7 pt -60.26 -36.32 67.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-O 117.221 -1.371 . . . . 1.0 112.38 -176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -43.78 -43.15 5.96 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.58 1.952 . . . . 1.0 115.435 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.4 m-70 -60.34 -33.57 72.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.672 -0.643 . . . . 1.0 109.692 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.62 136.65 33.68 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 102.924 -2.991 . . . . 1.0 102.924 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 153.89 15.14 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 118.694 -1.202 . . . . 1.0 110.456 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.59 159.21 16.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 m -165.84 130.21 2.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.632 -1.248 . . . . 1.0 107.632 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.32 -176.77 3.75 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.801 -1.555 . . . . 1.0 106.801 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.5 m80 -123.69 -76.6 0.59 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.549 -2.019 . . . . 1.0 105.549 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' CB ' HD13 ' A' ' 115' ' ' ILE . 3.8 m -122.51 118.47 28.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.891 -2.263 . . . . 1.0 104.891 178.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -110.97 113.33 25.81 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.407 -2.071 . . . . 1.0 105.407 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 21.4 mt -88.1 119.09 34.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 106.029 -1.841 . . . . 1.0 106.029 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.29 141.9 58.61 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.437 -1.69 . . . . 1.0 106.437 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -53.14 -24.99 11.8 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 124.442 1.097 . . . . 1.0 111.324 175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.37 34.57 0.95 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.529 1.132 . . . . 1.0 111.845 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.48 48.2 86.28 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 120.112 -1.617 . . . . 1.0 115.944 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.48 156.26 31.86 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.5 mt -116.08 113.51 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 104.948 -2.241 . . . . 1.0 104.948 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.26 139.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 105.109 -2.182 . . . . 1.0 105.109 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -124.79 113.96 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.952 -1.129 . . . . 1.0 107.952 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -109.87 140.41 43.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.911 2.484 . . . . 1.0 104.384 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t 63.18 90.91 0.08 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 120.65 1.568 . . . . 1.0 113.519 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -66.67 -177.55 0.97 Allowed 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 120.807 1.005 . . . . 1.0 110.432 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -63.69 28.18 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.682 2.793 . . . . 1.0 115.558 -175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -149.89 120.36 7.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 128.523 2.729 . . . . 1.0 107.204 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 84.07 81.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.662 2.785 . . . . 1.0 110.639 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -41.04 152.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 129.699 3.2 . . . . 1.0 114.603 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.72 -178.77 3.76 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.318 2.247 . . . . 1.0 110.219 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -152.34 118.44 5.51 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.26 -1.015 . . . . 1.0 108.26 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -162.73 62.5 0.2 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.969 0.89 . . . . 1.0 110.914 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -165.76 -61.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 117.635 -3.166 . . . . 1.0 113.296 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.96 -73.65 1.14 Allowed Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.203 -1.332 . . . . 1.0 112.943 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.7 t -137.95 129.4 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.973 1.387 . . . . 1.0 111.633 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.2 p -165.96 146.73 6.67 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.824 1.65 . . . . 1.0 108.231 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.563 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -144.53 146.39 32.35 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.762 2.025 . . . . 1.0 108.533 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -150.32 149.65 30.4 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 104.943 -2.244 . . . . 1.0 104.943 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 43.49 53.61 5.65 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.745 1.218 . . . . 1.0 114.273 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.8 39.46 67.84 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 121.011 -1.056 . . . . 1.0 113.09 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -146.48 113.57 6.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 104.579 -2.378 . . . . 1.0 104.579 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -105.98 132.84 51.59 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 -176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -102.55 118.26 36.48 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.5 t -61.31 -25.05 66.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.931 1.292 . . . . 1.0 111.611 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -153.77 161.08 42.39 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.189 -2.893 . . . . 1.0 103.189 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.3 76.76 8.23 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -77.04 40.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.821 2.448 . . . . 1.0 109.74 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -123.73 133.79 53.8 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 124.852 1.261 . . . . 1.0 110.96 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.39 56.83 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.162 -1.421 . . . . 1.0 107.162 175.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.02 -137.01 3.79 Favored Glycine 0 CA--C 1.525 0.668 0 O-C-N 120.909 -1.119 . . . . 1.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 1.1 mm -143.15 164.77 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.238 -2.875 . . . . 1.0 103.238 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -143.33 137.18 28.6 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.329 2.651 . . . . 1.0 103.898 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.91 141.62 33.54 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 120.589 -1.319 . . . . 1.0 109.407 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 6.0 tm-20 -103.92 154.3 19.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.465 -0.198 . . . . 1.0 110.465 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.02 -177.62 46.11 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 128.49 2.948 . . . . 1.0 109.401 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 28.0 p -156.35 116.64 3.65 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.735 -2.321 . . . . 1.0 104.735 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.4 t0 50.59 40.45 23.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.986 1.476 . . . . 1.0 114.986 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.261 65.4 p 58.8 38.48 24.71 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.249 2.22 . . . . 1.0 115.163 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.44 146.08 30.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.906 1.682 . . . . 1.0 107.886 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -42.4 113.38 0.44 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -81.02 -5.75 57.97 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 115.855 1.798 . . . . 1.0 115.855 -175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.8 p 51.62 77.78 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 120.194 1.361 . . . . 1.0 111.505 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -23.84 -33.57 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 128.245 2.618 . . . . 1.0 114.159 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -41.62 -36.22 0.9 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.497 2.319 . . . . 1.0 109.452 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -48.17 -50.07 30.32 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.594 0.757 . . . . 1.0 110.375 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -58.84 -47.73 83.82 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.321 0.648 . . . . 1.0 109.982 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -60.02 -51.95 67.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.578 0.704 . . . . 1.0 109.72 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -66.45 -47.9 71.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.135 1.374 . . . . 1.0 110.837 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 115' ' ' ILE . 21.5 tp -55.76 -41.77 74.47 Favored 'General case' 0 C--O 1.223 -0.318 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 175.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.81 98.26 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 120.458 1.481 . . . . 1.0 111.907 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.74 47.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.384 0.674 . . . . 1.0 109.246 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.474 HG11 HD11 ' A' ' 115' ' ' ILE . 22.0 t -60.62 -48.25 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.8 -0.444 . . . . 1.0 109.8 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 87.5 m -55.85 -49.35 73.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.843 1.257 . . . . 1.0 109.893 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -62.39 -41.08 98.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.488 0.715 . . . . 1.0 110.338 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.74 68.03 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.268 -0.895 . . . . 1.0 110.673 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.12 -41.13 74.83 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.876 -1.059 . . . . 1.0 112.05 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.68 -43.24 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 119.678 1.126 . . . . 1.0 108.574 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 5.8 m -65.61 -22.03 66.63 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.386 0.674 . . . . 1.0 111.799 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.62 -56.15 3.48 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 120.478 -1.389 . . . . 1.0 108.098 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.36 112.54 23.44 Favored Pre-proline 0 C--O 1.239 0.527 0 N-CA-C 106.979 -1.489 . . . . 1.0 106.979 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -89.97 108.55 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 117.05 -1.5 . . . . 1.0 110.122 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -153.41 -50.42 0.1 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.081 1.752 . . . . 1.0 109.033 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.9 mt -47.33 -33.63 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.847 3.259 . . . . 1.0 110.765 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.08 -26.3 4.29 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.405 1.082 . . . . 1.0 113.272 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.92 17.92 5.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 126.676 1.991 . . . . 1.0 111.267 177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -139.47 88.02 2.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.34 1.427 . . . . 1.0 109.717 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 46.0 mtt -129.89 113.86 15.16 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -148.6 -165.9 2.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -155.45 -131.41 1.43 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 106.326 -2.709 . . . . 1.0 106.326 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.467 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.0 m170 -114.08 -23.51 9.49 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.588 1.194 . . . . 1.0 111.907 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.93 -11.59 17.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.787 0.835 . . . . 1.0 109.573 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -88.52 39.56 0.92 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.1 -1.0 . . . . 1.0 110.393 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -74.43 -11.69 14.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 O-C-N 121.251 -0.906 . . . . 1.0 108.68 175.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -159.59 -54.16 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 125.956 1.702 . . . . 1.0 113.037 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -87.12 108.86 0.73 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 122.71 2.004 . . . . 1.0 111.277 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.23 -13.42 37.6 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.198 -0.938 . . . . 1.0 113.219 -177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.09 -25.74 63.66 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.544 -1.347 . . . . 1.0 111.957 175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -113.91 141.6 47.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 105.954 -1.869 . . . . 1.0 105.954 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.7 m -140.37 -15.07 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 118.872 -1.131 . . . . 1.0 111.427 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.71 177.55 0.43 Allowed Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 131.0 3.72 . . . . 1.0 104.092 175.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.07 77.86 3.35 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.33 2.02 . . . . 1.0 109.892 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 127.17 67.27 0.15 Allowed Glycine 0 CA--C 1.538 1.505 0 C-N-CA 126.086 1.803 . . . . 1.0 109.582 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 88.0 Cg_endo -74.62 -89.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.08 2.52 . . . . 1.0 109.551 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.4 t 53.4 42.98 31.96 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.876 2.07 . . . . 1.0 114.095 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CD2' HG11 ' A' ' 33' ' ' VAL . 65.8 t80 -95.13 19.28 10.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 119.862 -1.774 . . . . 1.0 113.982 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.5 t0 45.61 56.2 6.02 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 120.213 -1.554 . . . . 1.0 113.479 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -45.2 -40.5 7.32 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 126.096 1.758 . . . . 1.0 113.011 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.63 -60.85 2.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.973 -1.013 . . . . 1.0 110.381 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -64.55 -36.2 83.45 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 117.884 -1.526 . . . . 1.0 111.251 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -60.55 -57.56 12.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.589 0.556 . . . . 1.0 110.397 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -64.38 -32.72 74.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.761 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.75 96.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.536 0.607 . . . . 1.0 111.715 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.82 -46.48 62.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.243 1.017 . . . . 1.0 112.262 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.04 166.87 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.371 1.868 . . . . 1.0 111.702 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -38.78 121.6 1.17 Allowed Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.951 1.7 . . . . 1.0 108.876 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.08 45.2 1.86 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 124.327 3.351 . . . . 1.0 112.699 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.5 t 53.86 33.96 18.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.765 2.026 . . . . 1.0 110.702 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.7 t -167.49 94.9 0.45 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.476 -1.305 . . . . 1.0 107.476 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -166.97 125.17 1.33 Allowed 'General case' 0 C--O 1.231 0.098 0 O-C-N 121.167 -0.958 . . . . 1.0 109.217 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -149.05 165.35 31.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.459 -1.312 . . . . 1.0 107.459 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.14 -172.17 3.87 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 129.02 2.928 . . . . 1.0 105.824 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.7 tpp 34.06 -85.97 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.585 2.754 . . . . 1.0 116.323 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 C--O 1.249 1.073 0 C-N-CA 128.214 2.606 . . . . 1.0 106.04 176.225 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.0 tp -57.15 129.46 41.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 170.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -133.91 135.11 43.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 101.723 -3.436 . . . . 1.0 101.723 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -119.01 124.06 46.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.045 -1.095 . . . . 1.0 108.045 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 52.92 33.97 15.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.99 0.814 . . . . 1.0 112.381 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.38 -2.77 6.82 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-O 118.681 -1.066 . . . . 1.0 113.809 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -87.75 161.43 17.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 104.176 -2.527 . . . . 1.0 104.176 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.66 124.34 27.49 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.283 -1.511 . . . . 1.0 107.258 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.12 176.33 5.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.895 0.878 . . . . 1.0 112.037 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 45.79 57.97 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.971 2.108 . . . . 1.0 109.694 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 139.83 13.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.557 -1.339 . . . . 1.0 111.294 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.03 130.11 39.18 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.847 -0.797 . . . . 1.0 108.847 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -83.61 133.2 34.85 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.024 0.53 . . . . 1.0 110.319 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.84 73.12 28.24 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 106.422 -1.696 . . . . 1.0 106.422 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.62 123.27 9.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 N-CA-C 108.08 -1.546 . . . . 1.0 108.08 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -113.91 114.51 46.5 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 29.1 Cg_endo -79.86 38.93 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.665 2.91 . . . . 1.0 113.989 -175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -123.97 44.53 2.7 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.503 1.121 . . . . 1.0 109.254 -175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 17' ' ' PRO . 21.9 m-85 -73.52 178.52 4.6 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.066 0.946 . . . . 1.0 112.863 -175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -119.67 178.6 4.51 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 118.919 2.933 . . . . 1.0 118.919 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.2 m -162.83 118.73 1.84 Allowed 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 135.911 5.684 . . . . 1.0 101.173 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -130.09 154.96 81.39 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.439 -2.06 . . . . 1.0 105.439 175.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.26 51.97 4.12 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.985 3.124 . . . . 1.0 114.398 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -139.59 151.18 45.83 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.904 1.282 . . . . 1.0 110.205 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -148.43 103.82 3.46 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.791 1.236 . . . . 1.0 108.179 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -136.44 173.53 11.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.082 0.953 . . . . 1.0 109.01 175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -79.46 124.32 84.01 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 119.648 1.113 . . . . 1.0 109.789 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.72 103.95 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.504 2.136 . . . . 1.0 112.436 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -178.13 83.85 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.067 1.747 . . . . 1.0 108.002 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 tt -155.67 141.04 17.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.571 1.149 . . . . 1.0 108.183 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.1 tp -94.25 127.48 40.13 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.475 1.51 . . . . 1.0 108.478 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.14 140.43 24.28 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -135.56 113.72 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 104.888 -2.264 . . . . 1.0 104.888 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.6 OUTLIER -170.16 152.16 4.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.796 1.638 . . . . 1.0 107.601 175.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -94.88 112.42 24.14 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 36' ' ' ILE . 5.2 mm -128.05 166.67 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 106.179 -1.785 . . . . 1.0 106.179 175.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -139.13 122.25 16.87 Favored 'General case' 0 N--CA 1.444 -0.733 1 N-CA-C 94.35 -6.167 . . . . 1.0 94.35 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.366 0.7 OUTLIER -142.96 -66.1 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.462 0 N-CA-C 114.466 1.284 . . . . 1.0 114.466 179.4 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 27.4 Cg_endo -87.85 155.92 7.36 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.096 2.531 . . . . 1.0 114.352 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.19 59.09 5.86 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 125.174 3.916 . . . . 1.0 116.157 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.79 -71.77 0.95 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -156.48 123.46 5.24 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.463 1.505 . . . . 1.0 110.496 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -168.56 166.4 12.01 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.227 2.611 . . . . 1.0 110.715 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.06 6.49 25.4 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.623 2.059 . . . . 1.0 111.649 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.2 118.74 6.27 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.187 -1.965 . . . . 1.0 108.187 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.23 -7.88 20.25 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.825 2.35 . . . . 1.0 114.457 -175.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.476 ' CZ2' ' HB2' ' A' ' 60' ' ' ALA . 13.6 m95 -45.95 -49.63 15.62 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 125.283 1.433 . . . . 1.0 113.293 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.5 mt -65.12 -46.01 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.619 -175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -66.4 -38.31 87.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.163 -0.681 . . . . 1.0 109.163 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -61.16 -34.24 74.71 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.68 1.192 . . . . 1.0 111.897 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 68' ' ' ALA . 1.4 tm? -59.66 -51.89 67.85 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.905 1.282 . . . . 1.0 109.152 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -70.03 -48.66 57.1 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.609 1.163 . . . . 1.0 111.558 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.05 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.046 0.938 . . . . 1.0 109.378 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.53 1.82 24.48 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.006 -1.441 . . . . 1.0 115.319 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -89.07 9.29 25.9 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.301 2.05 . . . . 1.0 113.038 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.4 tt -53.51 145.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 125.648 1.579 . . . . 1.0 114.431 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.82 136.77 20.56 Favored Pre-proline 0 CA--C 1.546 0.804 1 C-N-CA 131.77 4.028 . . . . 1.0 113.02 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.51 38.1 0.29 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 124.769 3.646 . . . . 1.0 113.695 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -103.16 -33.36 9.23 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.229 1.832 . . . . 1.0 111.061 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HB2' ' CZ2' ' A' ' 47' ' ' TRP . . . -50.9 -52.96 36.78 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 106.207 -1.775 . . . . 1.0 106.207 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 12.9 p80 -171.31 178.38 0.79 Allowed Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 131.046 3.738 . . . . 1.0 104.181 174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -73.3 -43.54 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 121.69 1.593 . . . . 1.0 113.658 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -42.28 -47.64 4.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.889 1.676 . . . . 1.0 114.105 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -55.66 -55.6 30.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.758 1.223 . . . . 1.0 109.136 -175.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.33 99.08 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.253 1.021 . . . . 1.0 110.745 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.77 -57.49 10.75 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 125.87 1.7 . . . . 1.0 113.1 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 pt -61.7 -39.88 84.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.121 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -38.15 -43.26 0.74 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.89 2.476 . . . . 1.0 115.188 -176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -56.4 -40.05 74.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.008 0.923 . . . . 1.0 108.868 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.56 136.93 32.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 1.0 105.062 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 154.98 5.62 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.131 -0.98 . . . . 1.0 112.399 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 m -116.73 160.65 16.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.349 1.86 . . . . 1.0 108.872 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.7 m -174.24 120.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.583 1.553 . . . . 1.0 107.586 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.23 -169.39 1.91 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.243 1.417 . . . . 1.0 108.153 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 24.7 m80 -120.18 -59.04 1.82 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.854 1.261 . . . . 1.0 109.42 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 78.3 m -142.72 119.12 10.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 119.709 -1.869 . . . . 1.0 106.684 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp -98.88 113.74 26.02 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 102.579 -3.119 . . . . 1.0 102.579 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.0 mt -95.83 114.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.686 -1.968 . . . . 1.0 105.686 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -67.22 152.57 45.49 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 118.519 0.6 . . . . 1.0 110.165 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -60.78 -14.0 18.74 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 125.467 1.507 . . . . 1.0 112.784 175.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -91.88 20.35 5.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.834 1.654 . . . . 1.0 111.755 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.56 47.71 89.79 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 127.743 2.592 . . . . 1.0 114.118 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -119.36 115.05 23.32 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.383 0.673 . . . . 1.0 110.521 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.92 117.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 175.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 t -111.55 147.28 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 104.62 -2.363 . . . . 1.0 104.62 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -124.3 117.92 25.6 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.569 1.548 . . . . 1.0 112.321 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.64 123.24 41.44 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 128.391 2.676 . . . . 1.0 105.205 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.0 t 64.34 91.29 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 122.339 2.336 . . . . 1.0 112.696 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -69.1 -169.13 0.28 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 122.144 1.896 . . . . 1.0 112.031 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.93 17.58 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.996 2.918 . . . . 1.0 114.994 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -143.68 125.27 14.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.687 2.395 . . . . 1.0 107.249 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? 85.09 81.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.559 3.144 . . . . 1.0 109.678 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HB3' HH11 ' A' ' 93' ' ' ARG . 0.1 OUTLIER -38.71 141.44 0.27 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.598 2.759 . . . . 1.0 115.246 -175.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -105.45 -178.54 3.68 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 129.002 2.921 . . . . 1.0 111.625 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -153.71 118.32 4.95 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.678 1.591 . . . . 1.0 108.318 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -160.12 63.19 0.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 123.401 1.572 . . . . 1.0 111.498 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -159.53 -53.97 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 118.747 -2.471 . . . . 1.0 113.457 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.57 -69.41 0.74 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.5 t -145.86 137.57 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.154 1.382 . . . . 1.0 108.019 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.9 p -166.46 165.96 16.68 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.092 1.757 . . . . 1.0 108.875 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 157' ' ' ILE . 5.3 p -159.27 146.38 17.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -156.48 152.81 27.85 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.62 -1.252 . . . . 1.0 107.62 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 39.85 53.41 2.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.368 1.467 . . . . 1.0 111.846 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.16 28.47 26.33 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.396 -1.224 . . . . 1.0 114.872 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -129.22 117.36 20.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.83 146.64 30.81 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.424 1.49 . . . . 1.0 111.191 -175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 54.8 mtm-85 -126.15 117.99 24.28 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 50.7 t -78.38 -23.87 46.6 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.207 1.003 . . . . 1.0 110.133 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.13 169.98 16.59 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.912 -1.885 . . . . 1.0 105.912 176.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 6.1 t70 -93.43 76.0 4.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 38.42 0.72 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.099 1.759 . . . . 1.0 109.497 -175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.6 m -128.23 143.07 51.0 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.574 1.55 . . . . 1.0 109.343 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -78.96 56.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.208 2.203 . . . . 1.0 107.451 175.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.07 -136.59 1.57 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 122.227 0.904 . . . . 1.0 112.773 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 136' ' ' VAL . 28.2 mm -147.26 155.44 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 129.522 3.129 . . . . 1.0 104.104 -175.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.43 129.97 21.35 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 103.397 -2.816 . . . . 1.0 103.397 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.97 161.5 13.81 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 119.646 -1.909 . . . . 1.0 110.626 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -122.68 144.82 48.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.815 0.846 . . . . 1.0 111.084 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -162.4 174.71 38.84 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.55 2.024 . . . . 1.0 111.232 175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.3 p -149.42 106.51 3.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.026 -1.842 . . . . 1.0 106.026 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 40.6 t0 45.52 48.81 10.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.59 1.956 . . . . 1.0 112.593 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.2 p 52.32 38.39 24.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.695 1.998 . . . . 1.0 114.881 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.605 HD22 ' HD2' ' A' ' 80' ' ' ARG . 5.9 tt -60.6 142.05 55.95 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 104.482 -2.414 . . . . 1.0 104.482 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' N ' HD23 ' A' ' 123' ' ' LEU . . . -32.09 113.6 0.13 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.057 1.743 . . . . 1.0 112.039 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -79.59 -14.68 58.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 116.322 -1.799 . . . . 1.0 115.388 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 25.4 p 64.2 78.09 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.747 1.612 . . . . 1.0 111.841 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -24.39 -33.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.819 1.648 . . . . 1.0 113.335 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.59 -34.54 0.89 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 128.911 2.884 . . . . 1.0 110.644 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.59 -57.06 11.2 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 124.915 1.286 . . . . 1.0 107.998 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -54.01 -42.6 69.27 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.153 0.981 . . . . 1.0 109.715 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -66.03 -58.77 4.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.552 1.141 . . . . 1.0 111.542 -176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.5 -36.25 82.27 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.667 -1.271 . . . . 1.0 112.368 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 tt -61.09 -39.22 89.12 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.897 -1.127 . . . . 1.0 108.146 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.94 -39.72 95.47 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.963 -1.086 . . . . 1.0 111.337 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.45 -53.53 57.23 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 115' ' ' ILE . 55.6 t -55.22 -41.72 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.763 0.825 . . . . 1.0 110.869 176.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.9 m -59.59 -44.53 93.33 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.124 -0.985 . . . . 1.0 109.908 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -58.64 -44.57 90.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.894 0.77 . . . . 1.0 109.748 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.67 -56.22 22.1 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.941 0.896 . . . . 1.0 110.264 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -56.07 -44.76 79.25 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 118.241 -0.885 . . . . 1.0 112.325 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.3 -42.13 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.854 0.752 . . . . 1.0 109.786 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -20.28 66.04 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.225 0.61 . . . . 1.0 112.193 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt-85 -93.1 -51.2 5.15 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.693 1.197 . . . . 1.0 110.304 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.51 112.54 23.06 Favored Pre-proline 0 C--O 1.243 0.757 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -90.74 107.89 0.33 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 CA-C-N 121.539 1.585 . . . . 1.0 108.64 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.28 -50.99 0.11 Allowed 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.603 2.361 . . . . 1.0 108.427 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.26 -33.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 130.367 3.467 . . . . 1.0 110.995 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.84 -26.49 10.05 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.036 1.125 . . . . 1.0 114.036 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -128.97 18.58 6.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.412 2.285 . . . . 1.0 111.374 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -138.15 83.36 1.97 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.4 mtt -127.61 114.02 16.83 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.317 -2.475 . . . . 1.0 104.317 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.9 t -154.47 -173.43 4.57 Favored 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.96 -122.84 1.75 Allowed Glycine 0 C--O 1.234 0.106 0 N-CA-C 106.413 -2.675 . . . . 1.0 106.413 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.483 ' CE1' ' CE1' ' A' ' 34' ' ' HIS 0.255 14.9 m170 -118.3 -23.82 7.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.557 2.343 . . . . 1.0 112.029 176.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.79 -18.39 15.8 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.466 -0.778 . . . . 1.0 109.991 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -86.55 44.0 1.12 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.33 -23.08 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 120.446 -1.409 . . . . 1.0 107.427 175.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.522 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -151.6 -53.98 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 128.521 2.728 . . . . 1.0 111.164 175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 95.1 Cg_endo -80.88 109.23 2.18 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.662 2.241 . . . . 1.0 113.348 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -62.64 -25.52 68.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 120.837 -1.164 . . . . 1.0 113.221 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -60.44 -23.18 64.22 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.8 1.037 . . . . 1.0 113.8 -175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -135.68 131.95 36.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.2 m -113.69 -16.04 12.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.858 0.361 . . . . 1.0 110.13 -175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.1 -179.18 0.65 Allowed Pre-proline 0 CA--C 1.55 0.963 1 C-N-CA 132.572 4.349 . . . . 1.0 103.252 175.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.74 77.11 2.3 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 122.415 1.898 . . . . 1.0 111.432 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.36 73.58 0.81 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 125.1 1.333 . . . . 1.0 110.468 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.09 -57.54 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.816 0 CA-C-N 119.952 1.876 . . . . 1.0 113.645 -175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 53.35 43.08 31.89 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.32 1.448 . . . . 1.0 111.971 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -99.01 19.53 14.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.928 0.331 . . . . 1.0 111.486 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.264 22.6 t0 42.96 67.03 0.68 Allowed 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 126.38 1.872 . . . . 1.0 111.185 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -53.56 -32.96 53.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.209 -0.905 . . . . 1.0 111.904 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.41 -52.69 43.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.96 1.254 . . . . 1.0 110.755 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -65.94 -46.01 79.76 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.264 0.938 . . . . 1.0 111.254 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -61.33 -51.85 67.11 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.921 1.237 . . . . 1.0 111.58 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -39.26 83.17 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.329 -0.857 . . . . 1.0 110.049 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.06 77.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.9 mt -66.19 -52.64 46.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.932 0.787 . . . . 1.0 108.996 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.53 161.6 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 122.115 0.959 . . . . 1.0 110.747 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.9 m -42.59 131.79 2.9 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 127.799 2.44 . . . . 1.0 108.864 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.54 39.83 0.65 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.359 3.373 . . . . 1.0 115.755 -175.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 t 46.81 39.74 7.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.665 1.586 . . . . 1.0 109.409 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.8 t -159.85 101.31 1.46 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.898 1.679 . . . . 1.0 106.59 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -176.49 126.95 0.19 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.333 -1.729 . . . . 1.0 106.333 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -71.92 131.75 43.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.865 -1.902 . . . . 1.0 105.865 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -178.34 5.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.867 1.667 . . . . 1.0 109.778 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.7 tpp -142.2 74.02 1.43 Allowed 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.946 -1.096 . . . . 1.0 109.111 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . 0.296 46.9 m . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.538 1.535 . . . . 1.0 111.552 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.714 ' HA ' ' HB1' ' A' ' 139' ' ' ALA . 20.2 ttt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.45 124.19 19.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 155.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.06 123.55 41.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 103.279 -2.86 . . . . 1.0 103.279 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -118.39 148.74 42.22 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.299 1.04 . . . . 1.0 108.757 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 53.99 33.06 16.66 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.709 1.604 . . . . 1.0 109.348 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.25 21.07 56.11 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.135 -0.978 . . . . 1.0 112.618 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -131.19 175.81 8.8 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.541 1.536 . . . . 1.0 108.086 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.28 124.58 24.22 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.442 -1.318 . . . . 1.0 107.442 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.32 135.29 55.14 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.715 0.634 . . . . 1.0 112.095 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 52.72 58.72 5.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.087 1.755 . . . . 1.0 111.294 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.75 141.6 25.77 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.774 -1.557 . . . . 1.0 108.378 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 tpt85 -76.38 123.44 25.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 104.088 -2.56 . . . . 1.0 104.088 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 ptt-85 -88.07 119.59 28.59 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.25 1.02 . . . . 1.0 111.388 -175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -143.45 73.98 17.28 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.175 0.99 . . . . 1.0 109.833 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.17 149.69 76.51 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 121.421 1.414 . . . . 1.0 109.87 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 t -137.44 134.1 18.42 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 124.576 1.15 . . . . 1.0 108.064 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.18 43.9 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.258 2.638 . . . . 1.0 113.251 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -123.47 43.67 2.9 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.351 -0.843 . . . . 1.0 109.381 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -73.52 178.74 4.46 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.676 1.19 . . . . 1.0 110.298 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -121.08 178.35 4.78 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.661 1.22 . . . . 1.0 113.003 -175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.0 m -148.64 118.61 7.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.079 2.952 . . . . 1.0 104.344 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.9 mmt-85 -138.81 139.21 23.24 Favored Pre-proline 0 N--CA 1.475 0.779 0 CA-C-N 121.292 1.86 . . . . 1.0 108.717 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.28 75.18 4.76 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.511 2.807 . . . . 1.0 110.69 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -154.35 144.71 22.13 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.186 2.594 . . . . 1.0 106.853 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -149.8 103.44 3.23 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 127.257 2.223 . . . . 1.0 105.855 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -136.66 165.23 26.39 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.816 1.646 . . . . 1.0 107.613 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -64.49 123.61 83.45 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.615 -0.707 . . . . 1.0 111.33 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -86.85 103.59 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.506 2.137 . . . . 1.0 111.802 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -176.46 85.04 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 104.596 -2.372 . . . . 1.0 104.596 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -145.96 146.09 30.9 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.974 2.509 . . . . 1.0 105.489 176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.26 127.84 56.07 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.026 -1.472 . . . . 1.0 107.026 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.18 135.66 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 105.326 -2.102 . . . . 1.0 105.326 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 169' ' ' PHE . 70.1 t -135.57 114.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 125.753 1.621 . . . . 1.0 107.839 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -164.56 161.89 21.36 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.38 1.472 . . . . 1.0 107.236 175.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.64 112.42 24.3 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mm -127.99 176.42 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 127.809 2.444 . . . . 1.0 108.21 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -156.92 122.13 4.62 Favored 'General case' 0 N--CA 1.438 -1.039 1 N-CA-C 97.483 -5.006 . . . . 1.0 97.483 174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.51 -65.89 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.551 0 CA-C-N 120.298 1.408 . . . . 1.0 108.38 177.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.09 150.71 66.57 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 CA-C-N 121.527 1.581 . . . . 1.0 109.924 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.29 28.49 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.105 3.204 . . . . 1.0 113.846 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -18.21 -71.64 0.01 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 127.686 2.565 . . . . 1.0 110.443 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -155.52 122.75 5.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -176.84 175.95 1.55 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.88 2.872 . . . . 1.0 108.089 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.56 1.54 8.09 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.91 -0.939 . . . . 1.0 113.743 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.35 118.52 5.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 119.219 1.509 . . . . 1.0 112.584 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.2 -4.29 13.36 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.936 2.424 . . . . 1.0 113.758 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -57.98 -38.77 76.69 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.948 -1.095 . . . . 1.0 110.292 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 38' ' ' LEU . 84.1 mt -64.35 -44.08 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -58.81 -48.01 82.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.108 0.867 . . . . 1.0 109.274 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.36 -35.08 62.38 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.128 1.371 . . . . 1.0 111.565 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.12 -61.06 2.88 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 123.792 0.837 . . . . 1.0 109.835 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -67.23 -49.98 62.43 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -57.73 -33.86 68.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 1.0 109.753 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 40.64 3.19 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.916 0.78 . . . . 1.0 111.879 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -131.3 16.28 5.01 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 117.972 0.886 . . . . 1.0 110.691 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.74 139.39 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.338 1.055 . . . . 1.0 110.445 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -98.42 127.47 36.05 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 127.641 2.376 . . . . 1.0 106.91 -177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.4 56.94 3.4 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.077 3.185 . . . . 1.0 111.819 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.77 -57.92 1.96 Allowed 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 124.961 1.304 . . . . 1.0 112.34 -175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.58 -60.33 1.58 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.744 1.217 . . . . 1.0 112.292 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.443 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 23.0 p80 -168.51 177.79 1.18 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.491 1.116 . . . . 1.0 108.548 175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 20.2 Cg_endo -72.87 -43.45 0.81 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.726 1.618 . . . . 1.0 113.684 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -50.54 -60.1 3.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.672 1.189 . . . . 1.0 111.928 -175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -60.84 -51.65 68.4 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.846 0.858 . . . . 1.0 110.395 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.54 77.75 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.415 1.086 . . . . 1.0 111.508 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.19 -65.36 3.62 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 125.418 1.485 . . . . 1.0 110.603 176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.91 -24.24 32.09 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-O 116.68 -1.629 . . . . 1.0 113.544 -175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.18 -43.41 10.01 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.526 1.512 . . . . 1.0 113.659 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -57.41 -34.11 68.56 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.612 0.365 . . . . 1.0 110.956 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.49 136.38 33.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -66.04 149.29 50.49 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.909 -1.119 . . . . 1.0 109.402 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.3 m -117.09 162.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.068 1.347 . . . . 1.0 109.952 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.477 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.5 m -166.34 130.57 2.13 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.256 2.223 . . . . 1.0 105.976 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.11 -157.09 0.56 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -130.21 -61.27 0.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.192 0.997 . . . . 1.0 108.821 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' HD13 ' A' ' 115' ' ' ILE . 45.8 m -140.7 118.55 11.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.911 -1.885 . . . . 1.0 105.911 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.22 113.8 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.717 2.007 . . . . 1.0 105.607 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.64 114.13 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 106.974 -1.491 . . . . 1.0 106.974 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -70.99 152.84 43.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -14.05 2.58 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.693 0.797 . . . . 1.0 112.952 175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -91.5 19.61 6.05 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 127.477 2.311 . . . . 1.0 112.1 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 28.94 70.48 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.686 2.565 . . . . 1.0 115.551 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -102.6 109.09 20.59 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.208 -1.404 . . . . 1.0 107.208 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 132' ' ' GLN . 34.1 mt -76.54 121.12 28.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 105.073 -2.195 . . . . 1.0 105.073 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.33 125.78 67.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 104.506 -2.405 . . . . 1.0 104.506 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.36 113.6 27.05 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.146 0.978 . . . . 1.0 108.519 -175.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.9 114.31 20.83 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 105.127 -2.175 . . . . 1.0 105.127 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.7 t 83.75 91.62 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.537 1.971 . . . . 1.0 110.357 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -67.72 -170.37 0.27 Allowed 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.755 2.303 . . . . 1.0 110.68 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -63.3 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.243 2.217 . . . . 1.0 115.26 -176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -143.76 123.0 12.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.485 1.914 . . . . 1.0 109.531 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 0.4 OUTLIER 86.44 82.0 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 129.22 3.008 . . . . 1.0 111.506 177.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -34.62 138.58 0.1 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.15 2.58 . . . . 1.0 113.04 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -103.88 -178.83 3.77 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.554 2.342 . . . . 1.0 111.353 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.2 t90 -150.28 118.73 6.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.241 1.416 . . . . 1.0 108.003 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -167.46 63.13 0.08 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.483 1.135 . . . . 1.0 110.442 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.08 -69.92 0.1 Allowed 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 118.606 -2.559 . . . . 1.0 111.749 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.26 -82.36 0.33 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 125.187 1.554 . . . . 1.0 110.0 -175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 t -144.72 145.96 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.827 1.651 . . . . 1.0 109.899 -175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 p -165.82 149.54 7.93 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.626 1.171 . . . . 1.0 110.573 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.606 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -143.71 132.21 22.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.788 -1.93 . . . . 1.0 105.788 175.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -159.59 124.26 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.447 1.022 . . . . 1.0 108.313 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 58.79 71.69 0.57 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.41 1.884 . . . . 1.0 113.571 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.38 28.6 44.24 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.527 2.489 . . . . 1.0 113.312 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.4 ttm105 -147.02 113.22 5.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -90.36 141.42 28.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.5 mtt-85 -123.95 117.86 25.74 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 102.997 -2.964 . . . . 1.0 102.997 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.4 t -66.23 -35.13 79.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -145.01 172.1 13.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 128.787 2.835 . . . . 1.0 106.006 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -84.84 77.11 10.15 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.413 1.102 . . . . 1.0 108.829 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.75 35.13 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.406 1.882 . . . . 1.0 111.417 175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -123.72 153.05 41.42 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 123.879 0.872 . . . . 1.0 112.475 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.26 0.0 OUTLIER -88.86 57.11 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.534 1.934 . . . . 1.0 107.029 175.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.95 -136.59 1.2 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.947 -1.095 . . . . 1.0 111.74 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.713 HD11 HG11 ' A' ' 136' ' ' VAL . 6.2 mm -142.55 161.47 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 129.329 3.052 . . . . 1.0 103.096 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -134.44 130.13 36.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.309 2.244 . . . . 1.0 105.001 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mt -101.19 153.03 19.95 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.736 -1.228 . . . . 1.0 108.919 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.08 158.03 45.4 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.73 0.776 . . . . 1.0 111.641 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.99 -169.92 39.53 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.453 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.9 p -146.48 104.0 3.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 103.367 -2.827 . . . . 1.0 103.367 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t0 43.87 49.66 7.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.751 2.02 . . . . 1.0 112.984 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.6 p 50.31 38.08 16.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.051 2.14 . . . . 1.0 114.191 -176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.48 136.2 57.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.114 -1.81 . . . . 1.0 106.114 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.19 0.04 OUTLIER 'General case' 0 C--N 1.347 0.486 0 C-N-CA 127.373 2.269 . . . . 1.0 110.615 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -78.03 -10.3 59.54 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 115.892 -2.004 . . . . 1.0 116.339 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.333 44.8 p 64.74 77.31 0.32 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 121.355 1.889 . . . . 1.0 110.987 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -24.43 -32.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.246 1.818 . . . . 1.0 114.683 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -39.85 -43.67 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.314 1.846 . . . . 1.0 109.231 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -43.71 -50.93 7.45 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.779 1.231 . . . . 1.0 111.668 175.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.31 -39.81 88.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.458 0.572 . . . . 1.0 111.032 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -61.63 -58.57 7.54 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.032 0.533 . . . . 1.0 109.667 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.401 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.1 mp0 -65.92 -47.12 75.81 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.544 -0.741 . . . . 1.0 111.599 -176.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 115' ' ' ILE . 53.4 tp -54.85 -46.55 74.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.048 1.295 . . . . 1.0 109.34 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.5 -40.44 96.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.535 1.061 . . . . 1.0 111.416 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.1 50.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.001 0.52 . . . . 1.0 109.654 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD11 ' A' ' 115' ' ' ILE . 98.0 t -52.2 -64.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.533 1.933 . . . . 1.0 108.61 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.9 m -53.96 -53.6 50.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.484 1.914 . . . . 1.0 112.209 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -57.85 -41.93 83.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.763 1.165 . . . . 1.0 109.555 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -69.86 -44.34 70.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.205 -0.935 . . . . 1.0 111.165 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.97 -36.77 70.71 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.12 -1.612 . . . . 1.0 111.458 175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 mt -62.1 -35.57 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.01 -1.107 . . . . 1.0 108.01 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -64.96 -13.61 57.88 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.785 1.234 . . . . 1.0 110.774 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -98.63 -65.89 0.93 Allowed 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.158 -1.589 . . . . 1.0 106.981 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -119.41 112.91 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 106.673 -1.603 . . . . 1.0 106.673 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -92.78 108.19 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.649 1.566 . . . . 1.0 112.288 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.05 -49.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.587 1.955 . . . . 1.0 106.583 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.0 mt -48.41 -33.61 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 128.934 2.894 . . . . 1.0 110.829 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.42 12.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.344 1.057 . . . . 1.0 113.395 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.31 18.58 4.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 127.085 2.154 . . . . 1.0 110.656 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.83 83.62 1.97 Allowed 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.67 1.188 . . . . 1.0 107.967 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.3 mtt -118.78 120.19 36.63 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.592 -1.633 . . . . 1.0 106.592 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -155.26 -169.57 3.2 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.27 -0.894 . . . . 1.0 110.339 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.03 -131.19 1.51 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 106.353 -2.699 . . . . 1.0 106.353 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.457 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 14.2 m170 -113.39 -23.51 9.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 118.362 1.081 . . . . 1.0 111.791 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -11.16 18.56 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.232 -0.655 . . . . 1.0 109.232 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -91.36 38.92 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.742 1.156 . . . . 1.0 108.489 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.07 -12.91 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 O-C-N 120.295 -1.503 . . . . 1.0 110.267 175.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -157.8 -54.39 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.546 1.939 . . . . 1.0 111.088 175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 62.7 Cg_endo -87.38 117.94 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.293 1.996 . . . . 1.0 113.395 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.85 -24.29 61.88 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.271 -0.893 . . . . 1.0 111.785 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.1 tpt85 -57.49 -19.35 23.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.64 2.376 . . . . 1.0 112.087 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -138.98 141.44 38.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 106.748 -1.575 . . . . 1.0 106.748 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 m -130.91 -16.72 3.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 119.898 1.226 . . . . 1.0 109.831 175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.98 179.88 0.36 Allowed Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 129.844 3.257 . . . . 1.0 104.772 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.33 79.75 3.24 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.149 1.899 . . . . 1.0 108.423 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.15 59.26 0.53 Allowed Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.389 -1.229 . . . . 1.0 115.251 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 -52.3 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.616 0 CA-C-N 121.069 2.435 . . . . 1.0 112.357 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.0 t 54.07 43.62 30.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.197 1.399 . . . . 1.0 111.866 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CD2' HG11 ' A' ' 33' ' ' VAL 0.253 83.5 t80 -107.27 18.34 21.76 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.986 1.847 . . . . 1.0 115.986 -175.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.327 5.8 t70 42.05 75.0 0.1 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.424 1.49 . . . . 1.0 113.625 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -50.18 -35.34 25.84 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.64 79.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.861 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -51.28 68.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.849 1.204 . . . . 1.0 109.651 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 66.5 t80 -63.22 -52.82 60.67 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.825 0.306 . . . . 1.0 111.825 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -63.74 -26.65 68.74 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.265 -0.897 . . . . 1.0 111.772 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.11 88.65 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 1.0 109.992 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.29 -61.21 1.85 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.677 1.591 . . . . 1.0 111.7 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 94.6 t -66.26 165.77 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.3 1.04 . . . . 1.0 110.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 54.4 m -41.12 113.6 1.07 Allowed Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.331 1.453 . . . . 1.0 110.717 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.01 54.78 4.03 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.3 2.667 . . . . 1.0 107.822 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 t 50.45 33.99 8.6 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.565 1.146 . . . . 1.0 113.134 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 t -149.91 -46.47 0.13 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.272 0.842 . . . . 1.0 113.272 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -78.16 81.73 4.52 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -147.01 129.7 16.07 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.341 1.456 . . . . 1.0 107.953 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -66.66 175.33 2.4 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.063 0.392 . . . . 1.0 111.047 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 tpt -66.74 155.55 37.8 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.215 1.006 . . . . 1.0 112.083 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 114.97 -2.443 . . . . 1.0 108.439 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 104.218 -2.512 . . . . 1.0 104.218 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 19.5 tp -58.23 153.45 15.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.181 0.993 . . . . 1.0 110.615 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.8 131.22 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.129 -2.175 . . . . 1.0 105.129 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -116.17 137.73 51.88 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 52.64 32.97 12.73 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.974 1.31 . . . . 1.0 110.601 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.91 1.52 32.93 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.967 1.27 . . . . 1.0 114.37 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -107.41 159.76 16.15 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 103.225 -2.879 . . . . 1.0 103.225 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tt -65.01 141.13 58.88 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 119.61 -1.931 . . . . 1.0 107.718 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 156.53 32.69 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.515 0.726 . . . . 1.0 110.24 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 38.7 58.08 1.74 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 127.133 2.173 . . . . 1.0 111.304 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.95 143.83 23.73 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.424 -0.797 . . . . 1.0 111.341 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -82.34 124.23 29.8 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.027 1.331 . . . . 1.0 108.687 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -83.57 119.23 24.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.9 t -142.18 75.34 20.25 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.011 1.324 . . . . 1.0 108.198 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 123.58 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 121.516 1.478 . . . . 1.0 112.673 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -49.8 146.08 7.99 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.434 1.894 . . . . 1.0 111.92 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.76 -37.42 6.8 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 N-CA-C 114.734 1.013 . . . . 1.0 114.734 -175.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -151.48 135.67 16.73 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.314 -0.995 . . . . 1.0 108.314 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -104.28 -170.88 1.83 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.553 1.141 . . . . 1.0 109.675 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.69 178.95 5.79 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.283 2.633 . . . . 1.0 111.61 175.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.1 m -140.92 153.95 45.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 129.522 3.129 . . . . 1.0 104.993 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -131.16 157.03 79.27 Favored Pre-proline 0 N--CA 1.467 0.377 0 O-C-N 120.918 -1.114 . . . . 1.0 109.444 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -85.31 51.08 2.92 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.072 2.515 . . . . 1.0 111.883 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -148.6 153.63 38.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 126.305 1.842 . . . . 1.0 109.988 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.72 103.2 3.76 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.347 -0.612 . . . . 1.0 109.347 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -137.0 164.65 27.85 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.734 -0.603 . . . . 1.0 109.431 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.87 123.8 78.98 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.438 1.895 . . . . 1.0 108.068 175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -81.27 103.48 1.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 N-CA-C 108.318 -1.455 . . . . 1.0 108.318 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 t -165.09 67.67 0.13 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 tp -141.37 129.58 22.22 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 tp -95.13 128.64 42.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.959 -1.867 . . . . 1.0 105.959 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -106.17 140.11 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 105.1 -2.185 . . . . 1.0 105.1 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.31 114.2 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -169.61 133.6 1.31 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.81 113.57 8.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.105 -1.443 . . . . 1.0 107.105 175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.4 mm -126.41 177.06 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 127.741 2.416 . . . . 1.0 107.623 175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -155.5 121.72 5.17 Favored 'General case' 0 C--N 1.316 -0.871 1 N-CA-C 95.421 -5.77 . . . . 1.0 95.421 173.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HD2' ' A' ' 39' ' ' PRO 0.324 0.5 OUTLIER -141.44 -61.45 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 119.119 0.872 . . . . 1.0 111.336 175.848 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 61.3 Cg_endo -79.77 157.79 24.53 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.676 2.25 . . . . 1.0 112.024 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.15 -0.23 10.57 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 CA-C-O 114.159 -2.517 . . . . 1.0 115.172 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -11.79 -71.05 0.01 OUTLIER Glycine 0 C--N 1.352 1.44 0 C-N-CA 127.278 2.37 . . . . 1.0 113.36 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -155.02 122.97 5.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.345 1.858 . . . . 1.0 109.05 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -175.77 175.42 2.03 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 130.009 3.324 . . . . 1.0 107.614 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.31 6.96 24.89 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.235 1.398 . . . . 1.0 112.83 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.41 118.5 6.2 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.533 1.666 . . . . 1.0 109.951 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.73 -13.08 22.16 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.261 1.974 . . . . 1.0 114.386 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -62.01 -35.94 80.05 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.399 1.454 . . . . 1.0 110.928 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.2 mm -64.18 -47.03 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.061 0.944 . . . . 1.0 109.238 176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.77 -34.74 78.88 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.482 -0.761 . . . . 1.0 112.126 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.8 -33.78 50.6 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.132 1.373 . . . . 1.0 111.625 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.69 -55.92 28.34 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.965 1.306 . . . . 1.0 110.259 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 39' ' ' PRO . 42.0 m-85 -71.31 -40.74 70.64 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 126.649 1.98 . . . . 1.0 112.969 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.0 -33.32 75.55 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.222 -0.924 . . . . 1.0 109.538 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.56 24.86 10.51 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 118.698 -1.057 . . . . 1.0 113.525 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -121.46 16.63 11.31 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.185 1.492 . . . . 1.0 111.575 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.7 135.27 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.408 1.083 . . . . 1.0 110.758 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -98.95 136.59 20.56 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 126.199 1.8 . . . . 1.0 109.095 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.78 56.87 3.01 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.798 2.999 . . . . 1.0 113.204 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -103.47 -49.65 3.65 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 113.586 0.958 . . . . 1.0 113.586 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.93 -60.62 2.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.972 0.805 . . . . 1.0 112.674 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 22.7 p80 -170.53 177.79 0.95 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.558 1.543 . . . . 1.0 107.477 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 16.8 Cg_endo -72.85 -43.53 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.304 1.336 . . . . 1.0 114.996 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -50.77 -59.11 4.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.954 1.252 . . . . 1.0 112.857 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 1.6 t80 -60.12 -49.83 76.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.139 0.976 . . . . 1.0 110.251 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.68 90.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.818 0.847 . . . . 1.0 111.108 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.14 -63.63 4.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.048 1.785 . . . . 1.0 110.075 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.89 -26.83 41.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 116.408 -1.758 . . . . 1.0 112.947 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.67 -42.98 3.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.105 1.762 . . . . 1.0 114.729 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -52.49 -39.08 60.81 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.572 1.549 . . . . 1.0 110.871 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.78 136.28 33.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' H ' ' CD ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.06 161.26 22.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.416 -0.802 . . . . 1.0 109.035 175.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.49 164.39 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.896 1.279 . . . . 1.0 109.537 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.7 m -169.52 118.05 0.63 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.909 1.284 . . . . 1.0 108.332 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.61 -174.48 3.17 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.79 1.236 . . . . 1.0 109.052 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 28.3 m80 -112.17 -73.64 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.242 1.017 . . . . 1.0 111.628 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.4 m -124.02 118.74 27.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 103.66 -2.719 . . . . 1.0 103.66 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 tp -104.23 113.34 26.82 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.264 -2.865 . . . . 1.0 103.264 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.03 113.49 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 105.644 -1.984 . . . . 1.0 105.644 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -85.37 149.22 25.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.115 0.87 . . . . 1.0 110.399 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -46.82 -13.85 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 128.418 2.687 . . . . 1.0 115.547 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -91.89 27.98 1.95 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.929 1.291 . . . . 1.0 112.711 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.3 28.96 70.14 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.584 1.564 . . . . 1.0 114.484 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -103.48 153.05 20.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 118.299 1.05 . . . . 1.0 111.502 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.45 114.08 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 104.668 -2.345 . . . . 1.0 104.668 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.86 145.69 13.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.686 -2.338 . . . . 1.0 104.686 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -124.3 115.49 21.11 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.947 0.899 . . . . 1.0 110.403 -175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -110.38 129.8 55.69 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 127.828 2.451 . . . . 1.0 105.525 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' A' ' 19' ' ' TYR . 16.6 t 63.4 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 121.985 2.175 . . . . 1.0 115.148 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -64.1 -174.11 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 121.658 1.572 . . . . 1.0 111.423 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -67.18 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.57 1.948 . . . . 1.0 114.372 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -140.84 111.53 6.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.734 2.014 . . . . 1.0 108.482 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 tptt 84.05 81.86 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.421 2.289 . . . . 1.0 109.976 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -37.33 146.28 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 129.675 3.19 . . . . 1.0 111.469 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -104.14 -178.35 3.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.859 1.264 . . . . 1.0 111.674 -176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.7 t90 -141.78 118.6 11.12 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 105.814 -1.921 . . . . 1.0 105.814 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.2 63.16 0.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 122.852 1.31 . . . . 1.0 107.964 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.24 -69.04 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 119.224 -2.172 . . . . 1.0 114.454 -175.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.96 -85.67 0.4 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 103.203 -3.959 . . . . 1.0 103.203 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.21 146.45 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 119.797 1.799 . . . . 1.0 110.502 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.5 p -155.84 155.77 33.52 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.055 1.742 . . . . 1.0 108.096 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.484 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -147.99 132.32 17.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.094 -1.817 . . . . 1.0 106.094 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -160.63 156.93 26.35 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.228 0.611 . . . . 1.0 109.565 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 39.13 53.65 2.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.4 1.48 . . . . 1.0 112.251 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 51.21 28.26 18.36 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 128.298 2.856 . . . . 1.0 114.895 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -129.86 121.4 26.63 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 119.619 1.709 . . . . 1.0 107.058 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -92.62 141.96 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.993 -0.743 . . . . 1.0 108.993 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -116.35 118.52 32.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.8 -1.556 . . . . 1.0 106.8 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.5 t -55.69 -38.83 70.2 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.815 0.846 . . . . 1.0 110.09 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -152.98 164.79 37.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.997 2.919 . . . . 1.0 105.019 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.28 76.71 10.08 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 122.584 1.183 . . . . 1.0 111.154 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.85 43.42 0.42 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.894 2.478 . . . . 1.0 108.542 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 m -123.29 156.79 34.57 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 126.391 1.876 . . . . 1.0 111.434 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -96.54 57.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.705 2.002 . . . . 1.0 107.92 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.13 -136.96 1.65 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 120.983 -1.073 . . . . 1.0 112.033 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 133' ' ' LEU . 4.8 mt -152.29 164.88 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 131.512 3.925 . . . . 1.0 102.36 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -144.86 143.1 30.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.053 2.141 . . . . 1.0 105.277 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -101.46 155.39 18.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.824 -1.173 . . . . 1.0 110.303 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -131.43 138.87 49.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 111.958 0.355 . . . . 1.0 111.958 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.33 -172.73 39.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.353 0.978 . . . . 1.0 110.906 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -133.78 92.46 2.97 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.578 -0.954 . . . . 1.0 108.628 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.4 t0 54.34 56.97 6.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.471 1.508 . . . . 1.0 113.49 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 16.5 p 60.91 38.42 17.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.181 1.792 . . . . 1.0 113.605 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.6 132.02 47.26 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 104.29 -2.485 . . . . 1.0 104.29 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -30.32 115.03 0.12 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 126.387 1.875 . . . . 1.0 110.536 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -78.09 -2.45 37.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 114.943 -2.456 . . . . 1.0 116.975 -174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.341 42.4 p 67.39 78.05 0.25 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 115.727 -2.083 . . . . 1.0 111.374 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -24.23 -34.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 121.596 1.998 . . . . 1.0 116.157 177.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.84 -40.75 14.45 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.163 2.185 . . . . 1.0 110.333 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -49.15 -50.55 37.07 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 125.077 1.351 . . . . 1.0 109.826 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -60.87 -40.63 93.71 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.832 -0.604 . . . . 1.0 110.396 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -65.38 -47.88 74.82 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.354 0.524 . . . . 1.0 111.061 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.89 -54.04 31.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.451 1.1 . . . . 1.0 110.254 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 115' ' ' ILE . 14.5 tp -54.5 -46.47 73.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.122 1.369 . . . . 1.0 108.805 175.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.93 -37.46 87.12 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 119.934 1.243 . . . . 1.0 111.664 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.28 -53.64 54.24 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.7 -53.11 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 118.623 -0.703 . . . . 1.0 109.365 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 67.4 m -55.38 -61.31 2.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.403 1.881 . . . . 1.0 111.059 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -53.75 -43.08 68.84 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.606 0.717 . . . . 1.0 110.878 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 -48.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.009 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 mt -56.76 -36.93 70.38 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.087 -1.633 . . . . 1.0 111.373 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -59.04 -31.88 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.655 1.182 . . . . 1.0 109.727 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.8 m -64.26 -16.88 62.96 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.88 0.764 . . . . 1.0 111.006 176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.9 -65.15 0.98 Allowed 'General case' 0 C--N 1.342 0.266 0 O-C-N 120.664 -1.272 . . . . 1.0 108.274 175.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -110.29 112.84 56.92 Favored Pre-proline 0 N--CA 1.468 0.453 0 N-CA-C 108.004 -1.109 . . . . 1.0 108.004 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -104.07 108.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-N 119.697 0.927 . . . . 1.0 111.372 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.15 -51.41 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.097 2.559 . . . . 1.0 105.912 174.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.9 mt -45.2 -33.51 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 1 C-N-CA 131.82 4.048 . . . . 1.0 110.013 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.15 -25.54 0.91 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.37 1.248 . . . . 1.0 114.37 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -132.59 18.97 4.29 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.582 2.353 . . . . 1.0 111.133 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.75 84.29 2.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.88 1.272 . . . . 1.0 109.687 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.61 116.58 21.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.03 -1.841 . . . . 1.0 106.03 175.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 -173.25 4.49 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.846 0.748 . . . . 1.0 109.852 -176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.31 -131.06 2.64 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 106.696 -2.562 . . . . 1.0 106.696 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 19.8 m170 -112.71 -23.87 9.94 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.59 0.756 . . . . 1.0 111.215 -177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 11.3 t -102.89 -17.05 15.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.615 1.166 . . . . 1.0 111.081 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -85.12 40.3 0.81 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.338 1.426 . . . . 1.0 109.196 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -69.71 -9.2 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 O-C-N 120.744 -1.222 . . . . 1.0 109.019 175.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -157.13 -53.52 0.02 OUTLIER Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 128.001 2.52 . . . . 1.0 111.538 175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -96.42 121.61 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.852 2.368 . . . . 1.0 114.217 -175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.51 -17.09 63.57 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.564 -1.335 . . . . 1.0 112.141 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -24.93 67.92 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.115 -0.991 . . . . 1.0 111.48 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -144.31 123.77 13.16 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.475 -2.046 . . . . 1.0 105.475 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.2 m -114.16 -16.29 12.1 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.402 0.438 . . . . 1.0 112.045 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.24 171.46 1.06 Allowed Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 128.446 2.698 . . . . 1.0 104.755 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.27 87.34 0.76 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.308 2.006 . . . . 1.0 109.747 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.74 75.42 0.68 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.143 1.83 . . . . 1.0 110.996 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.14 -95.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.736 2.291 . . . . 1.0 110.024 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t 54.3 43.64 30.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.188 2.595 . . . . 1.0 111.0 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -97.53 18.58 15.08 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.348 0.659 . . . . 1.0 111.94 -176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.4 t0 44.88 67.22 0.74 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.745 1.218 . . . . 1.0 111.803 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -57.19 -25.51 59.14 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.706 -0.621 . . . . 1.0 112.474 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -55.75 15.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 117.794 -1.098 . . . . 1.0 109.605 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -62.4 -42.84 99.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 117.312 -1.328 . . . . 1.0 110.547 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -61.41 -52.67 63.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.108 1.322 . . . . 1.0 110.881 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -34.36 77.78 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.16 86.96 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.098 0.777 . . . . 1.0 113.098 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 29.9 mt -68.68 -54.8 14.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 125.79 1.636 . . . . 1.0 111.007 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.8 160.09 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.133 0.973 . . . . 1.0 109.098 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 26.4 m -46.86 115.91 3.62 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.51 1.924 . . . . 1.0 105.89 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.97 49.07 3.02 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.705 2.937 . . . . 1.0 114.28 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.1 t 47.33 35.19 3.7 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 123.481 1.61 . . . . 1.0 111.662 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 t -158.92 168.55 26.48 Favored 'General case' 0 N--CA 1.445 -0.711 1 C-N-CA 132.313 4.245 . . . . 1.0 102.243 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 55.69 49.03 17.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.95 1.25 . . . . 1.0 107.74 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.8 tmmt? -130.68 167.01 19.49 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.298 1.039 . . . . 1.0 110.433 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 155.15 50.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.371 2.668 . . . . 1.0 105.956 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 16.4 ttt -171.42 164.72 7.02 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.852 1.261 . . . . 1.0 107.847 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.249 1.074 0 N-CA-C 102.374 -3.195 . . . . 1.0 102.374 174.846 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 106.208 -1.775 . . . . 1.0 106.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.8 tt -64.86 134.41 53.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.233 -1.025 . . . . 1.0 108.233 161.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.0 mt -122.75 136.3 54.83 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -116.97 133.44 56.01 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 45.38 33.3 1.23 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.829 1.652 . . . . 1.0 115.021 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.78 20.71 79.38 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 119.838 -1.789 . . . . 1.0 112.273 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -127.28 164.58 21.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 103.665 -2.717 . . . . 1.0 103.665 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.56 124.23 27.29 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.527 -1.657 . . . . 1.0 106.527 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.33 173.86 8.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.605 0.762 . . . . 1.0 111.042 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 40.04 57.75 2.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.721 2.408 . . . . 1.0 109.993 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.14 153.6 20.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -81.68 130.15 34.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -83.55 118.64 23.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.2 t -138.48 88.74 14.27 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.11 123.82 11.41 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 N-CA-C 109.333 -1.064 . . . . 1.0 109.333 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -63.64 146.53 96.65 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.05 -25.29 19.55 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 N-CA-C 117.393 2.036 . . . . 1.0 117.393 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -150.82 117.89 5.93 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.841 -1.911 . . . . 1.0 105.841 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 88' ' ' VAL . 3.3 m-85 -86.92 178.17 7.04 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.084 0.954 . . . . 1.0 112.543 -175.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.38 178.99 4.09 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.931 1.693 . . . . 1.0 111.859 -175.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.3 m -164.94 127.46 2.22 Favored 'General case' 0 CA--C 1.534 0.354 1 C-N-CA 133.356 4.662 . . . . 1.0 103.184 175.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -131.33 153.78 81.74 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.699 1.136 . . . . 1.0 108.614 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.92 67.67 8.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 124.104 3.203 . . . . 1.0 110.804 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -143.48 159.5 42.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.632 1.573 . . . . 1.0 110.734 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -150.91 103.92 3.11 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.856 -1.905 . . . . 1.0 105.856 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -137.25 176.48 8.67 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -84.48 123.0 75.2 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.792 -1.559 . . . . 1.0 106.792 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.26 103.02 1.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 N-CA-C 108.3 -1.462 . . . . 1.0 108.3 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 t -175.76 69.05 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.8 -1.185 . . . . 1.0 107.8 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 150' ' ' ASN . 26.6 tp -147.9 130.45 15.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.99 0.916 . . . . 1.0 108.705 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.476 HD11 HD11 ' A' ' 133' ' ' LEU . 15.7 tp -84.38 124.52 31.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.28 114.04 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 169' ' ' PHE . 87.8 t -114.22 113.93 45.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.429 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 1.3 p80 -163.54 143.58 8.63 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 105.545 -2.021 . . . . 1.0 105.545 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 8.0 mm -127.59 176.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 130.835 3.654 . . . . 1.0 107.851 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -160.28 121.78 3.12 Favored 'General case' 0 N--CA 1.432 -1.365 1 N-CA-C 97.829 -4.878 . . . . 1.0 97.829 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.652 ' H ' ' HD2' ' A' ' 39' ' ' PRO . 4.8 tt -142.57 -43.9 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 116.398 -1.763 . . . . 1.0 112.941 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.652 ' HD2' ' H ' ' A' ' 38' ' ' LEU . 44.7 Cg_endo -82.99 150.31 13.93 Favored 'Trans proline' 0 C--N 1.354 0.818 0 CA-C-N 121.662 1.629 . . . . 1.0 114.833 -175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 7.38 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.843 3.028 . . . . 1.0 116.777 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -23.49 -71.3 0.01 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 121.059 1.754 . . . . 1.0 112.525 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -156.6 123.21 5.09 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.339 -0.985 . . . . 1.0 108.339 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . 0.291 14.1 m-85 -177.76 153.94 0.9 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 129.649 3.18 . . . . 1.0 109.862 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.31 2.09 77.75 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 119.05 -0.861 . . . . 1.0 112.885 176.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.85 118.54 5.51 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.01 -4.05 14.45 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.373 2.049 . . . . 1.0 113.213 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' CZ2' ' CD1' ' A' ' 64' ' ' PHE . 32.6 t-105 -64.55 -39.55 93.97 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.598 1.09 . . . . 1.0 110.305 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 38' ' ' LEU . 5.8 mt -65.86 -46.63 88.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 126.568 1.947 . . . . 1.0 109.274 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.63 -46.37 89.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.861 0.755 . . . . 1.0 110.552 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.2 -34.06 63.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.236 1.414 . . . . 1.0 111.39 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.27 -54.79 27.7 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.195 0.452 . . . . 1.0 110.524 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -70.1 -42.5 72.62 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 119.014 -0.517 . . . . 1.0 112.297 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.16 -34.23 77.58 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.33 1.052 . . . . 1.0 109.049 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.21 -0.47 31.29 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.367 1.46 . . . . 1.0 115.681 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.3 p -88.99 11.19 18.94 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.057 1.928 . . . . 1.0 112.934 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.566 HG21 ' CB ' ' A' ' 68' ' ' ALA . 10.8 tt -51.63 135.9 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 126.108 1.763 . . . . 1.0 112.793 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -98.62 131.31 26.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 127.446 2.299 . . . . 1.0 109.29 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.2 63.01 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 124.68 3.587 . . . . 1.0 110.184 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -104.54 -65.93 1.0 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.407 1.883 . . . . 1.0 113.15 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.35 -54.76 15.55 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.69 1.196 . . . . 1.0 110.714 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 18.2 p80 -171.32 177.82 0.87 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.685 1.994 . . . . 1.0 106.766 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.4 Cg_endo -72.49 -43.63 0.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.494 1.462 . . . . 1.0 114.033 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -50.84 -57.6 8.03 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HD1' HD11 ' A' ' 56' ' ' ILE . 20.8 t80 -59.27 -44.96 92.4 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.205 0.602 . . . . 1.0 111.475 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.67 97.94 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.831 -0.543 . . . . 1.0 111.324 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.68 -60.81 8.23 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.827 1.203 . . . . 1.0 112.026 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.2 pt -51.0 -41.48 22.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 124.798 1.239 . . . . 1.0 112.96 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' A' ' 56' ' ' ILE . . . -38.01 -43.53 0.73 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 127.901 2.48 . . . . 1.0 115.158 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -60.8 -35.58 76.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.449 0.7 . . . . 1.0 110.423 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.77 135.75 33.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 103.543 -2.762 . . . . 1.0 103.543 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.79 153.46 32.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.377 -0.929 . . . . 1.0 110.05 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.6 m -116.54 163.94 13.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.165 1.386 . . . . 1.0 108.671 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 88' ' ' VAL . 2.4 m -170.67 128.04 0.78 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.306 -1.739 . . . . 1.0 106.306 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.17 -154.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.461 -1.681 . . . . 1.0 106.461 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -124.63 -58.55 1.5 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.879 1.672 . . . . 1.0 110.0 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' HB2' HD13 ' A' ' 115' ' ' ILE . 68.0 m -142.65 121.35 12.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.53 113.93 21.48 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.385 1.474 . . . . 1.0 107.853 -176.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 HE21 ' A' ' 129' ' ' GLN . 62.3 mt -97.55 116.59 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.711 1.204 . . . . 1.0 108.078 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.7 ttm105 -78.92 153.35 30.53 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.345 1.884 . . . . 1.0 109.574 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.621 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -46.87 -23.23 0.41 Allowed 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 126.711 2.004 . . . . 1.0 114.259 176.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.621 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . 18.3 t0 -91.42 34.61 0.95 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.225 0.921 . . . . 1.0 110.478 -175.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.08 29.56 71.33 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.109 -0.995 . . . . 1.0 113.868 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.53 140.67 32.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.9 mt -116.01 114.07 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 103.838 -2.653 . . . . 1.0 103.838 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 t -111.67 139.6 35.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 123.362 0.665 . . . . 1.0 109.514 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -104.87 118.83 37.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -117.65 113.34 21.76 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 103.239 -2.874 . . . . 1.0 103.239 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 19' ' ' TYR . 48.1 t 69.2 91.8 0.07 OUTLIER Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 120.31 1.414 . . . . 1.0 112.332 -176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -66.88 -168.25 0.15 Allowed 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 122.471 2.114 . . . . 1.0 111.669 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -60.71 22.76 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 129.378 3.071 . . . . 1.0 116.811 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -159.69 133.49 7.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 120.972 1.714 . . . . 1.0 107.865 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 tptm 86.29 82.14 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 129.453 3.101 . . . . 1.0 109.665 -177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -35.12 147.5 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.991 3.317 . . . . 1.0 115.425 -174.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.07 175.95 5.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 129.342 3.057 . . . . 1.0 111.076 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -156.12 118.19 4.02 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.074 1.75 . . . . 1.0 107.343 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -161.9 63.22 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.287 -1.508 . . . . 1.0 112.318 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.14 -62.79 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.202 -2.186 . . . . 1.0 114.358 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.32 -91.4 0.47 Allowed Glycine 0 CA--C 1.53 1.005 0 N-CA-C 103.608 -3.797 . . . . 1.0 103.608 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.84 146.4 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.807 1.803 . . . . 1.0 108.327 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 p -154.77 166.51 33.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.479 1.511 . . . . 1.0 110.312 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.43 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.8 p -150.9 146.83 26.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.4 1.48 . . . . 1.0 110.745 175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.54 133.88 21.81 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.832 -0.543 . . . . 1.0 110.054 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 39.36 65.77 0.65 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.74 2.016 . . . . 1.0 111.367 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 29.26 67.21 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.089 1.196 . . . . 1.0 116.089 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -130.55 136.25 48.73 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.854 -1.906 . . . . 1.0 105.854 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.05 146.83 28.55 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 127.529 2.332 . . . . 1.0 111.931 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -127.42 118.35 23.92 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.763 1.225 . . . . 1.0 107.814 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -79.68 -23.42 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.469 0.708 . . . . 1.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -144.97 175.22 10.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.863 2.065 . . . . 1.0 106.547 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -101.2 76.73 1.74 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.086 -1.45 . . . . 1.0 107.086 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.55 33.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.011 2.124 . . . . 1.0 113.72 -175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -129.37 138.98 51.84 Favored 'General case' 0 C--O 1.224 -0.27 0 O-C-N 121.201 -0.937 . . . . 1.0 111.491 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.257 0.1 OUTLIER -78.54 56.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.931 2.092 . . . . 1.0 109.798 -177.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.6 -136.4 1.39 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 122.289 0.939 . . . . 1.0 111.247 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.74 HD11 HG11 ' A' ' 136' ' ' VAL . 8.5 mm -144.02 166.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 130.151 3.38 . . . . 1.0 103.144 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -143.43 136.85 28.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 103.222 -2.881 . . . . 1.0 103.222 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mt -98.81 134.28 41.91 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.166 -0.959 . . . . 1.0 109.766 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 24.3 tt0 -105.61 138.28 42.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.806 0.812 . . . . 1.0 110.285 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.49 177.47 40.11 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 126.47 1.986 . . . . 1.0 109.41 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -153.28 116.18 4.53 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.32 39.7 30.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.865 1.316 . . . . 1.0 112.194 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.1 p 45.08 37.73 2.72 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.293 2.237 . . . . 1.0 112.529 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.04 136.69 58.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.66 113.38 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.695 2.398 . . . . 1.0 112.618 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -78.67 -16.2 57.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 116.554 -1.689 . . . . 1.0 112.876 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.359 10.3 p 66.51 77.54 0.28 Allowed 'General case' 0 C--N 1.346 0.441 0 CA-C-N 121.183 1.81 . . . . 1.0 112.118 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.25 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.699 2.045 . . . . 1.0 115.25 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.12 -36.92 3.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.548 1.539 . . . . 1.0 109.354 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.429 HE21 HG22 ' A' ' 78' ' ' ILE . 37.3 mt-30 -56.41 -58.49 7.77 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 125.564 1.546 . . . . 1.0 107.559 175.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -52.79 -44.73 66.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.263 0.938 . . . . 1.0 110.075 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -66.16 -58.15 6.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.549 0.74 . . . . 1.0 111.947 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -66.3 -34.33 77.75 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.503 1.047 . . . . 1.0 112.09 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.599 HD13 HG21 ' A' ' 115' ' ' ILE . 9.2 tp -61.14 -44.56 97.13 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 106.962 -1.495 . . . . 1.0 106.962 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 -37.5 80.44 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.134 -0.936 . . . . 1.0 110.412 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.99 -55.35 35.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.447 1.021 . . . . 1.0 109.972 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 HD11 ' A' ' 115' ' ' ILE . 57.6 t -54.33 -49.18 65.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 1.0 109.338 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.1 m -58.38 -53.89 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.594 1.158 . . . . 1.0 109.873 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -56.09 -43.67 78.25 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.914 1.285 . . . . 1.0 110.478 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.32 -49.62 63.4 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.12 0.568 . . . . 1.0 111.713 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -56.56 -34.57 67.24 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 117.918 -1.039 . . . . 1.0 111.264 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 52.5 mt -61.28 -43.38 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 120.159 1.345 . . . . 1.0 109.144 175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 58.5 m -64.43 -23.1 67.17 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 118.854 0.752 . . . . 1.0 111.524 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -83.77 -58.55 2.75 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.788 -1.195 . . . . 1.0 108.438 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.61 113.15 22.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 125.549 1.54 . . . . 1.0 109.104 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.54 107.78 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 CA-C-N 120.857 1.342 . . . . 1.0 111.867 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.23 -51.62 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.014 2.125 . . . . 1.0 107.798 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.4 mt -45.16 -33.4 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 131.508 3.923 . . . . 1.0 111.078 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.99 -23.42 5.08 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.222 1.009 . . . . 1.0 113.541 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -140.52 30.75 1.9 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.687 2.395 . . . . 1.0 109.089 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.549 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.7 m120 -140.7 83.78 1.91 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.367 1.867 . . . . 1.0 110.311 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.57 116.65 16.15 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 126.661 1.984 . . . . 1.0 105.718 175.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.451 HG22 HD11 ' A' ' 30' ' ' LEU . 10.6 t -151.69 -173.2 4.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.98 -131.52 2.29 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 105.604 -2.998 . . . . 1.0 105.604 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.429 ' HE1' ' CE1' ' A' ' 34' ' ' HIS 0.306 13.0 m170 -112.98 -22.28 10.67 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.867 1.267 . . . . 1.0 111.311 -176.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.02 -11.25 17.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.493 0.588 . . . . 1.0 109.807 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -86.57 36.41 0.7 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.632 1.105 . . . . 1.0 108.532 174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -67.8 -12.07 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 120.399 -1.438 . . . . 1.0 109.859 175.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -148.06 -66.01 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.74 2.416 . . . . 1.0 111.16 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 95.3 Cg_endo -92.65 127.89 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.275 1.983 . . . . 1.0 114.075 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.46 -26.25 65.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.938 1.295 . . . . 1.0 112.615 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -63.13 -21.66 66.34 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.856 1.263 . . . . 1.0 111.774 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.09 138.92 53.29 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 105.174 -2.158 . . . . 1.0 105.174 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -132.39 -16.63 2.7 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 118.868 -1.133 . . . . 1.0 110.844 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -179.27 0.35 Allowed Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 129.171 2.989 . . . . 1.0 104.292 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.29 52.23 4.2 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 122.543 2.162 . . . . 1.0 112.5 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.72 73.24 0.12 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.005 1.764 . . . . 1.0 112.538 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.15 -63.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.46 2.106 . . . . 1.0 111.955 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.7 t 54.46 43.8 29.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.932 2.093 . . . . 1.0 110.446 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 33' ' ' VAL . 58.2 t80 -94.02 18.25 10.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.236 1.199 . . . . 1.0 114.236 -175.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.72 71.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.942 1.297 . . . . 1.0 112.858 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -54.78 -32.28 59.87 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 115.154 -0.93 . . . . 1.0 112.634 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.06 71.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.356 -0.83 . . . . 1.0 110.148 176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -61.66 -55.96 24.94 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.399 0.999 . . . . 1.0 110.74 176.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -59.86 -51.28 70.4 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.727 1.751 . . . . 1.0 115.727 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.492 HH21 ' HA ' ' A' ' 180' ' ' PRO . 0.0 OUTLIER -60.04 -39.11 84.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.137 0.881 . . . . 1.0 109.279 -175.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.39 78.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.566 0.95 . . . . 1.0 113.566 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.2 mt -63.12 -45.33 92.5 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.352 1.461 . . . . 1.0 114.068 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.34 160.18 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -43.66 114.01 1.64 Allowed Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.869 1.668 . . . . 1.0 106.554 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.492 ' HA ' HH21 ' A' ' 175' ' ' ARG . 42.4 Cg_endo -79.28 41.03 1.02 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.145 1.897 . . . . 1.0 114.578 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.6 t 50.3 33.75 7.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.922 2.089 . . . . 1.0 111.087 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.9 t -155.66 34.81 0.36 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.094 1.757 . . . . 1.0 109.131 -175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -158.15 81.27 0.84 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.992 1.317 . . . . 1.0 107.938 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -156.91 126.38 6.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.54 153.81 17.63 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.195 -1.409 . . . . 1.0 107.195 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 9.4 tpt -115.4 75.46 0.94 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.79 0.805 . . . . 1.0 110.523 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 99.7 m . . . . . 0 C--O 1.251 1.141 0 N-CA-C 103.068 -2.938 . . . . 1.0 103.068 175.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 tpt . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.3 tp -81.37 123.56 28.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt -136.02 136.35 40.19 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 105.974 -1.862 . . . . 1.0 105.974 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.48 123.43 42.02 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 125.981 1.712 . . . . 1.0 109.318 -175.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 47.23 37.83 6.19 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.472 1.509 . . . . 1.0 114.711 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.74 16.55 76.2 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.288 -0.882 . . . . 1.0 113.167 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -126.84 173.04 9.88 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 128.613 2.765 . . . . 1.0 105.301 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tt -80.63 130.28 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.112 -1.811 . . . . 1.0 106.112 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.3 165.91 23.3 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.556 0.743 . . . . 1.0 112.239 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 42.28 58.46 2.99 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.815 1.646 . . . . 1.0 109.046 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.49 145.94 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.656 1.183 . . . . 1.0 109.683 -176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 tpt85 -76.08 123.15 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.45 118.96 30.33 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.906 0.775 . . . . 1.0 109.027 -179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -129.19 73.52 81.64 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.3 123.92 11.11 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.724 1.616 . . . . 1.0 108.812 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 t -137.53 113.51 9.38 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 126.566 1.947 . . . . 1.0 106.949 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.25 58.8 7.11 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.275 1.983 . . . . 1.0 110.845 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -123.73 43.53 2.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.925 1.69 . . . . 1.0 106.709 -176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.487 ' CD1' HG22 ' A' ' 88' ' ' VAL . 1.4 m-30 -82.82 179.28 7.82 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.385 1.474 . . . . 1.0 110.374 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -127.3 178.57 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.666 1.586 . . . . 1.0 109.031 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.4 m -150.55 131.64 14.38 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.865 2.466 . . . . 1.0 105.121 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.26 149.28 72.11 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 108.258 -1.015 . . . . 1.0 108.258 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.04 97.38 1.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 N-CA-C 106.601 -2.115 . . . . 1.0 106.601 175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -162.6 147.95 12.3 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 105.935 -1.876 . . . . 1.0 105.935 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -146.73 108.07 4.25 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 118.979 0.809 . . . . 1.0 109.699 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -136.2 160.24 39.29 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 127.399 2.28 . . . . 1.0 106.952 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -69.36 123.4 88.28 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.59 103.0 1.65 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 N-CA-C 108.626 -1.336 . . . . 1.0 108.626 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -175.9 70.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.225 -1.028 . . . . 1.0 108.225 -175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -148.07 127.35 13.02 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 105.091 -2.188 . . . . 1.0 105.091 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.6 tp -94.31 129.37 41.01 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.9 139.53 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 105.976 -1.861 . . . . 1.0 105.976 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -135.84 122.9 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 104.978 -2.23 . . . . 1.0 104.978 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' HE1' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -171.07 150.22 3.02 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.275 1.43 . . . . 1.0 107.357 175.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -95.3 111.9 23.69 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mm -127.37 176.4 7.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 128.333 2.653 . . . . 1.0 107.59 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 t -148.89 122.18 8.99 Favored 'General case' 0 C--O 1.247 0.938 1 N-CA-C 94.825 -5.991 . . . . 1.0 94.825 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.338 0.4 OUTLIER -142.57 -65.15 0.02 OUTLIER Pre-proline 0 C--O 1.222 -0.347 0 CA-C-O 117.823 -1.084 . . . . 1.0 113.316 178.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -86.81 162.25 9.09 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.822 3.015 . . . . 1.0 115.523 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.58 28.83 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.831 3.021 . . . . 1.0 114.973 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -40.87 -71.42 0.31 Allowed Glycine 0 C--N 1.35 1.339 0 CA-C-N 120.78 1.627 . . . . 1.0 109.312 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 41' ' ' GLY . 23.4 mt-10 -156.31 123.48 5.34 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.648 2.379 . . . . 1.0 107.124 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -176.89 176.95 1.38 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 131.366 3.866 . . . . 1.0 108.098 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.67 4.95 8.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.316 1.436 . . . . 1.0 111.603 175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.61 136.56 14.75 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 119.368 1.584 . . . . 1.0 110.497 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.32 -16.99 15.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.828 2.352 . . . . 1.0 113.782 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -54.32 -39.9 67.46 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.528 1.058 . . . . 1.0 111.556 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.3 mt -64.99 -48.73 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.352 1.061 . . . . 1.0 109.047 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.55 -49.65 76.69 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -57.02 -34.68 68.42 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.942 0.897 . . . . 1.0 111.727 -176.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.92 -49.31 68.44 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.151 0.98 . . . . 1.0 110.26 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -70.41 -48.27 56.87 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.257 0.623 . . . . 1.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -66.14 -37.47 85.78 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.305 1.842 . . . . 1.0 109.955 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 111.24 1.65 28.1 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.222 1.391 . . . . 1.0 115.357 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.1 p -89.08 9.89 23.75 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.322 2.061 . . . . 1.0 113.045 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.81 136.5 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.142 1.777 . . . . 1.0 113.116 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.88 122.7 51.94 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.87 2.468 . . . . 1.0 109.375 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.56 58.77 5.98 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.032 3.155 . . . . 1.0 111.016 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.09 -54.72 2.56 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 117.752 -1.118 . . . . 1.0 111.914 -175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.65 -51.15 61.39 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.59 1.087 . . . . 1.0 110.43 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 20.8 p80 -170.4 178.02 0.93 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.701 2.0 . . . . 1.0 107.032 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 25.4 Cg_endo -75.95 -43.31 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.36 1.373 . . . . 1.0 114.125 -176.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -42.41 -47.54 4.99 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.886 1.675 . . . . 1.0 113.758 -175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.81 -55.45 34.7 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.839 1.256 . . . . 1.0 109.6 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.5 -43.0 95.5 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.265 1.426 . . . . 1.0 110.733 175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -43.61 -64.11 1.96 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 127.048 2.261 . . . . 1.0 111.874 176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.4 pt -61.42 -32.66 53.94 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-O 117.243 -1.36 . . . . 1.0 112.661 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.0 -43.12 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 117.004 2.224 . . . . 1.0 117.004 -175.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -60.55 -33.83 73.25 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.489 -0.757 . . . . 1.0 110.33 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.4 mp -85.88 135.37 33.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' H ' ' NE ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -66.17 162.67 19.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 175.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -116.48 158.54 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 124.513 1.125 . . . . 1.0 108.691 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.57 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.4 m -175.44 125.28 0.24 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.042 1.337 . . . . 1.0 108.887 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.18 -168.8 1.81 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 105.649 -1.982 . . . . 1.0 105.649 174.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -113.22 -76.12 0.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 106.856 -1.535 . . . . 1.0 106.856 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.643 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.2 m -124.03 118.41 26.91 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.86 113.69 27.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.081 -2.192 . . . . 1.0 105.081 -175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.7 mt -99.26 113.4 34.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.5 ttp85 -85.28 153.4 22.61 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.54 -1.282 . . . . 1.0 107.54 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -48.65 -20.24 0.44 Allowed 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.543 1.937 . . . . 1.0 115.266 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.68 28.24 1.82 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.104 0.962 . . . . 1.0 112.442 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.83 30.04 71.89 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.297 1.903 . . . . 1.0 113.766 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.68 113.08 25.01 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.674 0.79 . . . . 1.0 110.474 -174.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.38 120.97 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 104.822 -2.288 . . . . 1.0 104.822 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.43 149.08 14.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 104.666 -2.346 . . . . 1.0 104.666 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -126.12 122.1 34.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.731 0.812 . . . . 1.0 110.818 176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -121.21 129.51 53.24 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 128.856 2.862 . . . . 1.0 103.922 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 73' ' ' SER . 3.8 t 64.42 91.72 0.07 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 CA-C-N 121.684 2.038 . . . . 1.0 113.753 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -66.44 -170.43 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.515 2.143 . . . . 1.0 113.396 177.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -63.09 15.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.455 2.702 . . . . 1.0 115.099 -175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -137.87 116.69 12.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.329 2.252 . . . . 1.0 108.021 -175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 tttt 78.86 81.24 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 128.288 2.635 . . . . 1.0 107.554 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.28 150.78 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 130.266 3.426 . . . . 1.0 113.67 -175.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.28 -178.24 3.6 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.993 2.117 . . . . 1.0 110.104 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -147.88 118.9 7.67 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.175 1.352 . . . . 1.0 110.34 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.49 63.06 0.17 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.728 1.251 . . . . 1.0 110.186 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -158.26 -54.89 0.07 Allowed 'General case' 0 CA--C 1.513 -0.481 0 O-C-N 118.76 -2.463 . . . . 1.0 114.354 176.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.81 -74.83 1.12 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.029 -2.028 . . . . 1.0 108.029 -175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.8 t -149.26 135.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.605 1.703 . . . . 1.0 110.933 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -166.98 149.24 6.18 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.202 1.801 . . . . 1.0 109.789 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.69 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -134.03 146.45 50.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 128.374 2.669 . . . . 1.0 110.785 177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -150.17 142.61 24.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.258 -1.386 . . . . 1.0 107.258 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 39.13 53.81 2.14 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.507 1.523 . . . . 1.0 112.802 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.01 29.16 70.14 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-O 119.374 -0.681 . . . . 1.0 114.751 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -130.11 113.8 14.95 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.444 -1.688 . . . . 1.0 106.444 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -93.49 146.7 23.59 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.776 1.23 . . . . 1.0 107.721 175.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.5 mtm-85 -112.29 118.58 35.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.849 1.26 . . . . 1.0 108.076 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.6 t -64.51 -30.11 71.14 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.807 0.692 . . . . 1.0 110.338 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -146.03 170.14 17.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.516 1.126 . . . . 1.0 108.192 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -81.91 76.89 8.79 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.208 1.004 . . . . 1.0 109.485 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.95 33.8 1.3 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 125.054 1.341 . . . . 1.0 112.415 -176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 m -127.89 156.47 42.55 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.08 1.352 . . . . 1.0 112.628 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.08 56.83 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.832 2.053 . . . . 1.0 109.089 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.22 -136.78 3.84 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.05 -1.031 . . . . 1.0 112.385 -176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 76' ' ' CYS . 12.3 mm -145.15 165.81 11.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 128.44 2.696 . . . . 1.0 104.549 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.49 138.55 26.2 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 104.492 -2.41 . . . . 1.0 104.492 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.8 151.38 22.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.897 0.771 . . . . 1.0 110.52 176.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -130.43 138.93 50.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.294 0.568 . . . . 1.0 111.064 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.85 -171.75 37.88 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.002 1.763 . . . . 1.0 110.124 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.0 p -148.65 115.33 5.97 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 103.346 -2.835 . . . . 1.0 103.346 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t0 42.18 53.15 4.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 129.393 3.077 . . . . 1.0 113.994 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 49.32 38.87 14.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.793 1.637 . . . . 1.0 113.493 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.4 tp -56.66 143.81 34.71 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 107.127 -1.435 . . . . 1.0 107.127 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -34.84 115.67 0.29 Allowed 'General case' 0 C--N 1.347 0.493 0 C-N-CA 126.625 1.97 . . . . 1.0 109.867 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.67 -7.85 58.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.776 -2.059 . . . . 1.0 114.517 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.397 20.3 p 66.5 78.59 0.26 Allowed 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 121.398 1.908 . . . . 1.0 112.528 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.34 -34.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.007 1.73 . . . . 1.0 114.372 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.42 -41.33 9.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.072 2.149 . . . . 1.0 111.635 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -48.97 -51.18 31.87 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.023 1.329 . . . . 1.0 109.29 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -58.67 -37.35 75.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.536 -0.745 . . . . 1.0 110.541 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -64.61 -55.85 17.64 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.154 0.888 . . . . 1.0 110.861 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.93 -47.32 75.1 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.069 0.948 . . . . 1.0 110.918 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.436 HD13 HG21 ' A' ' 115' ' ' ILE . 56.4 tp -56.36 -47.36 79.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.021 1.328 . . . . 1.0 108.43 175.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.37 99.26 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.493 1.042 . . . . 1.0 110.236 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.72 54.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.027 0.831 . . . . 1.0 110.036 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.493 HG11 HD11 ' A' ' 115' ' ' ILE . 89.7 t -55.88 -47.3 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.657 0.783 . . . . 1.0 109.375 176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 72.9 m -57.12 -53.31 59.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.253 1.021 . . . . 1.0 109.785 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -56.04 -45.7 79.12 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.927 0.891 . . . . 1.0 110.542 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.7 63.93 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.524 -0.735 . . . . 1.0 110.385 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.86 -45.32 82.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.528 1.531 . . . . 1.0 110.763 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.51 -42.96 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.191 0.996 . . . . 1.0 109.582 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -64.73 -24.93 67.72 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.969 -0.457 . . . . 1.0 110.508 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -84.08 -59.29 2.45 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.263 -1.384 . . . . 1.0 107.263 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -122.2 113.0 31.27 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -102.92 107.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 116.595 -1.803 . . . . 1.0 112.809 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.5 -44.08 0.1 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 128.674 2.79 . . . . 1.0 106.809 174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 42.8 mt -45.2 -33.4 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 128.546 2.738 . . . . 1.0 110.592 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.43 -21.97 4.24 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.476 1.51 . . . . 1.0 113.929 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -135.12 18.57 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.091 2.156 . . . . 1.0 109.452 175.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -138.97 83.69 1.97 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.614 1.097 . . . . 1.0 109.595 -175.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 124.56 29.28 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 104.154 -2.535 . . . . 1.0 104.154 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.9 t -156.96 -174.42 4.92 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.265 0.484 . . . . 1.0 109.885 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -143.59 -131.8 2.54 Favored Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.541 -2.224 . . . . 1.0 107.541 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.496 ' HE1' ' CE1' ' A' ' 34' ' ' HIS . 11.8 m170 -121.2 -23.52 5.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.956 1.378 . . . . 1.0 112.694 -175.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.56 -6.29 22.99 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.414 -1.328 . . . . 1.0 107.414 175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.516 ' HB3' ' H ' ' A' ' 153' ' ' GLY . 19.6 t-20 -83.58 15.59 3.06 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 128.556 2.743 . . . . 1.0 111.549 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.69 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.53 -15.72 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.609 0.763 . . . . 1.0 111.815 -175.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.74 -53.74 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 126.617 1.967 . . . . 1.0 110.282 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -81.22 108.74 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 121.594 1.605 . . . . 1.0 111.367 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -61.25 -26.16 67.57 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 120.485 -1.384 . . . . 1.0 110.049 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -60.2 -25.96 66.0 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.446 1.898 . . . . 1.0 111.946 -177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -127.22 124.26 38.51 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 105.161 -2.163 . . . . 1.0 105.161 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 23.9 m -119.29 -16.69 8.99 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.913 -0.715 . . . . 1.0 112.43 -175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.46 179.67 0.39 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.812 2.445 . . . . 1.0 104.679 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.47 88.01 1.2 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.027 2.485 . . . . 1.0 109.862 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 69.7 0.67 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.093 1.33 . . . . 1.0 109.96 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -76.13 -81.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.303 2.052 . . . . 1.0 110.995 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.7 t 53.66 42.9 31.75 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.453 1.501 . . . . 1.0 109.576 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.29 17.53 19.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.27 0.486 . . . . 1.0 112.178 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.3 t0 44.52 68.01 0.61 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.905 1.682 . . . . 1.0 113.008 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -54.88 -33.0 61.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 119.059 -0.496 . . . . 1.0 111.717 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.29 22.54 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.853 -1.07 . . . . 1.0 109.912 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -60.12 -47.66 84.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 119.257 0.935 . . . . 1.0 111.982 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -57.37 -58.94 6.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.771 0.669 . . . . 1.0 110.942 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -34.03 74.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.922 -0.561 . . . . 1.0 111.687 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.29 -40.03 93.3 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 117.941 0.337 . . . . 1.0 111.667 176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.16 -50.72 30.36 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.796 0.839 . . . . 1.0 111.647 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.95 166.38 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.664 1.986 . . . . 1.0 111.255 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.3 m -48.05 113.45 2.75 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -85.71 40.63 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.875 2.384 . . . . 1.0 112.479 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.7 t 56.48 51.88 10.7 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.536 1.534 . . . . 1.0 107.969 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.6 t -175.58 179.99 1.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 131.574 3.95 . . . . 1.0 105.599 175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 54.99 54.81 8.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.234 1.014 . . . . 1.0 111.888 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -108.85 162.17 14.44 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.74 169.82 17.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.187 1.795 . . . . 1.0 108.448 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.0 tpt 74.91 -107.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 128.65 2.78 . . . . 1.0 111.836 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.42 1.888 . . . . 1.0 106.294 -177.75 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 2.0 tpp . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 105.256 -2.127 . . . . 1.0 105.256 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.7 152.65 0.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 117.356 -3.34 . . . . 1.0 111.682 -162.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.71 126.36 44.29 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 123.109 1.433 . . . . 1.0 112.204 -174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -136.17 153.99 51.1 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.781 2.032 . . . . 1.0 109.534 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 43.8 43.08 4.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.888 1.675 . . . . 1.0 113.48 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 8.99 72.6 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.86 -1.522 . . . . 1.0 114.499 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -131.32 170.19 14.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.932 1.866 . . . . 1.0 107.258 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.651 HD22 ' HB2' ' A' ' 11' ' ' ALA . 5.8 tt -101.29 123.51 45.51 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.08 148.34 26.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.619 1.099 . . . . 1.0 110.368 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 47.33 75.05 0.14 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.004 1.722 . . . . 1.0 110.799 -175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' HD22 ' A' ' 8' ' ' LEU . . . -161.63 155.49 21.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 127.984 2.514 . . . . 1.0 107.916 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.1 ttm-85 -76.71 123.38 26.09 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 104.728 -2.323 . . . . 1.0 104.728 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 ptt85 -93.19 138.43 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.12 76.69 50.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.711 1.204 . . . . 1.0 107.785 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.66 125.91 13.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.454 2.103 . . . . 1.0 109.416 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -144.5 113.32 5.11 Favored Pre-proline 0 CA--C 1.518 -0.288 0 C-N-CA 124.887 1.275 . . . . 1.0 107.626 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.21 65.39 8.83 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.307 2.005 . . . . 1.0 111.288 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -130.29 43.63 3.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.837 1.655 . . . . 1.0 107.358 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.76 178.49 7.32 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.427 1.091 . . . . 1.0 110.337 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.53 178.07 4.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.727 0.775 . . . . 1.0 112.718 -175.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.6 m -165.07 118.48 1.24 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 128.329 2.652 . . . . 1.0 108.177 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 158.36 62.95 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 106.346 -1.724 . . . . 1.0 106.346 175.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.84 88.08 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.468 1.445 . . . . 1.0 109.762 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -145.68 143.37 29.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 105.919 -1.882 . . . . 1.0 105.919 175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -151.52 103.35 2.96 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.645 1.111 . . . . 1.0 110.738 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -137.37 162.67 32.97 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -69.63 123.23 88.1 Favored Pre-proline 0 C--O 1.239 0.526 0 N-CA-C 104.928 -2.249 . . . . 1.0 104.928 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HB2' HG22 ' A' ' 113' ' ' ILE . 91.4 Cg_endo -78.2 103.37 1.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.789 1.318 . . . . 1.0 108.72 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 t -169.3 80.49 0.12 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -152.77 124.1 7.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 104.106 -2.553 . . . . 1.0 104.106 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -99.31 126.45 45.17 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.764 1.626 . . . . 1.0 108.381 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.5 145.03 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' A' ' 169' ' ' PHE . 21.4 t -136.36 123.91 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 104.181 -2.526 . . . . 1.0 104.181 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -175.38 146.93 0.84 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 117.339 -1.315 . . . . 1.0 107.507 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.15 112.32 22.58 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.414 1.006 . . . . 1.0 110.468 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.25 174.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.8 t -144.06 121.84 11.93 Favored 'General case' 0 C--O 1.247 0.93 1 N-CA-C 97.146 -5.131 . . . . 1.0 97.146 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 48' ' ' ILE 0.324 1.1 tm? -141.67 -65.58 0.02 OUTLIER Pre-proline 0 C--O 1.224 -0.266 0 N-CA-C 115.654 1.724 . . . . 1.0 115.654 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.3 157.66 22.79 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 121.982 1.744 . . . . 1.0 112.066 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.43 12.26 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.102 3.201 . . . . 1.0 116.363 -175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -28.18 -71.13 0.05 OUTLIER Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.697 -1.613 . . . . 1.0 114.062 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -156.54 123.64 5.27 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.712 1.605 . . . . 1.0 111.257 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -169.39 150.72 4.31 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.503 1.521 . . . . 1.0 110.795 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -100.8 -6.53 52.27 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.122 -1.377 . . . . 1.0 112.089 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.25 118.61 5.7 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.566 -1.813 . . . . 1.0 108.566 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.262 88.6 Cg_endo -65.26 -3.06 6.75 Favored 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 126.123 4.549 . . . . 1.0 118.964 -175.143 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -55.63 -46.93 77.35 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 121.922 2.146 . . . . 1.0 113.262 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' LEU . 9.4 mm -61.38 -47.05 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.567 -1.271 . . . . 1.0 107.567 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -52.89 -48.58 67.07 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 124.841 1.257 . . . . 1.0 109.129 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.23 -38.79 77.53 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.254 1.022 . . . . 1.0 112.381 -176.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tt -65.75 -51.13 61.69 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.784 0.434 . . . . 1.0 109.878 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.28 -39.51 71.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 112.346 0.499 . . . . 1.0 112.346 -176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -66.58 -52.63 43.36 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.645 1.178 . . . . 1.0 110.647 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.94 9.82 2.68 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 118.439 -1.201 . . . . 1.0 115.45 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.3 p -107.87 9.07 28.88 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.658 2.229 . . . . 1.0 114.86 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.2 134.4 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.76 1.164 . . . . 1.0 111.981 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -121.15 136.5 25.76 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 129.141 2.976 . . . . 1.0 109.338 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.7 76.33 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 1.0 106.923 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -103.55 -64.14 1.12 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.266 0.626 . . . . 1.0 111.266 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.09 -44.6 79.15 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.614 0.766 . . . . 1.0 111.07 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 24.3 p80 -170.08 177.96 0.97 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 126.623 1.969 . . . . 1.0 107.047 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -76.05 -43.71 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.393 1.395 . . . . 1.0 114.33 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -46.14 -45.78 16.78 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 114.101 1.148 . . . . 1.0 114.101 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -56.12 -53.92 51.24 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.951 0.901 . . . . 1.0 109.193 -175.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.57 84.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.235 1.014 . . . . 1.0 111.665 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.66 -53.94 15.39 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 125.639 1.59 . . . . 1.0 111.515 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 pt -61.02 -43.45 96.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 CA-C-O 117.303 -1.332 . . . . 1.0 110.908 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.56 -43.05 1.8 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.084 2.154 . . . . 1.0 115.19 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -46.96 -56.64 6.05 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.75 136.98 53.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 129.149 2.979 . . . . 1.0 106.912 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.65 155.13 16.26 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 120.475 -1.391 . . . . 1.0 109.211 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.83 158.39 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.543 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 m -173.66 131.73 0.44 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.582 1.553 . . . . 1.0 108.645 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.5 -176.64 3.68 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.67 -1.604 . . . . 1.0 106.67 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -120.02 -76.28 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.115 0.966 . . . . 1.0 109.481 175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.745 ' HB2' HD13 ' A' ' 115' ' ' ILE . 85.6 m -117.34 118.37 32.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 tt -122.3 114.15 20.4 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.432 1.093 . . . . 1.0 108.318 -175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 mt -94.4 117.21 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.927 0.891 . . . . 1.0 108.641 -175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -77.21 149.7 35.5 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.073 1.306 . . . . 1.0 109.171 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -23.74 2.93 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 126.466 1.906 . . . . 1.0 114.917 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -92.03 35.0 0.99 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.764 1.226 . . . . 1.0 113.798 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.24 40.8 99.09 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.757 1.17 . . . . 1.0 114.661 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -108.4 151.69 25.68 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 117.982 0.891 . . . . 1.0 110.676 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -116.16 113.98 44.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 102.492 -3.151 . . . . 1.0 102.492 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.11 145.45 17.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 119.29 27.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.779 1.632 . . . . 1.0 106.776 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -120.15 140.99 50.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.975 -2.231 . . . . 1.0 104.975 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 73' ' ' SER . 15.9 t 65.23 92.09 0.07 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 115.162 1.541 . . . . 1.0 115.162 175.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -56.73 169.65 1.71 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 N-CA-C 109.052 -1.172 . . . . 1.0 109.052 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.74 28.38 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.944 2.572 . . . . 1.0 117.944 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -134.51 117.05 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 128.735 2.814 . . . . 1.0 105.807 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 86.65 81.93 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.37 2.668 . . . . 1.0 109.539 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -35.02 148.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 131.205 3.802 . . . . 1.0 114.356 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -104.25 178.55 4.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.933 2.093 . . . . 1.0 109.657 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -149.49 119.01 6.92 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.246 1.384 . . . . 1.0 110.568 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -157.68 62.92 0.47 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.076 1.417 . . . . 1.0 110.185 -176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.506 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -163.27 -63.8 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 119.015 -2.303 . . . . 1.0 113.852 176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.96 -68.87 0.21 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 106.274 -2.73 . . . . 1.0 106.274 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -145.53 146.49 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.075 1.35 . . . . 1.0 109.519 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 9.8 p -160.38 166.31 29.57 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.092 1.757 . . . . 1.0 107.857 175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 p -159.28 145.83 16.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -159.77 154.0 23.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.612 1.096 . . . . 1.0 109.343 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 39.43 54.99 2.33 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.3 1.84 . . . . 1.0 111.153 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.65 84.98 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.933 -0.926 . . . . 1.0 113.117 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -144.75 119.24 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.842 1.321 . . . . 1.0 108.492 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.91 146.74 33.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.255 1.422 . . . . 1.0 111.699 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -124.45 118.22 26.17 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 45.5 t -72.02 -31.03 65.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.674 0.79 . . . . 1.0 111.683 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -151.22 176.24 11.4 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 128.407 2.683 . . . . 1.0 106.401 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.331 15.3 t70 -87.19 77.07 9.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.104 0.954 . . . . 1.0 111.78 175.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -90.51 44.54 1.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.616 -1.253 . . . . 1.0 107.616 175.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -123.26 133.45 54.18 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.272 1.029 . . . . 1.0 110.785 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 28' ' ' PRO 0.256 0.1 OUTLIER -91.21 56.92 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 175.57 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.39 -136.4 3.82 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 122.488 1.049 . . . . 1.0 111.217 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.745 HD13 ' HB2' ' A' ' 76' ' ' CYS . 7.9 mm -139.65 165.14 22.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 128.156 2.582 . . . . 1.0 104.114 176.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -146.18 131.34 18.38 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 102.961 -2.977 . . . . 1.0 102.961 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.71 127.98 48.23 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.055 -1.653 . . . . 1.0 108.727 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -103.36 138.37 40.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.425 0.631 . . . . 1.0 111.224 -175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.03 40.49 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.945 1.26 . . . . 1.0 111.586 -175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.7 p -142.32 108.3 5.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.408 1.483 . . . . 1.0 107.923 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t0 49.76 55.67 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 127.124 2.17 . . . . 1.0 113.83 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 p 48.96 38.38 12.27 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.255 1.822 . . . . 1.0 113.973 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.19 142.8 58.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 105.283 -2.118 . . . . 1.0 105.283 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -43.03 114.78 0.65 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.683 1.193 . . . . 1.0 108.771 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -78.52 -2.12 37.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 116.783 -1.579 . . . . 1.0 114.83 -174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 29.0 p 64.01 76.5 0.35 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.077 1.308 . . . . 1.0 111.013 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.35 -32.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.723 2.009 . . . . 1.0 113.132 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.01 -38.35 4.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.629 2.372 . . . . 1.0 111.837 174.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -47.6 -43.88 25.99 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.242 1.417 . . . . 1.0 110.112 176.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -60.64 -39.6 88.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.284 -0.865 . . . . 1.0 110.811 -175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -65.59 -51.56 58.78 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.492 1.042 . . . . 1.0 110.27 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -65.4 -40.18 93.12 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.488 0.315 . . . . 1.0 111.293 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 29.9 tp -59.11 -51.94 67.89 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 126.249 1.82 . . . . 1.0 108.201 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.57 -40.03 78.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.83 -0.605 . . . . 1.0 110.256 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -53.96 51.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.131 0.878 . . . . 1.0 111.659 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.23 -47.83 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 56.9 m -58.15 -47.01 84.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.357 1.463 . . . . 1.0 112.029 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -60.19 -38.13 82.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.553 0.741 . . . . 1.0 109.606 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.18 -43.52 86.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 117.823 -1.084 . . . . 1.0 110.332 176.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.17 -45.67 79.61 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 120.252 1.387 . . . . 1.0 110.595 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.4 mt -58.81 -41.62 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.0 m -62.04 -27.24 68.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.366 0.666 . . . . 1.0 111.269 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -83.9 -61.23 1.88 Allowed 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.956 -1.09 . . . . 1.0 108.111 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -125.8 112.79 24.8 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.27 -1.381 . . . . 1.0 107.27 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -93.18 107.8 0.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-O 123.425 1.344 . . . . 1.0 109.731 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.39 -44.8 0.1 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.559 1.944 . . . . 1.0 109.412 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.3 mt -49.36 -33.51 6.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 130.731 3.613 . . . . 1.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.01 -26.43 37.0 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.155 0.428 . . . . 1.0 112.155 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -133.46 25.65 4.11 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.123 2.569 . . . . 1.0 110.184 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -139.09 83.51 1.95 Allowed 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 50.9 mtt -126.88 118.57 24.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.66 -2.348 . . . . 1.0 104.66 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -148.21 -175.38 4.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.586 1.084 . . . . 1.0 109.237 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -145.21 -131.77 2.39 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 105.789 -2.924 . . . . 1.0 105.789 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.566 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 24.2 m170 -114.78 -23.47 9.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.675 1.238 . . . . 1.0 110.381 175.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.34 -18.67 14.75 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -83.84 38.31 0.63 Allowed 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.19 0.905 . . . . 1.0 108.918 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -16.6 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 O-C-N 120.513 -1.367 . . . . 1.0 108.715 175.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.465 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -155.49 -54.4 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 127.783 2.433 . . . . 1.0 111.518 175.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.465 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 98.2 Cg_endo -76.57 109.51 2.88 Favored 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 122.146 1.802 . . . . 1.0 113.608 -175.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -62.36 -12.29 20.41 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.145 -0.972 . . . . 1.0 110.688 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -22.5 57.37 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 120.313 -1.492 . . . . 1.0 114.553 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.26 125.75 20.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.559 1.527 . . . . 1.0 107.091 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 167' ' ' PRO . 2.6 m -114.79 -16.7 11.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.19 -178.83 0.3 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 126.3 1.84 . . . . 1.0 106.311 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.22 80.71 2.96 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 N-CA-C 105.633 -2.487 . . . . 1.0 105.633 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.404 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.22 72.28 0.23 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.513 2.006 . . . . 1.0 109.866 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.492 ' HB3' ' H ' ' A' ' 163' ' ' THR . 68.7 Cg_endo -79.0 -99.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.301 2.667 . . . . 1.0 111.066 176.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 21.7 t 53.82 42.9 31.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.513 1.525 . . . . 1.0 111.538 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.41 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -96.81 17.87 15.72 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.978 -1.076 . . . . 1.0 113.453 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.7 t0 43.79 63.74 1.49 Allowed 'General case' 0 N--CA 1.475 0.814 0 O-C-N 119.421 -2.049 . . . . 1.0 111.831 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -54.07 -35.17 61.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.344 0.658 . . . . 1.0 111.725 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.05 -54.35 48.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 118.453 -0.784 . . . . 1.0 110.157 176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -60.29 -48.54 81.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 117.814 -1.089 . . . . 1.0 112.13 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -56.32 -53.54 56.07 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.883 0.765 . . . . 1.0 109.938 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.32 -48.81 80.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 117.962 -1.018 . . . . 1.0 108.773 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.7 76.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.931 0.893 . . . . 1.0 112.981 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.3 mt -71.28 -44.21 65.66 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.878 0.871 . . . . 1.0 110.62 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.37 157.07 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 122.958 1.361 . . . . 1.0 110.051 175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 183' ' ' HIS . 7.3 m -55.15 139.05 65.42 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.952 1.701 . . . . 1.0 111.607 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -80.23 42.22 1.28 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.718 2.945 . . . . 1.0 110.947 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.6 t 53.07 33.64 15.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.44 2.696 . . . . 1.0 111.754 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.7 t -163.63 106.3 0.97 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.728 1.611 . . . . 1.0 107.41 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.425 ' HB2' HG23 ' A' ' 179' ' ' THR . 32.8 t60 -160.06 125.56 4.05 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 106.222 -1.77 . . . . 1.0 106.222 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -64.52 142.42 58.43 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.44 124.13 20.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -153.62 107.04 2.96 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.352 -0.842 . . . . 1.0 110.022 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 C-N-CA 126.48 1.912 . . . . 1.0 109.723 176.614 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 tpt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.8 tp -81.57 138.15 35.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.24 136.13 45.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 102.837 -3.023 . . . . 1.0 102.837 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -125.55 123.53 39.29 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.808 -1.553 . . . . 1.0 106.808 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 49.82 33.59 6.6 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.062 0.846 . . . . 1.0 111.967 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.55 -6.68 5.77 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.64 1.591 . . . . 1.0 113.89 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -81.65 161.55 23.4 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 103.857 -2.646 . . . . 1.0 103.857 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.6 tm? -79.65 124.11 28.26 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.912 -1.514 . . . . 1.0 106.912 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.63 175.92 9.95 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.469 0.708 . . . . 1.0 111.408 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 42.33 57.86 3.22 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.286 1.834 . . . . 1.0 109.464 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.29 155.2 30.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.983 1.313 . . . . 1.0 109.1 -176.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -81.29 123.46 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.79 124.6 33.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.379 0.99 . . . . 1.0 108.334 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -134.92 82.53 43.02 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.99 124.03 7.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.034 1.823 . . . . 1.0 110.299 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -119.74 114.19 34.25 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 105.51 -2.033 . . . . 1.0 105.51 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.87 56.39 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.183 1.922 . . . . 1.0 111.416 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -126.05 44.56 2.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.811 2.045 . . . . 1.0 105.632 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.465 ' CE2' HG13 ' A' ' 88' ' ' VAL . 1.8 m-30 -73.66 177.98 5.05 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.417 0.687 . . . . 1.0 111.142 -174.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.56 178.62 4.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.693 1.597 . . . . 1.0 113.513 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.6 m -154.19 124.67 7.01 Favored 'General case' 0 N--CA 1.448 -0.574 1 C-N-CA 132.028 4.131 . . . . 1.0 103.137 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.64 142.77 45.09 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 117.981 -1.009 . . . . 1.0 108.831 176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -81.57 69.1 7.88 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.598 2.865 . . . . 1.0 113.454 -175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -151.71 158.54 43.54 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 127.073 2.149 . . . . 1.0 106.799 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -151.17 104.67 3.14 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.309 1.444 . . . . 1.0 107.481 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -136.77 158.67 43.92 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.915 1.686 . . . . 1.0 106.61 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -67.51 123.67 87.3 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 118.679 0.672 . . . . 1.0 109.441 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.16 103.65 1.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 N-CA-C 108.974 -1.202 . . . . 1.0 108.974 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 t -165.38 65.57 0.12 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.469 -1.394 . . . . 1.0 108.265 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tt -148.3 137.63 22.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.73 1.612 . . . . 1.0 107.175 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -89.85 133.4 34.76 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.243 1.417 . . . . 1.0 108.111 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.91 142.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 104.938 -2.245 . . . . 1.0 104.938 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 98.5 t -136.16 115.77 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 105.977 -1.86 . . . . 1.0 105.977 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -176.3 132.82 0.23 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.348 0.976 . . . . 1.0 108.835 175.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -63.39 118.73 8.49 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.925 0.89 . . . . 1.0 110.22 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 7.5 mm -145.71 176.43 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.174 2.59 . . . . 1.0 107.153 176.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.2 t -160.93 117.97 2.33 Favored 'General case' 0 C--N 1.322 -0.624 1 N-CA-C 96.695 -5.298 . . . . 1.0 96.695 174.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.447 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 1.3 tm? -144.78 -61.3 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 116.022 -1.942 . . . . 1.0 112.79 -174.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 23.8 Cg_endo -87.34 157.3 8.1 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 122.825 2.35 . . . . 1.0 112.92 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.37 70.45 4.78 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 124.326 3.35 . . . . 1.0 118.658 -175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.94 -72.2 1.06 Allowed Glycine 0 CA--C 1.533 1.187 0 N-CA-C 105.811 -2.916 . . . . 1.0 105.811 175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -157.2 123.42 4.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.324 2.25 . . . . 1.0 109.186 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -176.94 176.42 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 130.706 3.602 . . . . 1.0 107.836 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.41 22.78 10.04 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.91 1.719 . . . . 1.0 109.464 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.38 118.6 5.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.116 -1.38 . . . . 1.0 110.203 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.8 -21.03 38.9 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.415 2.077 . . . . 1.0 112.331 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -53.9 -34.19 58.79 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.853 0.861 . . . . 1.0 111.082 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 mt -66.12 -50.01 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 118.246 -0.883 . . . . 1.0 109.755 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.94 -46.46 78.1 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.076 -1.049 . . . . 1.0 110.395 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -52.78 -33.89 50.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.114 0.966 . . . . 1.0 111.887 -176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -63.83 -58.49 6.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.616 1.566 . . . . 1.0 110.296 176.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -70.6 -41.32 72.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.4 0.68 . . . . 1.0 112.545 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.6 t -65.91 -34.28 77.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.59 1.156 . . . . 1.0 108.455 176.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.22 54.77 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 117.308 -1.829 . . . . 1.0 116.153 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 p -89.15 8.27 30.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.743 2.272 . . . . 1.0 113.615 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 68' ' ' ALA . 13.4 tt -60.02 132.93 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.629 1.572 . . . . 1.0 111.891 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -99.02 135.99 20.7 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 128.636 2.774 . . . . 1.0 109.529 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.39 80.68 1.04 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.502 2.801 . . . . 1.0 106.909 175.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -103.23 -63.43 1.18 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.034 0.534 . . . . 1.0 111.012 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.57 78.85 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.06 0.944 . . . . 1.0 110.646 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 17.4 p80 -170.35 177.95 0.95 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.403 2.281 . . . . 1.0 106.331 175.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 22.7 Cg_endo -74.05 -43.43 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.531 1.488 . . . . 1.0 114.796 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -43.23 -53.58 5.03 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.7 OUTLIER -51.51 -58.22 6.89 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 125.07 1.348 . . . . 1.0 110.513 -175.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.61 -43.6 89.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.167 0.587 . . . . 1.0 111.521 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.45 -63.54 4.0 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.127 1.346 . . . . 1.0 111.863 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -61.49 -38.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.24 0.52 . . . . 1.0 112.065 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.506 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.52 -43.53 11.87 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 116.625 2.083 . . . . 1.0 116.625 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.262 88.0 m-70 -57.9 -33.54 68.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.721 -0.657 . . . . 1.0 109.779 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.32 136.61 33.83 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.504 -2.776 . . . . 1.0 103.504 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 141.67 40.74 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.227 0.921 . . . . 1.0 111.723 178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -116.97 165.49 12.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.663 2.385 . . . . 1.0 109.59 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -172.52 116.64 0.33 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.955 1.302 . . . . 1.0 108.632 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.44 -176.89 3.77 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -110.68 -76.27 0.61 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.884 1.22 . . . . 1.0 112.478 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.7 m -116.97 118.26 31.94 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 105.543 -2.021 . . . . 1.0 105.543 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -102.57 113.55 27.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.761 -2.311 . . . . 1.0 104.761 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.5 mm -96.14 113.38 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 104.662 -2.348 . . . . 1.0 104.662 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.0 tpp85 -68.74 148.13 50.8 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.696 1.134 . . . . 1.0 108.502 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -13.74 22.09 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 122.824 0.45 . . . . 1.0 111.645 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -90.27 24.51 2.51 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.25 2.22 . . . . 1.0 111.896 176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.93 31.01 76.96 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.456 1.979 . . . . 1.0 115.623 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -99.94 156.57 17.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.726 1.763 . . . . 1.0 110.58 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.1 mt -116.24 116.53 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 102.628 -3.101 . . . . 1.0 102.628 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.71 141.68 25.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.45 121.57 37.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.411 -1.7 . . . . 1.0 106.411 -176.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -114.94 123.93 50.38 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.829 2.452 . . . . 1.0 106.495 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG13 ' CE2' ' A' ' 19' ' ' TYR . 36.2 t 67.16 92.1 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 120.091 1.314 . . . . 1.0 113.664 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -60.8 -179.15 0.26 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.192 1.261 . . . . 1.0 109.963 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -59.18 26.98 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 129.812 3.245 . . . . 1.0 116.678 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -146.97 117.48 7.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.905 2.482 . . . . 1.0 108.788 -176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.268 28.0 ttmt 85.93 81.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.903 2.481 . . . . 1.0 111.844 175.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -36.44 156.47 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.721 4.009 . . . . 1.0 117.216 -175.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -108.75 -179.2 3.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.909 3.684 . . . . 1.0 115.857 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 46.7 t90 -156.46 118.52 3.95 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.514 1.926 . . . . 1.0 109.709 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -162.78 62.85 0.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.228 0.922 . . . . 1.0 111.439 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.55 -53.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 118.785 -2.447 . . . . 1.0 114.779 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.84 -90.74 1.1 Allowed Glycine 0 CA--C 1.531 1.057 0 N-CA-C 105.248 -3.141 . . . . 1.0 105.248 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.07 139.5 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 118.734 1.267 . . . . 1.0 109.456 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 p -165.98 157.32 13.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.119 2.168 . . . . 1.0 108.118 176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' H ' HG22 ' A' ' 157' ' ' ILE . 78.1 p -153.46 147.1 25.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.386 1.074 . . . . 1.0 110.763 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -149.46 148.98 30.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.586 -1.265 . . . . 1.0 107.586 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 38.66 53.93 1.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.368 1.867 . . . . 1.0 111.446 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.7 28.44 65.47 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.605 -1.108 . . . . 1.0 115.465 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.99 113.22 13.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 120.544 2.172 . . . . 1.0 105.245 175.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 12.8 tt0 -79.83 145.65 32.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -105.22 118.24 36.05 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.38 -23.7 60.22 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.322 0.389 . . . . 1.0 110.559 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -145.58 170.69 15.93 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.485 2.314 . . . . 1.0 106.857 176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.52 76.66 7.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.358 1.075 . . . . 1.0 108.919 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -89.49 40.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.454 1.502 . . . . 1.0 110.108 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.0 m -131.67 130.4 42.0 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 119.977 -1.702 . . . . 1.0 111.882 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.65 56.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.809 2.044 . . . . 1.0 107.947 176.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -88.5 -136.62 5.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 mm -142.67 164.19 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.77 116.33 8.12 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.664 -2.347 . . . . 1.0 104.664 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.3 135.42 34.32 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.298 -1.501 . . . . 1.0 109.604 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 31.1 tt0 -103.67 152.94 21.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -163.65 173.46 39.74 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.821 1.677 . . . . 1.0 111.04 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -147.13 107.08 3.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.575 -2.009 . . . . 1.0 105.575 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.7 t0 46.08 47.75 12.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.471 2.308 . . . . 1.0 112.282 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.7 p 46.78 38.27 5.73 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.301 1.84 . . . . 1.0 113.417 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.24 146.52 54.84 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 126.236 1.814 . . . . 1.0 108.542 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -33.0 113.14 0.13 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.079 2.152 . . . . 1.0 110.508 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -78.31 -9.0 59.06 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.701 -2.095 . . . . 1.0 114.985 -175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.407 11.7 p 69.26 78.41 0.21 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 121.404 1.911 . . . . 1.0 113.537 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -22.99 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 119.709 -1.869 . . . . 1.0 115.403 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.37 -46.45 13.15 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.236 2.214 . . . . 1.0 110.472 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -51.26 -49.34 61.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.571 1.078 . . . . 1.0 109.904 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -60.71 -40.09 90.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.546 -0.74 . . . . 1.0 109.757 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -65.97 -50.55 63.94 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.988 0.813 . . . . 1.0 111.424 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -63.1 -48.49 78.35 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.985 1.714 . . . . 1.0 110.255 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.7 tp -57.16 -49.98 74.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.217 1.407 . . . . 1.0 108.856 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.57 -39.84 89.47 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 118.722 -0.656 . . . . 1.0 110.155 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.81 -53.58 56.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.829 0.852 . . . . 1.0 110.304 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.01 -46.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 63.6 m -58.29 -53.6 56.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.983 1.313 . . . . 1.0 109.964 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -56.76 -46.04 81.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.67 1.188 . . . . 1.0 110.12 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.15 77.71 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.792 0.437 . . . . 1.0 111.535 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.8 mt -57.03 -38.24 72.89 Favored 'General case' 0 C--O 1.23 0.039 0 CA-C-O 118.436 -0.792 . . . . 1.0 111.029 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.28 -38.75 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.547 0.739 . . . . 1.0 109.752 175.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 19.3 m -57.42 -35.07 69.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.089 0.859 . . . . 1.0 110.55 175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -83.67 -52.66 6.25 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.129 -0.982 . . . . 1.0 108.6 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -126.33 112.9 23.49 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.92 107.15 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 CA-C-N 121.378 1.528 . . . . 1.0 109.031 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.18 -49.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.094 1.758 . . . . 1.0 107.685 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 65.8 mt -48.35 -34.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 129.018 2.927 . . . . 1.0 109.586 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.12 -25.67 9.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.738 1.615 . . . . 1.0 113.627 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -134.31 22.01 3.73 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.037 1.735 . . . . 1.0 109.63 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -139.06 85.9 2.1 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.016 1.726 . . . . 1.0 107.7 -177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.2 mtt -131.96 119.13 20.68 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.893 2.077 . . . . 1.0 106.609 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -152.15 -176.34 5.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.532 1.514 . . . . 1.0 108.992 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.57 -131.4 2.73 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 106.875 -2.49 . . . . 1.0 106.875 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 25.5 m170 -116.35 -23.9 8.15 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 118.327 1.064 . . . . 1.0 112.12 176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.4 t -103.63 -12.55 16.98 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.368 0.667 . . . . 1.0 109.255 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.49 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 0.7 OUTLIER -85.41 17.96 2.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.449 1.9 . . . . 1.0 110.478 -175.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -63.59 -20.14 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.764 0.825 . . . . 1.0 112.489 -175.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -147.47 -66.14 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.11 1.364 . . . . 1.0 107.995 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 86.0 Cg_endo -80.06 108.85 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.877 1.718 . . . . 1.0 111.202 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -59.97 -17.46 38.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.391 1.076 . . . . 1.0 112.096 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -60.06 -24.24 64.41 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 120.239 -1.538 . . . . 1.0 112.687 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -131.22 140.57 49.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 104.1 -2.556 . . . . 1.0 104.1 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 20.2 m -123.19 -16.76 6.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.34 177.92 0.95 Allowed Pre-proline 0 C--O 1.244 0.815 0 C-N-CA 131.316 3.846 . . . . 1.0 103.333 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.25 57.91 6.7 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.772 2.314 . . . . 1.0 109.438 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.5 78.81 0.02 OUTLIER Glycine 0 CA--C 1.541 1.671 0 C-N-CA 128.918 3.151 . . . . 1.0 108.054 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.01 -72.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.1 2.534 . . . . 1.0 112.107 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 11.3 t 53.94 43.79 30.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.514 1.926 . . . . 1.0 113.176 175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 76.4 t80 -122.04 17.56 10.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.347 0.976 . . . . 1.0 112.731 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.1 t0 42.6 68.47 0.48 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.288 1.435 . . . . 1.0 110.604 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -48.85 -34.95 13.53 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.59 -48.18 73.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 118.362 -0.828 . . . . 1.0 111.246 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 11.8 mmt-85 -60.78 -51.14 70.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 120.51 1.504 . . . . 1.0 110.893 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.51 -46.6 82.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.187 0.903 . . . . 1.0 111.619 -175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -62.44 -32.78 73.69 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.567 0.621 . . . . 1.0 110.119 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.93 -44.42 80.72 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.786 -1.197 . . . . 1.0 111.436 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 mt -67.87 -55.27 13.5 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.601 1.56 . . . . 1.0 112.636 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.43 150.12 11.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 122.766 0.426 . . . . 1.0 109.92 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.8 m -47.33 113.74 2.65 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.49 1.516 . . . . 1.0 110.327 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.72 74.07 5.2 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.673 2.249 . . . . 1.0 111.402 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 t 35.54 41.39 0.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.932 2.493 . . . . 1.0 113.966 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.2 t -159.79 -44.96 0.05 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.637 0.775 . . . . 1.0 110.587 -175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -73.8 45.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 1.0 110.752 177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -84.75 124.14 31.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.849 -1.157 . . . . 1.0 108.218 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 5.4 pm0 -64.16 -164.47 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 130.742 3.617 . . . . 1.0 112.676 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -150.27 119.13 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.39 1.476 . . . . 1.0 107.932 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.253 1.254 1 C-N-CA 135.313 5.445 . . . . 1.0 106.152 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.675 ' HA ' ' HB1' ' A' ' 139' ' ' ALA . 19.0 ttt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.79 124.51 18.73 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 104.155 -2.535 . . . . 1.0 104.155 153.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -119.55 124.02 45.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 103.656 -2.72 . . . . 1.0 103.656 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -124.67 148.53 47.93 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.09 33.53 15.23 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.359 1.463 . . . . 1.0 110.325 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.66 18.61 52.77 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.625 1.107 . . . . 1.0 113.074 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -131.45 176.26 8.45 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.113 -1.81 . . . . 1.0 106.113 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.04 130.77 44.19 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.784 -1.197 . . . . 1.0 108.35 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 136.74 55.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.194 0.198 . . . . 1.0 111.351 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 49.25 58.42 5.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.973 2.109 . . . . 1.0 110.807 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.47 133.25 21.11 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.382 -1.281 . . . . 1.0 109.475 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.1 tpt85 -67.87 123.34 20.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.615 -1.994 . . . . 1.0 105.615 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -91.87 128.16 37.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.185 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 t -145.82 85.58 7.63 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.092 . . . . 1.0 108.796 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.39 152.08 71.22 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 121.285 1.323 . . . . 1.0 110.578 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -146.75 132.67 9.43 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 126.056 1.742 . . . . 1.0 107.788 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.49 45.13 1.63 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.005 2.47 . . . . 1.0 113.133 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -123.88 43.2 3.04 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.384 -0.823 . . . . 1.0 109.982 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' CB ' ' HG2' ' A' ' 92' ' ' LYS . 36.6 m-85 -73.57 -179.83 3.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.088 1.355 . . . . 1.0 109.878 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.39 178.6 4.39 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 122.754 1.264 . . . . 1.0 112.898 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -152.66 118.5 5.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.066 -2.939 . . . . 1.0 103.066 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -135.71 145.61 53.79 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 120.273 1.397 . . . . 1.0 108.742 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.23 67.22 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.459 2.773 . . . . 1.0 111.71 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -154.41 143.82 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.661 2.384 . . . . 1.0 107.131 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.92 103.93 3.11 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.898 2.079 . . . . 1.0 106.681 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -136.44 169.46 17.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.817 2.447 . . . . 1.0 106.972 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -63.97 123.54 82.27 Favored Pre-proline 0 C--O 1.24 0.601 0 C-N-CA 124.912 1.285 . . . . 1.0 110.371 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -86.69 103.44 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.831 1.687 . . . . 1.0 110.512 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.1 t -177.1 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 104.51 -2.404 . . . . 1.0 104.51 176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -148.34 145.75 28.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.395 3.078 . . . . 1.0 104.181 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.5 tp -114.5 129.76 56.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG12 ' CD2' ' A' ' 34' ' ' HIS . 2.4 t -105.89 136.03 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 -178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 169' ' ' PHE . 74.0 t -135.02 113.95 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.763 -1.94 . . . . 1.0 105.763 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CD2' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -165.15 167.26 18.32 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.273 1.429 . . . . 1.0 107.276 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -96.93 116.67 29.59 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.89 -0.781 . . . . 1.0 108.89 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -142.03 172.2 9.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.943 2.097 . . . . 1.0 106.926 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.2 t -155.55 118.04 4.2 Favored 'General case' 0 N--CA 1.443 -0.795 1 N-CA-C 98.981 -4.451 . . . . 1.0 98.981 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 -66.74 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.529 0 CA-C-O 116.007 -1.949 . . . . 1.0 109.285 -176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.24 136.94 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 CA-C-N 123.943 2.444 . . . . 1.0 107.36 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.25 44.73 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.096 3.198 . . . . 1.0 114.986 -175.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -31.5 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.241 0 C-N-CA 126.125 1.822 . . . . 1.0 110.829 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -154.29 122.69 6.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.167 -2.531 . . . . 1.0 104.167 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -176.76 175.54 1.64 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 128.884 2.874 . . . . 1.0 107.942 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -130.76 26.58 4.02 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.588 1.566 . . . . 1.0 112.331 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.65 118.24 6.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.26 1.53 . . . . 1.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.13 -5.0 15.41 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.316 2.011 . . . . 1.0 113.148 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.5 t-105 -62.02 -38.65 89.48 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.415 1.086 . . . . 1.0 109.43 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.5 mt -65.7 -45.06 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 176.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.44 -46.61 89.43 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.334 -0.617 . . . . 1.0 109.334 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.53 -36.18 63.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.172 1.389 . . . . 1.0 111.719 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -60.45 3.78 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.694 0.798 . . . . 1.0 109.655 176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -68.78 -46.92 67.48 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 118.574 0.625 . . . . 1.0 112.384 -175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -60.48 -33.89 73.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.486 1.114 . . . . 1.0 108.732 -177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.56 35.8 4.25 Favored Glycine 0 C--N 1.342 0.879 0 C-N-CA 124.552 1.072 . . . . 1.0 113.349 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -124.77 18.05 8.67 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.885 1.342 . . . . 1.0 111.752 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.03 140.0 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.701 0.801 . . . . 1.0 110.427 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -98.37 128.01 34.5 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 127.713 2.405 . . . . 1.0 106.257 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.21 70.51 2.38 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.211 3.274 . . . . 1.0 109.472 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -106.9 -65.28 1.1 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.948 1.299 . . . . 1.0 112.843 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.4 -60.46 1.49 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.917 1.687 . . . . 1.0 113.225 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 64' ' ' PHE . 20.8 p80 -168.48 177.69 1.2 Allowed Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.562 1.145 . . . . 1.0 108.13 175.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.9 Cg_endo -70.25 -43.62 2.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 121.733 1.622 . . . . 1.0 113.926 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -50.48 -62.26 1.69 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.805 1.242 . . . . 1.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.428 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 5.2 t80 -56.88 -50.35 72.75 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.409 0.684 . . . . 1.0 111.201 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.17 96.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.892 0.477 . . . . 1.0 110.849 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -57.73 17.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 124.791 1.186 . . . . 1.0 110.629 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.49 -24.15 34.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 CA-C-O 116.589 -1.672 . . . . 1.0 113.734 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.11 -43.52 20.58 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.716 1.598 . . . . 1.0 113.0 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -58.04 -33.85 69.45 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.095 0.558 . . . . 1.0 110.806 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.39 136.4 33.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -65.28 146.49 54.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.163 -1.415 . . . . 1.0 109.445 175.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -116.92 162.26 15.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 125.506 1.522 . . . . 1.0 110.507 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.612 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.8 m -174.05 128.1 0.37 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.543 2.337 . . . . 1.0 108.151 175.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.26 -172.47 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.453 -1.684 . . . . 1.0 106.453 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -110.81 -58.72 2.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.597 1.159 . . . . 1.0 111.767 176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.507 ' HB2' HD13 ' A' ' 115' ' ' ILE . 19.9 m -141.04 118.44 11.46 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 106.189 -1.782 . . . . 1.0 106.189 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.94 113.42 25.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 104.825 -2.287 . . . . 1.0 104.825 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.6 mt -89.16 113.48 25.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.61 -1.996 . . . . 1.0 105.61 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.6 ttp85 -71.22 150.63 45.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.871 -1.159 . . . . 1.0 107.871 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.25 -13.76 0.96 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.565 1.146 . . . . 1.0 113.917 175.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -91.7 21.03 5.01 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 128.037 2.535 . . . . 1.0 112.737 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.51 29.32 71.42 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 126.792 2.139 . . . . 1.0 114.885 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -102.14 108.94 20.5 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 118.652 1.226 . . . . 1.0 108.239 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.03 113.69 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.767 -2.679 . . . . 1.0 103.767 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.57 123.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 103.084 -2.932 . . . . 1.0 103.084 175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.29 113.44 26.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.977 -1.49 . . . . 1.0 106.977 -175.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.91 114.35 20.9 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.639 -2.356 . . . . 1.0 104.639 175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 89.11 91.57 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 122.432 2.378 . . . . 1.0 110.554 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.26 -171.66 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.208 1.938 . . . . 1.0 109.907 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -64.57 21.77 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.498 1.919 . . . . 1.0 115.941 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -141.44 126.14 17.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.625 1.97 . . . . 1.0 109.127 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' HG2' ' CB ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER 86.56 81.92 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.849 3.26 . . . . 1.0 111.762 175.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -36.7 135.38 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 128.259 2.624 . . . . 1.0 112.373 176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.612 ' HB1' ' O ' ' A' ' 73' ' ' SER . . . -104.04 -178.67 3.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.769 2.428 . . . . 1.0 111.058 -175.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' HE1' ' ND2' ' A' ' 109' ' ' ASN . 80.0 t90 -146.23 118.55 8.4 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.418 1.887 . . . . 1.0 107.114 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -164.96 63.29 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.224 1.012 . . . . 1.0 110.601 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.64 -68.72 0.07 Allowed 'General case' 0 C--O 1.237 0.425 0 O-C-N 118.792 -2.443 . . . . 1.0 112.274 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.38 -90.41 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.421 -1.872 . . . . 1.0 108.421 -175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.6 t -140.32 146.11 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.473 1.909 . . . . 1.0 110.758 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.8 p -163.47 155.49 17.58 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.059 1.743 . . . . 1.0 109.044 175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.662 ' H ' HG22 ' A' ' 157' ' ' ILE . 3.0 p -146.86 133.55 19.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.58 -2.378 . . . . 1.0 104.58 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -161.49 124.59 3.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.286 0.948 . . . . 1.0 108.898 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 60.13 71.57 0.57 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.044 1.738 . . . . 1.0 113.622 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.4 30.3 55.12 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 126.433 1.968 . . . . 1.0 113.922 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 28.7 ttm105 -150.05 113.63 4.99 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.441 1.096 . . . . 1.0 108.566 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -82.05 145.13 30.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.226 -2.139 . . . . 1.0 105.226 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -128.98 118.03 21.92 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.992 -1.855 . . . . 1.0 105.992 -176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 t -66.11 -36.02 82.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.842 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.46 ' ND2' ' HE1' ' A' ' 95' ' ' TRP . 15.8 m120 -146.73 174.12 11.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.91 2.884 . . . . 1.0 106.037 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.48 76.84 9.91 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 106.533 -1.655 . . . . 1.0 106.533 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 39.68 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.482 1.913 . . . . 1.0 109.889 176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -124.23 156.72 36.34 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.204 1.802 . . . . 1.0 112.29 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.255 0.0 OUTLIER -99.98 57.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 105.971 -1.862 . . . . 1.0 105.971 175.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -80.35 -136.53 1.65 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.225 -0.922 . . . . 1.0 111.595 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 136' ' ' VAL . 7.5 mm -142.25 163.15 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 128.888 2.875 . . . . 1.0 103.723 176.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -136.12 129.3 31.59 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.393 2.277 . . . . 1.0 105.338 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.8 mt -101.24 153.81 19.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 120.258 1.39 . . . . 1.0 109.305 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.34 47.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.83 0.824 . . . . 1.0 111.36 -176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.31 -173.47 41.1 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.294 2.378 . . . . 1.0 108.946 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 p -136.44 100.2 4.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 102.692 -3.077 . . . . 1.0 102.692 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 43.01 55.63 4.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.848 2.459 . . . . 1.0 112.472 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.4 p 52.69 38.09 25.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.089 2.155 . . . . 1.0 114.155 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 tp -60.2 136.01 57.9 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 105.392 -2.077 . . . . 1.0 105.392 175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -23.84 113.2 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.29 2.236 . . . . 1.0 110.411 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -78.02 -8.17 57.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 115.683 -2.103 . . . . 1.0 116.371 -174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.325 37.3 p 63.89 77.96 0.3 Allowed 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 121.636 2.016 . . . . 1.0 111.383 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -23.64 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.901 2.081 . . . . 1.0 113.97 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.09 -38.61 1.72 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.435 2.294 . . . . 1.0 109.455 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.67 -48.82 58.3 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.999 1.32 . . . . 1.0 110.575 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -59.16 -38.27 79.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.079 0.854 . . . . 1.0 110.509 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -66.02 -55.03 18.72 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.253 0.621 . . . . 1.0 110.156 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 136' ' ' VAL . 12.1 mt-30 -61.69 -54.06 47.66 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.861 0.865 . . . . 1.0 109.131 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 115' ' ' ILE . 55.3 tp -53.22 -49.32 67.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 124.251 1.021 . . . . 1.0 109.728 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.04 -37.0 85.44 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 120.408 1.458 . . . . 1.0 111.682 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.85 51.05 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.741 0.7 . . . . 1.0 109.294 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 115' ' ' ILE . 95.7 t -52.91 -64.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 126.758 2.023 . . . . 1.0 108.417 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 64.0 m -54.35 -52.43 61.63 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.902 2.081 . . . . 1.0 111.456 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -57.22 -42.02 80.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.382 1.447 . . . . 1.0 110.408 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -68.58 -47.48 66.65 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.266 -0.896 . . . . 1.0 111.352 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.7 mt -56.91 -34.71 68.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.58 -1.325 . . . . 1.0 111.598 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.61 -40.08 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.474 -1.306 . . . . 1.0 107.474 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.6 m -63.15 -13.44 37.05 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.13 1.372 . . . . 1.0 110.965 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -95.93 -65.39 0.98 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.158 -1.589 . . . . 1.0 107.406 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -120.89 112.99 33.23 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 106.021 -1.844 . . . . 1.0 106.021 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.455 ' HB2' ' HE2' ' A' ' 184' ' ' LYS . 71.5 Cg_endo -95.89 107.89 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 CA-C-N 120.182 1.101 . . . . 1.0 111.208 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.91 -49.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.365 1.866 . . . . 1.0 106.636 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 38.5 mt -45.9 -33.37 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 128.944 2.898 . . . . 1.0 110.815 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.16 -26.53 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 1.0 113.412 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -133.13 18.62 4.07 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.945 2.098 . . . . 1.0 110.178 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -138.44 83.74 1.98 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.454 -1.404 . . . . 1.0 107.842 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.6 mtt -121.55 114.05 20.66 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -149.18 -168.07 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.963 -0.754 . . . . 1.0 108.963 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.93 -130.67 1.64 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 105.017 -3.233 . . . . 1.0 105.017 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . 0.259 14.7 m170 -112.73 -24.43 9.61 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.978 0.911 . . . . 1.0 111.277 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.9 t -102.67 -16.03 16.16 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.417 0.687 . . . . 1.0 110.359 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -86.59 39.62 0.85 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 107.893 -1.151 . . . . 1.0 107.893 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.662 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.62 -17.5 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 O-C-N 120.322 -1.486 . . . . 1.0 109.294 175.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -149.54 -64.53 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 125.553 1.541 . . . . 1.0 109.715 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 98.4 Cg_endo -78.51 115.06 3.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.365 2.043 . . . . 1.0 113.23 -175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -22.48 58.66 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 1.0 112.273 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.2 tpt85 -58.65 -17.15 19.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.199 2.2 . . . . 1.0 112.686 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -141.66 141.02 33.38 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.8 m -131.84 -16.72 2.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 118.903 -1.119 . . . . 1.0 110.358 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.9 -179.62 0.34 Allowed Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 130.117 3.367 . . . . 1.0 104.085 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.06 78.25 3.5 Favored 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 121.876 1.717 . . . . 1.0 108.561 175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.44 64.08 0.56 Allowed Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.866 -1.519 . . . . 1.0 114.811 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.52 -54.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 121.429 2.615 . . . . 1.0 111.599 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.0 t 54.52 44.5 28.66 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.918 1.687 . . . . 1.0 112.468 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' CD2' HG11 ' A' ' 33' ' ' VAL . 81.4 t80 -108.73 17.68 21.62 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.372 1.619 . . . . 1.0 115.372 -175.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.369 11.3 t70 43.0 75.69 0.09 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.086 1.754 . . . . 1.0 113.194 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -48.65 -34.16 11.27 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.838 0.681 . . . . 1.0 112.838 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.63 75.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.942 -1.028 . . . . 1.0 111.707 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.4 -49.45 77.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.773 1.17 . . . . 1.0 109.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 34.3 t80 -66.2 -52.15 50.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.424 0.898 . . . . 1.0 113.424 -176.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.5 ttm105 -61.55 -28.26 69.2 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.592 0.633 . . . . 1.0 111.476 -175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.45 87.28 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.125 0.875 . . . . 1.0 111.341 175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.8 mt -71.04 -61.53 1.73 Allowed 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.292 1.437 . . . . 1.0 111.065 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 90.4 t -66.35 166.36 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 124.13 0.972 . . . . 1.0 110.062 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 92.7 m -43.18 113.8 1.47 Allowed Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.297 1.439 . . . . 1.0 109.369 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -86.21 53.85 3.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.368 2.712 . . . . 1.0 107.019 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.4 t 54.32 34.01 19.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.732 0.813 . . . . 1.0 111.473 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -153.35 -46.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.854 1.057 . . . . 1.0 113.854 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -74.27 78.76 1.82 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.693 1.197 . . . . 1.0 107.977 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 145' ' ' PRO . 33.1 tttm -139.05 153.24 48.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.677 1.991 . . . . 1.0 107.69 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.77 -176.32 4.01 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.9 tpt -65.16 164.76 12.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.129 0.971 . . . . 1.0 112.075 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.4 m . . . . . 0 C--O 1.253 1.244 0 C-N-CA 127.46 2.304 . . . . 1.0 111.366 177.406 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HA ' ' HB1' ' A' ' 139' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -64.91 123.76 20.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.649 -1.612 . . . . 1.0 106.649 175.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.89 123.61 29.35 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.881 -2.266 . . . . 1.0 104.881 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.86 145.2 45.87 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 51.97 33.05 11.03 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.486 -0.759 . . . . 1.0 112.64 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.94 17.58 51.6 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.364 0.983 . . . . 1.0 113.492 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.0 m95 -129.07 170.26 13.72 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.345 -2.094 . . . . 1.0 105.345 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.09 131.66 46.27 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.432 -1.418 . . . . 1.0 108.837 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.02 36.25 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 40.67 57.88 2.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.553 2.741 . . . . 1.0 108.6 -175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.61 150.98 30.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.838 1.255 . . . . 1.0 109.375 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB3' HG13 ' A' ' 85' ' ' VAL . 25.6 tpt85 -86.21 123.24 31.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -84.63 129.62 34.82 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.031 -1.1 . . . . 1.0 108.031 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 t -140.43 79.33 20.84 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 108.189 -1.041 . . . . 1.0 108.189 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.27 127.93 12.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.409 2.072 . . . . 1.0 109.104 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 t -128.18 120.93 21.4 Favored Pre-proline 0 C--O 1.232 0.184 0 N-CA-C 106.894 -1.521 . . . . 1.0 106.894 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -77.3 52.08 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.128 2.552 . . . . 1.0 112.465 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -123.63 43.44 2.97 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 105.941 -1.874 . . . . 1.0 105.941 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.457 ' CE2' HG13 ' A' ' 88' ' ' VAL . 22.9 m-85 -74.26 178.46 5.12 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.723 0.809 . . . . 1.0 109.694 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.65 179.48 5.66 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.94 1.296 . . . . 1.0 110.975 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.5 m -162.67 118.63 1.88 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.756 2.822 . . . . 1.0 105.738 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -131.9 138.47 32.55 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 117.257 -1.354 . . . . 1.0 107.455 175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.61 99.66 1.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.473 2.782 . . . . 1.0 109.389 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -168.03 151.48 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.9 2.48 . . . . 1.0 105.966 176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -151.53 106.74 3.31 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.261 1.391 . . . . 1.0 108.288 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -136.36 165.48 25.7 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.85 2.06 . . . . 1.0 107.28 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -67.43 123.47 86.7 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.173 -1.047 . . . . 1.0 108.173 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.96 103.71 0.85 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.548 2.165 . . . . 1.0 110.528 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 t -170.54 73.88 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 107.669 -1.234 . . . . 1.0 107.669 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -147.57 124.03 11.01 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.666 1.587 . . . . 1.0 106.97 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.5 tp -88.44 131.64 34.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.119 0.968 . . . . 1.0 109.389 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.3 143.17 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 105.756 -1.942 . . . . 1.0 105.756 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 64.6 t -136.14 116.46 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 105.991 -1.855 . . . . 1.0 105.991 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.4 OUTLIER -172.08 152.19 2.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.264 1.425 . . . . 1.0 107.465 175.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.04 112.4 24.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.409 -2.071 . . . . 1.0 105.409 175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 6.8 mm -128.27 176.76 7.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 128.672 2.789 . . . . 1.0 106.545 175.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 t -153.28 121.47 6.19 Favored 'General case' 0 C--N 1.31 -1.124 1 N-CA-C 93.728 -6.397 . . . . 1.0 93.728 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 48' ' ' ILE 0.297 0.3 OUTLIER -142.0 -60.33 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.488 0 CA-C-N 119.459 1.027 . . . . 1.0 110.537 176.488 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.52 134.31 11.06 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 CA-C-N 121.904 1.716 . . . . 1.0 110.419 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.27 75.81 3.25 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.341 2.694 . . . . 1.0 115.408 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.82 -71.7 0.85 Allowed Glycine 0 CA--C 1.532 1.132 0 N-CA-C 106.615 -2.594 . . . . 1.0 106.615 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -156.21 123.63 5.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.888 1.275 . . . . 1.0 110.7 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -174.2 148.22 1.29 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.778 2.831 . . . . 1.0 108.294 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.51 -35.37 55.89 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.442 0.565 . . . . 1.0 113.406 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.39 118.94 11.38 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 124.558 1.075 . . . . 1.0 113.157 -175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.78 -5.88 17.42 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.636 2.891 . . . . 1.0 115.262 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -48.36 -45.73 35.92 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.439 1.472 . . . . 1.0 110.905 176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 38' ' ' LEU . 7.0 mt -65.98 -45.14 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.816 -176.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.16 -39.35 92.34 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 120.542 -0.463 . . . . 1.0 109.768 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.503 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -58.48 -34.25 70.68 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.238 0.472 . . . . 1.0 111.686 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.69 -52.4 51.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.573 1.149 . . . . 1.0 109.372 175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.28 -41.37 73.49 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 113.313 0.857 . . . . 1.0 113.313 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.9 t -66.02 -48.58 70.65 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 176.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.86 2.46 11.35 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.713 1.625 . . . . 1.0 114.503 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -89.08 9.21 26.22 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.913 1.856 . . . . 1.0 113.008 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.2 tt -52.21 129.53 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.293 1.437 . . . . 1.0 112.543 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.0 135.52 20.84 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 127.272 2.229 . . . . 1.0 109.599 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.88 78.1 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.604 2.869 . . . . 1.0 106.951 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -103.2 -65.07 1.02 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.036 0.534 . . . . 1.0 111.055 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 -46.45 79.01 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.226 0.61 . . . . 1.0 111.117 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -171.08 178.08 0.85 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.037 1.735 . . . . 1.0 107.71 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.22 -43.4 4.62 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.596 2.197 . . . . 1.0 114.972 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -46.14 -50.88 14.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.373 1.249 . . . . 1.0 114.373 -175.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -54.62 42.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.302 1.041 . . . . 1.0 110.025 -175.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.24 -43.27 99.22 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.434 1.093 . . . . 1.0 111.29 175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.99 -58.15 12.55 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 126.106 1.813 . . . . 1.0 112.184 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.7 pt -57.94 -38.26 65.47 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 117.954 -1.022 . . . . 1.0 111.879 -176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.79 -43.1 2.84 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.304 2.241 . . . . 1.0 115.318 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -61.22 -33.39 73.41 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.599 -0.688 . . . . 1.0 110.377 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.76 135.78 33.6 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 103.376 -2.824 . . . . 1.0 103.376 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' H ' ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -65.54 145.7 55.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.583 -0.698 . . . . 1.0 109.152 176.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 m -116.91 161.85 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 127.587 2.355 . . . . 1.0 111.418 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -175.97 139.96 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.412 2.285 . . . . 1.0 106.847 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -160.21 0.78 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.837 1.255 . . . . 1.0 108.074 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -130.41 -58.85 1.04 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.437 1.495 . . . . 1.0 108.539 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.97 119.42 17.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 104.196 -2.52 . . . . 1.0 104.196 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 tp -107.3 113.55 27.02 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.199 -2.519 . . . . 1.0 104.199 175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 mt -94.16 114.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 105.961 -1.866 . . . . 1.0 105.961 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -76.0 145.39 40.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.231 -1.396 . . . . 1.0 107.231 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.76 -20.55 2.21 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.97 1.471 . . . . 1.0 114.97 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -91.4 29.95 1.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.271 1.828 . . . . 1.0 112.105 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.42 52.28 52.38 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 126.127 1.822 . . . . 1.0 114.085 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -126.77 117.34 22.47 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.331 -0.842 . . . . 1.0 110.465 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 132' ' ' GLN . 83.4 mt -83.02 114.73 24.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 101.6 -3.481 . . . . 1.0 101.6 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.3 t -110.48 142.27 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 103.34 -2.837 . . . . 1.0 103.34 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -121.14 114.04 20.87 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.074 -1.641 . . . . 1.0 111.264 -175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -108.98 120.17 41.74 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 104.864 -2.273 . . . . 1.0 104.864 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.457 HG13 ' CE2' ' A' ' 19' ' ' TYR . 72.8 t 64.93 88.6 0.11 Allowed Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 120.024 1.284 . . . . 1.0 112.869 175.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.19 178.21 5.7 Favored 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 121.528 1.485 . . . . 1.0 109.548 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -43.55 9.26 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.149 1 C-N-CA 133.476 4.71 . . . . 1.0 120.198 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -133.89 111.12 10.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 119.371 -2.081 . . . . 1.0 107.552 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 86.25 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.889 2.076 . . . . 1.0 111.41 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -34.0 156.29 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.302 2.641 . . . . 1.0 114.669 177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.59 -178.51 3.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 130.008 3.323 . . . . 1.0 109.998 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 65.6 t90 -145.93 118.54 8.57 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.95 1.25 . . . . 1.0 110.246 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -154.79 62.82 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 123.132 1.444 . . . . 1.0 110.747 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -161.76 -55.77 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 118.944 -2.348 . . . . 1.0 112.917 176.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.92 -74.41 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.177 -1.969 . . . . 1.0 108.177 -175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.18 128.82 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.244 1.417 . . . . 1.0 109.675 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.6 p -166.19 154.28 10.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.68 1.592 . . . . 1.0 112.14 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 157' ' ' ILE . 60.6 p -153.21 146.63 24.91 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 120.864 -1.147 . . . . 1.0 110.812 178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -153.88 154.62 34.21 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.549 0.613 . . . . 1.0 110.504 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 38.91 55.38 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.223 1.809 . . . . 1.0 111.612 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.38 33.67 77.1 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.86 -0.967 . . . . 1.0 114.468 176.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -136.55 119.86 16.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.503 -1.665 . . . . 1.0 106.503 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 1.2 tt0 -100.44 138.7 37.16 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.635 -0.506 . . . . 1.0 109.635 -176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 36.4 mtm180 -113.31 118.34 34.32 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.1 t -58.07 -41.75 84.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.348 1.059 . . . . 1.0 111.212 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -148.19 177.02 9.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 129.514 3.126 . . . . 1.0 108.059 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.0 76.91 10.01 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-O 122.387 1.089 . . . . 1.0 108.689 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 107' ' ' ARG . 0.6 OUTLIER -87.51 33.92 0.7 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.198 0.999 . . . . 1.0 111.185 177.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.2 m -135.46 137.61 42.35 Favored 'General case' 0 C--O 1.223 -0.316 0 O-C-N 120.034 -1.666 . . . . 1.0 113.013 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.98 57.0 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.932 2.093 . . . . 1.0 109.843 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.18 -136.79 2.41 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 120.85 -1.156 . . . . 1.0 111.029 177.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 136' ' ' VAL . 1.1 mm -142.63 162.02 18.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 129.177 2.991 . . . . 1.0 103.329 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.94 130.22 29.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.76 -3.052 . . . . 1.0 102.76 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -93.54 157.53 16.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 107.435 -1.321 . . . . 1.0 107.435 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -131.08 155.82 46.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.959 0.885 . . . . 1.0 111.12 -178.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.55 179.36 43.35 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.393 -1.276 . . . . 1.0 111.027 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -147.88 116.35 6.62 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 128.229 2.611 . . . . 1.0 105.434 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.8 t0 54.17 32.48 15.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.858 2.463 . . . . 1.0 115.109 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.0 p 51.25 37.53 18.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.3 1.84 . . . . 1.0 113.212 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.44 146.46 54.85 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.749 1.62 . . . . 1.0 108.508 175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -29.3 113.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.658 1.983 . . . . 1.0 111.206 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -78.36 -9.41 59.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -174.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.354 18.3 p 66.84 77.66 0.27 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 116.711 -1.614 . . . . 1.0 111.84 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -24.45 -33.59 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 121.148 1.795 . . . . 1.0 113.729 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -42.12 -43.08 3.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.728 2.011 . . . . 1.0 110.245 174.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -55.53 -44.65 76.91 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 124.263 1.025 . . . . 1.0 111.461 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -60.55 -43.31 97.38 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 119.755 1.162 . . . . 1.0 109.902 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -63.08 -55.54 24.57 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' ILE . 82.3 mt-30 -66.01 -43.06 88.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.767 0.827 . . . . 1.0 111.08 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.75 -48.01 80.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 120.314 1.415 . . . . 1.0 108.902 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.26 -46.06 89.53 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.292 -0.861 . . . . 1.0 109.438 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.58 -53.89 45.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.991 0.916 . . . . 1.0 110.797 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 115' ' ' ILE . 61.6 t -55.84 -53.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 109.311 -0.626 . . . . 1.0 109.311 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 59.0 m -57.88 -57.6 12.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.405 1.482 . . . . 1.0 110.452 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -56.19 -46.4 79.41 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.653 1.581 . . . . 1.0 110.738 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.558 ' HB1' ' HA ' ' A' ' 1' ' ' MET . . . -70.67 -41.38 72.15 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.968 -0.539 . . . . 1.0 111.379 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 29.9 mt -56.71 -42.69 79.6 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.927 -1.108 . . . . 1.0 109.93 174.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.8 -41.03 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.673 1.189 . . . . 1.0 109.721 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.7 m -59.25 -13.08 6.57 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.337 1.055 . . . . 1.0 112.394 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -111.85 -43.61 3.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.275 -1.345 . . . . 1.0 111.39 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.52 112.81 23.03 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -97.97 107.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 121.286 1.495 . . . . 1.0 111.493 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.81 -54.02 0.13 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.71 2.004 . . . . 1.0 108.251 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 60.0 mt -49.77 -32.76 7.79 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 129.5 3.12 . . . . 1.0 110.813 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.36 -21.46 2.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.708 1.203 . . . . 1.0 113.345 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.57 18.39 3.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 126.881 2.072 . . . . 1.0 110.894 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -143.2 83.96 1.81 Allowed 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.125 -0.984 . . . . 1.0 109.899 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.26 127.9 40.49 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.835 -1.543 . . . . 1.0 106.835 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.0 t -158.53 -168.23 2.38 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.32 -0.992 . . . . 1.0 108.32 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -151.75 -131.67 1.77 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 106.7 -2.56 . . . . 1.0 106.7 175.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 97' ' ' ALA . 9.2 m170 -113.78 -23.2 9.8 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.111 0.964 . . . . 1.0 111.276 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.3 -15.89 15.32 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.145 0.978 . . . . 1.0 109.543 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -87.82 38.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.173 -0.954 . . . . 1.0 109.759 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -68.92 -17.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 120.914 -1.116 . . . . 1.0 109.446 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -155.02 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.232 1.813 . . . . 1.0 111.453 175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 60.0 Cg_endo -92.3 110.24 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.795 2.33 . . . . 1.0 112.781 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -58.39 -25.95 62.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.346 1.858 . . . . 1.0 113.924 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.75 -25.31 62.87 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.497 0.719 . . . . 1.0 112.794 -175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -127.69 139.73 52.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -127.65 -16.43 4.77 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.978 -0.378 . . . . 1.0 109.978 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.18 178.85 0.48 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 131.281 3.832 . . . . 1.0 103.725 176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.13 85.63 1.36 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.186 1.924 . . . . 1.0 109.994 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.96 68.32 0.62 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.236 1.398 . . . . 1.0 111.64 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 168' ' ' SER . 71.9 Cg_endo -75.38 -70.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.688 2.259 . . . . 1.0 112.592 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.403 ' H ' ' HG2' ' A' ' 167' ' ' PRO . 15.4 t 53.7 42.9 31.72 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 127.582 2.353 . . . . 1.0 111.408 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -99.56 18.92 16.75 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.11 -1.619 . . . . 1.0 113.9 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.8 t0 43.35 70.77 0.28 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.781 1.233 . . . . 1.0 112.93 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -56.27 -30.09 62.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 1.0 112.66 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.86 -60.07 3.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 119.037 0.835 . . . . 1.0 109.065 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -64.18 -34.54 78.32 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.371 -0.931 . . . . 1.0 111.967 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.423 ' CZ ' HG21 ' A' ' 178' ' ' VAL . 85.6 t80 -66.01 -52.7 46.89 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 119.823 1.192 . . . . 1.0 110.618 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -34.64 74.6 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 119.049 -0.5 . . . . 1.0 109.985 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.06 89.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.868 0.867 . . . . 1.0 112.557 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.54 -58.86 3.25 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.793 1.237 . . . . 1.0 110.155 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 174' ' ' PHE . 53.5 t -66.03 166.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.327 1.051 . . . . 1.0 110.23 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 86.3 m -40.26 114.68 1.07 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 109.765 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -80.95 46.38 2.25 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 124.142 3.228 . . . . 1.0 114.623 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.8 t 49.18 34.56 6.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.495 1.918 . . . . 1.0 113.507 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -162.43 89.99 0.71 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -166.2 100.54 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.04 -1.037 . . . . 1.0 108.495 -175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt -69.39 123.64 21.77 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 118.617 -1.233 . . . . 1.0 108.29 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 0.3 OUTLIER -86.03 -162.55 0.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.275 2.63 . . . . 1.0 108.861 175.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -152.41 114.77 4.49 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.463 -1.68 . . . . 1.0 106.463 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.895 1.678 . . . . 1.0 109.762 -176.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' HG22 ' A' ' 136' ' ' VAL . 52.9 ttm . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.7 tp -141.5 170.75 15.14 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.282 1.833 . . . . 1.0 106.923 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.7 mt -108.76 123.35 48.88 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 101.558 -3.497 . . . . 1.0 101.558 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -114.34 123.11 48.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 47.09 36.44 4.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.073 0.949 . . . . 1.0 111.435 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.43 2.03 39.79 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.551 1.072 . . . . 1.0 114.615 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -97.04 167.71 10.9 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.148 -2.167 . . . . 1.0 105.148 175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 tt -80.2 124.04 28.45 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.811 -1.181 . . . . 1.0 108.382 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.86 139.77 41.86 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 117.964 0.347 . . . . 1.0 110.682 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 57.24 65.99 1.25 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 127.062 2.145 . . . . 1.0 112.818 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.41 148.48 37.89 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.262 1.425 . . . . 1.0 107.289 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -72.07 123.38 22.71 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 104.545 -2.391 . . . . 1.0 104.545 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.91 38.32 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.734 0.814 . . . . 1.0 111.929 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.67 72.92 77.08 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.066 0.946 . . . . 1.0 108.803 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.57 123.26 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 107.513 -1.764 . . . . 1.0 107.513 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 t -136.02 113.38 10.62 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -86.3 61.78 4.8 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.97 2.447 . . . . 1.0 108.926 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -124.01 44.69 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.892 -1.892 . . . . 1.0 105.892 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.495 ' HE1' HG22 ' A' ' 88' ' ' VAL . 14.4 m-85 -82.01 178.38 8.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.819 2.048 . . . . 1.0 113.466 -175.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -103.87 -179.3 3.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 128.268 2.627 . . . . 1.0 112.912 177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.5 m -157.65 118.59 3.54 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.173 4.589 . . . . 1.0 101.337 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -132.92 138.46 31.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 116.728 -1.606 . . . . 1.0 107.975 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.68 86.95 1.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.57 2.846 . . . . 1.0 108.675 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB2' HH12 ' A' ' 93' ' ' ARG . 13.2 m-20 -160.29 150.88 18.58 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.828 2.451 . . . . 1.0 106.226 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -151.49 104.06 3.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.322 1.849 . . . . 1.0 106.134 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -137.11 170.36 16.23 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 120.476 1.489 . . . . 1.0 108.138 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -75.43 123.19 88.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 119.905 -1.747 . . . . 1.0 109.033 176.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.22 103.54 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.967 1.778 . . . . 1.0 110.712 -175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' A' ' 146' ' ' ALA . 11.3 t -171.08 77.23 0.07 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.55 -1.648 . . . . 1.0 106.55 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' HB3' ' A' ' 150' ' ' ASN . 5.0 tp -145.8 124.72 12.72 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.23 127.26 35.75 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.834 -1.543 . . . . 1.0 106.834 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.09 113.8 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 -175.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 163' ' ' THR . 48.4 t -108.79 114.58 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 104.916 -2.253 . . . . 1.0 104.916 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.63 149.18 5.54 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 116.731 -1.604 . . . . 1.0 106.868 175.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -95.54 111.43 23.34 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 117.145 -1.822 . . . . 1.0 110.138 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -127.6 176.78 6.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 129.98 3.312 . . . . 1.0 107.273 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.1 t -149.15 121.04 8.16 Favored 'General case' 0 C--N 1.313 -1.016 1 N-CA-C 94.697 -6.038 . . . . 1.0 94.697 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.545 HD11 HG21 ' A' ' 72' ' ' VAL 0.295 0.1 OUTLIER -142.36 -61.39 0.02 OUTLIER Pre-proline 0 C--O 1.22 -0.48 0 CA-C-N 119.26 0.937 . . . . 1.0 109.8 175.603 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 11.8 Cg_exo -73.07 124.67 9.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.212 1.942 . . . . 1.0 110.013 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.8 68.89 7.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.538 2.825 . . . . 1.0 111.73 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -50.92 -71.1 0.69 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 108.855 -1.698 . . . . 1.0 108.855 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -152.33 123.48 7.61 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.545 1.938 . . . . 1.0 106.121 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -175.71 158.58 2.18 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.42 2.688 . . . . 1.0 107.857 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.84 -0.75 63.87 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.558 -1.134 . . . . 1.0 113.058 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.14 118.47 4.79 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.67 1.735 . . . . 1.0 110.903 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.35 -12.88 15.43 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.64 2.227 . . . . 1.0 114.101 -175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -61.81 -33.92 75.0 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.921 1.237 . . . . 1.0 111.017 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.6 mt -64.17 -55.42 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.314 -1.365 . . . . 1.0 107.314 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.6 -33.28 75.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.439 0.563 . . . . 1.0 112.271 -177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -53.25 -34.25 56.42 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.74 0.816 . . . . 1.0 111.3 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.36 -51.11 60.53 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.14 -0.975 . . . . 1.0 109.559 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -61.23 -50.63 72.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 1.0 110.884 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 50' ' ' ALA . 4.7 t -61.76 -33.91 74.91 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.346 1.458 . . . . 1.0 110.548 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.63 2.75 37.44 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 117.804 -1.554 . . . . 1.0 115.666 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.5 p -93.04 9.3 36.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.177 1.988 . . . . 1.0 113.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 tt -49.13 137.55 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.344 1.058 . . . . 1.0 112.19 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 136.33 20.75 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 126.415 1.886 . . . . 1.0 107.015 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.49 67.25 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.967 3.112 . . . . 1.0 110.296 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.56 -48.31 4.0 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.486 1.291 . . . . 1.0 114.486 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.46 -64.51 0.81 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.065 0.946 . . . . 1.0 112.76 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -171.04 178.01 0.87 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.376 1.47 . . . . 1.0 108.199 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.78 -43.9 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.848 2.365 . . . . 1.0 115.154 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -51.45 -59.04 4.68 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.984 1.266 . . . . 1.0 112.246 -175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.7 -49.22 69.32 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.718 0.807 . . . . 1.0 111.094 -175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.04 95.1 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.32 0.648 . . . . 1.0 111.595 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.43 -63.47 5.28 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 125.29 1.424 . . . . 1.0 110.751 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.33 -26.12 38.47 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-O 116.06 -1.924 . . . . 1.0 112.49 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -42.79 -43.22 3.89 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 121.002 1.728 . . . . 1.0 115.059 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -60.01 -34.5 73.43 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.499 0.72 . . . . 1.0 111.188 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.8 mt -86.43 136.18 33.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.946 -2.613 . . . . 1.0 103.946 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.86 164.29 15.18 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.853 -1.154 . . . . 1.0 109.358 175.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 38' ' ' LEU . 29.1 m -116.58 166.39 10.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 124.346 1.058 . . . . 1.0 109.593 175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.5 m -170.73 121.56 0.58 Allowed 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.351 1.46 . . . . 1.0 107.653 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.29 -155.5 0.48 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.382 1.873 . . . . 1.0 107.329 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -136.06 -59.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.327 1.851 . . . . 1.0 108.029 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' HB2' HD13 ' A' ' 115' ' ' ILE . 78.1 m -132.63 118.97 19.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.657 -1.238 . . . . 1.0 107.657 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -109.01 113.63 26.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.425 -2.065 . . . . 1.0 105.425 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 22.4 mt -95.37 114.25 31.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.173 -2.158 . . . . 1.0 105.173 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.92 148.91 43.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.394 0.997 . . . . 1.0 108.323 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -13.61 2.51 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.232 1.197 . . . . 1.0 114.232 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -91.82 23.41 3.64 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.258 1.023 . . . . 1.0 110.986 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.52 53.75 41.44 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 127.674 2.559 . . . . 1.0 112.891 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.98 154.63 44.33 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.077 0.951 . . . . 1.0 108.956 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm -115.96 113.77 44.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.53 146.95 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 106.686 -1.598 . . . . 1.0 106.686 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -124.7 113.78 18.44 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.278 1.031 . . . . 1.0 108.876 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -114.05 114.8 26.61 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 104.149 -2.538 . . . . 1.0 104.149 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 19' ' ' TYR . 5.6 t 81.46 91.95 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 119.898 1.226 . . . . 1.0 109.254 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -64.83 -167.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.964 1.776 . . . . 1.0 110.289 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -77.29 51.26 0.83 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 120.377 -1.452 . . . . 1.0 110.976 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -154.99 129.57 9.18 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.545 2.738 . . . . 1.0 105.611 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.6 tttp 62.93 81.52 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 127.04 2.136 . . . . 1.0 112.773 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.434 HH12 ' HB2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -35.45 155.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 129.138 2.975 . . . . 1.0 112.972 -176.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . 0.272 . . -103.45 178.5 4.54 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 127.81 2.444 . . . . 1.0 114.42 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -151.79 118.05 5.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.855 2.062 . . . . 1.0 105.497 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -165.33 62.96 0.12 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 123.135 1.445 . . . . 1.0 109.734 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.89 -69.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 O-C-N 119.114 -2.241 . . . . 1.0 114.758 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.04 -78.04 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.6 t -141.58 143.44 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.166 0.987 . . . . 1.0 108.727 -176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.9 p -166.32 158.32 13.83 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.636 2.375 . . . . 1.0 106.956 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.448 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.9 p -161.25 145.57 13.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.13 -1.804 . . . . 1.0 106.13 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -166.03 155.05 11.49 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . 0.275 37.6 mm-40 39.16 58.01 1.91 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.46 1.904 . . . . 1.0 113.008 -176.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 55.16 28.74 50.42 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.344 1.45 . . . . 1.0 114.247 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -128.9 113.26 15.01 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.796 -1.927 . . . . 1.0 105.796 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 26.5 tp10 -89.76 135.15 33.79 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 -175.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 29.0 mtt85 -125.54 140.71 52.52 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.384 0.993 . . . . 1.0 109.155 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 10.6 t -86.32 -24.72 25.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.844 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -158.34 170.44 22.22 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.085 2.554 . . . . 1.0 106.238 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -84.5 76.3 10.18 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 123.095 1.426 . . . . 1.0 110.507 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.05 44.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.69 2.396 . . . . 1.0 110.297 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 m -123.5 156.56 35.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.439 1.495 . . . . 1.0 112.549 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.262 0.0 OUTLIER -97.65 56.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.705 2.002 . . . . 1.0 108.189 176.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.24 -135.38 3.44 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.512 -1.035 . . . . 1.0 110.512 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 136' ' ' VAL . 10.7 mm -143.92 161.12 15.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 128.827 2.851 . . . . 1.0 104.848 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -131.92 113.66 13.7 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 101.536 -3.505 . . . . 1.0 101.536 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.8 mt -82.51 148.26 28.2 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.291 -1.374 . . . . 1.0 107.291 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.05 155.26 47.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.635 0.731 . . . . 1.0 112.175 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.12 173.4 43.57 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 113.811 -1.541 . . . . 1.0 111.556 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.4 p -137.89 103.15 4.9 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.484 1.913 . . . . 1.0 106.297 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.4 t70 57.87 30.46 19.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.041 1.736 . . . . 1.0 113.344 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.255 81.7 p 57.82 38.74 27.3 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.545 1.938 . . . . 1.0 113.444 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 56.1 tp -69.66 145.58 52.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -28.36 113.46 0.07 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 128.059 2.543 . . . . 1.0 111.778 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -79.02 -9.84 59.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 115.163 -2.351 . . . . 1.0 116.043 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.339 43.6 p 65.08 77.04 0.32 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 121.801 2.091 . . . . 1.0 112.698 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -23.36 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.548 1.539 . . . . 1.0 114.578 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.05 -40.71 6.93 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.301 2.24 . . . . 1.0 111.379 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -47.73 -54.0 13.5 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.394 1.078 . . . . 1.0 109.378 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -59.13 -38.82 80.54 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.334 0.654 . . . . 1.0 111.597 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -65.59 -57.38 8.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.4 0.545 . . . . 1.0 110.888 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -65.08 -37.12 86.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.972 0.805 . . . . 1.0 110.765 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.1 tp -56.52 -47.88 78.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.43 1.014 . . . . 1.0 108.603 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.16 93.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 118.589 -0.72 . . . . 1.0 110.527 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -53.82 53.95 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.071 0.85 . . . . 1.0 110.292 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 115' ' ' ILE . 25.8 t -57.1 -48.61 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.909 -0.775 . . . . 1.0 108.909 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.0 m -56.45 -49.52 74.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.976 1.311 . . . . 1.0 110.438 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -59.02 -46.87 87.12 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.89 0.876 . . . . 1.0 109.944 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.35 -49.3 77.49 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.864 0.302 . . . . 1.0 110.594 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.0 mt -55.94 -44.21 78.16 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.988 0.915 . . . . 1.0 111.187 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.5 mt -59.73 -41.08 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.126 0.875 . . . . 1.0 110.432 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.8 m -65.69 -14.26 60.91 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.826 -1.171 . . . . 1.0 112.252 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -98.68 -59.24 1.78 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.632 1.105 . . . . 1.0 108.191 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -124.82 112.88 27.04 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -101.76 107.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 123.347 1.311 . . . . 1.0 112.465 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' SER . . . -152.29 -41.26 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.073 2.549 . . . . 1.0 105.85 174.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.4 mt -47.75 -33.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 C-N-CA 128.869 2.868 . . . . 1.0 109.851 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.81 -26.25 13.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.023 0.929 . . . . 1.0 112.89 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -129.9 18.58 5.59 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.565 1.946 . . . . 1.0 109.992 175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.502 ' HB3' HD12 ' A' ' 30' ' ' LEU . 9.4 m120 -138.84 83.31 1.95 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 122.221 1.01 . . . . 1.0 108.332 -177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.0 mtt -124.91 113.41 17.82 Favored 'General case' 0 N--CA 1.448 -0.563 1 N-CA-C 99.988 -4.079 . . . . 1.0 99.988 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 t -152.98 -166.67 2.51 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' A' ' 156' ' ' ASN . . . -149.41 -131.78 2.0 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.148 -2.381 . . . . 1.0 107.148 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -116.63 -23.76 8.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.467 1.134 . . . . 1.0 110.629 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 8.5 t -103.86 2.34 32.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 163' ' ' THR . 4.1 t-20 -104.08 22.83 13.98 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.356 1.463 . . . . 1.0 111.459 -175.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.2 OUTLIER -63.59 -15.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.34 0.656 . . . . 1.0 111.949 -175.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.49 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -152.26 -57.48 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 125.847 1.659 . . . . 1.0 108.934 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.49 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 84.6 Cg_endo -79.4 117.12 3.69 Favored 'Trans proline' 0 C--N 1.352 0.755 0 CA-C-N 122.085 1.78 . . . . 1.0 112.204 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 156' ' ' ASN . 0.7 OUTLIER -59.31 -25.56 64.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.784 0.834 . . . . 1.0 111.926 175.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -62.32 -19.27 63.14 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.476 2.31 . . . . 1.0 114.905 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -137.25 141.92 42.0 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.393 -1.336 . . . . 1.0 107.393 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.475 ' HA ' ' HB2' ' A' ' 156' ' ' ASN . 2.5 m -130.94 -17.05 3.17 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 117.158 -1.817 . . . . 1.0 112.422 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.58 -178.34 0.28 Allowed Pre-proline 0 C--O 1.249 1.036 0 C-N-CA 128.894 2.878 . . . . 1.0 105.093 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.29 80.01 2.31 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 N-CA-C 106.704 -2.076 . . . . 1.0 106.704 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 128.38 79.15 0.25 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.105 1.812 . . . . 1.0 111.035 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.57 -113.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 123.93 3.087 . . . . 1.0 110.237 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.8 t 56.36 43.51 26.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.284 1.833 . . . . 1.0 112.807 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -95.94 17.68 14.86 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.351 1.46 . . . . 1.0 112.105 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.0 t0 44.08 77.27 0.07 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.106 1.362 . . . . 1.0 112.351 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -54.98 -32.87 62.01 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.392 0.516 . . . . 1.0 112.392 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.01 -46.38 78.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.723 0.692 . . . . 1.0 111.252 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -59.8 -57.61 12.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.916 0.78 . . . . 1.0 110.07 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -58.55 -50.29 74.33 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.19 0.811 . . . . 1.0 113.19 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.33 -38.96 81.65 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 118.481 0.582 . . . . 1.0 110.403 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -33.67 76.17 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.839 0.681 . . . . 1.0 112.839 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.59 -44.71 66.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.322 1.049 . . . . 1.0 111.862 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.64 162.89 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.17 0.988 . . . . 1.0 109.745 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 93.0 m -59.49 118.01 27.36 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.367 1.067 . . . . 1.0 109.084 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.87 50.34 3.54 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.918 3.079 . . . . 1.0 113.244 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 7.5 t 47.14 33.81 2.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.989 1.716 . . . . 1.0 113.543 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 12.2 t -158.4 153.93 26.11 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 103.636 -2.727 . . . . 1.0 103.636 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 52.87 79.75 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.399 1.079 . . . . 1.0 112.472 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.402 ' HE2' ' OE2' ' A' ' 185' ' ' GLU . 16.2 tttt -66.14 149.67 49.94 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 175.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.402 ' OE2' ' HE2' ' A' ' 184' ' ' LYS . 0.3 OUTLIER -67.6 179.25 1.39 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.214 1.007 . . . . 1.0 112.15 176.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.5 tpt -162.06 158.21 24.56 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.707 2.803 . . . . 1.0 105.727 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 114.693 -2.575 . . . . 1.0 110.079 -178.917 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ttt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.1 tp -50.92 123.45 9.21 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 152.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.0 mt -136.3 135.21 38.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 103.407 -2.812 . . . . 1.0 103.407 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -135.54 153.15 51.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.491 0.716 . . . . 1.0 109.71 -175.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 51.46 33.36 10.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.109 1.764 . . . . 1.0 110.494 -175.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 59.42 20.01 49.54 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.634 -1.291 . . . . 1.0 112.208 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -131.59 176.87 7.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.318 3.047 . . . . 1.0 106.366 -175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 129.87 43.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.46 145.29 44.43 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 114.871 1.434 . . . . 1.0 114.871 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 40.25 58.77 2.18 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 128.085 2.554 . . . . 1.0 108.941 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.66 156.71 46.67 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.467 1.107 . . . . 1.0 110.624 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -88.81 123.76 33.52 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -83.59 132.58 34.9 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.749 -0.834 . . . . 1.0 108.749 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -137.1 70.34 56.11 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.25 135.18 11.91 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.874 2.382 . . . . 1.0 111.787 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 t -159.18 113.2 1.57 Allowed Pre-proline 0 CA--C 1.514 -0.41 0 N-CA-C 104.846 -2.279 . . . . 1.0 104.846 175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.11 69.83 7.75 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.57 2.18 . . . . 1.0 110.207 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -123.19 43.57 2.91 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 126.876 2.071 . . . . 1.0 107.109 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 88' ' ' VAL . 3.5 m-85 -106.7 177.78 4.75 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.087 1.355 . . . . 1.0 110.005 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -132.25 -175.15 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.055 2.142 . . . . 1.0 112.101 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.87 130.16 14.65 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 128.712 2.805 . . . . 1.0 104.377 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.29 171.33 6.9 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 119.407 1.003 . . . . 1.0 109.345 -175.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -78.1 76.64 4.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.103 1.869 . . . . 1.0 112.738 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -149.81 144.0 25.72 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.849 2.46 . . . . 1.0 108.516 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -144.0 104.2 4.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.879 -1.526 . . . . 1.0 106.879 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -136.27 157.58 46.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.349 1.46 . . . . 1.0 109.224 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -70.7 123.56 89.37 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 107.14 -1.43 . . . . 1.0 107.14 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -86.25 103.14 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 121.04 1.407 . . . . 1.0 110.394 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.4 t -177.9 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.53 -1.655 . . . . 1.0 106.53 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.512 HD21 ' CG2' ' A' ' 152' ' ' THR . 7.7 tt -155.51 137.31 14.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.623 -1.991 . . . . 1.0 105.623 175.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.443 ' HB2' HG23 ' A' ' 147' ' ' ILE . 19.0 tp -99.21 125.44 44.8 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.878 0.871 . . . . 1.0 109.594 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.46 113.81 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG11 ' CD2' ' A' ' 169' ' ' PHE . 46.8 t -107.13 120.93 59.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 104.902 -2.259 . . . . 1.0 104.902 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 2.2 p80 -169.82 134.23 1.32 Allowed 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -90.45 112.26 23.82 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.602 -1.259 . . . . 1.0 107.602 175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm -127.38 176.62 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 130.627 3.571 . . . . 1.0 107.259 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 t -140.77 122.71 15.5 Favored 'General case' 0 C--O 1.245 0.842 1 N-CA-C 95.789 -5.634 . . . . 1.0 95.789 174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.309 1.0 OUTLIER -141.79 -64.3 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 114.139 1.163 . . . . 1.0 114.139 176.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.98 159.86 33.91 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.275 1.134 . . . . 1.0 112.867 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HD3' ' CE1' ' A' ' 52' ' ' PHE . 92.1 Cg_endo -82.04 0.76 9.64 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.044 3.163 . . . . 1.0 116.524 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -19.82 -66.48 0.01 OUTLIER Glycine 0 C--N 1.347 1.181 0 C-N-CA 126.178 1.847 . . . . 1.0 112.607 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -152.68 123.7 7.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.169 1.388 . . . . 1.0 112.021 175.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -176.6 164.79 2.54 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 129.412 3.085 . . . . 1.0 108.617 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.97 18.75 16.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.534 2.016 . . . . 1.0 111.2 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.8 118.47 6.16 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 107.69 -2.164 . . . . 1.0 107.69 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.2 -19.4 26.0 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 CA-C-N 121.286 2.543 . . . . 1.0 113.682 -177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -56.95 -34.61 68.2 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.651 1.18 . . . . 1.0 112.705 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 mm -66.06 -53.97 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -66.27 -33.22 75.26 Favored 'General case' 0 N--CA 1.463 0.175 0 O-C-N 121.773 -0.58 . . . . 1.0 112.228 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -47.19 -33.94 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.25 1.02 . . . . 1.0 111.017 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.8 tp -64.08 -51.28 64.81 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.363 -0.835 . . . . 1.0 111.335 175.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.411 ' CE1' ' HD3' ' A' ' 40' ' ' PRO . 70.1 m-85 -71.01 -39.43 72.39 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.377 1.071 . . . . 1.0 112.419 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 50' ' ' ALA . 3.1 t -66.35 -40.37 89.77 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.158 -1.053 . . . . 1.0 108.158 175.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.96 16.88 6.58 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 124.939 1.257 . . . . 1.0 115.55 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.5 p -110.84 18.39 19.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.894 1.847 . . . . 1.0 113.805 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.72 132.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.465 1.029 . . . . 1.0 111.509 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.66 136.81 20.62 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 127.558 2.343 . . . . 1.0 108.887 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.65 62.67 1.72 Allowed 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.31 2.674 . . . . 1.0 113.157 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -103.53 -50.16 3.51 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 114.042 1.127 . . . . 1.0 114.042 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.49 -63.27 1.19 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.729 0.695 . . . . 1.0 112.333 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 7.0 p80 -170.83 178.01 0.89 Allowed Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.653 1.581 . . . . 1.0 107.639 175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 9.8 Cg_endo -62.67 -44.2 18.19 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.067 1.845 . . . . 1.0 114.789 178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -51.36 -58.7 5.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.41 1.005 . . . . 1.0 111.855 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -43.73 98.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.716 0.806 . . . . 1.0 110.136 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.8 98.35 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.404 -0.81 . . . . 1.0 111.817 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.44 -63.02 5.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.147 2.308 . . . . 1.0 112.742 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 pt -57.57 -34.26 46.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-O 117.9 -1.048 . . . . 1.0 113.077 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -39.5 -43.79 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 117.236 2.31 . . . . 1.0 117.236 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -64.88 -33.61 76.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.848 0.459 . . . . 1.0 110.189 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.9 mp -84.83 119.6 25.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.137 -1.801 . . . . 1.0 106.137 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.33 132.64 50.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.621 -0.674 . . . . 1.0 109.841 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.0 m -83.65 162.79 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.366 1.466 . . . . 1.0 111.108 -175.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.633 ' HB3' HG21 ' A' ' 88' ' ' VAL . 71.2 m -161.7 115.94 1.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.749 0.82 . . . . 1.0 109.363 176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.45 -156.98 0.53 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.628 1.171 . . . . 1.0 108.809 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.48 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 17.8 m80 -134.87 -75.98 0.46 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.645 ' HB2' HD13 ' A' ' 115' ' ' ILE . 55.5 m -124.08 118.28 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 102.207 -3.257 . . . . 1.0 102.207 175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.03 113.57 27.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 103.688 -2.708 . . . . 1.0 103.688 176.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.6 mt -95.62 122.04 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 106.174 -1.787 . . . . 1.0 106.174 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -77.04 150.16 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.578 -0.897 . . . . 1.0 108.578 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -57.12 -14.75 4.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.924 -1.512 . . . . 1.0 114.144 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -91.34 19.33 6.12 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 120.505 1.502 . . . . 1.0 112.267 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.78 51.88 54.33 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.028 1.775 . . . . 1.0 112.58 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -121.27 111.02 16.85 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.586 -1.635 . . . . 1.0 106.586 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.7 mt -79.74 120.17 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 106.669 -1.604 . . . . 1.0 106.669 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.66 141.4 26.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 102.819 -3.03 . . . . 1.0 102.819 175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 116.87 21.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 -175.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -118.38 131.02 56.31 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 127.966 2.507 . . . . 1.0 105.615 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.807 HG22 ' CE1' ' A' ' 19' ' ' TYR . 3.0 t 69.05 91.51 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 120.726 1.603 . . . . 1.0 111.465 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' ASP . 74.0 Cg_endo -66.32 -169.48 0.17 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.827 2.351 . . . . 1.0 112.026 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -69.59 30.41 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.319 1.447 . . . . 1.0 110.668 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 89' ' ' PRO . 3.0 t0 -144.5 115.32 7.78 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 128.57 2.748 . . . . 1.0 108.305 -176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.14 82.19 0.06 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.241 2.616 . . . . 1.0 112.486 174.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -34.38 146.22 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.337 2.655 . . . . 1.0 114.834 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.09 -178.55 3.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.863 2.065 . . . . 1.0 113.194 -175.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -155.91 118.28 4.12 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.63 2.372 . . . . 1.0 108.472 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -161.01 63.03 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.715 1.245 . . . . 1.0 109.402 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -162.83 -70.85 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 119.627 -1.921 . . . . 1.0 113.261 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.93 -74.7 0.23 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 106.35 -2.7 . . . . 1.0 106.35 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.3 t -133.19 140.53 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 118.582 1.191 . . . . 1.0 110.061 -175.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.3 p -166.32 162.45 17.23 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.969 1.307 . . . . 1.0 110.282 175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 106' ' ' GLU . 11.0 p -166.23 146.79 6.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.736 1.614 . . . . 1.0 108.928 175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -156.39 147.24 21.95 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.333 0.97 . . . . 1.0 110.674 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 38.91 56.36 1.98 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.343 1.857 . . . . 1.0 112.142 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.95 28.89 69.41 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.289 0.947 . . . . 1.0 114.527 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -128.63 113.79 15.86 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.432 -2.062 . . . . 1.0 105.432 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 0.3 OUTLIER -89.96 146.5 24.33 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -123.17 118.89 28.68 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.031 0.533 . . . . 1.0 111.108 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 4.1 t -77.52 -25.8 50.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.976 0.91 . . . . 1.0 110.042 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -143.67 168.88 18.86 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 127.558 2.343 . . . . 1.0 107.857 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -88.18 75.91 8.54 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 105.918 -1.882 . . . . 1.0 105.918 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.98 33.83 1.84 Allowed 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.521 1.128 . . . . 1.0 112.276 -175.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.3 m -126.94 131.07 51.18 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.938 0.895 . . . . 1.0 109.542 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.289 0.1 OUTLIER -79.01 56.25 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 126.214 1.806 . . . . 1.0 110.073 -177.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -86.44 -133.26 3.42 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 122.578 1.099 . . . . 1.0 111.684 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 76' ' ' CYS . 20.6 mm -137.03 166.38 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.351 3.46 . . . . 1.0 104.085 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -144.85 135.38 24.42 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 101.839 -3.393 . . . . 1.0 101.839 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -101.3 165.69 11.14 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 120.522 -1.361 . . . . 1.0 110.412 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.15 150.35 49.02 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.771 0.829 . . . . 1.0 110.256 -175.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.1 175.6 45.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.872 1.262 . . . . 1.0 112.383 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.5 p -141.28 110.1 6.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.983 2.113 . . . . 1.0 106.111 -177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 t0 45.67 48.73 11.43 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 128.301 2.64 . . . . 1.0 111.82 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.9 p 50.7 38.08 18.3 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 128.776 2.831 . . . . 1.0 115.404 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.4 145.92 50.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.123 2.169 . . . . 1.0 110.55 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.34 114.68 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 129.405 3.082 . . . . 1.0 110.987 175.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -84.36 -8.05 59.11 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 114.123 -2.846 . . . . 1.0 113.155 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.391 26.5 p 64.9 77.92 0.3 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 122.568 2.44 . . . . 1.0 115.014 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -23.22 -33.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 121.073 1.76 . . . . 1.0 114.815 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -45.9 -43.1 13.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.827 2.051 . . . . 1.0 110.733 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -50.15 -50.72 48.0 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 118.299 -0.857 . . . . 1.0 109.738 176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -60.56 -36.36 78.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 117.559 -1.21 . . . . 1.0 111.222 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -65.29 -60.04 3.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.512 1.051 . . . . 1.0 109.713 177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -62.8 -41.45 99.28 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.483 0.313 . . . . 1.0 111.138 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.01 -52.98 63.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.812 1.645 . . . . 1.0 109.122 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.64 -33.71 76.23 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 118.289 -0.862 . . . . 1.0 110.273 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.79 52.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.683 0.793 . . . . 1.0 108.929 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.633 HG11 HD11 ' A' ' 115' ' ' ILE . 47.4 t -55.61 -50.29 68.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 N-CA-C 108.203 -1.036 . . . . 1.0 108.203 176.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.5 m -58.27 -57.39 13.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.266 1.026 . . . . 1.0 112.13 -175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -55.79 -43.16 76.57 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.537 1.062 . . . . 1.0 110.328 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -51.85 51.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.788 -0.57 . . . . 1.0 111.264 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -56.53 -34.06 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.144 1.378 . . . . 1.0 112.105 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.6 mt -63.58 -39.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.405 -1.332 . . . . 1.0 107.405 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.8 m -64.53 -14.35 57.02 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.297 1.039 . . . . 1.0 110.4 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -90.23 -64.93 1.07 Allowed 'General case' 0 C--N 1.347 0.47 0 O-C-N 120.24 -1.538 . . . . 1.0 106.942 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.85 113.01 24.66 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 106.922 -1.511 . . . . 1.0 106.922 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -88.65 107.25 0.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 CA-C-N 121.865 1.702 . . . . 1.0 111.288 -175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.27 -51.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.296 1.438 . . . . 1.0 108.723 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 31' ' ' LEU . 32.0 mt -46.04 -35.11 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 130.823 3.649 . . . . 1.0 111.789 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.06 63.49 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -131.39 18.34 4.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 127.353 2.261 . . . . 1.0 109.803 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -143.17 83.45 1.79 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 49.4 mtt -121.67 122.02 38.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.666 -2.716 . . . . 1.0 103.666 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.512 ' CG2' HD21 ' A' ' 30' ' ' LEU . 5.2 t -158.65 -176.45 5.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.261 -1.385 . . . . 1.0 107.261 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.02 -131.33 2.89 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 105.787 -2.925 . . . . 1.0 105.787 175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.488 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 16.1 m170 -118.15 -23.12 7.47 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.134 0.974 . . . . 1.0 110.63 176.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.4 t -103.36 -18.4 14.86 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -91.78 45.83 1.25 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.925 1.29 . . . . 1.0 107.521 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER -71.45 -14.68 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 120.319 -1.488 . . . . 1.0 109.933 175.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -153.65 -65.95 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.73 0 C-N-CA 127.304 2.241 . . . . 1.0 107.334 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 89.7 Cg_endo -76.16 113.29 3.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.932 1.726 . . . . 1.0 113.382 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -18.71 36.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.121 1.368 . . . . 1.0 112.056 175.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -59.11 -25.99 64.29 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.536 1.934 . . . . 1.0 112.759 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -139.6 135.14 33.03 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.499 -2.037 . . . . 1.0 105.499 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 37.4 m -119.96 -16.49 8.63 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.103 0.408 . . . . 1.0 112.103 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.24 175.35 1.31 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 128.689 2.795 . . . . 1.0 105.095 175.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -78.73 69.3 7.85 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.953 2.435 . . . . 1.0 109.563 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 167' ' ' PRO . . . 124.33 69.69 0.21 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 127.978 2.704 . . . . 1.0 108.54 -175.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.473 ' HD3' ' H ' ' A' ' 166' ' ' GLY . 87.4 Cg_endo -82.39 -87.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.022 3.148 . . . . 1.0 112.263 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 t 53.49 73.35 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 129.211 3.005 . . . . 1.0 109.214 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' CD2' HG11 ' A' ' 33' ' ' VAL . 56.8 t80 -119.35 18.97 12.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.411 1.085 . . . . 1.0 113.885 -175.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t0 43.13 74.54 0.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.879 -1.763 . . . . 1.0 112.759 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -58.65 -31.57 68.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.039 -0.982 . . . . 1.0 111.866 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.07 77.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.857 -1.068 . . . . 1.0 110.666 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -60.81 -51.66 68.37 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.555 1.07 . . . . 1.0 110.516 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -60.79 -56.48 20.75 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.213 0.82 . . . . 1.0 113.213 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -64.29 -25.63 68.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 118.018 -0.991 . . . . 1.0 112.176 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.62 -43.79 83.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.042 0.837 . . . . 1.0 111.093 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.16 -59.9 2.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.327 1.451 . . . . 1.0 111.019 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.3 t -66.48 166.02 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 m -45.1 113.72 1.92 Allowed Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.329 1.051 . . . . 1.0 110.225 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.7 34.75 0.55 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.691 2.26 . . . . 1.0 111.323 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 50.26 50.34 18.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.472 2.709 . . . . 1.0 109.598 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 t -166.16 -36.63 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.882 2.073 . . . . 1.0 108.819 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 58.9 t60 62.9 44.56 6.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.869 2.067 . . . . 1.0 113.532 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -75.6 -176.52 3.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -72.46 169.12 17.08 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.167 -0.958 . . . . 1.0 109.426 175.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.495 ' HG3' ' H ' ' A' ' 187' ' ' THR . 9.8 tpt -171.25 -150.72 0.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 104.577 -2.379 . . . . 1.0 104.577 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.495 ' H ' ' HG3' ' A' ' 186' ' ' MET . 25.4 m . . . . . 0 C--O 1.247 0.937 0 N-CA-C 102.547 -3.131 . . . . 1.0 102.547 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.8 tp -142.02 152.41 43.36 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 155.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.51 127.87 36.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 103.719 -2.697 . . . . 1.0 103.719 175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -136.19 129.1 31.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.756 -1.202 . . . . 1.0 107.756 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 44.22 48.52 7.78 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.54 1.936 . . . . 1.0 113.732 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.11 27.01 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.64 1.114 . . . . 1.0 113.377 176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -96.78 165.62 12.03 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.394 1.478 . . . . 1.0 107.126 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tt -89.86 122.86 33.31 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 103.957 -2.609 . . . . 1.0 103.957 175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.91 175.04 7.02 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.19 0.996 . . . . 1.0 112.186 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 43.87 58.17 3.74 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 126.229 1.812 . . . . 1.0 109.697 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.0 132.93 7.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.462 1.905 . . . . 1.0 107.322 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -63.83 123.47 19.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.31 142.36 28.54 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.999 -1.063 . . . . 1.0 109.681 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.34 70.4 72.99 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 105.351 -2.092 . . . . 1.0 105.351 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.21 124.22 9.82 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.639 2.226 . . . . 1.0 111.047 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 t -160.24 113.46 1.41 Allowed Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.67 71.1 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.866 2.377 . . . . 1.0 110.756 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -123.69 54.2 1.32 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.783 1.633 . . . . 1.0 107.281 175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE1' HG22 ' A' ' 88' ' ' VAL . 1.8 m-30 -95.53 -175.71 3.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.302 2.241 . . . . 1.0 112.352 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.09 -177.08 3.23 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.959 2.104 . . . . 1.0 108.488 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 m -163.77 122.11 1.91 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 130.135 3.374 . . . . 1.0 103.82 175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.8 152.94 52.21 Favored Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -80.88 36.6 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.991 2.461 . . . . 1.0 113.344 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.11 143.22 37.15 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.873 2.469 . . . . 1.0 104.497 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -146.69 103.26 3.64 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 9.2 tp10 -137.04 165.36 26.22 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.109 -1.441 . . . . 1.0 107.109 175.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -68.67 124.1 89.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.447 1.099 . . . . 1.0 110.695 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.5 113.94 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.025 2.484 . . . . 1.0 111.483 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t 178.91 85.29 0.01 OUTLIER 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.616 1.967 . . . . 1.0 105.983 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tp -148.32 143.15 26.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.259 -1.756 . . . . 1.0 106.259 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.7 tp -110.68 116.06 30.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.996 -1.853 . . . . 1.0 105.996 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.78 122.73 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 106.508 -1.664 . . . . 1.0 106.508 -175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.3 t -112.95 120.7 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 105.32 -2.104 . . . . 1.0 105.32 176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 1.8 p80 -167.04 128.56 1.63 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 107.526 -1.287 . . . . 1.0 107.526 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -80.34 112.63 17.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 116.63 -2.028 . . . . 1.0 108.142 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -128.13 176.97 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 C-N-CA 131.993 4.117 . . . . 1.0 106.086 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 t -152.09 121.95 7.03 Favored 'General case' 0 N--CA 1.44 -0.96 1 N-CA-C 95.305 -5.813 . . . . 1.0 95.305 174.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' O ' HG23 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -142.82 -66.17 0.02 OUTLIER Pre-proline 0 C--O 1.219 -0.511 0 CA-C-N 119.432 1.014 . . . . 1.0 110.86 175.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 4.0 Cg_exo -76.65 136.33 17.06 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.16 2.574 . . . . 1.0 110.838 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.86 77.76 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.73 1.62 . . . . 1.0 111.919 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.08 -72.09 0.72 Allowed Glycine 0 CA--C 1.533 1.194 0 N-CA-C 105.308 -3.117 . . . . 1.0 105.308 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -155.34 122.89 5.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.012 1.725 . . . . 1.0 107.857 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -176.84 167.64 2.55 Favored 'General case' 0 N--CA 1.469 0.523 1 C-N-CA 132.107 4.163 . . . . 1.0 107.157 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.99 16.11 20.75 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.088 1.328 . . . . 1.0 111.691 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.52 118.78 4.89 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.101 -1.6 . . . . 1.0 109.101 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 -7.69 21.23 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.018 2.479 . . . . 1.0 114.143 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -60.78 -38.86 86.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.638 1.108 . . . . 1.0 109.808 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 38' ' ' LEU . 58.7 mt -66.16 -46.58 87.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.68 -47.76 79.15 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.697 -0.627 . . . . 1.0 110.675 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -55.5 -33.66 63.91 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.479 1.512 . . . . 1.0 111.794 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.2 -57.45 10.46 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.23 1.012 . . . . 1.0 109.744 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -64.76 -45.24 87.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.834 0.854 . . . . 1.0 112.423 -175.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 50' ' ' ALA . 5.2 t -65.86 -37.12 85.33 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.07 0.948 . . . . 1.0 109.853 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.11 37.94 3.96 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 118.36 -1.245 . . . . 1.0 115.648 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 p -130.68 20.61 5.09 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.398 1.599 . . . . 1.0 112.163 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 tt -56.29 151.32 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.996 1.319 . . . . 1.0 112.26 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -98.68 129.36 30.25 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 127.271 2.228 . . . . 1.0 107.937 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.82 67.99 3.07 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.33 3.353 . . . . 1.0 109.599 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -104.77 -65.63 1.02 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.026 1.33 . . . . 1.0 112.64 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.68 4.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.177 1.391 . . . . 1.0 112.772 -175.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 21.4 p80 -170.5 177.86 0.95 Allowed Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.559 1.544 . . . . 1.0 107.86 175.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 13.2 Cg_endo -70.93 -43.44 1.68 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.536 1.49 . . . . 1.0 115.34 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -50.62 -58.31 6.15 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.005 1.275 . . . . 1.0 113.026 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -45.04 91.79 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.0 0.92 . . . . 1.0 111.005 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.77 86.86 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.704 -0.622 . . . . 1.0 111.997 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.08 -60.36 9.05 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 125.797 1.665 . . . . 1.0 111.271 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 pp -57.2 -32.45 40.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 116.435 -1.745 . . . . 1.0 112.052 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -35.86 -43.36 0.3 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.241 2.216 . . . . 1.0 115.775 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -62.19 -39.84 94.05 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.846 1.258 . . . . 1.0 109.949 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.88 135.25 33.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.519 -2.401 . . . . 1.0 104.519 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 159.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 121.057 -1.027 . . . . 1.0 108.595 175.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.49 164.27 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.911 1.284 . . . . 1.0 107.867 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.5 m -164.31 118.2 1.41 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.334 0.654 . . . . 1.0 110.31 175.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.79 -153.89 0.35 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.606 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 41.7 m80 -129.94 -62.19 0.96 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.3 1.44 . . . . 1.0 108.598 175.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 82.5 m -130.4 119.05 22.12 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.82 -1.918 . . . . 1.0 105.82 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.86 113.43 25.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 103.816 -2.661 . . . . 1.0 103.816 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 mt -100.91 124.45 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 106.836 -1.542 . . . . 1.0 106.836 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -83.95 148.0 27.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.573 -1.269 . . . . 1.0 107.573 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -16.38 0.77 Allowed 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 115.314 1.598 . . . . 1.0 115.314 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.99 22.45 4.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.12 56.23 23.4 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 120.425 -1.422 . . . . 1.0 112.808 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -128.7 143.34 50.91 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.647 -1.612 . . . . 1.0 106.647 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mt -116.46 125.6 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 120.059 1.3 . . . . 1.0 109.973 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.3 t -111.75 153.29 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 105.572 -2.01 . . . . 1.0 105.572 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -125.73 120.6 31.07 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.106 -0.996 . . . . 1.0 110.27 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -120.56 113.61 20.52 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 103.352 -2.833 . . . . 1.0 103.352 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.671 HG22 ' CE1' ' A' ' 19' ' ' TYR . 9.1 t 80.17 91.84 0.05 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 CA-C-N 121.412 1.914 . . . . 1.0 114.461 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.35 -173.52 0.17 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.313 2.675 . . . . 1.0 111.816 175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -80.65 51.59 1.52 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.873 -1.142 . . . . 1.0 108.989 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -148.86 113.04 5.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 130.287 3.435 . . . . 1.0 105.806 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.358 27.9 tttp 73.64 82.37 0.12 Allowed 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 115.497 1.665 . . . . 1.0 115.497 175.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 ttm-85 -32.72 138.11 0.06 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.855 2.862 . . . . 1.0 111.388 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.606 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -103.96 -178.87 3.78 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.118 1.767 . . . . 1.0 113.247 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -148.01 120.26 8.36 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.051 1.74 . . . . 1.0 109.976 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -162.08 62.85 0.23 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 106.49 -1.67 . . . . 1.0 106.49 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . . . -157.8 -65.2 0.09 Allowed 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 119.356 -2.09 . . . . 1.0 114.082 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.16 -68.25 0.71 Allowed Glycine 0 CA--C 1.531 1.06 0 CA-C-O 118.99 -0.895 . . . . 1.0 112.873 -175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.3 t -132.25 136.23 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.071 1.348 . . . . 1.0 109.726 -175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 p -166.35 137.13 3.44 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.54 1.136 . . . . 1.0 111.136 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.417 ' H ' HG22 ' A' ' 157' ' ' ILE . 16.1 p -154.96 132.42 11.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 104.48 -2.415 . . . . 1.0 104.48 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -152.96 159.66 42.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 119.117 0.871 . . . . 1.0 108.907 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 41.66 53.69 3.87 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.331 1.452 . . . . 1.0 111.11 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.53 32.49 53.2 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.951 -0.916 . . . . 1.0 113.382 177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.1 ttt85 -139.54 114.88 9.8 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 119.084 1.442 . . . . 1.0 107.81 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -78.36 144.69 35.75 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -123.51 118.42 27.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.9 t -53.04 -39.15 63.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 118.663 0.665 . . . . 1.0 111.012 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -143.68 162.41 36.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.753 3.221 . . . . 1.0 104.896 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . 0.298 28.6 t70 -86.95 76.71 9.35 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 123.283 1.516 . . . . 1.0 109.297 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -75.24 44.19 0.24 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 131.133 3.773 . . . . 1.0 110.255 175.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.5 m -123.15 155.43 37.05 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.133 1.373 . . . . 1.0 112.289 -175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.2 57.08 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 127.914 2.486 . . . . 1.0 109.005 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.21 -136.9 6.05 Favored Glycine 0 CA--C 1.527 0.834 0 O-C-N 120.174 -1.578 . . . . 1.0 114.055 -177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 133' ' ' LEU . 8.1 mm -142.12 159.55 20.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 129.129 2.972 . . . . 1.0 103.776 -175.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -145.54 119.05 9.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.094 -2.928 . . . . 1.0 103.094 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.14 133.23 34.47 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.604 -1.31 . . . . 1.0 107.635 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -103.52 138.51 40.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.904 0.882 . . . . 1.0 108.765 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.94 -179.55 33.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.699 1.142 . . . . 1.0 110.484 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.1 p -150.31 113.57 4.89 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.897 -1.89 . . . . 1.0 105.897 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.85 41.42 22.51 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.58 1.552 . . . . 1.0 114.384 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.7 p 45.77 38.16 4.04 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.295 1.838 . . . . 1.0 113.014 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -59.89 138.02 57.92 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.894 -1.891 . . . . 1.0 105.894 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -24.33 113.53 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.567 2.347 . . . . 1.0 111.25 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -78.54 -4.29 47.92 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 116.468 -1.73 . . . . 1.0 115.147 -174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.315 73.5 p 55.37 78.02 0.2 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.465 -1.731 . . . . 1.0 113.648 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -23.31 -33.18 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 128.176 2.591 . . . . 1.0 113.421 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.04 -35.71 7.14 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.485 1.914 . . . . 1.0 110.148 175.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.7 -50.14 63.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.342 0.973 . . . . 1.0 109.959 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.41 -39.19 86.51 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 123.672 0.789 . . . . 1.0 110.43 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.02 -54.52 28.95 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.844 1.258 . . . . 1.0 109.839 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -66.52 -47.47 72.83 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.695 0.68 . . . . 1.0 111.146 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 115' ' ' ILE . 25.1 tp -50.7 -49.51 57.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.874 1.27 . . . . 1.0 109.74 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.09 89.36 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 119.172 0.897 . . . . 1.0 110.519 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.33 59.04 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.424 0.689 . . . . 1.0 110.561 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -53.72 -46.5 62.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.685 -0.857 . . . . 1.0 108.685 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.4 m -59.9 -43.36 94.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.459 1.104 . . . . 1.0 110.576 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -58.82 -47.47 84.7 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.605 1.093 . . . . 1.0 109.564 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.73 -58.19 9.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.227 1.011 . . . . 1.0 109.253 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.3 -38.1 68.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 117.871 -1.062 . . . . 1.0 113.554 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.7 mt -61.25 -49.38 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 120.041 1.291 . . . . 1.0 108.991 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 2.5 m -66.36 -20.53 66.1 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 122.272 -0.268 . . . . 1.0 110.811 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -83.64 -57.1 3.37 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.01 1.724 . . . . 1.0 108.943 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.46 112.97 23.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 106.537 -1.653 . . . . 1.0 106.537 177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -95.07 107.87 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 CA-C-N 120.848 1.339 . . . . 1.0 113.459 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.99 -50.64 0.11 Allowed 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 125.855 1.662 . . . . 1.0 108.471 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.7 mt -48.35 -33.64 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 129.689 3.196 . . . . 1.0 111.282 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.73 -21.98 1.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.704 1.601 . . . . 1.0 113.994 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -141.43 18.6 2.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.889 1.676 . . . . 1.0 110.398 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -138.44 84.17 2.01 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.707 -1.246 . . . . 1.0 108.046 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 53.0 mtt -121.5 114.38 21.16 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 103.955 -2.609 . . . . 1.0 103.955 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.8 t -145.37 -169.37 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.78 -131.51 2.57 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 106.285 -2.726 . . . . 1.0 106.285 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 20.2 m170 -117.49 -23.17 7.83 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.052 1.341 . . . . 1.0 109.314 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.5 t -102.76 -23.07 13.82 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -84.14 42.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.539 1.063 . . . . 1.0 108.367 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.6 -14.14 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 O-C-N 120.073 -1.642 . . . . 1.0 108.281 175.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.506 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -158.02 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 128.634 2.774 . . . . 1.0 111.584 175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 91.7 Cg_endo -79.61 108.44 2.29 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.199 1.933 . . . . 1.0 113.144 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -62.33 -21.68 65.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.246 1.418 . . . . 1.0 111.813 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -67.59 -24.39 65.49 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.656 -1.277 . . . . 1.0 113.002 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -132.7 124.29 27.91 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 105.177 -2.156 . . . . 1.0 105.177 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -114.18 -17.41 11.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 118.624 -1.23 . . . . 1.0 111.479 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -176.69 178.98 0.41 Allowed Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 131.398 3.879 . . . . 1.0 103.603 176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.17 91.64 0.65 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 121.697 1.642 . . . . 1.0 108.07 175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 114.18 76.81 0.73 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.776 1.655 . . . . 1.0 111.263 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.83 -90.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.553 2.836 . . . . 1.0 110.452 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 7.6 t 53.01 46.85 25.93 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 127.695 2.398 . . . . 1.0 113.782 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -118.24 16.46 14.0 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.851 -1.156 . . . . 1.0 112.629 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.5 t0 43.84 80.61 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.068 -1.645 . . . . 1.0 113.756 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -62.73 -33.93 76.13 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.237 -0.915 . . . . 1.0 112.396 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.72 -42.47 91.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.299 0.954 . . . . 1.0 110.934 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -65.91 -52.52 49.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.115 0.87 . . . . 1.0 110.237 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.86 -51.84 67.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -62.04 -35.42 78.55 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.702 -0.666 . . . . 1.0 111.222 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.51 -35.62 80.71 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 46.2 mt -70.6 -46.91 62.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.128 0.571 . . . . 1.0 110.046 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.18 166.52 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.618 1.967 . . . . 1.0 111.488 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 183' ' ' HIS . 2.8 m -41.09 118.88 1.69 Allowed Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 127.168 2.187 . . . . 1.0 108.499 175.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -76.66 55.2 4.72 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.464 3.443 . . . . 1.0 113.924 -175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.4 t 54.68 35.83 24.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.127 0.971 . . . . 1.0 110.101 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.6 t -164.59 103.12 0.82 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.686 1.194 . . . . 1.0 109.792 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.499 ' HB2' HG23 ' A' ' 179' ' ' THR . 4.7 t60 -173.3 115.94 0.26 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.777 1.631 . . . . 1.0 107.164 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -65.98 156.32 33.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.49 1.495 . . . . 1.0 107.612 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -93.96 178.7 5.57 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.664 1.986 . . . . 1.0 110.609 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.4 tpt 85.46 33.29 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.23 2.612 . . . . 1.0 116.322 175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.249 1.051 0 O-C-N 119.718 -1.864 . . . . 1.0 110.266 175.367 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.5 tpp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 107.395 -1.335 . . . . 1.0 107.395 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 3' ' ' LEU . 8.2 tp -142.06 176.24 9.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.317 1.047 . . . . 1.0 109.201 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 2' ' ' LEU . 22.7 mt -109.92 123.57 49.85 Favored 'General case' 0 C--N 1.327 -0.407 1 N-CA-C 98.897 -4.482 . . . . 1.0 98.897 174.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.96 126.46 39.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.965 -1.494 . . . . 1.0 106.965 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 55.31 33.33 20.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.635 1.574 . . . . 1.0 109.598 -175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.19 12.56 38.34 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.511 -1.368 . . . . 1.0 113.767 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -107.71 170.8 7.76 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 103.309 -2.848 . . . . 1.0 103.309 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.73 139.88 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.354 -1.466 . . . . 1.0 108.475 176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.09 172.45 12.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.542 0.61 . . . . 1.0 110.738 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 37.51 57.85 1.36 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.959 2.904 . . . . 1.0 110.71 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.03 156.73 22.53 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.155 -0.966 . . . . 1.0 110.074 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -88.0 123.06 32.33 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.152 0.433 . . . . 1.0 111.769 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -98.22 130.02 44.95 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.47 1.108 . . . . 1.0 111.212 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.87 92.43 9.91 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.987 0.915 . . . . 1.0 108.654 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.4 160.47 44.62 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.54 1.493 . . . . 1.0 112.576 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.4 t -159.94 113.41 1.45 Allowed Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.4 61.17 7.78 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.792 2.328 . . . . 1.0 111.983 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -133.53 43.26 2.91 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.099 1.76 . . . . 1.0 107.068 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' HG13 ' A' ' 88' ' ' VAL . 2.6 m-85 -73.84 178.47 4.85 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.994 1.317 . . . . 1.0 109.832 -175.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -111.07 178.79 4.23 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 124.117 1.913 . . . . 1.0 113.953 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -138.13 118.44 13.68 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 111.921 -2.4 . . . . 1.0 106.729 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -126.16 167.26 17.52 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 129.045 2.938 . . . . 1.0 106.144 175.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -179.1 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.619 1.546 . . . . 1.0 109.132 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.85 143.33 45.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.627 -2.361 . . . . 1.0 104.627 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -150.99 167.33 27.96 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 102.727 -3.064 . . . . 1.0 102.727 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -79.77 163.46 24.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.713 1.605 . . . . 1.0 108.962 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.39 123.59 3.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.307 2.243 . . . . 1.0 110.282 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.524 ' HB2' ' H ' ' A' ' 113' ' ' ILE . 63.2 Cg_endo -66.11 135.28 39.86 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.495 2.797 . . . . 1.0 111.008 -175.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.5 t 178.88 84.12 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.523 1.929 . . . . 1.0 106.768 175.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -155.27 125.15 6.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 105.038 -2.208 . . . . 1.0 105.038 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.1 126.01 39.07 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.431 -1.322 . . . . 1.0 107.431 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.77 144.31 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 104.593 -2.373 . . . . 1.0 104.593 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 169' ' ' PHE . 47.2 t -135.67 113.88 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 102.544 -3.132 . . . . 1.0 102.544 177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -167.39 143.04 4.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.51 112.51 21.61 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.868 0.73 . . . . 1.0 109.409 177.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.4 176.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 126.629 1.972 . . . . 1.0 107.387 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.3 t -141.47 122.4 14.51 Favored 'General case' 0 N--CA 1.442 -0.834 1 N-CA-C 95.345 -5.798 . . . . 1.0 95.345 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HB3' ' HD3' ' A' ' 39' ' ' PRO 0.353 0.7 OUTLIER -142.58 -66.7 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 CA-C-O 116.337 -1.792 . . . . 1.0 115.162 -178.656 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 38' ' ' LEU . 32.2 Cg_endo -94.38 157.74 2.03 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.588 2.192 . . . . 1.0 114.783 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.25 51.72 4.02 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 125.215 3.943 . . . . 1.0 117.487 -175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -61.15 -71.2 0.83 Allowed Glycine 0 CA--C 1.541 1.681 0 N-CA-C 107.373 -2.291 . . . . 1.0 107.373 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -156.32 122.82 5.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.72 2.008 . . . . 1.0 108.251 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -176.74 161.74 2.09 Favored 'General case' 0 C--O 1.235 0.295 1 C-N-CA 132.745 4.418 . . . . 1.0 108.229 175.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.18 4.0 29.99 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.522 1.058 . . . . 1.0 111.005 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.81 119.09 4.88 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 117.952 -1.471 . . . . 1.0 110.015 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -5.48 14.08 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.78 2.32 . . . . 1.0 114.771 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -60.9 -47.63 85.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.565 1.984 . . . . 1.0 110.926 175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.5 mt -62.27 -51.28 74.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.004 -1.48 . . . . 1.0 107.004 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.35 -46.91 86.55 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 119.396 -0.335 . . . . 1.0 110.308 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -60.1 -37.48 80.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.04 0.936 . . . . 1.0 111.361 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -62.2 -49.94 73.76 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.485 0.584 . . . . 1.0 110.143 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -70.85 -46.91 61.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 119.177 -0.439 . . . . 1.0 110.93 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.7 t -65.9 -37.83 87.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.516 1.126 . . . . 1.0 109.63 -178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 8.09 11.26 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.915 1.721 . . . . 1.0 115.513 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -104.3 19.4 20.29 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.234 2.017 . . . . 1.0 113.34 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -59.41 125.25 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.306 1.442 . . . . 1.0 111.709 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -99.14 136.65 20.46 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.44 1.896 . . . . 1.0 110.671 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -71.36 70.38 2.5 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.788 2.992 . . . . 1.0 111.225 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -103.3 -62.5 1.28 Allowed 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.659 -0.651 . . . . 1.0 111.808 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.22 76.0 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 122.949 0.5 . . . . 1.0 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.3 p80 -170.63 177.98 0.91 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.865 1.666 . . . . 1.0 107.396 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 18.8 Cg_endo -69.8 -43.33 2.69 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.049 1.833 . . . . 1.0 114.718 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -46.47 -51.05 16.03 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.171 1.174 . . . . 1.0 114.171 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -57.48 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.128 0.971 . . . . 1.0 111.243 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.2 96.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.671 0.788 . . . . 1.0 111.05 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -46.04 -61.47 3.94 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.171 1.843 . . . . 1.0 111.672 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 pt -59.89 -33.98 54.49 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 116.743 -1.599 . . . . 1.0 112.709 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.38 -43.15 2.45 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.538 1.935 . . . . 1.0 115.154 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -54.67 -36.51 64.69 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.912 0.885 . . . . 1.0 110.616 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.39 136.54 33.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.352 -2.462 . . . . 1.0 104.352 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -60.49 152.06 26.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.088 -1.007 . . . . 1.0 108.55 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -116.7 158.7 17.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 124.481 1.112 . . . . 1.0 110.273 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -171.59 128.68 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.875 2.07 . . . . 1.0 108.127 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.13 -172.2 2.61 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 105.557 -2.016 . . . . 1.0 105.557 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -120.77 -59.71 1.72 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -138.97 118.72 13.13 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.433 -1.691 . . . . 1.0 106.433 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -102.77 113.47 26.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 mt -95.44 118.28 41.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.077 -1.823 . . . . 1.0 106.077 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -72.67 148.3 44.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 117.994 -1.003 . . . . 1.0 108.304 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -45.45 -35.14 3.55 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 113.438 0.903 . . . . 1.0 113.438 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -91.67 36.64 0.95 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.882 0.873 . . . . 1.0 112.068 -176.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.17 52.76 49.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 125.274 1.416 . . . . 1.0 115.299 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -119.49 111.92 18.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.388 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 132' ' ' GLN . 86.6 mt -85.78 113.88 24.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 105.295 -2.113 . . . . 1.0 105.295 175.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.59 140.27 30.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.273 -1.751 . . . . 1.0 106.273 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -121.85 114.87 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.487 1.115 . . . . 1.0 108.321 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -114.11 121.06 42.64 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 103.538 -2.764 . . . . 1.0 103.538 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG13 ' CE2' ' A' ' 19' ' ' TYR . 88.4 t 70.8 92.01 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 121.041 1.746 . . . . 1.0 111.344 -177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.57 -168.4 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.405 2.737 . . . . 1.0 111.891 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -59.61 2.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.965 2.506 . . . . 1.0 115.596 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -125.58 135.08 51.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 128.025 2.53 . . . . 1.0 104.372 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.261 14.4 tptp 77.19 82.15 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.303 1.841 . . . . 1.0 111.882 175.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -34.11 136.77 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.521 1.928 . . . . 1.0 113.878 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -103.64 -178.39 3.65 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.451 2.3 . . . . 1.0 108.989 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -148.2 118.58 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.77 62.89 0.47 Allowed 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.591 -1.318 . . . . 1.0 111.035 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.74 -68.22 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 119.177 -2.202 . . . . 1.0 113.99 -175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.99 -84.57 0.37 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 106.959 -2.456 . . . . 1.0 106.959 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.85 145.45 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 118.683 1.242 . . . . 1.0 109.468 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.6 p -165.97 145.47 6.21 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.8 1.24 . . . . 1.0 111.248 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.504 ' H ' HG22 ' A' ' 157' ' ' ILE . 2.7 p -133.23 146.55 51.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.43 1.892 . . . . 1.0 109.79 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -151.72 148.91 28.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 41.53 53.5 3.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.24 1.816 . . . . 1.0 110.224 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 56.66 28.43 56.58 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.167 1.841 . . . . 1.0 116.277 177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 -132.82 136.6 46.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.145 1.973 . . . . 1.0 107.08 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 15.0 tp10 -96.2 145.79 25.24 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.65 1.18 . . . . 1.0 109.222 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -112.7 120.28 40.99 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 105.413 -2.069 . . . . 1.0 105.413 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.7 t -54.42 -31.2 54.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.418 0.687 . . . . 1.0 112.826 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -164.27 176.29 9.3 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 129.552 3.141 . . . . 1.0 104.602 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -81.29 76.45 8.23 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 123.038 1.399 . . . . 1.0 109.628 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -80.94 33.52 0.33 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.233 1.813 . . . . 1.0 110.62 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 40.4 m -129.54 143.26 50.75 Favored 'General case' 0 C--O 1.218 -0.558 0 C-N-CA 124.182 0.993 . . . . 1.0 113.124 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.524 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 0.1 OUTLIER -80.01 57.09 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.56 2.344 . . . . 1.0 107.825 176.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -79.41 -136.58 1.35 Allowed Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.526 1.07 . . . . 1.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 133' ' ' LEU . 8.2 mm -143.19 163.2 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 103.299 -2.852 . . . . 1.0 103.299 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -141.71 130.79 23.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 103.471 -2.788 . . . . 1.0 103.471 175.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mp -101.13 166.03 11.0 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.529 0.681 . . . . 1.0 109.387 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -139.42 158.38 44.25 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.979 0.895 . . . . 1.0 111.4 -175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -172.75 173.04 45.4 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 113.759 -1.564 . . . . 1.0 110.876 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.8 p -141.14 101.94 4.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.796 -1.928 . . . . 1.0 105.796 -175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.0 t70 49.48 55.74 8.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.584 1.954 . . . . 1.0 111.842 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.321 18.6 p 47.29 38.69 7.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.836 2.854 . . . . 1.0 115.131 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.7 tp -65.55 146.19 55.15 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.574 -1.269 . . . . 1.0 107.574 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -38.14 114.13 0.34 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.14 2.176 . . . . 1.0 112.679 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -79.06 0.54 27.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 116.202 -1.856 . . . . 1.0 114.541 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.506 4.8 p 55.43 77.97 0.2 Allowed 'General case' 0 C--O 1.216 -0.701 0 CA-C-O 115.017 -2.42 . . . . 1.0 117.443 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -23.4 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 122.479 2.399 . . . . 1.0 116.346 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.87 -41.73 16.22 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.722 1.609 . . . . 1.0 109.549 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -51.97 -50.92 60.31 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.919 0.887 . . . . 1.0 110.549 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -59.99 -43.27 95.28 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.221 0.918 . . . . 1.0 110.157 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -66.12 -51.05 61.63 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.864 0.466 . . . . 1.0 110.754 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.481 ' HB3' HD11 ' A' ' 84' ' ' ILE . 38.2 mm-40 -62.84 -50.2 71.87 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.142 1.777 . . . . 1.0 109.713 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.442 HD13 HG21 ' A' ' 115' ' ' ILE . 35.7 tp -54.14 -49.08 70.05 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.4 76.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.147 0.885 . . . . 1.0 111.37 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.01 -53.42 55.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.7 0.8 . . . . 1.0 109.253 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.52 -47.69 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 177.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 90.8 m -52.75 -48.84 66.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.696 1.598 . . . . 1.0 110.232 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -59.66 -46.93 87.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.795 0.725 . . . . 1.0 111.951 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.17 74.66 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.271 0.487 . . . . 1.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.34 -41.23 75.74 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.934 0.893 . . . . 1.0 112.583 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.56 -49.47 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.726 1.148 . . . . 1.0 109.605 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.1 m -59.77 -16.65 29.44 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.439 0.695 . . . . 1.0 111.903 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -94.34 -58.87 2.09 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.467 -1.396 . . . . 1.0 109.55 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -125.95 112.9 24.41 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 107.068 -1.456 . . . . 1.0 107.068 176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.77 107.48 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.644 1.266 . . . . 1.0 112.814 -175.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -151.64 -50.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.919 2.088 . . . . 1.0 107.73 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.5 mt -44.78 -33.77 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.5 0 C-N-CA 129.478 3.111 . . . . 1.0 110.543 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.06 4.84 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.7 2.0 . . . . 1.0 114.118 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -136.54 18.57 3.11 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.803 1.641 . . . . 1.0 109.75 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.76 84.62 2.03 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.262 0.937 . . . . 1.0 110.176 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.37 114.07 19.04 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.067 -1.827 . . . . 1.0 106.067 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.9 t -146.73 -171.08 3.67 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 121.571 -0.706 . . . . 1.0 110.012 -175.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.67 -131.59 2.04 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 107.021 -2.431 . . . . 1.0 107.021 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -113.58 -23.23 9.88 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.688 0.795 . . . . 1.0 111.639 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -103.59 -12.34 17.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.124 0.57 . . . . 1.0 109.695 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -88.09 40.02 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.153 0.888 . . . . 1.0 110.448 175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -65.8 -26.57 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 O-C-N 120.955 -1.091 . . . . 1.0 108.449 175.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.469 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . . . -143.68 -65.48 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.667 1.587 . . . . 1.0 111.767 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 158' ' ' ALA . 96.2 Cg_endo -82.9 110.68 1.86 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.744 2.296 . . . . 1.0 112.807 -176.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.23 -18.76 39.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.303 1.441 . . . . 1.0 113.609 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 ttm-85 -57.42 -26.29 60.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.594 1.557 . . . . 1.0 112.154 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -126.22 141.16 52.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.085 -2.191 . . . . 1.0 105.085 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.5 m -132.15 -16.45 2.81 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.696 -0.628 . . . . 1.0 110.634 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -173.8 176.23 0.82 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 131.434 3.894 . . . . 1.0 102.805 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.45 70.31 6.31 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.802 2.335 . . . . 1.0 111.756 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 119.18 78.18 0.57 Allowed Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.34 -2.304 . . . . 1.0 107.34 -176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.13 -62.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.028 2.485 . . . . 1.0 112.155 -175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.2 t 53.53 51.67 14.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.793 2.037 . . . . 1.0 114.027 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' CD2' HG11 ' A' ' 33' ' ' VAL . 33.6 t80 -124.22 18.18 9.1 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.203 0.91 . . . . 1.0 113.232 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . 0.386 19.9 t0 41.01 76.46 0.07 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.245 1.818 . . . . 1.0 113.748 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -51.29 -34.29 32.42 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.708 0.632 . . . . 1.0 112.708 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.43 91.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 117.56 -1.21 . . . . 1.0 111.634 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.7 mtp85 -66.57 -53.17 37.5 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.294 1.406 . . . . 1.0 109.221 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -58.85 -51.24 70.84 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.369 0.507 . . . . 1.0 112.369 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -66.11 -23.49 66.51 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.84 0.745 . . . . 1.0 110.321 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.77 -51.9 50.44 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.298 -1.501 . . . . 1.0 109.754 174.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.79 -57.82 8.75 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.144 1.377 . . . . 1.0 111.339 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.86 166.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.4 m -49.81 122.36 13.68 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -83.5 53.24 4.12 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.44 2.76 . . . . 1.0 110.038 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.1 t 51.14 37.7 18.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.065 1.746 . . . . 1.0 111.204 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.7 t -154.4 23.22 0.48 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.423 1.089 . . . . 1.0 112.425 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -158.7 90.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.15 1.341 . . . . 1.0 113.753 -175.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -155.76 131.96 10.1 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.48 -1.674 . . . . 1.0 106.48 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.44 177.99 3.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.315 1.046 . . . . 1.0 110.915 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.401 ' CE ' ' H ' ' A' ' 187' ' ' THR . 7.9 tpt -69.65 171.57 8.8 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.509 -0.923 . . . . 1.0 108.509 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.401 ' H ' ' CE ' ' A' ' 186' ' ' MET . 2.7 m . . . . . 0 C--O 1.251 1.156 0 C-N-CA 126.715 2.006 . . . . 1.0 106.177 -175.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 tpt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.06 123.45 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 103.281 -2.859 . . . . 1.0 103.281 168.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.3 mt -129.89 135.93 48.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 102.32 -3.215 . . . . 1.0 102.32 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.87 135.39 49.96 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 118.962 -0.542 . . . . 1.0 109.734 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 50.0 33.91 7.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.159 1.384 . . . . 1.0 110.918 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.39 1.43 21.64 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.429 1.49 . . . . 1.0 113.77 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -100.97 174.29 6.09 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 104.76 -2.311 . . . . 1.0 104.76 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 8' ' ' LEU . 1.7 tm? -70.69 127.44 32.68 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.0 158.22 33.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 114.657 1.354 . . . . 1.0 114.657 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 38.56 57.98 1.7 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.587 2.755 . . . . 1.0 109.759 -175.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.24 51.82 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.703 -1.135 . . . . 1.0 108.593 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.551 HH11 ' HB2' ' A' ' 12' ' ' ARG . 8.5 ttm105 -79.11 123.14 27.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.329 -2.471 . . . . 1.0 104.329 175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.9 122.5 29.27 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.4 t -143.01 79.54 14.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.994 -1.854 . . . . 1.0 105.994 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 132.95 30.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 121.927 1.751 . . . . 1.0 111.217 -176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.2 t -69.34 145.41 95.73 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 124.765 1.226 . . . . 1.0 109.587 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.54 -23.41 7.19 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 117.025 1.894 . . . . 1.0 117.025 -175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -150.16 121.46 7.85 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.049 -1.093 . . . . 1.0 108.049 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.511 ' CE2' HG13 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -96.57 178.98 5.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 178.45 4.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 123.11 1.433 . . . . 1.0 111.612 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.1 m -154.69 118.5 4.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 131.603 3.961 . . . . 1.0 101.594 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -130.69 155.21 81.62 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 125.853 1.661 . . . . 1.0 108.121 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -88.01 56.41 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.268 2.645 . . . . 1.0 109.794 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -140.25 143.64 36.06 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.41 103.92 3.73 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 104.922 -2.251 . . . . 1.0 104.922 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.56 171.22 14.09 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 105.877 -1.897 . . . . 1.0 105.877 -175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -71.37 123.3 89.16 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 119.53 1.059 . . . . 1.0 108.915 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.12 103.61 1.46 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 CA-C-N 120.687 1.281 . . . . 1.0 109.519 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.0 t -175.76 78.46 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.165 1.786 . . . . 1.0 107.337 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.415 HD12 HD22 ' A' ' 150' ' ' ASN . 4.9 tp -143.69 140.79 30.22 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.143 1.777 . . . . 1.0 106.722 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.7 tp -106.11 126.59 52.39 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.665 1.121 . . . . 1.0 108.376 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.37 130.15 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 105.408 -2.071 . . . . 1.0 105.408 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.443 HG13 HD13 ' A' ' 117' ' ' LEU . 59.4 t -134.6 112.98 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.337 -0.986 . . . . 1.0 108.337 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -158.52 149.71 20.71 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 176.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 119' ' ' GLY . 2.6 t-20 -81.54 111.26 17.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.644 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.3 mm -127.18 176.79 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.763 2.025 . . . . 1.0 107.451 174.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.7 t -161.84 122.31 2.61 Favored 'General case' 0 C--N 1.313 -0.986 1 N-CA-C 93.93 -6.322 . . . . 1.0 93.93 174.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . 0.273 1.2 tm? -142.66 -56.97 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.205 0 O-C-N 121.035 -1.04 . . . . 1.0 109.688 175.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -71.53 149.29 55.53 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.133 1.889 . . . . 1.0 112.631 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -82.41 39.66 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.56 3.506 . . . . 1.0 114.265 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -53.0 -71.61 0.66 Allowed Glycine 0 C--N 1.35 1.31 0 CA-C-O 117.461 -1.744 . . . . 1.0 110.581 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -156.6 122.87 4.98 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.707 1.754 . . . . 1.0 111.996 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -177.8 160.92 1.56 Allowed 'General case' 0 N--CA 1.47 0.525 1 C-N-CA 132.493 4.317 . . . . 1.0 108.183 175.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.94 6.13 59.97 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.137 0.875 . . . . 1.0 111.846 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.89 118.65 4.73 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.0 1.4 . . . . 1.0 109.651 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.79 -21.44 44.62 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.364 2.043 . . . . 1.0 114.083 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -52.06 -43.09 63.64 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.099 0.863 . . . . 1.0 112.08 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 11.0 mm -65.75 -44.3 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.449 1.1 . . . . 1.0 109.665 -175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -66.51 -45.64 78.88 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.05 0.841 . . . . 1.0 110.363 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 53' ' ' THR . . . -54.23 -33.56 58.67 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.476 1.511 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 68' ' ' ALA . 0.8 OUTLIER -55.06 -61.28 2.42 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.633 1.573 . . . . 1.0 108.985 175.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.99 -37.54 75.75 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.13 0.972 . . . . 1.0 113.279 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 50' ' ' ALA . 2.5 t -65.82 -33.84 76.79 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.218 -1.03 . . . . 1.0 108.218 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.92 -5.43 53.5 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 125.211 1.386 . . . . 1.0 115.505 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -89.42 8.9 28.48 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.295 2.048 . . . . 1.0 112.515 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 tt -51.94 134.42 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 125.961 1.705 . . . . 1.0 111.176 175.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -98.72 134.18 21.85 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 127.585 2.354 . . . . 1.0 110.225 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 77.52 1.82 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.641 2.894 . . . . 1.0 107.422 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.32 -63.26 1.19 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.364 0.666 . . . . 1.0 110.639 -174.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.91 -46.0 78.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.755 0.822 . . . . 1.0 110.69 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 19.5 p80 -171.0 178.0 0.87 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.737 2.015 . . . . 1.0 107.167 175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 61' ' ' HIS . 26.1 Cg_endo -73.05 -43.48 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.049 1.832 . . . . 1.0 114.684 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -46.38 -47.61 18.74 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.29 1.219 . . . . 1.0 114.29 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' HB2' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -55.4 -58.13 8.99 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.451 1.1 . . . . 1.0 110.066 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.42 92.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.899 0.88 . . . . 1.0 111.37 176.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -49.59 -65.78 2.62 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.645 1.593 . . . . 1.0 111.553 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.15 -38.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 CA-C-O 117.477 -1.249 . . . . 1.0 111.476 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB2' HD22 ' A' ' 51' ' ' LEU . . . -45.18 -43.41 10.05 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.359 1.864 . . . . 1.0 114.951 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -57.36 -33.55 67.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.71 -0.619 . . . . 1.0 110.323 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.9 mp -86.51 134.23 33.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 102.2 -3.259 . . . . 1.0 102.2 174.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.78 152.14 19.74 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.949 0.795 . . . . 1.0 110.967 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.43 161.43 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.772 1.629 . . . . 1.0 110.74 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB3' HG21 ' A' ' 88' ' ' VAL . 4.0 m -172.88 123.12 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.584 1.554 . . . . 1.0 108.242 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.51 -154.05 0.43 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 94' ' ' ALA . 28.1 m80 -128.89 -65.18 0.88 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.487 1.115 . . . . 1.0 110.133 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.462 ' HB2' HD13 ' A' ' 115' ' ' ILE . 18.8 m -133.99 118.69 18.12 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 120.678 -1.264 . . . . 1.0 107.689 176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -103.47 113.97 27.89 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 105.809 -1.923 . . . . 1.0 105.809 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.9 mt -95.56 114.59 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.686 -1.227 . . . . 1.0 107.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -66.36 148.62 51.59 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.72 1.145 . . . . 1.0 108.532 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -13.62 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.721 1.608 . . . . 1.0 112.306 175.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -91.21 18.96 6.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 131.478 3.911 . . . . 1.0 112.304 -176.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.5 46.97 93.37 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.229 1.395 . . . . 1.0 113.168 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -123.97 110.25 14.56 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.706 1.253 . . . . 1.0 110.156 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' A' ' 132' ' ' GLN . 52.0 mt -81.48 117.45 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 106.729 -1.582 . . . . 1.0 106.729 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 t -111.45 147.9 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.216 -1.772 . . . . 1.0 106.216 175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -125.75 124.26 40.64 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.14 0.976 . . . . 1.0 110.141 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -121.0 117.86 28.36 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 129.463 3.105 . . . . 1.0 103.755 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 19' ' ' TYR . 39.5 t 72.06 91.78 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 122.656 2.48 . . . . 1.0 113.205 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.91 -166.61 0.23 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.331 2.021 . . . . 1.0 111.079 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -70.85 46.07 0.09 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.856 2.862 . . . . 1.0 113.703 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.01 127.16 4.5 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 127.215 2.206 . . . . 1.0 106.508 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.0 tptm 77.35 81.48 0.08 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.543 1.137 . . . . 1.0 111.377 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -39.53 154.9 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.462 2.305 . . . . 1.0 113.232 -175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 75' ' ' HIS . . . -108.31 -178.29 3.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.566 2.346 . . . . 1.0 113.008 -175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -153.12 118.73 5.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.905 1.682 . . . . 1.0 108.956 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -166.32 64.02 0.1 Allowed 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 122.595 1.188 . . . . 1.0 111.167 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.15 -54.36 0.09 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 118.103 -2.873 . . . . 1.0 112.602 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.37 -74.73 0.25 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 117.347 -1.807 . . . . 1.0 109.137 -175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.55 142.2 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.935 1.694 . . . . 1.0 110.018 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -166.33 163.66 17.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.984 2.514 . . . . 1.0 110.643 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.7 p -163.14 146.23 10.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.525 -2.028 . . . . 1.0 105.525 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -159.65 157.48 29.74 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.738 1.154 . . . . 1.0 108.94 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 39.9 53.28 2.63 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.623 1.569 . . . . 1.0 109.994 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 53.57 30.3 42.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 116.262 1.265 . . . . 1.0 116.262 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -129.0 121.98 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 120.019 1.909 . . . . 1.0 106.861 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.45 141.06 38.55 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -119.51 118.2 30.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t -60.5 -42.87 97.26 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 113.3 0.852 . . . . 1.0 113.3 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.95 176.52 8.74 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.277 1.831 . . . . 1.0 108.968 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -83.15 76.46 9.86 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.899 -1.519 . . . . 1.0 106.899 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.91 38.41 1.23 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.986 1.315 . . . . 1.0 111.758 -175.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -134.14 149.94 51.09 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 124.094 0.958 . . . . 1.0 113.013 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . 0.267 0.1 OUTLIER -82.52 56.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.845 2.058 . . . . 1.0 109.645 177.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.51 -136.86 2.15 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 122.393 0.996 . . . . 1.0 113.359 -176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.504 HD11 HG11 ' A' ' 136' ' ' VAL . 14.7 mm -140.86 160.74 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 103.532 -2.766 . . . . 1.0 103.532 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -138.46 126.04 22.05 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 103.324 -2.843 . . . . 1.0 103.324 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.443 HD13 HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -101.51 139.56 37.0 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.993 -1.067 . . . . 1.0 109.459 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 5.4 tm-20 -104.53 154.09 20.34 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.471 0.653 . . . . 1.0 110.539 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.451 ' C ' HD21 ' A' ' 35' ' ' ASN . . . -174.42 -179.74 45.22 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 126.405 1.955 . . . . 1.0 110.213 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.2 p -141.87 106.41 4.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.074 -1.824 . . . . 1.0 106.074 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.266 43.7 t0 38.95 56.63 1.98 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.107 2.563 . . . . 1.0 113.986 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.3 p 56.16 38.2 29.61 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.564 1.32 . . . . 1.0 114.564 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -69.17 146.0 52.81 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 105.389 -2.078 . . . . 1.0 105.389 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -37.26 113.55 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.133 1.373 . . . . 1.0 111.062 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.94 -6.62 56.69 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 115.521 1.674 . . . . 1.0 115.521 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.395 10.9 p 66.7 76.96 0.29 Allowed 'General case' 0 C--N 1.352 0.704 0 CA-C-N 120.872 1.669 . . . . 1.0 112.797 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -25.54 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 115.734 1.753 . . . . 1.0 115.734 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -43.93 -44.75 7.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.669 1.588 . . . . 1.0 109.719 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -48.47 -48.79 37.48 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.037 1.335 . . . . 1.0 110.64 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.65 -40.52 92.34 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.13 0.877 . . . . 1.0 110.266 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -65.95 -50.12 65.48 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.38 0.536 . . . . 1.0 110.208 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HB3' HD11 ' A' ' 84' ' ' ILE . 90.8 mt-30 -62.15 -52.66 62.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.689 1.596 . . . . 1.0 110.274 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.2 tp -54.23 -47.99 71.59 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.835 1.654 . . . . 1.0 109.656 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.9 98.05 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.304 0.956 . . . . 1.0 110.54 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.83 -54.15 49.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 115' ' ' ILE . 97.1 t -59.47 -43.29 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.868 0.867 . . . . 1.0 110.766 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 92.8 m -57.57 -54.0 51.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 1.0 109.492 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -65.69 -33.75 76.61 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.463 0.542 . . . . 1.0 112.463 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.2 -59.25 5.77 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . 0.341 2.9 mm? -56.71 -33.83 66.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.738 -1.125 . . . . 1.0 113.555 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 37.4 mt -60.68 -39.68 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.597 1.544 . . . . 1.0 107.908 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.2 m -60.18 -24.63 64.93 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.726 0.811 . . . . 1.0 110.866 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -84.3 -64.85 1.09 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 106.367 -1.716 . . . . 1.0 106.367 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -126.92 113.38 22.07 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.219 1.008 . . . . 1.0 109.976 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -90.63 107.36 0.33 Allowed 'Trans proline' 0 N--CA 1.44 -1.658 0 CA-C-N 120.287 1.138 . . . . 1.0 110.838 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -152.3 -47.23 0.1 Allowed 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 128.212 2.605 . . . . 1.0 105.855 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 17.5 mt -48.54 -34.09 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 129.555 3.142 . . . . 1.0 110.644 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.19 -14.91 7.98 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.803 0.841 . . . . 1.0 113.076 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -137.27 18.33 2.95 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.5 2.32 . . . . 1.0 109.926 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.415 HD22 HD12 ' A' ' 30' ' ' LEU . 5.5 m120 -141.99 83.67 1.85 Allowed 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.409 1.004 . . . . 1.0 110.148 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.24 114.83 18.16 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 102.878 -3.008 . . . . 1.0 102.878 175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.6 t -153.38 -166.98 2.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.315 0.579 . . . . 1.0 111.688 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.26 -131.93 1.59 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 115.473 -0.785 . . . . 1.0 112.378 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' CE1' ' A' ' 34' ' ' HIS . 13.9 m170 -112.83 -23.26 10.23 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.899 0.88 . . . . 1.0 109.223 -176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' CYS . . . . . . . . . . . . . 5.6 t -108.39 -21.98 12.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.104 1.361 . . . . 1.0 108.991 175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -83.85 34.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.883 -1.136 . . . . 1.0 109.074 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -22.53 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 N-CA-C 108.462 -0.94 . . . . 1.0 108.462 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.434 ' H ' ' HD2' ' A' ' 159' ' ' PRO . . . -149.19 -55.92 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.952 2.501 . . . . 1.0 110.926 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 158' ' ' ALA . 83.8 Cg_endo -81.78 112.01 2.33 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.27 1.98 . . . . 1.0 112.907 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.42 -26.19 64.96 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.847 -1.158 . . . . 1.0 111.705 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.74 -21.94 66.19 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.857 1.263 . . . . 1.0 112.091 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -137.81 124.7 21.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.4 m -113.75 -15.75 12.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.395 0.543 . . . . 1.0 110.937 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.86 178.08 0.5 Allowed Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 129.645 3.178 . . . . 1.0 105.314 -178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -78.99 50.02 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.45 2.1 . . . . 1.0 111.185 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.55 65.82 0.02 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.36 1.933 . . . . 1.0 110.804 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.88 -88.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.222 2.615 . . . . 1.0 111.51 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 30.1 t 53.61 50.66 16.7 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.603 1.161 . . . . 1.0 111.036 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.439 ' CD2' HG11 ' A' ' 33' ' ' VAL . 27.7 t80 -105.33 17.73 23.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.967 1.258 . . . . 1.0 113.175 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.1 t0 43.74 62.56 1.87 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.702 -1.873 . . . . 1.0 110.905 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -52.15 -33.43 40.3 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 118.748 -0.644 . . . . 1.0 111.279 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.98 -60.45 3.81 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.622 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -60.45 -42.3 95.86 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 117.574 -1.203 . . . . 1.0 111.411 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -60.94 -62.0 2.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.107 0.867 . . . . 1.0 111.128 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -61.14 -32.4 72.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.702 -0.666 . . . . 1.0 110.858 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.76 76.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.021 0.828 . . . . 1.0 112.233 175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 33.1 mt -70.75 -57.23 4.88 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.889 -1.132 . . . . 1.0 108.367 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -62.67 164.6 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.084 1.754 . . . . 1.0 110.76 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 m -55.65 121.07 36.71 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.405 1.482 . . . . 1.0 109.019 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.37 43.24 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.774 2.983 . . . . 1.0 109.511 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.0 t 46.34 53.2 9.86 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.795 2.438 . . . . 1.0 108.931 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -158.17 -45.47 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.729 1.611 . . . . 1.0 109.418 -176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -73.73 34.26 0.08 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.904 2.082 . . . . 1.0 111.001 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -67.02 161.82 23.51 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.564 -1.272 . . . . 1.0 107.564 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.69 -172.87 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.17 1.788 . . . . 1.0 114.085 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -115.53 -4.55 12.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.567 1.547 . . . . 1.0 112.895 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.4 m . . . . . 0 C--O 1.247 0.957 0 O-C-N 119.497 -2.002 . . . . 1.0 106.913 175.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_